Psyllid ID: psy7592
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 246 | 2.2.26 [Sep-21-2011] | |||||||
| Q9JJX8 | 414 | Serine/threonine-protein | yes | N/A | 0.922 | 0.548 | 0.600 | 1e-79 | |
| Q9NY57 | 414 | Serine/threonine-protein | yes | N/A | 0.922 | 0.548 | 0.592 | 2e-78 | |
| Q8QZV4 | 488 | Serine/threonine-protein | no | N/A | 0.922 | 0.465 | 0.575 | 3e-78 | |
| Q86UX6 | 486 | Serine/threonine-protein | no | N/A | 0.922 | 0.467 | 0.575 | 4e-78 | |
| Q8BGW6 | 398 | Serine/threonine-protein | no | N/A | 0.914 | 0.565 | 0.557 | 3e-75 | |
| Q8WU08 | 396 | Serine/threonine-protein | no | N/A | 0.914 | 0.568 | 0.566 | 1e-74 | |
| Q8MYF1 | 456 | Probable serine/threonine | yes | N/A | 0.894 | 0.482 | 0.369 | 6e-37 | |
| P54644 | 444 | RAC family serine/threoni | no | N/A | 0.890 | 0.493 | 0.365 | 2e-35 | |
| Q39030 | 471 | Serine/threonine-protein | yes | N/A | 0.756 | 0.394 | 0.397 | 2e-35 | |
| P34102 | 910 | Protein kinase 3 OS=Dicty | no | N/A | 0.886 | 0.239 | 0.371 | 3e-35 |
| >sp|Q9JJX8|ST32B_MOUSE Serine/threonine-protein kinase 32B OS=Mus musculus GN=Stk32b PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 295 bits (756), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 140/233 (60%), Positives = 176/233 (75%), Gaps = 6/233 (2%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
KVCIVQK+DTK+MYAMKYM+K +C+ERD ++NV RE++I+ LEHPFLVNLW+ FQDEE
Sbjct: 35 GKVCIVQKRDTKKMYAMKYMNKQKCVERDEVRNVFRELQIMQGLEHPFLVNLWYSFQDEE 94
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
D+FMV DLLLGGDLRYH+ Q++ F T+ LY EL LAL+YL+ HIIHRDIKP
Sbjct: 95 DMFMVVDLLLGGDLRYHLQQNVHFTE-----GTVKLYICELALALEYLQRYHIIHRDIKP 149
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
DNILLDE GH HITDFNIATVL+ ++ A+SM+GTKPY+APE+F V D GYSY VDWW
Sbjct: 150 DNILLDEHGHVHITDFNIATVLKGSEKASSMAGTKPYMAPEVFQVYVDGGPGYSYPVDWW 209
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDVKAII-YSPVHYPTAWSESTKHLLSQV 243
SLGVT +E+L RP++IHS T + ++ + VHY + W E LL ++
Sbjct: 210 SLGVTAYELLRGWRPYEIHSATPIDEILNMFKVERVHYSSTWCEGMVSLLKKL 262
|
Mus musculus (taxid: 10090) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9NY57|ST32B_HUMAN Serine/threonine-protein kinase 32B OS=Homo sapiens GN=STK32B PE=2 SV=1 | Back alignment and function description |
|---|
Score = 292 bits (747), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 138/233 (59%), Positives = 175/233 (75%), Gaps = 6/233 (2%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
KVCIVQK+DTK+MYAMKYM+K +CIERD ++NV RE++I+ LEHPFLVNLW+ FQDEE
Sbjct: 35 GKVCIVQKRDTKKMYAMKYMNKQKCIERDEVRNVFRELQIMQGLEHPFLVNLWYSFQDEE 94
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
D+FMV DLLLGGDLRYH+ Q++ F T+ LY EL LAL+YL+ HIIHRDIKP
Sbjct: 95 DMFMVVDLLLGGDLRYHLQQNVHFTE-----GTVKLYICELALALEYLQRYHIIHRDIKP 149
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
DNILLDE GH HITDFNIATV++ + A+SM+GTKPY+APE+F V D GYSY VDWW
Sbjct: 150 DNILLDEHGHVHITDFNIATVVKGAERASSMAGTKPYMAPEVFQVYMDRGPGYSYPVDWW 209
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDVKAII-YSPVHYPTAWSESTKHLLSQV 243
SLG+T +E+L RP++IHS T + ++ + VHY + W + LL ++
Sbjct: 210 SLGITAYELLRGWRPYEIHSVTPIDEILNMFKVERVHYSSTWCKGMVALLRKL 262
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8QZV4|ST32C_MOUSE Serine/threonine-protein kinase 32C OS=Mus musculus GN=Stk32c PE=2 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (745), Expect = 3e-78, Method: Compositional matrix adjust.
Identities = 134/233 (57%), Positives = 180/233 (77%), Gaps = 6/233 (2%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
KVCIVQK+DT++MYAMKYM+K QCIERD ++NV RE+EIL +EH FLVNLW+ FQDEE
Sbjct: 106 GKVCIVQKRDTEKMYAMKYMNKQQCIERDEVRNVFRELEILQEIEHVFLVNLWYSFQDEE 165
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
D+FMV DLLLGGDLRYH+ Q+++F DT+ LY E+ LALDYL+++HIIHRD+KP
Sbjct: 166 DMFMVVDLLLGGDLRYHLQQNVQF-----SEDTVRLYICEMALALDYLRSQHIIHRDVKP 220
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
DNILLDE+GHAH+TDFNIAT++++ + AT+++GTKPY+APEIF + GYS+ VDWW
Sbjct: 221 DNILLDEQGHAHLTDFNIATIIKDGERATALAGTKPYMAPEIFHSFVNGGTGYSFEVDWW 280
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHLLSQV 243
S+GV +E+L RP+DIHS+ +V+ + + + V Y WS+ LL ++
Sbjct: 281 SVGVMAYELLRGWRPYDIHSSNAVESLVQLFSTVSVQYVPTWSKEMVALLRKL 333
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q86UX6|ST32C_HUMAN Serine/threonine-protein kinase 32C OS=Homo sapiens GN=STK32C PE=1 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (744), Expect = 4e-78, Method: Compositional matrix adjust.
Identities = 134/233 (57%), Positives = 178/233 (76%), Gaps = 6/233 (2%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
KVCIVQK+DT++MYAMKYM+K QCIERD ++NV RE+EIL +EH FLVNLW+ FQDEE
Sbjct: 105 GKVCIVQKRDTEKMYAMKYMNKQQCIERDEVRNVFRELEILQEIEHVFLVNLWYSFQDEE 164
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
D+FMV DLLLGGDLRYH+ Q+++F DT+ LY E+ LALDYL+ +HIIHRD+KP
Sbjct: 165 DMFMVVDLLLGGDLRYHLQQNVQFS-----EDTVRLYICEMALALDYLRGQHIIHRDVKP 219
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
DNILLDE GHAH+TDFNIAT++++ + AT+++GTKPY+APEIF + GYS+ VDWW
Sbjct: 220 DNILLDERGHAHLTDFNIATIIKDGERATALAGTKPYMAPEIFHSFVNGGTGYSFEVDWW 279
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHLLSQV 243
S+GV +E+L RP+DIHS+ +V+ + + + V Y WS+ LL ++
Sbjct: 280 SVGVMAYELLRGWRPYDIHSSNAVESLVQLFSTVSVQYVPTWSKEMVALLRKL 332
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8BGW6|ST32A_MOUSE Serine/threonine-protein kinase 32A OS=Mus musculus GN=Stk32a PE=2 SV=1 | Back alignment and function description |
|---|
Score = 281 bits (719), Expect = 3e-75, Method: Compositional matrix adjust.
Identities = 130/233 (55%), Positives = 178/233 (76%), Gaps = 8/233 (3%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
KVCIV+K DTK+MYAMKYM+K +C+ER+ ++NV +E++I+ LEHPFLVNLW+ FQDEE
Sbjct: 35 GKVCIVRKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 94
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
D+FMV DLLLGGDLRYH+ Q++ F + DT+ L+ EL +ALDYL+++ IIHRD+KP
Sbjct: 95 DMFMVVDLLLGGDLRYHLQQNVHF-----QEDTVKLFICELAMALDYLQSQRIIHRDMKP 149
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
DNILLDE GH HITDFNIA +L + T+++GTKPY+APE+F + + GYS++VDWW
Sbjct: 150 DNILLDEHGHVHITDFNIAAMLPKETRITTVAGTKPYMAPEMF--TSRKETGYSFAVDWW 207
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSP-VHYPTAWSESTKHLLSQV 243
SLGVT +E+L RP+ I S+TS K++ + + V YP+AWS+ LL ++
Sbjct: 208 SLGVTAYELLRGRRPYHIRSSTSSKEIVNMFETAIVTYPSAWSQEMVSLLKKL 260
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8WU08|ST32A_HUMAN Serine/threonine-protein kinase 32A OS=Homo sapiens GN=STK32A PE=1 SV=2 | Back alignment and function description |
|---|
Score = 279 bits (714), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 132/233 (56%), Positives = 176/233 (75%), Gaps = 8/233 (3%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
KVCIVQK DTK+MYAMKYM+K +C+ER+ ++NV +E++I+ LEHPFLVNLW+ FQDEE
Sbjct: 35 GKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 94
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
D+FMV DLLLGGDLRYH+ Q++ F + +T+ L+ EL +ALDYL+ + IIHRD+KP
Sbjct: 95 DMFMVVDLLLGGDLRYHLQQNVHF-----KEETVKLFICELVMALDYLQNQRIIHRDMKP 149
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
DNILLDE GH HITDFNIA +L T+M+GTKPY+APE+F ++ + GYS++VDWW
Sbjct: 150 DNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF--SSRKGAGYSFAVDWW 207
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKD-VKAIIYSPVHYPTAWSESTKHLLSQV 243
SLGVT +E+L RP+ I S+TS K+ V + V YP+AWS+ LL ++
Sbjct: 208 SLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKL 260
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8MYF1|Y2070_DICDI Probable serine/threonine-protein kinase DDB_G0277449 OS=Dictyostelium discoideum GN=DDB_G0277449 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 154 bits (389), Expect = 6e-37, Method: Compositional matrix adjust.
Identities = 86/233 (36%), Positives = 138/233 (59%), Gaps = 13/233 (5%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
G KV V DT+++YA+K + K+ I + ++ N L E +IL + HPF+VNL + FQ+
Sbjct: 138 GFGKVFQVVHVDTQKVYALKVIKKNHIIAKKSVVNTLAEKDILKKISHPFIVNLHYAFQN 197
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
E+ L++V D + GG L YH+ ++ F D + Y EL LAL++L +I+HRD+
Sbjct: 198 EKKLYLVMDFVNGGQLFYHLQKEAIF-----SEDQVRFYMAELILALEHLHDSNIVHRDL 252
Query: 130 KPDNILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
KP+NILLD +GH +TDF +A + ++ N S +GT Y+APE+ AT +V
Sbjct: 253 KPENILLDSQGHCILTDFGLAKLEVKTNNETFSFAGTLEYMAPEMIQHAT-----CGKAV 307
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241
DWWS+G+ +++++ PF+ H N ++ K II +P S S + L++
Sbjct: 308 DWWSIGILMYDMMIGKPPFE-HKNRALMQEK-IISEKAKFPKFVSSSARSLIN 358
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P54644|KRAC_DICDI RAC family serine/threonine-protein kinase homolog OS=Dictyostelium discoideum GN=pkbA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 149 bits (376), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 86/235 (36%), Positives = 131/235 (55%), Gaps = 16/235 (6%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
KV V+KKDT ++YAMK + K +E + +++ L E IL + HPFLVNL + FQ E+
Sbjct: 132 GKVIQVRKKDTGEVYAMKVLSKKHIVEHNEVEHTLSERNILQKINHPFLVNLNYSFQTED 191
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L+ + D + GG+L YH+ +D KF D + Y E+ LAL++L +I+RD+KP
Sbjct: 192 KLYFILDYVNGGELFYHLQKDKKF-----TEDRVRYYGAEIVLALEHLHLSGVIYRDLKP 246
Query: 132 DNILLDEEGHAHITDFNIAT--VLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
+N+LL EGH +TDF + +L + GT Y+APE+ + GY VD
Sbjct: 247 ENLLLTNEGHICMTDFGLCKEGLLTPTDKTGTFCGTPEYLAPEVL-----QGNGYGKQVD 301
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKDV-KAIIYSPVHYPTAWSESTKHLLSQV 243
WWS G L+E+L PF N V+++ + I+ + +P S + LL Q+
Sbjct: 302 WWSFGSLLYEMLTGLPPF---YNQDVQEMYRKIMMEKLSFPHFISPDARSLLEQL 353
|
Predominantly involved during the aggregation to control cell polarity and chemotaxis. Phosphorylates talB, gefN, gefS, PI4P 5-kinase and gacQ. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39030|KPK2_ARATH Serine/threonine-protein kinase AtPK2/AtPK19 OS=Arabidopsis thaliana GN=ATPK2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 149 bits (376), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 78/196 (39%), Positives = 117/196 (59%), Gaps = 10/196 (5%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
KV V+KKDT ++YAMK M K + +E++ + + E +ILT ++HPF+V L + FQ +
Sbjct: 152 GKVYQVRKKDTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKY 211
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L++V D + GG L + + F R D +Y E+ A+ +L K I+HRD+KP
Sbjct: 212 RLYLVLDFINGGHLFFQLYHQGLF-----REDLARVYTAEIVSAVSHLHEKGIMHRDLKP 266
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
+NIL+D +GH +TDF +A EEN + SM GT Y+APEI G+ + DWW
Sbjct: 267 ENILMDVDGHVMLTDFGLAKEFEENTRSNSMCGTTEYMAPEIVRGK-----GHDKAADWW 321
Query: 192 SLGVTLFEILARGRPF 207
S+G+ L+E+L PF
Sbjct: 322 SVGILLYEMLTGKPPF 337
|
Downstream effector of TOR signaling pathway. May be involved in adaptation of plant to cold or high-salt conditions. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P34102|PK3_DICDI Protein kinase 3 OS=Dictyostelium discoideum GN=pkgC PE=3 SV=2 | Back alignment and function description |
|---|
Score = 148 bits (374), Expect = 3e-35, Method: Compositional matrix adjust.
Identities = 90/242 (37%), Positives = 140/242 (57%), Gaps = 24/242 (9%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V +V++KDT + YAMK ++K +++ + + E +L+T++HPF+V L F FQ+E+
Sbjct: 511 RVYLVRRKDTGKFYAMKVLNKKDMLKKKQIAHTNTEKMVLSTMDHPFIVRLHFAFQNEDF 570
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
LFM D + GG+L +H+ + KF + Y E+ +L YL + +II+RDIKP+
Sbjct: 571 LFMCMDYVPGGELFHHLQKAGKFPE-----ELAKFYIAEVICSLHYLHSNNIIYRDIKPE 625
Query: 133 NILLDEEGHAHITDF-----NIATVL-----EENQLATSMSGTKPYIAPEIFLVATDEVL 182
NILLDEEGH +TDF I +V+ E AT+ GT Y+APEI A
Sbjct: 626 NILLDEEGHIKLTDFGLSKSGITSVVGSKNGGEGGFATTFCGTPEYLAPEIITGA----- 680
Query: 183 GYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDV-KAIIYSPVHYPTAWSESTKHLLS 241
G+ + DWWS+G+ LFE+L PF + SN + D+ K++I + P S + LL
Sbjct: 681 GHGKAADWWSVGILLFEMLTGRSPF-LASNRN--DMYKSMIQGNLRMPMFLSSDAQDLLE 737
Query: 242 QV 243
++
Sbjct: 738 KL 739
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 246 | ||||||
| 189240904 | 478 | PREDICTED: similar to serine/threonine k | 0.922 | 0.474 | 0.693 | 7e-90 | |
| 270013473 | 584 | hypothetical protein TcasGA2_TC012072 [T | 0.930 | 0.392 | 0.683 | 3e-89 | |
| 115869839 | 411 | PREDICTED: serine/threonine-protein kina | 0.918 | 0.549 | 0.642 | 4e-84 | |
| 242017892 | 297 | RAC protein kinase DRAC-PK85, putative [ | 0.857 | 0.710 | 0.657 | 3e-81 | |
| 443704393 | 345 | hypothetical protein CAPTEDRAFT_92464 [C | 0.922 | 0.657 | 0.609 | 5e-81 | |
| 260817908 | 410 | hypothetical protein BRAFLDRAFT_101330 [ | 0.922 | 0.553 | 0.618 | 1e-80 | |
| 119917965 | 962 | PREDICTED: uncharacterized protein LOC52 | 0.918 | 0.234 | 0.586 | 1e-80 | |
| 221377805 | 449 | CG32944, isoform E [Drosophila melanogas | 0.922 | 0.505 | 0.594 | 1e-78 | |
| 380026707 | 461 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.922 | 0.492 | 0.621 | 1e-78 | |
| 328792362 | 461 | PREDICTED: serine/threonine-protein kina | 0.922 | 0.492 | 0.621 | 2e-78 |
| >gi|189240904|ref|XP_966572.2| PREDICTED: similar to serine/threonine kinase 32B [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 335 bits (860), Expect = 7e-90, Method: Compositional matrix adjust.
Identities = 161/232 (69%), Positives = 186/232 (80%), Gaps = 5/232 (2%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
KVCIVQKKD+KQM+AMKYM+K QC+ERDALKNVLRE+EILT LEHPFLVN+WF FQDEE
Sbjct: 35 GKVCIVQKKDSKQMFAMKYMNKHQCMERDALKNVLREVEILTRLEHPFLVNIWFSFQDEE 94
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
DLFMV+DLLLGGDLRYHI Q++ F D + L EL LALDYL+TK IIHRDIKP
Sbjct: 95 DLFMVTDLLLGGDLRYHIQQEVNFSE-----DAVKLMVCELALALDYLQTKQIIHRDIKP 149
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
DNILLDEEGH HITDFNIATVLE+ LATSMSGTKPYIAPEIF A D +GYSY VDWW
Sbjct: 150 DNILLDEEGHFHITDFNIATVLEDTHLATSMSGTKPYIAPEIFDCAVDLCVGYSYPVDWW 209
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQV 243
SLGV +E+L RPFDIHSNT +++V+ + + YP +WSE L+S++
Sbjct: 210 SLGVVAYEMLRGLRPFDIHSNTGIQEVRILFQIGLDYPPSWSEGIVDLISRL 261
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270013473|gb|EFA09921.1| hypothetical protein TcasGA2_TC012072 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 333 bits (855), Expect = 3e-89, Method: Compositional matrix adjust.
Identities = 160/234 (68%), Positives = 186/234 (79%), Gaps = 5/234 (2%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
+ VCIVQKKD+KQM+AMKYM+K QC+ERDALKNVLRE+EILT LEHPFLVN+WF FQD
Sbjct: 139 ASRTVCIVQKKDSKQMFAMKYMNKHQCMERDALKNVLREVEILTRLEHPFLVNIWFSFQD 198
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
EEDLFMV+DLLLGGDLRYHI Q++ F D + L EL LALDYL+TK IIHRDI
Sbjct: 199 EEDLFMVTDLLLGGDLRYHIQQEVNFSE-----DAVKLMVCELALALDYLQTKQIIHRDI 253
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
KPDNILLDEEGH HITDFNIATVLE+ LATSMSGTKPYIAPEIF A D +GYSY VD
Sbjct: 254 KPDNILLDEEGHFHITDFNIATVLEDTHLATSMSGTKPYIAPEIFDCAVDLCVGYSYPVD 313
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQV 243
WWSLGV +E+L RPFDIHSNT +++V+ + + YP +WSE L+S++
Sbjct: 314 WWSLGVVAYEMLRGLRPFDIHSNTGIQEVRILFQIGLDYPPSWSEGIVDLISRL 367
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|115869839|ref|XP_796535.2| PREDICTED: serine/threonine-protein kinase 32B-like [Strongylocentrotus purpuratus] | Back alignment and taxonomy information |
|---|
Score = 316 bits (810), Expect = 4e-84, Method: Compositional matrix adjust.
Identities = 149/232 (64%), Positives = 183/232 (78%), Gaps = 6/232 (2%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KVCIVQK+DTK+MYAMKYM+K+ CI +DA++NVLRE EIL LEHPFLVNLWF FQDEED
Sbjct: 36 KVCIVQKRDTKKMYAMKYMNKAMCIRKDAVRNVLREQEILQALEHPFLVNLWFTFQDEED 95
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+FMV DLLLGGDLRYHI Q +KF + + + LY E+ LALDYL+T IIHRDIKPD
Sbjct: 96 MFMVVDLLLGGDLRYHILQGVKFDA-----ERVKLYLCEITLALDYLRTHLIIHRDIKPD 150
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
NILLDE+GH HITDFNIAT+++ N TSMSGTKPY+APEIF ATD+ GYSY VDWWS
Sbjct: 151 NILLDEDGHVHITDFNIATIVKANVYGTSMSGTKPYMAPEIFQTATDDCKGYSYPVDWWS 210
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHLLSQV 243
LGV +E+L RP+DIH+N+S+ D++ + + VHYP+ W+ S L+ Q+
Sbjct: 211 LGVCAYEMLRTKRPYDIHANSSIADIQHLFSTNTVHYPSTWNPSLTDLIRQL 262
|
Source: Strongylocentrotus purpuratus Species: Strongylocentrotus purpuratus Genus: Strongylocentrotus Family: Strongylocentrotidae Order: Echinoida Class: Echinoidea Phylum: Echinodermata Superkingdom: Eukaryota |
| >gi|242017892|ref|XP_002429418.1| RAC protein kinase DRAC-PK85, putative [Pediculus humanus corporis] gi|212514344|gb|EEB16680.1| RAC protein kinase DRAC-PK85, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 307 bits (786), Expect = 3e-81, Method: Compositional matrix adjust.
Identities = 142/216 (65%), Positives = 173/216 (80%), Gaps = 5/216 (2%)
Query: 28 MKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRY 87
MKYM+K+QC+ERDAL NVL+E+EILTTLEHPFLVNLWF FQDEEDLFMVSDL GGDLRY
Sbjct: 1 MKYMNKTQCMERDALNNVLKEVEILTTLEHPFLVNLWFSFQDEEDLFMVSDLFTGGDLRY 60
Query: 88 HITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDF 147
HI Q + F + D + LY ELGLAL+YL+ K I+HRD+KPDNILLDE GHAH+TDF
Sbjct: 61 HIQQKVHF-----KEDCVRLYILELGLALEYLQRKSIVHRDVKPDNILLDENGHAHLTDF 115
Query: 148 NIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
NIAT+L+E QLATSMSGTKPY+APEIF TDE +GY+++VDWWSLGV +E+L+ RP+
Sbjct: 116 NIATILKEGQLATSMSGTKPYMAPEIFACVTDECVGYNFAVDWWSLGVCAYEMLSLSRPY 175
Query: 208 DIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQV 243
DIHS TS+ DV+ + P+ Y W+ T LLS++
Sbjct: 176 DIHSTTSIGDVRNLFNIPLVYSKTWTHETVDLLSKL 211
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|443704393|gb|ELU01456.1| hypothetical protein CAPTEDRAFT_92464 [Capitella teleta] | Back alignment and taxonomy information |
|---|
Score = 306 bits (784), Expect = 5e-81, Method: Compositional matrix adjust.
Identities = 142/233 (60%), Positives = 179/233 (76%), Gaps = 6/233 (2%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
KVCIVQKKDTK+M+AMKYM+K+ CI++DA++NV RE+E+L L+HPFLVNLWF FQD+E
Sbjct: 35 GKVCIVQKKDTKKMFAMKYMNKNMCIKKDAIRNVFREVELLQNLDHPFLVNLWFTFQDDE 94
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
D+FMV DLLLGGDLRYHI QD+KF + LY E+ LAL+YL+ I+HRDIKP
Sbjct: 95 DMFMVVDLLLGGDLRYHIQQDVKFDEA-----RVKLYICEIALALEYLQKNRIVHRDIKP 149
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
DNILLDE GH HITDFNIAT L + QLATS+SGTKPY+APE+F A D +GY+Y+VDWW
Sbjct: 150 DNILLDENGHVHITDFNIATELLDGQLATSLSGTKPYMAPEVFACALDNCVGYTYAVDWW 209
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHLLSQV 243
SLGV ++E+L RP++IHS T+ +V + S V YP +W E + LL Q+
Sbjct: 210 SLGVCIYEMLRAKRPYEIHSATTANEVTQLFASHSVSYPLSWDEDMRDLLRQL 262
|
Source: Capitella teleta Species: Capitella teleta Genus: Capitella Family: Capitellidae Order: Capitellida Class: Polychaeta Phylum: Annelida Superkingdom: Eukaryota |
| >gi|260817908|ref|XP_002603827.1| hypothetical protein BRAFLDRAFT_101330 [Branchiostoma floridae] gi|229289150|gb|EEN59838.1| hypothetical protein BRAFLDRAFT_101330 [Branchiostoma floridae] | Back alignment and taxonomy information |
|---|
Score = 305 bits (781), Expect = 1e-80, Method: Compositional matrix adjust.
Identities = 144/233 (61%), Positives = 184/233 (78%), Gaps = 6/233 (2%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
KVCIV+KKD KQMYAMKYM K+ C+E+DA +VLRE+EIL LEHPFLVNLWF FQDEE
Sbjct: 31 GKVCIVRKKDNKQMYAMKYMSKAACLEKDASHHVLRELEILQKLEHPFLVNLWFSFQDEE 90
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
D+F+V DLLLGGDLRYH+ QD+ F D + Y EL LALDYL++K+I+HRD+KP
Sbjct: 91 DMFIVVDLLLGGDLRYHMGQDVNFTE-----DIVKFYICELVLALDYLQSKNILHRDLKP 145
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
DNILLDE+GHAH+TDFN+ATVL EN+LATS+SGTKPY+APE+++ A + GYSYSVDWW
Sbjct: 146 DNILLDEQGHAHLTDFNVATVLRENELATSLSGTKPYMAPEVYMCALEMCRGYSYSVDWW 205
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKD-VKAIIYSPVHYPTAWSESTKHLLSQV 243
SLGV +E+L R RP+ IH+ TS+++ V + VH+ + WS+ T +LL ++
Sbjct: 206 SLGVVAYEMLRRKRPYHIHTVTSLQEVVHQFETTGVHFSSQWSKDTCNLLRKL 258
|
Source: Branchiostoma floridae Species: Branchiostoma floridae Genus: Branchiostoma Family: Branchiostomidae Order: Class: Phylum: Chordata Superkingdom: Eukaryota |
| >gi|119917965|ref|XP_602539.3| PREDICTED: uncharacterized protein LOC524218 [Bos taurus] | Back alignment and taxonomy information |
|---|
Score = 305 bits (780), Expect = 1e-80, Method: Composition-based stats.
Identities = 136/232 (58%), Positives = 181/232 (78%), Gaps = 6/232 (2%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KVCIVQK+DT++MYAMKYM+K QCIERD ++NV RE+EIL +EH FLVNLW+ FQDEED
Sbjct: 587 KVCIVQKRDTEKMYAMKYMNKQQCIERDEVRNVFRELEILQEIEHVFLVNLWYSFQDEED 646
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+FMV DLLLGGDLRYH+ Q+++F DT+ LY E+ LALDYL+ +HIIHRD+KPD
Sbjct: 647 MFMVVDLLLGGDLRYHLQQNVQF-----SEDTVRLYVCEMALALDYLRGQHIIHRDVKPD 701
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
NILLDE GHAH+TDFNIAT++++ + AT+++GTKPY+APEIF + GYS+ VDWWS
Sbjct: 702 NILLDERGHAHLTDFNIATIIKDGERATALAGTKPYMAPEIFQSFVNGGTGYSFEVDWWS 761
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHLLSQV 243
+GV +E+L RP+DIHS+++V+ + + + V Y AWS+ T LL ++
Sbjct: 762 VGVMAYELLRGWRPYDIHSSSAVQSLVQLFSTVSVQYVPAWSKETVALLRKL 813
|
Source: Bos taurus Species: Bos taurus Genus: Bos Family: Bovidae Order: Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|221377805|ref|NP_001036666.2| CG32944, isoform E [Drosophila melanogaster] gi|220902990|gb|ABI31127.2| CG32944, isoform E [Drosophila melanogaster] | Back alignment and taxonomy information |
|---|
Score = 298 bits (764), Expect = 1e-78, Method: Compositional matrix adjust.
Identities = 138/232 (59%), Positives = 174/232 (75%), Gaps = 5/232 (2%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
KVCIVQK+DT +YAMKY+ +S C R AL V++E+E+L++LEHPFLVNLWF FQDEE
Sbjct: 36 GKVCIVQKRDTGILYAMKYVSRSACEMRGALGGVIKEVELLSSLEHPFLVNLWFSFQDEE 95
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
DLFMV DLL GGDLRYH+ ++F ++ L ELG AL+YL+ ++HRDIKP
Sbjct: 96 DLFMVCDLLTGGDLRYHLQNRVEF-----SEQSVALLVCELGSALEYLQANRVVHRDIKP 150
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
DNILLD+ GHAH+TDFNIAT L++N LA SMSGTKPY+APE+FL A DEV GYSY VDWW
Sbjct: 151 DNILLDDAGHAHLTDFNIATRLQKNALACSMSGTKPYMAPEVFLCALDEVAGYSYPVDWW 210
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQV 243
SLGV +E+ RPF +HSNT + ++K I+ +PVHYP WS + LL ++
Sbjct: 211 SLGVVAYEMRGNIRPFVVHSNTPLAEIKNILNTPVHYPRYWSSNFVDLLQRL 262
|
Source: Drosophila melanogaster Species: Drosophila melanogaster Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380026707|ref|XP_003697086.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase 32B-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 298 bits (763), Expect = 1e-78, Method: Compositional matrix adjust.
Identities = 146/235 (62%), Positives = 178/235 (75%), Gaps = 8/235 (3%)
Query: 12 SKVCIVQKKD-TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE 70
KVCIVQK+D T MYAMKY+HK +C R ALKNV RE+EIL+ LEHPFLVNLWF FQDE
Sbjct: 33 GKVCIVQKRDRTGNMYAMKYVHKGECAARGALKNVAREVEILSQLEHPFLVNLWFSFQDE 92
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
EDLFMVSDLLLGGDLRYHI Q++ F ++I LY E+GLALDYL++ +I+HRDIK
Sbjct: 93 EDLFMVSDLLLGGDLRYHIQQEVVFT-----EESIILYVAEIGLALDYLQSHNIVHRDIK 147
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDE--VLGYSYSV 188
PDNILLDEEGHAH+TDFNIATVL+ +LA+SMSGTKPYIAPEI++ E LGYSY+V
Sbjct: 148 PDNILLDEEGHAHVTDFNIATVLKGGELASSMSGTKPYIAPEIYMCYLSEYCTLGYSYAV 207
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQV 243
DWWSLG+ +E LA RP+ + S T+ ++ I+ PT WS + LL ++
Sbjct: 208 DWWSLGILAWETLAGERPYPLCSTTTYREALEILQDERPMPTGWSSTICELLDRL 262
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328792362|ref|XP_397018.2| PREDICTED: serine/threonine-protein kinase 32B-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 298 bits (762), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 146/235 (62%), Positives = 178/235 (75%), Gaps = 8/235 (3%)
Query: 12 SKVCIVQKKD-TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE 70
KVCIVQK+D T MYAMKY+HK +C R ALKNV RE+EIL+ LEHPFLVNLWF FQDE
Sbjct: 33 GKVCIVQKRDRTGNMYAMKYVHKGECAARGALKNVAREVEILSQLEHPFLVNLWFSFQDE 92
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
EDLFMVSDLLLGGDLRYHI Q++ F ++I LY E+GLALDYL++ +I+HRDIK
Sbjct: 93 EDLFMVSDLLLGGDLRYHIQQEVVFT-----EESIILYVAEIGLALDYLQSHNIVHRDIK 147
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDE--VLGYSYSV 188
PDNILLDEEGHAH+TDFNIATVL+ +LA+SMSGTKPYIAPEI++ E LGYSY+V
Sbjct: 148 PDNILLDEEGHAHVTDFNIATVLKGGELASSMSGTKPYIAPEIYMCYLSEYCTLGYSYAV 207
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQV 243
DWWSLG+ +E LA RP+ + S T+ ++ I+ PT WS + LL ++
Sbjct: 208 DWWSLGILAWETLAGERPYPLCSTTTYREALEILQDERPTPTGWSSTICELLDKL 262
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 246 | ||||||
| MGI|MGI:1927552 | 414 | Stk32b "serine/threonine kinas | 0.918 | 0.545 | 0.603 | 5.1e-74 | |
| FB|FBgn0052944 | 576 | CG32944 [Drosophila melanogast | 0.918 | 0.392 | 0.597 | 3.6e-73 | |
| UNIPROTKB|F1MLL2 | 375 | STK32C "Uncharacterized protei | 0.914 | 0.6 | 0.584 | 4.6e-73 | |
| UNIPROTKB|Q9NY57 | 414 | STK32B "Serine/threonine-prote | 0.918 | 0.545 | 0.594 | 9.6e-73 | |
| MGI|MGI:2385336 | 488 | Stk32c "serine/threonine kinas | 0.918 | 0.463 | 0.577 | 9.6e-73 | |
| RGD|1305864 | 488 | Stk32c "serine/threonine kinas | 0.918 | 0.463 | 0.577 | 9.6e-73 | |
| UNIPROTKB|E1C1K7 | 414 | STK32B "Uncharacterized protei | 0.918 | 0.545 | 0.586 | 1.2e-72 | |
| UNIPROTKB|F1PZ50 | 414 | STK32B "Uncharacterized protei | 0.918 | 0.545 | 0.590 | 3.2e-72 | |
| UNIPROTKB|B7Z7J1 | 499 | STK32C "cDNA FLJ56265, highly | 0.918 | 0.452 | 0.577 | 3.2e-72 | |
| UNIPROTKB|F2Z300 | 381 | STK32C "Serine/threonine-prote | 0.918 | 0.593 | 0.577 | 3.2e-72 |
| MGI|MGI:1927552 Stk32b "serine/threonine kinase 32B" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 747 (268.0 bits), Expect = 5.1e-74, P = 5.1e-74
Identities = 140/232 (60%), Positives = 176/232 (75%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KVCIVQK+DTK+MYAMKYM+K +C+ERD ++NV RE++I+ LEHPFLVNLW+ FQDEED
Sbjct: 36 KVCIVQKRDTKKMYAMKYMNKQKCVERDEVRNVFRELQIMQGLEHPFLVNLWYSFQDEED 95
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+FMV DLLLGGDLRYH+ Q++ F T+ LY EL LAL+YL+ HIIHRDIKPD
Sbjct: 96 MFMVVDLLLGGDLRYHLQQNVHF-----TEGTVKLYICELALALEYLQRYHIIHRDIKPD 150
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
NILLDE GH HITDFNIATVL+ ++ A+SM+GTKPY+APE+F V D GYSY VDWWS
Sbjct: 151 NILLDEHGHVHITDFNIATVLKGSEKASSMAGTKPYMAPEVFQVYVDGGPGYSYPVDWWS 210
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAII-YSPVHYPTAWSESTKHLLSQV 243
LGVT +E+L RP++IHS T + ++ + VHY + W E LL ++
Sbjct: 211 LGVTAYELLRGWRPYEIHSATPIDEILNMFKVERVHYSSTWCEGMVSLLKKL 262
|
|
| FB|FBgn0052944 CG32944 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 739 (265.2 bits), Expect = 3.6e-73, P = 3.6e-73
Identities = 138/231 (59%), Positives = 174/231 (75%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KVCIVQK+DT +YAMKY+ +S C R AL V++E+E+L++LEHPFLVNLWF FQDEED
Sbjct: 164 KVCIVQKRDTGILYAMKYVSRSACEMRGALGGVIKEVELLSSLEHPFLVNLWFSFQDEED 223
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
LFMV DLL GGDLRYH+ ++F ++ L ELG AL+YL+ ++HRDIKPD
Sbjct: 224 LFMVCDLLTGGDLRYHLQNRVEF-----SEQSVALLVCELGSALEYLQANRVVHRDIKPD 278
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
NILLD+ GHAH+TDFNIAT L++N LA SMSGTKPY+APE+FL A DEV GYSY VDWWS
Sbjct: 279 NILLDDAGHAHLTDFNIATRLQKNALACSMSGTKPYMAPEVFLCALDEVAGYSYPVDWWS 338
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQV 243
LGV +E+ RPF +HSNT + ++K I+ +PVHYP WS + LL ++
Sbjct: 339 LGVVAYEMRGNIRPFVVHSNTPLAEIKNILNTPVHYPRYWSSNFVDLLQRL 389
|
|
| UNIPROTKB|F1MLL2 STK32C "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 738 (264.8 bits), Expect = 4.6e-73, P = 4.6e-73
Identities = 135/231 (58%), Positives = 180/231 (77%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDL 73
VCIVQK+DT++MYAMKYM+K QCIERD ++NV RE+EIL +EH FLVNLW+ FQDEED+
Sbjct: 1 VCIVQKRDTEKMYAMKYMNKQQCIERDEVRNVFRELEILQEIEHVFLVNLWYSFQDEEDM 60
Query: 74 FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDN 133
FMV DLLLGGDLRYH+ Q+++F DT+ LY E+ LALDYL+ +HIIHRD+KPDN
Sbjct: 61 FMVVDLLLGGDLRYHLQQNVQF-----SEDTVRLYVCEMALALDYLRGQHIIHRDVKPDN 115
Query: 134 ILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSL 193
ILLDE GHAH+TDFNIAT++++ + AT+++GTKPY+APEIF + GYS+ VDWWS+
Sbjct: 116 ILLDERGHAHLTDFNIATIIKDGERATALAGTKPYMAPEIFQSFVNGGTGYSFEVDWWSV 175
Query: 194 GVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHLLSQV 243
GV +E+L RP+DIHS+++V+ + + + V Y AWS+ T LL ++
Sbjct: 176 GVMAYELLRGWRPYDIHSSSAVQSLVQLFSTVSVQYVPAWSKETVALLRKL 226
|
|
| UNIPROTKB|Q9NY57 STK32B "Serine/threonine-protein kinase 32B" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 735 (263.8 bits), Expect = 9.6e-73, P = 9.6e-73
Identities = 138/232 (59%), Positives = 175/232 (75%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KVCIVQK+DTK+MYAMKYM+K +CIERD ++NV RE++I+ LEHPFLVNLW+ FQDEED
Sbjct: 36 KVCIVQKRDTKKMYAMKYMNKQKCIERDEVRNVFRELQIMQGLEHPFLVNLWYSFQDEED 95
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+FMV DLLLGGDLRYH+ Q++ F T+ LY EL LAL+YL+ HIIHRDIKPD
Sbjct: 96 MFMVVDLLLGGDLRYHLQQNVHF-----TEGTVKLYICELALALEYLQRYHIIHRDIKPD 150
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
NILLDE GH HITDFNIATV++ + A+SM+GTKPY+APE+F V D GYSY VDWWS
Sbjct: 151 NILLDEHGHVHITDFNIATVVKGAERASSMAGTKPYMAPEVFQVYMDRGPGYSYPVDWWS 210
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAII-YSPVHYPTAWSESTKHLLSQV 243
LG+T +E+L RP++IHS T + ++ + VHY + W + LL ++
Sbjct: 211 LGITAYELLRGWRPYEIHSVTPIDEILNMFKVERVHYSSTWCKGMVALLRKL 262
|
|
| MGI|MGI:2385336 Stk32c "serine/threonine kinase 32C" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 735 (263.8 bits), Expect = 9.6e-73, P = 9.6e-73
Identities = 134/232 (57%), Positives = 180/232 (77%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KVCIVQK+DT++MYAMKYM+K QCIERD ++NV RE+EIL +EH FLVNLW+ FQDEED
Sbjct: 107 KVCIVQKRDTEKMYAMKYMNKQQCIERDEVRNVFRELEILQEIEHVFLVNLWYSFQDEED 166
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+FMV DLLLGGDLRYH+ Q+++F DT+ LY E+ LALDYL+++HIIHRD+KPD
Sbjct: 167 MFMVVDLLLGGDLRYHLQQNVQF-----SEDTVRLYICEMALALDYLRSQHIIHRDVKPD 221
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
NILLDE+GHAH+TDFNIAT++++ + AT+++GTKPY+APEIF + GYS+ VDWWS
Sbjct: 222 NILLDEQGHAHLTDFNIATIIKDGERATALAGTKPYMAPEIFHSFVNGGTGYSFEVDWWS 281
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHLLSQV 243
+GV +E+L RP+DIHS+ +V+ + + + V Y WS+ LL ++
Sbjct: 282 VGVMAYELLRGWRPYDIHSSNAVESLVQLFSTVSVQYVPTWSKEMVALLRKL 333
|
|
| RGD|1305864 Stk32c "serine/threonine kinase 32C" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 735 (263.8 bits), Expect = 9.6e-73, P = 9.6e-73
Identities = 134/232 (57%), Positives = 180/232 (77%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KVCIVQK+DT++MYAMKYM+K QCIERD ++NV RE+EIL +EH FLVNLW+ FQDEED
Sbjct: 107 KVCIVQKRDTEKMYAMKYMNKQQCIERDEVRNVFRELEILQEIEHVFLVNLWYSFQDEED 166
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+FMV DLLLGGDLRYH+ Q+++F DT+ LY E+ LALDYL+++HIIHRD+KPD
Sbjct: 167 MFMVVDLLLGGDLRYHLQQNVQF-----SEDTVRLYICEMALALDYLRSQHIIHRDVKPD 221
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
NILLDE+GHAH+TDFNIAT++++ + AT+++GTKPY+APEIF + GYS+ VDWWS
Sbjct: 222 NILLDEQGHAHLTDFNIATIIKDGERATALAGTKPYMAPEIFHSFVNGGTGYSFEVDWWS 281
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHLLSQV 243
+GV +E+L RP+DIHS+ +V+ + + + V Y WS+ LL ++
Sbjct: 282 VGVMAYELLRGWRPYDIHSSNAVESLVQLFSTVSVQYVPTWSKGMVALLRKL 333
|
|
| UNIPROTKB|E1C1K7 STK32B "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 734 (263.4 bits), Expect = 1.2e-72, P = 1.2e-72
Identities = 136/232 (58%), Positives = 175/232 (75%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KVCIVQK+DTK+MYAMKYM+K +CIERD ++NV RE++I+ LEHPFLVNLW+ FQDEED
Sbjct: 36 KVCIVQKRDTKKMYAMKYMNKQKCIERDEVRNVFRELQIMQGLEHPFLVNLWYSFQDEED 95
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+FMV DLLLGGDLRYH+ Q++ F T+ LY EL L+LDYL+ HIIHRDIKPD
Sbjct: 96 MFMVVDLLLGGDLRYHLQQNVHF-----NEGTVKLYICELALSLDYLQRYHIIHRDIKPD 150
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
NILLDE GH HITDFNIAT+++ ++ A+SM+GTKPY+APE+F D GYSY VDWWS
Sbjct: 151 NILLDEHGHVHITDFNIATIVKGSEKASSMAGTKPYMAPEVFQAFMDGGPGYSYPVDWWS 210
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAII-YSPVHYPTAWSESTKHLLSQV 243
LG+T +E+L RP++IHS T + ++ + VHY + W + LL ++
Sbjct: 211 LGITAYELLRGWRPYEIHSATPIDEILNMFKIERVHYSSTWCKGMIALLKKL 262
|
|
| UNIPROTKB|F1PZ50 STK32B "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 730 (262.0 bits), Expect = 3.2e-72, P = 3.2e-72
Identities = 137/232 (59%), Positives = 174/232 (75%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KVCIVQK+DTK+MYAMKYM+K +CIERD ++NV RE++I+ LEHPFLVNLW+ FQDEED
Sbjct: 36 KVCIVQKRDTKKMYAMKYMNKQKCIERDEVRNVFRELQIMQGLEHPFLVNLWYSFQDEED 95
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+FMV DLLLGGDLRYH+ Q++ F + LY EL LAL+YL+ HIIHRDIKPD
Sbjct: 96 MFMVVDLLLGGDLRYHLQQNVHF-----TEGAVKLYICELALALEYLQRFHIIHRDIKPD 150
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
NILLDE GH HITDFNIAT+++ + A+SM+GTKPY+APE+F V D GYSY VDWWS
Sbjct: 151 NILLDEHGHVHITDFNIATIVKGAEKASSMAGTKPYMAPEVFQVYVDGGPGYSYPVDWWS 210
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAII-YSPVHYPTAWSESTKHLLSQV 243
LGVT +E+L RP++IHS T + ++ + VHY + W + LL ++
Sbjct: 211 LGVTAYELLRGWRPYEIHSATPIDEILNMFKVERVHYSSTWCKGMVALLKKL 262
|
|
| UNIPROTKB|B7Z7J1 STK32C "cDNA FLJ56265, highly similar to Serine/threonine-protein kinase 32C (EC 2.7.11.1)" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 730 (262.0 bits), Expect = 3.2e-72, P = 3.2e-72
Identities = 134/232 (57%), Positives = 178/232 (76%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KVCIVQK+DT++MYAMKYM+K QCIERD ++NV RE+EIL +EH FLVNLW+ FQDEED
Sbjct: 119 KVCIVQKRDTEKMYAMKYMNKQQCIERDEVRNVFRELEILQEIEHVFLVNLWYSFQDEED 178
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+FMV DLLLGGDLRYH+ Q+++F DT+ LY E+ LALDYL+ +HIIHRD+KPD
Sbjct: 179 MFMVVDLLLGGDLRYHLQQNVQF-----SEDTVRLYICEMALALDYLRGQHIIHRDVKPD 233
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
NILLDE GHAH+TDFNIAT++++ + AT+++GTKPY+APEIF + GYS+ VDWWS
Sbjct: 234 NILLDERGHAHLTDFNIATIIKDGERATALAGTKPYMAPEIFHSFVNGGTGYSFEVDWWS 293
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHLLSQV 243
+GV +E+L RP+DIHS+ +V+ + + + V Y WS+ LL ++
Sbjct: 294 VGVMAYELLRGWRPYDIHSSNAVESLVQLFSTVSVQYVPTWSKEMVALLRKL 345
|
|
| UNIPROTKB|F2Z300 STK32C "Serine/threonine-protein kinase 32C" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 730 (262.0 bits), Expect = 3.2e-72, P = 3.2e-72
Identities = 134/232 (57%), Positives = 178/232 (76%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KVCIVQK+DT++MYAMKYM+K QCIERD ++NV RE+EIL +EH FLVNLW+ FQDEED
Sbjct: 45 KVCIVQKRDTEKMYAMKYMNKQQCIERDEVRNVFRELEILQEIEHVFLVNLWYSFQDEED 104
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+FMV DLLLGGDLRYH+ Q+++F DT+ LY E+ LALDYL+ +HIIHRD+KPD
Sbjct: 105 MFMVVDLLLGGDLRYHLQQNVQF-----SEDTVRLYICEMALALDYLRGQHIIHRDVKPD 159
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
NILLDE GHAH+TDFNIAT++++ + AT+++GTKPY+APEIF + GYS+ VDWWS
Sbjct: 160 NILLDERGHAHLTDFNIATIIKDGERATALAGTKPYMAPEIFHSFVNGGTGYSFEVDWWS 219
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHLLSQV 243
+GV +E+L RP+DIHS+ +V+ + + + V Y WS+ LL ++
Sbjct: 220 VGVMAYELLRGWRPYDIHSSNAVESLVQLFSTVSVQYVPTWSKEMVALLRKL 271
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9NY57 | ST32B_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.5922 | 0.9227 | 0.5483 | yes | N/A |
| Q9JJX8 | ST32B_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6008 | 0.9227 | 0.5483 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 246 | |||
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-110 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-82 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-66 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-59 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-49 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-49 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-47 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-46 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-46 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-44 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-43 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-43 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-43 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-43 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-42 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-42 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-42 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-42 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-42 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-41 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-41 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-41 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-41 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-41 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-41 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-40 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-40 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-39 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-38 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-38 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-37 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-37 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-37 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-37 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-37 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-37 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-37 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-37 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-36 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-36 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-36 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-36 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-36 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-36 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-36 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-36 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-35 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-35 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-35 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-35 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-35 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-35 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-35 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-34 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-34 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-34 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-33 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-33 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-33 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-32 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-32 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-32 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-32 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-31 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-30 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-24 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-24 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-24 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-22 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-22 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-21 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-18 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-15 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-14 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-10 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.001 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 317 bits (814), Expect = e-110
Identities = 122/232 (52%), Positives = 160/232 (68%), Gaps = 11/232 (4%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
KVCIVQK+DTK+M+AMKYM+K +C+E+ +++NVL E IL L HPFLVNLW+ FQDEE
Sbjct: 14 GKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE 73
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
++++V DLLLGGDLRYH++Q +KF + + + E+ LAL+YL +K IIHRDIKP
Sbjct: 74 NMYLVVDLLLGGDLRYHLSQKVKF-----SEEQVKFWICEIVLALEYLHSKGIIHRDIKP 128
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
DNILLDE+GH HITDFNIAT + + L TS SGT Y+APE+ GYS +VDWW
Sbjct: 129 DNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQ-----GYSVAVDWW 183
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDVKAII-YSPVHYPTAWSESTKHLLSQ 242
SLGVT +E L RP+ HS T ++A + V YP WS +++
Sbjct: 184 SLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK 235
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 246 bits (630), Expect = 2e-82
Identities = 89/232 (38%), Positives = 137/232 (59%), Gaps = 13/232 (5%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
KV +V+KKDT ++YAMK + K + I+R +++ L E IL+ + HPF+V L + FQ EE
Sbjct: 7 GKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE 66
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L++V + GG+L H++++ +F + YA E+ LAL+YL + II+RD+KP
Sbjct: 67 KLYLVLEYAPGGELFSHLSKEGRF-----SEERARFYAAEIVLALEYLHSLGIIYRDLKP 121
Query: 132 DNILLDEEGHAHITDFNIATVL-EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
+NILLD +GH +TDF +A L E + GT Y+APE+ L GY +VDW
Sbjct: 122 ENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK-----GYGKAVDW 176
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
WSLGV L+E+L PF ++ + + I+ P+ +P S + L+S
Sbjct: 177 WSLGVLLYEMLTGKPPF--YAEDRKEIYEKILKDPLRFPEFLSPEARDLISG 226
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 3e-66
Identities = 77/233 (33%), Positives = 121/233 (51%), Gaps = 14/233 (6%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
KV + + K T ++ A+K + K + + + +LRE++IL L+HP +V L+ F+DE+
Sbjct: 13 GKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPNIVRLYDVFEDED 70
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L++V + GGDL + + + D Y ++ AL+YL +K I+HRD+KP
Sbjct: 71 KLYLVMEYCEGGDLFDLLKKRGRL-----SEDEARFYLRQILSALEYLHSKGIVHRDLKP 125
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
+NILLDE+GH + DF +A L+ + T+ GT Y+APE+ L GY +VD W
Sbjct: 126 ENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL-----GKGYGKAVDIW 180
Query: 192 SLGVTLFEILARGRPFDIHSNTSV--KDVKAIIYSPVHYPTAWSESTKHLLSQ 242
SLGV L+E+L PF K + S K L+ +
Sbjct: 181 SLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 6e-59
Identities = 77/232 (33%), Positives = 132/232 (56%), Gaps = 18/232 (7%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V +V+ K + + YA+K + K++ ++ +++VL E IL ++ HPFLVNL+ FQD+ +
Sbjct: 16 RVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN 75
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L++V + + GG+L H+ + +F YA ++ LAL+YL + I++RD+KP+
Sbjct: 76 LYLVMEYVPGGELFSHLRKSGRF-----PEPVARFYAAQVVLALEYLHSLDIVYRDLKPE 130
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
N+LLD +G+ ITDF A ++ ++ GT Y+APEI L GY +VDWW+
Sbjct: 131 NLLLDSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSK-----GYGKAVDWWA 183
Query: 193 LGVTLFEILARGRPFDIHS--NTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
LG+ ++E+LA PF + K ++ + P + S K L+
Sbjct: 184 LGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFF----SPDAKDLIRN 231
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-51
Identities = 83/231 (35%), Positives = 122/231 (52%), Gaps = 16/231 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEE 71
KV + + K T ++YA+K + K ++ D ++ + E +L +HPFL L CFQ ++
Sbjct: 10 KVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD 69
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
LF V + + GGDL +HI + +F R YA E+ L L +L + II+RD+K
Sbjct: 70 RLFFVMEYVNGGDLMFHIQRSGRFDEPRAR-----FYAAEIVLGLQFLHERGIIYRDLKL 124
Query: 132 DNILLDEEGHAHITDFNIAT--VLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
DN+LLD EGH I DF + +L +T GT YIAPEI Y +VD
Sbjct: 125 DNVLLDSEGHIKIADFGMCKEGILGGVTTST-FCGTPDYIAPEILS-----YQPYGPAVD 178
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240
WW+LGV L+E+LA PF+ + +I+ V YP S+ K +L
Sbjct: 179 WWALGVLLYEMLAGQSPFEGDDEDELFQ--SILEDEVRYPRWLSKEAKSIL 227
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-49
Identities = 72/238 (30%), Positives = 115/238 (48%), Gaps = 16/238 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
V + K T ++ A+K + K + + RE+ IL L HP +V L F+D
Sbjct: 11 SFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPNIVRLIDAFED 69
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
++ L++V + GGDL ++++ + ++ A ++ L+YL + IIHRD+
Sbjct: 70 KDHLYLVMEYCEGGDLFDYLSRGGPL----SEDEAKK-IALQILRGLEYLHSNGIIHRDL 124
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQ-LATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
KP+NILLDE G I DF +A L ++ T+ GT Y+APE+ L GY V
Sbjct: 125 KPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGN----GYGPKV 180
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTS-----VKDVKAIIYSPVHYPTAWSESTKHLLS 241
D WSLGV L+E+L PF + + + + ++ SE K L+
Sbjct: 181 DVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIK 238
|
Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-49
Identities = 80/238 (33%), Positives = 127/238 (53%), Gaps = 16/238 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
G +VC Q K T +MYA K + K + +R + L E +IL + F+V+L + F+
Sbjct: 5 GFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET 64
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTR---NDTIHLYAFELGLALDYLKTKHIIH 126
++DL +V L+ GGDL+YHI Y+VG YA ++ L++L + I++
Sbjct: 65 KDDLCLVMTLMNGGDLKYHI------YNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSY 186
RD+KP+N+LLD+ G+ I+D +A L+ + +GT Y+APE+ EV Y +
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ---GEV--YDF 173
Query: 187 SVDWWSLGVTLFEILARGRPFDIH-SNTSVKDVKAIIYS-PVHYPTAWSESTKHLLSQ 242
SVDW++LG TL+E++A PF +++K V YP +S K L
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEA 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-47
Identities = 76/240 (31%), Positives = 123/240 (51%), Gaps = 22/240 (9%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
G +V +V+ K + +A+K + K +E +++ E EIL HPF+V L+ F+D
Sbjct: 5 GFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD 64
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
++ ++M+ + LGG+L + I +D + T Y + LA +YL + II+RD+
Sbjct: 65 KKYIYMLMEYCLGGEL-WTILRDRGLFD----EYTARFYIACVVLAFEYLHNRGIIYRDL 119
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
KP+N+LLD G+ + DF A L+ Q + GT Y+APEI L GY +SVD
Sbjct: 120 KPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNK-----GYDFSVD 174
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY-------SPVHYPTAWSESTKHLLSQ 242
+WSLG+ L+E+L PF + IY + +P ++ K L+ Q
Sbjct: 175 YWSLGILLYELLTGRPPF-----GEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQ 229
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 1e-46
Identities = 80/212 (37%), Positives = 123/212 (58%), Gaps = 23/212 (10%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
+V + +KK T +YA+K + K+ I ++ + VL E +IL+ + P++V L++ FQ ++
Sbjct: 7 GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK 66
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRN-DTIHLYAFELGLALDYLKTKHIIHRDIK 130
+L++V + L GGDL + + +VG+ + D +Y E+ LAL+YL + IIHRD+K
Sbjct: 67 NLYLVMEYLPGGDL-ASLLE-----NVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 131 PDNILLDEEGHAHITDFNIATV-LEENQLATSMS--------GTKPYIAPEIFLVATDEV 181
PDNIL+D GH +TDF ++ V L Q+ + GT YIAPE+ L
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ---- 176
Query: 182 LGYSYSVDWWSLGVTLFEILARGRPFDIHSNT 213
G+S +VDWWSLG L+E L PF H T
Sbjct: 177 -GHSKTVDWWSLGCILYEFLVGIPPF--HGET 205
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 9e-46
Identities = 80/225 (35%), Positives = 111/225 (49%), Gaps = 42/225 (18%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDL 73
V +V+ KDT Q+YAMK + KS I+R+ + +V E +IL + P++V L++ FQDEE L
Sbjct: 17 VWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHL 76
Query: 74 FMVSDLLLGGDLRYH-ITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
++V + + GGDL I +D+ +T Y EL LALD + IHRDIKPD
Sbjct: 77 YLVMEYMPGGDLMNLLIRKDV------FPEETARFYIAELVLALDSVHKLGFIHRDIKPD 130
Query: 133 NILLDEEGHAHITDFNIATVLEEN------------------------------QLATSM 162
NIL+D +GH + DF + + + A S
Sbjct: 131 NILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANST 190
Query: 163 SGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
GT YIAPE+ Y DWWSLGV L+E+L PF
Sbjct: 191 VGTPDYIAPEVLR-----GTPYGLECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 6e-44
Identities = 81/199 (40%), Positives = 119/199 (59%), Gaps = 15/199 (7%)
Query: 13 KVCIVQK---KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
KV +V+K D Q+YAMK + K+ RD ++ + E +IL + HPF+V L + FQ
Sbjct: 11 KVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIVKLHYAFQT 69
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
E L+++ D L GGDL +++++ F T D + Y EL LALD+L + II+RD+
Sbjct: 70 EGKLYLILDFLRGGDLFTRLSKEVMF----TEED-VKFYLAELALALDHLHSLGIIYRDL 124
Query: 130 KPDNILLDEEGHAHITDFNIAT-VLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
KP+NILLDEEGH +TDF ++ ++ + A S GT Y+APE+ G++ S
Sbjct: 125 KPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-----NRRGHTQSA 179
Query: 189 DWWSLGVTLFEILARGRPF 207
DWWS GV +FE+L PF
Sbjct: 180 DWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-43
Identities = 85/234 (36%), Positives = 124/234 (52%), Gaps = 16/234 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILT-TLEHPFLVNLWFCFQDEE 71
KV + + K T + +A+K + K +E D ++ + E +L EHPFL +L+ FQ +E
Sbjct: 10 KVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE 69
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
LF V + L GGDL +HI +F R YA E+ L +L K II+RD+K
Sbjct: 70 HLFFVMEYLNGGDLMFHIQSSGRFDEARAR-----FYAAEIICGLQFLHKKGIIYRDLKL 124
Query: 132 DNILLDEEGHAHITDFNIA--TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
DN+LLD++GH I DF + + E + A++ GT YIAPEI Y+ SVD
Sbjct: 125 DNVLLDKDGHIKIADFGMCKENMNGEGK-ASTFCGTPDYIAPEILK-----GQKYNESVD 178
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQV 243
WWS GV L+E+L PF H + +I+ H+P S+ K LS++
Sbjct: 179 WWSFGVLLYEMLIGQSPF--HGEDEDELFDSILNDRPHFPRWISKEAKDCLSKL 230
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-43
Identities = 77/222 (34%), Positives = 114/222 (51%), Gaps = 38/222 (17%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDE 70
S V + ++K+T + YA+K + K Q I+ +K V E E+LT L HP ++ L++ FQDE
Sbjct: 15 STVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE 74
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
E+L+ V + G+L +I K+ S+ YA E+ LAL+YL +K IIHRD+K
Sbjct: 75 ENLYFVLEYAPNGELLQYIR---KYGSLDE--KCTRFYAAEILLALEYLHSKGIIHRDLK 129
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQL---------------------ATSMSGTKPYI 169
P+NILLD++ H ITDF A VL+ N S GT Y+
Sbjct: 130 PENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYV 189
Query: 170 APEIFLVATDEVLGY---SYSVDWWSLGVTLFEILARGRPFD 208
+P E+L S D W+LG ++++L PF
Sbjct: 190 SP--------ELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 7e-43
Identities = 84/258 (32%), Positives = 129/258 (50%), Gaps = 44/258 (17%)
Query: 11 TSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE 70
+V +V+ K T +++A+K + K + I+R+ +K VL E EIL TL+HPFL L+ FQ E
Sbjct: 14 VGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE 73
Query: 71 EDLFMVSDLLLGGDLRYHI--TQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRD 128
L +V D GG+L + + Q K S + YA E+ LAL+YL I++RD
Sbjct: 74 TYLCLVMDYCPGGEL-FRLLQRQPGKCLSE----EVARFYAAEVLLALEYLHLLGIVYRD 128
Query: 129 IKPDNILLDEEGHAHITDF------NIATVLEENQL----------------------AT 160
+KP+NILL E GH ++DF ++ L
Sbjct: 129 LKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFR 188
Query: 161 SMS--GTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDV 218
S S GT+ YIAPE+ ++ D G+ +VDWW+LG+ L+E+L PF + +
Sbjct: 189 SNSFVGTEEYIAPEV--ISGD---GHGSAVDWWTLGILLYEMLYGTTPFKGSNRD--ETF 241
Query: 219 KAIIYSPVHYPTAWSEST 236
I+ V +P + S+
Sbjct: 242 SNILKKEVTFPGSPPVSS 259
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 8e-43
Identities = 85/238 (35%), Positives = 126/238 (52%), Gaps = 19/238 (7%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDE 70
+KV +V+ K T+++YAMK + K + + + V E + T HPFLV L CFQ E
Sbjct: 9 AKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE 68
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
LF V + + GGDL +H+ + K R Y+ E+ LAL++L + II+RD+K
Sbjct: 69 SRLFFVIEFVSGGDLMFHMQRQRKLPEEHAR-----FYSAEISLALNFLHERGIIYRDLK 123
Query: 131 PDNILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
DN+LLD EGH +TD+ + + ++ GT YIAPEI L D Y +SVD
Sbjct: 124 LDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEI-LRGED----YGFSVD 178
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKD-------VKAIIYSPVHYPTAWSESTKHLL 240
WW+LGV +FE++A PFDI + D + I+ + P + S +L
Sbjct: 179 WWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL 236
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-42
Identities = 77/230 (33%), Positives = 125/230 (54%), Gaps = 14/230 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEIL-TTLEHPFLVNLWFCFQDEE 71
KV + + K + YA+K + K +++ K+++ E +L ++HPFLV L + FQ +
Sbjct: 10 KVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD 69
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L+ V D + GG+L +H+ ++ F R YA E+ AL YL + +II+RD+KP
Sbjct: 70 KLYFVLDYVNGGELFFHLQRERSFPEPRAR-----FYAAEIASALGYLHSLNIIYRDLKP 124
Query: 132 DNILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
+NILLD +GH +TDF + +E ++ ++ GT Y+APE+ Y +VDW
Sbjct: 125 ENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP-----YDRTVDW 179
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240
W LG L+E+L PF +S + + I+ P+ S S +HLL
Sbjct: 180 WCLGAVLYEMLYGLPPF--YSRDTAEMYDNILNKPLRLKPNISVSARHLL 227
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-42
Identities = 82/230 (35%), Positives = 124/230 (53%), Gaps = 14/230 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILT-TLEHPFLVNLWFCFQDEE 71
KV + + K T ++YA+K + K ++ D + + E IL +HPFL L CFQ ++
Sbjct: 10 KVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD 69
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
LF V + + GGDL + I + KF +R YA E+ LAL +L +I+RD+K
Sbjct: 70 RLFFVMEYVNGGDLMFQIQRSRKFDEPRSR-----FYAAEVTLALMFLHRHGVIYRDLKL 124
Query: 132 DNILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
DNILLD EGH + DF + + T+ GT YIAPEI + L Y SVDW
Sbjct: 125 DNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL-----QELEYGPSVDW 179
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240
W+LGV ++E++A PF+ + + + +I++ V YP S+ +L
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFE--SILHDDVLYPVWLSKEAVSIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 4e-42
Identities = 67/193 (34%), Positives = 102/193 (52%), Gaps = 12/193 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
G V + + K T + A+K + K L+ +LRE+EIL L HP +V L+ F+D
Sbjct: 5 GFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYGVFED 62
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
E L++V + GG L+ + ++ S D I ++ L+YL + IIHRD+
Sbjct: 63 ENHLYLVMEYCEGGSLKDLLKENEGKLS----EDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 130 KPDNILLDE-EGHAHITDFNIATVLEEN-QLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
KP+NILLD G + DF ++ +L + L ++ GT Y+APE+ L YS
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL----GKGYYSEK 174
Query: 188 VDWWSLGVTLFEI 200
D WSLGV L+E+
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 4e-42
Identities = 77/212 (36%), Positives = 125/212 (58%), Gaps = 16/212 (7%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
G +VC VQ K+T +MYA K + K + ++ K L E EIL + PF+VNL + F+
Sbjct: 5 GFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES 64
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTR----NDTIHLYAFELGLALDYLKTKHII 125
+ L +V L+ GGDL+YHI Y+VG R IH Y+ ++ + +L + I+
Sbjct: 65 KTHLCLVMSLMNGGDLKYHI------YNVGERGLEMERVIH-YSAQITCGILHLHSMDIV 117
Query: 126 HRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYS 185
+RD+KP+N+LLD++G+ ++D +A L++ + T +GT Y+APEI +E YS
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILK---EEP--YS 172
Query: 186 YSVDWWSLGVTLFEILARGRPFDIHSNTSVKD 217
Y VDW+++G +++E++A PF H K+
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 5e-42
Identities = 77/230 (33%), Positives = 129/230 (56%), Gaps = 13/230 (5%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KV V+K+DT+++YA+K + K+ + R + + L E +L + PF+V L F FQ E
Sbjct: 8 KVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEK 67
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L++V + GG+L +H+ ++ +F R Y EL AL+ L ++I+RD+KP+
Sbjct: 68 LYLVLAFINGGELFHHLQREGRFDLSRAR-----FYTAELLCALENLHKFNVIYRDLKPE 122
Query: 133 NILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
NILLD +GH + DF + + ++++ + GT Y+APE+ L GY+ +VDWW
Sbjct: 123 NILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL-----GHGYTKAVDWW 177
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241
+LGV L+E+L PF + + + I+ P+ +P + K LL
Sbjct: 178 TLGVLLYEMLTGLPPF--YDENVNEMYRKILQEPLRFPDGFDRDAKDLLI 225
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 6e-42
Identities = 78/221 (35%), Positives = 128/221 (57%), Gaps = 15/221 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEIL---TTLEHPFLVNLWFCFQD 69
+V V+KKDT+++YAMK + K + + + + + + E IL E PF+V L F FQ
Sbjct: 8 QVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT 67
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+ DL++V+D + GG+L +H+ ++ +F D Y EL LAL++L I++RD+
Sbjct: 68 DSDLYLVTDYMSGGELFWHLQKEGRF-----SEDRAKFYIAELVLALEHLHKYDIVYRDL 122
Query: 130 KPDNILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
KP+NILLD GH + DF ++ L +N+ + GT Y+APE+ L + GY+ V
Sbjct: 123 KPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL----DEKGYTKHV 178
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP 229
D+WSLGV +FE+ PF ++ + + + I + V +P
Sbjct: 179 DFWSLGVLVFEMCCGWSPF--YAEDTQQMYRNIAFGKVRFP 217
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-41
Identities = 82/233 (35%), Positives = 121/233 (51%), Gaps = 49/233 (21%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDL 73
V +VQKKDT +YAMK + KS+ +E++ + +V E +IL ++P++V L++ FQDE L
Sbjct: 17 VRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYL 76
Query: 74 FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDN 133
+++ + L GGD+ +T +K T +T Y E LA+D + IHRDIKPDN
Sbjct: 77 YLIMEYLPGGDM---MTLLMK-KDTFTEEET-RFYIAETILAIDSIHKLGYIHRDIKPDN 131
Query: 134 ILLDEEGHAHITDFNIATVLEEN------------------------------------- 156
+LLD +GH ++DF + T L+++
Sbjct: 132 LLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRN 191
Query: 157 --QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
LA S GT YIAPE+FL GY+ DWWSLGV ++E+L PF
Sbjct: 192 RRALAYSTVGTPDYIAPEVFLQT-----GYNKECDWWSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 1e-41
Identities = 78/224 (34%), Positives = 114/224 (50%), Gaps = 23/224 (10%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL---EHPFLVNLWFCFQD 69
KV + + K T ++YA+K + K I RD +++++ E I T HPFLVNL+ CFQ
Sbjct: 14 KVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT 73
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
E+ + V + GGDL HI D+ F YA + L L YL I++RD+
Sbjct: 74 EDHVCFVMEYAAGGDLMMHIHTDV-FSEPRAV-----FYAACVVLGLQYLHENKIVYRDL 127
Query: 130 KPDNILLDEEGHAHITDFNIATVLEEN----QLATSMSGTKPYIAPEIFLVATDEVLGYS 185
K DN+LLD EG I DF + +E ++ GT ++APE+ + Y+
Sbjct: 128 KLDNLLLDTEGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETS-----YT 179
Query: 186 YSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP 229
+VDWW LGV ++E+L PF V D +I+ V YP
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD--SIVNDEVRYP 221
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 2e-41
Identities = 65/200 (32%), Positives = 105/200 (52%), Gaps = 8/200 (4%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
KV +V++K ++Y +K + S E++ ++ L E++IL L HP ++ + F++
Sbjct: 12 SFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE-REDALNEVKILKKLNHPNIIKYYESFEE 70
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+ L +V + GGDL I + K + I + +L LAL YL ++ I+HRDI
Sbjct: 71 KGKLCIVMEYADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDI 129
Query: 130 KPDNILLDEEGHAHITDFNIATVLEEN-QLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
KP NI L G + DF I+ VL LA ++ GT Y++PE+ + Y+Y
Sbjct: 130 KPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC-----QNKPYNYKS 184
Query: 189 DWWSLGVTLFEILARGRPFD 208
D WSLG L+E+ PF+
Sbjct: 185 DIWSLGCVLYELCTLKHPFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-41
Identities = 79/240 (32%), Positives = 131/240 (54%), Gaps = 23/240 (9%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
G +V Q + T ++YA K ++K + +R + + E IL + F+V+L + FQ
Sbjct: 5 GFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT 64
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIH-----LYAFELGLALDYLKTKHI 124
+ DL +V ++ GGDLRYHI Y+V N Y ++ L++L + I
Sbjct: 65 KTDLCLVMTIMNGGDLRYHI------YNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118
Query: 125 IHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT-SMSGTKPYIAPEIFLVATDEVLG 183
I+RD+KP+N+LLD +G+ I+D +A L++ Q T +GT ++APE L+ +E
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPE--LLQGEE--- 173
Query: 184 YSYSVDWWSLGVTLFEILARGRPFDIH----SNTSVKDVKAIIYSPVHYPTAWSESTKHL 239
Y +SVD+++LGVTL+E++A PF N +K + I+ V YP +S ++K
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--QRILNDSVTYPDKFSPASKSF 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 4e-41
Identities = 80/223 (35%), Positives = 117/223 (52%), Gaps = 14/223 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHP-FLVNLWFCFQDEE 71
KV + ++K T ++YA+K + K I+ D ++ + E +L P FL L CFQ +
Sbjct: 15 KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 74
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L+ V + + GGDL YHI Q KF + YA E+ + L +L +K II+RD+K
Sbjct: 75 RLYFVMEYVNGGDLMYHIQQVGKF-----KEPHAVFYAAEIAIGLFFLHSKGIIYRDLKL 129
Query: 132 DNILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
DN++LD EGH I DF + + + + GT YIAPEI Y SVDW
Sbjct: 130 DNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP-----YGKSVDW 184
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWS 233
W+ GV L+E+LA PFD + ++I+ V YP + S
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDEL--FQSIMEHNVSYPKSLS 225
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 6e-41
Identities = 75/223 (33%), Positives = 127/223 (56%), Gaps = 15/223 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V I + K T + YA+K + K + ++ +++V +E IL L HPF+VN+ FQDE
Sbjct: 33 RVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
++ + + ++GG+L H+ + +F ND Y EL LA +YL +K II+RD+KP+
Sbjct: 93 VYFLLEFVVGGELFTHLRKAGRF-----PNDVAKFYHAELVLAFEYLHSKDIIYRDLKPE 147
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
N+LLD +GH +TDF A + + ++ GT Y+APE+ + G+ +VDWW+
Sbjct: 148 NLLLDNKGHVKVTDFGFAKKVPDRTF--TLCGTPEYLAPEVI-----QSKGHGKAVDWWT 200
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSES 235
+GV L+E +A PF +T + + I+ + +P W +
Sbjct: 201 MGVLLYEFIAGYPPF--FDDTPFRIYEKILAGRLKFPN-WFDG 240
|
Length = 329 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 6e-41
Identities = 81/240 (33%), Positives = 127/240 (52%), Gaps = 17/240 (7%)
Query: 13 KVCIVQK---KDTKQMYAMKYMHKSQCIER-DALKNVLREMEILTTLEH-PFLVNLWFCF 67
KV +V+K D ++YAMK + K+ +++ ++ E ++L + PFLV L + F
Sbjct: 15 KVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74
Query: 68 QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
Q + L ++ D + GG+L H+ Q F + +Y E+ LALD+L II+R
Sbjct: 75 QTDTKLHLILDYVNGGELFTHLYQREHF-----TESEVRVYIAEIVLALDHLHQLGIIYR 129
Query: 128 DIKPDNILLDEEGHAHITDFNIATVL--EENQLATSMSGTKPYIAPEIFLVATDEVLGYS 185
DIK +NILLD EGH +TDF ++ EE + A S GT Y+APE+ + G+
Sbjct: 130 DIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG---GHD 186
Query: 186 YSVDWWSLGVTLFEILARGRPF--DIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQV 243
+VDWWSLGV FE+L PF D N+ + + I+ S +P S + + ++
Sbjct: 187 KAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKL 246
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-40
Identities = 82/230 (35%), Positives = 126/230 (54%), Gaps = 14/230 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILT-TLEHPFLVNLWFCFQDEE 71
KV + + K++ ++YA+K + K ++ D ++ + E IL+ HPFL L+ CFQ +
Sbjct: 10 KVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD 69
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
LF V + + GGDL +HI + +F YA E+ AL +L K II+RD+K
Sbjct: 70 RLFFVMEFVNGGDLMFHIQKSRRF-----DEARARFYAAEITSALMFLHDKGIIYRDLKL 124
Query: 132 DNILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
DN+LLD EGH + DF + + + ++ GT YIAPEI E+L Y SVDW
Sbjct: 125 DNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL----QEML-YGPSVDW 179
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240
W++GV L+E+L PF+ + + +AI+ V YPT S+ +L
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDL--FEAILNDEVVYPTWLSQDAVDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 9e-40
Identities = 66/195 (33%), Positives = 114/195 (58%), Gaps = 12/195 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V +V+ + ++ YA+K M + I ++V E +L + HPF++ L++ D+
Sbjct: 16 RVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF 75
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L+M+ + + GG+L ++ +F N T YA E+ AL+YL +K I++RD+KP+
Sbjct: 76 LYMLMEYVPGGELFSYLRNSGRF-----SNSTGLFYASEIVCALEYLHSKEIVYRDLKPE 130
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
NILLD+EGH +TDF A L + ++ GT Y+APE+ + G++ +VDWW+
Sbjct: 131 NILLDKEGHIKLTDFGFAKKLRDRTW--TLCGTPEYLAPEVI-----QSKGHNKAVDWWA 183
Query: 193 LGVTLFEILARGRPF 207
LG+ ++E+L PF
Sbjct: 184 LGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-39
Identities = 68/201 (33%), Positives = 110/201 (54%), Gaps = 14/201 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
G +VC Q + T +MYA K + K + +R L E +IL + F+V+L + ++
Sbjct: 12 GFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGT---RNDTIHLYAFELGLALDYLKTKHIIH 126
++ L +V L+ GGDL++HI Y++G + YA E+ L+ L + I++
Sbjct: 72 KDALCLVLTLMNGGDLKFHI------YNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSY 186
RD+KP+NILLD+ GH I+D +A + E + GT Y+APE V +E Y++
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPE---VVKNE--RYTF 180
Query: 187 SVDWWSLGVTLFEILARGRPF 207
S DWW LG ++E++ PF
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-39
Identities = 66/241 (27%), Positives = 112/241 (46%), Gaps = 27/241 (11%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
G +V + K T + A+K + ++ + ++ E++IL +HP +V + +
Sbjct: 12 GFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHPNIVKYYGSYLK 68
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+++L++V + GG L+ +K + I EL L+YL + IIHRDI
Sbjct: 69 KDELWIVMEFCSGGSLK----DLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDI 124
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
K NILL +G + DF ++ L + + +M GT ++APE V + Y Y D
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPE---VINGK--PYDYKAD 179
Query: 190 WWSLGVTLFEILARGRP--FDIHSNTSVKDVKAIIYSPVH------YPTAWSESTKHLLS 241
WSLG+T E LA G+P ++ +KA+ + P WS+ K L
Sbjct: 180 IWSLGITAIE-LAEGKPPYSELPP------MKALFKIATNGPPGLRNPEKWSDEFKDFLK 232
Query: 242 Q 242
+
Sbjct: 233 K 233
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-38
Identities = 82/208 (39%), Positives = 117/208 (56%), Gaps = 12/208 (5%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDE 70
+KV +V+ K T+++YAMK + K + + + V E + HPFLV L CFQ E
Sbjct: 9 AKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 68
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
LF V + + GGDL +H+ + K R Y+ E+ LAL+YL + II+RD+K
Sbjct: 69 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR-----FYSAEISLALNYLHERGIIYRDLK 123
Query: 131 PDNILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
DN+LLD EGH +TD+ + L ++ GT YIAPEI L D Y +SVD
Sbjct: 124 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI-LRGED----YGFSVD 178
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKD 217
WW+LGV +FE++A PFDI ++ D
Sbjct: 179 WWALGVLMFEMMAGRSPFDIVGSSDNPD 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-38
Identities = 84/236 (35%), Positives = 125/236 (52%), Gaps = 17/236 (7%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDE 70
+KV +V+ K Q+YAMK + K + + + V E + +PFLV L CFQ
Sbjct: 9 AKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT 68
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
LF+V + + GGDL +H+ + K R YA E+ +AL++L + II+RD+K
Sbjct: 69 SRLFLVIEYVNGGDLMFHMQRQRKLPEEHAR-----FYAAEICIALNFLHERGIIYRDLK 123
Query: 131 PDNILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
DN+LLD +GH +TD+ + L ++ GT YIAPEI L + Y +SVD
Sbjct: 124 LDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEI-LRGEE----YGFSVD 178
Query: 190 WWSLGVTLFEILARGRPFDIHS-----NTSVKDVKAIIYSPVHYPTAWSESTKHLL 240
WW+LGV +FE++A PFDI + NT + I+ P+ P S H+L
Sbjct: 179 WWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL 234
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-37
Identities = 71/200 (35%), Positives = 111/200 (55%), Gaps = 14/200 (7%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
G +V + +KKDT ++ A+K M KS + + +++VL E +ILTT + +LV L + FQD
Sbjct: 13 GYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD 72
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGT-RNDTIHLYAFELGLALDYLKTKHIIHRD 128
+E L++ + + GGD R + ++G D Y E+ A+D L IHRD
Sbjct: 73 DEYLYLAMEYVPGGDFRTLLN------NLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 129 IKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
+KP+N L+D GH +TDF ++ + A S+ G+ Y+APE+ GY ++V
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVL-----RGKGYDFTV 179
Query: 189 DWWSLGVTLFEILARGRPFD 208
D+WSLG L+E L PF
Sbjct: 180 DYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-37
Identities = 78/245 (31%), Positives = 118/245 (48%), Gaps = 56/245 (22%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+VC+V+K DT +YAMK + K+ + R+ +V E +IL ++ ++V L++ FQD+++
Sbjct: 16 EVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN 75
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L+ V D + GGD+ + + F D Y EL A++ + IHRDIKPD
Sbjct: 76 LYFVMDYIPGGDMMSLLIRLGIF-----EEDLARFYIAELTCAIESVHKMGFIHRDIKPD 130
Query: 133 NILLDEEGHAHITDFNIAT-------------------------------------VLE- 154
NIL+D +GH +TDF + T LE
Sbjct: 131 NILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLER 190
Query: 155 ------ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFD 208
+ LA S+ GT YIAPE+ L GY+ DWWS+GV L+E+L PF
Sbjct: 191 RRKRQHQRCLAHSLVGTPNYIAPEVLLRT-----GYTQLCDWWSVGVILYEMLVGQPPF- 244
Query: 209 IHSNT 213
++T
Sbjct: 245 -LADT 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-37
Identities = 78/230 (33%), Positives = 125/230 (54%), Gaps = 14/230 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEIL-TTLEHPFLVNLWFCFQDEE 71
KV + + K ++ YA+K + K +++ K+++ E +L ++HPFLV L F FQ +
Sbjct: 10 KVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 69
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L+ V D + GG+L YH+ ++ F R YA E+ AL YL + +I++RD+KP
Sbjct: 70 KLYFVLDYINGGELFYHLQRERCFLEPRAR-----FYAAEIASALGYLHSLNIVYRDLKP 124
Query: 132 DNILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
+NILLD +GH +TDF + +E N ++ GT Y+APE+ Y +VDW
Sbjct: 125 ENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL-----HKQPYDRTVDW 179
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240
W LG L+E+L PF +S + + I+ P+ + S +HLL
Sbjct: 180 WCLGAVLYEMLYGLPPF--YSRNTAEMYDNILNKPLQLKPNITNSARHLL 227
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-37
Identities = 82/236 (34%), Positives = 121/236 (51%), Gaps = 17/236 (7%)
Query: 1 MFCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHP-F 59
M G F KV + ++K T ++YA+K + K I+ D ++ + E +L + P F
Sbjct: 6 MVLGKGSF---GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF 62
Query: 60 LVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYL 119
L L CFQ + L+ V + + GGDL YHI Q KF + YA E+ + L +L
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKF-----KEPQAVFYAAEISVGLFFL 117
Query: 120 KTKHIIHRDIKPDNILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVAT 178
+ II+RD+K DN++LD EGH I DF + + + + GT YIAPEI
Sbjct: 118 HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 179 DEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSE 234
Y SVDWW+ GV L+E+LA PFD + ++I+ V YP + S+
Sbjct: 178 -----YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL--FQSIMEHNVSYPKSLSK 226
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-37
Identities = 75/230 (32%), Positives = 122/230 (53%), Gaps = 14/230 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEIL-TTLEHPFLVNLWFCFQDEE 71
KV + ++K YA+K + K +++ +++ E +L L+HPFLV L + FQ E
Sbjct: 10 KVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE 69
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L+ V D + GG+L +H+ ++ F R YA E+ A+ YL + +II+RD+KP
Sbjct: 70 KLYFVLDYVNGGELFFHLQRERCFLEPRAR-----FYAAEVASAIGYLHSLNIIYRDLKP 124
Query: 132 DNILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
+NILLD +GH +TDF + +E + ++ GT Y+APE+ Y +VDW
Sbjct: 125 ENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP-----YDRTVDW 179
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240
W LG L+E+L PF +S + I++ P+ P + + LL
Sbjct: 180 WCLGAVLYEMLYGLPPF--YSRDVSQMYDNILHKPLQLPGGKTVAACDLL 227
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 3e-37
Identities = 75/232 (32%), Positives = 120/232 (51%), Gaps = 17/232 (7%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KV +V++K T + YAMK + K I +D + + L E +L HPFL L + FQ +
Sbjct: 10 KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDR 69
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L V + GG+L +H++++ F R Y E+ AL YL + +++RD+K +
Sbjct: 70 LCFVMEYANGGELFFHLSRERVFSEDRAR-----FYGAEIVSALGYLHSCDVVYRDLKLE 124
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMS---GTKPYIAPEIFLVATDEVLGYSYSVD 189
N++LD++GH ITDF + E +M GT Y+APE+ E Y +VD
Sbjct: 125 NLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVL-----EDNDYGRAVD 177
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241
WW LGV ++E++ PF ++ K + I+ + +P S K LL+
Sbjct: 178 WWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEEIRFPRTLSPEAKSLLA 227
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-37
Identities = 86/234 (36%), Positives = 122/234 (52%), Gaps = 22/234 (9%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILT-TLEHPFLVNLWFCFQDEE 71
KV + + K T Q +A+K + K + D ++ + E +L+ EHPFL +L+ FQ +E
Sbjct: 10 KVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE 69
Query: 72 DLFMVSDLLLGGDLRYHITQDIKF-YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
+LF V + L GGDL +HI KF T YA E+ L +L +K I++RD+K
Sbjct: 70 NLFFVMEYLNGGDLMFHIQSCHKFDLPRAT------FYAAEIICGLQFLHSKGIVYRDLK 123
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQLA----TSMSGTKPYIAPEIFLVATDEVLGYSY 186
DNILLD +GH I DF + +EN L + GT YIAPEI L Y+
Sbjct: 124 LDNILLDTDGHIKIADFGMC---KENMLGDAKTCTFCGTPDYIAPEILLGQK-----YNT 175
Query: 187 SVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240
SVDWWS GV L+E+L PF H + + ++I YP + K +L
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPF--HGHDEEELFQSIRMDNPCYPRWLTREAKDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 7e-37
Identities = 82/236 (34%), Positives = 127/236 (53%), Gaps = 20/236 (8%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILT-TLEHPFLVNLWFCFQDEE 71
KV + + K + +A+K + K + D ++ + E +L E+PFL +L+ FQ +E
Sbjct: 10 KVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE 69
Query: 72 DLFMVSDLLLGGDLRYHITQDIKF--YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
LF V + L GGDL +HI +F Y YA E+ L +L +K II+RD+
Sbjct: 70 HLFFVMEFLNGGDLMFHIQDKGRFDLYRAT-------FYAAEIVCGLQFLHSKGIIYRDL 122
Query: 130 KPDNILLDEEGHAHITDFNIA--TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
K DN++LD +GH I DF + V +N+ A++ GT YIAPEI L Y++S
Sbjct: 123 KLDNVMLDRDGHIKIADFGMCKENVFGDNR-ASTFCGTPDYIAPEILQ-----GLKYTFS 176
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQV 243
VDWWS GV L+E+L PF H + + ++I HYP ++ +K +L ++
Sbjct: 177 VDWWSFGVLLYEMLIGQSPF--HGDDEDELFESIRVDTPHYPRWITKESKDILEKL 230
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-36
Identities = 74/210 (35%), Positives = 113/210 (53%), Gaps = 26/210 (12%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDL 73
V +V+ K+T+Q +AMK ++K I R+ ++ V E +ILT E+PF+V+++ F+ + L
Sbjct: 17 VYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHL 76
Query: 74 FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDN 133
MV + + GGD + ++I V D +Y E LAL+YL I+HRD+KPDN
Sbjct: 77 CMVMEYVEGGDCA-TLLKNIGALPV----DMARMYFAETVLALEYLHNYGIVHRDLKPDN 131
Query: 134 ILLDEEGHAHITDF--------NIATVLEENQLAT--------SMSGTKPYIAPEIFLVA 177
+L+ GH +TDF ++ T L E + + GT YIAPE+ L
Sbjct: 132 LLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ 191
Query: 178 TDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
GY VDWW++G+ L+E L PF
Sbjct: 192 -----GYGKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-36
Identities = 74/233 (31%), Positives = 113/233 (48%), Gaps = 20/233 (8%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEED 72
V + +K+ T +A+K + KS I ++ + NV E I+ E P++ L++ FQ ++
Sbjct: 12 VYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDY 71
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L++V + L GGD I G D Y E+ L ++ L + IIHRDIKP+
Sbjct: 72 LYLVMEYLNGGDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
N+L+D+ GH +TDF ++ EN+ GT Y+APE L D+ + DWWS
Sbjct: 127 NLLIDQTGHLKLTDFGLSRNGLENK---KFVGTPDYLAPETILGVGDDKMS-----DWWS 178
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQVHR 245
LG +FE L PF H+ T A+ + + W E K S
Sbjct: 179 LGCVIFEFLFGYPPF--HAET----PDAVFDNILSRRINWPEEVKEFCSPEAV 225
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-36
Identities = 76/230 (33%), Positives = 125/230 (54%), Gaps = 13/230 (5%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KV +V++K + + YAMK + K I +D + + L E +L HPFL +L + FQ ++
Sbjct: 10 KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDR 69
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L V + + GG+L +H++++ F TR Y E+ ALDYL + I++RD+K +
Sbjct: 70 LCFVMEYVNGGELFFHLSRERVFSEDRTR-----FYGAEIVSALDYLHSGKIVYRDLKLE 124
Query: 133 NILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
N++LD++GH ITDF + + + + GT Y+APE+ E Y +VDWW
Sbjct: 125 NLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL-----EDNDYGRAVDWW 179
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241
LGV ++E++ PF ++ K + I+ + +P S K LLS
Sbjct: 180 GLGVVMYEMMCGRLPF--YNQDHEKLFELILMEDIKFPRTLSADAKSLLS 227
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-36
Identities = 82/243 (33%), Positives = 120/243 (49%), Gaps = 58/243 (23%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V +VQKKDT ++YAMK + KS+ ++D L +V E ++L + P++V+L++ FQD +
Sbjct: 16 EVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY 75
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L+++ + L GGDL +T IK+ + D Y E LA++ + IHRDIKPD
Sbjct: 76 LYLIMEFLPGGDL---MTMLIKYDTFS--EDVTRFYMAECVLAIEAVHKLGFIHRDIKPD 130
Query: 133 NILLDEEGHAHITDFNIA--------------------------------------TVLE 154
NIL+D GH ++DF ++ T+
Sbjct: 131 NILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSS 190
Query: 155 ENQLAT----------SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
++Q+AT S GT YIAPEIFL GY DWWSLG +FE L
Sbjct: 191 KDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-----GYGQECDWWSLGAIMFECLIGW 245
Query: 205 RPF 207
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-36
Identities = 80/240 (33%), Positives = 134/240 (55%), Gaps = 17/240 (7%)
Query: 13 KVCIVQK---KDTKQMYAMKYMHKSQCIERDALKNVLR-EMEILTTL-EHPFLVNLWFCF 67
KV +V+K D+ ++YAMK + K+ +++ R E ++L + + PFLV L + F
Sbjct: 15 KVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74
Query: 68 QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
Q + L ++ D + GG+L H++Q +F + + +Y+ E+ LAL++L II+R
Sbjct: 75 QTDTKLHLILDYINGGELFTHLSQRERF-----KEQEVQIYSGEIVLALEHLHKLGIIYR 129
Query: 128 DIKPDNILLDEEGHAHITDFNIAT--VLEENQLATSMSGTKPYIAPEIFLVATDEVLGYS 185
DIK +NILLD GH +TDF ++ +E + A S GT Y+AP+I V + G+
Sbjct: 130 DIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI--VRGGDG-GHD 186
Query: 186 YSVDWWSLGVTLFEILARGRPF--DIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQV 243
+VDWWS+GV ++E+L PF D N+ + + I+ S YP S K ++ ++
Sbjct: 187 KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRL 246
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 6e-36
Identities = 82/239 (34%), Positives = 123/239 (51%), Gaps = 23/239 (9%)
Query: 1 MFCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILT-TLEHPF 59
M G F KV + ++K T ++YA+K + K I+ D ++ + E +L + + PF
Sbjct: 6 MVLGKGSF---GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 60 LVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYL 119
L L CFQ + L+ V + + GGDL Y I Q +F + YA E+ + L +L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRF-----KEPHAVFYAAEIAIGLFFL 117
Query: 120 KTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL----ATSMSGTKPYIAPEIFL 175
+K II+RD+K DN++LD EGH I DF + +EN + GT YIAPEI
Sbjct: 118 HSKGIIYRDLKLDNVMLDSEGHIKIADFGMC---KENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 176 VATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSE 234
Y SVDWW+ GV L+E+LA PF+ + ++I+ V YP + S+
Sbjct: 175 YQP-----YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQSIMEHNVAYPKSMSK 226
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 7e-36
Identities = 74/219 (33%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
+V +V++K T +YAMK M KS + ++ + E +IL+ P++ L + FQD++
Sbjct: 15 GEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD 74
Query: 72 DLFMVSDLLLGGDL-----RYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
+L++V + GGDL RY D D Y EL LA+ + +H
Sbjct: 75 NLYLVMEYQPGGDLLSLLNRYEDQFD---------EDMAQFYLAELVLAIHSVHQMGYVH 125
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQ--LATSMSGTKPYIAPEIFLV-ATDEVLG 183
RDIKP+N+L+D GH + DF A L N+ + GT YIAPE+ D
Sbjct: 126 RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 184 YSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII 222
Y DWWSLGV +E++ PF H TS K I+
Sbjct: 186 YGVECDWWSLGVIAYEMIYGRSPF--HEGTSAKTYNNIM 222
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 9e-36
Identities = 71/217 (32%), Positives = 128/217 (58%), Gaps = 14/217 (6%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR 86
A+K KS+ I++ + +V E +IL + HPF VNL+ F+DE L++V + ++GG+
Sbjct: 60 AIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFF 119
Query: 87 YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITD 146
+ ++ +F ND YA ++ L +YL++ +I++RD+KP+N+LLD++G +TD
Sbjct: 120 TFLRRNKRF-----PNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTD 174
Query: 147 FNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP 206
F A V++ ++ GT YIAPEI L +G+ + DWW+LG+ ++EIL P
Sbjct: 175 FGFAKVVDTR--TYTLCGTPEYIAPEILL-----NVGHGKAADWWTLGIFIYEILVGCPP 227
Query: 207 FDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQV 243
F ++N + + I+ +++P + KHL+ ++
Sbjct: 228 F--YANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKL 262
|
Length = 340 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-35
Identities = 72/231 (31%), Positives = 123/231 (53%), Gaps = 15/231 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KV +V++K T + YAMK + K I +D + + + E +L HPFL L + FQ +
Sbjct: 10 KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 69
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L V + GG+L +H++++ F + Y E+ AL+YL ++ +++RDIK +
Sbjct: 70 LCFVMEYANGGELFFHLSRERVF-----TEERARFYGAEIVSALEYLHSRDVVYRDIKLE 124
Query: 133 NILLDEEGHAHITDFNIAT--VLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
N++LD++GH ITDF + + + + T GT Y+APE+ E Y +VDW
Sbjct: 125 NLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVL-----EDNDYGRAVDW 178
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241
W LGV ++E++ PF ++ + + I+ + +P S K LL+
Sbjct: 179 WGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSLLA 227
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-35
Identities = 84/249 (33%), Positives = 131/249 (52%), Gaps = 21/249 (8%)
Query: 7 KFCGTS---KVCIVQK---KDTKQMYAMKYMHKSQCIERDALKNVLR-EMEILTTL-EHP 58
K GT KV +V+K DT ++YAMK + K+ +++ R E +L + + P
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 59 FLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDY 118
FLV L + FQ E L ++ D + GG++ H+ Q F D + Y+ E+ LAL++
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNF-----SEDEVRFYSGEIILALEH 120
Query: 119 LKTKHIIHRDIKPDNILLDEEGHAHITDFNIAT--VLEENQLATSMSGTKPYIAPEIFLV 176
L I++RDIK +NILLD EGH +TDF ++ + EE + S GT Y+APEI
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180
Query: 177 ATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS--NTSVKDVKAIIYSPVHYPTAWSE 234
G+ +VDWWSLG+ +FE+L PF + NT + + I+ +P+
Sbjct: 181 KG----GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGP 236
Query: 235 STKHLLSQV 243
+ LL ++
Sbjct: 237 EAQDLLHKL 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 2e-35
Identities = 70/198 (35%), Positives = 108/198 (54%), Gaps = 8/198 (4%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
G +VC Q + T +MYA K + K + +R L E +IL + F+V+L + ++
Sbjct: 12 GFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
++ L +V L+ GGDL++HI G YA E+ L+ L + I++RD+
Sbjct: 72 KDALCLVLTLMNGGDLKFHIYH---MGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDL 128
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
KP+NILLD+ GH I+D +A + E Q GT Y+APE V +E Y++S D
Sbjct: 129 KPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPE---VVKNE--RYTFSPD 183
Query: 190 WWSLGVTLFEILARGRPF 207
WW+LG L+E++A PF
Sbjct: 184 WWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-35
Identities = 72/200 (36%), Positives = 112/200 (56%), Gaps = 10/200 (5%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
+V +V+ K+T Q+YAMK ++K + ++R E ++L + ++ NL + FQDE
Sbjct: 15 GEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN 74
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTR--NDTIHLYAFELGLALDYLKTKHIIHRDI 129
+L++V D +GGDL +T KF R D Y E+ LA+D + +HRDI
Sbjct: 75 NLYLVMDYYVGGDL---LTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDI 128
Query: 130 KPDNILLDEEGHAHITDF-NIATVLEENQLATSMS-GTKPYIAPEIFLVATDEVLGYSYS 187
KPDN+LLD+ GH + DF + +L + + ++++ GT YI+PEI D Y
Sbjct: 129 KPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPE 188
Query: 188 VDWWSLGVTLFEILARGRPF 207
DWWSLGV ++E+L PF
Sbjct: 189 CDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-35
Identities = 71/234 (30%), Positives = 108/234 (46%), Gaps = 27/234 (11%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED----LFM 75
KDT ++ A+K + S E + L+ + RE+ IL++L+HP +V + +DEE +F+
Sbjct: 22 KDTGELMAVKSVELSGDSEEE-LEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80
Query: 76 --VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDN 133
VS GG L + + K I Y ++ L YL + I+HRDIK N
Sbjct: 81 EYVS----GGSLSSLLKKFGKL-----PEPVIRKYTRQILEGLAYLHSNGIVHRDIKGAN 131
Query: 134 ILLDEEGHAHITDFNIATVLEENQLA---TSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
IL+D +G + DF A L + + S+ GT ++APE V E Y + D
Sbjct: 132 ILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE---VIRGE--EYGRAADI 186
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVH--YPTAWSESTKHLLSQ 242
WSLG T+ E+ P+ N + + I S P SE K L +
Sbjct: 187 WSLGCTVIEMATGKPPWSELGN-PMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 5e-35
Identities = 75/231 (32%), Positives = 124/231 (53%), Gaps = 14/231 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KV +V++K T + YAMK + K + +D + + L E +L HPFL L + FQ +
Sbjct: 10 KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 69
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKP 131
L V + GG+L +H++++ F D Y E+ ALDYL + K++++RD+K
Sbjct: 70 LCFVMEYANGGELFFHLSRERVF-----SEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 124
Query: 132 DNILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
+N++LD++GH ITDF + +++ + GT Y+APE+ E Y +VDW
Sbjct: 125 ENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL-----EDNDYGRAVDW 179
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241
W LGV ++E++ PF ++ K + I+ + +P S K LLS
Sbjct: 180 WGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEEIRFPRTLSPEAKSLLS 228
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-35
Identities = 73/204 (35%), Positives = 116/204 (56%), Gaps = 17/204 (8%)
Query: 10 GTSKVCIVQK---KDTKQMYAMKYMHKSQCIERDA--LKNVLREMEILTTLEHPFLVNLW 64
G KV V+K DT +++AMK + K+ I R+ + E IL ++HPF+V+L
Sbjct: 8 GYGKVFQVRKVTGADTGKIFAMKVLKKAT-IVRNQKDTAHTKAERNILEAVKHPFIVDLI 66
Query: 65 FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHI 124
+ FQ L+++ + L GG+L H+ ++ F DT Y E+ LAL++L + I
Sbjct: 67 YAFQTGGKLYLILEYLSGGELFMHLEREGIFME-----DTACFYLSEISLALEHLHQQGI 121
Query: 125 IHRDIKPDNILLDEEGHAHITDFNIAT-VLEENQLATSMSGTKPYIAPEIFLVATDEVLG 183
I+RD+KP+NILLD +GH +TDF + + E + + GT Y+APEI + + G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS-----G 176
Query: 184 YSYSVDWWSLGVTLFEILARGRPF 207
+ +VDWWSLG ++++L PF
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 9e-35
Identities = 77/226 (34%), Positives = 120/226 (53%), Gaps = 15/226 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEIL-TTLEHPFLVNLWFCFQDEE 71
KV + ++K + YA+K + K + R K+++ E +L ++HPFLV L + FQ E
Sbjct: 10 KVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE 69
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L+ V D + GG+L +H+ ++ F R YA E+ AL YL + +I++RD+KP
Sbjct: 70 KLYFVLDFVNGGELFFHLQRERSFPEPRAR-----FYAAEIASALGYLHSINIVYRDLKP 124
Query: 132 DNILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
+NILLD +GH +TDF + + ++ T+ GT Y+APE+ Y +VDW
Sbjct: 125 ENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQP-----YDNTVDW 179
Query: 191 WSLGVTLFEILARGRPF---DIHSNTSVKDVKAIIYSPVHYPTAWS 233
W LG L+E+L PF D+ K ++ P TAWS
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWS 225
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-34
Identities = 68/204 (33%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
G +VC Q + T +MYA K + K + +R L E IL + F+V+L + ++
Sbjct: 12 GFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET 71
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGT---RNDTIHLYAFELGLALDYLKTKHIIH 126
++ L +V ++ GGDL++HI Y++G YA EL L+ L+ + I++
Sbjct: 72 KDALCLVLTIMNGGDLKFHI------YNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSY 186
RD+KP+NILLD+ GH I+D +A + E + GT Y+APE V +E Y++
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPE---VINNE--KYTF 180
Query: 187 SVDWWSLGVTLFEILARGRPFDIH 210
S DWW LG ++E++ PF
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-34
Identities = 65/201 (32%), Positives = 109/201 (54%), Gaps = 14/201 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
G +VC Q + T +MYA K + K + +R L E +IL + F+VNL + ++
Sbjct: 12 GFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET 71
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGT---RNDTIHLYAFELGLALDYLKTKHIIH 126
++ L +V ++ GGDL++HI Y++G + YA E+ L+ L ++ ++
Sbjct: 72 KDALCLVLTIMNGGDLKFHI------YNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSY 186
RD+KP+NILLD+ GH I+D +A + E + GT Y+APE V ++ Y+
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPE---VLNNQ--RYTL 180
Query: 187 SVDWWSLGVTLFEILARGRPF 207
S D+W LG ++E++ PF
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-34
Identities = 74/231 (32%), Positives = 117/231 (50%), Gaps = 46/231 (19%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V +VQKKDT +YAMK + K+ +E++ + ++ E +IL + ++V +++ FQD+ +
Sbjct: 16 EVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN 75
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L+++ + L GGD+ + + T+ Y E LA+D + IHRDIKPD
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQ-----FYIAETVLAIDAIHQLGFIHRDIKPD 130
Query: 133 NILLDEEGHAHITDFNIATVLEE------------------------------------N 156
N+LLD +GH ++DF + T L++
Sbjct: 131 NLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRR 190
Query: 157 QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
QLA S GT YIAPE+F+ GY+ DWWSLGV ++E+L PF
Sbjct: 191 QLAYSTVGTPDYIAPEVFMQT-----GYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-33
Identities = 74/235 (31%), Positives = 123/235 (52%), Gaps = 14/235 (5%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLRE---MEILTTLEHPFLVNLWFC 66
G +V +K DT +MYAMK + K + + L E + +++T + PF+V + +
Sbjct: 6 GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA 65
Query: 67 FQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
F + L + DL+ GGDL YH++Q + V + + + YA E+ L L+++ + +++
Sbjct: 66 FHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEAE-MRFYAAEIILGLEHMHNRFVVY 120
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSY 186
RD+KP NILLDE GH I+D +A + + S+ GT Y+APE+ Y
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGV----AYDS 175
Query: 187 SVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHLL 240
S DW+SLG LF++L PF H ++ + + V P ++S + LL
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 2e-33
Identities = 76/235 (32%), Positives = 124/235 (52%), Gaps = 14/235 (5%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLRE---MEILTTLEHPFLVNLWFC 66
G +V +K DT +MYAMK + K + + L E + +++T + PF+V + +
Sbjct: 6 GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYA 65
Query: 67 FQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
F + L + DL+ GGDL YH++Q + V + + + YA E+ L L+++ + +++
Sbjct: 66 FHTPDKLCFILDLMNGGDLHYHLSQ----HGVFSEKE-MRFYATEIILGLEHMHNRFVVY 120
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSY 186
RD+KP NILLDE GH I+D +A + + S+ GT Y+APE+ T Y
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGT----AYDS 175
Query: 187 SVDWWSLGVTLFEILARGRPFDIHSNTSVKDV-KAIIYSPVHYPTAWSESTKHLL 240
S DW+SLG LF++L PF H ++ + + V P ++S K LL
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLL 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 9e-33
Identities = 70/203 (34%), Positives = 107/203 (52%), Gaps = 23/203 (11%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDL 73
V +V+ K +KQ+YAMK + K + I+R E +I+ ++V L + FQD++ L
Sbjct: 59 VQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118
Query: 74 FMVSDLLLGGDL-----RYHITQD-IKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
+MV + + GGDL Y I + +FY+ E+ LALD + + IHR
Sbjct: 119 YMVMEYMPGGDLVNLMSNYDIPEKWARFYTA------------EVVLALDAIHSMGFIHR 166
Query: 128 DIKPDNILLDEEGHAHITDFNIATVLEENQLATSMS--GTKPYIAPEIFLVATDEVLG-Y 184
D+KPDN+LLD+ GH + DF ++ N + + GT YI+PE+ + G Y
Sbjct: 167 DVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLK--SQGGDGYY 224
Query: 185 SYSVDWWSLGVTLFEILARGRPF 207
DWWS+GV L+E+L PF
Sbjct: 225 GRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-32
Identities = 70/199 (35%), Positives = 106/199 (53%), Gaps = 10/199 (5%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V +V+ K T+++YAMK ++K + ++R E +L + ++ L + FQDE
Sbjct: 16 EVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY 75
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L++V D +GGDL +++ + D Y E+ LA+ + H +HRDIKPD
Sbjct: 76 LYLVMDYYVGGDLLTLLSK----FEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPD 131
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMS----GTKPYIAPEIFLVATDEVLGYSYSV 188
N+LLD GH + DF + L+ NQ T S GT YI+PEI D + Y
Sbjct: 132 NVLLDMNGHIRLADF--GSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 189
Query: 189 DWWSLGVTLFEILARGRPF 207
DWWSLGV ++E+L PF
Sbjct: 190 DWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 1e-32
Identities = 87/279 (31%), Positives = 129/279 (46%), Gaps = 69/279 (24%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+VC+ K DT +YAMK + K + R+ + +V E +IL ++ ++V L++ FQD+++
Sbjct: 16 EVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN 75
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L+ V D + GGD+ + + F V R Y EL LA++ + IHRDIKPD
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMEVFPEVLAR-----FYIAELTLAIESVHKMGFIHRDIKPD 130
Query: 133 NILLDEEGHAHITDFNIAT----------------------------------------- 151
NIL+D +GH +TDF + T
Sbjct: 131 NILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLK 190
Query: 152 VLEENQ-------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
LE+ LA S+ GT YIAPE+ L GY+ DWWS+GV LFE+L
Sbjct: 191 TLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-----GYTQLCDWWSVGVILFEMLVGQ 245
Query: 205 RPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQV 243
PF + T + +K I + E+T H+ QV
Sbjct: 246 PPFLAPTPTETQ-LKVINW----------ENTLHIPPQV 273
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-32
Identities = 74/231 (32%), Positives = 117/231 (50%), Gaps = 46/231 (19%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V +VQKKDT +YAMK + K+ +E++ + ++ E +IL + ++V +++ FQD+ +
Sbjct: 16 EVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN 75
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L+++ + L GGD+ + + T+ Y E LA+D + IHRDIKPD
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQ-----FYIAETVLAIDSIHQLGFIHRDIKPD 130
Query: 133 NILLDEEGHAHITDFNIATVLEE------------------------------------N 156
N+LLD +GH ++DF + T L++
Sbjct: 131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRR 190
Query: 157 QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
QLA S GT YIAPE+F+ GY+ DWWSLGV ++E+L PF
Sbjct: 191 QLAFSTVGTPDYIAPEVFMQT-----GYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-32
Identities = 73/208 (35%), Positives = 110/208 (52%), Gaps = 23/208 (11%)
Query: 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNL 63
GSS V V+ K T ++YA+K +H + + K +LRE++ L + E P++V
Sbjct: 12 GSS-----GVVYKVRHKPTGKIYALKKIHVD--GDEEFRKQLLRELKTLRSCESPYVVKC 64
Query: 64 WFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLY-AFELGLALDYL-KT 121
+ F E ++ +V + + GG L D+ VG + + Y A ++ LDYL
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSL-----ADL-LKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 122 KHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LATSMSGTKPYIAPEIFLVATDE 180
+HIIHRDIKP N+L++ +G I DF I+ VLE + GT Y++PE +
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES-- 176
Query: 181 VLGYSYSVDWWSLGVTLFEILARGR-PF 207
YSY+ D WSLG+TL E A G+ PF
Sbjct: 177 ---YSYAADIWSLGLTLLE-CALGKFPF 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 5e-32
Identities = 68/214 (31%), Positives = 112/214 (52%), Gaps = 16/214 (7%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQ 68
+V + + + ++ A+K + K + ++ LRE++IL +L P +V L+ FQ
Sbjct: 12 SFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ 68
Query: 69 DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRD 128
DE L++V + + GG L + + + + ++ AL+YL +K IIHRD
Sbjct: 69 DEGSLYLVMEYVDGGSLEDLLKKIGRKGPL--SESEALFILAQILSALEYLHSKGIIHRD 126
Query: 129 IKPDNILLDEEGH-AHITDFNIATVLEE-------NQLATSMSGTKPYIAPEIFLVATDE 180
IKP+NILLD +G + DF +A +L + L ++ GT Y+APE+ L +
Sbjct: 127 IKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLA 186
Query: 181 VLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS 214
S S D WSLG+TL+E+L PF+ N+S
Sbjct: 187 --YASSSSDIWSLGITLYELLTGLPPFEGEKNSS 218
|
Length = 384 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 6e-32
Identities = 76/243 (31%), Positives = 115/243 (47%), Gaps = 58/243 (23%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+VC+ +K DTK +YAMK + K + R+ + +V E +IL ++ ++V L++ FQD+++
Sbjct: 16 EVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 75
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L+ V D + GGD+ + + F D Y EL A++ + IHRDIKPD
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMGIF-----PEDLARFYIAELTCAVESVHKMGFIHRDIKPD 130
Query: 133 NILLDEEGHAHITDFNIAT----------------------------------------- 151
NIL+D +GH +TDF + T
Sbjct: 131 NILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLK 190
Query: 152 -----VLEENQ--LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
++Q LA S+ GT YIAPE+ L GY+ DWWS+GV L+E+L
Sbjct: 191 PLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-----GYTQLCDWWSVGVILYEMLVGQ 245
Query: 205 RPF 207
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 65/197 (32%), Positives = 111/197 (56%), Gaps = 6/197 (3%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V +V+ K+ +++AMK ++K + ++R E ++L ++ ++ L + FQDE +
Sbjct: 16 EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN 75
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L++V D +GGDL +++ + D Y E+ +A+D + H +HRDIKPD
Sbjct: 76 LYLVMDYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPD 131
Query: 133 NILLDEEGHAHITDF-NIATVLEENQLATSMS-GTKPYIAPEIFLVATDEVLGYSYSVDW 190
NIL+D GH + DF + ++E+ + +S++ GT YI+PEI D Y DW
Sbjct: 132 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDW 191
Query: 191 WSLGVTLFEILARGRPF 207
WSLGV ++E+L PF
Sbjct: 192 WSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 4e-30
Identities = 68/197 (34%), Positives = 108/197 (54%), Gaps = 9/197 (4%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V +V+ K ++++YAMK + K + I+R E +I+ P++V L+ FQD++
Sbjct: 58 EVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L+MV + + GGDL ++ Y V + Y E+ LALD + + +IHRD+KPD
Sbjct: 118 LYMVMEYMPGGDLVNLMSN----YDVPEK--WAKFYTAEVVLALDAIHSMGLIHRDVKPD 171
Query: 133 NILLDEEGHAHITDFNIATVLEENQLA--TSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
N+LLD+ GH + DF ++E + + GT YI+PE+ + Y DW
Sbjct: 172 NMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGY-YGRECDW 230
Query: 191 WSLGVTLFEILARGRPF 207
WS+GV LFE+L PF
Sbjct: 231 WSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-30
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 21/201 (10%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
+ +V + T + A+K M + + + ++ E+ I+ +HP +V+ + +
Sbjct: 31 ASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
++L++V + + GG L T I V I E+ L+YL ++++IHRDI
Sbjct: 87 GDELWVVMEYMDGGSL----TDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDI 142
Query: 130 KPDNILLDEEGHAHITDFNIATVL-EENQLATSMSGTKPY-IAPEIFLVATDEVLG--YS 185
K DNILL ++G + DF A L +E S+ GT PY +APE+ + Y
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGT-PYWMAPEV-------IKRKDYG 194
Query: 186 YSVDWWSLGVTLFEILARGRP 206
VD WSLG+ E +A G P
Sbjct: 195 PKVDIWSLGIMCIE-MAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-29
Identities = 67/197 (34%), Positives = 106/197 (53%), Gaps = 9/197 (4%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V +V+ K T+++YAMK + K + I+R E +I+ P++V L++ FQD+
Sbjct: 58 EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L+MV + + GGDL ++ Y V + Y E+ LALD + + IHRD+KPD
Sbjct: 118 LYMVMEYMPGGDLVNLMSN----YDVPEK--WARFYTAEVVLALDAIHSMGFIHRDVKPD 171
Query: 133 NILLDEEGHAHITDFNIATVLEENQLA--TSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
N+LLD+ GH + DF + + + + GT YI+PE+ + Y DW
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY-YGRECDW 230
Query: 191 WSLGVTLFEILARGRPF 207
WS+GV L+E+L PF
Sbjct: 231 WSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 9 CGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQ 68
G V V + T ++ A+K + I K +LRE++IL P++V + F
Sbjct: 14 SGV--VSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGFYGAFY 69
Query: 69 DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH-IIHR 127
+ D+ + + + GG L + +K + A + L YL KH IIHR
Sbjct: 70 NNGDISICMEYMDGGSL----DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR 125
Query: 128 DIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
D+KP NIL++ G + DF ++ L N LA + GT Y+APE + G YS
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTFVGTSSYMAPE-------RIQGNDYS 177
Query: 188 V--DWWSLGVTLFEILARGR-PFDIHSNTS 214
V D WSLG++L E LA GR P+ ++
Sbjct: 178 VKSDIWSLGLSLIE-LATGRFPYPPENDPP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-26
Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 18/198 (9%)
Query: 14 VCIVQKKDTKQMYAMKYM---HKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE 70
V + K T ++ A+K + +S+ I + AL RE+++L L HP ++ L F+ +
Sbjct: 15 VYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELNHPNIIKLLDVFRHK 70
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
DL++V + + DL Y + IK G I Y ++L L + + I+HRD+K
Sbjct: 71 GDLYLVFEFMDT-DL-YKL---IKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLK 125
Query: 131 PDNILLDEEGHAHITDFNIATVLE-ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
P+N+L++ EG + DF +A + T T+ Y APE+ L GYS VD
Sbjct: 126 PENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK----GYSTPVD 181
Query: 190 WWSLGVTLFEILARGRPF 207
WS+G E+L RP
Sbjct: 182 IWSVGCIFAELL-SRRPL 198
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-26
Identities = 70/234 (29%), Positives = 110/234 (47%), Gaps = 38/234 (16%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
V K+T Q+ A+K + +E D L+ +++E+ IL + P++V + + D
Sbjct: 18 SVYKAIHKETGQVVAIKVVP----VEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTD 72
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIH-------LYAFELGLALDYLKTKHII 125
L++V + G + DI + N T+ LY GL YL + I
Sbjct: 73 LWIVMEYCGAGSVS-----DI----MKITNKTLTEEEIAAILYQTLKGLE--YLHSNKKI 121
Query: 126 HRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLATSMSGTKPYIAPEIFLVATDEVLGY 184
HRDIK NILL+EEG A + DF ++ L + ++ GT ++APE+ GY
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI-----GY 176
Query: 185 SYSVDWWSLGVTLFEILARGRP--FDIHSNTSVKDVKAIIYSP---VHYPTAWS 233
+ D WSLG+T E +A G+P DIH ++ + I P + P WS
Sbjct: 177 NNKADIWSLGITAIE-MAEGKPPYSDIH---PMRAIFMIPNKPPPTLSDPEKWS 226
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-25
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
V V++ Q YA+K + + + ++ + E+ IL ++ HP +++ F D
Sbjct: 14 GSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN 72
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRN----DTIHLYAFELGLALDYLKTKHIIHR 127
L +V + GDL I++ K R I +L L L + I+HR
Sbjct: 73 KLCIVMEYAPFGDLSKAISKRKK-----KRKLIPEQEIWRIFIQLLRGLQALHEQKILHR 127
Query: 128 DIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
D+K NILL I D I+ VL++N +A + GT Y+APE++ + YSY
Sbjct: 128 DLKSANILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVW-----KGRPYSYK 181
Query: 188 VDWWSLGVTLFEILARGRPFD 208
D WSLG L+E+ PF+
Sbjct: 182 SDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-24
Identities = 66/200 (33%), Positives = 100/200 (50%), Gaps = 19/200 (9%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDAL-KNVLREMEILTTLEHPFLVNLWFCFQDEED 72
V + K+T ++A+K + L K +LRE+EI + + P++V + F DE
Sbjct: 17 VTKCRLKNTGMIFALKTI---TTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73
Query: 73 --LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
+ + + GG L I + +K + A + L YL ++ IIHRDIK
Sbjct: 74 SSIGIAMEYCEGGSLD-SIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIK 132
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV-- 188
P NILL +G + DF ++ L N LA + +GT Y+APE + G YS+
Sbjct: 133 PSNILLTRKGQVKLCDFGVSGEL-VNSLAGTFTGTSFYMAPE-------RIQGKPYSITS 184
Query: 189 DWWSLGVTLFEILARGR-PF 207
D WSLG+TL E+ A+ R PF
Sbjct: 185 DVWSLGLTLLEV-AQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-24
Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 15/233 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KV Q K+T A K + Q + L++ + E++IL+ +HP +V L+ + E
Sbjct: 20 KVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENK 76
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L+++ + GG L + + + G I ++ AL++L + +IHRD+K
Sbjct: 77 LWILIEFCDGGALDSIMLELER----GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAG 132
Query: 133 NILLDEEGHAHITDFNI-ATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
NILL +G + DF + A Q + GT ++APE+ T + Y Y D W
Sbjct: 133 NILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIW 192
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDVK-AIIYSP---VHYPTAWSESTKHLL 240
SLG+TL E LA+ P H + V I+ S + P+ WS S L
Sbjct: 193 SLGITLIE-LAQMEP--PHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFL 242
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-24
Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 14/191 (7%)
Query: 21 DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80
+ A+K + +C + ++ + +E++ ++ HP +V + F ++L++V L
Sbjct: 24 PNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81
Query: 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG 140
GG L I + + G I E+ L+YL + IHRDIK NILL E+G
Sbjct: 82 SGGSL-LDIMKS-SYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG 139
Query: 141 HAHITDFNIATVLEENQLATSMS-----GTKPYIAPEIFLVATDEVLGYSYSVDWWSLGV 195
I DF ++ L + T GT ++APE+ ++V GY + D WS G+
Sbjct: 140 SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM----EQVHGYDFKADIWSFGI 195
Query: 196 TLFEILARGRP 206
T E LA G
Sbjct: 196 TAIE-LATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 4e-24
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 19 KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVS 77
+ A+K + + ++ LRE I+ L+HP +V L C ++E L +V
Sbjct: 24 GDGKEVEVAVKTLKEDA--SEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP-LMIVM 80
Query: 78 DLLLGGDL----RYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDN 133
+ + GGDL R + +++ + +A ++ ++YL++K+ IHRD+ N
Sbjct: 81 EYMPGGDLLDYLRKNRPKELS-------LSDLLSFALQIARGMEYLESKNFIHRDLAARN 133
Query: 134 ILLDEEGHAHITDFNIATVLEENQLATSMSGTKPY--IAPEIFLVATDEVLGYSYSVDWW 191
L+ E I+DF ++ L ++ G P +APE ++ D W
Sbjct: 134 CLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK-----FTSKSDVW 188
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDVKAII 222
S GV L+EI G + S +V +
Sbjct: 189 SFGVLLWEIFTLGEEP--YPGMSNAEVLEYL 217
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 5e-24
Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 15/177 (8%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR-YHITQDIKFYSVGTRNDT 104
L E I+ L HP +V L E L++V++ + GGDL + K
Sbjct: 49 LEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKL-----TLKD 103
Query: 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG 164
+ A ++ ++YL++K+ +HRD+ N L+ E I+DF ++ + E+ G
Sbjct: 104 LLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGG 163
Query: 165 TK---PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSVKD 217
K ++APE + ++ D WS GV L+EI G P+ SN V +
Sbjct: 164 GKLPIKWMAPESL-----KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE 215
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 5e-24
Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 19 KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVS 77
K A+K + + ++ LRE I+ L+HP +V L C ++E L++V
Sbjct: 24 GGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEP-LYIVM 80
Query: 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD 137
+ + GGDL ++ ++ S+ + +A ++ ++YL++K+ IHRD+ N L+
Sbjct: 81 EYMEGGDLLSYLRKNRPKLSL----SDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG 136
Query: 138 EEGHAHITDFNIATVLEENQLATSMSGTKPY--IAPEIFLVATDEVLGYSYSVDWWSLGV 195
E I+DF ++ L ++ G P +APE ++ D WS GV
Sbjct: 137 ENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK-----FTSKSDVWSFGV 191
Query: 196 TLFEILARG-RPFDIHSNTSVK 216
L+EI G +P+ SN V
Sbjct: 192 LLWEIFTLGEQPYPGMSNEEVL 213
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-24
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVN 62
F +V + T Q +A+K + +E+ +L+ L+HP +V
Sbjct: 22 LDDGDFFAVKEVSLADDGQTGQ---------------EAVKQLEQEIALLSKLQHPNIVQ 66
Query: 63 LWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK 122
++E++L++ +L+ GG L K+ S I LY ++ L L+YL +
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLA---KLLKKYGSF--PEPVIRLYTRQILLGLEYLHDR 121
Query: 123 HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVL 182
+ +HRDIK NIL+D G + DF +A + E A S G+ ++APE+ +
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEV-IAQQG--- 177
Query: 183 GYSYSVDWWSLGVTLFEILARGRP 206
GY + D WSLG T+ E +A G+P
Sbjct: 178 GYGLAADIWSLGCTVLE-MATGKP 200
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 9e-24
Identities = 65/232 (28%), Positives = 113/232 (48%), Gaps = 21/232 (9%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76
V +K K++YAMK + S+ R+ + + E +L L+ +++ + F D+ L +V
Sbjct: 19 VVRKADKRVYAMKQIDLSKMNRRER-EEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV 77
Query: 77 SDLLLGGDLRYHITQDIKFYSVGTR--NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNI 134
+ GDL + +K G D + + ++ L L +L +K I+HRDIK N+
Sbjct: 78 MEYAENGDLH----KLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNL 132
Query: 135 LLDEEGHAHITDFNIATVLEENQ-LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSL 193
LD + I D +A +L +N A ++ GT Y++PE+ E Y+ D W+L
Sbjct: 133 FLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC-----EDKPYNEKSDVWAL 187
Query: 194 GVTLFEILARGRPFDIHSNTSVKDVKAII---YSPVHYPTAWSESTKHLLSQ 242
GV L+E PFD ++ ++ + II + PV +S+ L+ Q
Sbjct: 188 GVVLYECCTGKHPFDANNQGAL--ILKIIRGVFPPV--SQMYSQQLAQLIDQ 235
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-23
Identities = 54/162 (33%), Positives = 91/162 (56%), Gaps = 14/162 (8%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KV + +KK+ ++YA+K + K+ I ++ + V E + L + PF+V+L++ Q +
Sbjct: 19 KVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANN 78
Query: 73 LFMVSDLLLGGDLR--YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
+++V + L+GGD++ HI ++ + Y E+ LALDYL IIHRD+K
Sbjct: 79 VYLVMEYLIGGDVKSLLHI---YGYFD----EEMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 131 PDNILLDEEGHAHITDFNIATV-----LEENQLATSMSGTKP 167
PDN+L+ EGH +TDF ++ V L + T+ S KP
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-23
Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 21/196 (10%)
Query: 21 DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80
DT ++ A+K + + Q + +K + EM++L L+HP LV + E +++ +
Sbjct: 23 DTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81
Query: 81 LGGDL----RYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL 136
GG L + D I +Y +L L YL + I+HRDIKP NI L
Sbjct: 82 SGGTLEELLEHGRILDEH---------VIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL 132
Query: 137 DEEGHAHITDFNIATVLEENQLA-----TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
D G + DF A L+ N S++GT Y+APE+ + G+ + D W
Sbjct: 133 DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK--GHGRAADIW 190
Query: 192 SLGVTLFEILARGRPF 207
SLG + E+ RP+
Sbjct: 191 SLGCVVLEMATGKRPW 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 5e-23
Identities = 59/189 (31%), Positives = 95/189 (50%), Gaps = 13/189 (6%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79
K T ++ A+K +S+ E D K LRE+++L L H +VNL F+ + L++V +
Sbjct: 23 KATGEIVAIKKFKESEDDE-DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81
Query: 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE 139
+ + + ++ G D + Y ++L A+ Y + +IIHRDIKP+NIL+ E
Sbjct: 82 V-----ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES 136
Query: 140 GHAHITDFNIATVLEEN--QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTL 197
G + DF A L T T+ Y APE+ + T+ Y VD W++G +
Sbjct: 137 GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN----YGKPVDVWAIGCIM 192
Query: 198 FEILARGRP 206
E+L G P
Sbjct: 193 AELLD-GEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-22
Identities = 71/239 (29%), Positives = 121/239 (50%), Gaps = 21/239 (8%)
Query: 13 KVCIVQKKDTKQMYAMKYMH--KSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE 70
K +V+ K+ + Y +K ++ K ER+ + +E+ +L+ ++HP +V F++
Sbjct: 15 KAILVKSKEDGKQYVIKEINISKMSPKEREESR---KEVAVLSNMKHPNIVQYQESFEEN 71
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
+L++V D GGDL I V D I + ++ LAL ++ + I+HRDIK
Sbjct: 72 GNLYIVMDYCEGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIK 128
Query: 131 PDNILLDEEGHAHITDFNIATVLEEN-QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
NI L ++G + DF IA VL +LA + GT Y++PEI E Y+ D
Sbjct: 129 SQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC-----ENRPYNNKSD 183
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKDVKAII---YSPVHYPTAWSESTKHLLSQVHR 245
W+LG L+E+ F+ + ++ V II Y PV + +S ++L+SQ+ +
Sbjct: 184 IWALGCVLYEMCTLKHAFEAGNMKNL--VLKIIRGSYPPV--SSHYSYDLRNLVSQLFK 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 3e-22
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 34/213 (15%)
Query: 9 CGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEI-LTTLEHPFLVNLWFCF 67
CG V ++ K T + A+K M ++ ++ K +L ++++ L + + P++V + F
Sbjct: 28 CGQ--VYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYF 83
Query: 68 QDEEDLFMVSDLL----------LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALD 117
+ D+F+ +L+ + G + I + +V AL
Sbjct: 84 ITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKM---TVAIVK------------ALH 128
Query: 118 YLKTKH-IIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLV 176
YLK KH +IHRD+KP NILLD G+ + DF I+ L +++ T +G Y+APE +
Sbjct: 129 YLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPE-RID 187
Query: 177 ATDEVLGYSYSVDWWSLGVTLFEILARGR-PFD 208
D Y D WSLG++L E LA G+ P+
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVE-LATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-22
Identities = 57/184 (30%), Positives = 83/184 (45%), Gaps = 26/184 (14%)
Query: 38 ERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYS 97
D + + +E+ +L HP +V + + + L++V + GG L QDI Y
Sbjct: 40 PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL-----QDI--YQ 92
Query: 98 VGTR---NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154
V I E L YL IHRDIK NILL E+G + DF ++
Sbjct: 93 VTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSA--- 149
Query: 155 ENQLATSMS------GTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP-- 206
QL +++ GT ++APE+ V GY D W+LG+T E LA +P
Sbjct: 150 --QLTATIAKRKSFIGTPYWMAPEVAAVERKG--GYDGKCDIWALGITAIE-LAELQPPM 204
Query: 207 FDIH 210
FD+H
Sbjct: 205 FDLH 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-22
Identities = 59/189 (31%), Positives = 104/189 (55%), Gaps = 15/189 (7%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79
+T A+K + + I+ +ALK++++E+++L L+HP +V + + L+++ +
Sbjct: 22 LETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80
Query: 80 LLGGDLRYHITQDIKFYSVGTRNDT-IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE 138
G LR Q IK + G ++ + +Y +++ L YL + +IHRDIK NIL +
Sbjct: 81 AENGSLR----QIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK 134
Query: 139 EGHAHITDFNIATVLEEN-QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTL 197
+G + DF +AT L + + S+ GT ++APE+ E+ G S + D WSLG T+
Sbjct: 135 DGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI-----EMSGASTASDIWSLGCTV 189
Query: 198 FEILARGRP 206
E+L G P
Sbjct: 190 IELLT-GNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 9e-22
Identities = 42/96 (43%), Positives = 59/96 (61%), Gaps = 5/96 (5%)
Query: 115 ALDYLKTK-HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEI 173
AL+YLK + IIHRD+KP NILLD G+ + DF I+ L ++ T +G +PY+APE
Sbjct: 119 ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE- 177
Query: 174 FLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFD 208
+ GY D WSLG+TL+E +A G+ P+
Sbjct: 178 -RIDPSARDGYDVRSDVWSLGITLYE-VATGKFPYP 211
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (226), Expect = 1e-21
Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 10 GTS-KVCIVQKKDTKQMYAMKYMHKSQCIERDAL-KNVLREMEILTTLEHPFLVNLWFCF 67
GT V + K T ++ A+K + E + + LRE+ +L L+HP +V L
Sbjct: 10 GTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVI 67
Query: 68 QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
E L++V + DL+ ++ + I ++L L Y + I+HR
Sbjct: 68 HTERKLYLVFEYC-DMDLKKYL----DKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHR 122
Query: 128 DIKPDNILLDEEGHAHITDFNIATVLEENQLA-TSMSGTKPYIAPEIFLVATDEVLGYSY 186
D+KP NIL++ +G + DF +A T T Y APEI L + YS
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH----YST 178
Query: 187 SVDWWSLGVTLFEILARGRPF 207
+VD WS+G E + G+P
Sbjct: 179 AVDIWSVGCIFAE-MITGKPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-21
Identities = 68/234 (29%), Positives = 115/234 (49%), Gaps = 18/234 (7%)
Query: 16 IVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFM 75
+VQ ++ Q YAMK + + A+++ +E +L ++HP +V F+ + L++
Sbjct: 18 LVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYI 75
Query: 76 VSDLLLGGDLRYHIT-QDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNI 134
V + GGDL I Q K + DTI + ++ L + ++ K ++HRDIK NI
Sbjct: 76 VMEYCDGGDLMQKIKLQRGKLFP----EDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNI 131
Query: 135 LLDEEGHAHITDFNIATVLEE-NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSL 193
L + G + DF A +L A + GT Y+ PEI+ E + Y+ D WSL
Sbjct: 132 FLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW-----ENMPYNNKSDIWSL 186
Query: 194 GVTLFEILARGRPFDIHS--NTSVKDVKAIIYSPVHYPTAWSESTKHLLSQVHR 245
G L+E+ PF +S N +K + Y P+ P+ +S + L+ Q+ +
Sbjct: 187 GCILYELCTLKHPFQANSWKNLILKVCQG-SYKPL--PSHYSYELRSLIKQMFK 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 1e-21
Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 46/219 (21%)
Query: 9 CGT-SKVCIVQKKDTKQMYAMKYMHKSQCIERDALK-NVLREMEILTTLEHPFLVNLWFC 66
GT +V + K T ++ A+K + E++ +RE+++L L HP +V L
Sbjct: 9 EGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRL--- 63
Query: 67 FQDEE--------DLFMV--------SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAF 110
+E ++MV + LL ++++ +Q IK Y
Sbjct: 64 ---KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQ-IKCY------------MK 107
Query: 111 ELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA--TSMSGTKPY 168
+L L YL + I+HRDIK NIL++ +G + DF +A + A T+ T Y
Sbjct: 108 QLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWY 167
Query: 169 IAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
PE+ L AT Y VD WS+G L E+ G+P
Sbjct: 168 RPPELLLGATR----YGPEVDMWSVGCILAELF-LGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 2e-21
Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 21/206 (10%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVL-REMEILTTLEHPFLVNL--WFCFQD 69
V V++K ++ K + E++ K L E+ IL L+HP +V +
Sbjct: 15 TVRKVRRKSDGKILVWKEIDYGNMTEKE--KQQLVSEVNILRELKHPNIVRYYDRIIDRS 72
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTR--NDTIHLYAFELGLALDY-----LKTK 122
+ L++V + GGDL I K + I +L LAL
Sbjct: 73 NQTLYIVMEYCEGGDLAQLIQ---KCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN 129
Query: 123 HIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLATSMSGTKPYIAPEIFLVATDEV 181
++HRD+KP NI LD + + DF +A +L + A + GT Y++PE +
Sbjct: 130 TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS--- 186
Query: 182 LGYSYSVDWWSLGVTLFEILARGRPF 207
Y D WSLG ++E+ A PF
Sbjct: 187 --YDEKSDIWSLGCLIYELCALSPPF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 5e-21
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 22/199 (11%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
S+ C++++ D +M E++A K E+ +L ++HP +V + FQ+
Sbjct: 25 SEHCVIKEIDLTKMPVK---------EKEASKK---EVILLAKMKHPNIVTFFASFQENG 72
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
LF+V + GGDL I + V D I + ++ L L ++ + I+HRDIK
Sbjct: 73 RLFIVMEYCDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKS 129
Query: 132 DNILLDEEGH-AHITDFNIATVLEEN-QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
NI L + G A + DF IA L ++ +LA + GT Y++PEI + Y+ D
Sbjct: 130 QNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC-----QNRPYNNKTD 184
Query: 190 WWSLGVTLFEILARGRPFD 208
WSLG L+E+ PF+
Sbjct: 185 IWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 5e-21
Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 24/201 (11%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDAL--KNVLREMEILTTLEHPFLVNLWFCFQ--- 68
VC K T + A+K + + D + K +LRE+++L L H ++ L +
Sbjct: 16 VCSAVDKRTGRKVAIKKISN---VFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPS 72
Query: 69 --DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
D D+++V++L+ DL I +D I + +++ L YL + ++IH
Sbjct: 73 PEDFNDVYIVTELM-ETDLHKVIKSPQP-----LTDDHIQYFLYQILRGLKYLHSANVIH 126
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQLATS-MSG---TKPYIAPEIFLVATDEVL 182
RD+KP NIL++ I DF +A ++ ++ ++ T+ Y APE+ L ++
Sbjct: 127 RDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSR--- 183
Query: 183 GYSYSVDWWSLGVTLFEILAR 203
Y+ ++D WS+G E+L R
Sbjct: 184 -YTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 1e-20
Identities = 49/191 (25%), Positives = 91/191 (47%), Gaps = 19/191 (9%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDL 85
A+K + + + K+ L+E ++ L HP +V L C ++E L++V + + GGDL
Sbjct: 27 AVKTLKED--ASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEP-LYLVLEYMEGGDL 83
Query: 86 RYHITQDIKFYSVGTRNDTI-----HLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG 140
++ + + T+ +A ++ ++YL +K +HRD+ N L+ E+
Sbjct: 84 LDYL-RKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL 142
Query: 141 HAHITDFNIATVLEENQLATSMSGTKPYI---APEIFLVATDEVLGYSYSVDWWSLGVTL 197
I+DF ++ + ++ +G K I APE D + ++ D WS GV L
Sbjct: 143 VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL---KDGI--FTSKSDVWSFGVLL 197
Query: 198 FEILARGR-PF 207
+EI G P+
Sbjct: 198 WEIFTLGATPY 208
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-20
Identities = 70/239 (29%), Positives = 114/239 (47%), Gaps = 24/239 (10%)
Query: 17 VQKKDTKQMY-AMK--YMH----KSQCIERD-ALKNVLREMEILT-TLEHPFLVNLWFCF 67
V+KK+ Q A+K +H ERD ++ +++ E+ I+ L HP +V + F
Sbjct: 19 VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF 78
Query: 68 QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYL-KTKHIIH 126
+ + L++V DL+ G L H +K + I ++ LAL YL K K I+H
Sbjct: 79 LENDRLYIVMDLIEGAPLGEHFNS-LKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVH 137
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSY 186
RD+ P+NI+L E+ ITDF +A + TS+ GT Y PEI + Y
Sbjct: 138 RDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV-----KNEPYGE 192
Query: 187 SVDWWSLGVTLFEILARGRPFDIHSNT----SVKDVKAIIYSPVHYPTAWSESTKHLLS 241
D W+ G L+++ PF +S + K V+A +Y P+ +SE +++
Sbjct: 193 KADVWAFGCILYQMCTLQPPF--YSTNMLSLATKIVEA-VYEPLPEGM-YSEDVTDVIT 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-20
Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 8/189 (4%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KV + K+T + A K + + L++ + E+EIL T HP++V L F +
Sbjct: 27 KVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGK 83
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L+++ + GG + + + G I + ++ AL YL + IIHRD+K
Sbjct: 84 LWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAG 139
Query: 133 NILLDEEGHAHITDFNI-ATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
N+LL +G + DF + A ++ Q S GT ++APE+ + T + Y Y D W
Sbjct: 140 NVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIW 199
Query: 192 SLGVTLFEI 200
SLG+TL E+
Sbjct: 200 SLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-20
Identities = 53/192 (27%), Positives = 93/192 (48%), Gaps = 23/192 (11%)
Query: 22 TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH---PFLVNLWFCFQDEEDLFMVSD 78
T ++ A+K ++ D + ++ RE+ +L+ L P + + + L+++ +
Sbjct: 25 TGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82
Query: 79 LLLGGDLRYHITQ---DIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNIL 135
GG +R + K+ SV R E+ +AL Y+ +IHRDIK NIL
Sbjct: 83 YAEGGSVRTLMKAGPIAEKYISVIIR---------EVLVALKYIHKVGVIHRDIKAANIL 133
Query: 136 LDEEGHAHITDFNIATVLEENQLA-TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLG 194
+ G+ + DF +A +L +N ++ GT ++APE+ E Y D WSLG
Sbjct: 134 VTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT----EGKYYDTKADIWSLG 189
Query: 195 VTLFEILARGRP 206
+T++E+ A G P
Sbjct: 190 ITIYEM-ATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 4e-20
Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 11 TSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE 70
T VCI K T + A+K M + R+ L N E+ I+ +HP +V ++ +
Sbjct: 32 TGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN---EVVIMRDYQHPNIVEMYSSYLVG 88
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRND-----TIHLYAFELGLALDYLKTKHII 125
++L++V + L GG L +T TR + T+ L + AL +L + +I
Sbjct: 89 DELWVVMEFLEGGALTDIVTH--------TRMNEEQIATVCLAVLK---ALSFLHAQGVI 137
Query: 126 HRDIKPDNILLDEEGHAHITDFNI-ATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGY 184
HRDIK D+ILL +G ++DF A V +E S+ GT ++APE+ L Y
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-----SRLPY 192
Query: 185 SYSVDWWSLGVTLFEILARGRPF 207
VD WSLG+ + E++ P+
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-20
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCI-------ERDALKNVLREMEILTTLEHPFLVNLWF 65
+V + T +M A+K + I ++D +K + E+E L L+H +V
Sbjct: 16 RVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLG 75
Query: 66 CFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHII 125
EE L + + + GG + + +F R T + GLA YL +K I+
Sbjct: 76 FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE---GLA--YLHSKGIL 130
Query: 126 HRDIKPDNILLDEEGHAHITDFNIATVLEE---NQLATSMSGTKPYIAPEIFLVATDEVL 182
HRD+K DN+L+D +G I+DF I+ ++ N SM G+ ++APE+ + +
Sbjct: 131 HRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV--IHSYS-Q 187
Query: 183 GYSYSVDWWSLGVTLFEILARGRPF 207
GYS VD WSLG + E+ A RP+
Sbjct: 188 GYSAKVDIWSLGCVVLEMFAGRRPW 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-20
Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 17/174 (9%)
Query: 38 ERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYS 97
E +AL+ E+++L L+H +V + C +D+E L + + + GG ++ + K Y
Sbjct: 47 EVNALEC---EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL----KAYG 99
Query: 98 VGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157
T T Y ++ ++YL + I+HRDIK NIL D G+ + DF + L+
Sbjct: 100 ALTETVT-RKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158
Query: 158 LAT----SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
+ S++GT +++PE+ GY D WS+G T+ E+L P+
Sbjct: 159 SSGTGMKSVTGTPYWMSPEVISGE-----GYGRKADVWSVGCTVVEMLTEKPPW 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-19
Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
G +C ++K +++ +K + Q + +D E ++L L HP ++ + F +
Sbjct: 14 GIVHLC--RRKADQKLVIIKQIPVEQ-MTKDERLAAQNECQVLKLLSHPNIIEYYENFLE 70
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
++ L +V + GG L +I + DTI + ++ LAL ++ TK I+HRD+
Sbjct: 71 DKALMIVMEYAPGGTLAEYIQKRCNSL---LDEDTILHFFVQILLALHHVHTKLILHRDL 127
Query: 130 KPDNILLDEEGH-AHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
K NILLD+ I DF I+ +L A ++ GT YI+PE+ E Y+
Sbjct: 128 KTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC-----EGKPYNQKS 182
Query: 189 DWWSLGVTLFEILARGRPFD 208
D W+LG L+E+ + R F+
Sbjct: 183 DIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-19
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 40 DALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVG 99
DAL RE+ +L L+H +V D + L + + + GG + + F
Sbjct: 51 DALA---REIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL 107
Query: 100 TRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159
RN + ++ L+YL + IIHRDIK NIL+D +G I+DF I+ LE N L+
Sbjct: 108 VRN-----FVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLS 162
Query: 160 TSMSGTKPYIAPEIFLVATDEVLGYSYS--VDWWSLGVTLFEILARGRPFDIHSNTSVKD 217
T +G +P + +F +A + V SY+ D WSLG + E+L PF
Sbjct: 163 TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF-----PDCTQ 217
Query: 218 VKAII----YSPVHYPTAWSESTKHLLSQV 243
++AI + P+ S L +
Sbjct: 218 LQAIFKIGENASPEIPSNISSEAIDFLEKT 247
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-19
Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 17/213 (7%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V +V+ + + Y +K ++ R+ K +E ++L+ L+HP +V ++ E+
Sbjct: 15 EVSLVRHRTDGKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAYRESWEGEDG 73
Query: 73 -LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L++V GGDL YH ++ K + N + + ++ +AL YL KHI+HRD+K
Sbjct: 74 LLYIVMGFCEGGDL-YHKLKEQK-GKLLPENQVVEWFV-QIAMALQYLHEKHILHRDLKT 130
Query: 132 DNILLDEEGHAHITDFNIATVLE-ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
N+ L + D IA VLE + +A+++ GT Y++PE+F Y+Y D
Sbjct: 131 QNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP-----YNYKSDV 185
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY 223
W+LG ++E+ F+ KD+ +++Y
Sbjct: 186 WALGCCVYEMATLKHAFN------AKDMNSLVY 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-18
Identities = 61/188 (32%), Positives = 96/188 (51%), Gaps = 20/188 (10%)
Query: 22 TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81
T Q A+K M+ Q +++ + N E+ ++ +HP +VN + ++L++V + L
Sbjct: 43 TGQEVAIKQMNLQQQPKKELIIN---EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99
Query: 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAF--ELGLALDYLKTKHIIHRDIKPDNILLDEE 139
GG L +T+ T D + A E AL++L + +IHRDIK DNILL +
Sbjct: 100 GGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 151
Query: 140 GHAHITDFNI-ATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLF 198
G +TDF A + E ++M GT ++APE V T + Y VD WSLG+
Sbjct: 152 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE---VVTRK--AYGPKVDIWSLGIMAI 206
Query: 199 EILARGRP 206
E++ G P
Sbjct: 207 EMV-EGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-18
Identities = 69/238 (28%), Positives = 112/238 (47%), Gaps = 40/238 (16%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH--PFLVNLWFCFQDE 70
KV +V T+Q + +K + KS R E LT + H P +V L E
Sbjct: 8 KVLLVMDTRTQQTFILKGLRKSSEYSR----------ERLTIIPHCVPNMVCLHKYIVSE 57
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
+ +F+V GG L HI+ KF ++ + + +A E+ +ALD L + I+ RD+
Sbjct: 58 DSVFLVLQHAEGGKLWSHIS---KFLNI--PEECVKRWAAEMVVALDALHREGIVCRDLN 112
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
P+NILLD+ GH +T F+ + +E++ ++ Y APE+ + + + DW
Sbjct: 113 PNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVE--NMYCAPEV-----GGISEETEACDW 165
Query: 191 WSLGVTLFEI-----LARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQV 243
WSLG LFE+ L P I+++T++ P SE + LL Q+
Sbjct: 166 WSLGAILFELLTGKTLVECHPSGINTHTTLN-----------IPEWVSEEARSLLQQL 212
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-18
Identities = 49/197 (24%), Positives = 79/197 (40%), Gaps = 31/197 (15%)
Query: 22 TKQMYAMKYMH---KSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78
T + A+K + I LRE++ L +HP++V L F +V +
Sbjct: 24 TGETVALKKVALRRLEGGIP----NQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79
Query: 79 LLLGG------DLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+ D + + + Y L + Y+ I+HRD+KP
Sbjct: 80 YMPSDLSEVLRDEERPLPEAQ-----------VKSYMRMLLKGVAYMHANGIMHRDLKPA 128
Query: 133 NILLDEEGHAHITDFNIATVL--EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
N+L+ +G I DF +A + EE +L + T+ Y APE+ A Y VD
Sbjct: 129 NLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK----YDPGVDL 184
Query: 191 WSLGVTLFEILARGRPF 207
W++G E+L G P
Sbjct: 185 WAVGCIFAELL-NGSPL 200
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-18
Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 10 GT-SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCF 67
GT KV + K T Q+ A+K M + E + + E IL HP + + F
Sbjct: 17 GTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE----IKEEYNILRKYSNHPNIATFYGAF 72
Query: 68 ------QDEEDLFMVSDLLLGG---DLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDY 118
+++ L++V +L GG DL + ++ + + I E L Y
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDL----VKGLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 119 LKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMS-GTKPYIAPEIFLVA 177
L +IHRDIK NILL + + DF ++ L+ + GT ++APE+ +A
Sbjct: 129 LHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV--IA 186
Query: 178 TDEVLGYSYSV--DWWSLGVTLFEILARGRP--FDIH 210
DE SY D WSLG+T E LA G+P D+H
Sbjct: 187 CDEQPDASYDARSDVWSLGITAIE-LADGKPPLCDMH 222
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-18
Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 27/221 (12%)
Query: 39 RDALKNVLREMEILTTL-EHPFLVNLWFCFQDEE-----DLFMVSDLLLGGDLRYHITQD 92
D + + E IL +L HP +V + F + L++V +L GG +T+
Sbjct: 59 SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGS----VTEL 114
Query: 93 IK-FYSVGTRND--TIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNI 149
+K G R D I + L L +L IIHRD+K +NILL EG + DF +
Sbjct: 115 VKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174
Query: 150 ATVLEENQLATSMS-GTKPYIAPEIFLVATDEVLGYSYSV--DWWSLGVTLFEILARGRP 206
+ L +L + S GT ++APE+ +A ++ YSY D WSLG+T E L G P
Sbjct: 175 SAQLTSTRLRRNTSVGTPFWMAPEV--IACEQQYDYSYDARCDVWSLGITAIE-LGDGDP 231
Query: 207 --FDIHSNTSVKDVKAIIYSP---VHYPTAWSESTKHLLSQ 242
FD+H VK + I +P + +P W S H +SQ
Sbjct: 232 PLFDMH---PVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQ 269
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-18
Identities = 63/225 (28%), Positives = 109/225 (48%), Gaps = 22/225 (9%)
Query: 22 TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81
++ A+K M S + +++++E+ L L HP + C+ E ++V + L
Sbjct: 39 NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98
Query: 82 GG-----DLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL 136
G ++ Q+++ +V + GLA YL + ++IHRD+K NILL
Sbjct: 99 GSASDLLEVHKKPLQEVEIAAV--------THGALQGLA--YLHSHNMIHRDVKAGNILL 148
Query: 137 DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVT 196
E G + DF A+++ A GT ++APE+ L A DE Y VD WSLG+T
Sbjct: 149 SEPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVIL-AMDEG-QYDGKVDVWSLGIT 203
Query: 197 LFEILARGRP-FDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240
E+ R P F++++ +++ + A SP WSE ++ +
Sbjct: 204 CIELAERKPPLFNMNAMSALYHI-AQNESPALQSGHWSEYFRNFV 247
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-18
Identities = 40/96 (41%), Positives = 59/96 (61%), Gaps = 4/96 (4%)
Query: 115 ALDYLKTK-HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEI 173
AL+YL +K +IHRD+KP N+L++ G + DF I+ L ++ T +G KPY+APE
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPER 174
Query: 174 FLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFD 208
++ GY D WSLG+T+ E+ A GR P+D
Sbjct: 175 INPELNQK-GYDVKSDVWSLGITMIEL-ATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 8e-18
Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 22/196 (11%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KV Q K+T + A K + + L++ + E++IL + +HP +V L F E +
Sbjct: 20 KVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENN 76
Query: 73 LFMVSDLLLGG-------DLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHII 125
L+++ + GG +L +T+ I + + AL+YL II
Sbjct: 77 LWILIEFCAGGAVDAVMLELERPLTEP-----------QIRVVCKQTLEALNYLHENKII 125
Query: 126 HRDIKPDNILLDEEGHAHITDFNI-ATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGY 184
HRD+K NIL +G + DF + A Q S GT ++APE+ + T + Y
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 185 SYSVDWWSLGVTLFEI 200
Y D WSLG+TL E+
Sbjct: 186 DYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 9e-18
Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 19/200 (9%)
Query: 11 TSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE 70
T VCI +K T + A+K M + R+ L N E+ I+ H +V+++ +
Sbjct: 35 TGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYHHENVVDMYNSYLVG 91
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTR--NDTIHLYAFELGLALDYLKTKHIIHRD 128
++L++V + L GG L +T TR + I + AL YL + +IHRD
Sbjct: 92 DELWVVMEFLEGGALTDIVTH--------TRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143
Query: 129 IKPDNILLDEEGHAHITDFNI-ATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
IK D+ILL +G ++DF A V +E S+ GT ++APE+ L Y
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI-----SRLPYGTE 198
Query: 188 VDWWSLGVTLFEILARGRPF 207
VD WSLG+ + E++ P+
Sbjct: 199 VDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-17
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDAL-KNVLRE---MEILTTLEHPFLVNLWFCFQ 68
V + +T + A+K + + + + + LRE ++ L + EHP +V L
Sbjct: 14 TVYKARDLNTGRFVALKKVR--VPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71
Query: 69 -----DEEDLFMVSDLLLGGDLRYHITQDIKFY-----SVGTRNDTIHLYAFELGLALDY 118
E L +V + H+ QD+ Y G +TI +L +D+
Sbjct: 72 GPRTDRELKLTLVFE---------HVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 119 LKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVAT 178
L + I+HRD+KP NIL+ +G I DF +A + TS+ T Y APE+ L ++
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS 182
Query: 179 DEVLGYSYSVDWWSLGVTLFEILARGRP 206
Y+ VD WS+G E L R RP
Sbjct: 183 -----YATPVDMWSVGCIFAE-LFRRRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 1e-17
Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 19/194 (9%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKN-----VLREMEILTTLEHPFLVNLWFCFQDEEDLF 74
K+T ++ A+K K + ER K+ LRE+++L L+HP ++ L F + ++
Sbjct: 22 KETGRIVAIK---KIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNIN 78
Query: 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNI 134
+V + + DL I + I Y L+YL + I+HRD+KP+N+
Sbjct: 79 LVFEFMET-DLEKVIKDKSIVLTPAD----IKSYMLMTLRGLEYLHSNWILHRDLKPNNL 133
Query: 135 LLDEEGHAHITDFNIATVL-EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSL 193
L+ +G + DF +A N+ T T+ Y APE+ A Y VD WS+
Sbjct: 134 LIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARH----YGVGVDMWSV 189
Query: 194 GVTLFEILARGRPF 207
G E+L R PF
Sbjct: 190 GCIFAELLLR-VPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-17
Identities = 56/192 (29%), Positives = 87/192 (45%), Gaps = 23/192 (11%)
Query: 20 KDTKQMYAMKYMHKSQCIE----RDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFM 75
K T Q+ A+K I+ D ++++ +E++ L+ P++ + F L++
Sbjct: 23 KRTNQVVAIK------VIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76
Query: 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNIL 135
+ + GG + + K I E+ L L+YL + IHRDIK NIL
Sbjct: 77 IMEYCGGGSCL-DLLKPGKL-----DETYIAFILREVLLGLEYLHEEGKIHRDIKAANIL 130
Query: 136 LDEEGHAHITDFNIATVLEENQL-ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLG 194
L EEG + DF ++ L + GT ++APE V GY D WSLG
Sbjct: 131 LSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPE---VIKQS--GYDEKADIWSLG 185
Query: 195 VTLFEILARGRP 206
+T E LA+G P
Sbjct: 186 ITAIE-LAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
GT V V + T ++YA+K ++ + E + + RE+EIL + HP +V F
Sbjct: 88 GT--VYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDH 143
Query: 70 EEDLFMVSDLLLGGDLR-YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRD 128
++ ++ + + GG L HI + V A ++ + YL +HI+HRD
Sbjct: 144 NGEIQVLLEFMDGGSLEGTHIADEQFLADV----------ARQILSGIAYLHRRHIVHRD 193
Query: 129 IKPDNILLDEEGHAHITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLG-Y 184
IKP N+L++ + I DF ++ +L Q S GT Y++PE + TD G Y
Sbjct: 194 IKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNSSVGTIAYMSPE--RINTDLNHGAY 249
Query: 185 S-YSVDWWSLGVTLFEILARGRPF 207
Y+ D WSLGV++ E PF
Sbjct: 250 DGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-17
Identities = 51/189 (26%), Positives = 97/189 (51%), Gaps = 13/189 (6%)
Query: 23 KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82
++ A+K + + ++ A ++ ++E+++L L HP ++ F ++ +L +V +L
Sbjct: 27 RKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA 86
Query: 83 GDLRYHITQDIKFYSVGTR---NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE 139
GDL +Q IK++ R T+ Y +L A++++ ++ ++HRDIKP N+ +
Sbjct: 87 GDL----SQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT 142
Query: 140 GHAHITDFNIATVL-EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLF 198
G + D + + A S+ GT Y++PE GY++ D WSLG L+
Sbjct: 143 GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI-----HENGYNFKSDIWSLGCLLY 197
Query: 199 EILARGRPF 207
E+ A PF
Sbjct: 198 EMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-17
Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 20/171 (11%)
Query: 43 KNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVG--T 100
K +LRE++I+ P++V+ + F +E ++ M + + G L + Y G
Sbjct: 48 KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLD-------RIYKKGGPI 100
Query: 101 RNDTIHLYAFELGLALDYLKTKH-IIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159
+ + A + L YL H I+HRDIKP NIL++ G + DF ++ L N +A
Sbjct: 101 PVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIA 159
Query: 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSV--DWWSLGVTLFEILARGRPFD 208
+ GT Y++PE + G Y+V D WSLG+++ E+ PF
Sbjct: 160 DTFVGTSTYMSPE-------RIQGGKYTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-17
Identities = 51/185 (27%), Positives = 92/185 (49%), Gaps = 13/185 (7%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR 86
A+K + ++ A + ++E+++L L HP ++ + F ++ +L +V +L GDL
Sbjct: 31 ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL- 89
Query: 87 YHITQDIKFYSVGTR---NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAH 143
++ IK + R T+ Y +L AL+++ ++ ++HRDIKP N+ + G
Sbjct: 90 ---SRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVK 146
Query: 144 ITDFNIATVLEENQLAT-SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA 202
+ D + A S+ GT Y++PE GY++ D WSLG L+E+ A
Sbjct: 147 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI-----HENGYNFKSDIWSLGCLLYEMAA 201
Query: 203 RGRPF 207
PF
Sbjct: 202 LQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-17
Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 22/222 (9%)
Query: 22 TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81
T ++ A+K M S + +++++E++ L L+HP + C+ E ++V + L
Sbjct: 45 TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104
Query: 82 GG-----DLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL 136
G ++ Q+++ ++ + + GLA YL + ++IHRDIK NILL
Sbjct: 105 GSASDLLEVHKKPLQEVEIAAI--THGALQ------GLA--YLHSHNMIHRDIKAGNILL 154
Query: 137 DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVT 196
E G + DF A+ A S GT ++APE+ L A DE Y VD WSLG+T
Sbjct: 155 TEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVIL-AMDEG-QYDGKVDVWSLGIT 209
Query: 197 LFEILARGRP-FDIHSNTSVKDVKAIIYSPVHYPTAWSESTK 237
E+ R P F++++ +++ + A SP W++S +
Sbjct: 210 CIELAERKPPLFNMNAMSALYHI-AQNDSPTLQSNEWTDSFR 250
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 2e-17
Identities = 63/219 (28%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 22 TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81
T ++ A+K M S + +++++E++ L ++HP + C+ E ++V + L
Sbjct: 49 TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL 108
Query: 82 GG-----DLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL 136
G ++ Q+++ ++ + GLA YL + ++IHRDIK NILL
Sbjct: 109 GSASDLLEVHKKPLQEVEIAAI--------THGALQGLA--YLHSHNMIHRDIKAGNILL 158
Query: 137 DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVT 196
E G + DF A++ A S GT ++APE+ L A DE Y VD WSLG+T
Sbjct: 159 TEPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVIL-AMDEG-QYDGKVDVWSLGIT 213
Query: 197 LFEILARGRP-FDIHSNTSVKDVKAIIYSPVHYPTAWSE 234
E+ R P F++++ +++ + A SP WS+
Sbjct: 214 CIELAERKPPLFNMNAMSALYHI-AQNESPTLQSNEWSD 251
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-17
Identities = 56/190 (29%), Positives = 101/190 (53%), Gaps = 14/190 (7%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKNV-LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78
K+T Q+ A+K +S+ + +K + +RE+ +L L H LVNL F+ ++ L++V +
Sbjct: 23 KETGQIVAIKKFLESE--DDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80
Query: 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE 138
+ + + D++ Y G + Y F++ +++ + +IIHRDIKP+NIL+ +
Sbjct: 81 FV-----DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ 135
Query: 139 EGHAHITDFNIA-TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTL 197
G + DF A T+ ++ T T+ Y APE+ + T Y +VD W++G +
Sbjct: 136 SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK----YGRAVDIWAVGCLV 191
Query: 198 FEILARGRPF 207
E+L G P
Sbjct: 192 TEMLT-GEPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-17
Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 15/167 (8%)
Query: 47 REMEILTTLEHPFLVNLWFCFQD--EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDT 104
RE+EIL TL+H +V + L ++ + L G LR ++ + +
Sbjct: 55 REIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL----QRHRDQINLKR 110
Query: 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ--LATSM 162
+ L++ ++ +DYL ++ IHRD+ NIL++ E I+DF +A VL E++
Sbjct: 111 LLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKE 170
Query: 163 SGTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
G P + APE + +S + D WS GVTL+E+ G P
Sbjct: 171 PGESPIFWYAPECLRTSK-----FSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-17
Identities = 60/235 (25%), Positives = 112/235 (47%), Gaps = 21/235 (8%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76
V + T AMK + ++ ++ E++IL P++V+ + F E ++M
Sbjct: 20 VLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC 77
Query: 77 SDLLLGGDLRYHITQDIKFYSVGTRN-----DTIHLYAFELGLALDYLKTKH-IIHRDIK 130
+ + G L K Y+ G D + + + L +LK +H IIHRD+K
Sbjct: 78 MEYMDAGSLD-------KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVK 130
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPE-IFLVATDEVLGYSYSVD 189
P N+L++ G + DF ++ L + LA + G + Y+APE I ++ Y+ D
Sbjct: 131 PTNVLVNGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSD 189
Query: 190 WWSLGVTLFEILARGR-PFDIHSNTSV-KDVKAIIY-SPVHYPTAWSESTKHLLS 241
WSLG+++ E +A GR P+ + ++ + AI+ P P+ +S+ + ++
Sbjct: 190 VWSLGLSILE-MALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVA 243
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-17
Identities = 64/219 (29%), Positives = 113/219 (51%), Gaps = 33/219 (15%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIE-RDALKN-VLREMEILTTLEHPFLVNLWFCFQDEEDLF 74
VQ K + + A K +H +E + A++N ++RE+++L P++V + F + ++
Sbjct: 24 VQHKPSGLIMARKLIH----LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79
Query: 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH-IIHRDIKPDN 133
+ + + GG L + + + + + + + L YL+ KH I+HRD+KP N
Sbjct: 80 ICMEHMDGGSLDQVLKEAKRI-----PEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSN 134
Query: 134 ILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV--DWW 191
IL++ G + DF ++ L ++ +A S GT+ Y++PE + G YSV D W
Sbjct: 135 ILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-------RLQGTHYSVQSDIW 186
Query: 192 SLGVTLFEILARGR----PFDIHSNTSVKDVKAIIYSPV 226
S+G++L E LA GR P D K+++AI PV
Sbjct: 187 SMGLSLVE-LAIGRYPIPPPD------AKELEAIFGRPV 218
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-17
Identities = 54/166 (32%), Positives = 85/166 (51%), Gaps = 16/166 (9%)
Query: 45 VLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDT 104
++ E+ ++ L++P +VN F ++LF+V + L GG L +T+ T D
Sbjct: 63 IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--------TCMDE 114
Query: 105 IHLYAF--ELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNI-ATVLEENQLATS 161
+ A E AL++L +IHRDIK DN+LL +G +TDF A + E ++
Sbjct: 115 AQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174
Query: 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
M GT ++APE V T + Y VD WSLG+ E++ P+
Sbjct: 175 MVGTPYWMAPE---VVTRK--AYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 6e-17
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 32/213 (15%)
Query: 16 IVQKKDTKQMYAMKYMHKSQCIERD---ALKNV--------------LREMEILTTLEHP 58
++KK K +++ Y K+ C+ ALK V L+E+++L L+HP
Sbjct: 5 KIEKKIGKGQFSVVY--KAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 59 FLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTR---NDTIHLYAFELGLA 115
++ F + +L +V +L GDL ++ IK + R TI Y +L A
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDL----SRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 116 LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL-EENQLATSMSGTKPYIAPEIF 174
L+++ +K I+HRDIKP N+ + G + D + + A S+ GT Y++PE
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 175 LVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
GY++ D WSLG L+E+ A PF
Sbjct: 179 HEN-----GYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 7e-17
Identities = 50/165 (30%), Positives = 84/165 (50%), Gaps = 20/165 (12%)
Query: 43 KNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRN 102
K ++ E+EIL + P+++ + F E + + ++ + GG L + + I + +G
Sbjct: 44 KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL--DVYRKIPEHVLGR-- 99
Query: 103 DTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSM 162
A + L YL + I+HRD+KP N+L++ G + DF ++T L N +A +
Sbjct: 100 -----IAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTY 153
Query: 163 SGTKPYIAPEIFLVATDEVLGYSYSV--DWWSLGVTLFEILARGR 205
GT Y+APE + G Y + D WSLG++ E LA GR
Sbjct: 154 VGTNAYMAPE-------RISGEQYGIHSDVWSLGISFME-LALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 54/152 (35%), Positives = 78/152 (51%), Gaps = 22/152 (14%)
Query: 68 QDEEDLFMVS---DLLLGGDLRYHITQDIKFYSVGTRNDTIH---LYAFELGLALDYLKT 121
++ E++ M++ D GDLR Q+IK + R H L ++ LA+ ++ +
Sbjct: 106 RNPENVLMIALVLDYANAGDLR----QEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS 161
Query: 122 KHIIHRDIKPDNILLDEEGHAHITDFNI-----ATVLEENQLATSMSGTKPYIAPEIFLV 176
KH+IHRDIK NILL G + DF ATV + + + GT Y+APEI+
Sbjct: 162 KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATV--SDDVGRTFCGTPYYVAPEIWRR 219
Query: 177 ATDEVLGYSYSVDWWSLGVTLFEILARGRPFD 208
YS D +SLGV L+E+L RPFD
Sbjct: 220 KP-----YSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-16
Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 11/166 (6%)
Query: 45 VLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHIT-QDIKFYSVGTRND 103
L E+ IL+ L+HP ++ + F D+ L + + GG L I Q + + +
Sbjct: 46 ALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE----EE 101
Query: 104 TIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL-EENQLATSM 162
+ Y F++ A+ Y+ I+HRDIK NI L + G + DF I+ +L E +A ++
Sbjct: 102 MVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV 161
Query: 163 SGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFD 208
GT Y++PE+ + + Y++ D W+LG L+E+L R FD
Sbjct: 162 VGTPYYMSPELC-----QGVKYNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-16
Identities = 60/200 (30%), Positives = 101/200 (50%), Gaps = 29/200 (14%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIE-RDALKN-VLREMEILTTLEHPFLVNLWFCFQDEE 71
V V + + + A K +H +E + A++N ++RE+++L P++V + F +
Sbjct: 17 VTKVLHRPSGLIMARKLIH----LEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG 72
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIH---LYAFELGLALDYLKTKH-IIHR 127
++ + + + GG L D G + I A GL YL+ KH I+HR
Sbjct: 73 EISICMEHMDGGSL------DQVLKKAGRIPENILGKISIAVLRGLT--YLREKHKIMHR 124
Query: 128 DIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
D+KP NIL++ G + DF ++ L + +A S GT+ Y++PE + G Y+
Sbjct: 125 DVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPE-------RLQGTHYT 176
Query: 188 V--DWWSLGVTLFEILARGR 205
V D WSLG++L E +A GR
Sbjct: 177 VQSDIWSLGLSLVE-MAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-16
Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 11 TSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE 70
T VCI K + ++ A+K M + R+ L N E+ I+ +H +V ++ +
Sbjct: 33 TGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYNSYLVG 89
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGL--ALDYLKTKHIIHRD 128
++L++V + L GG L +T TR + + A L + AL L + +IHRD
Sbjct: 90 DELWVVMEFLEGGALTDIVTH--------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 129 IKPDNILLDEEGHAHITDFNI-ATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
IK D+ILL +G ++DF A V +E S+ GT ++APE+ L Y
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-----SRLPYGPE 196
Query: 188 VDWWSLGVTLFEILARGRPF 207
VD WSLG+ + E++ P+
Sbjct: 197 VDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-16
Identities = 55/193 (28%), Positives = 97/193 (50%), Gaps = 19/193 (9%)
Query: 22 TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81
TK++ A+K + + D ++++ +E+ +L+ + P++ + + L+++ + L
Sbjct: 28 TKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85
Query: 82 GGDLRYHITQDIKFYSVGTRNDT-IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG 140
GG + G +T I E+ LDYL ++ IHRDIK N+LL E+G
Sbjct: 86 GGSA-------LDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG 138
Query: 141 HAHITDFNIATVLEENQLA-TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFE 199
+ DF +A L + Q+ + GT ++APE+ + Y + D WSLG+T E
Sbjct: 139 DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-----AYDFKADIWSLGITAIE 193
Query: 200 ILARGRP--FDIH 210
LA+G P D+H
Sbjct: 194 -LAKGEPPNSDLH 205
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-16
Identities = 52/187 (27%), Positives = 94/187 (50%), Gaps = 17/187 (9%)
Query: 22 TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81
T+++ A+K + + D ++++ +E+ +L+ + P++ + + + L+++ + L
Sbjct: 28 TQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85
Query: 82 GGDLRYHITQDIKFYSVGTRNDT-IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG 140
GG + G ++T I E+ LDYL ++ IHRDIK N+LL E G
Sbjct: 86 GGSA-------LDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG 138
Query: 141 HAHITDFNIATVLEENQLATS-MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFE 199
+ DF +A L + Q+ + GT ++APE+ + Y D WSLG+T E
Sbjct: 139 EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-----AYDSKADIWSLGITAIE 193
Query: 200 ILARGRP 206
LA+G P
Sbjct: 194 -LAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 48 EMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKF------YSVGTR 101
E+ L +H +V + F+ ++ L ++ + GGDL I Q +K Y VG
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG-- 172
Query: 102 NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN---QL 158
L +++ LALD + ++ ++HRD+K NI L G + DF + ++ +
Sbjct: 173 -----LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227
Query: 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV-KD 217
A+S GT Y+APE++ E YS D WSLGV L+E+L RPF S + +
Sbjct: 228 ASSFCGTPYYLAPELW-----ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ 282
Query: 218 VKAIIYSPVHYPTAWSESTKHLL 240
V Y P +P S K LL
Sbjct: 283 VLYGKYDP--FPCPVSSGMKALL 303
|
Length = 478 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-16
Identities = 60/189 (31%), Positives = 96/189 (50%), Gaps = 19/189 (10%)
Query: 22 TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81
T Q A+K M+ Q +++ + N E+ ++ ++P +VN + ++L++V + L
Sbjct: 43 TGQEVAIKQMNLQQQPKKELIIN---EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99
Query: 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAF--ELGLALDYLKTKHIIHRDIKPDNILLDEE 139
GG L +T+ T D + A E ALD+L + +IHRDIK DNILL +
Sbjct: 100 GGSLTDVVTE--------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD 151
Query: 140 GHAHITDFNI-ATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLF 198
G +TDF A + E ++M GT ++APE V T + Y VD WSLG+
Sbjct: 152 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE---VVTRK--AYGPKVDIWSLGIMAI 206
Query: 199 EILARGRPF 207
E++ P+
Sbjct: 207 EMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-16
Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 21/171 (12%)
Query: 43 KNVLREMEILTTLEHPFLVNLWFCFQDEE----DLFMVSDLLLGGDLRYHITQDIKFYSV 98
K LRE++IL +H ++ + + D+++V DL+ DL +HI +S
Sbjct: 49 KRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDL-HHI-----IHSD 101
Query: 99 GT-RNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157
+ I + ++L L Y+ + ++IHRD+KP N+L++E+ I DF +A L +
Sbjct: 102 QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161
Query: 158 L-----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILAR 203
T T+ Y APE+ L + Y+ ++D WS+G E+L R
Sbjct: 162 TEHKYFMTEYVATRWYRAPELLLS----LPEYTTAIDMWSVGCIFAEMLGR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 3e-16
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 26/201 (12%)
Query: 14 VCIVQKKDTKQMYAMKYMHK-----SQCIERDALKNVLREMEILTTL-EHPFLVNLWFCF 67
V + + K+T ++ A+K M K +C+ LRE++ L L EHP +V L F
Sbjct: 15 VYLARNKETGELVAIKKMKKKFYSWEECMN-------LREVKSLRKLNEHPNIVKLKEVF 67
Query: 68 QDEEDLFMVSDLLLGGDLRYHI--TQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHII 125
++ ++L+ V + + G+L Y + + K +S I +++ L ++
Sbjct: 68 RENDELYFVFEYM-EGNL-YQLMKDRKGKPFS----ESVIRSIIYQILQGLAHIHKHGFF 121
Query: 126 HRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYS 185
HRD+KP+N+L+ I DF +A + T T+ Y APEI L +T YS
Sbjct: 122 HRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTS----YS 177
Query: 186 YSVDWWSLGVTLFEILARGRP 206
VD W+LG + E L RP
Sbjct: 178 SPVDIWALGCIMAE-LYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-16
Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 11 TSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE 70
T VCI ++K + + A+K M + R+ L N E+ I+ +H +V ++ +
Sbjct: 34 TGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHQNVVEMYKSYLVG 90
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
E+L+++ + L GG L ++Q + I + AL YL ++ +IHRDIK
Sbjct: 91 EELWVLMEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144
Query: 131 PDNILLDEEGHAHITDFNI-ATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
D+ILL +G ++DF A + ++ S+ GT ++APE+ Y VD
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP-----YGTEVD 199
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSP 225
WSLG+ + E++ P+ S++ V+ +K + SP
Sbjct: 200 IWSLGIMVIEMVDGEPPY--FSDSPVQAMKRLRDSP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-16
Identities = 56/183 (30%), Positives = 84/183 (45%), Gaps = 21/183 (11%)
Query: 45 VLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFY-----SV 98
VLR +E T EHP +V L+ C D L+ H+ QD+ Y
Sbjct: 54 VLRHLE---TFEHPNVVRLFDVCTVSRTDRETKLTLVF-----EHVDQDLTTYLDKVPEP 105
Query: 99 GTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158
G +TI F+L LD+L + ++HRD+KP NIL+ G + DF +A +
Sbjct: 106 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 165
Query: 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDV 218
TS+ T Y APE+ L ++ Y+ VD WS+G E+ R +P ++ V +
Sbjct: 166 LTSVVVTLWYRAPEVLLQSS-----YATPVDLWSVGCIFAEMFRR-KPL-FRGSSDVDQL 218
Query: 219 KAI 221
I
Sbjct: 219 GKI 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-15
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 18/218 (8%)
Query: 22 TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81
T ++ A+K M S + +++++E+ L L HP + C+ E ++V + L
Sbjct: 39 TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL 98
Query: 82 G--GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE 139
G D+ ++ + + I L YL + IHRDIK NILL E
Sbjct: 99 GSASDI-------LEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP 151
Query: 140 GHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG-YSYSVDWWSLGVTLF 198
G + DF A+++ A S GT ++APE+ L A DE G Y VD WSLG+T
Sbjct: 152 GTVKLADFGSASLVSP---ANSFVGTPYWMAPEVIL-AMDE--GQYDGKVDVWSLGITCI 205
Query: 199 EILARGRP-FDIHSNTSVKDVKAIIYSPVHYPTAWSES 235
E+ R P F++++ +++ + A SP WS+
Sbjct: 206 ELAERKPPLFNMNAMSALYHI-AQNDSPTLSSNDWSDY 242
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-15
Identities = 55/192 (28%), Positives = 96/192 (50%), Gaps = 14/192 (7%)
Query: 18 QKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77
+ K+TK++ A+K S+ E + + LRE+++L TL+ +V L F+ L++V
Sbjct: 21 RHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79
Query: 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD 137
+ + ++ + ++ G + + Y ++L A+ + I+HRDIKP+N+L+
Sbjct: 80 EYV-----EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS 134
Query: 138 EEGHAHITDFNIATVLEENQLA--TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGV 195
+ DF A L E A T T+ Y +PE+ L A Y +VD WS+G
Sbjct: 135 HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-----YGKAVDMWSVGC 189
Query: 196 TLFEILARGRPF 207
L E L+ G+P
Sbjct: 190 ILGE-LSDGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-15
Identities = 59/196 (30%), Positives = 102/196 (52%), Gaps = 27/196 (13%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIE-RDALKN-VLREMEILTTLEHPFLVNLWFCFQDEEDLF 74
V K + + A K +H +E + A++N ++RE+++L P++V + F + ++
Sbjct: 24 VSHKPSGLIMARKLIH----LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79
Query: 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGL--ALDYLKTKH-IIHRDIKP 131
+ + + GG L D G + I L + + L YL+ KH I+HRD+KP
Sbjct: 80 ICMEHMDGGSL------DQVLKKAGRIPEQI-LGKVSIAVIKGLTYLREKHKIMHRDVKP 132
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV--D 189
NIL++ G + DF ++ L ++ +A S GT+ Y++PE + G YSV D
Sbjct: 133 SNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-------RLQGTHYSVQSD 184
Query: 190 WWSLGVTLFEILARGR 205
WS+G++L E +A GR
Sbjct: 185 IWSMGLSLVE-MAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 4e-15
Identities = 46/228 (20%), Positives = 92/228 (40%), Gaps = 37/228 (16%)
Query: 12 SKVCIVQKKDTKQMYAMKY--MHKSQCIE---RDALKNVLREMEILTTLEHPFLVNLWFC 66
KV +++ K T++++ K IE +K+ +P + L++
Sbjct: 30 GKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKD------------NPNFIKLYYS 77
Query: 67 FQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
+ ++ D + GDL + ++ K + +L AL+ L +IIH
Sbjct: 78 VTTLKGHVLIMDYIKDGDLFDLLKKEGKL-----SEAEVKKIIRQLVEALNDLHKHNIIH 132
Query: 127 RDIKPDNILLDE-EGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG-- 183
DIK +N+L D + ++ D+ + + + GT Y +PE ++ G
Sbjct: 133 NDIKLENVLYDRAKDRIYLCDYGLCKI--IGT-PSCYDGTLDYFSPE-------KIKGHN 182
Query: 184 YSYSVDWWSLGVTLFEILARGRPFDIHSNT--SVKDVKAIIYSPVHYP 229
Y S DWW++GV +E+L PF + ++ + + +
Sbjct: 183 YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI 230
|
Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-15
Identities = 51/164 (31%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
+RE+ +L L HP +V L E L++V + L QD+K + + I
Sbjct: 47 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASPLSGI 97
Query: 106 HL-----YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE-ENQLA 159
L Y F+L L + + ++HRD+KP N+L++ EG + DF +A +
Sbjct: 98 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157
Query: 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILAR 203
T T Y APEI L YS +VD WSLG E++ R
Sbjct: 158 THEVVTLWYRAPEILLGCK----YYSTAVDIWSLGCIFAEMVTR 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-15
Identities = 58/189 (30%), Positives = 96/189 (50%), Gaps = 19/189 (10%)
Query: 22 TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81
T Q A++ M+ Q +++ + N E+ ++ ++P +VN + ++L++V + L
Sbjct: 44 TGQEVAIRQMNLQQQPKKELIIN---EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100
Query: 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAF--ELGLALDYLKTKHIIHRDIKPDNILLDEE 139
GG L +T+ T D + A E AL++L + +IHRDIK DNILL +
Sbjct: 101 GGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152
Query: 140 GHAHITDFNI-ATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLF 198
G +TDF A + E ++M GT ++APE V T + Y VD WSLG+
Sbjct: 153 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE---VVTRK--AYGPKVDIWSLGIMAI 207
Query: 199 EILARGRPF 207
E++ P+
Sbjct: 208 EMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-15
Identities = 54/193 (27%), Positives = 96/193 (49%), Gaps = 19/193 (9%)
Query: 22 TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81
T+Q+ A+K + + D ++++ +E+ +L+ + P++ + + L+++ + L
Sbjct: 28 TQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG 85
Query: 82 GGDLRYHITQDIKFYSVGTRND-TIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG 140
GG + G ++ I E+ LDYL ++ IHRDIK N+LL E+G
Sbjct: 86 GGSA-------LDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG 138
Query: 141 HAHITDFNIATVLEENQLA-TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFE 199
+ DF +A L + Q+ + GT ++APE+ + Y D WSLG+T E
Sbjct: 139 DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-----QQSAYDSKADIWSLGITAIE 193
Query: 200 ILARGRP--FDIH 210
LA+G P D+H
Sbjct: 194 -LAKGEPPNSDMH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 6e-15
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 4 GSSKFCGTSKVCIVQKKDTKQM-YAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVN 62
G F G+ + K K++ A+K + + K LRE ++ L+HP +V
Sbjct: 4 GHGNF-GSVVKGVYLMKSGKEVEVAVKTLKQEH--IAAGKKEFLREASVMAQLDHPCIVR 60
Query: 63 LWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK 122
L E L +V +L G L ++ + + + A ++ + + YL++K
Sbjct: 61 L-IGVCKGEPLMLVMELAPLGPLLKYLKKRREI-----PVSDLKELAHQVAMGMAYLESK 114
Query: 123 HIIHRDIKPDNILLDEEGHAHITDFNIATVL----EENQLATSMSGTKP--YIAPEIFLV 176
H +HRD+ N+LL A I+DF ++ L + + T +G P + APE
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT--AGRWPLKWYAPECINY 172
Query: 177 ATDEVLGYSYSVDWWSLGVTLFEILARGRP 206
+S D WS GVTL+E + G
Sbjct: 173 GK-----FSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 6e-15
Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 10 GT-SKVCIVQKKDTKQMYAMKYMHKS-QCIERDALKNVLREMEILTTLE-HPFLVNLWFC 66
GT S+V Q + T + YA+K M K + +E+ N LRE++ L L HP ++ L
Sbjct: 10 GTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV---NNLREIQALRRLSPHPNILRLIEV 66
Query: 67 FQDEED--LFMVSDLLLGGDLR-YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH 123
D + L +V +L+ D+ Y + + K + Y ++L +LD++
Sbjct: 67 LFDRKTGRLALVFELM---DMNLYELIKGRKRP---LPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 124 IIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG 183
I HRDIKP+NIL+ ++ + DF + T T+ Y APE L TD
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLL--TDGY-- 175
Query: 184 YSYSVDWWSLGVTLFEILA 202
Y +D W++G FEIL+
Sbjct: 176 YGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-15
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 28 MKYMHKSQCIERDALK-------NVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80
M Y + S + LK L E ++ TL+H LV L+ EE ++++++ +
Sbjct: 24 MGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83
Query: 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDE 138
G L + D G + L F +A + Y++ K+ IHRD++ N+L+ E
Sbjct: 84 AKGSLLDFLKSD-----EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSE 138
Query: 139 EGHAHITDFNIATVLEENQLATSMSGTK---PYIAPEIFLVATDEVLGYSYSVDWWSLGV 195
I DF +A V+E+N+ T+ G K + APE + ++ D WS G+
Sbjct: 139 SLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGS-----FTIKSDVWSFGI 192
Query: 196 TLFEILARGR-PFDIHSNTSV 215
L+EI+ G+ P+ SN+ V
Sbjct: 193 LLYEIVTYGKIPYPGMSNSDV 213
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-15
Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 15/165 (9%)
Query: 43 KNVLREMEILTTLEHPFLVNLWFCF-QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTR 101
K RE+++L L H +++L F ED++ V++LL G DL +T S
Sbjct: 54 KRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT------SRPLE 106
Query: 102 NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161
I + +++ L Y+ + ++HRD+KP NIL++E I DF +A + ++ Q+ T
Sbjct: 107 KQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI-QDPQM-TG 164
Query: 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP 206
T+ Y APEI L Y VD WS G E+L G+P
Sbjct: 165 YVSTRYYRAPEIMLTWQK----YDVEVDIWSAGCIFAEML-EGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-14
Identities = 52/184 (28%), Positives = 84/184 (45%), Gaps = 34/184 (18%)
Query: 35 QCIERD--ALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDL------ 85
+C++ D A + L E ++TTL HP LV L Q L++V++ + G L
Sbjct: 35 KCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGN-PLYIVTEYMAKGSLVDYLRS 93
Query: 86 --RYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAH 143
R IT +A ++ ++YL+ K+ +HRD+ N+L+ E+ A
Sbjct: 94 RGRAVITLA-----------QQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAK 142
Query: 144 ITDFNIATVLEENQLATSMSGTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
++DF +A + Q SG P + APE +S D WS G+ L+EI
Sbjct: 143 VSDFGLAKEASQGQ----DSGKLPVKWTAPEAL-----REKKFSTKSDVWSFGILLWEIY 193
Query: 202 ARGR 205
+ GR
Sbjct: 194 SFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-14
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 19/180 (10%)
Query: 35 QCIERDALKNV----LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHIT 90
+C++ D L ++ L+E I+ +L+H L+ L+ L MV++L G L +
Sbjct: 29 KCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLR 87
Query: 91 QDIK-FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNI 149
+D + + T + YA ++ + YL++K IHRD+ NILL + I DF +
Sbjct: 88 KDALGHFLIST----LCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGL 143
Query: 150 ATVLEENQLATSMSGTK----PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205
L +N+ M + APE +S++ D W GVTL+E+ G
Sbjct: 144 MRALPQNEDHYVMEEHLKVPFAWCAPESL-----RTRTFSHASDVWMFGVTLWEMFTYGE 198
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 45/213 (21%)
Query: 16 IVQK---KDTKQMYAMKYMHKSQCIERDALKNV------LREMEILTTL-EHPFLVNLWF 65
IV K + TK++ A+K + DA +N RE+ L L +HP +V L
Sbjct: 22 IVWKAIDRRTKEVVALKKIF-------DAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74
Query: 66 CF--QDEEDLFMVSDLL---LGGDLRYHITQDI-KFYSVGTRNDTIHLYAFELGLALDYL 119
++++D+++V + + L +R +I +D+ K Y + ++L AL Y+
Sbjct: 75 VIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIM-----------YQLLKALKYI 123
Query: 120 KTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL------EENQLATSMSGTKPYIAPEI 173
+ ++IHRD+KP NILL+ + + DF +A L EN + T T+ Y APEI
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183
Query: 174 FLVATDEVLGYSYSVDWWSLGVTLFEILARGRP 206
L +T Y+ VD WS+G L E+L G+P
Sbjct: 184 LLGSTR----YTKGVDMWSVGCILGEML-LGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-14
Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 17/196 (8%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE--- 70
VC + +T + A+K + + DA K LRE+++L L+H ++ +
Sbjct: 21 VCSAKNSETNEKVAIKKIANAFDNRIDA-KRTLREIKLLRHLDHENVIAIKDIMPPPHRE 79
Query: 71 --EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRD 128
D+++V +L+ D H Q I+ + +D + ++L L Y+ + +++HRD
Sbjct: 80 AFNDVYIVYELM---DTDLH--QIIRSSQTLS-DDHCQYFLYQLLRGLKYIHSANVLHRD 133
Query: 129 IKPDNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
+KP N+LL+ I DF +A T E+ T T+ Y APE+ L ++ Y+ +
Sbjct: 134 LKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSE----YTTA 189
Query: 188 VDWWSLGVTLFEILAR 203
+D WS+G E+L R
Sbjct: 190 IDVWSVGCIFAELLGR 205
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-14
Identities = 58/184 (31%), Positives = 93/184 (50%), Gaps = 30/184 (16%)
Query: 38 ERDALKNVL-------REMEILTTLEHP---FLVNLWF--CFQDEEDLFMVSDLLLGGDL 85
E+ A+K VL RE+ I+ L H FL + ++ CF+ E ++ L +
Sbjct: 92 EKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE-----KNIFLNVVM 146
Query: 86 RYHITQDI-KFYSVGTRNDT------IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE 138
+ I Q + K+ RN+ + LY+++L AL Y+ +K I HRD+KP N+L+D
Sbjct: 147 EF-IPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP 205
Query: 139 EGHA-HITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTL 197
H + DF A L Q + S ++ Y APE+ L AT+ Y+ +D WSLG +
Sbjct: 206 NTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATN----YTTHIDLWSLGCII 261
Query: 198 FEIL 201
E++
Sbjct: 262 AEMI 265
|
Length = 440 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-14
Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 16/166 (9%)
Query: 48 EMEILTTLEHPFLVNLWFCFQD--EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
E+++L L+H +V + C +D E+ L + + + GG ++ +K Y T + T
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVT- 108
Query: 106 HLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFN----IATVLEENQLATS 161
Y ++ + YL + I+HRDIK NIL D G+ + DF + T+ S
Sbjct: 109 RKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS 168
Query: 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
++GT +++PE V + E GY D WSLG T+ E+L P+
Sbjct: 169 VTGTPYWMSPE---VISGE--GYGRKADVWSLGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-14
Identities = 62/223 (27%), Positives = 93/223 (41%), Gaps = 59/223 (26%)
Query: 18 QKKDTKQMYAMK--YMHKSQCIERDALK-NVLREMEILTTLEHPFLVNLWFCFQDEEDL- 73
++ T ++ A+K MH E+D LRE++IL L+HP +V L + D
Sbjct: 28 RQIKTGRVVALKKILMHN----EKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83
Query: 74 ------------FMVSDL--LLGGDLRYHITQ-DIKFYSVGTRNDTIHLYAFELGLALDY 118
+M DL LL +T+ IK Y +L ++Y
Sbjct: 84 KRKRGSVYMVTPYMDHDLSGLLENP-SVKLTESQIK------------CYMLQLLEGINY 130
Query: 119 LKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA------------TSMSGTK 166
L HI+HRDIK NIL+D +G I DF +A + T++ T+
Sbjct: 131 LHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190
Query: 167 PYIAPEIFLVATDEVLG---YSYSVDWWSLGVTLFEILARGRP 206
Y PE+ +LG Y+ +VD W +G E+ R RP
Sbjct: 191 WYRPPEL-------LLGERRYTTAVDIWGIGCVFAEMFTR-RP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-14
Identities = 45/195 (23%), Positives = 84/195 (43%), Gaps = 22/195 (11%)
Query: 28 MKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRY 87
+ Y+ + + + ++ + +E+ ++ L HP ++ + ++ + + + GG
Sbjct: 33 VTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGS--- 89
Query: 88 HITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH-AHITD 146
++ + Y I+ Y +L L YL IIHRD+K N+L+D G I D
Sbjct: 90 -VSHLLSKYGAFKEAVIIN-YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIAD 147
Query: 147 FNIA-----TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSY--SVDWWSLGVTLFE 199
F A + + GT ++APE+ + G Y S D WS+G + E
Sbjct: 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV-------LRGEQYGRSCDVWSVGCVIIE 200
Query: 200 ILARGRPF--DIHSN 212
+ P+ + HSN
Sbjct: 201 MATAKPPWNAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-14
Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 16/166 (9%)
Query: 48 EMEILTTLEHPFLVNLWFCFQDEED--LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
E+++L L H +V + C +D E+ L + + + GG ++ +K Y T N T
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVT- 108
Query: 106 HLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFN----IATVLEENQLATS 161
Y ++ + YL + I+HRDIK NIL D G+ + DF I T+ S
Sbjct: 109 RRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168
Query: 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
++GT +++PE V + E GY D WS+ T+ E+L P+
Sbjct: 169 VTGTPYWMSPE---VISGE--GYGRKADVWSVACTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-14
Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 25/219 (11%)
Query: 18 QKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77
+ K T+ + A+K + E A +RE+ +L L+H +V L E L +V
Sbjct: 25 RSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82
Query: 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD 137
+ L DL+ ++ S+ + ++ F+L L Y + I+HRD+KP N+L++
Sbjct: 83 EYL-DSDLKQYLDNCGNLMSM----HNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN 137
Query: 138 EEGHAHITDFNIA------TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
E+G + DF +A T N++ T Y P++ L +T+ YS +D W
Sbjct: 138 EKGELKLADFGLARAKSVPTKTYSNEVVTLW-----YRPPDVLLGSTE----YSTPIDMW 188
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPT 230
+G L+E +A GRP + ++VK+ +I+ + PT
Sbjct: 189 GVGCILYE-MATGRP--MFPGSTVKEELHLIFRLLGTPT 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 9e-14
Identities = 43/190 (22%), Positives = 89/190 (46%), Gaps = 21/190 (11%)
Query: 39 RDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSV 98
A K +L E ++ +++HP +V L + +++ L+ G L ++
Sbjct: 50 PKANKEILDEAYVMASVDHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNH------ 102
Query: 99 GTRNDTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156
+ +L + + +A + YL+ K ++HRD+ N+L+ H ITDF +A +L+ +
Sbjct: 103 KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162
Query: 157 QLATSMSGTK---PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIHSN 212
+ G K ++A E L Y++ D WS GVT++E++ G +P++
Sbjct: 163 EKEYHAEGGKVPIKWMALESILHRI-----YTHKSDVWSYGVTVWELMTFGAKPYE---G 214
Query: 213 TSVKDVKAII 222
++ ++
Sbjct: 215 IPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 41 ALKNVLREMEILTTLEHPFLVNLWFCFQDE-----EDLFMVSDLLLGGDLRYHITQDIKF 95
+ K V RE+++L +H +++ Q E++++V++ L+ DL I
Sbjct: 42 SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE-LMQSDLHKIIVSPQPL 100
Query: 96 YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE- 154
S D + ++ +++ L YL + I+HRDIKP N+L++ I DF +A V E
Sbjct: 101 SS-----DHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155
Query: 155 -ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT 213
E++ T T+ Y APEI + + Y+ +VD WS+G E+L R F + +
Sbjct: 156 DESKHMTQEVVTQYYRAPEILMGSRH----YTSAVDIWSVGCIFAELLGRRILF--QAQS 209
Query: 214 SVKDVKAII-----YSPVHYPTAWSESTKHLLSQVHR 245
++ + I S +A + H+L H+
Sbjct: 210 PIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHK 246
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-13
Identities = 51/194 (26%), Positives = 85/194 (43%), Gaps = 24/194 (12%)
Query: 44 NVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFY--SVGTR 101
+ LRE+ +L L+H +V L+ ++ L +V + + QD+K Y S
Sbjct: 45 SALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE---------YCDQDLKKYFDSCNGD 95
Query: 102 ND--TIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159
D + + F+L L + + +++HRD+KP N+L+++ G + DF +A
Sbjct: 96 IDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPV 153
Query: 160 TSMSG---TKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK 216
S T Y P++ A YS S+D WS G E+ GRP + V
Sbjct: 154 RCYSAEVVTLWYRPPDVLFGAK----LYSTSIDMWSAGCIFAELANAGRP--LFPGNDVD 207
Query: 217 DVKAIIYSPVHYPT 230
D I+ + PT
Sbjct: 208 DQLKRIFRLLGTPT 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-13
Identities = 52/166 (31%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 48 EMEILTTLEHPFLVNLWFCFQD--EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
E+++L L H +V + C +D E L + + + GG I +K Y T N T
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVT- 108
Query: 106 HLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA----TS 161
Y ++ + YL + I+HRDIK NIL D G+ + DF + L+ L+ S
Sbjct: 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS 168
Query: 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
++GT +++PE V + E GY D WS+G T+ E+L P+
Sbjct: 169 VTGTPYWMSPE---VISGE--GYGRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-13
Identities = 50/180 (27%), Positives = 85/180 (47%), Gaps = 19/180 (10%)
Query: 43 KNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRN 102
K+ L E +I+ L HP L+ L+ EE +++V++L+ G L ++ R
Sbjct: 46 KDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG------AGRA 99
Query: 103 DTIHL---YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159
+ A ++ + YL+ ++ IHRD+ N+L+ E + DF +A V++E+
Sbjct: 100 LKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158
Query: 160 TSMSGTK---PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSV 215
+ G K + APE L +S D WS G+ L EI+ GR P+ +N V
Sbjct: 159 EAREGAKFPIKWTAPEAALYNR-----FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV 213
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-13
Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 19/193 (9%)
Query: 21 DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD--EEDLFMVSD 78
T +M A+K + K +C +++ +E+ IL TL H +V C + + L ++ +
Sbjct: 31 GTGEMVAVKTL-KRECGQQNT-SGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88
Query: 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE 138
+ G LR ++ + + + + L+A ++ + YL ++H IHRD+ N+LLD
Sbjct: 89 YVPLGSLRDYLPK----HKLNLAQ--LLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN 142
Query: 139 EGHAHITDFNIATVLEENQL--ATSMSGTKPYIAPEIFLVATD--EVLGYSYSVDWWSLG 194
+ I DF +A + E G P +F A + + +SY+ D WS G
Sbjct: 143 DRLVKIGDFGLAKAVPEGHEYYRVREDGDSP-----VFWYAVECLKENKFSYASDVWSFG 197
Query: 195 VTLFEILARGRPF 207
VTL+E+L
Sbjct: 198 VTLYELLTHCDSK 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 27/202 (13%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCF------ 67
VC T + A+K + + A K RE+ +L ++H ++ L F
Sbjct: 31 VCSAFDTKTGRKVAIKKLSRPFQSAIHA-KRTYRELRLLKHMDHENVIGLLDVFTPASSL 89
Query: 68 QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
+D +D+++V+ L+ G DL +I + K +D I +++ L Y+ + IIHR
Sbjct: 90 EDFQDVYLVTHLM-GADL-NNIVKCQKL-----SDDHIQFLVYQILRGLKYIHSAGIIHR 142
Query: 128 DIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG---TKPYIAPEIFLVATDEVLGY 184
D+KP NI ++E+ I DF +A M+G T+ Y APEI L + Y
Sbjct: 143 DLKPSNIAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRAPEIML----NWMHY 193
Query: 185 SYSVDWWSLGVTLFEILARGRP 206
+ +VD WS+G + E+L G+
Sbjct: 194 NQTVDIWSVGCIMAELLT-GKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-13
Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 25/189 (13%)
Query: 43 KNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRN 102
K RE++IL T+ H ++NL ++ + + MV + D+ ++ R+
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV--------MP-KYKCDL--FTYVDRS 179
Query: 103 DTIHL---YAFELGL--ALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157
+ L + L AL YL + IIHRD+K +NI LDE +A + DF A L+ +
Sbjct: 180 GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239
Query: 158 LATS---MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP-FDIHSNT 213
SGT +PE L+A D Y D WS G+ LFE+ + F +
Sbjct: 240 DTPQCYGWSGTLETNSPE--LLALDP---YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294
Query: 214 SVKDVKAII 222
S +++II
Sbjct: 295 SSSQLRSII 303
|
Length = 392 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-13
Identities = 47/174 (27%), Positives = 84/174 (48%), Gaps = 14/174 (8%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
+ E +++ L HP LV L+ ++ L++V++ + G L ++ Q S D +
Sbjct: 47 IEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLS----KDML 102
Query: 106 HLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGT 165
++ ++YL+ IHRD+ N L+ G ++DF + + +++ TS SG
Sbjct: 103 LSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGA 161
Query: 166 K---PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSV 215
K + PE+F + YS D WS GV ++E+ G+ PF+ SN V
Sbjct: 162 KFPVKWSPPEVFNFSK-----YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-13
Identities = 50/195 (25%), Positives = 95/195 (48%), Gaps = 18/195 (9%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR 86
A+K + + E D + E +++ L HP LV L+ + +F+V++ + G L
Sbjct: 32 AIKMIREGAMSEDD----FIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87
Query: 87 YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITD 146
++ + D ++ A++YL++ IHRD+ N L+ E+ ++D
Sbjct: 88 NYLRERKGKLGTEWLLDM----CSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSD 143
Query: 147 FNIATVLEENQLATSMSGTK---PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILAR 203
F +A + ++Q TS GTK + PE+F + +S D WS GV ++E+ +
Sbjct: 144 FGLARYVLDDQY-TSSQGTKFPVKWAPPEVFDYSR-----FSSKSDVWSFGVLMWEVFSE 197
Query: 204 GR-PFDIHSNTSVKD 217
G+ P++ SN+ V +
Sbjct: 198 GKMPYERFSNSEVVE 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-13
Identities = 51/169 (30%), Positives = 76/169 (44%), Gaps = 19/169 (11%)
Query: 44 NVLREMEILTTLE---HPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFY--- 96
+ +RE+ +L LE HP +V L C D L+ H+ QD++ Y
Sbjct: 45 STVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVF-----EHVDQDLRTYLDK 99
Query: 97 --SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154
G +TI + LD+L I+HRD+KP+NIL+ G + DF +A +
Sbjct: 100 VPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159
Query: 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILAR 203
T + T Y APE+ L +T Y+ VD WS+G E+ R
Sbjct: 160 CQMALTPVVVTLWYRAPEVLLQST-----YATPVDMWSVGCIFAEMFRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 4e-13
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 33/207 (15%)
Query: 14 VCIVQKKDTKQMYAMK----YMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW----- 64
VC K T A+K + H++ C LRE++IL +H ++ +
Sbjct: 21 VCSATHKPTGVKVAIKKISPFEHQTFCQR------TLREIKILRRFKHENIIGILDIIRP 74
Query: 65 FCFQDEEDLFMVSDLLLGGDLRYHI-TQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH 123
F+ D+++V +L+ DL I TQ + ND I + +++ L Y+ + +
Sbjct: 75 PSFESFNDVYIVQELM-ETDLYKLIKTQHLS-------NDHIQYFLYQILRGLKYIHSAN 126
Query: 124 IIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSM----SGTKPYIAPEIFLVATD 179
++HRD+KP N+LL+ I DF +A + + T T+ Y APEI L +
Sbjct: 127 VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSK- 185
Query: 180 EVLGYSYSVDWWSLGVTLFEILARGRP 206
GY+ ++D WS+G L E+L+ RP
Sbjct: 186 ---GYTKAIDIWSVGCILAEMLS-NRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-13
Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 18 QKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77
+ K T + A+K + E A +RE+ +L L+H +V L E+ L +V
Sbjct: 26 RSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83
Query: 78 DLLLGGDLRYHITQDIKFYSVGTRN----DTIHLYAFELGLALDYLKTKHIIHRDIKPDN 133
+ ++ +D+K Y N + L+ F+L L+Y + ++HRD+KP N
Sbjct: 84 E---------YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQN 134
Query: 134 ILLDEEGHAHITDFNIA------TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
+L++E G + DF +A T N++ T Y P+I L +TD YS
Sbjct: 135 LLINERGELKLADFGLARAKSIPTKTYSNEVVTLW-----YRPPDILLGSTD----YSTQ 185
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPT 230
+D W +G +E ++ GRP + ++V++ I+ + PT
Sbjct: 186 IDMWGVGCIFYE-MSTGRP--LFPGSTVEEQLHFIFRILGTPT 225
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 6e-13
Identities = 55/190 (28%), Positives = 93/190 (48%), Gaps = 16/190 (8%)
Query: 20 KDTKQMYAMKYMHKSQCIERDAL--KNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77
++T Q+ A+K +S E D + K LRE+ +L L+HP LVNL F+ + L +V
Sbjct: 23 RETGQIVAIKKFVES---EDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79
Query: 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD 137
+ + + +++ G I ++ A+++ + IHRD+KP+NIL+
Sbjct: 80 EYC-----DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT 134
Query: 138 EEGHAHITDFNIATVLEENQLA-TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVT 196
++G + DF A +L T T+ Y APE+ + T Y VD W++G
Sbjct: 135 KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ----YGPPVDVWAIGCV 190
Query: 197 LFEILARGRP 206
E+L G+P
Sbjct: 191 FAELL-TGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-13
Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 8/154 (5%)
Query: 48 EMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHL 107
E ++L+ L+HP +V F + + ++++ G DL + + + N
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 108 YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLATSMSGTK 166
+ +L L + Y+ + I+HRD+K NI L + I DF ++ +L + LAT+ +GT
Sbjct: 112 F-IQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTP 169
Query: 167 PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEI 200
Y++PE + GY D WSLG L+E+
Sbjct: 170 YYMSPEAL-----KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-12
Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 21/178 (11%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
L+E +I+ L H LV L+ +EE +++V++ + G L + F G +
Sbjct: 49 LQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSL-------LDFLKSGEGKK-L 100
Query: 106 HL-----YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160
L A ++ + YL++++ IHRD+ NIL+ E I DF +A ++E+++
Sbjct: 101 RLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160
Query: 161 SMSGTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSV 215
P + APE ++ D WS G+ L EI+ GR P+ +N V
Sbjct: 161 REGAKFPIKWTAPEAANYGR-----FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV 213
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 25/219 (11%)
Query: 18 QKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77
+ K T+ + A+K + E A +RE+ +L L+H +V L ++ L +V
Sbjct: 26 RSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83
Query: 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD 137
+ L DL+ ++ S+ N I LY GLA Y + ++HRD+KP N+L++
Sbjct: 84 EYL-DKDLKQYMDDCGNIMSM--HNVKIFLYQILRGLA--YCHRRKVLHRDLKPQNLLIN 138
Query: 138 EEGHAHITDFNIA------TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
E G + DF +A T N++ T Y P++ L +++ YS +D W
Sbjct: 139 ERGELKLADFGLARAKSVPTKTYSNEVVTLW-----YRPPDVLLGSSE----YSTQIDMW 189
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPT 230
+G FE +A GRP + ++V+D +I+ + PT
Sbjct: 190 GVGCIFFE-MASGRP--LFPGSTVEDELHLIFRLLGTPT 225
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-12
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 29/204 (14%)
Query: 48 EMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHL 107
E +++ L HP LV L+ + + +V + + G L ++ +S T
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL------ 102
Query: 108 YAFELGLALD------YLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161
LG+ LD YL++ ++IHRD+ N L+ E ++DF + + ++Q TS
Sbjct: 103 ----LGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS 157
Query: 162 MSGTK---PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTS-VK 216
+GTK + +PE+F + YS D WS GV ++E+ + G+ P++ SN+ V+
Sbjct: 158 STGTKFPVKWSSPEVFSFSK-----YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE 212
Query: 217 DVKA--IIYSPVHYPTAWSESTKH 238
+ A +Y P + E +H
Sbjct: 213 TINAGFRLYKPRLASQSVYELMQH 236
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-12
Identities = 40/107 (37%), Positives = 56/107 (52%), Gaps = 8/107 (7%)
Query: 103 DTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE-EGHAHITDFNIATVLEE-NQLAT 160
TI Y ++ L YL I+HRDIK DN+L++ G I+DF + L N
Sbjct: 108 QTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167
Query: 161 SMSGTKPYIAPEIFLVATDE-VLGYSYSVDWWSLGVTLFEILARGRP 206
+ +GT Y+APE+ D+ GY D WSLG T+ E +A G+P
Sbjct: 168 TFTGTLQYMAPEVI----DKGPRGYGAPADIWSLGCTIVE-MATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-12
Identities = 48/175 (27%), Positives = 87/175 (49%), Gaps = 16/175 (9%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDL-RYHITQDIKFYSVGTRNDT 104
L E ++ L+HP LV L + +E ++++++ + G L + T + ++ D
Sbjct: 49 LAEANLMKQLQHPRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDM 107
Query: 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG 164
A ++ + +++ K+ IHRD++ NIL+ E I DF +A ++E+N+ T+ G
Sbjct: 108 ----AAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREG 162
Query: 165 TK---PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSV 215
K + APE T ++ D WS G+ L EI+ GR P+ +N V
Sbjct: 163 AKFPIKWTAPEAINYGT-----FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-12
Identities = 54/184 (29%), Positives = 87/184 (47%), Gaps = 13/184 (7%)
Query: 24 QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGG 83
Q+ A+K + E +RE +L L+H +V L +E L V + +
Sbjct: 31 QLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HT 87
Query: 84 DLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAH 143
DL ++ Q + G + L+ F+L L Y+ +HI+HRD+KP N+L+ G
Sbjct: 88 DLAQYMIQ----HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELK 143
Query: 144 ITDFNIATVLE-ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA 202
+ DF +A +Q +S T Y P++ L ATD YS ++D W G E+L
Sbjct: 144 LADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD----YSSALDIWGAGCIFIEML- 198
Query: 203 RGRP 206
+G+P
Sbjct: 199 QGQP 202
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-12
Identities = 39/177 (22%), Positives = 87/177 (49%), Gaps = 16/177 (9%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
+ E +++ L H LV L+ + +++V++ + G L ++ G R
Sbjct: 47 IEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLR------EHGKRFQPS 100
Query: 106 HL--YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMS 163
L ++ + YL++K IHRD+ N L+D++G ++DF ++ + +++ +S+
Sbjct: 101 QLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160
Query: 164 GTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSVKD 217
P + PE+ L + +S D W+ GV ++E+ + G+ P++ +N+ +
Sbjct: 161 SKFPVRWSPPEVLLYSK-----FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE 212
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-12
Identities = 44/161 (27%), Positives = 83/161 (51%), Gaps = 19/161 (11%)
Query: 47 REMEILTTLEHPFLVNLWFCF------QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGT 100
RE+ +L ++H ++ L F ++ ++++V++L+ G DL +K +
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADL----NNIVKCQKLS- 116
Query: 101 RNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160
++ + ++L L Y+ + IIHRD+KP N+ ++E+ I DF +A ++ T
Sbjct: 117 -DEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM--T 173
Query: 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
T+ Y APEI L + Y+ +VD WS+G + E+L
Sbjct: 174 GYVATRWYRAPEIML----NWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-12
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 32/196 (16%)
Query: 38 ERDALKNV---------LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYH 88
++ A+KN+ L E ++T L H LV L L++V +L+ G+L
Sbjct: 30 QKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL-HNGLYIVMELMSKGNL--- 85
Query: 89 ITQDIKFYSVGTRN--DTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHI 144
+ F R I L F L +A ++YL++K ++HRD+ NIL+ E+G A +
Sbjct: 86 ----VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKV 141
Query: 145 TDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
+DF +A V + S K + APE +S D WS GV L+E+ + G
Sbjct: 142 SDFGLARV-GSMGVDNSKLPVK-WTAPEALKHKK-----FSSKSDVWSYGVLLWEVFSYG 194
Query: 205 R-PFDIHSNTSVKDVK 219
R P+ S+K+VK
Sbjct: 195 RAPY---PKMSLKEVK 207
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-12
Identities = 69/245 (28%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCI--ERDALKNVLREMEILTTLEHPFLVNLWFCF--- 67
KV V K A+K + I E +A N+L+ + +HP +V + +
Sbjct: 33 KVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPNVVKFYGMYYKK 87
Query: 68 --QDEEDLFMVSDLLLGGDLRYHITQDIK-FYSVGTR-NDTIHLYAF-ELGLALDYLKTK 122
++ + L++V +L GG +T +K F G R + I Y E + L +L
Sbjct: 88 DVKNGDQLWLVLELCNGGS----VTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN 143
Query: 123 HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMS-GTKPYIAPEIFLVATDEV 181
IHRD+K +NILL EG + DF ++ L +L + S GT ++APE+ +A ++
Sbjct: 144 KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV--IACEQQ 201
Query: 182 LGYSYSV--DWWSLGVTLFEILARGRP--FDIHSNTSVKDVKAIIYSPVHYPTAWSESTK 237
L +Y D WSLG+T E L G P D+H ++ + +H P WS
Sbjct: 202 LDSTYDARCDVWSLGITAIE-LGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFN 260
Query: 238 HLLSQ 242
+ +
Sbjct: 261 DFIRK 265
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-12
Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 13/170 (7%)
Query: 45 VLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR--YHITQDIKFYSVGTRN 102
V +E+ ++ +H +V + + + L++ + GG L+ YH+T +
Sbjct: 53 VQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLS-------E 105
Query: 103 DTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNI-ATVLEENQLATS 161
I + E L YL +K +HRDIK NILL + GH + DF + A + S
Sbjct: 106 SQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165
Query: 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP-FDIH 210
GT ++APE+ A + GY+ D W++G+T E+ P FD+H
Sbjct: 166 FIGTPYWMAPEV--AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-12
Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 15/162 (9%)
Query: 47 REMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIH 106
+E++ L L H L++L+ E ++++++L+ G L + G
Sbjct: 51 KEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS-----PEGQVLPVAS 105
Query: 107 L--YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG 164
L A ++ + YL+ ++ IHRD+ NIL+ E+ + DF +A +++E+ +S
Sbjct: 106 LIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS-DK 164
Query: 165 TKPY--IAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
PY APE T +S D WS G+ L+E+ G
Sbjct: 165 KIPYKWTAPEAASHGT-----FSTKSDVWSFGILLYEMFTYG 201
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-12
Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 22/194 (11%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79
K T Q+ AMK + + + E +RE+ +L L+HP +V L E L+++ +
Sbjct: 22 KKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80
Query: 80 LLGGDLRYHITQDIKFYSVGTRND------TIHLYAFELGLALDYLKTKHIIHRDIKPDN 133
L + D+K Y + Y +++ + + ++ ++HRD+KP N
Sbjct: 81 L---------SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQN 131
Query: 134 ILLDEEGHAHITDFNIATVLE-ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
+L+D +G + DF +A ++ T T Y APE+ L + YS VD WS
Sbjct: 132 LLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR----YSTPVDIWS 187
Query: 193 LGVTLFEILARGRP 206
+G T+F +A +P
Sbjct: 188 IG-TIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-12
Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 29/184 (15%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
L+E IL HP +V L ++ +++V +L+ GGD + R +
Sbjct: 41 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-----------RTEGP 89
Query: 106 HLYAFEL-------GLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158
L EL ++YL++KH IHRD+ N L+ E+ I+DF ++ EE+ +
Sbjct: 90 RLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGV 148
Query: 159 ATSMSGTK----PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNT 213
S G K + APE YS D WS G+ L+E + G P+ SN
Sbjct: 149 YASTGGMKQIPVKWTAPEALNYGR-----YSSESDVWSFGILLWEAFSLGAVPYANLSNQ 203
Query: 214 SVKD 217
++
Sbjct: 204 QTRE 207
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 6e-12
Identities = 50/162 (30%), Positives = 75/162 (46%), Gaps = 10/162 (6%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
+RE+ +L L HP +V L E L++V + L DL+ ++ G I
Sbjct: 46 IREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDS---SPLTGLDPPLI 101
Query: 106 HLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-TSMSG 164
Y ++L + Y + ++HRD+KP N+L+D EG + DF +A T
Sbjct: 102 KSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV 161
Query: 165 TKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP 206
T Y APEI L + YS VD WS+G +F + RP
Sbjct: 162 TLWYRAPEILLGSRQ----YSTPVDIWSIG-CIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-12
Identities = 47/165 (28%), Positives = 84/165 (50%), Gaps = 19/165 (11%)
Query: 43 KNVLREMEILTTLEHPFLVNLWFCF------QDEEDLFMVSDLLLGGDLRYHITQDIKFY 96
K RE+ +L ++H ++ L F ++ D+++V+ L+ G DL +I + K
Sbjct: 61 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLN-NIVKCQKL- 117
Query: 97 SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156
+D + +++ L Y+ + IIHRD+KP N+ ++E+ I DF +A ++
Sbjct: 118 ----TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173
Query: 157 QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
T T+ Y APEI L + Y+ +VD WS+G + E+L
Sbjct: 174 M--TGYVATRWYRAPEIML----NWMHYNQTVDIWSVGCIMAELL 212
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 47/167 (28%), Positives = 64/167 (38%), Gaps = 23/167 (13%)
Query: 21 DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED-LFMVSDL 79
T A+K + E RE + L HP +V L + LF V +
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH---IIHRDIKPDNILL 136
+ G LR + D +T L LD L H I+HRD+KP NI++
Sbjct: 61 VPGRTLREVLAAD----GALPAGETGRLML----QVLDALACAHNQGIVHRDLKPQNIMV 112
Query: 137 ---DEEGHAHITDFNIATVL------EENQL--ATSMSGTKPYIAPE 172
HA + DF I T+L + L T + GT Y APE
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-11
Identities = 55/188 (29%), Positives = 93/188 (49%), Gaps = 22/188 (11%)
Query: 21 DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNL-WFCFQ-DEEDLFMVSD 78
+T ++ A+K K Q + L++ RE+EIL +L+H +V C+ +L +V +
Sbjct: 31 NTGEVVAVK---KLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87
Query: 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHL--YAFELGLALDYLKTKHIIHRDIKPDNILL 136
L G LR ++ + + R D L YA ++ ++YL +K +HRD+ NIL+
Sbjct: 88 YLPYGSLRDYLQKHRE------RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV 141
Query: 137 DEEGHAHITDFNIATVLEENQ--LATSMSGTKP--YIAPEIFLVATDEVLGYSYSVDWWS 192
+ E I DF + VL +++ G P + APE T+ +S + D WS
Sbjct: 142 ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL---TESK--FSVASDVWS 196
Query: 193 LGVTLFEI 200
GV L+E+
Sbjct: 197 FGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-11
Identities = 50/183 (27%), Positives = 82/183 (44%), Gaps = 27/183 (14%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
L+E EIL +HP +V L ++ +++V +L+ GG L + + +V
Sbjct: 40 LQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL---- 95
Query: 106 HLYAFELGLALD------YLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159
L ++LD YL++K+ IHRD+ N L+ E I+DF ++ EE +
Sbjct: 96 ------LQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRE-EEGGIY 148
Query: 160 TSMSGTK----PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTS 214
T G K + APE Y+ D WS G+ L+E + G P+ SN
Sbjct: 149 TVSDGLKQIPIKWTAPEALNYGR-----YTSESDVWSYGILLWETFSLGDTPYPGMSNQQ 203
Query: 215 VKD 217
++
Sbjct: 204 TRE 206
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-11
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 25/202 (12%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDL 73
VC + T A+K +++ E A K RE+ +L ++H ++ L F + L
Sbjct: 31 VCSALDRRTGAKVAIKKLYRPFQSELFA-KRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89
Query: 74 FMVSDLLL-----GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRD 128
D L G DL + +K + D I +++ L Y+ IIHRD
Sbjct: 90 DRFHDFYLVMPFMGTDL----GKLMKHEKLS--EDRIQFLVYQMLKGLKYIHAAGIIHRD 143
Query: 129 IKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG---TKPYIAPEIFLVATDEVLGYS 185
+KP N+ ++E+ I DF +A Q + M+G T+ Y APE+ L + Y+
Sbjct: 144 LKPGNLAVNEDCELKILDFGLA-----RQTDSEMTGYVVTRWYRAPEVIL----NWMHYT 194
Query: 186 YSVDWWSLGVTLFEILARGRPF 207
+VD WS+G + E+L G+P
Sbjct: 195 QTVDIWSVGCIMAEMLT-GKPL 215
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-11
Identities = 44/175 (25%), Positives = 81/175 (46%), Gaps = 12/175 (6%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
L+E +++ L H LV L + EE +++V++ + G L + + R +
Sbjct: 49 LQEAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGE---MGKYLRLPQL 104
Query: 106 HLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGT 165
A ++ + Y++ + +HRD++ NIL+ E + DF +A ++E+N+
Sbjct: 105 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 164
Query: 166 KP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSVKD 217
P + APE L ++ D WS G+ L E+ +GR P+ N V D
Sbjct: 165 FPIKWTAPEAALYGR-----FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 214
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-11
Identities = 43/175 (24%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 41 ALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVG 99
A K +L E ++ ++++P + L C L ++ L+ G L ++ + ++G
Sbjct: 52 ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKD--NIG 107
Query: 100 TRNDTIHL--YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157
++ +L + ++ ++YL+ + ++HRD+ N+L+ H ITDF +A +L ++
Sbjct: 108 SQ----YLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
Query: 158 LATSMSGTK---PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFD 208
G K ++A E L Y++ D WS GVT++E++ G +P+D
Sbjct: 164 KEYHAEGGKVPIKWMALESILHRI-----YTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-11
Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 22/201 (10%)
Query: 19 KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVS 77
+ A+K M K E+D L +++ EME++ + +H ++NL E L++V
Sbjct: 38 NPNETSTVAVK-MLKDDATEKD-LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV 95
Query: 78 DLLLGGDLRYH------ITQDIKFYSVGTRNDTIHLY-----AFELGLALDYLKTKHIIH 126
+ G+LR + +T+ A+++ +++L +K IH
Sbjct: 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIH 155
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMS-GTKPY--IAPEIFLVATDEVLG 183
RD+ N+L+ E+ I DF +A + + G P +APE D V
Sbjct: 156 RDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF---DRV-- 210
Query: 184 YSYSVDWWSLGVTLFEILARG 204
Y++ D WS GV L+EI G
Sbjct: 211 YTHQSDVWSFGVLLWEIFTLG 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-11
Identities = 37/113 (32%), Positives = 54/113 (47%), Gaps = 4/113 (3%)
Query: 101 RNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLA 159
+ D I E+ L +L +IHRDIK N+LL E + DF ++ L+
Sbjct: 119 KEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 178
Query: 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP--FDIH 210
+ GT ++APE+ + Y Y D WSLG+T E +A G P D+H
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE-MAEGAPPLCDMH 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-11
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCF-----Q 68
VC T + A+K ++ DA + +LRE+++L L HP +V + +
Sbjct: 16 VCSAIDTHTGEKVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDIVEIKHIMLPPSRR 74
Query: 69 DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRD 128
+ +D+++V +L+ DL Q IK T + + ++L AL Y+ T ++ HRD
Sbjct: 75 EFKDIYVVFELM-ESDLH----QVIKANDDLTP-EHHQFFLYQLLRALKYIHTANVFHRD 128
Query: 129 IKPDNILLDEEGHAHITDFNIATVLEENQ----LATSMSGTKPYIAPEI---FLVATDEV 181
+KP NIL + + I DF +A V + T T+ Y APE+ F
Sbjct: 129 LKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK---- 184
Query: 182 LGYSYSVDWWSLGVTLFEILARGRP 206
Y+ ++D WS+G E+L G+P
Sbjct: 185 --YTPAIDIWSIGCIFAEVL-TGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-11
Identities = 51/198 (25%), Positives = 98/198 (49%), Gaps = 20/198 (10%)
Query: 17 VQKKDTKQM-YAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNL-WFCFQDEEDLF 74
V K KQ+ A+K + E+ ++RE EI+ L++P++V + C + E L
Sbjct: 15 VYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVC--EAEALM 70
Query: 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNI 134
+V ++ GG L ++ +V + +H ++ + + YL+ K+ +HRD+ N+
Sbjct: 71 LVMEMASGGPLNKFLSGKKDEITVSNVVELMH----QVSMGMKYLEGKNFVHRDLAARNV 126
Query: 135 LLDEEGHAHITDFNIATVL--EENQLATSMSGTKP--YIAPEIFLVATDEVLGYSYSVDW 190
LL + +A I+DF ++ L +++ +G P + APE +S D
Sbjct: 127 LLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK-----FSSRSDV 181
Query: 191 WSLGVTLFEILARG-RPF 207
WS G+T++E + G +P+
Sbjct: 182 WSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-11
Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 16/175 (9%)
Query: 35 QCIERDALKNV-LREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQD 92
+CI+ DA L E ++T L H LV L +++ L++V++ + G L ++
Sbjct: 35 KCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 94
Query: 93 IKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATV 152
+ G D + ++ ++ A++YL+ + +HRD+ N+L+ E+ A ++DF
Sbjct: 95 GRSVLGG---DCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFG---- 147
Query: 153 LEENQLATSMSGTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205
L + +T +G P + APE A E +S D WS G+ L+EI + GR
Sbjct: 148 LTKEASSTQDTGKLPVKWTAPE----ALREKK-FSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 7e-11
Identities = 44/163 (26%), Positives = 80/163 (49%), Gaps = 13/163 (7%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQ-DIKFYSVGTRNDT 104
L+E +I+ L H LV L + EE +++V++ + G L + + D K+ + D
Sbjct: 49 LQEAQIMKKLRHDKLVPL-YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM 107
Query: 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG 164
A ++ + Y++ + IHRD++ NIL+ + I DF +A ++E+N+
Sbjct: 108 ----AAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163
Query: 165 TKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205
P + APE L ++ D WS G+ L E++ +GR
Sbjct: 164 KFPIKWTAPEAALYGR-----FTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-10
Identities = 40/157 (25%), Positives = 76/157 (48%), Gaps = 10/157 (6%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
+RE +L L+H +V L +E L +V + + + Q + + G + +
Sbjct: 51 IREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-----HTDLCQYMDKHPGGLHPENV 105
Query: 106 HLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE-ENQLATSMSG 164
L+ F+L L Y+ ++I+HRD+KP N+L+ + G + DF +A + ++
Sbjct: 106 KLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV 165
Query: 165 TKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
T Y P++ L +T+ YS +D W +G E++
Sbjct: 166 TLWYRPPDVLLGSTE----YSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-10
Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKN-VLREMEILTTLEHPFLVN 62
GS F GT K + + K +++ A+K + ALK+ +LRE ++ L++P++V
Sbjct: 4 GSGNF-GTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVR 60
Query: 63 -LWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT 121
+ C + E +V +L G L + ++ K + + +H ++ + + YL+
Sbjct: 61 MIGIC--EAESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVH----QVSMGMKYLEE 113
Query: 122 KHIIHRDIKPDNILLDEEGHAHITDFNIATVL--EENQLATSMSGTKP--YIAPEIFLVA 177
+ +HRD+ N+LL + +A I+DF ++ L +EN G P + APE
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM--- 170
Query: 178 TDEVLGYSYSVDWWSLGVTLFEILARG-RPF 207
+S D WS GV ++E + G +P+
Sbjct: 171 --NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 51/219 (23%), Positives = 93/219 (42%), Gaps = 26/219 (11%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+ ++ ++ K++ A+K + K DA K+ RE E+LT +H +V + + +
Sbjct: 25 ECYHLEPENDKELVAVKTL-KETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82
Query: 73 LFMVSDLLLGGD----LRYHITQDIKFYSVGTRNDT-------IHLYAFELGLALDYLKT 121
MV + + GD LR H D F + + A ++ + YL +
Sbjct: 83 PIMVFEYMEHGDLNKFLRSH-GPDAAF-LKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140
Query: 122 KHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL----ATSMSGTKPYIAPEIFLVA 177
+H +HRD+ N L+ + I DF ++ + +M + ++ PE +
Sbjct: 141 QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR-WMPPESIMYR 199
Query: 178 TDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSV 215
++ D WS GV L+EI G+ P+ SN V
Sbjct: 200 K-----FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 30/199 (15%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALK-NVLREMEILTTLEHPFLVNLWFCFQDE--EDLFMV 76
+ ++ A+K + ERD + + LRE+ +L L HP +V L + + +F+V
Sbjct: 29 TTSGEIVALKKVRMDN--ERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86
Query: 77 -----SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
DL L ++ V + L L YL IIHRD+K
Sbjct: 87 MEYCEQDL---ASLLDNMPTPFSESQV----KCLMLQLLR---GLQYLHENFIIHRDLKV 136
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSG---TKPYIAPEIFLVATDEVLGYSYSV 188
N+LL ++G I DF +A A M+ T Y APE+ L T Y+ ++
Sbjct: 137 SNLLLTDKGCLKIADFGLARTYGL--PAKPMTPKVVTLWYRAPELLLGCTT----YTTAI 190
Query: 189 DWWSLGVTLFEILARGRPF 207
D W++G L E+LA +P
Sbjct: 191 DMWAVGCILAELLA-HKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-10
Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 15/176 (8%)
Query: 40 DALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR--YHITQDIKFYS 97
D + +E+ ++ +H +V + + E L++ + GG L+ YH+T +
Sbjct: 48 DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLS--- 104
Query: 98 VGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157
I E L YL +K +HRDIK NILL + G + DF +A +
Sbjct: 105 ----ELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160
Query: 158 LA-TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP--FDIH 210
S GT ++APE+ A ++ GY+ D W++G+T E LA +P FD+H
Sbjct: 161 AKRKSFIGTPYWMAPEV--AAVEKNGGYNQLCDIWAVGITAIE-LAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 31/172 (18%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDL-----FMVSDLLLGGDLRYHITQDIKFYSVGT 100
+RE +L L+H +V L ++ L ++ +DL Q + G
Sbjct: 51 IREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDL----------KQYMDDCGGGL 100
Query: 101 RNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA------TVLE 154
+ L+ F+L L Y + ++HRD+KP N+L+ E G + DF +A +
Sbjct: 101 SMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160
Query: 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP 206
N++ T Y P++ L +T+ YS S+D W +G +E +A GRP
Sbjct: 161 SNEVVTLW-----YRPPDVLLGSTE----YSTSLDMWGVGCIFYE-MATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-10
Identities = 49/189 (25%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 31 MHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHI 89
M KS E+D L +++ EME++ + +H ++NL + L+++ + G+LR ++
Sbjct: 57 MLKSDATEKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 115
Query: 90 TQ----DIKFYSVGTRNDTIHLY-------AFELGLALDYLKTKHIIHRDIKPDNILLDE 138
+++ T+ L A+++ ++YL +K IHRD+ N+L+ E
Sbjct: 116 RARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175
Query: 139 EGHAHITDFNIATVLEE-NQLATSMSGTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGV 195
+ I DF +A + + + +G P ++APE D + Y++ D WS GV
Sbjct: 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF---DRI--YTHQSDVWSFGV 230
Query: 196 TLFEILARG 204
L+EI G
Sbjct: 231 LLWEIFTLG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 115 ALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-----TSMSGTKPYI 169
L Y+ + +++HRD+KP N+L++ + I DF +A EN T T+ Y
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR 176
Query: 170 APEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
APEI L Y+ ++D WS+G L E+L R +P
Sbjct: 177 APEIML----SFQSYTKAIDVWSVGCILAELLGR-KPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-10
Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 36 CIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKF 95
C + L+E I+ +HP +V L + +++V +L G+LR ++ +
Sbjct: 45 CTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYS 103
Query: 96 YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155
+ + + LY+++L AL YL++K +HRDI N+L+ + DF ++ LE+
Sbjct: 104 LDLAS----LILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159
Query: 156 NQLATSMSGTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPF 207
+ G P ++APE + ++ + D W GV ++EIL G +PF
Sbjct: 160 ESYYKASKGKLPIKWMAPE-----SINFRRFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDL 73
V + + K T + A+K ++ C + D LK + +E+ L+HP ++ F + +L
Sbjct: 16 VHLAKHKPTNTLVAVKKINLDSCSKED-LKLLQQEIITSRQLQHPNILPYVTSFIVDSEL 74
Query: 74 FMVSDLLLGGD----LRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
++VS L+ G L+ H + G I ++ ALDY+ +K IHR +
Sbjct: 75 YVVSPLMAYGSCEDLLKTH-------FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSV 127
Query: 130 KPDNILLDEEGHAHITDF--NIATVLEENQLATSMSGTK------PYIAPEIFLVATDEV 181
K +ILL +G ++ +++ + + K P+++PE+ +
Sbjct: 128 KASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL---QQNL 184
Query: 182 LGYSYSVDWWSLGVTLFEILARG-RPF 207
GY+ D +S+G+T E LA G PF
Sbjct: 185 QGYNEKSDIYSVGITACE-LANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-10
Identities = 35/118 (29%), Positives = 59/118 (50%), Gaps = 20/118 (16%)
Query: 110 FELGLALDYLKTK-HIIHRDIKPDNILL-------DEEGHAH-------ITDFNIATVLE 154
F+ G+ALDY T+ H++H D+KP+NIL+ D + + ++ +
Sbjct: 238 FQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD 297
Query: 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN 212
E T++ T+ Y +PE+ L LG+ YS D WS+G ++E+ +D H N
Sbjct: 298 ERHSRTAIVSTRHYRSPEVVLG-----LGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350
|
Length = 467 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-10
Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 37/237 (15%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALK-NVLREMEILTTLEHPFLVNLWFCFQDEED------ 72
KDT ++ A+K + E++ +RE++IL L H +VNL D++D
Sbjct: 29 KDTGELVALKKVRLDN--EKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86
Query: 73 -------LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHII 125
+F D L G L + V D I + +L L+Y K+ +
Sbjct: 87 DKGAFYLVFEYMDHDLMGLLESGL--------VHFSEDHIKSFMKQLLEGLNYCHKKNFL 138
Query: 126 HRDIKPDNILLDEEGHAHITDFNIATVL--EENQLATSMSGTKPYIAPEIFLVATDEVLG 183
HRDIK NILL+ +G + DF +A + EE++ T+ T Y PE+ L +E
Sbjct: 139 HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLL--GEER-- 194
Query: 184 YSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY---SPVHYPTAWSESTK 237
Y ++D WS G L E+ + +P +N + ++ I SP P W + K
Sbjct: 195 YGPAIDVWSCGCILGELFTK-KPI-FQANQELAQLELISRLCGSPC--PAVWPDVIK 247
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-10
Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 9/89 (10%)
Query: 116 LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA--TVLEENQLATSMSGTKPYIAPEI 173
L YL + IIHRD+K +NI +++ I D A V+ L ++GT APE+
Sbjct: 170 LRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVETNAPEV 227
Query: 174 FLVATDEVLGYSYSVDWWSLGVTLFEILA 202
+A D+ Y+ D WS G+ LFE+LA
Sbjct: 228 --LARDK---YNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-10
Identities = 43/185 (23%), Positives = 88/185 (47%), Gaps = 31/185 (16%)
Query: 41 ALKNVLREMEILTTLEHPFLVNLWFCF-----QDEEDLFMVSDL--------LLGGDLRY 87
++K+ LRE++I+ L+H +V ++ ED+ +++L + DL
Sbjct: 45 SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLAN 104
Query: 88 HITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHA-HITD 146
+ Q + L+ ++L L Y+ + +++HRD+KP N+ ++ E I D
Sbjct: 105 VLEQGP------LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158
Query: 147 FNIATVLEEN-----QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
F +A +++ + L+ + TK Y +P + L + Y+ ++D W+ G E+L
Sbjct: 159 FGLARIVDPHYSHKGYLSEGLV-TKWYRSPRLLLSPNN----YTKAIDMWAAGCIFAEML 213
Query: 202 ARGRP 206
G+P
Sbjct: 214 T-GKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-10
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 30/210 (14%)
Query: 22 TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNL-WFCFQDEEDLFMVSDLL 80
+ A+K + +S C E+D + L E I++ H +V L F+ F++ +L+
Sbjct: 35 VELQVAVKTLPES-CSEQDES-DFLMEALIMSKFNHQNIVRLIGVSFE-RLPRFILLELM 91
Query: 81 LGGDL-------RYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDN 133
GGDL R + S T D + A ++ YL+ H IHRDI N
Sbjct: 92 AGGDLKSFLRENRPRPERP----SSLTMKDLLFC-ARDVAKGCKYLEENHFIHRDIAARN 146
Query: 134 ILLDEEGH---AHITDFNIATVLEENQL----ATSMSGTKPYIAPEIFLVATDEVLGYSY 186
LL +G A I DF +A + +M K ++ PE FL D + ++
Sbjct: 147 CLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK-WMPPEAFL---DGI--FTS 200
Query: 187 SVDWWSLGVTLFEILARGR-PFDIHSNTSV 215
D WS GV L+EI + G P+ +N V
Sbjct: 201 KTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-10
Identities = 37/164 (22%), Positives = 78/164 (47%), Gaps = 15/164 (9%)
Query: 44 NVLREMEILTTLEHPFLVNLWFCFQDEED--LFMVSDLLLGGDLRYHITQDIKFYSVGTR 101
++ +E+EIL L H +V ++ + ++ + L G L+ ++ ++ ++
Sbjct: 52 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--- 108
Query: 102 NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---- 157
YA ++ +DYL ++ +HRD+ N+L++ E I DF + +E ++
Sbjct: 109 -KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 167
Query: 158 LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
+ + + APE + + + + D WS GVTL+E+L
Sbjct: 168 VKDDLDSPVFWYAPECLIQSK-----FYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-10
Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEED 72
+ I + K K + M K ++D L +++ EME++ + +H ++NL +
Sbjct: 34 IGIDKDKPNKPVTVAVKMLKDDATDKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92
Query: 73 LFMVSDLLLGGDLRYHIT------QDIKFYSVGTRNDTIHLY-----AFELGLALDYLKT 121
L+++ + G+LR ++ D F + + + A+++ ++YL +
Sbjct: 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS 152
Query: 122 KHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTKP--YIAPEIFLVAT 178
+ IHRD+ N+L+ E+ I DF +A V + + +G P ++APE
Sbjct: 153 QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF--- 209
Query: 179 DEVLGYSYSVDWWSLGVTLFEILARG 204
D V Y++ D WS GV L+EI G
Sbjct: 210 DRV--YTHQSDVWSFGVLLWEIFTLG 233
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-10
Identities = 47/191 (24%), Positives = 92/191 (48%), Gaps = 13/191 (6%)
Query: 18 QKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77
+ + T ++ A+K +H E +RE+ ++ L+H +V L E L +V
Sbjct: 20 RNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF 77
Query: 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD 137
+ + DL+ ++ D +T+ + ++L + + ++HRD+KP N+L++
Sbjct: 78 EYM-DKDLKKYM--DTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN 134
Query: 138 EEGHAHITDFNIATV--LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGV 195
+ G + DF +A + N + + T Y AP++ L + YS S+D WS+G
Sbjct: 135 KRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRT----YSTSIDIWSVGC 189
Query: 196 TLFEILARGRP 206
+ E++ GRP
Sbjct: 190 IMAEMIT-GRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-10
Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 4/103 (3%)
Query: 111 ELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLATSMSGTKPYI 169
E+ L +L +IHRDIK N+LL E + DF ++ L+ + GT ++
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178
Query: 170 APEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP--FDIH 210
APE+ + Y + D WSLG+T E +A G P D+H
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIE-MAEGAPPLCDMH 220
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-10
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH-PFLVNLWFCFQDEE 71
KV + K+T ++ A+K + + E LRE+ +L L ++V L EE
Sbjct: 16 KVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74
Query: 72 D-----LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
L++V + L DL+ + + + TI + ++L + + ++H
Sbjct: 75 KNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMH 133
Query: 127 RDIKPDNILLDEEGHA-HITDFNIATVLE-ENQLATSMSGTKPYIAPEIFLVATDEVLGY 184
RD+KP N+L+D++ I D + + T T Y APE+ L +T Y
Sbjct: 134 RDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTH----Y 189
Query: 185 SYSVDWWSLGVTLFEILARGRP 206
S VD WS+G +F ++R +P
Sbjct: 190 STPVDIWSVGC-IFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-10
Identities = 42/168 (25%), Positives = 81/168 (48%), Gaps = 14/168 (8%)
Query: 41 ALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGT 100
++ L+E ++ ++HP LV L E +++++ + G+L ++ + +
Sbjct: 45 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR----QE 100
Query: 101 RNDTIHLY-AFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159
N + LY A ++ A++YL+ K+ IHRD+ N L+ E + DF ++ ++ +
Sbjct: 101 VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 159
Query: 160 TSMSGTK---PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
T+ +G K + APE +S D W+ GV L+EI G
Sbjct: 160 TAHAGAKFPIKWTAPESLAYNK-----FSIKSDVWAFGVLLWEIATYG 202
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-10
Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 16/175 (9%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQ-DIKFYSVGTRNDT 104
L E +I+ L H LV L + EE +++V++ + G L + + + + D
Sbjct: 49 LEEAQIMKKLRHDKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM 107
Query: 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG 164
A ++ + Y++ + IHRD++ NIL+ + I DF +A ++E+N+ T+ G
Sbjct: 108 ----AAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TARQG 162
Query: 165 TK---PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSV 215
K + APE L ++ D WS G+ L E++ +GR P+ +N V
Sbjct: 163 AKFPIKWTAPEAALYGR-----FTIKSDVWSFGILLTELVTKGRVPYPGMNNREV 212
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-10
Identities = 41/172 (23%), Positives = 78/172 (45%), Gaps = 25/172 (14%)
Query: 45 VLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDT 104
LRE++I+ ++H ++ L + + + + +V D++ DL+ + + I+
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRL-----TESQ 120
Query: 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA------------TV 152
+ ++ L+ L + +HRD+ P NI ++ +G I DF +A +
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 153 LEENQLATSMSG---TKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
E Q M+ T Y APE+ + A Y ++VD WS+G E+L
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEK----YHFAVDMWSVGCIFAELL 228
|
Length = 335 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-10
Identities = 42/165 (25%), Positives = 82/165 (49%), Gaps = 19/165 (11%)
Query: 43 KNVLREMEILTTLEHPFLVNLWFCF------QDEEDLFMVSDLLLGGDLRYHITQDIKFY 96
K RE+ +L + H +++L F ++ +D+++V +L+ +L I ++
Sbjct: 65 KRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELD-- 121
Query: 97 SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156
++ + +++ + +L + IIHRD+KP NI++ + I DF +A N
Sbjct: 122 -----HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176
Query: 157 QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
+ T T+ Y APE+ L +GY +VD WS+G + E++
Sbjct: 177 FMMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 18 QKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMV 76
+ D A+K M K ++D L +++ EME++ + +H ++NL E L+++
Sbjct: 39 SRPDQTVTVAVK-MLKDNATDKD-LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVI 96
Query: 77 SDLLLGGDLRYHI------TQDIKFYSVGTRNDTIHLY-----AFELGLALDYLKTKHII 125
+ G+LR + D F + + A+++ ++YL+++ I
Sbjct: 97 VEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI 156
Query: 126 HRDIKPDNILLDEEGHAHITDFNIAT-VLEENQLATSMSGTKP--YIAPEIFLVATDEVL 182
HRD+ N+L+ E+ I DF +A V + + + +G P ++APE D V
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF---DRV- 212
Query: 183 GYSYSVDWWSLGVTLFEILARG 204
Y++ D WS G+ ++EI G
Sbjct: 213 -YTHQSDVWSFGILMWEIFTLG 233
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-09
Identities = 58/237 (24%), Positives = 102/237 (43%), Gaps = 34/237 (14%)
Query: 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNL 63
G+ +F +V +V+ K T++ + K + ER+ + V+ E+ ++ L+H +V
Sbjct: 22 GNGRF---GEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-EVNVMRELKHKNIVRY 77
Query: 64 W--FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYS-------VGTRNDTIHLYAFELGL 114
F + + L+++ + GDL +I + K + V +H A+ L
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNL 137
Query: 115 ALDYLKTKHIIHRDIKPDNILLDE---------------EGH--AHITDFNIATVLEENQ 157
D + ++HRD+KP NI L G A I DF ++ +
Sbjct: 138 K-DGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES 196
Query: 158 LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS 214
+A S GT Y +PE+ L E Y D W+LG ++E+ + PF +N S
Sbjct: 197 MAHSCVGTPYYWSPELLL---HETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250
|
Length = 1021 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 51/220 (23%), Positives = 93/220 (42%), Gaps = 38/220 (17%)
Query: 18 QKKDTKQMYAMKYMHKSQCIERDAL-KNVLREMEILTTLEHPFLVNLWFCFQDEED--LF 74
+ + YA+K K + + ++ RE+ +L L+H +V+L F + D ++
Sbjct: 22 KNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80
Query: 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYA-------FELGLALDYLKTKHIIHR 127
++ D DL + I IKF+ + + + +++ + YL + ++HR
Sbjct: 81 LLFDYA-EHDL-WQI---IKFHR---QAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHR 132
Query: 128 DIKPDNILL----DEEGHAHITDFNIATVLEENQLATSMSGTKP-----YIAPEIFLVAT 178
D+KP NIL+ E G I D +A + L Y APE+ L A
Sbjct: 133 DLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPLADLDPVVVTIWYRAPELLLGAR 191
Query: 179 DEVLGYSYSVDWWSLGVTLFEILA-----RGRPFDIHSNT 213
Y+ ++D W++G E+L +GR I +
Sbjct: 192 H----YTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSN 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-09
Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 16/175 (9%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
L E ++ TL+H LV L +E ++++++ + G L + D G++
Sbjct: 49 LAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSD-----EGSKQPLP 102
Query: 106 HLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMS 163
L F +A + +++ ++ IHRD++ NIL+ I DF +A V+E+N+
Sbjct: 103 KLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162
Query: 164 GTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSV 215
P + APE + ++ D WS G+ L EI+ GR P+ SN V
Sbjct: 163 AKFPIKWTAPEAINFGS-----FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 212
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-09
Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 22/168 (13%)
Query: 48 EMEILTTLEHPFLVN-LWFCFQDEE-DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
E+++L +L+H +V L C D +FM + + GG + + +
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTISIFM--EFVPGGSISSILNRFGPLPEPVFCK--- 106
Query: 106 HLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL-------EENQL 158
Y ++ + YL ++HRDIK +N++L G + DF A L + +
Sbjct: 107 --YTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM 164
Query: 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP 206
SM GT ++APE+ GY D WS+G T+FE +A G+P
Sbjct: 165 LKSMHGTPYWMAPEVI-----NESGYGRKSDIWSIGCTVFE-MATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 49/168 (29%), Positives = 76/168 (45%), Gaps = 25/168 (14%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQ---DIKFYSVGTRN 102
L E IL +HP +V L + +++V +L+ GGD + + ++K
Sbjct: 40 LSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELK-------- 91
Query: 103 DTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160
T L F L A + YL++K+ IHRD+ N L+ E I+DF ++ +E+
Sbjct: 92 -TKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIY 148
Query: 161 SMSGTK----PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
S SG K + APE YS D WS G+ L+E + G
Sbjct: 149 SSSGLKQIPIKWTAPEALNYGR-----YSSESDVWSYGILLWETFSLG 191
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 57/242 (23%), Positives = 103/242 (42%), Gaps = 26/242 (10%)
Query: 8 FCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCF 67
FC + V + + T + ++ C E + LK + E+ + HP ++ W F
Sbjct: 10 FCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVF 68
Query: 68 QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
L+++S + G + ++ G I F L+YL IHR
Sbjct: 69 TTGSWLWVISPFMAYGSANSLLKT---YFPEGMSEALIGNILFGALRGLNYLHQNGYIHR 125
Query: 128 DIKPDNILLDEEGHAHITDFNIATVLEEN-----------QLATSMSGTKPYIAPEIFLV 176
+IK +IL+ +G ++ + L N Q +TS+ P+++PE+
Sbjct: 126 NIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELL-- 180
Query: 177 ATDEVLGYSYSVDWWSLGVTLFEILARGR-PF-DIH-SNTSVKDVKAIIYSPVHYPTAWS 233
++ GY+ D +S+G+T E LA GR PF D+ + ++ +K YSP+ T +
Sbjct: 181 -RQDLYGYNVKSDIYSVGITACE-LATGRVPFQDMLRTQMLLQKLKGPPYSPL-DITTFP 237
Query: 234 ES 235
Sbjct: 238 CE 239
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 41/165 (24%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 46 LREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDT 104
+ E I+ +++HP LV L C + +V+ L+ G L ++ + ++G++
Sbjct: 57 MDEALIMASMDHPHLVRLLGVCLS--PTIQLVTQLMPHGCLLDYVHEHKD--NIGSQ--L 110
Query: 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG 164
+ + ++ + YL+ + ++HRD+ N+L+ H ITDF +A +LE ++ + G
Sbjct: 111 LLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170
Query: 165 TKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFD 208
K I + + +++ D WS GVT++E++ G+P+D
Sbjct: 171 GKMPI--KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-09
Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 15/191 (7%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDL 73
VC K T + A+K + + E A K RE+ +L ++H ++ L F
Sbjct: 31 VCSAIDKRTGEKVAIKKLSRPFQSEIFA-KRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89
Query: 74 FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDN 133
D L + Y T K D + +++ L Y+ + IIHRD+KP N
Sbjct: 90 DEFQDFYLV--MPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGN 147
Query: 134 ILLDEEGHAHITDFNIATVLEENQLATSMSG---TKPYIAPEIFLVATDEVLGYSYSVDW 190
+ ++E+ I DF +A M+G T+ Y APE+ L + Y+ +VD
Sbjct: 148 LAVNEDCELKILDFGLA-----RHADAEMTGYVVTRWYRAPEVIL----NWMHYNQTVDI 198
Query: 191 WSLGVTLFEIL 201
WS+G + E+L
Sbjct: 199 WSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 42/166 (25%), Positives = 81/166 (48%), Gaps = 9/166 (5%)
Query: 43 KNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR-YHITQDIKFYSVGTR 101
K RE+ ++ + H ++ L F ++ L D+ + +L ++ Q I+ +
Sbjct: 68 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELD 124
Query: 102 NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161
++ + +++ + +L + IIHRD+KP NI++ + I DF +A + + T
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 184
Query: 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
T+ Y APE+ L +GY +VD WS+G + E++ G F
Sbjct: 185 YVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMIKGGVLF 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-09
Identities = 41/160 (25%), Positives = 80/160 (50%), Gaps = 9/160 (5%)
Query: 43 KNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR-YHITQDIKFYSVGTR 101
K RE+ ++ + H +++L F ++ L D+ L +L ++ Q I+ +
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MELD 117
Query: 102 NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161
++ + +++ + +L + IIHRD+KP NI++ + I DF +A + + T
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 177
Query: 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
T+ Y APE+ L +GY +VD WS+G + E++
Sbjct: 178 YVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 43/169 (25%), Positives = 83/169 (49%), Gaps = 20/169 (11%)
Query: 43 KNVLREMEILTTLEHPFLVNLWFCF------QDEEDLFMVSDLLLGGDLRYHITQDIKFY 96
K RE+ ++ + H ++ L F ++ +D+++V +L+ +L I D+
Sbjct: 60 KRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLD-- 116
Query: 97 SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156
++ + +++ + +L + IIHRD+KP NI++ + I DF +A +
Sbjct: 117 -----HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171
Query: 157 QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205
+ T T+ Y APE+ L +GY +VD WS+G + E++ RG
Sbjct: 172 FMMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMI-RGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-09
Identities = 53/190 (27%), Positives = 87/190 (45%), Gaps = 21/190 (11%)
Query: 40 DALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGD----LRYHITQDIKF 95
+A K+ RE E+LT L+H +V + + + L MV + + GD LR H D
Sbjct: 49 NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAH-GPDAVL 107
Query: 96 YSVG------TRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNI 149
+ G T++ +H+ A ++ + YL ++H +HRD+ N L+ E I DF +
Sbjct: 108 MAEGNRPAELTQSQMLHI-AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGM 166
Query: 150 A-TVLEENQLATSMSGTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR- 205
+ V + P ++ PE + ++ D WSLGV L+EI G+
Sbjct: 167 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-----FTTESDVWSLGVVLWEIFTYGKQ 221
Query: 206 PFDIHSNTSV 215
P+ SN V
Sbjct: 222 PWYQLSNNEV 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-09
Identities = 44/189 (23%), Positives = 81/189 (42%), Gaps = 23/189 (12%)
Query: 47 REMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDT-- 104
+E ++ L HP +V L E+ + M+ + L GDL + VG +D
Sbjct: 56 QEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115
Query: 105 -----------IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL 153
+H+ A ++ ++YL + +H+D+ NIL+ E+ H I+D ++ +
Sbjct: 116 TVKSSLDHGDFLHI-AIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREI 174
Query: 154 EENQLATSMSGTK---PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDI 209
+ ++ PE + +S D WS GV L+EI + G +P+
Sbjct: 175 YSADYYRVQPKSLLPIRWMPPEAIMYGK-----FSSDSDIWSFGVVLWEIFSFGLQPYYG 229
Query: 210 HSNTSVKDV 218
SN V ++
Sbjct: 230 FSNQEVIEM 238
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 5e-09
Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 20 KDTKQMYAMKY--MHKSQCIERDALK-NVLREMEILTTLEHPFLVNLWFCFQDEE----- 71
K T ++ A+K M K E++ LRE+ IL L+HP +V + +E
Sbjct: 27 KKTGEIVALKKLKMEK----EKEGFPITSLREINILLKLQHPNIVTV------KEVVVGS 76
Query: 72 ---DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRD 128
++MV + + DL+ + + + + +L + +L I+HRD
Sbjct: 77 NLDKIYMVMEYV-EHDLKSLMETMKQPFLQSEVKCLML----QLLSGVAHLHDNWILHRD 131
Query: 129 IKPDNILLDEEGHAHITDFNIATVLEEN-QLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
+K N+LL+ G I DF +A + T + T Y APE+ L A + YS +
Sbjct: 132 LKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKE----YSTA 187
Query: 188 VDWWSLGVTLFEILAR 203
+D WS+G E+L +
Sbjct: 188 IDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-09
Identities = 50/190 (26%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 41 ALKNVLREMEILTTLEHPFLVN-LWFCFQDEEDLFMVSDLLLGGDL----RYHITQD--- 92
A ++ L+E++IL+ L P + L C D L M+ + + GDL + H+ +
Sbjct: 62 AREDFLKEVKILSRLSDPNIARLLGVCTVDPP-LCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 93 ---IKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNI 149
K S T +++ A ++ + YL++ + +HRD+ N L+ + I DF +
Sbjct: 121 ACNSKSLSFST---LLYM-ATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 150 ATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG--YSYSVDWWSLGVTLFEI--LARGR 205
+ L + + G P P I +A + VL ++ D W+ GVTL+EI L R +
Sbjct: 177 SRNLYSSDY-YRVQGRAP--LP-IRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232
Query: 206 PFDIHSNTSV 215
P++ ++ V
Sbjct: 233 PYEHLTDQQV 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-09
Identities = 46/185 (24%), Positives = 82/185 (44%), Gaps = 27/185 (14%)
Query: 42 LKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIK-----FY 96
L+++L E +L + HP ++ L+ + L ++ + G LR + + K
Sbjct: 47 LRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLG 106
Query: 97 SVGTRNDT--------------IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHA 142
S G RN + + +A+++ + YL ++HRD+ N+L+ E
Sbjct: 107 SDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKM 166
Query: 143 HITDFNIA-TVLEENQLATSMSGTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFE 199
I+DF ++ V EE+ G P ++A E D + Y+ D WS GV L+E
Sbjct: 167 KISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF---DHI--YTTQSDVWSFGVLLWE 221
Query: 200 ILARG 204
I+ G
Sbjct: 222 IVTLG 226
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-09
Identities = 48/186 (25%), Positives = 90/186 (48%), Gaps = 20/186 (10%)
Query: 43 KNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRN 102
++ L E I+ +HP +++L + + +V++ + G L + + ++V
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV---- 105
Query: 103 DTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA- 159
I L G+A + YL +HRD+ NIL++ ++DF ++ VLE++ A
Sbjct: 106 --IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163
Query: 160 -TSMSGTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIHSNTSV 215
T+ G P + APE ++ + D WS G+ ++E+++ G RP+ SN V
Sbjct: 164 YTTRGGKIPIRWTAPEAIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV 218
Query: 216 KDVKAI 221
+KAI
Sbjct: 219 --IKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-09
Identities = 47/191 (24%), Positives = 94/191 (49%), Gaps = 17/191 (8%)
Query: 37 IERDALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKF 95
+ + A + L+E++I++ L++P ++ L C D+ L M+++ + GDL ++Q +
Sbjct: 56 VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP-LCMITEYMENGDLNQFLSQR-EI 113
Query: 96 YSVGTRNDTIH-------LY-AFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDF 147
S T + I LY A ++ + YL + + +HRD+ N L+ I DF
Sbjct: 114 ESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADF 173
Query: 148 NIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG-YSYSVDWWSLGVTLFEI--LARG 204
++ L + G + P ++ +LG ++ + D W+ GVTL+E+ L +
Sbjct: 174 GMSRNLYSGDY-YRIQGRA--VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE 230
Query: 205 RPFDIHSNTSV 215
+P+ + S+ V
Sbjct: 231 QPYSLLSDEQV 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-09
Identities = 49/201 (24%), Positives = 90/201 (44%), Gaps = 28/201 (13%)
Query: 40 DALKNV----LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKF 95
DA KN L+E++IL+ L+ P ++ L DE+ L M+++ + GDL ++
Sbjct: 57 DANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLD 116
Query: 96 YSVGTRNDT---------------IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG 140
ND +H+ A ++ + YL + + +HRD+ N L+ E
Sbjct: 117 DKEENGNDAVPPAHCLPAISYSSLLHV-ALQIASGMKYLSSLNFVHRDLATRNCLVGENL 175
Query: 141 HAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVL--GYSYSVDWWSLGVTLF 198
I DF ++ N A + I +A + +L ++ + D W+ GVTL+
Sbjct: 176 TIKIADFGMS----RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLW 231
Query: 199 EILA--RGRPFDIHSNTSVKD 217
EIL + +P+ ++ V +
Sbjct: 232 EILMLCKEQPYGELTDEQVIE 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-09
Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 18/175 (10%)
Query: 46 LREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDT 104
L+E I+ HP +++L C E +V + GDLR I + T N T
Sbjct: 44 LKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE-------THNPT 96
Query: 105 IH-LYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161
+ L F L +A ++YL +K +HRD+ N +LDE + DF +A + + + +
Sbjct: 97 VKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156
Query: 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP-------FDI 209
+ T + + + + + ++ D WS GV L+E++ RG P FDI
Sbjct: 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI 211
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 108 YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTK 166
Y+F++ +++L ++ IHRD+ NILL E I DF +A + ++ S
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 167 P--YIAPE-IFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
P ++APE IF D+V Y+ D WS GV L+EI + G
Sbjct: 239 PLKWMAPESIF----DKV--YTTQSDVWSFGVLLWEIFSLG 273
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 31/204 (15%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALK-NVLREMEILTTLEHPFLVNLW-FCF------- 67
+ K TKQ+ A+K + E++ LRE++IL L+H +VNL C
Sbjct: 31 ARHKKTKQIVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88
Query: 68 QDEEDLFMVSDLL---LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHI 124
+ + ++V + L G L +++KF + L L Y+ I
Sbjct: 89 RYKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLN-----GLYYIHRNKI 140
Query: 125 IHRDIKPDNILLDEEGHAHITDFNIA--TVLEENQLATSMSG---TKPYIAPEIFLVATD 179
+HRD+K NIL+ ++G + DF +A L +N + T Y PE+ L D
Sbjct: 141 LHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERD 200
Query: 180 EVLGYSYSVDWWSLGVTLFEILAR 203
Y +D W G + E+ R
Sbjct: 201 ----YGPPIDMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDT- 104
+RE+ +L ++H +V L E+ L++V + L DL+ H+ F +N
Sbjct: 49 IREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDF----AKNPRL 103
Query: 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHA-HITDFNIATVLE-ENQLATSM 162
I Y +++ + Y + ++HRD+KP N+L+D +A + DF +A + T
Sbjct: 104 IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
Query: 163 SGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
T Y APEI L + YS VD WS+G E++
Sbjct: 164 VVTLWYRAPEILLGSRH----YSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 21/189 (11%)
Query: 31 MHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHI 89
M K E+D L +++ EME++ + +H ++NL + L+++ + G+LR ++
Sbjct: 54 MLKDDATEKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 112
Query: 90 TQ----DIKF-YSVGTRNDTIHLY------AFELGLALDYLKTKHIIHRDIKPDNILLDE 138
+++ Y + D + +++ ++YL ++ IHRD+ N+L+ E
Sbjct: 113 RARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE 172
Query: 139 EGHAHITDFNIATVLEE-NQLATSMSGTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGV 195
I DF +A + + + +G P ++APE D V Y++ D WS GV
Sbjct: 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF---DRV--YTHQSDVWSFGV 227
Query: 196 TLFEILARG 204
++EI G
Sbjct: 228 LMWEIFTLG 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 53/195 (27%), Positives = 79/195 (40%), Gaps = 43/195 (22%)
Query: 33 KSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQD 92
K +C ER K V LE+ L + E++ + ++L Y ITQ
Sbjct: 189 KPKC-ERLIAKRVKAGSRAAIQLENEILA---LGRLNHENILKIEEILRSEANTYMITQK 244
Query: 93 IKFYSVGTRNDTIHLYAF----------------------ELGLALDYLKTKHIIHRDIK 130
F LY+F +L A++Y+ K +IHRDIK
Sbjct: 245 YDF----------DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIK 294
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQLATSMS--GTKPYIAPEIFLVATDEVLGYSYSV 188
+NI L+ +G + DF A E+ + A GT +PEI +A D GY
Sbjct: 295 LENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEI--LAGD---GYCEIT 349
Query: 189 DWWSLGVTLFEILAR 203
D WS G+ L ++L+
Sbjct: 350 DIWSCGLILLDMLSH 364
|
Length = 501 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-08
Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDL 85
A+K M + C R +++ L E + +HP ++ L C Q E S +++ L
Sbjct: 30 AVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVI---L 85
Query: 86 RYHITQDIKFYSVGTR---------NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL 136
+ D+ + + +R + + ++ ++YL +K IHRD+ N +L
Sbjct: 86 PFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML 145
Query: 137 DEEGHAHITDFNIATVLEENQLATSMSGTK---PYIAPEIFLVATDEVLGYSYSVDWWSL 193
+E + + DF ++ + K +IA E D V Y+ D WS
Sbjct: 146 NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL---ADRV--YTTKSDVWSF 200
Query: 194 GVTLFEILARGR-PFDIHSNTSVKD 217
GVT++EI RG+ P+ N+ + D
Sbjct: 201 GVTMWEIATRGQTPYPGVENSEIYD 225
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 55/181 (30%), Positives = 80/181 (44%), Gaps = 31/181 (17%)
Query: 36 CIERDALKNVL----------REMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDL 85
CI+ ++V+ E IL + HP ++ L F + + L+L
Sbjct: 111 CIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNK----FTCLILP--- 163
Query: 86 RYHITQDIKFYSVGTRNDTI-HLYAFELGL--ALDYLKTKHIIHRDIKPDNILLDEEGHA 142
RY D+ Y RN I + A E + A+ YL IIHRDIK +NI ++ G
Sbjct: 164 RYK--TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDV 221
Query: 143 HITDFNIATV---LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFE 199
+ DF A + N+ +GT APE L+A D Y +VD WS G+ LFE
Sbjct: 222 CLGDFGAACFPVDINANKY-YGWAGTIATNAPE--LLARDP---YGPAVDIWSAGIVLFE 275
Query: 200 I 200
+
Sbjct: 276 M 276
|
Length = 391 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-08
Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVN-LWFCFQDEEDLFMVSDLLLGGDL 85
A+K + K + K L+E +++ HP +V L C E +++ +L+ GGDL
Sbjct: 30 AVKTLRKGATDQEK--KEFLKEAHLMSNFNHPNIVKLLGVCL-LNEPQYIIMELMEGGDL 86
Query: 86 RYHI--TQDIKFYSVG-TRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHA 142
++ + +F T + + + ++ YL+ H IHRD+ N L+ E+G+
Sbjct: 87 LSYLRDARVERFGPPLLTLKELLDI-CLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYD 145
Query: 143 -----HITDFNIATVLEENQ-LATSMSGTKP--YIAPEIFLVATDEVLGYSYSVDWWSLG 194
I DF +A + ++ G P ++APE L ++ D WS G
Sbjct: 146 ADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-----FTTQSDVWSFG 200
Query: 195 VTLFEILARG-RPFDIHSNTSV 215
V ++EIL G +P+ +N V
Sbjct: 201 VLMWEILTLGQQPYPALNNQEV 222
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-08
Identities = 45/211 (21%), Positives = 87/211 (41%), Gaps = 16/211 (7%)
Query: 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNL 63
G +F + + Q ++ A+K M + ++ L E + +HP ++ L
Sbjct: 8 GEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE-IEEFLSEAACMKDFDHPNVMKL 66
Query: 64 W-FCFQDEEDLFMVSDLLL-----GGDLR-YHITQDIKFYSVGTRNDTIHLYAFELGLAL 116
CF+ + +++ GDL + + + T+ + ++ L +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 117 DYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTKP--YIAPEI 173
+YL ++ IHRD+ N +L E+ + DF ++ + + P +IA E
Sbjct: 127 EYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 186
Query: 174 FLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
D V Y+ D W+ GVT++EI RG
Sbjct: 187 L---ADRV--YTSKSDVWAFGVTMWEIATRG 212
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-08
Identities = 43/172 (25%), Positives = 87/172 (50%), Gaps = 14/172 (8%)
Query: 41 ALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVG 99
A K +L E ++ + P++ L C L V+ L+ G L ++ ++ +G
Sbjct: 52 ANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL--VTQLMPYGCLLDYVRENKD--RIG 107
Query: 100 TRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159
+++ + + ++ + YL+ ++HRD+ N+L+ H ITDF +A +L+ ++
Sbjct: 108 SQD--LLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165
Query: 160 TSMSGTKPYIAPEIFLVATDEVL--GYSYSVDWWSLGVTLFEILARG-RPFD 208
G K P I +A + +L +++ D WS GVT++E++ G +P+D
Sbjct: 166 YHADGGK---VP-IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-08
Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 20/184 (10%)
Query: 47 REMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDL-----RYHITQDIKFYSVGTR 101
+E E+++ L+HP +V L E+ M+ + L GDL R D+ S
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 102 -------NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154
+D +H+ A ++ ++YL + H +HRD+ N L+ E I+DF ++ +
Sbjct: 117 VKSSLDCSDFLHI-AIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV--DWWSLGVTLFEILARG-RPFDIHS 211
S + + P + + + +L ++ D WS GV L+EI + G +P+ S
Sbjct: 176 SADYYRVQSKS---LLP-VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231
Query: 212 NTSV 215
N V
Sbjct: 232 NQEV 235
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-08
Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 10/101 (9%)
Query: 108 YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLATSMSGTK 166
Y+F++ +++L ++ IHRD+ NILL E I DF +A + ++
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 167 P--YIAPE-IFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
P ++APE IF D+V Y+ D WS GV L+EI + G
Sbjct: 238 PLKWMAPESIF----DKV--YTTQSDVWSFGVLLWEIFSLG 272
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-08
Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 27/202 (13%)
Query: 43 KNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDL-RYHITQDIKFYSVGTR 101
++ L E I+ H ++ L + ++++ + G L +Y D +F S
Sbjct: 51 QDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSS---- 106
Query: 102 NDTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159
L G+A + YL + +HRD+ NIL++ ++DF ++ VLE++
Sbjct: 107 ---YQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163
Query: 160 T-SMSGTK---PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIHSNTS 214
T + SG K + APE ++ + D WS G+ ++E+++ G RP+ SN
Sbjct: 164 TYTTSGGKIPIRWTAPEAIAYRK-----FTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218
Query: 215 VKDVKAI-----IYSPVHYPTA 231
V +KAI + +P+ P+A
Sbjct: 219 V--MKAINDGFRLPAPMDCPSA 238
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 10/101 (9%)
Query: 108 YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTK 166
Y+F++ +++L ++ IHRD+ NILL E I DF +A + ++
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 167 P--YIAPE-IFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
P ++APE IF D V Y+ D WS GV L+EI + G
Sbjct: 244 PLKWMAPETIF----DRV--YTIQSDVWSFGVLLWEIFSLG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-07
Identities = 43/182 (23%), Positives = 86/182 (47%), Gaps = 20/182 (10%)
Query: 43 KNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRN 102
++ L E I+ +HP +++L + ++++ + G L + Q+ ++V
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV---- 105
Query: 103 DTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ--- 157
I L G+A + YL + +HRD+ NIL++ ++DF ++ LE++
Sbjct: 106 --IQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163
Query: 158 -LATSMSGTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIHSNT 213
+S+ G P + APE ++ + D WS G+ ++E+++ G RP+ SN
Sbjct: 164 TYTSSLGGKIPIRWTAPEAI-----AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218
Query: 214 SV 215
V
Sbjct: 219 DV 220
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 8/88 (9%)
Query: 115 ALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE---ENQLATSMSGTKPYIAP 171
A+DY+ + IIHRDIK +N+L++ + DF A ++GT AP
Sbjct: 272 AIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331
Query: 172 EIFLVATDEVLGYSYSVDWWSLGVTLFE 199
E+ +A D Y+ SVD WS G+ +FE
Sbjct: 332 EV--LAGDP---YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 37/111 (33%), Positives = 54/111 (48%), Gaps = 24/111 (21%)
Query: 116 LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-------------TVLEENQLATSM 162
++Y+ +K ++HRD+KPDNILL G I D+ A V E N +SM
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 163 S------GTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
+ GT Y+APE L S S D ++LGV L+++L P+
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPA-----SESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-07
Identities = 47/172 (27%), Positives = 87/172 (50%), Gaps = 17/172 (9%)
Query: 38 ERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFY 96
ER+AL + E++I++ L H +VNL + ++++ GDL + + K
Sbjct: 81 EREAL---MSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR--KRE 135
Query: 97 SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLEE 155
S T D + +++++ + +L +K+ IHRD+ N+LL I DF +A ++ +
Sbjct: 136 SFLTLEDLLS-FSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194
Query: 156 NQLATSMSGTKP--YIAPE-IFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
+ + P ++APE IF + V Y++ D WS G+ L+EI + G
Sbjct: 195 SNYVVKGNARLPVKWMAPESIF----NCV--YTFESDVWSYGILLWEIFSLG 240
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 42/182 (23%), Positives = 72/182 (39%), Gaps = 16/182 (8%)
Query: 44 NVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHI------TQDIKFYS 97
L E ++ +V L + +V +L+ GDL+ ++ ++
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLG 114
Query: 98 VGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLEEN 156
T A E+ + YL K +HRD+ N ++ E+ I DF + + E +
Sbjct: 115 PPTLQK-FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD 173
Query: 157 QLATSMSGTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIHSNT 213
G P ++APE D V ++ D WS GV L+E+ +P+ SN
Sbjct: 174 YYRKGGKGLLPVRWMAPESL---KDGV--FTTKSDVWSFGVVLWEMATLAEQPYQGLSNE 228
Query: 214 SV 215
V
Sbjct: 229 EV 230
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-07
Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 21/186 (11%)
Query: 47 REMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDL-RY--------HITQDIKFYS 97
RE E+LT L+H +V + + L MV + + GDL R+ I + +
Sbjct: 56 REAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVA 115
Query: 98 VG--TRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLE 154
G T + + A ++ + YL + H +HRD+ N L+ + I DF ++ +
Sbjct: 116 PGQLTLGQMLAI-ASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 174
Query: 155 ENQLATSMSGTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHS 211
+ P ++ PE L ++ D WS GV L+EI G+ P+ S
Sbjct: 175 TDYYRVGGRTMLPIRWMPPESILYRK-----FTTESDIWSFGVVLWEIFTYGKQPWYQLS 229
Query: 212 NTSVKD 217
NT +
Sbjct: 230 NTEAIE 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-07
Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 22/191 (11%)
Query: 41 ALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGD----LRYHITQDIKFY 96
A K+ RE E+LT L+H +V + D + L MV + + GD LR H +
Sbjct: 50 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 109
Query: 97 SVGTR--------NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFN 148
R + +H+ A ++ + YL ++H +HRD+ N L+ I DF
Sbjct: 110 DGQPRQAKGELGLSQMLHI-ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFG 168
Query: 149 IA-TVLEENQLATSMSGTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205
++ V + P ++ PE + ++ D WS GV L+EI G+
Sbjct: 169 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-----FTTESDVWSFGVILWEIFTYGK 223
Query: 206 -PFDIHSNTSV 215
P+ SNT V
Sbjct: 224 QPWFQLSNTEV 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-07
Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 21/170 (12%)
Query: 47 REMEILTTLEHPFLVNLWFCFQDEED-----LFMVSDLLLGGDLRYHITQDIKFYSVGTR 101
RE+ +L L+HP +++L F D LF ++ L +++H V
Sbjct: 47 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 106
Query: 102 NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL----DEEGHAHITDFNIATVLEENQ 157
+ +++ + YL ++HRD+KP NIL+ E G I D A + N
Sbjct: 107 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NS 164
Query: 158 LATSMSGTKP------YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
++ P Y APE+ L A Y+ ++D W++G E+L
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARH----YTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 22/200 (11%)
Query: 19 KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVS 77
KKD +M A M K E D ++ E+E+L L HP ++NL ++ L++
Sbjct: 24 KKDGLKMNAAIKMLKEFASENDH-RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82
Query: 78 DLLLGGDLRYHITQ------DIKFYSVGTRNDTIH-----LYAFELGLALDYLKTKHIIH 126
+ G+L + + D F T+ +A ++ + YL K IH
Sbjct: 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIH 142
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKP--YIAPEIFLVATDEVLGY 184
RD+ N+L+ E + I DF ++ EE + +M G P ++A E + Y
Sbjct: 143 RDLAARNVLVGENLASKIADFGLSRG-EEVYVKKTM-GRLPVRWMAIESLNYSV-----Y 195
Query: 185 SYSVDWWSLGVTLFEILARG 204
+ D WS GV L+EI++ G
Sbjct: 196 TTKSDVWSFGVLLWEIVSLG 215
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 49/202 (24%), Positives = 92/202 (45%), Gaps = 34/202 (16%)
Query: 33 KSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLL----LGGDLRYH 88
K+ ++ L + L E I+ +HP ++ L + ++++ + L LR +
Sbjct: 41 KAGSSDKQRL-DFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN 99
Query: 89 ITQDIKFYSVGTRNDTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHITD 146
D KF L G+A + YL + +HRD+ NIL++ ++D
Sbjct: 100 ---DGKFT-------VGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSD 149
Query: 147 FNIATVLEENQLA-TSMSGTKP--YIAPEIFLVATDEVLGY---SYSVDWWSLGVTLFEI 200
F ++ LE+++ T+ G P + AP E + Y + + D WS G+ ++E+
Sbjct: 150 FGLSRRLEDSEATYTTKGGKIPIRWTAP--------EAIAYRKFTSASDVWSFGIVMWEV 201
Query: 201 LARG-RPFDIHSNTSVKDVKAI 221
++ G RP+ SN V +KA+
Sbjct: 202 MSYGERPYWDMSNQDV--IKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-06
Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 21/170 (12%)
Query: 47 REMEILTTLEHPFLVNLWFCFQDEED-----LFMVSDLLLGGDLRYHITQDIKFYSVGTR 101
RE+ +L L+HP ++ L F D LF ++ L +++H +
Sbjct: 47 REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLP 106
Query: 102 NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL----DEEGHAHITDFNIATVLEENQ 157
+ +++ + YL ++HRD+KP NIL+ E G I D A + N
Sbjct: 107 RSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NS 164
Query: 158 LATSMSGTKP------YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
++ P Y APE+ L A Y+ ++D W++G E+L
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARH----YTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 43/174 (24%), Positives = 78/174 (44%), Gaps = 23/174 (13%)
Query: 39 RDALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYS 97
R + + M + +L+H ++V L C L +V+ L G L H+ Q
Sbjct: 50 RQTFQEITDHMLAMGSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQH----- 102
Query: 98 VGTRNDTIHL-YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156
+ + L + ++ + YL+ ++HR++ NILL + I DF +A +L +
Sbjct: 103 RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162
Query: 157 QLATSMSGTKPYIAPE----IFLVATDEVL--GYSYSVDWWSLGVTLFEILARG 204
K Y E I +A + +L Y++ D WS GVT++E+++ G
Sbjct: 163 D--------KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYG 208
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-06
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 22/200 (11%)
Query: 19 KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVS 77
KKD +M A K + D ++ E+E+L L HP ++NL + L++
Sbjct: 17 KKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 75
Query: 78 DLLLGGDLRYHITQ------DIKFYSVGTRNDTIH-----LYAFELGLALDYLKTKHIIH 126
+ G+L + + D F + T+ +A ++ +DYL K IH
Sbjct: 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIH 135
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKP--YIAPEIFLVATDEVLGY 184
RD+ NIL+ E A I DF ++ +E + +M G P ++A E + Y
Sbjct: 136 RDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTM-GRLPVRWMAIESLNYSV-----Y 188
Query: 185 SYSVDWWSLGVTLFEILARG 204
+ + D WS GV L+EI++ G
Sbjct: 189 TTNSDVWSYGVLLWEIVSLG 208
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-06
Identities = 27/101 (26%), Positives = 50/101 (49%), Gaps = 8/101 (7%)
Query: 108 YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTK- 166
+ ++ ++YL +K+ IHRD+ N +L+E + DF ++ + +K
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 167 --PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205
++A E D V Y+ D W+ GVT++EI+ RG+
Sbjct: 178 PVKWLALESL---ADNV--YTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 32/102 (31%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 108 YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTK 166
++ ++ +D+L +K+ IHRD+ N+LL + A I DF +A ++ ++ +
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 167 P--YIAPE-IFLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205
P ++APE IF D V Y+ D WS G+ L+EI + G+
Sbjct: 277 PVKWMAPESIF----DCV--YTVQSDVWSYGILLWEIFSLGK 312
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-06
Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 19 KKDTKQM-YAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMV 76
KKD +M A+K M + +D ++ E+E+L L HP ++NL + L++
Sbjct: 29 KKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86
Query: 77 SDLLLGGDL-----RYHITQDIKFYSVGTRNDTI----HLYAFELGLA--LDYLKTKHII 125
+ G+L + + + +++ + L F +A +DYL K I
Sbjct: 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 146
Query: 126 HRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKP--YIAPEIFLVATDEVLG 183
HRD+ NIL+ E A I DF ++ +E + +M G P ++A E +
Sbjct: 147 HRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTM-GRLPVRWMAIESLNYSV----- 199
Query: 184 YSYSVDWWSLGVTLFEILARG 204
Y+ + D WS GV L+EI++ G
Sbjct: 200 YTTNSDVWSYGVLLWEIVSLG 220
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 29/101 (28%), Positives = 55/101 (54%), Gaps = 10/101 (9%)
Query: 108 YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTK 166
+ +++ +++L +K+ +HRD+ N+LL + I DF +A ++ ++ + S
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 167 P--YIAPE-IFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
P ++APE IF D + Y+ D WS G+ L+EI + G
Sbjct: 302 PVKWMAPESIF----DNL--YTTLSDVWSYGILLWEIFSLG 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-05
Identities = 42/183 (22%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 47 REMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHI----TQDIKFYSVGTRN 102
RE+++ L H +V L ++ E +M+ + GDL+ + ++D K
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 103 DTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHI-------TDFNIATVLEE 155
++ L +D+L +HRD+ N L+ + + +N
Sbjct: 117 KQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR 176
Query: 156 NQLATSMSGTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSN 212
N L P ++APE V D+ +S D WS GV ++E+ +G PF S+
Sbjct: 177 NALI-------PLRWLAPEA--VQEDD---FSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
Query: 213 TSV 215
V
Sbjct: 225 EEV 227
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 20/45 (44%), Positives = 26/45 (57%), Gaps = 5/45 (11%)
Query: 164 GTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFD 208
GT Y+APE+ L + +VDWW+LGV LFE L PF+
Sbjct: 542 GTPDYLAPELLLGK-----PHGPAVDWWALGVCLFEFLTGIPPFN 581
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-05
Identities = 29/101 (28%), Positives = 51/101 (50%), Gaps = 10/101 (9%)
Query: 108 YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTK 166
+++++ + +L +K+ IHRD+ NILL I DF +A + ++ +
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 167 P--YIAPE-IFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
P ++APE IF Y++ D WS G+ L+EI + G
Sbjct: 279 PVKWMAPESIFNCV------YTFESDVWSYGILLWEIFSLG 313
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 39/185 (21%), Positives = 80/185 (43%), Gaps = 22/185 (11%)
Query: 47 REMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDT-- 104
E + + L+HP +V L E+ L M+ DL + VG+ +D
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116
Query: 105 ----------IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154
+H+ ++ +++L + H++H+D+ N+L+ ++ + I+D + +
Sbjct: 117 VKSTLEPADFVHIVT-QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 155 ENQLATSMSGTK---PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIH 210
M + +++PE + +S D WS GV L+E+ + G +P+ +
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGK-----FSIDSDIWSYGVVLWEVFSYGLQPYCGY 230
Query: 211 SNTSV 215
SN V
Sbjct: 231 SNQDV 235
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 8e-05
Identities = 39/176 (22%), Positives = 75/176 (42%), Gaps = 6/176 (3%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
L+E++ L HP ++ + +V + GDL+ ++ + + + D +
Sbjct: 43 LQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL 102
Query: 106 HLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLEENQLATSMSG 164
A E+ L +L IH D+ N L + I D+ +A E+ T
Sbjct: 103 QRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH 162
Query: 165 TKP--YIAPEIFLVATDEVL--GYSYSVDWWSLGVTLFEILARG-RPFDIHSNTSV 215
P ++APE+ + ++L + + WSLGVT++E+ +P+ S+ V
Sbjct: 163 AVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV 218
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 8e-05
Identities = 48/154 (31%), Positives = 68/154 (44%), Gaps = 35/154 (22%)
Query: 66 CFQDEEDLFMVSDLLLGG--DLRYHITQDI-----KFYSVGTRNDTIHLYAFELGLALDY 118
C +D E++ MV + + G DL H D+ KF A +L AL Y
Sbjct: 73 CVRDVENI-MVEEFVEFGPLDLFMHRKSDVLTTPWKFK-----------VAKQLASALSY 120
Query: 119 LKTKHIIHRDIKPDNILLDEEG-------HAHITDFNIA-TVLEENQLATSMSGTKPYIA 170
L+ K ++H ++ NILL EG ++D I TVL + + P+IA
Sbjct: 121 LEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI----PWIA 176
Query: 171 PEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
PE V + L S + D WS G TL+EI G
Sbjct: 177 PEC--VEDSKNL--SIAADKWSFGTTLWEICYNG 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 14/143 (9%)
Query: 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHA 142
GDL+ ++ K + T+ A E+ L L +L + IH D+ N LL +
Sbjct: 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTV 139
Query: 143 HITDFNIATV-LEENQLATSMSGTKP--YIAPEIFLVATDEVLGYSYSVDW------WSL 193
I D+ ++ +E+ T P +IAPE+ DEV G VD WSL
Sbjct: 140 KIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV----DEVHGNLLVVDQTKESNVWSL 195
Query: 194 GVTLFEILARG-RPFDIHSNTSV 215
GVT++E+ G +P+ S+ V
Sbjct: 196 GVTIWELFELGSQPYRHLSDEQV 218
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 1e-04
Identities = 43/173 (24%), Positives = 80/173 (46%), Gaps = 14/173 (8%)
Query: 40 DALKNV----LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHIT----- 90
DA KN L+E++I++ L+ P ++ L + L M+++ + GDL ++
Sbjct: 57 DANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQ 116
Query: 91 -QDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNI 149
K V T+ A ++ + YL + + +HRD+ N L+ + I DF +
Sbjct: 117 EAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 150 ATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG-YSYSVDWWSLGVTLFEIL 201
+ L + G + P ++ +LG ++ + D W+ GVTL+EIL
Sbjct: 177 SRNLYSGDY-YRIQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 26/100 (26%), Positives = 51/100 (51%), Gaps = 8/100 (8%)
Query: 108 YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTK 166
+++++ +++L +K+ +HRD+ N+L+ E I DF +A ++ ++ + S
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 167 P--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
P ++APE Y+ D WS G+ L+EI G
Sbjct: 304 PLKWMAPESIFNNL-----YTTLSDVWSFGILLWEIFTLG 338
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 45/209 (21%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76
V K + + A+K ++++ + R+ ++ L E ++ +V L + ++
Sbjct: 30 VVKDEPETRVAIKTVNEAASM-RERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87
Query: 77 SDLLLGGDLRYHI------TQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
+L+ GDL+ ++ ++ + + I + A E+ + YL +HRD+
Sbjct: 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM-AGEIADGMAYLNANKFVHRDLA 146
Query: 131 PDNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTKP--YIAPEIFLVATDEVLGYSYS 187
N ++ E+ I DF + + E + G P +++PE D V ++
Sbjct: 147 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL---KDGV--FTTY 201
Query: 188 VDWWSLGVTLFEILARG-RPFDIHSNTSV 215
D WS GV L+EI +P+ SN V
Sbjct: 202 SDVWSFGVVLWEIATLAEQPYQGMSNEQV 230
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 29/212 (13%)
Query: 15 CIVQKKDTKQMYAMKYMHKSQCIERDAL-KNV------------LREMEILTTLEHP-FL 60
++Q+ +++ + + E + K V L+E +L L H L
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 61 VNLWFCFQDEEDLFMVSDLLLGGDLRYHITQ-----DIKFYSVGTRNDTIHLYAFELGLA 115
L C +D E F++ + G+L+ + Q ++ T+ +H+ A ++
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ-QLVHM-AIQIACG 129
Query: 116 LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL---EENQLATSMSGTKPYIAPE 172
+ YL + +IH+DI N ++DEE ITD ++ L + + L + + ++A E
Sbjct: 130 MSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALE 189
Query: 173 IFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
+ YS + D WS GV L+E++ G
Sbjct: 190 SLVNKE-----YSSASDVWSFGVLLWELMTLG 216
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 5e-04
Identities = 30/105 (28%), Positives = 48/105 (45%), Gaps = 17/105 (16%)
Query: 109 AFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAH--------ITDFNIA-TVLEENQLA 159
A +L AL +L+ K + H ++ N+LL E ++D I+ TVL + L
Sbjct: 106 AKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILL 165
Query: 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
+ P++ PE + S + D WS G TL+EI + G
Sbjct: 166 ERI----PWVPPE----CIENPQNLSLAADKWSFGTTLWEIFSGG 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 5e-04
Identities = 32/100 (32%), Positives = 43/100 (43%), Gaps = 16/100 (16%)
Query: 109 AFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA--------TVLEENQLAT 160
A +L AL YL+ K+++H ++ NILL G A T I T L +
Sbjct: 123 AQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE 182
Query: 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEI 200
+ P+IAPE S + D WS G TL EI
Sbjct: 183 RI----PWIAPE----CVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 13/25 (52%), Positives = 17/25 (68%)
Query: 115 ALDYLKTKHIIHRDIKPDNILLDEE 139
ALD L + I+HRD+KP NI+ E
Sbjct: 267 ALDGLHSTGIVHRDVKPQNIIFSEG 291
|
Length = 566 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.001
Identities = 35/112 (31%), Positives = 52/112 (46%), Gaps = 11/112 (9%)
Query: 109 AFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTKP 167
A E+ + YL K +HRD+ N ++ + I DF + + E + G P
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 168 --YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEI--LARGRPFDIHSNTSV 215
++APE D V ++ S D WS GV L+EI LA +P+ SN V
Sbjct: 185 VRWMAPESL---KDGV--FTTSSDMWSFGVVLWEITSLAE-QPYQGLSNEQV 230
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 26/95 (27%), Positives = 42/95 (44%), Gaps = 10/95 (10%)
Query: 113 GLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTKP--YI 169
G+A YL + +HRD+ N L+ E I DF ++ + + S + P ++
Sbjct: 142 GMA--YLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWM 199
Query: 170 APEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
PE Y+ D W+ GV L+EI + G
Sbjct: 200 PPESIFYNR-----YTTESDVWAYGVVLWEIFSYG 229
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 246 | |||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0588|consensus | 786 | 100.0 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600|consensus | 560 | 100.0 | ||
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661|consensus | 538 | 100.0 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| KOG4721|consensus | 904 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0983|consensus | 391 | 100.0 | ||
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0984|consensus | 282 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| KOG0666|consensus | 438 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152|consensus | 772 | 99.98 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG0200|consensus | 609 | 99.98 | ||
| KOG3653|consensus | 534 | 99.97 | ||
| KOG2052|consensus | 513 | 99.97 | ||
| KOG1025|consensus | 1177 | 99.97 | ||
| KOG0669|consensus | 376 | 99.97 | ||
| KOG0668|consensus | 338 | 99.97 | ||
| KOG0664|consensus | 449 | 99.97 | ||
| KOG0670|consensus | 752 | 99.97 | ||
| KOG1027|consensus | 903 | 99.97 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1345|consensus | 378 | 99.96 | ||
| KOG0665|consensus | 369 | 99.96 | ||
| KOG0576|consensus | 829 | 99.94 | ||
| KOG1290|consensus | 590 | 99.94 | ||
| KOG1165|consensus | 449 | 99.93 | ||
| KOG1167|consensus | 418 | 99.93 | ||
| KOG1163|consensus | 341 | 99.93 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1024|consensus | 563 | 99.92 | ||
| KOG1164|consensus | 322 | 99.92 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG0603|consensus | 612 | 99.88 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0590|consensus | 601 | 99.87 | ||
| KOG1240|consensus | 1431 | 99.86 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG1166|consensus | 974 | 99.83 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG0195|consensus | 448 | 99.81 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| KOG0606|consensus | 1205 | 99.78 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| KOG4158|consensus | 598 | 99.74 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| KOG1023|consensus | 484 | 99.68 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG0590|consensus | 601 | 99.61 | ||
| KOG1033|consensus | 516 | 99.58 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.57 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| KOG1243|consensus | 690 | 99.54 | ||
| KOG3741|consensus | 655 | 99.53 | ||
| KOG1266|consensus | 458 | 99.49 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| KOG0601|consensus | 524 | 99.47 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| KOG3087|consensus | 229 | 99.38 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.34 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.25 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.19 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.17 | |
| KOG0601|consensus | 524 | 99.14 | ||
| KOG0606|consensus | 1205 | 99.13 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.13 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.05 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.98 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.96 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.94 | |
| KOG2137|consensus | 700 | 98.86 | ||
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.86 | |
| KOG1235|consensus | 538 | 98.71 | ||
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.56 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.55 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.55 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.43 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.23 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.21 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.12 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.11 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.07 | |
| KOG0576|consensus | 829 | 98.03 | ||
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.88 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.67 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.64 | |
| KOG2268|consensus | 465 | 97.58 | ||
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.54 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.54 | |
| KOG1035|consensus | 1351 | 97.49 | ||
| PRK05231 | 319 | homoserine kinase; Provisional | 97.4 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.37 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.35 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.34 | |
| KOG2270|consensus | 520 | 97.18 | ||
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.16 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.14 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.03 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.96 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.9 | |
| PLN02236 | 344 | choline kinase | 96.8 | |
| KOG1826|consensus | 2724 | 96.77 | ||
| PRK10593 | 297 | hypothetical protein; Provisional | 96.72 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.57 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.52 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.26 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.18 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.16 | |
| KOG1236|consensus | 565 | 95.95 | ||
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.87 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.52 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.23 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.05 | |
| KOG1093|consensus | 725 | 93.83 | ||
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 92.85 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 92.78 |
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=319.23 Aligned_cols=228 Identities=28% Similarity=0.470 Sum_probs=203.3
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC-eEEEEEeecC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE-DLFMVSDLLL 81 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~v~e~~~ 81 (246)
||+|.. |+|++|+|+.|++.+|+|.+.... +++..+++.+|++++.+.+||+||.+|+.|..+. .++++||||+
T Consensus 87 lG~G~g---G~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 87 LGSGNG---GTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred cccCCC---cEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 567766 999999999999999999995543 4667799999999999999999999999999988 4999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
+|||.+.+...++. ++..+-.++.+++++|.|||+ ++|+||||||+|+|++.+|.+||||||.+....+. ...
T Consensus 162 gGSLd~~~k~~g~i-----~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~ 235 (364)
T KOG0581|consen 162 GGSLDDILKRVGRI-----PEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IAN 235 (364)
T ss_pred CCCHHHHHhhcCCC-----CHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hcc
Confidence 99999999877665 999999999999999999995 99999999999999999999999999999877655 567
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC---CCccHHHHHhhhcC-CCCCCCC-CCHh
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH---SNTSVKDVKAIIYS-PVHYPTA-WSES 235 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~---~~~~~~~~~~~~~~-~~~~~~~-~s~~ 235 (246)
.+.||..|||||.+.+.. ++.++||||||+.++|+..|+.||... ..+......+|+.+ ++.+|.. +|++
T Consensus 236 tfvGT~~YMsPERi~g~~-----Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~e 310 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGES-----YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPE 310 (364)
T ss_pred cccccccccChhhhcCCc-----CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHH
Confidence 789999999999999886 899999999999999999999999654 22335567777774 7777886 9999
Q ss_pred HHHHHHHhhhC
Q psy7592 236 TKHLLSQVHRY 246 (246)
Q Consensus 236 l~~li~~~l~~ 246 (246)
++++|..||++
T Consensus 311 f~~FV~~CL~K 321 (364)
T KOG0581|consen 311 FRSFVSCCLRK 321 (364)
T ss_pred HHHHHHHHhcC
Confidence 99999999985
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-51 Score=316.56 Aligned_cols=230 Identities=40% Similarity=0.701 Sum_probs=206.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+|++|+.+.|++.||+|++++....+....+....|..++++++||+||+++..|++...+|+|+||+.
T Consensus 32 viGkG~f---GkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 32 VIGKGSF---GKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeccCC---ceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 4799999 9999999999999999999999888777778899999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-cccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~ 160 (246)
||.|..++++.+.. +++.++.++.+|+.||.|||+.||+|||+||+|||++..|.++++|||+++..... ....
T Consensus 109 GGeLf~hL~~eg~F-----~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~ 183 (357)
T KOG0598|consen 109 GGELFYHLQREGRF-----SEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATR 183 (357)
T ss_pred CccHHHHHHhcCCc-----chhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccc
Confidence 99999999987766 99999999999999999999999999999999999999999999999999865433 4445
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCC-CCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY-PTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~l 239 (246)
.+.||+.|+|||++.+.. ++..+|.||||+++|+|++|.+||.+.+. ......+...+... |.-+|.+.+++
T Consensus 184 tfcGT~eYmAPEil~~~g-----y~~~vDWWsLGillYeML~G~pPF~~~~~--~~~~~~I~~~k~~~~p~~ls~~ardl 256 (357)
T KOG0598|consen 184 TFCGTPEYMAPEILLGKG-----YDKAVDWWSLGILLYEMLTGKPPFYAEDV--KKMYDKILKGKLPLPPGYLSEEARDL 256 (357)
T ss_pred cccCCccccChHHHhcCC-----CCcccchHhHHHHHHHHhhCCCCCcCccH--HHHHHHHhcCcCCCCCccCCHHHHHH
Confidence 579999999999998885 89999999999999999999999975543 34556677777444 44599999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|+++|..
T Consensus 257 l~~LL~r 263 (357)
T KOG0598|consen 257 LKKLLKR 263 (357)
T ss_pred HHHHhcc
Confidence 9999863
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=329.58 Aligned_cols=229 Identities=29% Similarity=0.490 Sum_probs=209.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
|||+|+| .++|.+++..+|+.||+|++.+.....+...+.+.+|+++-++|+|||||+++++|++.+++|+|.|+|.
T Consensus 25 ~LGkGgF---A~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~ 101 (592)
T KOG0575|consen 25 FLGKGGF---ARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCH 101 (592)
T ss_pred eeccCcc---eEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecC
Confidence 6899999 9999999999999999999999888888888999999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-cccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~ 160 (246)
.++|..+++.... ++|+++..+++||+.++.|||+++|+|||||..|+|++++.++||+|||+|...... ....
T Consensus 102 ~~sL~el~Krrk~-----ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~ 176 (592)
T KOG0575|consen 102 RGSLMELLKRRKP-----LTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK 176 (592)
T ss_pred CccHHHHHHhcCC-----CCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence 9999999886544 499999999999999999999999999999999999999999999999999998754 5667
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
...||+-|.|||++.... .+.++||||+||++|.|+.|++||+. .+...-...+......+|...|.+.++||
T Consensus 177 TlCGTPNYIAPEVl~k~g-----HsfEvDiWSlGcvmYtLL~G~PPFet--k~vkety~~Ik~~~Y~~P~~ls~~A~dLI 249 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLNKSG-----HSFEVDIWSLGCVMYTLLVGRPPFET--KTVKETYNKIKLNEYSMPSHLSAEAKDLI 249 (592)
T ss_pred eecCCCcccChhHhccCC-----CCCchhhhhhhhHHHhhhhCCCCccc--chHHHHHHHHHhcCcccccccCHHHHHHH
Confidence 789999999999998554 89999999999999999999999963 23334556677778899999999999999
Q ss_pred HHhhh
Q psy7592 241 SQVHR 245 (246)
Q Consensus 241 ~~~l~ 245 (246)
.+||+
T Consensus 250 ~~lL~ 254 (592)
T KOG0575|consen 250 RKLLR 254 (592)
T ss_pred HHHhc
Confidence 99996
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=317.36 Aligned_cols=227 Identities=30% Similarity=0.511 Sum_probs=197.5
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||.|+| ++||+++++.++..||||.+.+... ....++.+..|+.+|+.++|||||++++++.+.+.+|+|||||.|
T Consensus 18 iG~Gsf---avVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g 93 (429)
T KOG0595|consen 18 IGSGSF---AVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG 93 (429)
T ss_pred ccCcce---EEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence 788888 9999999999999999999988753 466678899999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC------CCeEEeecceeeeeccC
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE------GHAHITDFNIATVLEEN 156 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~------~~~~l~d~~~~~~~~~~ 156 (246)
|+|.+++.+.+.+ ++++++.++.||+.|+++||+++|+||||||.|||++.+ -.+||+|||+++...+.
T Consensus 94 GDLs~yi~~~~~l-----~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 94 GDLSDYIRRRGRL-----PEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred CCHHHHHHHcCCC-----CHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 9999999987765 999999999999999999999999999999999999875 35799999999999888
Q ss_pred ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCCCCCC
Q psy7592 157 QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPTAWS 233 (246)
Q Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~s 233 (246)
.......|++.|||||++..+. |+.|.|+||+|+++|+|++|+.||+.....+.. ..+... ...+|...+
T Consensus 169 ~~a~tlcGSplYMAPEV~~~~~-----YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~--~~~~k~~~~~~~~~~~~s 241 (429)
T KOG0595|consen 169 SMAETLCGSPLYMAPEVIMSQQ-----YDAKADLWSIGTILYQCLTGKPPFDAETPKELL--LYIKKGNEIVPVLPAELS 241 (429)
T ss_pred hHHHHhhCCccccCHHHHHhcc-----ccchhhHHHHHHHHHHHHhCCCCccccCHHHHH--HHHhccccccCchhhhcc
Confidence 8888899999999999997765 899999999999999999999999755544333 233222 333455678
Q ss_pred HhHHHHHHHhhh
Q psy7592 234 ESTKHLLSQVHR 245 (246)
Q Consensus 234 ~~l~~li~~~l~ 245 (246)
..+.+++-..|+
T Consensus 242 ~~~~~Ll~~ll~ 253 (429)
T KOG0595|consen 242 NPLRELLISLLQ 253 (429)
T ss_pred CchhhhhhHHHh
Confidence 887777766654
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-51 Score=321.54 Aligned_cols=233 Identities=32% Similarity=0.468 Sum_probs=199.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHH----HHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERD----ALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||+|+| |.|-+|.++.||+.||||.+++......+ -.....+|+++|++|+|||||+++++|+..+..|+||
T Consensus 179 ~LGsGaf---g~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVl 255 (475)
T KOG0615|consen 179 TLGSGAF---GLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVL 255 (475)
T ss_pred eecCCce---eEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEE
Confidence 3788888 99999999999999999999876543211 2234679999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC---CCeEEeecceeeeec
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE---GHAHITDFNIATVLE 154 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~---~~~~l~d~~~~~~~~ 154 (246)
||++||.|.+.+..++.. .++.-+.+++|++.|+.|||++||+||||||+|||+..+ ..+||+|||+++...
T Consensus 256 E~v~GGeLfd~vv~nk~l-----~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 256 EYVEGGELFDKVVANKYL-----REDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG 330 (475)
T ss_pred EEecCccHHHHHHhcccc-----ccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence 999999999999887766 888899999999999999999999999999999999877 578999999999988
Q ss_pred cCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCC-C---C
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY-P---T 230 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~---~ 230 (246)
.........||+.|.|||++.....+. +..++|+||+||++|-+++|.+||+..-++. ....++......+ | .
T Consensus 331 ~~sfm~TlCGTpsYvAPEVl~~kg~~~--~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~eQI~~G~y~f~p~~w~ 407 (475)
T KOG0615|consen 331 EGSFMKTLCGTPSYVAPEVLASKGVEY--YPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLKEQILKGRYAFGPLQWD 407 (475)
T ss_pred cceehhhhcCCccccChhheecCCeec--ccchheeeeccceEEEEeccCCCcccccCCc-cHHHHHhcCcccccChhhh
Confidence 888888899999999999998765332 3458999999999999999999998665544 1344556555544 2 3
Q ss_pred CCCHhHHHHHHHhhh
Q psy7592 231 AWSESTKHLLSQVHR 245 (246)
Q Consensus 231 ~~s~~l~~li~~~l~ 245 (246)
.+|++..+||++||.
T Consensus 408 ~Iseea~dlI~~mL~ 422 (475)
T KOG0615|consen 408 RISEEALDLINWMLV 422 (475)
T ss_pred hhhHHHHHHHHHhhE
Confidence 579999999999985
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=294.74 Aligned_cols=227 Identities=35% Similarity=0.653 Sum_probs=209.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|+| |+|.+++++.+|..||+|.+.+.....-.+++...+|..+|+.+.||++++++..|.+.+.+++||||.+
T Consensus 51 tlGtGSF---GrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~ 127 (355)
T KOG0616|consen 51 TLGTGSF---GRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVP 127 (355)
T ss_pred eeccCcc---ceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccC
Confidence 4788999 9999999999999999999999888888888999999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
||.|..++.+.++. ++..++.++.|++.|++|||+.++++||+||+|||++++|-++++|||++++.... .-.
T Consensus 128 GGElFS~Lrk~~rF-----~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~T 200 (355)
T KOG0616|consen 128 GGELFSYLRKSGRF-----SEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWT 200 (355)
T ss_pred CccHHHHHHhcCCC-----CchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--EEE
Confidence 99999999887665 99999999999999999999999999999999999999999999999999987654 445
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..||+.|+|||.+.... +...+|-||||+++|||+.|.+||.... .......|+.....+|.-+|+++++||+
T Consensus 201 lCGTPeYLAPEii~sk~-----ynkavDWWalGVLIYEMlaG~pPF~~~~--~~~iY~KI~~~~v~fP~~fs~~~kdLl~ 273 (355)
T KOG0616|consen 201 LCGTPEYLAPEIIQSKG-----YNKAVDWWALGVLIYEMLAGYPPFYDDN--PIQIYEKILEGKVKFPSYFSSDAKDLLK 273 (355)
T ss_pred ecCCccccChHHhhcCC-----CCcchhHHHHHHHHHHHHcCCCCCcCCC--hHHHHHHHHhCcccCCcccCHHHHHHHH
Confidence 67999999999998776 7889999999999999999999996433 3667888999999999999999999999
Q ss_pred Hhhh
Q psy7592 242 QVHR 245 (246)
Q Consensus 242 ~~l~ 245 (246)
++|+
T Consensus 274 ~LL~ 277 (355)
T KOG0616|consen 274 KLLQ 277 (355)
T ss_pred HHHh
Confidence 9986
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=317.47 Aligned_cols=230 Identities=36% Similarity=0.582 Sum_probs=207.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|+| ++|++|+++.+++.||||++.+.....+.-++....|-..|.+| .||+|+++|..|+++..+|+|+||+
T Consensus 80 ~lGeGSY---StV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A 156 (604)
T KOG0592|consen 80 ILGEGSY---STVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYA 156 (604)
T ss_pred eeccccc---eeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEec
Confidence 4789999 99999999999999999999887766666677788999999999 7999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-- 158 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 158 (246)
++|.|.+++.+.+.+ .+.-.+.++.||+.||+|||+.||+||||||+|||++.++.++|+|||.++.+.....
T Consensus 157 ~nGdll~~i~K~Gsf-----de~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~ 231 (604)
T KOG0592|consen 157 PNGDLLDLIKKYGSF-----DETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ 231 (604)
T ss_pred CCCcHHHHHHHhCcc-----hHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence 999999999988776 8888999999999999999999999999999999999999999999999988743211
Q ss_pred ------------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCC
Q psy7592 159 ------------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPV 226 (246)
Q Consensus 159 ------------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (246)
...+.||..|.+||++.... .++.+|+|+|||++|+|+.|++||. ...+...++.|+.-..
T Consensus 232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-----~~~~sDiWAlGCilyQmlaG~PPFr--a~NeyliFqkI~~l~y 304 (604)
T KOG0592|consen 232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-----AGPSSDLWALGCILYQMLAGQPPFR--AANEYLIFQKIQALDY 304 (604)
T ss_pred cCccCcccccCcccceeeeecccCHHHhcCCC-----CCcccchHHHHHHHHHHhcCCCCCc--cccHHHHHHHHHHhcc
Confidence 14478999999999998776 7889999999999999999999996 4455677888888899
Q ss_pred CCCCCCCHhHHHHHHHhhhC
Q psy7592 227 HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ~~~~~~s~~l~~li~~~l~~ 246 (246)
.+|+.+++.+++||+++|+.
T Consensus 305 ~fp~~fp~~a~dLv~KLLv~ 324 (604)
T KOG0592|consen 305 EFPEGFPEDARDLIKKLLVR 324 (604)
T ss_pred cCCCCCCHHHHHHHHHHHcc
Confidence 99999999999999999863
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=299.92 Aligned_cols=231 Identities=28% Similarity=0.406 Sum_probs=198.2
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeee-eeee-CCeEEEEEeec
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWF-CFQD-EEDLFMVSDLL 80 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~-~~~~~~v~e~~ 80 (246)
||.|+| |+||+|.+..+|+.+|.|.++-.. .+....+++..|+.+|++|+|||||++|+ .|.+ ..-++++||++
T Consensus 27 IG~GsF---g~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c 102 (375)
T KOG0591|consen 27 IGRGSF---GEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELC 102 (375)
T ss_pred HcCCcc---hheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhh
Confidence 788999 999999999999999999998443 45566788999999999999999999997 5544 44489999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH--CC--cccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT--KH--IIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~--~~--~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
.+|+|.+.++.... -+..+|+.++|.++.|++.||..+|. .. +.||||||.||+++.+|.+|+.|||+++.++..
T Consensus 103 ~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~ 181 (375)
T KOG0591|consen 103 DAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK 181 (375)
T ss_pred cccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch
Confidence 99999999976543 35567999999999999999999999 44 999999999999999999999999999998766
Q ss_pred ccc-cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCC-CCCC
Q psy7592 157 QLA-TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYP-TAWS 233 (246)
Q Consensus 157 ~~~-~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-~~~s 233 (246)
... ....||+.|++||.+.+.. ++++|||||+||++|||+.-++||.+. .-....+.|.++ .++.| .-+|
T Consensus 182 ~tfA~S~VGTPyYMSPE~i~~~~-----Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qgd~~~~p~~~YS 254 (375)
T KOG0591|consen 182 TTFAHSLVGTPYYMSPERIHESG-----YNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQGDYPPLPDEHYS 254 (375)
T ss_pred hHHHHhhcCCCcccCHHHHhcCC-----CCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcCCCCCCcHHHhh
Confidence 544 4578999999999998876 899999999999999999999999865 333445556555 44467 5699
Q ss_pred HhHHHHHHHhhh
Q psy7592 234 ESTKHLLSQVHR 245 (246)
Q Consensus 234 ~~l~~li~~~l~ 245 (246)
.++++||+.|++
T Consensus 255 ~~l~~li~~ci~ 266 (375)
T KOG0591|consen 255 TDLRELINMCIA 266 (375)
T ss_pred hHHHHHHHHHcc
Confidence 999999999985
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=299.00 Aligned_cols=231 Identities=28% Similarity=0.460 Sum_probs=201.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc-h-HHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI-E-RDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~-~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|+| |+|+.+.+..++..||+|.+...... . ....+.+.+|+.+++.++ ||||+++++++.....+++|||
T Consensus 24 ~lG~Gsf---gkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmE 100 (370)
T KOG0583|consen 24 TLGSGSF---GKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVME 100 (370)
T ss_pred eecCCCC---eeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEE
Confidence 4788888 99999999999999999987765221 1 134566778999999998 9999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC-CCeEEeecceeeee-ccC
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE-GHAHITDFNIATVL-EEN 156 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~-~~~~l~d~~~~~~~-~~~ 156 (246)
|+.||+|.+++.+.+++ ++..+..++.|++.|++|||++|++||||||+|++++.+ +++|++|||++... ...
T Consensus 101 y~~gGdL~~~i~~~g~l-----~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~ 175 (370)
T KOG0583|consen 101 YCSGGDLFDYIVNKGRL-----KEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGED 175 (370)
T ss_pred ecCCccHHHHHHHcCCC-----ChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCC
Confidence 99999999999886555 889999999999999999999999999999999999999 99999999999987 466
Q ss_pred ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCC-CHh
Q psy7592 157 QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAW-SES 235 (246)
Q Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~ 235 (246)
.......|++.|+|||.+.+... ..+.++|+||+|+++|.|++|..||+. .+.......+......+|..+ |++
T Consensus 176 ~~l~t~cGsp~Y~aPEvl~~~~~---Y~g~~aDvWS~GViLy~ml~G~~PF~d--~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 176 GLLKTFCGSPAYAAPEVLSGKGT---YSGKAADVWSLGVILYVLLCGRLPFDD--SNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred CcccCCCCCcccCCHHHhCCCCC---cCCchhhhhhhHHHHHHHHhCCCCCCC--ccHHHHHHHHhcCCccCCCCcCCHH
Confidence 66777899999999999987652 135789999999999999999999975 334445556788899999999 999
Q ss_pred HHHHHHHhhh
Q psy7592 236 TKHLLSQVHR 245 (246)
Q Consensus 236 l~~li~~~l~ 245 (246)
+++||++||+
T Consensus 251 ~~~Li~~mL~ 260 (370)
T KOG0583|consen 251 ARSLIEKMLV 260 (370)
T ss_pred HHHHHHHHcC
Confidence 9999999996
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=295.47 Aligned_cols=231 Identities=24% Similarity=0.357 Sum_probs=196.2
Q ss_pred cCCCCccCeeeEEEEEecCCCcE-EEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC-eEEEEEeec
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQM-YAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE-DLFMVSDLL 80 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~-~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~v~e~~ 80 (246)
+|.|+| |+||.+... |+. ||+|.+......... .+.+.+|+.++.+++|||||++++++.+.. ..++||||+
T Consensus 49 iG~G~~---g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 49 LGSGSF---GTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred cccCCc---eeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 688888 999999985 666 999999876654444 789999999999999999999999999887 799999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC-cccCCCCCCcEEEcCCC-CeEEeecceeeeeccC-c
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH-IIHRDIKPDNILLDEEG-HAHITDFNIATVLEEN-Q 157 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~-~~h~~i~~~nil~~~~~-~~~l~d~~~~~~~~~~-~ 157 (246)
++|+|.+++... ....++...+..++.||+.|+.|||+.+ |+|+||||+|+|++.++ .+||+|||+++..... .
T Consensus 123 ~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~ 199 (362)
T KOG0192|consen 123 PGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT 199 (362)
T ss_pred CCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccc
Confidence 999999999873 2334699999999999999999999999 99999999999999998 9999999999887654 3
Q ss_pred cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHH
Q psy7592 158 LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTK 237 (246)
Q Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 237 (246)
......||..|+|||.+.+. ...++.++||||||+++|||++|..||.................++.+|..+++.+.
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~---~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~ 276 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGE---KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLS 276 (362)
T ss_pred cccCCCCCccccChhhhcCC---CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 34447889999999999854 224899999999999999999999999866552233333334447778888999999
Q ss_pred HHHHHhhh
Q psy7592 238 HLLSQVHR 245 (246)
Q Consensus 238 ~li~~~l~ 245 (246)
.+|+.||+
T Consensus 277 ~l~~~CW~ 284 (362)
T KOG0192|consen 277 SLMERCWL 284 (362)
T ss_pred HHHHHhCC
Confidence 99999986
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=296.28 Aligned_cols=229 Identities=34% Similarity=0.647 Sum_probs=198.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |.||+|+.+.||..||+|+++++.-....+++.+..|-++|...++|+||++|-.|++.+++|+||||++
T Consensus 148 ~IgkGAf---GeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 148 VIGKGAF---GEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred eeccccc---eeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 3788988 9999999999999999999999988888888999999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc------
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE------ 155 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~------ 155 (246)
||++..++.+.+.+ +++.++.++.+++.|+..+|+.|++|+||||+|+|++.+|.+||+|||++.....
T Consensus 225 GGD~mTLL~~~~~L-----~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~ 299 (550)
T KOG0605|consen 225 GGDMMTLLMRKDTL-----TEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES 299 (550)
T ss_pred CccHHHHHHhcCcC-----chHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence 99999999887766 9999999999999999999999999999999999999999999999999855311
Q ss_pred ---------C-------ccc--------------------------cccccCCCccCCceecccccccCCCCcchhHHHH
Q psy7592 156 ---------N-------QLA--------------------------TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSL 193 (246)
Q Consensus 156 ---------~-------~~~--------------------------~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~sl 193 (246)
. ... ....|||-|+|||++.+.. ++..+|.|||
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-----Y~~~cDwWSL 374 (550)
T KOG0605|consen 300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-----YGKECDWWSL 374 (550)
T ss_pred hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-----CCccccHHHH
Confidence 0 000 0123889999999998876 8999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCC--CCCHhHHHHHHHhhh
Q psy7592 194 GVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPT--AWSESTKHLLSQVHR 245 (246)
Q Consensus 194 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~--~~s~~l~~li~~~l~ 245 (246)
||++||||.|.+||.+.. +....+.++.- ...+|. ..|++.++||..||.
T Consensus 375 G~ImyEmLvGyPPF~s~t--p~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~ 428 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSET--PQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC 428 (550)
T ss_pred HHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc
Confidence 999999999999997544 34444555444 345554 579999999999874
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=294.89 Aligned_cols=230 Identities=32% Similarity=0.594 Sum_probs=197.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+||+|++ |+||+|+++.+|+.||+|+++............+.+|++++++++||||+++++++..++..++||||+.
T Consensus 2 ~lG~G~~---g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 2 LLGKGTF---GKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred eeeeCCC---eEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 5899999 9999999999999999999987654445556778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Ccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~ 160 (246)
+++|.+.+..... +++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 79 ~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 153 (323)
T cd05571 79 GGELFFHLSRERV-----FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence 9999998876543 48999999999999999999999999999999999999999999999999875322 22233
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
...+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+ .......+......+|..++++++++|
T Consensus 154 ~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlG~il~elltg~~Pf~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~li 226 (323)
T cd05571 154 TFCGTPEYLAPEVLEDND-----YGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILMEEIRFPRTLSPEAKSLL 226 (323)
T ss_pred ceecCccccChhhhcCCC-----CCccccCcccchhhhhhhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 456889999999987654 7889999999999999999999996433 333445556667788899999999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
++||++
T Consensus 227 ~~~L~~ 232 (323)
T cd05571 227 AGLLKK 232 (323)
T ss_pred HHHccC
Confidence 999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=302.69 Aligned_cols=230 Identities=24% Similarity=0.385 Sum_probs=206.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|+. |.|-+|++.+||+..|||.+.+..-.+......+.+|+.+++-+.|||++++|++|++..++|+|.||++
T Consensus 19 TLG~Gst---g~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 19 TLGKGST---GCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred cccCCCC---ceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 3677777 8999999999999999999988755556666778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
||.|++++...+.+ ++.+...++.||+.++.|+|..+|+|+|+||+|+|++.+++|||+|||++.....+.....
T Consensus 96 gGELFdylv~kG~l-----~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT 170 (786)
T KOG0588|consen 96 GGELFDYLVRKGPL-----PEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET 170 (786)
T ss_pred CchhHHHHHhhCCC-----CCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence 99999999887665 9999999999999999999999999999999999999999999999999998777777888
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
-+|++.|.|||++.+.+. .+.++||||+|+++|.|++|+.||+. .+-...+..+..+.+.+|.++|+++++||.
T Consensus 171 SCGSPHYA~PEIV~G~pY----dG~~sDVWSCGVILfALLtG~LPFdD--dNir~LLlKV~~G~f~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 171 SCGSPHYAAPEIVSGRPY----DGRPSDVWSCGVILFALLTGKLPFDD--DNIRVLLLKVQRGVFEMPSNISSEAQDLLR 244 (786)
T ss_pred cCCCcccCCchhhcCCCC----CCCccccchhHHHHHHHHhCCCCCCC--ccHHHHHHHHHcCcccCCCcCCHHHHHHHH
Confidence 899999999999998873 57799999999999999999999973 333344555666699999999999999999
Q ss_pred Hhhh
Q psy7592 242 QVHR 245 (246)
Q Consensus 242 ~~l~ 245 (246)
.||.
T Consensus 245 ~ml~ 248 (786)
T KOG0588|consen 245 RMLD 248 (786)
T ss_pred HHhc
Confidence 9985
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=291.95 Aligned_cols=230 Identities=31% Similarity=0.601 Sum_probs=196.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+||+|++ |.||+++++.+|+.||+|.++............+.+|++++++++||||+++++++..+...++||||++
T Consensus 2 ~lG~G~~---g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 2 LLGKGTF---GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred eeeeCCC---EEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 5899999 9999999999999999999987654445556778889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Ccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~ 160 (246)
+++|..++..... +++..++.++.|++.||.|||+.|++|+||+|+||++++++.++++|||++..... .....
T Consensus 79 ~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 153 (323)
T cd05595 79 GGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence 9999988866443 48999999999999999999999999999999999999999999999998875322 22233
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
...++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+ .......+......+|..+++.++++|
T Consensus 154 ~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlGvil~ell~g~~Pf~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~li 226 (323)
T cd05595 154 TFCGTPEYLAPEVLEDND-----YGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILMEEIRFPRTLSPEAKSLL 226 (323)
T ss_pred cccCCcCcCCcccccCCC-----CCchhchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 456788999999987664 7889999999999999999999996433 233445555667778889999999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
++||+.
T Consensus 227 ~~~L~~ 232 (323)
T cd05595 227 AGLLKK 232 (323)
T ss_pred HHHccC
Confidence 999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=288.13 Aligned_cols=230 Identities=27% Similarity=0.413 Sum_probs=191.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC--eEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE--DLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~~v~e~ 79 (246)
+||+|+| |+||++.++++|...|||.+....... .+.+.+|+++|.+++|||||++++...... .+++.|||
T Consensus 24 ~lG~Gs~---G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 24 LLGRGSF---GSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred cccCccc---eEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 5788888 999999999999999999987763222 678999999999999999999999744333 69999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC-CCCeEEeecceeeeecc---
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE-EGHAHITDFNIATVLEE--- 155 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~-~~~~~l~d~~~~~~~~~--- 155 (246)
+.+|||.+++.+.+. +++++.++.++.|++.+|.|||++|++|+||||+|||++. ++.+||+|||.+.....
T Consensus 98 ~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred cCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999987652 3599999999999999999999999999999999999999 79999999999887663
Q ss_pred -CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCCCC
Q psy7592 156 -NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAW 232 (246)
Q Consensus 156 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~ 232 (246)
........+++.|+|||++.... ...+++|||||||++.||+||+.||... .........+... .+.+|...
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~----~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~~~P~ip~~l 248 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGE----VARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGREDSLPEIPDSL 248 (313)
T ss_pred cccccccccCCccccCchhhcCCC----cCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccCCCCCCCccc
Confidence 12234577899999999998532 1335999999999999999999999753 2222333333333 46789999
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
|+++++++.+|+++
T Consensus 249 s~~a~~Fl~~C~~~ 262 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKR 262 (313)
T ss_pred CHHHHHHHHHHhhc
Confidence 99999999999974
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=298.26 Aligned_cols=228 Identities=34% Similarity=0.554 Sum_probs=205.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |.||++++|.+.+.||+|++.+.. ..+..++.+.+|++++++++||||+.+++.|+...+.|+|.||+.
T Consensus 9 ~iG~Gsf---g~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~ 84 (808)
T KOG0597|consen 9 MIGEGSF---GRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAV 84 (808)
T ss_pred HhcCCcc---ceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhh
Confidence 3799999 999999999999999999998754 345668899999999999999999999999999999999999997
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc-c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-T 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~ 160 (246)
| +|...+..++.+ |++.+..++.|+..||.|||+.+|.|+|++|.||++..+|.+|+||||+++.+..++.. .
T Consensus 85 g-~L~~il~~d~~l-----pEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 85 G-DLFTILEQDGKL-----PEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred h-hHHHHHHhccCC-----CHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence 7 999999988877 99999999999999999999999999999999999999999999999999998876654 3
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
...|++.|+|||.+.+++ ++..+|.|||||++||+..|++||-.. .-....+.|..++..+|.+.|..+.+++
T Consensus 159 sikGtPlYmAPElv~e~p-----yd~~sDlWslGcilYE~~~G~PPF~a~--si~~Lv~~I~~d~v~~p~~~S~~f~nfl 231 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQP-----YDHTSDLWSLGCILYELYVGQPPFYAR--SITQLVKSILKDPVKPPSTASSSFVNFL 231 (808)
T ss_pred eccCcccccCHHHHcCCC-----ccchhhHHHHHHHHHHHhcCCCCchHH--HHHHHHHHHhcCCCCCcccccHHHHHHH
Confidence 467899999999999887 899999999999999999999999532 2334566677778888999999999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
+.+|++
T Consensus 232 ~gLL~k 237 (808)
T KOG0597|consen 232 QGLLIK 237 (808)
T ss_pred HHHhhc
Confidence 999874
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=287.80 Aligned_cols=229 Identities=23% Similarity=0.432 Sum_probs=205.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |.|-+|++...|+.||||.++++...++..+-.+.+|+++++.|+||||+.+|++|+..+.+.+||||..
T Consensus 60 tLGkGTY---GKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS 136 (668)
T KOG0611|consen 60 TLGKGTY---GKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYAS 136 (668)
T ss_pred HhcCCcc---cceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecC
Confidence 4899999 8999999989999999999999998888888889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+|.|.+++...+.+ ++.+...++.||..|+.|+|.++++|+|++.+|||+++|+++||+|||++..+........
T Consensus 137 ~GeLYDYiSer~~L-----sErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqT 211 (668)
T KOG0611|consen 137 GGELYDYISERGSL-----SEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQT 211 (668)
T ss_pred CccHHHHHHHhccc-----cHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHH
Confidence 99999999987776 9999999999999999999999999999999999999999999999999999988888889
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
+.|++.|.+||++.+.+. -++++|-||||+++|.++.|.+||++.+-. ...+++..+...- +.-+.+..-||.
T Consensus 212 FCGSPLYASPEIvNG~PY----~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk--~lvrQIs~GaYrE-P~~PSdA~gLIR 284 (668)
T KOG0611|consen 212 FCGSPLYASPEIVNGTPY----KGPEVDSWSLGVLLYTLVYGTMPFDGRDHK--RLVRQISRGAYRE-PETPSDASGLIR 284 (668)
T ss_pred hcCCcccCCccccCCCCC----CCCccchhhHHHHHHHHhhcccccCCchHH--HHHHHhhcccccC-CCCCchHHHHHH
Confidence 999999999999988773 478999999999999999999999875532 2334444443333 345667888999
Q ss_pred Hhhh
Q psy7592 242 QVHR 245 (246)
Q Consensus 242 ~~l~ 245 (246)
+||.
T Consensus 285 wmLm 288 (668)
T KOG0611|consen 285 WMLM 288 (668)
T ss_pred HHHh
Confidence 9984
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=278.43 Aligned_cols=200 Identities=29% Similarity=0.437 Sum_probs=171.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.+|+|+| |+|++|++++||+.||||++-.+. .++...+-..+|+++|++|+|+|+|.+.++|.....+++|+||++
T Consensus 9 kvGEGSY---GvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~d 84 (396)
T KOG0593|consen 9 KVGEGSY---GVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCD 84 (396)
T ss_pred ccccCcc---eEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecc
Confidence 3677777 999999999999999999996654 334555668899999999999999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec-cCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE-ENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~~ 160 (246)
..-|. .+... +.+.+...++.+++|++.|+.|+|+++++||||||+|||++.+|.+|+||||+++... ++....
T Consensus 85 hTvL~-eLe~~----p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 85 HTVLH-ELERY----PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred hHHHH-HHHhc----cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 55444 44432 3345999999999999999999999999999999999999999999999999999887 444445
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS 214 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~ 214 (246)
...-|+.|.|||.+.+.. .|++.+||||+||++.||++|.+.|.+.+.-+
T Consensus 160 DYVATRWYRaPELLvGDt----qYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD 209 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDT----QYGKPVDIWAIGCVFAELLTGEPLWPGRSDID 209 (396)
T ss_pred hhhhhhhccChhhhcccC----cCCCcccchhhhHHHHHHhcCCcCCCCcchHH
Confidence 566788899999999866 48999999999999999999999997765433
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=290.13 Aligned_cols=229 Identities=33% Similarity=0.614 Sum_probs=197.5
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|+| |+||+++++.+++.||+|.+......+......+.+|+.++++++||||+++++++.++...++||||+++
T Consensus 1 lg~G~~---g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSF---GKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCC---eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence 688888 99999999999999999999875544455567788999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-ccccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~ 161 (246)
++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++...... .....
T Consensus 78 g~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 152 (312)
T cd05585 78 GELFHHLQREGR-----FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152 (312)
T ss_pred CcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccc
Confidence 999999876544 488999999999999999999999999999999999999999999999998754322 22233
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.... .......+......+|..+++.++++|+
T Consensus 153 ~~gt~~y~aPE~~~~~~-----~~~~~DvwslGvil~el~tg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~ 225 (312)
T cd05585 153 FCGTPEYLAPELLLGHG-----YTKAVDWWTLGVLLYEMLTGLPPFYDEN--VNEMYRKILQEPLRFPDGFDRDAKDLLI 225 (312)
T ss_pred ccCCcccCCHHHHcCCC-----CCCccceechhHHHHHHHhCCCCcCCCC--HHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 56789999999987654 7889999999999999999999997533 3344556677788888999999999999
Q ss_pred HhhhC
Q psy7592 242 QVHRY 246 (246)
Q Consensus 242 ~~l~~ 246 (246)
+||++
T Consensus 226 ~~L~~ 230 (312)
T cd05585 226 GLLSR 230 (312)
T ss_pred HHcCC
Confidence 99974
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=300.83 Aligned_cols=229 Identities=35% Similarity=0.635 Sum_probs=206.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|+| |+|+++..+.+++.||||.+++......+.++..+.|.+++...+ ||++++++.+|+.++++|+||||.
T Consensus 375 vLGkGsF---GkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~ 451 (694)
T KOG0694|consen 375 VLGRGSF---GKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV 451 (694)
T ss_pred EeccCcC---ceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence 3789999 999999999999999999999999988899999999999999885 999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec-cCccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE-ENQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~ 159 (246)
.||++.... .... +++..+..++..++.||+|||++||++||||.+|||++..|.+||+|||+++.-. .+...
T Consensus 452 ~Ggdm~~~~-~~~~-----F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~T 525 (694)
T KOG0694|consen 452 AGGDLMHHI-HTDV-----FSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRT 525 (694)
T ss_pred CCCcEEEEE-eccc-----ccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCcc
Confidence 999954333 2233 4999999999999999999999999999999999999999999999999998754 44566
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
..+.||+.|+|||++.+.. |+..+|.|||||++|+|+.|+.||++. ++.+..-.|+.....+|..+|.+..++
T Consensus 526 sTfCGTpey~aPEil~e~~-----Yt~aVDWW~lGVLlyeML~Gq~PF~gd--dEee~FdsI~~d~~~yP~~ls~ea~~i 598 (694)
T KOG0694|consen 526 STFCGTPEFLAPEVLTEQS-----YTRAVDWWGLGVLLYEMLVGESPFPGD--DEEEVFDSIVNDEVRYPRFLSKEAIAI 598 (694)
T ss_pred ccccCChhhcChhhhccCc-----ccchhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCCCCCCCcccHHHHHH
Confidence 6789999999999999987 999999999999999999999999753 445667788888999999999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
++.+|++
T Consensus 599 l~~ll~k 605 (694)
T KOG0694|consen 599 MRRLLRK 605 (694)
T ss_pred HHHHhcc
Confidence 9999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=287.43 Aligned_cols=228 Identities=31% Similarity=0.558 Sum_probs=196.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++.++.+++.||+|.+......+....+.+.+|+.++++++||||+++++++.++...++||||+.
T Consensus 8 ~lg~G~~---g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 84 (291)
T cd05612 8 TVGTGTF---GRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVP 84 (291)
T ss_pred eeecCCC---eEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCC
Confidence 4788888 9999999999999999999976554344456678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++...... ...
T Consensus 85 ~~~L~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~ 157 (291)
T cd05612 85 GGELFSYLRNSGR-----FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWT 157 (291)
T ss_pred CCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--ccc
Confidence 9999999876544 488899999999999999999999999999999999999999999999998765432 223
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.... .......+......+|..+++.++++|+
T Consensus 158 ~~gt~~y~aPE~~~~~~-----~~~~~DiwSlG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~li~ 230 (291)
T cd05612 158 LCGTPEYLAPEVIQSKG-----HNKAVDWWALGILIYEMLVGYPPFFDDN--PFGIYEKILAGKLEFPRHLDLYAKDLIK 230 (291)
T ss_pred ccCChhhcCHHHHcCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCcCCCccCCHHHHHHHH
Confidence 45788999999987654 6889999999999999999999997533 3344566666778888899999999999
Q ss_pred HhhhC
Q psy7592 242 QVHRY 246 (246)
Q Consensus 242 ~~l~~ 246 (246)
+||+.
T Consensus 231 ~~l~~ 235 (291)
T cd05612 231 KLLVV 235 (291)
T ss_pred HHcCC
Confidence 99974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=290.24 Aligned_cols=230 Identities=33% Similarity=0.604 Sum_probs=196.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||+++++.+++.||+|++.............+.+|+++++.++||||+++++++..++..++||||++
T Consensus 2 ~lG~G~~---g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 2 LLGKGTF---GKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred eeeeCCC---EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 5899999 9999999999999999999987655455566788899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Ccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~ 160 (246)
+++|...+..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++..... .....
T Consensus 79 ~g~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 153 (328)
T cd05593 79 GGELFFHLSRERV-----FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153 (328)
T ss_pred CCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence 9999988866443 48999999999999999999999999999999999999999999999999875322 22223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
...+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+ .......+......+|..++++++++|
T Consensus 154 ~~~gt~~y~aPE~~~~~~-----~~~~~DiwslGvil~elltG~~Pf~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~li 226 (328)
T cd05593 154 TFCGTPEYLAPEVLEDND-----YGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILMEDIKFPRTLSADAKSLL 226 (328)
T ss_pred cccCCcCccChhhhcCCC-----CCccCCccccchHHHHHhhCCCCCCCCC--HHHHHHHhccCCccCCCCCCHHHHHHH
Confidence 356788999999987654 7889999999999999999999996433 233444555567778899999999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
++||+.
T Consensus 227 ~~~L~~ 232 (328)
T cd05593 227 SGLLIK 232 (328)
T ss_pred HHHcCC
Confidence 999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=291.21 Aligned_cols=228 Identities=33% Similarity=0.643 Sum_probs=196.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.+...........+.+.+|+.++++++||||+++++++.+++..+++|||+.
T Consensus 25 ~lg~G~~---g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 101 (329)
T PTZ00263 25 TLGTGSF---GRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVV 101 (329)
T ss_pred EEEecCC---eEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCC
Confidence 3788888 8999999999999999999987654444556778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+.+...... ++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++++|||++...... ...
T Consensus 102 ~~~L~~~l~~~~~~-----~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 174 (329)
T PTZ00263 102 GGELFTHLRKAGRF-----PNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--TFT 174 (329)
T ss_pred CChHHHHHHHcCCC-----CHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--cce
Confidence 99999998765443 88899999999999999999999999999999999999999999999998765432 223
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||... ........+......+|..+++.++++|+
T Consensus 175 ~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 175 LCGTPEYLAPEVIQSKG-----HGKAVDWWTMGVLLYEFIAGYPPFFDD--TPFRIYEKILAGRLKFPNWFDGRARDLVK 247 (329)
T ss_pred ecCChhhcCHHHHcCCC-----CCCcceeechHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCCcCCCCCCCHHHHHHHH
Confidence 46788999999987665 678999999999999999999999643 23344455666677788889999999999
Q ss_pred HhhhC
Q psy7592 242 QVHRY 246 (246)
Q Consensus 242 ~~l~~ 246 (246)
+||+.
T Consensus 248 ~~L~~ 252 (329)
T PTZ00263 248 GLLQT 252 (329)
T ss_pred HHhhc
Confidence 99974
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=277.46 Aligned_cols=232 Identities=31% Similarity=0.553 Sum_probs=202.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|.. |+||+|+.+.++..+|+|++.+.....+..+.+++.|.++|+.++||.++.+|..|+.+...|++||||+
T Consensus 84 ~LG~Gdi---G~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 84 RLGCGDI---GTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HcCCCCc---eeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence 4778777 9999999999999999999999888888888999999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec-------
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE------- 154 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~------- 154 (246)
||+|...+++.. ...+++..++.++.+++.||+|||..|||+|||||+|||+.++|.+.++||+++....
T Consensus 161 GGdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~ 237 (459)
T KOG0610|consen 161 GGDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVK 237 (459)
T ss_pred CccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeec
Confidence 999999887653 4457999999999999999999999999999999999999999999999999864320
Q ss_pred c--------------------------C-cc-----------------------ccccccCCCccCCceecccccccCCC
Q psy7592 155 E--------------------------N-QL-----------------------ATSMSGTKPYIAPEIFLVATDEVLGY 184 (246)
Q Consensus 155 ~--------------------------~-~~-----------------------~~~~~~~~~~~aPE~~~~~~~~~~~~ 184 (246)
. . .. ...+.||-+|+|||++++.. .
T Consensus 238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-----H 312 (459)
T KOG0610|consen 238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-----H 312 (459)
T ss_pred cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-----C
Confidence 0 0 00 01134677899999999886 7
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCC--CCCHhHHHHHHHhhhC
Q psy7592 185 SYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPT--AWSESTKHLLSQVHRY 246 (246)
Q Consensus 185 ~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~l~~li~~~l~~ 246 (246)
+.++|.|+||+++|||+.|..||.+.++. +-+.+++..+..+|. .+|..+++||+++|.+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~--~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK--ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCch--hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhcc
Confidence 88999999999999999999999876654 446677878888875 5799999999999975
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=279.78 Aligned_cols=234 Identities=30% Similarity=0.544 Sum_probs=194.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||++.+..+++.||+|.+.............+.+|++++++++|++|+++++++.+++..+++|||+.
T Consensus 7 ~lg~G~~---g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 7 VLGKGGF---GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEecCCC---EEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence 4789998 8999999999999999999987654433444567789999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+.+.... ..++++..+..++.|++.|+.|||+.|++|+||+|+||++++++.++++|||++...........
T Consensus 84 ~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 84 GGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred CCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 999988875432 22458889999999999999999999999999999999999999999999999987654433344
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-H-HHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV-K-DVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~-~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
..++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||........ . ....+......++..+|+++.+|
T Consensus 161 ~~g~~~y~aPE~~~~~~-----~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 235 (285)
T cd05631 161 RVGTVGYMAPEVINNEK-----YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI 235 (285)
T ss_pred CCCCCCccCHhhhcCCC-----CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence 56789999999997664 78899999999999999999999976543221 1 22223344566778899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 236 i~~~l~~ 242 (285)
T cd05631 236 CRMLLTK 242 (285)
T ss_pred HHHHhhc
Confidence 9999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=285.48 Aligned_cols=230 Identities=36% Similarity=0.632 Sum_probs=195.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
+||+|++ |+||+++++.+++.||+|.+.+.........+.+..|.+.+..+ +||||+++++++......++||||+
T Consensus 2 ~lg~G~~---g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 2 VLGKGSF---GKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred eeeeCCC---eEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 5899999 99999999999999999999876544445566777888888877 6999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-ccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~ 159 (246)
++++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++...... ...
T Consensus 79 ~~g~L~~~i~~~~~-----l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 79 NGGDLMFHIQKSRR-----FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred CCchHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 99999988876544 489999999999999999999999999999999999999999999999998764322 223
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||.... .......+......+|..++++++++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~el~~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~l 226 (320)
T cd05590 154 STFCGTPDYIAPEILQEML-----YGPSVDWWAMGVLLYEMLCGHAPFEAEN--EDDLFEAILNDEVVYPTWLSQDAVDI 226 (320)
T ss_pred cccccCccccCHHHHcCCC-----CCCccchhhhHHHHHHHhhCCCCCCCCC--HHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 3456788999999987654 7889999999999999999999997533 33445556666777888899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||++
T Consensus 227 i~~~L~~ 233 (320)
T cd05590 227 LKAFMTK 233 (320)
T ss_pred HHHHccc
Confidence 9999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=286.10 Aligned_cols=232 Identities=35% Similarity=0.636 Sum_probs=195.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |.||+++++.+++.||+|.++.....+.+..+.+.+|..++.++ +||||+++++++.+....++||||+
T Consensus 2 ~lG~G~~---g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 2 VIGRGSY---AKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred eEeeCCC---eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 4799999 99999999999999999999876554555567788999999998 6999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec-cCccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE-ENQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~ 159 (246)
++++|..++..... +++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++.... .....
T Consensus 79 ~~g~L~~~~~~~~~-----l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 79 SGGDLMFHMQRQRK-----LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 99999988866443 4999999999999999999999999999999999999999999999999986532 22233
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-------HHHHHhhhcCCCCCCCCC
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS-------VKDVKAIIYSPVHYPTAW 232 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 232 (246)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||+...... ......+......+|..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 228 (329)
T cd05588 154 STFCGTPNYIAPEILRGED-----YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228 (329)
T ss_pred ccccCCccccCHHHHcCCC-----CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCC
Confidence 3456788999999987654 7889999999999999999999996422111 123344555677788899
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
+..+.++|++||++
T Consensus 229 ~~~~~~li~~~L~~ 242 (329)
T cd05588 229 SVKASSVLKGFLNK 242 (329)
T ss_pred CHHHHHHHHHHhcc
Confidence 99999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=263.40 Aligned_cols=231 Identities=28% Similarity=0.447 Sum_probs=206.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|.| |.||+++.++++-.||+|++.++.........++.+|+++-+.|+||||.++|++|.++..+|+++||..
T Consensus 29 ~LgkgkF---G~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~ 105 (281)
T KOG0580|consen 29 PLGKGKF---GNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAP 105 (281)
T ss_pred cccCCcc---ccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecC
Confidence 4899999 8999999999999999999998877666667889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+|++...+.... ...+.+.....+..|++.|+.|+|..+++||||+|+|+|++.++.++++|||.+.... .+....
T Consensus 106 ~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR~t 181 (281)
T KOG0580|consen 106 RGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKRKT 181 (281)
T ss_pred CchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCcee
Confidence 999999998432 2234888889999999999999999999999999999999999999999999887644 445566
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..|+..|.+||...+.. .+..+|+|++|++.|+++.|.+||+... ..+..+++......+|..+|...+++|.
T Consensus 182 lcgt~dyl~pEmv~~~~-----hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~etYkrI~k~~~~~p~~is~~a~dlI~ 254 (281)
T KOG0580|consen 182 LCGTLDYLPPEMVEGRG-----HDKFVDLWSLGVLCYEFLVGLPPFESQS--HSETYKRIRKVDLKFPSTISGGAADLIS 254 (281)
T ss_pred eecccccCCHhhcCCCC-----ccchhhHHHHHHHHHHHHhcCCchhhhh--hHHHHHHHHHccccCCcccChhHHHHHH
Confidence 78999999999998876 7889999999999999999999997444 5566788888899999999999999999
Q ss_pred HhhhC
Q psy7592 242 QVHRY 246 (246)
Q Consensus 242 ~~l~~ 246 (246)
.||.+
T Consensus 255 ~ll~~ 259 (281)
T KOG0580|consen 255 RLLVK 259 (281)
T ss_pred HHhcc
Confidence 99974
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=287.59 Aligned_cols=230 Identities=33% Similarity=0.610 Sum_probs=195.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||++.+..+++.||+|.+.............+.+|++.++.++||||+++++++..+...++||||+.
T Consensus 2 ~lG~G~~---g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 2 LLGKGTF---GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred eeeeCCC---EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 5899999 9999999999999999999987654444556777889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Cccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~ 159 (246)
+++|..++..... +++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 79 ~~~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (325)
T cd05594 79 GGELFFHLSRERV-----FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153 (325)
T ss_pred CCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence 9999988866443 4899999999999999999997 7999999999999999999999999999875432 2223
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.... .......+......+|..+++++.++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~el~tG~~Pf~~~~--~~~~~~~i~~~~~~~p~~~~~~~~~l 226 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDND-----YGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILMEEIRFPRTLSPEAKSL 226 (325)
T ss_pred ccccCCcccCCHHHHccCC-----CCCccccccccceeeeeccCCCCCCCCC--HHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 3456889999999987654 7889999999999999999999996533 23344455566777888999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||++
T Consensus 227 i~~~L~~ 233 (325)
T cd05594 227 LSGLLKK 233 (325)
T ss_pred HHHHhhc
Confidence 9999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=286.62 Aligned_cols=224 Identities=24% Similarity=0.377 Sum_probs=188.4
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|.| |.|+.+..+ ....||+|.++..... .+++.+|++++++|+|++||+++++|..+..+++||||++.
T Consensus 214 LG~G~F---G~V~~g~~~-~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 214 LGSGQF---GEVWLGKWN-GSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred hcCCcc---ceEEEEEEc-CCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 788888 999999996 3558999999875422 25677999999999999999999999998899999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc-
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS- 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~- 161 (246)
|||.+++.... ...+....++.++.|||.+++||+++++|||||...|||++++..+||+|||+++...+......
T Consensus 286 GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 286 GSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred CcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 99999998721 22358889999999999999999999999999999999999999999999999995544433222
Q ss_pred -cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC--CCCCCCCCCHhHH
Q psy7592 162 -MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSESTK 237 (246)
Q Consensus 162 -~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~l~ 237 (246)
......|.|||.+.... ++.+|||||||++|+|++| |+.||.+- ......+.+.. +.+.|+++|+++.
T Consensus 363 ~~kfPIkWtAPEa~~~~~-----FS~kSDVWSFGVlL~E~fT~G~~py~~m---sn~ev~~~le~GyRlp~P~~CP~~vY 434 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGK-----FSSKSDVWSFGVLLWELFTYGRVPYPGM---SNEEVLELLERGYRLPRPEGCPDEVY 434 (468)
T ss_pred CCCCCceecCHHHHhhCC-----cccccceeehhhhHHHHhccCCCCCCCC---CHHHHHHHHhccCcCCCCCCCCHHHH
Confidence 22345699999998776 8999999999999999999 89999643 33434444444 6667889999999
Q ss_pred HHHHHhhh
Q psy7592 238 HLLSQVHR 245 (246)
Q Consensus 238 ~li~~~l~ 245 (246)
++++.||+
T Consensus 435 ~lM~~CW~ 442 (468)
T KOG0197|consen 435 ELMKSCWH 442 (468)
T ss_pred HHHHHHhh
Confidence 99999997
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=289.43 Aligned_cols=225 Identities=28% Similarity=0.439 Sum_probs=194.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.+|+|.. |.||.++...+++.||||.+....- ...+-+.+|+.+++.++|+|||.+++.+-.++.+|+||||++
T Consensus 280 kigqgaS---G~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 280 KIGQGAT---GGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhccccc---cceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 3677777 8999999999999999999987542 223558899999999999999999999988899999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
|++|.+.+.... +++.+|..+..+++.||+|||.+||+|+|||.+||+++.+|.+|++|||++..+.... ...
T Consensus 354 ggsLTDvVt~~~------~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~ 427 (550)
T KOG0578|consen 354 GGSLTDVVTKTR------MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS 427 (550)
T ss_pred CCchhhhhhccc------ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence 999999997753 3899999999999999999999999999999999999999999999999999886554 455
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCCCCCCHhHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPTAWSESTK 237 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~l~ 237 (246)
...||+.|+|||.+.... |+++.||||||++++||+.|.+||-.++ +.+.+..+... ....|+.+|+.++
T Consensus 428 TmVGTPYWMAPEVvtrk~-----YG~KVDIWSLGIMaIEMveGEPPYlnE~--PlrAlyLIa~ng~P~lk~~~klS~~~k 500 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKP-----YGPKVDIWSLGIMAIEMVEGEPPYLNEN--PLRALYLIATNGTPKLKNPEKLSPELK 500 (550)
T ss_pred cccCCCCccchhhhhhcc-----cCccccchhhhhHHHHHhcCCCCccCCC--hHHHHHHHhhcCCCCcCCccccCHHHH
Confidence 688999999999998765 8999999999999999999999996433 33333333222 5556788999999
Q ss_pred HHHHHhhh
Q psy7592 238 HLLSQVHR 245 (246)
Q Consensus 238 ~li~~~l~ 245 (246)
+++.+||+
T Consensus 501 dFL~~cL~ 508 (550)
T KOG0578|consen 501 DFLDRCLV 508 (550)
T ss_pred HHHHHHhh
Confidence 99999996
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=282.26 Aligned_cols=232 Identities=27% Similarity=0.500 Sum_probs=192.9
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchH-----------HHHHHHHHHHHHHhhCCCCcceeeeeeeee--
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIER-----------DALKNVLREMEILTTLEHPFLVNLWFCFQD-- 69 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 69 (246)
||+|.| |.|-+|++..+++.||||++.+..+... ..+++..+|+.+++++.|||||+++++..+
T Consensus 105 iG~G~y---GkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~ 181 (576)
T KOG0585|consen 105 IGSGQY---GKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE 181 (576)
T ss_pred hcCCcc---ceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence 688888 9999999999999999999976443211 123578899999999999999999999975
Q ss_pred CCeEEEEEeecCCCChHHHHhhccccccCC-CChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecc
Q psy7592 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVG-TRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFN 148 (246)
Q Consensus 70 ~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~-~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~ 148 (246)
.+.+|+|+||+..|.+...- .+.+ +.+.+++.++..+..+|+|||.+||+||||||+|+|++.+|.+||+|||
T Consensus 182 s~~~YlVley~s~G~v~w~p------~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 182 SDKLYLVLEYCSKGEVKWCP------PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred cCceEEEEEeccCCccccCC------CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence 56799999999877664322 1222 6899999999999999999999999999999999999999999999999
Q ss_pred eeeeecc------CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh
Q psy7592 149 IATVLEE------NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII 222 (246)
Q Consensus 149 ~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 222 (246)
.+..+.. ........||+.|+|||...+... ....+.+.||||+|+.||.|+.|+.||. +....+....|+
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~-~~~~g~a~DiWalGVTLYCllfG~~PF~--~~~~~~l~~KIv 332 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS-FSYSGFALDIWALGVTLYCLLFGQLPFF--DDFELELFDKIV 332 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCC-ccccchhhhhhhhhhhHHHhhhccCCcc--cchHHHHHHHHh
Confidence 9987632 222344679999999999877442 2235778999999999999999999996 444566778888
Q ss_pred cCCCCCCCC--CCHhHHHHHHHhhhC
Q psy7592 223 YSPVHYPTA--WSESTKHLLSQVHRY 246 (246)
Q Consensus 223 ~~~~~~~~~--~s~~l~~li~~~l~~ 246 (246)
+.+..+|.. ..+.+++||++||.+
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~K 358 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEK 358 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhc
Confidence 888889865 799999999999975
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=286.18 Aligned_cols=228 Identities=32% Similarity=0.601 Sum_probs=195.2
Q ss_pred CcCCCCccCeeeEEEEEecCCC-cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK-QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |.||+|.++.++ ..||+|.+...........+.+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 37 ~ig~G~~---g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~ 113 (340)
T PTZ00426 37 TLGTGSF---GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFV 113 (340)
T ss_pred EEeecCC---eEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCC
Confidence 3688888 899999976654 789999998765444555677889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
.+++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++...... ..
T Consensus 114 ~~g~L~~~i~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--~~ 186 (340)
T PTZ00426 114 IGGEFFTFLRRNKR-----FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--TY 186 (340)
T ss_pred CCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--cc
Confidence 99999999876544 489999999999999999999999999999999999999999999999998765432 23
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
...+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||... +.......+......+|..+++.++++|
T Consensus 187 ~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlGvil~ell~G~~Pf~~~--~~~~~~~~i~~~~~~~p~~~~~~~~~li 259 (340)
T PTZ00426 187 TLCGTPEYIAPEILLNVG-----HGKAADWWTLGIFIYEILVGCPPFYAN--EPLLIYQKILEGIIYFPKFLDNNCKHLM 259 (340)
T ss_pred eecCChhhcCHHHHhCCC-----CCccccccchhhHHHHHhcCCCCCCCC--CHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 456788999999987654 678999999999999999999999743 3344455666667778889999999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
++||+.
T Consensus 260 ~~~l~~ 265 (340)
T PTZ00426 260 KKLLSH 265 (340)
T ss_pred HHHccc
Confidence 999973
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=281.89 Aligned_cols=230 Identities=36% Similarity=0.613 Sum_probs=192.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||+++++.+++.||+|.++.......+..+....|..++... +||||+++++++..+...++||||+
T Consensus 2 ~lG~G~~---g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 2 VLGKGSF---GKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred eeeeCCC---eEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 5899999 99999999999999999999875543344455566677777654 8999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-cc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 159 (246)
+|++|.+++..... +++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||++....... ..
T Consensus 79 ~gg~L~~~~~~~~~-----~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 79 NGGDLMFHIQSSGR-----FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence 99999998876543 4899999999999999999999999999999999999999999999999987643322 22
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.+. ......+......+|..++.+++++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~-----~~~~~DvwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~l 226 (316)
T cd05592 154 STFCGTPDYIAPEILKGQK-----YNESVDWWSFGVLLYEMLIGQSPFHGEDE--DELFDSILNDRPHFPRWISKEAKDC 226 (316)
T ss_pred ccccCCccccCHHHHcCCC-----CCCcccchhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 3356789999999987654 78899999999999999999999975432 3344455556777888899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 227 l~~~l~~ 233 (316)
T cd05592 227 LSKLFER 233 (316)
T ss_pred HHHHccC
Confidence 9999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=288.18 Aligned_cols=229 Identities=34% Similarity=0.636 Sum_probs=189.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+|+++.+++.||+|+++.....+......+.+|+.++.+++|++|+++++.+.++..+++||||++
T Consensus 8 ~LG~G~~---g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 8 VIGRGAF---GEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EEEeCCC---EEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 4788888 9999999999999999999987654445556778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc----
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---- 157 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 157 (246)
|++|.+++.+... +++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 85 gg~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 85 GGDMMTLLMKKDT-----LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred CCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 9999999876544 4899999999999999999999999999999999999999999999999986542110
Q ss_pred --------------------------------cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCC
Q psy7592 158 --------------------------------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205 (246)
Q Consensus 158 --------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~ 205 (246)
......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-----YNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-----CCCchhhhhhHHHHHHHHhCCC
Confidence 011245788999999987664 7889999999999999999999
Q ss_pred CCCCCCCccHHHHHhhhc--CCCCCCC--CCCHhHHHHHHHhhh
Q psy7592 206 PFDIHSNTSVKDVKAIIY--SPVHYPT--AWSESTKHLLSQVHR 245 (246)
Q Consensus 206 p~~~~~~~~~~~~~~~~~--~~~~~~~--~~s~~l~~li~~~l~ 245 (246)
||.... .......+.. ....+|+ .+|++++++|..|+.
T Consensus 235 Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~ 276 (363)
T cd05628 235 PFCSET--PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC 276 (363)
T ss_pred CCCCCC--HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC
Confidence 997533 2333344443 2344554 479999999998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=282.92 Aligned_cols=230 Identities=36% Similarity=0.607 Sum_probs=195.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
+||+|++ |+||+++++.+++.||+|.+........+..+.+..|.+++..+ +||+|+++++++.++...++||||+
T Consensus 2 ~lG~G~~---g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 2 VLGKGSF---GKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred ccccCCC---eEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 5899999 89999999999999999999876544455566777888888876 7999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-ccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~ 159 (246)
++++|...+..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 79 ~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 79 NGGDLMFQIQRSRK-----FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence 99999988876544 388899999999999999999999999999999999999999999999998764322 223
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+ .......+......+|..+++++.++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~-----~~~~~DvwslG~il~el~tg~~Pf~~~~--~~~~~~~i~~~~~~~p~~~~~~~~~l 226 (321)
T cd05591 154 TTFCGTPDYIAPEILQELE-----YGPSVDWWALGVLMYEMMAGQPPFEADN--EDDLFESILHDDVLYPVWLSKEAVSI 226 (321)
T ss_pred cccccCccccCHHHHcCCC-----CCCccceechhHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 3355788999999987654 7889999999999999999999997533 34445566666777788899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 227 l~~~L~~ 233 (321)
T cd05591 227 LKAFMTK 233 (321)
T ss_pred HHHHhcc
Confidence 9999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=282.45 Aligned_cols=232 Identities=34% Similarity=0.628 Sum_probs=196.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||++.++.+++.||+|++......+.+..+.+.+|..++.++ +||+|+++++++.+...+++||||+
T Consensus 2 ~lG~G~~---g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 2 VIGRGSY---AKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred eeeeCCC---eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 5899999 99999999999999999999876655556677788999999888 6999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec-cCccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE-ENQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~ 159 (246)
++++|..++..... +++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||++.... .....
T Consensus 79 ~~~~L~~~~~~~~~-----l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 79 NGGDLMFHMQRQRK-----LPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 99999988876443 4999999999999999999999999999999999999999999999999987532 22233
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----cHHHHHhhhcCCCCCCCCCCH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT-----SVKDVKAIIYSPVHYPTAWSE 234 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~s~ 234 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...... .....+.+...+..+|..+|.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 228 (327)
T cd05617 154 STFCGTPNYIAPEILRGEE-----YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSV 228 (327)
T ss_pred ecccCCcccCCHHHHCCCC-----CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCH
Confidence 3456889999999987664 788999999999999999999999643221 122344455557778889999
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.+.++|++||++
T Consensus 229 ~~~~li~~~L~~ 240 (327)
T cd05617 229 KASHVLKGFLNK 240 (327)
T ss_pred HHHHHHHHHhcc
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=282.59 Aligned_cols=230 Identities=33% Similarity=0.627 Sum_probs=190.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHH-HHhhCCCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREME-ILTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
+||+|++ |+||+++++.+|+.||+|.+.............+..|.. +++.++||||+++++.+.+....++||||+
T Consensus 2 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 2 VIGKGSF---GKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred eeeeCCC---eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 5899999 899999999999999999998754333333445555544 567789999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Cccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~ 159 (246)
.+++|..++..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++..... ....
T Consensus 79 ~~g~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 79 NGGELFFHLQRERS-----FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred CCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence 99999998876543 48899999999999999999999999999999999999999999999998865322 2223
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+ .......+.......++.+++.+.++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~-----~~~~~DvwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~l 226 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQP-----YDRTVDWWCLGAVLYEMLYGLPPFYSRD--TAEMYDNILNKPLRLKPNISVSARHL 226 (323)
T ss_pred ccccCChhhcChhhhcCCC-----CCccccccccchhhhhhhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 3356788999999987654 7889999999999999999999997533 33444556666677778899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 227 i~~~l~~ 233 (323)
T cd05575 227 LEGLLQK 233 (323)
T ss_pred HHHHhhc
Confidence 9999973
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=284.20 Aligned_cols=230 Identities=25% Similarity=0.415 Sum_probs=205.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|.| .+|-+|++.-||++||||++.+.... +-.-..+.+|++.++-++|||||++|+++..+..+|+|.|+=+
T Consensus 25 TlG~GHF---AVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD 100 (864)
T KOG4717|consen 25 TLGRGHF---AVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGD 100 (864)
T ss_pred hhcCCce---ehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecC
Confidence 3788888 99999999999999999999887642 3334678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc-CCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD-EEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
+|+|++++.+... .+.++..+.++.||+.|+.|+|+.++||+|+||+|+.+. .-|.+|++|||++..+.++....
T Consensus 101 ~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~ 176 (864)
T KOG4717|consen 101 GGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT 176 (864)
T ss_pred CchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence 9999999988643 468999999999999999999999999999999999775 56789999999999999988888
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
...|+..|.|||++.+.. ...+++||||||+++|.+++|++||+. .++-+.+..|..++...|.-+|.++++||
T Consensus 177 TsCGSLAYSAPEILLGDs----YDAPAVDiWSLGVILyMLVCGq~PFqe--ANDSETLTmImDCKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDS----YDAPAVDIWSLGVILYMLVCGQPPFQE--ANDSETLTMIMDCKYTVPSHVSKECRDLI 250 (864)
T ss_pred cccchhhccCchhhhcCc----cCCcchhhhHHHHHHHHHHhCCCcccc--ccchhhhhhhhcccccCchhhhHHHHHHH
Confidence 899999999999999876 246899999999999999999999973 33345567888899999999999999999
Q ss_pred HHhhh
Q psy7592 241 SQVHR 245 (246)
Q Consensus 241 ~~~l~ 245 (246)
..||.
T Consensus 251 ~sMLv 255 (864)
T KOG4717|consen 251 QSMLV 255 (864)
T ss_pred HHHHh
Confidence 99996
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=290.33 Aligned_cols=229 Identities=36% Similarity=0.625 Sum_probs=189.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++.++.+++.||+|.+........+..+.+.+|++++++++||||+++++++.+....|+||||++
T Consensus 8 ~lG~G~~---g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 8 VIGKGAF---GEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred EEeecCC---EEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 4788888 8999999999999999999977554445566788899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc----
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---- 157 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 157 (246)
|++|.+++..... +++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++++|||++..+....
T Consensus 85 gg~L~~~l~~~~~-----~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 85 GGDLMTMLIKYDT-----FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred CCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999999876543 4889999999999999999999999999999999999999999999999986432100
Q ss_pred --------c------------------------------------ccccccCCCccCCceecccccccCCCCcchhHHHH
Q psy7592 158 --------L------------------------------------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSL 193 (246)
Q Consensus 158 --------~------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~sl 193 (246)
. .....+++.|+|||.+.+.. ++.++|+|||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSl 234 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-----YGQECDWWSL 234 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-----CCCceeeEec
Confidence 0 00134788899999987654 7889999999
Q ss_pred HHHHHHHHhCCCCCCCCCCccHHHHHhhhc--CCCCCCC--CCCHhHHHHHHHhhh
Q psy7592 194 GVTLFEILARGRPFDIHSNTSVKDVKAIIY--SPVHYPT--AWSESTKHLLSQVHR 245 (246)
Q Consensus 194 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~--~~s~~l~~li~~~l~ 245 (246)
||++|+|++|..||..... ......+.. ....+|. .+|.+++++|++||+
T Consensus 235 Gvil~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~ 288 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS--HETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT 288 (377)
T ss_pred chhhhhhhcCCCCCCCCCH--HHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999999999975432 233333332 2344454 489999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=285.77 Aligned_cols=231 Identities=26% Similarity=0.469 Sum_probs=204.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCe-EEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED-LFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~v~e~~ 80 (246)
.+|.|.| |.++.++++.+++.||+|.++-....++. .+...+|+.++++++|||||.+++.|.+++. .+++|+|+
T Consensus 11 ~iG~Gaf---G~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~ 86 (426)
T KOG0589|consen 11 QVGRGAF---GSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYC 86 (426)
T ss_pred hcCcccc---chhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeec
Confidence 3788999 89999999999999999999876643333 4578899999999999999999999998877 99999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-cc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 159 (246)
+||++.+.+.... +.-++++.++.|+.|++.|+.|||+.+++||||++.|||++.++.+++.|||+++.+.+.. ..
T Consensus 87 eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a 163 (426)
T KOG0589|consen 87 EGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLA 163 (426)
T ss_pred CCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhh
Confidence 9999999998754 3446999999999999999999999999999999999999999999999999999988776 66
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKH 238 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~ 238 (246)
....|++.|++||.+.+.+ +..++|||||||++|||++-+++|.+.+ ....+..+.+. ..+.|..+|.+++.
T Consensus 164 ~tvvGTp~YmcPEil~d~p-----Yn~KSDiWsLGC~~yEm~~lk~aF~a~~--m~~Li~ki~~~~~~Plp~~ys~el~~ 236 (426)
T KOG0589|consen 164 STVVGTPYYMCPEILSDIP-----YNEKSDIWSLGCCLYEMCTLKPAFKASN--MSELILKINRGLYSPLPSMYSSELRS 236 (426)
T ss_pred heecCCCcccCHHHhCCCC-----CCccCcchhhcchHHHHHhcccccCccc--hHHHHHHHhhccCCCCCccccHHHHH
Confidence 7788999999999998887 8899999999999999999999997544 34455566666 47889999999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|+.||+.
T Consensus 237 lv~~~l~~ 244 (426)
T KOG0589|consen 237 LVKSMLRK 244 (426)
T ss_pred HHHHHhhc
Confidence 99999973
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=280.08 Aligned_cols=230 Identities=35% Similarity=0.618 Sum_probs=195.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||+++++.+++.||+|.++.......+....+..|..+++.+ +||||+++++++...+..++||||+
T Consensus 2 ~lG~G~~---g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 2 VLGKGSF---GKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred eeeeCCC---eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 5899999 89999999999999999999876544445566778888998888 6999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Cccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~ 159 (246)
.+++|.+.+..... +++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++++|||++..... ....
T Consensus 79 ~~~~L~~~~~~~~~-----l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 79 NGGDLMFHIQRSGR-----FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 99999988876544 48999999999999999999999999999999999999999999999998865322 2222
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+ .......+......+|..+++.++++
T Consensus 154 ~~~~g~~~y~aPE~~~~~~-----~~~~~DiwslGvil~~l~~G~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~l 226 (318)
T cd05570 154 STFCGTPDYIAPEILSYQP-----YGPAVDWWALGVLLYEMLAGQSPFEGDD--EDELFQSILEDEVRYPRWLSKEAKSI 226 (318)
T ss_pred cceecCccccCHHHhcCCC-----CCcchhhhhHHHHHHHHhhCCCCCCCCC--HHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 3345788999999997665 7889999999999999999999996433 33344555666777788899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 227 i~~~l~~ 233 (318)
T cd05570 227 LKSFLTK 233 (318)
T ss_pred HHHHccC
Confidence 9999974
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=282.27 Aligned_cols=232 Identities=35% Similarity=0.638 Sum_probs=194.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
+||+|++ |+||+++++.+++.||+|.+++....+......+.+|..++.++ +||||+++++++..+...++||||+
T Consensus 2 ~lG~G~~---g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 2 VIGRGSY---AKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred eeeeCCC---eEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 5899999 99999999999999999999876554555567788899888877 7999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Cccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~ 159 (246)
++++|..++..... +++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 79 ~~~~L~~~~~~~~~-----l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 79 NGGDLMFHMQRQRK-----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 99999988866443 48999999999999999999999999999999999999999999999999875322 2223
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc------cH-HHHHhhhcCCCCCCCCC
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT------SV-KDVKAIIYSPVHYPTAW 232 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~------~~-~~~~~~~~~~~~~~~~~ 232 (246)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...... .. .....+......+|...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 228 (329)
T cd05618 154 STFCGTPNYIAPEILRGED-----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 228 (329)
T ss_pred ccccCCccccCHHHHcCCC-----CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCC
Confidence 3456788999999987664 788999999999999999999999532211 11 12334455577788999
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
+..++++|++||++
T Consensus 229 ~~~~~~ll~~~L~~ 242 (329)
T cd05618 229 SVKAASVLKSFLNK 242 (329)
T ss_pred CHHHHHHHHHHhcC
Confidence 99999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=281.73 Aligned_cols=230 Identities=32% Similarity=0.601 Sum_probs=190.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHH-HHHhhCCCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREM-EILTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||+++++.+++.||+|.+.............+..|. .+++.++||||+++++.+.+.+..++||||+
T Consensus 2 ~lg~G~~---g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 2 VIGKGSF---GKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred eeeeCCC---EEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 4789988 89999999999999999999875443333344455554 4678889999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Cccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~ 159 (246)
++++|...+..... +++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 79 ~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 79 NGGELFFHLQRERC-----FLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred CCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence 99999888865443 48889999999999999999999999999999999999999999999998875322 2223
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+ .......+...+..+|...+..+.++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~l 226 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEP-----YDRTVDWWCLGAVLYEMLYGLPPFYSRD--VSQMYDNILHKPLQLPGGKTVAACDL 226 (321)
T ss_pred ccccCCcccCCHHHhcCCC-----CCCcCcccccchhhhhhhcCCCCCCCCC--HHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 3355788999999987654 7889999999999999999999997543 23344555666777888999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|.+||+.
T Consensus 227 i~~~l~~ 233 (321)
T cd05603 227 LVGLLHK 233 (321)
T ss_pred HHHHccC
Confidence 9999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=287.96 Aligned_cols=229 Identities=35% Similarity=0.619 Sum_probs=188.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+++++.+++.||+|+++.....+....+.+.+|++++++++||||+++++++.+++.+++||||++
T Consensus 8 ~LG~G~~---g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 8 TLGIGAF---GEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEeecCC---EEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 4788888 9999999999999999999987655555667788999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc----
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---- 157 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 157 (246)
|++|.+++.+... +++..++.++.|++.||.|||+.|++|+||||+||+++.++.++++|||++.......
T Consensus 85 gg~L~~~l~~~~~-----~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 85 GGDMMSLLIRMEV-----FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred CCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 9999999876543 4889999999999999999999999999999999999999999999999875321000
Q ss_pred --------------------------------------------cccccccCCCccCCceecccccccCCCCcchhHHHH
Q psy7592 158 --------------------------------------------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSL 193 (246)
Q Consensus 158 --------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~sl 193 (246)
......++..|+|||.+.+.. ++.++|+|||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----~~~~~DiwSl 234 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-----YTQLCDWWSV 234 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-----CCCccceeeh
Confidence 011235788999999987654 7889999999
Q ss_pred HHHHHHHHhCCCCCCCCCCccHHHHHhhhc--CCCCCCC--CCCHhHHHHHHHhhh
Q psy7592 194 GVTLFEILARGRPFDIHSNTSVKDVKAIIY--SPVHYPT--AWSESTKHLLSQVHR 245 (246)
Q Consensus 194 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~--~~s~~l~~li~~~l~ 245 (246)
||++|+|++|..||..... ......+.. ....+|. .+|++++++|++|+.
T Consensus 235 G~il~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~ 288 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTP--TETQLKVINWENTLHIPPQVKLSPEAVDLITKLCC 288 (381)
T ss_pred hhHHHHHHhCCCCCcCCCH--HHHHHHHHccccccCCCCCCCCCHHHHHHHHHHcc
Confidence 9999999999999975432 222233332 2333443 589999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=282.96 Aligned_cols=227 Identities=32% Similarity=0.558 Sum_probs=188.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||+++++.+++.||+|+++..........+.+.+|+++++.++||||+++++++.++...++||||++
T Consensus 8 ~ig~G~~---g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (333)
T cd05600 8 QVGQGGY---GQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVP 84 (333)
T ss_pred EEeecCC---eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCC
Confidence 3788888 9999999999999999999987654444556778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
|++|.+++..... +++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 85 g~~L~~~l~~~~~-----l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~ 157 (333)
T cd05600 85 GGDFRTLLNNLGV-----LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANS 157 (333)
T ss_pred CCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCC
Confidence 9999999976543 48899999999999999999999999999999999999999999999999876543 2334
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc--CCCCCC------CCCC
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY--SPVHYP------TAWS 233 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~------~~~s 233 (246)
..+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||........ ...+.. .....| ..+|
T Consensus 158 ~~gt~~y~aPE~~~~~~-----~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~s 230 (333)
T cd05600 158 VVGSPDYMAPEVLRGKG-----YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET--WENLKYWKETLQRPVYDDPRFNLS 230 (333)
T ss_pred cccCccccChhHhcCCC-----CCCccceecchHHHhhhhhCCCCCCCCCHHHH--HHHHHhccccccCCCCCccccccC
Confidence 56788999999987664 78899999999999999999999975443222 222211 111112 1569
Q ss_pred HhHHHHHHHhhh
Q psy7592 234 ESTKHLLSQVHR 245 (246)
Q Consensus 234 ~~l~~li~~~l~ 245 (246)
+++.++|++||+
T Consensus 231 ~~~~~li~~~l~ 242 (333)
T cd05600 231 DEAWDLITKLIN 242 (333)
T ss_pred HHHHHHHHHHhh
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=278.87 Aligned_cols=230 Identities=36% Similarity=0.613 Sum_probs=194.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCC-cceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHP-FLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |.||++.++.+++.||+|++...........+.+..|.+++..++|+ +|+++++++.+.+..|+||||+
T Consensus 7 ~lg~G~~---g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (324)
T cd05587 7 VLGKGSF---GKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (324)
T ss_pred EEeeccC---eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCC
Confidence 4788888 89999999999999999999876544445567788899999999764 6888999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Cccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~ 159 (246)
++++|.+++...... ++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++..... ....
T Consensus 84 ~~g~L~~~~~~~~~~-----~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 84 NGGDLMYHIQQVGKF-----KEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158 (324)
T ss_pred CCCcHHHHHHHcCCC-----CHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence 999999988765443 8889999999999999999999999999999999999999999999999865322 2223
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....++..|+|||.+.+.. ++.++|+||+|+++|+|++|+.||.+.. .......+......+|..+++.+.++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslGvil~elltG~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~l 231 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQP-----YGKSVDWWAFGVLLYEMLAGQPPFDGED--EDELFQSIMEHNVSYPKSLSKEAVSI 231 (324)
T ss_pred eeecCCccccChhhhcCCC-----CCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 3456789999999998765 7889999999999999999999997543 33445566666778888999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 232 i~~~l~~ 238 (324)
T cd05587 232 CKGLLTK 238 (324)
T ss_pred HHHHhhc
Confidence 9999963
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=271.69 Aligned_cols=235 Identities=31% Similarity=0.554 Sum_probs=193.5
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|+| |+||++.++.+++.||+|.+...........+.+..|++++++++|++|+++.+++..+...++||||+++
T Consensus 1 lg~G~~---g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGF---GEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCc---eeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence 688888 89999999999999999999765443344456678899999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-ccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-ATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~ 161 (246)
++|...+..... ....+++..++.++.|++.++.|||+.|++|+||+|+||+++.++.++++|||.+........ ...
T Consensus 78 g~L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 78 GDLRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred CCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence 999887754221 123468999999999999999999999999999999999999999999999999876544322 223
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS--VKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
..++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||....... ......+......+|..+|+.++++
T Consensus 157 ~~g~~~y~aPE~~~~~~-----~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (280)
T cd05608 157 YAGTPGFMAPELLQGEE-----YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSF 231 (280)
T ss_pred cCCCcCccCHHHhcCCC-----CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHH
Confidence 46788999999997664 7789999999999999999999997543321 2223334445566778899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
+.+||+.
T Consensus 232 i~~~l~~ 238 (280)
T cd05608 232 CEALLAK 238 (280)
T ss_pred HHHHhcC
Confidence 9999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=272.26 Aligned_cols=231 Identities=25% Similarity=0.439 Sum_probs=197.8
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||.|.- ++||+|+...+++.||||+++-+.|.+. +..+++|+..++.++||||++++.+|..+..+|+||.+|.+
T Consensus 34 IG~G~s---a~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~ 108 (516)
T KOG0582|consen 34 IGVGAS---AVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAG 108 (516)
T ss_pred Eeccce---eEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcC
Confidence 677777 8999999999999999999999887554 78999999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-cc--
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LA-- 159 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~-- 159 (246)
||+.+.+... .+..+.+..|..+++++++||.|||++|.+|||+|+.|||++.+|.++|+|||.+..+.... ..
T Consensus 109 GS~ldIik~~---~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~ 185 (516)
T KOG0582|consen 109 GSLLDIIKTY---YPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVT 185 (516)
T ss_pred CcHHHHHHHH---ccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeE
Confidence 9999999764 34567999999999999999999999999999999999999999999999999876664432 21
Q ss_pred --cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC--------
Q psy7592 160 --TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP-------- 229 (246)
Q Consensus 160 --~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 229 (246)
..+.+++.|+|||.+..... .|+.|+||||||+...|+.+|+.||..+.. .+.+...++..++.|
T Consensus 186 rf~tfvgtp~wmAPEvl~q~~~---GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--mkvLl~tLqn~pp~~~t~~~~~d 260 (516)
T KOG0582|consen 186 RFNTFVGTPCWMAPEVLMQQLH---GYDFKADIWSFGITACELAHGHAPFSKYPP--MKVLLLTLQNDPPTLLTSGLDKD 260 (516)
T ss_pred eeccccCcccccChHHhhhccc---CccchhhhhhhhHHHHHHhcCCCCcccCCh--HHHHHHHhcCCCCCcccccCChH
Confidence 23478999999999766654 389999999999999999999999975543 444555566655432
Q ss_pred --CCCCHhHHHHHHHhhhC
Q psy7592 230 --TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 --~~~s~~l~~li~~~l~~ 246 (246)
..++...+++|..||++
T Consensus 261 ~~k~~~ksf~e~i~~CL~k 279 (516)
T KOG0582|consen 261 EDKKFSKSFREMIALCLVK 279 (516)
T ss_pred HhhhhcHHHHHHHHHHhhc
Confidence 23688899999999975
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=279.57 Aligned_cols=230 Identities=34% Similarity=0.588 Sum_probs=194.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||+++++.+++.||+|.+.+.........+....|..++..+ +|++|+++++++.+.+..++||||+
T Consensus 7 ~lg~G~~---g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (323)
T cd05616 7 VLGKGSF---GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (323)
T ss_pred EEeeCCC---eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCC
Confidence 4788888 89999999999999999999876544444456677788888777 5899999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Cccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~ 159 (246)
++++|.+.+..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++..... ....
T Consensus 84 ~~g~L~~~~~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 84 NGGDLMYQIQQVGR-----FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred CCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence 99999988876544 48899999999999999999999999999999999999999999999999875432 2223
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.. .......+......+|..++++++++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlGvil~elltg~~Pf~~~~--~~~~~~~i~~~~~~~p~~~s~~~~~l 231 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQP-----YGKSVDWWAFGVLLYEMLAGQAPFEGED--EDELFQSIMEHNVAYPKSMSKEAVAI 231 (323)
T ss_pred ccCCCChhhcCHHHhcCCC-----CCCccchhchhHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence 3456788999999997664 7889999999999999999999997543 33445566666777888999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||++
T Consensus 232 i~~~l~~ 238 (323)
T cd05616 232 CKGLMTK 238 (323)
T ss_pred HHHHccc
Confidence 9999963
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=279.26 Aligned_cols=230 Identities=32% Similarity=0.604 Sum_probs=192.5
Q ss_pred CcCCCCccCeeeEEEEEec---CCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK---DTKQMYAMKYMHKSQCI-ERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||+|+| |.||+|++. .+++.||+|.+...... +......+.+|+.+++.++||||+++++++..++..++||
T Consensus 3 ~lg~G~~---g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 3 VLGKGGY---GKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred eeeecCC---eEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 4789988 899999874 57899999999865432 2233456778999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||+.+++|.+.+..... +++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 80 EYLSGGELFMHLEREGI-----FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred eCCCCchHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999999876543 3788899999999999999999999999999999999999999999999987543222
Q ss_pred -cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhH
Q psy7592 158 -LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSEST 236 (246)
Q Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l 236 (246)
......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.... .......+......+|..+++.+
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~G~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 227 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSG-----HGKAVDWWSLGALMYDMLTGAPPFTAEN--RKKTIDKILKGKLNLPPYLTPEA 227 (323)
T ss_pred CcccccCCCccccChhhccCCC-----CCCcceecccHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCHHH
Confidence 223346788999999987654 6789999999999999999999997533 33445566666778888999999
Q ss_pred HHHHHHhhhC
Q psy7592 237 KHLLSQVHRY 246 (246)
Q Consensus 237 ~~li~~~l~~ 246 (246)
+++|++||+.
T Consensus 228 ~~li~~~l~~ 237 (323)
T cd05584 228 RDLLKKLLKR 237 (323)
T ss_pred HHHHHHHccc
Confidence 9999999964
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=278.20 Aligned_cols=230 Identities=34% Similarity=0.586 Sum_probs=191.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |.||+++++.+|+.||+|.++.......+..+....|..++... +||+|+++++++.+++..++||||+
T Consensus 2 ~lg~G~~---g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 2 VLGKGSF---GKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred eeeeCCC---eEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 5899999 89999999999999999999875433333455667788887765 8999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-ccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~ 159 (246)
.+++|..++..... +++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++++|||++...... ...
T Consensus 79 ~~g~L~~~i~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 79 NGGDLMFHIQDKGR-----FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence 99999988876543 388899999999999999999999999999999999999999999999988653222 222
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+ .......+......+|..++.+++++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslGvil~el~~g~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (316)
T cd05620 154 STFCGTPDYIAPEILQGLK-----YTFSVDWWSFGVLLYEMLIGQSPFHGDD--EDELFESIRVDTPHYPRWITKESKDI 226 (316)
T ss_pred eccCCCcCccCHHHHcCCC-----CCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 3456789999999987664 7889999999999999999999997543 23334445555667788899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 227 i~~~l~~ 233 (316)
T cd05620 227 LEKLFER 233 (316)
T ss_pred HHHHccC
Confidence 9999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=285.96 Aligned_cols=229 Identities=37% Similarity=0.653 Sum_probs=189.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|++.............+.+|+++++.++||||+++++++.++...++||||+.
T Consensus 8 ~lG~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 8 VIGRGAF---GEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEecCC---EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence 4788888 8999999999999999999987654444556778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc---
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--- 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--- 158 (246)
+++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++........
T Consensus 85 ~g~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 85 GGDMMTLLMKKDT-----FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CcHHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 9999999876543 48999999999999999999999999999999999999999999999999876432110
Q ss_pred ------------------------------------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh
Q psy7592 159 ------------------------------------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA 202 (246)
Q Consensus 159 ------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~ 202 (246)
.....+++.|+|||.+.... ++.++|+|||||++|+|++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-----YNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-----CCCeeeeecchhHHHHhhc
Confidence 01134788999999987654 7889999999999999999
Q ss_pred CCCCCCCCCCccHHHHHhhhcC--CCCCCC--CCCHhHHHHHHHhhh
Q psy7592 203 RGRPFDIHSNTSVKDVKAIIYS--PVHYPT--AWSESTKHLLSQVHR 245 (246)
Q Consensus 203 g~~p~~~~~~~~~~~~~~~~~~--~~~~~~--~~s~~l~~li~~~l~ 245 (246)
|..||.... .......+... ...+|. .+|++++++|++||+
T Consensus 235 G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~ 279 (364)
T cd05599 235 GYPPFCSDN--PQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC 279 (364)
T ss_pred CCCCCCCCC--HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc
Confidence 999997543 23333333332 233343 579999999999985
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=279.76 Aligned_cols=230 Identities=33% Similarity=0.631 Sum_probs=189.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHH-HHHHhhCCCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLRE-MEILTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e-~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||+++++.+++.||+|++.............+..| ...++.++||||+++++++.+++..++||||+
T Consensus 2 ~lg~G~f---g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 2 VIGKGSF---GKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred eeeeCCC---eEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 4789998 8999999999999999999986543322333344444 44567889999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Cccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~ 159 (246)
.+++|.+.+..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++..... ....
T Consensus 79 ~~~~L~~~~~~~~~-----~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~ 153 (325)
T cd05602 79 NGGELFYHLQRERC-----FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT 153 (325)
T ss_pred CCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence 99999998876543 37888999999999999999999999999999999999999999999999875432 2223
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.... .......+......+++.+++.++++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~l 226 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQP-----YDRTVDWWCLGAVLYEMLYGLPPFYSRN--TAEMYDNILNKPLQLKPNITNSARHL 226 (325)
T ss_pred ccccCCccccCHHHHcCCC-----CCCccccccccHHHHHHhcCCCCCCCCC--HHHHHHHHHhCCcCCCCCCCHHHHHH
Confidence 3456889999999987664 7889999999999999999999997433 33444555556667778899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 227 i~~~l~~ 233 (325)
T cd05602 227 LEGLLQK 233 (325)
T ss_pred HHHHccc
Confidence 9999973
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=276.49 Aligned_cols=230 Identities=36% Similarity=0.598 Sum_probs=190.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||+++++.+++.||+|.++.......+..+....|...+... +||||+++++++.+++..++||||+
T Consensus 2 ~lG~G~~---g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 2 MLGKGSF---GKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred eeeeCCC---EEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 4789999 99999999999999999999875433333445666777777764 8999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-ccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~ 159 (246)
++++|.+++..... +++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||++...... ...
T Consensus 79 ~~g~L~~~l~~~~~-----~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 79 NGGDLMFHIQSCHK-----FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence 99999999876433 488899999999999999999999999999999999999999999999998754322 222
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+. ......+......+|..++.+++++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~-----~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~l 226 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQK-----YNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSIRMDNPCYPRWLTREAKDI 226 (316)
T ss_pred eeecCCccccCHHHHcCCC-----CCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCCCccCCHHHHHH
Confidence 3355788999999987654 78899999999999999999999975432 2333344444556777899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|.+||+.
T Consensus 227 i~~~l~~ 233 (316)
T cd05619 227 LVKLFVR 233 (316)
T ss_pred HHHHhcc
Confidence 9999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=278.35 Aligned_cols=230 Identities=35% Similarity=0.604 Sum_probs=194.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||+|.++.+++.||+|.+........+..+.+..|..++..+. |++|+++++++.+.+..++||||+
T Consensus 7 ~lg~G~~---g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~ 83 (323)
T cd05615 7 VLGKGSF---GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYV 83 (323)
T ss_pred EEEecCC---eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCC
Confidence 4789998 999999999999999999998765444445667788888988885 578888999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-cc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 159 (246)
++++|.+++..... +++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||++....... ..
T Consensus 84 ~~g~L~~~i~~~~~-----l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 84 NGGDLMYHIQQVGK-----FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred CCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence 99999998876544 4899999999999999999999999999999999999999999999999987543222 22
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||.+.. .......+......+|..++.++.++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslGvil~elltG~~pf~~~~--~~~~~~~i~~~~~~~p~~~~~~~~~l 231 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQP-----YGKSVDWWAYGVLLYEMLAGQPPFDGED--EDELFQSIMEHNVSYPKSLSKEAVSI 231 (323)
T ss_pred cCccCCccccCHHHHcCCC-----CCCccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 3355789999999987654 7889999999999999999999997533 33445566666777888999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
+++||++
T Consensus 232 i~~~l~~ 238 (323)
T cd05615 232 CKGLMTK 238 (323)
T ss_pred HHHHccc
Confidence 9999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=278.22 Aligned_cols=229 Identities=34% Similarity=0.613 Sum_probs=190.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHH---hhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEIL---TTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |.||++.++.+++.||+|.++.......+..+.+.+|.+.+ +.++||||+++++++.++...|+|||
T Consensus 6 ~lg~G~~---g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 6 VLGRGHF---GKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEeecCC---EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 4788888 89999999999999999999876543444456666666655 56679999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Cc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQ 157 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~ 157 (246)
|+.+++|...+... .+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||++..... ..
T Consensus 83 ~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 83 YAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred CCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999998877542 348999999999999999999999999999999999999999999999998865322 22
Q ss_pred cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHH
Q psy7592 158 LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTK 237 (246)
Q Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 237 (246)
......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.. .......+......+|..+++.+.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~-----~~~~~DiwslG~il~el~~G~~pf~~~~--~~~~~~~i~~~~~~~p~~~~~~~~ 229 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETS-----YTRAVDWWGLGVLIYEMLVGESPFPGDD--EEEVFDSIVNDEVRYPRFLSREAI 229 (324)
T ss_pred cccccccCccccCHhHhcCCC-----CCcccchhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCCCCCHHHH
Confidence 233456788999999987654 7889999999999999999999997433 333445556666778889999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|++||+.
T Consensus 230 ~li~~~L~~ 238 (324)
T cd05589 230 SIMRRLLRR 238 (324)
T ss_pred HHHHHHhhc
Confidence 999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=268.77 Aligned_cols=233 Identities=32% Similarity=0.582 Sum_probs=189.6
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|+| |+||++.++.+|+.||+|.+.............+..|++++++++||||+++++++.++...++||||+.|
T Consensus 1 lg~G~~---g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGF---GEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCc---eEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence 688888 89999999999999999999764433333344566799999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSM 162 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 162 (246)
++|.+.+.... ..++++..+..++.|++.|+++||+.|++|+||+|+||++++++.++++|||++............
T Consensus 78 ~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 78 GDLKYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred CCHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeecc
Confidence 99998875432 223588888999999999999999999999999999999999999999999998876554433445
Q ss_pred ccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHhhhcCCCCCC-CCCCHhHHHH
Q psy7592 163 SGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT--SVKDVKAIIYSPVHYP-TAWSESTKHL 239 (246)
Q Consensus 163 ~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~-~~~s~~l~~l 239 (246)
.++..|+|||.+.+.. ++.++|+||+|+++|+|++|+.||...... ...............+ ..++++++++
T Consensus 155 ~~~~~y~aPE~~~~~~-----~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (277)
T cd05607 155 AGTNGYMAPEILKEEP-----YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDI 229 (277)
T ss_pred CCCCCccCHHHHccCC-----CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHH
Confidence 6788999999987664 788999999999999999999999653322 1222333333333332 4689999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||++
T Consensus 230 i~~~L~~ 236 (277)
T cd05607 230 CRLFLAK 236 (277)
T ss_pred HHHHhcc
Confidence 9999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=279.01 Aligned_cols=197 Identities=27% Similarity=0.404 Sum_probs=173.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC--CeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE--EDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~ 79 (246)
.||+|+| |.||+|++..+|+.||+|+++.+. .++....-..+|+.+|++|+||||+++.++..+. ..+|+|+||
T Consensus 124 kIGeGTy---g~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeY 199 (560)
T KOG0600|consen 124 KIGEGTY---GQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEY 199 (560)
T ss_pred HhcCcch---hheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEec
Confidence 5899999 999999999999999999998765 3345567788999999999999999999999876 679999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc--
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-- 157 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (246)
| ..+|..++... ...+++.+|+.+++||+.+|+|||.+|++|||||.+|||++++|.+||+|||+++.+....
T Consensus 200 M-dhDL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 200 M-DHDLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred c-cchhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 9 55687777653 2235999999999999999999999999999999999999999999999999999876544
Q ss_pred cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 158 LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.......|..|.|||++.+.. .|++.+|+||.|||+.||+.|++.|.+..
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t----~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGAT----SYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred ccccceEEeeccChHHhcCCc----ccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 345567788999999999887 59999999999999999999999998654
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=278.77 Aligned_cols=230 Identities=32% Similarity=0.591 Sum_probs=190.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHH-HHhhCCCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREME-ILTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||++.++.+|+.||+|++......+......+..|.. +++.++||||+++++.+..++..++||||+
T Consensus 2 ~lG~G~~---g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 2 VIGKGSF---GKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred ceeeCCC---eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 4799999 899999999999999999998754433334445555554 567789999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Cccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~ 159 (246)
.+++|...+..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++..... ....
T Consensus 79 ~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 79 NGGELFFHLQRERS-----FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred CCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence 99999988876543 48999999999999999999999999999999999999999999999999875322 2223
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+ .......+......+++..+..+.++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~-----~~~~~DvwslG~il~el~~G~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQP-----YDNTVDWWCLGAVLYEMLYGLPPFYCRD--VAEMYDNILHKPLVLRPGASLTAWSI 226 (325)
T ss_pred ccccCChhhCCHHHHcCCC-----CCCcCccccccceehhhhcCCCCCCCCC--HHHHHHHHHcCCccCCCCCCHHHHHH
Confidence 3456788999999987664 7789999999999999999999997533 33444555555666777899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 227 l~~ll~~ 233 (325)
T cd05604 227 LEELLEK 233 (325)
T ss_pred HHHHhcc
Confidence 9999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=270.36 Aligned_cols=234 Identities=30% Similarity=0.565 Sum_probs=193.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++.+..+++.||+|.+.............+.+|+.++++++||||+++++.+.++...+++|||+.
T Consensus 7 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05605 7 VLGKGGF---GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred EEecCCC---eEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccC
Confidence 4788888 8999999999999999999977554334444567789999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++.... ..++++..+..++.|++.+++|||+.|++|+||+|+||++++++.++++|||++...........
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 84 GGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred CCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 999998875432 22458999999999999999999999999999999999999999999999999877654433334
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-HHH-HhhhcCCCCCCCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV-KDV-KAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~-~~~~~~~~~~~~~~s~~l~~l 239 (246)
..++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||.+...... ... ..+......+|..+++.++++
T Consensus 161 ~~~~~~y~aPE~~~~~~-----~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05605 161 RVGTVGYMAPEVVKNER-----YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI 235 (285)
T ss_pred ccCCCCccCcHHhcCCC-----CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence 56788999999987654 78899999999999999999999976543222 122 223333556677899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|..||+.
T Consensus 236 i~~~l~~ 242 (285)
T cd05605 236 CRQLLTK 242 (285)
T ss_pred HHHHccC
Confidence 9999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=284.71 Aligned_cols=229 Identities=35% Similarity=0.637 Sum_probs=187.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.+...........+.+.+|++++++++||||+++++.+.++...++||||++
T Consensus 8 ~LG~G~~---g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 8 TLGIGAF---GEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEeCCC---EEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 4788888 9999999999999999999987654445566788899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-----
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN----- 156 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~----- 156 (246)
+++|.+.+..... +++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||++..+...
T Consensus 85 gg~L~~~l~~~~~-----~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 85 GGDMMSLLIRMGI-----FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 9999999876543 488999999999999999999999999999999999999999999999986432100
Q ss_pred -------------------------------------------ccccccccCCCccCCceecccccccCCCCcchhHHHH
Q psy7592 157 -------------------------------------------QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSL 193 (246)
Q Consensus 157 -------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~sl 193 (246)
.......+++.|+|||.+.+.. ++.++|+|||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----~~~~~DiwSl 234 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-----YTQLCDWWSV 234 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-----CCCeeeEEec
Confidence 0001235788999999987654 7889999999
Q ss_pred HHHHHHHHhCCCCCCCCCCccHHHHHhhhc--CCCCCC--CCCCHhHHHHHHHhhh
Q psy7592 194 GVTLFEILARGRPFDIHSNTSVKDVKAIIY--SPVHYP--TAWSESTKHLLSQVHR 245 (246)
Q Consensus 194 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~--~~~s~~l~~li~~~l~ 245 (246)
||++|+|++|..||.... .......+.. ....+| ..+++++.++|.+|+.
T Consensus 235 Gvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~ 288 (382)
T cd05625 235 GVILYEMLVGQPPFLAQT--PLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR 288 (382)
T ss_pred hHHHHHHHhCCCCCCCCC--HHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHcc
Confidence 999999999999997543 2233333332 223333 4689999999988753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=283.35 Aligned_cols=229 Identities=37% Similarity=0.643 Sum_probs=192.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+|+++.+++.||+|+++............+.+|++++..++||||+++++++.++...++||||+.
T Consensus 8 ~lg~G~~---g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (350)
T cd05573 8 VIGRGAF---GEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMP 84 (350)
T ss_pred EEEeCCc---EEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCC
Confidence 4788888 9999999999999999999987654444556778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc----
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---- 157 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 157 (246)
+++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++.......
T Consensus 85 ~~~L~~~l~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 85 GGDLMNLLIRKDV-----FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred CCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 9999999976533 4899999999999999999999999999999999999999999999999987654332
Q ss_pred --------------------------cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 158 --------------------------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 158 --------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-----YGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCC-----CCCceeeEecchhhhhhccCCCCCCCCC
Confidence 122345788999999987764 7889999999999999999999997544
Q ss_pred CccHHHHHhhhc--CCCCCCC--CCCHhHHHHHHHhhh
Q psy7592 212 NTSVKDVKAIIY--SPVHYPT--AWSESTKHLLSQVHR 245 (246)
Q Consensus 212 ~~~~~~~~~~~~--~~~~~~~--~~s~~l~~li~~~l~ 245 (246)
.......+.. ....+|. .+++++.++|.+||+
T Consensus 235 --~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~ 270 (350)
T cd05573 235 --LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC 270 (350)
T ss_pred --HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc
Confidence 2233334443 3333443 469999999999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=259.99 Aligned_cols=234 Identities=28% Similarity=0.464 Sum_probs=200.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeecccc-----chHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC-----IERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 75 (246)
.+|.|.. ++|.++.++++|..+|+|++.-..- .-.+..+.-.+|+.+|+++ .||+|+++.++++.+...++
T Consensus 24 ilgrgvs---s~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~Fl 100 (411)
T KOG0599|consen 24 ILGRGVS---SVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFL 100 (411)
T ss_pred Hhcccch---hhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhh
Confidence 3677777 8999999999999999999864321 1233456677899999999 59999999999999999999
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
|+|.++.|.|.++++....+ ++.....++.|++.+++|||.++|||+|+||+|||++++.+++++|||++.....
T Consensus 101 VFdl~prGELFDyLts~Vtl-----SEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 101 VFDLMPRGELFDYLTSKVTL-----SEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhcccchHHHHhhhheee-----cHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999999886655 9999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccccCCCccCCceeccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCC--CC--
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEV-LGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY--PT-- 230 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~-- 230 (246)
+.......||++|+|||.+.+...+. +.++.++|+|++|+++|.++.|.+||- .....-....+.+++..+ |.
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--HRkQmlMLR~ImeGkyqF~speWa 253 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--HRKQMLMLRMIMEGKYQFRSPEWA 253 (411)
T ss_pred chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh--HHHHHHHHHHHHhcccccCCcchh
Confidence 88888899999999999998765433 348889999999999999999999993 444444555566665555 32
Q ss_pred CCCHhHHHHHHHhhh
Q psy7592 231 AWSESTKHLLSQVHR 245 (246)
Q Consensus 231 ~~s~~l~~li~~~l~ 245 (246)
++|+..++||++||+
T Consensus 254 dis~~~KdLIsrlLq 268 (411)
T KOG0599|consen 254 DISATVKDLISRLLQ 268 (411)
T ss_pred hccccHHHHHHHHHe
Confidence 579999999999986
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=280.71 Aligned_cols=232 Identities=32% Similarity=0.566 Sum_probs=190.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.+...........+.+.+|+.+++.++||||+++++++.++...++||||++
T Consensus 50 ~lg~G~~---g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05596 50 VIGRGAF---GEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEeeCCC---EEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCC
Confidence 3788888 8999999999999999999976543334445667889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--A 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 159 (246)
|++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 127 gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~ 200 (370)
T cd05596 127 GGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccC
Confidence 99999988643 248888999999999999999999999999999999999999999999999877643321 2
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCC--CCCHh
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPT--AWSES 235 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~--~~s~~ 235 (246)
....+++.|+|||.+.+... ...++.++|+||||+++|+|++|..||...+. ......+... ...+|. .+|.+
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTYSKIMDHKNSLTFPDDIEISKQ 277 (370)
T ss_pred CCCCCCcCeECHHHhccCCC-CCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--HHHHHHHHcCCCcCCCCCcCCCCHH
Confidence 33568899999999865431 12367899999999999999999999975432 2333444433 344454 57999
Q ss_pred HHHHHHHhhh
Q psy7592 236 TKHLLSQVHR 245 (246)
Q Consensus 236 l~~li~~~l~ 245 (246)
++++|++||+
T Consensus 278 ~~~li~~~L~ 287 (370)
T cd05596 278 AKDLICAFLT 287 (370)
T ss_pred HHHHHHHHcc
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=283.29 Aligned_cols=228 Identities=34% Similarity=0.649 Sum_probs=188.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+|.++.+++.||+|+++.......+....+.+|+.++.+++||+|+++++.+.++..+++||||++
T Consensus 8 ~lG~G~~---g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 8 VIGRGAF---GEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEeeCCC---EEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 4788888 8999999999999999999987654445566788899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc----
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---- 157 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 157 (246)
|++|.+++.+... +++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++++|||++.......
T Consensus 85 gg~L~~~l~~~~~-----l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 85 GGDMMTLLMKKDT-----LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred CccHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 9999999876544 4899999999999999999999999999999999999999999999999876432110
Q ss_pred --------------------------------cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCC
Q psy7592 158 --------------------------------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205 (246)
Q Consensus 158 --------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~ 205 (246)
......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-----~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-----YNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-----CCCcceeccccceeeecccCCC
Confidence 011235788999999987664 7889999999999999999999
Q ss_pred CCCCCCCccHHHHHhhhc--CCCCCCC--CCCHhHHHHHHHhh
Q psy7592 206 PFDIHSNTSVKDVKAIIY--SPVHYPT--AWSESTKHLLSQVH 244 (246)
Q Consensus 206 p~~~~~~~~~~~~~~~~~--~~~~~~~--~~s~~l~~li~~~l 244 (246)
||..... ......+.. ....+|. .+|++++++|.+|+
T Consensus 235 Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~ 275 (360)
T cd05627 235 PFCSETP--QETYRKVMNWKETLVFPPEVPISEKAKDLILRFC 275 (360)
T ss_pred CCCCCCH--HHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc
Confidence 9975432 233333332 2334444 47999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=284.28 Aligned_cols=229 Identities=35% Similarity=0.617 Sum_probs=186.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.+...........+.+.+|++++++++|+||+++++.+.+++.+++||||++
T Consensus 8 ~lG~G~~---g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 8 TIGIGAF---GEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEeCCC---eEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 4788888 9999999999999999999977554444455778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-----
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN----- 156 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~----- 156 (246)
+++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+...
T Consensus 85 ~g~L~~~i~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 85 GGDMMSLLIRLGI-----FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 9999999876543 488899999999999999999999999999999999999999999999987432100
Q ss_pred ---------------------------------------ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHH
Q psy7592 157 ---------------------------------------QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTL 197 (246)
Q Consensus 157 ---------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l 197 (246)
.......+++.|+|||.+.+.. ++.++|+|||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlGvil 234 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-----YTQLCDWWSVGVIL 234 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-----CCcceeeeecccee
Confidence 0001235788999999987664 78899999999999
Q ss_pred HHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCC--CCCCHhHHHHHHHhhh
Q psy7592 198 FEILARGRPFDIHSNTSVKDVKAIIYS--PVHYP--TAWSESTKHLLSQVHR 245 (246)
Q Consensus 198 ~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~--~~~s~~l~~li~~~l~ 245 (246)
|+|++|+.||..... ......+... ...+| ..+++.+.++|.+|+.
T Consensus 235 yell~G~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~ 284 (376)
T cd05598 235 YEMLVGQPPFLADTP--AETQLKVINWETTLHIPSQAKLSREASDLILRLCC 284 (376)
T ss_pred eehhhCCCCCCCCCH--HHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhc
Confidence 999999999975442 2222233221 22233 4689999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=276.21 Aligned_cols=231 Identities=23% Similarity=0.370 Sum_probs=192.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCC-eEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEE-DLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~~v~e~ 79 (246)
.||+|+| |.||++..+++|+.||||.++......++. --.+|+..|++++ ||||+++.+++.+.+ .+++||||
T Consensus 17 klGDGTf---GsV~la~~~~~~~~VAIK~MK~Kf~s~ee~--~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~ 91 (538)
T KOG0661|consen 17 KLGDGTF---GSVYLAKSKETGELVAIKKMKKKFYSWEEC--MNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEF 91 (538)
T ss_pred HhcCCcc---eeEEEeeecCCCceeeHHHHHhhhccHHHH--HHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHh
Confidence 3799999 999999999999999999998766443332 3457999999998 999999999999887 89999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (246)
| ..+|.+.+..+ ...+++..+..|+.||+.+|.++|.+|+.|||+||+|||+..+..+||+|||+++........
T Consensus 92 M-d~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 92 M-DCNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY 166 (538)
T ss_pred h-hhhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCc
Confidence 9 77899998775 345799999999999999999999999999999999999998889999999999998888888
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHhhhcC--------------
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK-DVKAIIYS-------------- 224 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~-------------- 224 (246)
.....|+.|.|||++.... .|+.+.|+||+||+++|+.+-++.|.|.+..+.. -+-+++..
T Consensus 167 TeYVSTRWYRAPEvLLrs~----~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSG----YYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred chhhhcccccchHHhhhcc----ccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 8888999999999987655 4899999999999999999999999765432211 11111111
Q ss_pred --CCCCC-----------CCCCHhHHHHHHHhhhC
Q psy7592 225 --PVHYP-----------TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 225 --~~~~~-----------~~~s~~l~~li~~~l~~ 246 (246)
.+.+| +++++++.+||..||+|
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~W 277 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAW 277 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcC
Confidence 01111 34799999999999875
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=278.37 Aligned_cols=229 Identities=36% Similarity=0.610 Sum_probs=192.1
Q ss_pred CcCCCCccCeeeEEEEEec---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKK---DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |.||++++. .+|+.||+|++...... ......+.+|++++++++||||+++++++.++...|+|||
T Consensus 3 ~lg~G~~---g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 3 VLGQGSF---GKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred eeeeCCC---EEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence 4788888 899988863 57899999999865432 2233556789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-c
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-Q 157 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~ 157 (246)
|+.+++|.+.+.+... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 79 ~~~~~~L~~~l~~~~~-----l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 79 FLRGGDLFTRLSKEVM-----FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 9999999998866443 489999999999999999999999999999999999999999999999998765433 2
Q ss_pred cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHH
Q psy7592 158 LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTK 237 (246)
Q Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 237 (246)
......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.... .......+......+|..+++.++
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~-----~~~~~DiwslG~il~el~tg~~p~~~~~--~~~~~~~i~~~~~~~p~~~~~~~~ 226 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRG-----HTQSADWWSFGVLMFEMLTGSLPFQGKD--RKETMTMILKAKLGMPQFLSPEAQ 226 (318)
T ss_pred ceecccCChhhcCHHHHcCCC-----CCCccceeccceEeeeeccCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCHHHH
Confidence 223356788999999987654 6789999999999999999999997533 334445566667778889999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|++||+.
T Consensus 227 ~li~~~l~~ 235 (318)
T cd05582 227 SLLRALFKR 235 (318)
T ss_pred HHHHHHhhc
Confidence 999999973
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=275.67 Aligned_cols=235 Identities=33% Similarity=0.552 Sum_probs=190.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.+.+.........+.+.+|..+++.++|++|+++++++.++...++||||+.
T Consensus 8 ~lG~G~~---g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (331)
T cd05597 8 VIGRGAF---GEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYV 84 (331)
T ss_pred EEEecCC---eEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCC
Confidence 4788888 8999999999999999999986544444556778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-- 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (246)
+++|.+++.+.. ..+++..+..++.|++.+++|||+.|++|+||+|+||+++.++.++++|||++.........
T Consensus 85 g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 85 GGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 999999986522 23488999999999999999999999999999999999999999999999998766443222
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCC---CCCCH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYP---TAWSE 234 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~---~~~s~ 234 (246)
....+++.|+|||.+.........++.++|+||+|+++|+|++|+.||...... .....+... ...+| ..+|+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--HHHHHHHcCCCcccCCCccCCCCH
Confidence 224578899999998753322223678999999999999999999999754322 222223221 22333 35799
Q ss_pred hHHHHHHHhhh
Q psy7592 235 STKHLLSQVHR 245 (246)
Q Consensus 235 ~l~~li~~~l~ 245 (246)
.++++|++||.
T Consensus 239 ~~~~li~~ll~ 249 (331)
T cd05597 239 EAKDLIRRLIC 249 (331)
T ss_pred HHHHHHHHHcc
Confidence 99999999884
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=278.69 Aligned_cols=232 Identities=32% Similarity=0.576 Sum_probs=189.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||+++++.+++.||+|.+...........+.+.+|..+++.++||||+++++.+.++...++||||++
T Consensus 50 ~lG~G~f---g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (371)
T cd05622 50 VIGRGAF---GEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 126 (371)
T ss_pred EEeecCC---eEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 3788888 8999999999999999999976543344445667889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--A 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 159 (246)
|++|.+++... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 127 gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~ 200 (371)
T cd05622 127 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200 (371)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccc
Confidence 99999988643 248888999999999999999999999999999999999999999999999987643321 2
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCC--CCCCHh
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYP--TAWSES 235 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~--~~~s~~ 235 (246)
....+++.|+|||.+..... ...++.++|+||||+++|+|++|..||...+. ......+... ..++| ..+|+.
T Consensus 201 ~~~~gt~~y~aPE~l~~~~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (371)
T cd05622 201 DTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTYSKIMNHKNSLTFPDDNDISKE 277 (371)
T ss_pred cCcccCccccCHHHHhccCC-CccCCCccceeehhHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCcccCCCcCCCCHH
Confidence 24568899999999875431 11267899999999999999999999975332 2333444332 23344 368999
Q ss_pred HHHHHHHhhh
Q psy7592 236 TKHLLSQVHR 245 (246)
Q Consensus 236 l~~li~~~l~ 245 (246)
++++|..||+
T Consensus 278 ~~~li~~~L~ 287 (371)
T cd05622 278 AKNLICAFLT 287 (371)
T ss_pred HHHHHHHHcC
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=258.20 Aligned_cols=227 Identities=27% Similarity=0.428 Sum_probs=198.6
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|.| +.|+++.+..+|+.+|+|.++-...... .-+++.+|+++-+.|+||||+++.+.+.+....|+|+|+++|
T Consensus 19 igkG~F---SvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 19 LGKGAF---SVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred HccCch---HHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccc
Confidence 788888 9999999999999999999876554333 347889999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC---CeEEeecceeeeeccCccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG---HAHITDFNIATVLEENQLA 159 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~ 159 (246)
+.|...+.+...+ ++..+.....||+.+|.|+|++||+|+|++|.|+++-.+. -+|++|||++.....+...
T Consensus 95 ~dl~~eIV~R~~y-----SEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~ 169 (355)
T KOG0033|consen 95 GELFEDIVAREFY-----SEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW 169 (355)
T ss_pred hHHHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccc
Confidence 9999998877555 8888999999999999999999999999999999995433 5899999999988866666
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCC----CCCHh
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPT----AWSES 235 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~s~~ 235 (246)
..+.|++.|+|||+++..+ ++..+|||+.|+++|-++.|.+||.+++ ..+...++......+|. +++++
T Consensus 170 ~G~~GtP~fmaPEvvrkdp-----y~kpvDiW~cGViLfiLL~G~~PF~~~~--~~rlye~I~~g~yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 170 HGFAGTPGYLSPEVLKKDP-----YSKPVDIWACGVILYILLVGYPPFWDED--QHRLYEQIKAGAYDYPSPEWDTVTPE 242 (355)
T ss_pred ccccCCCcccCHHHhhcCC-----CCCcchhhhhhHHHHHHHhCCCCCCCcc--HHHHHHHHhccccCCCCcccCcCCHH
Confidence 6788999999999998776 8889999999999999999999997544 44566777777666653 57999
Q ss_pred HHHHHHHhhh
Q psy7592 236 TKHLLSQVHR 245 (246)
Q Consensus 236 l~~li~~~l~ 245 (246)
.++||+.||.
T Consensus 243 Ak~LvrrML~ 252 (355)
T KOG0033|consen 243 AKSLIRRMLT 252 (355)
T ss_pred HHHHHHHHhc
Confidence 9999999996
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=278.84 Aligned_cols=232 Identities=32% Similarity=0.576 Sum_probs=189.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||+++++.+++.||+|.+.+.........+.+.+|+.+++.++||||+++++++.++...++||||++
T Consensus 50 ~lG~G~f---g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05621 50 VIGRGAF---GEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEecCC---eEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCC
Confidence 3788888 9999999999999999999976443334445668889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--A 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 159 (246)
+++|.+++... .+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||++........ .
T Consensus 127 gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~ 200 (370)
T cd05621 127 GGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceec
Confidence 99999988643 248889999999999999999999999999999999999999999999999987643322 2
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCC--CCCHh
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPT--AWSES 235 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~--~~s~~ 235 (246)
....+++.|+|||.+.+... ...++.++|+||||+++|+|++|..||...+. ......+... ...+|. .+|..
T Consensus 201 ~~~~gt~~Y~aPE~~~~~~~-~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 201 DTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--VGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred ccCCCCcccCCHHHHhccCC-CCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCcccCCCCcccCCHH
Confidence 34568899999999875431 11267899999999999999999999975432 2333444432 344554 57999
Q ss_pred HHHHHHHhhh
Q psy7592 236 TKHLLSQVHR 245 (246)
Q Consensus 236 l~~li~~~l~ 245 (246)
++++|..||+
T Consensus 278 ~~~li~~~L~ 287 (370)
T cd05621 278 AKNLICAFLT 287 (370)
T ss_pred HHHHHHHHcc
Confidence 9999999984
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=273.81 Aligned_cols=231 Identities=26% Similarity=0.413 Sum_probs=185.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+++.||+|.+.... .....+.+.+|+++++.++|+||+++++++.++..+++||||+.
T Consensus 81 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 81 RIGSGAG---GTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred hccCCCC---eEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 4788888 999999999999999999986543 23445778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|..... ..+..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 156 ~~~L~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 226 (353)
T PLN00034 156 GGSLEGTHI---------ADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN 226 (353)
T ss_pred CCccccccc---------CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccccc
Confidence 999864321 2677788999999999999999999999999999999999999999999987754322 223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHhhh-cCCCCCCCCCCHhHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK-DVKAII-YSPVHYPTAWSESTKH 238 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~-~~~~~~~~~~s~~l~~ 238 (246)
...++..|+|||.+..........+.++||||||+++|+|++|+.||......... ....+. ......+..++.++++
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 306 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRH 306 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHH
Confidence 45678899999988644322223456899999999999999999999743333322 222222 2244556789999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|.+||+.
T Consensus 307 li~~~l~~ 314 (353)
T PLN00034 307 FISCCLQR 314 (353)
T ss_pred HHHHHccC
Confidence 99999964
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=274.27 Aligned_cols=235 Identities=32% Similarity=0.555 Sum_probs=190.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.+.+...........+.+|..++..++|++|+++++++.+++..|+||||+.
T Consensus 8 ~lG~G~f---g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~ 84 (331)
T cd05624 8 VIGRGAF---GEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYV 84 (331)
T ss_pred EEeeCCC---eEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 4788888 8999999999999999999976543344445668889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-- 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (246)
|++|.+++.... ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++++|||++.........
T Consensus 85 gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 85 GGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 999999997632 23488899999999999999999999999999999999999999999999998776443222
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCC---CCCH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPT---AWSE 234 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~---~~s~ 234 (246)
....++..|+|||.+.+.......++.++|+||||+++|+|++|+.||...+. ......+... ..++|. .+++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--HHHHHHHHcCCCcccCCCccccCCH
Confidence 23457899999999876432222367899999999999999999999975432 2223333332 333443 4699
Q ss_pred hHHHHHHHhhh
Q psy7592 235 STKHLLSQVHR 245 (246)
Q Consensus 235 ~l~~li~~~l~ 245 (246)
+++++|.+||.
T Consensus 239 ~~~~li~~ll~ 249 (331)
T cd05624 239 EAKDLIQRLIC 249 (331)
T ss_pred HHHHHHHHHcc
Confidence 99999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=264.23 Aligned_cols=234 Identities=31% Similarity=0.568 Sum_probs=192.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||++.+..+++.||+|.+...........+.+.+|+.++++++|++++++++.+.+++..+++|||+.
T Consensus 7 ~ig~G~~---g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 7 VLGKGGF---GEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred EeecCCC---eEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 4789888 8999999999999999999977654444445667789999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++.... ...+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||++...........
T Consensus 84 g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 84 GGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred CCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 999998885432 22458889999999999999999999999999999999999999999999999876554433334
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHhhhcC-CCCCCCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV-KDVKAIIYS-PVHYPTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~~s~~l~~l 239 (246)
..++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||........ ......... ...++..++++++++
T Consensus 161 ~~g~~~y~aPE~~~~~~-----~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05630 161 RVGTVGYMAPEVVKNER-----YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235 (285)
T ss_pred CCCCccccChHHHcCCC-----CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence 56788999999987654 78899999999999999999999975443221 122222221 334567899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|.+||++
T Consensus 236 i~~~l~~ 242 (285)
T cd05630 236 CKMLLCK 242 (285)
T ss_pred HHHHhhc
Confidence 9999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=275.70 Aligned_cols=230 Identities=34% Similarity=0.658 Sum_probs=187.7
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC---CCCcceeeeeeeeeCCeEEEEEee
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL---EHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
||+|+| |+||+++++.+++.||+|++................|..++... +||+|+++++++......++||||
T Consensus 1 lG~G~~---g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTF---GQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCc---eEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 688888 89999999999999999999765433334445556666776665 699999999999999999999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-cc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QL 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~ 158 (246)
+.+++|.+.+...... ++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||++...... ..
T Consensus 78 ~~~g~L~~~l~~~~~~-----~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 78 MSGGELFWHLQKEGRF-----SEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152 (330)
T ss_pred CCCChHHHHHHhcCCC-----CHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence 9999999888765443 89999999999999999999999999999999999999999999999998754322 22
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCC-CCCHhHH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPT-AWSESTK 237 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~l~ 237 (246)
.....++..|+|||.+.+.. .++.++|+||||+++|+|++|..||.... .......+......+|. .++++++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~ 226 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEK----GYTKHVDFWSLGVLVFEMCCGWSPFYAED--TQQMYRNIAFGKVRFPKNVLSDEGR 226 (330)
T ss_pred ccCccCCccccCHHHHcCCC----CCCCccceeccccEEEEeccCCCCCCCCC--HHHHHHHHHcCCCCCCCccCCHHHH
Confidence 33456888999999986543 26789999999999999999999996533 23334445555555654 5799999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|++||+.
T Consensus 227 ~li~~~L~~ 235 (330)
T cd05586 227 QFVKGLLNR 235 (330)
T ss_pred HHHHHHcCC
Confidence 999999973
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=264.34 Aligned_cols=227 Identities=34% Similarity=0.660 Sum_probs=195.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.+..+++.||+|.+........+..+.+.+|++.+++++||||+++++++.++...++||||+.
T Consensus 8 ~ig~g~~---~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (290)
T cd05580 8 TLGTGSF---GRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP 84 (290)
T ss_pred EeecCCC---eEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCC
Confidence 3678877 8999999999999999999987655445556788899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++..... +++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||++...... ...
T Consensus 85 ~~~L~~~~~~~~~-----l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~ 157 (290)
T cd05580 85 GGELFSHLRKSGR-----FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYT 157 (290)
T ss_pred CCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCC
Confidence 9999999876544 489999999999999999999999999999999999999999999999998775443 233
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..+++.|+|||.+.+.. .+.++|+||||+++++|++|..||.... .......+.....++|..+++.++++|+
T Consensus 158 ~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~ 230 (290)
T cd05580 158 LCGTPEYLAPEIILSKG-----YGKAVDWWALGILIYEMLAGYPPFFDDN--PIQIYEKILEGKVRFPSFFSPDAKDLIR 230 (290)
T ss_pred CCCCccccChhhhcCCC-----CCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCccCCccCCHHHHHHHH
Confidence 45778899999887654 6788999999999999999999996433 3344455566677888899999999999
Q ss_pred Hhhh
Q psy7592 242 QVHR 245 (246)
Q Consensus 242 ~~l~ 245 (246)
+||+
T Consensus 231 ~~l~ 234 (290)
T cd05580 231 NLLQ 234 (290)
T ss_pred HHcc
Confidence 9996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=272.62 Aligned_cols=235 Identities=32% Similarity=0.559 Sum_probs=190.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+++++.+++.||+|.+.+...........+.+|..++..++|++|+++++++.++...++||||+.
T Consensus 8 ~lG~G~f---g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~ 84 (332)
T cd05623 8 VIGRGAF---GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYV 84 (332)
T ss_pred EEEeCCC---eEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccC
Confidence 4788888 8999999999999999999976543344445668889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-- 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (246)
+++|.+++.+.. ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++.........
T Consensus 85 ~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 85 GGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 999999997532 23488899999999999999999999999999999999999999999999998765332221
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCC---CCCCH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYP---TAWSE 234 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~---~~~s~ 234 (246)
....+++.|+|||++.........++.++|+||||+++|+|++|+.||..... ......+... ...+| ..+|+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCccccCCCccccCCH
Confidence 23457899999999864332223478899999999999999999999975432 2333333332 23344 35799
Q ss_pred hHHHHHHHhhh
Q psy7592 235 STKHLLSQVHR 245 (246)
Q Consensus 235 ~l~~li~~~l~ 245 (246)
+++++|++||.
T Consensus 239 ~~~~li~~ll~ 249 (332)
T cd05623 239 DAKDLIRRLIC 249 (332)
T ss_pred HHHHHHHHHcc
Confidence 99999999984
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=250.81 Aligned_cols=197 Identities=26% Similarity=0.429 Sum_probs=172.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.+|+|+| |.||++++.+||+.||||+++.....+ ..-....+|++.|+.++|+||+.+.++|...+.+.+|+||+
T Consensus 9 ~lGEG~~---gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm- 83 (318)
T KOG0659|consen 9 KLGEGTY---GVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM- 83 (318)
T ss_pred hhcCcce---EEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec-
Confidence 4899999 999999999999999999998765332 23456788999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
..+|...+.... ..+....++.++.+++++++|||+..|+||||||+|+|++.+|.+|++|||+++.+.+......
T Consensus 84 ~tdLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 84 PTDLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred cccHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 667888886543 3468889999999999999999999999999999999999999999999999998876554433
Q ss_pred -cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 162 -MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 162 -~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
...++.|.|||.+.|.. .|+..+|+||.||++.||+-|.+-|.+.+
T Consensus 160 ~~V~TRWYRAPELLfGsr----~Yg~~VDmWavGCI~AELllr~P~fpG~s 206 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSR----QYGTGVDMWAVGCIFAELLLRVPFFPGDS 206 (318)
T ss_pred cceeeeeccChHHhccch----hcCCcchhhhHHHHHHHHHccCCCCCCCc
Confidence 36788899999998887 58999999999999999999999886543
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=269.99 Aligned_cols=229 Identities=28% Similarity=0.465 Sum_probs=199.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||.|.| |.||.++++.||+.||+|.+.+...........+.+|+.++++++ ||||+.+++.|++...+++|||++
T Consensus 42 ~lG~G~F---g~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~ 118 (382)
T KOG0032|consen 42 ELGRGQF---GVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELC 118 (382)
T ss_pred hhCCCCc---eEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEec
Confidence 4788888 999999999999999999999877665556678999999999998 999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC----CCeEEeecceeeeeccC
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE----GHAHITDFNIATVLEEN 156 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~----~~~~l~d~~~~~~~~~~ 156 (246)
.|+.|.+.+... . +++..+..++.|++.+++|||+.|++|+|++|+|+|+... +.++++|||++......
T Consensus 119 ~GGeLfd~i~~~-~-----~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 119 EGGELFDRIVKK-H-----YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred CCchHHHHHHHc-c-----CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 999999999875 1 5999999999999999999999999999999999999643 47999999999988775
Q ss_pred ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CCC
Q psy7592 157 QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAW 232 (246)
Q Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~ 232 (246)
.......|++.|+|||.+.... ++..+|+||+|+++|.|++|.+||.+.... .....+......++ +.+
T Consensus 193 ~~~~~~~Gtp~y~APEvl~~~~-----y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~--~~~~~i~~~~~~f~~~~w~~i 265 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLGGRP-----YGDEVDVWSIGVILYILLSGVPPFWGETEF--EIFLAILRGDFDFTSEPWDDI 265 (382)
T ss_pred ceEeeecCCccccCchhhcCCC-----CCcccchhHHHHHHHHHhhCCCCCcCCChh--HHHHHHHcCCCCCCCCCcccc
Confidence 5666788999999999998655 899999999999999999999999765433 33446666544443 357
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
|+.++++|..||.+
T Consensus 266 s~~akd~i~~ll~~ 279 (382)
T KOG0032|consen 266 SESAKDFIRKLLEF 279 (382)
T ss_pred CHHHHHHHHHhccc
Confidence 99999999999863
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=259.51 Aligned_cols=230 Identities=32% Similarity=0.595 Sum_probs=196.9
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||.|++ |.||+++++.+++.||+|.+......+....+.+.+|+..+++++||||+++++.+.++...++++||+++
T Consensus 1 lg~g~~---~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGF---GRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCc---eEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence 678888 89999999999999999999876655555667899999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSM 162 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 162 (246)
++|.+++.+... +++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+............
T Consensus 78 ~~L~~~l~~~~~-----l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~ 152 (262)
T cd05572 78 GELWTILRDRGL-----FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF 152 (262)
T ss_pred CcHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccc
Confidence 999999976543 488999999999999999999999999999999999999999999999998876554333344
Q ss_pred ccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh--cCCCCCCCCCCHhHHHHH
Q psy7592 163 SGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII--YSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 163 ~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~l~~li 240 (246)
.++..|++||.+.... ++.++|+||+|+++|+|++|..||.....+.......+. .....+|...+++++++|
T Consensus 153 ~~~~~~~~PE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 227 (262)
T cd05572 153 CGTPEYVAPEIILNKG-----YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLI 227 (262)
T ss_pred cCCcCccChhHhcCCC-----CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHH
Confidence 5678899999876543 788999999999999999999999765543444455555 346667778899999999
Q ss_pred HHhhh
Q psy7592 241 SQVHR 245 (246)
Q Consensus 241 ~~~l~ 245 (246)
++||+
T Consensus 228 ~~~l~ 232 (262)
T cd05572 228 KQLLR 232 (262)
T ss_pred HHHcc
Confidence 99986
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=274.97 Aligned_cols=235 Identities=31% Similarity=0.536 Sum_probs=191.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.++.......+..+.+.+|+.+++.++|++|+++++++.+....++||||++
T Consensus 8 ~lg~G~~---g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (330)
T cd05601 8 LVGRGHF---GEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQP 84 (330)
T ss_pred EEEeccC---EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCC
Confidence 4788888 8999999999999999999987654445566778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-- 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (246)
+++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 85 GGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999987642 23589999999999999999999999999999999999999999999999999876543222
Q ss_pred cccccCCCccCCceecccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCC--CCCCH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDE-VLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYP--TAWSE 234 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~-~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~--~~~s~ 234 (246)
....+++.|+|||.+...... ...++.++|+||||+++|+|++|..||.... .......+... ...+| ..+++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT--SAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC--HHHHHHHHHcCCCccCCCCCCCCCH
Confidence 224578899999998643221 2236789999999999999999999996533 22333333322 23333 36899
Q ss_pred hHHHHHHHhhh
Q psy7592 235 STKHLLSQVHR 245 (246)
Q Consensus 235 ~l~~li~~~l~ 245 (246)
++++||++||+
T Consensus 239 ~~~~li~~ll~ 249 (330)
T cd05601 239 DFLDLIQSLLC 249 (330)
T ss_pred HHHHHHHHHcc
Confidence 99999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=265.45 Aligned_cols=229 Identities=28% Similarity=0.433 Sum_probs=186.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC-----CeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE-----EDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v 76 (246)
++|+|+| |.||++...++++.||||+.-.+. +--.+|+++++++.|||||++..+|... -...+|
T Consensus 31 liG~GsF---g~Vyq~~~~e~~~~vAIKKv~~d~-------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 31 LIGSGSF---GVVYQAKLRETEEEVAIKKVLQDK-------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEeeccc---ceEEEEEEcCCCceeEEEEecCCC-------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5789999 999999999999999999886654 2445689999999999999999888632 246779
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC-CCeEEeecceeeeecc
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE-GHAHITDFNIATVLEE 155 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~-~~~~l~d~~~~~~~~~ 155 (246)
|||+ -.+|.+.+..... .....+.-.++-+..||++|+.|||+.||+||||||.|+|++.+ |.+||||||.|+....
T Consensus 101 leym-P~tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 101 LEYM-PETLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHhc-hHHHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9999 6678888875321 13344888899999999999999999999999999999999965 8999999999999988
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHhhh------------
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV-KDVKAII------------ 222 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~------------ 222 (246)
+.......+++.|.|||.+.+.. .++.+.||||.|||+.||+.|++.|.+.+..+. ..+..+.
T Consensus 179 ~epniSYicSRyYRaPELifga~----~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFGAT----EYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred CCCceeEEEeccccCHHHHcCcc----ccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 88888899999999999999887 599999999999999999999999987653332 1222211
Q ss_pred cC--CCC------------CCCCCCHhHHHHHHHhhhC
Q psy7592 223 YS--PVH------------YPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 223 ~~--~~~------------~~~~~s~~l~~li~~~l~~ 246 (246)
.. ... +....++++-+|++++|.|
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y 292 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQY 292 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhcc
Confidence 11 111 1234689999999999875
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=279.50 Aligned_cols=231 Identities=26% Similarity=0.436 Sum_probs=189.3
Q ss_pred CcCCCCccCeeeEEEEEecCC-CcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT-KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||.|++ |.||.|.+..+ ++.||+|.+.... ......+.+|+..++.++||||+++++++..++..++||||+
T Consensus 74 ~lg~G~~---g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 74 LVGRNPT---TAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred EEEeCCC---cEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3678888 89999999887 7889999775443 344456778999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-- 158 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 158 (246)
++++|.+.+..... ...++++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++++|||++........
T Consensus 148 ~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 148 SGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 99999988764321 133568889999999999999999999999999999999999999999999999987644321
Q ss_pred -ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhH
Q psy7592 159 -ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSEST 236 (246)
Q Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l 236 (246)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||..... ......+... ..++|..+++++
T Consensus 227 ~~~~~~gt~~y~aPE~~~~~~-----~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~s~~~ 299 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWERKR-----YSKKADMWSLGVILYELLTLHRPFKGPSQ--REIMQQVLYGKYDPFPCPVSSGM 299 (478)
T ss_pred cccccCCCccccCHhHhCCCC-----CCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCCCCccCCHHH
Confidence 23345889999999987654 78899999999999999999999965332 2233333333 445677899999
Q ss_pred HHHHHHhhhC
Q psy7592 237 KHLLSQVHRY 246 (246)
Q Consensus 237 ~~li~~~l~~ 246 (246)
+++|..||+.
T Consensus 300 ~~li~~~L~~ 309 (478)
T PTZ00267 300 KALLDPLLSK 309 (478)
T ss_pred HHHHHHHhcc
Confidence 9999999963
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=252.24 Aligned_cols=236 Identities=25% Similarity=0.328 Sum_probs=194.2
Q ss_pred CCcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC-----eEEE
Q psy7592 1 MFCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE-----DLFM 75 (246)
Q Consensus 1 ~~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~~ 75 (246)
+.||.|+| +-|+++....+++.||+|++..+. .+..+..++|++..++++|||++++++....+. ..|+
T Consensus 27 ~~LgeGGf---sfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 27 RLLGEGGF---SFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred eeecCCCc---eeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 36888888 999999999999999999998775 455788999999999999999999998775433 3899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH--IIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~--~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
++.|+..|||.+.+...... +...++..++.|+.+++.+|++||+.. +.|+||||.||++++.+.+++.|||.+...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 99999999999999875432 445799999999999999999999999 999999999999999999999999998775
Q ss_pred ccCcc----------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc
Q psy7592 154 EENQL----------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY 223 (246)
Q Consensus 154 ~~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 223 (246)
..... .....++..|.|||.+...... ..+.++|||||||++|.|+.|..||+..-........++..
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~--ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n 257 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHC--TITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN 257 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCc--ccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec
Confidence 32211 1234578999999998765532 36889999999999999999999996433322233445556
Q ss_pred CCCCCCC--CCCHhHHHHHHHhhh
Q psy7592 224 SPVHYPT--AWSESTKHLLSQVHR 245 (246)
Q Consensus 224 ~~~~~~~--~~s~~l~~li~~~l~ 245 (246)
.+..+|. .+|+.+.++|++||+
T Consensus 258 ~q~s~P~~~~yse~l~~lik~mlq 281 (302)
T KOG2345|consen 258 AQISIPNSSRYSEALHQLIKSMLQ 281 (302)
T ss_pred cccccCCCCCccHHHHHHHHHHhc
Confidence 5666764 499999999999996
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=262.98 Aligned_cols=228 Identities=14% Similarity=0.134 Sum_probs=185.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee----CCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD----EEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~v~ 77 (246)
.+|+|++ +.||++.. +|+.||+|.++.......+..+.+.+|++.+++++||||+++++++.+ ....+++|
T Consensus 27 ~i~~g~~---~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~ 101 (283)
T PHA02988 27 LIKENDQ---NSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101 (283)
T ss_pred EEeeCCc---eEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence 4677777 89999988 699999999987654445556788899999999999999999999876 35689999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
||+++++|.+++.+... ++......++.|++.++.+||+ .+++|+||+|+|+++++++.++++|||++......
T Consensus 102 Ey~~~g~L~~~l~~~~~-----~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 102 EYCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred EeCCCCcHHHHHhhCCC-----CChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 99999999999976543 4888899999999999999998 49999999999999999999999999998754332
Q ss_pred ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh--cCCCCCCCCCCH
Q psy7592 157 QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII--YSPVHYPTAWSE 234 (246)
Q Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~s~ 234 (246)
. ....++..|+|||.+.+.. ..++.++||||||+++|+|++|..||...... .....+. ....++|..+++
T Consensus 177 ~--~~~~~~~~y~aPE~~~~~~---~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~ 249 (283)
T PHA02988 177 P--FKNVNFMVYFSYKMLNDIF---SEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLIINKNNSLKLPLDCPL 249 (283)
T ss_pred c--ccccCcccccCHHHhhhcc---ccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhcCCCCCCCCcCcH
Confidence 1 2345678899999986521 13788999999999999999999999754322 2223332 235556668999
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.++++|.+||+.
T Consensus 250 ~l~~li~~cl~~ 261 (283)
T PHA02988 250 EIKCIVEACTSH 261 (283)
T ss_pred HHHHHHHHHhcC
Confidence 999999999974
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=270.52 Aligned_cols=233 Identities=33% Similarity=0.586 Sum_probs=190.4
Q ss_pred CcCCCCccCeeeEEEEEec---CCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK---DTKQMYAMKYMHKSQCI-ERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |+||++++. .+++.||+|++...... .....+.+..|+.+++.+ +|++|+++++++..+...++|
T Consensus 7 ~lg~G~~---g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (332)
T cd05614 7 VLGTGAY---GKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLI 83 (332)
T ss_pred EEeecCC---EEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEE
Confidence 3788888 899998874 57899999999764422 233456678899999999 599999999999999999999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
|||+.+++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 84 LDYVSGGEMFTHLYQRDN-----FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 999999999999876543 489999999999999999999999999999999999999999999999998765332
Q ss_pred c--cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHhhhcCCCCCCCCC
Q psy7592 157 Q--LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT--SVKDVKAIIYSPVHYPTAW 232 (246)
Q Consensus 157 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (246)
. ......++..|+|||.+.+.. .++.++|+||||+++|+|++|..||...... .......+.....++|..+
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKG----GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFI 234 (332)
T ss_pred CCCccccccCCccccCHHHhcCCC----CCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 2 122356789999999987543 2577899999999999999999999644322 2233344555567778889
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
++.++++|++||+.
T Consensus 235 ~~~~~~li~~~l~~ 248 (332)
T cd05614 235 GPEAQDLLHKLLRK 248 (332)
T ss_pred CHHHHHHHHHHcCC
Confidence 99999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=261.09 Aligned_cols=234 Identities=29% Similarity=0.535 Sum_probs=192.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||.+.+..+++.||+|.+.............+.+|++++++++|++++++.+.+..++..+++|||+.
T Consensus 7 ~lg~G~~---g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 7 VLGKGGF---GEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEecCCC---eEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 4788888 8999999999999999999977654444445667889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++.... ..++++..+..++.|++.++.|||+.|++|+||+|+||++++++.++++|||++...........
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 84 GGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred CccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 999998875432 22469999999999999999999999999999999999999999999999999876544333334
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-HHH-HhhhcCCCCCCCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV-KDV-KAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~-~~~~~~~~~~~~~~s~~l~~l 239 (246)
..++..|+|||.+.+.. ++.++|+||||+++++|++|..||........ ... .........++..+++.+.++
T Consensus 161 ~~g~~~~~aPE~~~~~~-----~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05632 161 RVGTVGYMAPEVLNNQR-----YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI 235 (285)
T ss_pred CCCCcCccChHHhcCCC-----CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence 56788999999987654 78899999999999999999999975443221 122 222233445667899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
+..||+.
T Consensus 236 i~~~l~~ 242 (285)
T cd05632 236 CKMLLTK 242 (285)
T ss_pred HHHHccC
Confidence 9999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=260.39 Aligned_cols=230 Identities=32% Similarity=0.599 Sum_probs=206.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+||+|+| |.|.+|+.+.+++.||+|+++++.....+.+..-..|-++|+..+||.+..+...|+..+++|+||||..
T Consensus 175 vLGkGTF---GKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyan 251 (516)
T KOG0690|consen 175 VLGKGTF---GKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYAN 251 (516)
T ss_pred HhcCCcc---ceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEcc
Confidence 5899999 8999999999999999999999888888888899999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec-cCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE-ENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~~ 160 (246)
||.|..++..... ++++....+-..|..||.|||+++||.+|+|.+|++++.+|.+||+|||+++.-. .+....
T Consensus 252 GGeLf~HLsrer~-----FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~k 326 (516)
T KOG0690|consen 252 GGELFFHLSRERV-----FSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTK 326 (516)
T ss_pred CceEeeehhhhhc-----ccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceec
Confidence 9999999876443 4888888999999999999999999999999999999999999999999998643 344556
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
.+.|++.|+|||.+.... ++..+|.|.+|+++|+|++|+.||...+ -.+...-+..+...+|..+|++.+.|+
T Consensus 327 TFCGTPEYLAPEVleDnD-----YgraVDWWG~GVVMYEMmCGRLPFyn~d--h~kLFeLIl~ed~kFPr~ls~eAktLL 399 (516)
T KOG0690|consen 327 TFCGTPEYLAPEVLEDND-----YGRAVDWWGVGVVMYEMMCGRLPFYNKD--HEKLFELILMEDLKFPRTLSPEAKTLL 399 (516)
T ss_pred cccCChhhcCchhhcccc-----ccceeehhhhhHHHHHHHhccCcccccc--hhHHHHHHHhhhccCCccCCHHHHHHH
Confidence 789999999999997554 8999999999999999999999996433 345555677778899999999999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
..+|.+
T Consensus 400 sGLL~k 405 (516)
T KOG0690|consen 400 SGLLKK 405 (516)
T ss_pred HHHhhc
Confidence 999863
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=255.73 Aligned_cols=230 Identities=23% Similarity=0.403 Sum_probs=189.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI--ERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|++ |.||.+.+..+++.||+|.+...... .....+.+.+|++.+++++||||+++++++.++...++++|+
T Consensus 9 ~lg~g~~---~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 9 LLGQGAF---GRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred eecCCCc---eEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 4788888 89999999999999999998765422 223456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (246)
+++++|.+.+..... +++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+.........
T Consensus 86 ~~~~~l~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 86 MPGGSVKDQLKAYGA-----LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred CCCCcHHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 999999999876543 388889999999999999999999999999999999999999999999998765432111
Q ss_pred ----cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc--CCCCCCCCCC
Q psy7592 160 ----TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY--SPVHYPTAWS 233 (246)
Q Consensus 160 ----~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~s 233 (246)
....++..|+|||.+.+.. .+.++|+||||+++|++++|+.||..... ......... ....+|..++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEG-----YGRKADVWSVGCTVVEMLTEKPPWAEFEA--MAAIFKIATQPTNPQLPSHVS 233 (263)
T ss_pred cccccCCCcCccccCcceeccCC-----CCchhhhHHHHHHHHHHHhCCCCccccch--HHHHHHHhccCCCCCCCccCC
Confidence 2244667899999998764 78899999999999999999999964332 222222222 2455677899
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
..+.++|++||++
T Consensus 234 ~~~~~li~~~l~~ 246 (263)
T cd06625 234 PDARNFLRRTFVE 246 (263)
T ss_pred HHHHHHHHHHhhc
Confidence 9999999999963
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=258.37 Aligned_cols=230 Identities=27% Similarity=0.461 Sum_probs=188.2
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee-----CCeEEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD-----EEDLFMVS 77 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~~v~ 77 (246)
||.|.+ |.|+.+.++.+|+.||+|++.... ...-..++..+|+++++.++|+||+.+++++.. -..+|+|+
T Consensus 30 iG~GAy---GvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 30 IGRGAY---GVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred ccCcce---eeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence 788888 899999999999999999996433 345556888899999999999999999999875 34689999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc--
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-- 155 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-- 155 (246)
|+| +.+|...+.....+ +.+.+..+++|++.+|+|+|+.+++|||+||+|++++.+...|++|||+++....
T Consensus 106 elM-etDL~~iik~~~~L-----~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 106 ELM-ETDLHQIIKSQQDL-----TDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred hHH-hhHHHHHHHcCccc-----cHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 999 88899999876555 9999999999999999999999999999999999999999999999999998764
Q ss_pred -CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-------------HHHH---
Q psy7592 156 -NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS-------------VKDV--- 218 (246)
Q Consensus 156 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~-------------~~~~--- 218 (246)
........-|..|.|||+..... +++...||||+||++.||++|++.|.|.+.-. ....
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~----~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSS----EYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccchhcceeeeeecCHHHHhccc----cccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 33334566788899999986554 58999999999999999999999997653211 1111
Q ss_pred -----HhhhcCCCCCC--------CCCCHhHHHHHHHhhhC
Q psy7592 219 -----KAIIYSPVHYP--------TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 219 -----~~~~~~~~~~~--------~~~s~~l~~li~~~l~~ 246 (246)
...+...+..| ++.++...+|+++||.+
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~f 296 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVF 296 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhcc
Confidence 11122222222 45789999999999874
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=259.39 Aligned_cols=232 Identities=52% Similarity=0.924 Sum_probs=198.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |.||++.++.+++.||+|.+......+....+.+.+|++.+++++||||+++++++.++...++|+||+.
T Consensus 7 ~i~~g~~---~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (258)
T cd05578 7 VIGKGAF---GKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLL 83 (258)
T ss_pred EeccCCC---ceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCC
Confidence 3688888 8999999999999999999987665555567889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
|++|.+++.... ++++..+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||.+...........
T Consensus 84 ~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 84 GGDLRYHLSQKV-----KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence 999999987653 348899999999999999999999999999999999999999999999999877655443444
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc-CCCCCCCCCCHhHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY-SPVHYPTAWSESTKHLL 240 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~l~~li 240 (246)
..++..|+|||.+.... .+.++|+||||+++|+|++|..||................ .....|..++..+.++|
T Consensus 159 ~~~~~~y~~PE~~~~~~-----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (258)
T cd05578 159 TSGTPGYMAPEVLCRQG-----YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAI 233 (258)
T ss_pred cCCChhhcCHHHHcccC-----CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHH
Confidence 55777899999987654 6789999999999999999999997655433444444444 46667888999999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
.+||+.
T Consensus 234 ~~~l~~ 239 (258)
T cd05578 234 NKLLER 239 (258)
T ss_pred HHHccC
Confidence 999964
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=267.25 Aligned_cols=233 Identities=21% Similarity=0.358 Sum_probs=182.1
Q ss_pred CcCCCCccCeeeEEEEEe-----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeC-CeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQK-----KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDE-EDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~ 74 (246)
.||+|+| |.||++.+ ..+++.||+|.+.... ..+..+.+.+|++++.++ +||||+++++.+... ..++
T Consensus 14 ~lG~G~f---g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (338)
T cd05102 14 VLGHGAF---GKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM 88 (338)
T ss_pred EeccCCc---ceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence 4788888 89999975 2456789999987543 233456788999999999 899999999988754 4689
Q ss_pred EEEeecCCCChHHHHhhcccc---------------------------------------------------------cc
Q psy7592 75 MVSDLLLGGDLRYHITQDIKF---------------------------------------------------------YS 97 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~---------------------------------------------------------~~ 97 (246)
++|||+++++|.+++...... ..
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 999999999999998753210 12
Q ss_pred CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc---ccccccCCCccCCcee
Q psy7592 98 VGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL---ATSMSGTKPYIAPEIF 174 (246)
Q Consensus 98 ~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~ 174 (246)
.++++..+..++.|++.||.|||+.|++|+||||+||+++.++.++++|||++........ .....++..|+|||.+
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 248 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence 3467778899999999999999999999999999999999999999999999876532211 1122345679999998
Q ss_pred cccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHHHHHHhhh
Q psy7592 175 LVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 175 ~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~li~~~l~ 245 (246)
.+.. ++.++||||||+++|+|++ |..||.+..... .....+... ....|..+++.+.++|.+||+
T Consensus 249 ~~~~-----~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 315 (338)
T cd05102 249 FDKV-----YTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLKDGTRMRAPENATPEIYRIMLACWQ 315 (338)
T ss_pred hcCC-----CCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 7654 7889999999999999997 999997644332 222222222 444567899999999999996
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=259.29 Aligned_cols=233 Identities=33% Similarity=0.577 Sum_probs=192.3
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|++ |+||+|.+..+|+.||+|.+...........+.+..|++++++++|||++++++++...+..|+||||+++
T Consensus 1 lg~g~~---g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGF---GEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCc---eeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence 688888 89999999999999999999875543344456677899999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSM 162 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 162 (246)
++|.+++.+... ..+++..+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||.+............
T Consensus 78 ~~L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 78 GDLKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred CcHHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccc
Confidence 999999876432 24589999999999999999999999999999999999999999999999988765443333344
Q ss_pred ccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHH-HHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 163 SGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT-SVK-DVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 163 ~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-~~~-~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
.++..|+|||...+.. ++.++|+||||+++++|++|+.||...... ... ............|..+++.++++|
T Consensus 155 ~~~~~y~~PE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 229 (277)
T cd05577 155 AGTPGYMAPEVLQGEV-----YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLC 229 (277)
T ss_pred cCCCCcCCHHHhcCCC-----CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHH
Confidence 5677899999987654 778999999999999999999999654431 122 222233345666778999999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
++||+.
T Consensus 230 ~~~l~~ 235 (277)
T cd05577 230 EALLQK 235 (277)
T ss_pred HHHccC
Confidence 999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=270.81 Aligned_cols=228 Identities=25% Similarity=0.399 Sum_probs=196.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+||.|+| |.||++.++.+++.||+|++.-+.. .+.++++++|+.++.+++++||.++|+.+..+..++++|||+.
T Consensus 20 ~IgrGsf---G~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 20 LIGRGSF---GEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred hcccccc---ceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 5889999 9999999999999999999987663 4557899999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-AT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 160 (246)
||++.+.+.....+ .+..+..++.+++.|+.|||.++.+|+||++.||++...|.++++|||.+........ ..
T Consensus 95 gGsv~~lL~~~~~~-----~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 95 GGSVLDLLKSGNIL-----DEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred CcchhhhhccCCCC-----ccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 99999998765543 7888889999999999999999999999999999999999999999999988765433 35
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~l 239 (246)
.+.||+.|||||++.+.. |+.++||||||+..++|++|.+|+.....+.. ..-|-.. ++.+...||+.++++
T Consensus 170 tfvGTPfwMAPEVI~~~~-----Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--lflIpk~~PP~L~~~~S~~~kEF 242 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSG-----YDTKADIWSLGITAIELAKGEPPHSKLHPMRV--LFLIPKSAPPRLDGDFSPPFKEF 242 (467)
T ss_pred cccccccccchhhhcccc-----ccchhhhhhhhHHHHHHhcCCCCCcccCcceE--EEeccCCCCCccccccCHHHHHH
Confidence 688999999999999654 89999999999999999999999976665332 2222222 333335799999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|..||++
T Consensus 243 V~~CL~k 249 (467)
T KOG0201|consen 243 VEACLDK 249 (467)
T ss_pred HHHHhhc
Confidence 9999985
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=262.30 Aligned_cols=196 Identities=28% Similarity=0.439 Sum_probs=165.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.+..... .....+.+.+|++.+++++||||+++++++..++..++||||+.
T Consensus 8 ~lg~g~~---~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07848 8 VVGEGAY---GVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE 83 (287)
T ss_pred EecccCC---EEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence 3678888 8999999999999999999976532 23345677889999999999999999999999999999999998
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc--cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ--LA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 159 (246)
++++....... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++....... ..
T Consensus 84 ~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 84 KNMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 87776554332 235888999999999999999999999999999999999999999999999987754322 12
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~-----~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 159 TEYVATRWYRSPELLLGAP-----YGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred cccccccccCCcHHHcCCC-----CCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 2345788999999987654 7889999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=254.87 Aligned_cols=200 Identities=29% Similarity=0.397 Sum_probs=172.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCc-ceeeeeeeeeCC------eEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPF-LVNLWFCFQDEE------DLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~------~~~ 74 (246)
.||+|+| |+||+|+++.+|+.||+|+++-+.-. +..-....+|+.++++|+|+| |+++++++.... ..+
T Consensus 18 klGeGty---g~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~ 93 (323)
T KOG0594|consen 18 KLGEGTY---GVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLY 93 (323)
T ss_pred HhCCCCc---eEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEE
Confidence 3899999 99999999999999999999876521 223356788999999999999 999999998877 789
Q ss_pred EEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec
Q psy7592 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~ 154 (246)
+|+|+. ..+|..++....... ...+...++.++.||+.|+.|||+++|+||||||.|++++++|.+|++|||+++...
T Consensus 94 lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 94 LVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred EEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 999999 778999987754321 345778999999999999999999999999999999999999999999999998766
Q ss_pred cC-ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 155 EN-QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 155 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.. ........|..|.|||.+.+.. .+++..||||+||++.||+++++.|.+..
T Consensus 172 ip~~~yt~evvTlWYRaPEvLlGs~----~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s 225 (323)
T KOG0594|consen 172 IPMRTYTPEVVTLWYRAPEVLLGST----SYSTSVDIWSLGCIFAEMFTRRPLFPGDS 225 (323)
T ss_pred CCcccccccEEEeeccCHHHhcCCC----cCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence 33 3345566788899999998886 38999999999999999999999997644
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=262.59 Aligned_cols=193 Identities=26% Similarity=0.481 Sum_probs=168.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++++..++..||+|.+.... .....+.+.+|++.+++++||||+++++++.+++..++||||++
T Consensus 12 ~lg~G~~---g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (331)
T cd06649 12 ELGAGNG---GVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (331)
T ss_pred eecCCCC---EEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence 3788888 899999999999999999997643 24455778999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK-HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~-~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
+++|.+++..... +++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++++|||++...... ...
T Consensus 87 ~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 160 (331)
T cd06649 87 GGSLDQVLKEAKR-----IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN 160 (331)
T ss_pred CCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-ccc
Confidence 9999999876443 48999999999999999999986 5999999999999999999999999998765432 223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
...++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...
T Consensus 161 ~~~g~~~y~aPE~~~~~~-----~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 161 SFVGTRSYMSPERLQGTH-----YSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred cCCCCcCcCCHhHhcCCC-----CCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 346788999999987654 788999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=284.08 Aligned_cols=231 Identities=24% Similarity=0.378 Sum_probs=196.2
Q ss_pred cCCCCccCeeeEEEEEec-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKK-----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
||+|.| |+||+++-- .+...||||.++..+ +.....+|++|++++..|+|||||+++++|.+++..++|+
T Consensus 494 LGegaF---GkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 494 LGEGAF---GKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred hcCchh---hhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 788888 899999865 356789999998765 3446789999999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccccc---------cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecc
Q psy7592 78 DLLLGGDLRYHITQDIKFY---------SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFN 148 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~ 148 (246)
||+..|+|.+++....... +.+++..+.+.++.||+.+++||-++.+||+||...|+|+.++-.+||+|||
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfG 648 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFG 648 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccc
Confidence 9999999999997654321 2337788899999999999999999999999999999999999999999999
Q ss_pred eeeeeccCccccc---cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC
Q psy7592 149 IATVLEENQLATS---MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS 224 (246)
Q Consensus 149 ~~~~~~~~~~~~~---~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 224 (246)
+++-....+.... ..-..+|||||.|.... +|++|||||+||++||+++ |..||.+..+++. +..+...
T Consensus 649 LsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-----FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV--Ie~i~~g 721 (774)
T KOG1026|consen 649 LSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-----FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV--IECIRAG 721 (774)
T ss_pred cchhhhhhhhhcccCCceeeeecCCHHHhhcCc-----ccchhhhhhhhhhhhhhhccccCcccccchHHH--HHHHHcC
Confidence 9987765544332 23356899999998775 9999999999999999999 9999987766544 3333333
Q ss_pred -CCCCCCCCCHhHHHHHHHhhh
Q psy7592 225 -PVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 225 -~~~~~~~~s~~l~~li~~~l~ 245 (246)
..+-|+++|.++.+|+..||+
T Consensus 722 ~lL~~Pe~CP~~vY~LM~~CW~ 743 (774)
T KOG1026|consen 722 QLLSCPENCPTEVYSLMLECWN 743 (774)
T ss_pred CcccCCCCCCHHHHHHHHHHhh
Confidence 355689999999999999997
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=275.69 Aligned_cols=218 Identities=22% Similarity=0.324 Sum_probs=189.8
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|.. |-||+.+- .++.||||+++.. -..+++-|++|+||||+.+.++|.+..-+|+|||||..
T Consensus 132 lGSGaQ---GAVF~Grl--~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 132 LGSGAQ---GAVFLGRL--HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hccCcc---cceeeeec--cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 789999 89999987 5899999977543 23478889999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSM 162 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 162 (246)
|.|...+...... ....+..|.++|+.++.|||.+.|+|+|||.-|||++.+..+||+|||.++........-.+
T Consensus 197 GqL~~VLka~~~i-----tp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 197 GQLYEVLKAGRPI-----TPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred ccHHHHHhccCcc-----CHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhh
Confidence 9999999876554 77889999999999999999999999999999999999999999999999988777777788
Q ss_pred ccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHHH
Q psy7592 163 SGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242 (246)
Q Consensus 163 ~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~ 242 (246)
.||..|||||+++..+ .+.++||||||||||||+||..||..-+..-..+.....--..+.|..+++.++-||++
T Consensus 272 aGTVaWMAPEvIrneP-----csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kq 346 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEP-----CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQ 346 (904)
T ss_pred hhhHhhhCHHHhhcCC-----cccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHH
Confidence 9999999999999887 89999999999999999999999964443222222222222677889999999999999
Q ss_pred hhh
Q psy7592 243 VHR 245 (246)
Q Consensus 243 ~l~ 245 (246)
||+
T Consensus 347 cw~ 349 (904)
T KOG4721|consen 347 CWN 349 (904)
T ss_pred HHh
Confidence 996
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=259.23 Aligned_cols=196 Identities=26% Similarity=0.397 Sum_probs=163.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |+||+++++.+++.||+|.++.... ......+.+|++.+++++||||+++++++..+...++||||+.
T Consensus 12 ~lg~G~~---g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 12 KLGEGTY---ATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred EEecCCC---EEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 3688888 8999999999999999999875431 1223456789999999999999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+ +|.+++..... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++....... ...
T Consensus 87 ~-~l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 87 S-DLKQYLDNCGN----LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred c-CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence 5 88888765322 34888899999999999999999999999999999999999999999999987653322 223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
...++..|+|||.+.+.. .++.++|+||+|+++|+|++|+.||.+..
T Consensus 162 ~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 162 NEVVTLWYRPPDVLLGST----EYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred CceecccccChHHhcCCc----ccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 345688899999886533 36889999999999999999999997544
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=261.38 Aligned_cols=196 Identities=24% Similarity=0.391 Sum_probs=162.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.++.... ......+.+|+.++++++||||+++++++.++...++||||+.
T Consensus 12 ~lg~G~~---g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 12 KLGEGSY---ATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred eEEecCC---EEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 4788888 9999999999999999999975432 1223456789999999999999999999999999999999994
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-cccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~ 160 (246)
++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++...... ....
T Consensus 87 -~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 87 -TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred -cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 57777765432 23488889999999999999999999999999999999999999999999998754322 2223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
...++..|+|||.+.+.. .++.++|+||||+++|+|++|..||.+..
T Consensus 162 ~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 162 NEVVTLWYRPPDVLLGST----EYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred CCcccCCCCChHHHcCCC----CCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 355688899999886543 36788999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=272.12 Aligned_cols=229 Identities=28% Similarity=0.449 Sum_probs=204.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|.| ++|.++++..++..||||.+.+... +....+.+.+|+++++.|+|||||+++.+...+..+|+||||+.
T Consensus 63 tig~g~f---~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~ 138 (596)
T KOG0586|consen 63 TIGKGNF---AKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYAS 138 (596)
T ss_pred eecccee---EEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEecc
Confidence 4788888 9999999999999999999988764 34445668999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
++.+++++.++++. .+......+.|+..|++|||+.+++|+||+++|++++.+.+++|+|||++..+........
T Consensus 139 ~ge~~~yl~~~gr~-----~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt 213 (596)
T KOG0586|consen 139 GGELFDYLVKHGRM-----KEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQT 213 (596)
T ss_pred CchhHHHHHhcccc-----hhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccc
Confidence 99999999998877 6788999999999999999999999999999999999999999999999999988777888
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
+.+++.|.|||+..+.. ..++++|+||+|+++|.|+.|..||++..-... -.+.+..+..+|-.+|-++.++|+
T Consensus 214 ~cgsppyAaPEl~~g~~----y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L--r~rvl~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 214 FCGSPPYAAPELFNGKK----YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL--RPRVLRGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cCCCCCccChHhhcCcc----cCCcceehhhhhhhheeeeecccccCCcccccc--cchheeeeecccceeechhHHHHH
Confidence 99999999999998876 368899999999999999999999986554332 234566678888889999999999
Q ss_pred Hhhh
Q psy7592 242 QVHR 245 (246)
Q Consensus 242 ~~l~ 245 (246)
++|.
T Consensus 288 k~lv 291 (596)
T KOG0586|consen 288 KFLV 291 (596)
T ss_pred Hhhc
Confidence 9874
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=254.54 Aligned_cols=232 Identities=32% Similarity=0.577 Sum_probs=183.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHH---HHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREME---ILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
+||+|++ |.||++.+..+++.||+|.+...............++.. .+...+||+|+.+++.+..++..++|||
T Consensus 1 ~lg~G~~---g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGF---GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCC---eEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 5899999 899999999999999999997654322222222333433 3344479999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+.+++|.+++..... +++..+..++.|++.|+.+||+.|++|+||+|+||++++++.++++|||++.......
T Consensus 78 ~~~~~~L~~~i~~~~~-----l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 78 LMNGGDLHYHLSQHGV-----FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred cCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 9999999988876543 4999999999999999999999999999999999999999999999999986554322
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh-cCCCCCCCCCCHhHH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII-YSPVHYPTAWSESTK 237 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~l~ 237 (246)
.....++..|+|||...... .++.++|+||+|+++++|++|..||............... .....+|..++++++
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGT----AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELK 227 (279)
T ss_pred ccCcCCCcCccCHHHhcCCC----CCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHH
Confidence 22345788999999875322 2678999999999999999999999754443333333332 335566788999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|++||+.
T Consensus 228 ~li~~~l~~ 236 (279)
T cd05633 228 SLLEGLLQR 236 (279)
T ss_pred HHHHHHhcC
Confidence 999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=273.21 Aligned_cols=233 Identities=25% Similarity=0.353 Sum_probs=190.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC--------eE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE--------DL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~ 73 (246)
.||+|+| |+||++++..+++.||+|.+..... +......+.+|+..+..++|++|+++++.+.... .+
T Consensus 39 ~LG~G~f---G~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i 114 (496)
T PTZ00283 39 VLGSGAT---GTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMI 114 (496)
T ss_pred EEecCCC---EEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEE
Confidence 4788888 8999999999999999999976543 3344567888999999999999999988775332 36
Q ss_pred EEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 74 FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
++||||+.+++|.+.+..... ...++++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||+++..
T Consensus 115 ~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~ 193 (496)
T PTZ00283 115 ALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY 193 (496)
T ss_pred EEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeec
Confidence 899999999999998865432 2345689999999999999999999999999999999999999999999999998765
Q ss_pred ccC---ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCC
Q psy7592 154 EEN---QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYP 229 (246)
Q Consensus 154 ~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~ 229 (246)
... .......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+... ......+... ..++|
T Consensus 194 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~s~k~DVwSlGvilyeLltG~~Pf~~~~~--~~~~~~~~~~~~~~~~ 266 (496)
T PTZ00283 194 AATVSDDVGRTFCGTPYYVAPEIWRRKP-----YSKKADMFSLGVLLYELLTLKRPFDGENM--EEVMHKTLAGRYDPLP 266 (496)
T ss_pred cccccccccccccCCcceeCHHHhCCCC-----CCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhcCCCCCCC
Confidence 432 2223456888999999997664 78899999999999999999999975432 2223333332 45578
Q ss_pred CCCCHhHHHHHHHhhhC
Q psy7592 230 TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 ~~~s~~l~~li~~~l~~ 246 (246)
..++++++++|.+||+.
T Consensus 267 ~~~~~~l~~li~~~L~~ 283 (496)
T PTZ00283 267 PSISPEMQEIVTALLSS 283 (496)
T ss_pred CCCCHHHHHHHHHHccc
Confidence 89999999999999963
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=269.73 Aligned_cols=227 Identities=26% Similarity=0.375 Sum_probs=175.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC--------CeE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE--------EDL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~ 73 (246)
.||+|+| |+||++.+..+++.||+|++.... ....+|+.++++++||||+++++++... ..+
T Consensus 73 ~LG~G~f---g~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 73 IIGNGSF---GVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred EEEeCCC---EEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 3788888 899999999999999999886542 2234699999999999999998876432 246
Q ss_pred EEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-CeEEeecceeee
Q psy7592 74 FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG-HAHITDFNIATV 152 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~-~~~l~d~~~~~~ 152 (246)
++||||++ +++.+.+..... ....+++..++.++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||+++.
T Consensus 143 ~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 143 NVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 78999996 467666543211 133468999999999999999999999999999999999998665 699999999987
Q ss_pred eccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc---C-----
Q psy7592 153 LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY---S----- 224 (246)
Q Consensus 153 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~----- 224 (246)
...........+++.|+|||.+.+.. .++.++|+||||+++|+|++|.+||.+..... ....+.. .
T Consensus 221 ~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 221 LLAGQRSVSYICSRFYRAPELMLGAT----NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQVLGTPTEDQ 294 (440)
T ss_pred ccCCCCcccCCCCcCccCHHHhcCCC----CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHH
Confidence 65544444566788999999986543 37889999999999999999999997644322 1111111 0
Q ss_pred ---------C------------CCCCCCCCHhHHHHHHHhhhC
Q psy7592 225 ---------P------------VHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 225 ---------~------------~~~~~~~s~~l~~li~~~l~~ 246 (246)
. ..+|...|+++++||++||++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~ 337 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKY 337 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCC
Confidence 0 113445789999999999974
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=251.08 Aligned_cols=236 Identities=24% Similarity=0.364 Sum_probs=190.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |.||+++++.+++.||+|.+......+.+....+.+|++.++.++||||+++++++.+.+..++++||++
T Consensus 9 ~l~~g~~---~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08228 9 KIGRGQF---SEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELAD 85 (267)
T ss_pred eeccCCC---eeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecC
Confidence 3688888 8999999999999999999876554455666778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-AT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 160 (246)
+++|.+.+..... ....+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||.+........ ..
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 164 (267)
T cd08228 86 AGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164 (267)
T ss_pred CCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHh
Confidence 9999988864322 123458889999999999999999999999999999999999999999999999877644322 12
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCC-CCCCCHhHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHY-PTAWSESTKH 238 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~-~~~~s~~l~~ 238 (246)
...++..|+|||.+.+.. ++.++|+||+|+++++|++|..||.............+... ..+. +..++..+++
T Consensus 165 ~~~~~~~~~aPE~~~~~~-----~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 165 SLVGTPYYMSPERIHENG-----YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred cCCCCccccChhhhccCC-----CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 345677899999887654 67899999999999999999999965443333333332222 2222 2357899999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|.+||+.
T Consensus 240 li~~cl~~ 247 (267)
T cd08228 240 LVSMCIYP 247 (267)
T ss_pred HHHHHCCC
Confidence 99999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=250.03 Aligned_cols=236 Identities=27% Similarity=0.393 Sum_probs=191.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |.||++.+..+|+.||+|.++.....+....+.+.+|++.+++++|++++++++++.++...+++|||++
T Consensus 9 ~lg~g~~---~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (267)
T cd08224 9 KIGKGQF---SVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELAD 85 (267)
T ss_pred eeccCCc---eEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCC
Confidence 4788888 8999999999999999999976544445556788899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-AT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 160 (246)
+++|..++..... ....+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+........ ..
T Consensus 86 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 164 (267)
T cd08224 86 AGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164 (267)
T ss_pred CCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccc
Confidence 9999998865321 233468899999999999999999999999999999999999999999999999876544322 22
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCC-CCCHhHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPT-AWSESTKH 238 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~-~~s~~l~~ 238 (246)
...++..|.|||.+.+.. ++.++|+||||+++++|++|+.||................. ..+.|. .++..+++
T Consensus 165 ~~~~~~~y~apE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08224 165 SLVGTPYYMSPERIHENG-----YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239 (267)
T ss_pred eecCCccccCHHHhccCC-----CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHH
Confidence 345677899999887654 78899999999999999999999965443322222222222 334454 78999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|++||+.
T Consensus 240 ~i~~cl~~ 247 (267)
T cd08224 240 LVSRCINP 247 (267)
T ss_pred HHHHHcCC
Confidence 99999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=280.80 Aligned_cols=236 Identities=22% Similarity=0.328 Sum_probs=187.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++++..+++.||+|+++..........+++.+|++++++++||||+++++++.+++..+++|||++
T Consensus 9 ~LGkGgf---G~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~e 85 (932)
T PRK13184 9 LIGKGGM---GEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIE 85 (932)
T ss_pred EEecCCC---EEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence 4788888 9999999999999999999976544444556778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhcccc------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 82 GGDLRYHITQDIKF------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 82 ~~sL~~~~~~~~~~------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
|++|.+.+...... .....+...+..++.|++.||+|||+.|++||||+|+||+++.++.++++|||++.....
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~ 165 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKL 165 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceeccc
Confidence 99999988642111 112345667889999999999999999999999999999999999999999999876521
Q ss_pred Cc-------------------cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH
Q psy7592 156 NQ-------------------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK 216 (246)
Q Consensus 156 ~~-------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~ 216 (246)
.. ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.........
T Consensus 166 ~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-----~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 166 EEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-----ASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred ccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-----CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 10 011235788999999987665 788999999999999999999999754332222
Q ss_pred HHHhhhcCCCCC--CCCCCHhHHHHHHHhhhC
Q psy7592 217 DVKAIIYSPVHY--PTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 217 ~~~~~~~~~~~~--~~~~s~~l~~li~~~l~~ 246 (246)
.......+... ...+++.+.+++.+||+.
T Consensus 241 -~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~ 271 (932)
T PRK13184 241 -YRDVILSPIEVAPYREIPPFLSQIAMKALAV 271 (932)
T ss_pred -hhhhccChhhccccccCCHHHHHHHHHHccC
Confidence 11222222222 236899999999999863
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=258.52 Aligned_cols=193 Identities=25% Similarity=0.467 Sum_probs=166.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |.||++.++.++..+|+|.+.... .....+++.+|++.+++++||||+++++++.++...++||||+.
T Consensus 12 ~lg~g~~---g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (333)
T cd06650 12 ELGAGNG---GVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (333)
T ss_pred cccCCCC---EEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCC
Confidence 4788888 899999999999999999987653 23445678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK-HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~-~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
+++|.+++..... +++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++++|||++...... ...
T Consensus 87 ~~~L~~~l~~~~~-----~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 160 (333)
T cd06650 87 GGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN 160 (333)
T ss_pred CCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccc
Confidence 9999999876543 38899999999999999999985 7999999999999999999999999988654332 122
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
...++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...
T Consensus 161 ~~~~~~~y~aPE~~~~~~-----~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 161 SFVGTRSYMSPERLQGTH-----YSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred cCCCCccccCHHHhcCCC-----CCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 345788999999987654 788999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=248.88 Aligned_cols=228 Identities=23% Similarity=0.372 Sum_probs=184.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.+.... ..+....+.+|++++++++||||+++++++..+...++||||+.
T Consensus 2 ~lg~g~~---g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 2 RIGRGNF---GEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred ccCcccC---ccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence 4789999 899999999999999999886543 34445778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc-
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT- 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~- 160 (246)
+++|.+++.... ..+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++++|||.+..........
T Consensus 77 ~~~L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 77 GGDFLTFLRTEG----PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred CCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 999999986532 235888999999999999999999999999999999999999999999999987543321111
Q ss_pred --ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc--CCCCCCCCCCHh
Q psy7592 161 --SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY--SPVHYPTAWSES 235 (246)
Q Consensus 161 --~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~ 235 (246)
....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||....... ...... ...+.|..++..
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 224 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGR-----YSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TREAIEQGVRLPCPELCPDA 224 (252)
T ss_pred CCCCCCceeecCchhhcCCC-----CChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HHHHHHcCCCCCCcccCCHH
Confidence 112234699999986654 7889999999999999998 888986433222 222222 245667789999
Q ss_pred HHHHHHHhhhC
Q psy7592 236 TKHLLSQVHRY 246 (246)
Q Consensus 236 l~~li~~~l~~ 246 (246)
+.+++++||+.
T Consensus 225 ~~~li~~~l~~ 235 (252)
T cd05084 225 VYRLMERCWEY 235 (252)
T ss_pred HHHHHHHHcCC
Confidence 99999999963
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=261.68 Aligned_cols=197 Identities=26% Similarity=0.427 Sum_probs=162.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC-----CeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE-----EDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v 76 (246)
.||+|++ |.||+++++.+++.||+|.+.... .......++.+|++++++++||||+++++++... ...++|
T Consensus 7 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv 82 (338)
T cd07859 7 VIGKGSY---GVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 82 (338)
T ss_pred EEeecCC---eEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence 4788888 899999999999999999987532 1223345688999999999999999999988543 348999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
|||+ +++|.+.+..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~e~~-~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 83 FELM-ESDLHQVIKANDD-----LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EecC-CCCHHHHHHhccc-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999 5688888866543 489999999999999999999999999999999999999999999999998764322
Q ss_pred cc----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 157 QL----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 157 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.. .....++..|+|||.+.+.. ..++.++|+||||+++|+|++|+.||.+.+
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccc---cccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 11 12345788999999876521 127889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=250.28 Aligned_cols=236 Identities=25% Similarity=0.383 Sum_probs=190.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||+++++.+++.||+|.+......+......+.+|+++++.++||||+++++++.++...+++||++.
T Consensus 9 ~ig~g~~---g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08229 9 KIGRGQF---SEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 85 (267)
T ss_pred hhcccCC---eEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecC
Confidence 3788888 8999999999999999999876554445556788899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-AT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 160 (246)
+++|.+++..... ....+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++........ ..
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd08229 86 AGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164 (267)
T ss_pred CCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccc
Confidence 9999998864221 123468899999999999999999999999999999999999999999999998876543322 22
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCC-CCCCHhHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYP-TAWSESTKH 238 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-~~~s~~l~~ 238 (246)
...++..|+|||.+.+.. .+.++|+||||+++++|++|..||.+...........+... ..+.+ ..+++.+++
T Consensus 165 ~~~~~~~~~ape~~~~~~-----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 165 SLVGTPYYMSPERIHENG-----YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred cccCCcCccCHHHhcCCC-----ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 345678899999986654 67899999999999999999999965443322323333222 22222 458999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|.+||+.
T Consensus 240 li~~~l~~ 247 (267)
T cd08229 240 LVNMCINP 247 (267)
T ss_pred HHHHhcCC
Confidence 99999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=251.43 Aligned_cols=233 Identities=21% Similarity=0.338 Sum_probs=187.3
Q ss_pred CcCCCCccCeeeEEEEEecCCC-----cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK-----QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |.||++.+...+ ..||+|.++... ..+....+.+|++.+++++||||+++++++.+....+++
T Consensus 12 ~lg~G~~---g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 12 ELGEGAF---GKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cccCccC---CcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 3678888 899999987655 789999987543 344456788999999999999999999999998899999
Q ss_pred EeecCCCChHHHHhhcccccc-----------CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEe
Q psy7592 77 SDLLLGGDLRYHITQDIKFYS-----------VGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHIT 145 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~ 145 (246)
+||+++++|.+++........ ..+++..+..++.|++.|+.+||+.|++|+||+|+||++++++.++++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~ 166 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKIS 166 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEEC
Confidence 999999999999876432111 346788899999999999999999999999999999999999999999
Q ss_pred ecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhh
Q psy7592 146 DFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAI 221 (246)
Q Consensus 146 d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~ 221 (246)
|||++........ .....++..|+|||.+.... ++.++|+||||+++|+|++ |..||.+.... .....+
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~~i 239 (283)
T cd05048 167 DFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-----FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIEMI 239 (283)
T ss_pred CCcceeeccccccccccCCCcccccccCHHHhccCc-----CchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence 9999876543321 12234467799999887654 7889999999999999998 99999754432 222333
Q ss_pred hcC-CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 222 IYS-PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 222 ~~~-~~~~~~~~s~~l~~li~~~l~~ 246 (246)
... ..+.|..+|+++.+++.+||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~l~~~c~~~ 265 (283)
T cd05048 240 RSRQLLPCPEDCPARVYALMIECWNE 265 (283)
T ss_pred HcCCcCCCcccCCHHHHHHHHHHccC
Confidence 222 4456778999999999999963
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=261.38 Aligned_cols=234 Identities=32% Similarity=0.575 Sum_probs=207.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |.||-+.-..||+.||+|++.+.......-..-..+|-.++++++.++||.+-.-|+..+.+|+|+..|.
T Consensus 192 vlGkGGF---GEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMN 268 (591)
T KOG0986|consen 192 VLGKGGF---GEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMN 268 (591)
T ss_pred EEecccc---cceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeec
Confidence 4899999 8999999999999999999988765554444567789999999999999999888999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
||+|..++-+.+. ..+++..+..++.+|+-+|++||.++||+||+||.|||+|+.|.+.|+|+|++..+........
T Consensus 269 GGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~ 345 (591)
T KOG0986|consen 269 GGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRG 345 (591)
T ss_pred CCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcccc
Confidence 9999999977653 4569999999999999999999999999999999999999999999999999999998888888
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS--VKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
+.||.+|||||++.... |+...|-|||||++|+|+.|+.||..+.... .+.-+++.+....+|..+|+++++|
T Consensus 346 rvGT~GYMAPEvl~ne~-----Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl 420 (591)
T KOG0986|consen 346 RVGTVGYMAPEVLQNEV-----YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL 420 (591)
T ss_pred ccCcccccCHHHHcCCc-----ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence 89999999999998776 8999999999999999999999996555333 2344556666888999999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
.+.+|.+
T Consensus 421 c~~LL~K 427 (591)
T KOG0986|consen 421 CEGLLTK 427 (591)
T ss_pred HHHHHcc
Confidence 9999864
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=250.55 Aligned_cols=232 Identities=31% Similarity=0.584 Sum_probs=183.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHH---HHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLRE---MEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
+||+|++ |.||++.+..+++.||+|.+................| ...++...||+|+++++++.+++..++|||
T Consensus 1 ~ig~g~~---g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGF---GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCC---eEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence 4799999 8999999999999999999876543222111222223 344555689999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+.|++|.+++..... +++..++.++.|++.++.|||+.+++|+||+|+||+++.++.++++|||++.......
T Consensus 78 ~~~g~~L~~~l~~~~~-----l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 78 LMNGGDLHYHLSQHGV-----FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred cCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 9999999988865443 4899999999999999999999999999999999999999999999999987553322
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH-HhhhcCCCCCCCCCCHhHH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDV-KAIIYSPVHYPTAWSESTK 237 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~l~ 237 (246)
.....++..|+|||.+.+.. .++.++|+||+|+++++|++|..||........... .........+|..+|..+.
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 227 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGV----AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 227 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCC----CCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHH
Confidence 22345788999999986432 267889999999999999999999976543332222 2233335667778999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||+.
T Consensus 228 ~li~~~l~~ 236 (278)
T cd05606 228 SLLEGLLQR 236 (278)
T ss_pred HHHHHHhhc
Confidence 999999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=262.22 Aligned_cols=234 Identities=21% Similarity=0.327 Sum_probs=183.0
Q ss_pred CcCCCCccCeeeEEEEEe-----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQK-----KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 75 (246)
.||+|+| |+||++++ ..++..||+|.++.... ....+.+.+|+++++.+ +||||+++++++.++...++
T Consensus 42 ~LG~G~f---G~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 42 TLGAGAF---GKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eecCCcc---ceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 4788888 89999974 35677999999975432 23346788999999999 89999999999999999999
Q ss_pred EEeecCCCChHHHHhhcccc------------------------------------------------------------
Q psy7592 76 VSDLLLGGDLRYHITQDIKF------------------------------------------------------------ 95 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~------------------------------------------------------------ 95 (246)
||||+++++|.+++......
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 99999999999998653210
Q ss_pred ----------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc---ccc
Q psy7592 96 ----------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA---TSM 162 (246)
Q Consensus 96 ----------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~ 162 (246)
....+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++++|||++......... ...
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 276 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCC
Confidence 0123577889999999999999999999999999999999999999999999998765433211 112
Q ss_pred ccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHHHH
Q psy7592 163 SGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHLL 240 (246)
Q Consensus 163 ~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~li 240 (246)
..+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||....... .....+... ....|...+.+++++|
T Consensus 277 ~~~~~y~aPE~~~~~~-----~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 277 RLPVKWMAPESIFNCV-----YTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred CCCcceeChhHhcCCC-----CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 2345799999987665 7889999999999999998 888996543322 122222222 3344667789999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
.+||+.
T Consensus 351 ~~cl~~ 356 (375)
T cd05104 351 KSCWDA 356 (375)
T ss_pred HHHccC
Confidence 999963
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=262.23 Aligned_cols=233 Identities=21% Similarity=0.315 Sum_probs=183.0
Q ss_pred CcCCCCccCeeeEEEEEecCC-----CcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT-----KQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 75 (246)
.||+|+| |.||++++..+ +..||+|.++.... .+..+.+.+|+++++.+ +|+||+++++.+......++
T Consensus 45 ~LG~G~f---g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~l 119 (374)
T cd05106 45 TLGAGAF---GKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLV 119 (374)
T ss_pred eecCCCc---ccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEE
Confidence 4788888 89999986543 45799999976542 33456788999999999 89999999999999999999
Q ss_pred EEeecCCCChHHHHhhcccc------------------------------------------------------------
Q psy7592 76 VSDLLLGGDLRYHITQDIKF------------------------------------------------------------ 95 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~------------------------------------------------------------ 95 (246)
||||+++++|.+++......
T Consensus 120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (374)
T cd05106 120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD 199 (374)
T ss_pred eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence 99999999999988643210
Q ss_pred -----ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc---cccccCCC
Q psy7592 96 -----YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA---TSMSGTKP 167 (246)
Q Consensus 96 -----~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~ 167 (246)
...++++..+..++.|++.||.|||+.|++|+||+|+||++++++.++++|||++......... ....++..
T Consensus 200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~ 279 (374)
T cd05106 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279 (374)
T ss_pred hhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccc
Confidence 0123677889999999999999999999999999999999999999999999998765432211 11223457
Q ss_pred ccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC--CCCCCCCCCHhHHHHHHHhh
Q psy7592 168 YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSESTKHLLSQVH 244 (246)
Q Consensus 168 ~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~l~~li~~~l 244 (246)
|+|||.+.... ++.++|+||||+++|+|++ |..||....... ........ ....|...+++++++|..||
T Consensus 280 y~aPE~~~~~~-----~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 280 WMAPESIFDCV-----YTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKMVKRGYQMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred eeCHHHhcCCC-----CCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence 99999986654 7889999999999999997 999997544322 22222222 44456678999999999999
Q ss_pred hC
Q psy7592 245 RY 246 (246)
Q Consensus 245 ~~ 246 (246)
+.
T Consensus 353 ~~ 354 (374)
T cd05106 353 NL 354 (374)
T ss_pred CC
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=249.26 Aligned_cols=232 Identities=28% Similarity=0.451 Sum_probs=187.7
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|++ |.||++.+..++..+++|.+.... ....+.+.+|++.++.++|||++++++++..+...++++||+++
T Consensus 13 lg~g~~---g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 13 LGDGAF---GKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred cccCCC---eEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677777 899999999999999999986543 34467788899999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-cccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~ 161 (246)
++|...+.+. ..++++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||++....... ....
T Consensus 87 ~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 87 GAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence 9998877542 2245889999999999999999999999999999999999999999999999986643321 2233
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCCCCCCHhHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPTAWSESTKH 238 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~l~~ 238 (246)
..++..|+|||.+.........++.++|+||+|+++|+|++|+.||.... .......+... ....|..++.++++
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--HHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 45778899999986443333347789999999999999999999997543 22222233222 33346678999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|.+||+.
T Consensus 241 li~~~l~~ 248 (282)
T cd06643 241 FLKKCLEK 248 (282)
T ss_pred HHHHHccC
Confidence 99999963
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=248.53 Aligned_cols=230 Identities=26% Similarity=0.423 Sum_probs=188.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccch------HHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIE------RDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 75 (246)
.||+|++ |.||++.+..+++.||+|.+....... ....+.+.+|+.++++++||||+++++++.++...++
T Consensus 7 ~ig~g~~---~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 7 LIGSGSF---GSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred eeecCCC---eEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 4678877 899999999999999999987644321 2334678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
++||+++++|.+++..... +++..+..++.|++.++++||+.|++|+||+|+||+++.++.++++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 84 FLEYVPGGSVAALLNNYGA-----FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEecCCCCHHHHHHhccC-----ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 9999999999999976543 38888999999999999999999999999999999999999999999999876642
Q ss_pred Ccc-------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCC
Q psy7592 156 NQL-------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVH 227 (246)
Q Consensus 156 ~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~ 227 (246)
... .....++..|+|||.+.+.. ++.++|+||||+++++|++|+.||..... ......+... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-----~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~ 231 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTS-----YTRKADIWSLGCLVVEMLTGKHPFPDCTQ--LQAIFKIGENASPE 231 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCC-----CCchhhhHHHHHHHHHHhhCCCCCCCccH--HHHHHHHhccCCCc
Confidence 211 11234677899999887654 67899999999999999999999975432 2222332222 455
Q ss_pred CCCCCCHhHHHHHHHhhhC
Q psy7592 228 YPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 228 ~~~~~s~~l~~li~~~l~~ 246 (246)
.|..+++.++++|++||+.
T Consensus 232 ~~~~~~~~~~~li~~~l~~ 250 (267)
T cd06628 232 IPSNISSEAIDFLEKTFEI 250 (267)
T ss_pred CCcccCHHHHHHHHHHccC
Confidence 6778999999999999963
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=254.30 Aligned_cols=232 Identities=34% Similarity=0.587 Sum_probs=191.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |+||++.+..+++.||+|.+...........+.+.+|++.++.++|+||+++++.+.++...+++|||+.
T Consensus 8 ~ig~g~~---g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (316)
T cd05574 8 LLGKGDV---GRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCP 84 (316)
T ss_pred eecCCcc---EEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence 3688888 8999999999999999999987665444566788999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc---
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--- 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--- 158 (246)
+++|.+++.... ...+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++++|||++........
T Consensus 85 ~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 85 GGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred CCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 999999886532 23458899999999999999999999999999999999999999999999998765432110
Q ss_pred ---------------------------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 159 ---------------------------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 159 ---------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-----~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-----HGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-----CCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11234677899999987654 7889999999999999999999997543
Q ss_pred CccHHHHHhhhcCCCCCCCC--CCHhHHHHHHHhhhC
Q psy7592 212 NTSVKDVKAIIYSPVHYPTA--WSESTKHLLSQVHRY 246 (246)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~--~s~~l~~li~~~l~~ 246 (246)
. ......+......+|.. .++.++++|++||+.
T Consensus 237 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 271 (316)
T cd05574 237 R--DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVK 271 (316)
T ss_pred h--HHHHHHHhcCCccCCCccccCHHHHHHHHHHccC
Confidence 3 33344455555555544 699999999999963
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=286.48 Aligned_cols=233 Identities=33% Similarity=0.569 Sum_probs=200.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|.| |.|.+|+++.|++.||+|.+++-.-..+..-..|..|-+++..-+.+.|++++-.|+++.++|+||||++
T Consensus 82 vIGrGaF---GEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~p 158 (1317)
T KOG0612|consen 82 VIGRGAF---GEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMP 158 (1317)
T ss_pred Hhccccc---ceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEeccc
Confidence 4899999 8999999999999999999987433333344678999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-- 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (246)
||+|-..+.+... +|++-++.++..+..||..+|+.|+|||||||+|||++..|.++++|||.+-.+...+..
T Consensus 159 GGDlltLlSk~~~-----~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s 233 (1317)
T KOG0612|consen 159 GGDLLTLLSKFDR-----LPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRS 233 (1317)
T ss_pred CchHHHHHhhcCC-----ChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEe
Confidence 9999999987653 499999999999999999999999999999999999999999999999999888755443
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCC--CCCCHh
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYP--TAWSES 235 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~--~~~s~~ 235 (246)
....|||-|.+||++.........|++.+|.||+|+++|+|+.|..||.... -..-+..|... ...|| ..+|+.
T Consensus 234 ~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--lveTY~KIm~hk~~l~FP~~~~VSee 311 (1317)
T KOG0612|consen 234 SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--LVETYGKIMNHKESLSFPDETDVSEE 311 (1317)
T ss_pred ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--HHHHHHHHhchhhhcCCCcccccCHH
Confidence 3367999999999998776655679999999999999999999999996433 23334444444 67777 469999
Q ss_pred HHHHHHHhh
Q psy7592 236 TKHLLSQVH 244 (246)
Q Consensus 236 l~~li~~~l 244 (246)
.++||..++
T Consensus 312 akdLI~~ll 320 (1317)
T KOG0612|consen 312 AKDLIEALL 320 (1317)
T ss_pred HHHHHHHHh
Confidence 999999886
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=262.75 Aligned_cols=184 Identities=23% Similarity=0.276 Sum_probs=157.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||+|++..+++.||+|.... ..+.+|++++++++||||+++++++..+...++++|++
T Consensus 99 ~lg~G~~---g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~- 165 (391)
T PHA03212 99 TFTPGAE---GFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY- 165 (391)
T ss_pred EEcCCCC---eEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-
Confidence 3677887 9999999999999999996432 34678999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC--ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN--QLA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~--~~~ 159 (246)
+++|..++..... +++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 166 ~~~L~~~l~~~~~-----l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 166 KTDLYCYLAAKRN-----IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240 (391)
T ss_pred CCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence 5678887765433 488999999999999999999999999999999999999999999999998653221 122
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFD 208 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~ 208 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.
T Consensus 241 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 241 YGWAGTIATNAPELLARDP-----YGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred ccccCccCCCChhhhcCCC-----CCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 3356889999999987654 7889999999999999999998763
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=245.64 Aligned_cols=230 Identities=27% Similarity=0.429 Sum_probs=190.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.++.+++.|++|.+...... ......+.+|++.+++++||||+++++++.+++..+++|||++
T Consensus 7 ~l~~g~~---~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 7 KIGKGSF---GVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred EecCCCC---eEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 3678877 89999999999999999998764432 3445678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-AT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 160 (246)
+++|.+++.... ...++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++........ ..
T Consensus 83 ~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 83 NGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred CCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 999999987641 23458889999999999999999999999999999999999999999999999877654322 22
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~l 239 (246)
...++..|+|||...... ++.++|+||||+++++|++|+.||.... .......+... ..+.+..++.++.++
T Consensus 160 ~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd08529 160 TIVGTPYYLSPELCEDKP-----YNEKSDVWALGVVLYECCTGKHPFDANN--QGALILKIIRGVFPPVSQMYSQQLAQL 232 (256)
T ss_pred ccccCccccCHHHhcCCC-----CCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCCccccCHHHHHH
Confidence 345678899999987654 6789999999999999999999996544 22223333333 445566889999999
Q ss_pred HHHhhh
Q psy7592 240 LSQVHR 245 (246)
Q Consensus 240 i~~~l~ 245 (246)
|.+||+
T Consensus 233 i~~~l~ 238 (256)
T cd08529 233 IDQCLT 238 (256)
T ss_pred HHHHcc
Confidence 999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=248.76 Aligned_cols=229 Identities=17% Similarity=0.263 Sum_probs=182.9
Q ss_pred CcCCCCccCeeeEEEEEec---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKK---DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|+| |.||++.++ ..+..||+|.++... +......+.+|+..+++++||||+++++++..+...++|||
T Consensus 12 ~ig~G~f---g~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 86 (266)
T cd05064 12 ILGTGRF---GELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE 86 (266)
T ss_pred eecccCC---CeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEE
Confidence 4789999 899999765 456789999987653 23445678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+++++|.+++.... ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 87 ~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 87 YMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred eCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence 999999999886532 2358899999999999999999999999999999999999999999999997655322211
Q ss_pred cc--ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCH
Q psy7592 159 AT--SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSE 234 (246)
Q Consensus 159 ~~--~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~ 234 (246)
.. ...++..|+|||.+.+.. ++.++|+||||+++|++++ |..||..... ......+... ..+.|..++.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 235 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHH-----FSSASDVWSFGIVMWEVMSYGERPYWDMSG--QDVIKAVEDGFRLPAPRNCPN 235 (266)
T ss_pred hcccCCCCceeecCHHHHhhCC-----ccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHHCCCCCCCCCCCCH
Confidence 11 122346799999887654 7889999999999999775 9999964332 2223333322 4456778999
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.+.+++..||+.
T Consensus 236 ~~~~li~~c~~~ 247 (266)
T cd05064 236 LLHQLMLDCWQK 247 (266)
T ss_pred HHHHHHHHHcCC
Confidence 999999999963
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=246.00 Aligned_cols=230 Identities=27% Similarity=0.460 Sum_probs=189.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |.||++.++.+++.||+|.++... .....+.+.+|+..++.++|+||+++++.+.+++..++++||++
T Consensus 7 ~lg~g~~---g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 7 VVGEGSF---GRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred EeeccCC---eEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 4678888 899999999999999999987543 23345678889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-AT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 160 (246)
+++|.+++.... ...+++..+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||.+........ ..
T Consensus 82 ~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 82 GGDLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 999998876422 22358889999999999999999999999999999999999999999999999876644322 23
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~l 239 (246)
...++..|+|||.+.+.. ++.++|+||||+++++|++|..||...+. ......+... ..+.|..++..++++
T Consensus 159 ~~~~~~~~~aPE~~~~~~-----~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (255)
T cd08219 159 TYVGTPYYVPPEIWENMP-----YNNKSDIWSLGCILYELCTLKHPFQANSW--KNLILKVCQGSYKPLPSHYSYELRSL 231 (255)
T ss_pred cccCCccccCHHHHccCC-----cCchhhhhhhchhheehhhccCCCCCCCH--HHHHHHHhcCCCCCCCcccCHHHHHH
Confidence 345778899999987654 78899999999999999999999974332 2222233222 445677899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|.+||+.
T Consensus 232 i~~~l~~ 238 (255)
T cd08219 232 IKQMFKR 238 (255)
T ss_pred HHHHHhC
Confidence 9999973
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=266.53 Aligned_cols=228 Identities=23% Similarity=0.347 Sum_probs=188.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|.| |+||++++ --.||||.++... .+++.++.|.+|+..+++-+|.||+-+.++|..... .+|+.+|+
T Consensus 399 rIGsGsF---GtV~Rg~w---hGdVAVK~Lnv~~-pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCe 470 (678)
T KOG0193|consen 399 RIGSGSF---GTVYRGRW---HGDVAVKLLNVDD-PTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCE 470 (678)
T ss_pred eeccccc---cceeeccc---ccceEEEEEecCC-CCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhcc
Confidence 3789999 99999987 5568999998766 455688999999999999999999999999987766 89999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC---cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN---QL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~---~~ 158 (246)
|.+|+.++.... ..+...+.+.|+.|++.++.|||..+|+|+|||.+|||+.+++.++|+|||++....-. ..
T Consensus 471 GsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q 546 (678)
T KOG0193|consen 471 GSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQ 546 (678)
T ss_pred Cchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccc
Confidence 999999997643 33588899999999999999999999999999999999999999999999998664322 23
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC------CCC
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP------TAW 232 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~ 232 (246)
.....+...|+|||+++-+ +..++++.+||||||+|+|||++|..||.....+. +.-++....-.| .++
T Consensus 547 ~~qp~gsilwmAPEvIRmq--d~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq---IifmVGrG~l~pd~s~~~s~~ 621 (678)
T KOG0193|consen 547 LEQPHGSLLWMAPEVIRMQ--DDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ---IIFMVGRGYLMPDLSKIRSNC 621 (678)
T ss_pred cCCCccchhhhcHHHHhhc--ccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh---eEEEecccccCccchhhhccC
Confidence 3445678889999999844 36679999999999999999999999998444332 333333332222 356
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
+.++++|+..||.|
T Consensus 622 pk~mk~Ll~~C~~~ 635 (678)
T KOG0193|consen 622 PKAMKRLLSDCWKF 635 (678)
T ss_pred HHHHHHHHHHHHhc
Confidence 77999999999975
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=247.32 Aligned_cols=229 Identities=22% Similarity=0.388 Sum_probs=186.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC--CeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQ--CIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE--EDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~ 77 (246)
.||+|++ |.||++++..+++.||+|.+.... .........+.+|++.+++++|+||+++++++.+. ..+++++
T Consensus 9 ~lg~g~~---g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (264)
T cd06653 9 LLGRGAF---GEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV 85 (264)
T ss_pred eEccCCC---eEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence 4788888 899999999999999999886432 12334567888999999999999999999998754 4688999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN- 156 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~- 156 (246)
||+++++|.+.+..... +++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++......
T Consensus 86 e~~~~~~L~~~~~~~~~-----l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 86 EYMPGGSIKDQLKAYGA-----LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EeCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 99999999999876443 388889999999999999999999999999999999999999999999998765321
Q ss_pred ---ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCCC
Q psy7592 157 ---QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTA 231 (246)
Q Consensus 157 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 231 (246)
.......++..|+|||.+.+.. .+.++|+||||++++++++|+.||.... ......++... ...+|..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~p~~ 233 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEG-----YGRKADVWSVACTVVEMLTEKPPWAEYE--AMAAIFKIATQPTKPMLPDG 233 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCC-----CCccccHHHHHHHHHHHHhCCCCCCccC--HHHHHHHHHcCCCCCCCCcc
Confidence 1112345678899999987654 6789999999999999999999996432 23333333322 4556888
Q ss_pred CCHhHHHHHHHhhh
Q psy7592 232 WSESTKHLLSQVHR 245 (246)
Q Consensus 232 ~s~~l~~li~~~l~ 245 (246)
+++.++++|++||+
T Consensus 234 ~~~~~~~~i~~~l~ 247 (264)
T cd06653 234 VSDACRDFLKQIFV 247 (264)
T ss_pred cCHHHHHHHHHHhc
Confidence 99999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=260.39 Aligned_cols=196 Identities=29% Similarity=0.438 Sum_probs=164.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC-----eEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE-----DLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~~v 76 (246)
.||+|++ |+||++.+..+++.||+|.+.... .+....+.+.+|+++++.++||||+++++++.... ..++|
T Consensus 7 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 7 PIGYGAF---GVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred eeeeCCC---EEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 4788888 999999999999999999986532 22334567889999999999999999999998776 78999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
+||+. ++|.+.+..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~e~~~-~~l~~~~~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 83 TELMQ-SDLHKIIVSPQP-----LSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred eeccc-cCHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 99995 577777755433 489999999999999999999999999999999999999999999999998765432
Q ss_pred c--cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 157 Q--LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 157 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
. ......++..|+|||.+.+.. .++.++|+||+|+++++|++|+.||.+.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSR----HYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCC----CCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 2 122345678899999987643 26789999999999999999999997644
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=246.08 Aligned_cols=228 Identities=21% Similarity=0.357 Sum_probs=182.1
Q ss_pred CcCCCCccCeeeEEEEEe--cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQK--KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|++ |.||++.. +.++..||+|.+.... .+....+.+.+|+.+++.++||||+++++++.. ...+++|||
T Consensus 2 ~lg~G~~---g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNF---GTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMEL 76 (257)
T ss_pred cCCCcCC---cceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEec
Confidence 3788888 89999864 4678999999986543 234456778899999999999999999998764 467899999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (246)
+.+++|.+++..... +++..+..++.|++.++++||+.|++|+||+|+||+++.++.++++|||.+.........
T Consensus 77 ~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 77 AELGPLNKFLQKNKH-----VTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 999999999875433 488999999999999999999999999999999999999999999999998765433211
Q ss_pred ----cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCC
Q psy7592 160 ----TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWS 233 (246)
Q Consensus 160 ----~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s 233 (246)
....++..|+|||.+.... ++.++|+||||+++|+|++ |..||...... .....+... ..+.|..++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~~~~~~~~~~ 224 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYK-----FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGERMECPQRCP 224 (257)
T ss_pred eeecCCCCCCccccCHhHhccCC-----cCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCCCCCCCCCCC
Confidence 1122346899999886543 6789999999999999998 99999754332 222222222 455677899
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
++++++|.+||+.
T Consensus 225 ~~l~~li~~~~~~ 237 (257)
T cd05116 225 PEMYDLMKLCWTY 237 (257)
T ss_pred HHHHHHHHHHhcc
Confidence 9999999999963
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=266.29 Aligned_cols=205 Identities=25% Similarity=0.359 Sum_probs=175.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-C-----CcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-H-----PFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~~~ 75 (246)
+||+|+| |.|-+|.+.+|++.||||+++.. .+...+...|+.+|..|+ | -|+|+++++|.-.++.|+
T Consensus 193 ~LGkGtF---GQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 193 VLGKGSF---GQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred Eeccccc---ceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 5899999 99999999999999999999876 456678888999999996 3 499999999999999999
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC--CeEEeecceeeee
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG--HAHITDFNIATVL 153 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~--~~~l~d~~~~~~~ 153 (246)
|+|.+ +.+|.++++.+.. .+++...++.++.||+.||.+||+.||+|+||||+|||+.+.+ .+||+|||.+...
T Consensus 266 VfELL-~~NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 8899999988753 3578999999999999999999999999999999999997544 7999999999865
Q ss_pred ccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCC
Q psy7592 154 EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPV 226 (246)
Q Consensus 154 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (246)
...- ....-++.|.|||++.+.+ ++.+.|||||||++.||++|.+.|.+.+. ..++..|++-..
T Consensus 342 ~q~v--ytYiQSRfYRAPEVILGlp-----Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne--~DQl~~I~e~lG 405 (586)
T KOG0667|consen 342 SQRV--YTYIQSRFYRAPEVILGLP-----YDTAIDMWSLGCILAELFTGEPLFPGDNE--YDQLARIIEVLG 405 (586)
T ss_pred CCcc--eeeeeccccccchhhccCC-----CCCccceeehhhhHHhHhcCccccCCCCH--HHHHHHHHHHhC
Confidence 4432 2566788999999999997 99999999999999999999999975443 334444444433
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=248.44 Aligned_cols=231 Identities=27% Similarity=0.452 Sum_probs=188.0
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||.|++ |+||++.+..+++.||+|.+.... ....+.+.+|++++++++||||+++++.+.++...++||||+++
T Consensus 13 l~~g~~---~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 13 LGDGAF---GKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred hcCCCC---ceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 677887 899999999899999999987543 44557788999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-cccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~ 161 (246)
++|.+++.... .++++..++.++.|++.++.|||+.|++|+||+|+||+++.++.++++|||.+....... ....
T Consensus 87 ~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (280)
T cd06611 87 GALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162 (280)
T ss_pred CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence 99999886532 235899999999999999999999999999999999999999999999999876543322 2223
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCCCCCCHhHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPTAWSESTKH 238 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~l~~ 238 (246)
..++..|+|||.+.........++.++|+||||+++|+|++|..||..... ......+... ....|..++.++.+
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--MRVLLKILKSEPPTLDQPSKWSSSFND 240 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--HHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence 456788999999864433333467899999999999999999999975432 2223333332 22335679999999
Q ss_pred HHHHhhh
Q psy7592 239 LLSQVHR 245 (246)
Q Consensus 239 li~~~l~ 245 (246)
+|..||+
T Consensus 241 li~~~l~ 247 (280)
T cd06611 241 FLKSCLV 247 (280)
T ss_pred HHHHHhc
Confidence 9999996
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=258.08 Aligned_cols=193 Identities=25% Similarity=0.376 Sum_probs=161.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC------eEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE------DLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~~ 75 (246)
.||+|++ |.||++.+..+|+.||+|.+.... .+......+.+|+.+++.++||||+++++++.... ..++
T Consensus 28 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 103 (359)
T cd07876 28 PIGSGAQ---GIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL 103 (359)
T ss_pred EeecCCC---EEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEE
Confidence 3788888 899999999999999999997543 23344567778999999999999999999986443 4799
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||||+.+ +|...+.. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 104 v~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 104 VMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred EEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 9999954 56555532 237888999999999999999999999999999999999999999999999876544
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
........++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+
T Consensus 176 ~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 176 NFMMTPYVVTRYYRAPEVILGMG-----YKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred CccCCCCcccCCCCCchhccCCC-----CCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 33334456788999999997664 7889999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=267.46 Aligned_cols=231 Identities=26% Similarity=0.390 Sum_probs=194.9
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||.|+| |-||-|+++.+.+.||||++..+--.+.+...++..|+++|++++|||++.+.+|+-.+...|+||||| -
T Consensus 34 IGHGSF---GAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-l 109 (948)
T KOG0577|consen 34 IGHGSF---GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-L 109 (948)
T ss_pred hcCCcc---ceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-h
Confidence 688888 899999999999999999987655455666789999999999999999999999999888899999999 5
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSM 162 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 162 (246)
||-.+.+.- .++|+-+.+|..|..+.+.+|.|||+.+.+|+|||..|||+++.|.+|++|||.+....+ ...+
T Consensus 110 GSAsDlleV----hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---AnsF 182 (948)
T KOG0577|consen 110 GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---ANSF 182 (948)
T ss_pred ccHHHHHHH----HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hhcc
Confidence 677777754 345678899999999999999999999999999999999999999999999999876555 4578
Q ss_pred ccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHHH
Q psy7592 163 SGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242 (246)
Q Consensus 163 ~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~ 242 (246)
.||+.|+|||++...... .|+-++||||||+...++...++|...-+.++.-+..+-...+.-..+.||+.++++|..
T Consensus 183 vGTPywMAPEVILAMDEG--qYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEG--QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 260 (948)
T ss_pred cCCccccchhHheecccc--ccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence 899999999999765422 488899999999999999999999865444443333333333333346799999999999
Q ss_pred hhhC
Q psy7592 243 VHRY 246 (246)
Q Consensus 243 ~l~~ 246 (246)
||++
T Consensus 261 CLqK 264 (948)
T KOG0577|consen 261 CLQK 264 (948)
T ss_pred HHhh
Confidence 9985
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=246.19 Aligned_cols=227 Identities=19% Similarity=0.316 Sum_probs=185.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.++.+++.||+|.+.... .....+.+|++.+++++||||+++++++..+...+++|||++
T Consensus 13 ~ig~g~~---~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 13 KLGGGQY---GEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred ecCCccc---ceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 3788888 899999999999999999987543 234678889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc-
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT- 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~- 160 (246)
+++|.+++.... ...++...+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||.+..........
T Consensus 86 ~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 86 YGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred CCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 999999986532 2235888899999999999999999999999999999999999999999999987654432211
Q ss_pred -ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 161 -SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 161 -~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+... ......+... ....|..++..+.
T Consensus 163 ~~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNK-----FSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKGYRMERPEGCPPKVY 235 (263)
T ss_pred CCCCCccccCCHHHhccCC-----CCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCCCCCCCCCCHHHH
Confidence 122345799999886654 7889999999999999998 8999975433 2222333322 5566788999999
Q ss_pred HHHHHhhh
Q psy7592 238 HLLSQVHR 245 (246)
Q Consensus 238 ~li~~~l~ 245 (246)
++|++||+
T Consensus 236 ~li~~cl~ 243 (263)
T cd05052 236 ELMRACWQ 243 (263)
T ss_pred HHHHHHcc
Confidence 99999996
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=245.97 Aligned_cols=232 Identities=23% Similarity=0.348 Sum_probs=191.2
Q ss_pred CcCCCCccCeeeEEEEEecCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT---KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |.||++.+... +..|++|.+....... ..+.+.+|++.++.++|+|++++++++..+...+++||
T Consensus 2 ~ig~g~~---g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 2 KLGEGAF---GEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred ccccCCc---eEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 5889999 89999999876 9999999997765322 46788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhcccc----ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec
Q psy7592 79 LLLGGDLRYHITQDIKF----YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~ 154 (246)
|+++++|.+++...... ....+++..++.++.|++.|+.+||+.|++|+||+|+||++++++.++++|||.+....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999998764110 12346999999999999999999999999999999999999999999999999998765
Q ss_pred cCc---cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhh-cCCCCCC
Q psy7592 155 ENQ---LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAII-YSPVHYP 229 (246)
Q Consensus 155 ~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 229 (246)
... ......++..|+|||.+.... ++.++|+||||+++++|++ |..||..... ......+. ......|
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~ 229 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGI-----FTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRKGYRLPKP 229 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCC-----cchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCCCCC
Confidence 432 122344567899999887653 7889999999999999999 6999975432 22233333 2355667
Q ss_pred CCCCHhHHHHHHHhhh
Q psy7592 230 TAWSESTKHLLSQVHR 245 (246)
Q Consensus 230 ~~~s~~l~~li~~~l~ 245 (246)
..+|+++.+++.+||+
T Consensus 230 ~~~~~~~~~li~~~l~ 245 (262)
T cd00192 230 EYCPDELYELMLSCWQ 245 (262)
T ss_pred ccCChHHHHHHHHHcc
Confidence 8899999999999996
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=248.01 Aligned_cols=233 Identities=28% Similarity=0.452 Sum_probs=187.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |.||++.++.+++.|++|.+.... .+..+.+.+|+..++.++||||+++++++..+...++||||++
T Consensus 19 ~lg~g~~---g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 19 ELGDGAF---GKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred eecCCCC---eEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 3677777 899999999999999999987643 4556778889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-cccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~ 160 (246)
+++|...+.+.. ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+...... ....
T Consensus 93 ~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 93 GGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred CCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 999988775422 23588999999999999999999999999999999999999999999999987654322 1223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCCCCCCHhHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPTAWSESTK 237 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~l~ 237 (246)
...++..|+|||.+.+.......++.++|+||||+++|+|++|..||.... .......+... ....|..++.++.
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSEPPTLSQPSKWSMEFR 246 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc--HHHHHHHHhcCCCccCCCCcccCHHHH
Confidence 345677899999986543333346789999999999999999999996533 22222333222 2233567899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|++||++
T Consensus 247 ~li~~~l~~ 255 (292)
T cd06644 247 DFLKTALDK 255 (292)
T ss_pred HHHHHHhcC
Confidence 999999963
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=250.54 Aligned_cols=235 Identities=21% Similarity=0.366 Sum_probs=180.7
Q ss_pred CcCCCCccCeeeEEEEEecC----------------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD----------------TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWF 65 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~----------------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 65 (246)
.||+|+| |.||+|.+.. ++..||+|.+.... +......+.+|++.+.+++||||+++++
T Consensus 12 ~lg~G~f---g~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~ 86 (304)
T cd05096 12 KLGEGQF---GEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNIIRLLG 86 (304)
T ss_pred EecccCC---eEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 3788888 9999998642 34579999987653 2344567889999999999999999999
Q ss_pred eeeeCCeEEEEEeecCCCChHHHHhhcccc--------------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCC
Q psy7592 66 CFQDEEDLFMVSDLLLGGDLRYHITQDIKF--------------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131 (246)
Q Consensus 66 ~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~--------------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~ 131 (246)
++.+....+++|||+.+++|.+++...... ....++...+..++.|++.|+.|||+.|++|+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp 166 (304)
T cd05096 87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLAT 166 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcch
Confidence 999999999999999999999988653211 012356678899999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh--CCCC
Q psy7592 132 DNILLDEEGHAHITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA--RGRP 206 (246)
Q Consensus 132 ~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~--g~~p 206 (246)
+||+++.++.++++|||++........ .....++..|+|||.+.... ++.++|+||||+++|+|++ +..|
T Consensus 167 ~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-----FTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred hheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-----CCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999876543321 11233467899999987654 7889999999999999987 5567
Q ss_pred CCCCCCccHH-HHHhhhc-----CCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 207 FDIHSNTSVK-DVKAIIY-----SPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 207 ~~~~~~~~~~-~~~~~~~-----~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
|......... ....... .....|+.++..+.++|.+||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 287 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSR 287 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccC
Confidence 7643322211 1111111 12234567899999999999963
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=250.40 Aligned_cols=230 Identities=33% Similarity=0.575 Sum_probs=186.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.+..+++.||+|.+...........+.+.+|+++++.++||||+++++.+..+...+++|||++
T Consensus 8 ~l~~g~~---~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (305)
T cd05609 8 LISNGAY---GAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVE 84 (305)
T ss_pred EeecCCC---eeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 3677777 8999999999999999999987654344456778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc----
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---- 157 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 157 (246)
|++|.+++..... +++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++++|||.++......
T Consensus 85 g~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 85 GGDCATLLKNIGA-----LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 9999999876543 4889999999999999999999999999999999999999999999999876321000
Q ss_pred ------------cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCC
Q psy7592 158 ------------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSP 225 (246)
Q Consensus 158 ------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 225 (246)
......++..|+|||.+.... ++.++|+||||+++|++++|..||.+... ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~vl~el~~g~~pf~~~~~--~~~~~~~~~~~ 232 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-----YGKPVDWWAMGIILYEFLVGCVPFFGDTP--EELFGQVISDD 232 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcc
Confidence 001134567899999987654 78899999999999999999999964332 23333333333
Q ss_pred CCCC---CCCCHhHHHHHHHhhhC
Q psy7592 226 VHYP---TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 226 ~~~~---~~~s~~l~~li~~~l~~ 246 (246)
...| ..++++++++|++||+.
T Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~ 256 (305)
T cd05609 233 IEWPEGDEALPADAQDLISRLLRQ 256 (305)
T ss_pred cCCCCccccCCHHHHHHHHHHhcc
Confidence 2333 35899999999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=244.61 Aligned_cols=230 Identities=28% Similarity=0.462 Sum_probs=190.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC--IERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|++ |+||++.++.+++.|++|.+..... ...+..+.+.+|+..++.++|+||+++++++.++...++++||
T Consensus 7 ~ig~g~~---~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 7 LLGSGSF---GSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred eeeecCC---ceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 4788888 8999999998999999999875432 2344567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (246)
+++++|.+++.+... +++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+.........
T Consensus 84 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 84 VPGGSLAKLLKKYGS-----FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred cCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccc
Confidence 999999999876433 488889999999999999999999999999999999999999999999998776544433
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh--cCCCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII--YSPVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~l~ 237 (246)
....++..|++||.+.... .++.++|+||||++++++++|+.||.... ......... .....+|..+++.++
T Consensus 159 ~~~~~~~~y~~pe~~~~~~----~~~~~~D~~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQG----GYGLAADIWSLGCTVLEMATGKPPWSQLE--GVAAVFKIGRSKELPPIPDHLSDEAK 232 (258)
T ss_pred cccCCCcceeCHHHhcCCC----CCCchhhhHHHHHHHHHHHhCCCCcccCc--HHHHHHHHHhcccCCCcCCCcCHHHH
Confidence 4456778899999875432 26788999999999999999999996544 222222222 234556778999999
Q ss_pred HHHHHhhh
Q psy7592 238 HLLSQVHR 245 (246)
Q Consensus 238 ~li~~~l~ 245 (246)
+++++||+
T Consensus 233 ~li~~~l~ 240 (258)
T cd06632 233 DFILKCLQ 240 (258)
T ss_pred HHHHHHhh
Confidence 99999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=246.39 Aligned_cols=228 Identities=34% Similarity=0.622 Sum_probs=190.5
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||.|++ |.||++.+..+++.|++|.+...........+.+.+|++.+++++||||+++++.+..+...++++|++.+
T Consensus 1 lg~g~~---~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAY---GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCc---eEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence 578888 89999999999999999999776554455677889999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-----
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ----- 157 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~----- 157 (246)
++|.+++.+... +++..+..++.|++.+|.+||+.|++|+||+|+||++++++.++++|||++.......
T Consensus 78 ~~L~~~l~~~~~-----~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 78 GDLASLLENVGS-----LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred CcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 999999876443 4899999999999999999999999999999999999999999999999887643321
Q ss_pred ----cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCC-
Q psy7592 158 ----LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAW- 232 (246)
Q Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 232 (246)
......++..|++||...... .+.++|+||||++++++++|..||..... ......+......+|...
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~-----~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 225 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQG-----HSKTVDWWSLGCILYEFLVGIPPFHGETP--EEIFQNILNGKIEWPEDVE 225 (265)
T ss_pred cccccccCcccCccccCHHHhcCCC-----CCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcCCcCCCcccc
Confidence 112234667899999887654 67899999999999999999999965442 233344444455566555
Q ss_pred -CHhHHHHHHHhhh
Q psy7592 233 -SESTKHLLSQVHR 245 (246)
Q Consensus 233 -s~~l~~li~~~l~ 245 (246)
++.+.++|.+||+
T Consensus 226 ~~~~~~~~i~~~l~ 239 (265)
T cd05579 226 VSDEAIDLISKLLV 239 (265)
T ss_pred CCHHHHHHHHHHhc
Confidence 9999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=251.68 Aligned_cols=232 Identities=24% Similarity=0.341 Sum_probs=180.9
Q ss_pred cCCCCccCeeeEEEEEecCCCcE--EEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEee
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQM--YAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
||+|++ |+||+|.+..++.. +|+|.+... .+....+.+.+|++.+.++ +|+||+++++++..++..+++|||
T Consensus 15 lg~G~~---g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 15 IGEGNF---GQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred ecCCCC---ceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 688888 89999999877765 466666532 2344557788899999999 899999999999999999999999
Q ss_pred cCCCChHHHHhhcccc-----------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecc
Q psy7592 80 LLGGDLRYHITQDIKF-----------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFN 148 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~ 148 (246)
+++++|.+++...... ....+++..++.++.|++.|+++||+.|++|+||+|+||+++.++.++++|||
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg 169 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 169 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccc
Confidence 9999999998754321 11246888999999999999999999999999999999999999999999999
Q ss_pred eeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CC
Q psy7592 149 IATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PV 226 (246)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~ 226 (246)
++..............+..|+|||.+.+.. ++.++|+||||+++++|++ |..||...... ......... ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~~ 242 (303)
T cd05088 170 LSRGQEVYVKKTMGRLPVRWMAIESLNYSV-----YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQGYRL 242 (303)
T ss_pred cCcccchhhhcccCCCcccccCHHHHhccC-----CcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHHHhcCCcC
Confidence 886432211111122345799999886554 6789999999999999998 99999644332 222222222 33
Q ss_pred CCCCCCCHhHHHHHHHhhhC
Q psy7592 227 HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ~~~~~~s~~l~~li~~~l~~ 246 (246)
..|...++++.++|.+||+.
T Consensus 243 ~~~~~~~~~~~~li~~~l~~ 262 (303)
T cd05088 243 EKPLNCDDEVYDLMRQCWRE 262 (303)
T ss_pred CCCCCCCHHHHHHHHHHcCC
Confidence 45567899999999999964
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=251.20 Aligned_cols=230 Identities=28% Similarity=0.409 Sum_probs=175.2
Q ss_pred CcCCCCccCeeeEEEEEecC-CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC---CCCcceeeeeeee-----eCCe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD-TKQMYAMKYMHKSQCIERDALKNVLREMEILTTL---EHPFLVNLWFCFQ-----DEED 72 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~~~~ 72 (246)
.||+|++ |+||+|++.. +++.||+|.++.....+ .......+|+..++.+ +||||+++++++. ....
T Consensus 8 ~lg~G~~---g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~ 83 (290)
T cd07862 8 EIGEGAY---GKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 83 (290)
T ss_pred EeccCCC---eEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCc
Confidence 3788888 9999999864 57889999987644222 1223445566666655 6999999999885 2456
Q ss_pred EEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 73 ~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
.+++||++. ++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++..
T Consensus 84 ~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 84 LTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred EEEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 899999995 68888886532 22358899999999999999999999999999999999999999999999999987
Q ss_pred eccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-----CC-
Q psy7592 153 LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-----PV- 226 (246)
Q Consensus 153 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~- 226 (246)
...........++..|+|||.+.+.. ++.++|+||||+++|+|++|.+||.+.... .....+... ..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DiwslG~il~el~~g~~~f~~~~~~--~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSS-----YATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGEED 232 (290)
T ss_pred ccCCcccccccccccccChHHHhCCC-----CCCccchHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhh
Confidence 65443344456788999999987654 788999999999999999999999754322 222222111 00
Q ss_pred ---------------------CCCCCCCHhHHHHHHHhhhC
Q psy7592 227 ---------------------HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ---------------------~~~~~~s~~l~~li~~~l~~ 246 (246)
.+.+.+++.++++|.+||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 273 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 273 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhcc
Confidence 01135788999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=264.22 Aligned_cols=230 Identities=24% Similarity=0.380 Sum_probs=191.0
Q ss_pred CcCCCCccCeeeEEEEEecCCC----cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK----QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||+|.| |.||+++.+..+ ..||+|..+.+...+.+.+..+.+|++++++++|||||++|+++.++..+++||
T Consensus 164 kLGeGaF---GeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 164 KLGEGAF---GEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred eeecccc---cEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 4789999 899999988542 238999998755567788899999999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
|++.||+|.+++.+.+. .++..+...++.+.+.+++|||+.+++||||...|+|++.++.+||+|||++..-....
T Consensus 241 El~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred EecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 99999999999988754 24889999999999999999999999999999999999999999999999976543111
Q ss_pred ccc-ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc--CCCCCCCCCC
Q psy7592 158 LAT-SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY--SPVHYPTAWS 233 (246)
Q Consensus 158 ~~~-~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~s 233 (246)
... ...-...|+|||.+.... +++++||||||+++||+.+ |..||.+...... ...+.. .+.+.|...+
T Consensus 317 ~~~~~~klPirWLAPEtl~~~~-----~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v--~~kI~~~~~r~~~~~~~p 389 (474)
T KOG0194|consen 317 MKKFLKKLPIRWLAPETLNTGI-----FSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV--KAKIVKNGYRMPIPSKTP 389 (474)
T ss_pred eccccccCcceecChhhhccCc-----cccccchhheeeeEEeeeccCCCCCCCCCHHHH--HHHHHhcCccCCCCCCCH
Confidence 111 112245799999998775 8999999999999999999 8889976544332 333323 3566677899
Q ss_pred HhHHHHHHHhhh
Q psy7592 234 ESTKHLLSQVHR 245 (246)
Q Consensus 234 ~~l~~li~~~l~ 245 (246)
.++..++++|+.
T Consensus 390 ~~~~~~~~~c~~ 401 (474)
T KOG0194|consen 390 KELAKVMKQCWK 401 (474)
T ss_pred HHHHHHHHHhcc
Confidence 999999999985
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=247.62 Aligned_cols=233 Identities=21% Similarity=0.322 Sum_probs=186.8
Q ss_pred CcCCCCccCeeeEEEEEec-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK-----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||.|++ |.||++.+. .+++.||+|.+..... .+..+.+.+|++.+++++|+||+++++++..+...+++
T Consensus 12 ~lg~g~~---~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 86 (280)
T cd05049 12 ELGEGAF---GKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMV 86 (280)
T ss_pred hccccCC---ceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEE
Confidence 4788888 899999875 3468899999876542 33457889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccc---------cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeec
Q psy7592 77 SDLLLGGDLRYHITQDIK---------FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDF 147 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~---------~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~ 147 (246)
|||+++++|.+++..... .....+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++||
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~ 166 (280)
T cd05049 87 FEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDF 166 (280)
T ss_pred EecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCc
Confidence 999999999999976532 11234688889999999999999999999999999999999999999999999
Q ss_pred ceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc
Q psy7592 148 NIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY 223 (246)
Q Consensus 148 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~ 223 (246)
|++........ ......+..|+|||.+.+.. +++++|+||||+++|+|++ |..||...... .....+..
T Consensus 167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~~~~ 239 (280)
T cd05049 167 GMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-----FTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIECITQ 239 (280)
T ss_pred ccceecccCcceecCCCCcccceecChhhhccCC-----cchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc
Confidence 99876433221 11223456799999987665 7889999999999999998 99999654432 22333333
Q ss_pred C-CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 224 S-PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 224 ~-~~~~~~~~s~~l~~li~~~l~~ 246 (246)
. ....|..++..++++|.+||+.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~~l~~ 263 (280)
T cd05049 240 GRLLQRPRTCPSEVYDIMLGCWKR 263 (280)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCC
Confidence 3 3344567999999999999963
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=245.92 Aligned_cols=229 Identities=23% Similarity=0.384 Sum_probs=184.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC--CeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQ--CIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE--EDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~ 77 (246)
+||+|++ |.||.+.+..+++.||+|.+.... .......+.+.+|++.+++++||||+++++++.+. ..++++|
T Consensus 9 ~l~~g~~---g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 9 LLGQGAF---GRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EEecCCc---eEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 4788888 899999999999999999986432 12234567888999999999999999999998763 4688999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||+++++|.+++..... +++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 86 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 86 EHMPGGSIKDQLKSYGA-----LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EecCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 99999999999876443 3788889999999999999999999999999999999999999999999887653211
Q ss_pred ----cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCCC
Q psy7592 158 ----LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTA 231 (246)
Q Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 231 (246)
......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.... ........... ....|..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEG-----YGRKADIWSVGCTVVEMLTEKPPWAEFE--AMAAIFKIATQPTNPVLPPH 233 (265)
T ss_pred ccccccccCCCCccccChhhhcCCC-----CCcchhHHHHHHHHHHHhhCCCCCCccc--hHHHHHHHhcCCCCCCCchh
Confidence 122234677899999987654 7889999999999999999999996432 22223333322 3445667
Q ss_pred CCHhHHHHHHHhhh
Q psy7592 232 WSESTKHLLSQVHR 245 (246)
Q Consensus 232 ~s~~l~~li~~~l~ 245 (246)
.+..+.++|.+|+.
T Consensus 234 ~~~~~~~~i~~~l~ 247 (265)
T cd06652 234 VSDHCRDFLKRIFV 247 (265)
T ss_pred hCHHHHHHHHHHhc
Confidence 89999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=244.94 Aligned_cols=230 Identities=23% Similarity=0.356 Sum_probs=183.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++++..+++.||+|.++... ......+.+|+..++.++||||+++++++..+...++++||++
T Consensus 16 ~lg~g~~---~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 16 RIGSGTY---GDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HhCCCCC---eEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 3688888 899999999999999999987653 2234567789999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|.+++..... +++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 90 ~~~L~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 90 GGSLQDIYHVTGP-----LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164 (267)
T ss_pred CCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence 9999999876544 4899999999999999999999999999999999999999999999999987654322 223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCC--CCCCCHh
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHY--PTAWSES 235 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~--~~~~s~~ 235 (246)
...++..|+|||.+.... ...++.++|+||||+++|+|++|..||....... ........ .... ...+++.
T Consensus 165 ~~~~~~~y~aPE~~~~~~--~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 165 SFIGTPYWMAPEVAAVER--KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccCcccccChhhhcccc--CCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHhhhccCCCCCcccccCCCCHH
Confidence 346788999999874221 1126789999999999999999999985433221 11111111 1111 1257899
Q ss_pred HHHHHHHhhhC
Q psy7592 236 TKHLLSQVHRY 246 (246)
Q Consensus 236 l~~li~~~l~~ 246 (246)
++++|.+||++
T Consensus 241 ~~~li~~~l~~ 251 (267)
T cd06645 241 FHHFVKMALTK 251 (267)
T ss_pred HHHHHHHHccC
Confidence 99999999963
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=276.34 Aligned_cols=235 Identities=23% Similarity=0.391 Sum_probs=185.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee--CCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD--EEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~ 79 (246)
.||.|+| |+||+|.++.++..||+|.+..... .......+..|+.++++++||||++++++|.+ ...+|+||||
T Consensus 20 kLG~GgF---GtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY 95 (1021)
T PTZ00266 20 KIGNGRF---GEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEF 95 (1021)
T ss_pred EEecCCC---eEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeC
Confidence 4788888 9999999999999999999876543 23445778899999999999999999998864 4568999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC-------CcccCCCCCCcEEEcC--------------
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK-------HIIHRDIKPDNILLDE-------------- 138 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~-------~~~h~~i~~~nil~~~-------------- 138 (246)
+.+++|.+++..... ....+++..++.++.||+.||.|||+. +|+|+||+|+|||++.
T Consensus 96 ~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n 174 (1021)
T PTZ00266 96 CDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174 (1021)
T ss_pred CCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccc
Confidence 999999999875322 123469999999999999999999985 4999999999999964
Q ss_pred ---CCCeEEeecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH
Q psy7592 139 ---EGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV 215 (246)
Q Consensus 139 ---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~ 215 (246)
.+.++|+|||++.............+++.|+|||.+.+... .++.++|||||||++|+|++|..||.... ..
T Consensus 175 ~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~---~~s~KSDVWSLG~ILYELLTGk~PF~~~~--~~ 249 (1021)
T PTZ00266 175 LNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETK---SYDDKSDMWALGCIIYELCSGKTPFHKAN--NF 249 (1021)
T ss_pred cCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCC---CCCchhHHHHHHHHHHHHHHCCCCCCcCC--cH
Confidence 23489999999877654433344568899999999864321 26789999999999999999999996433 22
Q ss_pred HHHHhhhcCCCCCC-CCCCHhHHHHHHHhhhC
Q psy7592 216 KDVKAIIYSPVHYP-TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 216 ~~~~~~~~~~~~~~-~~~s~~l~~li~~~l~~ 246 (246)
......+...+.+| ..++.++.+||..||++
T Consensus 250 ~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~ 281 (1021)
T PTZ00266 250 SQLISELKRGPDLPIKGKSKELNILIKNLLNL 281 (1021)
T ss_pred HHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcC
Confidence 23333333333343 46899999999999974
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=244.47 Aligned_cols=233 Identities=28% Similarity=0.447 Sum_probs=196.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
+||+|.| +.|-.+....+|..||||++.+.. .....+..+|++.+.+.+ |+||++++++|+++..+|+|||-+
T Consensus 85 ~LGeGAy---asVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm 158 (463)
T KOG0607|consen 85 LLGEGAY---ASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM 158 (463)
T ss_pred HhcCccc---eeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence 5899999 889899999999999999999875 455678889999999995 999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC---CeEEeecceeeeeccCc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG---HAHITDFNIATVLEENQ 157 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~---~~~l~d~~~~~~~~~~~ 157 (246)
.||+|..++.+.... .+.++..+.+.|+.||.+||..||.|+|+||+|||-.... -+|||||.+...+...+
T Consensus 159 ~GGplLshI~~~~~F-----~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 159 RGGPLLSHIQKRKHF-----NEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred cCchHHHHHHHhhhc-----cHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 999999999887655 9999999999999999999999999999999999997655 47999999987654322
Q ss_pred c--------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-------------HH
Q psy7592 158 L--------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS-------------VK 216 (246)
Q Consensus 158 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~-------------~~ 216 (246)
. .....|+..|||||+...-...-..|+.++|.||||+++|-|++|.+||.+.-..+ ..
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~ 313 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK 313 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence 1 22345788899999976555555568889999999999999999999997654332 23
Q ss_pred HHHhhhcCCCCCCCC----CCHhHHHHHHHhhh
Q psy7592 217 DVKAIIYSPVHYPTA----WSESTKHLLSQVHR 245 (246)
Q Consensus 217 ~~~~~~~~~~~~~~~----~s~~l~~li~~~l~ 245 (246)
.+..|.+...+||.. +|.+.+++|+.+|.
T Consensus 314 LFesIQEGkYeFPdkdWahIS~eakdlisnLlv 346 (463)
T KOG0607|consen 314 LFESIQEGKYEFPDKDWAHISSEAKDLISNLLV 346 (463)
T ss_pred HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHh
Confidence 445566669999963 69999999999874
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=256.40 Aligned_cols=230 Identities=37% Similarity=0.635 Sum_probs=207.0
Q ss_pred CCcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEee
Q psy7592 1 MFCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 1 ~~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
|.||+|+| |.|.++..+.+.+.||||+++++.....+.++.-+.|-++|.-. +-|.+++++.+|+.-+++|+||||
T Consensus 355 ~VlGKGSF---GKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEy 431 (683)
T KOG0696|consen 355 MVLGKGSF---GKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEY 431 (683)
T ss_pred EEeccCcc---ceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEE
Confidence 56899999 89999999999999999999998877777778888888888766 578999999999999999999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec-cCcc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE-ENQL 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~-~~~~ 158 (246)
+.||+|-.++++-++. .++.+..++..|+.+|-+||++||++|||+.+|++++.+|.++|.|||+++.-- ....
T Consensus 432 vnGGDLMyhiQQ~GkF-----KEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 432 VNGGDLMYHIQQVGKF-----KEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT 506 (683)
T ss_pred ecCchhhhHHHHhccc-----CCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcc
Confidence 9999999999988776 888899999999999999999999999999999999999999999999998743 2334
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKH 238 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ 238 (246)
...+.|++-|+|||++..++ |+..+|.||+|+++|||+.|++||++++ +.+..+.|.+....+|..+|.+..+
T Consensus 507 TkTFCGTPdYiAPEIi~YqP-----YgksvDWWa~GVLLyEmlaGQpPFdGeD--E~elF~aI~ehnvsyPKslSkEAv~ 579 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQP-----YGKSVDWWAFGVLLYEMLAGQPPFDGED--EDELFQAIMEHNVSYPKSLSKEAVA 579 (683)
T ss_pred eeeecCCCcccccceEEecc-----cccchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHccCcCcccccHHHHH
Confidence 55688999999999999887 8899999999999999999999998655 4466788898999999999999999
Q ss_pred HHHHhhh
Q psy7592 239 LLSQVHR 245 (246)
Q Consensus 239 li~~~l~ 245 (246)
+++..|-
T Consensus 580 ickg~lt 586 (683)
T KOG0696|consen 580 ICKGLLT 586 (683)
T ss_pred HHHHHhh
Confidence 9998874
|
|
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=239.17 Aligned_cols=231 Identities=24% Similarity=0.409 Sum_probs=189.8
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
||+|+- |+|++++...+|...|||.++... +.+..+++...+++..+-. +|+||+.+++|..+..+++.||.|
T Consensus 100 lGsGtc---G~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM- 173 (391)
T KOG0983|consen 100 LGSGTC---GQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM- 173 (391)
T ss_pred hcCCCc---cceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence 455555 999999999999999999998875 4555677777888777764 999999999999998899999988
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
+..+...+.. ...++|+..+-.+...+.+||.||.+ +|++|||+||+|||+++.|++|+||||.+.++-+.....
T Consensus 174 s~C~ekLlkr----ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht 249 (391)
T KOG0983|consen 174 STCAEKLLKR----IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT 249 (391)
T ss_pred HHHHHHHHHH----hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence 4444444433 34567999999999999999999975 579999999999999999999999999999988877777
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCC--CCCHhHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPT--AWSESTK 237 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~--~~s~~l~ 237 (246)
...|.+.|+|||.+.-.. ..+|+.++||||||+.++++.||+.||.+.+.+-. ....+.++ ++.+|. .+|++++
T Consensus 250 rsAGC~~YMaPERidp~~--~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-~ltkvln~ePP~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPD--KPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-VLTKVLNEEPPLLPGHMGFSPDFQ 326 (391)
T ss_pred cccCCccccCccccCCCC--CCccchhhhhhhhccchhhhhcccCCCCCCCccHH-HHHHHHhcCCCCCCcccCcCHHHH
Confidence 778999999999886543 44589999999999999999999999987665443 34444444 555554 4899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++++.||++
T Consensus 327 ~fv~~CL~k 335 (391)
T KOG0983|consen 327 SFVKDCLTK 335 (391)
T ss_pred HHHHHHhhc
Confidence 999999974
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=251.02 Aligned_cols=229 Identities=28% Similarity=0.432 Sum_probs=182.6
Q ss_pred CcCCCCccCeeeEEEEEec----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||.|.| |.||++... ..+..|+||.++... +.+..+.+.+|++.+++++||||+++++++......++|+
T Consensus 6 ~ig~G~f---g~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 6 QIGEGSF---GKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEESS---EEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEccCCC---cEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeecccccccccccccccccccccccccccccc
Confidence 4788888 899999998 567889999995532 3445788999999999999999999999999888899999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||+++++|.+++... ....++...+..++.|++.|+.|||+.+++|++|+++||+++.++.+|++|||++.......
T Consensus 81 e~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999875 12235889999999999999999999999999999999999999999999999987763221
Q ss_pred c---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCC
Q psy7592 158 L---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAW 232 (246)
Q Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (246)
. .........|+|||.+.... ++.++||||||+++|++++ |+.||..... ......+... ..+.|..+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~-----~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGE-----YTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKLKQGQRLPIPDNC 230 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSE-----ESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHHHTTEETTSBTTS
T ss_pred cccccccccccccccccccccccc-----cccccccccccccccccccccccccccccc--ccccccccccccceeccch
Confidence 1 12233566799999987775 7889999999999999999 6789865433 2223333333 45567789
Q ss_pred CHhHHHHHHHhhh
Q psy7592 233 SESTKHLLSQVHR 245 (246)
Q Consensus 233 s~~l~~li~~~l~ 245 (246)
+..+.++|.+||+
T Consensus 231 ~~~~~~li~~C~~ 243 (259)
T PF07714_consen 231 PKDIYSLIQQCWS 243 (259)
T ss_dssp BHHHHHHHHHHT-
T ss_pred hHHHHHHHHHHcC
Confidence 9999999999996
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=246.37 Aligned_cols=230 Identities=23% Similarity=0.317 Sum_probs=182.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||+++++.+++.||+|++.... ......+.+|+..+++++||||+++++++..+...++||||++
T Consensus 16 ~lg~g~~---g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 16 RVGSGTY---GDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred eeecCCC---eEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 3677888 899999999999999999997543 2223567789999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|.+++..... +++..+..++.|++.++.+||+.|++|+|++|+||+++.++.++++|||++....... ...
T Consensus 90 ~~~L~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 90 GGSLQDIYHVTGP-----LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred CCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 9999998865433 4889999999999999999999999999999999999999999999999988764322 223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCC-----CCCCCCCCHh
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSP-----VHYPTAWSES 235 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~ 235 (246)
...++..|+|||.+.... ...++.++|+||+|+++++|++|+.||....... ....+.... ...+..+|..
T Consensus 165 ~~~~~~~y~~PE~~~~~~--~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEK--NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred ccccCccccCHhHccccc--CCCCcchhhHHHHHHHHHHHHhCCCCccccchhh--hheeeecCCCCCCCCccccccCHH
Confidence 345778899999875322 1126778999999999999999999985433211 111111111 1112357999
Q ss_pred HHHHHHHhhhC
Q psy7592 236 TKHLLSQVHRY 246 (246)
Q Consensus 236 l~~li~~~l~~ 246 (246)
+.++|+.||+.
T Consensus 241 ~~~li~~~l~~ 251 (267)
T cd06646 241 FHNFVKISLTK 251 (267)
T ss_pred HHHHHHHHhhC
Confidence 99999999963
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=291.04 Aligned_cols=233 Identities=28% Similarity=0.394 Sum_probs=202.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+||.|.| |.||.+.+.++|+.-|+|.++..... ........+|..++..++|||+|++|++=...+..++.||||+
T Consensus 1242 ~Ig~G~f---G~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1242 FIGGGTF---GKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCE 1317 (1509)
T ss_pred ccCCcce---eeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhc
Confidence 7899999 99999999999999999999876643 4445778889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc----
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---- 157 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 157 (246)
+|+|.+.+....-. ++.....+..|++.++.|||++||||+||||.||+++.+|.+|+.|||.+....++.
T Consensus 1318 ~GsLa~ll~~gri~-----dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1318 GGSLASLLEHGRIE-----DEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred cCcHHHHHHhcchh-----hhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 99999999876444 788888899999999999999999999999999999999999999999998876543
Q ss_pred -cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhH
Q psy7592 158 -LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSEST 236 (246)
Q Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l 236 (246)
......||+.|+|||.+.+... +...-+.||||||||+.||+||+.||...+.+-.....--....+.+|..+|.+.
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~--kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKG--KGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEG 1470 (1509)
T ss_pred HHHHhhcCCchhcCchhhccccc--CCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhH
Confidence 2345679999999999987652 2356789999999999999999999987666554444444556888899999999
Q ss_pred HHHHHHhhh
Q psy7592 237 KHLLSQVHR 245 (246)
Q Consensus 237 ~~li~~~l~ 245 (246)
+++|..||.
T Consensus 1471 ~dFle~Cl~ 1479 (1509)
T KOG4645|consen 1471 RDFLEHCLE 1479 (1509)
T ss_pred HHHHHHHHh
Confidence 999999995
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=251.90 Aligned_cols=196 Identities=23% Similarity=0.381 Sum_probs=162.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.++.... ......+.+|++.+++++||||+++++++..++..++||||+.
T Consensus 13 ~lg~G~~---g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 13 KLGEGTY---ATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred EecccCC---EEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 3788888 9999999999999999999875432 1223456789999999999999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+ +|.+.+.... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 88 ~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (309)
T cd07872 88 K-DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162 (309)
T ss_pred C-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence 4 7777765432 224788899999999999999999999999999999999999999999999987653322 222
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
...++..|+|||.+.+.. .++.++|+||||+++++|++|+.||...+
T Consensus 163 ~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSS----EYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred cccccccccCCHHHhCCC----CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 345678899999886543 36789999999999999999999997544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=245.57 Aligned_cols=225 Identities=24% Similarity=0.418 Sum_probs=182.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+||+|++ |.||++.+..+++.||+|.+.... +.+..+.+.+|++++++++||||+++++.+......++||||++
T Consensus 8 ~lg~g~~---~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 8 ILGHGNG---GTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred eeccCCC---eEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 4788888 899999999999999999987643 23445678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|..+. .+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++++|||++....... ...
T Consensus 83 ~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-~~~ 152 (279)
T cd06619 83 GGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-AKT 152 (279)
T ss_pred CCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-ccC
Confidence 99986542 13788899999999999999999999999999999999999999999999987654322 233
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHHhhhcC-CCCC-CCCCCH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS-----VKDVKAIIYS-PVHY-PTAWSE 234 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~-----~~~~~~~~~~-~~~~-~~~~s~ 234 (246)
..++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||....... ......+... .... ...+++
T Consensus 153 ~~~~~~y~aPE~~~~~~-----~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (279)
T cd06619 153 YVGTNAYMAPERISGEQ-----YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSE 227 (279)
T ss_pred CCCChhhcCceeecCCC-----CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCH
Confidence 46788999999987654 7889999999999999999999995432211 1112222222 2222 235889
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
+++++|.+||+.
T Consensus 228 ~~~~li~~~l~~ 239 (279)
T cd06619 228 KFVHFITQCMRK 239 (279)
T ss_pred HHHHHHHHHhhC
Confidence 999999999963
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=244.57 Aligned_cols=229 Identities=25% Similarity=0.356 Sum_probs=185.4
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|++ |.||++.+..+++.+++|.+.... .+..+.+.+|++++++++||||+++++++.++...+++|||+.+
T Consensus 11 l~~g~~---~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 11 IGSGTY---GDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred ecCCCc---eEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 678888 899999999999999999997654 23457888999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-cccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~ 161 (246)
++|.+++.... .++++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... ....
T Consensus 85 ~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 85 GSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 99999886541 235899999999999999999999999999999999999999999999999987654332 2233
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-----CCCCCCCCCHhH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-----PVHYPTAWSEST 236 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~l 236 (246)
..++..|+|||.+..... ..++.++|+||||+++++|++|..||........ ....... ....+..++.++
T Consensus 161 ~~~~~~y~~Pe~~~~~~~--~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 161 FIGTPYWMAPEVAAVERK--GGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred ccCCccccCchhhccccc--CCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCCCccccchhhhhHHH
Confidence 456778999999876521 1267899999999999999999999975443222 1222212 111234578999
Q ss_pred HHHHHHhhh
Q psy7592 237 KHLLSQVHR 245 (246)
Q Consensus 237 ~~li~~~l~ 245 (246)
+++|++||.
T Consensus 237 ~~li~~~l~ 245 (262)
T cd06613 237 HDFIKKCLT 245 (262)
T ss_pred HHHHHHHcC
Confidence 999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=241.96 Aligned_cols=228 Identities=39% Similarity=0.709 Sum_probs=196.2
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||.|++ |.||++.+..+++.||+|.++.......+....+.+|++.+++++||||+++++.+..+...+++||++.+
T Consensus 1 lg~G~~---~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSF---GKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCc---eEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence 688888 89999999989999999999887655555677889999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-cccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~ 161 (246)
++|.+++..... +++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+....... ....
T Consensus 78 ~~L~~~l~~~~~-----l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (250)
T cd05123 78 GELFSHLSKEGR-----FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT 152 (250)
T ss_pred CcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccC
Confidence 999999876543 4899999999999999999999999999999999999999999999999987765432 2334
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..++..|.+||...+.. .+.++|+||||++++++++|..||..... ......+.....++|...+..+.++|+
T Consensus 153 ~~~~~~~~~Pe~~~~~~-----~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~i~ 225 (250)
T cd05123 153 FCGTPEYLAPEVLLGKG-----YGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKILKDPLRFPEFLSPEARDLIS 225 (250)
T ss_pred CcCCccccChHHhCCCC-----CCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 55677899999987654 67899999999999999999999964432 344455555677788889999999999
Q ss_pred Hhhh
Q psy7592 242 QVHR 245 (246)
Q Consensus 242 ~~l~ 245 (246)
+||.
T Consensus 226 ~~l~ 229 (250)
T cd05123 226 GLLQ 229 (250)
T ss_pred HHhc
Confidence 9986
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=270.22 Aligned_cols=224 Identities=24% Similarity=0.383 Sum_probs=185.3
Q ss_pred CCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeee-e------CCeEEEE
Q psy7592 5 SSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQ-D------EEDLFMV 76 (246)
Q Consensus 5 ~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~------~~~~~~v 76 (246)
+|+| +.||+|.+...|..||+|++-.. ++..++.+.+|++++++|+ |+|||.+++... . ...+.+.
T Consensus 47 EGGF---a~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL 120 (738)
T KOG1989|consen 47 EGGF---AQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL 120 (738)
T ss_pred cCCc---EEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence 4555 99999999988899999988665 4777899999999999996 999999999322 1 1247889
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCcEEEcCCCCeEEeecceeeeec
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH--IIHRDIKPDNILLDEEGHAHITDFNIATVLE 154 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~--~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~ 154 (246)
||||.|++|-+++.++.. ..+++.+++.|+.|+++|+.+||... ++|||||-+|+|++.+|..||||||.+....
T Consensus 121 mEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred hhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 999999999999986432 23799999999999999999999998 9999999999999999999999999986543
Q ss_pred cCc-cc---------cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC
Q psy7592 155 ENQ-LA---------TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS 224 (246)
Q Consensus 155 ~~~-~~---------~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~ 224 (246)
..- .. -....|+.|+|||.+.-.. ...++.|+|||+|||+||-|+....||+..+. .+|+..
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlys--g~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------laIlng 269 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYS--GLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------LAILNG 269 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhc--CCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------eeEEec
Confidence 211 11 1123678899999986443 33489999999999999999999999976432 467777
Q ss_pred CCCCCC--CCCHhHHHHHHHhhh
Q psy7592 225 PVHYPT--AWSESTKHLLSQVHR 245 (246)
Q Consensus 225 ~~~~~~--~~s~~l~~li~~~l~ 245 (246)
...+|+ .+|..+++||..||+
T Consensus 270 ~Y~~P~~p~ys~~l~~LI~~mL~ 292 (738)
T KOG1989|consen 270 NYSFPPFPNYSDRLKDLIRTMLQ 292 (738)
T ss_pred cccCCCCccHHHHHHHHHHHHhc
Confidence 777765 799999999999996
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=244.82 Aligned_cols=225 Identities=25% Similarity=0.418 Sum_probs=187.1
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||.|++ |.||++.+..+++.||+|.+.... .......+.+|++.+++++|+||+++++++.++...++++|++.+
T Consensus 9 lg~g~~---~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (274)
T cd06609 9 IGKGSF---GEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG 83 (274)
T ss_pred hcCCCC---eEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence 677777 899999999999999999987653 233456788899999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-cccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~ 161 (246)
++|.+++... ++++..+..++.|++.++.+||+.+++|+||+|+|+++++++.++++|||.+....... ....
T Consensus 84 ~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 84 GSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred CcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 9999998653 45899999999999999999999999999999999999999999999999998775442 2334
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCC-CCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTA-WSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~-~s~~l~~l 239 (246)
..++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ......+... ....+.. +++++.++
T Consensus 158 ~~~~~~y~~PE~~~~~~-----~~~~sDv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
T cd06609 158 FVGTPFWMAPEVIKQSG-----YDEKADIWSLGITAIELAKGEPPLSDLHP--MRVLFLIPKNNPPSLEGNKFSKPFKDF 230 (274)
T ss_pred ccCCccccChhhhccCC-----CCchhhHHHHHHHHHHHHhCCCCcccCch--HHHHHHhhhcCCCCCcccccCHHHHHH
Confidence 55677899999987665 78899999999999999999999965432 2222222222 3334444 89999999
Q ss_pred HHHhhh
Q psy7592 240 LSQVHR 245 (246)
Q Consensus 240 i~~~l~ 245 (246)
+.+||+
T Consensus 231 l~~~l~ 236 (274)
T cd06609 231 VSLCLN 236 (274)
T ss_pred HHHHhh
Confidence 999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=247.60 Aligned_cols=236 Identities=23% Similarity=0.451 Sum_probs=188.3
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|++ |.||++.++.+++.||+|.+.... +.....++.+|++.+++++||||+++++.+......++||||+++
T Consensus 9 ig~g~~---g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (286)
T cd06622 9 LGKGNY---GSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83 (286)
T ss_pred hcccCC---eEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence 677877 999999999999999999986542 334457788999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
++|..++.... ....+++..+..++.|++.++.|||+ .|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 84 ~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 160 (286)
T cd06622 84 GSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-AKT 160 (286)
T ss_pred CCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-ccc
Confidence 99988876531 12245899999999999999999997 599999999999999999999999999887653322 222
Q ss_pred cccCCCccCCceeccccc-ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHhhhc-CCCCCCCCCCHhHHH
Q psy7592 162 MSGTKPYIAPEIFLVATD-EVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK-DVKAIIY-SPVHYPTAWSESTKH 238 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~-~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~-~~~~~~~~~s~~l~~ 238 (246)
..++..|+|||.+.+... ....++.++|+||||+++|+|++|+.||......... ....+.. .....|..+++++++
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd06622 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQD 240 (286)
T ss_pred CCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHH
Confidence 346778999999865432 2223578999999999999999999999654332221 2222332 245567789999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|++||+.
T Consensus 241 li~~~l~~ 248 (286)
T cd06622 241 FVAKCLNK 248 (286)
T ss_pred HHHHHccc
Confidence 99999963
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=245.48 Aligned_cols=232 Identities=21% Similarity=0.382 Sum_probs=188.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI---ERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
+||+|++ |.||++.+..+++.||+|.+...... .+...+.+.+|++.+++++|+||+++++++.+....++|+|
T Consensus 7 ~lg~g~~---~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 7 QLGTGAF---SSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred eecCcCc---eEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 4788888 89999999999999999998754321 23346788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-CeEEeecceeeeeccCc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG-HAHITDFNIATVLEENQ 157 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~-~~~l~d~~~~~~~~~~~ 157 (246)
|+.+++|.+++..... +++..++.++.|++.|+.+||+.|++|+||+|+||+++.++ .++++|||.+.......
T Consensus 84 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 84 WMAGGSVSHLLSKYGA-----FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred ccCCCcHHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 9999999999876433 48899999999999999999999999999999999998776 58999999987764321
Q ss_pred c-----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHhhh--cCCCCCC
Q psy7592 158 L-----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS-VKDVKAII--YSPVHYP 229 (246)
Q Consensus 158 ~-----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~--~~~~~~~ 229 (246)
. .....++..|+|||.+.+.. ++.++|+||+|++++++++|..||....... .....+.. ......|
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~-----~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQ-----YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233 (268)
T ss_pred ccCCccccccccccceeCHhHhccCC-----CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCc
Confidence 1 12245677899999987654 6789999999999999999999996544322 22222221 2245566
Q ss_pred CCCCHhHHHHHHHhhhC
Q psy7592 230 TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 ~~~s~~l~~li~~~l~~ 246 (246)
...++++++++.+||+.
T Consensus 234 ~~~~~~~~~~i~~~l~~ 250 (268)
T cd06630 234 EHLSPGLRDVTLRCLEL 250 (268)
T ss_pred hhhCHHHHHHHHHHcCC
Confidence 78899999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=248.37 Aligned_cols=226 Identities=26% Similarity=0.409 Sum_probs=185.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |+||++.+..+++.||+|.+.... ....+.+.+|+..++.++|||++++++++.++...++|+||+.
T Consensus 26 ~lg~g~~---g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 26 KIGQGAS---GTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred EEecCCC---eEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 3677887 899999999999999999987543 2234567889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-AT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 160 (246)
+++|..++... .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++........ ..
T Consensus 100 ~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 100 GGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 99999988643 248899999999999999999999999999999999999999999999998876543322 22
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc---CCCCCCCCCCHhHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY---SPVHYPTAWSESTK 237 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~l~ 237 (246)
...++..|+|||.+.+.. ++.++|+||||+++|++++|..||........ ...+.. .....|..+++.++
T Consensus 174 ~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKA-----YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIATNGTPELQNPEKLSPIFR 246 (296)
T ss_pred CcCCCccccCcchhcCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcCCcccCCcccCCHHHH
Confidence 345677899999987654 67899999999999999999999975443221 222211 13334567899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||+.
T Consensus 247 ~li~~~l~~ 255 (296)
T cd06655 247 DFLNRCLEM 255 (296)
T ss_pred HHHHHHhhc
Confidence 999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=248.99 Aligned_cols=226 Identities=25% Similarity=0.381 Sum_probs=183.9
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||.|++ |.||++.+..+++.||+|.+...... ..+.+.+|+.+++.++|+|++++++.+..+...++||||+++
T Consensus 28 lg~g~~---~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~ 101 (296)
T cd06654 28 IGQGAS---GTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (296)
T ss_pred ecCCCC---eEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence 677888 89999999999999999998765432 236688899999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-ccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-ATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~ 161 (246)
++|.+++... .++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+........ ...
T Consensus 102 ~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 102 GSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred CCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 9999988543 237888999999999999999999999999999999999999999999998876433221 223
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~l~~l 239 (246)
..++..|+|||.+.+.. .+.++|+||||+++|+|++|..||......... ....... ....|..+++.+.++
T Consensus 176 ~~~~~~y~aPE~~~~~~-----~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 176 MVGTPYWMAPEVVTRKA-----YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred ccCCccccCHHHHcCCC-----CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH-HHHhcCCCCCCCCccccCHHHHHH
Confidence 45678899999987654 678999999999999999999999654332211 1111112 223456789999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|.+||++
T Consensus 250 i~~~l~~ 256 (296)
T cd06654 250 LNRCLDM 256 (296)
T ss_pred HHHHCcC
Confidence 9999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=251.36 Aligned_cols=201 Identities=19% Similarity=0.322 Sum_probs=164.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+||+|. +++++||+++++.+|+.||+|.+...... .+..+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 5 ~ig~G~-~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 5 VIGRGF-EDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hccccc-cceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 478883 35589999999999999999999765432 3345678889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc---
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--- 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--- 158 (246)
+++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+++.||+..........
T Consensus 83 ~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999986532 12358899999999999999999999999999999999999999999999876433221110
Q ss_pred -----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 159 -----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 159 -----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
.....++..|+|||.+.+... .++.++|+||||+++++|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQ---GYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccceecccChHHhhcccC---CCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 111234567999999865321 2678999999999999999999999643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=240.66 Aligned_cols=231 Identities=24% Similarity=0.450 Sum_probs=190.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |.|+.+++..+++.+++|.+...... ....+++.+|++.+++++|+||+++++++.++...+++|||++
T Consensus 7 ~ig~g~~---g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 7 VLGKGAF---GEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred EecccCC---ceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 3788888 89999999999999999998765432 3445678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|.+.+.... ...+++..+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||.+....... ...
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 83 GGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred CCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 999999987642 2345889999999999999999999999999999999999999999999999987764433 223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~l 239 (246)
...++..|.|||...+.. .+.++|+||||+++++|++|..||.... .......+... ..+.+..++..+.++
T Consensus 160 ~~~~~~~y~ape~~~~~~-----~~~~~Dv~slG~i~~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd08221 160 TVVGTPYYMSPELCQGVK-----YNFKSDIWALGCVLYELLTLKRTFDATN--PLNLVVKIVQGNYTPVVSVYSSELISL 232 (256)
T ss_pred ccCCCccccCHhhcCCCC-----CCCcchhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCCCCCccccCHHHHHH
Confidence 355788999999987654 6778999999999999999999996533 22333333333 333456789999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|.+||+.
T Consensus 233 i~~~l~~ 239 (256)
T cd08221 233 VHSLLQQ 239 (256)
T ss_pred HHHHccc
Confidence 9999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=249.23 Aligned_cols=193 Identities=24% Similarity=0.456 Sum_probs=166.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.+..++..||+|.+.... ..+...++.+|++.+++++||||+++++++.++...+++|||++
T Consensus 8 ~lg~G~~---g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 8 ELGAGNG---GVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred eccCCCC---eEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 4788888 899999999999999999987543 24455678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
+++|.+++.+... +++..+..++.|++.++.|||+ .+++|+||+|+||+++.++.++++|||++....... ..
T Consensus 83 ~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 156 (308)
T cd06615 83 GGSLDQVLKKAGR-----IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-AN 156 (308)
T ss_pred CCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-cc
Confidence 9999999876543 4889999999999999999997 589999999999999999999999999886543321 22
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
...++..|+|||.+.+.. ++.++|+||||+++++|++|..||...
T Consensus 157 ~~~~~~~~~aPE~~~~~~-----~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 157 SFVGTRSYMSPERLQGTH-----YTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred cCCCCcCccChhHhcCCC-----CCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 345678899999886554 678999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=243.81 Aligned_cols=231 Identities=24% Similarity=0.344 Sum_probs=185.9
Q ss_pred CcCCCCccCeeeEEEEEecC-CCc--EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD-TKQ--MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~-~~~--~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |.||++.+.. .++ .||+|.+...... +..+.+.+|++.+++++||||+++++++.+ ...++++|
T Consensus 2 ~ig~g~~---~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e 75 (257)
T cd05040 2 KLGDGSF---GVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE 75 (257)
T ss_pred cCCccCc---ccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence 4788888 8999999865 333 6899999876532 556789999999999999999999999988 88999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+++++|.+.+..... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 76 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 76 LAPLGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred ecCCCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999999876532 3458899999999999999999999999999999999999999999999999877643211
Q ss_pred ----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcCCCCCCCCCC
Q psy7592 159 ----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYSPVHYPTAWS 233 (246)
Q Consensus 159 ----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s 233 (246)
.....++..|+|||.+.... ++.++|+||||+++++|++ |..||.....................|...+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~-----~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRT-----FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACP 227 (257)
T ss_pred ceecccCCCCCceecCHHHhcccC-----cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCC
Confidence 11233566799999887655 7889999999999999998 9999965433222111111223444567789
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
..+.+++..||+.
T Consensus 228 ~~~~~li~~~l~~ 240 (257)
T cd05040 228 QDIYNVMLQCWAH 240 (257)
T ss_pred HHHHHHHHHHCCC
Confidence 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=244.00 Aligned_cols=228 Identities=21% Similarity=0.328 Sum_probs=184.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeecccc---chHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC---IERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
+||+|++ |+||++.+ .+++.+|+|.+..... .......++.+|++.+++++|+||+++++++.++...++++|
T Consensus 7 ~ig~g~~---~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 7 VLGKGAY---GTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred eEeccCC---eEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 4788888 89999986 4789999999875431 123345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC--
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-- 156 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-- 156 (246)
|+++++|.+++..... ++++.+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+......
T Consensus 83 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 83 FVPGGSISSILNRFGP-----LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred cCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999999876443 488999999999999999999999999999999999999999999999987654211
Q ss_pred -----ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc---CCCCC
Q psy7592 157 -----QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY---SPVHY 228 (246)
Q Consensus 157 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~ 228 (246)
.......++..|+|||.+.+.. ++.++|+||||+++++|++|..||...... .....+.. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~-----~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~ 230 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESG-----YGRKSDIWSIGCTVFEMATGKPPLASMDRL--AAMFYIGAHRGLMPRL 230 (265)
T ss_pred cccccccccccCCCccccChhhhcCCC-----CcchhhHHHHHHHHHHHHhCCCccccCChH--HHHHHhhhccCCCCCC
Confidence 1112344677899999987654 678999999999999999999999653322 22222221 23456
Q ss_pred CCCCCHhHHHHHHHhhh
Q psy7592 229 PTAWSESTKHLLSQVHR 245 (246)
Q Consensus 229 ~~~~s~~l~~li~~~l~ 245 (246)
|..+++++.++|.+||+
T Consensus 231 ~~~~~~~~~~~i~~~l~ 247 (265)
T cd06631 231 PDSFSAAAIDFVTSCLT 247 (265)
T ss_pred CCCCCHHHHHHHHHHhc
Confidence 77899999999999996
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=245.43 Aligned_cols=196 Identities=26% Similarity=0.355 Sum_probs=168.1
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC--CeEEEEEeec
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE--EDLFMVSDLL 80 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~~ 80 (246)
|++|+| |.||+++|+.|++.||+|+++.+.-. +..--.-.+|+.++.+.+|||||.+.++.... +.+|+||||+
T Consensus 84 I~EGty---GiVYRakdk~t~eIVALKr~kmekek-~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~ 159 (419)
T KOG0663|consen 84 IEEGTY---GVVYRAKDKKTDEIVALKRLKMEKEK-EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV 159 (419)
T ss_pred cccCcc---eeEEEeccCCcceeEEeeeccccccc-CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH
Confidence 688999 99999999999999999999876521 12223356799999999999999999998754 5699999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-cc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 159 (246)
..+|...+.+.. .++...+++-+..|++.+++|||.+.|+|||+||+|+|++..|.+|++|||+++.+.... ..
T Consensus 160 -EhDLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~ 234 (419)
T KOG0663|consen 160 -EHDLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY 234 (419)
T ss_pred -HhhHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence 556888887653 456888999999999999999999999999999999999999999999999999887653 34
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.....|..|.|||.+.+.. .+++..|+||+||++.+|+++++.|.+.+
T Consensus 235 T~lVVTLWYRaPELLLG~~----tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAK----TYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred cceEEEeeecCHHHhcCCc----ccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 4566788999999999887 48999999999999999999999997654
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=245.73 Aligned_cols=231 Identities=23% Similarity=0.364 Sum_probs=184.6
Q ss_pred CcCCCCccCeeeEEEEEe-----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQK-----KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||.|++ |+||++.. ..++..||+|.+.... ....+.+.+|++.+++++||||+++++++......+++
T Consensus 12 ~lg~G~~---~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 12 ELGEGAF---GKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred ccCCcCC---eeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 4678888 89999985 3456779999886543 34457788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccc--------cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecc
Q psy7592 77 SDLLLGGDLRYHITQDIK--------FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFN 148 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~ 148 (246)
+||+++++|.+++..... .....+++..+..++.|++.++++||+.|++|+||+|+||++++++.++++|||
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg 165 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFG 165 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCC
Confidence 999999999999875431 112246899999999999999999999999999999999999999999999999
Q ss_pred eeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC
Q psy7592 149 IATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS 224 (246)
Q Consensus 149 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 224 (246)
.+........ .....++..|+|||.+.+.. ++.++|+||||+++++|++ |..||..... ......+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~sDiwslG~il~~l~t~g~~p~~~~~~--~~~~~~i~~~ 238 (288)
T cd05093 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-----FTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIECITQG 238 (288)
T ss_pred ccccccCCceeecCCCCCccccccCHHHhccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcC
Confidence 9876533211 11223456799999987654 7889999999999999998 8999964432 2223333333
Q ss_pred -CCCCCCCCCHhHHHHHHHhhh
Q psy7592 225 -PVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 225 -~~~~~~~~s~~l~~li~~~l~ 245 (246)
....+..+++++.+++.+||+
T Consensus 239 ~~~~~~~~~~~~l~~li~~~l~ 260 (288)
T cd05093 239 RVLQRPRTCPKEVYDLMLGCWQ 260 (288)
T ss_pred CcCCCCCCCCHHHHHHHHHHcc
Confidence 344566789999999999996
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=241.30 Aligned_cols=230 Identities=27% Similarity=0.427 Sum_probs=190.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |.||++.+..+++.+|+|.+..... +.+..+.+.+|++.+++++|||++++++.+..+...++|+||++
T Consensus 7 ~lg~g~~---~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 7 VVGRGAF---GIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred EecccCc---eEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence 4788888 8999999999999999999976543 23446788899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-CeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG-HAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~ 160 (246)
+++|.+++.... ...+++..+..++.|++.++.+||+.|++|+||+|+||++++++ .++++|||.+..........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 83 GGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 999999987632 23358889999999999999999999999999999999998655 57999999998766544444
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc-CCCCCCCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY-SPVHYPTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~l~~l 239 (246)
...++..|+|||.+.+.. .+.++|+||||+++++|++|+.||...+.. .....+.. ...++|..+++.++++
T Consensus 160 ~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~l 232 (256)
T cd08220 160 TVVGTPCYISPELCEGKP-----YNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIMSGTFAPISDRYSPDLRQL 232 (256)
T ss_pred ccccCCcccCchhccCCC-----CCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHHHHhcCCCCCCCCcCHHHHHH
Confidence 456778899999987554 678999999999999999999999754432 22333332 2455677899999999
Q ss_pred HHHhhh
Q psy7592 240 LSQVHR 245 (246)
Q Consensus 240 i~~~l~ 245 (246)
|.+||+
T Consensus 233 i~~~l~ 238 (256)
T cd08220 233 ILSMLN 238 (256)
T ss_pred HHHHcc
Confidence 999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=257.96 Aligned_cols=193 Identities=30% Similarity=0.392 Sum_probs=166.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC-eEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE-DLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~v~e~~ 80 (246)
+||+|+| |.||++.-.. ++.||||.+....... .+++.+|+.++.+++|||+|+++++|.+.+ ..++|+||+
T Consensus 82 ~ig~Ggf---g~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym 154 (361)
T KOG1187|consen 82 LIGEGGF---GTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYM 154 (361)
T ss_pred ceecCCC---eEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEcc
Confidence 5889998 9999999864 5999999887655321 355999999999999999999999999988 599999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCCCcEEEcCCCCeEEeecceeeeecc-C
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH---IIHRDIKPDNILLDEEGHAHITDFNIATVLEE-N 156 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~---~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~ 156 (246)
.+|||.+++...... ++++..+..|+.+++.||+|||+.. ++|+|||++|||+|++...|++|||++..... .
T Consensus 155 ~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 155 PNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD 231 (361)
T ss_pred CCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence 999999999875432 6699999999999999999999865 99999999999999999999999999965443 3
Q ss_pred cccccc-ccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy7592 157 QLATSM-SGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDI 209 (246)
Q Consensus 157 ~~~~~~-~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~ 209 (246)
...... .++.+|++||+...+. .+.++||||||++++|+++|+.|.+.
T Consensus 232 ~~~~~~~~gt~gY~~PEy~~~g~-----lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 232 TSVSTTVMGTFGYLAPEYASTGK-----LTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred cceeeecCCCCccCChhhhccCC-----cCcccccccchHHHHHHHhCCcccCC
Confidence 333333 7899999999998754 78899999999999999999988864
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=242.48 Aligned_cols=226 Identities=30% Similarity=0.498 Sum_probs=180.5
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHH-HhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEI-LTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
||.|++ |.||+|.+..+++.||+|.++............+..|... ....+|+|++++++++..++..++++||+.
T Consensus 4 l~~g~~---~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 4 ISKGAF---GSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred CCcCCC---eeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 688888 8999999999999999999976543333333444445444 345589999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++..... +++..+..++.|++.+|.+||+.|++|+||+|+||++++++.++++|||++..... ...
T Consensus 81 ~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~ 152 (260)
T cd05611 81 GGDCASLIKTLGG-----LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKK 152 (260)
T ss_pred CCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---ccc
Confidence 9999999876543 48999999999999999999999999999999999999999999999998875433 223
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCC----CCCCCCHhHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVH----YPTAWSESTK 237 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~l~ 237 (246)
..++..|+|||...+.. ++.++|+||||+++|+|++|..||..... ......+...... .+..+++.+.
T Consensus 153 ~~~~~~y~~pe~~~~~~-----~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd05611 153 FVGTPDYLAPETILGVG-----DDKMSDWWSLGCVIFEFLFGYPPFHAETP--DAVFDNILSRRINWPEEVKEFCSPEAV 225 (260)
T ss_pred CCCCcCccChhhhcCCC-----CcchhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcccCCCCcccccCCHHHH
Confidence 44677899999987654 67899999999999999999999975433 2223333332222 2346899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|++||+.
T Consensus 226 ~~i~~~l~~ 234 (260)
T cd05611 226 DLINRLLCM 234 (260)
T ss_pred HHHHHHccC
Confidence 999999963
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=256.64 Aligned_cols=233 Identities=21% Similarity=0.329 Sum_probs=182.9
Q ss_pred CcCCCCccCeeeEEEEEecC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD-----TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 75 (246)
+||+|+| |.||++++.. ++..||+|+++... .....+.+.+|+++++++. ||||+++++++.+....++
T Consensus 44 ~LG~G~f---G~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (400)
T cd05105 44 ILGSGAF---GKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYI 118 (400)
T ss_pred eecCCCC---ceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEE
Confidence 4788888 8999998743 34579999997643 2334567889999999996 9999999999999999999
Q ss_pred EEeecCCCChHHHHhhcccc------------------------------------------------------------
Q psy7592 76 VSDLLLGGDLRYHITQDIKF------------------------------------------------------------ 95 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~------------------------------------------------------------ 95 (246)
||||+++++|.+++......
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (400)
T cd05105 119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS 198 (400)
T ss_pred EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence 99999999999988653210
Q ss_pred -------------------------------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEE
Q psy7592 96 -------------------------------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHI 144 (246)
Q Consensus 96 -------------------------------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l 144 (246)
....+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.+++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL 278 (400)
T cd05105 199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKI 278 (400)
T ss_pred hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEE
Confidence 0123577788999999999999999999999999999999999999999
Q ss_pred eecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHh
Q psy7592 145 TDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKA 220 (246)
Q Consensus 145 ~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~ 220 (246)
+|||++........ .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.....+... ...
T Consensus 279 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~-~~~ 352 (400)
T cd05105 279 CDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-----YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF-YNK 352 (400)
T ss_pred EeCCcceeccccccccccCCcCCCcceEChhhhcCCC-----CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH-HHH
Confidence 99999876543221 12233556799999887654 7889999999999999997 89999654332221 222
Q ss_pred hhcC-CCCCCCCCCHhHHHHHHHhhh
Q psy7592 221 IIYS-PVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 221 ~~~~-~~~~~~~~s~~l~~li~~~l~ 245 (246)
+... ..+.|..++..+.++|.+||+
T Consensus 353 ~~~~~~~~~~~~~~~~l~~li~~cl~ 378 (400)
T cd05105 353 IKSGYRMAKPDHATQEVYDIMVKCWN 378 (400)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHCc
Confidence 2222 445567899999999999996
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=241.72 Aligned_cols=228 Identities=22% Similarity=0.363 Sum_probs=180.4
Q ss_pred CcCCCCccCeeeEEEEEec--CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKK--DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
-||+|++ |.||.+... .++..||+|.+.... .....+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 2 ~ig~G~~---g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNF---GCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEM 75 (257)
T ss_pred ccCCCCc---ccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEe
Confidence 4788998 899998765 456679999987653 23445678899999999999999999998864 468899999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (246)
+++++|.+++.... ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+.........
T Consensus 76 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 76 ASGGPLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151 (257)
T ss_pred CCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence 99999999886422 23588999999999999999999999999999999999999999999999998765433211
Q ss_pred c--c--cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc-CCCCCCCCCC
Q psy7592 160 T--S--MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY-SPVHYPTAWS 233 (246)
Q Consensus 160 ~--~--~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~s 233 (246)
. . ..++..|+|||.+.... ++.++|+||||+++|++++ |..||....... ....+.. .....|...+
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 224 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRK-----FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGKRLDCPAECP 224 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCC-----CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCCCCCCCCCCC
Confidence 1 1 12245799999887654 6789999999999999996 999996543322 2222222 2455677899
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
+++.++|..||++
T Consensus 225 ~~l~~li~~c~~~ 237 (257)
T cd05115 225 PEMYALMKDCWIY 237 (257)
T ss_pred HHHHHHHHHHcCC
Confidence 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=269.79 Aligned_cols=234 Identities=22% Similarity=0.370 Sum_probs=199.1
Q ss_pred CCcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 1 MFCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 1 ~~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
+.||+|+| |+||.++|..|....|||.+.... ....+-+.+|+.+=+.|+|.|||++++.+.+++++-+.||-.
T Consensus 581 vVLGKGTY---G~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqV 654 (1226)
T KOG4279|consen 581 VVLGKGTY---GTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQV 654 (1226)
T ss_pred EEeecCce---eEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecC
Confidence 46899999 999999999999999999887654 334567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc-CCCCeEEeecceeeeeccCc-c
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD-EEGHAHITDFNIATVLEENQ-L 158 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~-~~~~~~l~d~~~~~~~~~~~-~ 158 (246)
+||||...+..... +..-.+.++-.+.+||+++|.|||++.|||||||-+|+|++ ..|.+||+|||.+++...-+ -
T Consensus 655 PGGSLSsLLrskWG--PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWG--PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccC--CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 99999999976321 12226788999999999999999999999999999999996 67789999999998864333 3
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHhhhcCCCCCCCCCCHhHH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK-DVKAIIYSPVHYPTAWSESTK 237 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~l~ 237 (246)
...+.||..|+|||++..++- .|+.+.|||||||.+.||.||++||......... ....+..-.+++|.++|.+++
T Consensus 733 TETFTGTLQYMAPEvIDqG~R---GYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak 809 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPR---GYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAK 809 (1226)
T ss_pred ccccccchhhhChHhhccCCc---CCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHH
Confidence 345789999999999987764 4889999999999999999999999655544443 334455668899999999999
Q ss_pred HHHHHhhh
Q psy7592 238 HLLSQVHR 245 (246)
Q Consensus 238 ~li~~~l~ 245 (246)
++|.+|+.
T Consensus 810 ~FilrcFe 817 (1226)
T KOG4279|consen 810 NFILRCFE 817 (1226)
T ss_pred HHHHHHcC
Confidence 99999974
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=243.10 Aligned_cols=234 Identities=22% Similarity=0.342 Sum_probs=187.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+||+|++ |.||++++..++..||+|.+.... ....+.+.+|+..+++++|+||+++++++..+...++++||++
T Consensus 15 ~lg~g~~---g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 15 VLGKGTY---GIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred EEecCCc---eEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 5889998 899999999999999999887654 3345678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC-CCCeEEeecceeeeeccCcc-c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE-EGHAHITDFNIATVLEENQL-A 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~-~~~~~l~d~~~~~~~~~~~~-~ 159 (246)
+++|.+++...... ...++..+..++.|++.++.+||+.|++|+||+|+||+++. ++.++++|||.+........ .
T Consensus 89 ~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 89 GGSLSALLRSKWGP--LKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCHHHHHHHhccc--CCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence 99999998753211 11267788889999999999999999999999999999976 66899999999876543222 2
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH-HHhhhcCCCCCCCCCCHhHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKD-VKAIIYSPVHYPTAWSESTKH 238 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~l~~ 238 (246)
....++..|+|||.+..... .++.++|+||+|+++++|++|..||.......... ..........+|...++++++
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~---~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPR---GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN 243 (268)
T ss_pred ccCCCCccccChhhhccccc---cCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHH
Confidence 23456788999999865321 26779999999999999999999996543222221 122233355677889999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
++++||+.
T Consensus 244 li~~~l~~ 251 (268)
T cd06624 244 FILRCFEP 251 (268)
T ss_pred HHHHHcCC
Confidence 99999963
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=257.18 Aligned_cols=193 Identities=24% Similarity=0.393 Sum_probs=162.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC------CeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE------EDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~~ 75 (246)
.||+|++ |.||++++..+++.||+|.+.... .+......+.+|+.+++.++||||+++++++... ...++
T Consensus 31 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~l 106 (364)
T cd07875 31 PIGSGAQ---GIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106 (364)
T ss_pred EeecCCC---eEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEE
Confidence 4788888 899999999999999999987543 2233456778899999999999999999987543 35799
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||||+. ++|.+.+.. .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++.....
T Consensus 107 v~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 107 VMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred EEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 999995 467666643 237888999999999999999999999999999999999999999999999976554
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
........++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 179 SFMMTPYVVTRYYRAPEVILGMG-----YKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred CCcccCCcccCCcCCHHHHhCCC-----CCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 43334456788999999987664 7889999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=264.31 Aligned_cols=228 Identities=21% Similarity=0.389 Sum_probs=191.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCe--EEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC-IERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED--LFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~~v~e 78 (246)
.||+|.+ -+||++.|..+|..||...++-... .++..++++..|+.+|+.|+||||+++|++|.+... +.+|+|
T Consensus 47 vLGrGaf---KtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 47 VLGRGAF---KTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hcccccc---eeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4789999 9999999999999999776654432 456667999999999999999999999999987654 889999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCcEEEc-CCCCeEEeecceeeeecc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH--IIHRDIKPDNILLD-EEGHAHITDFNIATVLEE 155 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~--~~h~~i~~~nil~~-~~~~~~l~d~~~~~~~~~ 155 (246)
.+.+|+|..+..+..+. ....++.|+.||+++|.|||++. |+|||||.+|||++ ..|.+||+|+|++.....
T Consensus 124 L~TSGtLr~Y~kk~~~v-----n~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRV-----NIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHhccC-----CHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999988776 88899999999999999999998 99999999999997 567999999999987665
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCC--CCCCCCC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPV--HYPTAWS 233 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~s 233 (246)
.... ...|||.|||||..... |...+||||||++++||+|+..||.- ........+.++.+.. .+..--.
T Consensus 199 s~ak-svIGTPEFMAPEmYEE~------YnE~VDVYaFGMCmLEMvT~eYPYsE-C~n~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 199 SHAK-SVIGTPEFMAPEMYEEN------YNELVDVYAFGMCMLEMVTSEYPYSE-CTNPAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred cccc-eeccCccccChHHHhhh------cchhhhhhhhhHHHHHHHhccCChhh-hCCHHHHHHHHHcCCCHHHhhccCC
Confidence 5433 37899999999998744 78899999999999999999999953 3344444555554422 2223348
Q ss_pred HhHHHHHHHhhh
Q psy7592 234 ESTKHLLSQVHR 245 (246)
Q Consensus 234 ~~l~~li~~~l~ 245 (246)
++++++|.+||+
T Consensus 271 Pevr~fIekCl~ 282 (632)
T KOG0584|consen 271 PEVREFIEKCLA 282 (632)
T ss_pred HHHHHHHHHHhc
Confidence 999999999986
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=243.89 Aligned_cols=233 Identities=22% Similarity=0.364 Sum_probs=182.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeC------CeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDE------EDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~~~~ 74 (246)
.||+|++ |.||++.++.+++.||+|.+.... .....+.+|+..++++ +|+|++++++++... ...+
T Consensus 13 ~lg~g~~---g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 13 LVGNGTY---GQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred heeecCC---eEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 4788888 899999999999999999987643 1234677889999998 699999999998753 4689
Q ss_pred EEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec
Q psy7592 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~ 154 (246)
++|||+.+++|.+++.... ...+++..+..++.|++.++.|||+.+++|+||+|+||++++++.++++|||++....
T Consensus 86 iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999999987532 2235888899999999999999999999999999999999999999999999987654
Q ss_pred cC-ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCCC
Q psy7592 155 EN-QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTA 231 (246)
Q Consensus 155 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 231 (246)
.. .......++..|+|||.+.+.......++.++|+||+|+++|+|++|..||......... ...... ....+..
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 240 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL--FLIPRNPAPRLKSKK 240 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH--HHHhcCCCCCCCCCC
Confidence 32 222335577889999998654322334788999999999999999999999643322211 111111 2222346
Q ss_pred CCHhHHHHHHHhhhC
Q psy7592 232 WSESTKHLLSQVHRY 246 (246)
Q Consensus 232 ~s~~l~~li~~~l~~ 246 (246)
++..++++|.+||+.
T Consensus 241 ~~~~~~~li~~~l~~ 255 (272)
T cd06637 241 WSKKFQSFIESCLVK 255 (272)
T ss_pred cCHHHHHHHHHHcCC
Confidence 899999999999963
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=249.75 Aligned_cols=231 Identities=32% Similarity=0.542 Sum_probs=185.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.+......... .....+|+..+++++||||+++++++.++...+++||++.
T Consensus 6 ~lg~G~~---g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 6 KLGSGGF---GTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEESS---EEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEEeCCC---EEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccccc
Confidence 4788888 99999999999999999999887633322 2344569999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeee-ccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL-EENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~-~~~~~~~ 160 (246)
+++|.+++...... ++..++.++.|++.+|.+||+.|++|+||+|+||++++++.++++|||.+... .......
T Consensus 82 ~~~L~~~l~~~~~~-----~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 82 GGSLQDYLQKNKPL-----SEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp TEBHHHHHHHHSSB-----BHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccccccc-----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999844443 99999999999999999999999999999999999999999999999998764 2223334
Q ss_pred ccccCCCccCCceec-ccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-ccHHHHHhhhcCCCCCC----CCCCH
Q psy7592 161 SMSGTKPYIAPEIFL-VATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN-TSVKDVKAIIYSPVHYP----TAWSE 234 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~-~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~----~~~s~ 234 (246)
...++..|.|||.+. +.. .+.++|+||||+++++|++|..||..... +...............+ ...++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~-----~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKK-----YTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSE 231 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSS-----BSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHH
T ss_pred ccccccccccccccccccc-----ccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHH
Confidence 456788899999987 333 78899999999999999999999975421 12222333332211111 22348
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.+.++|++||+.
T Consensus 232 ~l~~li~~~l~~ 243 (260)
T PF00069_consen 232 ELRDLIKKMLSK 243 (260)
T ss_dssp HHHHHHHHHSSS
T ss_pred HHHHHHHHHccC
Confidence 999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=243.06 Aligned_cols=233 Identities=24% Similarity=0.339 Sum_probs=182.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCc--EEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ--MYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
+||+|++ |.||++.++.++. .+++|.++... +.+..+.+.+|++.++++ +||||+++++++......+++||
T Consensus 2 ~lg~g~~---g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNF---GQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred cCCCCCC---ceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 5789998 8999999988776 45788776432 234456788899999999 79999999999999999999999
Q ss_pred ecCCCChHHHHhhcccc-----------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeec
Q psy7592 79 LLLGGDLRYHITQDIKF-----------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDF 147 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~ 147 (246)
|+++++|.+++...... ....+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++++||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence 99999999998764321 1123578899999999999999999999999999999999999999999999
Q ss_pred ceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-C
Q psy7592 148 NIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-P 225 (246)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~ 225 (246)
|++..............+..|+|||.+.... ++.++|+||||+++++|++ |..||...... .....+... .
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~-----~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~~ 229 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-----YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQGYR 229 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHccCC-----CCchhhHHHHHHHHHHHHcCCCCCccccCHH--HHHHHHhCCCC
Confidence 9875322211111122345699999886554 7889999999999999997 99999643322 222223222 3
Q ss_pred CCCCCCCCHhHHHHHHHhhhC
Q psy7592 226 VHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 226 ~~~~~~~s~~l~~li~~~l~~ 246 (246)
...|...+.++.+++.+||+.
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~ 250 (270)
T cd05047 230 LEKPLNCDDEVYDLMRQCWRE 250 (270)
T ss_pred CCCCCcCCHHHHHHHHHHccc
Confidence 345667899999999999963
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=240.59 Aligned_cols=227 Identities=22% Similarity=0.345 Sum_probs=182.5
Q ss_pred CcCCCCccCeeeEEEEEecCCC---cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK---QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |.||++....++ ..||+|.+...... ...+++.+|++.+++++|+||+++++++. ....+++||
T Consensus 2 ~ig~G~~---g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 75 (257)
T cd05060 2 ELGHGNF---GSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME 75 (257)
T ss_pred ccCccCc---eeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence 4889998 899999876554 78999998766532 34567888999999999999999999876 446799999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+.+++|.+++..... +++..+..++.|++.++++||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 76 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 76 LAPLGPLLKYLKKRRE-----IPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred eCCCCcHHHHHHhCCC-----CCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999999999976543 48999999999999999999999999999999999999999999999999877644322
Q ss_pred ccc----cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCC
Q psy7592 159 ATS----MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAW 232 (246)
Q Consensus 159 ~~~----~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (246)
... ..++..|+|||...+.. ++.++|+||||+++|++++ |..||...+. ......+... ..+.|..+
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 223 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGK-----FSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGERLPRPEEC 223 (257)
T ss_pred ccccccCccccccccCHHHhcCCC-----CCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCcCCCCCCC
Confidence 111 11235699999886654 7889999999999999998 9999965432 2222223222 44567789
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
+..++++|.+||+.
T Consensus 224 ~~~l~~li~~cl~~ 237 (257)
T cd05060 224 PQEIYSIMLSCWKY 237 (257)
T ss_pred CHHHHHHHHHHhcC
Confidence 99999999999963
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=245.04 Aligned_cols=233 Identities=20% Similarity=0.284 Sum_probs=184.7
Q ss_pred CcCCCCccCeeeEEEEEecCC-----CcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT-----KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |.||++.++.. +..||+|.+.... .......+.+|+..++.++||||+++++++.+....+++
T Consensus 13 ~lg~g~~---g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 87 (277)
T cd05032 13 ELGQGSF---GMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVV 87 (277)
T ss_pred EecCCCC---ceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEE
Confidence 3688888 89999998744 4889999986543 233346788899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccccc-----cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 77 SDLLLGGDLRYHITQDIKFY-----SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
|||+++++|.+++....... ...+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++++|||.+.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~ 167 (277)
T cd05032 88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167 (277)
T ss_pred EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccch
Confidence 99999999999986543211 1235777899999999999999999999999999999999999999999999987
Q ss_pred eeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CC
Q psy7592 152 VLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PV 226 (246)
Q Consensus 152 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~ 226 (246)
....... .....++..|+|||.+.... ++.++|+||||+++|++++ |..||....... ....+... ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~~~ 240 (277)
T cd05032 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGV-----FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLKFVIDGGHL 240 (277)
T ss_pred hhccCcccccCCCCCccccccCHHHHhcCC-----CCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHHHHhcCCCC
Confidence 6543221 11233456899999886554 7889999999999999998 899996543322 22222322 45
Q ss_pred CCCCCCCHhHHHHHHHhhhC
Q psy7592 227 HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ~~~~~~s~~l~~li~~~l~~ 246 (246)
+.|..++..+.++|.+||+.
T Consensus 241 ~~~~~~~~~~~~li~~~l~~ 260 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQY 260 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCC
Confidence 66788999999999999973
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=241.80 Aligned_cols=229 Identities=31% Similarity=0.493 Sum_probs=191.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |.||++.+..+++.||+|.+...... ...+.+.+|+..+.+++|+|++++++++......++++||++
T Consensus 8 ~i~~g~~---~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 8 VLGQGSS---GVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred eeeecCC---eEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 4677777 89999999999999999998776422 445778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
+++|.+++.... ++++..++.++.|++.++.+||+ .|++|+||+|+||+++.++.++++|||.+..........
T Consensus 83 ~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 83 GGSLADLLKKVG-----KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 999999997653 34899999999999999999999 999999999999999999999999999988765443332
Q ss_pred -ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-ccHHHHHhhhcC-CCCCCCC-CCHhH
Q psy7592 161 -SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN-TSVKDVKAIIYS-PVHYPTA-WSEST 236 (246)
Q Consensus 161 -~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~-~~~~~~~-~s~~l 236 (246)
...++..|+|||.+.... ++.++|+||||+++|+|++|..||..... ........+... ....+.. +++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~-----~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (264)
T cd06623 158 NTFVGTVTYMSPERIQGES-----YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232 (264)
T ss_pred cceeecccccCHhhhCCCC-----CCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 345678899999987654 78899999999999999999999965542 222233333333 4445566 89999
Q ss_pred HHHHHHhhh
Q psy7592 237 KHLLSQVHR 245 (246)
Q Consensus 237 ~~li~~~l~ 245 (246)
.++|++||+
T Consensus 233 ~~li~~~l~ 241 (264)
T cd06623 233 RDFISACLQ 241 (264)
T ss_pred HHHHHHHcc
Confidence 999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=249.07 Aligned_cols=226 Identities=26% Similarity=0.427 Sum_probs=184.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |.||++.+..+++.||+|.+..... ...+.+.+|+..++.++|||++++++++..+...++++||++
T Consensus 28 ~ig~g~~---g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 28 KIGEGST---GIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hcCCCCc---eeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 5788888 8999999999999999999865432 234567889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|..++... .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++....... ...
T Consensus 102 ~~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 102 GGALTDIVSQT------RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred CCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 99999877542 24889999999999999999999999999999999999999999999999886543322 122
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCCCCCCHhHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPTAWSESTK 237 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~l~ 237 (246)
...++..|+|||.+.+.. ++.++|+||||+++++|++|..||..... ......+... ....+..+++.+.
T Consensus 176 ~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~ 248 (297)
T cd06659 176 SLVGTPYWMAPEVISRTP-----YGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPPKLKNAHKISPVLR 248 (297)
T ss_pred ceecCccccCHHHHccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhccCCCCccccCCCCHHHH
Confidence 345778899999987654 78899999999999999999999964332 2222222222 2223446889999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||++
T Consensus 249 ~~i~~~l~~ 257 (297)
T cd06659 249 DFLERMLTR 257 (297)
T ss_pred HHHHHHhcC
Confidence 999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=247.79 Aligned_cols=226 Identities=27% Similarity=0.395 Sum_probs=184.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.+..+++.||+|.+..... ...+.+.+|+..++.++|+||+++++++..+...++||||++
T Consensus 26 ~lg~g~~---g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 26 KIGQGAS---GTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred eeccCCC---eEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 3678888 8999999999999999999976542 223567889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-AT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 160 (246)
+++|.+++.+. .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+........ ..
T Consensus 100 ~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 100 GGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred CCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence 99999988643 237888999999999999999999999999999999999999999999999876543322 22
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh-cC--CCCCCCCCCHhHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII-YS--PVHYPTAWSESTK 237 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~~~s~~l~ 237 (246)
...++..|+|||.+.+.. ++.++|+||||+++|++++|..||...+.... ...+. .. ....|..+++.++
T Consensus 174 ~~~~~~~y~aPE~~~~~~-----~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKA-----YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIATNGTPELQNPERLSAVFR 246 (297)
T ss_pred cccCCccccCHHHHcCCC-----CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eeeeccCCCCCCCCccccCHHHH
Confidence 345677899999987654 77899999999999999999999965432211 11111 11 2234567899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||++
T Consensus 247 ~li~~~l~~ 255 (297)
T cd06656 247 DFLNRCLEM 255 (297)
T ss_pred HHHHHHccC
Confidence 999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=242.50 Aligned_cols=227 Identities=24% Similarity=0.403 Sum_probs=182.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHhhCCCCcceeeeeeeee--CCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC--IERDALKNVLREMEILTTLEHPFLVNLWFCFQD--EEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~ 77 (246)
.||+|++ |.||++.+..+++.||+|.+..... ........+.+|+.++++++||||+++++++.+ +...++++
T Consensus 9 ~lg~g~~---g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 9 LLGQGAF---GRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred eecCCCC---EEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 4788888 8999999999999999999875432 223455778899999999999999999999875 35788999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||+++++|.+.+..... ++...++.++.|++.++.+||+.+++|+||+|+||+++.++.++++|||++.......
T Consensus 86 e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 86 EYMPGGSVKDQLKAYGA-----LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred eCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 99999999999876543 3888899999999999999999999999999999999999999999999987653211
Q ss_pred ----cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCCC
Q psy7592 158 ----LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTA 231 (246)
Q Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 231 (246)
......++..|+|||.+.+.. ++.++|+||+|+++|++++|+.||..... .......... ...+|..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~i~~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~ 233 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEG-----YGRKADVWSLGCTVVEMLTEKPPWAEYEA--MAAIFKIATQPTNPQLPSH 233 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCC-----CCchhhhHHHHHHHHHHHHCCCCccccch--HHHHHHHhcCCCCCCCchh
Confidence 112234677899999987654 78899999999999999999999975432 2222222222 4455677
Q ss_pred CCHhHHHHHHHh
Q psy7592 232 WSESTKHLLSQV 243 (246)
Q Consensus 232 ~s~~l~~li~~~ 243 (246)
+++.++++|+.|
T Consensus 234 ~~~~~~~li~~~ 245 (266)
T cd06651 234 ISEHARDFLGCI 245 (266)
T ss_pred cCHHHHHHHHHh
Confidence 899999999543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=242.93 Aligned_cols=226 Identities=24% Similarity=0.415 Sum_probs=185.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||.+.+..+++.||+|.+..... ......+.+|+..+++++||||+++++++.++...++||||++
T Consensus 11 ~lg~g~~---~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06640 11 RIGKGSF---GEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred hcccCCC---eEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence 3788888 8999999999999999999875432 3345778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-AT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 160 (246)
+++|.+++... ++++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||++........ ..
T Consensus 86 ~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 86 GGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 99999988643 248888999999999999999999999999999999999999999999999876544322 22
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh-cCCCCCCCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII-YSPVHYPTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~l~~l 239 (246)
...++..|.|||.+.+.. .+.++|+||||+++|+|++|..||...... .....+. ......+..++..+.++
T Consensus 160 ~~~~~~~y~apE~~~~~~-----~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l 232 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSA-----YDSKADIWSLGITAIELAKGEPPNSDMHPM--RVLFLIPKNNPPTLTGEFSKPFKEF 232 (277)
T ss_pred cccCcccccCHhHhccCC-----CccHHHHHHHHHHHHHHHHCCCCCCCcChH--hHhhhhhcCCCCCCchhhhHHHHHH
Confidence 234677899999987654 788999999999999999999999654322 1111221 12344455789999999
Q ss_pred HHHhhh
Q psy7592 240 LSQVHR 245 (246)
Q Consensus 240 i~~~l~ 245 (246)
|++||+
T Consensus 233 i~~~l~ 238 (277)
T cd06640 233 IDACLN 238 (277)
T ss_pred HHHHcc
Confidence 999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=246.10 Aligned_cols=233 Identities=21% Similarity=0.322 Sum_probs=181.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCc--EEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ--MYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |.||++.++.++. .+++|.++... +....+.+.+|+..+.++ +||||+++++++.+....++++|
T Consensus 9 ~lg~g~~---g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 9 VIGEGNF---GQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred eecCCCc---ceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 4788888 8999999887765 46888776422 233356788899999999 79999999999999999999999
Q ss_pred ecCCCChHHHHhhcccc-----------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeec
Q psy7592 79 LLLGGDLRYHITQDIKF-----------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDF 147 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~ 147 (246)
|+++++|.+++.+.... ....+++..+..++.|++.|+++||+.|++|+||+|+||++++++.++++||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~df 163 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADF 163 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCc
Confidence 99999999998754311 1123688899999999999999999999999999999999999999999999
Q ss_pred ceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-C
Q psy7592 148 NIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-P 225 (246)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~ 225 (246)
|++..............+..|+|||...+.. ++.++|+||||+++|+|++ |..||...... ......... .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--~~~~~~~~~~~ 236 (297)
T cd05089 164 GLSRGEEVYVKKTMGRLPVRWMAIESLNYSV-----YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQGYR 236 (297)
T ss_pred CCCccccceeccCCCCcCccccCchhhccCC-----CCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhcCCC
Confidence 9875432211111122245699999887654 7889999999999999997 99999654322 222333322 3
Q ss_pred CCCCCCCCHhHHHHHHHhhhC
Q psy7592 226 VHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 226 ~~~~~~~s~~l~~li~~~l~~ 246 (246)
...|..+++.++++|.+||+.
T Consensus 237 ~~~~~~~~~~~~~li~~~l~~ 257 (297)
T cd05089 237 MEKPRNCDDEVYELMRQCWRD 257 (297)
T ss_pred CCCCCCCCHHHHHHHHHHcCC
Confidence 445678999999999999963
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=242.91 Aligned_cols=233 Identities=18% Similarity=0.272 Sum_probs=182.2
Q ss_pred CcCCCCccCeeeEEEEEec-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK-----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||.|++ |+||++.++ .++..||+|.++... .......+.+|+..++.++||||+++++++.++...++|
T Consensus 13 ~ig~G~~---g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 13 ELGQGSF---GMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred eeccccC---CeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence 3688888 899998865 346789999986543 223345688899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccccc-----cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 77 SDLLLGGDLRYHITQDIKFY-----SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
|||+++++|.+++....... ....+...+..++.|++.++.|||+.|++|+||+|+||+++.++.++++|||++.
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~ 167 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCcc
Confidence 99999999999986532211 1234667889999999999999999999999999999999999999999999987
Q ss_pred eeccCccc---cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CC
Q psy7592 152 VLEENQLA---TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PV 226 (246)
Q Consensus 152 ~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~ 226 (246)
........ ....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||..... ......+... ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~~~~ 240 (277)
T cd05062 168 DIYETDYYRKGGKGLLPVRWMSPESLKDGV-----FTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQVLRFVMEGGLL 240 (277)
T ss_pred ccCCcceeecCCCCccCHhhcChhHhhcCC-----cCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcCCcC
Confidence 55332211 1123356799999987654 7889999999999999999 7889865432 2222223332 45
Q ss_pred CCCCCCCHhHHHHHHHhhhC
Q psy7592 227 HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ~~~~~~s~~l~~li~~~l~~ 246 (246)
..|...++.++++|.+||+.
T Consensus 241 ~~~~~~~~~~~~li~~~l~~ 260 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQY 260 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCC
Confidence 56778999999999999974
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=240.29 Aligned_cols=233 Identities=28% Similarity=0.420 Sum_probs=189.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.+..+++.||+|.+...... ....+.+.+|+..++.++|+||+++++++......++++||++
T Consensus 7 ~lg~G~~---~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06626 7 KIGGGTF---GKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS 82 (264)
T ss_pred EeecCCC---cEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence 4788888 89999999999999999999876532 4567889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc-
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT- 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~- 160 (246)
+++|.+.+..... +++..+..++.|++.++++||+.|++|+||+|+||++++++.++++|||.+..........
T Consensus 83 ~~~L~~~~~~~~~-----~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 83 GGTLEELLEHGRI-----LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCcHHHHHhhcCC-----CChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999999876433 3888899999999999999999999999999999999999999999999988765432211
Q ss_pred ----ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCC--CCH
Q psy7592 161 ----SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTA--WSE 234 (246)
Q Consensus 161 ----~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~s~ 234 (246)
...++..|+|||.+.+.. ....+.++|+||||++++++++|+.||....................+|.. +++
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~--~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGK--GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred ccccCCcCCcCccChhhccCCC--CCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence 234677899999987553 123678999999999999999999999654322221111112224445554 499
Q ss_pred hHHHHHHHhhh
Q psy7592 235 STKHLLSQVHR 245 (246)
Q Consensus 235 ~l~~li~~~l~ 245 (246)
.+.++|++||+
T Consensus 236 ~~~~li~~~l~ 246 (264)
T cd06626 236 EGKDFLDRCLE 246 (264)
T ss_pred HHHHHHHHHcc
Confidence 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=253.84 Aligned_cols=193 Identities=24% Similarity=0.382 Sum_probs=161.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC------CeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE------EDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~~ 75 (246)
.||+|++ |.||++.+..+++.||+|.+..... +......+.+|+.+++.++||||+++++++... ...++
T Consensus 24 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 99 (355)
T cd07874 24 PIGSGAQ---GIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99 (355)
T ss_pred EeeecCC---EEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEE
Confidence 3788888 8999999999999999999876432 234456778899999999999999999988643 35799
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
+|||+++ ++.+.+.. .++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++.....
T Consensus 100 v~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 100 VMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred Ehhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 9999954 56665543 237888999999999999999999999999999999999999999999999976554
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
........++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 172 SFMMTPYVVTRYYRAPEVILGMG-----YKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred ccccCCccccCCccCHHHHcCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 44444456788999999987654 7889999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=238.30 Aligned_cols=231 Identities=26% Similarity=0.459 Sum_probs=186.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee-CCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD-EEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~v~e~~ 80 (246)
.||.|++ |.||++.++.+++.||+|.+..... .....+.+.+|++.+++++|+|++++++.+.. +...++++||+
T Consensus 7 ~lg~g~~---~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (257)
T cd08223 7 VVGKGSY---GEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82 (257)
T ss_pred EecCCCC---eEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence 3678877 8999999999999999999875432 23345668889999999999999999988764 44689999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-c
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-A 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 159 (246)
++++|.+++.... ..++++.+++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+........ .
T Consensus 83 ~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 83 EGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred CCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 9999999887532 23458999999999999999999999999999999999999999999999999887643322 2
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKH 238 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~ 238 (246)
....++..|+|||...+.. ++.++|+||||++++++++|+.||...+. ......+... ....|..+++.+.+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
T cd08223 160 STLIGTPYYMSPELFSNKP-----YNYKSDVWALGCCVYEMATLKHAFNAKDM--NSLVYRIIEGKLPPMPKDYSPELGE 232 (257)
T ss_pred ccccCCcCccChhHhcCCC-----CCchhhhHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHhcCCCCCccccCHHHHH
Confidence 2345678899999987654 77899999999999999999999964332 2222333333 33456789999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|.+||+.
T Consensus 233 li~~~l~~ 240 (257)
T cd08223 233 LIATMLSK 240 (257)
T ss_pred HHHHHhcc
Confidence 99999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=246.81 Aligned_cols=197 Identities=27% Similarity=0.404 Sum_probs=158.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC---CCCcceeeeeeeee-----CCeE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL---EHPFLVNLWFCFQD-----EEDL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~~ 73 (246)
.||+|++ |+||+++++.+++.||+|.++.....+ .......+|++.++.+ +||||+++++++.. ....
T Consensus 7 ~lg~g~~---g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 7 EIGVGAY---GTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred EEeecCC---eEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 3788888 999999999999999999987543211 1122344566666555 79999999998864 3458
Q ss_pred EEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 74 FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
++++|++. ++|..++.... ...+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||++...
T Consensus 83 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 83 TLVFEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred EEEEcccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 99999996 47888776532 223589999999999999999999999999999999999999999999999998776
Q ss_pred ccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 154 EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 154 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
..........++..|+|||.+.+.. ++.++|+||+|+++|+|++|.+||....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQST-----YATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred cCcccCCCccccccccCchHhhCCC-----CCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 5443333455688899999987654 7889999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=240.49 Aligned_cols=227 Identities=24% Similarity=0.412 Sum_probs=185.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|.+ |.||++.+..+++.|++|.+.... ..+++.+|++.+++++||||+++++++.++...++++|++.
T Consensus 10 ~i~~g~~---~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 10 KLGEGSY---GSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred hhcCCCC---eEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 3678887 899999999889999999986542 15788999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|.+.+.... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 82 ~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 82 AGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence 999999986532 235899999999999999999999999999999999999999999999999988765433 223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH-hhhcCCCCCCCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVK-AIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~l~~l 239 (246)
...++..|+|||.+.+.. ++.++|+||||+++++|++|+.||............ .........+..++..+.++
T Consensus 158 ~~~~~~~y~~PE~~~~~~-----~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIG-----YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDF 232 (256)
T ss_pred cccCCccccCHHHHhcCC-----CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHH
Confidence 344678899999986654 788999999999999999999999754332211111 11111233455688999999
Q ss_pred HHHhhh
Q psy7592 240 LSQVHR 245 (246)
Q Consensus 240 i~~~l~ 245 (246)
|.+||+
T Consensus 233 i~~~l~ 238 (256)
T cd06612 233 VKKCLV 238 (256)
T ss_pred HHHHHh
Confidence 999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=239.81 Aligned_cols=231 Identities=28% Similarity=0.445 Sum_probs=189.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.+|.+.+..+++.||+|.+...... ....+.+.+|++.+++++||||+++++++.+....++++||+.
T Consensus 7 ~lg~g~~---g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08218 7 KIGEGSF---GKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE 82 (256)
T ss_pred EeccCCc---eEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence 4788888 89999999999999999999764432 3345678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc-c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-T 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~ 160 (246)
+++|.+.+.... ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+......... .
T Consensus 83 ~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 83 GGDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred CCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 999999886532 123588889999999999999999999999999999999999999999999998765443221 2
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~l 239 (246)
...++..|+|||...+.. .+.++|+||||+++++|++|..||..... ......+... ..+.|..++.++.++
T Consensus 160 ~~~~~~~~~~pe~~~~~~-----~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (256)
T cd08218 160 TCIGTPYYLSPEICENRP-----YNNKSDIWALGCVLYEMCTLKHAFEAGNM--KNLVLKIIRGSYPPVSSHYSYDLRNL 232 (256)
T ss_pred hccCCccccCHHHhCCCC-----CCCccchhHHHHHHHHHHcCCCCccCCCH--HHHHHHHhcCCCCCCcccCCHHHHHH
Confidence 234677899999987654 67899999999999999999999964332 2223333333 445677899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 233 i~~~l~~ 239 (256)
T cd08218 233 VSQLFKR 239 (256)
T ss_pred HHHHhhC
Confidence 9999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=242.27 Aligned_cols=231 Identities=22% Similarity=0.344 Sum_probs=183.8
Q ss_pred CcCCCCccCeeeEEEEEe-----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQK-----KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |.||++.. ..++..+|+|.+.... ......+.+|++.++.++|+||+++++++.++...+++
T Consensus 12 ~lg~g~~---g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 12 ELGEGAF---GKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred ccCCccC---CeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 4778877 89999964 3457789999876543 44567889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhcccc----------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEee
Q psy7592 77 SDLLLGGDLRYHITQDIKF----------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITD 146 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d 146 (246)
|||+++++|.+++...... ....+++..+..++.|++.|++|||+.|++|+||+|+||++++++.++++|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECC
Confidence 9999999999998754310 112358888999999999999999999999999999999999999999999
Q ss_pred cceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhh
Q psy7592 147 FNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAII 222 (246)
Q Consensus 147 ~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~ 222 (246)
||++........ .....++..|+|||...+.. ++.++|+||||+++|+|++ |..||..... ......+.
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~ 238 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-----FTTESDIWSFGVVLWEIFTYGKQPWYQLSN--TEAIECIT 238 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCC-----cCchhhHHHHHHHHHHHHcCCCCCCccCCH--HHHHHHHH
Confidence 999876543221 11223356799999887664 7889999999999999998 8999854332 22233333
Q ss_pred cC-CCCCCCCCCHhHHHHHHHhhh
Q psy7592 223 YS-PVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 223 ~~-~~~~~~~~s~~l~~li~~~l~ 245 (246)
.. ....|..+++.+.++|.+||+
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~ 262 (280)
T cd05092 239 QGRELERPRTCPPEVYAIMQGCWQ 262 (280)
T ss_pred cCccCCCCCCCCHHHHHHHHHHcc
Confidence 32 445567899999999999996
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=259.15 Aligned_cols=227 Identities=29% Similarity=0.460 Sum_probs=189.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|.| |+||-+.+.++|+.||||++.+..+.+.. ..++++|+.+|+++.||+||.+--.|+..+.+++|||-+.
T Consensus 571 vLGSGQF---G~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 571 VLGSGQF---GTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH 646 (888)
T ss_pred hccCCcc---eeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence 4799999 99999999999999999999987765544 3889999999999999999999999999999999999995
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC---CeEEeecceeeeeccCcc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG---HAHITDFNIATVLEENQL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~---~~~l~d~~~~~~~~~~~~ 158 (246)
| ++.+.+....+ -.+++..-+.++.||+-||+|||-.+|+|+|+||+|+|+.... ++|+||||+++.+.....
T Consensus 647 G-DMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 647 G-DMLEMILSSEK---GRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred c-hHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 5 44444433321 2358888899999999999999999999999999999997654 789999999999988888
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CCCCH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAWSE 234 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~s~ 234 (246)
.....|++.|+|||.+.... +...-|+||.|+++|.-++|.-||.. +.+-..+ +.+..+-+| .++|+
T Consensus 723 RrsVVGTPAYLaPEVLrnkG-----yNrSLDMWSVGVIiYVsLSGTFPFNE-dEdIndQ---IQNAaFMyPp~PW~eis~ 793 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKG-----YNRSLDMWSVGVIIYVSLSGTFPFNE-DEDINDQ---IQNAAFMYPPNPWSEISP 793 (888)
T ss_pred hhhhcCCccccCHHHHhhcc-----ccccccceeeeEEEEEEecccccCCC-ccchhHH---hhccccccCCCchhhcCH
Confidence 88899999999999998775 77789999999999999999999942 2121222 223334444 35799
Q ss_pred hHHHHHHHhhh
Q psy7592 235 STKHLLSQVHR 245 (246)
Q Consensus 235 ~l~~li~~~l~ 245 (246)
...+||+.+|+
T Consensus 794 ~AidlIn~LLq 804 (888)
T KOG4236|consen 794 EAIDLINNLLQ 804 (888)
T ss_pred HHHHHHHHHHH
Confidence 99999999986
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=247.86 Aligned_cols=227 Identities=19% Similarity=0.338 Sum_probs=181.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcE----EEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQM----YAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||+|++ |+||++++..+++. ||+|.++... .....+.+.+|+..++.++||||+++++++... ..++++
T Consensus 14 ~lg~G~~---g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~ 87 (316)
T cd05108 14 VLGSGAF---GTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 87 (316)
T ss_pred eeecCCC---ceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence 4788998 89999998766554 8999986543 234456788999999999999999999998765 467899
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
+++.+++|.+++..... .++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++++|||++.......
T Consensus 88 e~~~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 88 QLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred ecCCCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 99999999999876432 24788899999999999999999999999999999999999999999999998765432
Q ss_pred ccc---ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC--CCCCCCC
Q psy7592 158 LAT---SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS--PVHYPTA 231 (246)
Q Consensus 158 ~~~---~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 231 (246)
... ....+..|+|||.+.... ++.++|+||||+++|+|++ |..||.+..... ...+... ..+.|..
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~-----~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 235 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRI-----YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKGERLPQPPI 235 (316)
T ss_pred cceeccCCccceeecChHHhccCC-----CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHhCCCCCCCCCC
Confidence 221 122345799999987654 7889999999999999997 999997543222 2233322 4445678
Q ss_pred CCHhHHHHHHHhhhC
Q psy7592 232 WSESTKHLLSQVHRY 246 (246)
Q Consensus 232 ~s~~l~~li~~~l~~ 246 (246)
++.++.++|.+||+.
T Consensus 236 ~~~~~~~li~~cl~~ 250 (316)
T cd05108 236 CTIDVYMIMVKCWMI 250 (316)
T ss_pred CCHHHHHHHHHHccC
Confidence 899999999999863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=240.19 Aligned_cols=229 Identities=19% Similarity=0.322 Sum_probs=184.3
Q ss_pred CcCCCCccCeeeEEEEEecCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT---KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|+| |+||++.++.+ ...||+|.++... .......+.+|+..+++++||||+++++.+.++...+++||
T Consensus 11 ~lg~g~~---g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 11 VIGGGEF---GEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred EecCCcc---ceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 4788888 89999998744 5689999887543 33445678889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ- 157 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (246)
++.+++|.+++..... .++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 86 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 86 YMENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred cCCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 9999999999865322 35888999999999999999999999999999999999999999999999998764211
Q ss_pred ccc--ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCC
Q psy7592 158 LAT--SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWS 233 (246)
Q Consensus 158 ~~~--~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s 233 (246)
... ....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||..... ......+... ..+.|..++
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~-----~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 234 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRK-----FTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDVIKAVEDGYRLPPPMDCP 234 (266)
T ss_pred ceeccCCCCCccccChhhhccCC-----CccccchHHHHHHHHHHHccCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCC
Confidence 111 122345799999987654 7889999999999999998 9999964332 2223333332 445567899
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
+.+.+++.+||+.
T Consensus 235 ~~l~~li~~cl~~ 247 (266)
T cd05033 235 SALYQLMLDCWQK 247 (266)
T ss_pred HHHHHHHHHHcCC
Confidence 9999999999963
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=243.66 Aligned_cols=232 Identities=22% Similarity=0.330 Sum_probs=184.0
Q ss_pred CcCCCCccCeeeEEEEEec-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK-----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |.||++.+. .++..+++|.+.... ....+.+.+|+..+++++|+||+++++++..+...++|
T Consensus 12 ~lg~g~~---g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 12 ELGEGAF---GKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred eecccCC---CeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 4788888 899999854 356679999886543 33446788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccc-----------cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEe
Q psy7592 77 SDLLLGGDLRYHITQDIK-----------FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHIT 145 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~-----------~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~ 145 (246)
|||+++++|.+++..... .....+++..+..++.|++.++++||+.|++|+||+|+||+++.++.++++
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEEC
Confidence 999999999999976431 112236888999999999999999999999999999999999999999999
Q ss_pred ecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhh
Q psy7592 146 DFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAI 221 (246)
Q Consensus 146 d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~ 221 (246)
|||++........ .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...... .....+
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~ 238 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-----FTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EVIECI 238 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH
Confidence 9999876533221 12234567899999887654 7889999999999999998 99998654432 222223
Q ss_pred hcC-CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 222 IYS-PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 222 ~~~-~~~~~~~~s~~l~~li~~~l~~ 246 (246)
... ....+..++..+.++|.+||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~li~~~l~~ 264 (291)
T cd05094 239 TQGRVLERPRVCPKEVYDIMLGCWQR 264 (291)
T ss_pred hCCCCCCCCccCCHHHHHHHHHHccc
Confidence 332 3344567899999999999963
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=246.66 Aligned_cols=226 Identities=25% Similarity=0.422 Sum_probs=183.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.+..++..||+|.+.... ....+.+.+|+..+++++|+||+++++.+..++..+++|||++
T Consensus 29 ~lg~g~~---g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 29 KIGEGST---GIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred cccCCCC---eEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 4788888 899999999999999999986543 3445678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|.+++... . +++..+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||++....... ...
T Consensus 103 ~~~L~~~~~~~-~-----l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 103 GGALTDIVTHT-R-----MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred CCcHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 99999887542 2 4888999999999999999999999999999999999999999999999886543222 122
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc---CCCCCCCCCCHhHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY---SPVHYPTAWSESTK 237 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~l~ 237 (246)
...++..|+|||...+.. ++.++|+||||+++++|++|..||...... .....+.. .....+...++.++
T Consensus 177 ~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (292)
T cd06658 177 SLVGTPYWMAPEVISRLP-----YGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRDNLPPRVKDSHKVSSVLR 249 (292)
T ss_pred eeecCccccCHHHHccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCccccccccCHHHH
Confidence 345678899999886554 778999999999999999999999654322 22222222 22222345799999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
+++.+||+.
T Consensus 250 ~li~~~l~~ 258 (292)
T cd06658 250 GFLDLMLVR 258 (292)
T ss_pred HHHHHHccC
Confidence 999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=242.81 Aligned_cols=231 Identities=20% Similarity=0.343 Sum_probs=183.1
Q ss_pred CcCCCCccCeeeEEEEEec----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||+|++ |+||++... .++..||+|.+.... .......+.+|++++++++||||+++++++..+...+++|
T Consensus 12 ~lg~g~~---g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 12 ELGECAF---GKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred eccccCC---cceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 3788888 899999853 466899999997543 2334567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhcccc------------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEe
Q psy7592 78 DLLLGGDLRYHITQDIKF------------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHIT 145 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~ 145 (246)
||+.+++|.+++...... ....+++..+..++.|++.++.|||+.|++|+||+|+||++++++.++++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKIS 166 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEec
Confidence 999999999998543210 01235788889999999999999999999999999999999999999999
Q ss_pred ecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhh
Q psy7592 146 DFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAI 221 (246)
Q Consensus 146 d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~ 221 (246)
|||++........ .....++..|+|||.+.+.. ++.++|+||||+++++|++ |..||.+.... .....
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05090 167 DLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-----FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cccccccccCCcceecccCCCccceecChHHhccCC-----CCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 9999876543221 12233456799999886654 7889999999999999998 88999654322 22222
Q ss_pred hcC--CCCCCCCCCHhHHHHHHHhhh
Q psy7592 222 IYS--PVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 222 ~~~--~~~~~~~~s~~l~~li~~~l~ 245 (246)
+.. ..+.|..+++.++++|.+||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~ 264 (283)
T cd05090 239 VRKRQLLPCSEDCPPRMYSLMTECWQ 264 (283)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcc
Confidence 222 345567899999999999996
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=241.82 Aligned_cols=235 Identities=25% Similarity=0.398 Sum_probs=185.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCC------eEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEE------DLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~------~~~ 74 (246)
.||.|++ |+||++.++.+++.|++|.+.... ...+++.+|+.+++++ +|+||+++++++.... ..+
T Consensus 13 ~l~~g~~---~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 13 VIGEGTY---GKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred eecCCCC---eEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 3677777 899999999999999999987654 2336788999999999 6999999999997644 489
Q ss_pred EEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec
Q psy7592 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~ 154 (246)
++|||+++++|.+.+..... ....+++..+..++.|++.|+.+||+.|++|+||+|+||++++++.++++|||.+....
T Consensus 86 lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 99999999999988865321 12346899999999999999999999999999999999999999999999999987654
Q ss_pred cCc-cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCCC
Q psy7592 155 ENQ-LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPT 230 (246)
Q Consensus 155 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 230 (246)
... ......++..|+|||.+.........++.++|+||||+++++|++|+.||.... .......+... ....+.
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~ 242 (275)
T cd06608 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH--PMRALFKIPRNPPPTLKSPE 242 (275)
T ss_pred cchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc--hHHHHHHhhccCCCCCCchh
Confidence 322 222345677899999886554444457889999999999999999999996432 22223333332 222234
Q ss_pred CCCHhHHHHHHHhhhC
Q psy7592 231 AWSESTKHLLSQVHRY 246 (246)
Q Consensus 231 ~~s~~l~~li~~~l~~ 246 (246)
.+++.++++|++||+.
T Consensus 243 ~~~~~~~~li~~~l~~ 258 (275)
T cd06608 243 NWSKKFNDFISECLIK 258 (275)
T ss_pred hcCHHHHHHHHHHhhc
Confidence 5899999999999963
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=242.15 Aligned_cols=229 Identities=25% Similarity=0.423 Sum_probs=187.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.++.+++.||+|.+..... .+..+++.+|++.+++++||||+++++.+..+...++++|++.
T Consensus 8 ~ig~g~~---~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 8 ELGAGNS---GVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred HhcCCCC---eEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 3678888 8999999999999999999877542 3445778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
+++|.+++.... .++++..+..++.|++.++.+||+ .|++|+||+|+||++++++.++++|||.+..........
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 158 (265)
T cd06605 83 GGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT 158 (265)
T ss_pred CCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence 999999987642 345889999999999999999999 999999999999999999999999999886654332222
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---ccHHHHHhhhcC-CCCCCCC-CCHh
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN---TSVKDVKAIIYS-PVHYPTA-WSES 235 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~-~~~~~~~-~s~~ 235 (246)
..++..|+|||.+.+.. ++.++|+||||+++++|++|..||..... ......+.+... ....|.. +++.
T Consensus 159 -~~~~~~y~~PE~~~~~~-----~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd06605 159 -FVGTSSYMAPERIQGND-----YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD 232 (265)
T ss_pred -ccCChhccCHHHHcCCC-----CCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence 55677899999987654 78899999999999999999999964421 112233333333 3344444 8999
Q ss_pred HHHHHHHhhh
Q psy7592 236 TKHLLSQVHR 245 (246)
Q Consensus 236 l~~li~~~l~ 245 (246)
++++|.+||.
T Consensus 233 ~~~li~~~l~ 242 (265)
T cd06605 233 FQDFVNLCLI 242 (265)
T ss_pred HHHHHHHHcC
Confidence 9999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=239.00 Aligned_cols=224 Identities=22% Similarity=0.389 Sum_probs=180.5
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|++ |.||++..+ ++..+|+|.+..... ..+++.+|++.+++++||||+++++++.++...+++|||+++
T Consensus 12 lg~G~~---~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 12 LGSGQF---GVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred ecCCcC---ceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 688888 899999886 466899998865432 135678899999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--c
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA--T 160 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~ 160 (246)
++|.+++.... ..+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++++|||.+......... .
T Consensus 84 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 84 GCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999886532 12488899999999999999999999999999999999999999999999988764332211 1
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKH 238 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~ 238 (246)
...++..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||...+. ......+... ....|...+..+.+
T Consensus 160 ~~~~~~~y~aPE~~~~~~-----~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~ 232 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSK-----YSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFRLYRPKLASMTVYE 232 (256)
T ss_pred CCCCchhhCChhhcccCc-----cchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 223445799999987554 7889999999999999999 8999964432 2333344333 44456678999999
Q ss_pred HHHHhhh
Q psy7592 239 LLSQVHR 245 (246)
Q Consensus 239 li~~~l~ 245 (246)
++.+||+
T Consensus 233 li~~c~~ 239 (256)
T cd05114 233 VMYSCWH 239 (256)
T ss_pred HHHHHcc
Confidence 9999996
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=240.81 Aligned_cols=228 Identities=21% Similarity=0.318 Sum_probs=185.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |.||++.++. ++.+|+|.+.... .....++.+|+..++.++|+||+++++++.+....+++|||++
T Consensus 13 ~ig~g~~---~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 13 KLGSGYF---GEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred hhccCCC---ccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 3688888 8999999987 9999999987654 3334678889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc-c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-T 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~ 160 (246)
+++|.+++.... ...++...+..++.|++.|+.+||+.|++|+||+|+||++++++.++++|||.+......... .
T Consensus 86 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 86 KGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred cCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence 999999987532 234588899999999999999999999999999999999999999999999998765432221 1
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKH 238 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~ 238 (246)
...++..|+|||...... ++.++|+||||+++++|++ |+.||..... ......+... ..+.|...++++.+
T Consensus 163 ~~~~~~~~~~PE~~~~~~-----~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05148 163 DKKIPYKWTAPEAASHGT-----FSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQITAGYRMPCPAKCPQEIYK 235 (261)
T ss_pred CCCCceEecCHHHHccCC-----CCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHHhCCcCCCCCCCCHHHHH
Confidence 223455799999886554 7789999999999999998 8999965432 2223333332 44566789999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|.+||+.
T Consensus 236 ~i~~~l~~ 243 (261)
T cd05148 236 IMLECWAA 243 (261)
T ss_pred HHHHHcCC
Confidence 99999963
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=238.53 Aligned_cols=225 Identities=21% Similarity=0.366 Sum_probs=180.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.++ ++..+|+|.+...... ...+.+|++++++++||||+++++++.+....+++|||++
T Consensus 11 ~lg~G~~---~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 11 ELGSGQF---GVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred hhccCCC---ceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3688888 899999886 5778999998654321 2457779999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc-
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT- 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~- 160 (246)
+++|.+++..... .+++..+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||.+..........
T Consensus 83 ~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 83 NGCLLNYLRERKG----KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 9999999865322 35888999999999999999999999999999999999999999999999887654322111
Q ss_pred -ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 161 -SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 161 -~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....+..|+|||.+.+.. ++.++|+||||+++|++++ |..||...... .....+... ....|..+|+.+.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~-----~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSR-----FSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSAGYRLYRPKLAPTEVY 231 (256)
T ss_pred CCCCCCccccCHHHhccCC-----CCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHcCCcCCCCCCCCHHHH
Confidence 112234699999887654 7889999999999999999 89999654322 222233222 4456678999999
Q ss_pred HHHHHhhh
Q psy7592 238 HLLSQVHR 245 (246)
Q Consensus 238 ~li~~~l~ 245 (246)
+++.+||+
T Consensus 232 ~li~~cl~ 239 (256)
T cd05059 232 TIMYSCWH 239 (256)
T ss_pred HHHHHHhc
Confidence 99999996
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=246.21 Aligned_cols=196 Identities=26% Similarity=0.402 Sum_probs=162.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||+++++.+++.||+|.++.... ......+.+|+..+++++||||+++++++.++...++||||+.
T Consensus 13 ~lg~g~~---g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 13 KLGEGTY---ATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred EeccCcC---EEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 3788888 8999999999999999999875432 1223456789999999999999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
++|.+.+.... ..+++..+..++.|++.|+.+||+.|++|+||+|+||++++++.++++|||.+....... ...
T Consensus 88 -~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (301)
T cd07873 88 -KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS 162 (301)
T ss_pred -cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence 58888775532 234888999999999999999999999999999999999999999999999987643322 122
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
...++..|+|||.+.+.. .++.++|+||||+++|+|++|+.||...+
T Consensus 163 ~~~~~~~y~~PE~~~~~~----~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 163 NEVVTLWYRPPDILLGST----DYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred ccceeecccCcHHHhCCC----CCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 344577899999876543 36789999999999999999999997544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=244.54 Aligned_cols=230 Identities=25% Similarity=0.389 Sum_probs=182.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|.+ |+||++.+..+++.||+|.+........+..+.+.+|+++++.++||||+++.+++.++...++|+||+.
T Consensus 22 ~lg~g~~---g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 98 (307)
T cd06607 22 EIGHGSF---GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL 98 (307)
T ss_pred eecCCCC---eEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC
Confidence 4788888 8999999999999999999876554445556778899999999999999999999999999999999995
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++.+.+.... .++++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++++|||++...... ..
T Consensus 99 -g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~ 170 (307)
T cd06607 99 -GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NS 170 (307)
T ss_pred -CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CC
Confidence 56666664321 23588999999999999999999999999999999999999999999999988654332 23
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc-CCCCC-CCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY-SPVHY-PTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~-~~~~s~~l~~l 239 (246)
..++..|+|||.+.+.. ...++.++|+||||+++|+|++|..||...... .....+.. ..... +..++..++++
T Consensus 171 ~~~~~~y~aPE~~~~~~--~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (307)
T cd06607 171 FVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNDSPTLSSNDWSDYFRNF 246 (307)
T ss_pred ccCCccccCceeeeccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCccHH--HHHHHHhcCCCCCCCchhhCHHHHHH
Confidence 45677899999875321 113678999999999999999999999643322 22222222 22222 34689999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|.+||+.
T Consensus 247 i~~~l~~ 253 (307)
T cd06607 247 VDSCLQK 253 (307)
T ss_pred HHHHhcC
Confidence 9999963
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=242.15 Aligned_cols=232 Identities=19% Similarity=0.261 Sum_probs=183.6
Q ss_pred cCCCCccCeeeEEEEEecC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKD-----TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
||+|++ |.||++.+.. +++.||+|.++... .....+.+.+|+.++.+++||||+++++++.+....++++
T Consensus 13 lg~G~~---g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (283)
T cd05091 13 LGEDRF---GKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIF 87 (283)
T ss_pred hCCCCC---CeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEE
Confidence 688888 8999998754 36789999997543 2334567888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccc-----------cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEee
Q psy7592 78 DLLLGGDLRYHITQDIK-----------FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITD 146 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~-----------~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d 146 (246)
||+.+++|.+++..... .....++...+..++.|++.|+.+||+.|++|+||+|+||++++++.++++|
T Consensus 88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~D 167 (283)
T cd05091 88 SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISD 167 (283)
T ss_pred EcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecc
Confidence 99999999999853211 0122367788999999999999999999999999999999999999999999
Q ss_pred cceeeeeccCccc---cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhh
Q psy7592 147 FNIATVLEENQLA---TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAII 222 (246)
Q Consensus 147 ~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~ 222 (246)
||++......... .....++.|+|||.+.... ++.++|+||||+++|+|++ |..||.+... ......+.
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~i~ 240 (283)
T cd05091 168 LGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-----FSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVIEMIR 240 (283)
T ss_pred cccccccccchheeeccCccCCccccCHHHHhcCC-----CCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH
Confidence 9998765332211 1223456899999986654 7889999999999999998 8889865332 22233333
Q ss_pred cC-CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 223 YS-PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 223 ~~-~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.. ..+.|..+++.+.+++.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~ 265 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNE 265 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCC
Confidence 33 3445778999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=239.12 Aligned_cols=231 Identities=26% Similarity=0.404 Sum_probs=188.7
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee--CCeEEEEEeec
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD--EEDLFMVSDLL 80 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~ 80 (246)
||+|++ |.||++.+..+++.||+|.+..... +....+++.+|++.+++++||||+++++.+.. +...+++|||+
T Consensus 8 lg~g~~---~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~ 83 (265)
T cd08217 8 IGKGSF---GTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83 (265)
T ss_pred eccCCC---eEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence 677777 8999999999999999999876543 34445778899999999999999999998753 45689999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHH-----HCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLK-----TKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh-----~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
++++|.+++..... ...++++..++.++.|++.++.+|| +.+++|+||+|+||++++++.++++|||.+.....
T Consensus 84 ~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 84 EGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred cCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 99999999876421 1334688899999999999999999 88999999999999999999999999999887654
Q ss_pred Ccc-ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCC
Q psy7592 156 NQL-ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWS 233 (246)
Q Consensus 156 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s 233 (246)
... .....++..|+|||.+.... ++.++|+||||+++++|++|+.||..... ......+... ...+|..++
T Consensus 163 ~~~~~~~~~~~~~~~~pE~~~~~~-----~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd08217 163 DSSFAKTYVGTPYYMSPEQLNHMS-----YDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKIKEGKFRRIPYRYS 235 (265)
T ss_pred CcccccccccCCCccChhhhcCCC-----CCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHHhcCCCCCCccccC
Confidence 433 33456788899999987654 67899999999999999999999976442 2222233322 345677899
Q ss_pred HhHHHHHHHhhh
Q psy7592 234 ESTKHLLSQVHR 245 (246)
Q Consensus 234 ~~l~~li~~~l~ 245 (246)
..+.+++.+||+
T Consensus 236 ~~~~~l~~~~l~ 247 (265)
T cd08217 236 SELNEVIKSMLN 247 (265)
T ss_pred HHHHHHHHHHcc
Confidence 999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=239.36 Aligned_cols=234 Identities=19% Similarity=0.277 Sum_probs=184.2
Q ss_pred CcCCCCccCeeeEEEEEecCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCe------
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT---KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED------ 72 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------ 72 (246)
.||+|++ |.||++....+ +..||+|.++.... +......+.+|++.+++++||||+++++++.....
T Consensus 6 ~lg~G~~---g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 6 ILGEGEF---GSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccCcCCC---ceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 3788888 89999987653 48899999876432 23445778999999999999999999998865443
Q ss_pred EEEEEeecCCCChHHHHhhcccc-ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 73 LFMVSDLLLGGDLRYHITQDIKF-YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 73 ~~~v~e~~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
.++++||+++++|..++...... ....+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++++|||.+.
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 161 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCcccee
Confidence 79999999999999888553211 12346888999999999999999999999999999999999999999999999988
Q ss_pred eeccCccc---cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CC
Q psy7592 152 VLEENQLA---TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PV 226 (246)
Q Consensus 152 ~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~ 226 (246)
........ .....+..|+|||.+.... ++.++|+||||+++|+|++ |..||..... ......+... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-----~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~~ 234 (273)
T cd05035 162 KIYSGDYYRQGRIAKMPVKWIAIESLADRV-----YTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYLRHGNRL 234 (273)
T ss_pred eccccccccccccccCCccccCHhhcccCC-----CCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCC
Confidence 76543221 1122356799999886554 7889999999999999999 8889864332 2333333332 55
Q ss_pred CCCCCCCHhHHHHHHHhhhC
Q psy7592 227 HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ~~~~~~s~~l~~li~~~l~~ 246 (246)
..|..+++.+.++|.+||+.
T Consensus 235 ~~~~~~~~~~~~li~~~l~~ 254 (273)
T cd05035 235 KQPEDCLDELYDLMYSCWRA 254 (273)
T ss_pred CCCcCCCHHHHHHHHHHcCC
Confidence 56788999999999999973
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=238.37 Aligned_cols=227 Identities=22% Similarity=0.350 Sum_probs=182.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.++ +++.||+|.++.... ..+++.+|++.+++++||||+++++++..++..+++||++.
T Consensus 13 ~lg~g~~---~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 13 KLGAGQF---GEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred EecccCC---ccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 3678888 899999975 467899999876432 23567889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++.... ...++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++...........
T Consensus 85 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 85 YGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred CCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 999999987643 22358899999999999999999999999999999999999999999999999987653322111
Q ss_pred --cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 162 --MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 162 --~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
......|+|||...+.. ++.++|+||||+++++|++ |+.||.+.... .....+... ..+.+..+++.+.
T Consensus 162 ~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNR-----FSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVDQGYRMPCPPGCPKELY 234 (261)
T ss_pred CCCcCceeccCccccccCC-----CCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCCCCCCcCCHHHH
Confidence 12235799999887654 7889999999999999999 99999654322 222222222 3445678899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
+++.+||+.
T Consensus 235 ~li~~~l~~ 243 (261)
T cd05068 235 DIMLDCWKE 243 (261)
T ss_pred HHHHHHhhc
Confidence 999999963
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=236.65 Aligned_cols=229 Identities=29% Similarity=0.446 Sum_probs=193.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC--CeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE--EDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~ 79 (246)
.||+|++ |.||++.+..+++.|++|.+...... ....+.+.+|+..+++++||||+++++.+.+. ...++++|+
T Consensus 7 ~i~~g~~---~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 7 LLGRGSF---GSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred EeeecCc---eEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 3678888 89999999999999999999765432 34567889999999999999999999999988 889999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL- 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (246)
+.+++|.+++.+.. .+++..+..++.|++.++.+||+.|++|+|++|+||+++.++.++++|||.+........
T Consensus 83 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 83 VSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred cCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999987654 348999999999999999999999999999999999999999999999999988765543
Q ss_pred --ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh--cCCCCCCCCCCH
Q psy7592 159 --ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII--YSPVHYPTAWSE 234 (246)
Q Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~s~ 234 (246)
.....++..|.|||...... .+.++|+||||+++++|++|..||.... +......... .....+|..++.
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~-----~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEE-----YGRAADIWSLGCTVIEMATGKPPWSELG-NPMAALYKIGSSGEPPEIPEHLSE 231 (260)
T ss_pred ccccCCCCCccccCHhhhcCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHhccccCCCcCCCcccCH
Confidence 34456778899999987664 6789999999999999999999997655 2223333333 235566778899
Q ss_pred hHHHHHHHhhh
Q psy7592 235 STKHLLSQVHR 245 (246)
Q Consensus 235 ~l~~li~~~l~ 245 (246)
.++++|.+||+
T Consensus 232 ~l~~~i~~~l~ 242 (260)
T cd06606 232 EAKDFLRKCLR 242 (260)
T ss_pred HHHHHHHHhCc
Confidence 99999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=242.78 Aligned_cols=226 Identities=24% Similarity=0.430 Sum_probs=184.6
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|++ |.||++.+..+++.||+|.+..... ....+.+.+|++.+++++||||+++++++..+...++|+||+++
T Consensus 12 l~~g~~---~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06642 12 IGKGSF---GEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred hcCCCC---eeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCC
Confidence 688888 8999999999999999999875432 33456788999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-ccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-ATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~ 161 (246)
++|.+++... ++++..+..++.|++.++.|||+.|++|+||+|+||++++++.++++|||++........ ...
T Consensus 87 ~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 87 GSALDLLKPG------PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence 9999887542 248889999999999999999999999999999999999999999999999876543321 122
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHLL 240 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~li 240 (246)
..++..|+|||.+.+.. ++.++|+||||+++++|++|..||...... .....+... ....+...+.++.++|
T Consensus 161 ~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li 233 (277)
T cd06642 161 FVGTPFWMAPEVIKQSA-----YDFKADIWSLGITAIELAKGEPPNSDLHPM--RVLFLIPKNSPPTLEGQYSKPFKEFV 233 (277)
T ss_pred ccCcccccCHHHhCcCC-----CchhhhHHHHHHHHHHHHhCCCCCcccchh--hHHhhhhcCCCCCCCcccCHHHHHHH
Confidence 34677899999987654 778999999999999999999998643322 212222222 3334556899999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
.+||+.
T Consensus 234 ~~~l~~ 239 (277)
T cd06642 234 EACLNK 239 (277)
T ss_pred HHHccC
Confidence 999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=241.95 Aligned_cols=236 Identities=23% Similarity=0.430 Sum_probs=180.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHH-HHhhCCCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREME-ILTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |.||++.++.+|+.||+|.++..... .. ..++..|.. .++.++||||+++++++..+...+++|||+
T Consensus 8 ~ig~g~~---g~v~~~~~~~~~~~vaiK~~~~~~~~-~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 8 ELGRGAY---GVVDKMRHVPTGTIMAVKRIRATVNS-QE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred EecccCC---eEEEEEEEcCCCcEEEEEEEecCCCc-HH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 3688888 89999999999999999999765422 22 234444555 466678999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK-HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~-~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (246)
+ ++|.+++..... ....+++..++.++.|++.++.|||++ +++|+||+|+||+++.++.++++|||.+.........
T Consensus 83 ~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (283)
T cd06617 83 D-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK 160 (283)
T ss_pred c-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 5 678777754322 124569999999999999999999997 9999999999999999999999999998765443333
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCC-CCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYP-TAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-~~~s~~l~ 237 (246)
....++..|+|||.+.+... ...++.++|+||||+++|+|++|+.||...... .......... ...+| ..+|+++.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (283)
T cd06617 161 TIDAGCKPYMAPERINPELN-QKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQVVEEPSPQLPAEKFSPEFQ 238 (283)
T ss_pred ccccCCccccChhhcCCccc-ccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHHHHhcCCCCCCccccCHHHH
Confidence 33456788999998865321 123678999999999999999999999643322 2333333332 33444 35899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||+.
T Consensus 239 ~li~~~l~~ 247 (283)
T cd06617 239 DFVNKCLKK 247 (283)
T ss_pred HHHHHHccC
Confidence 999999963
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=242.72 Aligned_cols=197 Identities=27% Similarity=0.389 Sum_probs=165.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||+++++.+++.||+|.+..... .....+.+.+|+.++++++|+|++++++++......+++|||++
T Consensus 8 ~l~~g~~---~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 83 (286)
T cd07847 8 KIGEGSY---GVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD 83 (286)
T ss_pred eecccCC---eEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence 4688888 8999999999999999999865431 12233557889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|......... +++..+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||.+....... ...
T Consensus 84 ~~~l~~~~~~~~~-----~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 84 HTVLNELEKNPRG-----VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred ccHHHHHHhCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence 8888877654333 4899999999999999999999999999999999999999999999999998765433 222
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
...++..|+|||.+.+.. .++.++|+||||+++++|++|..||.+..
T Consensus 159 ~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 159 DYVATRWYRAPELLVGDT----QYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred CcccccccCCHHHHhCCC----CcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 344677899999876532 26789999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=251.17 Aligned_cols=234 Identities=20% Similarity=0.317 Sum_probs=182.9
Q ss_pred CcCCCCccCeeeEEEEEec-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK-----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 75 (246)
+||+|+| |.||++++. .+++.||+|+++.... ....+.+.+|++++.++. ||||+++++.+..+...++
T Consensus 44 ~lG~G~f---G~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~i 118 (401)
T cd05107 44 TLGSGAF---GRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYI 118 (401)
T ss_pred hccCCCc---eeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEE
Confidence 5889999 999999953 4567899999976532 233457889999999997 9999999999999999999
Q ss_pred EEeecCCCChHHHHhhcccc------------------------------------------------------------
Q psy7592 76 VSDLLLGGDLRYHITQDIKF------------------------------------------------------------ 95 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~------------------------------------------------------------ 95 (246)
||||+.+++|.+++......
T Consensus 119 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (401)
T cd05107 119 ITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGT 198 (401)
T ss_pred EEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhh
Confidence 99999999999998654210
Q ss_pred ---------------------------------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCe
Q psy7592 96 ---------------------------------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHA 142 (246)
Q Consensus 96 ---------------------------------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~ 142 (246)
....++...+..++.|++.||.|||+.+++|+||+|+||+++.++.+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~ 278 (401)
T cd05107 199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLV 278 (401)
T ss_pred hhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEE
Confidence 01224566788899999999999999999999999999999999999
Q ss_pred EEeecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHH
Q psy7592 143 HITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDV 218 (246)
Q Consensus 143 ~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~ 218 (246)
+++|||++........ .....++..|+|||.+.... ++.++|+||||+++++|++ |..||........ ..
T Consensus 279 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-~~ 352 (401)
T cd05107 279 KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-----YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-FY 352 (401)
T ss_pred EEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-----CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-HH
Confidence 9999999876532211 12234567799999987654 7889999999999999998 8889864332221 11
Q ss_pred HhhhcC-CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 219 KAIIYS-PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 219 ~~~~~~-~~~~~~~~s~~l~~li~~~l~~ 246 (246)
..+... ....|..++..+.+++++||+.
T Consensus 353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~ 381 (401)
T cd05107 353 NAIKRGYRMAKPAHASDEIYEIMQKCWEE 381 (401)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 222222 3455678899999999999963
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=243.66 Aligned_cols=230 Identities=20% Similarity=0.336 Sum_probs=182.4
Q ss_pred CcCCCCccCeeeEEEEEe-----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQK-----KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 75 (246)
.||.|++ |.||++.+ ..++..||+|.++... ..+..+.+.+|+++++++ +||||+++++++......++
T Consensus 42 ~ig~G~~---g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 42 TLGAGAF---GKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred eeeccCC---eeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 3688888 89999975 3456689999987643 233456788999999999 79999999999999999999
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
+|||+.+++|.+++..... ..+++.++..++.|++.++.|||+.|++|+||+|+||+++.++.++++|||++.....
T Consensus 117 v~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred EEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999865321 2258999999999999999999999999999999999999999999999999876543
Q ss_pred Ccc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC--CCCCC
Q psy7592 156 NQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS--PVHYP 229 (246)
Q Consensus 156 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~--~~~~~ 229 (246)
... .....++..|+|||.+.+.. ++.++|+||+|+++|+|++ |..||....... ........ ....|
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~~~~ 266 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCV-----YTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYKLIKEGYRMAQP 266 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCC-----CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHHHHHcCCcCCCC
Confidence 221 11223456799999887665 7889999999999999998 999996544322 22222222 33345
Q ss_pred CCCCHhHHHHHHHhhhC
Q psy7592 230 TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 ~~~s~~l~~li~~~l~~ 246 (246)
...++.+.+++.+||++
T Consensus 267 ~~~~~~~~~li~~cl~~ 283 (302)
T cd05055 267 EHAPAEIYDIMKTCWDA 283 (302)
T ss_pred CCCCHHHHHHHHHHcCC
Confidence 67899999999999963
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=240.01 Aligned_cols=229 Identities=19% Similarity=0.349 Sum_probs=182.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCc---EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ---MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |.||++.++.+++ .||+|.+.... +.+..+.+..|+..+++++||||+++++++.++...+++||
T Consensus 11 ~lg~g~~---g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 11 VIGAGEF---GEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred EecCCCC---CeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 4788888 8999999987665 69999987543 34456789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+.+++|.+++.... ..++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 86 FMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred cCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999886532 2348888999999999999999999999999999999999999999999998876543221
Q ss_pred ccc----cc--cCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCC
Q psy7592 159 ATS----MS--GTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPT 230 (246)
Q Consensus 159 ~~~----~~--~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 230 (246)
... .. .+..|+|||.+.+.. ++.++|+||||+++|++++ |..||...... .....+... ..+.|.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~-----~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~~~~~~~ 234 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDYRLPPPM 234 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCc-----ccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCcCCCcc
Confidence 111 11 134699999987654 7889999999999999886 99999654322 222222222 445566
Q ss_pred CCCHhHHHHHHHhhhC
Q psy7592 231 AWSESTKHLLSQVHRY 246 (246)
Q Consensus 231 ~~s~~l~~li~~~l~~ 246 (246)
.++..+.+++.+||+.
T Consensus 235 ~~~~~~~~li~~~l~~ 250 (269)
T cd05065 235 DCPTALHQLMLDCWQK 250 (269)
T ss_pred cCCHHHHHHHHHHcCC
Confidence 7899999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=241.21 Aligned_cols=227 Identities=23% Similarity=0.432 Sum_probs=184.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC---CCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE---HPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||.|++ |.||++.++.+++.||+|.++... .....+++.+|+.++++++ |||++++++++.++...+++||
T Consensus 8 ~l~~g~~---g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 8 LIGRGAY---GAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred heeccCC---ceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 3788888 899999999999999999987643 2334567888999999996 9999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+++++|.+++... ++++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 83 ~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 83 YAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred cCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999999887543 348899999999999999999999999999999999999999999999999887654332
Q ss_pred -ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc-CCCCCCC-CCCHh
Q psy7592 159 -ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY-SPVHYPT-AWSES 235 (246)
Q Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~-~~s~~ 235 (246)
.....++..|+|||.+.+.. .++.++|+||||+++|+|++|..||...... .....+.. ....++. .++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~----~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGK----YYDTKADIWSLGITIYEMATGNPPYSDVDAF--RAMMLIPKSKPPRLEDNGYSKL 230 (277)
T ss_pred ccccccCCcceeCHHHhccCC----ccccchhHHHHHHHHHHHHhCCCCCCCCChh--hhhhccccCCCCCCCcccCCHH
Confidence 22345777899999876433 2678999999999999999999999654322 21211111 1233343 38899
Q ss_pred HHHHHHHhhh
Q psy7592 236 TKHLLSQVHR 245 (246)
Q Consensus 236 l~~li~~~l~ 245 (246)
+.+++..||+
T Consensus 231 ~~~~i~~~l~ 240 (277)
T cd06917 231 LREFVAACLD 240 (277)
T ss_pred HHHHHHHHcC
Confidence 9999999996
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=235.53 Aligned_cols=228 Identities=21% Similarity=0.369 Sum_probs=182.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+||+|++ |.||++... ++..||+|.++... ..+....+.+|++.+++++||||+++++++......+++|||++
T Consensus 2 ~ig~g~~---g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (250)
T cd05085 2 LLGKGNF---GEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP 75 (250)
T ss_pred ccCCCCC---ceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence 5789999 899999865 68899999987654 23334568889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc-
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT- 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~- 160 (246)
+++|.+++.... ..+++..+..++.|++.++.++|+.|++|+||+|+||+++.++.++++|||++..........
T Consensus 76 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 151 (250)
T cd05085 76 GGDFLSFLRKKK----DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS 151 (250)
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccC
Confidence 999999886432 234788899999999999999999999999999999999999999999999987543322111
Q ss_pred -ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 161 -SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 161 -~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....+..|+|||...... ++.++|+||||+++|++++ |..||...... .....+... ....|..++..+.
T Consensus 152 ~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 224 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGR-----YSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVEKGYRMSCPQKCPDDVY 224 (250)
T ss_pred CCCCCcccccCHHHhccCC-----CCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHHHH
Confidence 122345799999886554 7889999999999999998 99999643322 222222222 3455678899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
+++.+||+.
T Consensus 225 ~li~~~l~~ 233 (250)
T cd05085 225 KVMQRCWDY 233 (250)
T ss_pred HHHHHHccc
Confidence 999999963
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=241.31 Aligned_cols=233 Identities=22% Similarity=0.374 Sum_probs=181.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeee------CCeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQD------EEDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~~~ 74 (246)
.||.|++ |.||++.++.+++.||+|.+.... ....++..|+..++++ +|+||+++++++.. +...+
T Consensus 23 ~lg~g~~---~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 23 VVGNGTY---GQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred eeccCCC---eEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 3678877 999999999999999999986542 2345677899999998 69999999999853 45789
Q ss_pred EEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec
Q psy7592 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~ 154 (246)
++|||+.+++|.+++.... ...+++..++.++.|++.++.|||+.|++|+||+|+||++++++.++++|||.+....
T Consensus 96 iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 9999999999999886532 2235788899999999999999999999999999999999999999999999887543
Q ss_pred cC-ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CC-CCCCC
Q psy7592 155 EN-QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PV-HYPTA 231 (246)
Q Consensus 155 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~ 231 (246)
.. .......++..|+|||.+.........++.++|+||||+++|+|++|..||..... ......+... .. ..+..
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 250 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP--MRALFLIPRNPPPKLKSKK 250 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH--HhhhhhHhhCCCCCCcccc
Confidence 22 12233557788999998864332233477899999999999999999999964332 2222222222 11 22346
Q ss_pred CCHhHHHHHHHhhhC
Q psy7592 232 WSESTKHLLSQVHRY 246 (246)
Q Consensus 232 ~s~~l~~li~~~l~~ 246 (246)
+++++.++|.+||+.
T Consensus 251 ~~~~~~~li~~cl~~ 265 (282)
T cd06636 251 WSKKFIDFIEGCLVK 265 (282)
T ss_pred cCHHHHHHHHHHhCC
Confidence 899999999999963
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=241.64 Aligned_cols=232 Identities=21% Similarity=0.377 Sum_probs=182.6
Q ss_pred CcCCCCccCeeeEEEEEecC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD-----TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |+||++++.. ....+++|.+.... +....+++.+|+..++.++||||+++++.+..+...+++
T Consensus 7 ~lg~g~~---g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 7 TLGEGEF---GKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred cccCcCC---cceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 4788888 8999998753 23578888886543 233457788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhcccc-------------------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc
Q psy7592 77 SDLLLGGDLRYHITQDIKF-------------------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD 137 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~-------------------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~ 137 (246)
+||+.+++|.+++...... ...+++...+..++.|++.++++||+.|++|+||+|+||+++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~ 161 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA 161 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEc
Confidence 9999999999998653211 112467888999999999999999999999999999999999
Q ss_pred CCCCeEEeecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCc
Q psy7592 138 EEGHAHITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNT 213 (246)
Q Consensus 138 ~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~ 213 (246)
+++.++++|||++........ ......+..|+|||.+.+.. ++.++|+||||+++++|++ |..||.+...
T Consensus 162 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-----~~~~~Di~slG~~l~el~t~g~~p~~~~~~- 235 (290)
T cd05045 162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-----YTTQSDVWSFGVLLWEIVTLGGNPYPGIAP- 235 (290)
T ss_pred CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-----cchHhHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 999999999999876533221 11223456799999886554 7889999999999999998 9999965432
Q ss_pred cHHHHHhhhcC--CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 214 SVKDVKAIIYS--PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 214 ~~~~~~~~~~~--~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.. ....... ..+.|..++.++.++|.+||+.
T Consensus 236 -~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~ 268 (290)
T cd05045 236 -ER-LFNLLKTGYRMERPENCSEEMYNLMLTCWKQ 268 (290)
T ss_pred -HH-HHHHHhCCCCCCCCCCCCHHHHHHHHHHccC
Confidence 22 2222222 3445678999999999999963
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=236.62 Aligned_cols=227 Identities=23% Similarity=0.338 Sum_probs=183.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+||.|++ |.||++.++. ++.||+|.+...... +....+.+|++++++++|+||+++++++.+....++++|++.
T Consensus 2 ~lg~g~~---g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 75 (251)
T cd05041 2 KIGKGNF---GDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP 75 (251)
T ss_pred ccccCCC---ceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence 5788888 8999999987 999999998765432 345678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc-
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT- 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~- 160 (246)
+++|.+++.... ..++...+..++.|++.++.+||+++++|+||+|+||+++.++.++++|||.+..........
T Consensus 76 ~~~l~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 76 GGSLLTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec
Confidence 999999986532 134888899999999999999999999999999999999999999999999987654221111
Q ss_pred --ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc-CCCCCCCCCCHhH
Q psy7592 161 --SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY-SPVHYPTAWSEST 236 (246)
Q Consensus 161 --~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~l 236 (246)
....+..|+|||.+.+.. ++.++|+||||+++++|++ |..||......... ..+.. ...+.|...+..+
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~-----~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 224 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGR-----YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR--ERIESGYRMPAPQLCPEEI 224 (251)
T ss_pred cccCcceeccCChHhhccCC-----CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH--HHHhcCCCCCCCccCCHHH
Confidence 112245699999887654 7889999999999999998 88898654432222 12211 2444567889999
Q ss_pred HHHHHHhhh
Q psy7592 237 KHLLSQVHR 245 (246)
Q Consensus 237 ~~li~~~l~ 245 (246)
.++|.+||+
T Consensus 225 ~~li~~~l~ 233 (251)
T cd05041 225 YRLMLQCWA 233 (251)
T ss_pred HHHHHHHhc
Confidence 999999996
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=238.46 Aligned_cols=220 Identities=21% Similarity=0.408 Sum_probs=177.5
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+|+|++ |.||++.++.+++.||+|.+........ |+.....+ +||||+++++.+..++..++||||++
T Consensus 24 lg~g~~---g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~ 92 (267)
T PHA03390 24 LIDGKF---GKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIK 92 (267)
T ss_pred ecCCCc---eEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCC
Confidence 588888 8999999999999999999876532211 11122212 69999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-CeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG-HAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~ 160 (246)
+++|.+++.... ++++..++.++.|++.++.+||+.|++|+||+|+||+++.++ .++++|||.+...... .
T Consensus 93 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~ 164 (267)
T PHA03390 93 DGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---S 164 (267)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---c
Confidence 999999987654 349999999999999999999999999999999999999988 9999999988765432 2
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHhhhcCCCCCCCCCCHhHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS--VKDVKAIIYSPVHYPTAWSESTKH 238 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~l~~ 238 (246)
...++..|+|||.+.+.. ++.++|+||+|+++++|++|..||....... ............+.+..+|+.+++
T Consensus 165 ~~~~~~~y~aPE~~~~~~-----~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T PHA03390 165 CYDGTLDYFSPEKIKGHN-----YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND 239 (267)
T ss_pred cCCCCCcccChhhhcCCC-----CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence 245678899999987654 6789999999999999999999997443222 122223334455566689999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|.+||+.
T Consensus 240 li~~~l~~ 247 (267)
T PHA03390 240 FVQSMLKY 247 (267)
T ss_pred HHHHHhcc
Confidence 99999973
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=241.22 Aligned_cols=226 Identities=25% Similarity=0.441 Sum_probs=183.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.++.+++.+++|.+.... ....+.+.+|+..++.++|||++++++++..++..++++||+.
T Consensus 26 ~lg~g~~---g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 26 KIGEGST---GIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred EeccCCC---eEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4788888 899999999999999999886543 3334668889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|.+++.. .. ++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 100 ~~~L~~~~~~-~~-----~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 100 GGALTDIVTH-TR-----MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred CCCHHHHHHh-CC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 9999998865 22 4888999999999999999999999999999999999999999999999876543322 122
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCCCCCCHhHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPTAWSESTK 237 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~l~ 237 (246)
...++..|+|||.+.+.. ++.++|+||+|+++++|++|..||.... .......+... ....+..+++.+.
T Consensus 174 ~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slGv~l~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~ 246 (285)
T cd06648 174 SLVGTPYWMAPEVISRLP-----YGTEVDIWSLGIMVIEMVDGEPPYFNEP--PLQAMKRIRDNLPPKLKNLHKVSPRLR 246 (285)
T ss_pred cccCCccccCHHHhcCCC-----CCCcccHHHHHHHHHHHHhCCCCCcCCC--HHHHHHHHHhcCCCCCcccccCCHHHH
Confidence 345678899999987654 6789999999999999999999996432 22222222222 1222334889999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||++
T Consensus 247 ~li~~~l~~ 255 (285)
T cd06648 247 SFLDRMLVR 255 (285)
T ss_pred HHHHHHccc
Confidence 999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=240.38 Aligned_cols=232 Identities=26% Similarity=0.411 Sum_probs=182.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc-------hHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI-------ERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 74 (246)
.||.|++ |.||++.+..+++.||+|.++..... .....+.+.+|+..+++++|||++++++++......+
T Consensus 8 ~lg~g~~---~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 8 LIGKGTY---GRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred eecccCc---eEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 4788888 89999999999999999988643211 1123456788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec
Q psy7592 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~ 154 (246)
+||||+++++|.+++..... ++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTYGR-----FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred EEEecCCCCcHHHHHhhccC-----CCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 99999999999999876533 4888899999999999999999999999999999999999999999999987643
Q ss_pred cCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh--cCCCCCC
Q psy7592 155 ENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII--YSPVHYP 229 (246)
Q Consensus 155 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~ 229 (246)
.... .....++..|+|||.+.... ..++.++|+||||++++++++|..||...... ....... .....+|
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~ 234 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYS---QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFKLGNKRSAPPIP 234 (272)
T ss_pred ccccccccccccCCccccCHHHhcccc---CCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHHhhccccCCcCC
Confidence 2211 12234677899999876543 12678899999999999999999999643322 1111211 1123333
Q ss_pred C----CCCHhHHHHHHHhhhC
Q psy7592 230 T----AWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 ~----~~s~~l~~li~~~l~~ 246 (246)
. .++.+++++|.+||+.
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~ 255 (272)
T cd06629 235 PDVSMNLSPVALDFLNACFTI 255 (272)
T ss_pred ccccccCCHHHHHHHHHHhcC
Confidence 3 4689999999999963
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=241.52 Aligned_cols=198 Identities=26% Similarity=0.407 Sum_probs=163.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++++..+++.||+|.+..... +......+.+|+..+++++||||+++++++.++...++||||+.
T Consensus 7 ~l~~g~~---~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 7 KIGEGTY---GVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred EecccCc---eEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 3688888 8999999999999999999875432 22234567889999999999999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-AT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 160 (246)
++|.+++..... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++........ ..
T Consensus 83 -~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 83 -MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred -CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 578777754321 23458999999999999999999999999999999999999999999999999876543221 12
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
...++..|+|||.+.+.. .++.++|+||||+++++|++|+.||.+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~----~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSP----RYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred CCcccccccChHHhcCCC----CcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 234577899999876543 2678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=240.28 Aligned_cols=233 Identities=22% Similarity=0.324 Sum_probs=184.0
Q ss_pred CcCCCCccCeeeEEEEEecC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD-----TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |.||++.+.. ++..||+|.+.... .......+.+|+.++++++|+||+++++++.+....+++
T Consensus 13 ~lg~g~~---g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 13 ALGHGAF---GEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred ECCCCCC---CcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 4788888 8999999987 78899999886543 233346788899999999999999999999988899999
Q ss_pred EeecCCCChHHHHhhcccc--ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC---CeEEeecceee
Q psy7592 77 SDLLLGGDLRYHITQDIKF--YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG---HAHITDFNIAT 151 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~---~~~l~d~~~~~ 151 (246)
|||+.+++|.+++...... ....+++..+..++.|++.+++|||+.+++|+||+|+||+++.++ .++++|||++.
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~ 167 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcccc
Confidence 9999999999998764321 122468888999999999999999999999999999999998765 58999999987
Q ss_pred eeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhh-cCCC
Q psy7592 152 VLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAII-YSPV 226 (246)
Q Consensus 152 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~-~~~~ 226 (246)
....... ......+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||....... ....+. ....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~ 240 (277)
T cd05036 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGI-----FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVTGGGRL 240 (277)
T ss_pred ccCCccceecCCCCCccHhhCCHHHHhcCC-----cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCCcC
Confidence 6532211 11122345799999987654 7889999999999999997 999997543322 222222 2255
Q ss_pred CCCCCCCHhHHHHHHHhhhC
Q psy7592 227 HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ~~~~~~s~~l~~li~~~l~~ 246 (246)
..|..++..+.+++.+||+.
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~ 260 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQH 260 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCC
Confidence 56778999999999999963
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=243.06 Aligned_cols=230 Identities=25% Similarity=0.405 Sum_probs=183.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.+..++..||+|.+........+....+.+|++.+++++|||++++++++.++...++||||+.
T Consensus 32 ~lg~G~~---~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 32 EIGHGSF---GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred eeccCCC---eEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 3788888 8999999999999999999976554455556788899999999999999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
| ++.+.+... ..++++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++..... ...
T Consensus 109 g-~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~ 180 (317)
T cd06635 109 G-SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANS 180 (317)
T ss_pred C-CHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---ccc
Confidence 5 677666442 22358899999999999999999999999999999999999999999999998765432 223
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-C-CCCCCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-P-VHYPTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~-~~~~~~~s~~l~~l 239 (246)
..++..|+|||.+.... ....+.++|+||||+++++|++|..||..... ......+... . ...+..+++.++++
T Consensus 181 ~~~~~~y~aPE~~~~~~--~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 181 FVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred ccCCccccChhhhhcCC--CCCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHhccCCCCCCccccHHHHHH
Confidence 45677899999975321 11267899999999999999999999865332 2222233322 2 22235689999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|.+||+.
T Consensus 257 i~~~l~~ 263 (317)
T cd06635 257 VDSCLQK 263 (317)
T ss_pred HHHHccC
Confidence 9999963
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=238.04 Aligned_cols=226 Identities=21% Similarity=0.379 Sum_probs=180.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.+. +++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.++...++++||+.
T Consensus 13 ~lg~g~~---g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 13 KLGAGQF---GEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred ecCCcCC---ceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 3677777 899999975 56789999886543 224678889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-- 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (246)
+++|.+++.... ...++...+..++.|++.+++|||+.|++|+||+|+||+++.++.++++|||.+.........
T Consensus 85 ~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 999999986532 223578889999999999999999999999999999999999999999999999876433211
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...... .....+... ..+.+..++.++.
T Consensus 162 ~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGS-----FTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYRMPRMENCPDELY 234 (261)
T ss_pred CCCccceecCCHHHhccCC-----CChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHHHH
Confidence 1223456799999886654 7889999999999999998 99999653322 222222222 3344457899999
Q ss_pred HHHHHhhh
Q psy7592 238 HLLSQVHR 245 (246)
Q Consensus 238 ~li~~~l~ 245 (246)
++|++||+
T Consensus 235 ~li~~~l~ 242 (261)
T cd05072 235 DIMKTCWK 242 (261)
T ss_pred HHHHHHcc
Confidence 99999996
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=248.72 Aligned_cols=192 Identities=27% Similarity=0.476 Sum_probs=160.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC------CeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE------EDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~~ 75 (246)
.||+|++ |+||++.+..+++.||+|.+..... +....+.+.+|++.+++++||||+++++++... ...++
T Consensus 22 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 97 (343)
T cd07878 22 PVGSGAY---GSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYL 97 (343)
T ss_pred ecccCCC---eEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEE
Confidence 3788888 9999999999999999999876432 222345677899999999999999999988643 34789
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
+++++ +++|.+.+... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++.....
T Consensus 98 ~~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 98 VTNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred EeecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 99988 88898776532 248999999999999999999999999999999999999999999999999876543
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
. .....++..|+|||.+.+.. .++.++|+||||+++|+|++|+.||.+.
T Consensus 171 ~--~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 171 E--MTGYVATRWYRAPEIMLNWM----HYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred C--cCCccccccccCchHhcCCc----cCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 2 23346788999999986532 3678999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=236.11 Aligned_cols=223 Identities=24% Similarity=0.360 Sum_probs=182.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.++...+++||++.
T Consensus 13 ~ig~g~~---g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 13 TIGKGEF---GDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred eeecCCC---ceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 3688888 899999874 89999999976542 45778899999999999999999999998899999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++..... ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+........ .
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--~ 158 (256)
T cd05039 84 KGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--S 158 (256)
T ss_pred CCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--c
Confidence 9999999876431 1358999999999999999999999999999999999999999999999999877633222 2
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC--CCCCCCCCCHhHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSESTKH 238 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~l~~ 238 (246)
...+..|.|||.+.... ++.++|+||||++++++++ |..||..... ......... ....|..+++.+.+
T Consensus 159 ~~~~~~~~ape~~~~~~-----~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05039 159 GKLPVKWTAPEALREKK-----FSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEKGYRMEAPEGCPPEVYK 230 (256)
T ss_pred CCCcccccCchhhcCCc-----CCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhcCCCCCCccCCCHHHHH
Confidence 23356799999886554 6789999999999999997 9999964432 222222222 44556778999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|.+||+.
T Consensus 231 li~~~l~~ 238 (256)
T cd05039 231 VMKDCWEL 238 (256)
T ss_pred HHHHHhcc
Confidence 99999973
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=240.77 Aligned_cols=229 Identities=24% Similarity=0.431 Sum_probs=186.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++.+..+++.||+|.+.... .....+.+.+|+++++.++||||+++++++.....+++|+||++
T Consensus 12 ~ig~g~~---g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (284)
T cd06620 12 DLGAGNG---GSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD 86 (284)
T ss_pred HcCCCCC---eEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCC
Confidence 4788888 999999999999999999987643 23445778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
+++|.+++..... +++..+..++.|++.++.|||+ .|++|+||+|+||++++++.++++|||++....... ..
T Consensus 87 ~~~L~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-~~ 160 (284)
T cd06620 87 CGSLDRIYKKGGP-----IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-AD 160 (284)
T ss_pred CCCHHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-cC
Confidence 9999998866433 4889999999999999999997 589999999999999999999999999876543222 22
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----c----HHHHHhhhcC-CCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT-----S----VKDVKAIIYS-PVHYPT 230 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-----~----~~~~~~~~~~-~~~~~~ 230 (246)
...++..|+|||.+.+.. ++.++|+||||++++++++|..||...... . ......+..+ ...++.
T Consensus 161 ~~~~~~~~~aPE~~~~~~-----~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 161 TFVGTSTYMSPERIQGGK-----YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred ccccCcccCCHHHHccCC-----CCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence 345788999999886553 788999999999999999999999754321 0 1122233322 333443
Q ss_pred C-CCHhHHHHHHHhhhC
Q psy7592 231 A-WSESTKHLLSQVHRY 246 (246)
Q Consensus 231 ~-~s~~l~~li~~~l~~ 246 (246)
. ++..+.++|.+||+.
T Consensus 236 ~~~~~~~~~li~~~l~~ 252 (284)
T cd06620 236 SDFPEDLRDFVDACLLK 252 (284)
T ss_pred hhcCHHHHHHHHHHhcC
Confidence 3 889999999999963
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=241.61 Aligned_cols=229 Identities=35% Similarity=0.584 Sum_probs=194.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |.||++.+..+++.||+|++......+....+.+.+|.+.+++++ ||||+++++++.++...+++||++
T Consensus 8 ~lg~g~~---~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd05581 8 IIGEGSF---STVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYA 84 (280)
T ss_pred eecCCCc---eEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCC
Confidence 3678888 899999999999999999998765544555677888999999998 999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-- 158 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 158 (246)
.+++|.+.+.+... +++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 85 ~~~~L~~~l~~~~~-----l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 85 PNGELLQYIRKYGS-----LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred CCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 99999999976543 49999999999999999999999999999999999999999999999999876543221
Q ss_pred -------------------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH
Q psy7592 159 -------------------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVK 219 (246)
Q Consensus 159 -------------------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 219 (246)
.....++..|+|||...... .+.++|+||||++++++++|..||.... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-----~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~ 232 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-----AGKSSDLWALGCIIYQMLTGKPPFRGSN--EYLTFQ 232 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCC-----CChhhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHH
Confidence 11234567899999877654 6789999999999999999999997544 334445
Q ss_pred hhhcCCCCCCCCCCHhHHHHHHHhhh
Q psy7592 220 AIIYSPVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 220 ~~~~~~~~~~~~~s~~l~~li~~~l~ 245 (246)
.+......+|..+++.+.++|.+||+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~~l~ 258 (280)
T cd05581 233 KILKLEYSFPPNFPPDAKDLIEKLLV 258 (280)
T ss_pred HHHhcCCCCCCccCHHHHHHHHHHhc
Confidence 55566677888999999999999996
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=237.61 Aligned_cols=234 Identities=19% Similarity=0.278 Sum_probs=182.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCc--EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC------CeE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ--MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE------EDL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~ 73 (246)
.||+|++ |.||++.++.++. .||+|.++... .+....+.+.+|++.++.++|+||+++++++... ...
T Consensus 6 ~ig~G~~---g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 6 TLGEGEF---GSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccCcccC---ceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4788888 8999999987765 68999887643 2344567888999999999999999999877432 246
Q ss_pred EEEEeecCCCChHHHHhhccc-cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 74 FMVSDLLLGGDLRYHITQDIK-FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
++++||+.+++|.+++..... .....+++..+..++.|++.|+.|||+.|++|+||+|+||++++++.++++|||++..
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 899999999999988753221 1123468889999999999999999999999999999999999999999999999887
Q ss_pred eccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCC
Q psy7592 153 LEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVH 227 (246)
Q Consensus 153 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~ 227 (246)
...... ......+..|++||...+.. ++.++|+||||+++|+|++ |..||...... .....+... ..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-----~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~ 234 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRV-----YTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQGNRLK 234 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCC-----cChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCCCCC
Confidence 643321 11223456799999887654 7889999999999999999 78899653322 222222222 345
Q ss_pred CCCCCCHhHHHHHHHhhhC
Q psy7592 228 YPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 228 ~~~~~s~~l~~li~~~l~~ 246 (246)
.+..+++.++++|.+||+.
T Consensus 235 ~~~~~~~~~~~li~~~l~~ 253 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLL 253 (272)
T ss_pred CCCCCCHHHHHHHHHHcCC
Confidence 5678999999999999963
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=240.60 Aligned_cols=234 Identities=33% Similarity=0.610 Sum_probs=187.0
Q ss_pred CcCCCCccCeeeEEEEEec---CCCcEEEEEEeeccccch-HHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK---DTKQMYAMKYMHKSQCIE-RDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~---~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||.|++ |.||.|++. .+|+.||+|.++...... ....+.+.+|+++++++ +|++|+++++++..+...++|
T Consensus 7 ~lg~G~~---g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 7 VLGTGAY---GKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeccCCc---ceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 4788888 899999885 479999999997644222 22345677899999999 599999999999999999999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
+||+++++|.+++..... +++..+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 84 LDYINGGELFTHLSQRER-----FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EecCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 999999999999876443 488899999999999999999999999999999999999999999999998765432
Q ss_pred cc--ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-c-HHHHHhhhcCCCCCCCCC
Q psy7592 157 QL--ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT-S-VKDVKAIIYSPVHYPTAW 232 (246)
Q Consensus 157 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-~-~~~~~~~~~~~~~~~~~~ 232 (246)
.. .....++..|+|||.+..... .++.++|+||||+++|+|++|..||...... . ............++|..+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDG---GHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 235 (290)
T ss_pred cccccccccCCcccCChhhccCCCC---CCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccC
Confidence 21 123456788999999865321 2567899999999999999999999643221 2 223333444456677889
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
++.+.+++++||+.
T Consensus 236 ~~~~~~ll~~~l~~ 249 (290)
T cd05613 236 SALAKDIIQRLLMK 249 (290)
T ss_pred CHHHHHHHHHHhcC
Confidence 99999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=246.02 Aligned_cols=234 Identities=21% Similarity=0.318 Sum_probs=181.2
Q ss_pred CcCCCCccCeeeEEEEEecC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeee-CCeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD-----TKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQD-EEDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~ 74 (246)
.||.|+| |.||+|.+.. +++.||+|.++... ..+..+.+.+|+..++++ +|+||+++++.+.. +..++
T Consensus 14 ~lG~G~f---g~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~ 88 (337)
T cd05054 14 PLGRGAF---GKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (337)
T ss_pred ccccCcC---ceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEE
Confidence 4788888 8999997543 45889999987543 233456778899999999 79999999998764 45688
Q ss_pred EEEeecCCCChHHHHhhcccc--------------------------------------------------------ccC
Q psy7592 75 MVSDLLLGGDLRYHITQDIKF--------------------------------------------------------YSV 98 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~--------------------------------------------------------~~~ 98 (246)
+++||+++++|.+.+...... ...
T Consensus 89 ~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (337)
T cd05054 89 VIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKE 168 (337)
T ss_pred EEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhc
Confidence 999999999999988643210 012
Q ss_pred CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc---ccccccCCCccCCceec
Q psy7592 99 GTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL---ATSMSGTKPYIAPEIFL 175 (246)
Q Consensus 99 ~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~ 175 (246)
+++...+..++.|++.++.|||+.|++|+||+|+||+++.++.++++|||++........ .....++..|+|||.+.
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 248 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF 248 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhc
Confidence 568888999999999999999999999999999999999999999999999876533221 11233456799999987
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc-CCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 176 VATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY-SPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 176 ~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
+.. ++.++|+||||+++++|++ |..||.+...... ....+.. .....|..+++++.+++..||+.
T Consensus 249 ~~~-----~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 249 DKV-----YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRRLKEGTRMRAPEYATPEIYSIMLDCWHN 315 (337)
T ss_pred CCC-----CCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHHHhccCCCCCCccCCHHHHHHHHHHccC
Confidence 665 7889999999999999998 9999975332221 1112211 24445677899999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=241.07 Aligned_cols=235 Identities=25% Similarity=0.388 Sum_probs=181.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeee-----eCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQ-----DEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~~~ 75 (246)
.||+|++ |+||++.++.+++.||+|.+.... .....+..|+..++++ +||||+++++++. .+...++
T Consensus 25 ~lg~g~~---~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 25 TIGKGTY---GKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred eeccCCC---cEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 3677888 899999999999999999886532 1224577799999999 6999999999874 3456899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
+|||+++++|.+.+..... ....+++..++.++.|++.++.|||+.+++|+||+|+||+++.++.++++|||++.....
T Consensus 98 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 176 (286)
T cd06638 98 VLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176 (286)
T ss_pred EEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence 9999999999988754211 123458888999999999999999999999999999999999999999999999876543
Q ss_pred Cc-cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCCCC
Q psy7592 156 NQ-LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPTA 231 (246)
Q Consensus 156 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 231 (246)
.. ......++..|+|||.+.........++.++|+||+|+++|+|++|+.||..... .......... ....|..
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd06638 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP--MRALFKIPRNPPPTLHQPEL 254 (286)
T ss_pred CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch--hHHHhhccccCCCcccCCCC
Confidence 22 2223457788999999864322222368899999999999999999999964332 1222221111 2223556
Q ss_pred CCHhHHHHHHHhhhC
Q psy7592 232 WSESTKHLLSQVHRY 246 (246)
Q Consensus 232 ~s~~l~~li~~~l~~ 246 (246)
++..++++|.+||+.
T Consensus 255 ~~~~~~~li~~~l~~ 269 (286)
T cd06638 255 WSNEFNDFIRKCLTK 269 (286)
T ss_pred cCHHHHHHHHHHccC
Confidence 889999999999963
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=239.19 Aligned_cols=227 Identities=19% Similarity=0.323 Sum_probs=180.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCc----EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ----MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||.|++ |+||++++..+++ .||+|.++... .....+.+.+|+..++.++||||+++++++... ..++++
T Consensus 14 ~lg~G~~---g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~ 87 (279)
T cd05109 14 VLGSGAF---GTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVT 87 (279)
T ss_pred ecCCCCC---ceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEE
Confidence 4788888 8999999877766 48999987543 234456788899999999999999999998754 467899
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
+++++++|.+.+.... ..+++..+..++.|++.|+.|||+.|++|+||+|+||++++++.++++|||+++......
T Consensus 88 ~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 88 QLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 9999999999986532 235888999999999999999999999999999999999999999999999988764332
Q ss_pred cc---cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC--CCCCCCC
Q psy7592 158 LA---TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS--PVHYPTA 231 (246)
Q Consensus 158 ~~---~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 231 (246)
.. .....+..|+|||...+.. ++.++|+||||+++|+|++ |..||......... ..+.. ..+.+..
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~-----~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~ 235 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHRR-----FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP---DLLEKGERLPQPPI 235 (279)
T ss_pred ceeecCCCccchhhCCHHHhccCC-----CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHHCCCcCCCCcc
Confidence 21 1123356799999987654 7889999999999999998 89999654432222 22222 3445667
Q ss_pred CCHhHHHHHHHhhhC
Q psy7592 232 WSESTKHLLSQVHRY 246 (246)
Q Consensus 232 ~s~~l~~li~~~l~~ 246 (246)
++..+.++|.+||+.
T Consensus 236 ~~~~~~~li~~~l~~ 250 (279)
T cd05109 236 CTIDVYMIMVKCWMI 250 (279)
T ss_pred CCHHHHHHHHHHcCC
Confidence 999999999999963
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=246.16 Aligned_cols=226 Identities=23% Similarity=0.398 Sum_probs=189.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |.||++.++++|..+|+|.+.-+ ..++.+..|+.++++.+.|++|++|+.+.....+|+|||||.
T Consensus 40 KLGEGSY---GSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 40 KLGEGSY---GSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HhcCCcc---hHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3677777 89999999999999999988664 336789999999999999999999999988889999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-cccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~ 160 (246)
.||+.+.+..+ .+++.++++..++...+++|+|||...=+||||+..|||++.+|..++.|||.+....+- ....
T Consensus 112 AGSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 112 AGSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred CCcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 99999998653 456799999999999999999999999999999999999999999999999998775432 2234
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhh-hcCCCCC--CCCCCHhHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAI-IYSPVHY--PTAWSESTK 237 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~s~~l~ 237 (246)
...|++.|+|||++..-. |....||||||+...+|..|++||..-..... +-.+ ..+++.+ |+.||.++-
T Consensus 188 TVIGTPFWMAPEVI~EIG-----Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--IFMIPT~PPPTF~KPE~WS~~F~ 260 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIG-----YDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--IFMIPTKPPPTFKKPEEWSSEFN 260 (502)
T ss_pred ccccCcccccHHHHHHhc-----cchhhhHhhhcchhhhhhcCCCCcccccccce--eEeccCCCCCCCCChHhhhhHHH
Confidence 467999999999987654 78899999999999999999999964433221 1111 1122223 678999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|++||.+
T Consensus 261 DFi~~CLiK 269 (502)
T KOG0574|consen 261 DFIRSCLIK 269 (502)
T ss_pred HHHHHHhcC
Confidence 999999953
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=241.00 Aligned_cols=227 Identities=25% Similarity=0.407 Sum_probs=183.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++..+.+++.||+|.+.... ......+.+|+..++.++|+|++++++++..++..+++|||++
T Consensus 27 ~lg~g~~---g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 27 KIGEGST---GIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HcCCCCC---eEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 4788888 899999999999999999885432 3345678889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|.+.+... .+++..+..++.|++.++++||+.|++|+||+|+||+++.++.++++|||++....... ...
T Consensus 101 ~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 101 GGALTDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred CCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence 99999877542 24888899999999999999999999999999999999999999999999887654322 222
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV-KDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
...++..|+|||.+.... ++.++|+||+|+++++|++|..||........ ................+++.+.++
T Consensus 175 ~~~~~~~y~~pE~~~~~~-----~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (292)
T cd06657 175 SLVGTPYWMAPELISRLP-----YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGF 249 (292)
T ss_pred ccccCccccCHHHhcCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHH
Confidence 345678899999886554 67899999999999999999999975432221 111111222222345689999999
Q ss_pred HHHhhh
Q psy7592 240 LSQVHR 245 (246)
Q Consensus 240 i~~~l~ 245 (246)
|.+||+
T Consensus 250 i~~~l~ 255 (292)
T cd06657 250 LDRLLV 255 (292)
T ss_pred HHHHHh
Confidence 999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=241.94 Aligned_cols=197 Identities=31% Similarity=0.472 Sum_probs=166.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.++.+++.||+|.++.... +.+..+.+.+|++.+++++|+||+++++++..++..++++||++
T Consensus 8 ~i~~g~~---~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 83 (288)
T cd07833 8 VVGEGAY---GVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE 83 (288)
T ss_pred EecccCC---eeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCC
Confidence 3688888 8999999999999999999875432 23345778899999999999999999999999999999999998
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc--cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ--LA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 159 (246)
++.+.....+.. ++++..++.++.|++.++.+||+.|++|+|++|+||++++++.++++|||.+....... ..
T Consensus 84 ~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 84 RTLLELLEASPG-----GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 877766554432 24899999999999999999999999999999999999999999999999987765443 22
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
....++..|+|||.+.+.. .++.++|+||||+++++|++|+.||.+..
T Consensus 159 ~~~~~~~~~~~PE~~~~~~----~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 206 (288)
T cd07833 159 TDYVATRWYRAPELLVGDT----NYGKPVDVWAIGCIMAELLDGEPLFPGDS 206 (288)
T ss_pred cCcccccCCcCCchhcCCC----CcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3355678899999987652 27789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=233.85 Aligned_cols=229 Identities=26% Similarity=0.421 Sum_probs=191.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|.+ |.+|+++++.+++.|++|.+...... ....+.+.+|++.+++++|+|++++++++.++...++++|++.
T Consensus 7 ~l~~g~~---~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 7 LIGRGAF---GVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred EEcccCC---eEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence 4678888 89999999999999999999876532 3456789999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc-c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-T 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~ 160 (246)
+++|.+.+..... +++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+......... .
T Consensus 83 ~~~L~~~~~~~~~-----l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 83 NGSLRQIIKKFGP-----FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCcHHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 9999999876543 489999999999999999999999999999999999999999999999999876544332 2
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
...++..|.|||...+.. .+.++|+||+|+++++|++|..||..... ..............+|..+++.++++|
T Consensus 158 ~~~~~~~y~~pe~~~~~~-----~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i 231 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSG-----ASTASDIWSLGCTVIELLTGNPPYYDLNP-MAALFRIVQDDHPPLPEGISPELKDFL 231 (254)
T ss_pred ccccchhhcCHhhhcCCC-----CCcchhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 345677899999886554 67899999999999999999999975442 222222223345566778999999999
Q ss_pred HHhhh
Q psy7592 241 SQVHR 245 (246)
Q Consensus 241 ~~~l~ 245 (246)
.+||+
T Consensus 232 ~~~l~ 236 (254)
T cd06627 232 MQCFQ 236 (254)
T ss_pred HHHHh
Confidence 99996
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=241.67 Aligned_cols=229 Identities=26% Similarity=0.415 Sum_probs=181.6
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|++ |+||++++..+++.|++|.+...........+.+.+|++.++.++|||++++++++.++...+++|||+.
T Consensus 29 lg~g~~---g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 29 IGHGSF---GAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred eccCCC---eEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 677777 8999999999999999999976554445556778889999999999999999999999999999999995
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSM 162 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 162 (246)
+++.+.+... ..++++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++++|||++..... ....
T Consensus 105 ~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~ 177 (313)
T cd06633 105 GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSF 177 (313)
T ss_pred CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCc
Confidence 5676666542 22358889999999999999999999999999999999999999999999998754322 2234
Q ss_pred ccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCCCCCHhHHHHH
Q psy7592 163 SGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSESTKHLL 240 (246)
Q Consensus 163 ~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~l~~li 240 (246)
.++..|+|||.+.... ...++.++|+||||+++++|++|..||...... .....+... +......++..++++|
T Consensus 178 ~~~~~y~aPE~~~~~~--~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (313)
T cd06633 178 VGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNDSPTLQSNEWTDSFRGFV 253 (313)
T ss_pred cccccccChhhccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 5678899999975321 112678999999999999999999999654322 222222222 2222346889999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
.+||++
T Consensus 254 ~~~l~~ 259 (313)
T cd06633 254 DYCLQK 259 (313)
T ss_pred HHHccC
Confidence 999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=238.01 Aligned_cols=229 Identities=21% Similarity=0.327 Sum_probs=182.6
Q ss_pred CcCCCCccCeeeEEEEEecCCC---cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK---QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |.||++.++.++ ..+|+|.++... ..+..+.+.+|+..+++++||||+++++++..++..+++||
T Consensus 11 ~lg~g~~---g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (267)
T cd05066 11 VIGAGEF---GEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE 85 (267)
T ss_pred eecccCC---CceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 4788888 899999987544 379999886543 23445788899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+++++|.+++.... ..++..++..++.|++.++.+||+.|++|+||+|+|++++.++.++++|||.+........
T Consensus 86 ~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 86 YMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred cCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999999986532 2358888999999999999999999999999999999999999999999999876644322
Q ss_pred ccc----cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCC
Q psy7592 159 ATS----MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAW 232 (246)
Q Consensus 159 ~~~----~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (246)
... ...+..|+|||.+.+.. ++.++|+||||++++++++ |..||...... .....+... ..+.+..+
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~-----~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~ 234 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGYRLPAPMDC 234 (267)
T ss_pred eeeecCCCccceeecCHhHhccCc-----cCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCCcCCCCCCC
Confidence 111 11235699999987654 7889999999999999886 99999654422 223333322 34455678
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
++.+++++.+||+.
T Consensus 235 ~~~~~~li~~~l~~ 248 (267)
T cd05066 235 PAALHQLMLDCWQK 248 (267)
T ss_pred CHHHHHHHHHHccc
Confidence 99999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=242.18 Aligned_cols=236 Identities=25% Similarity=0.395 Sum_probs=181.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |.||++.+..+++.||+|.+..... .+....+.+|+..+.++. |+||+++++++..+...+++||++
T Consensus 11 ~lg~G~~---g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 11 EIGRGAF---GTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred HhCCCCc---eEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 3788888 8999999999999999999876542 234567888999999996 999999999999888899999998
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK-HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~-~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (246)
. .++.+............+++..+..++.|++.+++|||+. +++|+||+|+||+++.++.++++|||++.........
T Consensus 86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 164 (288)
T cd06616 86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164 (288)
T ss_pred c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence 4 4555543221111123458999999999999999999975 9999999999999999999999999998765443333
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCC----CCCCH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYP----TAWSE 234 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~----~~~s~ 234 (246)
....++..|+|||.+.... ...++.++|+||+|+++++|++|+.||.... .......+.... ....+ ..+++
T Consensus 165 ~~~~~~~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSA--RDGYDVRSDVWSLGITLYEVATGKFPYPKWN-SVFDQLTQVVKGDPPILSNSEEREFSP 241 (288)
T ss_pred ccccCccCccCHHHhcccc--ccCCcchhhhhHHHHHHHHHHhCCCCchhcc-hHHHHHhhhcCCCCCcCCCcCCCccCH
Confidence 3445678899999986542 1237889999999999999999999997544 222222333222 22222 24899
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.+.+||++||+.
T Consensus 242 ~l~~li~~~l~~ 253 (288)
T cd06616 242 SFVNFINLCLIK 253 (288)
T ss_pred HHHHHHHHHccC
Confidence 999999999963
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=240.46 Aligned_cols=233 Identities=21% Similarity=0.349 Sum_probs=182.8
Q ss_pred CcCCCCccCeeeEEEEEecCCC----------------cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK----------------QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWF 65 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~----------------~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 65 (246)
.||+|++ |.||++.+..++ ..||+|.+..... ....+.+.+|++.+++++||||+++++
T Consensus 12 ~lg~G~~---g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (296)
T cd05051 12 KLGEGQF---GEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNIARLLG 86 (296)
T ss_pred cccCCCC---ccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 3688888 899998877544 5689999876542 345678889999999999999999999
Q ss_pred eeeeCCeEEEEEeecCCCChHHHHhhccccc------cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC
Q psy7592 66 CFQDEEDLFMVSDLLLGGDLRYHITQDIKFY------SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE 139 (246)
Q Consensus 66 ~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~ 139 (246)
++..+...++++|++.+++|.+++....... ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~ 166 (296)
T cd05051 87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN 166 (296)
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCC
Confidence 9999999999999999999999987654211 1246899999999999999999999999999999999999999
Q ss_pred CCeEEeecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCcc
Q psy7592 140 GHAHITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA--RGRPFDIHSNTS 214 (246)
Q Consensus 140 ~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~--g~~p~~~~~~~~ 214 (246)
+.++++|||.+........ .....++..|+|||...+.. ++.++|+||||+++|+|++ +..||.......
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 167 YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-----FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-----CCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 9999999999876543321 11233456799999887654 7889999999999999998 677886433222
Q ss_pred HHHHHhhhc--------CCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 215 VKDVKAIIY--------SPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 215 ~~~~~~~~~--------~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
....... ...+.|..+|+++.++|.+||+.
T Consensus 242 --~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 279 (296)
T cd05051 242 --VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRR 279 (296)
T ss_pred --HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhcc
Confidence 1222111 12334556789999999999963
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=235.44 Aligned_cols=230 Identities=24% Similarity=0.361 Sum_probs=186.3
Q ss_pred CcCCCCccCeeeEEEEEecCCC----cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK----QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||.|++ |.||++.+..++ ..||+|.+..... .+..+.+.+|++.++.++|+||+++++++.+.+..+++|
T Consensus 6 ~lg~g~~---g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 6 KLGEGAF---GEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred eeccCCC---cceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3678888 899999998776 9999999976542 225678889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
|++++++|.+++...... .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK---ELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhc---cCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999998764321 14899999999999999999999999999999999999999999999999987765432
Q ss_pred ccc--ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCC
Q psy7592 158 LAT--SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWS 233 (246)
Q Consensus 158 ~~~--~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s 233 (246)
... ...++..|+|||.+.+.. ++.++|+||||+++++|++ |..||...... .....+... ....|..++
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~-----~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGK-----FTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVLEYLKKGYRLPKPENCP 230 (258)
T ss_pred ccccccCCCcccccChHHhccCC-----CCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCCCCCCCcCC
Confidence 221 122557899999885443 7889999999999999998 78888653322 222232222 445567789
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
..+.+++.+||+.
T Consensus 231 ~~~~~~i~~~l~~ 243 (258)
T smart00219 231 PEIYKLMLQCWAE 243 (258)
T ss_pred HHHHHHHHHHCcC
Confidence 9999999999863
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=269.50 Aligned_cols=232 Identities=22% Similarity=0.379 Sum_probs=192.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCc-----EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ-----MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|.| |.||.++-..-.. .||+|.+++.. +++...+|.+|+.+++.++||||+++.+++-+....+++
T Consensus 699 ~lG~G~F---G~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 699 VLGKGAF---GEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eeccccc---cceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 5899999 8999999875433 38999987764 566788999999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhcccc--ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec
Q psy7592 77 SDLLLGGDLRYHITQDIKF--YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~ 154 (246)
+|||.||+|..++.+.... ....++...+..++.|++++++||++.++|||||...|+|++....+||.|||+++-+.
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy 853 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIY 853 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhh
Confidence 9999999999999875221 23446888899999999999999999999999999999999999999999999998544
Q ss_pred cCccccccc---cCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHH-hhhcCCCCCC
Q psy7592 155 ENQLATSMS---GTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVK-AIIYSPVHYP 229 (246)
Q Consensus 155 ~~~~~~~~~---~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~-~~~~~~~~~~ 229 (246)
......... -...|+|||.+..+. +++++|||||||++||+++ |..||...++.+. .. -....+.+.|
T Consensus 854 ~~~yyr~~~~a~lPvkWm~PEsl~d~i-----FtskSDvWsFGVllWEifslG~~PY~~~~n~~v--~~~~~~ggRL~~P 926 (1025)
T KOG1095|consen 854 DKDYYRKHGEAMLPVKWMPPESLKDGI-----FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV--LLDVLEGGRLDPP 926 (1025)
T ss_pred hchheeccCccccceecCCHHHHhhcc-----cccccchhhhHHHHHHHHhCCCCCCCCcchHHH--HHHHHhCCccCCC
Confidence 333222211 124699999998776 8999999999999999999 8899976554433 22 2233377778
Q ss_pred CCCCHhHHHHHHHhhh
Q psy7592 230 TAWSESTKHLLSQVHR 245 (246)
Q Consensus 230 ~~~s~~l~~li~~~l~ 245 (246)
..+++.+-+++.+||+
T Consensus 927 ~~CP~~ly~lM~~CW~ 942 (1025)
T KOG1095|consen 927 SYCPEKLYQLMLQCWK 942 (1025)
T ss_pred CCCChHHHHHHHHHcc
Confidence 8999999999999996
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=236.41 Aligned_cols=225 Identities=19% Similarity=0.365 Sum_probs=180.1
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|++ |+||.+.... +..+|+|.+..... + .+.+.+|+..+++++||||+++++++.+....+++|||+.+
T Consensus 12 lg~G~~---~~vy~~~~~~-~~~~aik~~~~~~~-~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 12 LGTGQF---GVVKYGKWRG-QYDVAIKMIKEGSM-S---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred ecCccc---ceEEEEEecC-CCcEEEEEcCCCcc-c---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 677777 8999998753 55699999875432 1 25678899999999999999999999988899999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--c
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA--T 160 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~ 160 (246)
++|.+++..... .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+......... .
T Consensus 84 ~~l~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 84 GCLLNYLREHGK----RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 999999865321 3588899999999999999999999999999999999999999999999988765433211 1
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKH 238 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~ 238 (246)
...++..|+|||...+.. ++.++|+||||+++|+|++ |..||...... .....+... ....|...++.+++
T Consensus 160 ~~~~~~~y~~pe~~~~~~-----~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSK-----FSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQGLRLYRPHLASEKVYA 232 (256)
T ss_pred CCccChhhCCHHHHhcCc-----ccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhcCCCCCCCCCCCHHHHH
Confidence 223446799999987654 7789999999999999998 99999654422 222233332 34456678999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
++.+||+.
T Consensus 233 li~~cl~~ 240 (256)
T cd05113 233 IMYSCWHE 240 (256)
T ss_pred HHHHHcCC
Confidence 99999963
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=238.78 Aligned_cols=228 Identities=23% Similarity=0.363 Sum_probs=176.6
Q ss_pred CcCCCCccCeeeEEEEE----ecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee--CCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQ----KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD--EEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~ 75 (246)
.||+|++ |+||++. ...+++.||+|.+.... .......+.+|++.+++++||||+++++++.. ....++
T Consensus 11 ~lg~g~~---g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 11 VLGEGHF---GKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ecccCCC---cEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 4788888 8997764 34578899999987643 22334677889999999999999999998765 346899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
+|||+.+++|.+++... .+++..+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||++.....
T Consensus 86 v~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999998653 248999999999999999999999999999999999999999999999999876543
Q ss_pred Ccc----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH------------HHHH
Q psy7592 156 NQL----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV------------KDVK 219 (246)
Q Consensus 156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~------------~~~~ 219 (246)
... .....++..|+|||.+.+.. ++.++|+||||+++++|++|..||........ ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~-----~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENK-----FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccC-----CCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 221 11123455699999886554 78899999999999999999999854321110 0111
Q ss_pred hhhc--CCCCCCCCCCHhHHHHHHHhhh
Q psy7592 220 AIIY--SPVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 220 ~~~~--~~~~~~~~~s~~l~~li~~~l~ 245 (246)
.... ...+.|..++..+.+++..||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~ 262 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWE 262 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhc
Confidence 1111 1233466789999999999996
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=237.60 Aligned_cols=224 Identities=27% Similarity=0.406 Sum_probs=184.6
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeee----CCeEEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQD----EEDLFMVS 77 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~~~v~ 77 (246)
||-|-. |.|..+.++.|++.+|+|++... .+.++|+++=... .|||||.++++++. ...+.+||
T Consensus 70 LG~Gin---GkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 70 LGAGIN---GKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred hccccC---CceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 555555 89999999999999999988553 3566677776555 59999999999874 34578899
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC---CeEEeecceeeeec
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG---HAHITDFNIATVLE 154 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~---~~~l~d~~~~~~~~ 154 (246)
|.++||.|...++..+. ..+++.++..|..||+.|+.|||+.+|.|||+||+|+|++.++ ..|++|||+++...
T Consensus 139 E~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred ecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 99999999999987653 3569999999999999999999999999999999999997544 68999999999877
Q ss_pred cCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHhhhcCCCCCCC--
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN--TSVKDVKAIIYSPVHYPT-- 230 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~-- 230 (246)
..........|+.|.|||.+.... ++..+|+||+|+++|-|++|.+||..... -+...-.+|......||.
T Consensus 216 ~~~~L~TPc~TPyYvaPevlg~eK-----ydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE 290 (400)
T KOG0604|consen 216 EPGDLMTPCFTPYYVAPEVLGPEK-----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE 290 (400)
T ss_pred CCccccCCcccccccCHHHhCchh-----cCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence 666666778899999999886554 88899999999999999999999932221 222344566677888874
Q ss_pred --CCCHhHHHHHHHhhh
Q psy7592 231 --AWSESTKHLLSQVHR 245 (246)
Q Consensus 231 --~~s~~l~~li~~~l~ 245 (246)
.+|++.+++|+.+|+
T Consensus 291 Ws~VSe~aKdlIR~LLk 307 (400)
T KOG0604|consen 291 WSCVSEAAKDLIRKLLK 307 (400)
T ss_pred HhHHHHHHHHHHHHHhc
Confidence 369999999999986
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=237.69 Aligned_cols=236 Identities=19% Similarity=0.255 Sum_probs=177.5
Q ss_pred CcCCCCccCeeeEEEEEecC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD--TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|+| |.||++.... ....+|+|.+.... .......+.+|+..++.++||||+++++.+.+....++||||
T Consensus 2 ~lg~G~f---g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWF---GKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred cCCccCC---ceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 3788888 8999986543 45678888876543 233456788899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL- 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (246)
+.+++|.+++...........++..+..++.|++.+++|||+.|++|+||+|+||+++.++.++++|||++........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 9999999998765433223346778889999999999999999999999999999999999999999998865332211
Q ss_pred --ccccccCCCccCCceeccccc--ccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-C-----CC
Q psy7592 159 --ATSMSGTKPYIAPEIFLVATD--EVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-P-----VH 227 (246)
Q Consensus 159 --~~~~~~~~~~~aPE~~~~~~~--~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~-----~~ 227 (246)
.....++..|+|||....... .....+.++|+||||+++|+|++ |..||..... .......... . ..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhhccCccCCCCc
Confidence 122334567999998754221 11236789999999999999999 7788864332 2222222222 2 22
Q ss_pred CCCCCCHhHHHHHHHhh
Q psy7592 228 YPTAWSESTKHLLSQVH 244 (246)
Q Consensus 228 ~~~~~s~~l~~li~~~l 244 (246)
.+..+++.+.+++..|+
T Consensus 235 ~~~~~~~~~~~~~~~~~ 251 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW 251 (269)
T ss_pred ccccCCHHHHHHHHHHh
Confidence 34468899999999887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=239.54 Aligned_cols=234 Identities=25% Similarity=0.388 Sum_probs=191.1
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
||.|.| |+|++..++.+|+..|||.++.... +...+++..|.+...+- ++|+||++|+.+..++..|+.||.|
T Consensus 72 iG~G~f---G~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 72 IGNGAF---GTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred hcCCcc---hhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 677777 9999999999999999999988764 44567888888877666 6999999999998888999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLK-TKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh-~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
+.||..+...-.......+++..+-.+......||.||. +..++|||+||+|||++..|.+|+||||.+.....+....
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT 225 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT 225 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh
Confidence 778777665433333455699999999999999999997 4579999999999999999999999999998776665555
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCC---CC---CCCH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY---PT---AWSE 234 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~---~~s~ 234 (246)
.-.|...|+|||.+..... .++.+||+||||+.+||+.||..|+.+.+. ..+++..++...++. +. .+|.
T Consensus 226 ~daGCrpYmAPERi~p~~~---gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDPSDK---GYDIRSDVWSLGITLYEVATGNFPYRKWDS-VFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred hccCCccccChhccCCccC---CcchhhhhhhhcceEeeeecCCCCcchHHH-HHHHHHHHHcCCCCeecCcccccccCH
Confidence 6678999999999865542 488999999999999999999999987764 233444444443332 22 3899
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.++.+|+.||.+
T Consensus 302 ~~~~fintCl~K 313 (361)
T KOG1006|consen 302 SMVRFINTCLIK 313 (361)
T ss_pred HHHHHHHHHhhc
Confidence 999999999864
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=240.97 Aligned_cols=197 Identities=28% Similarity=0.423 Sum_probs=165.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.++.+++.||+|.+....... ...+.+.+|++.++.++||||+++++++.++...++++||++
T Consensus 8 ~lg~g~~---~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (286)
T cd07846 8 LVGEGSY---GMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83 (286)
T ss_pred eeccCCC---eEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence 3788888 899999999999999999986644322 345678889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-AT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 160 (246)
+++|......... +++..++.++.|++.++.|||+.|++|+||+|+||++++++.++++|||++........ ..
T Consensus 84 ~~~l~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 84 HTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred ccHHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence 9888877654322 48899999999999999999999999999999999999999999999999877544322 22
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
...++..|+|||...+.. .++.++|+||||+++++|++|.+||....
T Consensus 159 ~~~~~~~y~aPE~~~~~~----~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 159 DYVATRWYRAPELLVGDT----KYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred cccceeeccCcHHhcccc----ccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 344677899999886432 25678999999999999999999996443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=239.44 Aligned_cols=235 Identities=27% Similarity=0.409 Sum_probs=181.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeC-----CeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDE-----EDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-----~~~~~ 75 (246)
.||+|++ |.||++.++.+++.||+|.+.... .....+.+|+..++++ +|||++++++++... ...++
T Consensus 29 ~l~~g~~---~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l 101 (291)
T cd06639 29 TIGKGTY---GKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101 (291)
T ss_pred EeecCCC---eEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence 3677888 899999999999999999986543 1234566788899998 799999999998753 35899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
|+||+.+++|.+++..... ....+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+.....
T Consensus 102 v~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 102 VLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 9999999999998764211 123458899999999999999999999999999999999999999999999998876543
Q ss_pred Ccc-ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCCCC
Q psy7592 156 NQL-ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPTA 231 (246)
Q Consensus 156 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 231 (246)
... .....++..|+|||.+.........++.++|+||||+++|+|++|..||.... .......+... ....|..
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~ 258 (291)
T cd06639 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH--PVKTLFKIPRNPPPTLLHPEK 258 (291)
T ss_pred ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc--HHHHHHHHhcCCCCCCCcccc
Confidence 221 22245677899999876443222236789999999999999999999996432 22222222222 2223567
Q ss_pred CCHhHHHHHHHhhhC
Q psy7592 232 WSESTKHLLSQVHRY 246 (246)
Q Consensus 232 ~s~~l~~li~~~l~~ 246 (246)
++..++++|.+||++
T Consensus 259 ~~~~l~~li~~~l~~ 273 (291)
T cd06639 259 WCRSFNHFISQCLIK 273 (291)
T ss_pred cCHHHHHHHHHHhhc
Confidence 889999999999964
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=242.98 Aligned_cols=194 Identities=24% Similarity=0.414 Sum_probs=160.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||+++++.+|+.||+|.+..... +......+.+|+..+++++||||+++++++.+....++++||+.
T Consensus 7 ~l~~g~~---~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 7 KIGEGTY---GTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred EecccCC---eEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 3688888 8999999999999999999875432 22233567789999999999999999999999999999999995
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
++|.+++.... ..+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 83 -~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 83 -QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred -CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 57777765421 235899999999999999999999999999999999999999999999999987654322 122
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFD 208 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~ 208 (246)
...++..|+|||.+.+.. .++.++|+||||+++|+|++|..|+.
T Consensus 158 ~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAK----LYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CCccccCCcChHHHhCCc----ccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 344577899999886543 26789999999999999999988863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=238.08 Aligned_cols=225 Identities=20% Similarity=0.259 Sum_probs=175.8
Q ss_pred CcCCCCccCeeeEEEEEecC------------------------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD------------------------TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH 57 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~------------------------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h 57 (246)
+||+|+| |.||++.... ....|++|.+.... .+....+.+|+.++++++|
T Consensus 2 ~lG~G~~---~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h 75 (274)
T cd05076 2 HLGQGTR---TNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSH 75 (274)
T ss_pred CcCcccc---cceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCC
Confidence 6899999 8999987432 22458899886543 3344668889999999999
Q ss_pred CcceeeeeeeeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc
Q psy7592 58 PFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD 137 (246)
Q Consensus 58 ~~iv~~~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~ 137 (246)
|||+++++++.++...++||||+++++|..++.... ..+++..+..++.|++.|++|||+.|++|+||+|+||+++
T Consensus 76 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 76 IHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred CCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 999999999999999999999999999998886532 1348888999999999999999999999999999999997
Q ss_pred CCC-------CeEEeecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHH-hCCCCCCC
Q psy7592 138 EEG-------HAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL-ARGRPFDI 209 (246)
Q Consensus 138 ~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll-~g~~p~~~ 209 (246)
..+ .++++|||.+...... ....++..|+|||.+.+.. .++.++|+||||+++|+++ +|..||..
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~----~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGN----SLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred ccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCC----CCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 654 3799999987543221 2234567899999886532 3788999999999999985 68999975
Q ss_pred CCCccHHHHHhhhcCCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 210 HSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
...... ..........|...++.+.++|.+||+.
T Consensus 225 ~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~cl~~ 258 (274)
T cd05076 225 RTPSEK---ERFYEKKHRLPEPSCKELATLISQCLTY 258 (274)
T ss_pred cChHHH---HHHHHhccCCCCCCChHHHHHHHHHccc
Confidence 443222 2333344456666788999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=236.44 Aligned_cols=238 Identities=20% Similarity=0.232 Sum_probs=178.8
Q ss_pred CcCCCCccCeeeEEEEEec--CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKK--DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|++ |.||++... .++..+|+|.++.... ......+.+|+..+++++||||+++++++.+....++||||
T Consensus 2 ~lg~G~~---g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 2 EIGNGWF---GKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred cccccCC---ceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence 4789999 899999864 3567899998876542 23345788899999999999999999999988899999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL- 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (246)
+++++|.+++...........+...+..++.|++.++.|||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9999999998754322223346677888999999999999999999999999999999999999999998865332211
Q ss_pred --ccccccCCCccCCceecccccc--cCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcCCC-----CC
Q psy7592 159 --ATSMSGTKPYIAPEIFLVATDE--VLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYSPV-----HY 228 (246)
Q Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~--~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~-----~~ 228 (246)
.....++..|+|||.+...... ...++.++|+||||+++++|++ |..||.......... ..+..... ..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT-YTVREQQLKLPKPRL 235 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH-HHhhcccCCCCCCcc
Confidence 1223456789999988643211 1125779999999999999996 999996544322211 11111212 22
Q ss_pred CCCCCHhHHHHHHHhhh
Q psy7592 229 PTAWSESTKHLLSQVHR 245 (246)
Q Consensus 229 ~~~~s~~l~~li~~~l~ 245 (246)
+...++.+.++++.|+.
T Consensus 236 ~~~~~~~~~~l~~~c~~ 252 (269)
T cd05087 236 KLPLSDRWYEVMQFCWL 252 (269)
T ss_pred CCCCChHHHHHHHHHhc
Confidence 23578899999999973
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=238.88 Aligned_cols=233 Identities=23% Similarity=0.347 Sum_probs=183.9
Q ss_pred CcCCCCccCeeeEEEEEecCCC------cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK------QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 75 (246)
.||+|++ |.||++.++... +.+|+|.+.... ..+....+.+|+..++.++||||+++++++......++
T Consensus 2 ~lg~g~~---g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
T cd05044 2 FLGSGAF---GEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI 76 (269)
T ss_pred ccccccc---eeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence 5899999 899999987544 789999886542 23345678889999999999999999999998889999
Q ss_pred EEeecCCCChHHHHhhcccc--ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-----CeEEeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKF--YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG-----HAHITDFN 148 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~-----~~~l~d~~ 148 (246)
+|||+++++|.+++...... ....+++..+..++.|++.++.|||+.+++|+||+|+||+++.++ .++++|||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999998653221 122357888999999999999999999999999999999999877 89999999
Q ss_pred eeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc-
Q psy7592 149 IATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY- 223 (246)
Q Consensus 149 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~- 223 (246)
++........ ......+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||..... ......+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~ 229 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-----FTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHVTAG 229 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCC-----cccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHHhcC
Confidence 9876533221 11223456899999987654 7889999999999999998 9999964332 222222222
Q ss_pred CCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 224 SPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 224 ~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.....+...|+.+.++|.+||+.
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~ 252 (269)
T cd05044 230 GRLQKPENCPDKIYQLMTNCWAQ 252 (269)
T ss_pred CccCCcccchHHHHHHHHHHcCC
Confidence 24455678899999999999963
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=235.51 Aligned_cols=228 Identities=20% Similarity=0.297 Sum_probs=181.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCc---EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ---MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
+||+|++ |.||+++++.++. .+|+|.+.... .....+.+..|++.+++++|||++++.+++.+.+..+++||
T Consensus 12 ~lg~g~~---g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 12 VIGAGEF---GEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred EecCCCC---ccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 4788998 8999999986654 79999886543 23345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+.+++|.+++.... ..++...+..++.|++.|+++||+.|++|+||+|+||+++.++.++++|||++........
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 87 YMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred cCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 999999999986532 2348888999999999999999999999999999999999999999999999876543221
Q ss_pred cc----ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCC
Q psy7592 159 AT----SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAW 232 (246)
Q Consensus 159 ~~----~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (246)
.. ....+..|+|||.+.... ++.++|+||||+++|++++ |..||..... ......+... ..+.+..+
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~-----~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~~~ 235 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRK-----FTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAINDGFRLPAPMDC 235 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCC-----cChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhcCCCCCCCCCC
Confidence 11 111234699999887654 7889999999999999997 9999965432 2233333322 33445568
Q ss_pred CHhHHHHHHHhhh
Q psy7592 233 SESTKHLLSQVHR 245 (246)
Q Consensus 233 s~~l~~li~~~l~ 245 (246)
+..+.+++.+||+
T Consensus 236 ~~~~~~li~~c~~ 248 (268)
T cd05063 236 PSAVYQLMLQCWQ 248 (268)
T ss_pred CHHHHHHHHHHcC
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=240.42 Aligned_cols=233 Identities=22% Similarity=0.366 Sum_probs=184.2
Q ss_pred CcCCCCccCeeeEEEEEecCC-----CcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT-----KQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 75 (246)
.||+|++ |.||++.++.. ...+|+|.+.... +......+.+|+++++++ +|+||+++++++..+...++
T Consensus 19 ~ig~g~~---g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 19 PLGEGAF---GQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred Eeccccc---ccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence 4788888 89999998643 3789999987643 233456788999999999 79999999999999999999
Q ss_pred EEeecCCCChHHHHhhccc-----------cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEE
Q psy7592 76 VSDLLLGGDLRYHITQDIK-----------FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHI 144 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~-----------~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l 144 (246)
+|||+.+++|..++..... .....+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.+++
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL 173 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKI 173 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEe
Confidence 9999999999999865321 12334688889999999999999999999999999999999999999999
Q ss_pred eecceeeeeccCccc---cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHh
Q psy7592 145 TDFNIATVLEENQLA---TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKA 220 (246)
Q Consensus 145 ~d~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~ 220 (246)
+|||.+......... .....+..|+|||.+.+.. ++.++|+||||+++|++++ |..||...... .....
T Consensus 174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~ 246 (293)
T cd05053 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-----YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--ELFKL 246 (293)
T ss_pred CccccccccccccceeccCCCCCCccccCHHHhccCC-----cCcccceeehhhHHHHHhcCCCCCCCCCCHH--HHHHH
Confidence 999998765432211 1122345799999886654 7889999999999999997 99999654322 22222
Q ss_pred hhcC-CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 221 IIYS-PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 221 ~~~~-~~~~~~~~s~~l~~li~~~l~~ 246 (246)
+... ....|...+..+.+++.+||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~li~~~l~~ 273 (293)
T cd05053 247 LKEGYRMEKPQNCTQELYHLMRDCWHE 273 (293)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHccc
Confidence 2222 4456778899999999999963
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=239.03 Aligned_cols=227 Identities=27% Similarity=0.427 Sum_probs=184.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.+|+|++ |.||++.+..+++.|++|.+..... ..+.+.+|++.+++++|+|++++++++..+...++++||++
T Consensus 26 ~l~~g~~---~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 26 KIGEGAS---GEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred hccCCCC---eEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 3677877 8999999998999999999976542 34678889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-AT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 160 (246)
+++|.+++.... ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+........ ..
T Consensus 99 ~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 174 (286)
T cd06614 99 GGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174 (286)
T ss_pred CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence 999999998754 2458899999999999999999999999999999999999999999999998765433221 12
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh-cCCCC--CCCCCCHhHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII-YSPVH--YPTAWSESTK 237 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~s~~l~ 237 (246)
...++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+... ....+. ..... .+..++..++
T Consensus 175 ~~~~~~~y~~PE~~~~~~-----~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~ 247 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKD-----YGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALFLITTKGIPPLKNPEKWSPEFK 247 (286)
T ss_pred cccCCcccCCHhHhcCCC-----CCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcCCCCCcchhhCCHHHH
Confidence 234567899999887654 6889999999999999999999997543322 122222 22222 2334899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|++||+.
T Consensus 248 ~li~~~l~~ 256 (286)
T cd06614 248 DFLNKCLVK 256 (286)
T ss_pred HHHHHHhcc
Confidence 999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=257.59 Aligned_cols=190 Identities=25% Similarity=0.428 Sum_probs=153.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC------CCcceeeeeeeeeC-CeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE------HPFLVNLWFCFQDE-EDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~-~~~~ 74 (246)
.||+|+| |+||++.+..+++.||||+++... ...+....|+++++.++ |.+++++++++..+ .++|
T Consensus 136 ~lG~G~f---g~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 136 LLGEGTF---GKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred EEEeccC---EEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 4788888 999999999999999999996532 12234455666666664 44588888888754 5789
Q ss_pred EEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCC-------------
Q psy7592 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEG------------- 140 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~------------- 140 (246)
+||+++ |++|.+++.+... +++..+..++.|++.||.|||+ .|++|+||||+||+++.++
T Consensus 209 iv~~~~-g~~l~~~l~~~~~-----l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHGP-----FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred EEEecc-CCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 999988 7888888876443 4889999999999999999998 5999999999999998765
Q ss_pred ---CeEEeecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 141 ---HAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 141 ---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.++|+|||.+..... ......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+
T Consensus 283 ~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~-----~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLG-----WMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred CCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCC-----CCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 489999998754222 223456789999999998765 7889999999999999999999997654
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=237.48 Aligned_cols=196 Identities=25% Similarity=0.414 Sum_probs=166.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.+..+|+.||+|.+..... .......+.+|+..+++++||||+++++++.++...++|+||+
T Consensus 7 ~l~~g~~---~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~- 81 (286)
T cd07832 7 RIGEGAH---GIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM- 81 (286)
T ss_pred ecccCCC---cEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence 3678888 8999999999999999999976542 2234567889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--A 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 159 (246)
+++|.+.+.... .++++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+........ .
T Consensus 82 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 82 PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 999999886532 3468999999999999999999999999999999999999999999999999877654331 2
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
....++..|+|||.+.+.. .++.++|+||+|+++++|++|.+||...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 158 SHQVATRWYRAPELLYGAR----KYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred ccccCcccccCceeeeccc----cCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 2345677899999886543 2578999999999999999998888643
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=243.52 Aligned_cols=201 Identities=22% Similarity=0.392 Sum_probs=164.3
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||.| +|++++||++.+..+|+.||+|.+...... .+..+.+.+|+.+++.++||||++++++|..++..++++||+.+
T Consensus 6 ig~g-~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 6 IGRG-FCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred hCCc-ccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 6776 667799999999999999999998765432 34457889999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc---
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA--- 159 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--- 159 (246)
+++.+.+.... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999887642 224588899999999999999999999999999999999999999999999754332211100
Q ss_pred -----cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 160 -----TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 160 -----~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
....+...|+|||.+.+... .++.++|+||+|+++++|++|..||....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLY---GYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cccccccccCccCccChhhhcCCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 01123456999999865421 26789999999999999999999996543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=242.31 Aligned_cols=198 Identities=27% Similarity=0.422 Sum_probs=165.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI--ERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|++ |.||++.+..+++.||+|.+...... .......+..|++.+++++|+||+++++++.++...++||||
T Consensus 7 ~lg~g~~---~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (298)
T cd07841 7 KLGEGTY---AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF 83 (298)
T ss_pred eeeeccc---cEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcc
Confidence 4788888 89999999999999999999876532 122345577899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL- 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (246)
+ +++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 84 M-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred c-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 9 889999986543 1358999999999999999999999999999999999999999999999999877654321
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
......+..|.|||.+.+.. .++.++|+||||+++++|++|.+||.+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~----~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGAR----HYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred ccccccceeeeCHHHHhCCC----CCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 22234567799999875432 36789999999999999999988886543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=243.00 Aligned_cols=196 Identities=24% Similarity=0.407 Sum_probs=157.5
Q ss_pred CcCCCCccCeeeEEEEEec--CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee--CCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK--DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD--EEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~ 77 (246)
.||+|+| |+||+|+++ .+++.||+|.+..... ...+.+|++++++++||||+++++++.. +...++++
T Consensus 8 ~lG~G~~---g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 8 KVGRGTY---GHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccCCC---eEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 4788888 999999976 4778999999865431 2346679999999999999999999864 45689999
Q ss_pred eecCCCChHHHHhhccc----cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE----cCCCCeEEeecce
Q psy7592 78 DLLLGGDLRYHITQDIK----FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL----DEEGHAHITDFNI 149 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~----~~~~~~~l~d~~~ 149 (246)
||+ +++|.+.+..... .....+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++++|||+
T Consensus 80 e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 80 DYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred ecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 998 5578777653221 112346899999999999999999999999999999999999 4567899999999
Q ss_pred eeeeccCc----cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 150 ATVLEENQ----LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 150 ~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
+....... ......+++.|+|||.+.+.. .++.++|+||+|+++++|++|++||.+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR----HYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCC----CcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 97754322 122345788899999987643 3678999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=250.67 Aligned_cols=188 Identities=26% Similarity=0.340 Sum_probs=158.7
Q ss_pred CcCCCCccCeeeEEEEEec--CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKK--DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||.|++ |.||++... .+++.||+|.+.... ...+|++++++++||||+++++++..+...+++||+
T Consensus 99 ~Lg~G~~---g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 99 SLTPGSE---GEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred eecCCCC---eEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 4688888 899999764 457889999886532 345799999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL- 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (246)
+ +++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 168 ~-~~~l~~~l~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 168 Y-KCDLFTYVDRSG-----PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred c-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9 467887774433 348999999999999999999999999999999999999999999999999876543322
Q ss_pred --ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 159 --ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+..
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDP-----YCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred ccccccccccCccCHhHhcCCC-----CCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 22356889999999987654 7889999999999999999999996644
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=240.45 Aligned_cols=232 Identities=20% Similarity=0.343 Sum_probs=181.5
Q ss_pred CcCCCCccCeeeEEEEEecC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD-------TKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 73 (246)
.||+|++ |.||++.+.. +...||+|.+.... .......+.+|++.++.+ +||||+++++++..+...
T Consensus 25 ~lg~G~~---g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (307)
T cd05098 25 PLGEGCF---GQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 99 (307)
T ss_pred eeccCCC---eeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 3688888 8999998643 33579999997643 233346788899999999 799999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcccc-----------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCe
Q psy7592 74 FMVSDLLLGGDLRYHITQDIKF-----------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHA 142 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~ 142 (246)
+++|||+.+++|.+++...... ....++..+++.++.|++.+|++||+.|++|+||+|+||+++.++.+
T Consensus 100 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~ 179 (307)
T cd05098 100 YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 179 (307)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcE
Confidence 9999999999999999764321 11236788899999999999999999999999999999999999999
Q ss_pred EEeecceeeeeccCcccc---ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHH
Q psy7592 143 HITDFNIATVLEENQLAT---SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDV 218 (246)
Q Consensus 143 ~l~d~~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~ 218 (246)
+++|||.+.......... ....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||..... ....
T Consensus 180 kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~~~~ 252 (307)
T cd05098 180 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-----YTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EELF 252 (307)
T ss_pred EECCCcccccccccchhhccccCCCccceeChHHhccCC-----CCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHHH
Confidence 999999987654322111 112345799999887654 7889999999999999998 8889864332 2222
Q ss_pred HhhhcC-CCCCCCCCCHhHHHHHHHhhh
Q psy7592 219 KAIIYS-PVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 219 ~~~~~~-~~~~~~~~s~~l~~li~~~l~ 245 (246)
..+... ....|..++.+++++|.+||+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~li~~~l~ 280 (307)
T cd05098 253 KLLKEGHRMDKPSNCTNELYMMMRDCWH 280 (307)
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcc
Confidence 222222 345677899999999999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=235.58 Aligned_cols=225 Identities=24% Similarity=0.436 Sum_probs=184.4
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|++ |.||++.++.+++.||+|.+..... ....+.+.+|+..+++++||||+++++.+.++...++||||+.+
T Consensus 12 ig~G~~---~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06641 12 IGKGSF---GEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 86 (277)
T ss_pred EeecCC---eEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCC
Confidence 678888 8999999999999999998865432 33456788999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-ccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-ATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~ 161 (246)
++|.+++.+. .++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++........ ...
T Consensus 87 ~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 87 GSALDLLEPG------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence 9999888642 248888999999999999999999999999999999999999999999998876543321 222
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc-CCCCCCCCCCHhHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY-SPVHYPTAWSESTKHLL 240 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~l~~li 240 (246)
..++..|+|||.+.+.. .+.++|+||||+++++|++|..||..... ......+.. ....++..++.++.++|
T Consensus 161 ~~~~~~y~~PE~~~~~~-----~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (277)
T cd06641 161 FVGTPFWMAPEVIKQSA-----YDSKADIWSLGITAIELAKGEPPHSELHP--MKVLFLIPKNNPPTLEGNYSKPLKEFV 233 (277)
T ss_pred ccCCccccChhhhccCC-----CCchhhHHHHHHHHHHHHcCCCCCCccch--HHHHHHHhcCCCCCCCcccCHHHHHHH
Confidence 34677899999887554 67899999999999999999999964332 222222222 24445667899999999
Q ss_pred HHhhh
Q psy7592 241 SQVHR 245 (246)
Q Consensus 241 ~~~l~ 245 (246)
.+||+
T Consensus 234 ~~~l~ 238 (277)
T cd06641 234 EACLN 238 (277)
T ss_pred HHHcc
Confidence 99986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=238.16 Aligned_cols=232 Identities=18% Similarity=0.285 Sum_probs=183.2
Q ss_pred CcCCCCccCeeeEEEEEec-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK-----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||.|++ |.||++.++ .++..||+|.+.... +.+..+++.+|+.++++++||||+++++++.++...+++
T Consensus 12 ~lg~g~~---g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 12 DIGQGAF---GRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred ccccccc---ccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence 3677777 899999975 368899999987543 234456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhcccc-----------------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC
Q psy7592 77 SDLLLGGDLRYHITQDIKF-----------------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE 139 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~-----------------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~ 139 (246)
+||+++++|.+++...... ....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~ 166 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN 166 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCC
Confidence 9999999999998753211 11235788899999999999999999999999999999999999
Q ss_pred CCeEEeecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccH
Q psy7592 140 GHAHITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSV 215 (246)
Q Consensus 140 ~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~ 215 (246)
+.++++|||.+........ ......+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+... .
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~il~el~~~~~~p~~~~~~--~ 239 (288)
T cd05050 167 MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-----YTTESDVWAYGVVLWEIFSYGMQPYYGMAH--E 239 (288)
T ss_pred CceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-----CCchhHHHHHHHHHHHHHhCCCCCCCCCCH--H
Confidence 9999999999876533221 11223356799999886654 7889999999999999997 8888854332 2
Q ss_pred HHHHhhhcC-CCCCCCCCCHhHHHHHHHhhh
Q psy7592 216 KDVKAIIYS-PVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 216 ~~~~~~~~~-~~~~~~~~s~~l~~li~~~l~ 245 (246)
.....+... ..+.|...+.++.++|.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 270 (288)
T cd05050 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWS 270 (288)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 223333323 334567889999999999996
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=234.92 Aligned_cols=231 Identities=27% Similarity=0.414 Sum_probs=189.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |.||++.++.+++.||+|.+...... ......+.+|++.+++++|+||+++++++.++...++++||++
T Consensus 7 ~i~~g~~---~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 7 KLGKGSY---GSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred eecCCCc---eeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 3677777 89999999999999999999765432 3345677889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|..++..... ....+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+...... ....
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~ 160 (256)
T cd08530 83 FGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKT 160 (256)
T ss_pred CCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cccc
Confidence 9999998866322 1344688899999999999999999999999999999999999999999999998766544 2223
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHLL 240 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~li 240 (246)
..++..|+|||.+.+.. ++.++|+||||+++++|++|+.||...+.. .....+... ..+.+..++.+++++|
T Consensus 161 ~~~~~~~~~Pe~~~~~~-----~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li 233 (256)
T cd08530 161 QIGTPHYMAPEVWKGRP-----YSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQRGKYPPIPPIYSQDLQNFI 233 (256)
T ss_pred ccCCccccCHHHHCCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhcCCCCCCchhhCHHHHHHH
Confidence 45678899999987654 678999999999999999999999754432 222222222 4455668999999999
Q ss_pred HHhhh
Q psy7592 241 SQVHR 245 (246)
Q Consensus 241 ~~~l~ 245 (246)
++||+
T Consensus 234 ~~~l~ 238 (256)
T cd08530 234 RSMLQ 238 (256)
T ss_pred HHHcC
Confidence 99996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=232.39 Aligned_cols=228 Identities=27% Similarity=0.458 Sum_probs=188.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.+..+++.|++|.++.... +..+.+.+|++.+++++|++++++++++......++++||++
T Consensus 7 ~l~~g~~---~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 7 KIGKGGF---GEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred eeccCCc---eEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677777 8999999999999999999977652 456788899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+.+.... .++++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 81 GGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred CCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence 999999987642 3458999999999999999999999999999999999999999999999999877655432334
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC--CCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP--TAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~l 239 (246)
..++..|+|||.+.+.. .+.++|+||||+++++|++|..||...+......... .......+ ..++..+.++
T Consensus 157 ~~~~~~~~~PE~~~~~~-----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 230 (253)
T cd05122 157 MVGTPYWMAPEVINGKP-----YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA-TNGPPGLRNPEKWSDEFKDF 230 (253)
T ss_pred eecCCcccCHHHHcCCC-----CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-hcCCCCcCcccccCHHHHHH
Confidence 56778899999987654 6789999999999999999999997553322221111 12223333 3459999999
Q ss_pred HHHhhh
Q psy7592 240 LSQVHR 245 (246)
Q Consensus 240 i~~~l~ 245 (246)
|.+||+
T Consensus 231 i~~~l~ 236 (253)
T cd05122 231 LKKCLQ 236 (253)
T ss_pred HHHHcc
Confidence 999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=246.82 Aligned_cols=186 Identities=25% Similarity=0.318 Sum_probs=156.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++++..+++.||+|...... ...|+.++++++||||+++++++.++...++|+|++
T Consensus 73 ~lg~G~~---g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~- 139 (357)
T PHA03209 73 TLTPGSE---GRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY- 139 (357)
T ss_pred EecCCCC---eEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-
Confidence 3678888 999999999999999999754432 345889999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
.++|.+++... ..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||.+...........
T Consensus 140 ~~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 215 (357)
T PHA03209 140 SSDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215 (357)
T ss_pred CCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccccc
Confidence 45777777543 23458999999999999999999999999999999999999999999999999875433333334
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCC-CCCC
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDI 209 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~-p~~~ 209 (246)
..++..|+|||.+.+.. ++.++|+||||+++|+|+++.. +|..
T Consensus 216 ~~gt~~y~aPE~~~~~~-----~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 216 LAGTVETNAPEVLARDK-----YNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred ccccccccCCeecCCCC-----CCchhhHHHHHHHHHHHHHcCCccccC
Confidence 56788999999997664 7889999999999999998554 4443
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=236.58 Aligned_cols=227 Identities=20% Similarity=0.333 Sum_probs=181.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCc----EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ----MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||+|++ |+||++.++.+++ .||+|....... ......+.+|+..+++++||||+++++++.. ...++++
T Consensus 14 ~ig~g~~---g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 14 VLGSGAF---GTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred eecCCCC---ccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence 4788888 8999999876665 689998876542 3445678889999999999999999999887 6789999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||+.+++|.+++..... .+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 88 e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 88 QLMPLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred ecCCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 99999999999876422 25889999999999999999999999999999999999999999999999987654322
Q ss_pred ccc---ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc-CCCCCCCCC
Q psy7592 158 LAT---SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY-SPVHYPTAW 232 (246)
Q Consensus 158 ~~~---~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (246)
... ....+..|+|||.+.... ++.++|+||||++++++++ |..||........ ...+.. ...+.|...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~-----~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~ 236 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRI-----YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI--PDLLEKGERLPQPPIC 236 (279)
T ss_pred cceecCCCcccccccCHHHhhcCC-----cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH--HHHHhCCCCCCCCCCC
Confidence 111 111245799999886554 7789999999999999998 9999975443222 222222 245566778
Q ss_pred CHhHHHHHHHhhh
Q psy7592 233 SESTKHLLSQVHR 245 (246)
Q Consensus 233 s~~l~~li~~~l~ 245 (246)
+..+.+++.+||.
T Consensus 237 ~~~~~~~~~~~l~ 249 (279)
T cd05057 237 TIDVYMVLVKCWM 249 (279)
T ss_pred CHHHHHHHHHHcC
Confidence 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=240.51 Aligned_cols=226 Identities=26% Similarity=0.391 Sum_probs=181.5
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|++ |.||++.+..+++.||+|.+.... ....+.+.+|+..+++++|||++++++++......++|+||+++
T Consensus 27 lg~g~~---g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 100 (293)
T cd06647 27 IGQGAS---GTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100 (293)
T ss_pred ecCCCC---eEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCC
Confidence 678888 899999999899999999986543 22346678899999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-ccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-ATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~ 161 (246)
++|.+++.+. .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++........ ...
T Consensus 101 ~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 101 GSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred CcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 9999988653 237888999999999999999999999999999999999999999999998876543322 222
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCC--CCCCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPV--HYPTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~l~~l 239 (246)
..++..|++||.+.... ++.++|+||||++++++++|..||......... ......... ..+...+..++++
T Consensus 175 ~~~~~~y~~PE~~~~~~-----~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 175 MVGTPYWMAPEVVTRKA-----YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTPELQNPEKLSAIFRDF 248 (293)
T ss_pred ccCChhhcCchhhccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-eehhcCCCCCCCCccccCHHHHHH
Confidence 35677899999986654 688999999999999999999999654322111 111111222 2234578899999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 249 i~~~l~~ 255 (293)
T cd06647 249 LNRCLEM 255 (293)
T ss_pred HHHHccC
Confidence 9999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=238.03 Aligned_cols=231 Identities=21% Similarity=0.377 Sum_probs=179.5
Q ss_pred CcCCCCccCeeeEEEEEe----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC--CeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQK----KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE--EDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~ 75 (246)
.||+|++ |.||++.. +.++..||+|.++... .....+.+.+|++.+++++|||++++++++.+. ...++
T Consensus 11 ~lg~g~~---g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 11 DLGEGHF---GKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred ecCCCCc---eeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 4788888 89999974 4678999999987553 234456789999999999999999999998765 56899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
+|||++|++|.+++.... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+.....
T Consensus 86 v~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999986532 1358889999999999999999999999999999999999999999999999876543
Q ss_pred Cccc----cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------------ccHHHHH
Q psy7592 156 NQLA----TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN------------TSVKDVK 219 (246)
Q Consensus 156 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~------------~~~~~~~ 219 (246)
.... ....++..|+|||.+.+.. ++.++|+||||+++|+|+++..|+..... .......
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~-----~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSK-----FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCC-----CCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 3211 1234556799999887654 77899999999999999998765421100 0011111
Q ss_pred hhhcC--CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 220 AIIYS--PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 220 ~~~~~--~~~~~~~~s~~l~~li~~~l~~ 246 (246)
..... ..+.+..+++.+.++|.+||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 265 (284)
T cd05079 237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEF 265 (284)
T ss_pred HHHHcCccCCCCCCCCHHHHHHHHHHccC
Confidence 11111 3344567899999999999963
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=240.11 Aligned_cols=232 Identities=20% Similarity=0.354 Sum_probs=181.6
Q ss_pred CcCCCCccCeeeEEEEEec-------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK-------DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 73 (246)
.||+|++ |.||++++. .....||+|.++... .......+.+|++.++++ +||||+++++++.++...
T Consensus 19 ~lg~G~~---g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 93 (314)
T cd05099 19 PLGEGCF---GQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPL 93 (314)
T ss_pred eecCCCc---ccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCce
Confidence 4788888 899999863 235679999987543 234456788899999999 699999999999998999
Q ss_pred EEEEeecCCCChHHHHhhcccc-----------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCe
Q psy7592 74 FMVSDLLLGGDLRYHITQDIKF-----------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHA 142 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~ 142 (246)
+++|||+.+++|.+++...... ....++...+..++.|++.||.|||+.|++|+||+|+||+++.++.+
T Consensus 94 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~ 173 (314)
T cd05099 94 YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVM 173 (314)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcE
Confidence 9999999999999999764210 12336788899999999999999999999999999999999999999
Q ss_pred EEeecceeeeeccCcccc---ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHH
Q psy7592 143 HITDFNIATVLEENQLAT---SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDV 218 (246)
Q Consensus 143 ~l~d~~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~ 218 (246)
+++|||.++......... ....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...... ...
T Consensus 174 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~ 246 (314)
T cd05099 174 KIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-----YTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--ELF 246 (314)
T ss_pred EEccccccccccccccccccccCCCCccccCHHHHccCC-----cCccchhhHHHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 999999987654322111 112335699999886654 7889999999999999999 88899653322 222
Q ss_pred HhhhcC-CCCCCCCCCHhHHHHHHHhhh
Q psy7592 219 KAIIYS-PVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 219 ~~~~~~-~~~~~~~~s~~l~~li~~~l~ 245 (246)
..+... ....|..++.+++++|.+||+
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~ 274 (314)
T cd05099 247 KLLREGHRMDKPSNCTHELYMLMRECWH 274 (314)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 222222 345567889999999999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=232.85 Aligned_cols=226 Identities=21% Similarity=0.351 Sum_probs=179.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.+. ++..+|+|.+...... .+.+.+|+.++++++|++++++++++.+ ...+++|||+.
T Consensus 13 ~ig~g~~---~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (260)
T cd05070 13 KLGNGQF---GEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS 83 (260)
T ss_pred eeccccC---ceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence 3678888 899999876 5677999998764421 2457889999999999999999998854 45789999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-- 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (246)
+++|.+++.... ...+++..+..++.|++.++.|||+.|++|+||+|+||++++++.++++|||.+.........
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 999999986532 223588899999999999999999999999999999999999999999999999775433211
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||...... ++.++|+||||+++|+|++ |..||..... ......+... ..+.|...+..++
T Consensus 161 ~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGR-----FTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQVERGYRMPCPQDCPISLH 233 (260)
T ss_pred cCCCCCccccChHHHhcCC-----CcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCCCCCCcCCHHHH
Confidence 1223445799999876554 7889999999999999999 8899965332 2222233322 4556778999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
+++.+||+.
T Consensus 234 ~li~~~l~~ 242 (260)
T cd05070 234 ELMLQCWKK 242 (260)
T ss_pred HHHHHHccc
Confidence 999999963
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=239.04 Aligned_cols=235 Identities=19% Similarity=0.332 Sum_probs=180.1
Q ss_pred CcCCCCccCeeeEEEEEecCCC--------------cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK--------------QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCF 67 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~--------------~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 67 (246)
.||+|++ |.||++++..++ ..||+|.++... .......+.+|++.+++++|+|++++++++
T Consensus 12 ~lg~G~~---g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 86 (295)
T cd05097 12 KLGEGQF---GEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRLLGVC 86 (295)
T ss_pred ccCCCCC---ceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence 3788888 899999875432 358999987643 234456788999999999999999999999
Q ss_pred eeCCeEEEEEeecCCCChHHHHhhcccc-------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC
Q psy7592 68 QDEEDLFMVSDLLLGGDLRYHITQDIKF-------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG 140 (246)
Q Consensus 68 ~~~~~~~~v~e~~~~~sL~~~~~~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~ 140 (246)
......++||||+.+++|.+++...... ....+++..+..++.|++.|++|||+.|++|+||+|+||+++.++
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~ 166 (295)
T cd05097 87 VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHY 166 (295)
T ss_pred cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCC
Confidence 9999999999999999999998653211 012357788999999999999999999999999999999999999
Q ss_pred CeEEeecceeeeeccCccc---cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCccH
Q psy7592 141 HAHITDFNIATVLEENQLA---TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA--RGRPFDIHSNTSV 215 (246)
Q Consensus 141 ~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~--g~~p~~~~~~~~~ 215 (246)
.++++|||++......... ....++..|+|||...... ++.++|+||||+++++|++ +..||........
T Consensus 167 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 167 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-----FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred cEEecccccccccccCcceeccCcCcCceeecChhhhccCC-----cCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 9999999998765432211 1123356799999887654 7889999999999999988 5678865433221
Q ss_pred H-HHHhh-----hcCCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 216 K-DVKAI-----IYSPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 216 ~-~~~~~-----~~~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
. ..... .......+...++.+.++|.+||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 278 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSR 278 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCC
Confidence 1 11111 1112334567899999999999963
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=254.75 Aligned_cols=228 Identities=27% Similarity=0.517 Sum_probs=203.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|+| |.|-++..+.....+|+|++++...-+..+.+....|-+++.+.+.|+||++|..|.++.++|+.||-|-
T Consensus 427 TLGvGgF---GRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl 503 (732)
T KOG0614|consen 427 TLGVGGF---GRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACL 503 (732)
T ss_pred hcccCcc---ceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhc
Confidence 3677888 8899988887777799999999888788888889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
||.|...+...+.. ...+.+.+...+++|++|||..||++||+||+|++++.+|-+|+.|||+++....+...-.
T Consensus 504 GGElWTiLrdRg~F-----dd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwT 578 (732)
T KOG0614|consen 504 GGELWTILRDRGSF-----DDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWT 578 (732)
T ss_pred CchhhhhhhhcCCc-----ccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceee
Confidence 99999999887665 8888999999999999999999999999999999999999999999999999888777777
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~l~~l 239 (246)
+.||+.|.|||++.... .+..+|.||||+++||+++|.+||.+.+.... ...|+.. ...+|..++....+|
T Consensus 579 FcGTpEYVAPEIILnKG-----HD~avDyWaLGIli~ELL~G~pPFs~~dpmkt--Yn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 579 FCGTPEYVAPEIILNKG-----HDRAVDYWALGILIYELLTGSPPFSGVDPMKT--YNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred ecCCcccccchhhhccC-----cchhhHHHHHHHHHHHHHcCCCCCCCCchHHH--HHHHHhhhhhhhcccccchhHHHH
Confidence 89999999999998775 77899999999999999999999986655443 3334433 778899999999999
Q ss_pred HHHhh
Q psy7592 240 LSQVH 244 (246)
Q Consensus 240 i~~~l 244 (246)
|+++=
T Consensus 652 ik~LC 656 (732)
T KOG0614|consen 652 IKKLC 656 (732)
T ss_pred HHHHH
Confidence 98763
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=236.14 Aligned_cols=233 Identities=20% Similarity=0.288 Sum_probs=180.7
Q ss_pred CcCCCCccCeeeEEEEEec-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK-----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |.||++..+ .++..||+|.++... .......+.+|+..++.++||||+++++++.+....+++
T Consensus 13 ~lg~G~~---g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (288)
T cd05061 13 ELGQGSF---GMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 87 (288)
T ss_pred eecCCCC---cEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 4788888 899998765 235689999886543 222334577899999999999999999999998999999
Q ss_pred EeecCCCChHHHHhhcccc-----ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 77 SDLLLGGDLRYHITQDIKF-----YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
|||+.+++|.+++...... .....+...+..++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||++.
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~ 167 (288)
T cd05061 88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167 (288)
T ss_pred EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccc
Confidence 9999999999999753321 11234566788999999999999999999999999999999999999999999887
Q ss_pred eeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CC
Q psy7592 152 VLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PV 226 (246)
Q Consensus 152 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~ 226 (246)
....... .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+.... .....+... ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-----~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~~~~~~ 240 (288)
T cd05061 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGV-----FTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLKFVMDGGYL 240 (288)
T ss_pred cccccccccccCCCcccccccCHHHhccCC-----CChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC
Confidence 5433221 11122356799999987654 7889999999999999998 78899653322 222233322 44
Q ss_pred CCCCCCCHhHHHHHHHhhhC
Q psy7592 227 HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ~~~~~~s~~l~~li~~~l~~ 246 (246)
..|...++.+++++.+||+.
T Consensus 241 ~~~~~~~~~~~~li~~~l~~ 260 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQF 260 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCC
Confidence 55677899999999999963
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=237.26 Aligned_cols=225 Identities=20% Similarity=0.303 Sum_probs=178.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCc-------EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ-------MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~-------~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 74 (246)
.||+|+| |+||++.++.++. .||+|.+.... ....+.+.+|+..+++++|||++++++++..+...+
T Consensus 2 ~lg~G~~---~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 2 SLGQGTF---TKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCcccc---hhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence 4788888 8999999876554 48888775432 344567888999999999999999999999988999
Q ss_pred EEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC--------eEEee
Q psy7592 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH--------AHITD 146 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~--------~~l~d 146 (246)
+||||+.+++|..++..... .+++..+..++.|++.++.|||+.|++|+||+|+||+++.++. ++++|
T Consensus 76 lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999999999999875432 3488889999999999999999999999999999999987765 58999
Q ss_pred cceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCccHHHHHhhhcCC
Q psy7592 147 FNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIHSNTSVKDVKAIIYSP 225 (246)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~~ 225 (246)
||.+...... ....++..|+|||.+.+.. .++.++|+||||+++|+|++|. .||..... ..........
T Consensus 152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~ 221 (258)
T cd05078 152 PGISITVLPK---EILLERIPWVPPECIENPQ----NLSLAADKWSFGTTLWEIFSGGDKPLSALDS---QKKLQFYEDR 221 (258)
T ss_pred cccccccCCc---hhccccCCccCchhccCCC----CCCchhhHHHHHHHHHHHHcCCCCChhhccH---HHHHHHHHcc
Confidence 9987654332 2234567899999987532 2677899999999999999985 66643222 2223334445
Q ss_pred CCCCCCCCHhHHHHHHHhhhC
Q psy7592 226 VHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 226 ~~~~~~~s~~l~~li~~~l~~ 246 (246)
..+|...+.++.++|++||++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~ 242 (258)
T cd05078 222 HQLPAPKWTELANLINQCMDY 242 (258)
T ss_pred ccCCCCCcHHHHHHHHHHhcc
Confidence 667777889999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=238.54 Aligned_cols=231 Identities=19% Similarity=0.345 Sum_probs=181.6
Q ss_pred cCCCCccCeeeEEEEEec-------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEE
Q psy7592 3 CGSSKFCGTSKVCIVQKK-------DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLF 74 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 74 (246)
||+|++ |.||.+++. .++..||+|.+.... .....+.+.+|+..++.+ +||||+++++++......+
T Consensus 23 lg~G~~---g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (304)
T cd05101 23 LGEGCF---GQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 97 (304)
T ss_pred eeccCC---ceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceE
Confidence 688888 899999752 245689999887542 234457788999999999 8999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcccc-----------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeE
Q psy7592 75 MVSDLLLGGDLRYHITQDIKF-----------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAH 143 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~ 143 (246)
++|||+.+++|.+++...... ....++...+..++.|++.|+.|||+.|++|+||+|+||+++.++.++
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~k 177 (304)
T cd05101 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMK 177 (304)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEE
Confidence 999999999999998764221 112357778999999999999999999999999999999999999999
Q ss_pred EeecceeeeeccCccc---cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHH
Q psy7592 144 ITDFNIATVLEENQLA---TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVK 219 (246)
Q Consensus 144 l~d~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~ 219 (246)
++|||.+......... ....++..|+|||.+.+.. ++.++|+||||+++|++++ |..||.+... .....
T Consensus 178 l~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~ 250 (304)
T cd05101 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-----YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EELFK 250 (304)
T ss_pred ECCCccceecccccccccccCCCCCceeeCchhhccCC-----CCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHH
Confidence 9999998876432221 1123456799999886654 7889999999999999998 7888864432 22222
Q ss_pred hhhcC-CCCCCCCCCHhHHHHHHHhhh
Q psy7592 220 AIIYS-PVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 220 ~~~~~-~~~~~~~~s~~l~~li~~~l~ 245 (246)
.+... ....|..++..++++|..||+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~li~~cl~ 277 (304)
T cd05101 251 LLKEGHRMDKPANCTNELYMMMRDCWH 277 (304)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcc
Confidence 22222 334567899999999999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=234.17 Aligned_cols=227 Identities=23% Similarity=0.379 Sum_probs=180.4
Q ss_pred CcCCCCccCeeeEEEEEecCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT---KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||.|++ |.||++.+... ...||+|....... .+..+.+.+|+..+++++||||+++++++.++ ..+++||
T Consensus 13 ~lg~g~~---g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv~e 86 (270)
T cd05056 13 CIGEGQF---GDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIVME 86 (270)
T ss_pred eeCCccc---eeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEEEE
Confidence 4688888 89999987644 45789998865542 34456788999999999999999999998764 5679999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+++++|.+++.+.. ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++........
T Consensus 87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 87 LAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred cCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999999987642 2358899999999999999999999999999999999999999999999999876544322
Q ss_pred cc--ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc-CCCCCCCCCCH
Q psy7592 159 AT--SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY-SPVHYPTAWSE 234 (246)
Q Consensus 159 ~~--~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~s~ 234 (246)
.. ....+..|+|||.+.... ++.++|+||||++++++++ |..||....... ....+.. ...+.|..+++
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 235 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRR-----FTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIENGERLPMPPNCPP 235 (270)
T ss_pred eecCCCCccccccChhhhccCC-----CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCCcCCCCCCCCH
Confidence 11 122345799999886554 7889999999999999986 999996544322 2222222 24556778999
Q ss_pred hHHHHHHHhhh
Q psy7592 235 STKHLLSQVHR 245 (246)
Q Consensus 235 ~l~~li~~~l~ 245 (246)
.+.++|.+||+
T Consensus 236 ~~~~li~~~l~ 246 (270)
T cd05056 236 TLYSLMTKCWA 246 (270)
T ss_pred HHHHHHHHHcC
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=233.93 Aligned_cols=226 Identities=21% Similarity=0.373 Sum_probs=179.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||+|..+ +++.||+|.+..... ..+++.+|+.++++++|+||+++++++. .+..+++||++.
T Consensus 13 ~ig~G~~---g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 13 KLGAGQF---GEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred eeccCcc---ceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 3677777 899999865 578899999876442 1356788999999999999999999875 456899999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-- 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (246)
+++|.+++.... ...++...+..++.|++.++++||+.|++|+||+|+|+++++++.++++|||.+.........
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 84 NGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 999999886532 224588889999999999999999999999999999999999999999999998775532211
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||.+.... ++.++|+||||++++++++ |..||.+... ......+... ..+.|...+.++.
T Consensus 161 ~~~~~~~~y~~pe~~~~~~-----~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGT-----FTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQNLERGYRMPRPDNCPEELY 233 (260)
T ss_pred cCCcccccccCHHHhccCC-----cCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHHcCCCCCCCCCCCHHHH
Confidence 1223456799999887654 7789999999999999998 9999975432 2222222222 4455677899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||+.
T Consensus 234 ~li~~~l~~ 242 (260)
T cd05067 234 ELMRLCWKE 242 (260)
T ss_pred HHHHHHccC
Confidence 999999963
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=233.63 Aligned_cols=225 Identities=20% Similarity=0.266 Sum_probs=174.1
Q ss_pred CcCCCCccCeeeEEEEEecC------------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD------------TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~------------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 69 (246)
.||+|++ |.||+++... ....+++|.+.... .+....+.+|+..++.++||||+++++++.+
T Consensus 2 ~lg~G~~---~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~ 75 (262)
T cd05077 2 HLGRGTR---TQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVR 75 (262)
T ss_pred ccccCCc---ceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4788999 8999998542 23368899876543 3445678889999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC-------e
Q psy7592 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH-------A 142 (246)
Q Consensus 70 ~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~-------~ 142 (246)
+...+++|||+++++|..++.... .++++..+..++.|++.|++|||+.|++|+||+|+||+++.++. +
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCcee
Confidence 889999999999999988876432 23588889999999999999999999999999999999987664 8
Q ss_pred EEeecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCccHHHHHhh
Q psy7592 143 HITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL-ARGRPFDIHSNTSVKDVKAI 221 (246)
Q Consensus 143 ~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll-~g~~p~~~~~~~~~~~~~~~ 221 (246)
+++|||.+...... ....++..|+|||.+.... .++.++||||||+++|+|+ .|..||....... ....
T Consensus 152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~ 221 (262)
T cd05077 152 KLSDPGIPITVLSR---QECVERIPWIAPECVEDSK----NLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE---KERF 221 (262)
T ss_pred EeCCCCCCccccCc---ccccccccccChhhhcCCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---HHHH
Confidence 99999987654322 2234577899999876332 3778999999999999998 4888886433222 2222
Q ss_pred hcCCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 222 IYSPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 222 ~~~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
...........+++++++|.+||+.
T Consensus 222 ~~~~~~~~~~~~~~~~~li~~cl~~ 246 (262)
T cd05077 222 YEGQCMLVTPSCKELADLMTHCMNY 246 (262)
T ss_pred HhcCccCCCCChHHHHHHHHHHcCC
Confidence 3333334445678999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=233.39 Aligned_cols=226 Identities=22% Similarity=0.367 Sum_probs=177.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+ ..||+|.++.... ..+.+.+|++.+++++||||+++++++.+ ...+++|||+.
T Consensus 13 ~lg~g~~---~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 13 KLGQGCF---GEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred ecCCCCC---CcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 3677887 89999998755 4699999976432 12467889999999999999999998754 55789999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-- 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (246)
+++|.+++.... ...+++..+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||.+.........
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 999999987532 223488899999999999999999999999999999999999999999999998766433221
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||...... ++.++|+||||+++|++++ |..||...... .....+... ..+.+..++..+.
T Consensus 161 ~~~~~~~~y~~PE~~~~~~-----~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~ 233 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGR-----FTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYRMPCPPECPESLH 233 (262)
T ss_pred cCCcccceecCHhHhccCC-----CCchhhHHHHHHHHHHHHcCCCCCCCCCChH--HHHHHHhcCCCCCCccccCHHHH
Confidence 1233456799999876554 7889999999999999999 88898654322 222222222 3344567899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||+.
T Consensus 234 ~li~~~l~~ 242 (262)
T cd05071 234 DLMCQCWRK 242 (262)
T ss_pred HHHHHHccC
Confidence 999999963
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=236.79 Aligned_cols=229 Identities=23% Similarity=0.372 Sum_probs=177.1
Q ss_pred CcCCCCccCeeeEEEEE----ecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee--CCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQ----KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD--EEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~ 75 (246)
.||+|++ |+||.+. +..+++.||+|.+.... ....+.+.+|++.+++++||||+++++++.. ....++
T Consensus 11 ~lg~g~~---g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 11 QLGKGNF---GSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred eccCCCC---ceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 4788888 8999987 45678999999987643 4456778899999999999999999998753 346899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
|+||+++++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||++.....
T Consensus 85 v~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999986532 1248889999999999999999999999999999999999999999999999886543
Q ss_pred Cccc----cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-------------HHHH
Q psy7592 156 NQLA----TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS-------------VKDV 218 (246)
Q Consensus 156 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~-------------~~~~ 218 (246)
.... ........|+|||...+.. ++.++|+||||+++++|++|..|+....... ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESK-----FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCC-----cChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 2211 1112234589999886654 7789999999999999999877653221110 0111
Q ss_pred HhhhcC--CCCCCCCCCHhHHHHHHHhhh
Q psy7592 219 KAIIYS--PVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 219 ~~~~~~--~~~~~~~~s~~l~~li~~~l~ 245 (246)
...... ..+.+..+++.+.++|.+||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 264 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWN 264 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHcc
Confidence 122222 334456789999999999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=232.83 Aligned_cols=226 Identities=22% Similarity=0.345 Sum_probs=177.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.+..+ ..+|+|.+..... ..+.+.+|++++++++|+|++++++++.. ...+++|||+.
T Consensus 13 ~ig~g~~---~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 13 KLGQGCF---GEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred eecCcCC---CeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 4788888 89999998654 4689998865432 23567789999999999999999998754 46789999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-- 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (246)
+++|.+++.... ...+++..+..++.|++.|+.|||+.|++|+||+|+||++++++.++++|||.+.........
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 999999986532 223588889999999999999999999999999999999999999999999998765433211
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||...+.. .+.++|+||||+++|+|++ |..||..... ......+... ..+.|...+..++
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~-----~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGR-----FTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQVERGYRMPCPQGCPESLH 233 (260)
T ss_pred CCCccchhhCCHHHhccCC-----cChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCcccCHHHH
Confidence 1223456799999886554 7889999999999999999 8999965332 2222233322 3455678999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|++||+.
T Consensus 234 ~li~~~l~~ 242 (260)
T cd05069 234 ELMKLCWKK 242 (260)
T ss_pred HHHHHHccC
Confidence 999999973
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=233.28 Aligned_cols=225 Identities=22% Similarity=0.358 Sum_probs=182.1
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|++ |+||++.++ +++.||+|.+..... ..+++.+|+..+++++|+||+++++++.++...+++||++++
T Consensus 14 ig~g~~---~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (261)
T cd05034 14 LGAGQF---GEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSK 85 (261)
T ss_pred eccCcc---eEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCC
Confidence 677777 899999976 568899999876442 235688899999999999999999999988899999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--c
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA--T 160 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~ 160 (246)
++|.+++.... ...++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+......... .
T Consensus 86 ~~L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (261)
T cd05034 86 GSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE 162 (261)
T ss_pred CCHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhh
Confidence 99999987642 123588899999999999999999999999999999999999999999999998766432211 1
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKH 238 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~ 238 (246)
....+..|+|||.+.+.. .++++|+||||++++++++ |+.||.+.. .......+... ..+.|...+.++.+
T Consensus 163 ~~~~~~~y~~PE~~~~~~-----~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05034 163 GAKFPIKWTAPEAANYGR-----FTIKSDVWSFGILLTEIVTYGRVPYPGMT--NREVLEQVERGYRMPRPPNCPEELYD 235 (261)
T ss_pred ccCCCccccCHHHhccCC-----cCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 222346799999887654 7889999999999999998 999996433 22333344333 44556778999999
Q ss_pred HHHHhhh
Q psy7592 239 LLSQVHR 245 (246)
Q Consensus 239 li~~~l~ 245 (246)
++.+||+
T Consensus 236 ~i~~~l~ 242 (261)
T cd05034 236 LMLQCWD 242 (261)
T ss_pred HHHHHcc
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=231.30 Aligned_cols=232 Identities=31% Similarity=0.534 Sum_probs=191.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |.||++.+..+++.||+|.+..... ..+..+.+.+|++.+++++|+|++++.+.+..+...++++|+++
T Consensus 7 ~l~~g~~---~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 7 QIGKGSF---GKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred eeccCCC---eEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 3678888 8999999999999999999976543 23445678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|.+++..... ....+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (258)
T cd08215 83 GGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK 161 (258)
T ss_pred CCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceec
Confidence 9999999876421 12446899999999999999999999999999999999999999999999999987765443 223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~l 239 (246)
...++..|+|||...... .+.++|+||+|+++++|++|..||...... ......... ..+.|..++..+.++
T Consensus 162 ~~~~~~~y~~pe~~~~~~-----~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (258)
T cd08215 162 TVVGTPYYLSPELCQNKP-----YNYKSDIWSLGCVLYELCTLKHPFEGENLL--ELALKILKGQYPPIPSQYSSELRNL 234 (258)
T ss_pred ceeeeecccChhHhccCC-----CCccccHHHHHHHHHHHHcCCCCCCCCcHH--HHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 345677899999876654 678999999999999999999999654422 222222222 555667899999999
Q ss_pred HHHhhh
Q psy7592 240 LSQVHR 245 (246)
Q Consensus 240 i~~~l~ 245 (246)
|.+||+
T Consensus 235 i~~~l~ 240 (258)
T cd08215 235 VSSLLQ 240 (258)
T ss_pred HHHHcC
Confidence 999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=238.75 Aligned_cols=230 Identities=25% Similarity=0.396 Sum_probs=182.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||+++++.+++.+|+|.+...........+++.+|+++++.++|+|++++++++..+...++|+||+.
T Consensus 22 ~lg~g~~---g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 98 (308)
T cd06634 22 EIGHGSF---GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (308)
T ss_pred heeeCCC---EEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC
Confidence 3678888 8999999999999999999876443344556778899999999999999999999999999999999995
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++.+.+.... .++++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+...... ..
T Consensus 99 -~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~ 170 (308)
T cd06634 99 -GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NX 170 (308)
T ss_pred -CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---cc
Confidence 57777664322 23588899999999999999999999999999999999999999999999988765432 23
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCC-CCCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVH-YPTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~-~~~~~s~~l~~l 239 (246)
..++..|+|||.+.+... ...+.++|+||||+++++|++|..||....... ........ ... .+..++..++++
T Consensus 171 ~~~~~~y~aPE~~~~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 171 FVGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred ccCCccccCHHHHhhccc--CCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHHHHhhcCCCCcCcccccHHHHHH
Confidence 456778999999753211 126779999999999999999999986533222 22222222 222 234789999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 247 i~~cl~~ 253 (308)
T cd06634 247 VDSCLQK 253 (308)
T ss_pred HHHHhhC
Confidence 9999963
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=233.82 Aligned_cols=231 Identities=25% Similarity=0.421 Sum_probs=185.9
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||.|++ |+||++....++..+|+|++....... ..+.+.+|++.++.++|+|++++++.+..+...++++|++++
T Consensus 9 lg~g~~---~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 9 IGVGAT---AVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred ecCCCC---eEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 677887 899999999899999999987644322 567889999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc---
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA--- 159 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--- 159 (246)
++|.+.+..... ...+++..+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||.+.........
T Consensus 84 ~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (267)
T cd06610 84 GSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161 (267)
T ss_pred CcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence 999999875322 123588899999999999999999999999999999999999999999999988766543222
Q ss_pred --cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCC-----CC
Q psy7592 160 --TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYP-----TA 231 (246)
Q Consensus 160 --~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-----~~ 231 (246)
....++..|+|||.+.... ..+.++|+||||+++++|++|+.||...... +........ ...++ ..
T Consensus 162 ~~~~~~~~~~y~~Pe~~~~~~----~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 162 VRKTFVGTPCWMAPEVMEQVH----GYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred ccccccCChhhcChHHHcccc----CcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHhcCCCCCcCCcccccc
Confidence 2234677899999886552 2678999999999999999999999654332 222222222 22222 25
Q ss_pred CCHhHHHHHHHhhhC
Q psy7592 232 WSESTKHLLSQVHRY 246 (246)
Q Consensus 232 ~s~~l~~li~~~l~~ 246 (246)
+++.+.+++.+||+.
T Consensus 236 ~~~~~~~li~~~l~~ 250 (267)
T cd06610 236 YSKSFRKMISLCLQK 250 (267)
T ss_pred ccHHHHHHHHHHcCC
Confidence 789999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=233.79 Aligned_cols=233 Identities=27% Similarity=0.448 Sum_probs=184.6
Q ss_pred CcCCCCccCeeeEEEEEecC-CCcEEEEEEeecccc-------chHHHHHHHHHHHHHHhh-CCCCcceeeeeeeeeCCe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD-TKQMYAMKYMHKSQC-------IERDALKNVLREMEILTT-LEHPFLVNLWFCFQDEED 72 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~ 72 (246)
.||+|++ |.||.+.++. +++.+|+|.+..... .......++.+|+..+.+ ++||||+++++++.+++.
T Consensus 7 ~ig~G~~---~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 83 (269)
T cd08528 7 HLGSGAF---GCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR 83 (269)
T ss_pred hhcCCCC---ceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCe
Confidence 4788888 8999999987 789999998864321 223445667788888875 699999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 73 ~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
.+++|||+++++|.+.+..... ....+++..++.++.|++.++.+||+ .|++|+||+|.||+++.++.++++|||.+.
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 162 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccccee
Confidence 9999999999999988754211 12346888999999999999999996 789999999999999999999999999998
Q ss_pred eeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCC-CCCCC
Q psy7592 152 VLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSP-VHYPT 230 (246)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 230 (246)
............++..|+|||...+.. ++.++|+||||+++|+|++|..||..... ......+.... .+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~-----~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~ 235 (269)
T cd08528 163 QKQPESKLTSVVGTILYSCPEIVKNEP-----YGEKADVWAFGCILYQMCTLQPPFYSTNM--LSLATKIVEAVYEPLPE 235 (269)
T ss_pred ecccccccccccCcccCcChhhhcCCC-----CchHHHHHHHHHHHHHHHhCCCcccccCH--HHHHHHHhhccCCcCCc
Confidence 765544334456778899999987654 78899999999999999999999964332 22222333222 22223
Q ss_pred -CCCHhHHHHHHHhhh
Q psy7592 231 -AWSESTKHLLSQVHR 245 (246)
Q Consensus 231 -~~s~~l~~li~~~l~ 245 (246)
.+++.+.++|.+||+
T Consensus 236 ~~~~~~l~~li~~cl~ 251 (269)
T cd08528 236 GMYSEDVTDVITSCLT 251 (269)
T ss_pred ccCCHHHHHHHHHHCC
Confidence 689999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=234.42 Aligned_cols=226 Identities=20% Similarity=0.332 Sum_probs=177.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCc----EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ----MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||.|++ |+||++.+..+++ .+++|.+.... .......+..|+..+.+++||||+++++++.. ...++++
T Consensus 14 ~lg~G~~---~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~ 87 (279)
T cd05111 14 LLGSGVF---GTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVT 87 (279)
T ss_pred ccCccCC---cceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEE
Confidence 4788888 8999999987776 47777775432 23344667788888999999999999998764 4577899
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||+.+++|.+++.... ..+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 88 e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 88 QLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999999986532 235888999999999999999999999999999999999999999999999987654322
Q ss_pred c---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC--CCCCCCC
Q psy7592 158 L---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS--PVHYPTA 231 (246)
Q Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 231 (246)
. .....++..|+|||...+.. ++.++|+||||+++|++++ |..||.+..... ....... ..+.|..
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~-----~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 235 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGR-----YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDLLEKGERLAQPQI 235 (279)
T ss_pred cccccCCCCCcccccCHHHhccCC-----cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCCcCCCCCC
Confidence 1 12234556799999987654 7889999999999999998 999996543222 2222222 3344566
Q ss_pred CCHhHHHHHHHhhh
Q psy7592 232 WSESTKHLLSQVHR 245 (246)
Q Consensus 232 ~s~~l~~li~~~l~ 245 (246)
++.++.+++..||.
T Consensus 236 ~~~~~~~li~~c~~ 249 (279)
T cd05111 236 CTIDVYMVMVKCWM 249 (279)
T ss_pred CCHHHHHHHHHHcC
Confidence 88899999999986
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=237.76 Aligned_cols=235 Identities=21% Similarity=0.372 Sum_probs=180.3
Q ss_pred CcCCCCccCeeeEEEEEecC----------------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD----------------TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWF 65 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~----------------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 65 (246)
.||+|++ |.||++.+.. ++..||+|.++... ......++.+|++.++.++|+||+++++
T Consensus 12 ~lg~G~~---g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 12 KLGEGQF---GEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred eccCCCC---CeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 3688888 8999986432 45579999987643 2344567889999999999999999999
Q ss_pred eeeeCCeEEEEEeecCCCChHHHHhhccccc------cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC
Q psy7592 66 CFQDEEDLFMVSDLLLGGDLRYHITQDIKFY------SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE 139 (246)
Q Consensus 66 ~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~ 139 (246)
++..++..+++|||+.+++|.+++....... ...+++..+..++.|++.|+++||+.|++|+||+|+||+++.+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~ 166 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN 166 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCC
Confidence 9999999999999999999999987643211 1225677899999999999999999999999999999999999
Q ss_pred CCeEEeecceeeeeccCccc---cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCcc
Q psy7592 140 GHAHITDFNIATVLEENQLA---TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA--RGRPFDIHSNTS 214 (246)
Q Consensus 140 ~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~--g~~p~~~~~~~~ 214 (246)
+.++++|||++......... .....+..|++||...+.. ++.++|+||||+++|+|++ |..||.......
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-----~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 167 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-----FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-----ccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999998765433211 1122346799999876554 7889999999999999998 678886443322
Q ss_pred HHH-HHhh-----hcCCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 215 VKD-VKAI-----IYSPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 215 ~~~-~~~~-----~~~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
... .... .....+.|..+++.++++|.+||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 279 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRR 279 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCC
Confidence 111 1110 1112344567899999999999963
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=235.56 Aligned_cols=233 Identities=17% Similarity=0.286 Sum_probs=182.4
Q ss_pred CcCCCCccCeeeEEEEEecC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD-----TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||.|++ |+||+++.+. +.+.|++|.+.... .....+.+.+|++++++++|+||+++++++.+....+++
T Consensus 12 ~lg~g~~---g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (275)
T cd05046 12 TLGRGEF---GEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMI 86 (275)
T ss_pred eecccce---eEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEE
Confidence 4678888 9999999764 35679999876543 233457788999999999999999999999998899999
Q ss_pred EeecCCCChHHHHhhccccc----cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 77 SDLLLGGDLRYHITQDIKFY----SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
|||+++++|.+++....... ...+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++.++++||+++..
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccc
Confidence 99999999999987644211 12468999999999999999999999999999999999999999999999998764
Q ss_pred eccCc--cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcCC--CC
Q psy7592 153 LEENQ--LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYSP--VH 227 (246)
Q Consensus 153 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~--~~ 227 (246)
..... ......++..|+|||.+.+.. .+.++|+||||++++++++ |..||..... ........... .+
T Consensus 167 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-----~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~~~~~~~~~~~~ 239 (275)
T cd05046 167 VYNSEYYKLRNALIPLRWLAPEAVQEDD-----FSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLNRLQAGKLELP 239 (275)
T ss_pred cCcccccccCCceeEEeecChhhhccCC-----CCchhhHHHHHHHHHHHHhCCCCCccccch--HHHHHHHHcCCcCCC
Confidence 32211 112234456799999886554 6788999999999999998 7889854332 22233333232 33
Q ss_pred CCCCCCHhHHHHHHHhhhC
Q psy7592 228 YPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 228 ~~~~~s~~l~~li~~~l~~ 246 (246)
.+..++..+.+++.+||+.
T Consensus 240 ~~~~~~~~l~~~i~~~l~~ 258 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAV 258 (275)
T ss_pred CCCCCCHHHHHHHHHHcCC
Confidence 4567899999999999963
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=257.93 Aligned_cols=197 Identities=33% Similarity=0.480 Sum_probs=171.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC------eEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE------DLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~~ 75 (246)
.||+|+| |.||+.+++++|+.||||.++.... ...++.-.+|++++++|+|||||+++++=++.. .-.+
T Consensus 20 ~LG~Ga~---g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 20 RLGKGAF---GNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred hhcCCcc---ceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4789999 9999999999999999999988653 233466778999999999999999998865433 4688
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc--CCC--CeEEeecceee
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD--EEG--HAHITDFNIAT 151 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~--~~~--~~~l~d~~~~~ 151 (246)
+||||.||||...+..-. -..++|+.+++.++..++.|+.|||++||+||||||.||++- .+| ..|++|||.++
T Consensus 95 vmEyC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EEeecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 999999999999997643 356789999999999999999999999999999999999884 334 35999999999
Q ss_pred eeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy7592 152 VLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDI 209 (246)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~ 209 (246)
...++.......||..|++||....+. .++..+|.|||||++|+++||..||.-
T Consensus 173 el~d~s~~~S~vGT~~YLhPel~E~q~----~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 173 ELDDNSLFTSLVGTEEYLHPELYERQK----KYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cCCCCCeeeeecCchhhcChHHHhhcc----CcCceeehhhhhhHHHHHhccCCCCCc
Confidence 999988888999999999999987422 488999999999999999999999943
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=234.64 Aligned_cols=232 Identities=28% Similarity=0.430 Sum_probs=182.4
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC--CeEEEEEeec
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE--EDLFMVSDLL 80 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~~ 80 (246)
||.|.+ |.||++.+..+++.||+|.+..... .+...++.+|++.+++++||||+++++++.+. ...++||||+
T Consensus 9 lg~g~~---~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 9 LGEGAG---GSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred eccCCc---eEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 678888 8999999999999999999876532 24457788999999999999999999988653 4689999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
++++|.+++..... ....+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++++|||++........ .
T Consensus 84 ~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 161 (287)
T cd06621 84 EGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-G 161 (287)
T ss_pred CCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc-c
Confidence 99999988754322 233458888999999999999999999999999999999999999999999999865443221 2
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---ccHHHHHhhhcC-CCCCC------C
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN---TSVKDVKAIIYS-PVHYP------T 230 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~-~~~~~------~ 230 (246)
...++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ........+... ...++ .
T Consensus 162 ~~~~~~~y~~pE~~~~~~-----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 162 TFTGTSFYMAPERIQGKP-----YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred cccCCccccCHHHhcCCC-----CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 344677899999887654 78899999999999999999999975422 222222222221 11121 2
Q ss_pred CCCHhHHHHHHHhhhC
Q psy7592 231 AWSESTKHLLSQVHRY 246 (246)
Q Consensus 231 ~~s~~l~~li~~~l~~ 246 (246)
.+++.++++|.+||++
T Consensus 237 ~~~~~~~~li~~~l~~ 252 (287)
T cd06621 237 KWSEEFKDFIKQCLEK 252 (287)
T ss_pred chHHHHHHHHHHHcCC
Confidence 4678999999999963
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=231.46 Aligned_cols=228 Identities=21% Similarity=0.342 Sum_probs=174.9
Q ss_pred CcCCCCccCeeeEEEEEecC---CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeee-eCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD---TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQ-DEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~~v~ 77 (246)
+||+|++ |.||++.+.. ++..||+|.+.... +....+.+.+|+.+++.++||||+++++++. .+...++++
T Consensus 2 ~lg~g~~---g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 2 VIGKGHF---GCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred cccccCC---ceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 5899999 8999998653 45689999875432 2344677888999999999999999999765 455688999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||+.+++|.+++.+... ..+...+..++.|++.|+.|||+.+++|+||+|+||+++.++.++++|||.+.......
T Consensus 77 e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 77 PYMKHGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred ecCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 99999999999865322 23666788899999999999999999999999999999999999999999987543321
Q ss_pred c-----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCccHHHHHhhhcC-CCCCCC
Q psy7592 158 L-----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILAR-GRPFDIHSNTSVKDVKAIIYS-PVHYPT 230 (246)
Q Consensus 158 ~-----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 230 (246)
. .....++..|+|||.+.... ++.++|+||||+++|+|++| .+||.... ........... ....|.
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 225 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYLLQGRRLLQPE 225 (262)
T ss_pred ceeecccccCcCCccccChhHhccCc-----cchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcCCCCCCCC
Confidence 1 11223456799999886654 78899999999999999995 56665322 22222222222 333456
Q ss_pred CCCHhHHHHHHHhhh
Q psy7592 231 AWSESTKHLLSQVHR 245 (246)
Q Consensus 231 ~~s~~l~~li~~~l~ 245 (246)
..++.+.+++.+||+
T Consensus 226 ~~~~~~~~li~~cl~ 240 (262)
T cd05058 226 YCPDPLYEVMLSCWH 240 (262)
T ss_pred cCCHHHHHHHHHHcC
Confidence 679999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=236.01 Aligned_cols=197 Identities=26% Similarity=0.365 Sum_probs=164.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC--CeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE--EDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~ 79 (246)
.||+|++ |.||++.++.+++.+|+|.++..... .+....+.+|+..+++++||||+++++++... ...++++||
T Consensus 12 ~lg~g~~---~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~ 87 (293)
T cd07843 12 RIEEGTY---GVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEY 87 (293)
T ss_pred hhcCCCC---eEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehh
Confidence 4788888 89999999999999999999765422 23334567899999999999999999998877 889999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-cc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QL 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~ 158 (246)
+. ++|.+.+..... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++++|||.+...... ..
T Consensus 88 ~~-~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 88 VE-HDLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred cC-cCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence 96 488888765322 4589999999999999999999999999999999999999999999999998876543 22
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.....++..|+|||.+.+.. ..+.++|+||||+++++|++|..||....
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAK----EYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred cccccccccccCchhhcCCc----cccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22344677899999886543 25779999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=237.03 Aligned_cols=196 Identities=27% Similarity=0.378 Sum_probs=159.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.+..+++.||+|.+..... ......+.+|++.++.++|+||+++++++.++...++|+||+.
T Consensus 12 ~ig~g~~---~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 12 KLGEGSY---ATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred EEEecCC---EEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 3688888 8999999999999999999865432 1222356689999999999999999999999999999999995
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++...+.... ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||++....... ...
T Consensus 87 -~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 87 -TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred -CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 66666654321 124777888999999999999999999999999999999999999999999887543221 122
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
...++..|+|||.+.+.. .++.++|+||||+++++|++|..||....
T Consensus 162 ~~~~~~~y~aPE~~~~~~----~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 162 SEVVTLWYRPPDVLLGAT----DYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CccccccccCCceeecCC----CCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 334577899999986543 26778999999999999999999997544
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=231.66 Aligned_cols=223 Identities=21% Similarity=0.353 Sum_probs=177.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeee-eCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQ-DEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~~v~e~~ 80 (246)
.||+|++ |.||++.. .+..||+|.+.... ..+.+.+|+..+++++|++++++++++. ++...++++||+
T Consensus 13 ~lg~g~~---~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 13 TIGKGEF---GDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred eecccCC---CeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4788888 89999976 48889999886532 2456888999999999999999998754 556789999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
++++|.+++.+... ..+++..+..++.|++.++++||+.|++|+||+|+||++++++.++++|||++....... .
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~ 157 (256)
T cd05082 83 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--D 157 (256)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--C
Confidence 99999999875432 235888999999999999999999999999999999999999999999999987654322 1
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKH 238 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~ 238 (246)
....+..|+|||.+.... ++.++|+||||+++|+|++ |+.||....... ....+... ....+..+++.+++
T Consensus 158 ~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05082 158 TGKLPVKWTAPEALREKK-----FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYKMDAPDGCPPVVYD 230 (256)
T ss_pred CCccceeecCHHHHccCC-----CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcCCCCCCCCCCCHHHHH
Confidence 223356799999886654 7889999999999999997 999996433221 12222222 44556789999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|.+||+.
T Consensus 231 li~~~l~~ 238 (256)
T cd05082 231 VMKQCWHL 238 (256)
T ss_pred HHHHHhcC
Confidence 99999963
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=240.99 Aligned_cols=233 Identities=20% Similarity=0.316 Sum_probs=179.2
Q ss_pred CcCCCCccCeeeEEEEEe-----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeee-CCeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQK-----KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQD-EEDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~ 74 (246)
.||+|+| |+||+|.+ ..+++.||||.++... ..+..+.+.+|+..+.++ +||||+++++++.. +...+
T Consensus 14 ~lG~G~f---g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (343)
T cd05103 14 PLGRGAF---GQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (343)
T ss_pred cccCCcc---ceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence 4788888 89999984 3568899999997643 233456788899999999 68999999998764 45688
Q ss_pred EEEeecCCCChHHHHhhcccc-----------------------------------------------------------
Q psy7592 75 MVSDLLLGGDLRYHITQDIKF----------------------------------------------------------- 95 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~----------------------------------------------------------- 95 (246)
++|||+++++|.+++......
T Consensus 89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (343)
T cd05103 89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ 168 (343)
T ss_pred EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence 999999999999998653210
Q ss_pred ---ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc---ccccccCCCcc
Q psy7592 96 ---YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL---ATSMSGTKPYI 169 (246)
Q Consensus 96 ---~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ 169 (246)
....++...+..++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||++........ .....++..|+
T Consensus 169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 248 (343)
T cd05103 169 EDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 248 (343)
T ss_pred hhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceE
Confidence 012357777889999999999999999999999999999999999999999999876532211 11123345799
Q ss_pred CCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc-CCCCCCCCCCHhHHHHHHHhhh
Q psy7592 170 APEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY-SPVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 170 aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~l~~li~~~l~ 245 (246)
|||.+.+.. ++.++|+||||+++++|++ |..||........ ....+.. ...+.|...++.+.+++..||+
T Consensus 249 aPE~~~~~~-----~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 249 APETIFDRV-----YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CcHHhcCCC-----CCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence 999886654 7889999999999999997 8999965443322 1222222 2445566788999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=235.54 Aligned_cols=195 Identities=30% Similarity=0.401 Sum_probs=158.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeC--CeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDE--EDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~~v~e 78 (246)
.||+|++ |.||++.++.+++.||+|.++.... +.+. ....+|+..+.++. |+|++++++++.++ +..++|+|
T Consensus 6 ~lg~g~~---~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 6 KIGEGTF---SEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred ecccccc---ceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 3677877 8999999999999999999876431 2222 23446888888885 99999999999887 88999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+. +++.+.+.... ..+++..+..++.|++.+|++||+.|++|+||+|+||+++. +.++++|||.+........
T Consensus 81 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 996 47777765432 23589999999999999999999999999999999999999 9999999999887654433
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.....++..|+|||.+.... ..+.++|+||||+++|+|++|..||.+.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDG----YYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred cCCCCCCcccCChhHhhcCC----CCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 33445678899999764322 26779999999999999999999997543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=248.59 Aligned_cols=228 Identities=25% Similarity=0.435 Sum_probs=190.1
Q ss_pred CcCCCCccCeeeEEEEEecC----CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD----TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
+||.|.| |.||.+.... .+-.||||..+.+. +.+.-+.|..|+.++++++||||+++.++|.+. ..|+||
T Consensus 396 ~iG~GqF---GdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 396 LIGEGQF---GDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred hhcCCcc---cceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 5899999 8888887653 23358888876643 334468899999999999999999999999866 688999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
|.++-|.|..+++.+.. .++..++..+..||+.|+.|||+...|||||...|||+.....+|++|||+++.+....
T Consensus 470 EL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred ecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999999999987543 35888999999999999999999999999999999999999999999999999887665
Q ss_pred ccccccc--CCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhh-cCCCCCCCCCC
Q psy7592 158 LATSMSG--TKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAII-YSPVHYPTAWS 233 (246)
Q Consensus 158 ~~~~~~~--~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~s 233 (246)
......+ .+-|+|||.+.... ++.+||||.||+++||++. |..||.+-.+.+.. ..+- .++.+.|++++
T Consensus 546 yYkaS~~kLPIKWmaPESINfRr-----FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--~~iEnGeRlP~P~nCP 618 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRR-----FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--GHIENGERLPCPPNCP 618 (974)
T ss_pred hhhccccccceeecCccccchhc-----ccchhhHHHHHHHHHHHHHhcCCccccccccceE--EEecCCCCCCCCCCCC
Confidence 4433332 34599999997665 8999999999999999988 88899877765542 2222 23778899999
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
+.+..|+.+||.|
T Consensus 619 p~LYslmskcWay 631 (974)
T KOG4257|consen 619 PALYSLMSKCWAY 631 (974)
T ss_pred hHHHHHHHHHhcc
Confidence 9999999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=231.48 Aligned_cols=212 Identities=29% Similarity=0.443 Sum_probs=171.4
Q ss_pred cCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCCCChHHH
Q psy7592 9 CGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYH 88 (246)
Q Consensus 9 ~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~sL~~~ 88 (246)
|.+++||+|+++.+++.||+|.++... ...+|...+....||||+++++++.+....+++|||+.+++|.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 444899999999999999999997653 122344445556799999999999999999999999999999999
Q ss_pred HhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccccccCCCc
Q psy7592 89 ITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPY 168 (246)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 168 (246)
+..... +++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+...... ......+..|
T Consensus 76 l~~~~~-----l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y 148 (237)
T cd05576 76 ISKFLN-----IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMY 148 (237)
T ss_pred HHHhcC-----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccc
Confidence 876433 489999999999999999999999999999999999999999999999987654332 2223446679
Q ss_pred cCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 169 IAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 169 ~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
+|||...... ++.++|+||+|+++|+|++|..|+....... .......+|..+++.++++|++||+.
T Consensus 149 ~aPE~~~~~~-----~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~ 215 (237)
T cd05576 149 CAPEVGGISE-----ETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTLNIPEWVSEEARSLLQQLLQF 215 (237)
T ss_pred cCCcccCCCC-----CCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccccccCCcccCCHHHHHHHHHHccC
Confidence 9999886554 6789999999999999999999885432110 01123456778999999999999964
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=239.01 Aligned_cols=231 Identities=20% Similarity=0.356 Sum_probs=180.9
Q ss_pred cCCCCccCeeeEEEEEecCC-------CcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDT-------KQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLF 74 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 74 (246)
||+|++ |.||.|++... +..||+|.++... +....+.+.+|+++++++ +||||+++++++.++...+
T Consensus 20 ig~G~~---g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (334)
T cd05100 20 LGEGCF---GQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 94 (334)
T ss_pred eccccC---CcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceE
Confidence 788888 89999986432 3368999887542 234457888999999999 7999999999999999999
Q ss_pred EEEeecCCCChHHHHhhccc-----------cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeE
Q psy7592 75 MVSDLLLGGDLRYHITQDIK-----------FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAH 143 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~-----------~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~ 143 (246)
+++||+.+++|.+++..... .....++..++..++.|++.|+.|||+.|++|+||+|+||+++.++.++
T Consensus 95 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~k 174 (334)
T cd05100 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMK 174 (334)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEE
Confidence 99999999999999875321 1122357778899999999999999999999999999999999999999
Q ss_pred EeecceeeeeccCccc---cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHH
Q psy7592 144 ITDFNIATVLEENQLA---TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVK 219 (246)
Q Consensus 144 l~d~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~ 219 (246)
++|||.++........ .....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.... ......
T Consensus 175 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~ 247 (334)
T cd05100 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-----YTHQSDVWSFGVLLWEIFTLGGSPYPGIP--VEELFK 247 (334)
T ss_pred ECCcccceecccccccccccCCCcCceEcCHHHhccCC-----cCchhhhHHHHHHHHHHHhcCCCCCCCCC--HHHHHH
Confidence 9999998765432211 1122345699999987654 7889999999999999998 888986433 222222
Q ss_pred hhhcC-CCCCCCCCCHhHHHHHHHhhh
Q psy7592 220 AIIYS-PVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 220 ~~~~~-~~~~~~~~s~~l~~li~~~l~ 245 (246)
.+... ..+.|..++..+.++|.+||+
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~ 274 (334)
T cd05100 248 LLKEGHRMDKPANCTHELYMIMRECWH 274 (334)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 33332 445567889999999999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=249.23 Aligned_cols=184 Identities=24% Similarity=0.256 Sum_probs=156.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++++..+++.||+|.... ....+|++++++++|+||+++++++..+...+++|+++
T Consensus 176 ~Lg~G~~---G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~- 242 (461)
T PHA03211 176 ALTPGSE---GCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY- 242 (461)
T ss_pred EEccCCC---eEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-
Confidence 3677888 9999999999999999995322 23567999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc---
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--- 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--- 158 (246)
.++|..++.... ..+++..++.++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 243 ~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 243 RSDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 567887775432 2458999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~ 207 (246)
.....++..|+|||.+.+.. ++.++|+||||+++|+|++|..|+
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~-----~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDP-----YTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccCCCcCCcCHHHHcCCC-----CCchHHHHHHHHHHHHHHHcCCCc
Confidence 12345889999999997664 788999999999999999987654
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=242.53 Aligned_cols=193 Identities=25% Similarity=0.388 Sum_probs=161.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC------CeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE------EDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~~ 75 (246)
.||+|++ |.||++++..+++.||+|.+..... +......+.+|+.++++++||||+++++++... ...++
T Consensus 23 ~lg~g~~---g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 98 (353)
T cd07850 23 PIGSGAQ---GIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98 (353)
T ss_pred EeccCCC---EEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEE
Confidence 3788888 9999999999999999999865432 233446677899999999999999999988643 35799
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||||+. ++|.+.+... ++...+..++.|++.||++||+.|++|+||+|+||+++.++.++++|||.+.....
T Consensus 99 v~e~~~-~~l~~~~~~~-------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 99 VMELMD-ANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred EEeccC-CCHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 999994 5787776532 38888999999999999999999999999999999999999999999999987654
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
........++..|+|||.+.+.. ++.++|+||||+++++|++|+.||...+
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 171 SFMMTPYVVTRYYRAPEVILGMG-----YKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred CCCCCCCcccccccCHHHHhCCC-----CCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 43333445678899999987654 7889999999999999999999996543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=239.85 Aligned_cols=197 Identities=24% Similarity=0.364 Sum_probs=162.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHH-----------HHHHHHHHHHHHhhCCCCcceeeeeeeeeC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERD-----------ALKNVLREMEILTTLEHPFLVNLWFCFQDE 70 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 70 (246)
+||+|++ |+||++.++.+++.||+|.+......... ....+.+|++++++++|+||+++++++..+
T Consensus 16 ~ig~G~~---g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 16 HLGEGTY---GKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred cccCCCc---eeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 4788888 89999999999999999998764422110 012467899999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeeccee
Q psy7592 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA 150 (246)
Q Consensus 71 ~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~ 150 (246)
...+++||++. ++|.+.+..... +++..+..++.|++.++++||+.|++|+||+|+||+++.++.++++|||.+
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKIR-----LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 99999999995 588888865433 489999999999999999999999999999999999999999999999998
Q ss_pred eeeccCc---------------cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 151 TVLEENQ---------------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 151 ~~~~~~~---------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
....... ......++..|+|||.+.+.. .++.++|+||||+++++|++|..||...+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE----KYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCC----CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 7654111 111123466799999986543 26789999999999999999999997544
|
|
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=254.25 Aligned_cols=235 Identities=29% Similarity=0.441 Sum_probs=199.4
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||..+-|.||.||+|.+++++..-|-|++.-. +++.++++.-|+++|....||+|+++++.+.-++.++++.|+|.|
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 45544455599999999999999999988654 377789999999999999999999999999888899999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec-cCccccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE-ENQLATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~~~ 161 (246)
|-....+... ..++++++|..+.+|++.||.|||+++|+|+||+..|||++.+|.++++|||.+.... .......
T Consensus 114 GAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 114 GAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred chHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence 9888877653 4567999999999999999999999999999999999999999999999999875532 2233456
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCC--CCCCCCHhHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVH--YPTAWSESTKH 238 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~s~~l~~ 238 (246)
+.|++.|+|||+..+....+.+|+-++||||||+.+.+|..+.+|-+..+ ..+.+..+... ++. .|..||..+++
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--pMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--hHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 88999999999998888888789999999999999999999999986444 34455555444 222 27789999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+++.||.+
T Consensus 268 fLk~cL~K 275 (1187)
T KOG0579|consen 268 FLKRCLVK 275 (1187)
T ss_pred HHHHHHhc
Confidence 99999964
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=239.92 Aligned_cols=203 Identities=23% Similarity=0.368 Sum_probs=164.5
Q ss_pred CcCCCCccCeeeEEEEEecC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC--CeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD--TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE--EDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~ 77 (246)
.||+|++ |.||++.++. +++.||+|.+...........+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 7 ~ig~g~~---g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 83 (316)
T cd07842 7 CIGRGTY---GRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF 83 (316)
T ss_pred EeccCCc---EEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEE
Confidence 3678887 9999999998 8999999999874322233346678899999999999999999999987 7899999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC----CCCeEEeecceeeee
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE----EGHAHITDFNIATVL 153 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~----~~~~~l~d~~~~~~~ 153 (246)
||+.+ ++.+.+.........++++..++.++.|++.++.|||+.+++|+||+|+||+++. ++.++++|||++...
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~ 162 (316)
T cd07842 84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162 (316)
T ss_pred eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccccc
Confidence 99954 6666664433222335689999999999999999999999999999999999999 889999999998765
Q ss_pred ccCcc----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7592 154 EENQL----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN 212 (246)
Q Consensus 154 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~ 212 (246)
..... .....++..|+|||.+.+.. .++.++|+||||+++++|++|..||.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 163 NAPLKPLADLDPVVVTIWYRAPELLLGAR----HYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred CCCcccccccCCccccccccCHHHHhCCC----CCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 43221 12234577899999876543 267899999999999999999999975543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=231.05 Aligned_cols=229 Identities=28% Similarity=0.456 Sum_probs=185.8
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|++ |.||++.++.++..||+|.+...... ....+.+.+|++.++.++|+||+++++.+.+....++++||+.+
T Consensus 8 l~~g~~---~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (257)
T cd08225 8 IGEGSF---GKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG 83 (257)
T ss_pred ecCCCc---ceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCC
Confidence 677877 89999999999999999998765432 23346778899999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-CeEEeecceeeeeccCccc-c
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG-HAHITDFNIATVLEENQLA-T 160 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~-~ 160 (246)
++|.+++.... ...+++..+..++.|++.++.+||+.+++|+||+|+||++++++ .++++|||.+......... .
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 84 GDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 99999886532 22358889999999999999999999999999999999999886 4699999988765443222 2
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~l 239 (246)
...++..|.|||...... ++.++|+||||+++++|++|..||..... .......... ..+.++..+.+++++
T Consensus 161 ~~~~~~~~~ape~~~~~~-----~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (257)
T cd08225 161 TCVGTPYYLSPEICQNRP-----YNNKTDIWSLGCVLYELCTLKHPFEGNNL--HQLVLKICQGYFAPISPNFSRDLRSL 233 (257)
T ss_pred ccCCCccccCHHHHcCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHhcccCCCCCCCCCHHHHHH
Confidence 234677899999876554 77899999999999999999999964332 2233333333 344566789999999
Q ss_pred HHHhhh
Q psy7592 240 LSQVHR 245 (246)
Q Consensus 240 i~~~l~ 245 (246)
|.+||+
T Consensus 234 i~~~l~ 239 (257)
T cd08225 234 ISQLFK 239 (257)
T ss_pred HHHHhc
Confidence 999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=240.30 Aligned_cols=196 Identities=24% Similarity=0.413 Sum_probs=156.3
Q ss_pred CcCCCCccCeeeEEEEEecC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee--CCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD--TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD--EEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~ 77 (246)
.||+|+| |+||+|+++. ++..||+|.+..... ...+.+|++++++++||||+++++++.. +...++++
T Consensus 8 ~lG~G~~---g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 8 KVGRGTY---GHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred EeccCCC---eeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 4788888 8999999764 678999998865431 2356789999999999999999999853 56789999
Q ss_pred eecCCCChHHHHhhccc----cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE----cCCCCeEEeecce
Q psy7592 78 DLLLGGDLRYHITQDIK----FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL----DEEGHAHITDFNI 149 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~----~~~~~~~l~d~~~ 149 (246)
||+. ++|.+.+..... .....+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||+
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 9985 577776643211 112346888899999999999999999999999999999999 5667899999999
Q ss_pred eeeeccCcc----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 150 ATVLEENQL----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 150 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
+........ .....++..|+|||.+.+.. .++.++|+||||+++|+|++|.+||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR----HYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCC----ccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 987643321 12345678899999986543 2678999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=235.63 Aligned_cols=232 Identities=36% Similarity=0.632 Sum_probs=203.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||.|+| .+|-+++.++|.+.||+|+++++...+.+.+.=.+.|-.+..+. +||.+|-++.+|+.+..+++|.||.
T Consensus 257 vigrgsy---akvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 257 VIGRGSY---AKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eecCcch---hhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 4788998 99999999999999999999988776666667777888888777 7999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeee-ccCccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL-EENQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~-~~~~~~ 159 (246)
+|++|-.+.+...++ |++.+..+...|+.||.|||++||+.+|+|.+|+|++..|.+|++|+|+++.- .+....
T Consensus 334 ~ggdlmfhmqrqrkl-----peeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~t 408 (593)
T KOG0695|consen 334 NGGDLMFHMQRQRKL-----PEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTT 408 (593)
T ss_pred cCcceeeehhhhhcC-----cHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCccc
Confidence 999998888776665 99999999999999999999999999999999999999999999999999874 455566
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------ccHHHHHhhhcCCCCCCCCCC
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN------TSVKDVKAIIYSPVHYPTAWS 233 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~s 233 (246)
..+.+++-|.|||++++.. +...+|.|+||+++++|+.|+.||+.-.. ++....+-+++.++.+|.+.|
T Consensus 409 stfcgtpnyiapeilrgee-----ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsls 483 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEE-----YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLS 483 (593)
T ss_pred ccccCCCcccchhhhcccc-----cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceee
Confidence 7789999999999999886 89999999999999999999999954331 112345556677999999999
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
-....+++..||+
T Consensus 484 vkas~vlkgflnk 496 (593)
T KOG0695|consen 484 VKASHVLKGFLNK 496 (593)
T ss_pred hhhHHHHHHhhcC
Confidence 8888888888874
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=231.40 Aligned_cols=224 Identities=21% Similarity=0.307 Sum_probs=176.0
Q ss_pred CcCCCCccCeeeEEEEEecCCC----------cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK----------QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~----------~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 71 (246)
.||+|++ |.||++.+..++ ..+++|.+.... .. ...+.+|+..+++++||||+++++++.. .
T Consensus 2 ~lg~G~~---~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 73 (259)
T cd05037 2 HLGQGTF---TNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D 73 (259)
T ss_pred ccccccc---ceEEEEEEeccCCccccCCccceeeeeeccccch---hh-HHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence 4789998 899999998776 457788765543 11 5678889999999999999999999887 6
Q ss_pred eEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-------CeEE
Q psy7592 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG-------HAHI 144 (246)
Q Consensus 72 ~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~-------~~~l 144 (246)
..++|+||+.+++|.+++..... .++...+..++.|++.+|+|||+.|++|+||+|+||+++.++ .+++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEe
Confidence 78999999999999999876432 348888999999999999999999999999999999999887 7999
Q ss_pred eecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc
Q psy7592 145 TDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY 223 (246)
Q Consensus 145 ~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~ 223 (246)
+|||.+..... .....+...|+|||.+.+.. ..++.++|+||||++++++++ |..||......... ....
T Consensus 150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~---~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~~~~ 220 (259)
T cd05037 150 SDPGIPITVLS---REERVERIPWIAPECIRNGQ---ASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---RFYQ 220 (259)
T ss_pred CCCCccccccc---ccccccCCCccChhhhcCCC---CCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---HHHh
Confidence 99998876443 22234566799999987652 127889999999999999999 57788654322211 1122
Q ss_pred CCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 224 SPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 224 ~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.....|...+..+.++|.+||+.
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~ 243 (259)
T cd05037 221 DQHRLPMPDCAELANLINQCWTY 243 (259)
T ss_pred cCCCCCCCCchHHHHHHHHHhcc
Confidence 23333444458999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=236.18 Aligned_cols=196 Identities=26% Similarity=0.388 Sum_probs=160.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++.++.+++.||+|.+...... .....+.+|++++++++|+||+++++++.++...++||||+.
T Consensus 12 ~lg~g~~---~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 12 KLGEGSY---ATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred EEeecCC---eEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 3688888 89999999999999999998764321 112345679999999999999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+ +|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 87 ~-~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (291)
T cd07844 87 T-DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS 161 (291)
T ss_pred C-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccc
Confidence 4 8888876532 245889999999999999999999999999999999999999999999999886543221 112
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
...++..|+|||.+.+.. .++.++|+||+|+++|+|++|..||....
T Consensus 162 ~~~~~~~~~aPE~~~~~~----~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 162 NEVVTLWYRPPDVLLGST----EYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ccccccccCCcHHhhcCc----ccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 223567899999876532 26779999999999999999999996443
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=229.88 Aligned_cols=226 Identities=21% Similarity=0.389 Sum_probs=179.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.+. .+..+|+|.+.... ...+.+.+|++++++++|+||+++++++.+ ...+++|||++
T Consensus 13 ~lg~g~~---~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 13 KLGAGQF---GEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred EecCccc---eEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 3788888 899999865 56679999886542 234678889999999999999999999887 67899999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-- 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (246)
+++|.+++.+.. ....+...+..++.|++.++.+||+.|++|+||+|+|++++.++.++++|||.+.........
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 84 KGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence 999999987632 223477889999999999999999999999999999999999999999999998765432211
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||.+.... ++.++|+||||++++++++ |..||...+.. .....+... ..+.+...+..+.
T Consensus 161 ~~~~~~~~y~~PE~~~~~~-----~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGS-----FTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRMPRPENCPEELY 233 (260)
T ss_pred cCCcccccccCHhHhccCC-----cCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCCCCCcccCCHHHH
Confidence 1223456799999986554 7889999999999999998 89999753322 222222222 3344567899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
+++.+||+.
T Consensus 234 ~~i~~~l~~ 242 (260)
T cd05073 234 NIMMRCWKN 242 (260)
T ss_pred HHHHHHccc
Confidence 999999963
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=244.74 Aligned_cols=232 Identities=24% Similarity=0.367 Sum_probs=185.3
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
||+|+. +.||+|..- +.+.||+|++.... .+...+..+.+|+.+|.+|+ |.+|++++++-..++.+|+|||+=
T Consensus 369 iG~GGS---SkV~kV~~s-~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G- 442 (677)
T KOG0596|consen 369 IGSGGS---SKVFKVLNS-DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG- 442 (677)
T ss_pred hcCCCc---ceeeeeecC-CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-
Confidence 566666 999999985 56677777664433 35566788999999999995 999999999999999999999974
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc---
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--- 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--- 158 (246)
..+|...+.+.... .+...++.++.|++.|+.++|+.||||.||||.|+++ -+|.+||+|||.+..+..++.
T Consensus 443 d~DL~kiL~k~~~~----~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~ 517 (677)
T KOG0596|consen 443 DIDLNKILKKKKSI----DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIV 517 (677)
T ss_pred cccHHHHHHhccCC----CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcccccee
Confidence 66899999875443 2445899999999999999999999999999999998 678999999999998876543
Q ss_pred ccccccCCCccCCceecccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCC
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDE------VLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPT 230 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~------~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 230 (246)
.....||.-|++||.+...... .-+.+++||||||||++|+|+.|+.||.... +....+.++..+ .+++|.
T Consensus 518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-n~~aKl~aI~~P~~~Iefp~ 596 (677)
T KOG0596|consen 518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-NQIAKLHAITDPNHEIEFPD 596 (677)
T ss_pred eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-HHHHHHHhhcCCCccccccC
Confidence 3457799999999998654433 2236789999999999999999999996433 234445566665 457776
Q ss_pred CCCHh-HHHHHHHhhhC
Q psy7592 231 AWSES-TKHLLSQVHRY 246 (246)
Q Consensus 231 ~~s~~-l~~li~~~l~~ 246 (246)
.-+.. +.++++.||.+
T Consensus 597 ~~~~~~li~~mK~CL~r 613 (677)
T KOG0596|consen 597 IPENDELIDVMKCCLAR 613 (677)
T ss_pred CCCchHHHHHHHHHHhc
Confidence 54444 99999999974
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=233.36 Aligned_cols=197 Identities=28% Similarity=0.446 Sum_probs=163.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|.+ |.||+++++.+|+.||+|.+..... +....+.+.+|++.++.++|||++++++++.++...++++||+
T Consensus 6 ~l~~g~~---~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~- 80 (283)
T cd07835 6 KIGEGTY---GVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL- 80 (283)
T ss_pred EecCCCC---eEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-
Confidence 4688888 8999999999999999999876532 2223356778999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|.+++..... ..+++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 81 ~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 DLDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred CcCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 5689888865431 235899999999999999999999999999999999999999999999999987653221 112
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
...++..|+|||.+.+.. .++.++|+||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 158 HEVVTLWYRAPEILLGSR----QYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred ccccccCCCCCceeecCc----ccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 234577899999876532 2577899999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=232.48 Aligned_cols=233 Identities=18% Similarity=0.244 Sum_probs=183.0
Q ss_pred CcCCCCccCeeeEEEEEecC----CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee-CCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD----TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD-EEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~v 76 (246)
+||+|++ |.||.+.++. ++..|++|.+.... +....+.+.+|+..+++++|+||+++++++.+ +...+++
T Consensus 13 ~i~~g~~---g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 87 (280)
T cd05043 13 LLQEGTF---GRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVL 87 (280)
T ss_pred eecccCC---ceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEE
Confidence 4788888 8999999876 36889999886432 34556778899999999999999999998765 5678899
Q ss_pred EeecCCCChHHHHhhcccc---ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 77 SDLLLGGDLRYHITQDIKF---YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
++++.+++|.+++...... ....+++..++.++.|++.|+.|||+.+++|+||+|+||+++.++.++++|||+++.+
T Consensus 88 ~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~ 167 (280)
T cd05043 88 YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167 (280)
T ss_pred EEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence 9999999999998654221 1134688999999999999999999999999999999999999999999999998765
Q ss_pred ccCccc---cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCC
Q psy7592 154 EENQLA---TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHY 228 (246)
Q Consensus 154 ~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~ 228 (246)
...... ....++..|+|||.+.+.. ++.++|+||||++++++++ |+.||...+. ......+... ....
T Consensus 168 ~~~~~~~~~~~~~~~~~y~apE~~~~~~-----~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~ 240 (280)
T cd05043 168 FPMDYHCLGDNENRPVKWMALESLVNKE-----YSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYRLAQ 240 (280)
T ss_pred cCCceEEeCCCCCcchhccCHHHHhcCC-----CCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCCCCC
Confidence 432211 1223456799999887654 7889999999999999998 9999965432 2222222222 3344
Q ss_pred CCCCCHhHHHHHHHhhhC
Q psy7592 229 PTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 229 ~~~~s~~l~~li~~~l~~ 246 (246)
+..+++++.+++.+||+.
T Consensus 241 ~~~~~~~~~~li~~~l~~ 258 (280)
T cd05043 241 PINCPDELFAVMACCWAL 258 (280)
T ss_pred CCcCCHHHHHHHHHHcCC
Confidence 567899999999999963
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=234.06 Aligned_cols=196 Identities=29% Similarity=0.446 Sum_probs=161.8
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|++ |.||+++++.+++.||+|.+..... .......+.+|++.+++++||||+++++++.++...+++|||+.
T Consensus 8 l~~g~~---~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 8 IGEGTY---GVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred ecCCCc---eEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence 677777 8999999999999999999875432 22233568889999999999999999999999999999999995
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-cccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~ 161 (246)
++|..++.... ...+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||.+....... ....
T Consensus 83 ~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 83 QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 57888775432 2235888999999999999999999999999999999999999999999999887553321 1122
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
..++..|+|||...+.. .++.++|+||||+++|+|++|+.||...
T Consensus 160 ~~~~~~y~aPE~~~~~~----~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 160 EVVTLWYRAPEILLGCK----YYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred ccccccccCCeEEecCC----CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 34567899999886543 2577899999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=230.17 Aligned_cols=221 Identities=24% Similarity=0.368 Sum_probs=175.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||.+.. +++.||+|.+.... ..+.+.+|+..+++++|||++++++++..+ ..+++|||+.
T Consensus 13 ~lg~g~~---g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 13 IIGEGEF---GAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred eeccCCC---CceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4788888 88998764 78899999986542 235678899999999999999999998765 4789999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++.... ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+...... ...
T Consensus 82 ~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~ 156 (254)
T cd05083 82 KGNLVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDN 156 (254)
T ss_pred CCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--CCC
Confidence 999999987642 223588889999999999999999999999999999999999999999999998764322 112
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~l 239 (246)
...+..|+|||.+.+.. ++.++|+||||+++++|++ |..||........ ...+... ....+..+++.+.++
T Consensus 157 ~~~~~~y~~pe~~~~~~-----~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 157 SKLPVKWTAPEALKHKK-----FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV--KECVEKGYRMEPPEGCPADVYVL 229 (254)
T ss_pred CCCCceecCHHHhccCC-----cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH--HHHHhCCCCCCCCCcCCHHHHHH
Confidence 23356799999886554 7889999999999999997 9999965433222 2222222 334456789999999
Q ss_pred HHHhhh
Q psy7592 240 LSQVHR 245 (246)
Q Consensus 240 i~~~l~ 245 (246)
|.+||+
T Consensus 230 i~~~l~ 235 (254)
T cd05083 230 MTSCWE 235 (254)
T ss_pred HHHHcC
Confidence 999996
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=242.17 Aligned_cols=235 Identities=27% Similarity=0.429 Sum_probs=188.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHH----HHHHHHHHHHHHhhCCCCcceeeeeeee-eCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERD----ALKNVLREMEILTTLEHPFLVNLWFCFQ-DEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~~v 76 (246)
+||.|+| +.||+|+|...++-||+|+-.....+.++ ..+...+|.++-+.|.||.||++|++|. +.+.+|-|
T Consensus 470 LLGrGGF---SEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV 546 (775)
T KOG1151|consen 470 LLGRGGF---SEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV 546 (775)
T ss_pred HhccccH---HHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence 6899998 99999999999999999986543322222 2355778999999999999999999997 56678999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCcEEEcC---CCCeEEeecceee
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH--IIHRDIKPDNILLDE---EGHAHITDFNIAT 151 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~--~~h~~i~~~nil~~~---~~~~~l~d~~~~~ 151 (246)
.||++|.+|..++...... ++.++..|++||+.||.||.+.. |+|.||+|.|||+.+ -|.++|+|||+++
T Consensus 547 LEYceGNDLDFYLKQhklm-----SEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQHKLM-----SEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred eeecCCCchhHHHHhhhhh-----hHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 9999999999999987766 99999999999999999998775 999999999999954 4579999999999
Q ss_pred eeccCcc--------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHh--h
Q psy7592 152 VLEENQL--------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKA--I 221 (246)
Q Consensus 152 ~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~--~ 221 (246)
.+..... .....|+..|++||.+.... +.++++.++||||+|+++|.++.|+.||.. +......++. +
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk-ePPKIsnKVDVWSvGVIFyQClYGrKPFGh-nqsQQdILqeNTI 699 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK-EPPKISNKVDVWSVGVIFYQCLYGRKPFGH-NQSQQDILQENTI 699 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCC-CCCccccceeeEeeehhhhhhhccCCCCCC-chhHHHHHhhhch
Confidence 8864432 23456888899999987664 344589999999999999999999999953 2222222222 1
Q ss_pred hcC---CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 222 IYS---PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 222 ~~~---~~~~~~~~s~~l~~li~~~l~~ 246 (246)
+.. .++..+-+|.+.+++|..||+|
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaY 727 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAY 727 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHh
Confidence 221 3333357999999999999986
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=235.46 Aligned_cols=228 Identities=21% Similarity=0.341 Sum_probs=178.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCc----EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ----MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||+|++ |.||++.+..+++ .||+|.+..... ......+.+|+.++++++||||+++++++... ..++++
T Consensus 14 ~lg~G~~---g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~ 87 (303)
T cd05110 14 VLGSGAF---GTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVT 87 (303)
T ss_pred ccccCCC---ccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeee
Confidence 4788888 8999999987776 568888865432 33345688899999999999999999998754 467899
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
|++++++|.+++..... .+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 88 e~~~~g~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 88 QLMPHGCLLDYVHEHKD----NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred hhcCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 99999999999865422 34788899999999999999999999999999999999999999999999997654322
Q ss_pred cc---cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcCCCCCCCCCC
Q psy7592 158 LA---TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYSPVHYPTAWS 233 (246)
Q Consensus 158 ~~---~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s 233 (246)
.. ....++..|+|||.+.+.. ++.++|+||||+++|++++ |+.||.+........... .....+.+..++
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~-----~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRK-----FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPICT 237 (303)
T ss_pred cccccCCCccccccCCHHHhccCC-----CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCC
Confidence 11 1223456799999886654 7889999999999999997 899996544322222211 122344456789
Q ss_pred HhHHHHHHHhhh
Q psy7592 234 ESTKHLLSQVHR 245 (246)
Q Consensus 234 ~~l~~li~~~l~ 245 (246)
..+.+++..||.
T Consensus 238 ~~~~~li~~c~~ 249 (303)
T cd05110 238 IDVYMVMVKCWM 249 (303)
T ss_pred HHHHHHHHHHcC
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=236.10 Aligned_cols=197 Identities=26% Similarity=0.370 Sum_probs=160.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC--CeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE--EDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~ 79 (246)
.||.|++ |.||++.++.+|+.||+|.+...... .+......+|+.++++++|+||+++++++.+. +..++||||
T Consensus 14 ~ig~g~~---~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (309)
T cd07845 14 RIGEGTY---GIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY 89 (309)
T ss_pred eeeecCC---EEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence 3688888 99999999999999999998754321 12223456799999999999999999998755 568999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-c
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-L 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 158 (246)
+. ++|.+.+.... ..+++..+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||.+....... .
T Consensus 90 ~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 90 CE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164 (309)
T ss_pred CC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence 95 47887776532 345889999999999999999999999999999999999999999999999988765432 1
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
......+..|+|||.+.+.. .++.++|+||||+++|+|++|..||...+
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~----~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCT----TYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred CCcccccccccChhhhcCCC----CcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22233466799999886533 26789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=234.52 Aligned_cols=200 Identities=27% Similarity=0.363 Sum_probs=161.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCe-----EEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEED-----LFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~-----~~~ 75 (246)
.||+|++ |.||++++..+++.||+|.++.... .......+.+|+..+++++ ||||+++++++..... .++
T Consensus 8 ~lg~g~~---g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l 83 (295)
T cd07837 8 KIGEGTY---GKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL 83 (295)
T ss_pred EecccCC---eEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence 4788888 8999999999999999999866432 1223356778999999995 6999999999886655 899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC-CCCeEEeecceeeeec
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE-EGHAHITDFNIATVLE 154 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~-~~~~~l~d~~~~~~~~ 154 (246)
+|||+++ +|.+++.........++++..++.++.|++.+|.|||+.|++|+||+|+||+++. ++.++++|||.+....
T Consensus 84 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~ 162 (295)
T cd07837 84 VFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162 (295)
T ss_pred EeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecC
Confidence 9999975 7888876543222345689999999999999999999999999999999999998 8899999999987653
Q ss_pred cC-ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 155 EN-QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 155 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
.. .......+++.|.|||.+.+.. .++.++|+||||+++|+|++|..||.+.
T Consensus 163 ~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 163 IPVKSYTHEIVTLWYRAPEVLLGST----HYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred CCccccCCcccccCCCChHHhhCCC----CCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 32 1112234567899999886432 3678999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=233.23 Aligned_cols=230 Identities=25% Similarity=0.389 Sum_probs=181.8
Q ss_pred cCCCCccCeeeEEEEEec----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee--CCeEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKK----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD--EEDLFMV 76 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~v 76 (246)
||+|++ |.||++... .+++.||+|.+...... ...+.+.+|++.++.++|+||+++++++.. +...+++
T Consensus 12 ig~g~~---~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05038 12 LGEGHF---GKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86 (284)
T ss_pred eccCCC---eeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEE
Confidence 788888 899999865 35889999999765432 345788999999999999999999999877 5678999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
|||+++++|.+++..... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+......
T Consensus 87 ~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 87 MEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred EecCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 999999999999876432 3588899999999999999999999999999999999999999999999998876532
Q ss_pred ccc----cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc------------HHHHHh
Q psy7592 157 QLA----TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS------------VKDVKA 220 (246)
Q Consensus 157 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~------------~~~~~~ 220 (246)
... ........|++||.+.+.. ++.++|+||||+++++|++|..|+....... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~-----~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSK-----FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCC-----CCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 111 1122345699999887654 7789999999999999999999985432221 111222
Q ss_pred hhcC--CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 221 IIYS--PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 221 ~~~~--~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.... ..+.|..++..+.+++.+||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~ 265 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEA 265 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhcc
Confidence 2222 3334567889999999999973
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=232.32 Aligned_cols=197 Identities=28% Similarity=0.401 Sum_probs=165.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC--CeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE--EDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~ 79 (246)
.||+|++ |.||++.+..+++.||+|.+.... ...+....+.+|++.+++++|||++++++++.+. ...++|+||
T Consensus 6 ~l~~g~~---~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 6 QIGEGTY---GQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred EeccCCC---eEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 3677777 999999999999999999998764 2334456788899999999999999999999887 889999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL- 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (246)
++ ++|...+.... ..+++..++.++.|++.|+++||+.|++|+||+|+||++++++.++++|||.+........
T Consensus 82 ~~-~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 82 MD-HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cc-ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 96 48888876532 2458999999999999999999999999999999999999999999999999887654431
Q ss_pred -ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 159 -ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.....++..|+|||.+.+.. .++.++|+||||+++++|++|..||+...
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~----~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGAT----RYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred cccccccccccCCceeeEccc----cCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22334567899999876543 26789999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=227.03 Aligned_cols=226 Identities=23% Similarity=0.369 Sum_probs=179.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |.||++.+. +++.+|+|.+...... ..++.+|++.+++++||+++++++++......++++||+.
T Consensus 11 ~ig~g~~---g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 11 EIGSGQF---GLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred eecCccc---ceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3688888 899999886 4778999988754422 2457789999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--A 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 159 (246)
+++|.+++.... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+........ .
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999886532 1247888999999999999999999999999999999999999999999998876533221 1
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
.....+..|+|||...+.. ++.++|+||||+++|+|++ |..||..... ......+... ....|...++.+.
T Consensus 159 ~~~~~~~~~~aPe~~~~~~-----~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSK-----YSSKSDVWSFGVLMWEVFSEGKTPYENRSN--SEVVETINAGFRLYKPRLASQSVY 231 (256)
T ss_pred CCCccchhhcCHhHhccCC-----cChHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHhCCCCCCCCCCCCHHHH
Confidence 1223456799999887654 7789999999999999998 8999964332 2222222222 3334566899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
+++.+||+.
T Consensus 232 ~l~~~~l~~ 240 (256)
T cd05112 232 ELMQHCWKE 240 (256)
T ss_pred HHHHHHccc
Confidence 999999963
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=234.16 Aligned_cols=197 Identities=22% Similarity=0.396 Sum_probs=162.8
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||.|++ |+||+++++.+++.||+|.++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+.+
T Consensus 8 l~~g~~---~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (284)
T cd07836 8 LGEGTY---ATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK 82 (284)
T ss_pred eccCCc---eEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence 677777 8999999999999999999976542 22235567799999999999999999999999999999999965
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-ccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-ATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~ 161 (246)
+|.+++..... ..++++..+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||.+........ ...
T Consensus 83 -~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 83 -DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred -cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 78887765331 23468999999999999999999999999999999999999999999999998875533211 122
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
..++..|++||.+.+.. .++.++|+||||+++++|++|..||....
T Consensus 160 ~~~~~~y~~PE~~~~~~----~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 160 EVVTLWYRAPDVLLGSR----TYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred ccccccccChHHhcCCC----CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 34567899999876543 26789999999999999999999997544
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=233.39 Aligned_cols=233 Identities=25% Similarity=0.413 Sum_probs=178.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |.||++.++.+++.||+|.++.... ......+..|...+.+. .||||+++++++.++...+++|||+
T Consensus 22 ~lg~g~~---~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 22 EIGSGTC---GQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred EeeccCC---eEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 3677877 8999999999999999999976542 22234555666666666 4999999999999999999999998
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (246)
++++........ .++++..+..++.|++.++.|||+ .|++|+||+|+||++++++.++|+|||.+.........
T Consensus 97 -~~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~ 171 (296)
T cd06618 97 -STCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171 (296)
T ss_pred -CcCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence 456776665422 245888899999999999999997 59999999999999999999999999998765443333
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCC--CCCCHhH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYP--TAWSEST 236 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~--~~~s~~l 236 (246)
....++..|+|||.+.+... ...++.++|+||||+++|+|++|+.||...... .......... ....+ ..+++++
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l 249 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDP-NPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQEEPPSLPPNEGFSPDF 249 (296)
T ss_pred cCCCCCccccCHhhcCCCCC-ccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhcCCCCCCCCCCCCCHHH
Confidence 33446778999999865431 123678999999999999999999999643322 2222233322 22333 2479999
Q ss_pred HHHHHHhhhC
Q psy7592 237 KHLLSQVHRY 246 (246)
Q Consensus 237 ~~li~~~l~~ 246 (246)
+++|++||++
T Consensus 250 ~~li~~~l~~ 259 (296)
T cd06618 250 CSFVDLCLTK 259 (296)
T ss_pred HHHHHHHccC
Confidence 9999999963
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=235.98 Aligned_cols=199 Identities=23% Similarity=0.363 Sum_probs=164.3
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
+|+|. |+.+.|+.++++.+++.||+|++.... .+.+..+.+.+|++.+++++|+||+++++++.++...+++|||+++
T Consensus 6 i~~~~-~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 6 IGKCF-EDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhHhh-cCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 55553 333778888998899999999997653 2344567899999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc----
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL---- 158 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~---- 158 (246)
++|.+++.... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++++||+.+........
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 84 GSCEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99999987532 22458889999999999999999999999999999999999999999999998866532211
Q ss_pred ----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy7592 159 ----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDI 209 (246)
Q Consensus 159 ----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~ 209 (246)
.....++..|+|||.+..... .++.++|+||+|+++++|++|..||..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQ---GYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred cccccccccccccccCHHHhcCCCC---CCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 112335567999999865321 267899999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=255.33 Aligned_cols=229 Identities=20% Similarity=0.356 Sum_probs=196.4
Q ss_pred CcCCCCccCeeeEEEEEecCCC---cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK---QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||.|.| |.||+.+.+..+ ..||||.++... ++.+..+|..|+.++-+++||||+++-++........+|+|
T Consensus 636 VIGaGEF---GEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 636 VIGAGEF---GEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred EEecccc---cceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 4799999 899999999665 479999998765 56778899999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
||++++|..++.++... +..-++..+++.|+.+++||-+.|+|||||...|||++.+-.+|++|||+++...++..
T Consensus 711 yMENGsLDsFLR~~DGq----ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQ----FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhCCcHHHHHhhcCCc----eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 99999999999876432 57788999999999999999999999999999999999999999999999998765442
Q ss_pred --ccccccC--CCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCC
Q psy7592 159 --ATSMSGT--KPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAW 232 (246)
Q Consensus 159 --~~~~~~~--~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (246)
.....|. .+|.|||.+-... ++++||+||+|+|+||.++ |..||= +....+.+..+.+. +.+.|..+
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RK-----FTsASDVWSyGIVmWEVmSyGERPYW--dmSNQdVIkaIe~gyRLPpPmDC 859 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYW--DMSNQDVIKAIEQGYRLPPPMDC 859 (996)
T ss_pred ccccccCCccceeecChhHhhhcc-----cCchhhccccceEEEEecccCCCccc--ccchHHHHHHHHhccCCCCCCCC
Confidence 1223333 4699999997665 8999999999999999888 999983 44445566666666 66667799
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
+..|.+|+..||++
T Consensus 860 P~aL~qLMldCWqk 873 (996)
T KOG0196|consen 860 PAALYQLMLDCWQK 873 (996)
T ss_pred cHHHHHHHHHHHHH
Confidence 99999999999985
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=233.25 Aligned_cols=196 Identities=26% Similarity=0.411 Sum_probs=159.6
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||.|.+ |+||++.++.+++.||+|.+..... +....+.+.+|++.+++++||||+++++++.++...++||||+.
T Consensus 10 l~~g~~---~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 84 (294)
T PLN00009 10 IGEGTY---GVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD- 84 (294)
T ss_pred ecCCCC---EEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-
Confidence 677777 8999999999999999999865432 22334667889999999999999999999999999999999995
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC-CCCeEEeecceeeeeccCc-ccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE-EGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~-~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
++|.+++..... ...++..++.++.|++.||++||+.|++|+||+|+||+++. ++.++++|||++....... ...
T Consensus 85 ~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (294)
T PLN00009 85 LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (294)
T ss_pred ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccc
Confidence 577777754322 23477888899999999999999999999999999999985 4578999999987653321 122
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
...++..|+|||.+.+.. .++.++|+||+|+++|+|++|..||...
T Consensus 162 ~~~~~~~y~~PE~~~~~~----~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 162 HEVVTLWYRAPEILLGSR----HYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred cCceeecccCHHHHhCCC----CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 234577899999886532 2678999999999999999999999643
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=239.58 Aligned_cols=195 Identities=27% Similarity=0.482 Sum_probs=161.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC-----CeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE-----EDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v 76 (246)
.||.|++ |+||++++..+++.||+|.+..... .......+.+|+.+++.++|+||+++++++... ...+++
T Consensus 12 ~lg~G~~---~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 87 (337)
T cd07858 12 PIGRGAY---GIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIV 87 (337)
T ss_pred EeccCCC---eEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEE
Confidence 4788888 9999999999999999999876432 222345677899999999999999999988644 348999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
+||+ +++|.+.+..... +++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||++......
T Consensus 88 ~e~~-~~~L~~~~~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 88 YELM-DTDLHQIIRSSQT-----LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EeCC-CCCHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 9999 5688888765433 489999999999999999999999999999999999999999999999998765443
Q ss_pred -ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 157 -QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 157 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
.......++..|+|||.+.... .++.++|+||||+++++|++|..||.+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCS----EYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred cccccccccccCccChHHHhcCC----CCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 2223345677899999876432 2678999999999999999999999654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=232.06 Aligned_cols=234 Identities=33% Similarity=0.577 Sum_probs=186.5
Q ss_pred CcCCCCccCeeeEEEEEec---CCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK---DTKQMYAMKYMHKSQCI-ERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v 76 (246)
+||+|++ |.||++++. .+++.||+|.++..... .....+.+.+|+++++++ +||+|+++++.+..+...++|
T Consensus 7 ~ig~G~~---~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 7 VLGTGAY---GKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EeccCCC---ceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 4788888 899998864 46789999999764322 223346678899999999 599999999999999999999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
|||+.+++|.+.+..... +++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 84 LDYVNGGELFTHLYQREH-----FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EecCCCCcHHHHHhhcCC-----cCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 999999999998865433 488899999999999999999999999999999999999999999999988765432
Q ss_pred cc--ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHhhhcCCCCCCCCC
Q psy7592 157 QL--ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT--SVKDVKAIIYSPVHYPTAW 232 (246)
Q Consensus 157 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (246)
.. .....++..|++||...+... ..+.++|+||||+++++|++|..||...+.. .......+.....+.|..+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSG---GHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTM 235 (288)
T ss_pred cccccccccCCccccCHHHhcCCCC---CCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCccc
Confidence 21 122346788999998765421 1567899999999999999999999543221 1223344445566777889
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
+..++++|.+||+.
T Consensus 236 ~~~l~~li~~~l~~ 249 (288)
T cd05583 236 SAEARDFIQKLLEK 249 (288)
T ss_pred CHHHHHHHHHHhcC
Confidence 99999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=246.35 Aligned_cols=218 Identities=31% Similarity=0.504 Sum_probs=178.0
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+|.|+| +.+..+.+..+++.+++|.+.+.. .+..+|+..+... +||||+++.+++.++.+.|+|||.+.
T Consensus 330 ~~~gs~---s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 330 LGEGSF---SAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred cCCCCc---cceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 466667 899999999999999999997763 3455567666666 69999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE-cCCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL-DEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~-~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
|+-+.+.+..... ....+..|+.||+.|+.|||++|++|||++|+|||+ ++.+.++++|||.++..... ..
T Consensus 400 g~ell~ri~~~~~------~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~ 471 (612)
T KOG0603|consen 400 GGELLRRIRSKPE------FCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CD 471 (612)
T ss_pred ccHHHHHHHhcch------hHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hc
Confidence 9988777765432 335677799999999999999999999999999999 69999999999998765544 33
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
....+..|.|||...... +++++|+||||+++|+|++|+.||...... .....++. .+++..++|+..++||
T Consensus 472 tp~~t~~y~APEvl~~~~-----yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~--~~~~s~~vS~~AKdLl 543 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQE-----YTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQ--MPKFSECVSDEAKDLL 543 (612)
T ss_pred ccchhhcccChhhhccCC-----CCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhc--CCccccccCHHHHHHH
Confidence 345577899999998554 899999999999999999999999765544 22222222 3334489999999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
++||+.
T Consensus 544 ~~LL~~ 549 (612)
T KOG0603|consen 544 QQLLQV 549 (612)
T ss_pred HHhccC
Confidence 999973
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=238.17 Aligned_cols=196 Identities=28% Similarity=0.473 Sum_probs=161.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee----CCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD----EEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~v~ 77 (246)
.||.|++ |.||++.++.+++.||+|.+..... .......+.+|+.++++++||||+++++++.. ....++|+
T Consensus 12 ~lg~g~~---g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 87 (334)
T cd07855 12 NIGSGAY---GVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVM 87 (334)
T ss_pred eeecCCC---eEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEE
Confidence 3677887 8999999999999999999876432 22335667789999999999999999998863 35689999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||+. ++|.+.+..... +++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 88 e~~~-~~l~~~~~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 88 DLME-SDLHHIIHSDQP-----LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred ehhh-hhHHHHhccCCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 9994 588888765433 4999999999999999999999999999999999999999999999999987654322
Q ss_pred c-----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 158 L-----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 158 ~-----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
. .....++..|.|||.+.... .++.++|+||||+++|+|++|+.||...+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLP----EYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred cCCCcccccccccccccChHHhcCCc----ccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 1 12235677899999876532 26789999999999999999999996543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=226.02 Aligned_cols=236 Identities=16% Similarity=0.215 Sum_probs=175.4
Q ss_pred CcCCCCccCeeeEEEEEecC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD--TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|++ |+||++.... ....+++|.+.... .....+.+.+|+..++.++||||+++++.+.+....+++|||
T Consensus 2 ~lg~G~~---g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWF---GKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcC---ceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence 4789998 8999987543 23456677765543 233456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc--
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-- 157 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (246)
+++++|.+++.+.... ....+...+..++.|++.||+|||+.+++|+||+|+||+++.++.++++|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 77 CELGDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCCCcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 9999999998764321 2234677788999999999999999999999999999999999999999999875432211
Q ss_pred -cccccccCCCccCCceeccccc--ccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC------CCC
Q psy7592 158 -LATSMSGTKPYIAPEIFLVATD--EVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS------PVH 227 (246)
Q Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~--~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~------~~~ 227 (246)
......++..|+|||.+..... .....+.++|+||||+++|+|++ |..||..... .......... ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHhhcccccCCCc
Confidence 1223456778999998753211 11135778999999999999997 5678854332 2222222111 223
Q ss_pred CCCCCCHhHHHHHHHhhh
Q psy7592 228 YPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 228 ~~~~~s~~l~~li~~~l~ 245 (246)
++..+++.+.+++..||.
T Consensus 234 ~~~~~~~~~~~l~~~c~~ 251 (268)
T cd05086 234 LELPYSERWYEVLQFCWL 251 (268)
T ss_pred cCCCCcHHHHHHHHHHhh
Confidence 345689999999999983
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=249.15 Aligned_cols=199 Identities=23% Similarity=0.298 Sum_probs=150.8
Q ss_pred CcCCCCccCeeeEEEEEecCC-CcEEEEEE--------------eeccccchHHHHHHHHHHHHHHhhCCCCcceeeeee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT-KQMYAMKY--------------MHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFC 66 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~-~~~~avK~--------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 66 (246)
.||+|+| |+||++..+.. +..++.|. +.+..........++.+|+.++++++||||++++++
T Consensus 155 ~LG~G~f---G~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 231 (501)
T PHA03210 155 DLPAGAF---GKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEI 231 (501)
T ss_pred EecCCCC---cceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEE
Confidence 3678888 99999876532 22222221 111111122345668899999999999999999999
Q ss_pred eeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEee
Q psy7592 67 FQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITD 146 (246)
Q Consensus 67 ~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d 146 (246)
+.+.+..+++++++ +.+|..++...............+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus 232 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~D 310 (501)
T PHA03210 232 LRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGD 310 (501)
T ss_pred EEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEe
Confidence 99999999999998 45666665443221122234567888999999999999999999999999999999999999999
Q ss_pred cceeeeeccCcc--ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCC-CCCC
Q psy7592 147 FNIATVLEENQL--ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDI 209 (246)
Q Consensus 147 ~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~-p~~~ 209 (246)
||++..+..... .....++..|+|||.+.+.. ++.++||||||+++|+|++|.. |+..
T Consensus 311 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 311 FGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-----YCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred CCCceecCcccccccccccCCcCCCCchhhcCCC-----CCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 999987654322 22356889999999987664 7889999999999999999875 5543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=236.99 Aligned_cols=194 Identities=28% Similarity=0.509 Sum_probs=158.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC-----CeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE-----EDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v 76 (246)
.||+|++ |.||++.++.+|+.||+|.+.... .......+.+|+.++++++||||+++++++... ...+++
T Consensus 12 ~lg~G~~---g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 12 YIGEGAY---GMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred EEEecCC---eEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 4788888 899999999999999999986432 223346677899999999999999999887644 357999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
+||+. ++|...+... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||++......
T Consensus 87 ~e~~~-~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 87 QELME-TDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ehhcc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 99995 5777766432 3488999999999999999999999999999999999999999999999998765432
Q ss_pred cc----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 157 QL----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 157 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.. .....++..|+|||.+.+.. .++.++|+||+|+++++|++|+.||.+.+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~DvwslGvil~el~~G~~~f~~~~ 214 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSK----GYTKAIDIWSVGCILAEMLSNRPLFPGKD 214 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCC----CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 12245678899999875432 26789999999999999999999996543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=213.55 Aligned_cols=217 Identities=26% Similarity=0.464 Sum_probs=180.2
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
||+|.+ |.|-+.++..+|+..|+|.++..- +....+++.+|+++..+- .+|++|++|+-...+...++.||.+
T Consensus 54 lGrGay---G~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M- 127 (282)
T KOG0984|consen 54 LGRGAY---GVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM- 127 (282)
T ss_pred hcCCcc---chhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-
Confidence 688888 899999999999999999997654 234456777788877766 6999999999888888899999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK-HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~-~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
..||..+..+-.. .+...|+..+-.++..+.+|+.+||++ .++|||+||+|||++.+|++|+||||.+....++-...
T Consensus 128 ~tSldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt 206 (282)
T KOG0984|consen 128 DTSLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT 206 (282)
T ss_pred hhhHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH
Confidence 7788777654322 244569999999999999999999975 79999999999999999999999999998877766555
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY 228 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (246)
.-.|...|+|||.+..... .+.|+.+|||||||+.+.||.+++.||+.... +-.+++++++++.+.
T Consensus 207 ~daGCkpYmaPEri~~e~n-~~gY~vksDvWSLGItmiElA~lr~PY~~w~t-pF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 207 MDAGCKPYMAPERINPELN-QKGYSVKSDVWSLGITMIEMAILRFPYESWGT-PFQQLKQVVEEPSPQ 272 (282)
T ss_pred HhcCCCccCChhhcCcccC-cccceeehhhhhhhhhhhhhhhccccccccCC-HHHHHHHHhcCCCCC
Confidence 5678899999999876653 33689999999999999999999999987654 455677777775544
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=241.51 Aligned_cols=231 Identities=22% Similarity=0.372 Sum_probs=189.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|.| |.|.+|.-. .+.+||+|.++..+. .....+|.+|+++|.+|+||||++++++|..++.+++|+||++
T Consensus 545 kiGeGqF---GEVhLCeve-g~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 545 KIGEGQF---GEVHLCEVE-GPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred hhcCccc---ceeEEEEec-CceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 4799999 899999875 479999999998874 3346889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+|+|.+++..+.... ........++.||+.+++||.+.++||||+.+.|+|++.++.+||+|||+++..........
T Consensus 619 nGDLnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 619 NGDLNQFLSAHELPT---AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred cCcHHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 999999998763221 23344667999999999999999999999999999999999999999999987655443322
Q ss_pred ---cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCccH-HHHHhhhcC-----CCCCCC
Q psy7592 162 ---MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA--RGRPFDIHSNTSV-KDVKAIIYS-----PVHYPT 230 (246)
Q Consensus 162 ---~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~--g~~p~~~~~~~~~-~~~~~~~~~-----~~~~~~ 230 (246)
..-..+|+|+|.+.... ++.+||+|+||+.+||+++ ...||+....+.. ++....... -...|.
T Consensus 696 qgr~vlpiRwmawEsillgk-----FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGK-----FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred ecceeeeeeehhHHHHHhcc-----ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence 23456899999998775 8999999999999999865 7789965443332 333344333 234477
Q ss_pred CCCHhHHHHHHHhhhC
Q psy7592 231 AWSESTKHLLSQVHRY 246 (246)
Q Consensus 231 ~~s~~l~~li~~~l~~ 246 (246)
-++..+-+++..||++
T Consensus 771 ~cp~~lyelml~Cw~~ 786 (807)
T KOG1094|consen 771 ACPQGLYELMLRCWRR 786 (807)
T ss_pred cCcHHHHHHHHHHhch
Confidence 8999999999999974
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=235.07 Aligned_cols=196 Identities=29% Similarity=0.487 Sum_probs=166.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC-----eEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE-----DLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~~v 76 (246)
.||.|++ |.||++++..+++.||+|.+.... .+....+.+.+|+..+++++|+||+++.+++.... ..+++
T Consensus 7 ~ig~g~~---~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 7 PIGSGAY---GVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eecCCCC---eEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 4788888 899999999999999999987643 22344577889999999999999999999988765 78999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
|||+. ++|.+.+.... ++++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+......
T Consensus 83 ~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 83 TELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred ecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99995 57888876543 4589999999999999999999999999999999999999999999999999887554
Q ss_pred c----cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 157 Q----LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 157 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
. ......++..|+|||.+.+.. ..+.++|+||||+++++|++|.+||....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSS----RYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ccccccccccccccCcCCceeeeccc----CCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 3 123345677899999987663 27889999999999999999999996544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=226.19 Aligned_cols=234 Identities=20% Similarity=0.309 Sum_probs=179.0
Q ss_pred CcCCCCccCeeeEEEEEec---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC------e
Q psy7592 2 FCGSSKFCGTSKVCIVQKK---DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE------D 72 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~ 72 (246)
.||+|++ |.||++.+. .+++.||+|.+..... +....+++.+|++.+++++||||+++++++.... .
T Consensus 6 ~ig~g~~---g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 6 MLGKGEF---GSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cccCCCC---CCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 4788888 899999865 3578999999976442 2334577889999999999999999999886432 2
Q ss_pred EEEEEeecCCCChHHHHhhccc-cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 73 LFMVSDLLLGGDLRYHITQDIK-FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 73 ~~~v~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
.+++++|+.+++|.+++..... .....++...++.++.|++.+++|||+.|++|+||+|+||+++.++.++++|||.+.
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~ 161 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccc
Confidence 4788899999999888753221 112346888899999999999999999999999999999999999999999999987
Q ss_pred eeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CC
Q psy7592 152 VLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PV 226 (246)
Q Consensus 152 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~ 226 (246)
....... ......+..|++||.+.... ++.++|+||||+++|+|++ |..||..... ......+... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-----~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~~ 234 (273)
T cd05074 162 KIYSGDYYRQGCASKLPVKWLALESLADNV-----YTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKGNRL 234 (273)
T ss_pred cccCCcceecCCCccCchhhcCHhHHhcCc-----cchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcCCcC
Confidence 6543221 11223446789999876554 6789999999999999999 8889864332 2222223222 34
Q ss_pred CCCCCCCHhHHHHHHHhhhC
Q psy7592 227 HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ~~~~~~s~~l~~li~~~l~~ 246 (246)
..+...+..+.+++.+||+.
T Consensus 235 ~~~~~~~~~~~~l~~~~l~~ 254 (273)
T cd05074 235 KQPPDCLEDVYELMCQCWSP 254 (273)
T ss_pred CCCCCCCHHHHHHHHHHcCC
Confidence 45567899999999999963
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=232.68 Aligned_cols=197 Identities=26% Similarity=0.349 Sum_probs=158.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC--------eE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE--------DL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~ 73 (246)
.||.|++ |.||++.++.+++.||+|.+..... .........+|++.+++++||||+++++++.... ..
T Consensus 19 ~lg~g~~---~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 94 (310)
T cd07865 19 KIGQGTF---GEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSF 94 (310)
T ss_pred EeecCCC---EEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceE
Confidence 3678888 9999999999999999999865432 1222234567999999999999999999986543 45
Q ss_pred EEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 74 FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
++||||+. ++|.+.+.... ..+++.+++.++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||.+...
T Consensus 95 ~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 95 YLVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred EEEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 99999995 57777765432 23589999999999999999999999999999999999999999999999998766
Q ss_pred ccCcc-----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 154 EENQL-----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 154 ~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
..... .....++..|+|||.+.+.. .++.++|+||||+++|+|++|..||....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGER----DYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCc----ccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 43221 12234567899999876543 25778999999999999999999996544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=246.36 Aligned_cols=229 Identities=22% Similarity=0.314 Sum_probs=190.8
Q ss_pred CcCCCCccCeeeEEEEEecCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT---KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
+||+|.| |+|+++.++.. -..||||+++...... .+.+|.+|+..+.+|+|+|++++|++..+ ....+|+|
T Consensus 117 ~LG~GsF---gvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 117 LLGEGSF---GVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HhcCcce---eeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 5899999 99999999853 3468999998766322 57899999999999999999999999887 67889999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
+++.|||.+.+.+. ....+....++.++.||+.++.||.++++||||+...|+++-....+||+|||+.+....+..
T Consensus 191 LaplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999999873 234568888999999999999999999999999999999999988999999999988765443
Q ss_pred ccc----cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcCCCCCCCCCC
Q psy7592 159 ATS----MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYSPVHYPTAWS 233 (246)
Q Consensus 159 ~~~----~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s 233 (246)
... ..-...|.|||.++... ++.+||+|++||.+|||++ |..||.+......-...+ ..+..+.|+.+|
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~k-----FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~cs 341 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRK-----FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCS 341 (1039)
T ss_pred ceEecCCCcCcccccCHhHhcccc-----ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCCh
Confidence 322 22345699999998876 8999999999999999999 788997765433322222 333667788999
Q ss_pred HhHHHHHHHhhh
Q psy7592 234 ESTKHLLSQVHR 245 (246)
Q Consensus 234 ~~l~~li~~~l~ 245 (246)
+++.++++.||.
T Consensus 342 edIY~imk~cWa 353 (1039)
T KOG0199|consen 342 EDIYQIMKNCWA 353 (1039)
T ss_pred HHHHHHHHHhcc
Confidence 999999999995
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=242.39 Aligned_cols=227 Identities=20% Similarity=0.337 Sum_probs=194.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|.| |.||...+++..-.||||.++.+ .-.++.|..|+.+++.++|||+|+++++|..+..+|+|+|||.
T Consensus 274 KLGGGQY---GeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 274 KLGGGQY---GEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred ccCCCcc---cceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 5899999 89999999999999999999765 3557889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-- 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (246)
.|+|.+++....+. ..+.-.++.++.||..|++||...+++|+||...|.|+.++..+|+.|||+++.+..++..
T Consensus 347 yGNLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred CccHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence 99999999875432 3466678889999999999999999999999999999999999999999999988655432
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC--CCCCCCCCCHhH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSEST 236 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~l 236 (246)
......+-|.|||.+-... ++.++|||+||+++||+.| |..||.+-+- .+....++. +..-|..|++..
T Consensus 424 AGAKFPIKWTAPEsLAyNt-----FSiKSDVWAFGVLLWEIATYGMsPYPGidl---SqVY~LLEkgyRM~~PeGCPpkV 495 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNT-----FSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYGLLEKGYRMDGPEGCPPKV 495 (1157)
T ss_pred cCccCcccccCcccccccc-----cccchhhHHHHHHHHHHHhcCCCCCCCccH---HHHHHHHhccccccCCCCCCHHH
Confidence 2233456799999987665 8999999999999999999 8889965443 333444444 445588999999
Q ss_pred HHHHHHhhhC
Q psy7592 237 KHLLSQVHRY 246 (246)
Q Consensus 237 ~~li~~~l~~ 246 (246)
.+|+..||++
T Consensus 496 YeLMraCW~W 505 (1157)
T KOG4278|consen 496 YELMRACWNW 505 (1157)
T ss_pred HHHHHHHhcC
Confidence 9999999986
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=227.02 Aligned_cols=197 Identities=28% Similarity=0.427 Sum_probs=164.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||.|++ |+||++....+++.||+|.+...... . ......+|+..+.+++ |+|++++++++.++...++||||+
T Consensus 6 ~ig~g~~---g~v~~~~~~~~~~~~~ik~~~~~~~~-~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 6 QLGDGTF---GSVYLARNKETGELVAIKKMKKKFYS-W-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred eeccCCc---eEEEEEEECCCCcEEEEEEehhhccc-h-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 3678888 89999999989999999998765321 1 1233456889999998 999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
+++|.+.+.... ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+..........
T Consensus 81 -~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 81 -EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred -CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence 788988886643 2245899999999999999999999999999999999999999999999999988765544434
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
...++..|+|||.+.... .++.++|+||||+++++|++|++||....
T Consensus 157 ~~~~~~~~~aPE~~~~~~----~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 157 DYVSTRWYRAPEILLRST----SYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred CCCCcccccCceeeecCc----CcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 455677899999875433 26789999999999999999999996544
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=230.62 Aligned_cols=196 Identities=28% Similarity=0.408 Sum_probs=158.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC----------
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE---------- 71 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---------- 71 (246)
.||+|++ |+||++.++.+++.||+|.++.... .......+.+|++.+++++|||++++++++.+..
T Consensus 14 ~lg~g~~---g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 89 (302)
T cd07864 14 QIGEGTY---GQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKG 89 (302)
T ss_pred eecccCC---EEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCC
Confidence 3677877 8999999999999999999976432 1222356678999999999999999999987654
Q ss_pred eEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 72 ~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
..++++||+++ ++...+... ...+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++++|||.+.
T Consensus 90 ~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 90 AFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 78999999965 666666542 1235889999999999999999999999999999999999999999999999987
Q ss_pred eeccCcc--ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 152 VLEENQL--ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 152 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
....... ......+..|+|||.+.+.. ..+.++|+||||+++++|++|+.||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEE----RYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCC----CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 6543321 11233466799999875432 2578999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=228.50 Aligned_cols=197 Identities=30% Similarity=0.470 Sum_probs=165.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|++ |.||++.+..+++.+++|.+...... +.....+.+|++.+++++|++|+++++++..+...++++||+.
T Consensus 6 ~i~~g~~---~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 6 KIGEGTY---GVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred eeecCCC---ceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 3677777 89999999999999999998765432 2345678889999999999999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+ ++.+.+.... .++++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 82 ~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 82 T-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred C-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 5 7777775532 245889999999999999999999999999999999999999999999999987765543 222
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
...++..|.|||.+.+.. .++.++|+||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~PE~~~~~~----~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 157 HYVVTRWYRAPELLLGDK----GYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred CccCcccccCcHHHhcCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 344677899999986542 37889999999999999999999996543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=232.24 Aligned_cols=195 Identities=30% Similarity=0.455 Sum_probs=159.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeC--CeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDE--EDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~~v~e 78 (246)
.||.|++ |.||++.+..+++.||+|++.... .+......+.+|+..++++ +||||+++++++... ...++|||
T Consensus 14 ~lg~g~~---~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07852 14 KLGKGAY---GIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFE 89 (337)
T ss_pred hhcCCCC---eeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEec
Confidence 3688888 899999999999999999886532 2223345677899999999 999999999998643 46899999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+. ++|..++... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 90 ~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 90 YME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred ccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 996 5888887653 237788888999999999999999999999999999999999999999999876543321
Q ss_pred ------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 159 ------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 159 ------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.....++..|+|||.+.+.. ..+.++|+||||+++|+|++|+.||.+..
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGST----RYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred cccCcchhcccccccccCceeeeccc----cccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 12234677899999876533 36778999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=241.89 Aligned_cols=229 Identities=34% Similarity=0.629 Sum_probs=188.4
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||=|.| |.|++|+...|+..||+|.+++.+...+-.+.....|-++|..-..+.||++|-.|++.+.+|+||||++|
T Consensus 637 iGvGAF---GeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 637 IGVGAF---GEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred eccccc---ceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 555666 99999999999999999999998887777788888999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec---cCccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE---ENQLA 159 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~---~~~~~ 159 (246)
|++-.++.+.+-. +++.+..++.++..|+++.|..|++||||||+|||+|.+|.|||+|||++..+. +....
T Consensus 714 GDmMSLLIrmgIF-----eE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 714 GDMMSLLIRMGIF-----EEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred ccHHHHHHHhccC-----HHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 9999888876655 899999999999999999999999999999999999999999999999987652 10000
Q ss_pred ----------------------------------------cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHH
Q psy7592 160 ----------------------------------------TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFE 199 (246)
Q Consensus 160 ----------------------------------------~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ 199 (246)
-...|+.-|+|||++.... ++.-+|.||.|++||+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-----~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-----YTQLCDWWSVGVILYE 863 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-----ccccchhhHhhHHHHH
Confidence 0113788899999987554 7889999999999999
Q ss_pred HHhCCCCCCCCCCccH--HHHHhhhcCCCCCCCCCCHhHHHHHHHhh
Q psy7592 200 ILARGRPFDIHSNTSV--KDVKAIIYSPVHYPTAWSESTKHLLSQVH 244 (246)
Q Consensus 200 ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~s~~l~~li~~~l 244 (246)
|+.|+.||........ +.+-+-..-.++.-.++|.++.+||.++-
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc 910 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC 910 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh
Confidence 9999999964332221 11111121233344689999999998764
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=232.59 Aligned_cols=193 Identities=27% Similarity=0.467 Sum_probs=160.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC------eEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE------DLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~~ 75 (246)
.||+|++ |.||++.+..+++.||+|.+.... ........+.+|++.+++++||||+++++++..+. .+++
T Consensus 22 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07880 22 QVGSGAY---GTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL 97 (343)
T ss_pred EeeecCC---eEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEE
Confidence 3788888 899999999999999999986532 22334456788999999999999999999987543 4689
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||+++ +++|.+.+... .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+.....
T Consensus 98 v~e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 98 VMPFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred EEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 99998 78898877532 348999999999999999999999999999999999999999999999999876543
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
. .....++..|+|||.+.+.. .++.++|+||||++++++++|..||....
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 171 E--MTGYVVTRWYRAPEVILNWM----HYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred C--ccccccCCcccCHHHHhCCC----CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 22345577899999886532 26789999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=233.56 Aligned_cols=192 Identities=22% Similarity=0.411 Sum_probs=155.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC-----------
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE----------- 70 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----------- 70 (246)
.||.|++ |.||+++++.+++.||+|.+..... ...+.+.+|++.+++++||||+++++++...
T Consensus 12 ~Lg~g~~---g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 12 PLGCGSN---GLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred EecCCCC---EEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 4788887 8999999999999999999876542 3456788899999999999999999876543
Q ss_pred ---CeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC-CCCeEEee
Q psy7592 71 ---EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE-EGHAHITD 146 (246)
Q Consensus 71 ---~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~-~~~~~l~d 146 (246)
...++++||+. ++|.+.+... .+++..++.++.|++.|+.|||+.|++|+||+|+||+++. ++.++++|
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35789999995 5887776532 2488999999999999999999999999999999999974 55789999
Q ss_pred cceeeeeccCcc----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 147 FNIATVLEENQL----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 147 ~~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
||.+........ .....++..|.|||.+.... .++.++|+||||+++++|++|..||...
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPN----NYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCcc----ccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999876532211 12234577899999865432 2677999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=224.33 Aligned_cols=233 Identities=22% Similarity=0.394 Sum_probs=183.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI--ERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|++ |.||++.+..++..+++|..+..... +.....++..|+..+++++||||+++++.+.+....++++||
T Consensus 7 ~ig~g~~---g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (260)
T cd08222 7 RLGKGSF---GTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEY 83 (260)
T ss_pred eecCCCC---ceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEe
Confidence 3788888 89999999888777777776653321 122234566789999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL- 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (246)
+++++|.+.+..... ....+++..++.++.|++.++.+||+.|++|+||+|+|+++++ +.++++|||.+........
T Consensus 84 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~ 161 (260)
T cd08222 84 CEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDL 161 (260)
T ss_pred CCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCccc
Confidence 999999988865321 2345689999999999999999999999999999999999975 5699999999877643322
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
.....++..|+|||...+.. ++.++|+||||+++++|++|..||.... .......+... ....|..++.++.
T Consensus 162 ~~~~~~~~~~~~pe~~~~~~-----~~~~~Dv~slG~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd08222 162 ATTFTGTPYYMSPEALKHQG-----YDSKSDIWSLGCILYEMCCLAHAFEGQN--FLSVVLRIVEGPTPSLPETYSRQLN 234 (260)
T ss_pred ccCCCCCcCccCHHHHccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHcCCCCCCcchhcHHHH
Confidence 22345677899999876544 6778999999999999999999996432 22333333333 4445678999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||++
T Consensus 235 ~li~~~l~~ 243 (260)
T cd08222 235 SIMQSMLNK 243 (260)
T ss_pred HHHHHHhcC
Confidence 999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=227.04 Aligned_cols=197 Identities=30% Similarity=0.432 Sum_probs=160.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC---CCCcceeeeeeeeeCCe-----E
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL---EHPFLVNLWFCFQDEED-----L 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~-----~ 73 (246)
.||+|++ |.||++.++.+++.||+|.++.... +......+.+|+.+++++ +|||++++++++.+... .
T Consensus 6 ~l~~g~~---~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 6 EIGEGAY---GTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred EecccCc---eEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 3688888 8999999998999999999975442 122234455677666655 69999999999987776 9
Q ss_pred EEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 74 FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
+++||++. ++|.+++..... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+...
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEEehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 99999995 478887765322 23588999999999999999999999999999999999999999999999998876
Q ss_pred ccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 154 EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 154 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
..........++..|+|||.+.+.. ++.++|+||||+++++|++|.+||....
T Consensus 158 ~~~~~~~~~~~~~~~~~PE~~~~~~-----~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 158 SFEMALTSVVVTLWYRAPEVLLQSS-----YATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred cCCcccccccccccccChHHhccCC-----CCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 5443333445677899999987654 6789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=226.35 Aligned_cols=230 Identities=16% Similarity=0.130 Sum_probs=166.4
Q ss_pred CcCCCCccCeeeEEEEEecCC---CcEEEEEEeeccccch--HHH------HHHHHHHHHHHhhCCCCcceeeeeeeeeC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT---KQMYAMKYMHKSQCIE--RDA------LKNVLREMEILTTLEHPFLVNLWFCFQDE 70 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~---~~~~avK~~~~~~~~~--~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 70 (246)
+||+|+| |+||++.+..+ +..+|+|......... +.. ......+...+..++|++++++++++...
T Consensus 19 ~LG~G~f---G~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 95 (294)
T PHA02882 19 LIGCGGF---GCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFK 95 (294)
T ss_pred EEecCCC---ceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEe
Confidence 4788888 89999999877 6777777644322110 100 01122344556677899999999876544
Q ss_pred C----eEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEee
Q psy7592 71 E----DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITD 146 (246)
Q Consensus 71 ~----~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d 146 (246)
. ..+++++++ ..++.+.+..... .++..+..++.|++.++.|||+.+++||||||+||+++.++.++++|
T Consensus 96 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 96 RCRMYYRFILLEKL-VENTKEIFKRIKC-----KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred cCCceEEEEEEehh-ccCHHHHHHhhcc-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 3 356778876 4566666544322 27788999999999999999999999999999999999999999999
Q ss_pred cceeeeeccCc--------cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH--
Q psy7592 147 FNIATVLEENQ--------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK-- 216 (246)
Q Consensus 147 ~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-- 216 (246)
||+++.+.... ......+++.|+|||...+.. ++.++|+||||+++++|++|+.||.........
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-----~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-----VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-----CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99998764221 112245788999999987665 788999999999999999999999765332211
Q ss_pred -----HHHhhhcCCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 217 -----DVKAIIYSPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 217 -----~~~~~~~~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
...++..... .+...+..+.++++.|+++
T Consensus 245 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 278 (294)
T PHA02882 245 AAKCDFIKRLHEGKI-KIKNANKFIYDFIECVTKL 278 (294)
T ss_pred HhHHHHHHHhhhhhh-ccCCCCHHHHHHHHHHHhC
Confidence 1122222222 2346789999999999863
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=229.43 Aligned_cols=193 Identities=31% Similarity=0.480 Sum_probs=159.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee-CCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD-EEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~v~e~~ 80 (246)
.||.|++ |.||++.++.+++.||+|.+.... .+....+.+.+|++++++++||||+++++++.. +...++++|++
T Consensus 17 ~ig~g~~---g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~ 92 (328)
T cd07856 17 PVGMGAF---GLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL 92 (328)
T ss_pred eecccCC---eEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh
Confidence 3677777 899999999999999999886543 223344677789999999999999999999865 56789999998
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
+++|...+... ++++..+..++.|++.++.+||+.|++|+||+|+|+++++++.++++|||.+...... ..
T Consensus 93 -~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--~~ 163 (328)
T cd07856 93 -GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MT 163 (328)
T ss_pred -ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--cC
Confidence 67888777542 2478888899999999999999999999999999999999999999999988754322 22
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
...++..|+|||.+.+.. .++.++|+||||+++++|++|..||....
T Consensus 164 ~~~~~~~y~aPE~~~~~~----~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQ----KYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred CCcccccccCceeeeccC----CcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 334567899999876532 26889999999999999999999996543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=226.32 Aligned_cols=197 Identities=28% Similarity=0.409 Sum_probs=165.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|.+ |.||++.+..+++.||+|.+.... .+....+.+..|+..+++++|+|++++++++.+....++++|++.
T Consensus 6 ~ig~g~~---~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 6 KLGEGTY---GVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred cccccCc---ceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 3677877 899999999999999999998754 223334667789999999999999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
++|.+++.... ..+++..+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||.+....... ...
T Consensus 82 -~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (282)
T cd07829 82 -MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156 (282)
T ss_pred -cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence 58999987642 235899999999999999999999999999999999999999999999999887654332 222
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
....+..|+|||.+.... ..+.++|+||||++++++++|..||....
T Consensus 157 ~~~~~~~~~aPE~~~~~~----~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 157 HEVVTLWYRAPEILLGSK----HYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred ccccCcCcCChHHhcCCc----CCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 234466799999986542 26889999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=232.00 Aligned_cols=192 Identities=28% Similarity=0.467 Sum_probs=157.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC------CeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE------EDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~~ 75 (246)
.||+|++ |.||++.+..+++.||+|++..... +....+.+.+|+..+++++||||+++++++... ...++
T Consensus 24 ~lg~G~~---g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 99 (345)
T cd07877 24 PVGSGAY---GSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 99 (345)
T ss_pred EeeecCC---eEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEE
Confidence 3788888 8999999999999999999876432 223346677899999999999999999988643 34678
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
+++++ +++|.+.+... .+++..++.++.|++.|+.|||+.|++|+||+|+||++++++.++++|||++.....
T Consensus 100 v~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 100 VTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred Eehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 88877 88898877542 248899999999999999999999999999999999999999999999999875432
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
......++..|+|||.+.+.. .++.++|+||||+++++|++|..||...
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~----~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 173 --EMTGYVATRWYRAPEIMLNWM----HYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred --cccccccCCCccCHHHHhCcc----CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 222345677899999876532 2678999999999999999999999643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=228.86 Aligned_cols=197 Identities=29% Similarity=0.437 Sum_probs=156.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC--------eE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE--------DL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~ 73 (246)
.||+|++ |.||++.++.+++.||+|.+......+ .......+|++.+++++||||+++++++.+.. ..
T Consensus 15 ~lg~g~~---~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 90 (311)
T cd07866 15 KLGEGTF---GEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV 90 (311)
T ss_pred EeccCCC---EEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence 3688888 899999999999999999987643222 12245678999999999999999999875433 46
Q ss_pred EEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 74 FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
+++++|+. .++...+... ...+++..+..++.|++.+|.+||+.|++|+||+|+||++++++.++++|||.+...
T Consensus 91 ~lv~~~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 91 YMVTPYMD-HDLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred EEEEecCC-cCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 99999985 4666665542 223599999999999999999999999999999999999999999999999988765
Q ss_pred ccCccc------------cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 154 EENQLA------------TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 154 ~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
...... ....++..|+|||.+.+.. .++.++|+||||+++|+|++|.+||.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER----RYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCC----ccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 332111 1123466799999876532 36789999999999999999999997544
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=231.59 Aligned_cols=193 Identities=28% Similarity=0.480 Sum_probs=160.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCe------EEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED------LFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~~ 75 (246)
.||+|++ |.||++++..+++.||+|.+.... .+....+.+.+|+.++++++|||++++.+++..... .++
T Consensus 22 ~ig~g~~---g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07851 22 PVGSGAY---GQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL 97 (343)
T ss_pred EeccCCc---eEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence 3677777 899999999999999999986543 223344667789999999999999999988876554 899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
|+|++ +++|.+++... ++++..+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||.+.....
T Consensus 98 v~e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 98 VTHLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred EEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 99998 77998887642 358999999999999999999999999999999999999999999999999876543
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
. .....++..|+|||.+.+.. ..+.++|+||||++++++++|..||....
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~----~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 171 E--MTGYVATRWYRAPEIMLNWM----HYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred c--ccCCcccccccCHHHHhCCC----CCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 22334677899999876532 26789999999999999999999996543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=231.75 Aligned_cols=192 Identities=27% Similarity=0.437 Sum_probs=156.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC------CeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE------EDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~~ 75 (246)
.||+|++ |.||++++..+|+.||+|.+.... .+......+.+|++.+++++||||+++++++... ..+++
T Consensus 22 ~ig~g~~---g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 97 (342)
T cd07879 22 QVGSGAY---GSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL 97 (342)
T ss_pred EeeecCC---eEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEE
Confidence 4688888 899999999999999999987543 1233345678899999999999999999998754 24689
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
++||+. .+|..... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||++.....
T Consensus 98 v~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 98 VMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred Eecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 999984 46665542 1348899999999999999999999999999999999999999999999999865432
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
......++..|+|||.+.+.. .++.++|+||||+++++|++|+.||.+.+
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~----~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 170 --EMTGYVVTRWYRAPEVILNWM----HYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred --CCCCceeeecccChhhhcCcc----ccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 122345577899999986532 26789999999999999999999997544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=226.88 Aligned_cols=196 Identities=26% Similarity=0.444 Sum_probs=158.7
Q ss_pred CcCCCCccCeeeEEEEEecCC--CcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeee----CCeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT--KQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQD----EEDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~~ 74 (246)
.||+|++ |.||++.+..+ +..||+|.+.... ......+.+.+|++.++++ +||||+++++.+.. ....+
T Consensus 7 ~lg~G~~---g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 7 ELGQGAY---GIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred EccccCC---eEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 4788888 89999999988 9999999986532 1223356678899999999 59999999987542 24578
Q ss_pred EEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec
Q psy7592 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~ 154 (246)
++++++ +++|.+.+..... +++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 83 ~~~e~~-~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 83 LYEELM-EADLHQIIRSGQP-----LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEecc-cCCHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 889988 5688888765433 4899999999999999999999999999999999999999999999999987654
Q ss_pred cCcc-----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 155 ENQL-----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 155 ~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.... .....++..|+|||...+.. .++.++|+||+|+++++|++|.+||...+
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQ----SYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCC----CCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 3221 12245778899999876532 26789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=242.25 Aligned_cols=142 Identities=33% Similarity=0.619 Sum_probs=129.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||.|+| |+||++.+..+++.||+|+++.....+......+.+|+..+..++||||++++.++.....+|+||||+.
T Consensus 11 ~LG~G~f---g~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~ 87 (669)
T cd05610 11 PISRGAF---GKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLI 87 (669)
T ss_pred EEecCCC---eEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCC
Confidence 4788888 9999999999999999999987665556667888999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
|++|.+++..... +++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||+++
T Consensus 88 g~~L~~li~~~~~-----l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 88 GGDVKSLLHIYGY-----FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999876443 3888899999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=212.89 Aligned_cols=223 Identities=36% Similarity=0.600 Sum_probs=183.4
Q ss_pred CeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCCCChHHHH
Q psy7592 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHI 89 (246)
Q Consensus 10 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~sL~~~~ 89 (246)
++|.||++.+..+++.+|+|.+........ .+.+.+|++.+++++|++++++++.+......++++|++.+++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 358999999998999999999987653222 578889999999999999999999999989999999999988999998
Q ss_pred hhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccccccCCCcc
Q psy7592 90 TQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYI 169 (246)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 169 (246)
..... ++...+..++.+++.++.+||+.+++|+||+|+||+++.++.++++|||.+.............++..|+
T Consensus 79 ~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 79 KKRGR-----LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred HhccC-----CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence 76432 4888999999999999999999999999999999999999999999999998876554444556778899
Q ss_pred CCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCC---CCHhHHHHHHHhhh
Q psy7592 170 APEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTA---WSESTKHLLSQVHR 245 (246)
Q Consensus 170 aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~s~~l~~li~~~l~ 245 (246)
+||...... .+.++|+||||++++++++|..||.... ................+.. ++..+.+++.+||.
T Consensus 154 ~pE~~~~~~-----~~~~~Di~slG~~l~~l~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 226 (244)
T smart00220 154 APEVLLGKG-----YGKAVDVWSLGVILYELLTGKPPFPGDD-QLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLV 226 (244)
T ss_pred CHHHHccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhccCCCCccccccCCHHHHHHHHHHcc
Confidence 999887544 6789999999999999999999996532 2222222233233322222 88999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=246.34 Aligned_cols=228 Identities=27% Similarity=0.396 Sum_probs=174.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC----------
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE---------- 71 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---------- 71 (246)
+||+|+| |.|++|+++-+|+.||||+++... +......+.+|+..+.+|+|||||++|..|.+..
T Consensus 486 lLGkGGF---G~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~ 560 (1351)
T KOG1035|consen 486 LLGKGGF---GSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVA 560 (1351)
T ss_pred HhcCCCC---ceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccc
Confidence 6899999 899999999999999999998776 5666788999999999999999999984432110
Q ss_pred --------------------------------------------------------------------------------
Q psy7592 72 -------------------------------------------------------------------------------- 71 (246)
Q Consensus 72 -------------------------------------------------------------------------------- 71 (246)
T Consensus 561 ~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~ 640 (1351)
T KOG1035|consen 561 SDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSV 640 (1351)
T ss_pred cchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcc
Confidence
Q ss_pred -----------------------------eEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC
Q psy7592 72 -----------------------------DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK 122 (246)
Q Consensus 72 -----------------------------~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~ 122 (246)
.+|+-||||+..++.+.+..+... -..+..|.++.||+.||.|+|+.
T Consensus 641 ~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 641 ILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred ccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHHHHHHHhC
Confidence 257888999777777777654321 14677999999999999999999
Q ss_pred CcccCCCCCCcEEEcCCCCeEEeecceeeeec---c--------C--------ccccccccCCCccCCceecccccccCC
Q psy7592 123 HIIHRDIKPDNILLDEEGHAHITDFNIATVLE---E--------N--------QLATSMSGTKPYIAPEIFLVATDEVLG 183 (246)
Q Consensus 123 ~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~---~--------~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~ 183 (246)
|++||||||.|||++.++.+||+|||+++... . . .......||.-|.|||.+.+... ..
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~--~~ 794 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS--NK 794 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc--cc
Confidence 99999999999999999999999999997721 0 0 01234568889999999876653 35
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHhhhcCCCCCC----CCCCHhHHHHHHHhhh
Q psy7592 184 YSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK-DVKAIIYSPVHYP----TAWSESTKHLLSQVHR 245 (246)
Q Consensus 184 ~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~----~~~s~~l~~li~~~l~ 245 (246)
++.++|+||||+|++||+.- |. ..++.. .+........+.| ..--+.-..+|.+||+
T Consensus 795 Yn~KiDmYSLGIVlFEM~yP---F~--TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLYP---FG--TSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred ccchhhhHHHHHHHHHHhcc---CC--chHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhc
Confidence 89999999999999999864 64 222322 3333333344444 2234556678888875
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=199.39 Aligned_cols=198 Identities=22% Similarity=0.366 Sum_probs=168.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||++++.++++.||+|.++.+.. ++..-....+|+-+++.++|.|||+++++...+..+.+|+|+|
T Consensus 9 kigegty---gtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c- 83 (292)
T KOG0662|consen 9 KIGEGTY---GTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC- 83 (292)
T ss_pred hhcCCcc---eeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-
Confidence 4899999 9999999999999999999987653 2233456788999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc-c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-T 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~ 160 (246)
+..|..++.+.. -.++.+.+...+.|+++++.++|++++.|+|++|.|++++.+|..++.|||+++.+...-.+ .
T Consensus 84 dqdlkkyfdsln----g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 84 DQDLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hHHHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 667777775522 22488889999999999999999999999999999999999999999999999887655432 3
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSN 212 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~ 212 (246)
....+..|.+|+.+.+.. -+++..|+||-||++.|+.. |.+.|.+.+.
T Consensus 160 aevvtlwyrppdvlfgak----ly~tsidmwsagcifaelanagrplfpg~dv 208 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAK----LYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_pred ceeeeeeccCcceeeeee----hhccchHhhhcchHHHHHhhcCCCCCCCCcH
Confidence 355678899999998876 38899999999999999988 6666765543
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=234.25 Aligned_cols=233 Identities=24% Similarity=0.399 Sum_probs=192.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeee-----eCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQ-----DEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~~~ 75 (246)
.+|.|++ |.||+++++++++..|+|+.......+ +....|.++++.+ .|||++.+|+++. .++.+|+
T Consensus 26 vig~Gty---gkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 26 VIGNGTY---GKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred EEeeccc---eeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 3788999 999999999999999999988765333 3445578888888 5999999999986 3567999
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
|||+|.|||..+++++.. +..+.+..+..|+..++.++.+||...++|+||+-.|||++.++.+|++|||.+.....
T Consensus 99 VMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 999999999999998754 55678999999999999999999999999999999999999999999999998876543
Q ss_pred -CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCC--CCC
Q psy7592 156 -NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHY--PTA 231 (246)
Q Consensus 156 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~ 231 (246)
........|++.|+|||++.+.......++..+|+||||+...||..|.+|+-. .-+.+.+-.+... ++.+ |..
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D--mHPmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD--MHPMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC--cchhhhhccCCCCCCccccchhh
Confidence 233445679999999999998888777889999999999999999999999842 2222222222222 2222 567
Q ss_pred CCHhHHHHHHHhhhC
Q psy7592 232 WSESTKHLLSQVHRY 246 (246)
Q Consensus 232 ~s~~l~~li~~~l~~ 246 (246)
|+..+.++|..||.+
T Consensus 254 Ws~~FndFIs~cL~K 268 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVK 268 (953)
T ss_pred HHHHHHHHHHHHHhh
Confidence 999999999999964
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=217.62 Aligned_cols=200 Identities=24% Similarity=0.372 Sum_probs=166.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCc----EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee-CCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ----MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD-EEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~v 76 (246)
+||.|+| |.||+|..++++. .||+|+++.+...+. ......+|+.+++.++|||++.+..+|-. +..++++
T Consensus 31 ~Ig~GTY---G~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~ 106 (438)
T KOG0666|consen 31 KIGRGTY---GKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL 106 (438)
T ss_pred eeccccc---ceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence 4788999 9999997776543 799999987643222 22456789999999999999999999987 7789999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC----CCeEEeecceeee
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE----GHAHITDFNIATV 152 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~----~~~~l~d~~~~~~ 152 (246)
+||.+. +|...+.-........+|...++.++.||+.++.|||++=++|||+||.||++..+ |.+||+|+|+++.
T Consensus 107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~ 185 (438)
T KOG0666|consen 107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARL 185 (438)
T ss_pred ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHH
Confidence 999954 57777655444344567999999999999999999999999999999999999877 8999999999988
Q ss_pred eccCc----cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 153 LEENQ----LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 153 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
+.+.. .......|..|.|||.+.+.. .++++.|+|++||++.||++..+.|.+.
T Consensus 186 ~~~plkpl~s~d~VVVTiWYRAPELLLGa~----hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 186 FNNPLKPLASLDPVVVTIWYRAPELLLGAR----HYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred hhccccccccCCceEEEEEecChHHhcccc----cccchhhhHHHHHHHHHHHccCccccch
Confidence 76542 223345688899999999887 5999999999999999999999998654
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=219.38 Aligned_cols=195 Identities=26% Similarity=0.407 Sum_probs=165.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCC--C----cceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH--P----FLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----~iv~~~~~~~~~~~~~~ 75 (246)
++|+|+| |.|..+.+.+++..||+|+++.- ....+...-|+++++++++ | -++++.++|.-.++.|+
T Consensus 96 ~lGeGtF---GkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCi 168 (415)
T KOG0671|consen 96 LLGEGTF---GKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICI 168 (415)
T ss_pred hhcCCcc---cceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEE
Confidence 5799999 89999999999999999999764 3445667779999999942 2 35677788999999999
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC-----------------
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE----------------- 138 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~----------------- 138 (246)
|+|.+ |.|+.+++..+.. .++|.+++..+..|+++++++||+.+++|.|+||+||++.+
T Consensus 169 vfell-G~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 169 VFELL-GLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred EEecc-ChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 99998 8899999987643 36799999999999999999999999999999999999932
Q ss_pred ---CCCeEEeecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc
Q psy7592 139 ---EGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS 214 (246)
Q Consensus 139 ---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~ 214 (246)
+..++++|||.+..-... ......|..|.|||++.+.. ++.++||||+||+|+|+.+|...|....+.+
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLG-----wS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLG-----WSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccC-----cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 335899999999875443 24556788999999999987 9999999999999999999999998766444
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=248.08 Aligned_cols=181 Identities=18% Similarity=0.309 Sum_probs=150.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+||+|++ |.||+++++.+++.||+|.++..... ...|++.+++++||||+++++++.++...++||||++
T Consensus 697 ~ig~G~~---g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 697 VISRGKK---GASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred EEccCCC---eeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 4788888 89999999999999999998654311 1235788899999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLK---TKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh---~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
+++|.+++.. +++..+..++.|++.|++||| +.+++|+|++|+||+++.++..++. ++.......
T Consensus 767 ~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 767 GKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 9999999853 378889999999999999999 6699999999999999988877665 444332211
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDI 209 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~ 209 (246)
.....++..|+|||++.+.. ++.++||||||+++|||++|+.||+.
T Consensus 835 ~~~~~~t~~y~aPE~~~~~~-----~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 835 DTKCFISSAYVAPETRETKD-----ITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred CCCccccccccCcccccCCC-----CCcccchhhHHHHHHHHHhCCCCCCc
Confidence 11235678899999987654 78899999999999999999999853
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-33 Score=227.13 Aligned_cols=193 Identities=24% Similarity=0.416 Sum_probs=169.6
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHH-----HHHHHHHHhhCC---CCcceeeeeeeeeCCeEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKN-----VLREMEILTTLE---HPFLVNLWFCFQDEEDLF 74 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~-----~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~ 74 (246)
+|.|.| |.|++|.+++++..|++|.+.++...-...+++ .-.|+++|..|+ |+||++++++|++++++|
T Consensus 569 lG~GAy---GkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 569 LGEGAY---GKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred cccccc---ceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 688888 999999999999999999999877655555444 446999999997 999999999999999999
Q ss_pred EEEeec-CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 75 MVSDLL-LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 75 ~v~e~~-~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
++||.. +|.+|++++.-..+. .+.+.+.|++|+..++++||++||+|||||-+|+.++.+|-++++|||.+...
T Consensus 646 l~te~hg~gIDLFd~IE~kp~m-----~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFKPRM-----DEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred EEecCCCCCcchhhhhhccCcc-----chHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 999987 467899999865555 99999999999999999999999999999999999999999999999988654
Q ss_pred ccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy7592 154 EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFD 208 (246)
Q Consensus 154 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~ 208 (246)
.++ ....+.||..|.|||.+.+... .+..-|||+||+++|.++...+||.
T Consensus 721 ksg-pfd~f~gtv~~aapevl~g~~y----~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 721 KSG-PFDVFVGTVDYAAPEVLGGEKY----LGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cCC-CcceeeeeccccchhhhCCCcc----CCCcchhhhhhheeeEEEeccCCCc
Confidence 433 4556889999999999988763 4667899999999999999999984
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-30 Score=199.71 Aligned_cols=209 Identities=33% Similarity=0.558 Sum_probs=171.6
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|++ ++||++.+..+++.+|+|.+...... ...+.+.+|++.+++++|+|++++++.+......++++|++++
T Consensus 7 i~~g~~---~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 7 LGEGAF---GKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred eecCCC---eEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 677777 89999999988999999999875432 2467888899999999999999999999988999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc--ccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ--LAT 160 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~ 160 (246)
++|.+++..... .+++..+..++.|++.++.+||+.+++|+|++|+|++++.++.++++|||.+....... ...
T Consensus 82 ~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 82 GDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999876433 14888999999999999999999999999999999999999999999999988765543 233
Q ss_pred ccccCCCccCCceec-ccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCC
Q psy7592 161 SMSGTKPYIAPEIFL-VATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSP 225 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~-~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 225 (246)
...+...|++||... .. .++.++|+|+||+++++|++|+.||.............+....
T Consensus 158 ~~~~~~~~~~pe~~~~~~-----~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGK-----GYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred ceeccCCcCCHhHhcCCC-----CCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 445677899999884 22 3677999999999999999999999642233323333444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-31 Score=227.89 Aligned_cols=233 Identities=20% Similarity=0.355 Sum_probs=187.8
Q ss_pred CcCCCCccCeeeEEEEEecC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD-------TKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 73 (246)
.+|+|.| |.|+++.-+. ....||||..+..... +..+.+..|+++++.+ .|+||+.+.+.+.++...
T Consensus 303 ~lg~g~f---G~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 303 YLGEGAF---GQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred eeecccc---cceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 3788888 8888887541 2567999999876643 5678899999999999 599999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcc---cccc--------CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCe
Q psy7592 74 FMVSDLLLGGDLRYHITQDI---KFYS--------VGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHA 142 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~---~~~~--------~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~ 142 (246)
++|+||+..|+|..++.... .... ..++...++.++.||+.+++||++..++|||+...|||++.+..+
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~ 457 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVI 457 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEE
Confidence 99999999999999998765 1111 136888899999999999999999999999999999999999999
Q ss_pred EEeecceeeeeccCcccccc--c--cCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHH
Q psy7592 143 HITDFNIATVLEENQLATSM--S--GTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKD 217 (246)
Q Consensus 143 ~l~d~~~~~~~~~~~~~~~~--~--~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~ 217 (246)
+++|||+++........... . -...|+|||.+.... ++.+|||||+|+++||+++ |..||.+-... ...
T Consensus 458 kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~-----ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~-~~l 531 (609)
T KOG0200|consen 458 KIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV-----FTSKSDVWSFGILLWEIFTLGGTPYPGIPPT-EEL 531 (609)
T ss_pred EEccccceeccCCCCceEecCCCCccceeecCHHHhccCc-----ccccchhhHHHHHHHHHhhCCCCCCCCCCcH-HHH
Confidence 99999999865443322211 1 123499999998765 8999999999999999999 88899763322 222
Q ss_pred HHhhhcC-CCCCCCCCCHhHHHHHHHhhh
Q psy7592 218 VKAIIYS-PVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 218 ~~~~~~~-~~~~~~~~s~~l~~li~~~l~ 245 (246)
...+..+ +...|..+++++.++++.||+
T Consensus 532 ~~~l~~G~r~~~P~~c~~eiY~iM~~CW~ 560 (609)
T KOG0200|consen 532 LEFLKEGNRMEQPEHCSDEIYDLMKSCWN 560 (609)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhC
Confidence 3333333 557788999999999999996
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=213.97 Aligned_cols=227 Identities=20% Similarity=0.346 Sum_probs=175.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC--CCCcceeeeeeeeeCC----eEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL--EHPFLVNLWFCFQDEE----DLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~----~~~~ 75 (246)
++|+|.| |.||++.. +++.||||++.... .+.+++|-++++-. +|+||++++..-.-.. .+++
T Consensus 217 li~~Grf---g~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 217 LIGRGRF---GCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred HhhcCcc---ceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 4788888 99999998 57999999996643 56777788877765 7999999987654333 6899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC---------CcccCCCCCCcEEEcCCCCeEEee
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK---------HIIHRDIKPDNILLDEEGHAHITD 146 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~---------~~~h~~i~~~nil~~~~~~~~l~d 146 (246)
|++|.+.|||.+++..+. .+....+.++..++++|+|||+. .|+|||||..|||+.+++.+.|+|
T Consensus 286 Vt~fh~kGsL~dyL~~nt------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EeeeccCCcHHHHHHhcc------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 999999999999998764 38999999999999999999985 399999999999999999999999
Q ss_pred cceeeeeccCcc---ccccccCCCccCCceeccccccc-CCCCcchhHHHHHHHHHHHHhCCC------------CCCC-
Q psy7592 147 FNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEV-LGYSYSVDWWSLGVTLFEILARGR------------PFDI- 209 (246)
Q Consensus 147 ~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~-~~~~~~~Di~slG~~l~~ll~g~~------------p~~~- 209 (246)
||++-++..... .....||.+|||||++.+...-. ...-.+.||||+|.|+|||++... ||+.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 999998864432 22367999999999998776322 111236999999999999998643 3421
Q ss_pred -CCCccHHHHHhhhcC---CCCCCCCC-----CHhHHHHHHHhhh
Q psy7592 210 -HSNTSVKDVKAIIYS---PVHYPTAW-----SESTKHLLSQVHR 245 (246)
Q Consensus 210 -~~~~~~~~~~~~~~~---~~~~~~~~-----s~~l~~li~~~l~ 245 (246)
..-...+..++.+.. ++.+|..| -..+++.++.||.
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWD 484 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWD 484 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcC
Confidence 112223444444433 55566554 5678888888874
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=208.89 Aligned_cols=226 Identities=22% Similarity=0.356 Sum_probs=166.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC--CCCcceeeeeeeeeC----CeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL--EHPFLVNLWFCFQDE----EDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~----~~~~~ 75 (246)
.||+|.| |.||++.+ -|+.||||++...+ .+...+|.++.+.. +|+||..+...-..+ ..+++
T Consensus 218 ~IGkGRy---GEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 218 IIGKGRF---GEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred EecCccc---cceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 3789999 89999999 59999999997643 24456677776655 999999987654322 24899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC--------CcccCCCCCCcEEEcCCCCeEEeec
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK--------HIIHRDIKPDNILLDEEGHAHITDF 147 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~--------~~~h~~i~~~nil~~~~~~~~l~d~ 147 (246)
|+||++.|||+|++... . ++.+....++..++.+|.+||.. +|.|||||..||++..++.+.|+|+
T Consensus 287 vTdYHe~GSL~DyL~r~-t-----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN-T-----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred eeecccCCcHHHHHhhc-c-----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 99999999999999874 2 37888999999999999999964 3999999999999999999999999
Q ss_pred ceeeeeccCc-----cccccccCCCccCCceecccccccCCCC-cchhHHHHHHHHHHHHhC----------CCCCCCC-
Q psy7592 148 NIATVLEENQ-----LATSMSGTKPYIAPEIFLVATDEVLGYS-YSVDWWSLGVTLFEILAR----------GRPFDIH- 210 (246)
Q Consensus 148 ~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~~-~~~Di~slG~~l~~ll~g----------~~p~~~~- 210 (246)
|++.+....+ ......||.+|+|||++.......-.-+ ..+||||||.|+||++.. +.||..-
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 9999876542 2344679999999999876542211111 248999999999998653 4677332
Q ss_pred CCc-cHHHHHhh---hcCCCCCCCCC--CHhHHH---HHHHhh
Q psy7592 211 SNT-SVKDVKAI---IYSPVHYPTAW--SESTKH---LLSQVH 244 (246)
Q Consensus 211 ~~~-~~~~~~~~---~~~~~~~~~~~--s~~l~~---li~~~l 244 (246)
+.+ +.++.... ...++++|+.| .+.++. +++.||
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW 483 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECW 483 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhh
Confidence 222 23333332 22366667666 344444 455555
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=226.12 Aligned_cols=228 Identities=21% Similarity=0.322 Sum_probs=188.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCc----EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ----MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||+|.| |+||+......|+ +||+|++.... ..+.-..+.+|+-.+.+++|||++++++++.... .-+|+
T Consensus 703 vLGsgAf---GtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 703 VLGSGAF---GTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred eeccccc---eeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 4788888 9999999886655 68889887654 3444577889999999999999999999998665 77899
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
+|+++|+|.++++.... .+-...++.|..||+++++|||.++++||||...|+|+..-..+++.|||+++......
T Consensus 777 q~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999987433 35778899999999999999999999999999999999999999999999998875443
Q ss_pred cccc-c--ccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcCCCCCCCCCC
Q psy7592 158 LATS-M--SGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYSPVHYPTAWS 233 (246)
Q Consensus 158 ~~~~-~--~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s 233 (246)
.... . ...+.|+|-|.+.... ++.++||||+||.+||++| |..|+++....+.....+.-+ +.+.|+.++
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~-----~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-RLsqPpiCt 926 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRK-----YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-RLSQPPICT 926 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccC-----CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-cCCCCCCcc
Confidence 2222 2 2345699999988776 8999999999999999999 999998766655554444433 466788999
Q ss_pred HhHHHHHHHhhh
Q psy7592 234 ESTKHLLSQVHR 245 (246)
Q Consensus 234 ~~l~~li~~~l~ 245 (246)
-++--++.+||-
T Consensus 927 iDVy~~mvkCwm 938 (1177)
T KOG1025|consen 927 IDVYMVMVKCWM 938 (1177)
T ss_pred HHHHHHHHHHhc
Confidence 999999998873
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=203.17 Aligned_cols=197 Identities=25% Similarity=0.351 Sum_probs=161.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee--------CCeE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD--------EEDL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~ 73 (246)
++|+|+| |.||+|+.+++|+.||+|++--+.- .+..-....+|+++++.|+|+|++.+.++|.. ...+
T Consensus 24 kigqGtf---geVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ 99 (376)
T KOG0669|consen 24 KIGQGTF---GEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATF 99 (376)
T ss_pred hcCCchH---HHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccccee
Confidence 5899999 8999999999999999987643221 11223456789999999999999999988853 2348
Q ss_pred EEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 74 FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
|+|+++| ..+|...+.+. ...++..+|+.+..+++.+|.|+|...|+|||+++.|+|++.+|.++++|||+++.+
T Consensus 100 ylVf~~c-ehDLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 100 YLVFDFC-EHDLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eeeHHHh-hhhHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 9999999 45677777653 123488999999999999999999999999999999999999999999999999877
Q ss_pred ccCccc-----cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 154 EENQLA-----TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 154 ~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
+..... ..+..+..|.+||.+.+.. .++++.|+|.-||++.+|+++.+.+.+..
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r----~yg~~iDiWgAgCimaeMwtrspimqgnt 233 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDR----EYGPPIDIWGAGCIMAEMWTRSPIMQGNT 233 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhccc----ccCCcchhHhHHHHHHHHHccCccccCCh
Confidence 644322 2344577899999999877 58999999999999999999999987543
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=189.46 Aligned_cols=192 Identities=26% Similarity=0.439 Sum_probs=163.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeC--CeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDE--EDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~~v~e 78 (246)
.+|.|.+ +.||.+....+++.++||.+++-. .+.+.+|+.+|+.|. ||||++++++..+. ....+|+|
T Consensus 45 k~GRGKY---SEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 45 KVGRGKY---SEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred HHcCccH---hhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 3688999 999999999999999999997753 467889999999997 99999999998754 45788999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-CeEEeecceeeeeccCc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG-HAHITDFNIATVLEENQ 157 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~-~~~l~d~~~~~~~~~~~ 157 (246)
+..+.+....... ++...+..++.|++.||.|+|+.||.|+|++|.|++++... ..+++|+|++.+.++..
T Consensus 116 ~v~n~Dfk~ly~t--------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 116 YVNNTDFKQLYPT--------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhccccHHHHhhh--------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 9977766555432 36777999999999999999999999999999999998544 78999999999998887
Q ss_pred cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCC-CCCCCcc
Q psy7592 158 LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF-DIHSNTS 214 (246)
Q Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~-~~~~~~~ 214 (246)
....+.-+..|--||.+.... .++-.-|+|||||++..|+..+.|| .+.++.+
T Consensus 188 eYnVRVASRyfKGPELLVdy~----~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D 241 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 241 (338)
T ss_pred eeeeeeehhhcCCchheeech----hccccHHHHHHHHHHHHHHhccCcccCCCCCHH
Confidence 777777788899999987665 3778899999999999999999887 5544433
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=204.76 Aligned_cols=194 Identities=27% Similarity=0.449 Sum_probs=158.1
Q ss_pred CccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC-----eEEEEEeecC
Q psy7592 7 KFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE-----DLFMVSDLLL 81 (246)
Q Consensus 7 ~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~~v~e~~~ 81 (246)
+||.||+||.++|..+|+.||+|++..-. .+-..-+.+.+|.+++..++|.|+...+++.+... .+|+++|.+
T Consensus 62 GYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm- 139 (449)
T KOG0664|consen 62 GYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM- 139 (449)
T ss_pred cccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-
Confidence 34555999999999999999999985432 33334577889999999999999999888876432 246677776
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc--cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ--LA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 159 (246)
..+|...+.+ +.+++.+.++.+++||+++|+|||+.+|.|+||||.|++++.|...||||||+++...... ..
T Consensus 140 QSDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 140 QSDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred Hhhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 4455555543 3445899999999999999999999999999999999999999999999999998765433 23
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.....+..|.|||++.+.. .++...||||.||++.|++..+..|...+
T Consensus 215 TqEVVTQYYRAPEiLMGaR----hYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGAR----RYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred HHHHHHHHhccHHHhhcch----hhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 3455688899999999887 58999999999999999999999886543
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=213.16 Aligned_cols=209 Identities=31% Similarity=0.453 Sum_probs=173.4
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCC------CcceeeeeeeeeCCeEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH------PFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~~~~~~v 76 (246)
.|+|.| ++|..|.+..-|..||||+++... -..+.-..|+++|++|+. -++++++..|...+++|+|
T Consensus 440 ~GkGvF---s~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClV 512 (752)
T KOG0670|consen 440 TGKGVF---STVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLV 512 (752)
T ss_pred ccccee---eeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEE
Confidence 466666 999999999999999999998753 334566789999999962 3889999999999999999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-CeEEeecceeeeecc
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG-HAHITDFNIATVLEE 155 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~-~~~l~d~~~~~~~~~ 155 (246)
+|.+ ..+|.+.+.+.+. ..++....+..++.|++.||..|...|++|.||+|+|||+++.. .++|||||.+.....
T Consensus 513 FE~L-slNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e 589 (752)
T KOG0670|consen 513 FEPL-SLNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASE 589 (752)
T ss_pred ehhh-hchHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccc
Confidence 9988 8899999988764 35568888999999999999999999999999999999998765 569999999987654
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP 229 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (246)
+. ...+..+..|.|||++.|.+ |+-..|+||.||.|||+.||+..|.+..++..- .-...-..++|
T Consensus 590 ne-itPYLVSRFYRaPEIiLG~~-----yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML--rl~me~KGk~p 655 (752)
T KOG0670|consen 590 NE-ITPYLVSRFYRAPEIILGLP-----YDYPIDTWSVGCTLYELYTGKILFPGRTNNQML--RLFMELKGKFP 655 (752)
T ss_pred cc-ccHHHHHHhccCcceeecCc-----ccCCccceeeceeeEEeeccceecCCCCcHHHH--HHHHHhcCCCc
Confidence 43 33455678899999999997 788999999999999999999999887665432 22233345555
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=222.83 Aligned_cols=222 Identities=24% Similarity=0.303 Sum_probs=171.2
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+|.|.-| +.||+..- .|+.||||.+-.+ ...-+++|+..++.- +||||+++|..-.+++..|+..|.|
T Consensus 517 lG~Gs~G--t~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 517 LGYGSNG--TVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred cccCCCC--cEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 5777776 68999887 6999999977443 345678899999998 5999999999888899999999999
Q ss_pred CCChHHHHhhccccccCCC-ChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC---CC--CeEEeecceeeeecc
Q psy7592 82 GGDLRYHITQDIKFYSVGT-RNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE---EG--HAHITDFNIATVLEE 155 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~-~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~---~~--~~~l~d~~~~~~~~~ 155 (246)
..+|++++..... .... ..-..+.++.|++.++++||+.+||||||+|.|||++. ++ .++|+|||+++++..
T Consensus 586 ~~sL~dlie~~~~--d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 586 ACSLQDLIESSGL--DVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhhHHHHHhcccc--chhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 7789999987411 1111 11345778899999999999999999999999999976 34 679999999999864
Q ss_pred Ccc----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCccHHHHHhhhcCCCCC--
Q psy7592 156 NQL----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILAR-GRPFDIHSNTSVKDVKAIIYSPVHY-- 228 (246)
Q Consensus 156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~-- 228 (246)
+.. .....|+-+|.|||.+.... -+.++||||+||++|+.++| .+||.. .......|+......
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~-----~~~avDiFslGCvfyYvltgG~HpFGd----~~~R~~NIl~~~~~L~~ 734 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDR-----KTQAVDIFSLGCVFYYVLTGGSHPFGD----SLERQANILTGNYTLVH 734 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccc-----cCcccchhhcCceEEEEecCCccCCCc----hHHhhhhhhcCccceee
Confidence 432 23456888999999998876 45589999999999999995 889953 223333444443333
Q ss_pred -CCCCCHhHHHHHHHhhhC
Q psy7592 229 -PTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 229 -~~~~s~~l~~li~~~l~~ 246 (246)
-+.-..+.++||.+||+.
T Consensus 735 L~~~~d~eA~dLI~~ml~~ 753 (903)
T KOG1027|consen 735 LEPLPDCEAKDLISRMLNP 753 (903)
T ss_pred eccCchHHHHHHHHHhcCC
Confidence 222222899999999974
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=215.36 Aligned_cols=197 Identities=20% Similarity=0.269 Sum_probs=134.6
Q ss_pred CcCCCCccCeeeEEEEEecCC----CcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeee------eeeCC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT----KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFC------FQDEE 71 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~~~~ 71 (246)
.||+|+| |.||++++..+ +..||+|.+...... +....+ .+....+.++..+... ...+.
T Consensus 139 ~LG~G~F---G~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 139 KLGEGAF---GVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred EEeeCCC---eEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 4788998 99999999988 999999987643211 111111 1111112222222111 23556
Q ss_pred eEEEEEeecCCCChHHHHhhccccc---------------cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE
Q psy7592 72 DLFMVSDLLLGGDLRYHITQDIKFY---------------SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL 136 (246)
Q Consensus 72 ~~~~v~e~~~~~sL~~~~~~~~~~~---------------~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~ 136 (246)
..++|+||+.+++|.+++....... ........+..++.|++.+|.|||+.|++|+||||+|||+
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl 288 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF 288 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEE
Confidence 7899999999999999886532100 0011234577899999999999999999999999999999
Q ss_pred cC-CCCeEEeecceeeeeccC--ccccccccCCCccCCceeccccccc-----------------CCCCcchhHHHHHHH
Q psy7592 137 DE-EGHAHITDFNIATVLEEN--QLATSMSGTKPYIAPEIFLVATDEV-----------------LGYSYSVDWWSLGVT 196 (246)
Q Consensus 137 ~~-~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~-----------------~~~~~~~Di~slG~~ 196 (246)
+. ++.++++|||++...... .......+++.|+|||.+....... ..+..++|||||||+
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi 368 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 368 (566)
T ss_pred eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence 85 578999999999765332 1223456788999999654322110 013346799999999
Q ss_pred HHHHHhCCCCCC
Q psy7592 197 LFEILARGRPFD 208 (246)
Q Consensus 197 l~~ll~g~~p~~ 208 (246)
+|+|+++..|++
T Consensus 369 L~el~~~~~~~~ 380 (566)
T PLN03225 369 FLQMAFPNLRSD 380 (566)
T ss_pred HHHHHhCcCCCc
Confidence 999999776653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=205.54 Aligned_cols=241 Identities=16% Similarity=0.138 Sum_probs=161.4
Q ss_pred CcCCCCccCeeeEEEEEec----------------CCCcEEEEEEeeccccchH-H----------HHHHHHHHHHHHhh
Q psy7592 2 FCGSSKFCGTSKVCIVQKK----------------DTKQMYAMKYMHKSQCIER-D----------ALKNVLREMEILTT 54 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~----------------~~~~~~avK~~~~~~~~~~-~----------~~~~~~~e~~~l~~ 54 (246)
.||+|+| |+||++... ..++.||||.++....... + ..+....|+..+.+
T Consensus 152 ~LG~GgF---G~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 152 KLGGGNF---GITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeecCCC---eEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 4789999 899998652 3457899999865431110 0 01123346667777
Q ss_pred CCCCcc-----eeeeeeeee--------CCeEEEEEeecCCCChHHHHhhcccc-------------------ccCCCCh
Q psy7592 55 LEHPFL-----VNLWFCFQD--------EEDLFMVSDLLLGGDLRYHITQDIKF-------------------YSVGTRN 102 (246)
Q Consensus 55 l~h~~i-----v~~~~~~~~--------~~~~~~v~e~~~~~sL~~~~~~~~~~-------------------~~~~~~~ 102 (246)
++|.++ ++++++|.. +...++|+||+.+++|.+++...... .....+.
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 766544 556666542 34579999999999999988642110 0112356
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc--cccCCCccCCceecccccc
Q psy7592 103 DTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS--MSGTKPYIAPEIFLVATDE 180 (246)
Q Consensus 103 ~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~aPE~~~~~~~~ 180 (246)
..++.++.|++.++.|||+.+++|+||+|+||+++.++.++++|||++........... ...++.|+|||.+......
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~ 388 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSC 388 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCC
Confidence 77899999999999999999999999999999999999999999999865543222211 2236789999987543211
Q ss_pred cC-----------------CCCcchhHHHHHHHHHHHHhCCC-CCCCCCCc--c-------HHHHHhhhcCCCCCC--CC
Q psy7592 181 VL-----------------GYSYSVDWWSLGVTLFEILARGR-PFDIHSNT--S-------VKDVKAIIYSPVHYP--TA 231 (246)
Q Consensus 181 ~~-----------------~~~~~~Di~slG~~l~~ll~g~~-p~~~~~~~--~-------~~~~~~~~~~~~~~~--~~ 231 (246)
.. ......|+||+|+++++|++|.. ||.....- . ......+......++ ..
T Consensus 389 ~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~ 468 (507)
T PLN03224 389 PRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDR 468 (507)
T ss_pred CccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccc
Confidence 00 01234799999999999999875 76432110 0 111111222233333 46
Q ss_pred CCHhHHHHHHHhhh
Q psy7592 232 WSESTKHLLSQVHR 245 (246)
Q Consensus 232 ~s~~l~~li~~~l~ 245 (246)
.++..++|+.+||.
T Consensus 469 ~s~~~~dLi~~LL~ 482 (507)
T PLN03224 469 NKEAGWDLACKLIT 482 (507)
T ss_pred cChHHHHHHHHHhc
Confidence 79999999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=182.13 Aligned_cols=185 Identities=36% Similarity=0.641 Sum_probs=158.0
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|.+ |.||++.+..+++.+++|.+....... ..+.+.+|++.++.++|++++++++++......++++|++.+
T Consensus 1 l~~g~~---~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGF---GTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCc---eEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCC
Confidence 578888 899999998889999999998765322 356788999999999999999999999998899999999988
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC-CCCeEEeecceeeeeccCc-ccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE-EGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~-~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
++|.+++.... ...+...+..++.+++.++.+||+.|++|+||+|.||+++. ++.++++||+.+....... ...
T Consensus 76 ~~l~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (215)
T cd00180 76 GSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151 (215)
T ss_pred CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhh
Confidence 99999987642 23488899999999999999999999999999999999999 8999999999988765432 123
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEI 200 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~l 200 (246)
.......|.+||...... ..+.++|+|++|++++++
T Consensus 152 ~~~~~~~~~~pe~~~~~~----~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKG----YYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cccCCCCccChhHhcccC----CCCchhhhHHHHHHHHHH
Confidence 345677899999886641 267899999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=191.44 Aligned_cols=228 Identities=21% Similarity=0.361 Sum_probs=174.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeee-eeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFC-FQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-~~~~~~~~~v~e~ 79 (246)
.||.|-| |.+-+|+++.+++.+|+|.+..+. .-++++.+|...--.|. |.||+.-|++ |+..+.+++++||
T Consensus 31 ~lgeG~F---gkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 31 QLGEGRF---GKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred Hhcccce---eeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 3788888 999999999999999999997764 33577888888877774 8999998877 4566789999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC--CeEEeecceeeeeccCc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG--HAHITDFNIATVLEENQ 157 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~--~~~l~d~~~~~~~~~~~ 157 (246)
++.|+|..-+... ++.+...+.++.|++.|+.|+|+.++||||||.+|||+-... .+|+||||.+.....
T Consensus 104 aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~-- 175 (378)
T KOG1345|consen 104 APRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT-- 175 (378)
T ss_pred CccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc--
Confidence 9999998777553 347888999999999999999999999999999999995333 799999998865332
Q ss_pred cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCCC---C
Q psy7592 158 LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPT---A 231 (246)
Q Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~---~ 231 (246)
..........|.+||.......+.....+.+|+|+||++++.+++|..||..-..+........... ....|. .
T Consensus 176 tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~ 255 (378)
T KOG1345|consen 176 TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNP 255 (378)
T ss_pred eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcc
Confidence 2222333456889998877766666678899999999999999999999975444443332222222 223343 4
Q ss_pred CCHhHHHHHHHhh
Q psy7592 232 WSESTKHLLSQVH 244 (246)
Q Consensus 232 ~s~~l~~li~~~l 244 (246)
+|+.+..+.++-|
T Consensus 256 fs~~a~r~Fkk~l 268 (378)
T KOG1345|consen 256 FSEKALRLFKKSL 268 (378)
T ss_pred cCHHHHHHHHHhc
Confidence 6777766666543
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-30 Score=196.32 Aligned_cols=200 Identities=23% Similarity=0.369 Sum_probs=166.3
Q ss_pred eEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC------eEEEEEeecCCCChH
Q psy7592 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE------DLFMVSDLLLGGDLR 86 (246)
Q Consensus 13 ~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~~v~e~~~~~sL~ 86 (246)
.|..|.|.-+++.||+|+.-.+ .......++..+|..++..++|+||++++.+|.... ..|+|||++ ..+|.
T Consensus 31 ~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~ 108 (369)
T KOG0665|consen 31 IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLC 108 (369)
T ss_pred eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHH
Confidence 5888888889999999998766 334445688899999999999999999999997543 479999999 77898
Q ss_pred HHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccccccCC
Q psy7592 87 YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTK 166 (246)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 166 (246)
+.+.. + ++=.++..++.|++.++++||+.||+||||||+||++..+...|+.|||++......-.......++
T Consensus 109 ~vi~~--e-----lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtR 181 (369)
T KOG0665|consen 109 QVILM--E-----LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTR 181 (369)
T ss_pred HHHHH--h-----cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcccccCchhhee
Confidence 88863 2 2677899999999999999999999999999999999999999999999998765543445567788
Q ss_pred CccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCC
Q psy7592 167 PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY 228 (246)
Q Consensus 167 ~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (246)
.|.|||++.+.. +...+||||+||++.+|+.|+..|.+.+ .......+++.....
T Consensus 182 yyrapevil~~~-----~ke~vdiwSvGci~gEli~~~Vlf~g~d--~idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 182 YYRAPEVILGMG-----YKENVDIWSVGCIMGELILGTVLFPGKD--HIDQWNKIIEQLGTP 236 (369)
T ss_pred eccCchheeccC-----CcccchhhhhhhHHHHHhhceEEecCch--HHHHHHHHHHHhcCC
Confidence 999999999887 7889999999999999999999997433 334444455444433
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-28 Score=200.89 Aligned_cols=229 Identities=24% Similarity=0.366 Sum_probs=187.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
-+|+|+| |.||+++++.+++..|+|.++-.. .+..+-+++|+-+++..+||||+.+++.+...+..+++|||+.
T Consensus 22 rvgsgTy---gdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 22 RVGSGTY---GDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred eecCCcc---cchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 4799999 899999999999999999998766 3345677889999999999999999999998999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-cccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~ 160 (246)
|++|++....++.+ ++.++..+.+..++++.|||+.|=+|||||-.||++++.|.+++.|||.+..+... ....
T Consensus 96 ggslQdiy~~Tgpl-----selqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 96 GGSLQDIYHVTGPL-----SELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK 170 (829)
T ss_pred CCcccceeeecccc-----hhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence 99999998876655 99999999999999999999999999999999999999999999999988665433 2334
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCC-----CCCCCHh
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY-----PTAWSES 235 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~s~~ 235 (246)
.+.|++.|+|||+---.. ...+...+|+|++|+...++-.-++|-..... .+...-+....+.. +..|++.
T Consensus 171 sfiGtpywmapEvaaver--kggynqlcdiwa~gitAiel~eLqpplfdlhp--mr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVER--KGGYNQLCDIWALGITAIELGELQPPLFDLHP--MRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred cccCCccccchhHHHHHh--cccccccccccccccchhhhhhcCCcccccch--HHHHHHhhccCCCCCcccCCccchHH
Confidence 588999999999853222 22377889999999999999888887543332 23333333332222 3469999
Q ss_pred HHHHHHHhhh
Q psy7592 236 TKHLLSQVHR 245 (246)
Q Consensus 236 l~~li~~~l~ 245 (246)
+.++++.+|-
T Consensus 247 fh~fvK~alt 256 (829)
T KOG0576|consen 247 FHNFVKGALT 256 (829)
T ss_pred HHHHHHHHhc
Confidence 9999999873
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-26 Score=182.05 Aligned_cols=123 Identities=28% Similarity=0.399 Sum_probs=104.5
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-----C---Ccceeeeeeee----eC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-----H---PFLVNLWFCFQ----DE 70 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~----~~ 70 (246)
||=|.| +|||+|.|..+.+.||+|+.+... ..-+....|+++|++++ | .+||++++.|. .+
T Consensus 86 LGWGHF---STVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG 158 (590)
T KOG1290|consen 86 LGWGHF---STVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNG 158 (590)
T ss_pred cccccc---ceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCC
Confidence 455555 999999999999999999998753 44567888999999984 2 47999999996 46
Q ss_pred CeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEE
Q psy7592 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILL 136 (246)
Q Consensus 71 ~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~ 136 (246)
.++|+|+|++ |.+|-..+.... -..+|...++.|++|++.+|.|||. .||+|.||||+|||+
T Consensus 159 ~HVCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 159 QHVCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred cEEEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 7899999999 888888887542 3457999999999999999999995 599999999999999
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=173.89 Aligned_cols=205 Identities=22% Similarity=0.285 Sum_probs=171.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|+| |..+..++--+++.||||.-... +...++..|.+..+.|. .++|...|-+-.++.+-.+|+|++
T Consensus 35 KIGeGsF---G~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 35 KIGEGSF---GVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ccccCcc---eeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 5899999 89999999999999999975442 23578999999999995 899999999999999999999998
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-----CeEEeecceeeeecc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG-----HAHITDFNIATVLEE 155 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~-----~~~l~d~~~~~~~~~ 155 (246)
|.||.+.+.- .+..++..++..++.|++.-++++|+.+++.|||||+|+|+...+ .+.++|||+++.+.+
T Consensus 107 -GPSLEDLFD~----CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDL----CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHH----hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 9999999854 445579999999999999999999999999999999999997544 589999999998865
Q ss_pred Cccc--------cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC
Q psy7592 156 NQLA--------TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS 224 (246)
Q Consensus 156 ~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~ 224 (246)
.... ....||.+||+-.-..+.. -+.+.|+-|||.++++.+-|..||.+...+..+.-.+.+.+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrE-----QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGRE-----QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccch-----hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 4332 3345888899877766654 57789999999999999999999999887766544444444
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=181.76 Aligned_cols=189 Identities=26% Similarity=0.408 Sum_probs=158.1
Q ss_pred CcCCCCccCeeeEEEEEecC---CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD---TKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
+||.|+| ++||++++.. .++.||+|.+.... ....+..|++.|..+ .+.||+++.+++..++...+|+
T Consensus 43 kigeGsF---ssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl 114 (418)
T KOG1167|consen 43 KIGEGSF---SSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL 114 (418)
T ss_pred cccccch---hhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence 5789999 9999999988 89999999987643 235688899999999 4999999999999999999999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC-CCCeEEeecceeeeecc-
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE-EGHAHITDFNIATVLEE- 155 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~-~~~~~l~d~~~~~~~~~- 155 (246)
+|+++.+..++.... +...+..++..++.||.++|..||+|+||||+|++++. .+.-.|+|||++.....
T Consensus 115 p~~~H~~f~~l~~~l--------~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 115 PYFEHDRFRDLYRSL--------SLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred cccCccCHHHHHhcC--------CHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 999998888887642 78889999999999999999999999999999999985 44678999999872100
Q ss_pred -------C------c-------------------------------cccccccCCCccCCceecccccccCCCCcchhHH
Q psy7592 156 -------N------Q-------------------------------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191 (246)
Q Consensus 156 -------~------~-------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~ 191 (246)
. . ......||++|.|||++...+ .-++++|||
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~----~QttaiDiw 262 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP----RQTTAIDIW 262 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc----CcCCcccee
Confidence 0 0 001234889999999987655 367899999
Q ss_pred HHHHHHHHHHhCCCCCCCC
Q psy7592 192 SLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 192 slG~~l~~ll~g~~p~~~~ 210 (246)
|.|++++.++++..||-..
T Consensus 263 s~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eccceeehhhccccccccC
Confidence 9999999999999998543
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-25 Score=162.95 Aligned_cols=224 Identities=20% Similarity=0.221 Sum_probs=175.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCC-CcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH-PFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|+| |.+|.+....+|+.||||.-....- -.++..|.++...|++ .+|..+..+..++.+-.+|||.+
T Consensus 22 kiGsGSF---GdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 22 KIGSGSF---GDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL 93 (341)
T ss_pred eecCCch---hheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence 4788988 8999999999999999997755431 2568889999999974 68999999999999999999998
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC---CeEEeecceeeeeccCc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG---HAHITDFNIATVLEENQ 157 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~---~~~l~d~~~~~~~~~~~ 157 (246)
|.||.+.++-- ...++..+++-++-|++.-++|+|.++++|+||||+|+|..-+- .+.++|||+++.+.+..
T Consensus 94 -GPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 94 -GPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred -CccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 99999988542 33458899999999999999999999999999999999997443 57899999999875432
Q ss_pred --------cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh-cCCCCC
Q psy7592 158 --------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII-YSPVHY 228 (246)
Q Consensus 158 --------~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~ 228 (246)
......||..|.+-....+.. -+...|+-|+|.++.++--|..||.+.......+..+.+ +-+...
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~e-----qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIE-----QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhh-----hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 223455788888777666554 466899999999999999999999887765544333333 334433
Q ss_pred C-----CCCCHhHHHHHHHh
Q psy7592 229 P-----TAWSESTKHLLSQV 243 (246)
Q Consensus 229 ~-----~~~s~~l~~li~~~ 243 (246)
| ..+|.+..-.++-|
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~ 263 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYC 263 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHH
Confidence 3 34566655555544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=175.27 Aligned_cols=158 Identities=21% Similarity=0.146 Sum_probs=120.6
Q ss_pred CcCCCCccCeeeEEEEEecC-CCcEEEEEEeecccc--chHHHHHHHHHHHHHHhhCCCCccee-eeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD-TKQMYAMKYMHKSQC--IERDALKNVLREMEILTTLEHPFLVN-LWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~~v~ 77 (246)
.||+|+| |+||+|+++. +++.||||++..... .+....+.+.+|++++++++|+|+++ +++. ...++||
T Consensus 25 ~IG~G~f---g~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVm 97 (365)
T PRK09188 25 VLKRDVF---STVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVR 97 (365)
T ss_pred EEeecCc---EEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEE
Confidence 3788888 9999999886 688889998753311 12334567899999999999999985 4432 3579999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCC-CCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI-KPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i-~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
||++|++|... . +.. ...++.|++.+|.+||+.|++|+|| ||+||+++.++.++|+|||+++.....
T Consensus 98 E~~~G~~L~~~-~----------~~~-~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 98 GWTEGVPLHLA-R----------PHG-DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred EccCCCCHHHh-C----------ccc-hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 99999999632 1 111 1357889999999999999999999 899999999999999999999876543
Q ss_pred ccc---------cccccCCCccCCceecccc
Q psy7592 157 QLA---------TSMSGTKPYIAPEIFLVAT 178 (246)
Q Consensus 157 ~~~---------~~~~~~~~~~aPE~~~~~~ 178 (246)
... ....++..|.|||.+....
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 211 1234566789999886443
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=171.37 Aligned_cols=232 Identities=17% Similarity=0.231 Sum_probs=175.6
Q ss_pred cCCCCccCeeeEEEEEecCC-----CcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC-CeEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDT-----KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE-EDLFMV 76 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~v 76 (246)
+-+|+| |.||.+.+.+. .+.|-+|.++... ++-++..+..|.-.+....|||+.++.+++.++ ...+++
T Consensus 292 lqEGtF---Gri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~ 366 (563)
T KOG1024|consen 292 LQEGTF---GRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVL 366 (563)
T ss_pred hhcCch---hheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEE
Confidence 446888 89999955432 3345567665554 344567788899899899999999999988654 456777
Q ss_pred EeecCCCChHHHHhhcc---ccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 77 SDLLLGGDLRYHITQDI---KFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~---~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
+.+..-++|..++..-. ..........++...+.|++.|+++||..|++|.||...|.++++.-++|++|=.+++-.
T Consensus 367 y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 367 YPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDL 446 (563)
T ss_pred EeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhcccc
Confidence 88887889999987321 112233455668888999999999999999999999999999999999999999988765
Q ss_pred ccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCC
Q psy7592 154 EENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHY 228 (246)
Q Consensus 154 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~ 228 (246)
-+.+. .....+...|++||.+.... ++..+|+||||+++|||++ |+.|+.. .++.+....+..+ +...
T Consensus 447 FP~DYhcLGDnEnRPvkWMslEal~n~~-----yssasDvWsfGVllWELmtlg~~Pyae--IDPfEm~~ylkdGyRlaQ 519 (563)
T KOG1024|consen 447 FPGDYHCLGDNENRPVKWMSLEALQNSH-----YSSASDVWSFGVLLWELMTLGKLPYAE--IDPFEMEHYLKDGYRLAQ 519 (563)
T ss_pred CcccccccCCCCCCcccccCHHHHhhhh-----hcchhhhHHHHHHHHHHHhcCCCCccc--cCHHHHHHHHhccceecC
Confidence 44332 22334566799999997665 8999999999999999999 8999853 3333333333333 5566
Q ss_pred CCCCCHhHHHHHHHhhhC
Q psy7592 229 PTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 229 ~~~~s~~l~~li~~~l~~ 246 (246)
|-++++++..++.-||+.
T Consensus 520 P~NCPDeLf~vMacCWal 537 (563)
T KOG1024|consen 520 PFNCPDELFTVMACCWAL 537 (563)
T ss_pred CCCCcHHHHHHHHHHHhc
Confidence 889999999999999973
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-23 Score=170.37 Aligned_cols=196 Identities=26% Similarity=0.270 Sum_probs=157.0
Q ss_pred CcCCCCccCeeeEEEEEecCCC-cEEEEEEeeccccchHHHHHHHHHHHHHHhhCC----CCcceeeeeee-eeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK-QMYAMKYMHKSQCIERDALKNVLREMEILTTLE----HPFLVNLWFCF-QDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~-~~~~~~~~ 75 (246)
.||+|+| |.||.|.+..++ +.+|+|.......... ..+..|..++..++ .+++..+++.. ..+...++
T Consensus 25 ~iG~G~f---G~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 25 KIGEGGF---GAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred eccccCC---ceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 4788888 999999998774 6888998766432111 15667888888886 26899999988 57888999
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-----CeEEeeccee
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG-----HAHITDFNIA 150 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~-----~~~l~d~~~~ 150 (246)
||+.+ |.+|.+...... ...++..++..++.|++.+|+++|+.|++||||||.|+.+.... .+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 999999886543 33469999999999999999999999999999999999998663 5899999999
Q ss_pred e--eec-cCcc--------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7592 151 T--VLE-ENQL--------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN 212 (246)
Q Consensus 151 ~--~~~-~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~ 212 (246)
+ .+. .... .....||..|.+++...+.. .+.+.|+||++.++.++..|..||.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-----~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-----QGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-----cCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 8 331 1110 12244889999999887775 78899999999999999999999965443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-25 Score=196.76 Aligned_cols=180 Identities=11% Similarity=0.088 Sum_probs=122.0
Q ss_pred hhCCC-Ccceeeeeeee-------eCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCc
Q psy7592 53 TTLEH-PFLVNLWFCFQ-------DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHI 124 (246)
Q Consensus 53 ~~l~h-~~iv~~~~~~~-------~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~ 124 (246)
+.++| +||+++++.|. +...++.++|++ +.+|.+++... ..++++.++..++.||+.||.|||++||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~gI 101 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQGI 101 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34455 57777777762 234567788887 77999998642 2235899999999999999999999999
Q ss_pred ccCCCCCCcEEEcCC-------------------CCeEEeecceeeeeccCc-----------------cccccccCCCc
Q psy7592 125 IHRDIKPDNILLDEE-------------------GHAHITDFNIATVLEENQ-----------------LATSMSGTKPY 168 (246)
Q Consensus 125 ~h~~i~~~nil~~~~-------------------~~~~l~d~~~~~~~~~~~-----------------~~~~~~~~~~~ 168 (246)
+|+||||+|||++.. +.++++|||+++...... ......+++.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 345666666654321100 00012357779
Q ss_pred cCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHHHhhh
Q psy7592 169 IAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 169 ~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~ 245 (246)
+|||.+.+.. ++.++|||||||++|||++|..|+..... ......... ..+.+....+...+++.+||+
T Consensus 182 ~APE~~~~~~-----~~~~sDVwSlGviL~ELl~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~~~~L~ 250 (793)
T PLN00181 182 TSPEEDNGSS-----SNCASDVYRLGVLLFELFCPVSSREEKSR-TMSSLRHRV--LPPQILLNWPKEASFCLWLLH 250 (793)
T ss_pred EChhhhccCC-----CCchhhhhhHHHHHHHHhhCCCchhhHHH-HHHHHHHhh--cChhhhhcCHHHHHHHHHhCC
Confidence 9999987765 78899999999999999999888753211 111111111 111111234556788888876
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=164.92 Aligned_cols=233 Identities=18% Similarity=0.237 Sum_probs=145.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCC----------Ccceeeeeeee---
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH----------PFLVNLWFCFQ--- 68 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------~~iv~~~~~~~--- 68 (246)
.||.|++ +.||.|++.+||+.+|+|.+..........++++.+|.-..+.+.+ -.++...+...
T Consensus 19 ~i~~g~~---~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 19 IIGKGGF---SIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEETT---EEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred ccccCCc---eEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3677777 9999999999999999999887665555567888888766666432 12222222221
Q ss_pred ------eC---C-----eEEEEEeecCCCChHHHHhhccccc--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q psy7592 69 ------DE---E-----DLFMVSDLLLGGDLRYHITQDIKFY--SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132 (246)
Q Consensus 69 ------~~---~-----~~~~v~e~~~~~sL~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~ 132 (246)
.. . ..+++|.-+ ..+|.+.+..-.... ..++.......+..|+.+.+++||..|++|+||+|+
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~ 174 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPE 174 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGG
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccccee
Confidence 11 1 235667766 667877764311110 111233345667789999999999999999999999
Q ss_pred cEEEcCCCCeEEeecceeeeeccCccccccccCCCccCCceeccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy7592 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATD---EVLGYSYSVDWWSLGVTLFEILARGRPFDI 209 (246)
Q Consensus 133 nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~~~~~~Di~slG~~l~~ll~g~~p~~~ 209 (246)
|++++++|.+.++||+........... ...+..|.|||....... ....++.+.|.|+||+++|.++++..||+.
T Consensus 175 nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 175 NFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp GEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred eEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence 999999999999999987765443222 334567899997654310 122368899999999999999999999964
Q ss_pred CCCccHHHHHhhhcCCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 210 HSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
......... .. ... ..+|+.++.||..||++
T Consensus 253 ~~~~~~~~~---~f-~~C--~~~Pe~v~~LI~~lL~~ 283 (288)
T PF14531_consen 253 SSPEADPEW---DF-SRC--RDMPEPVQFLIRGLLQR 283 (288)
T ss_dssp CGGGSTSGG---GG-TTS--S---HHHHHHHHHHT-S
T ss_pred CCccccccc---cc-hhc--CCcCHHHHHHHHHHccC
Confidence 332211100 00 111 27899999999999974
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=156.81 Aligned_cols=140 Identities=14% Similarity=0.100 Sum_probs=106.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHH-----------------------HHHHHHHHHHHHhhCCCC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERD-----------------------ALKNVLREMEILTTLEHP 58 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~ 58 (246)
.||+|++ |+||.+.+. +|+.||+|+++........ .......|++.+.++.++
T Consensus 4 ~ig~G~~---~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 4 CISTGKE---ANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred ccccccc---eEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 4788888 999999997 8999999999865321100 012234599999999888
Q ss_pred cceeeeeeeeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHH-HHCCcccCCCCCCcEEEc
Q psy7592 59 FLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYL-KTKHIIHRDIKPDNILLD 137 (246)
Q Consensus 59 ~iv~~~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L-h~~~~~h~~i~~~nil~~ 137 (246)
++.....+.. .. .++||||++|+++........ +++...+..++.|++.++.++ |+.|++|+||||+||+++
T Consensus 80 ~v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~~~-----~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~ 152 (190)
T cd05147 80 GIPCPEPILL-KS-HVLVMEFIGDDGWAAPRLKDA-----PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH 152 (190)
T ss_pred CCCCCcEEEe-cC-CEEEEEEeCCCCCcchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE
Confidence 8754443322 22 379999998877765433322 348888999999999999999 799999999999999998
Q ss_pred CCCCeEEeecceeeee
Q psy7592 138 EEGHAHITDFNIATVL 153 (246)
Q Consensus 138 ~~~~~~l~d~~~~~~~ 153 (246)
++.++++|||++...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 578999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-21 Score=158.01 Aligned_cols=233 Identities=33% Similarity=0.539 Sum_probs=178.8
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCC-cceeeeeeeeeCCeEEEEEeecC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHP-FLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
||.|++ +.||.+.+. ..+++|.+.............+.+|+..+..+.|+ +++++++.+......+++++++.
T Consensus 8 l~~g~~---~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 8 LGEGSF---GEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred ecCCCC---eEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 566666 999999987 88999999887655544578899999999999988 79999999987777899999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-CeEEeecceeeeeccCc---
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG-HAHITDFNIATVLEENQ--- 157 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~-~~~l~d~~~~~~~~~~~--- 157 (246)
++++.+........ ...+......++.|++.+++++|+.+++|+|++|+|++++..+ .++++|||.+.......
T Consensus 82 ~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 82 GGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred CCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence 99999666554310 2348889999999999999999999999999999999999988 69999999987654332
Q ss_pred ----cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHhhhcCCCC-CCC
Q psy7592 158 ----LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT--SVKDVKAIIYSPVH-YPT 230 (246)
Q Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~-~~~ 230 (246)
......++..|.+||.+.+.. ........|+|++|+++++++.|..||...... .......+.....+ ...
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~--~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLS--LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccCCHHHhcCCC--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 234567889999999987631 012678999999999999999999998655431 12222222222322 221
Q ss_pred CC--------CHhHHHHHHHhhh
Q psy7592 231 AW--------SESTKHLLSQVHR 245 (246)
Q Consensus 231 ~~--------s~~l~~li~~~l~ 245 (246)
.. ...+.+++..++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~ 260 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLA 260 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHh
Confidence 11 1478888887765
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-23 Score=152.93 Aligned_cols=141 Identities=20% Similarity=0.203 Sum_probs=106.5
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSM 162 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 162 (246)
|+|.+++.... .++++..++.++.|++.||.|||+.+ +|+||+++.++.+++ ||.+....... .
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~ 64 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----S 64 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----C
Confidence 57888886532 24599999999999999999999998 999999999999998 99887654322 2
Q ss_pred ccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCC-------CCCCCCCH-
Q psy7592 163 SGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPV-------HYPTAWSE- 234 (246)
Q Consensus 163 ~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~s~- 234 (246)
.+++.|+|||.+.+.. ++.++||||||+++|+|++|..||........ .......... ..+..+++
T Consensus 65 ~g~~~y~aPE~~~~~~-----~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (176)
T smart00750 65 RVDPYFMAPEVIQGQS-----YTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMPADDPRDRSNLESVSAA 138 (176)
T ss_pred CCcccccChHHhcCCC-----CcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhccCCccccccHHHHHhh
Confidence 5678999999997765 78899999999999999999999965432221 1222221111 11223444
Q ss_pred -hHHHHHHHhhh
Q psy7592 235 -STKHLLSQVHR 245 (246)
Q Consensus 235 -~l~~li~~~l~ 245 (246)
.++++|+.||+
T Consensus 139 ~~~~~~i~~cl~ 150 (176)
T smart00750 139 RSFADFMRVCAS 150 (176)
T ss_pred hhHHHHHHHHHh
Confidence 69999999986
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=158.20 Aligned_cols=164 Identities=15% Similarity=0.142 Sum_probs=123.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHH------HHHHHHHHhhCCCCcceeeeeeeeeC-----
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKN------VLREMEILTTLEHPFLVNLWFCFQDE----- 70 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~----- 70 (246)
++|+|++ |.||++.+ ++..+|+|.+++....++..... +.+|++.+.+++|++|..+.+++...
T Consensus 38 ~l~~~~f---~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~ 112 (232)
T PRK10359 38 VFRNIDD---TKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTL 112 (232)
T ss_pred EecCCCc---eEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccc
Confidence 3677888 89999765 47789999998766555554444 57899999999999999999886533
Q ss_pred ---CeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeec
Q psy7592 71 ---EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDF 147 (246)
Q Consensus 71 ---~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~ 147 (246)
...+++|||++|.+|.+.... ++. ...+++.++..+|..|++|+|++|+|++++.+| ++++||
T Consensus 113 ~~~~~~~lvmEyi~G~tL~~~~~~---------~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 113 RYAHTYIMLIEYIEGVELNDMPEI---------SED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred cccCCeEEEEEEECCccHHHhhhc---------cHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 347899999999999876321 222 355889999999999999999999999999988 999999
Q ss_pred ceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHH
Q psy7592 148 NIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEI 200 (246)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~l 200 (246)
|............. +..... +..++|+|+||+.+...
T Consensus 179 g~~~~~~e~~a~d~-----------~vler~-----y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 179 SGKRCTAQRKAKDR-----------IDLERH-----YGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CCcccccchhhHHH-----------HHHHhH-----hcccccccceeEeehHH
Confidence 98765432211111 111111 44689999999987653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=150.77 Aligned_cols=142 Identities=15% Similarity=0.080 Sum_probs=109.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccch---------------------H--HHHHHHHHHHHHHhhCCCC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIE---------------------R--DALKNVLREMEILTTLEHP 58 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~---------------------~--~~~~~~~~e~~~l~~l~h~ 58 (246)
.||+|++ |+||++.+. +|+.||||.++...... . .....+..|++.+.++.|+
T Consensus 4 ~ig~G~~---~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 4 CISTGKE---ANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred eeecCCC---cEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 4788888 999999987 89999999998753110 0 0112345789999999999
Q ss_pred cceeeeeeeeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEc
Q psy7592 59 FLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLD 137 (246)
Q Consensus 59 ~iv~~~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~ 137 (246)
++.....+.... .++||||++|+++........ +++...+..++.|++.++.++|+ .|++|+||+|.||+++
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDV-----PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhc-----cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 886555444333 479999998876544322222 23778889999999999999999 9999999999999998
Q ss_pred CCCCeEEeecceeeeecc
Q psy7592 138 EEGHAHITDFNIATVLEE 155 (246)
Q Consensus 138 ~~~~~~l~d~~~~~~~~~ 155 (246)
++.++++|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 78999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.8e-24 Score=175.91 Aligned_cols=221 Identities=33% Similarity=0.539 Sum_probs=182.6
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+|.|.+|....|-++.....+..||+|+.++......... ....|..++...+ ||.++++...++.+...+++.++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 6889994444444444556789999999987664433322 4556777888886 9999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
|+.|...+.+.... .+.........++.++..+|+.|++++|+|++||+++.+|.+++.|||.++..-..+..
T Consensus 81 gg~lft~l~~~~~f-----~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMF-----DELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cchhhhccccCCch-----HHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 99998888765544 77778888899999999999999999999999999999999999999998875443333
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
.|+..|+|||++.+ ....+|.||+|++.++|++|..||.. +....|......+|...+..+++++.
T Consensus 154 -cgt~eymApEI~~g-------h~~a~D~ws~gvl~felltg~~pf~~------~~~~~Il~~~~~~p~~l~~~a~~~~~ 219 (612)
T KOG0603|consen 154 -CGTYEYRAPEIING-------HLSAADWWSFGVLAFELLTGTLPFGG------DTMKRILKAELEMPRELSAEARSLFR 219 (612)
T ss_pred -ccchhhhhhHhhhc-------cCCcccchhhhhhHHHHhhCCCCCch------HHHHHHhhhccCCchhhhHHHHHHHH
Confidence 77999999999983 45689999999999999999999965 55667777788999999999999998
Q ss_pred Hhhh
Q psy7592 242 QVHR 245 (246)
Q Consensus 242 ~~l~ 245 (246)
.++.
T Consensus 220 ~l~~ 223 (612)
T KOG0603|consen 220 QLFK 223 (612)
T ss_pred HHHh
Confidence 8763
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-21 Score=143.80 Aligned_cols=181 Identities=17% Similarity=0.181 Sum_probs=133.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHH-HHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDA-LKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+++| |+|+.+.. .+.+++.+.+....+..... ...+.+|++++++|+ ++++++++++ ...+++|||
T Consensus 9 ~l~~~~f---~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 9 PLKSDTF---GRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred eecCCCc---ceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3677888 99998776 68888888887766433222 234788999999995 5789998885 346899999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCC-CCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI-KPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i-~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
+.|.+|...... . ...++.|++.+++++|+.|++|+|| +|+||+++.++.++++|||++........
T Consensus 80 I~G~~L~~~~~~-----------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR-----------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh-----------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998654311 1 1246789999999999999999999 79999999999999999999986554331
Q ss_pred c----c----------ccccCCCccCCceecccccccCCCC-cchhHHHHHHHHHHHHhCCCCC
Q psy7592 159 A----T----------SMSGTKPYIAPEIFLVATDEVLGYS-YSVDWWSLGVTLFEILARGRPF 207 (246)
Q Consensus 159 ~----~----------~~~~~~~~~aPE~~~~~~~~~~~~~-~~~Di~slG~~l~~ll~g~~p~ 207 (246)
. . -...++.++.|+.-.-.. ..+ ...+.++.|.-+|.++|+..+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~----~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLK----RTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc----cchhHHHHHHHhcchHHHHHhccCCc
Confidence 1 0 011455666666543322 012 4678899999999999999876
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=175.51 Aligned_cols=231 Identities=20% Similarity=0.299 Sum_probs=171.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeec---cccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHK---SQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~---~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.+|.|.+ |.|+.+......+.++.|.++. ...........+..|.-+-..+.|+|++...+.+.+.....-.||
T Consensus 325 ~~g~ga~---g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 325 VLGSGAY---GSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred eeeeccc---CceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3567777 5677777776677777776542 111122222336678888888899999988888777666666699
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+++ +|...+.....+ ....+...++|++.+++|+|+.|+.|+|++++|++++.+|.++++|||.+..+.....
T Consensus 402 ~~~~-Dlf~~~~~~~~~-----~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKL-----TPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhccccc-----chhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 999999876444 7788999999999999999999999999999999999999999999999888754332
Q ss_pred -----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-------CC
Q psy7592 159 -----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-------PV 226 (246)
Q Consensus 159 -----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-------~~ 226 (246)
.....++..|.|||.+.+... .....||||.|++++.|.+|+.||......+.......... +.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~y----dpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEY----DPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred hhhhhhcCcccCCcCcCccccccccc----CcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 234678899999999987762 34469999999999999999999965443322111111111 11
Q ss_pred CCCCCCCHhHHHHHHHhhh
Q psy7592 227 HYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 227 ~~~~~~s~~l~~li~~~l~ 245 (246)
.+-...+...+.+|..||+
T Consensus 552 ~~~~~lp~~~~~~~~~~l~ 570 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQ 570 (601)
T ss_pred HHHHhchhhHHHHHHHHcc
Confidence 1113478888889988886
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-22 Score=175.92 Aligned_cols=226 Identities=20% Similarity=0.232 Sum_probs=160.6
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQ-CIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
||++.| =+|.++.+. .|. |+||++-+.. -.+-+...+...|++ ....++||.+++..+.+.+..-|+|-+|.
T Consensus 31 LGstRF---lKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyv- 103 (1431)
T KOG1240|consen 31 LGSTRF---LKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYV- 103 (1431)
T ss_pred cCchhh---hhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHH-
Confidence 577777 788888885 355 8899986654 233334455566666 55668999999998887788888888888
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC--ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN--QLA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~--~~~ 159 (246)
..+|.|.+..+.-+ ..-+.+.++.|++.|+..+|..|++|||||.+|||++.=+++.++||...+...-. +..
T Consensus 104 khnLyDRlSTRPFL-----~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 104 KHNLYDRLSTRPFL-----VLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred hhhhhhhhccchHH-----HHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 66899988765544 77788899999999999999999999999999999999999999999987664211 111
Q ss_pred ------cccccCCCccCCceecccc------cccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcCCC
Q psy7592 160 ------TSMSGTKPYIAPEIFLVAT------DEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYSPV 226 (246)
Q Consensus 160 ------~~~~~~~~~~aPE~~~~~~------~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 226 (246)
....+-.+|.|||.+.... ......+++-||||+||++.|+++ |.+||+- .+ ..+......
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQ---L~aYr~~~~ 252 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQ---LLAYRSGNA 252 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HH---HHhHhccCc
Confidence 1112334699999975422 111116789999999999999998 7888842 11 111111111
Q ss_pred CCC-----CCCCHhHHHHHHHhhhC
Q psy7592 227 HYP-----TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ~~~-----~~~s~~l~~li~~~l~~ 246 (246)
..| .--+..+++||..|++.
T Consensus 253 ~~~e~~Le~Ied~~~Rnlil~Mi~r 277 (1431)
T KOG1240|consen 253 DDPEQLLEKIEDVSLRNLILSMIQR 277 (1431)
T ss_pred cCHHHHHHhCcCccHHHHHHHHHcc
Confidence 111 11355889999999863
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-20 Score=140.32 Aligned_cols=132 Identities=17% Similarity=0.143 Sum_probs=102.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-----CCCcceeeeeeeeeCC---e-
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-----EHPFLVNLWFCFQDEE---D- 72 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~- 72 (246)
+||+|++ +.||. +..++.. +||++..... ...+++.+|++.++.+ +||||++++++++.+. .
T Consensus 9 ~LG~G~~---~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 9 PLGTGRH---RKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred eecCCCc---eEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 5899998 89995 7777766 6998876432 2346789999999999 5799999999998763 3
Q ss_pred EEEEEee--cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHH-HHHHHCCcccCCCCCCcEEEcCC----CCeEEe
Q psy7592 73 LFMVSDL--LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLAL-DYLKTKHIIHRDIKPDNILLDEE----GHAHIT 145 (246)
Q Consensus 73 ~~~v~e~--~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l-~~Lh~~~~~h~~i~~~nil~~~~----~~~~l~ 145 (246)
+.+|+|| ..+++|.+++.+. . +++. ..++.|++.++ +|||+++|+|+||+|+||+++.+ +.++|+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~-----~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-R-----YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-c-----ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 3478999 4478999999653 2 2444 35577888777 99999999999999999999743 379999
Q ss_pred eccee
Q psy7592 146 DFNIA 150 (246)
Q Consensus 146 d~~~~ 150 (246)
|++.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 94443
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=163.32 Aligned_cols=188 Identities=18% Similarity=0.225 Sum_probs=152.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.+|.|+| |+||.|.+.. |+.||+|.-++..+++--...+++..++ ++. -+.|..+.....-.+..++|+||.+
T Consensus 705 e~G~g~y---~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~--~~~~~~~~~a~~~~~~S~lv~ey~~ 777 (974)
T KOG1166|consen 705 EIGEGSY---GSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQM--LPSIMHISSAHVFQNASVLVSEYSP 777 (974)
T ss_pred eeccccc---eEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hhh--hcchHHHHHHHccCCcceeeeeccc
Confidence 4788888 9999999987 9999999998887766555455544444 222 3456666666666667789999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC-------CCCeEEeecceeeeec
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE-------EGHAHITDFNIATVLE 154 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~-------~~~~~l~d~~~~~~~~ 154 (246)
.|+|.++++..... ++..+..++.|++..++.||..+||||||||+|+++.. ...++|+|||-+--+.
T Consensus 778 ~Gtlld~~N~~~~m-----~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 778 YGTLLDLINTNKVM-----DEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred cccHHHhhccCCCC-----CchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 99999999866555 88889999999999999999999999999999999953 2358999999875443
Q ss_pred ---cCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy7592 155 ---ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP 206 (246)
Q Consensus 155 ---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p 206 (246)
+.......+.+-.+-++|...+.+ ++-..|-|.|+.+++.|+.|+..
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grp-----WtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRP-----WTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCC-----CchhhhhHHHHHHHHHHHHHHHH
Confidence 344555677888899999998887 99999999999999999999753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=139.58 Aligned_cols=140 Identities=15% Similarity=0.097 Sum_probs=104.6
Q ss_pred CcCCCCccCeeeEEEEE-ecCCCcEEEEEEeeccccc--h------------------HH-HHHHHHHHHHHHhhCCCCc
Q psy7592 2 FCGSSKFCGTSKVCIVQ-KKDTKQMYAMKYMHKSQCI--E------------------RD-ALKNVLREMEILTTLEHPF 59 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~-~~~~~~~~avK~~~~~~~~--~------------------~~-~~~~~~~e~~~l~~l~h~~ 59 (246)
.||+|++ |.||+|+ +..+|+.||+|.++..... + .+ ....+.+|++.+.++.+.+
T Consensus 35 ~Lg~G~~---g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~ 111 (237)
T smart00090 35 CISTGKE---ANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG 111 (237)
T ss_pred eeccCcc---eeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3788888 9999999 6678999999999764311 0 00 1134568999999997533
Q ss_pred ceeeeeeeeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC-cccCCCCCCcEEEcC
Q psy7592 60 LVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH-IIHRDIKPDNILLDE 138 (246)
Q Consensus 60 iv~~~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~-~~h~~i~~~nil~~~ 138 (246)
+ ....++... ..++||||+.|.+|........ +.....+..++.|++.++++||+.| ++|+||+|+||+++
T Consensus 112 i-~~p~~~~~~-~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 112 V-PVPKPIAWR-RNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred C-CCCeeeEec-CceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 2 222222222 3479999999988866543322 2355667889999999999999999 99999999999998
Q ss_pred CCCeEEeecceeee
Q psy7592 139 EGHAHITDFNIATV 152 (246)
Q Consensus 139 ~~~~~l~d~~~~~~ 152 (246)
++.++++|||.+..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999998764
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=6e-20 Score=139.36 Aligned_cols=221 Identities=15% Similarity=0.241 Sum_probs=169.6
Q ss_pred eeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCCCChHHHHh
Q psy7592 11 TSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHIT 90 (246)
Q Consensus 11 ~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~sL~~~~~ 90 (246)
+|..|+.++. |..++.|+++-..+.. ...++|.+|.-.++-+.||||.++++.|.+..+..+|..|++.+||+..+.
T Consensus 203 sgelwrgrwq--gndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlh 279 (448)
T KOG0195|consen 203 SGELWRGRWQ--GNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLH 279 (448)
T ss_pred Cccccccccc--Ccchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHh
Confidence 4788888884 5667788877655433 334789999999999999999999999999999999999999999999997
Q ss_pred hccccccCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCcEEEcCCCCeEEe--ecceeeeeccCccccccccCC
Q psy7592 91 QDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH--IIHRDIKPDNILLDEEGHAHIT--DFNIATVLEENQLATSMSGTK 166 (246)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~--~~h~~i~~~nil~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~ 166 (246)
..... -.+-.+...++..++.++.|||+.. +----++...++++++-..+++ |-.++. .......++
T Consensus 280 e~t~v---vvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf------qe~gr~y~p 350 (448)
T KOG0195|consen 280 EQTSV---VVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------QEVGRAYSP 350 (448)
T ss_pred cCccE---EEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee------eccccccCc
Confidence 65322 2356678888999999999999986 4445678888999887765543 322221 123345678
Q ss_pred CccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHHHhhh
Q psy7592 167 PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 167 ~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~ 245 (246)
.|++||.+...+... --...|+|||++++||+.|...||...+..+-........-+..+|+..|.-...|++-|++
T Consensus 351 awmspealqrkped~--n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmn 427 (448)
T KOG0195|consen 351 AWMSPEALQRKPEDL--NIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMN 427 (448)
T ss_pred ccCCHHHHhcCchhc--chhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhc
Confidence 999999987665321 23479999999999999999999987666554433333444888899999999999999986
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-18 Score=133.12 Aligned_cols=136 Identities=18% Similarity=0.230 Sum_probs=112.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHH-----HHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERD-----ALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |.||+++. +|..+++|........... ....+.+|++.+..++|+++.....++.+....+++
T Consensus 3 ~l~~G~~---~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 77 (211)
T PRK14879 3 LIKRGAE---AEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIV 77 (211)
T ss_pred ccccCce---EEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEE
Confidence 5788888 99999987 6788999987654432211 234577899999999999998877777777788999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
|||++|.+|.+.+... .. ....++.+++.++.++|+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 ~e~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999888542 12 7888999999999999999999999999999998 78899999998765
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-18 Score=132.27 Aligned_cols=133 Identities=14% Similarity=0.136 Sum_probs=107.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccch-----HHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIE-----RDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
+||+|++ |+||++.. ++..+++|......... ....+++.+|++.++.++|+++.....++......+++
T Consensus 1 ~ig~G~~---~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 75 (199)
T TIGR03724 1 LIAKGAE---AIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIV 75 (199)
T ss_pred CCCCCce---EEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEE
Confidence 5899999 99999985 57889999865433211 11246678899999999988776655555666667899
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
|||++|++|.+.+.... . .++.|++.++.++|+.|++|+|++|.|++++ ++.++++|||.+..
T Consensus 76 ~e~~~g~~l~~~~~~~~-------~-----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGN-------D-----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEECCccHHHHHhhcH-------H-----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999998775421 1 6788999999999999999999999999998 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.4e-19 Score=155.44 Aligned_cols=189 Identities=33% Similarity=0.583 Sum_probs=137.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
++-.|.| |-||.++|+.+.+.+|+ +++++.. .++. +++....|.+|
T Consensus 90 lisngAy---gavylvrh~~trqrfa~-kiNkq~l----ilRn------ilt~a~npfvv-------------------- 135 (1205)
T KOG0606|consen 90 LISNGAY---GAVYLVRHKETRQRFAM-KINKQNL----ILRN------ILTFAGNPFVV-------------------- 135 (1205)
T ss_pred eeccCCC---Cceeeeeccccccchhh-cccccch----hhhc------cccccCCccee--------------------
Confidence 3456677 89999999999999999 5555431 1111 33333444444
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-----
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN----- 156 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~----- 156 (246)
++-...+...+.+ |.+ ++.+++|||+.|++|+|++|+|.+++.-|.+|++|||+++.....
T Consensus 136 -gDc~tllk~~g~l-----Pvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 -GDCATLLKNIGPL-----PVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred -chhhhhcccCCCC-----cch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 2233333332222 333 267899999999999999999999999999999999998764211
Q ss_pred -----------ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCC
Q psy7592 157 -----------QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSP 225 (246)
Q Consensus 157 -----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 225 (246)
-...+..+++.|.|||++..+. |+..+|.|++|+++|+.+-|..||.+. +.++.+...+...
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-----ygkpvdwwamGiIlyeFLVgcvpffGd--tpeelfg~visd~ 274 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-----YGKPVDWWAMGIILYEFLVGCVPFFGD--TPEELFGQVISDD 274 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhc-----cCCCccHHHHHHHHHHHheeeeeccCC--CHHHHHhhhhhhh
Confidence 0123346899999999998765 888999999999999999999999753 3445555566666
Q ss_pred CCCCC---CCCHhHHHHHHHhhh
Q psy7592 226 VHYPT---AWSESTKHLLSQVHR 245 (246)
Q Consensus 226 ~~~~~---~~s~~l~~li~~~l~ 245 (246)
..+|+ .++++.+++|.++|+
T Consensus 275 i~wpE~dea~p~Ea~dli~~LL~ 297 (1205)
T KOG0606|consen 275 IEWPEEDEALPPEAQDLIEQLLR 297 (1205)
T ss_pred ccccccCcCCCHHHHHHHHHHHH
Confidence 66764 589999999999986
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.4e-17 Score=124.99 Aligned_cols=134 Identities=18% Similarity=0.097 Sum_probs=101.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc------hH-------------HHHHHHHHHHHHHhhCCCCc--c
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI------ER-------------DALKNVLREMEILTTLEHPF--L 60 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~-------------~~~~~~~~e~~~l~~l~h~~--i 60 (246)
.||+|++ |.||++... +|+.||||.++..... .. ........|...+.++.+++ +
T Consensus 22 ~i~~G~~---g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v 97 (198)
T cd05144 22 QIGVGKE---SDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPV 97 (198)
T ss_pred ccccCcc---eEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCC
Confidence 3778888 899999885 7999999998754310 00 01123667888999987774 3
Q ss_pred eeeeeeeeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC
Q psy7592 61 VNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG 140 (246)
Q Consensus 61 v~~~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~ 140 (246)
...++ ....+++|||++|++|...... .....++.+++.++.++|+.|++|+||+|.||+++.++
T Consensus 98 ~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 98 PKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred Cceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 33332 2345899999999988765321 23456788999999999999999999999999999999
Q ss_pred CeEEeecceeeeec
Q psy7592 141 HAHITDFNIATVLE 154 (246)
Q Consensus 141 ~~~l~d~~~~~~~~ 154 (246)
.++++|||.+....
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.4e-17 Score=141.69 Aligned_cols=132 Identities=15% Similarity=0.144 Sum_probs=104.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc-----hHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI-----ERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
+||+|++ |+||++... +..+++|........ .....+.+.+|++.+++++|++++....++.+....++|
T Consensus 340 ~iG~G~~---g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 340 LIGKGAE---ADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred eeccCCc---EEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 4788888 999998874 334444443222111 112235678999999999999998887777777778899
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
|||++|++|.+.+. ....++.|++.++.+||+.|++|+|++|+||++ .++.++++|||++..
T Consensus 415 ~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 415 MEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999988874 235678899999999999999999999999999 677899999999865
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.2e-17 Score=130.64 Aligned_cols=182 Identities=21% Similarity=0.320 Sum_probs=130.2
Q ss_pred CCCcceeeeeeeeeC---------------------------CeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHH
Q psy7592 56 EHPFLVNLWFCFQDE---------------------------EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLY 108 (246)
Q Consensus 56 ~h~~iv~~~~~~~~~---------------------------~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~ 108 (246)
+|||||+++..|.++ ...|+||..+ ..+|.+++-.... +......+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~~------s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRHR------SYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCCC------chHHHHHH
Confidence 599999998777433 2478999888 5678888755432 56667788
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEc--CCC--CeEEeecceeeeeccCc-------cccccccCCCccCCceeccc
Q psy7592 109 AFELGLALDYLKTKHIIHRDIKPDNILLD--EEG--HAHITDFNIATVLEENQ-------LATSMSGTKPYIAPEIFLVA 177 (246)
Q Consensus 109 ~~qi~~~l~~Lh~~~~~h~~i~~~nil~~--~~~--~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~ 177 (246)
+.|+++++.+||.+|+.|+|+|.+|||+. +++ ...++|||-+---.... -.....|....+|||+.-..
T Consensus 347 laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999999999999999999995 333 56899999763322111 11223466678999987544
Q ss_pred ccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhh-hcCCCCCCCCCCHhHHHHHHHhhh
Q psy7592 178 TDEVLGY-SYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAI-IYSPVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 178 ~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~l~~li~~~l~ 245 (246)
+....-. -.+.|.|+.|.+.||++...+||......-.. .... ..+.+.+|..+++.++++|..+|+
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-~r~Yqe~qLPalp~~vpp~~rqlV~~lL~ 495 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-TRTYQESQLPALPSRVPPVARQLVFDLLK 495 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec-hhhhhhhhCCCCcccCChHHHHHHHHHhc
Confidence 4221111 23799999999999999999999654433222 1112 222777889999999999998886
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.3e-17 Score=120.88 Aligned_cols=138 Identities=16% Similarity=0.145 Sum_probs=95.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHH---------------------HHHHHHHHhhCCCCc-
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKN---------------------VLREMEILTTLEHPF- 59 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~---------------------~~~e~~~l~~l~h~~- 59 (246)
.||+|++ |+||++.+. +++.||+|.++............ ...|.+.+.++.+.+
T Consensus 4 ~lg~G~~---g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 4 PIGTGKE---ADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred ccccccc---eeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 4788888 999999987 89999999987643221111111 134566666664433
Q ss_pred -ceeeeeeeeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEc
Q psy7592 60 -LVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLD 137 (246)
Q Consensus 60 -iv~~~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~ 137 (246)
+.+.+.+ ...+++|||++++.+......... ....+..++.+++.++.++|. .|++|+||+|+||+++
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh------hcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 3333332 235899999988543221111100 115577889999999999999 9999999999999999
Q ss_pred CCCCeEEeecceeeeec
Q psy7592 138 EEGHAHITDFNIATVLE 154 (246)
Q Consensus 138 ~~~~~~l~d~~~~~~~~ 154 (246)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.5e-16 Score=122.33 Aligned_cols=132 Identities=16% Similarity=0.187 Sum_probs=98.8
Q ss_pred cCeeeEEEEEecCCCcEEEEEEeecccc----------chHHHHHHHHHHHHHHhhCCCCcc--eeeeeeeeeC-Ce---
Q psy7592 9 CGTSKVCIVQKKDTKQMYAMKYMHKSQC----------IERDALKNVLREMEILTTLEHPFL--VNLWFCFQDE-ED--- 72 (246)
Q Consensus 9 ~~~~~v~~~~~~~~~~~~avK~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~-~~--- 72 (246)
||-|+||.+... +..+|+|.++.... .+......+.+|++++..++|+++ +..+.+...+ ..
T Consensus 43 ~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~ 120 (239)
T PRK01723 43 KGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYR 120 (239)
T ss_pred CCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCccee
Confidence 333899998874 78899998864221 112234567889999999998885 5666654332 22
Q ss_pred EEEEEeecCC-CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 73 LFMVSDLLLG-GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 73 ~~~v~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
.++|||+++| .+|.+.+... ++++. .+.|++.++.+||+.|++|+||+|.||+++.++.++++|||.+.
T Consensus 121 ~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 121 ADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred eeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 3599999987 6888887542 12433 35689999999999999999999999999998899999999876
Q ss_pred e
Q psy7592 152 V 152 (246)
Q Consensus 152 ~ 152 (246)
.
T Consensus 191 ~ 191 (239)
T PRK01723 191 L 191 (239)
T ss_pred c
Confidence 5
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.9e-16 Score=131.85 Aligned_cols=190 Identities=21% Similarity=0.317 Sum_probs=143.1
Q ss_pred HhhCCCCcceeeeeeeeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCc-ccCCCC
Q psy7592 52 LTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHI-IHRDIK 130 (246)
Q Consensus 52 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~-~h~~i~ 130 (246)
++.+.|.|+.++++.+.++...+.|-+|+.-|+|.+.+... ....+......+.+.++.++.|+|..-+ .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence 35788999999999999999999999999999999999873 2234777788899999999999998765 999999
Q ss_pred CCcEEEcCCCCeEEeecceeeeeccC---ccccccccCCCccCCceecccccccC--CCCcchhHHHHHHHHHHHHhCCC
Q psy7592 131 PDNILLDEEGHAHITDFNIATVLEEN---QLATSMSGTKPYIAPEIFLVATDEVL--GYSYSVDWWSLGVTLFEILARGR 205 (246)
Q Consensus 131 ~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~--~~~~~~Di~slG~~l~~ll~g~~ 205 (246)
..|.+++.+..+|++|||+....... ...........|.|||.++....... ..+.+.|+||+|++++++++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998765321 11111223456999999987532221 24678999999999999999999
Q ss_pred CCCCCCCccH--HHHHhhhc-CC-CCCCC-----CCCHhHHHHHHHhhh
Q psy7592 206 PFDIHSNTSV--KDVKAIIY-SP-VHYPT-----AWSESTKHLLSQVHR 245 (246)
Q Consensus 206 p~~~~~~~~~--~~~~~~~~-~~-~~~~~-----~~s~~l~~li~~~l~ 245 (246)
||........ +....+.. .. ...|. ...+++..+++.||.
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~ 205 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWE 205 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcc
Confidence 9966433332 22333322 22 22232 345678899999985
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.9e-15 Score=108.21 Aligned_cols=128 Identities=20% Similarity=0.216 Sum_probs=104.8
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCC--CcceeeeeeeeeCCeEEEEEeec
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH--PFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
+|+|.+ +.||++.... ..+++|....... ...+.+|+..++.+++ .++++++.....++..++++||+
T Consensus 6 i~~g~~---~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 6 LKGGLT---NRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cccccc---cceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 677777 8999999853 7899998866542 3567889999999976 58889888888778899999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK---HIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~---~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
.|.++... +......+..+++.++..+|.. +++|+|++|+|++++..+.+++.||+.+..
T Consensus 76 ~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 88777543 3344566788999999999985 699999999999999988999999997753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.3e-17 Score=140.65 Aligned_cols=230 Identities=27% Similarity=0.350 Sum_probs=173.4
Q ss_pred cCCCCccCeeeEEEEEec-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeec
Q psy7592 3 CGSSKFCGTSKVCIVQKK-DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
||+|.+ +.|-.+... .+...+|+|.+.... .+.....+...|...-..+. |+|++..++...+.+..++++++.
T Consensus 28 ig~gs~---~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s 103 (601)
T KOG0590|consen 28 IGKGSF---SSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYS 103 (601)
T ss_pred cccccc---chhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccccccCcc
Confidence 577777 666666554 346667777765543 34455566677888888886 999999999999999999999999
Q ss_pred CCCChHHHH-hhccccccCCCChHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCcEEEcCCC-CeEEeecceeeeecc-C
Q psy7592 81 LGGDLRYHI-TQDIKFYSVGTRNDTIHLYAFELGLALDYLK-TKHIIHRDIKPDNILLDEEG-HAHITDFNIATVLEE-N 156 (246)
Q Consensus 81 ~~~sL~~~~-~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh-~~~~~h~~i~~~nil~~~~~-~~~l~d~~~~~~~~~-~ 156 (246)
.|+++.+.. .... ...+.......+.|+..++.|+| ..++.|+|++|+|.+++..+ .+++.||+++..+.. .
T Consensus 104 ~g~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 104 DGGSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cccccccccccCCc----cCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 999998887 3332 13366778889999999999999 99999999999999999999 999999999988765 3
Q ss_pred cc---cccccc-CCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCC
Q psy7592 157 QL---ATSMSG-TKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYP 229 (246)
Q Consensus 157 ~~---~~~~~~-~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~ 229 (246)
+. .....+ ++.|.|||...+.. ...+..|+||.|+++..+++|..||+............+... .....
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~----~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKA----YRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW 255 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchh----hcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence 22 223456 88999999987742 256789999999999999999999976554443323232222 12223
Q ss_pred CCCCHhHHHHHHHhh
Q psy7592 230 TAWSESTKHLLSQVH 244 (246)
Q Consensus 230 ~~~s~~l~~li~~~l 244 (246)
...+....+++.+++
T Consensus 256 ~~~~~~~~~~l~k~l 270 (601)
T KOG0590|consen 256 NSISDQAHDLLHKIL 270 (601)
T ss_pred ccCChhhhhcccccc
Confidence 567888888877776
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.7e-16 Score=127.85 Aligned_cols=121 Identities=27% Similarity=0.420 Sum_probs=105.1
Q ss_pred eEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 72 ~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
+.++.|+++.-.+|.+++..... ....+....+.++.|+..++.| +|.+|+|++|.||++..+..++|.|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 57899999999999999975432 3344777899999999999999 999999999999999999999999999988
Q ss_pred eeccCc-------cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh
Q psy7592 152 VLEENQ-------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA 202 (246)
Q Consensus 152 ~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~ 202 (246)
.+.... ......++..|++||.+.+.. ++.++||||||+++++++.
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-----y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-----YSEKVDIYALGLILAELLI 457 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhh-----hhhhcchhhHHHHHHHHHH
Confidence 776544 334566899999999999887 8999999999999999988
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.3e-14 Score=118.93 Aligned_cols=142 Identities=17% Similarity=0.151 Sum_probs=96.3
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHH---------------------------HH----------HHH
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERD---------------------------AL----------KNV 45 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~---------------------------~~----------~~~ 45 (246)
||+|++ |+||+|+.+ +|+.||||+.++.....-+ .+ -++
T Consensus 125 lasaSi---gQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 125 LAAASI---AQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred eeeeeh---hheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 577777 999999975 7999999998765311100 00 024
Q ss_pred HHHHHHHhhCC-----CCcceeeeeeeeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHH-HHHHH
Q psy7592 46 LREMEILTTLE-----HPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGL-ALDYL 119 (246)
Q Consensus 46 ~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~-~l~~L 119 (246)
.+|++.+.+++ ++++.-..-+.......++||||++|.+|.+....... .. ....++.+++. .+..+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~------~~-~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA------GL-DRKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc------CC-CHHHHHHHHHHHHHHHH
Confidence 45666666552 34433222222223456899999999999887643211 11 12344555555 36788
Q ss_pred HHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 120 KTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 120 h~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
|..|++|+|++|.||+++.++.++++|||++.....
T Consensus 274 ~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 274 LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999999988754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.7e-14 Score=121.79 Aligned_cols=142 Identities=16% Similarity=0.175 Sum_probs=90.1
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccch---------------------------H----HHHHH------H
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIE---------------------------R----DALKN------V 45 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~---------------------------~----~~~~~------~ 45 (246)
||+|++ |+||.|+.+.+|+.||||+.++..... . +..+. +
T Consensus 127 lasaSi---aQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~ 203 (537)
T PRK04750 127 LASASI---AQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDL 203 (537)
T ss_pred hcCCCc---cEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCH
Confidence 678888 999999998889999999998652110 0 11122 3
Q ss_pred HHHHHHHhhCC----CCcceeeeeeeee-CCeEEEEEeecCCCChHHHH--hhccccccCCCChHHHHHHHHHHHHHHHH
Q psy7592 46 LREMEILTTLE----HPFLVNLWFCFQD-EEDLFMVSDLLLGGDLRYHI--TQDIKFYSVGTRNDTIHLYAFELGLALDY 118 (246)
Q Consensus 46 ~~e~~~l~~l~----h~~iv~~~~~~~~-~~~~~~v~e~~~~~sL~~~~--~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 118 (246)
.+|+....+++ +...+.+-.++.+ ....++||||+.|+.+.+.- ...+. ....+.+..+..++.|+
T Consensus 204 ~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~~~la~~~v~~~~~Qi------ 276 (537)
T PRK04750 204 MREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-DMKLLAERGVEVFFTQV------ 276 (537)
T ss_pred HHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-CHHHHHHHHHHHHHHHH------
Confidence 34444444442 2222222222221 33467999999999998742 22110 00112333344444444
Q ss_pred HHHCCcccCCCCCCcEEEcCCC----CeEEeecceeeeecc
Q psy7592 119 LKTKHIIHRDIKPDNILLDEEG----HAHITDFNIATVLEE 155 (246)
Q Consensus 119 Lh~~~~~h~~i~~~nil~~~~~----~~~l~d~~~~~~~~~ 155 (246)
...|++|+|++|.||+++.++ .++++|||++.....
T Consensus 277 -f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 469999999999999999888 899999999988754
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.4e-13 Score=116.59 Aligned_cols=168 Identities=17% Similarity=0.300 Sum_probs=129.9
Q ss_pred EEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCCCChHHHHhhcccc
Q psy7592 16 IVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKF 95 (246)
Q Consensus 16 ~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~ 95 (246)
.+..+.++.+|.|..+.... .+......+.++.++.++||||+++++.++.+...|+|+|.+ .-|..++.+.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l--- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL--- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh---
Confidence 35667789999999887654 244566788899999999999999999999999999999987 4466666543
Q ss_pred ccCCCChHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc-cccCCCccCCce
Q psy7592 96 YSVGTRNDTIHLYAFELGLALDYLK-TKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS-MSGTKPYIAPEI 173 (246)
Q Consensus 96 ~~~~~~~~~~~~~~~qi~~~l~~Lh-~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~aPE~ 173 (246)
....++..+.||+.||.+|| ..+++|+|+.-+.++++..|..+|.+|..+......+.... ..--..|..|+.
T Consensus 102 -----~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 102 -----GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE 176 (690)
T ss_pred -----HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence 46668888999999999998 55799999999999999999999999998876543332111 112223556654
Q ss_pred ecccccccCCCCcchhHHHHHHHHHHHHhC
Q psy7592 174 FLVATDEVLGYSYSVDWWSLGVTLFEILAR 203 (246)
Q Consensus 174 ~~~~~~~~~~~~~~~Di~slG~~l~~ll~g 203 (246)
+... .-..|.|.||+++++++.|
T Consensus 177 ~~~s-------~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPS-------EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCcc-------ccchhhhhHHHHHHHHhCc
Confidence 3211 1246999999999999999
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.3e-13 Score=109.74 Aligned_cols=171 Identities=17% Similarity=0.187 Sum_probs=132.8
Q ss_pred eeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeee----eCCeEEEEEeecCC-CChH
Q psy7592 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQ----DEEDLFMVSDLLLG-GDLR 86 (246)
Q Consensus 12 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~~v~e~~~~-~sL~ 86 (246)
.+.|+++.+.+|..|++|.++....... ..-..-++.++++.|+|+|++.++|. .+..+++|++|+++ .+|.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 6899999999999999999955432221 22334678899999999999999987 34468999999874 5787
Q ss_pred HHHhhccccc----------cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 87 YHITQDIKFY----------SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 87 ~~~~~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
+......... ....++..+|.++.|+..||.++|+.|+...-+.|.+|+++.+..++++..|........
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 7765443322 234688999999999999999999999999999999999999989999988876654432
Q ss_pred ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy7592 157 QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP 206 (246)
Q Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p 206 (246)
. -+-+..+ .+-|.-.||.+++.|.+|..-
T Consensus 447 ~-------------~~~le~~--------Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 P-------------TEPLESQ--------QQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred C-------------CcchhHH--------hhhhHHHHHHHHHHHhhcccc
Confidence 2 0112222 267999999999999999653
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.7e-15 Score=115.68 Aligned_cols=190 Identities=15% Similarity=0.190 Sum_probs=139.1
Q ss_pred eeeEEEEEecCCCcEEEEEEeeccccchHHH-HHHHHHHHHHHhhCCCCcceeeeeeeeeCC-----eEEEEEeecCCCC
Q psy7592 11 TSKVCIVQKKDTKQMYAMKYMHKSQCIERDA-LKNVLREMEILTTLEHPFLVNLWFCFQDEE-----DLFMVSDLLLGGD 84 (246)
Q Consensus 11 ~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~~v~e~~~~~s 84 (246)
...||.+.+.+.|.+|+...++....++... .+........+.++-|.||++++.+|.+.. ...++.||+..++
T Consensus 79 id~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs 158 (458)
T KOG1266|consen 79 IDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGS 158 (458)
T ss_pred hHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchh
Confidence 3567888888888888765554433333222 233444567777888999999999997543 4789999999999
Q ss_pred hHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-----
Q psy7592 85 LRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH--IIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ----- 157 (246)
Q Consensus 85 L~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~--~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~----- 157 (246)
+..++++..+ ....+......+|+.||+.||.|||+.. ++|++++.+.+++..+|.+++..-..........
T Consensus 159 ~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~ 237 (458)
T KOG1266|consen 159 LKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREA 237 (458)
T ss_pred HHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHh
Confidence 9999987644 3455688889999999999999999987 9999999999999999988876433322211111
Q ss_pred cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy7592 158 LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP 206 (246)
Q Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p 206 (246)
......+.++|.+||+-.... .+..+|||++|....+|..+...
T Consensus 238 Ek~~~~~~~g~~a~~sg~~tn-----~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 238 EKSVNTSLPGFSAPESGTTTN-----TTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred hhhccccCCccccCCcCcccc-----cccchhhhhhhHHHHHHHHheec
Confidence 111233567889998643332 56689999999999999888664
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.1e-12 Score=98.07 Aligned_cols=139 Identities=14% Similarity=0.137 Sum_probs=96.5
Q ss_pred cCCCCccCeeeEEEEEecC------CCcEEEEEEeecccc--ch-----------------HHHHHH----HHHHHHHHh
Q psy7592 3 CGSSKFCGTSKVCIVQKKD------TKQMYAMKYMHKSQC--IE-----------------RDALKN----VLREMEILT 53 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~------~~~~~avK~~~~~~~--~~-----------------~~~~~~----~~~e~~~l~ 53 (246)
||.|.- +.||.+.... .+..+|+|+++-... .. ...... ..+|++.|+
T Consensus 5 i~~GKE---a~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 5 ISTGKE---SVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred cccCcc---eEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 677777 8999998653 358999999864211 00 011122 337999999
Q ss_pred hCCCC--cceeeeeeeeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHH-HHCCcccCCCC
Q psy7592 54 TLEHP--FLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYL-KTKHIIHRDIK 130 (246)
Q Consensus 54 ~l~h~--~iv~~~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L-h~~~~~h~~i~ 130 (246)
++... ++++++++ ..-++|||++.+..+.....+.. .++......+..|++.++..+ |..|++|||++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 99654 44555553 34578999996654432222211 224556677788999999988 89999999999
Q ss_pred CCcEEEcCCCCeEEeecceeeeec
Q psy7592 131 PDNILLDEEGHAHITDFNIATVLE 154 (246)
Q Consensus 131 ~~nil~~~~~~~~l~d~~~~~~~~ 154 (246)
+.||+++ ++.+.++||+.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999996 5689999999876644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.9e-14 Score=116.33 Aligned_cols=227 Identities=20% Similarity=0.240 Sum_probs=165.4
Q ss_pred cCC--CCccCeeeEEEEEe--cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEE
Q psy7592 3 CGS--SKFCGTSKVCIVQK--KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 3 lg~--g~~~~~~~v~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
+|. |.+ |.+|..+- ..++..+|+|.-+...- .+..-..-.+|+..-.+. .|++.++.+..+..++..++-+
T Consensus 122 ~g~~~g~~---~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt 197 (524)
T KOG0601|consen 122 TGSLPGSK---GSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT 197 (524)
T ss_pred cccCCCCC---ceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence 355 555 89999888 78999999998543321 111123334566666666 4999999999999999999999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHH----HHHHHHHCCcccCCCCCCcEEEcCC-CCeEEeecceeee
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGL----ALDYLKTKHIIHRDIKPDNILLDEE-GHAHITDFNIATV 152 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~----~l~~Lh~~~~~h~~i~~~nil~~~~-~~~~l~d~~~~~~ 152 (246)
|.+ +.+|..++..... -++...++..+.+... |+..+|+.+++|-+++|.|++...+ ..++++||+....
T Consensus 198 E~~-~~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 198 ELC-GESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred ccc-cchhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 998 7888888876433 2488889999999999 9999999999999999999999999 7899999999988
Q ss_pred eccCccccc------cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCC
Q psy7592 153 LEENQLATS------MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPV 226 (246)
Q Consensus 153 ~~~~~~~~~------~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (246)
+.+...... ..+...|.+||...+. ++...|+|++|-++.+...+..+........=.+..... -+.
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l------~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~ 345 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGL------ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPL 345 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhccc------cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cch
Confidence 876553222 1456679999998776 588999999999999998887765433222211111111 122
Q ss_pred CCCCCCCHhHHHHHHHhhh
Q psy7592 227 HYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 227 ~~~~~~s~~l~~li~~~l~ 245 (246)
++-..-+.+++..+.+|++
T Consensus 346 e~~~~~s~~l~~~~~~~~d 364 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLD 364 (524)
T ss_pred hhhcCcchhhhhHHHHhcC
Confidence 2223456666667776653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-12 Score=96.89 Aligned_cols=124 Identities=19% Similarity=0.225 Sum_probs=89.7
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcce-eeeeeeeeCCeEEEEEeecC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLV-NLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~v~e~~~ 81 (246)
+++|.. +.||+++.. ++.|++|....... ....+..|+..++.+.+.+++ +++... ....++|||+++
T Consensus 6 l~~G~~---~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~ 74 (170)
T cd05151 6 LKGGMT---NKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE 74 (170)
T ss_pred cCCccc---CceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence 455655 899999874 78899998765431 123456788888888655544 444443 223578999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCc-----ccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHI-----IHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~-----~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
|.++.... . . ....+.++..++..||+.++ +|+|++|+||+++ ++.++++||+.+.
T Consensus 75 G~~l~~~~-----~-----~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTED-----F-----S---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCcccccc-----c-----c---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 98875430 0 1 12345789999999999985 9999999999998 6689999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.2e-11 Score=89.49 Aligned_cols=135 Identities=19% Similarity=0.221 Sum_probs=97.8
Q ss_pred eeEEEEEecCCCcEEEEEEee-----ccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC-CCh
Q psy7592 12 SKVCIVQKKDTKQMYAMKYMH-----KSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG-GDL 85 (246)
Q Consensus 12 ~~v~~~~~~~~~~~~avK~~~-----~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~-~sL 85 (246)
+.|+++.. .|+.++||.=. .+.....-..++..+|++.+.++.--+|.-..-++.+...-.++|||++| .++
T Consensus 21 Arv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~v 98 (229)
T KOG3087|consen 21 ARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTV 98 (229)
T ss_pred eeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHH
Confidence 67777666 68888887632 22221222235567899999999776777666677777777899999977 467
Q ss_pred HHHHhhccccccCCCChHH-HHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC---CeEEeecceeee
Q psy7592 86 RYHITQDIKFYSVGTRNDT-IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG---HAHITDFNIATV 152 (246)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~-~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~---~~~l~d~~~~~~ 152 (246)
.+++...-.- ..++. ....+.++-..+.-||..+++||||+.+||++..++ .+.++|||++..
T Consensus 99 k~~i~~~~~~----~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 99 KDFILSTMED----ESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred HHHHHHHccC----cccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 7777654221 12222 367778888889999999999999999999997666 358999998764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.4e-11 Score=86.93 Aligned_cols=133 Identities=16% Similarity=0.147 Sum_probs=96.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHH-----HHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDA-----LKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
++++|.- +.++.+.. -|..+++|.=.+..+..++. .++-.+|++++.++.--+|....-+..+.....++
T Consensus 3 ~i~~GAE---a~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~ 77 (204)
T COG3642 3 LIKQGAE---AIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIV 77 (204)
T ss_pred hhhCCcc---eeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEE
Confidence 4556666 77777744 35556666533333322221 24456799999999877777766677777777899
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
|||.+|..|.+.+... . ..++..+-..+.-||..|++|||++++|+.++..+ +.++|||++..
T Consensus 78 me~I~G~~lkd~l~~~--------~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA--------R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc--------c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999999888653 1 23445556667789999999999999999996554 99999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.1e-10 Score=83.87 Aligned_cols=128 Identities=18% Similarity=0.128 Sum_probs=81.7
Q ss_pred EEEEEecCCCcEEEEEEeecccc-----------------------chHHHHHHHHHHHHHHhhCCCCc--ceeeeeeee
Q psy7592 14 VCIVQKKDTKQMYAMKYMHKSQC-----------------------IERDALKNVLREMEILTTLEHPF--LVNLWFCFQ 68 (246)
Q Consensus 14 v~~~~~~~~~~~~avK~~~~~~~-----------------------~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~ 68 (246)
||.+... +|..+|+|..+.... ..........+|++.|+++...+ +++++++
T Consensus 2 Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 2 VYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred EEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 7888874 688999999865211 11112345678999999998764 4555543
Q ss_pred eCCeEEEEEeecC--CCChHHHHhhccccccCCCChHHHHHHHHHHHHHH-HHHHHCCcccCCCCCCcEEEcCCCCeEEe
Q psy7592 69 DEEDLFMVSDLLL--GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLAL-DYLKTKHIIHRDIKPDNILLDEEGHAHIT 145 (246)
Q Consensus 69 ~~~~~~~v~e~~~--~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l-~~Lh~~~~~h~~i~~~nil~~~~~~~~l~ 145 (246)
.+ -++||||++ |..+........ .......++.+++..+ ..+|..|++|||+++.||+++++ .+.++
T Consensus 79 ~~--~~ivME~I~~~G~~~~~l~~~~~-------~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 79 NR--NVIVMEYIGEDGVPLPRLKDVDL-------SPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ET--TEEEEE--EETTEEGGCHHHCGG-------GGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred eC--CEEEEEecCCCccchhhHHhccc-------cchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence 22 368999997 666655443221 1334556667777744 44689999999999999999877 99999
Q ss_pred ecceeeeec
Q psy7592 146 DFNIATVLE 154 (246)
Q Consensus 146 d~~~~~~~~ 154 (246)
||+.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=9.8e-10 Score=86.56 Aligned_cols=134 Identities=13% Similarity=0.066 Sum_probs=94.0
Q ss_pred EEEEEecCCCcEEEEEEeeccccch-HH-------HHHHHHHHHHHHhhCCCCcceee--eeeeee-----CCeEEEEEe
Q psy7592 14 VCIVQKKDTKQMYAMKYMHKSQCIE-RD-------ALKNVLREMEILTTLEHPFLVNL--WFCFQD-----EEDLFMVSD 78 (246)
Q Consensus 14 v~~~~~~~~~~~~avK~~~~~~~~~-~~-------~~~~~~~e~~~l~~l~h~~iv~~--~~~~~~-----~~~~~~v~e 78 (246)
|.++.. .|+.|.+|......+.. .. ....+.+|.+.+.++...+|... ..+.+. ....++|+|
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 445543 57889999875543211 00 01137789999988865555433 334432 234789999
Q ss_pred ecCCC-ChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC-------CCCeEEeeccee
Q psy7592 79 LLLGG-DLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE-------EGHAHITDFNIA 150 (246)
Q Consensus 79 ~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~-------~~~~~l~d~~~~ 150 (246)
++++. +|.+++..... .+.+......++.++...+..||..|++|+|++++||+++. +..+.++||+.+
T Consensus 116 ~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 116 DLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred eCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99876 89888754211 12355667789999999999999999999999999999975 457899999977
Q ss_pred ee
Q psy7592 151 TV 152 (246)
Q Consensus 151 ~~ 152 (246)
..
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 53
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.8e-10 Score=87.60 Aligned_cols=137 Identities=16% Similarity=0.196 Sum_probs=90.4
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCc--ceeeeeeeeeCC---eEEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPF--LVNLWFCFQDEE---DLFMVS 77 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~---~~~~v~ 77 (246)
+|.|.. +.+|+++.. +|+.|++|........ ....++..|++.++.+++.+ +.+++.+..... ..+++|
T Consensus 6 l~~G~~---n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 6 LSGGQS---NLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred cCCCcc---ceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 566666 899999875 3689999998654321 12456788999999997544 466666665532 568999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH------------------------------------
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT------------------------------------ 121 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~------------------------------------ 121 (246)
|+++|.++...... ..++......++.+++..+..||+
T Consensus 80 e~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 80 ERVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred EEeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 99998887654321 001222333333333333333331
Q ss_pred --------------------CCcccCCCCCCcEEEcC--CCCeEEeecceee
Q psy7592 122 --------------------KHIIHRDIKPDNILLDE--EGHAHITDFNIAT 151 (246)
Q Consensus 122 --------------------~~~~h~~i~~~nil~~~--~~~~~l~d~~~~~ 151 (246)
..++|+|+.|+||+++. ++.+.++||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 34789999999999988 5667899999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.8e-11 Score=100.20 Aligned_cols=188 Identities=20% Similarity=0.212 Sum_probs=134.5
Q ss_pred cCCCCccCeeeEEEEEec-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 3 CGSSKFCGTSKVCIVQKK-DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
||.+.+ +.|+.+.-. .++..|++|-.........+.+..+ .|+-+...+ .|.+.+.++..|.+.+..++--||+
T Consensus 273 i~~~~~---~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl-~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 273 ISDGNF---SSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSL-GEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred ccCCcc---ccceeeeecCCCCceEeChhhhccccchHhhhcch-hhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 677777 455554433 6899999998877665554443333 344445555 5999999999999988888889999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC-CCeEEeecceeeeeccCccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE-GHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~ 159 (246)
.++++......... +.+..++....|++.++.++|+..++|.|++|+||++..+ +..++.|++....+.... .
T Consensus 349 ~~~s~~l~~~~~~~-----~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-~ 422 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQM-----LDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-G 422 (524)
T ss_pred cCcchhhhhHHHHh-----cCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec-c
Confidence 99887766633223 3778899999999999999999999999999999999886 677888988876522111 1
Q ss_pred cccccCCCc-cCCceecccccccCCCCcchhHHHHHHHHHHHHhCCC
Q psy7592 160 TSMSGTKPY-IAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205 (246)
Q Consensus 160 ~~~~~~~~~-~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~ 205 (246)
.....+..| .++...... .+..+.|++|||.-+.+..++..
T Consensus 423 ~~~~~~r~~p~~~~~~e~~-----~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 423 VFHHIDRLYPIAEILLEDY-----PHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred cccccccccccchhhcccc-----ccccccccccccccccccccCcc
Confidence 111122223 233333333 36778999999999988888765
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.4e-11 Score=107.81 Aligned_cols=226 Identities=25% Similarity=0.375 Sum_probs=154.5
Q ss_pred CccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCCCChH
Q psy7592 7 KFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR 86 (246)
Q Consensus 7 ~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~sL~ 86 (246)
..+.++.++.+....+|...+.|+.....-...-..+....+-...-...+|.++.....+......+++++|+.+++|.
T Consensus 813 qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~ 892 (1205)
T KOG0606|consen 813 QSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLP 892 (1205)
T ss_pred cCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCch
Confidence 33444777777777677656655543322100000111222222222223466666555566778899999999999998
Q ss_pred HHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec------------
Q psy7592 87 YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE------------ 154 (246)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~------------ 154 (246)
..+.+.+.. ..+........+..++++||...+.|++++|.+.+...++...+.+++......
T Consensus 893 Skl~~~~~~-----saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~ 967 (1205)
T KOG0606|consen 893 SKLHNSGCL-----SAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPS 967 (1205)
T ss_pred hhhhcCCCc-----ccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCccccc
Confidence 888775533 444555566677788999999999999999999999999999999987322210
Q ss_pred ---------cC-----------ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc
Q psy7592 155 ---------EN-----------QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS 214 (246)
Q Consensus 155 ---------~~-----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~ 214 (246)
.. .......+++.|.+||...+.. .....|.|+.|+++++.++|.+||.. ...
T Consensus 968 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-----hgs~ad~~~~g~~l~e~l~g~pp~na--~tp 1040 (1205)
T KOG0606|consen 968 SSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-----HGSAADWWSSGVCLFEVLTGIPPFNA--ETP 1040 (1205)
T ss_pred ccCccccccccccccccccchhhccccccCCCcccCCccccccc-----CCCcchhhhhhhhhhhhhcCCCCCCC--cch
Confidence 00 0011133678899999998876 67789999999999999999999963 344
Q ss_pred HHHHHhhhcCCCCCCC---CCCHhHHHHHHHhh
Q psy7592 215 VKDVKAIIYSPVHYPT---AWSESTKHLLSQVH 244 (246)
Q Consensus 215 ~~~~~~~~~~~~~~~~---~~s~~l~~li~~~l 244 (246)
.+.+..+.....++|. ..++..++++...|
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll 1073 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLL 1073 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhh
Confidence 4556777777777764 57999999988765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.9e-10 Score=91.62 Aligned_cols=138 Identities=14% Similarity=0.182 Sum_probs=106.7
Q ss_pred EEEEEeecCCCC-hHHHHhhccccccCC-CChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeeccee
Q psy7592 73 LFMVSDLLLGGD-LRYHITQDIKFYSVG-TRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA 150 (246)
Q Consensus 73 ~~~v~e~~~~~s-L~~~~~~~~~~~~~~-~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~ 150 (246)
.-+.|..+.|.. +.++.....+..+.+ ...+.+..+...++.+...||..|.+-||++++|+++++++.+.+.|-+..
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 667777776552 344443332222333 477889999999999999999999999999999999999999999987766
Q ss_pred eeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCC
Q psy7592 151 TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILAR-GRPFDIH 210 (246)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g-~~p~~~~ 210 (246)
..-.++.......+...|++||.-.-.....-+.+.++|.|.||+++++++.| .+||.+-
T Consensus 165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 55555666677788999999998764443344467899999999999999986 8899654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2e-09 Score=91.68 Aligned_cols=144 Identities=16% Similarity=0.146 Sum_probs=93.2
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc---------------------------hHHHH----------HHH
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI---------------------------ERDAL----------KNV 45 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~---------------------------~~~~~----------~~~ 45 (246)
+++++. |+||+|+.+ +|+.||||+.++.-.. -.+.+ =++
T Consensus 133 iAsASI---aQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 133 IASASI---AQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred hhhhhH---hhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence 345666 899999997 4999999998773211 00011 123
Q ss_pred HHHHHHHhhCC-----CCcceeeeeeeeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHH
Q psy7592 46 LREMEILTTLE-----HPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLK 120 (246)
Q Consensus 46 ~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh 120 (246)
.+|+..+.+++ .+++.-..=+++-.....++|||++|..+.+...... .+.+...+.....+++ ++.+-
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~k~ia~~~~~~f--~~q~~ 282 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDRKELAELLVRAF--LRQLL 282 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCHHHHHHHHHHHH--HHHHH
Confidence 45666666552 3444333333333455789999999999988853221 1123233333222222 45555
Q ss_pred HCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 121 TKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 121 ~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
..|++|+|.+|.|++++.+|.+.+.|||+.......
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 689999999999999999999999999998876543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.2e-08 Score=77.73 Aligned_cols=126 Identities=18% Similarity=0.174 Sum_probs=90.8
Q ss_pred CCcEEEEEEeeccccch----HHHHHHHHHHHHHHhhCCCCcce--eeeeeeeeC----CeEEEEEeecCCC-ChHHHHh
Q psy7592 22 TKQMYAMKYMHKSQCIE----RDALKNVLREMEILTTLEHPFLV--NLWFCFQDE----EDLFMVSDLLLGG-DLRYHIT 90 (246)
Q Consensus 22 ~~~~~avK~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv--~~~~~~~~~----~~~~~v~e~~~~~-sL~~~~~ 90 (246)
.++.|.+|........+ .-......+|.+.+..|...+|. +++.+.+.. ...++|+|.+++. +|.+.+.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 46667777543322111 11234677888888888655443 444555442 2358899999874 7998887
Q ss_pred hccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC---CeEEeecceeee
Q psy7592 91 QDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG---HAHITDFNIATV 152 (246)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~---~~~l~d~~~~~~ 152 (246)
..... +......++.++...+.-||..|++|+|+++.|||++.++ .+.++||+.+..
T Consensus 111 ~~~~~-----~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 111 QWEQL-----DPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hhccc-----chhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 63332 5666788899999999999999999999999999999887 789999997765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=2e-08 Score=75.53 Aligned_cols=138 Identities=16% Similarity=0.149 Sum_probs=95.7
Q ss_pred cCeeeEEEEEecCCCcEEEEEEeeccccch---HHHHHHHHHHHHHHhhCCCCcce--eeeeeee-e----CCeEEEEEe
Q psy7592 9 CGTSKVCIVQKKDTKQMYAMKYMHKSQCIE---RDALKNVLREMEILTTLEHPFLV--NLWFCFQ-D----EEDLFMVSD 78 (246)
Q Consensus 9 ~~~~~v~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv--~~~~~~~-~----~~~~~~v~e 78 (246)
||-+.|+..... |+.|-+|........+ +--...+.+|...+++|...++. ++. ++. . ...-++|+|
T Consensus 29 gG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 29 NGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEE
Confidence 344788887763 4478899875222111 11236788999999999654443 333 221 1 223688899
Q ss_pred ecCC-CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC--eEEeecceeee
Q psy7592 79 LLLG-GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH--AHITDFNIATV 152 (246)
Q Consensus 79 ~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~--~~l~d~~~~~~ 152 (246)
-+.| .+|.+.+..... .+.+......++.++..++.-||+.|+.|+|+.+.||+++.++. +.++||.-++.
T Consensus 106 ~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 7743 588888755321 12366667789999999999999999999999999999986676 89999997654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.2e-08 Score=76.45 Aligned_cols=133 Identities=18% Similarity=0.099 Sum_probs=91.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeecccc-----------------ch--HHHHHHHHHHHHHHhhCCCC--cc
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC-----------------IE--RDALKNVLREMEILTTLEHP--FL 60 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-----------------~~--~~~~~~~~~e~~~l~~l~h~--~i 60 (246)
.||-|.- +.||.+.+. .|.++|+|.=+.... .+ .-......+|.+.|++|... .+
T Consensus 98 ~IGvGKE---sdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 98 KIGVGKE---SDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred ccccCcc---ceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4778888 899999986 699999997432110 00 11234567899999999654 55
Q ss_pred eeeeeeeeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC
Q psy7592 61 VNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG 140 (246)
Q Consensus 61 v~~~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~ 140 (246)
.+.++ .+.-.+|||+.+|..|...-. .......++..|+..+...-..|++|||+++-||+++++|
T Consensus 174 P~P~~----~nRHaVvMe~ieG~eL~~~r~----------~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 174 PKPIA----WNRHAVVMEYIEGVELYRLRL----------DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCccc----cccceeeeehcccceeecccC----------cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC
Confidence 55543 345678999998877754431 1222233334444444444489999999999999999999
Q ss_pred CeEEeecceeee
Q psy7592 141 HAHITDFNIATV 152 (246)
Q Consensus 141 ~~~l~d~~~~~~ 152 (246)
.+.++||.-+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999986654
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.86 E-value=7.8e-10 Score=94.60 Aligned_cols=131 Identities=16% Similarity=0.287 Sum_probs=95.0
Q ss_pred HHHHHHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc----------cccCCCccCCceecccc
Q psy7592 110 FELGLALDYLKTK-HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS----------MSGTKPYIAPEIFLVAT 178 (246)
Q Consensus 110 ~qi~~~l~~Lh~~-~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~----------~~~~~~~~aPE~~~~~~ 178 (246)
.+...++.++|.. ++||++|.|++|.++.++.+|+++|+++........... ......|.|||++.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 3555889999955 799999999999999999999999998866544222111 11344699999998754
Q ss_pred cccCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCccHHHHHhhhcC--CCCCCCCCCHhHHHHHHHhhh
Q psy7592 179 DEVLGYSYSVDWWSLGVTLFEIL-ARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 179 ~~~~~~~~~~Di~slG~~l~~ll-~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~l~~li~~~l~ 245 (246)
.++++|+||+|+++|.+. .|+.-+...+.....-......+ ....+.+++.++++=++++|+
T Consensus 186 -----~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 186 -----NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred -----ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhc
Confidence 788999999999999998 56666665554443333333332 444557788888888887764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.86 E-value=6.2e-08 Score=73.16 Aligned_cols=118 Identities=14% Similarity=0.156 Sum_probs=74.8
Q ss_pred cCCCcEEEEEEeeccccchHHHHHH------HHHHHHHHhhCC---CCcceeeeeeeee-----CCeEEEEEeecCCCCh
Q psy7592 20 KDTKQMYAMKYMHKSQCIERDALKN------VLREMEILTTLE---HPFLVNLWFCFQD-----EEDLFMVSDLLLGGDL 85 (246)
Q Consensus 20 ~~~~~~~avK~~~~~~~~~~~~~~~------~~~e~~~l~~l~---h~~iv~~~~~~~~-----~~~~~~v~e~~~~~sL 85 (246)
.-+|+.|++|..+......+..... ..+.+....+++ ......++.+.+- ....+++|||++|..|
T Consensus 51 ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l 130 (229)
T PF06176_consen 51 EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVEL 130 (229)
T ss_pred EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeec
Confidence 3468899999887654322222211 223444444443 2333343433332 2345789999999988
Q ss_pred HHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 86 RYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
.+...- +++ +...+..++..+|+.|++|||.+|+|++++++ .+.++|++...
T Consensus 131 ~d~~~i---------~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 131 NDIEDI---------DED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred ccchhc---------CHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 765421 221 33456677899999999999999999999855 59999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.4e-07 Score=80.50 Aligned_cols=141 Identities=16% Similarity=0.175 Sum_probs=87.7
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc----------------------------hHHHHHH------HHHH
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI----------------------------ERDALKN------VLRE 48 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~----------------------------~~~~~~~------~~~e 48 (246)
||..+. +.|++|+.+. |+.||||+.++.--. -++..+. +.+|
T Consensus 169 iaaASl---aQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 169 IAAASL---AQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred hhhcch---hheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 456667 8999999985 999999998763211 0111111 2234
Q ss_pred HHHHhhC----CCCc------ceeeeeeeeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHH-HH
Q psy7592 49 MEILTTL----EHPF------LVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLA-LD 117 (246)
Q Consensus 49 ~~~l~~l----~h~~------iv~~~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~-l~ 117 (246)
++...+. .|-+ |.++|- .-.....++|||++|..+.+.-.-. +...+...+. ..+.++ ++
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~----~~gi~~~~i~---~~l~~~~~~ 315 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAID----KRGISPHDIL---NKLVEAYLE 315 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHH----HcCCCHHHHH---HHHHHHHHH
Confidence 3333333 2333 333322 2234578999999999877664322 1222444333 333333 45
Q ss_pred HHHHCCcccCCCCCCcEEEcC----CCCeEEeecceeeeeccC
Q psy7592 118 YLKTKHIIHRDIKPDNILLDE----EGHAHITDFNIATVLEEN 156 (246)
Q Consensus 118 ~Lh~~~~~h~~i~~~nil~~~----~~~~~l~d~~~~~~~~~~ 156 (246)
.+-..|++|+|-+|.||+++. ++.+.+.|+|+.......
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 556789999999999999984 558999999998776543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.6e-07 Score=64.39 Aligned_cols=125 Identities=19% Similarity=0.180 Sum_probs=91.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcce-eeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLV-NLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~v~e~~ 80 (246)
+|++|+. |.||++.. .|..+|+|+-+.++ ....+..|++++..++-.++. ++|.+-.+ ++.|||.
T Consensus 29 ~L~KG~~---s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i 94 (201)
T COG2112 29 ELAKGTT---SVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI 94 (201)
T ss_pred hhhcccc---cEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence 4788888 99999998 57789999887754 357788999999999866654 45554332 3449999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCC-CCCcEEEcCCCCeEEeecceeee
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI-KPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i-~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
.|.+|....... +..++. .+++....|-..||-|+.| .|...++..++.+.|+||..++.
T Consensus 95 ~G~~L~~~~~~~--------~rk~l~----~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG--------DRKHLL----RVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc--------cHHHHH----HHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 998887665432 222333 3445566678889999999 56666666666999999998874
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.7e-06 Score=66.88 Aligned_cols=136 Identities=13% Similarity=0.129 Sum_probs=80.3
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCc--ceeeeeeeeeCCeEEEEEeec
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPF--LVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~v~e~~ 80 (246)
+|+|.. +.||+. .+..+++|...... . .....+|++.++.+..-+ +.+.+.+..+.....++||++
T Consensus 9 i~~G~t---~~~y~~----~~~~~VlR~~~~~~--~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i 76 (226)
T TIGR02172 9 TGEGGN---GESYTH----KTGKWMLKLYNPGF--D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI 76 (226)
T ss_pred ecCCCC---cceeEe----cCCCEEEEeCCCCC--C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence 566766 788873 25567899886532 1 234677999999986443 467788887777888999999
Q ss_pred CCCC-hHHHHh--------------hc-cccccC---CCChHHH-HHHHHHH----------HHH-HHHHH----HCCcc
Q psy7592 81 LGGD-LRYHIT--------------QD-IKFYSV---GTRNDTI-HLYAFEL----------GLA-LDYLK----TKHII 125 (246)
Q Consensus 81 ~~~s-L~~~~~--------------~~-~~~~~~---~~~~~~~-~~~~~qi----------~~~-l~~Lh----~~~~~ 125 (246)
+|.. +..... .. ...... ..+.... ..+..++ ... ..+|. ...++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 8863 211111 00 001111 1111110 0110011 111 12222 12378
Q ss_pred cCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 126 HRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 126 h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
|+|+.|.|++++.++ +.++||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.5e-06 Score=66.55 Aligned_cols=140 Identities=14% Similarity=0.117 Sum_probs=91.1
Q ss_pred CCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHH----------------HH-----HHHHHHHHhhCCCCcc--
Q psy7592 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDAL----------------KN-----VLREMEILTTLEHPFL-- 60 (246)
Q Consensus 4 g~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~----------------~~-----~~~e~~~l~~l~h~~i-- 60 (246)
|..+.|--+.||.+.. .++..+|+|+++.....-.... ++ ..+|...|+++...++
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 4444444479999887 4699999999976432211100 01 2356677777643333
Q ss_pred eeeeeeeeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCC
Q psy7592 61 VNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEE 139 (246)
Q Consensus 61 v~~~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~ 139 (246)
.+.+.+. .-.+|||++.... ...+.+...+++......+..+++..+.-|-. .|+||+||+.-|||+. +
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g-----~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDG-----LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-D 202 (268)
T ss_pred CCceeec----CCeEEEEeccCCC-----CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-C
Confidence 3333332 2468999994332 22233334444444677777888888777755 8999999999999998 8
Q ss_pred CCeEEeecceeeeec
Q psy7592 140 GHAHITDFNIATVLE 154 (246)
Q Consensus 140 ~~~~l~d~~~~~~~~ 154 (246)
+.+.++|++-+....
T Consensus 203 ~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 GEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEECccccccC
Confidence 899999999876544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.43 E-value=5.8e-06 Score=64.66 Aligned_cols=69 Identities=14% Similarity=0.053 Sum_probs=48.9
Q ss_pred eeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeecCCCChHHH
Q psy7592 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYH 88 (246)
Q Consensus 12 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~sL~~~ 88 (246)
..||++... +..+++|...... ...+.+|++.++.+. +--+.+++.+...++..++||++++|.++...
T Consensus 13 ~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 13 ATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 689999764 4678888776542 234566888887773 44455677777666667899999999887654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.4e-05 Score=60.46 Aligned_cols=75 Identities=17% Similarity=0.196 Sum_probs=51.0
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCC--cceeeeeeee---eCCeEEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHP--FLVNLWFCFQ---DEEDLFMVS 77 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~---~~~~~~~v~ 77 (246)
+++|.. +.||.+.... ..+++|..... .....+.+|+.+++.+... .+.+++.... .....+++|
T Consensus 5 l~~G~~---n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 5 LSGGFS---NRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEESSS---SEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CCCCCe---eeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 455555 7899999864 58999987654 2345667788888888533 3455665332 334578999
Q ss_pred eecCCCChHH
Q psy7592 78 DLLLGGDLRY 87 (246)
Q Consensus 78 e~~~~~sL~~ 87 (246)
++++|..+..
T Consensus 75 ~~i~g~~~~~ 84 (239)
T PF01636_consen 75 EYIPGRPLDD 84 (239)
T ss_dssp EEESSEEHHH
T ss_pred EEeccccccc
Confidence 9999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.4e-05 Score=57.75 Aligned_cols=99 Identities=20% Similarity=0.182 Sum_probs=76.7
Q ss_pred HHHHHHHhhCCC-CcceeeeeeeeeCCeEEEEEeecCCCChHHH---HhhccccccCCCChHHHHHHHHHHHHHHHHHHH
Q psy7592 46 LREMEILTTLEH-PFLVNLWFCFQDEEDLFMVSDLLLGGDLRYH---ITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT 121 (246)
Q Consensus 46 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~v~e~~~~~sL~~~---~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~ 121 (246)
..|.-+++.+++ ++++++++.|- .+++.|+...+++... +... ...++..+..++.+++..+.+++.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~-----~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQF-----LQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccc-----cccCHHHHHHHHHHHHHHHHHHhc
Confidence 347888888975 69999999983 3578899876655321 1111 112888999999999999999987
Q ss_pred ---CCcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 122 ---KHIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 122 ---~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
..+.-.|++++|+-+++++.++++|++.....
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 34777999999999999999999999976543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.12 E-value=0.00013 Score=54.91 Aligned_cols=132 Identities=15% Similarity=0.211 Sum_probs=88.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeecccc-------------chHHHHHHHHHHHHHHhhCC------CCccee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC-------------IERDALKNVLREMEILTTLE------HPFLVN 62 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-------------~~~~~~~~~~~e~~~l~~l~------h~~iv~ 62 (246)
+||+|+. -.+|. -..+...+||+.+.... ......++..+|+.....+. +.+|.+
T Consensus 8 ~i~~G~~---R~cy~---HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 8 LIAQGGE---RDCYQ---HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred ccccCCC---ceEEE---CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 4566666 45555 33566668999887650 01122456666777776666 789999
Q ss_pred eeeeeeeCCeEEEEEeecC------CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE
Q psy7592 63 LWFCFQDEEDLFMVSDLLL------GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL 136 (246)
Q Consensus 63 ~~~~~~~~~~~~~v~e~~~------~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~ 136 (246)
+++..+.+....+|+|... ..+|.+++.... ++. .+. ..+-.-.++|-+.+|+.+|++|+||++
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~------~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG------LTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVV 151 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC------ccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEE
Confidence 9999999888889998864 235777774432 133 333 333344578889999999999999999
Q ss_pred cCCC----CeEEee-cce
Q psy7592 137 DEEG----HAHITD-FNI 149 (246)
Q Consensus 137 ~~~~----~~~l~d-~~~ 149 (246)
..+. .+.++| ||.
T Consensus 152 ~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EecCCCceEEEEEeCCCC
Confidence 6443 466676 553
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.11 E-value=4.6e-05 Score=69.87 Aligned_cols=72 Identities=15% Similarity=0.285 Sum_probs=48.9
Q ss_pred eeEEEEEecCCC--cEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcc--eeeeeeeeeC---CeEEEEEeecCCC
Q psy7592 12 SKVCIVQKKDTK--QMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFL--VNLWFCFQDE---EDLFMVSDLLLGG 83 (246)
Q Consensus 12 ~~v~~~~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~~v~e~~~~~ 83 (246)
..+|++.....+ ..+++|+........ ....+.+|+++++.+. |+++ .+++.++.+. ...|+|||+++|.
T Consensus 52 n~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~ 129 (822)
T PLN02876 52 NPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGR 129 (822)
T ss_pred CceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCc
Confidence 788988765432 478888765432111 1246778999999995 6665 6677776654 3578999999886
Q ss_pred Ch
Q psy7592 84 DL 85 (246)
Q Consensus 84 sL 85 (246)
.+
T Consensus 130 ~~ 131 (822)
T PLN02876 130 IF 131 (822)
T ss_pred cc
Confidence 53
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.07 E-value=4e-05 Score=59.61 Aligned_cols=29 Identities=24% Similarity=0.470 Sum_probs=24.8
Q ss_pred CcccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 123 HIIHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 123 ~~~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
+++|+|+.+.|++++.++...++||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 48999999999999876656799999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.03 E-value=9.4e-07 Score=75.77 Aligned_cols=177 Identities=19% Similarity=0.208 Sum_probs=117.5
Q ss_pred CCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCc-ceeeeeeeeeCCeEEEEEeecCC
Q psy7592 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPF-LVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 4 g~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
+++.+ +++++.+...+...+ .+++... ....-++++|.+++||| .+..++-.+.+.+.++.++++.+
T Consensus 251 vK~al---tknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 251 VKGAL---TKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred HHHHh---cCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 45566 788888887766666 6666443 23445789999999999 66677777778889999999866
Q ss_pred C-ChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 83 G-DLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 83 ~-sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+ +-....... ...+...+...+...-.+++.++|+.--+|+| ||+.++ +..+..+++.............
T Consensus 319 ~rs~~~~~~~s----e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t 389 (829)
T KOG0576|consen 319 GRSSALEMTVS----EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRT 389 (829)
T ss_pred CccccccCChh----hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccccccc
Confidence 5 222111110 01112233344444555678888877667777 666544 6778888887766554434455
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP 206 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p 206 (246)
..+++.++|||...... +....|.|++|.-..++.-|-+|
T Consensus 390 ~~~~~~~~~pev~~~~~-----~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENT-----IDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred CCCCCCCCCchhhcccc-----cccCCCccCCCcchhhcCCCCCC
Confidence 67788999999876665 66678999999765566555554
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00016 Score=56.14 Aligned_cols=67 Identities=19% Similarity=0.271 Sum_probs=41.3
Q ss_pred eeEEEEEecC-CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcc-eeeeeeeeeCCeEEEEEeecCCCChH
Q psy7592 12 SKVCIVQKKD-TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFL-VNLWFCFQDEEDLFMVSDLLLGGDLR 86 (246)
Q Consensus 12 ~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~v~e~~~~~sL~ 86 (246)
..+|++.... .++.|++|....... ..-+..+|+..++.+...++ ++++..+. + .++|||++|.++.
T Consensus 12 N~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~l~ 80 (235)
T cd05157 12 NKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRTLE 80 (235)
T ss_pred ceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCcCC
Confidence 6899887543 367899997754321 11233468888888853333 44444332 2 3799999887763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00083 Score=52.95 Aligned_cols=131 Identities=14% Similarity=0.150 Sum_probs=71.7
Q ss_pred eeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcc-eeeeeeeeeCCeEEEEEeecCCCChHHH--
Q psy7592 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFL-VNLWFCFQDEEDLFMVSDLLLGGDLRYH-- 88 (246)
Q Consensus 12 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~v~e~~~~~sL~~~-- 88 (246)
..+|++.. +++.+++|...... ...--+..+|.+.++.+...++ .+++... . -++|+||++|..+...
T Consensus 10 n~~y~~~~--~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~~~ 80 (256)
T TIGR02721 10 NRSWRIEH--PGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLDQF 80 (256)
T ss_pred CCeEEEEe--CCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccccc
Confidence 68998873 57789999765432 1100134568888888854334 3333332 2 2689999988765421
Q ss_pred -----Hh----hcccccc-----CCCCh-HHHHHHHHHH---------HHHHHHHHH--------CCcccCCCCCCcEEE
Q psy7592 89 -----IT----QDIKFYS-----VGTRN-DTIHLYAFEL---------GLALDYLKT--------KHIIHRDIKPDNILL 136 (246)
Q Consensus 89 -----~~----~~~~~~~-----~~~~~-~~~~~~~~qi---------~~~l~~Lh~--------~~~~h~~i~~~nil~ 136 (246)
.. .-.+... .+... ..+..+..++ ...+..+.. ..++|+|+.|.|+++
T Consensus 81 ~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~ 160 (256)
T TIGR02721 81 VALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVV 160 (256)
T ss_pred cCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEE
Confidence 00 0001111 11111 1122222112 111222221 248999999999999
Q ss_pred cCCCCeEEeecceeee
Q psy7592 137 DEEGHAHITDFNIATV 152 (246)
Q Consensus 137 ~~~~~~~l~d~~~~~~ 152 (246)
+.++ +.++||..+..
T Consensus 161 ~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 161 TPQG-LKLIDWEYASD 175 (256)
T ss_pred eCCC-CEEEeccccCc
Confidence 8877 78999997754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0017 Score=52.29 Aligned_cols=133 Identities=18% Similarity=0.147 Sum_probs=73.5
Q ss_pred eeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCc--ceeeeee------eeeCCeEEEEEeecCCC
Q psy7592 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPF--LVNLWFC------FQDEEDLFMVSDLLLGG 83 (246)
Q Consensus 12 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~~v~e~~~~~ 83 (246)
..+|++.. ++..+++|..... +. ..+..|++.++.+.+.+ +.+++.. ...++..+.++++++|.
T Consensus 28 n~~y~v~~--~~~~~vLr~~~~~---~~---~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~ 99 (296)
T cd05153 28 NTNYFVTT--DSGRYVLTLFEKV---SA---EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGE 99 (296)
T ss_pred cceEEEEe--CCCcEEEEEcCCC---Ch---HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCC
Confidence 67888865 3457899988652 12 34555677777764332 3344321 12234568899999887
Q ss_pred ChHH----HHhhcc----cc----ccCCCC------hHHHH------------HHHHHHHHHHHHHHH-------CCccc
Q psy7592 84 DLRY----HITQDI----KF----YSVGTR------NDTIH------------LYAFELGLALDYLKT-------KHIIH 126 (246)
Q Consensus 84 sL~~----~~~~~~----~~----~~~~~~------~~~~~------------~~~~qi~~~l~~Lh~-------~~~~h 126 (246)
.+.. .....+ .+ .....+ ..-.. .....+..++..+.. .+++|
T Consensus 100 ~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~H 179 (296)
T cd05153 100 HLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIH 179 (296)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCc
Confidence 7532 111000 00 000000 00000 001112223344432 46999
Q ss_pred CCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 127 RDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 127 ~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
+|+.|.|++++.++.+.++||+.+..
T Consensus 180 gD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 180 ADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCcCcccEEEeCCceEEEeehhhhcC
Confidence 99999999999877778999997654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00014 Score=58.25 Aligned_cols=131 Identities=18% Similarity=0.138 Sum_probs=84.6
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccc--c---------------chHHHH--HHHHHHHHHHhhCCCCcc--e
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQ--C---------------IERDAL--KNVLREMEILTTLEHPFL--V 61 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~--~---------------~~~~~~--~~~~~e~~~l~~l~h~~i--v 61 (246)
||=|.- +.+|.+-+. .|++.++|.=+... + .+.-.+ -...+|...++.|..... +
T Consensus 100 IGVGKE---SDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVP 175 (465)
T KOG2268|consen 100 IGVGKE---SDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVP 175 (465)
T ss_pred cccccc---cceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCC
Confidence 344555 688998875 68888988632211 0 011111 234568888888854322 2
Q ss_pred eeeeeeeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC
Q psy7592 62 NLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH 141 (246)
Q Consensus 62 ~~~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~ 141 (246)
+.++ .+.-++|||++.|-.|.....-. ..+++ ...+..-+--|..+|++|||.+-=||++++++.
T Consensus 176 kpiD----~~RH~Vvmelv~g~Pl~~v~~v~--------d~~~l---y~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 176 KPID----HNRHCVVMELVDGYPLRQVRHVE--------DPPTL---YDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred Cccc----ccceeeHHHhhcccceeeeeecC--------ChHHH---HHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 3333 34578899999888776554211 22222 334444566788999999999999999999999
Q ss_pred eEEeecceeee
Q psy7592 142 AHITDFNIATV 152 (246)
Q Consensus 142 ~~l~d~~~~~~ 152 (246)
++++||.-...
T Consensus 241 i~vIDFPQmvS 251 (465)
T KOG2268|consen 241 IVVIDFPQMVS 251 (465)
T ss_pred EEEeechHhhc
Confidence 99999986543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0044 Score=50.23 Aligned_cols=31 Identities=35% Similarity=0.668 Sum_probs=27.2
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 122 KHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 122 ~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
.+++|+|+++.|++++.++...++||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 5799999999999999887778999998743
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0035 Score=52.48 Aligned_cols=76 Identities=17% Similarity=0.091 Sum_probs=49.0
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeecccc---ch-HHHHHHHHHHHHHHhhCC---CCcceeeeeeeeeCCeEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC---IE-RDALKNVLREMEILTTLE---HPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~---~~-~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~ 75 (246)
||+|.. ..||++.....++.++||.-.+... .+ +...++...|++.|+.+. -..+++++.+ +....++
T Consensus 34 lggGn~---N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 34 IGDGNL---NLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred cCCCce---EEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 466666 8999999864346899998542110 00 123456667888888763 2356667666 3455789
Q ss_pred EEeecCCC
Q psy7592 76 VSDLLLGG 83 (246)
Q Consensus 76 v~e~~~~~ 83 (246)
|||++++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99998753
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00058 Score=63.00 Aligned_cols=157 Identities=20% Similarity=0.178 Sum_probs=107.8
Q ss_pred HHHHHHHHHHhhCCCCcceeeeeeeeeCCeE----EEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHH
Q psy7592 43 KNVLREMEILTTLEHPFLVNLWFCFQDEEDL----FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDY 118 (246)
Q Consensus 43 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~----~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 118 (246)
.....|...+.+..|+|++.++.+-.++... .+..+++...++...+..-... +..+.+.+..++..++.+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i-----~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSI-----PLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcccc-----CHHHHHHHHHHHhhhHHH
Confidence 3344578888888999999998887654332 2345677777777777665544 888999999999999999
Q ss_pred HHHCCcccCCCCCC---cEEEcCCCCeEEe--ecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHH
Q psy7592 119 LKTKHIIHRDIKPD---NILLDEEGHAHIT--DFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSL 193 (246)
Q Consensus 119 Lh~~~~~h~~i~~~---nil~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~sl 193 (246)
+|+....|.-+..+ +.-.+..+..... ||+......+.........+..+.+||........ .+...|+|++
T Consensus 302 ~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~---~~r~~dL~~l 378 (1351)
T KOG1035|consen 302 LHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAK---KSRLTDLWCL 378 (1351)
T ss_pred HHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccch---hhhhhHHHHH
Confidence 99987666655555 2223334444444 78877766555444444455567778776554421 2334799999
Q ss_pred HHHHHHHHhCCCCC
Q psy7592 194 GVTLFEILARGRPF 207 (246)
Q Consensus 194 G~~l~~ll~g~~p~ 207 (246)
|.....+..|..+-
T Consensus 379 gll~~~~~~~~~i~ 392 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDIS 392 (1351)
T ss_pred HHHHhhhhhcCccc
Confidence 99999988876653
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0072 Score=49.23 Aligned_cols=31 Identities=29% Similarity=0.512 Sum_probs=26.3
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 122 KHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 122 ~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
.+++|+|+.|+|++++.+....++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3799999999999998665568999998754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0014 Score=53.02 Aligned_cols=68 Identities=18% Similarity=0.207 Sum_probs=42.9
Q ss_pred eeEEEEEecC------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcc-eeeeeeeeeCCeEEEEEeecCCCC
Q psy7592 12 SKVCIVQKKD------TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFL-VNLWFCFQDEEDLFMVSDLLLGGD 84 (246)
Q Consensus 12 ~~v~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~v~e~~~~~s 84 (246)
..+|++.... +++.|++|...... ....+..+|.+.++.+...++ .+++..+.+ ..|++|++|.+
T Consensus 12 N~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~G~~ 83 (302)
T cd05156 12 NAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIPSRT 83 (302)
T ss_pred ceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeCCCc
Confidence 5888887643 26889999976542 112345668888888753333 345555432 25789988877
Q ss_pred hHH
Q psy7592 85 LRY 87 (246)
Q Consensus 85 L~~ 87 (246)
+..
T Consensus 84 l~~ 86 (302)
T cd05156 84 LTT 86 (302)
T ss_pred CCH
Confidence 643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0036 Score=49.93 Aligned_cols=30 Identities=33% Similarity=0.691 Sum_probs=24.7
Q ss_pred CcccCCCCCCcEEEcCCCC-eEEeecceeee
Q psy7592 123 HIIHRDIKPDNILLDEEGH-AHITDFNIATV 152 (246)
Q Consensus 123 ~~~h~~i~~~nil~~~~~~-~~l~d~~~~~~ 152 (246)
.++|+|++|.|++++.++. ..++||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999987554 56999997753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0051 Score=46.30 Aligned_cols=122 Identities=19% Similarity=0.157 Sum_probs=76.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeec---ccc-------ch-H-------HHHHHHHHHHHHHhhCC---CCcc
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHK---SQC-------IE-R-------DALKNVLREMEILTTLE---HPFL 60 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~---~~~-------~~-~-------~~~~~~~~e~~~l~~l~---h~~i 60 (246)
+||.|.-- |.|++++- +|+.||+|.++. ... .. + ....-+..|-+...+|+ +.++
T Consensus 44 fLg~g~~~--~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~ 119 (207)
T PF13095_consen 44 FLGHGSHD--GYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGL 119 (207)
T ss_pred ecCCCCce--eEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCc
Confidence 46666663 68888887 688999999332 110 00 0 11233566777777774 4566
Q ss_pred --eeeeeeeeeC------------------CeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHH
Q psy7592 61 --VNLWFCFQDE------------------EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLK 120 (246)
Q Consensus 61 --v~~~~~~~~~------------------~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh 120 (246)
++.+++..-. ..+.+|.||.+... ..... -+.++..-+..+|
T Consensus 120 ~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 120 WAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred eEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccchh----HHHHHHHHHHHHH
Confidence 8888776311 12456666654332 01222 2346667778899
Q ss_pred HCCcccCCCCCCcEEEcCCCCeEEeeccee
Q psy7592 121 TKHIIHRDIKPDNILLDEEGHAHITDFNIA 150 (246)
Q Consensus 121 ~~~~~h~~i~~~nil~~~~~~~~l~d~~~~ 150 (246)
..||+.+|+++.|.. .-+++||+.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999986 4578898854
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0091 Score=49.08 Aligned_cols=141 Identities=16% Similarity=0.135 Sum_probs=88.7
Q ss_pred CCCCccCeeeEEEEEecCCCcEEEEEEeecccc--chH--------------------HHHHH-HHHHHHHHhhCCCCcc
Q psy7592 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC--IER--------------------DALKN-VLREMEILTTLEHPFL 60 (246)
Q Consensus 4 g~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~--------------------~~~~~-~~~e~~~l~~l~h~~i 60 (246)
|+-+-|-=.-||.|+.. +|..+|||+++-+.. .++ ..++- ...|++.|.+++..+|
T Consensus 150 GCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred cccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 44444333689998875 688899999864321 111 11111 3358888888877665
Q ss_pred eeeeeeeeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHH-HHCCcccCCCCCCcEEEcCC
Q psy7592 61 VNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYL-KTKHIIHRDIKPDNILLDEE 139 (246)
Q Consensus 61 v~~~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L-h~~~~~h~~i~~~nil~~~~ 139 (246)
.-.--+. -. .-.+||+++....-. .+.+...+++...+..+-.|++.-+.-| +..++||.||+--|+|+ -+
T Consensus 229 P~PePIl-Lk-~hVLVM~FlGrdgw~-----aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hd 300 (520)
T KOG2270|consen 229 PCPEPIL-LK-NHVLVMEFLGRDGWA-----APKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HD 300 (520)
T ss_pred CCCCcee-ee-cceEeeeeccCCCCc-----CcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-EC
Confidence 4322221 12 246899998422221 1222344456666777777777776666 56689999999999999 56
Q ss_pred CCeEEeecceeeee
Q psy7592 140 GHAHITDFNIATVL 153 (246)
Q Consensus 140 ~~~~l~d~~~~~~~ 153 (246)
|.+.++|.+-+...
T Consensus 301 G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEH 314 (520)
T ss_pred CEEEEEEccccccC
Confidence 68899998876554
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.018 Score=46.79 Aligned_cols=30 Identities=20% Similarity=0.370 Sum_probs=27.1
Q ss_pred CcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 123 HIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 123 ~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
+++|+|+.++|++++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999998999999997753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.011 Score=47.90 Aligned_cols=29 Identities=31% Similarity=0.529 Sum_probs=25.1
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 122 KHIIHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 122 ~~~~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
.+++|||+.++|++++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0079 Score=48.70 Aligned_cols=138 Identities=14% Similarity=0.187 Sum_probs=79.6
Q ss_pred eeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCC--cceeeeeeeeeCC--eEEEEEeecCCCChHH
Q psy7592 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHP--FLVNLWFCFQDEE--DLFMVSDLLLGGDLRY 87 (246)
Q Consensus 12 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~--~~~~v~e~~~~~sL~~ 87 (246)
..+|.+.+. ++.++++ . +..........+..+|.+.++.+.-- -....+.+|.++. ..++||+|.+|.....
T Consensus 39 n~t~~~~~~--~~~~vlR-~-P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~ 114 (321)
T COG3173 39 NDTFRLGDT--GQKYVLR-K-PPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS 114 (321)
T ss_pred cceEEEecC--CceEEEe-c-CCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence 355555553 8889999 3 22222234456777888888888432 3344556666555 5689999998732211
Q ss_pred ----------HHh-hcc----------c--c--ccCC--CChHHHHHHHHHH--------------HHHHHHHHHC----
Q psy7592 88 ----------HIT-QDI----------K--F--YSVG--TRNDTIHLYAFEL--------------GLALDYLKTK---- 122 (246)
Q Consensus 88 ----------~~~-~~~----------~--~--~~~~--~~~~~~~~~~~qi--------------~~~l~~Lh~~---- 122 (246)
+.. ... . . ...+ .....+..+..+. .....+++++
T Consensus 115 ~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~ 194 (321)
T COG3173 115 ALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPW 194 (321)
T ss_pred cCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCc
Confidence 111 000 0 0 0000 0111222233332 1124444443
Q ss_pred ----CcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 123 ----HIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 123 ----~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
.++|||+++.|++++..+-+-+.||+++..-
T Consensus 195 ~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 195 AGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 3899999999999999988999999988653
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.011 Score=48.65 Aligned_cols=74 Identities=16% Similarity=0.089 Sum_probs=45.1
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeecccc----chHHHHHHHHHHHHHHhhCC--CC-cceeeeeeeeeCCeEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC----IERDALKNVLREMEILTTLE--HP-FLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~~ 75 (246)
||.|.. ..||++.+...++.++||.-.+-.. ..+-...+..-|++.|+... .| .++++|.+ +.....+
T Consensus 3 igdGnl---N~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~ 77 (370)
T TIGR01767 3 VGDGNL---NLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVT 77 (370)
T ss_pred CCCCce---EEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cccccee
Confidence 577777 8999999854446899997542111 01222345556777777763 34 34455544 4445568
Q ss_pred EEeecC
Q psy7592 76 VSDLLL 81 (246)
Q Consensus 76 v~e~~~ 81 (246)
+||+++
T Consensus 78 vMEdL~ 83 (370)
T TIGR01767 78 VMEDLS 83 (370)
T ss_pred hHhhCc
Confidence 899884
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.02 Score=48.05 Aligned_cols=73 Identities=12% Similarity=0.057 Sum_probs=44.5
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeecccc-chH---HHHHHHHHHHHHHhhCC---CCcceeeeeeeeeCCeEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC-IER---DALKNVLREMEILTTLE---HPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~---~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~ 75 (246)
+|.|.. ..||++.+. +..|+||.-..... ... ....+-..|++.|+.+. ...+++++.++.+. .++
T Consensus 40 iggGn~---N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vl 112 (418)
T PLN02756 40 VGDGNL---NFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALI 112 (418)
T ss_pred cCCCce---eeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEE
Confidence 345555 899999873 45688997652111 011 12344444566666653 24777888877643 567
Q ss_pred EEeecCC
Q psy7592 76 VSDLLLG 82 (246)
Q Consensus 76 v~e~~~~ 82 (246)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999966
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.015 Score=47.98 Aligned_cols=133 Identities=16% Similarity=0.150 Sum_probs=74.5
Q ss_pred eeEEEEEecC----CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcce-eeeeeeeeCCeEEEEEeecCCCChH
Q psy7592 12 SKVCIVQKKD----TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLV-NLWFCFQDEEDLFMVSDLLLGGDLR 86 (246)
Q Consensus 12 ~~v~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~v~e~~~~~sL~ 86 (246)
..+|++.... +++.|++|...... . ..-+..+|..+++.+...++. ++++.+..+ .|.+|+++.++.
T Consensus 50 N~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~ 121 (344)
T PLN02236 50 NEVFQIKWPTKEGNLGRKVLVRIYGEGV---E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLS 121 (344)
T ss_pred ceeEEEEeCCCCCCCCCeEEEEEccCCC---C-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCC
Confidence 5788886432 34789999876542 1 122335688888888544443 555655433 478888777764
Q ss_pred HHHhhc-----------cccccC-------CCChHHHHHHHHHHH-----------------HHHHHH----H----HCC
Q psy7592 87 YHITQD-----------IKFYSV-------GTRNDTIHLYAFELG-----------------LALDYL----K----TKH 123 (246)
Q Consensus 87 ~~~~~~-----------~~~~~~-------~~~~~~~~~~~~qi~-----------------~~l~~L----h----~~~ 123 (246)
..-... .+.... +.....+..+..++. ..+..| . ...
T Consensus 122 ~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~ 201 (344)
T PLN02236 122 AADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIG 201 (344)
T ss_pred HHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCce
Confidence 221100 001111 111223333332221 111111 1 225
Q ss_pred cccCCCCCCcEEEcC-CCCeEEeecceeee
Q psy7592 124 IIHRDIKPDNILLDE-EGHAHITDFNIATV 152 (246)
Q Consensus 124 ~~h~~i~~~nil~~~-~~~~~l~d~~~~~~ 152 (246)
++|+|+.+.||++++ ++.+.++||..+..
T Consensus 202 ~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 202 FCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred EEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 899999999999986 46799999998764
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.00037 Score=66.16 Aligned_cols=175 Identities=10% Similarity=0.000 Sum_probs=112.4
Q ss_pred EEEEeeccccch--HHHHHHHHHHHHHHhhCCCCcceeeeeeeee--CCeEEEEEeecCCCChHHHHhhccccccCCCCh
Q psy7592 27 AMKYMHKSQCIE--RDALKNVLREMEILTTLEHPFLVNLWFCFQD--EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRN 102 (246)
Q Consensus 27 avK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~ 102 (246)
.+++++..+++. +-..+-...|.+..+...|+++...+.-... ...-+..++++.+|.+...+.+..+.+ .+...
T Consensus 1256 k~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~-~~ld~ 1334 (2724)
T KOG1826|consen 1256 KFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEES-PDLDR 1334 (2724)
T ss_pred EEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccC-Ccchh
Confidence 455554444322 1122334445556666789998877655543 334577889999999999998764431 12222
Q ss_pred HHHHHHHHHHHHHHHHHHHCC-----cccCCCCCCcEEEcCCCCeEEeecceeeee-ccCccccccccCCCccCCceecc
Q psy7592 103 DTIHLYAFELGLALDYLKTKH-----IIHRDIKPDNILLDEEGHAHITDFNIATVL-EENQLATSMSGTKPYIAPEIFLV 176 (246)
Q Consensus 103 ~~~~~~~~qi~~~l~~Lh~~~-----~~h~~i~~~nil~~~~~~~~l~d~~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~ 176 (246)
.-+...-++.......+|.+. -+|.++++-|.++..+-.+++.++|+.+.. ..........+++.|+.|+..-.
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ 1414 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE 1414 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH
Confidence 223333333345555555432 679999999999999999999999998832 22233334556666777765433
Q ss_pred cccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy7592 177 ATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207 (246)
Q Consensus 177 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~ 207 (246)
.. ++.++|+|..|+-+|....|..+|
T Consensus 1415 ik-----~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1415 IK-----FTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred Hh-----hhhHHHHHHHHHHHHHHhcccHHH
Confidence 32 666799999999999988888887
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.02 Score=46.18 Aligned_cols=100 Identities=7% Similarity=-0.056 Sum_probs=62.2
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCC---CcceeeeeeeeeC---CeEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH---PFLVNLWFCFQDE---EDLFMV 76 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~---~~~~~v 76 (246)
||+|.. +.||.+... ++ .+++|..+... ....+..|++.++.+.- -.+.++++++..+ +..++|
T Consensus 22 i~~G~~---~~vy~~~~~-~~-~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 22 ISEQPY---AALWALYDS-QG-NPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred cCCccc---eeEEEEEcC-CC-CEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 566666 899998753 23 56777754311 12467789999998853 3577888777543 568999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK 122 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~ 122 (246)
||+++|.++.+. . . .......+..++..++..||+.
T Consensus 92 mE~i~G~~~~~~-~----~-----~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 92 LERLRGVSVEAP-A----R-----TPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred EeccCCEecCCC-C----C-----CHHHHHHHHHHHHHHHHHHhCC
Confidence 999998877541 0 0 1222333444555666666653
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.017 Score=48.27 Aligned_cols=74 Identities=16% Similarity=0.147 Sum_probs=44.8
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHhhCC--CC-cceeeeeeeeeCCeEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI---ERDALKNVLREMEILTTLE--HP-FLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~~v 76 (246)
||.|.. ..||++.+...++.++||.-.+-... .+-..++..-|.+.|+.+. .| .++++|.+ +.....+|
T Consensus 37 igdGnl---N~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 37 IGDGNL---NYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred cCCCce---EEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 566776 89999998544678899874321110 0222455666778887763 45 44556544 34445677
Q ss_pred EeecC
Q psy7592 77 SDLLL 81 (246)
Q Consensus 77 ~e~~~ 81 (246)
||+++
T Consensus 112 MEdL~ 116 (409)
T PRK12396 112 MEDLS 116 (409)
T ss_pred HHhCc
Confidence 87774
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.016 Score=47.50 Aligned_cols=29 Identities=31% Similarity=0.600 Sum_probs=25.3
Q ss_pred cccCCCCCCcEEEcC-CCCeEEeecceeee
Q psy7592 124 IIHRDIKPDNILLDE-EGHAHITDFNIATV 152 (246)
Q Consensus 124 ~~h~~i~~~nil~~~-~~~~~l~d~~~~~~ 152 (246)
.+|+|+.+.||++++ ++.++++||..+..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 789999999999975 56899999998755
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.11 Score=42.52 Aligned_cols=29 Identities=31% Similarity=0.479 Sum_probs=24.2
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 122 KHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 122 ~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
.+++|+|+.+.|++++ + .+.++||+-+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 4689999999999995 3 578999997754
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.024 Score=46.64 Aligned_cols=73 Identities=23% Similarity=0.357 Sum_probs=53.3
Q ss_pred eCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEeec
Q psy7592 69 DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGHAHITDF 147 (246)
Q Consensus 69 ~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~~~l~d~ 147 (246)
+..+.|++|++. |+++.-.-.. ...++..++.+.+..+.-+.. .-.-|+|++..||+++ +|++.++||
T Consensus 297 e~~y~yl~~kdh-gt~is~ik~~---------~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISIIKAD---------RSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred CceEEEEEEecC-Cceeeeeecc---------cHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEe
Confidence 445678888877 6666422211 456677777777766655543 3478999999999998 999999999
Q ss_pred ceeee
Q psy7592 148 NIATV 152 (246)
Q Consensus 148 ~~~~~ 152 (246)
-+++.
T Consensus 366 klsRl 370 (488)
T COG5072 366 KLSRL 370 (488)
T ss_pred eeeec
Confidence 99874
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.17 Score=41.47 Aligned_cols=29 Identities=41% Similarity=0.760 Sum_probs=25.7
Q ss_pred cccCCCCCCcEEEcCCCC-eEEeecceeee
Q psy7592 124 IIHRDIKPDNILLDEEGH-AHITDFNIATV 152 (246)
Q Consensus 124 ~~h~~i~~~nil~~~~~~-~~l~d~~~~~~ 152 (246)
++|+|+.|.||+++.+.. +.+.||+-+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 899999999999998885 88999997643
|
|
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.047 Score=45.66 Aligned_cols=60 Identities=18% Similarity=0.188 Sum_probs=41.6
Q ss_pred EEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHH-HHHHHCCcccCCCCCCcEEEcCC
Q psy7592 74 FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLAL-DYLKTKHIIHRDIKPDNILLDEE 139 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l-~~Lh~~~~~h~~i~~~nil~~~~ 139 (246)
.++=+|..|.++..++... . .|+.....++.--.+|+ +-+--.+.+|.|++|.||++.-+
T Consensus 321 vl~E~~~~Gl~v~~~v~~~-~-----~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWK-S-----QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred eeeeeccccccHHhhhhcc-c-----ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 4555677788888887543 2 26666666666666663 34456789999999999999643
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.14 Score=41.07 Aligned_cols=64 Identities=17% Similarity=0.119 Sum_probs=40.3
Q ss_pred eeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC---CCcceeeeeeeeeCCeEEEEEeecCCC
Q psy7592 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE---HPFLVNLWFCFQDEEDLFMVSDLLLGG 83 (246)
Q Consensus 12 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~v~e~~~~~ 83 (246)
..+|++. .+++.|.+|.-.... ...+..|++-|+.|. --.+++++.+...++.-++++||++.+
T Consensus 31 ~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 31 NEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp SEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred hheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 7888877 578889999776322 245667888888883 345678888877666779999998755
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.37 Score=45.77 Aligned_cols=31 Identities=32% Similarity=0.493 Sum_probs=25.4
Q ss_pred CCcccCCCCCCcEEEcCCC--Ce-EEeecceeee
Q psy7592 122 KHIIHRDIKPDNILLDEEG--HA-HITDFNIATV 152 (246)
Q Consensus 122 ~~~~h~~i~~~nil~~~~~--~~-~l~d~~~~~~ 152 (246)
.+++|+|+++.||+++.++ .+ -|+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4699999999999998775 44 5999997654
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.13 Score=43.19 Aligned_cols=30 Identities=27% Similarity=0.207 Sum_probs=24.4
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 122 KHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 122 ~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
...+|.|+.+.||+.++ +.+.++||.-+..
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence 45789999999999754 4699999987654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.05 E-value=0.65 Score=39.78 Aligned_cols=29 Identities=21% Similarity=0.411 Sum_probs=24.1
Q ss_pred CcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 123 HIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 123 ~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
.++|+|+.+.||+.+.+ .+.++||..+..
T Consensus 285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg~ 313 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK-CLRLIDFEYSGY 313 (442)
T ss_pred eEEeCCCCccceeecCC-CEEEEeeccccc
Confidence 47899999999988654 499999997754
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=93.83 E-value=0.34 Score=41.99 Aligned_cols=50 Identities=16% Similarity=0.175 Sum_probs=40.1
Q ss_pred HHHHHHHHHHhhCCCCcceeeeeeeeeC-CeEEEEEeecCCCChHHHHhhcc
Q psy7592 43 KNVLREMEILTTLEHPFLVNLWFCFQDE-EDLFMVSDLLLGGDLRYHITQDI 93 (246)
Q Consensus 43 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~v~e~~~~~sL~~~~~~~~ 93 (246)
.+.......++.++|++...+.++.... ....+|||++ +.||.+....+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 4566678899999999999999887643 3478899999 889999887653
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.85 E-value=0.2 Score=39.83 Aligned_cols=48 Identities=27% Similarity=0.418 Sum_probs=35.6
Q ss_pred HHHHHHHHHHHHHHHHHC--CcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 105 IHLYAFELGLALDYLKTK--HIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 105 ~~~~~~qi~~~l~~Lh~~--~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
+...+..+-..+...+.. -.+|+|+.|+|++.++.+.+.++||.-+..
T Consensus 134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 333444444455555544 489999999999999999999999997754
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=92.78 E-value=3.2 Score=32.36 Aligned_cols=65 Identities=14% Similarity=0.163 Sum_probs=44.0
Q ss_pred eEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCC---CcceeeeeeeeeCCeEEEEEeecCCCCh
Q psy7592 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH---PFLVNLWFCFQDEEDLFMVSDLLLGGDL 85 (246)
Q Consensus 13 ~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~~v~e~~~~~sL 85 (246)
..|.+.+ ...+|.+|+=.. +.+..+..|+.-|..+.- -.+.+++.+-.+..+.|+|+||++-+.+
T Consensus 31 ea~~v~d--g~~~~FvK~n~~------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 31 EAWRLRD--GTDPFFVKCNQR------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred ceeEeec--CCcceEEEecch------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 3444444 345677885433 335667778888877743 4566777777888999999999975443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 246 | ||||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-75 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-35 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-34 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-34 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-34 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-34 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-33 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-33 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-33 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-33 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-33 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-33 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-33 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-33 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-33 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-32 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-32 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-32 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-32 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-32 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-32 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-32 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-32 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-32 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-32 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-32 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-32 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-32 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-32 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-32 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-32 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-32 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-32 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-32 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-32 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-32 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-32 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-32 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-32 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-32 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-32 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-32 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-32 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-32 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-32 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-32 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-32 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-32 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-32 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-32 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-32 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-32 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-32 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-31 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-31 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-31 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-31 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-31 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-31 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-31 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-31 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-31 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-31 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-31 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-31 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-31 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-31 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-30 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-30 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-30 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-30 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-30 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-29 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-29 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-29 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-29 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-29 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-29 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-29 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-29 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-29 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-29 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-28 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-28 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-28 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-28 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-28 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-28 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-28 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-28 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-28 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-27 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-27 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-27 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-27 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-27 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-27 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-27 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-27 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-27 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-27 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-27 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-27 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-27 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-27 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-27 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-27 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-27 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-27 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-27 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-27 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-27 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-27 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-27 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-27 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-27 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-27 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-27 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-27 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-27 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-27 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-26 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-26 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-26 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-26 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-26 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-26 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-26 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-23 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-20 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-20 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-20 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-20 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-20 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-20 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-20 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-20 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-18 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-18 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-18 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-17 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-17 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-17 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-17 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-17 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-16 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-16 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-11 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 7e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 7e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 8e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 8e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 8e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 8e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 8e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 8e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 8e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 9e-10 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 9e-10 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 9e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-05 |
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 327 bits (840), Expect = e-112
Identities = 132/231 (57%), Positives = 174/231 (75%), Gaps = 8/231 (3%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KVCIVQK DTK+MYAMKYM+K +C+ER+ ++NV +E++I+ LEHPFLVNLW+ FQDEED
Sbjct: 30 KVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+FMV DLLLGGDLRYH+ Q++ F + +T+ L+ EL +ALDYL+ + IIHRD+KPD
Sbjct: 90 MFMVVDLLLGGDLRYHLQQNVHF-----KEETVKLFICELVMALDYLQNQRIIHRDMKPD 144
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
NILLDE GH HITDFNIA +L T+M+GTKPY+APE+F + + GYS++VDWWS
Sbjct: 145 NILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFS--SRKGAGYSFAVDWWS 202
Query: 193 LGVTLFEILARGRPFDIHSNTSVKD-VKAIIYSPVHYPTAWSESTKHLLSQ 242
LGVT +E+L RP+ I S+TS K+ V + V YP+AWS+ LL +
Sbjct: 203 LGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKK 253
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 4e-69
Identities = 77/230 (33%), Positives = 131/230 (56%), Gaps = 14/230 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V +++ + + YAMK + K + +++ E +L+ + HPF++ +W FQD +
Sbjct: 21 RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ 80
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+FM+ D + GG+L + + +F N YA E+ LAL+YL +K II+RD+KP+
Sbjct: 81 IFMIMDYIEGGELFSLLRKSQRF-----PNPVAKFYAAEVCLALEYLHSKDIIYRDLKPE 135
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
NILLD+ GH ITDF A + ++ GT YIAPE+ Y+ S+DWWS
Sbjct: 136 NILLDKNGHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTK-----PYNKSIDWWS 188
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
G+ ++E+LA PF + + ++K + I+ + + +P ++E K LLS+
Sbjct: 189 FGILIYEMLAGYTPF--YDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 9e-69
Identities = 74/235 (31%), Positives = 117/235 (49%), Gaps = 17/235 (7%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
S V + ++ T + YA+K + K I+ + + V RE ++++ L+HPF V L+F FQD+E
Sbjct: 44 STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 103
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L+ G+L +I + F Y E+ AL+YL K IIHRD+KP
Sbjct: 104 KLYFGLSYAKNGELLKYIRKIGSF-----DETCTRFYTAEIVSALEYLHGKGIIHRDLKP 158
Query: 132 DNILLDEEGHAHITDFNIATVL---EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
+NILL+E+ H ITDF A VL + A S GT Y++PE+ S
Sbjct: 159 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-----SACKSS 213
Query: 189 DWWSLGVTLFEILARGR-PFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
D W+LG +++++A G PF + + II +P + + L+ +
Sbjct: 214 DLWALGCIIYQLVA-GLPPF--RAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 1e-68
Identities = 73/234 (31%), Positives = 117/234 (50%), Gaps = 14/234 (5%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILT---TLEHPFLVNLWFCFQD 69
+V +K DT +MYAMK + K + + L E +L+ T + PF+V + + F
Sbjct: 204 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+ L + DL+ GGDL YH++Q F + YA E+ L L+++ + +++RD+
Sbjct: 264 PDKLSFILDLMNGGDLHYHLSQHGVF-----SEADMRFYAAEIILGLEHMHNRFVVYRDL 318
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
KP NILLDE GH I+D +A + + + GT Y+APE+ Y S D
Sbjct: 319 KPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGV----AYDSSAD 373
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKDV-KAIIYSPVHYPTAWSESTKHLLSQ 242
W+SLG LF++L PF H ++ + + V P ++S + LL
Sbjct: 374 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 427
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 3e-68
Identities = 73/232 (31%), Positives = 118/232 (50%), Gaps = 10/232 (4%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+VC Q + T +MYA K + K + +R L E +IL + F+V+L + ++ ++
Sbjct: 199 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L +V L+ GGDL++HI + G YA E+ L+ L + I++RD+KP+
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPE 315
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
NILLD+ GH I+D +A + E Q GT Y+APE+ Y++S DWW+
Sbjct: 316 NILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK-----NERYTFSPDWWA 370
Query: 193 LGVTLFEILARGRPFDIHSNTSVKD--VKAIIYSPVHYPTAWSESTKHLLSQ 242
LG L+E++A PF ++ + + P Y +S + L SQ
Sbjct: 371 LGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQ 422
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 8e-68
Identities = 68/233 (29%), Positives = 122/233 (52%), Gaps = 9/233 (3%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V Q K T ++YA K ++K + +R + + E +IL + F+V+L + F+ + D
Sbjct: 200 EVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L +V ++ GGD+RYHI + I Y ++ L++L ++II+RD+KP+
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI-FYTAQIVSGLEHLHQRNIIYRDLKPE 318
Query: 133 NILLDEEGHAHITDFNIA-TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
N+LLD++G+ I+D +A + +GT ++APE+ L Y +SVD++
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL-----GEEYDFSVDYF 373
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDV--KAIIYSPVHYPTAWSESTKHLLSQ 242
+LGVTL+E++A PF + ++ V YP +S ++K
Sbjct: 374 ALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-66
Identities = 72/230 (31%), Positives = 129/230 (56%), Gaps = 14/230 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V +V+ K++ YAMK + K + ++ +++ L E IL + PFLV L F F+D +
Sbjct: 56 RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L+MV + + GG++ H+ + +F YA ++ L +YL + +I+RD+KP+
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRF-----SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
N+L+D++G+ +TDF A ++ ++ GT +APEI L GY+ +VDWW+
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSK-----GYNKAVDWWA 223
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
LGV ++E+ A PF ++ ++ + I+ V +P+ +S K LL
Sbjct: 224 LGVLIYEMAAGYPPF--FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 3e-66
Identities = 71/232 (30%), Positives = 121/232 (52%), Gaps = 15/232 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KV +V++K T + YAMK + K I +D + + + E +L HPFL L + FQ +
Sbjct: 20 KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L V + GG+L +H++++ F + Y E+ AL+YL ++ +++RDIK +
Sbjct: 80 LCFVMEYANGGELFFHLSRERVF-----TEERARFYGAEIVSALEYLHSRDVVYRDIKLE 134
Query: 133 NILLDEEGHAHITDFNIA-TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
N++LD++GH ITDF + + + + GT Y+APE+ Y +VDWW
Sbjct: 135 NLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE-----DNDYGRAVDWW 189
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDV-KAIIYSPVHYPTAWSESTKHLLSQ 242
LGV ++E++ PF N + + + I+ + +P S K LL+
Sbjct: 190 GLGVVMYEMMCGRLPFY---NQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 5e-66
Identities = 84/239 (35%), Positives = 122/239 (51%), Gaps = 19/239 (7%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEIL-TTLEHPFLVNLWFCFQDEE 71
KV +V+ K T ++YAMK + K + + + V E + HPFLV L CFQ E
Sbjct: 24 KVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
LF V + + GGDL +H+ + K R Y+ E+ LAL+YL + II+RD+K
Sbjct: 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHAR-----FYSAEISLALNYLHERGIIYRDLKL 138
Query: 132 DNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
DN+LLD EGH +TD+ + L ++ GT YIAPEI Y +SVDW
Sbjct: 139 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR-----GEDYGFSVDW 193
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDV-------KAIIYSPVHYPTAWSESTKHLLSQ 242
W+LGV +FE++A PFDI ++ D + I+ + P + S +L
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS 252
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 9e-66
Identities = 70/238 (29%), Positives = 119/238 (50%), Gaps = 15/238 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V +V+ K+ +++AMK ++K + ++R E ++L + ++ L + FQD+ +
Sbjct: 89 EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148
Query: 73 LFMVSDLLLGGDLRYHITQ-DIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L++V D +GGDL +++ + + + Y E+ +A+D + H +HRDIKP
Sbjct: 149 LYLVMDYYVGGDLLTLLSKFEDRL-----PEEMARFYLAEMVIAIDSVHQLHYVHRDIKP 203
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMS--GTKPYIAPEIFLVATDEVLGYSYSVD 189
DNIL+D GH + DF L E+ S GT YI+PEI Y D
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECD 263
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVH-----YPTAWSESTKHLLSQ 242
WWSLGV ++E+L PF ++ + V+ I+ T SE+ K L+ +
Sbjct: 264 WWSLGVCMYEMLYGETPF--YAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRR 319
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 5e-65
Identities = 83/238 (34%), Positives = 122/238 (51%), Gaps = 19/238 (7%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEIL-TTLEHPFLVNLWFCFQDEE 71
KV +V+ K T ++YAM+ + K + + + V E + HPFLV L CFQ E
Sbjct: 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
LF V + + GGDL +H+ + K R Y+ E+ LAL+YL + II+RD+K
Sbjct: 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHAR-----FYSAEISLALNYLHERGIIYRDLKL 181
Query: 132 DNILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
DN+LLD EGH +TD+ + L ++ GT YIAPEI Y +SVDW
Sbjct: 182 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-----DYGFSVDW 236
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDV-------KAIIYSPVHYPTAWSESTKHLLS 241
W+LGV +FE++A PFDI ++ D + I+ + P + S +L
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 294
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 7e-65
Identities = 84/232 (36%), Positives = 120/232 (51%), Gaps = 14/232 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEIL-TTLEHPFLVNLWFCFQDEE 71
KV + + K T Q +A+K + K + D ++ + E +L EHPFL +++ FQ +E
Sbjct: 32 KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
+LF V + L GGDL YHI KF YA E+ L L +L +K I++RD+K
Sbjct: 92 NLFFVMEYLNGGDLMYHIQSCHKF-----DLSRATFYAAEIILGLQFLHSKGIVYRDLKL 146
Query: 132 DNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
DNILLD++GH I DF + + + + GT YIAPEI L Y++SVDW
Sbjct: 147 DNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL-----GQKYNHSVDW 201
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
WS GV L+E+L PF H + +I YP + K LL +
Sbjct: 202 WSFGVLLYEMLIGQSPF--HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 251
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 7e-65
Identities = 76/233 (32%), Positives = 123/233 (52%), Gaps = 16/233 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILT-TLEHPFLVNLWFCFQDEE 71
KV + + K + YA+K + K +++ K+++ E +L ++HPFLV L F FQ +
Sbjct: 53 KVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L+ V D + GG+L YH+ ++ F YA E+ AL YL + +I++RD+KP
Sbjct: 113 KLYFVLDYINGGELFYHLQRERCF-----LEPRARFYAAEIASALGYLHSLNIVYRDLKP 167
Query: 132 DNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
+NILLD +GH +TDF + +E N ++ GT Y+APE+ Y +VDW
Sbjct: 168 ENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH-----KQPYDRTVDW 222
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDV-KAIIYSPVHYPTAWSESTKHLLSQ 242
W LG L+E+L PF + + ++ I+ P+ + S +HLL
Sbjct: 223 WCLGAVLYEMLYGLPPFY---SRNTAEMYDNILNKPLQLKPNITNSARHLLEG 272
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-64
Identities = 81/232 (34%), Positives = 118/232 (50%), Gaps = 14/232 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTT-LEHPFLVNLWFCFQDEE 71
KV + + K+T +YA+K + K ++ D ++ + E IL+ HPFL L+ CFQ +
Sbjct: 38 KVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
LF V + + GGDL +HI + +F R YA E+ AL +L K II+RD+K
Sbjct: 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARAR-----FYAAEIISALMFLHDKGIIYRDLKL 152
Query: 132 DNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
DN+LLD EGH + DF + + + GT YIAPEI Y +VDW
Sbjct: 153 DNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM-----LYGPAVDW 207
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
W++GV L+E+L PF + +AI+ V YPT E +L
Sbjct: 208 WAMGVLLYEMLCGHAPF--EAENEDDLFEAILNDEVVYPTWLHEDATGILKS 257
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 3e-64
Identities = 82/239 (34%), Positives = 129/239 (53%), Gaps = 17/239 (7%)
Query: 13 KVCIVQK---KDTKQMYAMKYMHKSQCIERD-ALKNVLREMEILTTLEH-PFLVNLWFCF 67
KV +V+K DT ++YAMK + K+ +++ ++ E ++L + PFLV L + F
Sbjct: 69 KVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128
Query: 68 QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
Q E L ++ D + GG+L H++Q +F + +Y E+ LAL++L II+R
Sbjct: 129 QTETKLHLILDYINGGELFTHLSQRERF-----TEHEVQIYVGEIVLALEHLHKLGIIYR 183
Query: 128 DIKPDNILLDEEGHAHITDFNIA--TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYS 185
DIK +NILLD GH +TDF ++ V +E + A GT Y+AP+I G+
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR---GGDSGHD 240
Query: 186 YSVDWWSLGVTLFEILARGRPF--DIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
+VDWWSLGV ++E+L PF D N+ + + I+ S YP S K L+ +
Sbjct: 241 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQR 299
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 6e-64
Identities = 78/231 (33%), Positives = 119/231 (51%), Gaps = 14/231 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEIL-TTLEHPFLVNLWFCFQDEE 71
KV + ++K T ++YA+K + K I+ D ++ + E +L + PFL L CFQ +
Sbjct: 35 KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L+ V + + GGDL YHI Q +F YA E+ + L +L++K II+RD+K
Sbjct: 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAV-----FYAAEIAIGLFFLQSKGIIYRDLKL 149
Query: 132 DNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
DN++LD EGH I DF + + + + GT YIAPEI Y SVDW
Sbjct: 150 DNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA-----YQPYGKSVDW 204
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241
W+ GV L+E+LA PF + ++I+ V YP + S+ +
Sbjct: 205 WAFGVLLYEMLAGQAPF--EGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 253
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 4e-63
Identities = 68/239 (28%), Positives = 114/239 (47%), Gaps = 15/239 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V +V+ K T Q+YAMK M+K ++R + E ++L + ++ L F FQDE
Sbjct: 76 EVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L++V + +GGDL +++ + + Y E+ +A+D + +HRDIKPD
Sbjct: 136 LYLVMEYYVGGDLLTLLSKFGERIPA----EMARFYLAEIVMAIDSVHRLGYVHRDIKPD 191
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMS--GTKPYIAPEIFLVATDEVLGYSY--SV 188
NILLD GH + DF L + S+ GT Y++PEI SY
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPEC 251
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVH-----YPTAWSESTKHLLSQ 242
DWW+LGV +E+ PF +++++ + I++ H E + + +
Sbjct: 252 DWWALGVFAYEMFYGQTPF--YADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQR 308
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 4e-63
Identities = 73/232 (31%), Positives = 122/232 (52%), Gaps = 14/232 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KV +V++K T + YAMK + K + +D + + L E +L HPFL L + FQ +
Sbjct: 163 KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH-IIHRDIKP 131
L V + GG+L +H++++ F D Y E+ ALDYL ++ +++RD+K
Sbjct: 223 LCFVMEYANGGELFFHLSRERVF-----SEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 277
Query: 132 DNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
+N++LD++GH ITDF + +++ + GT Y+APE+ E Y +VDW
Sbjct: 278 ENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL-----EDNDYGRAVDW 332
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
W LGV ++E++ PF ++ K + I+ + +P K LLS
Sbjct: 333 WGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEEIRFPRTLGPEAKSLLSG 382
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-62
Identities = 84/234 (35%), Positives = 127/234 (54%), Gaps = 17/234 (7%)
Query: 13 KVCIVQK---KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
KV +V+K D +Q+YAMK + K+ RD E +IL + HPF+V L + FQ
Sbjct: 39 KVFLVKKISGSDARQLYAMKVLKKATLKVRDR-VRTKMERDILVEVNHPFIVKLHYAFQT 97
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
E L+++ D L GGDL +++++ F + + Y EL LALD+L + II+RD+
Sbjct: 98 EGKLYLILDFLRGGDLFTRLSKEVMF-----TEEDVKFYLAELALALDHLHSLGIIYRDL 152
Query: 130 KPDNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
KP+NILLDEEGH +TDF ++ ++ + A S GT Y+APE+ G++ S
Sbjct: 153 KPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN-----RRGHTQSA 207
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
DWWS GV +FE+L PF + + I+ + + P S + LL
Sbjct: 208 DWWSFGVLMFEMLTGTLPF--QGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM 259
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-62
Identities = 70/235 (29%), Positives = 124/235 (52%), Gaps = 17/235 (7%)
Query: 13 KVCIVQK---KDTKQMYAMKYMHKSQCIER-DALKNVLREMEILTTLEHPFLVNLWFCFQ 68
KV V+K +T +++AMK + K+ + + E IL ++HPF+V+L + FQ
Sbjct: 32 KVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91
Query: 69 DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRD 128
L+++ + L GG+L + ++ F DT Y E+ +AL +L K II+RD
Sbjct: 92 TGGKLYLILEYLSGGELFMQLEREGIF-----MEDTACFYLAEISMALGHLHQKGIIYRD 146
Query: 129 IKPDNILLDEEGHAHITDFNIATV-LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
+KP+NI+L+ +GH +TDF + + + + + GT Y+APEI + G++ +
Sbjct: 147 LKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM-----RSGHNRA 201
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
VDWWSLG ++++L PF K + I+ ++ P ++ + LL +
Sbjct: 202 VDWWSLGALMYDMLTGAPPF--TGENRKKTIDKILKCKLNLPPYLTQEARDLLKK 254
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-62
Identities = 71/236 (30%), Positives = 118/236 (50%), Gaps = 15/236 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V +V+ K T+++YAMK + K + I+R E +I+ P++V L++ FQD+
Sbjct: 84 EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L+MV + + GGDL ++ + Y E+ LALD + + IHRD+KPD
Sbjct: 144 LYMVMEYMPGGDL-VNLMSNYDV-----PEKWARFYTAEVVLALDAIHSMGFIHRDVKPD 197
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMS--GTKPYIAPEIFLVATDEVLGYSYSVDW 190
N+LLD+ GH + DF + + + + GT YI+PE+ L + Y DW
Sbjct: 198 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV-LKSQGGDGYYGRECDW 256
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAWSESTKHLLSQ 242
WS+GV L+E+L PF ++++ V I+ S+ K+L+
Sbjct: 257 WSVGVFLYEMLVGDTPF--YADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA 310
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 2e-61
Identities = 78/231 (33%), Positives = 119/231 (51%), Gaps = 14/231 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEIL-TTLEHPFLVNLWFCFQDEE 71
KV + ++K T ++YA+K + K I+ D ++ + E +L + PFL L CFQ +
Sbjct: 356 KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L+ V + + GGDL YHI Q +F YA E+ + L +L++K II+RD+K
Sbjct: 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAV-----FYAAEIAIGLFFLQSKGIIYRDLKL 470
Query: 132 DNILLDEEGHAHITDFNIA-TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
DN++LD EGH I DF + + + + GT YIAPEI Y SVDW
Sbjct: 471 DNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA-----YQPYGKSVDW 525
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241
W+ GV L+E+LA PF + ++I+ V YP + S+ +
Sbjct: 526 WAFGVLLYEMLAGQAPF--EGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 1e-59
Identities = 63/230 (27%), Positives = 110/230 (47%), Gaps = 13/230 (5%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
V + ++K K + A+K + KSQ + + RE+EI + L HP ++ ++ F D +
Sbjct: 29 NVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
++++ + G+L + + +F + EL AL Y + +IHRDIKP+
Sbjct: 89 IYLMLEFAPRGELYKELQKHGRF-----DEQRSATFMEELADALHYCHERKVIHRDIKPE 143
Query: 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
N+L+ +G I DF + + T M GT Y+ PE+ E + VD W
Sbjct: 144 NLLMGYKGELKIADFGWSVHAPSLRRRT-MCGTLDYLPPEMI-----EGKTHDEKVDLWC 197
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
GV +E L PFD S + + + I+ + +P S+ +K L+S+
Sbjct: 198 AGVLCYEFLVGMPPFD--SPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-59
Identities = 69/239 (28%), Positives = 112/239 (46%), Gaps = 16/239 (6%)
Query: 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNL 63
G KF V + ++K +K + A+K + K+Q + + RE+EI + L HP ++ L
Sbjct: 18 GKGKF---GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 64 WFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH 123
+ F D ++++ + G + + + KF Y EL AL Y +K
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKF-----DEQRTATYITELANALSYCHSKR 129
Query: 124 IIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG 183
+IHRDIKP+N+LL G I DF + ++ + GT Y+ PE+ E
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMI-----EGRM 183
Query: 184 YSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
+ VD WSLGV +E L PF+ +NT + K I +P +E + L+S+
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFE--ANTYQETYKRISRVEFTFPDFVTEGARDLISR 240
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-53
Identities = 50/232 (21%), Positives = 91/232 (39%), Gaps = 16/232 (6%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDE 70
+V V+ K+ ++YA+K +D L E+ + +HP V L +++
Sbjct: 71 GEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
L++ ++L G L+ H + Y + LAL +L ++ ++H D+K
Sbjct: 130 GILYLQTELC-GPSLQQHCEAWGASLP----EAQVWGYLRDTLLALAHLHSQGLVHLDVK 184
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
P NI L G + DF + L G Y+APE+ Y + D
Sbjct: 185 PANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG------SYGTAADV 238
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
+SLG+T+ E+ H + ++ P + S + +L
Sbjct: 239 FSLGLTILEVACNMELP--HGGEGWQQLRQGYLPP-EFTAGLSSELRSVLVM 287
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-49
Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 13/233 (5%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
K +V+ + + Y +K ++ S+ ++ + RE+ +L ++HP +V F++
Sbjct: 38 GKAILVKSTEDGRQYVIKEINISRMSSKE-REESRREVAVLANMKHPNIVQYRESFEENG 96
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L++V D GGDL I + D I + ++ LAL ++ + I+HRDIK
Sbjct: 97 SLYIVMDYCEGGDLFKRINAQKGVL---FQEDQILDWFVQICLALKHVHDRKILHRDIKS 153
Query: 132 DNILLDEEGHAHITDFNIATVLEEN-QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
NI L ++G + DF IA VL +LA + GT Y++PEI E Y+ D
Sbjct: 154 QNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC-----ENKPYNNKSDI 208
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPV-HYPTAWSESTKHLLSQ 242
W+LG L+E+ F+ S ++ V II +S + L+SQ
Sbjct: 209 WALGCVLYELCTLKHAFEAGSMKNL--VLKIISGSFPPVSLHYSYDLRSLVSQ 259
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 5e-48
Identities = 46/248 (18%), Positives = 100/248 (40%), Gaps = 25/248 (10%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQ--------------CIERDALKNVLREMEILTTLEHP 58
K+ + + + YA+K KS + + E++I+T +++
Sbjct: 46 KIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103
Query: 59 FLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHL---YAFELGLA 115
+ + + ++++++ + + + T I + + +
Sbjct: 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNS 163
Query: 116 LDYL-KTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIF 174
Y+ K+I HRD+KP NIL+D+ G ++DF + + + ++ S GT ++ PE F
Sbjct: 164 FSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR-GTYEFMPPEFF 222
Query: 175 LVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSE 234
++E VD WSLG+ L+ + PF + + + I + YP +
Sbjct: 223 ---SNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-ELFNNIRTKNIEYPLDRNH 278
Query: 235 STKHLLSQ 242
L ++
Sbjct: 279 FLYPLTNK 286
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-47
Identities = 55/240 (22%), Positives = 106/240 (44%), Gaps = 18/240 (7%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
+ +++K ++ K + E + + ++ E+ +L L+HP +V + D
Sbjct: 20 GRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHPNIVRYYDRIIDRT 78
Query: 72 D--LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYL-----KTKHI 124
+ L++V + GGDL IT+ K + + +L LAL +
Sbjct: 79 NTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLALKECHRRSDGGHTV 137
Query: 125 IHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLATSMSGTKPYIAPEIFLVATDEVLG 183
+HRD+KP N+ LD + + + DF +A +L + A + GT Y++PE +
Sbjct: 138 LHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM-----NRMS 192
Query: 184 YSYSVDWWSLGVTLFEILARGRPFDIHSNTS-VKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
Y+ D WSLG L+E+ A PF S ++ + + P +S+ ++++
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI--PYRYSDELNEIITR 250
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-46
Identities = 59/235 (25%), Positives = 105/235 (44%), Gaps = 11/235 (4%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
S+V A+K + ++ A + ++E+++L L HP ++ + F ++
Sbjct: 46 SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
+L +V +L GDL I + K T+ Y +L AL+++ ++ ++HRDIKP
Sbjct: 106 ELNIVLELADAGDLSRMI-KHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKP 164
Query: 132 DNILLDEEGHAHITDFNIATVLE-ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
N+ + G + D + + A S+ GT Y++PE GY++ D
Sbjct: 165 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI-----HENGYNFKSDI 219
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAII---YSPVHYPTAWSESTKHLLSQ 242
WSLG L+E+ A PF K I Y P+ +SE + L++
Sbjct: 220 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP-SDHYSEELRQLVNM 273
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-45
Identities = 53/261 (20%), Positives = 103/261 (39%), Gaps = 44/261 (16%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
+V + + YA+K + ++ + L +L E+ +L +L H ++V + + +
Sbjct: 20 GQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERR 75
Query: 72 D-------------LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDY 118
+ LF+ + G L I + D ++ AL Y
Sbjct: 76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR----DEYWRLFRQILEALSY 131
Query: 119 LKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE---------------ENQLATSMS 163
+ ++ IIHRD+KP NI +DE + I DF +A + + TS
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 164 GTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV-KDVKAII 222
GT Y+A E+ D Y+ +D +SLG+ FE++ ++ K ++++
Sbjct: 192 GTAMYVATEVL----DGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRSVS 245
Query: 223 YS-PVHYPTAWSESTKHLLSQ 242
P + + K ++
Sbjct: 246 IEFPPDFDDNKMKVEKKIIRL 266
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 9e-45
Identities = 51/247 (20%), Positives = 90/247 (36%), Gaps = 37/247 (14%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
+V + + + Y +K + + + RE++ L L+H +V+ C+ +
Sbjct: 25 GQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFD 77
Query: 72 D----------------LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLA 115
LF+ + G L I + ++
Sbjct: 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL---DKVLALELFEQITKG 134
Query: 116 LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFL 175
+DY+ +K +I+RD+KP NI L + I DF + T L+ + T GT Y++PE
Sbjct: 135 VDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQI- 193
Query: 176 VATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSES 235
Y VD ++LG+ L E+L S II + +
Sbjct: 194 ----SSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGII------SDIFDKK 243
Query: 236 TKHLLSQ 242
K LL +
Sbjct: 244 EKTLLQK 250
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-43
Identities = 49/212 (23%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
T+ V + K T ++A+K + + +RE E+L L H +V L+ ++
Sbjct: 21 ATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78
Query: 70 EED--LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
++ + G L + + + G + ++ +++L+ I+HR
Sbjct: 79 TTTRHKVLIMEFCPCGSLYTVLEE--PSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR 136
Query: 128 DIKPDNILL----DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIF---LVATDE 180
+IKP NI+ D + +TDF A LE+++ S+ GT+ Y+ P+++ ++ D
Sbjct: 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDH 196
Query: 181 VLGYSYSVDWWSLGVTLFEILARGRPFDIHSN 212
Y +VD WS+GVT + PF
Sbjct: 197 QKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-43
Identities = 49/212 (23%), Positives = 95/212 (44%), Gaps = 13/212 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
T+ V + K T ++A+K + + + +RE E+L L H +V L+ ++
Sbjct: 21 ATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78
Query: 70 EED--LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
++ + G L + + + G + ++ +++L+ I+HR
Sbjct: 79 TTTRHKVLIMEFCPCGSLYTVLEE--PSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR 136
Query: 128 DIKPDNILL----DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIF---LVATDE 180
+IKP NI+ D + +TDF A LE+++ S+ GT+ Y+ P+++ ++ D
Sbjct: 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDH 196
Query: 181 VLGYSYSVDWWSLGVTLFEILARGRPFDIHSN 212
Y +VD WS+GVT + PF
Sbjct: 197 QKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-43
Identities = 56/235 (23%), Positives = 108/235 (45%), Gaps = 14/235 (5%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
+ V + T A+K + K + ++ V E++I L+HP ++ L+ F+D
Sbjct: 23 SFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED 82
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+++V ++ G++ ++ +K +S + + ++ + YL + I+HRD+
Sbjct: 83 SNYVYLVLEMCHNGEMNRYLKNRVKPFS----ENEARHFMHQIITGMLYLHSHGILHRDL 138
Query: 130 KPDNILLDEEGHAHITDFNIATVLE-ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
N+LL + I DF +AT L+ ++ ++ GT YI+PEI +
Sbjct: 139 TLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA-----TRSAHGLES 193
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDV-KAIIYSPVHYPTAWSESTKHLLSQ 242
D WSLG + +L PFD +VK+ ++ + P+ S K L+ Q
Sbjct: 194 DVWSLGCMFYTLLIGRPPFD---TDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ 245
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-43
Identities = 54/246 (21%), Positives = 97/246 (39%), Gaps = 23/246 (9%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHP--FLVNLWFCF 67
G+SKV V + KQ+YA+KY++ + + L + E+ L L+ ++ L+
Sbjct: 40 GSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97
Query: 68 QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
++ ++MV + DL + + Y + A+ + I+H
Sbjct: 98 ITDQYIYMVMECG-NIDLNSWLKKKKSIDP-----WERKSYWKNMLEAVHTIHQHGIVHS 151
Query: 128 DIKPDNILLDEEGHAHITDFNIATVLEENQ---LATSMSGTKPYIAPEIFL------VAT 178
D+KP N L+ +G + DF IA ++ + + S GT Y+ PE
Sbjct: 152 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 210
Query: 179 DEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSEST 236
S D WSLG L+ + PF + + AII + +P +
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIPEKDL 269
Query: 237 KHLLSQ 242
+ +L
Sbjct: 270 QDVLKC 275
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-42
Identities = 54/246 (21%), Positives = 96/246 (39%), Gaps = 23/246 (9%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFL--VNLWFCF 67
G+SKV V + KQ+YA+KY++ + + L + E+ L L+ + L+
Sbjct: 21 GSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78
Query: 68 QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
++ ++MV + DL + + Y + A+ + I+H
Sbjct: 79 ITDQYIYMVMECG-NIDLNSWLKKKKSIDP-----WERKSYWKNMLEAVHTIHQHGIVHS 132
Query: 128 DIKPDNILLDEEGHAHITDFNIATVLEENQ---LATSMSGTKPYIAPEIFL------VAT 178
D+KP N L+ +G + DF IA ++ + + S GT Y+ PE
Sbjct: 133 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 191
Query: 179 DEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSEST 236
S D WSLG L+ + PF + + AII + +P +
Sbjct: 192 KSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIPEKDL 250
Query: 237 KHLLSQ 242
+ +L
Sbjct: 251 QDVLKC 256
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-41
Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 15/232 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
K + DTK+++A K + KS ++ + + E+ I +L H +V F+D +
Sbjct: 56 KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 115
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+F+V +L L + R Y ++ L YL +IHRD+K
Sbjct: 116 VFVVLELCRRRSLLELHKRRKALTEPEARY-----YLRQIVLGCQYLHRNRVIHRDLKLG 170
Query: 133 NILLDEEGHAHITDFNIATVLE-ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
N+ L+E+ I DF +AT +E + + + GT YIAPE+ G+S+ VD W
Sbjct: 171 NLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL-----SKKGHSFEVDVW 225
Query: 192 SLGVTLFEILARGRPFDIHSNTSVKDV-KAIIYSPVHYPTAWSESTKHLLSQ 242
S+G ++ +L PF+ + +K+ I + P + L+ +
Sbjct: 226 SIGCIMYTLLVGKPPFE---TSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-41
Identities = 53/246 (21%), Positives = 95/246 (38%), Gaps = 23/246 (9%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFL--VNLWFCF 67
G+SKV V + KQ+YA+KY++ + + L + E+ L L+ + L+
Sbjct: 68 GSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 68 QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
++ ++MV + DL + + Y + A+ + I+H
Sbjct: 126 ITDQYIYMVMECG-NIDLNSWLKKKKSI-----DPWERKSYWKNMLEAVHTIHQHGIVHS 179
Query: 128 DIKPDNILLDEEGHAHITDFNIATVLEENQ---LATSMSGTKPYIAPEIFL------VAT 178
D+KP N L+ +G + DF IA ++ + + S G Y+ PE
Sbjct: 180 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENG 238
Query: 179 DEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSEST 236
S D WSLG L+ + PF + + AII + +P +
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIPEKDL 297
Query: 237 KHLLSQ 242
+ +L
Sbjct: 298 QDVLKC 303
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-41
Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 17/233 (7%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
K + DTK+++A K + KS ++ + + E+ I +L H +V F+D +
Sbjct: 30 KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 89
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+F+V +L L + R Y ++ L YL +IHRD+K
Sbjct: 90 VFVVLELCRRRSLLELHKRRKALTEPEARY-----YLRQIVLGCQYLHRNRVIHRDLKLG 144
Query: 133 NILLDEEGHAHITDFNIATVLE-ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
N+ L+E+ I DF +AT +E + + + GT YIAPE+ G+S+ VD W
Sbjct: 145 NLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL-----SKKGHSFEVDVW 199
Query: 192 SLGVTLFEILARGRPFDIHSNTSV--KDVKAIIYSPVHYPTAWSESTKHLLSQ 242
S+G ++ +L PF+ S +K YS P + L+ +
Sbjct: 200 SIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYS---IPKHINPVAASLIQK 248
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 5e-41
Identities = 35/267 (13%), Positives = 82/267 (30%), Gaps = 39/267 (14%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNL------ 63
S V +V+ + + +A+K R L+ + L
Sbjct: 74 DRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRL 133
Query: 64 --------------WFCFQDEEDLFMVSDLLL-----GGDLRYHIT--QDIKFYSVGTRN 102
+ +D + V++ LL DL + + +
Sbjct: 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGI 193
Query: 103 DTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSM 162
+H+ +L L++K ++H PDN+ + +G + D + + +
Sbjct: 194 LALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPAS 251
Query: 163 SGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII 222
S Y E ++++++ W LG++++ + PF + + K
Sbjct: 252 SVPVTYAPRE---FLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS 308
Query: 223 YSPVHYPTAW-------SESTKHLLSQ 242
+ + K L+ +
Sbjct: 309 LRVPGTDSLAFGSCTPLPDFVKTLIGR 335
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 1e-39
Identities = 39/273 (14%), Positives = 89/273 (32%), Gaps = 55/273 (20%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLRE--------------------- 48
++T + + + + ++ +A+K + E
Sbjct: 85 DPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 144
Query: 49 ----MEILTTLEHPFLVNLWFCFQDEEDL-------FMVSDLL-LGGDLRYHITQDIKFY 96
+++ + ++ + +D L M S+L G L H +
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH---- 200
Query: 97 SVGTRNDTIHLYAF-ELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155
+ L ++ L L ++H ++P +I+LD+ G +T F
Sbjct: 201 --KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---R 255
Query: 156 NQLATSMSGTKPYIAPEIFLVAT------DEVLGYSYSVDWWSLGVTLFEILARGRPFDI 209
+ S ++ + PE+ D ++S D W+LG+ ++ I P
Sbjct: 256 DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT- 314
Query: 210 HSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
+ ++ + I S + P + + LL
Sbjct: 315 -KDAALGGSEWIFRSCKNIP----QPVRALLEG 342
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 144 bits (363), Expect = 1e-39
Identities = 64/243 (26%), Positives = 98/243 (40%), Gaps = 18/243 (7%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
G V +DT + A+K + ++ + E++I+ L HP +V+
Sbjct: 26 GFGYVLRWIHQDTGEQVAIKQCRQEL-SPKN-RERWCLEIQIMKKLNHPNVVSAREVPDG 83
Query: 70 EEDL------FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH 123
+ L + + GGDLR ++ Q G + I ++ AL YL
Sbjct: 84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQ--FENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 124 IIHRDIKPDNILLDEEGHAH---ITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDE 180
IIHRD+KP+NI+L I D A L++ +L T GT Y+APE+ E
Sbjct: 142 IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL-----E 196
Query: 181 VLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240
Y+ +VD+WS G FE + RPF + K S H +
Sbjct: 197 QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKF 256
Query: 241 SQV 243
S V
Sbjct: 257 SSV 259
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-39
Identities = 55/258 (21%), Positives = 102/258 (39%), Gaps = 41/258 (15%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
V + K YA+K + A + V+RE++ L LEHP +V + + ++
Sbjct: 19 GVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKN 76
Query: 72 D------------LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYL 119
L++ L +L+ + ++ A+++L
Sbjct: 77 TTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE--RERSVCLHIFLQIAEAVEFL 134
Query: 120 KTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-------------TSMSGTK 166
+K ++HRD+KP NI + + DF + T +++++ T GTK
Sbjct: 135 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTK 194
Query: 167 PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS--VKDVKAIIYS 224
Y++PE YS+ VD +SLG+ LFE+L PF + DV+ + +
Sbjct: 195 LYMSPEQI-----HGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNLKFP 246
Query: 225 PVHYPTAWSESTKHLLSQ 242
P+ T ++
Sbjct: 247 PL--FTQKYPCEYVMVQD 262
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 63/238 (26%), Positives = 114/238 (47%), Gaps = 20/238 (8%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
+V + + K T Q A+K + K Q ++ +++LRE+++L L+HP ++ L+ F+D+
Sbjct: 40 GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
++V ++ GG+L I +F V ++ + Y+ I+HRD+KP
Sbjct: 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAAR-----IIRQVLSGITYMHKNKIVHRDLKP 154
Query: 132 DNILL---DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
+N+LL ++ + I DF ++T E ++ GT YIAPE+ Y
Sbjct: 155 ENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT------YDEKC 208
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAW----SESTKHLLSQ 242
D WS GV L+ +L+ PF+ + + K + + SES K L+ +
Sbjct: 209 DVWSTGVILYILLSGCPPFNGANEYDIL--KKVEKGKYTFELPQWKKVSESAKDLIRK 264
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-39
Identities = 75/243 (30%), Positives = 120/243 (49%), Gaps = 21/243 (8%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCI-----ERDALKNVLREMEILTTLEHPFLVNLWFC 66
+V + ++ T + A++ + K + E D NV E+EIL L HP ++ +
Sbjct: 149 GEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208
Query: 67 FQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
F D ED ++V +L+ GG+L + + + + Y +++ LA+ YL IIH
Sbjct: 209 F-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-----YFYQMLLAVQYLHENGIIH 262
Query: 127 RDIKPDNILL---DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG 183
RD+KP+N+LL +E+ ITDF + +L E L ++ GT Y+APE+ + G
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA--G 320
Query: 184 YSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTA-W---SESTKHL 239
Y+ +VD WSLGV LF L+ PF H T V I ++ W SE L
Sbjct: 321 YNRAVDCWSLGVILFICLSGYPPFSEH-RTQVSLKDQITSGKYNFIPEVWAEVSEKALDL 379
Query: 240 LSQ 242
+ +
Sbjct: 380 VKK 382
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-39
Identities = 77/244 (31%), Positives = 120/244 (49%), Gaps = 23/244 (9%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCI-----ERDALKNVLREMEILTTLEHPFLVNLWFC 66
+V + ++ T + A+K + K + E D NV E+EIL L HP ++ +
Sbjct: 24 GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 83
Query: 67 FQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
F D ED ++V +L+ GG+L + + + + Y +++ LA+ YL IIH
Sbjct: 84 F-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-----YFYQMLLAVQYLHENGIIH 137
Query: 127 RDIKPDNILL---DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG 183
RD+KP+N+LL +E+ ITDF + +L E L ++ GT Y+APE+ + G
Sbjct: 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA--G 195
Query: 184 YSYSVDWWSLGVTLFEILARGR-PFDIHSNTSVKDVKAIIYSPVHYPTA-W---SESTKH 238
Y+ +VD WSLGV LF I G PF H T V I ++ W SE
Sbjct: 196 YNRAVDCWSLGVILF-ICLSGYPPFSEH-RTQVSLKDQITSGKYNFIPEVWAEVSEKALD 253
Query: 239 LLSQ 242
L+ +
Sbjct: 254 LVKK 257
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 9e-39
Identities = 35/261 (13%), Positives = 83/261 (31%), Gaps = 32/261 (12%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-------------- 55
++T + + + + ++ +A+K + E+ L L
Sbjct: 90 DPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149
Query: 56 --------EHPFLVNLWFCFQDEEDLFMVSDLLL----GGDLRYHITQDIKFYSVGTR-- 101
+ P + DE D++++S L +L+ + S
Sbjct: 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 209
Query: 102 NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--A 159
+ ++ L L ++H ++P +I+LD+ G +T F + +
Sbjct: 210 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPI 269
Query: 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVK 219
A + +++ D W+LG+ ++ I P + ++ +
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN--TDDAALGGSE 327
Query: 220 AIIYSPVHYPTAWSESTKHLL 240
I S + P + L
Sbjct: 328 WIFRSCKNIPQPVRALLEGFL 348
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-38
Identities = 38/248 (15%), Positives = 81/248 (32%), Gaps = 29/248 (11%)
Query: 12 SKVCIVQKKD-----TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFC 66
++V + D KQ + +K + E + ME L + +
Sbjct: 79 AQVYEATQGDLNDAKNKQKFVLKVQKPANPWE---FYIGTQLMERLKPSMQHMFMKFYSA 135
Query: 67 FQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
+ +V +L G L I + +A + ++ + IIH
Sbjct: 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIH 195
Query: 127 RDIKPDNILL-----------DEEGHAHITDFNIA---TVLEENQLATSMSGTKPYIAPE 172
DIKPDN +L D + D + + + + T+ T + E
Sbjct: 196 GDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE 255
Query: 173 IFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAW 232
+ ++Y +D++ + T++ +L + K ++ + + W
Sbjct: 256 ML-----SNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--PEGLFRRLPHLDMW 308
Query: 233 SESTKHLL 240
+E +L
Sbjct: 309 NEFFHVML 316
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-38
Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 21/238 (8%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
+V + + K T A+K + K+ +L E+ +L L+HP ++ L+ F+D+
Sbjct: 51 GEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKLYDFFEDKR 109
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
+ ++V + GG+L I +KF V ++ + YL +I+HRD+KP
Sbjct: 110 NYYLVMECYKGGELFDEIIHRMKFNEVDAAV-----IIKQVLSGVTYLHKHNIVHRDLKP 164
Query: 132 DNILL---DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
+N+LL +++ I DF ++ V E + GT YIAPE+ Y
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK------KYDEKC 218
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAW----SESTKHLLSQ 242
D WS+GV LF +LA PF T + ++ + + + SE K L+ Q
Sbjct: 219 DVWSIGVILFILLAGYPPF--GGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-37
Identities = 56/279 (20%), Positives = 100/279 (35%), Gaps = 53/279 (18%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALK--NVLREMEILTTLEHPFLVNLWFCFQD 69
V + + T+ + A+K M+K++ + + + E+ ++ L HP + L+ ++D
Sbjct: 40 GVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGL--------------- 114
E+ + +V +L GG L + I + D +
Sbjct: 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE 159
Query: 115 --------------------ALDYLKTKHIIHRDIKPDNILLDEEGHAH--ITDFNIATV 152
AL YL + I HRDIKP+N L + DF ++
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE 219
Query: 153 LE-----ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
E T+ +GT ++APE+ + Y D WS GV L +L PF
Sbjct: 220 FYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE---SYGPKCDAWSAGVLLHLLLMGAVPF 276
Query: 208 DIHSNTSVKDVKAIIYSPVHYPT-AW---SESTKHLLSQ 242
+ ++ + + + S + LLS
Sbjct: 277 P--GVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSN 313
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 62/238 (26%), Positives = 111/238 (46%), Gaps = 21/238 (8%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
+V + + T+Q YA+K ++K+ +D +LRE+E+L L+HP ++ L+ +D
Sbjct: 36 GEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSS 94
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
++V +L GG+L I + +F ++ + Y+ +I+HRD+KP
Sbjct: 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAAR-----IIKQVFSGITYMHKHNIVHRDLKP 149
Query: 132 DNILL---DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
+NILL +++ I DF ++T ++N GT YIAPE+ Y
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT------YDEKC 203
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAW----SESTKHLLSQ 242
D WS GV L+ +L+ PF + +K + + S+ K L+ +
Sbjct: 204 DVWSAGVILYILLSGTPPF--YGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-36
Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 21/238 (8%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
+V + + T+Q YA+K ++K+ +D +LRE+E+L L+HP ++ L+ +D
Sbjct: 36 GEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSS 94
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
++V +L GG+L I + +F +++ + Y+ +I+HRD+KP
Sbjct: 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS-----GITYMHKHNIVHRDLKP 149
Query: 132 DNILL---DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
+NILL +++ I DF ++T ++N GT YIAPE+ Y
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG------TYDEKC 203
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTA-W---SESTKHLLSQ 242
D WS GV L+ +L+ PF + +K + + W S+ K L+ +
Sbjct: 204 DVWSAGVILYILLSGTPPF--YGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-36
Identities = 54/239 (22%), Positives = 111/239 (46%), Gaps = 21/239 (8%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
V +V+++ + +K ++K + + ++ + E+E+L +L+HP ++ ++ F+D
Sbjct: 36 GDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH 93
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
++++V + GG+L I + L ++ AL Y ++H++H+D+KP
Sbjct: 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL-MKQMMNALAYFHSQHVVHKDLKP 152
Query: 132 DNILL---DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVL--GYSY 186
+NIL I DF +A + + ++ +T+ +GT Y+AP EV ++
Sbjct: 153 ENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP--------EVFKRDVTF 204
Query: 187 SVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAW---SESTKHLLSQ 242
D WS GV ++ +L PF + + + Y +Y + LL Q
Sbjct: 205 KCDIWSAGVVMYFLLTGCLPF--TGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQ 261
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-36
Identities = 55/249 (22%), Positives = 88/249 (35%), Gaps = 27/249 (10%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
S V +V+ YA+K + E+ + RE ++ HP ++ L E
Sbjct: 43 SYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRER 99
Query: 72 D----LFMVSDLLLGGDLRYHITQDIKFYSVGTR--NDTIHLYAFELGLALDYLKTKHII 125
+++ G L I + G D I + L+ + K
Sbjct: 100 GAKHEAWLLLPFFKRGTLWNEIE---RLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYA 156
Query: 126 HRDIKPDNILLDEEGHAHITDFNIATVLE----------ENQLATSMSGTKPYIAPEIFL 175
HRD+KP NILL +EG + D Q + T Y APE+F
Sbjct: 157 HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFS 216
Query: 176 VATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP--TAWS 233
V + V+ D WSLG L+ ++ P+D V + + + P S
Sbjct: 217 VQSHCVID--ERTDVWSLGCVLYAMMFGEGPYD-MVFQKGDSVALAVQNQLSIPQSPRHS 273
Query: 234 ESTKHLLSQ 242
+ LL+
Sbjct: 274 SALWQLLNS 282
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-36
Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 19/243 (7%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIE------RDALKNVLREMEILTTL-EHPFLVNLW 64
S V K T + YA+K + + ++ + L+E++IL + HP ++ L
Sbjct: 31 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90
Query: 65 FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHI 124
++ F+V DL+ G+L ++T+ + TR L + L +I
Sbjct: 91 DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE-----VICALHKLNI 145
Query: 125 IHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVL-G 183
+HRD+KP+NILLD++ + +TDF + L+ + + GT Y+APEI + ++ G
Sbjct: 146 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPG 205
Query: 184 YSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTA-W---SESTKHL 239
Y VD WS GV ++ +LA PF + ++ I+ + + W S++ K L
Sbjct: 206 YGKEVDMWSTGVIMYTLLAGSPPFW--HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDL 263
Query: 240 LSQ 242
+S+
Sbjct: 264 VSR 266
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-36
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQC-----IERDALKNVLREMEILTTL-EHPFLVNLWF 65
S V + T +A+K M + + + RE IL + HP ++ L
Sbjct: 108 SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167
Query: 66 CFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHII 125
++ +F+V DL+ G+L ++T+ + TR+ L A+ +L +I+
Sbjct: 168 SYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE-----AVSFLHANNIV 222
Query: 126 HRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVL-GY 184
HRD+KP+NILLD+ ++DF + LE + + GT Y+APEI + DE GY
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 185 SYSVDWWSLGVTLFEILARGRPFD 208
VD W+ GV LF +LA PF
Sbjct: 283 GKEVDLWACGVILFTLLAGSPPFW 306
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-36
Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 20/238 (8%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
S V K T +A K ++ + RD + + RE I L+HP +V L Q+E
Sbjct: 43 SVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEES 101
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
++V DL+ GG+L I + + D H L ++ Y + I+HR++KP
Sbjct: 102 FHYLVFDLVTGGELFEDIVAREFY----SEADASHCIQQILE-SIAYCHSNGIVHRNLKP 156
Query: 132 DNILL---DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
+N+LL + + DF +A + +++ +GT Y++PE+ + YS V
Sbjct: 157 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-----KKDPYSKPV 211
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTA-W---SESTKHLLSQ 242
D W+ GV L+ +L PF + I YP+ W + K L+
Sbjct: 212 DIWACGVILYILLVGYPPF--WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-36
Identities = 59/238 (24%), Positives = 102/238 (42%), Gaps = 20/238 (8%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
S V K T +A K ++ + RD + + RE I L+HP +V L Q+E
Sbjct: 20 SVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEES 78
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
++V DL+ GG+L I + + + ++ Y + I+HR++KP
Sbjct: 79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-----SIAYCHSNGIVHRNLKP 133
Query: 132 DNILL---DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
+N+LL + + DF +A + +++ +GT Y++PE+ + YS V
Sbjct: 134 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-----KKDPYSKPV 188
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTA-W---SESTKHLLSQ 242
D W+ GV L+ +L PF + I YP+ W + K L+
Sbjct: 189 DIWACGVILYILLVGYPPFWDEDQHRL--YAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-35
Identities = 60/250 (24%), Positives = 111/250 (44%), Gaps = 34/250 (13%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQ----------CIERDALKNVLREMEILTTLEHPFLV 61
+V + ++K+ A+K + KSQ + + E+ +L +L+HP ++
Sbjct: 50 GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109
Query: 62 NLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT 121
L+ F+D++ ++V++ GG+L I KF D ++ ++ + YL
Sbjct: 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF----DECDAANI-MKQILSGICYLHK 164
Query: 122 KHIIHRDIKPDNILL---DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVAT 178
+I+HRDIKP+NILL + + I DF +++ ++ GT YIAP
Sbjct: 165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP------- 217
Query: 179 DEVL--GYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAW---- 232
EVL Y+ D WS GV ++ +L PF ++ + + ++
Sbjct: 218 -EVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK--KVEKGKYYFDFNDWKNI 274
Query: 233 SESTKHLLSQ 242
S+ K L+
Sbjct: 275 SDEAKELIKL 284
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-35
Identities = 69/242 (28%), Positives = 106/242 (43%), Gaps = 21/242 (8%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDAL--KNVLREMEILTTLEHPFLVNLWFCFQD 69
S V ++T Q +A+K + ++ L +++ RE I L+HP +V L +
Sbjct: 38 SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS 97
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+ L+MV + + G DL + I + V + H Y ++ AL Y +IIHRD+
Sbjct: 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH-YMRQILEALRYCHDNNIIHRDV 156
Query: 130 KPDNILL---DEEGHAHITDFNIATVLEENQLA-TSMSGTKPYIAPEIFLVATDEVLGYS 185
KP +LL + + F +A L E+ L GT ++APE+ + Y
Sbjct: 157 KPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV-----KREPYG 211
Query: 186 YSVDWWSLGVTLFEILARG-RPFDIHSNTSVKDVKAIIYSPVHYPTA-W---SESTKHLL 240
VD W GV LF IL G PF T + + II W SES K L+
Sbjct: 212 KPVDVWGCGVILF-ILLSGCLPFY---GTKERLFEGIIKGKYKMNPRQWSHISESAKDLV 267
Query: 241 SQ 242
+
Sbjct: 268 RR 269
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-35
Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 18/198 (9%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
S+V +V+++ T +++A+K + KS +L+N E+ +L ++H +V L ++
Sbjct: 23 SEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKHENIVTLEDIYESTT 79
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
++V L+ GG+L I + + T D + L A+ YL I+HRD+KP
Sbjct: 80 HYYLVMQLVSGGELFDRILERGVY----TEKDASLVIQQVLS-AVKYLHENGIVHRDLKP 134
Query: 132 DNILL---DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
+N+L +E ITDF ++ + + ++T GT Y+APE+ YS +V
Sbjct: 135 ENLLYLTPEENSKIMITDFGLSKMEQNGIMST-ACGTPGYVAPEVLAQK-----PYSKAV 188
Query: 189 DWWSLGVTLFEILARGRP 206
D WS+GV + IL G P
Sbjct: 189 DCWSIGVITY-ILLCGYP 205
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-35
Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNL 63
GS F V +K T +++ K+++ +++ V E+ I+ L HP L+NL
Sbjct: 60 GSGAF---GVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISIMNQLHHPKLINL 113
Query: 64 WFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH 123
F+D+ ++ ++ + L GG+L I + + + I+ Y + L ++
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM---SEAEVIN-YMRQACEGLKHMHEHS 169
Query: 124 IIHRDIKPDNILLDEEGHAH--ITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEV 181
I+H DIKP+NI+ + + + I DF +AT L +++ + T + APEI +
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-----DR 224
Query: 182 LGYSYSVDWWSLGVTLFEILARGRPF 207
+ D W++GV + +L+ PF
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLSGLSPF 250
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-34
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDE 70
++V T Q YA+K + K R V RE+E+L + H ++ L F++E
Sbjct: 27 ARVQTCINLITSQEYAVKIIEKQPGHIRS---RVFREVEMLYQCQGHRNVLELIEFFEEE 83
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
+ ++V + + GG + HI + F + + ++ ALD+L K I HRD+K
Sbjct: 84 DRFYLVFEKMRGGSILSHIHKRRHF----NELEASVV-VQDVASALDFLHNKGIAHRDLK 138
Query: 131 PDNILLDEEGHAH---ITDFNIATVLEENQLATSMS--------GTKPYIAPEIFLVATD 179
P+NIL + I DF++ + ++ N + +S G+ Y+APE+ ++
Sbjct: 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198
Query: 180 EVLGYSYSVDWWSLGVTLFEILARGRP 206
E Y D WSLGV L+ IL G P
Sbjct: 199 EASIYDKRCDLWSLGVILY-ILLSGYP 224
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-34
Identities = 56/238 (23%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
+V I +K T+ A K + K + D K +E+EI+ +L+HP ++ L+ F+D
Sbjct: 23 GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRLYETFEDNT 79
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
D+++V +L GG+L + F + + A+ Y ++ HRD+KP
Sbjct: 80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS-----AVAYCHKLNVAHRDLKP 134
Query: 132 DNILL---DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
+N L + + DF +A + ++ + GT Y++P++ Y
Sbjct: 135 ENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE------GLYGPEC 188
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTA-W---SESTKHLLSQ 242
D WS GV ++ +L PF + T + + I +P W S + L+ +
Sbjct: 189 DEWSAGVMMYVLLCGYPPF--SAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNL 63
G +F +V ++ T A K + +++ V E+ ++ L+H L+ L
Sbjct: 98 GGGRF---GQVHKCEETATGLKLAAKIIKTRGMKDKE---EVKNEISVMNQLDHANLIQL 151
Query: 64 WFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH 123
+ F+ + D+ +V + + GG+L I + T DTI + ++ + ++ +
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNL---TELDTIL-FMKQICEGIRHMHQMY 207
Query: 124 IIHRDIKPDNILLDEEGHAHI--TDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEV 181
I+H D+KP+NIL I DF +A + + GT ++APE+ V D
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV--VNYD-- 263
Query: 182 LGYSYSVDWWSLGVTLFEILARGRP 206
S+ D WS+GV + +L G
Sbjct: 264 -FVSFPTDMWSVGVIAY-MLLSGLS 286
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-34
Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDAL---KNVLREMEILTTLEHPFL 60
GS +F + V ++K T YA K++ K Q + + RE+ IL + H +
Sbjct: 21 GSGQF---AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 61 VNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLK 120
+ L +++ D+ ++ +L+ GG+L + Q + + + ++ ++YL
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESL----SEEEATS-FIKQILDGVNYLH 132
Query: 121 TKHIIHRDIKPDNILL-DEEGHAH---ITDFNIATVLEENQLATSMSGTKPYIAPEIFLV 176
TK I H D+KP+NI+L D+ + DF +A +E+ ++ GT ++APEI
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-- 190
Query: 177 ATDEVLGYSYSVDWWSLGVTLFEILARGRP 206
D WS+GV + IL G
Sbjct: 191 ---NYEPLGLEADMWSIGVITY-ILLSGAS 216
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-34
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 9 CGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQ 68
G V V K + + A K +H I+ ++RE+++L P++V + F
Sbjct: 46 GGV--VFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 101
Query: 69 DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTR--NDTIHLYAFELGLALDYLKTKH-II 125
+ ++ + + + GG L + R + + + L YL+ KH I+
Sbjct: 102 SDGEISICMEHMDGGSLD-------QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 154
Query: 126 HRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYS 185
HRD+KP NIL++ G + DF ++ L + +A S GT+ Y++PE + YS
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERL-----QGTHYS 208
Query: 186 YSVDWWSLGVTLFEILARGRP 206
D WS+G++L E +A GR
Sbjct: 209 VQSDIWSMGLSLVE-MAVGRY 228
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-34
Identities = 44/251 (17%), Positives = 88/251 (35%), Gaps = 33/251 (13%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDE 70
V K+ +YA+K K D +N LRE+ L +H +V + + ++
Sbjct: 25 GSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAED 83
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
+ + + ++ GG L I+++ + S + ++G L Y+ + ++H DIK
Sbjct: 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKE-AELKDLLLQVGRGLRYIHSMSLVHMDIK 142
Query: 131 PDNILLDEEGHAH-------------------ITDFNIATVLEENQLATSMSGTKPYIAP 171
P NI + + I D T + Q G ++A
Sbjct: 143 PSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLAN 199
Query: 172 EIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTA 231
E+ E + D ++L +T+ + +++ + P
Sbjct: 200 EVL----QENYTHLPKADIFALALTVVCAAGAEPLP--RNGDQWHEIRQGRLPRI--PQV 251
Query: 232 WSESTKHLLSQ 242
S+ LL
Sbjct: 252 LSQEFTELLKV 262
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDAL---KNVLREMEILTTLEHPFL 60
GS +F + V ++K T YA K++ K Q + + RE+ IL + HP +
Sbjct: 21 GSGQF---AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 61 VNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLK 120
+ L +++ D+ ++ +L+ GG+L + Q + + + ++ ++YL
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESL----SEEEATS-FIKQILDGVNYLH 132
Query: 121 TKHIIHRDIKPDNILL----DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLV 176
TK I H D+KP+NI+L H + DF +A +E+ ++ GT ++APEI
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-- 190
Query: 177 ATDEVLGYSYSVDWWSLGVTLFEILARGRP 206
D WS+GV + IL G
Sbjct: 191 ---NYEPLGLEADMWSIGVITY-ILLSGAS 216
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-34
Identities = 59/239 (24%), Positives = 107/239 (44%), Gaps = 21/239 (8%)
Query: 17 VQK---KDTKQMYAMKYMHKSQCIERDALKNVLREMEI-LTTLEHPFLVNLWFCFQDEED 72
V K K + Q+ A+K + + ++ K +L ++++ + + + P++V + E D
Sbjct: 38 VNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRN-DTIHLYAFELGLALDYLKTKH-IIHRDIK 130
++ +L+ + + + + + AL++LK IIHRDIK
Sbjct: 96 CWICMELMSTSFDK--FYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
P NILLD G+ + DF I+ L ++ T +G +PY+APE + GY D
Sbjct: 154 PSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQ-GYDVRSDV 212
Query: 191 WSLGVTLFEILARGRP--FDIHSNTSVKDVKAIIYSP-----VHYPTAWSESTKHLLSQ 242
WSLG+TL+E LA GR +S + ++ +S S + ++
Sbjct: 213 WSLGITLYE-LATGRFPYPKWNSVFDQ--LTQVVKGDPPQLSNSEEREFSPSFINFVNL 268
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-34
Identities = 64/245 (26%), Positives = 103/245 (42%), Gaps = 30/245 (12%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDE 70
S K + Q +A+K I + N +E+ L HP +V L F D+
Sbjct: 25 SICRKCVHKKSNQAFAVK------IISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
F+V +LL GG+L I + F + + ++ +L A+ ++ ++HRD+K
Sbjct: 79 LHTFLVMELLNGGELFERIKKKKHF----SETEASYI-MRKLVSAVSHMHDVGVVHRDLK 133
Query: 131 PDNILL---DEEGHAHITDFNIATVL-EENQLATSMSGTKPYIAPEIFLVATDEVLGYSY 186
P+N+L ++ I DF A + +NQ + T Y APE+ GY
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-----NQNGYDE 188
Query: 187 SVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPV---HY---PTAW---SESTK 237
S D WSLGV L+ +L+ PF H + I + + AW S+ K
Sbjct: 189 SCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAK 248
Query: 238 HLLSQ 242
L+
Sbjct: 249 DLIQG 253
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-34
Identities = 58/236 (24%), Positives = 104/236 (44%), Gaps = 20/236 (8%)
Query: 17 VQK---KDTKQMYAMKYMHKSQCIERDALKNVLREMEIL-TTLEHPFLVNLWFCFQDEED 72
V K + T + A+K M +S ++ K +L +++++ + + P++V + F D
Sbjct: 41 VWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH-IIHRDIKP 131
+F+ +L+ + K + + AL YLK KH +IHRD+KP
Sbjct: 99 VFIAMELMGTCAE-----KLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKP 153
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWW 191
NILLDE G + DF I+ L +++ +G Y+APE Y D W
Sbjct: 154 SNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVW 213
Query: 192 SLGVTLFEILARGRP--FDIHSNTSVKDVKAIIYSP---VHYPTAWSESTKHLLSQ 242
SLG++L E LA G+ + ++ V + ++ + +S + +
Sbjct: 214 SLGISLVE-LATGQFPYKNCKTDFEV--LTKVLQEEPPLLPGHMGFSGDFQSFVKD 266
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-34
Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
S V ++K T++ YA+K + K+ + V E+ +L L HP ++ L F+
Sbjct: 67 SIVYRCKQKGTQKPYALKVLKKTVDKKI-----VRTEIGVLLRLSHPNIIKLKEIFETPT 121
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
++ +V +L+ GG+L I + + + D ++ A+ YL I+HRD+KP
Sbjct: 122 EISLVLELVTGGELFDRIVEKGYY----SERDAADA-VKQILEAVAYLHENGIVHRDLKP 176
Query: 132 DNILL-DEEGHAH--ITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
+N+L A I DF ++ ++E L ++ GT Y APEI Y V
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL-----RGCAYGPEV 231
Query: 189 DWWSLGVTLFEILARGRP 206
D WS+G+ + IL G
Sbjct: 232 DMWSVGIITY-ILLCGFE 248
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-34
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
KV + K+T + A K + + L++ + E+EIL T +HP++V L + +
Sbjct: 34 KVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK 90
Query: 73 LFMVSDLLLGGDLRYHITQDI-KFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L+++ + GG + I G I + ++ AL++L +K IIHRD+K
Sbjct: 91 LWIMIEFCPGGAV-----DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKA 145
Query: 132 DNILLDEEGHAHITDFNIATVLEENQL-ATSMSGTKPY-IAPEIFLVATDEVLGYSYSVD 189
N+L+ EG + DF ++ + S GT PY +APE+ + T + Y Y D
Sbjct: 146 GNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT-PYWMAPEVVMCETMKDTPYDYKAD 204
Query: 190 WWSLGVTLFEILARGRP--FDIH 210
WSLG+TL E +A+ P +++
Sbjct: 205 IWSLGITLIE-MAQIEPPHHELN 226
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-34
Identities = 62/239 (25%), Positives = 106/239 (44%), Gaps = 29/239 (12%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQ-----CIERDALKNVLREMEILTTLEHPFLVNLWFCF 67
V K+ + +K++ K + IE L V E+ IL+ +EH ++ + F
Sbjct: 39 FVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF 98
Query: 68 QDEEDLFMVSDLLL-GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
+++ +V + G DL I + + +L A+ YL+ K IIH
Sbjct: 99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY-----IFRQLVSAVGYLRLKDIIH 153
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSY 186
RDIK +NI++ E+ + DF A LE +L + GT Y APE+ +G Y
Sbjct: 154 RDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVL-------MGNPY 206
Query: 187 S---VDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
++ WSLGVTL+ ++ PF +++ + + +H P S+ L+S
Sbjct: 207 RGPELEMWSLGVTLYTLVFEENPFC--------ELEETVEAAIHPPYLVSKELMSLVSG 257
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-33
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 10 GTS-KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQ 68
G+ V + ++ A+K M S + +++++E+ L L HP + C+
Sbjct: 65 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124
Query: 69 DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRD 128
E ++V + LG + ++ + + I L YL + ++IHRD
Sbjct: 125 REHTAWLVMEYCLGS-----ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 179
Query: 129 IKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPY-IAPEIFLVATDEVLGYSYS 187
+K NILL E G + DF A+++ A S GT PY +APE+ + + Y
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGT-PYWMAPEV--ILAMDEGQYDGK 233
Query: 188 VDWWSLGVTLFEILARGRP--FDIH 210
VD WSLG+T E LA +P F+++
Sbjct: 234 VDVWSLGITCIE-LAERKPPLFNMN 257
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-33
Identities = 60/234 (25%), Positives = 112/234 (47%), Gaps = 18/234 (7%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
+KV + + T + A+K + K+Q + +L+ + RE+ I+ L HP +V L+ + E+
Sbjct: 29 AKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK 87
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L+++ + GG++ ++ + R+ ++ A+ Y K I+HRD+K
Sbjct: 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARS-----KFRQIVSAVQYCHQKRIVHRDLKA 142
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS---V 188
+N+LLD + + I DF + + G PY APE+F G Y V
Sbjct: 143 ENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF-------QGKKYDGPEV 195
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
D WSLGV L+ +++ PFD + ++ + ++ P S ++LL +
Sbjct: 196 DVWSLGVILYTLVSGSLPFDGQNLKELR--ERVLRGKYRIPFYMSTDCENLLKR 247
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-33
Identities = 62/235 (26%), Positives = 112/235 (47%), Gaps = 15/235 (6%)
Query: 16 IVQK---KDTKQMYAMKYMHKSQCIERDALKNVLREMEI-LTTLEHPFLVNLWFCFQDEE 71
+V+K + Q+ A+K + + + K +L +++I + T++ PF V + E
Sbjct: 22 VVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG 79
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH-IIHRDIK 130
D+++ +L+ + + + D + A + AL++L +K +IHRD+K
Sbjct: 80 DVWICMELMDTSLDK--FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVK 137
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
P N+L++ G + DF I+ L ++ +G KPY+APE ++ GYS D
Sbjct: 138 PSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK-GYSVKSDI 196
Query: 191 WSLGVTLFEILARGR-PFDIHSNTSVKDVKAIIYS--PVHYPTAWSESTKHLLSQ 242
WSLG+T+ E LA R P+D T + +K ++ P +S SQ
Sbjct: 197 WSLGITMIE-LAILRFPYD-SWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQ 249
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-33
Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALK---NVLREMEILTTLEHPFL 60
GS +F + V ++K T + YA K++ K + + RE+ IL + HP +
Sbjct: 14 GSGQF---AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 61 VNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLK 120
+ L F+++ D+ ++ +L+ GG+L + + T ++ + ++ + YL
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFLAEKESL----TEDEATQ-FLKQILDGVHYLH 125
Query: 121 TKHIIHRDIKPDNILL---DEEGHA-HITDFNIATVLEENQLATSMSGTKPYIAPEIFLV 176
+K I H D+KP+NI+L + + DF IA +E ++ GT ++APEI
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV-- 183
Query: 177 ATDEVLGYSYSVDWWSLGVTLFEILARGRP 206
D WS+GV + IL G
Sbjct: 184 ---NYEPLGLEADMWSIGVITY-ILLSGAS 209
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDAL---KNVLREMEILTTLEHPFL 60
GS +F + V ++K T YA K++ K + +++ RE+ IL ++HP +
Sbjct: 20 GSGQF---AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 61 VNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLK 120
+ L ++++ D+ ++ +L+ GG+L + + T + + ++ + YL
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELFDFLAEKESL----TEEEATE-FLKQILNGVYYLH 131
Query: 121 TKHIIHRDIKPDNILL----DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLV 176
+ I H D+KP+NI+L + I DF +A ++ ++ GT ++APEI
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-- 189
Query: 177 ATDEVLGYSYSVDWWSLGVTLFEILARGRP 206
D WS+GV + IL G
Sbjct: 190 ---NYEPLGLEADMWSIGVITY-ILLSGAS 215
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-33
Identities = 66/243 (27%), Positives = 112/243 (46%), Gaps = 30/243 (12%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDE 70
S K T +A+K + KS+ + E+EIL +HP ++ L + D
Sbjct: 36 SVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDG 88
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
+ +++V++L+ GG+L I + F + + + F + ++YL + ++HRD+K
Sbjct: 89 KYVYVVTELMKGGELLDKILRQKFF----SEREASAV-LFTITKTVEYLHAQGVVHRDLK 143
Query: 131 PDNILL-DEEGHAH---ITDFNIATVLE-ENQLATSMSGTKPYIAPEIFLVATDEVLGYS 185
P NIL DE G+ I DF A L EN L + T ++APE+ GY
Sbjct: 144 PSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ-----GYD 198
Query: 186 YSVDWWSLGVTLFEILARGR-PFDIHSNTSVKDV-KAIIYSPVHYPT-AW---SESTKHL 239
+ D WSLGV L+ + G PF + + +++ I W S++ K L
Sbjct: 199 AACDIWSLGVLLY-TMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDL 257
Query: 240 LSQ 242
+S+
Sbjct: 258 VSK 260
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-33
Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 27/242 (11%)
Query: 11 TSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE 70
+V + + T++ A+K + + + D +N+ +E+ I L H +V + ++
Sbjct: 20 YGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREG 77
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
++ + GG+L I DI + +L + YL I HRDIK
Sbjct: 78 NIQYLFLEYCSGGELFDRIEPDIGM-----PEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQ----LATSMSGTKPYIAPEIFLVATDEVLGYSY 186
P+N+LLDE + I+DF +ATV N L GT PY+APE+ +
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELL-------KRREF 184
Query: 187 ---SVDWWSLGVTLFEILARGRPFDIHSNTSV---KDVKAIIYSPVHYPTAWSESTKHLL 240
VD WS G+ L +LA P+D S++ + Y + LL
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PWKKIDSAPLALL 242
Query: 241 SQ 242
+
Sbjct: 243 HK 244
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-33
Identities = 49/206 (23%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNL 63
G+ F V V ++ T +A K++ +++ V +E++ ++ L HP LVNL
Sbjct: 166 GTGAF---GVVHRVTERATGNNFAAKFVMTPHESDKE---TVRKEIQTMSVLRHPTLVNL 219
Query: 64 WFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH 123
F+D+ ++ M+ + + GG+L + + + ++ + Y ++ L ++ +
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM---SEDEAVE-YMRQVCKGLCHMHENN 275
Query: 124 IIHRDIKPDNILLDEEGHAHI--TDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEV 181
+H D+KP+NI+ + + DF + L+ Q +GT + APE+ E
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-----EG 330
Query: 182 LGYSYSVDWWSLGVTLFEILARGRPF 207
Y D WS+GV + +L+ PF
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSPF 356
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 45/235 (19%), Positives = 93/235 (39%), Gaps = 25/235 (10%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSD 78
+ A+K I + RE+++L EHP ++ + +D + ++ +
Sbjct: 45 MFDNRDVAVK------RILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98
Query: 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE 138
L L+ ++ Q + + + L +L + +I+HRD+KP NIL+
Sbjct: 99 LC-AATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAHLHSLNIVHRDLKPHNILISM 153
Query: 139 EGH-----AHITDFNIATVLEENQLA----TSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
A I+DF + L + + + + GT+ +IAPE+ E +Y+VD
Sbjct: 154 PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKE--NPTYTVD 211
Query: 190 WWSLGVTLFEILARGRPF--DIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
+S G + +++ G + + A +H + L+ +
Sbjct: 212 IFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEK 266
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-32
Identities = 61/237 (25%), Positives = 110/237 (46%), Gaps = 21/237 (8%)
Query: 11 TSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE 70
KV I + + T A+K +++ + D + + RE++ L HP ++ L+
Sbjct: 24 FGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
D FMV + + GG+L +I + + + R ++ A+DY ++HRD+K
Sbjct: 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARR-----LFQQILSAVDYCHRHMVVHRDLK 138
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS--- 187
P+N+LLD +A I DF ++ ++ + + + G+ Y APE+ G Y+
Sbjct: 139 PENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI-------SGRLYAGPE 191
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSV--KDVKAIIYSPVHYPTAWSESTKHLLSQ 242
VD WS GV L+ +L PFD + K ++ ++ + P + S LL
Sbjct: 192 VDIWSCGVILYALLCGTLPFD-DEHVPTLFKKIRGGVF---YIPEYLNRSVATLLMH 244
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 60/239 (25%), Positives = 102/239 (42%), Gaps = 21/239 (8%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
S V K Q YA ++ + RD + + RE I L+HP +V L +E
Sbjct: 25 SVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHPNIVRLHDSISEEG 83
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
+++ DL+ GG+L I + + D H L A+ + ++HR++KP
Sbjct: 84 HHYLIFDLVTGGELFEDIVAREYY----SEADASHCIQQILE-AVLHCHQMGVVHRNLKP 138
Query: 132 DNILL---DEEGHAHITDFNIATVLE-ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
+N+LL + + DF +A +E E Q +GT Y++PE+ Y
Sbjct: 139 ENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-----RKDPYGKP 193
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTA-W---SESTKHLLSQ 242
VD W+ GV L+ +L PF + + I +P+ W + K L+++
Sbjct: 194 VDLWACGVILYILLVGYPPF--WDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 250
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-32
Identities = 62/243 (25%), Positives = 102/243 (41%), Gaps = 29/243 (11%)
Query: 11 TSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE 70
+V + + T++ A+K + + + D +N+ +E+ I L H +V + ++
Sbjct: 20 YGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREG 77
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
++ + GG+L I DI + +L + YL I HRDIK
Sbjct: 78 NIQYLFLEYCSGGELFDRIEPDIGM-----PEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQ----LATSMSGTKPYIAPEIFLVATDEVLGYSY 186
P+N+LLDE + I+DF +ATV N L GT PY+APE+ +
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELL-------KRREF 184
Query: 187 ---SVDWWSLGVTLFEILARGRPFDIHSNTSV---KDVKAIIYSPVHYPTAW-SESTKHL 239
VD WS G+ L +LA P+D S++ + Y P + L
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN---PWKKIDSAPLAL 241
Query: 240 LSQ 242
L +
Sbjct: 242 LHK 244
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-32
Identities = 41/215 (19%), Positives = 83/215 (38%), Gaps = 23/215 (10%)
Query: 10 GTSKVCIVQK---KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFC 66
G + V K T + ++ ++ C + + + E+ + HP +V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRAT 94
Query: 67 FQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRN-DTIHLYAFELGLALDYLKTKHII 125
F + +L++V+ + G + + I + + N I + ALDY+ +
Sbjct: 95 FIADNELWVVTSFMAYGSAK-DL---ICTHFMDGMNELAIAYILQGVLKALDYIHHMGYV 150
Query: 126 HRDIKPDNILLDEEGHAHITDFNIATVLEENQ--------LATSMSGTKPYIAPEIFLVA 177
HR +K +IL+ +G +++ + + P+++PE V
Sbjct: 151 HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE---VL 207
Query: 178 TDEVLGYSYSVDWWSLGVTLFEILARGRP--FDIH 210
+ GY D +S+G+T E LA G D+
Sbjct: 208 QQNLQGYDAKSDIYSVGITACE-LANGHVPFKDMP 241
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-32
Identities = 46/199 (23%), Positives = 84/199 (42%), Gaps = 17/199 (8%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
V + +K+ Y K++ ++ V +E+ IL H +++L F+ E
Sbjct: 19 GIVHRCVETSSKKTYMAKFVKVKG-TDQV---LVKKEISILNIARHRNILHLHESFESME 74
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
+L M+ + + G D+ I + + Y ++ AL +L + +I H DI+P
Sbjct: 75 ELVMIFEFISGLDIFERINTSAFEL---NEREIVS-YVHQVCEALQFLHSHNIGHFDIRP 130
Query: 132 DNILLDEEGHAH--ITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
+NI+ + I +F A L+ + Y APE+ + S + D
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH-----QHDVVSTATD 185
Query: 190 WWSLGVTLFEILARG-RPF 207
WSLG ++ +L G PF
Sbjct: 186 MWSLGTLVY-VLLSGINPF 203
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-32
Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH-PFLVN 62
G KF + V K T Q YA K++ K + + +L E+ +L + P ++N
Sbjct: 38 GRGKF---AVVRQCISKSTGQEYAAKFLKKRRRGQDC-RAEILHEIAVLELAKSCPRVIN 93
Query: 63 LWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK 122
L +++ ++ ++ + GG++ + + + ND I L ++ + YL
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRL-IKQILEGVYYLHQN 150
Query: 123 HIIHRDIKPDNILL---DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATD 179
+I+H D+KP NILL G I DF ++ + + GT Y+APEI
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL----- 205
Query: 180 EVLGYSYSVDWWSLGVTLFEILARGRPF 207
+ + D W++G+ + +L PF
Sbjct: 206 NYDPITTATDMWNIGIIAYMLLTHTSPF 233
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-31
Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
V K+T Q+ A+K + +E L+ +++E+ I+ + P +V + + D
Sbjct: 44 SVYKAIHKETGQIVAIKQVP----VE-SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD 98
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRN-DTIHLYAFELGLALDYLKTKHIIHRDIKP 131
L++V + G + DI T D I L+YL IHRDIK
Sbjct: 99 LWIVMEYCGAGSV-----SDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKA 153
Query: 132 DNILLDEEGHAHITDFNIATVLEENQL-ATSMSGTKPY-IAPEIFLVATDEVLGYSYSVD 189
NILL+ EGHA + DF +A L + ++ GT P+ +APE V + GY+ D
Sbjct: 154 GNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGT-PFWMAPE---VIQEI--GYNCVAD 207
Query: 190 WWSLGVTLFEILARGRP--FDIH 210
WSLG+T E +A G+P DIH
Sbjct: 208 IWSLGITAIE-MAEGKPPYADIH 229
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-31
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 10 GTS-KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQ 68
G++ VC+ ++K + + A+K M + R+ L N E+ I+ +H +V ++ +
Sbjct: 56 GSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHFNVVEMYKSYL 112
Query: 69 DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRN-DTIHLYAFELGLALDYLKTKHIIHR 127
E+L+++ + L GG L DI S N + I + AL YL + +IHR
Sbjct: 113 VGEELWVLMEFLQGGAL-----TDI--VSQVRLNEEQIATVCEAVLQALAYLHAQGVIHR 165
Query: 128 DIKPDNILLDEEGHAHITDFNIATVLEENQL-ATSMSGTKPY-IAPEIFLVATDEVLGYS 185
DIK D+ILL +G ++DF + ++ S+ GT PY +APE V + Y+
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT-PYWMAPE---VISRS--LYA 219
Query: 186 YSVDWWSLGVTLFEILARGRP--FDIH 210
VD WSLG+ + E + G P F
Sbjct: 220 TEVDIWSLGIMVIE-MVDGEPPYFSDS 245
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-31
Identities = 66/261 (25%), Positives = 114/261 (43%), Gaps = 44/261 (16%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCI-----------------------ERDALKNVLREM 49
V + ++ YAMK + K + I R ++ V +E+
Sbjct: 28 VVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI 87
Query: 50 EILTTLEHPFLVNLWFCFQD--EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHL 107
IL L+HP +V L D E+ L+MV +L+ G + + D
Sbjct: 88 AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-MEVPTLKPL-----SEDQARF 141
Query: 108 YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ--LATSMSGT 165
Y +L ++YL + IIHRDIKP N+L+ E+GH I DF ++ + + L+ + GT
Sbjct: 142 YFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT-VGT 200
Query: 166 KPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSVKDV-KAIIY 223
++APE G ++D W++GVTL+ + G+ PF + + + I
Sbjct: 201 PAFMAPESLSETRKIFSG--KALDVWAMGVTLYCFVF-GQCPFM---DERIMCLHSKIKS 254
Query: 224 SPVHYP--TAWSESTKHLLSQ 242
+ +P +E K L+++
Sbjct: 255 QALEFPDQPDIAEDLKDLITR 275
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-31
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 10 GTS-KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQ 68
G S V T Q A++ M+ Q +++ + N E+ ++ ++P +VN +
Sbjct: 31 GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKNPNIVNYLDSYL 87
Query: 69 DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRD 128
++L++V + L GG L +T+ I E AL++L + +IHRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 129 IKPDNILLDEEGHAHITDFNIATVLEENQL-ATSMSGTKPY-IAPEIFLVATDEVLGYSY 186
IK DNILL +G +TDF + Q ++M GT PY +APE V T + Y
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT-PYWMAPE---VVTRK--AYGP 195
Query: 187 SVDWWSLGVTLFEILARGRP--FDIH 210
VD WSLG+ E + G P + +
Sbjct: 196 KVDIWSLGIMAIE-MIEGEPPYLNEN 220
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 51/261 (19%), Positives = 101/261 (38%), Gaps = 36/261 (13%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQ 68
G+S + Q + A+K + D L E+++LT +HP ++ +
Sbjct: 26 GSSGTVVFQGSFQGRPVAVK------RMLIDFCDIALMEIKLLTESDDHPNVIRYYCSET 79
Query: 69 DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAF--ELGLALDYLKTKHIIH 126
+ L++ +L +L+ + + + ++ + +L + IIH
Sbjct: 80 TDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIH 138
Query: 127 RDIKPDNILLDEEGHAH-------------ITDFNIATVLEENQLA-----TSMSGTKPY 168
RD+KP NIL+ I+DF + L+ Q + + SGT +
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198
Query: 169 IAPEIFLVATDEVL--GYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSVKDVKAIIYSP 225
APE+ + + + S+D +S+G + IL++G+ PF + ++ I+S
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG-DKYSRESNIIRGIFSL 257
Query: 226 VHYPTAW----SESTKHLLSQ 242
L+SQ
Sbjct: 258 DEMKCLHDRSLIAEATDLISQ 278
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-31
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+V T+++ A+K + + D ++++ +E+ +L+ + P++ + + +
Sbjct: 37 EVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK 94
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L+++ + L GG + + I E+ LDYL ++ IHRDIK
Sbjct: 95 LWIIMEYLGGGSAL-DLLEPGPL-----DETQIATILREILKGLDYLHSEKKIHRDIKAA 148
Query: 133 NILLDEEGHAHITDFNIATVLEENQL-ATSMSGTKPY-IAPEIFLVATDEVLGYSYSVDW 190
N+LL E G + DF +A L + Q+ + GT P+ +APE V Y D
Sbjct: 149 NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT-PFWMAPE---VIKQS--AYDSKADI 202
Query: 191 WSLGVTLFEILARGRP--FDIH 210
WSLG+T E LARG P ++H
Sbjct: 203 WSLGITAIE-LARGEPPHSELH 223
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 11 TSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE 70
T+ V K+ A+K ++ +C + ++ +L+E++ ++ HP +V+ + F +
Sbjct: 28 TAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85
Query: 71 EDLFMVSDLLLGG---DLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
++L++V LL GG D+ HI + S TI E+ L+YL IHR
Sbjct: 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHR 145
Query: 128 DIKPDNILLDEEGHAHITDFNIATVLEENQLATSMS------GTKPY-IAPEIFLVATDE 180
D+K NILL E+G I DF ++ L T GT P +APE+ ++
Sbjct: 146 DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT-PCWMAPEV----MEQ 200
Query: 181 VLGYSYSVDWWSLGVTLFEILARGRP--FDIH 210
V GY + D WS G+T E LA G
Sbjct: 201 VRGYDFKADIWSFGITAIE-LATGAAPYHKYP 231
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-30
Identities = 65/240 (27%), Positives = 97/240 (40%), Gaps = 27/240 (11%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+++ K TK++ A+KY+ + I+ +NV RE+ +L HP +V
Sbjct: 35 VARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTH 90
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
L ++ + GG+L I +F D + +L + Y + I HRD+K +
Sbjct: 91 LAIIMEYASGGELYERICNAGRF-----SEDEARFFFQQLLSGVSYCHSMQICHRDLKLE 145
Query: 133 NILLDEEGHAH--ITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSY---S 187
N LLD I DF + + S GT YIAPE+ L Y
Sbjct: 146 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL-------LRQEYDGKI 198
Query: 188 VDWWSLGVTLFEILARGRPF-DIHSNTSVKDVKAIIYSPVHY---PTAW-SESTKHLLSQ 242
D WS GVTL+ +L PF D + I S V Y S HL+S+
Sbjct: 199 ADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS-VKYSIPDDIRISPECCHLISR 257
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 60/237 (25%), Positives = 110/237 (46%), Gaps = 21/237 (8%)
Query: 11 TSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE 70
KV + + + T A+K +++ + D + + RE++ L HP ++ L+
Sbjct: 29 FGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
D+FMV + + GG+L +I ++ + +R ++ +DY ++HRD+K
Sbjct: 89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRR-----LFQQILSGVDYCHRHMVVHRDLK 143
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS--- 187
P+N+LLD +A I DF ++ ++ + + + G+ Y APE+ G Y+
Sbjct: 144 PENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI-------SGRLYAGPE 196
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSV--KDVKAIIYSPVHYPTAWSESTKHLLSQ 242
VD WS GV L+ +L PFD + K + I+ + P + S LL
Sbjct: 197 VDIWSSGVILYALLCGTLPFD-DDHVPTLFKKICDGIF---YTPQYLNPSVISLLKH 249
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 22/237 (9%)
Query: 11 TSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE 70
KV + T+Q A+K++ + + D V RE+ L L HP ++ L+
Sbjct: 22 FGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP 81
Query: 71 EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
D+ MV + GG+L +I + + R + ++ A++Y I+HRD+K
Sbjct: 82 TDIVMVIEYA-GGELFDYIVEKKRMTEDEGRR-----FFQQIICAIEYCHRHKIVHRDLK 135
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS--- 187
P+N+LLD+ + I DF ++ ++ + + G+ Y APE+ G Y+
Sbjct: 136 PENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI-------NGKLYAGPE 188
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSV--KDVKAIIYSPVHYPTAWSESTKHLLSQ 242
VD WS G+ L+ +L PFD K V + +Y P S + L+ +
Sbjct: 189 VDVWSCGIVLYVMLVGRLPFD-DEFIPNLFKKVNSCVY---VMPDFLSPGAQSLIRR 241
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-29
Identities = 57/246 (23%), Positives = 106/246 (43%), Gaps = 33/246 (13%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDE 70
KV + T Q A+K ++ S +E++ P +V + +++
Sbjct: 43 GKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDVYENM 94
Query: 71 ED----LFMVSDLLLGGDLRYHITQ-DIKFYSVGTRNDTIHLYAFELGLALDYLKTKHII 125
L ++ + + GG+L I + + ++ + + ++G A+ +L + +I
Sbjct: 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR----DIGTAIQFLHSHNIA 150
Query: 126 HRDIKPDNILL---DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVL 182
HRD+KP+N+L +++ +TDF A +N L T T Y+APE+ L
Sbjct: 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT-PCYTPYYVAPEV-LGPE---- 204
Query: 183 GYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDV--KAIIYSPVHYPTA-W---SEST 236
Y S D WSLGV ++ +L PF ++ ++ + I +P W SE
Sbjct: 205 KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 264
Query: 237 KHLLSQ 242
K L+
Sbjct: 265 KQLIRL 270
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 4e-29
Identities = 38/247 (15%), Positives = 83/247 (33%), Gaps = 23/247 (9%)
Query: 9 CGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQ 68
+++ +++ + ++ + V
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 69 DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRD 128
+ L++ L +L+ + + + ++ A+++L +K ++HRD
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDR--EHGVCLHIFIQIAEAVEFLHSKGLMHRD 189
Query: 129 IKPDNILLDEEGHAHITDFNIATVLE-------------ENQLATSMSGTKPYIAPEIFL 175
+KP NI + + DF + T ++ T GTK Y++PE
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI- 248
Query: 176 VATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSES 235
YS+ VD +SLG+ LFE+L + DV+ + + + T
Sbjct: 249 ----HGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI-ITDVRNLKFPLL--FTQKYPQ 301
Query: 236 TKHLLSQ 242
++
Sbjct: 302 EHMMVQD 308
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-29
Identities = 50/190 (26%), Positives = 82/190 (43%), Gaps = 10/190 (5%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79
+ A+K + + L E+ + L+H +V F + + + +
Sbjct: 44 LSNQVRIAIKEIPERDSRYSQPLH---EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100
Query: 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD-E 138
+ GG L + + K+ + TI Y ++ L YL I+HRDIK DN+L++
Sbjct: 101 VPGGSLS-ALLRS-KWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY 158
Query: 139 EGHAHITDFNIATVLEE-NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTL 197
G I+DF + L N + +GT Y+APE + GY + D WSLG T+
Sbjct: 159 SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE---IIDKGPRGYGKAADIWSLGCTI 215
Query: 198 FEILARGRPF 207
E+ PF
Sbjct: 216 IEMATGKPPF 225
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-29
Identities = 60/241 (24%), Positives = 95/241 (39%), Gaps = 21/241 (8%)
Query: 11 TSKVCIVQKKDTKQMYAMKYMHKSQCIE-RDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
KV V +T A+K + K + + NV +E+++L L H ++ L +
Sbjct: 18 YGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN 77
Query: 70 EE--DLFMVSDLLLGGDLRYHITQDIKFYSVGTR--NDTIHLYAFELGLALDYLKTKHII 125
EE ++MV + + G Q++ R H Y +L L+YL ++ I+
Sbjct: 78 EEKQKMYMVMEYCVCG------MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 126 HRDIKPDNILLDEEGHAHITDF---NIATVLEENQLATSMSGTKPYIAPEIFLVATDEVL 182
H+DIKP N+LL G I+ + + G+ + PEI
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD---- 187
Query: 183 GYS-YSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241
+S + VD WS GVTL+ I PF+ N K + I P LL
Sbjct: 188 TFSGFKVDIWSAGVTLYNITTGLYPFE-GDNIY-KLFENIGKGSYAIPGDCGPPLSDLLK 245
Query: 242 Q 242
Sbjct: 246 G 246
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-29
Identities = 61/246 (24%), Positives = 105/246 (42%), Gaps = 32/246 (13%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQD- 69
KV + K T++ +A+K + R E+E+ + P +V + +++
Sbjct: 76 GKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVRIVDVYENL 127
Query: 70 ---EEDLFMVSDLLLGGDLRYHITQ-DIKFYSVGTRNDTIHLYAFELGLALDYLKTKHII 125
+ L +V + L GG+L I + ++ ++ + +G A+ YL + +I
Sbjct: 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK----SIGEAIQYLHSINIA 183
Query: 126 HRDIKPDNILL-DEEGHAH--ITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVL 182
HRD+KP+N+L + +A +TDF A + T+ T Y+APE+ L
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LGPE---- 238
Query: 183 GYSYSVDWWSLGVTLFEILARGRPF--DIHSNTSVKDVKAIIYSPVHYPTA-W---SEST 236
Y S D WSLGV ++ +L PF + S I +P W SE
Sbjct: 239 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 298
Query: 237 KHLLSQ 242
K L+
Sbjct: 299 KMLIRN 304
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-29
Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCF---- 67
+V + T Q+ A+K M + D + + +E+ +L H + + F
Sbjct: 39 QVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94
Query: 68 --QDEEDLFMVSDLLLGGDLR--YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH 123
++ L++V + G + T+ + + I E+ L +L
Sbjct: 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL-----KEEWIAYICREILRGLSHLHQHK 149
Query: 124 IIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-ATSMSGTKPY-IAPEIFLVATDEV 181
+IHRDIK N+LL E + DF ++ L+ + GT PY +APE+ +
Sbjct: 150 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT-PYWMAPEVIACDENPD 208
Query: 182 LGYSYSVDWWSLGVTLFEILARGRP--FDIH 210
Y + D WSLG+T E +A G P D+H
Sbjct: 209 ATYDFKSDLWSLGITAIE-MAEGAPPLCDMH 238
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-29
Identities = 51/243 (20%), Positives = 95/243 (39%), Gaps = 31/243 (12%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKN---VLREMEILTTLEH--PFLVNLW 64
G V + A+K++ K + + L N V E+ +L + ++ L
Sbjct: 55 GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114
Query: 65 FCFQDEEDLFMVSDLLLG-GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH 123
F+ + ++ + DL IT+ R+ + +++ A+ +
Sbjct: 115 DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQVLEAVRHCHNCG 169
Query: 124 IIHRDIKPDNILLDEE-GHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVL 182
++HRDIK +NIL+D G + DF +L++ GT+ Y PE
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-DGTRVYSPPEWI-------R 221
Query: 183 GYSY---SVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239
+ Y S WSLG+ L++++ PF+ + II V + S +HL
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFE--------HDEEIIRGQVFFRQRVSSECQHL 273
Query: 240 LSQ 242
+
Sbjct: 274 IRW 276
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 28/208 (13%)
Query: 40 DALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRY--HITQDIKFY 96
K + E+ L+ + HP +V L+ C + +V + GG L H + + +Y
Sbjct: 43 SERKAFIVELRQLSRVNHPNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYY 99
Query: 97 SVGTRNDTIHLYAFELGLALDYL---KTKHIIHRDIKPDNILLDEEG-HAHITDFNIATV 152
+ + + + YL + K +IHRD+KP N+LL G I DF A
Sbjct: 100 TAAHAMS----WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC- 154
Query: 153 LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN 212
+ T+ G+ ++APE+F E YS D +S G+ L+E++ R +PFD
Sbjct: 155 -DIQTHMTNNKGSAAWMAPEVF-----EGSNYSEKCDVFSWGIILWEVITRRKPFD-EIG 207
Query: 213 TSVKDVKAIIYS------PVHYPTAWSE 234
+ +++ + P
Sbjct: 208 GPAFRIMWAVHNGTRPPLIKNLPKPIES 235
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-28
Identities = 51/242 (21%), Positives = 101/242 (41%), Gaps = 33/242 (13%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKN---VLREMEILTTL----EHPFLVNLWF 65
V + + A+K + +++ + L + E+ +L + HP ++ L
Sbjct: 46 TVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105
Query: 66 CFQDEEDLFMVSDLLL-GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHI 124
F+ +E +V + L DL +IT+ +R + ++ A+ + ++ +
Sbjct: 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC-----FFGQVVAAIQHCHSRGV 160
Query: 125 IHRDIKPDNILLDEE-GHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG 183
+HRDIK +NIL+D G A + DF +L + GT+ Y PE
Sbjct: 161 VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF-DGTRVYSPPEWI-------SR 212
Query: 184 YSY---SVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240
+ Y WSLG+ L++++ PF+ + I+ + +H+P S L+
Sbjct: 213 HQYHALPATVWSLGILLYDMVCGDIPFE--------RDQEILEAELHFPAHVSPDCCALI 264
Query: 241 SQ 242
+
Sbjct: 265 RR 266
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-28
Identities = 48/233 (20%), Positives = 87/233 (37%), Gaps = 30/233 (12%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKNVL----REMEILTTLEHPFLVNLW-FCFQDEEDLF 74
K + A+K + + RE+ I++ L HP +V L+
Sbjct: 41 VKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP---PR 97
Query: 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYL--KTKHIIHRDIKPD 132
MV + + GDL + + + + L ++ L ++Y+ + I+HRD++
Sbjct: 98 MVMEFVPCGDLYHRLLDKAHPIKWSVK---LRL-MLDIALGIEYMQNQNPPIVHRDLRSP 153
Query: 133 NILLDEEG-----HAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
NI L A + DF ++ + + + G ++APE E Y+
Sbjct: 154 NIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPETI---GAEEESYTEK 208
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS------PVHYPTAWSE 234
D +S + L+ IL PFD +S +K + I P P
Sbjct: 209 ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRN 261
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-28
Identities = 43/186 (23%), Positives = 85/186 (45%), Gaps = 13/186 (6%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDL 85
A+K + Q + + LRE+ I+ L HP +V +L +V++ L G L
Sbjct: 64 AVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-TQPPNLSIVTEYLSRGSL 121
Query: 86 RYHITQDIKFYSVGTRNDTIHLYAFELGLALDYL--KTKHIIHRDIKPDNILLDEEGHAH 143
+ + + R A+++ ++YL + I+HR++K N+L+D++
Sbjct: 122 YRLLHKSGAREQLDER--RRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 144 ITDFNIATVLEENQL-ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA 202
+ DF ++ + L + S +GT ++APE+ + D +S GV L+E+
Sbjct: 180 VCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL-----RDEPSNEKSDVYSFGVILWELAT 234
Query: 203 RGRPFD 208
+P+
Sbjct: 235 LQQPWG 240
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-27
Identities = 47/194 (24%), Positives = 75/194 (38%), Gaps = 26/194 (13%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79
K T A+K + E+ L P +V L+ ++ + + +L
Sbjct: 80 KQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131
Query: 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE 139
L GG L I Q D Y + L+YL T+ I+H D+K DN+LL +
Sbjct: 132 LEGGSLGQLIKQMGCL-----PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSD 186
Query: 140 G-HAHITDFNIATVLEENQLAT------SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
G A + DF A L+ + L + GT+ ++APE+ + VD WS
Sbjct: 187 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK-----PCDAKVDIWS 241
Query: 193 LGVTLFEILARGRP 206
+ + G
Sbjct: 242 SCCMMLH-MLNGCH 254
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-27
Identities = 48/200 (24%), Positives = 80/200 (40%), Gaps = 18/200 (9%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR 86
A++ + + E D LK RE+ H +V L +++ L G L
Sbjct: 59 AIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117
Query: 87 YHI-TQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHIT 145
+ I N T + A E+ + YL K I+H+D+K N+ D G IT
Sbjct: 118 SVVRDAKIVL----DVNKTRQI-AQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVIT 171
Query: 146 DFNIATVLEENQLA------TSMSGTKPYIAPEIF----LVATDEVLGYSYSVDWWSLGV 195
DF + ++ Q +G ++APEI ++ L +S D ++LG
Sbjct: 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231
Query: 196 TLFEILARGRPFDIHSNTSV 215
+E+ AR PF ++
Sbjct: 232 IWYELHAREWPFKTQPAEAI 251
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-26
Identities = 49/261 (18%), Positives = 100/261 (38%), Gaps = 44/261 (16%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQ 68
G + V Q + + YA+K + + E + + +++E+ + L HP +V
Sbjct: 40 GFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96
Query: 69 DEED--------LFMVSDLLLGGDLRYHITQDIKFYSVGTR--NDTIHLYAFELGLALDY 118
++ ++++L G + + +K DT+ ++ A+ +
Sbjct: 97 IGKEESDTGQAEFLLLTELCKGQLV-----EFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 119 L--KTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-------------QLATSMS 163
+ + IIHRD+K +N+LL +G + DF AT + + + +
Sbjct: 152 MHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 164 GTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY 223
T Y PEI + ++ D W+LG L+ + R PF+ + I+
Sbjct: 212 TTPMYRTPEIIDLYSNFP--IGEKQDIWALGCILYLLCFRQHPFEDGA------KLRIVN 263
Query: 224 SPVHYPTAWSEST--KHLLSQ 242
P ++ T L+
Sbjct: 264 GKYSIPPHDTQYTVFHSLIRA 284
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-25
Identities = 47/233 (20%), Positives = 101/233 (43%), Gaps = 25/233 (10%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD----EEDLFM 75
+T A + + + + + E E+L L+HP +V + ++ ++ + +
Sbjct: 48 TETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106
Query: 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYL--KTKHIIHRDIKPDN 133
V++L+ G L+ ++ + + + + ++ L +L +T IIHRD+K DN
Sbjct: 107 VTELMTSGTLKTYLKRFKVM-----KIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDN 161
Query: 134 ILLD-EEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
I + G I D +AT+ + A ++ GT ++APE++ +E Y SVD ++
Sbjct: 162 IFITGPTGSVKIGDLGLATLKRASF-AKAVIGTPEFMAPEMY----EE--KYDESVDVYA 214
Query: 193 LGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPTAWSESTKHLLSQ 242
G+ + E+ P+ + + + S P + K ++
Sbjct: 215 FGMCMLEMATSEYPY--SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 7e-25
Identities = 34/188 (18%), Positives = 67/188 (35%), Gaps = 18/188 (9%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD--EEDLFMVSDLLLGGD 84
+K + R ++ E L HP ++ + Q +++ + G
Sbjct: 37 VVKVLKVRDWSTR-KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGS 95
Query: 85 LRYHITQDIKFYSVGTRNDTIHLYAFELGLA--LDYL--KTKHIIHRDIKPDNILLDEEG 140
L Y++ + + V D F L +A + +L I + ++++DE+
Sbjct: 96 L-YNVLHEGTNFVV----DQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM 150
Query: 141 HAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEI 200
A I+ ++ + ++APE S D WS V L+E+
Sbjct: 151 TARISMADVKFSFQS----PGRMYAPAWVAPEAL--QKKPEDTNRRSADMWSFAVLLWEL 204
Query: 201 LARGRPFD 208
+ R PF
Sbjct: 205 VTREVPFA 212
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 7e-25
Identities = 45/185 (24%), Positives = 79/185 (42%), Gaps = 14/185 (7%)
Query: 33 KSQCIERDALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHI-T 90
L+ E+ +L H ++ + L +V+ G L +H+
Sbjct: 55 NVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHA 112
Query: 91 QDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA 150
+ KF I + A + +DYL K IIHRD+K +NI L E+ I DF +A
Sbjct: 113 SETKF----EMKKLIDI-ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167
Query: 151 TV---LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
T + +SG+ ++APE+ + YS+ D ++ G+ L+E++ P+
Sbjct: 168 TEKSRWSGSHQFEQLSGSILWMAPEVI--RMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225
Query: 208 DIHSN 212
+N
Sbjct: 226 SNINN 230
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 41/188 (21%), Positives = 77/188 (40%), Gaps = 26/188 (13%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED------LFMVSDLL 80
+K + S + +A + E + L + HP +V + F F + D ++V + +
Sbjct: 110 VLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYV 166
Query: 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG 140
G L+ Q + + I Y E+ AL YL + +++ D+KP+NI+L EE
Sbjct: 167 GGQSLKRSKGQKL------PVAEAIA-YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ 219
Query: 141 HAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEI 200
+ D + + + GT + APEI + D +++G TL +
Sbjct: 220 -LKLIDLGAVSRINS---FGYLYGTPGFQAPEI---VRTGPTVAT---DIYTVGRTLAAL 269
Query: 201 LARGRPFD 208
+
Sbjct: 270 TLDLPTRN 277
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-24
Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 47 REMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIH 106
RE L+ P +V + + + L++ L+ G DL + + +
Sbjct: 83 REARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPL----APPRAVA 138
Query: 107 LYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-ATSMS-G 164
+ ++G ALD HRD+KP+NIL+ + A++ DF IA+ + +L + G
Sbjct: 139 I-VRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVG 197
Query: 165 TKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFD 208
T Y+APE ++ Y D ++L L+E L P+
Sbjct: 198 TLYYMAPE---RFSESHAT--YRADIYALTCVLYECLTGSPPYQ 236
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-23
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 12/184 (6%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR 86
A+K + + + LK RE+ + L H +V++ ++++ ++V + + G L
Sbjct: 40 AIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLS 99
Query: 87 YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITD 146
+I + + I+ + ++ + + I+HRDIKP NIL+D I D
Sbjct: 100 EYIESHGPL----SVDTAIN-FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFD 154
Query: 147 FNIATVLEENQLATSMS--GTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
F IA L E L + GT Y +PE + + D +S+G+ L+E+L
Sbjct: 155 FGIAKALSETSLTQTNHVLGTVQYFSPE--QAKGEATDECT---DIYSIGIVLYEMLVGE 209
Query: 205 RPFD 208
PF+
Sbjct: 210 PPFN 213
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-23
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 27/204 (13%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCF------ 67
V + D+ ++ A+K K + +D + RE++I+ L+H +V L + F
Sbjct: 70 VYQAKLCDSGELVAIK---K---VLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEK 122
Query: 68 QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTR---NDTIHLYAFELGLALDYLKTKHI 124
+DE L +V D + + Y + + YS + + LY ++L +L Y+ + I
Sbjct: 123 KDEVYLNLVLDYV-PETV-YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 177
Query: 125 IHRDIKPDNILLDEEGHA-HITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG 183
HRDIKP N+LLD + + DF A L + S ++ Y APE+ ATD
Sbjct: 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD---- 233
Query: 184 YSYSVDWWSLGVTLFEILARGRPF 207
Y+ S+D WS G L E+L G+P
Sbjct: 234 YTSSIDVWSAGCVLAELL-LGQPI 256
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 7e-23
Identities = 46/219 (21%), Positives = 92/219 (42%), Gaps = 41/219 (18%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71
+ V ++T ++ MK + + + + + L+E++++ LEHP ++ ++
Sbjct: 24 GQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80
Query: 72 DLFMVSDLLLGGDLRYHI-TQDIKFYSVGTRNDTIHLYAFELGLALD------YLKTKHI 124
L +++ + GG LR I + D ++ R + A D YL + +I
Sbjct: 81 RLNFITEYIKGGTLRGIIKSMDSQY-PWSQR----------VSFAKDIASGMAYLHSMNI 129
Query: 125 IHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA---------------TSMSGTKPYI 169
IHRD+ N L+ E + + DF +A ++ + + ++ G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 170 APEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFD 208
APE + Y VD +S G+ L EI+ R
Sbjct: 190 APE---MINGRS--YDEKVDVFSFGIVLCEIIGRVNADP 223
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-22
Identities = 50/207 (24%), Positives = 80/207 (38%), Gaps = 36/207 (17%)
Query: 27 AMKYMHKSQCIER-DALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDL 85
A+K + ++NV +E ++ L+HP ++ L E +L +V + GG L
Sbjct: 34 AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPL 93
Query: 86 RYHITQDIKFYSVGTRNDTIHLYAFELGLALD------YL---KTKHIIHRDIKPDNILL 136
+ I + A+ YL IIHRD+K NIL+
Sbjct: 94 NRVL-----------SGKRIPPDIL-VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILI 141
Query: 137 DEEGHAH--------ITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
++ ITDF +A S +G ++APE+ + +S
Sbjct: 142 LQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRASM-----FSKGS 195
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSV 215
D WS GV L+E+L PF +V
Sbjct: 196 DVWSYGVLLWELLTGEVPFRGIDGLAV 222
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-22
Identities = 50/204 (24%), Positives = 85/204 (41%), Gaps = 30/204 (14%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDE 70
S+V + +K ++ K + RE++IL L P ++ L +D
Sbjct: 50 SEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP 103
Query: 71 ED--LFMVSDLLLGGDLRYHI----TQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHI 124
+V + + D + DI+FY +Y E+ ALDY + I
Sbjct: 104 VSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY----------MY--EILKALDYCHSMGI 151
Query: 125 IHRDIKPDNILLDEEGHA-HITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG 183
+HRD+KP N+++D E + D+ +A Q ++ + PE+ +
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM---- 207
Query: 184 YSYSVDWWSLGVTLFEILARGRPF 207
Y YS+D WSLG L ++ R PF
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-21
Identities = 56/248 (22%), Positives = 93/248 (37%), Gaps = 57/248 (22%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQD- 69
KV + K T++ +A+K + R E+E+ + P +V + +++
Sbjct: 32 GKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVRIVDVYENL 83
Query: 70 ---EEDLFMVSDLLLGGDLRYHIT-QDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHII 125
+ L +V + L GG+L I + + + T + + +G A+ YL + +I
Sbjct: 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TEREASEI-MKSIGEAIQYLHSINIA 139
Query: 126 HRDIKPDNILL---DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVL 182
HRD+KP+N+L +TDF A E
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAK----------------------------ETT 171
Query: 183 GYSY--SVDWWSLGVTLFEILARGRPF--DIHSNTSVKDVKAIIYSPVHYPTA-W---SE 234
G Y S D WSLGV ++ +L PF + S I +P W SE
Sbjct: 172 GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 231
Query: 235 STKHLLSQ 242
K L+
Sbjct: 232 EVKMLIRN 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 7e-21
Identities = 46/200 (23%), Positives = 93/200 (46%), Gaps = 21/200 (10%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCF------ 67
VC + A+K + + + A K RE+ ++ + H +++L F
Sbjct: 78 VCAAYDAVLDRNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136
Query: 68 QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
++ +D+++V +L+ +L I ++ ++ + +++ + +L + IIHR
Sbjct: 137 EEFQDVYLVMELM-DANLCQVIQMELD-------HERMSYLLYQMLCGIKHLHSAGIIHR 188
Query: 128 DIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
D+KP NI++ + I DF +A + + T T+ Y APE+ L GY +
Sbjct: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-----GYKEN 243
Query: 188 VDWWSLGVTLFEILARGRPF 207
VD WS+G + E++ R +
Sbjct: 244 VDIWSVGCIMGEMV-RHKIL 262
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-20
Identities = 47/190 (24%), Positives = 79/190 (41%), Gaps = 18/190 (9%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDL----FMVSDLLLG 82
A+K + + RE + L HP +V ++ + E ++V + + G
Sbjct: 41 AVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDG 100
Query: 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHA 142
LR + + T I + AL++ IIHRD+KP NI++
Sbjct: 101 VTLRDIVHTEGPM----TPKRAIE-VIADACQALNFSHQNGIIHRDVKPANIMISATNAV 155
Query: 143 HITDFNIATVLEENQLATSMS----GTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLF 198
+ DF IA + ++ + + + GT Y++PE D V S D +SLG L+
Sbjct: 156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARS---DVYSLGCVLY 210
Query: 199 EILARGRPFD 208
E+L PF
Sbjct: 211 EVLTGEPPFT 220
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 28/204 (13%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCF------ 67
V + ++ ++ A+K + + + + RE++I+ ++HP +V+L F
Sbjct: 56 VFQAKLVESDEV-AIKKVLQDKRFK-------NRELQIMRIVKHPNVVDLKAFFYSNGDK 107
Query: 68 QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTR---NDTIHLYAFELGLALDYLKTKHI 124
+DE L +V + + + + + Y+ + I LY ++L +L Y+ + I
Sbjct: 108 KDEVFLNLVLEYV-PETVY----RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGI 162
Query: 125 IHRDIKPDNILLDEE-GHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG 183
HRDIKP N+LLD G + DF A +L + S ++ Y APE+ AT+
Sbjct: 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATN---- 218
Query: 184 YSYSVDWWSLGVTLFEILARGRPF 207
Y+ ++D WS G + E++ +G+P
Sbjct: 219 YTTNIDIWSTGCVMAELM-QGQPL 241
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 2e-20
Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79
+DT Q+ A+K +S+ K LRE+ +L L+HP LVNL F+ + L +V +
Sbjct: 25 RDTGQIVAIKKFLESEDDPVIK-KIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83
Query: 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE 139
+ ++ Y G + ++ A+++ + IHRD+KP+NIL+ +
Sbjct: 84 C-DHTVL----HELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH 138
Query: 140 GHAHITDFNIA-TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLF 198
+ DF A + + T+ Y +PE+ + T Y VD W++G
Sbjct: 139 SVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ----YGPPVDVWAIGCVFA 194
Query: 199 EILARGRPF 207
E L G P
Sbjct: 195 E-LLSGVPL 202
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-20
Identities = 50/190 (26%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKNV-LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78
KDT ++ A+K +S + +K + +RE+++L L H LVNL + ++ ++V +
Sbjct: 47 KDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104
Query: 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE 138
+ + D++ + G + Y F++ + + + +IIHRDIKP+NIL+ +
Sbjct: 105 FV-DHTIL----DDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ 159
Query: 139 EGHAHITDFNIATVL-EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTL 197
G + DF A L ++ T+ Y APE+ + Y +VD W++G +
Sbjct: 160 SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK----YGKAVDVWAIGCLV 215
Query: 198 FEILARGRPF 207
E + G P
Sbjct: 216 TE-MFMGEPL 224
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-20
Identities = 46/200 (23%), Positives = 93/200 (46%), Gaps = 21/200 (10%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCF------ 67
VC ++ A+K + + + A K RE+ ++ + H ++ L F
Sbjct: 41 VCAAYDAILERNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99
Query: 68 QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
++ +D+++V +L+ +L I ++ ++ + +++ + +L + IIHR
Sbjct: 100 EEFQDVYIVMELM-DANLCQVIQMELD-------HERMSYLLYQMLCGIKHLHSAGIIHR 151
Query: 128 DIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
D+KP NI++ + I DF +A + + T T+ Y APE+ L GY +
Sbjct: 152 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-----GYKEN 206
Query: 188 VDWWSLGVTLFEILARGRPF 207
VD WS+G + E++ +G
Sbjct: 207 VDIWSVGCIMGEMI-KGGVL 225
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 4e-20
Identities = 45/194 (23%), Positives = 89/194 (45%), Gaps = 21/194 (10%)
Query: 20 KDTKQMYAMKYMHKSQCIERDAL-KNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78
++T ++ A+K + + + + + LRE+ +L L+H +V L ++ L +V +
Sbjct: 24 RETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81
Query: 79 LLLGGDLRYHITQDIKFY----SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNI 134
QD+K Y + + + + F+L L + +++++HRD+KP N+
Sbjct: 82 ---------FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132
Query: 135 LLDEEGHAHITDFNIA-TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSL 193
L++ G + +F +A + ++ T Y P++ A YS S+D WS
Sbjct: 133 LINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL----YSTSIDMWSA 188
Query: 194 GVTLFEILARGRPF 207
G E+ GRP
Sbjct: 189 GCIFAELANAGRPL 202
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-20
Identities = 42/184 (22%), Positives = 87/184 (47%), Gaps = 20/184 (10%)
Query: 39 RDALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYS 97
A K +L E ++ ++++P + L C + +++ L+ G L ++ +
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREH----- 110
Query: 98 VGTRNDTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155
+ +L + + +A ++YL+ + ++HRD+ N+L+ H ITDF +A +L
Sbjct: 111 -KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 156 NQLATSMSGTK---PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIHS 211
+ G K ++A E L Y++ D WS GVT++E++ G +P+D
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRI-----YTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 212 NTSV 215
+ +
Sbjct: 225 ASEI 228
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-19
Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 31/209 (14%)
Query: 14 VCIVQKKDTKQMYAMK--YMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCF---- 67
V + ++K T A+K R+ L+ M+ L L HP +V L F
Sbjct: 39 VQLGKEKSTGMSVAIKKVIQDPRFRN-RE-----LQIMQDLAVLHHPNIVQLQSYFYTLG 92
Query: 68 -QDEEDLF--MVSDLLLGGDLRYHITQDIKFYSVGTR---NDTIHLYAFELGLALDYL-- 119
+D D++ +V + + L + + Y I ++ F+L ++ L
Sbjct: 93 ERDRRDIYLNVVMEYV-PDTL-HRC---CRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL 147
Query: 120 KTKHIIHRDIKPDNILLDEE-GHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVAT 178
+ ++ HRDIKP N+L++E G + DF A L ++ + ++ Y APE+
Sbjct: 148 PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQ 207
Query: 179 DEVLGYSYSVDWWSLGVTLFEILARGRPF 207
Y+ +VD WS+G E++ G P
Sbjct: 208 H----YTTAVDIWSVGCIFAEMM-LGEPI 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-19
Identities = 51/236 (21%), Positives = 101/236 (42%), Gaps = 59/236 (25%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCF------ 67
VC V ++ + +A+K K + +D + RE++I+ L+H ++ L F
Sbjct: 23 VCEVFDIESGKRFALK---K---VLQDP-RYKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75
Query: 68 --------------------------------QDEEDLFMVSDLLLGGDLRYHITQDIKF 95
+ L ++ + + L + +K
Sbjct: 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLH----KVLKS 130
Query: 96 YSVGTR---NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHA-HITDFNIAT 151
+ R + I +Y ++L A+ ++ + I HRDIKP N+L++ + + + DF A
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAK 190
Query: 152 VLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
L ++ + + ++ Y APE+ L AT+ Y+ S+D WS+G E++ G+P
Sbjct: 191 KLIPSEPSVAYICSRFYRAPELMLGATE----YTPSIDLWSIGCVFGELI-LGKPL 241
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-19
Identities = 42/184 (22%), Positives = 87/184 (47%), Gaps = 20/184 (10%)
Query: 39 RDALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYS 97
A K +L E ++ ++++P + L C + +++ L+ G L ++ +
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREH----- 110
Query: 98 VGTRNDTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155
+ +L + + +A ++YL+ + ++HRD+ N+L+ H ITDF +A +L
Sbjct: 111 -KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 156 NQLATSMSGTK---PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIHS 211
+ G K ++A E L Y++ D WS GVT++E++ G +P+D
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRI-----YTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 212 NTSV 215
+ +
Sbjct: 225 ASEI 228
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-19
Identities = 47/197 (23%), Positives = 89/197 (45%), Gaps = 28/197 (14%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCF------QDEEDL 73
K + + A+K + + E A K RE+ +L ++H ++ L F ++ D
Sbjct: 46 KRSGEKVAIKKLSRPFQSEIFA-KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104
Query: 74 FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDN 133
++V + DL+ + + I +++ L Y+ + ++HRD+KP N
Sbjct: 105 YLVMPFM-QTDLQKIMGLKFS-------EEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGN 156
Query: 134 ILLDEEGHAHITDFNIATVLEENQLATSMSG---TKPYIAPEIFLVATDEVLGYSYSVDW 190
+ ++E+ I DF +A + M+G T+ Y APE+ L Y+ +VD
Sbjct: 157 LAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWM----HYNQTVDI 207
Query: 191 WSLGVTLFEILARGRPF 207
WS+G + E+L G+
Sbjct: 208 WSVGCIMAEML-TGKTL 223
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 8e-19
Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 19/167 (11%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFY----SVGTR 101
+RE+ +L L HP +V+L E L +V + + +D+K G +
Sbjct: 67 IREISLLKELHHPNIVSLIDVIHSERCLTLVFE---------FMEKDLKKVLDENKTGLQ 117
Query: 102 NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLEENQLAT 160
+ I +Y ++L + + I+HRD+KP N+L++ +G + DF +A + T
Sbjct: 118 DSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT 177
Query: 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
T Y AP++ + + YS SVD WS+G E + G+P
Sbjct: 178 HEVVTLWYRAPDVLMGSKK----YSTSVDIWSIGCIFAE-MITGKPL 219
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 8e-19
Identities = 55/219 (25%), Positives = 83/219 (37%), Gaps = 38/219 (17%)
Query: 10 GT-SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL------EHPFLVN 62
G+ +V Q A+K + + R A + E+ IL L +++
Sbjct: 108 GSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE----EIRILEHLRKQDKDNTMNVIH 163
Query: 63 LWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK 122
+ F + M +LL +L Y + + KF G + +A + LD L
Sbjct: 164 MLENFTFRNHICMTFELL-SMNL-YELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN 219
Query: 123 HIIHRDIKPDNILLDEEGHAHI--TDFNIATVLEENQLATSMSGTKPYI------APEIF 174
IIH D+KP+NILL ++G + I DF + + YI APE+
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY--------TYIQSRFYRAPEVI 271
Query: 175 LVATDEVLGYSYSVDWWSLGVTLFEILARGRP-FDIHSN 212
L Y +D WSLG L E L G P
Sbjct: 272 L-----GARYGMPIDMWSLGCILAE-LLTGYPLLPGEDE 304
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 9e-19
Identities = 42/164 (25%), Positives = 80/164 (48%), Gaps = 8/164 (4%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHI-TQDIKFYSVGTRNDT 104
+RE+ ++ L+H +V L+ E L +V + + DL+ ++ ++ + G +
Sbjct: 51 IREISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNL 109
Query: 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLEENQLATSMS 163
+ + ++L L + I+HRD+KP N+L+++ G + DF +A +S
Sbjct: 110 VKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 164 GTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
T Y AP++ + + YS S+D WS G L E + G+P
Sbjct: 170 VTLWYRAPDVLMGSRT----YSTSIDIWSCGCILAE-MITGKPL 208
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-18
Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 19/167 (11%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFY----SVGTR 101
+RE+ IL L+H +V L+ ++ L +V + H+ QD+K G
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFE---------HLDQDLKKLLDVCEGGLE 98
Query: 102 NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL-EENQLAT 160
+ T + +L + Y + ++HRD+KP N+L++ EG I DF +A + T
Sbjct: 99 SVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158
Query: 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
T Y AP++ + + YS ++D WS+G E + G P
Sbjct: 159 HEIVTLWYRAPDVLMGSKK----YSTTIDIWSVGCIFAE-MVNGTPL 200
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-18
Identities = 39/185 (21%), Positives = 70/185 (37%), Gaps = 35/185 (18%)
Query: 47 REMEILTTLEHPFLVNLW-FCFQD---EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRN 102
E+ L ++H ++ + + DL++++ G L + +
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----------KA 115
Query: 103 DTIHLYAFELGLALD------YL----------KTKHIIHRDIKPDNILLDEEGHAHITD 146
+ + +A YL I HRDIK N+LL A I D
Sbjct: 116 NVVSWNEL-CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 147 FNIATVLEENQLATSMS---GTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILAR 203
F +A E + A GT+ Y+APE+ A + +D +++G+ L+E+ +R
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 204 GRPFD 208
D
Sbjct: 235 CTAAD 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-18
Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 15/170 (8%)
Query: 43 KNVLREMEILTTLEHPFLVNLWFCF-----QDEEDLFMVSDLLLGGDLRYHITQDIKFYS 97
K VLRE+ +L HP ++ L F L++V++L+ DL Q I
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLA----QVIHDQR 128
Query: 98 VGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157
+ I + + + L L L ++HRD+ P NILL + I DFN+A +
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 158 LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
T + Y APE+ + G++ VD WS G + E+ +
Sbjct: 189 NKTHYVTHRWYRAPELVMQFK----GFTKLVDMWSAGCVMAEMF-NRKAL 233
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-18
Identities = 45/193 (23%), Positives = 82/193 (42%), Gaps = 15/193 (7%)
Query: 40 DALKNVLREMEILTTLEHPFLVNLW-FCFQDEED-LFMVSDLLLGGDLRYHITQDIKFYS 97
+ L++ RE+EIL +L+H +V C+ L ++ + L G LR ++ + +
Sbjct: 53 EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 112
Query: 98 VGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157
+ Y ++ ++YL TK IHRD+ NIL++ E I DF + VL +++
Sbjct: 113 HIK----LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
Query: 158 LA-TSMSGTKPYI---APEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT 213
+ I APE + +S + D WS GV L+E+
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESK-----FSVASDVWSFGVVLYELFTYIEKSKSPPAE 223
Query: 214 SVKDVKAIIYSPV 226
++ + +
Sbjct: 224 FMRMIGNDKQGQM 236
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-18
Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 19/167 (11%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFY----SVGTR 101
+RE+ +L L+H +V L E+ L +V + ++ +D+K Y
Sbjct: 48 IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE---------YLDKDLKQYLDDCGNIIN 98
Query: 102 NDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL-EENQLAT 160
+ L+ F+L L Y + ++HRD+KP N+L++E G + DF +A +
Sbjct: 99 MHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158
Query: 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
+ T Y P+I L +TD YS +D W +G +E +A GRP
Sbjct: 159 NEVVTLWYRPPDILLGSTD----YSTQIDMWGVGCIFYE-MATGRPL 200
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-18
Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 23/201 (11%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCF------ 67
VC T A+K +++ E A K RE+ +L + H ++ L F
Sbjct: 41 VCSAVDGRTGAKVAIKKLYRPFQSELFA-KRAYRELRLLKHMRHENVIGLLDVFTPDETL 99
Query: 68 QDEEDLFMVSDLLLGGDLRYHI-TQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
D D ++V + G DL + + + D I +++ L Y+ IIH
Sbjct: 100 DDFTDFYLVMPFM-GTDLGKLMKHEKLG-------EDRIQFLVYQMLKGLRYIHAAGIIH 151
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSY 186
RD+KP N+ ++E+ I DF +A + T T+ Y APE+ L Y+
Sbjct: 152 RDLKPGNLAVNEDCELKILDFGLARQADSEM--TGYVVTRWYRAPEVILNWM----RYTQ 205
Query: 187 SVDWWSLGVTLFEILARGRPF 207
+VD WS+G + E++ G+
Sbjct: 206 TVDIWSVGCIMAEMI-TGKTL 225
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 3e-18
Identities = 44/187 (23%), Positives = 72/187 (38%), Gaps = 26/187 (13%)
Query: 46 LREMEI--LTTLEHPFLVNL----WFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVG 99
RE EI L H ++ L++VSD G L ++ + +V
Sbjct: 82 FREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVE 139
Query: 100 TRNDTIHLYAFELGLALDYLKTKH--------IIHRDIKPDNILLDEEGHAHITDFNIAT 151
I L A L +L + I HRD+K NIL+ + G I D +A
Sbjct: 140 GM---IKL-ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195
Query: 152 VLEENQLATSMS-----GTKPYIAPEIFLVATD-EVLGYSYSVDWWSLGVTLFEILARGR 205
+ ++ GTK Y+APE+ + + + D +++G+ +EI R
Sbjct: 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255
Query: 206 PFDIHSN 212
IH +
Sbjct: 256 IGGIHED 262
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-18
Identities = 50/229 (21%), Positives = 86/229 (37%), Gaps = 39/229 (17%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-----------EHPFL 60
S V + + AMK + + + +A E+++L + +
Sbjct: 33 STVWLAKDMVNNTHVAMKIV-RGDKVYTEA---AEDEIKLLQRVNDADNTKEDSMGANHI 88
Query: 61 VNL--WFCFQDEED--LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLAL 116
+ L F + + MV ++L G +L I K+ G + + +L L L
Sbjct: 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIK---KYEHRGIPLIYVKQISKQLLLGL 144
Query: 117 DYLKTK-HIIHRDIKPDNILLDEEGHAH------ITDFNIATVLEENQLATSMSGTKPYI 169
DY+ + IIH DIKP+N+L++ I D A ++ T+ T+ Y
Sbjct: 145 DYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHYTNSIQTREYR 202
Query: 170 APEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP-FDIHSNTSVKD 217
+PE+ L + D WS +FE L G F+ S
Sbjct: 203 SPEVLLG-----APWGCGADIWSTACLIFE-LITGDFLFEPDEGHSYTK 245
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-18
Identities = 53/205 (25%), Positives = 84/205 (40%), Gaps = 34/205 (16%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKNV----LREMEILTTL---EHPFLVNLWFCFQ---- 68
+ A+K + + +RE+ +L L EHP +V L
Sbjct: 31 PHSGHFVALKSVRVPN--GGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88
Query: 69 -DEEDLFMVSDLLLGGDLRYHITQDIKFY-----SVGTRNDTIHLYAFELGLALDYLKTK 122
E + +V + H+ QD++ Y G +TI + LD+L
Sbjct: 89 DREIKVTLVFE---------HVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 139
Query: 123 HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVL 182
I+HRD+KP+NIL+ G + DF +A + T + T Y APE+ L +T
Sbjct: 140 CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST---- 195
Query: 183 GYSYSVDWWSLGVTLFEILARGRPF 207
Y+ VD WS+G E + R +P
Sbjct: 196 -YATPVDMWSVGCIFAE-MFRRKPL 218
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-18
Identities = 40/180 (22%), Positives = 73/180 (40%), Gaps = 16/180 (8%)
Query: 41 ALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVG 99
+ + V M + +L+H +V L C L +V+ L G L H+ Q
Sbjct: 58 SFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHVRQHRGALGPQ 115
Query: 100 TRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159
+ + ++ + YL+ ++HR++ N+LL + DF +A +L +
Sbjct: 116 L----LLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171
Query: 160 TSMSGTK---PYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSV 215
S K ++A E Y++ D WS GVT++E++ G P+ V
Sbjct: 172 LLYSEAKTPIKWMALESIHFGK-----YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 5e-18
Identities = 42/194 (21%), Positives = 85/194 (43%), Gaps = 15/194 (7%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR 86
A+K K +E + L+E ++ ++HP LV L E +++++ + G+L
Sbjct: 249 AVK-TLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304
Query: 87 YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITD 146
++ + + + ++ A ++ A++YL+ K+ IHR++ N L+ E + D
Sbjct: 305 DYLRECNR--QEVSAVVLLY-MATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVAD 361
Query: 147 FNIATVLEENQLATSMSGTKPY--IAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204
F ++ ++ + P APE +S D W+ GV L+EI G
Sbjct: 362 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-----FSIKSDVWAFGVLLWEIATYG 416
Query: 205 R-PFDIHSNTSVKD 217
P+ + V +
Sbjct: 417 MSPYPGIDLSQVYE 430
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-18
Identities = 45/193 (23%), Positives = 82/193 (42%), Gaps = 15/193 (7%)
Query: 40 DALKNVLREMEILTTLEHPFLVNLW-FCFQDEED-LFMVSDLLLGGDLRYHITQDIKFYS 97
+ L++ RE+EIL +L+H +V C+ L ++ + L G LR ++ + +
Sbjct: 84 EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 143
Query: 98 VGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157
+ Y ++ ++YL TK IHRD+ NIL++ E I DF + VL +++
Sbjct: 144 HIK----LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
Query: 158 LA-TSMSGTKPYI---APEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT 213
+ I APE + +S + D WS GV L+E+
Sbjct: 200 EYYKVKEPGESPIFWYAPESLTESK-----FSVASDVWSFGVVLYELFTYIEKSKSPPAE 254
Query: 214 SVKDVKAIIYSPV 226
++ + +
Sbjct: 255 FMRMIGNDKQGQM 267
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-18
Identities = 52/163 (31%), Positives = 76/163 (46%), Gaps = 11/163 (6%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
LRE+++L L HP ++ L F + ++ +V D + DL I + + I
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSH----I 114
Query: 106 HLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL-EENQLATSMSG 164
Y L+YL I+HRD+KP+N+LLDE G + DF +A N+ T
Sbjct: 115 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 174
Query: 165 TKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
T+ Y APE+ A Y VD W++G L E L PF
Sbjct: 175 TRWYRAPELLFGARM----YGVGVDMWAVGCILAE-LLLRVPF 212
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-18
Identities = 38/174 (21%), Positives = 79/174 (45%), Gaps = 19/174 (10%)
Query: 40 DALKNVLREMEILTTLEHPFLVNLW-FCFQDEED-LFMVSDLLLGGDLRYHITQDIKFYS 97
+ + ++ +E+EIL L H +V C +D + + ++ + L G L+ ++ ++
Sbjct: 65 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN----- 119
Query: 98 VGTRNDTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155
+ + + + + +DYL ++ +HRD+ N+L++ E I DF + +E
Sbjct: 120 -KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178
Query: 156 NQLA-TSMSGTKPYI---APEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205
++ T + APE + + + + D WS GVTL E+L
Sbjct: 179 DKEYYTVKDDRDSPVFWYAPECLMQSK-----FYIASDVWSFGVTLHELLTYCD 227
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 9e-18
Identities = 43/195 (22%), Positives = 79/195 (40%), Gaps = 20/195 (10%)
Query: 20 KDTKQMYAMKYMHKSQCIERDAL-KNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78
T + A+K + E + + +RE+ +L L+H ++ L L ++ +
Sbjct: 56 TVTNETVAIKRIRLEH--EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113
Query: 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE 138
DL+ ++ ++ I + ++L +++ ++ +HRD+KP N+LL
Sbjct: 114 YA-ENDLKKYMDKNPDVSM-----RVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSV 167
Query: 139 EGHAH-----ITDFNIA-TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWS 192
+ I DF +A + T T Y PEI L + YS SVD WS
Sbjct: 168 SDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRH----YSTSVDIWS 223
Query: 193 LGVTLFEILARGRPF 207
+ E + P
Sbjct: 224 IACIWAE-MLMKTPL 237
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 9e-18
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 17/195 (8%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDL 85
A+K + + +A+ + +RE+ + +L+H L+ L+ + MV++L G L
Sbjct: 50 AVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL--TPPMKMVTELAPLGSL 107
Query: 86 RYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHIT 145
+ + + +GT + YA ++ + YL++K IHRD+ N+LL I
Sbjct: 108 LDRLRKHQGHFLLGT----LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIG 163
Query: 146 DFNIATVLEENQ-LATSMSGTK-PY--IAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
DF + L +N K P+ APE T +S++ D W GVTL+E+
Sbjct: 164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-----FSHASDTWMFGVTLWEMF 218
Query: 202 ARGR-PFDIHSNTSV 215
G+ P+ + + +
Sbjct: 219 TYGQEPWIGLNGSQI 233
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-18
Identities = 43/173 (24%), Positives = 73/173 (42%), Gaps = 17/173 (9%)
Query: 40 DALKNVLREMEILTTLEHPFLVNLW-FCFQDEED-LFMVSDLLLGGDLR-YHITQDIKFY 96
D ++ RE++IL L F+V + L +V + L G LR + +
Sbjct: 66 DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL- 124
Query: 97 SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156
+ LY+ ++ ++YL ++ +HRD+ NIL++ E H I DF +A +L +
Sbjct: 125 ----DASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180
Query: 157 Q-LATSMSGTKPYI---APEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205
+ + I APE +S D WS GV L+E+
Sbjct: 181 KDYYVVREPGQSPIFWYAPESLSDNI-----FSRQSDVWSFGVVLYELFTYCD 228
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-17
Identities = 62/175 (35%), Positives = 89/175 (50%), Gaps = 36/175 (20%)
Query: 48 EMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIH 106
E+E L+ HP LV+L FC + E + ++ + G+L+ H+ G+ T+
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDERNE-MILIYKYMENGNLKRHLY--------GSDLPTMS 135
Query: 107 LYAFE------LGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA---TVLEE 155
+ ++E +G A L YL T+ IIHRD+K NILLDE ITDF I+ T L++
Sbjct: 136 M-SWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 156 NQLATSMSGTKPYIAPEIF----LVATDEVLGYSYSVDWWSLGVTLFEILARGRP 206
L+T + GT YI PE F L +V YS+ GV LFE+L R
Sbjct: 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDV--YSF-------GVVLFEVLC-ARS 239
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-17
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 23/201 (11%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNL------WFCF 67
VC T A+K + + A K RE+ +L ++H ++ L
Sbjct: 45 VCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLKHMKHENVIGLLDVFTPARSL 103
Query: 68 QDEEDLFMVSDLLLGGDLRYHI-TQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
++ D+++V+ L+ G DL + Q + +D + +++ L Y+ + IIH
Sbjct: 104 EEFNDVYLVTHLM-GADLNNIVKCQKLT-------DDHVQFLIYQILRGLKYIHSADIIH 155
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSY 186
RD+KP N+ ++E+ I DF +A + T T+ Y APEI L Y+
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRAPEIMLNWMH----YNQ 209
Query: 187 SVDWWSLGVTLFEILARGRPF 207
+VD WS+G + E+L GR
Sbjct: 210 TVDIWSVGCIMAELL-TGRTL 229
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-17
Identities = 50/195 (25%), Positives = 79/195 (40%), Gaps = 21/195 (10%)
Query: 19 KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-FCFQDEED-LFMV 76
T +M A+K K+ + +E++IL TL H ++ C L +V
Sbjct: 56 NDGTGEMVAVK-ALKADAGPQH-RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113
Query: 77 SDLLLGGDLR-YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNIL 135
+ + G LR Y I + L+A ++ + YL +H IHRD+ N+L
Sbjct: 114 MEYVPLGSLRDYLPRHSIGL-------AQLLLFAQQICEGMAYLHAQHYIHRDLAARNVL 166
Query: 136 LDEEGHAHITDFNIATVLEENQLA-TSMSGTKPYI---APEIFLVATDEVLGYSYSVDWW 191
LD + I DF +A + E + APE + + Y+ D W
Sbjct: 167 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE---CLKEYK--FYYASDVW 221
Query: 192 SLGVTLFEILARGRP 206
S GVTL+E+L
Sbjct: 222 SFGVTLYELLTHCDS 236
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-17
Identities = 43/186 (23%), Positives = 70/186 (37%), Gaps = 30/186 (16%)
Query: 46 LREMEILTT--LEHPFLVNL----WFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVG 99
RE E+ T L H ++ L++++ G L ++
Sbjct: 48 FRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-------- 99
Query: 100 TRNDTIHLYAFELGLA--LDYLKTKH--------IIHRDIKPDNILLDEEGHAHITDFNI 149
T DT+ L +A L +L + I HRD+K NIL+ + G I D +
Sbjct: 100 TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159
Query: 150 ATVLEENQ-----LATSMSGTKPYIAPEIFLVATD-EVLGYSYSVDWWSLGVTLFEILAR 203
A + ++ GTK Y+APE+ + VD W+ G+ L+E+ R
Sbjct: 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
Query: 204 GRPFDI 209
I
Sbjct: 220 MVSNGI 225
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-17
Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 23/175 (13%)
Query: 43 KNVLREMEILTTLEHPFLVNLWFCFQDE-----EDLFMVSDLLLGGDLRYHI-TQDIKFY 96
+ LRE++IL H ++ + + +D+++V DL+ DL + TQ +
Sbjct: 70 QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLS-- 126
Query: 97 SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIA-TVLEE 155
ND I + +++ L Y+ + +++HRD+KP N+LL+ I DF +A +
Sbjct: 127 -----NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 156 NQLATSMSG---TKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
+ ++ T+ Y APEI L + Y+ S+D WS+G L E+L RP
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEML-SNRPI 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-17
Identities = 43/217 (19%), Positives = 85/217 (39%), Gaps = 42/217 (19%)
Query: 14 VCIVQKKDTKQMYAMK---YMHKSQCIERDALKNVLREMEILTTLEHPFLVNL------- 63
V D + A+K K+ LRE++I+ L+H +V +
Sbjct: 27 VFSAVDNDCDKRVAIKKIVLTDPQSV------KHALREIKIIRRLDHDNIVKVFEILGPS 80
Query: 64 -------WFCFQDEEDLFMVSDLLLGGDLRYHI-TQDIKFYSVGTRNDTIHLYAFELGLA 115
+ +++V + + DL + + + L+ ++L
Sbjct: 81 GSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLL-------EEHARLFMYQLLRG 132
Query: 116 LDYLKTKHIIHRDIKPDNILLDEEG-HAHITDFNIA-TVLEENQLATSMSG---TKPYIA 170
L Y+ + +++HRD+KP N+ ++ E I DF +A + +S TK Y +
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS 192
Query: 171 PEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
P + L + Y+ ++D W+ G E+L G+
Sbjct: 193 PRLLLSPNN----YTKAIDMWAAGCIFAEML-TGKTL 224
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-17
Identities = 56/233 (24%), Positives = 86/233 (36%), Gaps = 44/233 (18%)
Query: 10 GT-SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-----EHPFLVNL 63
GT +V + Q D K+ YA+K + ++ + E +IL + + +V
Sbjct: 46 GTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRS---AKIEADILKKIQNDDINNNNIVKY 101
Query: 64 WFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH 123
F + + ++ + L G L Y I + G + I LY E+ AL+YL+
Sbjct: 102 HGKFMYYDHMCLIFEPL-GPSL-YEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKMS 157
Query: 124 IIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTK----------------- 166
+ H D+KP+NILLD+ + T
Sbjct: 158 LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG 217
Query: 167 PYI------APEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP-FDIHSN 212
I APE+ L LG+ S D WS G L E L G F H +
Sbjct: 218 SIINTRQYRAPEVIL-----NLGWDVSSDMWSFGCVLAE-LYTGSLLFRTHEH 264
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-17
Identities = 39/187 (20%), Positives = 67/187 (35%), Gaps = 37/187 (19%)
Query: 46 LREMEI--LTTLEHPFLVNL-----WFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSV 98
+ E I + +EH + + +V + G L +++
Sbjct: 53 INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL------- 105
Query: 99 GTRNDTIHLYAFELGLA--LDYL---------KTKHIIHRDIKPDNILLDEEGHAHITDF 147
+D + + L YL I HRD+ N+L+ +G I+DF
Sbjct: 106 -HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164
Query: 148 NIATVLEENQLA---------TSMSGTKPYIAPEIF--LVATDEVLGYSYSVDWWSLGVT 196
++ L N+L S GT Y+APE+ V + VD ++LG+
Sbjct: 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI 224
Query: 197 LFEILAR 203
+EI R
Sbjct: 225 YWEIFMR 231
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 3e-17
Identities = 50/173 (28%), Positives = 72/173 (41%), Gaps = 25/173 (14%)
Query: 46 LREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHI--TQDIKFYSVGTRN 102
+E++++ +H LV L F ++ +V + G L + S R
Sbjct: 78 DQEIKVMAKCQHENLVELLGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 103 DTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160
G A +++L H IHRDIK NILLDE A I+DF +A E+ T
Sbjct: 137 KIA------QGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA-QT 189
Query: 161 SMS----GTKPYIAPEIFLVATDEVLGYSYS-VDWWSLGVTLFEILARGRPFD 208
M+ GT Y+APE + G D +S GV L EI+ D
Sbjct: 190 VMTSRIVGTTAYMAPEA-------LRGEITPKSDIYSFGVVLLEIITGLPAVD 235
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-17
Identities = 52/175 (29%), Positives = 76/175 (43%), Gaps = 25/175 (14%)
Query: 46 LREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSV---GTR 101
E+E+++ H L+ L FC E L +V + G + + + + R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 102 NDTIHLYAFELGLA--LDYLKTK---HIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156
LG A L YL IIHRD+K NILLDEE A + DF +A +++
Sbjct: 134 QRIA------LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 157 Q--LATSMSGTKPYIAPEIFLVATDEVLGY-SYSVDWWSLGVTLFEILARGRPFD 208
+ T++ GT +IAPE G S D + GV L E++ R FD
Sbjct: 188 DTHVTTAVRGTIGHIAPEYLS------TGKSSEKTDVFGYGVMLLELITGQRAFD 236
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 4e-17
Identities = 50/212 (23%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL------EHPFLVNLWF 65
+V + ++ A+K + K++ + E+ +L + ++V+L
Sbjct: 68 GQVVKAYDRVEQEWVAIKII-KNKKAFLNQ---AQIEVRLLELMNKHDTEMKYYIVHLKR 123
Query: 66 CFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK--H 123
F L +V ++L +L Y + ++ F G + +A ++ AL +L T
Sbjct: 124 HFMFRNHLCLVFEML-SYNL-YDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPELS 179
Query: 124 IIHRDIKPDNILLDEEGHAHIT--DFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEV 181
IIH D+KP+NILL + I DF + + Q ++ Y +PE+ L
Sbjct: 180 IIHCDLKPENILLCNPKRSAIKIVDFGSSC--QLGQRIYQYIQSRFYRSPEVLL-----G 232
Query: 182 LGYSYSVDWWSLGVTLFEILARGRP-FDIHSN 212
+ Y ++D WSLG L E + G P F +
Sbjct: 233 MPYDLAIDMWSLGCILVE-MHTGEPLFSGANE 263
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 6e-17
Identities = 40/185 (21%), Positives = 68/185 (36%), Gaps = 26/185 (14%)
Query: 46 LREMEILTT--LEHPFLVNL----WFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVG 99
RE EI T + H ++ L++++D G L ++ +
Sbjct: 77 FRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTL 131
Query: 100 TRNDTIHLYAFELGLALDYLKTK--------HIIHRDIKPDNILLDEEGHAHITDFNIAT 151
+ L A+ L +L T+ I HRD+K NIL+ + G I D +A
Sbjct: 132 DAKSMLKL-AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190
Query: 152 VLEENQ-----LATSMSGTKPYIAPEIFLVATD-EVLGYSYSVDWWSLGVTLFEILARGR 205
+ + GTK Y+ PE+ + + D +S G+ L+E+ R
Sbjct: 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250
Query: 206 PFDIH 210
I
Sbjct: 251 SGGIV 255
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 7e-17
Identities = 42/197 (21%), Positives = 86/197 (43%), Gaps = 23/197 (11%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDL 85
A+K + K++ + +L E ++ L++P++V + C + E +V ++ G L
Sbjct: 48 AVKIL-KNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPL 104
Query: 86 RYHITQDIKFYSVGTRNDTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAH 143
K+ ++ ++ + YL+ + +HRD+ N+LL + +A
Sbjct: 105 N-------KYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAK 157
Query: 144 ITDFNIATVLEENQLA-TSMSGTK-PY--IAPEIFLVATDEVLGYSYSVDWWSLGVTLFE 199
I+DF ++ L ++ + + K P APE +S D WS GV ++E
Sbjct: 158 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-----FSSKSDVWSFGVLMWE 212
Query: 200 ILARGR-PFDIHSNTSV 215
+ G+ P+ + V
Sbjct: 213 AFSYGQKPYRGMKGSEV 229
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-16
Identities = 46/203 (22%), Positives = 83/203 (40%), Gaps = 23/203 (11%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79
K A+K K +E + L+E ++ ++HP LV L E +++++
Sbjct: 35 KKYSLTVAVK-TLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90
Query: 80 LLGGD----LRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNIL 135
+ G+ LR Q++ + A ++ A++YL+ K+ IHRD+ N L
Sbjct: 91 MTYGNLLDYLRECNRQEVSA-------VVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 136 LDEEGHAHITDFNIATVLEENQLATSMSGTKPY--IAPEIFLVATDEVLGYSYSVDWWSL 193
+ E + DF ++ ++ + P APE +S D W+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNK--FSIKSDVWAF 198
Query: 194 GVTLFEILARGR-PFDIHSNTSV 215
GV L+EI G P+ + V
Sbjct: 199 GVLLWEIATYGMSPYPGIDLSQV 221
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-16
Identities = 50/226 (22%), Positives = 86/226 (38%), Gaps = 44/226 (19%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-------EHPFLVNLWFC 66
V + K A+K + ++ R+A E+ +L + + V +
Sbjct: 36 VECLDHARGKSQVALKII-RNVGKYREA---ARLEINVLKKIKEKDKENKFLC-VLMSDW 90
Query: 67 FQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
F + + +LL G + + ++ F + A++L AL +L + H
Sbjct: 91 FNFHGHMCIAFELL-GKNT-FEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHENQLTH 146
Query: 127 RDIKPDNILLDEEGHAHIT-------------------DFNIATVLEENQLATSMSGTKP 167
D+KP+NIL + DF AT +++ T++ T+
Sbjct: 147 TDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT--FDHEHHTTIVATRH 204
Query: 168 YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP-FDIHSN 212
Y PE+ L LG++ D WS+G LFE RG F H N
Sbjct: 205 YRPPEVIL-----ELGWAQPCDVWSIGCILFE-YYRGFTLFQTHEN 244
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-16
Identities = 53/213 (24%), Positives = 99/213 (46%), Gaps = 36/213 (16%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIER--DALKNVLREMEILTTLEHPFLVNLWFCF---- 67
VC K T ++ A+K K + ++ A LRE++IL +H ++ ++
Sbjct: 27 VCSATHKPTGEIVAIK---KIEPFDKPLFA-LRTLREIKILKHFKHENIITIFNIQRPDS 82
Query: 68 -QDEEDLFMVSDLLLGGDLRYHI-TQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHII 125
++ +++++ +L+ DL I TQ + +D I + ++ A+ L ++I
Sbjct: 83 FENFNEVYIIQELM-QTDLHRVISTQMLS-------DDHIQYFIYQTLRAVKVLHGSNVI 134
Query: 126 HRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG-----------TKPYIAPEIF 174
HRD+KP N+L++ + DF +A +++E+ S T+ Y APE+
Sbjct: 135 HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVM 194
Query: 175 LVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
L + YS ++D WS G L E+ RP
Sbjct: 195 LTSAK----YSRAMDVWSCGCILAELF-LRRPI 222
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-16
Identities = 46/193 (23%), Positives = 90/193 (46%), Gaps = 18/193 (9%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR 86
A+K M K + D +E + + L HP LV + E +++V++ + G L
Sbjct: 36 AVK-MIKEGSMSEDEF---FQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91
Query: 87 YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITD 146
++ K + +++ + +L++ IHRD+ N L+D + ++D
Sbjct: 92 NYLRSHGKGLEP----SQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSD 147
Query: 147 FNIATVLEENQLATSMSGTKPYI---APEIFLVATDEVLGYSYSVDWWSLGVTLFEILAR 203
F + + ++Q S GTK + APE V YS D W+ G+ ++E+ +
Sbjct: 148 FGMTRYVLDDQ-YVSSVGTKFPVKWSAPE---VFHYFK--YSSKSDVWAFGILMWEVFSL 201
Query: 204 GR-PFDIHSNTSV 215
G+ P+D+++N+ V
Sbjct: 202 GKMPYDLYTNSEV 214
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-16
Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 28/175 (16%)
Query: 46 LREMEILTTL---EHPFLVNL-----WFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFY- 96
+RE+ +L L EHP +V L E L +V + H+ QD+ Y
Sbjct: 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE---------HVDQDLTTYL 109
Query: 97 ----SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATV 152
G +TI F+L LD+L + ++HRD+KP NIL+ G + DF +A +
Sbjct: 110 DKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169
Query: 153 LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
TS+ T Y APE+ L ++ Y+ VD WS+G E + R +P
Sbjct: 170 YSFQMALTSVVVTLWYRAPEVLLQSS-----YATPVDLWSVGCIFAE-MFRRKPL 218
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 3e-16
Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR 86
A+K K + +A L+E +++ L H LV L+ EE +++V++ + G L
Sbjct: 295 AIK-TLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 349
Query: 87 -YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHIT 145
+ + K+ + + A ++ + Y++ + +HRD++ NIL+ E +
Sbjct: 350 DFLKGETGKYLRL----PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 405
Query: 146 DFNIATVLEENQLATSMSGTKPY--IAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILAR 203
DF +A ++E+N+ P APE L ++ D WS G+ L E+ +
Sbjct: 406 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-----FTIKSDVWSFGILLTELTTK 460
Query: 204 GR-PFDIHSNTSVKD 217
GR P+ N V D
Sbjct: 461 GRVPYPGMVNREVLD 475
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-16
Identities = 50/207 (24%), Positives = 78/207 (37%), Gaps = 36/207 (17%)
Query: 20 KDTKQMYAMK--YMHKSQCIERDALKNV-LREMEILTTLEHPFLVNL--------WFCFQ 68
+ T Q A+K M E++ LRE++IL L+H +VNL +
Sbjct: 39 RKTGQKVALKKVLMEN----EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94
Query: 69 DEEDLFMVSDLL---LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHII 125
+ +++V D L G L +KF I L L Y+ I+
Sbjct: 95 CKGSIYLVFDFCEHDLAGLLS---NVLVKFTL-----SEIKRVMQMLLNGLYYIHRNKIL 146
Query: 126 HRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKP-----YIAPEIFLVATDE 180
HRD+K N+L+ +G + DF +A + + T Y PE+ L D
Sbjct: 147 HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERD- 205
Query: 181 VLGYSYSVDWWSLGVTLFEILARGRPF 207
Y +D W G + E + P
Sbjct: 206 ---YGPPIDLWGAGCIMAE-MWTRSPI 228
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 5e-16
Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 28/198 (14%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR 86
A+K + + + + E E++ L HP LV L+ ++ + +V++ + G L
Sbjct: 36 AIK-TIREGAMSEEDF---IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91
Query: 87 YHITQDIKFYSVGTRNDTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHI 144
++ L L + + YL+ +IHRD+ N L+ E +
Sbjct: 92 DYLRTQ------RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKV 145
Query: 145 TDFNIATVLEENQLATSMSGTK-PY--IAPEIFLVATDEVLGYS-YSV--DWWSLGVTLF 198
+DF + + ++Q TS +GTK P +P EV +S YS D WS GV ++
Sbjct: 146 SDFGMTRFVLDDQY-TSSTGTKFPVKWASP--------EVFSFSRYSSKSDVWSFGVLMW 196
Query: 199 EILARGR-PFDIHSNTSV 215
E+ + G+ P++ SN+ V
Sbjct: 197 EVFSEGKIPYENRSNSEV 214
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 7e-16
Identities = 47/221 (21%), Positives = 90/221 (40%), Gaps = 44/221 (19%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-----FCFQ 68
VC K K++ A+K + + D K +LRE+ IL L H +V + +
Sbjct: 69 VCEAYDKLEKRVVAIKKILRVFEDLIDC-KRILREIAILNRLNHDHVVKVLDIVIPKDVE 127
Query: 69 DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRD 128
++L++V ++ D + + I + L + + Y+ + I+HRD
Sbjct: 128 KFDELYVVLEIA-DSDFKKLFRTPVYL-----TELHIKTLLYNLLVGVKYVHSAGILHRD 181
Query: 129 IKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG------------------------ 164
+KP N L++++ + DF +A ++ + S
Sbjct: 182 LKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLT 241
Query: 165 ----TKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
T+ Y APE+ L+ + Y+ ++D WS+G E+L
Sbjct: 242 GHVVTRWYRAPELILLQEN----YTEAIDVWSIGCIFAELL 278
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-15
Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 22/197 (11%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR 86
A+K K + +A L E ++ TL+H LV L +E ++++++ + G L
Sbjct: 216 AVK-TMKPGSMSVEAF---LAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLL 270
Query: 87 YHITQDIKFYSVGTRNDTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHI 144
+ D G++ L F +A + +++ ++ IHRD++ NIL+ I
Sbjct: 271 DFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKI 325
Query: 145 TDFNIATVLEENQLATSMSGTKPYI---APEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
DF +A V+E+N+ T+ G K I APE + ++ D WS G+ L EI+
Sbjct: 326 ADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGS-----FTIKSDVWSFGILLMEIV 379
Query: 202 ARGR-PFDIHSNTSVKD 217
GR P+ SN V
Sbjct: 380 TYGRIPYPGMSNPEVIR 396
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR 86
A+K K + +A L+E +++ L H LV L+ EE +++V++ + G L
Sbjct: 212 AIK-TLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 266
Query: 87 -YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHIT 145
+ + K+ + + A ++ + Y++ + +HRD++ NIL+ E +
Sbjct: 267 DFLKGETGKYLRL----PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 322
Query: 146 DFNIATVLEENQLATSMSGTKPY--IAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILAR 203
DF +A ++E+N+ P APE L ++ D WS G+ L E+ +
Sbjct: 323 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-----FTIKSDVWSFGILLTELTTK 377
Query: 204 GR-PFDIHSNTSVKD 217
GR P+ N V D
Sbjct: 378 GRVPYPGMVNREVLD 392
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-15
Identities = 42/192 (21%), Positives = 78/192 (40%), Gaps = 36/192 (18%)
Query: 46 LREMEILTTL-------EHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSV 98
E+++L L V + F+ + +V +LL G Y ++ F +
Sbjct: 59 RSEIQVLEHLNTTDPNSTFRC-VQMLEWFEHHGHICIVFELL-GLST-YDFIKENGF--L 113
Query: 99 GTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE---- 154
R D I A+++ ++++L + + H D+KP+NIL + + + I
Sbjct: 114 PFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173
Query: 155 -------------ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
+++ +++ T+ Y APE+ L LG+S D WS+G L E
Sbjct: 174 PDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVIL-----ALGWSQPCDVWSIGCILIE-Y 227
Query: 202 ARGRP-FDIHSN 212
G F H +
Sbjct: 228 YLGFTVFPTHDS 239
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-15
Identities = 43/175 (24%), Positives = 85/175 (48%), Gaps = 18/175 (10%)
Query: 46 LREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDT 104
L E ++T L H LV L +++ L++V++ + G L ++ + SV +
Sbjct: 62 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCL 119
Query: 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG 164
+ ++ ++ A++YL+ + +HRD+ N+L+ E+ A ++DF + + +++
Sbjct: 120 LK-FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDT 173
Query: 165 TK-PY--IAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSV 215
K P APE ++ +S D WS G+ L+EI + GR P+ V
Sbjct: 174 GKLPVKWTAPE---ALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 223
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-15
Identities = 45/194 (23%), Positives = 93/194 (47%), Gaps = 20/194 (10%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR 86
A+K M K + D + E +++ L H LV L+ + +F++++ + G L
Sbjct: 52 AIK-MIKEGSMSEDEF---IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107
Query: 87 -YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHIT 145
Y +F + ++ A++YL++K +HRD+ N L++++G ++
Sbjct: 108 NYLREMRHRF----QTQQLLE-MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVS 162
Query: 146 DFNIATVLEENQLATSMSGTKPYI---APEIFLVATDEVLGYSYSVDWWSLGVTLFEILA 202
DF ++ + +++ TS G+K + PE V +S D W+ GV ++EI +
Sbjct: 163 DFGLSRYVLDDEY-TSSVGSKFPVRWSPPE---VLMYSK--FSSKSDIWAFGVLMWEIYS 216
Query: 203 RGR-PFDIHSNTSV 215
G+ P++ +N+
Sbjct: 217 LGKMPYERFTNSET 230
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-15
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 23/179 (12%)
Query: 46 LREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLR-YHITQDIKFYSVGTRND 103
+RE +I+ L++P++V L C E L +V ++ GG L + + + +
Sbjct: 58 MREAQIMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREEI-------P 108
Query: 104 TIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-T 160
++ ++ + YL+ K+ +HRD+ N+LL +A I+DF ++ L + T
Sbjct: 109 VSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168
Query: 161 SMSGTK-PY--IAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIHSNTSV 215
+ S K P APE +S D WS GVT++E L+ G +P+ V
Sbjct: 169 ARSAGKWPLKWYAPECINFRK-----FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 222
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-15
Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 17/175 (9%)
Query: 46 LREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLR-YHITQDIKFYSVGTRND 103
L+E + +HP +V L E ++++ +L G+LR + +
Sbjct: 64 LQEALTMRQFDHPHIVKLIGVI--TENPVWIIMELCTLGELRSFLQVRKYSL-----DLA 116
Query: 104 TIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMS 163
++ LYA++L AL YL++K +HRDI N+L+ + DF ++ +E++ +
Sbjct: 117 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176
Query: 164 GTKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIHSNTSV 215
G P ++APE ++ + D W GV ++EIL G +PF N V
Sbjct: 177 GKLPIKWMAPE---SINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-15
Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 22/179 (12%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR-YHITQDIKFYSVGTRNDT 104
L E I+ +HP ++ L +V++ + G L + T D +F T
Sbjct: 98 LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF----TIMQL 153
Query: 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMS- 163
+ +G + YL +HRD+ N+L+D ++DF ++ VLE++ A +
Sbjct: 154 VG-MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 164 GTKPYI---APEIFLVATDEVLGYS-YSV--DWWSLGVTLFEILARG-RPFDIHSNTSV 215
G K I AP E + + +S D WS GV ++E+LA G RP+ +N V
Sbjct: 213 GGKIPIRWTAP--------EAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV 263
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-15
Identities = 51/190 (26%), Positives = 74/190 (38%), Gaps = 30/190 (15%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGD----LRYHITQDIKFYSVGTR 101
RE E+LT L+H +V + D + L MV + + GD LR H + R
Sbjct: 65 QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124
Query: 102 NDTIHLYAFEL-GLALD------YLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154
L ++ +A YL ++H +HRD+ N L+ I DF ++ +
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 155 ENQLATSMSGTKPYI---APE-----IFLVATDEVLGYSYSVDWWSLGVTLFEILARGR- 205
T I PE F +D V WS GV L+EI G+
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESD-V---------WSFGVILWEIFTYGKQ 234
Query: 206 PFDIHSNTSV 215
P+ SNT V
Sbjct: 235 PWFQLSNTEV 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-15
Identities = 43/206 (20%), Positives = 83/206 (40%), Gaps = 29/206 (14%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-FCFQDE-----EDLFMVSDLL 80
A+K + D ++ LRE + +HP + L + ++ +
Sbjct: 55 AVKMLKADIIASSD-IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFM 113
Query: 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDE 138
GDL + + L F + +A ++YL +++ IHRD+ N +L E
Sbjct: 114 KHGDLHAFL-LASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE 172
Query: 139 EGHAHITDFNIATVLEENQLATSMSGTK-P--YIAPE-----IFLVATDEVLGYSYSVDW 190
+ + DF ++ + +K P ++A E ++ V +D V
Sbjct: 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSD-V--------- 222
Query: 191 WSLGVTLFEILARGR-PFDIHSNTSV 215
W+ GVT++EI+ RG+ P+ N +
Sbjct: 223 WAFGVTMWEIMTRGQTPYAGIENAEI 248
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 3e-15
Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
+RE +I+ L++P++V L E L +V ++ GG L + + V +
Sbjct: 384 MREAQIMHQLDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-- 440
Query: 106 HLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-TSMSG 164
++ + + YL+ K+ +HR++ N+LL +A I+DF ++ L + T+ S
Sbjct: 441 --LLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498
Query: 165 TKPYI---APEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSV 215
K + APE +S D WS GVT++E L+ G+ P+ V
Sbjct: 499 GKWPLKWYAPECINFRK-----FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 548
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 3e-15
Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 15/174 (8%)
Query: 46 LREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDT 104
L+E + +HP +V L E ++++ +L G+LR + + +
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVI--TENPVWIIMELCTLGELRSFLQVRKFSLDLAS---- 492
Query: 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG 164
+ LYA++L AL YL++K +HRDI N+L+ + DF ++ +E++ + G
Sbjct: 493 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 165 TKP--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIHSNTSV 215
P ++APE ++ + D W GV ++EIL G +PF N V
Sbjct: 553 KLPIKWMAPESINFRR-----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 601
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-15
Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 17/178 (9%)
Query: 46 LREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDT 104
L+E IL HP +V L C Q ++ +++V +L+ GGD + + V T
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQ- 217
Query: 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG 164
+ ++YL++K IHRD+ N L+ E+ I+DF ++ + + G
Sbjct: 218 ---MVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY-AASGG 273
Query: 165 TK--PY--IAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSVKD 217
+ P APE YS D WS G+ L+E + G P+ SN ++
Sbjct: 274 LRQVPVKWTAPEALNYGR-----YSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE 326
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 4e-15
Identities = 59/275 (21%), Positives = 89/275 (32%), Gaps = 77/275 (28%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-----EHP---FLV 61
S V + K+ AMK + KS + E+ +L ++ P +V
Sbjct: 49 HFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL---DEIRLLKSVRNSDPNDPNREMVV 104
Query: 62 NLWFCFQDEED----LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALD 117
L F+ + MV ++L G L I IK G + ++ LD
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWI---IKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 118 YLKTK-HIIHRDIKPDNILL---------------------------------------- 136
YL TK IIH DIKP+NILL
Sbjct: 161 YLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220
Query: 137 ---------DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
E+ I D A + ++ T T+ Y + E+ + + GY+
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEVLIGS-----GYNTP 273
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII 222
D WS FE+ F+ HS + I
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 4e-15
Identities = 44/199 (22%), Positives = 81/199 (40%), Gaps = 23/199 (11%)
Query: 22 TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW--FCFQDEEDLFMVSDL 79
+ YA+K + + + RE+ +L L+HP +++L F + ++++ D
Sbjct: 47 DDKDYALKQIEGT-----GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 101
Query: 80 L---LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL 136
L +++H V + +++ + YL ++HRD+KP NIL+
Sbjct: 102 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILV 161
Query: 137 DEEGHAH----ITDFNIATVL-EENQLATSMSG---TKPYIAPEIFLVATDEVLGYSYSV 188
EG I D A + + + T Y APE+ L A Y+ ++
Sbjct: 162 MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH----YTKAI 217
Query: 189 DWWSLGVTLFEILARGRPF 207
D W++G E L P
Sbjct: 218 DIWAIGCIFAE-LLTSEPI 235
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-15
Identities = 21/182 (11%), Positives = 48/182 (26%), Gaps = 38/182 (20%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR 86
A+ ++ + D L+ L L+ ++ P + + +V++ + GG L+
Sbjct: 60 ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ 119
Query: 87 YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITD 146
+ I L A D + P + + +G +
Sbjct: 120 EVADTSP------SPVGAIRAMQ-SLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAY 172
Query: 147 FNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP 206
+ + D +G +L+ +L P
Sbjct: 173 PA-------------------TMPDA------------NPQDDIRGIGASLYALLVNRWP 201
Query: 207 FD 208
Sbjct: 202 LP 203
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-15
Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 20/178 (11%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR-YHITQDIKFYSVGTRNDT 104
L E I+ +HP ++ L + + +V++ + G L + D +F
Sbjct: 94 LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-------TV 146
Query: 105 IHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LATS 161
I L G+A + YL +HRD+ NIL++ ++DF + VLE++ A +
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 162 MSGTKPYI---APEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIHSNTSV 215
G K I +PE ++ + D WS G+ L+E+++ G RP+ SN V
Sbjct: 207 TRGGKIPIRWTSPEAIAYRK-----FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-15
Identities = 40/182 (21%), Positives = 71/182 (39%), Gaps = 26/182 (14%)
Query: 46 LREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDT 104
LRE ++ L HP ++ L E ++ + GDL I + +V
Sbjct: 70 LREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKD---- 125
Query: 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG 164
+ + ++ ++YL + +HRD+ N +LDE + DF +A + + + +
Sbjct: 126 LISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH 185
Query: 165 TKPYI-----APE-----IFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNT 213
+ A E F +D V WS GV L+E+L RG P+
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSD-V---------WSFGVLLWELLTRGAPPYRHIDPF 235
Query: 214 SV 215
+
Sbjct: 236 DL 237
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 5e-15
Identities = 44/201 (21%), Positives = 82/201 (40%), Gaps = 28/201 (13%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDL 85
A+K + + L E I+ HP +++L C + E +V + GDL
Sbjct: 121 AVK-SLNRITDIGE-VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 178
Query: 86 RYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHIT 145
R I + +V + + ++ + +L +K +HRD+ N +LDE+ +
Sbjct: 179 RNFIRNETHNPTVKD----LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVA 234
Query: 146 DFNIATVLEENQLATSMSGTKPYI-----APE-----IFLVATDEVLGYSYSVDWWSLGV 195
DF +A + + + + + T + A E F +D V WS GV
Sbjct: 235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD-V---------WSFGV 284
Query: 196 TLFEILARG-RPFDIHSNTSV 215
L+E++ RG P+ + +
Sbjct: 285 LLWELMTRGAPPYPDVNTFDI 305
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-15
Identities = 43/177 (24%), Positives = 85/177 (48%), Gaps = 18/177 (10%)
Query: 46 LREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDT 104
L E ++T L H LV L +++ L++V++ + G L ++ + SV +
Sbjct: 234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCL 291
Query: 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG 164
+ ++ ++ A++YL+ + +HRD+ N+L+ E+ A ++DF + + +++
Sbjct: 292 LK-FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDT 345
Query: 165 TK-PY--IAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSVKD 217
K P APE ++ +S D WS G+ L+EI + GR P+ V
Sbjct: 346 GKLPVKWTAPE---ALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 397
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 7e-15
Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 28/200 (14%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGD- 84
A+K K + DA L E ++ L+H LV L+ Q E ++++++ + G
Sbjct: 41 AVK-SLKQGSMSPDAF---LAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITEYMENGSL 94
Query: 85 ---LRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH 141
L+ + + + A ++ + +++ ++ IHRD++ NIL+ +
Sbjct: 95 VDFLKTPSGIKLTI-------NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 147
Query: 142 AHITDFNIATVLEENQLATSMSGTK-PY--IAPEIFLVATDEVLGYSYSVDWWSLGVTLF 198
I DF +A ++E+N+ T+ G K P APE ++ D WS G+ L
Sbjct: 148 CKIADFGLARLIEDNEY-TAREGAKFPIKWTAPE---AINYGT--FTIKSDVWSFGILLT 201
Query: 199 EILARGR-PFDIHSNTSVKD 217
EI+ GR P+ +N V
Sbjct: 202 EIVTHGRIPYPGMTNPEVIQ 221
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 8e-15
Identities = 47/201 (23%), Positives = 85/201 (42%), Gaps = 28/201 (13%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDL 85
A+K + + L E I+ HP +++L C + E +V + GDL
Sbjct: 57 AVK-SLNRITDIGE-VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 114
Query: 86 RYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHIT 145
R I + +V + + ++ + YL +K +HRD+ N +LDE+ +
Sbjct: 115 RNFIRNETHNPTVKD----LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVA 170
Query: 146 DFNIATVLEENQ--LATSMSGTK-P--YIAPE-----IFLVATDEVLGYSYSVDWWSLGV 195
DF +A + + + + +G K P ++A E F +D V WS GV
Sbjct: 171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSD-V---------WSFGV 220
Query: 196 TLFEILARG-RPFDIHSNTSV 215
L+E++ RG P+ + +
Sbjct: 221 LLWELMTRGAPPYPDVNTFDI 241
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 8e-15
Identities = 45/175 (25%), Positives = 84/175 (48%), Gaps = 17/175 (9%)
Query: 46 LREMEILTTLEHPFLVNLW-FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDT 104
+ E I+ L+HP +V L +EE +++ +L G+L +++ ++ V T
Sbjct: 61 MSEAVIMKNLDHPHIVKLIGII--EEEPTWIIMELYPYGELGHYLERNKNSLKVLT---- 114
Query: 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG 164
+ LY+ ++ A+ YL++ + +HRDI NIL+ + DF ++ +E+ S
Sbjct: 115 LVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-YYKASV 173
Query: 165 TKPYI---APEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSV 215
T+ I +PE ++ + D W V ++EIL+ G+ PF N V
Sbjct: 174 TRLPIKWMSPESINFRR-----FTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-14
Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 40/220 (18%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDE-- 70
V + T ++ A+K + + DA + RE+ ILT L H +VNL + +
Sbjct: 25 VWKSIDRRTGEVVAVKKIFDAFQNSTDA-QRTFREIMILTELSGHENIVNLLNVLRADND 83
Query: 71 EDLFMVSDLLLGGDLRYHI-TQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
D+++V D + DL I ++ ++L + YL + ++HRD+
Sbjct: 84 RDVYLVFDYM-ETDLHAVIRANILE-------PVHKQYVVYQLIKVIKYLHSGGLLHRDM 135
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMSG----------------------TKP 167
KP NILL+ E H + DF ++ + T+ T+
Sbjct: 136 KPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRW 195
Query: 168 YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207
Y APEI L +T Y+ +D WSLG L EIL G+P
Sbjct: 196 YRAPEILLGSTK----YTKGIDMWSLGCILGEIL-CGKPI 230
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-14
Identities = 41/205 (20%), Positives = 80/205 (39%), Gaps = 28/205 (13%)
Query: 27 AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-FCFQDE----EDLFMVSDLLL 81
A+K K + ++ L E + HP ++ L C + ++ +
Sbjct: 66 AVK-TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124
Query: 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEE 139
GDL ++ + + L F + +A ++YL ++ +HRD+ N +L ++
Sbjct: 125 YGDLHTYL-LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD 183
Query: 140 GHAHITDFNIATVLEENQLATSMSGTK-P--YIAPE-----IFLVATDEVLGYSYSVDWW 191
+ DF ++ + K P +IA E ++ +D V W
Sbjct: 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSD-V---------W 233
Query: 192 SLGVTLFEILARGR-PFDIHSNTSV 215
+ GVT++EI RG P+ N +
Sbjct: 234 AFGVTMWEIATRGMTPYPGVQNHEM 258
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-14
Identities = 43/177 (24%), Positives = 79/177 (44%), Gaps = 18/177 (10%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI 105
L E I+ H ++ L + + ++++ + G L + + +
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK------DGEFSVL 147
Query: 106 HLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT-SM 162
L G+A + YL + +HRD+ NIL++ ++DF ++ VLE++ AT +
Sbjct: 148 QLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 163 SGTKPYI---APEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIHSNTSV 215
SG K I APE ++ + D WS G+ ++E++ G RP+ SN V
Sbjct: 208 SGGKIPIRWTAPEAISYRK-----FTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 259
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-14
Identities = 49/216 (22%), Positives = 94/216 (43%), Gaps = 39/216 (18%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE--- 70
V + K+T++ A+K +++ D K +LRE+ IL L+ +++ L+ +
Sbjct: 42 VYLAYDKNTEKNVAIKKVNRMFEDLIDC-KRILREITILNRLKSDYIIRLYDLIIPDDLL 100
Query: 71 --EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRD 128
++L++V ++ DL+ I + I + L L +++ IIHRD
Sbjct: 101 KFDELYIVLEIA-DSDLKKLFKTPIFL-----TEEHIKTILYNLLLGENFIHESGIIHRD 154
Query: 129 IKPDNILLDEEGHAHITDFNIATVLEENQLATSMSG-----------------------T 165
+KP N LL+++ + DF +A + + ++ T
Sbjct: 155 LKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVT 214
Query: 166 KPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEIL 201
+ Y APE+ L+ + Y+ S+D WS G E+L
Sbjct: 215 RWYRAPELILLQEN----YTKSIDIWSTGCIFAELL 246
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-14
Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLW-FCFQDEEDLF 74
+ K T + A+K M K + + ++ E++IL + H +VNL C + L
Sbjct: 51 IDKTATCRTVAVK-MLKEGATHSE-HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 108
Query: 75 MVSDLLLGGD----LRYHITQDIKFYSVGTRNDTIHL-------YAFELGLALDYLKTKH 123
++ + G+ LR + + + L Y+F++ +++L ++
Sbjct: 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168
Query: 124 IIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTK-P--YIAPEIFLVATDE 180
IHRD+ NILL E+ I DF +A + ++ + P ++APE D
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE---TIFDR 225
Query: 181 VLGYSYSVDWWSLGVTLFEILARGR 205
V Y+ D WS GV L+EI + G
Sbjct: 226 V--YTIQSDVWSFGVLLWEIFSLGA 248
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-14
Identities = 44/214 (20%), Positives = 77/214 (35%), Gaps = 28/214 (13%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76
V K + + A+K R+ L E ++ +V L + ++
Sbjct: 49 VVKDEPETRVAIK-TVNEAASMRE-RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 106
Query: 77 SDLLLGGDLR------YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIK 130
+L+ GDL+ + + + + I A E+ + YL +HRD+
Sbjct: 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ-MAGEIADGMAYLNANKFVHRDLA 165
Query: 131 PDNILLDEEGHAHITDFNIATVLEENQLATSMSGTK-P--YIAPE-----IFLVATDEVL 182
N ++ E+ I DF + + E P +++PE +F +D V
Sbjct: 166 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSD-V- 223
Query: 183 GYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSV 215
WS GV L+EI P+ SN V
Sbjct: 224 --------WSFGVVLWEIATLAEQPYQGLSNEQV 249
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-14
Identities = 40/190 (21%), Positives = 71/190 (37%), Gaps = 30/190 (15%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGD----LRYHITQDIKFYSVGTR 101
E + L+HP +V L ++ L M+ GD L + R
Sbjct: 60 RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 102 NDTIHLYAFEL-GLALD------YLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154
L + L YL + H++H+D+ N+L+ ++ + I+D + +
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 155 ENQLATSMSGTKPYI---APE-----IFLVATDEVLGYSYSVDWWSLGVTLFEILARGR- 205
+ + I APE F + +D + WS GV L+E+ + G
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSD-I---------WSYGVVLWEVFSYGLQ 229
Query: 206 PFDIHSNTSV 215
P+ +SN V
Sbjct: 230 PYCGYSNQDV 239
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-13
Identities = 54/213 (25%), Positives = 84/213 (39%), Gaps = 26/213 (12%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76
+ + A+K C E+D + L E I++ H +V F++
Sbjct: 95 MPNDPSPLQVAVK-TLPEVCSEQD-ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 152
Query: 77 SDLLLGGDL-------RYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+L+ GGDL R +Q D +H+ A ++ YL+ H IHRDI
Sbjct: 153 LELMAGGDLKSFLRETRPRPSQPSSL----AMLDLLHV-ARDIACGCQYLEENHFIHRDI 207
Query: 130 KPDNILLDEEGHAH---ITDFNIATVLEENQLATSMSGTK-P--YIAPEIFLVATDEVLG 183
N LL G I DF +A + P ++ PE F+ + +
Sbjct: 208 AARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM---EGI-- 262
Query: 184 YSYSVDWWSLGVTLFEILARG-RPFDIHSNTSV 215
++ D WS GV L+EI + G P+ SN V
Sbjct: 263 FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 54/213 (25%), Positives = 84/213 (39%), Gaps = 26/213 (12%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76
+ + A+K C E+D + L E I++ H +V F++
Sbjct: 54 MPNDPSPLQVAVK-TLPEVCSEQD-ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 111
Query: 77 SDLLLGGDL-------RYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+L+ GGDL R +Q D +H+ A ++ YL+ H IHRDI
Sbjct: 112 MELMAGGDLKSFLRETRPRPSQPSSL----AMLDLLHV-ARDIACGCQYLEENHFIHRDI 166
Query: 130 KPDNILLDEEGHAH---ITDFNIATVLEENQLATSMSGTK-P--YIAPEIFLVATDEVLG 183
N LL G I DF +A + P ++ PE F+ + +
Sbjct: 167 AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM---EGI-- 221
Query: 184 YSYSVDWWSLGVTLFEILARGR-PFDIHSNTSV 215
++ D WS GV L+EI + G P+ SN V
Sbjct: 222 FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-13
Identities = 40/221 (18%), Positives = 77/221 (34%), Gaps = 31/221 (14%)
Query: 8 FCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-FC 66
F G + + + +K + K+ R+ ++ +++ L H LV + C
Sbjct: 25 FKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC 81
Query: 67 FQDEEDLFMVSDLLLGGDLR-YHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHII 125
+E +V + + G L Y + A +L A+ +L+ +I
Sbjct: 82 VCGDE-NILVQEFVKFGSLDTYLKKNKNCI----NILWKLE-VAKQLAAAMHFLEENTLI 135
Query: 126 HRDIKPDNILLDEEGHAH--------ITDFNIATVLEENQLATSMSGTKPY--IAPEIFL 175
H ++ NILL E ++D I+ + + + PE
Sbjct: 136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----ILQERIPWVPPE--- 187
Query: 176 VATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSV 215
+ + + D WS G TL+EI + G P +
Sbjct: 188 -CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-13
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 31/212 (14%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76
++ + A+K M K + L+++L E +L + HP ++ L+ + L ++
Sbjct: 47 LKGRAGYTTVAVK-MLKENASPSE-LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104
Query: 77 SDLLLGGDLR------------YHITQDIKFYSVGTRNDTIHL-------YAFELGLALD 117
+ G LR Y + + S D L +A+++ +
Sbjct: 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQ 164
Query: 118 YLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTK-P--YIAPE-I 173
YL ++HRD+ NIL+ E I+DF ++ + E S + P ++A E +
Sbjct: 165 YLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL 224
Query: 174 FLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205
F D + Y+ D WS GV L+EI+ G
Sbjct: 225 F----DHI--YTTQSDVWSFGVLLWEIVTLGG 250
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-13
Identities = 50/213 (23%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 8 FCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFC 66
+ K + A+K M KS E+D L +++ EME++ + +H ++NL
Sbjct: 86 VLAEAIGLDKDKPNRVTKVAVK-MLKSDATEKD-LSDLISEMEMMKMIGKHKNIINLLGA 143
Query: 67 FQDEEDLFMVSDLLLGGD----LRYHITQDIKFYSVGTRNDTIHL-------YAFELGLA 115
+ L+++ + G+ L+ +++ + N L A+++
Sbjct: 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARG 203
Query: 116 LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTK-P--YIAPE 172
++YL +K IHRD+ N+L+ E+ I DF +A + + + P ++APE
Sbjct: 204 MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 263
Query: 173 IFLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205
D + Y++ D WS GV L+EI G
Sbjct: 264 ---ALFDRI--YTHQSDVWSFGVLLWEIFTLGG 291
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-13
Identities = 50/196 (25%), Positives = 73/196 (37%), Gaps = 31/196 (15%)
Query: 40 DALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGD----LRYH-ITQDIK 94
A ++ RE E+LT L+H +V + + L MV + + GD LR H +
Sbjct: 85 SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLL 144
Query: 95 FYSVGTRNDTIHLYAFELGLALD------YLKTKHIIHRDIKPDNILLDEEGHAHITDFN 148
+ L L +A YL H +HRD+ N L+ + I DF
Sbjct: 145 AGGEDVAPGPLGLGQL-LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG 203
Query: 149 IATVLEENQLATSMSGTKPYI---APE-----IFLVATDEVLGYSYSVDWWSLGVTLFEI 200
++ + T I PE F +D V WS GV L+EI
Sbjct: 204 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESD-V---------WSFGVVLWEI 253
Query: 201 LARGR-PFDIHSNTSV 215
G+ P+ SNT
Sbjct: 254 FTYGKQPWYQLSNTEA 269
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-13
Identities = 48/211 (22%), Positives = 89/211 (42%), Gaps = 22/211 (10%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQ 68
+ K A+K M K E+D L +++ EME++ + +H ++NL
Sbjct: 54 AEAVGIDKDKPKEAVTVAVK-MLKDDATEKD-LSDLVSEMEMMKMIGKHKNIINLLGACT 111
Query: 69 DEEDLFMVSDLLLGGDL----RYHITQDIKFYSVGTRNDTIHL-------YAFELGLALD 117
+ L+++ + G+L R +++ R + ++L ++
Sbjct: 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGME 171
Query: 118 YLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTK-P--YIAPEIF 174
YL ++ IHRD+ N+L+ E I DF +A + + + P ++APE
Sbjct: 172 YLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 175 LVATDEVLGYSYSVDWWSLGVTLFEILARGR 205
D V Y++ D WS GV ++EI G
Sbjct: 232 F---DRV--YTHQSDVWSFGVLMWEIFTLGG 257
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-12
Identities = 40/175 (22%), Positives = 76/175 (43%), Gaps = 20/175 (11%)
Query: 46 LREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLLLGGD----LRYHITQDIKFYSVGT 100
+ EME++ + +H ++NL + L+++ + G+ LR +++
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193
Query: 101 RNDTIHL-------YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL 153
R + ++L ++YL ++ IHRD+ N+L+ E I DF +A +
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253
Query: 154 EENQLATSMSGTK-P--YIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205
+ + P ++APE D V Y++ D WS GV ++EI G
Sbjct: 254 NNIDYYKKTTNGRLPVKWMAPEALF---DRV--YTHQSDVWSFGVLMWEIFTLGG 303
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-12
Identities = 46/185 (24%), Positives = 77/185 (41%), Gaps = 25/185 (13%)
Query: 38 ERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR---------- 86
ER+AL + E+++L+ L H +VNL ++++ GDL
Sbjct: 69 EREAL---MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 125
Query: 87 -YHITQDIKFYSVGTRNDTIHLYAFELGLA--LDYLKTKHIIHRDIKPDNILLDEEGHAH 143
T D L +F +A + +L +K+ IHRD+ NILL
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITK 185
Query: 144 ITDFNIATVLEENQLATSMSGTK-PY--IAPEIFLVATDEVLGYSYSVDWWSLGVTLFEI 200
I DF +A ++ + + P +APE + V Y++ D WS G+ L+E+
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPE---SIFNCV--YTFESDVWSYGIFLWEL 240
Query: 201 LARGR 205
+ G
Sbjct: 241 FSLGS 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-12
Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 23/182 (12%)
Query: 38 ERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLLLGGD----LRYHITQD 92
E++AL + E++I++ L +H +VNL + ++++ GD LR
Sbjct: 92 EKEAL---MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVL 148
Query: 93 IKFYSVGTRNDTIHL-----YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDF 147
+ N T ++ ++ + +L +K+ IHRD+ N+LL A I DF
Sbjct: 149 ETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDF 208
Query: 148 NIATVLEENQLATSMSGTKPYI---APE-IFLVATDEVLGYSYSVDWWSLGVTLFEILAR 203
+A + + + + APE IF D V Y+ D WS G+ L+EI +
Sbjct: 209 GLARDIMNDSNYIVKGNARLPVKWMAPESIF----DCV--YTVQSDVWSYGILLWEIFSL 262
Query: 204 GR 205
G
Sbjct: 263 GL 264
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-12
Identities = 35/198 (17%), Positives = 69/198 (34%), Gaps = 38/198 (19%)
Query: 46 LREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLGGDLR--------------YHITQ 91
RE ++ ++P +V L + + ++ + + GDL H
Sbjct: 98 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 92 DIKFYSVGTRNDTIHL-----YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITD 146
+ + A ++ + YL + +HRD+ N L+ E I D
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 217
Query: 147 FNIATVLEENQLATSMSGTK-P--YIAPE-----IFLVATDEVLGYSYSVDWWSLGVTLF 198
F ++ + + P ++ PE + +D V W+ GV L+
Sbjct: 218 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD-V---------WAYGVVLW 267
Query: 199 EILARGR-PFDIHSNTSV 215
EI + G P+ ++ V
Sbjct: 268 EIFSYGLQPYYGMAHEEV 285
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-11
Identities = 52/210 (24%), Positives = 86/210 (40%), Gaps = 27/210 (12%)
Query: 13 KVC--IVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQD 69
+V ++K + A+K K + D ++ E+E+L L HP ++NL +
Sbjct: 40 QVLKARIKKDGLRMDAAIK-RMKEYASKDD-HRDFAGELEVLCKLGHHPNIINLLGACEH 97
Query: 70 EEDLFMVSDLLLGGD----LRYHITQDIKFYSVGTRNDTIHLYAFEL-GLALD------Y 118
L++ + G+ LR + + L + +L A D Y
Sbjct: 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 157
Query: 119 LKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTK-P--YIAPEIFL 175
L K IHRD+ NIL+ E A I DF ++ E + + P ++A E
Sbjct: 158 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIE--- 211
Query: 176 VATDEVLGYSYSVDWWSLGVTLFEILARGR 205
V Y+ + D WS GV L+EI++ G
Sbjct: 212 SLNYSV--YTTNSDVWSYGVLLWEIVSLGG 239
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-10
Identities = 44/213 (20%), Positives = 88/213 (41%), Gaps = 33/213 (15%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLW-FCFQDEEDLF 74
+ K A+K M K + + + ++ E++++T L H +VNL C ++
Sbjct: 69 ISKTGVSIQVAVK-MLKEKADSSE-REALMSELKMMTQLGSHENIVNLLGACTLSGP-IY 125
Query: 75 MVSDLLLGGDLR-----------YHITQDIKFYSVGTRNDTIHL-------YAFELGLAL 116
++ + GDL + + D L +A+++ +
Sbjct: 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 185
Query: 117 DYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTK-P--YIAPE- 172
++L+ K +HRD+ N+L+ I DF +A + + + P ++APE
Sbjct: 186 EFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 245
Query: 173 IFLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205
+F + + Y+ D WS G+ L+EI + G
Sbjct: 246 LF----EGI--YTIKSDVWSYGILLWEIFSLGV 272
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 32/154 (20%), Positives = 64/154 (41%), Gaps = 19/154 (12%)
Query: 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH-PFLVN 62
G F ++ + + T + A+K + + E L +
Sbjct: 18 GCGNFG---ELRLGKNLYTNEYVAIKLEP-----MKSRAPQLHLEYRFYKQLGSGDGIPQ 69
Query: 63 LWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK 122
+++ + MV +LL G L + +S+ T + + A +L ++Y+ +K
Sbjct: 70 VYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKT----VLMIAIQLISRMEYVHSK 124
Query: 123 HIIHRDIKPDNILLDEEGHA-----HITDFNIAT 151
++I+RD+KP+N L+ G+ HI DF +A
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-09
Identities = 29/144 (20%), Positives = 55/144 (38%), Gaps = 16/144 (11%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH-PFLVNLWFCFQDEED 72
+ Q A+K+ R + E L + N+++ Q+
Sbjct: 26 IFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+V DLL G L + + +SV T + + A ++ + + K +++RDIKPD
Sbjct: 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKT----VAMAAKQMLARVQSIHEKSLVYRDIKPD 135
Query: 133 NILLDEEGHA-----HITDFNIAT 151
N L+ ++ DF +
Sbjct: 136 NFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 9e-09
Identities = 32/142 (22%), Positives = 62/142 (43%), Gaps = 14/142 (9%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEED 72
+ + T + A+K + + +L E +I L+ + N+ + + +
Sbjct: 23 IYLGTNIQTNEEVAIKLEN-----VKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDY 77
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+V DLL G L + S+ T + + A ++ ++++ +K +HRDIKPD
Sbjct: 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKT----VLMLADQMINRVEFVHSKSFLHRDIKPD 132
Query: 133 NILLDEEGHAH---ITDFNIAT 151
N L+ A+ I DF +A
Sbjct: 133 NFLMGLGRRANQVYIIDFGLAK 154
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-08
Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 8/101 (7%)
Query: 108 YAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTK- 166
Y+F++ +++L ++ IHRD+ NILL E+ I DF +A + ++ +
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 167 PY--IAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR 205
P +APE D V Y+ D WS GV L+EI + G
Sbjct: 258 PLKWMAPETIF---DRV--YTIQSDVWSFGVLLWEIFSLGA 293
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-08
Identities = 22/145 (15%), Positives = 50/145 (34%), Gaps = 16/145 (11%)
Query: 17 VQKKDTKQMYAMKYMHK-------SQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
KQ +++K K +R A + + + L + +
Sbjct: 69 CDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVH 128
Query: 70 EEDL-FMVSDLLLGGDLRYHITQ-DIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
++ F+V L G L+ + S + + A L AL++L +H
Sbjct: 129 QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERS----VLQVACRLLDALEFLHENEYVHG 183
Query: 128 DIKPDNILL--DEEGHAHITDFNIA 150
++ +NI + +++ + + A
Sbjct: 184 NVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-08
Identities = 30/141 (21%), Positives = 60/141 (42%), Gaps = 14/141 (9%)
Query: 14 VCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH-PFLVNLWFCFQDEED 72
+ + + A+K + + E +I ++ + + +C + +
Sbjct: 25 IYLGTDIAAGEEVAIKLEC-----VKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
MV +LL G L + +S+ T+ L A ++ ++Y+ +K+ IHRD+KPD
Sbjct: 80 NVMVMELL-GPSLEDLFNFCSRKFSL----KTVLLLADQMISRIEYIHSKNFIHRDVKPD 134
Query: 133 NILLDEEGHAH---ITDFNIA 150
N L+ + I DF +A
Sbjct: 135 NFLMGLGKKGNLVYIIDFGLA 155
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 7e-08
Identities = 26/155 (16%), Positives = 51/155 (32%), Gaps = 34/155 (21%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDL--- 73
K + + +K +E + E++ + + W + + L
Sbjct: 59 TNKPEKDARHVVK-------VEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111
Query: 74 ----------------FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALD 117
FMV + L G DL+ Q+ F T+ + L+
Sbjct: 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTF-KK----STVLQLGIRMLDVLE 165
Query: 118 YLKTKHIIHRDIKPDNILLD--EEGHAHITDFNIA 150
Y+ +H DIK N+LL ++ D+ ++
Sbjct: 166 YIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 8e-07
Identities = 26/150 (17%), Positives = 50/150 (33%), Gaps = 33/150 (22%)
Query: 22 TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDL-------- 73
+ +K + E++ P + W + + L
Sbjct: 64 SDAPCVVKVEPSDN-------GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116
Query: 74 -----------FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK 122
FM+ D G DL+ + K +S T + L + + L+Y+
Sbjct: 117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKT---VLQL-SLRILDILEYIHEH 171
Query: 123 HIIHRDIKPDNILLD--EEGHAHITDFNIA 150
+H DIK N+LL+ ++ D+ +A
Sbjct: 172 EYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 246 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.2 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.01 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.92 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.83 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.69 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.47 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.25 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.24 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.11 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.02 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.89 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.76 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.72 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.69 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.39 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.34 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.24 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.18 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.09 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.98 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.96 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.96 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.78 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.6 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.81 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.5 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.84 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.59 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 80.91 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-58 Score=364.76 Aligned_cols=230 Identities=33% Similarity=0.557 Sum_probs=205.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+|+.||+|++++....+....+.+.+|++++++++|||||++++++++++.+|+||||++
T Consensus 39 ~lG~G~f---g~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~ 115 (311)
T 4aw0_A 39 ILGEGSF---STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 115 (311)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEecccC---eEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 4788988 9999999999999999999987665455556789999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc---c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---L 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~---~ 158 (246)
||+|.+++.+.+.+ ++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 116 gG~L~~~i~~~~~l-----~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~ 190 (311)
T 4aw0_A 116 NGELLKYIRKIGSF-----DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190 (311)
T ss_dssp TEEHHHHHHHHSSC-----CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred CCCHHHHHHHcCCC-----CHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence 99999999876544 999999999999999999999999999999999999999999999999999875432 2
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKH 238 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ 238 (246)
.....||+.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+. +.......+......+|..+|+++++
T Consensus 191 ~~~~~GTp~YmAPEvl~~~~-----y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~~~~p~~~s~~~~d 263 (311)
T 4aw0_A 191 ANSFVGTAQYVSPELLTEKS-----ACKSSDLWALGCIIYQLVAGLPPFRAG--NEGLIFAKIIKLEYDFPEKFFPKARD 263 (311)
T ss_dssp BCCCCSCGGGCCHHHHHHSC-----BCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCTTCCHHHHH
T ss_pred ccCcccCcccCCHHHHcCCC-----CCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCCcccCHHHHH
Confidence 34567999999999998765 889999999999999999999999753 34455667777888899999999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
||++||++
T Consensus 264 li~~lL~~ 271 (311)
T 4aw0_A 264 LVEKLLVL 271 (311)
T ss_dssp HHHHHSCS
T ss_pred HHHHHccC
Confidence 99999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-56 Score=350.20 Aligned_cols=230 Identities=27% Similarity=0.419 Sum_probs=186.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+|+.||+|++++....+.+..+.+.+|++++++++||||+++++++.+++.+|+||||+
T Consensus 20 ~lG~G~f---g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~- 95 (275)
T 3hyh_A 20 TLGEGSF---GKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA- 95 (275)
T ss_dssp EEEC------CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-
T ss_pred EEecCcC---eEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-
Confidence 3788888 999999999999999999998776555556678999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++.+... +++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++..........
T Consensus 96 ~g~L~~~l~~~~~-----l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 170 (275)
T 3hyh_A 96 GNELFDYIVQRDK-----MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 170 (275)
T ss_dssp CEEHHHHHHHSCS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred CCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence 7799999877554 49999999999999999999999999999999999999999999999999987766555566
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..||+.|+|||.+.+.. ..+.++|||||||++|+|++|+.||.+. +.......+.....++|..+|+++++||+
T Consensus 171 ~~GT~~Y~APE~~~~~~----y~~~~~DiwSlGvily~lltg~~PF~~~--~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYVMLCRRLPFDDE--SIPVLFKNISNGVYTLPKFLSPGAAGLIK 244 (275)
T ss_dssp ----CTTSCHHHHSSSS----CCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred eeECcccCChhhhcCCC----CCCChhhhHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 78999999999998765 2457999999999999999999999753 33445566777788899999999999999
Q ss_pred HhhhC
Q psy7592 242 QVHRY 246 (246)
Q Consensus 242 ~~l~~ 246 (246)
+||++
T Consensus 245 ~~L~~ 249 (275)
T 3hyh_A 245 RMLIV 249 (275)
T ss_dssp HHSCS
T ss_pred HHccC
Confidence 99974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=355.93 Aligned_cols=231 Identities=29% Similarity=0.460 Sum_probs=193.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+|+.||||+++.... +....+.+.+|++++++++|||||++++++.+++.+|+||||++
T Consensus 31 ~lG~G~f---g~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~ 106 (350)
T 4b9d_A 31 KIGEGSF---GKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE 106 (350)
T ss_dssp EC---------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEecCCC---eEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 3788888 9999999999999999999987653 33456789999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 107 gg~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 183 (350)
T 4b9d_A 107 GGDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183 (350)
T ss_dssp TCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHH
T ss_pred CCcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccccc
Confidence 999999996542 2235888999999999999999999999999999999999999999999999998765432 223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~l 239 (246)
...||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+ .......+... ..+.+..+|+++++|
T Consensus 184 ~~~GT~~YmAPE~l~~~~-----y~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~~~~~~~~~~~s~~~~~l 256 (350)
T 4b9d_A 184 ACIGTPYYLSPEICENKP-----YNNKSDIWALGCVLYELCTLKHAFEAGS--MKNLVLKIISGSFPPVSLHYSYDLRSL 256 (350)
T ss_dssp HHHSCCTTCCHHHHTTCC-----CCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred ccCCCccccCHHHHCCCC-----CCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 457999999999998765 8999999999999999999999997543 33444555554 445677899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||++
T Consensus 257 i~~~L~~ 263 (350)
T 4b9d_A 257 VSQLFKR 263 (350)
T ss_dssp HHHHTCS
T ss_pred HHHHccC
Confidence 9999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-55 Score=352.79 Aligned_cols=225 Identities=25% Similarity=0.416 Sum_probs=192.8
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|+| |+||+|+++.+|+.||||+++..... ..+.+.+|++++++++|||||+++++|.+++.+|+||||++|
T Consensus 82 iG~G~f---G~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 82 IGEGST---GIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEECSS---CEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eecCcC---eEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 788999 99999999999999999999765432 235678899999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-ccccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~ 161 (246)
++|.+++.+. .+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++...... .....
T Consensus 156 g~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 156 GALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp EEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred CcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 9999988653 2499999999999999999999999999999999999999999999999999887544 33455
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCCCCCCHhHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPTAWSESTKH 238 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~l~~ 238 (246)
..||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+ .......+... ..+.+..+|+++++
T Consensus 230 ~~GTp~YmAPEvl~~~~-----y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 230 LVGTPYWMAPELISRLP-----YGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRLKNLHKVSPSLKG 302 (346)
T ss_dssp CCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSSCCCCSCGGGSCHHHHH
T ss_pred cccCcCcCCHHHHCCCC-----CCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 78999999999987664 8899999999999999999999997543 33333444433 23334578999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
||++||++
T Consensus 303 li~~~L~~ 310 (346)
T 4fih_A 303 FLDRLLVR 310 (346)
T ss_dssp HHHHHSCS
T ss_pred HHHHHcCC
Confidence 99999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=349.37 Aligned_cols=229 Identities=37% Similarity=0.638 Sum_probs=192.1
Q ss_pred CcCCCCccCeeeEEEEEec---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKK---DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|+| |+||+|++. .+++.||+|++++......+ ...+.+|++++++++|||||++++++.+++.+|+|||
T Consensus 31 ~lG~G~f---g~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 106 (304)
T 3ubd_A 31 VLGQGSF---GKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILD 106 (304)
T ss_dssp EEECGGG---CEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEEEEEC
T ss_pred EEecCCC---eEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEE
Confidence 4788988 999999984 46889999999865432222 2457789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-c
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-Q 157 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~ 157 (246)
|++|++|.+++.+...+ ++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++..... .
T Consensus 107 y~~gg~L~~~l~~~~~l-----~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 107 FLRGGDLFTRLSKEVMF-----TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp CCTTCEEHHHHHHHCCC-----CHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred cCCCCCHHHHHHhcCCC-----CHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence 99999999999876544 99999999999999999999999999999999999999999999999999865433 3
Q ss_pred cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHH
Q psy7592 158 LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTK 237 (246)
Q Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 237 (246)
......||+.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+. +.......+.....++|..+|++++
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~-----y~~~~DiwSlGvilyemltG~~PF~~~--~~~~~~~~i~~~~~~~p~~~s~~~~ 254 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRG-----HTQSADWWSFGVLMFEMLTGTLPFQGK--DRKETMTMILKAKLGMPQFLSPEAQ 254 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSC-----CCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred cccccccCcccCCHHHhccCC-----CCCCCcccchHHHHHHHHhCCCCCCCc--CHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 344577999999999997765 889999999999999999999999753 3445566777788889999999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
+||++||++
T Consensus 255 ~li~~~L~~ 263 (304)
T 3ubd_A 255 SLLRMLFKR 263 (304)
T ss_dssp HHHHHHTCS
T ss_pred HHHHHHccc
Confidence 999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=337.52 Aligned_cols=227 Identities=22% Similarity=0.394 Sum_probs=188.9
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee----CCeEEEEEe
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD----EEDLFMVSD 78 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~v~e 78 (246)
||+|+| |+||+|+++.+++.||+|.+..... +....+.+.+|++++++++|||||+++++|.+ +..+|+|||
T Consensus 34 iG~G~f---g~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE 109 (290)
T 3fpq_A 34 IGRGSF---KTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEECSS---EEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EecCcC---cEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence 788998 9999999999999999999976543 34456789999999999999999999999875 356899999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCcEEEcC-CCCeEEeecceeeeecc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH--IIHRDIKPDNILLDE-EGHAHITDFNIATVLEE 155 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~--~~h~~i~~~nil~~~-~~~~~l~d~~~~~~~~~ 155 (246)
|++|++|.+++.+... +++..+..++.|++.||+|||++| |+||||||+|||++. ++.+||+|||+++...
T Consensus 110 y~~gg~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~- 183 (290)
T 3fpq_A 110 LMTSGTLKTYLKRFKV-----MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 183 (290)
T ss_dssp CCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred CCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC-
Confidence 9999999999987544 499999999999999999999999 999999999999974 7899999999997533
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCCCCC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWS 233 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~s 233 (246)
........||+.|+|||.+.+ .++.++|||||||++|+|++|+.||.+... .......+... +..+|..+|
T Consensus 184 ~~~~~~~~GTp~YmAPE~~~~------~y~~~~DiwSlGvilyelltg~~Pf~~~~~-~~~~~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 184 ASFAKAVIGTPEFMAPEMYEE------KYDESVDVYAFGMCMLEMATSEYPYSECQN-AAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-HHHHHHHHTTTCCCGGGGGCCC
T ss_pred CCccCCcccCccccCHHHcCC------CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-HHHHHHHHHcCCCCCCCCccCC
Confidence 233445679999999998753 278999999999999999999999965332 22223333333 233456789
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
+++++||.+||++
T Consensus 257 ~~~~~li~~~L~~ 269 (290)
T 3fpq_A 257 PEVKEIIEGCIRQ 269 (290)
T ss_dssp HHHHHHHHHHSCS
T ss_pred HHHHHHHHHHccC
Confidence 9999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-54 Score=346.46 Aligned_cols=221 Identities=25% Similarity=0.349 Sum_probs=188.4
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|+| |+||+|+++.+|+.||||+++.... ..+|+.++++++|||||++++++.+++.+|+||||++|
T Consensus 66 lG~G~f---G~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 66 VGRGSF---GEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEETT---EEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eccCCC---eEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 788888 9999999999999999999987542 23599999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-CeEEeecceeeeeccCcc---
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG-HAHITDFNIATVLEENQL--- 158 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~-~~~l~d~~~~~~~~~~~~--- 158 (246)
++|.+++.+... +++..+..++.|++.||.|||++||+||||||+|||++.+| .+||+|||+++.......
T Consensus 135 g~L~~~l~~~~~-----l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 135 GSLGQLIKQMGC-----LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp CBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred CcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 999999987554 49999999999999999999999999999999999999988 599999999987654321
Q ss_pred ---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCC---CCCCCC
Q psy7592 159 ---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPV---HYPTAW 232 (246)
Q Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 232 (246)
.....||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+...... ...+..... .+|+.+
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~-----y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~ 282 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKP-----CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLKIASEPPPIREIPPSC 282 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HHHHHHSCCGGGGSCTTS
T ss_pred eecCCccccCccccCHHHHCCCC-----CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHHHHcCCCCchhcCccC
Confidence 12346899999999998765 88999999999999999999999976554432 334444432 467889
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
|+.++++|.+||++
T Consensus 283 s~~~~~li~~~L~~ 296 (336)
T 4g3f_A 283 APLTAQAIQEGLRK 296 (336)
T ss_dssp CHHHHHHHHHHTCS
T ss_pred CHHHHHHHHHHccC
Confidence 99999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=353.41 Aligned_cols=225 Identities=25% Similarity=0.423 Sum_probs=193.2
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|+| |+||+|+++.+|+.||||++....... .+.+.+|+.++++++|||||+++++|.+++.+|+||||++|
T Consensus 159 iG~G~f---G~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 159 IGEGST---GIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEECSS---CEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eccCcC---cEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 788988 999999999999999999997654322 35688999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-ccccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~ 161 (246)
++|.+++... . +++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... .....
T Consensus 233 G~L~~~i~~~-~-----l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 233 GALTDIVTHT-R-----MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp EEHHHHHHHS-C-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred CcHHHHHhcc-C-----CCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 9999988653 2 499999999999999999999999999999999999999999999999999887544 33445
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCCCCCCHhHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPTAWSESTKH 238 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~l~~ 238 (246)
..||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+ .......+... ....+..+|+++++
T Consensus 307 ~~GTp~YmAPEvl~~~~-----y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~~~~~~~~s~~~~d 379 (423)
T 4fie_A 307 LVGTPYWMAPELISRLP-----YGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRLKNLHKVSPSLKG 379 (423)
T ss_dssp CEECTTTCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCCSCTTSSCHHHHH
T ss_pred cccCcCcCCHHHHCCCC-----CCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCCCcccccCCHHHHH
Confidence 78999999999987665 8899999999999999999999997543 33333344333 33345679999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
||++||++
T Consensus 380 li~~~L~~ 387 (423)
T 4fie_A 380 FLDRLLVR 387 (423)
T ss_dssp HHHHHSCS
T ss_pred HHHHHcCC
Confidence 99999974
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-53 Score=336.49 Aligned_cols=231 Identities=23% Similarity=0.361 Sum_probs=192.2
Q ss_pred cCCCCccCeeeEEEEEec-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKK-----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
||+|+| |+||++++. .+++.||||.++... ....+++.+|++++++++|||||++++++.+++..++||
T Consensus 21 lG~G~f---G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 94 (299)
T 4asz_A 21 LGEGAF---GKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 94 (299)
T ss_dssp EEC--C---CCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EeeCCC---cEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 799999 999999864 468899999997653 455678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccc--------cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecce
Q psy7592 78 DLLLGGDLRYHITQDIK--------FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNI 149 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~ 149 (246)
||+++|+|.+++..... .....+++..+..++.|++.|+.|||+++++||||||+|||++.++.+||+|||+
T Consensus 95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGl 174 (299)
T 4asz_A 95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGM 174 (299)
T ss_dssp ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSC
T ss_pred EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCccc
Confidence 99999999999976431 1234579999999999999999999999999999999999999999999999999
Q ss_pred eeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-
Q psy7592 150 ATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS- 224 (246)
Q Consensus 150 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~- 224 (246)
++....... .....+++.|+|||.+.+.. ++.++||||||+++|||+| |+.||.+.+. ......+...
T Consensus 175 a~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-----~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~i~~~~ 247 (299)
T 4asz_A 175 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-----FTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIECITQGR 247 (299)
T ss_dssp HHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHHHTC
T ss_pred ceecCCCCceeecCceecChhhcCHHHHcCCC-----CCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcCC
Confidence 976543322 22245788999999998775 8999999999999999998 8999975443 3334444444
Q ss_pred CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 225 PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 225 ~~~~~~~~s~~l~~li~~~l~~ 246 (246)
..+.|..+|+++.+||.+||+.
T Consensus 248 ~~~~p~~~~~~~~~li~~cl~~ 269 (299)
T 4asz_A 248 VLQRPRTCPQEVYELMLGCWQR 269 (299)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCCccchHHHHHHHHHHcCC
Confidence 5667889999999999999973
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=335.59 Aligned_cols=231 Identities=22% Similarity=0.345 Sum_probs=187.4
Q ss_pred cCCCCccCeeeEEEEEec-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKK-----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
||+|+| |+||+++.. .+++.||||.++... .+..+++.+|++++++++|||||+++++|.++...++||
T Consensus 49 LG~G~f---G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 122 (329)
T 4aoj_A 49 LGEGAF---GKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122 (329)
T ss_dssp EEECSS---EEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EccCCC---cEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 789999 999999864 468999999997653 555678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccc----------cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeec
Q psy7592 78 DLLLGGDLRYHITQDIK----------FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDF 147 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~----------~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~ 147 (246)
||+++|+|.+++.+... ....++++..+..++.|++.|+.|||+.+++||||||+|||+++++.+||+||
T Consensus 123 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DF 202 (329)
T 4aoj_A 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDF 202 (329)
T ss_dssp ECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCC
T ss_pred EcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEccc
Confidence 99999999999976432 12345799999999999999999999999999999999999999999999999
Q ss_pred ceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc
Q psy7592 148 NIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY 223 (246)
Q Consensus 148 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~ 223 (246)
|+++....... .....+++.|+|||.+.+.. ++.++||||||+++|||++ |+.||.+... ......+..
T Consensus 203 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-----~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~i~~ 275 (329)
T 4aoj_A 203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-----FTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TEAIDCITQ 275 (329)
T ss_dssp C----------------CCCCGGGCCHHHHTTCC-----CCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--HHHHHHHHH
T ss_pred ccceeccCCCcceecCcccccccccChhhhcCCC-----CCccccccchHHHHHHHHcCCCCCCCCCCH--HHHHHHHHc
Confidence 99987643322 23356788999999998765 8999999999999999999 8999975443 233334444
Q ss_pred C-CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 224 S-PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 224 ~-~~~~~~~~s~~l~~li~~~l~~ 246 (246)
. ..+.|..+|+++.+||.+||+.
T Consensus 276 g~~~~~p~~~~~~~~~li~~cl~~ 299 (329)
T 4aoj_A 276 GRELERPRACPPEVYAIMRGCWQR 299 (329)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHCCS
T ss_pred CCCCCCcccccHHHHHHHHHHcCc
Confidence 3 5677889999999999999973
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=331.61 Aligned_cols=232 Identities=20% Similarity=0.293 Sum_probs=190.9
Q ss_pred cCCCCccCeeeEEEEEe-----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQK-----KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
||+|+| |+||+++. ..+++.||||.++... +....+++.+|+.++++++|||||++++++.+++..++||
T Consensus 34 lG~G~f---G~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~ 108 (308)
T 4gt4_A 34 LGEDRF---GKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIF 108 (308)
T ss_dssp EEECSS---CEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eccCCC---cEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEE
Confidence 789999 99999985 3568899999997653 2334578999999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccc-----------cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEee
Q psy7592 78 DLLLGGDLRYHITQDIK-----------FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITD 146 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~-----------~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d 146 (246)
||+++|+|.+++..... .....+++..+..++.|++.|++|||+.+++||||||+|||+++++.+||+|
T Consensus 109 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~D 188 (308)
T 4gt4_A 109 SYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISD 188 (308)
T ss_dssp ECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECC
Confidence 99999999999965321 1134578899999999999999999999999999999999999999999999
Q ss_pred cceeeeeccCc---cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhh
Q psy7592 147 FNIATVLEENQ---LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAII 222 (246)
Q Consensus 147 ~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~ 222 (246)
||+++...... ......+++.|+|||.+.+.. ++.++||||||+++|||++ |..||.+.+.. .....+.
T Consensus 189 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-----~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~~~i~ 261 (308)
T 4gt4_A 189 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-----FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVEMIR 261 (308)
T ss_dssp SCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHHHHHH
T ss_pred cccceeccCCCceeEecccccCCcccCHHHHhCCC-----CCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence 99998654332 223356788999999998765 8999999999999999998 89999765432 3333333
Q ss_pred cC-CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 223 YS-PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 223 ~~-~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.. ..+.|..+|+++.+||.+||+.
T Consensus 262 ~~~~~~~p~~~~~~~~~li~~C~~~ 286 (308)
T 4gt4_A 262 NRQVLPCPDDCPAWVYALMIECWNE 286 (308)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred cCCCCCCcccchHHHHHHHHHHcCC
Confidence 33 5567889999999999999963
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=324.36 Aligned_cols=228 Identities=22% Similarity=0.318 Sum_probs=182.2
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|+| |+||+++.+ ..||||+++... .+.+..+.+.+|++++++++|||||++++++.+ +..++||||++|
T Consensus 44 iG~G~f---G~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g 115 (307)
T 3omv_A 44 IGSGSF---GTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG 115 (307)
T ss_dssp CCCCSS---SEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred EeeCCC---cEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence 799999 899999864 358999987544 345567889999999999999999999998865 468999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC---ccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN---QLA 159 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~ 159 (246)
++|.+++.... .++++..+..++.|++.||.|||+.+++||||||+|||+++++.+||+|||+++..... ...
T Consensus 116 GsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 116 SSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp CBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred CCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 99999996532 23599999999999999999999999999999999999999999999999999765432 223
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC------CCCCCCCCC
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS------PVHYPTAWS 233 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~s 233 (246)
....||+.|+|||++.+... ..++.++||||||+++|||++|+.||.+.+... .....+.. ....|..+|
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~--~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~ 267 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDN--NPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QIIFMVGRGYASPDLSKLYKNCP 267 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSS--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHTTCCCCCSTTSCTTSC
T ss_pred cccccCCCccCHHHhhccCC--CCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCCCCCCcccccccch
Confidence 34678999999999875431 137899999999999999999999997544322 22222222 123456799
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
+++.+||.+||+.
T Consensus 268 ~~l~~li~~cl~~ 280 (307)
T 3omv_A 268 KAMKRLVADCVKK 280 (307)
T ss_dssp HHHHHHHHHHTCS
T ss_pred HHHHHHHHHHcCC
Confidence 9999999999973
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=350.08 Aligned_cols=232 Identities=31% Similarity=0.563 Sum_probs=197.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHH---HHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERD---ALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|+| |+||+|+++.+|+.||||++++....... .......++.+++.++|||||+++++|++.+.+|+|||
T Consensus 196 ~LG~G~f---G~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmE 272 (689)
T 3v5w_A 196 IIGRGGF---GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272 (689)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEecccC---eEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEe
Confidence 4799999 99999999999999999999875432222 22333445777788899999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+.||+|.+++.+...+ ++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 273 y~~GGdL~~~l~~~~~l-----~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~- 346 (689)
T 3v5w_A 273 LMNGGDLHYHLSQHGVF-----SEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 346 (689)
T ss_dssp CCCSCBHHHHHHHHCCC-----CHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred cCCCCcHHHHHHhcCCC-----CHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence 99999999999876554 999999999999999999999999999999999999999999999999998765433
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHhhhcCCCCCCCCCCHhHH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV-KDVKAIIYSPVHYPTAWSESTK 237 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~l~ 237 (246)
.....||+.|+|||++.... .++.++|+|||||++|+|++|.+||.+...... .....+......+|..+|++++
T Consensus 347 ~~t~~GTp~YmAPEvl~~~~----~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~ 422 (689)
T 3v5w_A 347 PHASVGTHGYMAPEVLQKGV----AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422 (689)
T ss_dssp CCSCCSCGGGCCHHHHSTTC----CCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CCCccCCcCccCHHHHhCCC----CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHH
Confidence 34568999999999986432 388999999999999999999999976544333 3455566778889999999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
+||++||++
T Consensus 423 dLI~~lL~~ 431 (689)
T 3v5w_A 423 SLLEGLLQR 431 (689)
T ss_dssp HHHHHHTCS
T ss_pred HHHHHHccC
Confidence 999999974
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=323.91 Aligned_cols=229 Identities=24% Similarity=0.382 Sum_probs=174.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC----------
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE---------- 71 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---------- 71 (246)
.||+|+| |+||+|+++.+|+.||||+++... .+...+.+.+|++++++++|||||+++++|.+.+
T Consensus 12 ~lG~G~f---g~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 12 CLGRGGF---GVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEECC-----EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred EEecCCC---eEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 4788988 999999999999999999997654 3445578899999999999999999999997543
Q ss_pred --eEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecce
Q psy7592 72 --DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNI 149 (246)
Q Consensus 72 --~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~ 149 (246)
++|+||||++|++|.+++...... ...+...++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTI--EERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSG--GGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCC--ChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 379999999999999999765432 1235566889999999999999999999999999999999999999999999
Q ss_pred eeeeccCcc-------------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH
Q psy7592 150 ATVLEENQL-------------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK 216 (246)
Q Consensus 150 ~~~~~~~~~-------------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~ 216 (246)
++....... .....||+.|+|||.+.+.. ++.++|||||||++|+|++ ||.... +...
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-----y~~~~DiwSlGvilyell~---Pf~~~~-~~~~ 235 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-----YSHKVDIFSLGLILFELLY---PFSTQM-ERVR 235 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCC-----CCTHHHHHHHHHHHHHHHS---CCSSHH-HHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-----CCCHHHHHHHHHHHHHHcc---CCCCcc-HHHH
Confidence 987653321 12246899999999998765 8999999999999999996 775321 1112
Q ss_pred HHHhhhcCCC-CCCCCCCHhHHHHHHHhhhC
Q psy7592 217 DVKAIIYSPV-HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 217 ~~~~~~~~~~-~~~~~~s~~l~~li~~~l~~ 246 (246)
....+..... +.+...++.+.+||++||+.
T Consensus 236 ~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~ 266 (299)
T 4g31_A 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSP 266 (299)
T ss_dssp HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCS
T ss_pred HHHHHhcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 2222222221 12235678889999999974
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=323.34 Aligned_cols=234 Identities=20% Similarity=0.296 Sum_probs=191.7
Q ss_pred CcCCCCccCeeeEEEEEecCC-----CcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCC-Ccceeeeeeeee-CCeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT-----KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH-PFLVNLWFCFQD-EEDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~-~~~~~ 74 (246)
.||+|+| |+||++++..+ ++.||||.++... ..+..+.+.+|++++.+++| ||||+++++|.+ +..++
T Consensus 71 ~LG~G~f---G~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~ 145 (353)
T 4ase_A 71 PLGRGAF---GQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 145 (353)
T ss_dssp EEEECSS---EEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred EEecCCC---eEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEE
Confidence 3789999 99999997654 4689999997654 23446789999999999975 899999999865 45789
Q ss_pred EEEeecCCCChHHHHhhcccc-----------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeE
Q psy7592 75 MVSDLLLGGDLRYHITQDIKF-----------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAH 143 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~ 143 (246)
+||||+++|+|.+++.+.... ....+++..+..++.|++.|++|||+++++||||||+|||+++++.+|
T Consensus 146 iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vK 225 (353)
T 4ase_A 146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 225 (353)
T ss_dssp EEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEE
Confidence 999999999999999764321 133468899999999999999999999999999999999999999999
Q ss_pred EeecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHH
Q psy7592 144 ITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVK 219 (246)
Q Consensus 144 l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~ 219 (246)
|+|||+++....... .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+...... ...
T Consensus 226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-----y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~-~~~ 299 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-----YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCR 299 (353)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHH
T ss_pred ECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-----CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-HHH
Confidence 999999987643322 22345788999999998765 8999999999999999998 8999976554332 222
Q ss_pred hhhc-CCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 220 AIIY-SPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 220 ~~~~-~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.+.. ...+.|..+|+++.++|.+||+.
T Consensus 300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~ 327 (353)
T 4ase_A 300 RLKEGTRMRAPDYTTPEMYQTMLDCWHG 327 (353)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCc
Confidence 3333 36677889999999999999973
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=324.98 Aligned_cols=229 Identities=25% Similarity=0.405 Sum_probs=185.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee------CCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD------EEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~~ 75 (246)
.||+|+| |+||+|+++.+|+.||||+++.... .....+.+.+|++++++++|||||++++++.. ...+|+
T Consensus 61 ~lG~G~f---G~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~i 136 (398)
T 4b99_A 61 TIGNGAY---GVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 136 (398)
T ss_dssp EEEECSS---CEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred EEecccC---eEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEE
Confidence 3788988 8999999999999999999976542 33445778899999999999999999999764 357899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||||+. ++|.+++.+... +++..++.++.||+.||.|||+.|++||||||+|||++.++.+|++|||+++.+..
T Consensus 137 vmE~~~-g~L~~~i~~~~~-----l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 137 VLDLME-SDLHQIIHSSQP-----LTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEECCS-EEHHHHHTSSSC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEeCCC-CCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 999995 679999876544 49999999999999999999999999999999999999999999999999986533
Q ss_pred C-----ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---C--
Q psy7592 156 N-----QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---P-- 225 (246)
Q Consensus 156 ~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~-- 225 (246)
. .......||+.|+|||++.+.. .++.++||||+||++|+|++|++||.+.+... ....+... +
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~----~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~--~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLH----EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH--QLQLIMMVLGTPSP 284 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCS----CCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCG
T ss_pred CccccccccccceeChHhcCHHHhcCCC----CCCChhheehhHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhcCCCCh
Confidence 2 2234567999999999987654 36889999999999999999999997644322 22222111 0
Q ss_pred -------------------CCC-------CCCCCHhHHHHHHHhhhC
Q psy7592 226 -------------------VHY-------PTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 226 -------------------~~~-------~~~~s~~l~~li~~~l~~ 246 (246)
... .+.+|+++++||++||++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~ 331 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRF 331 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCS
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcC
Confidence 000 135799999999999974
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=333.84 Aligned_cols=227 Identities=23% Similarity=0.412 Sum_probs=195.4
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|+| |+||+|+++.+|+.||+|.+.... ....+.+.+|++++++++||||++++++|.++..+|+||||++|
T Consensus 165 lG~G~f---g~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 165 LGTGAF---GVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEETT---EEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred EeeccC---eEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 788888 999999999999999999997754 33456788999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC--CCeEEeecceeeeeccCcccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE--GHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~--~~~~l~d~~~~~~~~~~~~~~ 160 (246)
++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|||++.+ +.+||+|||++..........
T Consensus 239 g~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 239 GELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 99999886432 134899999999999999999999999999999999999854 789999999999887666666
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CCCCHhH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAWSEST 236 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~l 236 (246)
...||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+ .......+......+| ..+|+++
T Consensus 315 ~~~GT~~y~APEv~~~~~-----y~~~~DiWSlGvilyeml~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKP-----VGYYTDMWSVGVLSYILLSGLSPFGGEN--DDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp EECSSGGGCCHHHHTTCC-----BCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred eeEECccccCHHHhCCCC-----CCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 678999999999998765 8899999999999999999999997543 3344445555444443 5689999
Q ss_pred HHHHHHhhhC
Q psy7592 237 KHLLSQVHRY 246 (246)
Q Consensus 237 ~~li~~~l~~ 246 (246)
++||++||++
T Consensus 388 ~dli~~~L~~ 397 (573)
T 3uto_A 388 KDFIRKLLLA 397 (573)
T ss_dssp HHHHHTTSCS
T ss_pred HHHHHHHccC
Confidence 9999999974
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=306.95 Aligned_cols=230 Identities=31% Similarity=0.601 Sum_probs=199.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+|+++.+|+.||+|.+++......+..+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 12 ~lG~G~f---g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~ 88 (337)
T 1o6l_A 12 LLGKGTF---GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEecCCC---eEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 4788888 9999999999999999999987654344446778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Ccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~ 160 (246)
|++|..++..... +++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 89 gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 163 (337)
T 1o6l_A 89 GGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp TCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred CCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCccc
Confidence 9999999876544 48999999999999999999999999999999999999999999999999876432 23344
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
...+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+ .......+......+|..+|++++++|
T Consensus 164 ~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~~~~p~~~s~~~~~li 236 (337)
T 1o6l_A 164 TFCGTPEYLAPEVLEDND-----YGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILMEEIRFPRTLSPEAKSLL 236 (337)
T ss_dssp CCEECGGGCCGGGGSSSC-----BCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred ccccChhhCChhhhcCCC-----CCchhhcccchhHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 567899999999987654 7889999999999999999999996433 344455666777888999999999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
++||+.
T Consensus 237 ~~lL~~ 242 (337)
T 1o6l_A 237 AGLLKK 242 (337)
T ss_dssp HHHTCS
T ss_pred HHHhhc
Confidence 999963
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=310.76 Aligned_cols=235 Identities=57% Similarity=1.010 Sum_probs=204.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+++.||+|.+...........+.+.+|++++++++||||+++++++.+....++||||+.
T Consensus 22 ~LG~G~f---G~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 98 (384)
T 4fr4_A 22 AIGKGSF---GKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLL 98 (384)
T ss_dssp EEECCTT---CCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEeeCCC---eEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 4789998 8999999999999999999987665455556788999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
|++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 99 gg~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 173 (384)
T 4fr4_A 99 GGDLRYHLQQNVH-----FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173 (384)
T ss_dssp TEEHHHHHHTTCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCC
T ss_pred CCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCceec
Confidence 9999999987544 49999999999999999999999999999999999999999999999999988766655666
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK-DVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
..+++.|+|||.+.... ...++.++|+||||+++|+|++|..||......... ....+......+|..+|+.+.++|
T Consensus 174 ~~gt~~Y~aPE~~~~~~--~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li 251 (384)
T 4fr4_A 174 MAGTKPYMAPEMFSSRK--GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLL 251 (384)
T ss_dssp CCSCGGGCCGGGTCCCS--SCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred cCCCccccCCeeeccCC--CCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHH
Confidence 78999999999986432 113788999999999999999999999766555443 444555667888999999999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
++||+.
T Consensus 252 ~~lL~~ 257 (384)
T 4fr4_A 252 KKLLEP 257 (384)
T ss_dssp HHHSCS
T ss_pred HHHhcC
Confidence 999964
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=303.66 Aligned_cols=230 Identities=26% Similarity=0.430 Sum_probs=200.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|++..+|+.||+|++..... +....+++.+|+++++.++||||+++++++..+...++||||++
T Consensus 22 ~lG~G~~---g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 97 (328)
T 3fe3_A 22 TIGKGNF---AKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS 97 (328)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEeeCCC---EEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence 4788888 9999999999999999999987543 34456788899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++...... ++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 98 ~~~L~~~l~~~~~l-----~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 172 (328)
T 3fe3_A 98 GGEVFDYLVAHGRM-----KEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172 (328)
T ss_dssp TCBHHHHHHHHCCC-----CHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred CCcHHHHHHHcCCC-----CHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence 99999999775544 9999999999999999999999999999999999999999999999999977665555556
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||.+.+ .......+......+|..+|+++.++|+
T Consensus 173 ~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~p~~~s~~~~~li~ 246 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKK----YDGPEVDVWSLGVILYTLVSGSLPFDGQN--LKELRERVLRGKYRIPFYMSTDCENLLK 246 (328)
T ss_dssp TSSSGGGCCHHHHHTCC----CCSHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred ccCCcceeCcccccCCC----cCCchhhhhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 77899999999987664 13578999999999999999999997543 3344556667778888899999999999
Q ss_pred HhhhC
Q psy7592 242 QVHRY 246 (246)
Q Consensus 242 ~~l~~ 246 (246)
+||++
T Consensus 247 ~~L~~ 251 (328)
T 3fe3_A 247 RFLVL 251 (328)
T ss_dssp HHCCS
T ss_pred HHCCC
Confidence 99964
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=308.72 Aligned_cols=230 Identities=35% Similarity=0.615 Sum_probs=197.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|+| |+||+|+++.+++.||+|++++.........+.+.+|.++++.+ +||||+++++++.+....|+||||+
T Consensus 30 ~lG~G~f---g~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 106 (353)
T 3txo_A 30 VLGKGSF---GKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFV 106 (353)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEeeCCC---EEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCC
Confidence 4788888 99999999999999999999876544455567788999999998 7999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Cccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~ 159 (246)
.|++|..++..... +++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||+++.... ....
T Consensus 107 ~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 181 (353)
T 3txo_A 107 NGGDLMFHIQKSRR-----FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT 181 (353)
T ss_dssp CSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred CCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccc
Confidence 99999999977544 49999999999999999999999999999999999999999999999999875432 2233
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+. +.......+......+|..++++++++
T Consensus 182 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~~~~~p~~~~~~~~~l 254 (353)
T 3txo_A 182 ATFCGTPDYIAPEILQEML-----YGPAVDWWAMGVLLYEMLCGHAPFEAE--NEDDLFEAILNDEVVYPTWLHEDATGI 254 (353)
T ss_dssp ----CCGGGCCHHHHHHHH-----CTTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cccCCCcCeEChhhcCCCC-----cCCccCCCcchHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 4467899999999998765 788999999999999999999999753 344556677778888999999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||++
T Consensus 255 i~~lL~~ 261 (353)
T 3txo_A 255 LKSFMTK 261 (353)
T ss_dssp HHHHTCS
T ss_pred HHHHhhh
Confidence 9999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=310.94 Aligned_cols=232 Identities=35% Similarity=0.638 Sum_probs=198.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|+| |+||+|+++.+++.||+|++++.........+.+.+|..++.++ +||||+++++++.++...++||||+
T Consensus 59 ~LG~G~f---G~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~ 135 (396)
T 4dc2_A 59 VIGRGSY---AKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 135 (396)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEeeCCC---eEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcC
Confidence 4788888 99999999999999999999987665556667788899999887 8999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeee-ccCccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL-EENQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~-~~~~~~ 159 (246)
.|++|..++..... +++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.. ......
T Consensus 136 ~gg~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~ 210 (396)
T 4dc2_A 136 NGGDLMFHMQRQRK-----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 210 (396)
T ss_dssp TTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred CCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCcc
Confidence 99999999977544 499999999999999999999999999999999999999999999999999763 233344
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------ccHHHHHhhhcCCCCCCCCC
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN-------TSVKDVKAIIYSPVHYPTAW 232 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 232 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ........+......+|..+
T Consensus 211 ~~~~gt~~Y~aPE~l~~~~-----~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 285 (396)
T 4dc2_A 211 STFCGTPNYIAPEILRGED-----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 285 (396)
T ss_dssp CCCCBCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTS
T ss_pred ccccCCcccCCchhhcCCC-----CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcC
Confidence 5567899999999998764 78899999999999999999999964321 11234556677788899999
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
|+++++||++||++
T Consensus 286 s~~~~~li~~lL~~ 299 (396)
T 4dc2_A 286 SVKAASVLKSFLNK 299 (396)
T ss_dssp CHHHHHHHHHHTCS
T ss_pred CHHHHHHHHHHhcC
Confidence 99999999999974
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=306.53 Aligned_cols=190 Identities=22% Similarity=0.375 Sum_probs=161.9
Q ss_pred CcCCCCccCeeeEEEEEec---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK---DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||+|+| |+||+|+++ .+++.||+|.+..... ..++.+|+++++++ +||||+++++++.+++++|+||
T Consensus 28 ~lG~G~f---g~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 28 KIGEGTF---SSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp EEEECSS---EEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred EEecccC---cEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 3789999 999999875 4688999999876431 24577899999999 6999999999999999999999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC-CCeEEeecceeeeeccC
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE-GHAHITDFNIATVLEEN 156 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~-~~~~l~d~~~~~~~~~~ 156 (246)
||++|++|.+.+.. +++..++.++.|++.||+|||++||+||||||+|||++.+ +.++|+|||+++.....
T Consensus 100 E~~~g~~L~~~~~~--------l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 100 PYLEHESFLDILNS--------LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp ECCCCCCHHHHHTT--------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred eCCCcccHHHHHcC--------CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 99999999998842 4899999999999999999999999999999999999876 79999999999865432
Q ss_pred c-----------------------------cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy7592 157 Q-----------------------------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207 (246)
Q Consensus 157 ~-----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~ 207 (246)
. ......||+.|+|||.+.+.. .++.++|+||+||++|+|++|+.||
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP----NQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCS----CCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC----CCCCccchhhhHHHHHHHHHCCCCC
Confidence 1 112346899999999987654 3788999999999999999999999
Q ss_pred CCCC
Q psy7592 208 DIHS 211 (246)
Q Consensus 208 ~~~~ 211 (246)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 6443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=302.39 Aligned_cols=232 Identities=36% Similarity=0.634 Sum_probs=200.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||+|+++.+++.||+|++++....+....+.+.+|..+++++ +||||+++++++.++...++||||+
T Consensus 16 ~lG~G~f---g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~ 92 (345)
T 3a8x_A 16 VIGRGSY---AKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 92 (345)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEecCC---eEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCC
Confidence 4788888 99999999999999999999987666666778889999999988 8999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec-cCccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE-ENQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~ 159 (246)
.|++|.+++..... +++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.... .....
T Consensus 93 ~gg~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~ 167 (345)
T 3a8x_A 93 NGGDLMFHMQRQRK-----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167 (345)
T ss_dssp CSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCB
T ss_pred CCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcc
Confidence 99999999876544 4999999999999999999999999999999999999999999999999997643 22334
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------ccHHHHHhhhcCCCCCCCCC
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN-------TSVKDVKAIIYSPVHYPTAW 232 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 232 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ........+......+|..+
T Consensus 168 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 242 (345)
T 3a8x_A 168 STFCGTPNYIAPEILRGED-----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred cccCCCccccCccccCCCC-----CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence 4567899999999987654 78899999999999999999999965321 12233445666678889999
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
|+.++++|++||++
T Consensus 243 s~~~~~li~~lL~~ 256 (345)
T 3a8x_A 243 SVKAASVLKSFLNK 256 (345)
T ss_dssp CHHHHHHHHHHTCS
T ss_pred CHHHHHHHHHHhcC
Confidence 99999999999974
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=300.32 Aligned_cols=228 Identities=34% Similarity=0.661 Sum_probs=198.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+|+++.+|+.||+|++++.........+.+.+|..+++.++||||+++++++.+....++||||++
T Consensus 13 ~lG~G~~---g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~ 89 (318)
T 1fot_A 13 TLGTGSF---GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 89 (318)
T ss_dssp EEEECSS---CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEeeCCC---EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCC
Confidence 4788888 9999999999999999999987654333445678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
|++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 90 gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~~~ 162 (318)
T 1fot_A 90 GGELFSLLRKSQR-----FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYT 162 (318)
T ss_dssp SCBHHHHHHHTSS-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCC
T ss_pred CCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--ccc
Confidence 9999999976544 489999999999999999999999999999999999999999999999999875432 334
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||... +.......+......+|..++++++++|+
T Consensus 163 ~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 235 (318)
T 1fot_A 163 LCGTPDYIAPEVVSTKP-----YNKSIDWWSFGILIYEMLAGYTPFYDS--NTMKTYEKILNAELRFPPFFNEDVKDLLS 235 (318)
T ss_dssp CCSCTTTCCHHHHTTCC-----BCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred ccCCccccCHhHhcCCC-----CCcccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 56899999999987654 788999999999999999999999643 33455666777788889999999999999
Q ss_pred HhhhC
Q psy7592 242 QVHRY 246 (246)
Q Consensus 242 ~~l~~ 246 (246)
+||+.
T Consensus 236 ~lL~~ 240 (318)
T 1fot_A 236 RLITR 240 (318)
T ss_dssp HHTCS
T ss_pred HHhcc
Confidence 99963
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=299.26 Aligned_cols=230 Identities=20% Similarity=0.286 Sum_probs=172.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC----eEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE----DLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~v~ 77 (246)
.||+|+| |+||++++ +|+.||||+++... ........|+..+.+++|||||++++++.+++ .+++||
T Consensus 10 ~iG~G~f---G~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 10 SIGKGRF---GEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEEECSS---SEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEeeCCC---eEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3789999 89999998 58999999997643 11122335677777889999999999998654 589999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC--------CcccCCCCCCcEEEcCCCCeEEeecce
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK--------HIIHRDIKPDNILLDEEGHAHITDFNI 149 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~--------~~~h~~i~~~nil~~~~~~~~l~d~~~ 149 (246)
||+++++|.+++... +++++.+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+
T Consensus 81 Ey~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp ECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred cCCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999753 248899999999999999999987 899999999999999999999999999
Q ss_pred eeeeccCcc-----ccccccCCCccCCceecccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----------
Q psy7592 150 ATVLEENQL-----ATSMSGTKPYIAPEIFLVATDE-VLGYSYSVDWWSLGVTLFEILARGRPFDIHSN----------- 212 (246)
Q Consensus 150 ~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~-~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~----------- 212 (246)
++....... .....||+.|+|||++.+.... ...++.++||||||+++|||++|.+||.....
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 987654322 1235689999999998754211 11256789999999999999999776633211
Q ss_pred -ccHHHHHhhh-cC--CCCCCCCC-----CHhHHHHHHHhhhC
Q psy7592 213 -TSVKDVKAII-YS--PVHYPTAW-----SESTKHLLSQVHRY 246 (246)
Q Consensus 213 -~~~~~~~~~~-~~--~~~~~~~~-----s~~l~~li~~~l~~ 246 (246)
.........+ .. .+++|..+ ++.+.+||.+||+.
T Consensus 235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~ 277 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCS
T ss_pred cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHccc
Confidence 1122223322 22 33444332 35788999999863
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=304.19 Aligned_cols=230 Identities=34% Similarity=0.591 Sum_probs=199.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|+| |+||+|+++.+++.||+|++++.........+.+..|.+++..+ +||+|+++++++.+....|+||||+
T Consensus 27 ~lG~G~f---g~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~ 103 (353)
T 2i0e_A 27 VLGKGSF---GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 103 (353)
T ss_dssp EEEEETT---EEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEeeCCC---EEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCC
Confidence 4788888 99999999999999999999876543444467788899999988 7999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Cccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~ 159 (246)
+|++|.+++..... +++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 104 ~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 178 (353)
T 2i0e_A 104 NGGDLMYHIQQVGR-----FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 178 (353)
T ss_dssp CSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred CCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCccc
Confidence 99999999976544 49999999999999999999999999999999999999999999999999976432 2334
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+. +.......+......+|..+|++++++
T Consensus 179 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~~~~~p~~~s~~~~~l 251 (353)
T 2i0e_A 179 KTFCGTPDYIAPEIIAYQP-----YGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSIMEHNVAYPKSMSKEAVAI 251 (353)
T ss_dssp CCCCSCGGGCCHHHHTTCC-----BSTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ccccCCccccChhhhcCCC-----cCCcccccchHHHHHHHHcCCCCCCCC--CHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 4567899999999987664 788999999999999999999999753 334556677777888999999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 252 i~~lL~~ 258 (353)
T 2i0e_A 252 CKGLMTK 258 (353)
T ss_dssp HHHHTCS
T ss_pred HHHHhhc
Confidence 9999963
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=302.60 Aligned_cols=230 Identities=37% Similarity=0.607 Sum_probs=197.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|+| |+||+|+++.+|+.||+|.+++......+..+.+..|.++++.+ +||||+++++++.+....++||||+
T Consensus 24 ~lG~G~f---g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~ 100 (345)
T 1xjd_A 24 MLGKGSF---GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 100 (345)
T ss_dssp EEEECSS---SEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEeeCCC---eEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCC
Confidence 4788888 89999999999999999999876433334456778899998877 8999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Cccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~ 159 (246)
+|++|.+++..... +++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||+++.... ....
T Consensus 101 ~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 175 (345)
T 1xjd_A 101 NGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 175 (345)
T ss_dssp TTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred CCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcc
Confidence 99999999976544 48999999999999999999999999999999999999999999999999876432 2233
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.+ .......+......+|..+|++++++
T Consensus 176 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 176 NTFCGTPDYIAPEILLGQK-----YNHSVDWWSFGVLLYEMLIGQSPFHGQD--EEELFHSIRMDNPFYPRWLEKEAKDL 248 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cCCCCCcccCChhhhcCCC-----CCChhhhHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHhCCCCCCcccCHHHHHH
Confidence 4567899999999997764 7889999999999999999999997433 34455566667778889999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 249 i~~lL~~ 255 (345)
T 1xjd_A 249 LVKLFVR 255 (345)
T ss_dssp HHHHSCS
T ss_pred HHHHhcC
Confidence 9999963
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=302.86 Aligned_cols=228 Identities=32% Similarity=0.617 Sum_probs=199.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+|+++.+|+.||+|.+...........+.+.+|+++++.++||||+++++++.++...++||||++
T Consensus 48 ~lG~G~~---g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 124 (350)
T 1rdq_E 48 TLGTGSF---GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEECSS---CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EeecCcC---cEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 4788888 8999999999999999999987654344446778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
|++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 125 gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~~ 197 (350)
T 1rdq_E 125 GGEMFSHLRRIGR-----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWT 197 (350)
T ss_dssp TCBHHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCC
T ss_pred CCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--ccc
Confidence 9999999987544 499999999999999999999999999999999999999999999999999876442 234
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||... ........+......+|..+|++++++|+
T Consensus 198 ~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 198 LCGTPEALAPEIILSKG-----YNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp CEECGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred ccCCccccCHHHhcCCC-----CCCcCCEecccHhHhHHhhCCCCCCCC--CHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 56899999999987654 788999999999999999999999743 33455566777788889999999999999
Q ss_pred HhhhC
Q psy7592 242 QVHRY 246 (246)
Q Consensus 242 ~~l~~ 246 (246)
+||+.
T Consensus 271 ~lL~~ 275 (350)
T 1rdq_E 271 NLLQV 275 (350)
T ss_dssp HHSCS
T ss_pred HHhhc
Confidence 99963
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=303.18 Aligned_cols=230 Identities=33% Similarity=0.629 Sum_probs=189.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHH-HhhCCCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEI-LTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|+| |+||+++++.+++.||+|++++...........+.+|... ++.++||||+++++++.+.+..|+||||+
T Consensus 45 ~lG~G~f---g~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 121 (373)
T 2r5t_A 45 VIGKGSF---GKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 121 (373)
T ss_dssp EEECCTT---CEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEeeCCC---eEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCC
Confidence 4788998 8999999999999999999988766555556667777776 56789999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec-cCccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE-ENQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~ 159 (246)
.|++|.+++..... +++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||+++... .....
T Consensus 122 ~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~ 196 (373)
T 2r5t_A 122 NGGELFYHLQRERC-----FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT 196 (373)
T ss_dssp CSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCC
T ss_pred CCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCcc
Confidence 99999999976544 3899999999999999999999999999999999999999999999999987633 22334
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||... +.......+......+|..+++.++++
T Consensus 197 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~l 269 (373)
T 2r5t_A 197 STFCGTPEYLAPEVLHKQP-----YDRTVDWWCLGAVLYEMLYGLPPFYSR--NTAEMYDNILNKPLQLKPNITNSARHL 269 (373)
T ss_dssp CSBSCCCCCCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSSCTTCCS--BHHHHHHHHHHSCCCCCSSSCHHHHHH
T ss_pred ccccCCccccCHHHhCCCC-----CCchhhhHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHhcccCCCCCCCHHHHHH
Confidence 4567899999999987664 788999999999999999999999643 334556667777788889999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 270 i~~lL~~ 276 (373)
T 2r5t_A 270 LEGLLQK 276 (373)
T ss_dssp HHHHTCS
T ss_pred HHHHccc
Confidence 9999973
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=300.52 Aligned_cols=230 Identities=26% Similarity=0.416 Sum_probs=195.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+|++..+++.||+|++........+....+.+|+..++.++||||+++++++......++||||+
T Consensus 16 ~lG~G~~---g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~- 91 (336)
T 3h4j_B 16 TLGEGSF---GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA- 91 (336)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred EEecCCC---eEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-
Confidence 3788888 999999999999999999998654333333467889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++..... +++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||++...........
T Consensus 92 ~g~l~~~l~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~ 166 (336)
T 3h4j_B 92 GGELFDYIVEKKR-----MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166 (336)
T ss_dssp CEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred CCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence 7889888876544 49999999999999999999999999999999999999999999999999987666555556
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..+++.|+|||.+.+.. ..++++|+||||+++|+|++|..||....... ....+......+|..+|+.++++|+
T Consensus 167 ~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~~~~i~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 167 SCGSPNYAAPEVINGKL----YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--LFKKVNSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp CTTSTTTSCGGGSCCSG----GGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--CBCCCCSSCCCCCTTSCHHHHHHHH
T ss_pred ccCCcCcCCHHHHcCCC----CCCCccchhHHHHHHHHHHhCCCCCCCccHHH--HHHHHHcCCCCCcccCCHHHHHHHH
Confidence 67899999999987654 13679999999999999999999997544322 2223344466678889999999999
Q ss_pred HhhhC
Q psy7592 242 QVHRY 246 (246)
Q Consensus 242 ~~l~~ 246 (246)
+||+.
T Consensus 241 ~~L~~ 245 (336)
T 3h4j_B 241 RMIVA 245 (336)
T ss_dssp TTSCS
T ss_pred HHcCC
Confidence 99964
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=297.48 Aligned_cols=230 Identities=26% Similarity=0.424 Sum_probs=195.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchH---HHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIER---DALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|+| |+||+|+++.+|+.||+|.++....... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 19 ~LG~G~f---g~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e 95 (361)
T 2yab_A 19 ELGSGQF---AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILE 95 (361)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EEeeCcC---EEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEE
Confidence 3788888 9999999999999999999987543211 124678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC----CeEEeecceeeeec
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG----HAHITDFNIATVLE 154 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~----~~~l~d~~~~~~~~ 154 (246)
|+.|++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 96 ~~~gg~L~~~l~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 96 LVSGGELFDFLAQKES-----LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp CCCSCBHHHHHTTCSC-----CBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred cCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 9999999999976543 49999999999999999999999999999999999998877 79999999998876
Q ss_pred cCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----C
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----T 230 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~ 230 (246)
.........+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.. .......+......++ .
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslGvil~~ll~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 171 DGVEFKNIFGTPEFVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDT--KQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHTTCCCCCHHHHT
T ss_pred CCCccccCCCCccEECchHHcCCC-----CCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCchhcc
Confidence 655555667899999999987654 7889999999999999999999997533 3344455555555554 5
Q ss_pred CCCHhHHHHHHHhhhC
Q psy7592 231 AWSESTKHLLSQVHRY 246 (246)
Q Consensus 231 ~~s~~l~~li~~~l~~ 246 (246)
.+|+.+++||++||+.
T Consensus 244 ~~s~~~~~li~~~L~~ 259 (361)
T 2yab_A 244 QTSELAKDFIRKLLVK 259 (361)
T ss_dssp TSCHHHHHHHHHHSCS
T ss_pred CCCHHHHHHHHHHCCC
Confidence 7899999999999963
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=310.32 Aligned_cols=236 Identities=31% Similarity=0.564 Sum_probs=202.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+|+.||+|++.+.........+.+.+|++++++++||||+++++++.+....|+||||++
T Consensus 192 ~LG~G~f---G~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~ 268 (543)
T 3c4z_A 192 VLGRGGF---GEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN 268 (543)
T ss_dssp EEEECSS---SEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEeeCCC---eEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence 3788988 8999999999999999999987654444445778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-AT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 160 (246)
|++|.+++..... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 269 gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 347 (543)
T 3c4z_A 269 GGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347 (543)
T ss_dssp TCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBC
T ss_pred CCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccc
Confidence 9999999876432 133468999999999999999999999999999999999999999999999999987654433 23
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHhhhcCCCCCCCCCCHhHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN--TSVKDVKAIIYSPVHYPTAWSESTKH 238 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~l~~ 238 (246)
...+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ........+......+|..+|+.+++
T Consensus 348 ~~~GT~~Y~APE~l~~~~-----~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 422 (543)
T 3c4z_A 348 GYAGTPGFMAPELLLGEE-----YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422 (543)
T ss_dssp CCCSCTTTSCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred cccCCccccChhhhcCCC-----CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHH
Confidence 357899999999997754 78899999999999999999999976532 22345556667788889999999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|++||++
T Consensus 423 li~~lL~~ 430 (543)
T 3c4z_A 423 FCEALLQK 430 (543)
T ss_dssp HHHHHSCS
T ss_pred HHHHhccC
Confidence 99999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=306.50 Aligned_cols=231 Identities=26% Similarity=0.407 Sum_probs=200.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+|+.||+|+++.....+.+..+.+.+|+.+++.++||||+++++++......++||||++
T Consensus 23 ~LG~G~f---g~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 99 (476)
T 2y94_A 23 TLGVGTF---GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVS 99 (476)
T ss_dssp EEECCSS---SCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred EEeeCCC---eEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 3788888 8999999999999999999987654333446788999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
|++|.+++..... +++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 100 gg~L~~~l~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 174 (476)
T 2y94_A 100 GGELFDYICKNGR-----LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 174 (476)
T ss_dssp SEEHHHHTTSSSS-----CCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCC
T ss_pred CCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccccc
Confidence 9999999876544 49999999999999999999999999999999999999999999999999988766555556
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||.... .......+.......|..+++++++||+
T Consensus 175 ~~gt~~y~aPE~~~~~~----~~~~~~DiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 248 (476)
T 2y94_A 175 SCGSPNYAAPEVISGRL----YAGPEVDIWSSGVILYALLCGTLPFDDDH--VPTLFKKICDGIFYTPQYLNPSVISLLK 248 (476)
T ss_dssp CCSCSTTCCHHHHTTCC----BCSHHHHHHHHHHHHHHHHHSSCSSCCSS--SHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred cCCCcCeEChhhccCCC----CCCCcceehhhHHHHHHHhhCCCCCCCCC--HHHHHHHHhcCCcCCCccCCHHHHHHHH
Confidence 67899999999987654 14679999999999999999999997543 3344556666677788889999999999
Q ss_pred HhhhC
Q psy7592 242 QVHRY 246 (246)
Q Consensus 242 ~~l~~ 246 (246)
+||+.
T Consensus 249 ~~L~~ 253 (476)
T 2y94_A 249 HMLQV 253 (476)
T ss_dssp HHTCS
T ss_pred HHcCC
Confidence 99963
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=309.06 Aligned_cols=235 Identities=31% Similarity=0.547 Sum_probs=191.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+++++.+++.||+|++++.........+.+.+|..++..++||||+++++++.++...++||||+.
T Consensus 81 ~LG~G~f---G~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~ 157 (437)
T 4aw2_A 81 VIGRGAF---GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYV 157 (437)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEeCCC---EEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCC
Confidence 4788888 9999999999999999999987543333333458889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-- 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (246)
|++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 158 gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 233 (437)
T 4aw2_A 158 GGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233 (437)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred CCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence 999999997631 23599999999999999999999999999999999999999999999999999876543322
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCC---CCCCH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYP---TAWSE 234 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~---~~~s~ 234 (246)
....+++.|+|||.+.........++.++|+||||+++|+|++|..||.+.+. ......+... ...+| ..+|+
T Consensus 234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~~s~ 311 (437)
T 4aw2_A 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHKERFQFPTQVTDVSE 311 (437)
T ss_dssp CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHTHHHHCCCCSSCCCSCH
T ss_pred ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh--hHHHHhhhhccccccCCcccccCCH
Confidence 23578999999999874221122378899999999999999999999975432 2333333321 23444 45899
Q ss_pred hHHHHHHHhhh
Q psy7592 235 STKHLLSQVHR 245 (246)
Q Consensus 235 ~l~~li~~~l~ 245 (246)
++++||++||+
T Consensus 312 ~~~dLi~~lL~ 322 (437)
T 4aw2_A 312 NAKDLIRRLIC 322 (437)
T ss_dssp HHHHHHHTTSS
T ss_pred HHHHHHHHHhc
Confidence 99999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=312.01 Aligned_cols=234 Identities=32% Similarity=0.564 Sum_probs=200.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |.||+|+++.+|+.||+|++.............+.+|++++++++||||+++++++.++...++||||+.
T Consensus 191 ~LG~G~f---G~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 267 (576)
T 2acx_A 191 VLGKGGF---GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 267 (576)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEeeCCC---EEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence 4788888 9999999999999999999987654333445678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
|++|.+++..... ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 268 gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 344 (576)
T 2acx_A 268 GGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 344 (576)
T ss_dssp SCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEEC
T ss_pred CCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCccccc
Confidence 9999999876432 2358999999999999999999999999999999999999999999999999988765544455
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT--SVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
..+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...... .......+...+..+|..+|+++++|
T Consensus 345 ~~GT~~Y~APEvl~~~~-----~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dL 419 (576)
T 2acx_A 345 RVGTVGYMAPEVVKNER-----YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSL 419 (576)
T ss_dssp CCSCGGGCCHHHHTTCE-----ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cCCCccccCHHHHcCCC-----CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence 67899999999997765 788999999999999999999999765432 22334445556777888999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 420 I~~lL~~ 426 (576)
T 2acx_A 420 CSQLLCK 426 (576)
T ss_dssp HHHHTCS
T ss_pred HHHhccC
Confidence 9999963
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=307.87 Aligned_cols=230 Identities=32% Similarity=0.606 Sum_probs=188.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+++++.+|+.||+|++.............+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 155 ~lG~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 231 (446)
T 4ejn_A 155 LLGKGTF---GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 231 (446)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCS
T ss_pred EEeeCcC---EEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCC
Confidence 4788888 9999999999999999999987654455556778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Cccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~ 159 (246)
+++|.+++..... +++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 232 ~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 306 (446)
T 4ejn_A 232 GGELFFHLSRERV-----FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 306 (446)
T ss_dssp SCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred CCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCccc
Confidence 9999999876544 4999999999999999999998 9999999999999999999999999999875332 2233
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||... +.......+......+|..++++++++
T Consensus 307 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~p~~~~~~~~~l 379 (446)
T 4ejn_A 307 KTFCGTPEYLAPEVLEDND-----YGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILMEEIRFPRTLGPEAKSL 379 (446)
T ss_dssp CCSSSCGGGCCHHHHHTSC-----CCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ccccCCccccCHhhcCCCC-----CCCccchhhhHHHHHHHhhCCCCCCCC--CHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 4467899999999987664 889999999999999999999999643 334455566677888899999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|.+||++
T Consensus 380 i~~~L~~ 386 (446)
T 4ejn_A 380 LSGLLKK 386 (446)
T ss_dssp HHHHTCS
T ss_pred HHHHccc
Confidence 9999974
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=289.53 Aligned_cols=228 Identities=25% Similarity=0.373 Sum_probs=190.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+++.||+|.+....... .+.+.+|+.++++++||||+++++++..++..++||||+.
T Consensus 27 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 27 KIGQGAS---GTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp EEEEETT---EEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eeccCCC---eEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 3688888 999999999999999999997655332 3567889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 101 ~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 101 GGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp TCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred CCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 99999998754 24899999999999999999999999999999999999999999999999988765433 233
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH-HHhhhcCCCCCCCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKD-VKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~l~~l 239 (246)
...+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.......... ...........|..+|+.++++
T Consensus 175 ~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKA-----YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp CCCSCGGGCCHHHHHCSC-----BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred CccCCcCccChhhhcCCC-----CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence 456889999999987664 7889999999999999999999997544322211 1111222444567899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|.+||+.
T Consensus 250 i~~~l~~ 256 (297)
T 3fxz_A 250 LNRCLEM 256 (297)
T ss_dssp HHHHSCS
T ss_pred HHHHccC
Confidence 9999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=293.69 Aligned_cols=229 Identities=25% Similarity=0.390 Sum_probs=193.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||++.++.+++.||+|.+..... +....+.+.+|++++++++||||+++++++.++...++||||+.
T Consensus 36 ~lG~G~~---g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 111 (362)
T 2bdw_A 36 ELGKGAF---SVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 111 (362)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEecCCC---eEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 3788888 9999999999999999999987553 33445788999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC---CeEEeecceeeeeccCcc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG---HAHITDFNIATVLEENQL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~---~~~l~d~~~~~~~~~~~~ 158 (246)
|++|.+.+..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++........
T Consensus 112 gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 112 GGELFEDIVAREF-----YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp SCBHHHHHTTCSC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred CCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 9999999876543 48999999999999999999999999999999999998654 599999999987765544
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CCCCH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAWSE 234 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~s~ 234 (246)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+ .......+......+| ..+|+
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~~ll~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDP-----YSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAGAYDYPSPEWDTVTP 259 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred cccCCCCccccCHHHHccCC-----CCchhhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhCCCCCCcccccCCCH
Confidence 45567899999999987654 7889999999999999999999996533 3334444555544444 35799
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
+++++|.+||+.
T Consensus 260 ~~~~li~~~L~~ 271 (362)
T 2bdw_A 260 EAKSLIDSMLTV 271 (362)
T ss_dssp HHHHHHHHHSCS
T ss_pred HHHHHHHHHcCC
Confidence 999999999963
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=286.63 Aligned_cols=230 Identities=23% Similarity=0.293 Sum_probs=189.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+++.||+|.+........+..+.+.+|+..+++++||||+++++++.+++..++||||++
T Consensus 18 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 94 (294)
T 4eqm_A 18 KLGGGGM---STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIE 94 (294)
T ss_dssp EEEEETT---EEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEccCCC---EEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCC
Confidence 3677888 9999999999999999999977666666777889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc--cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ--LA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 159 (246)
|++|.+++..... +++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||++....... ..
T Consensus 95 g~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 95 GPTLSEYIESHGP-----LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp SCBHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred CCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence 9999999976543 4999999999999999999999999999999999999999999999999987654332 22
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCC-----CCCCCCCH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPV-----HYPTAWSE 234 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~s~ 234 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.... ........... ..+..+|+
T Consensus 170 ~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAKGEA-----TDECTDIYSIGIVLYEMLVGEPPFNGETAV--SIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp -----CCSSCCHHHHHTCC-----CCTTHHHHHHHHHHHHHHHSSCSSCSSCHH--HHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred CccccCccccCHhHhcCCC-----CCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhhccCCCcchhcccCCCH
Confidence 3356889999999987764 788999999999999999999999754422 22233333322 23467999
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.+.++|.+||+.
T Consensus 243 ~l~~li~~~l~~ 254 (294)
T 4eqm_A 243 SLSNVILRATEK 254 (294)
T ss_dssp HHHHHHHHHSCS
T ss_pred HHHHHHHHHhcC
Confidence 999999999863
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=290.05 Aligned_cols=230 Identities=30% Similarity=0.583 Sum_probs=185.9
Q ss_pred CcCCCCccCeeeEEEEEec---CCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK---DTKQMYAMKYMHKSQCI-ERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||+|++ |+||++++. .+++.||+|+++..... +......+.+|++++++++||||+++++++.+++..++||
T Consensus 24 ~lG~G~~---g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 100 (327)
T 3a62_A 24 VLGKGGY---GKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLIL 100 (327)
T ss_dssp EEEEETT---EEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEE
T ss_pred EEEeCCC---EEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEE
Confidence 4788888 999999985 68999999999875432 2334566788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN- 156 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~- 156 (246)
||+.|++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 101 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 175 (327)
T 3a62_A 101 EYLSGGELFMQLEREGI-----FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175 (327)
T ss_dssp ECCTTEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred eCCCCCcHHHHHHhCCC-----CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC
Confidence 99999999999976544 489999999999999999999999999999999999999999999999998764332
Q ss_pred ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhH
Q psy7592 157 QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSEST 236 (246)
Q Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l 236 (246)
.......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.. .......+......+|..+++.+
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~p~~~~~~~ 248 (327)
T 3a62_A 176 TVTHTFCGTIEYMAPEILMRSG-----HNRAVDWWSLGALMYDMLTGAPPFTGEN--RKKTIDKILKCKLNLPPYLTQEA 248 (327)
T ss_dssp ---CTTSSCCTTSCHHHHTTSC-----CCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTCCCCCTTSCHHH
T ss_pred ccccccCCCcCccCHhhCcCCC-----CCCcccchhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhCCCCCCCCCCHHH
Confidence 2233456889999999987654 7889999999999999999999997533 34455666777888899999999
Q ss_pred HHHHHHhhhC
Q psy7592 237 KHLLSQVHRY 246 (246)
Q Consensus 237 ~~li~~~l~~ 246 (246)
+++|++||+.
T Consensus 249 ~~li~~~L~~ 258 (327)
T 3a62_A 249 RDLLKKLLKR 258 (327)
T ss_dssp HHHHHHHSCS
T ss_pred HHHHHHHHhc
Confidence 9999999963
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=288.16 Aligned_cols=230 Identities=23% Similarity=0.397 Sum_probs=193.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchH---HHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIER---DALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |+||+++++.+++.||+|.+........ ...+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 18 ~lG~G~~---g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 94 (326)
T 2y0a_A 18 ELGSGQF---AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 94 (326)
T ss_dssp EEECCSS---EEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EEeeCCC---eEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEE
Confidence 4788888 9999999999999999999987543211 124678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC----CeEEeecceeeeec
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG----HAHITDFNIATVLE 154 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~----~~~l~d~~~~~~~~ 154 (246)
|+++++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 95 ~~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 95 LVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp CCCSCBHHHHHTTSSC-----CBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred cCCCCCHHHHHHhcCC-----cCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 9999999999976443 48999999999999999999999999999999999998887 79999999998876
Q ss_pred cCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----C
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----T 230 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~ 230 (246)
.........+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.. .......+......++ .
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 170 FGNEFKNIFGTPEFVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDT--KQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp TTSCCCCCCSCTTTCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHHTCCCCCHHHHT
T ss_pred CCCccccccCCcCcCCceeecCCC-----CCcHHHHHHHHHHHHHHHHCcCCCCCCC--HHHHHHHHHhcCCCcCccccc
Confidence 555555567899999999987654 7889999999999999999999996533 2233333443344443 5
Q ss_pred CCCHhHHHHHHHhhhC
Q psy7592 231 AWSESTKHLLSQVHRY 246 (246)
Q Consensus 231 ~~s~~l~~li~~~l~~ 246 (246)
.+|+.++++|++||+.
T Consensus 243 ~~~~~~~~li~~~L~~ 258 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVK 258 (326)
T ss_dssp TSCHHHHHHHHHHSCS
T ss_pred cCCHHHHHHHHHHccC
Confidence 7899999999999963
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=302.85 Aligned_cols=235 Identities=29% Similarity=0.502 Sum_probs=191.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+++++.+|+.||+|++++.........+.+.+|..++.+++||||+++++++.++...|+||||++
T Consensus 68 ~lG~G~f---G~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~ 144 (412)
T 2vd5_A 68 VIGRGAF---SEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV 144 (412)
T ss_dssp EEEECSS---CEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEeeCCC---eEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence 4788888 8999999999999999999987543333344568889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--A 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 159 (246)
|++|.+++.+.. ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........ .
T Consensus 145 gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~ 220 (412)
T 2vd5_A 145 GGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220 (412)
T ss_dssp SCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence 999999997642 2358999999999999999999999999999999999999999999999999987654432 2
Q ss_pred cccccCCCccCCceeccccc--ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc--CCCCC---CCCC
Q psy7592 160 TSMSGTKPYIAPEIFLVATD--EVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY--SPVHY---PTAW 232 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~--~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~---~~~~ 232 (246)
....+++.|+|||.+..... ....++.++|+||||+++|+|++|..||.+.+. ......+.. ....+ +..+
T Consensus 221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~~ 298 (412)
T 2vd5_A 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--AETYGKIVHYKEHLSLPLVDEGV 298 (412)
T ss_dssp SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHTHHHHCCCC----CC
T ss_pred ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--HHHHHHHHhcccCcCCCccccCC
Confidence 23578999999999874210 011278899999999999999999999975432 223333332 12223 4679
Q ss_pred CHhHHHHHHHhhh
Q psy7592 233 SESTKHLLSQVHR 245 (246)
Q Consensus 233 s~~l~~li~~~l~ 245 (246)
|+++++||++||+
T Consensus 299 s~~~~dli~~lL~ 311 (412)
T 2vd5_A 299 PEEARDFIQRLLC 311 (412)
T ss_dssp CHHHHHHHHTTSS
T ss_pred CHHHHHHHHHHcC
Confidence 9999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=314.93 Aligned_cols=230 Identities=34% Similarity=0.591 Sum_probs=201.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|+| |+||+++++.+++.||||++++......+..+.+..|.+++..+ +||+|+++++++.+.+.+|+||||+
T Consensus 348 ~LG~G~f---G~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~ 424 (674)
T 3pfq_A 348 VLGKGSF---GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 424 (674)
T ss_dssp ESSBTTT---BCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECC
T ss_pred EEccCCC---EEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCc
Confidence 4888998 99999999999999999999876544444567788899999988 6999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Cccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~ 159 (246)
.|++|.+++..... +++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||+++.... ....
T Consensus 425 ~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~ 499 (674)
T 3pfq_A 425 NGGDLMYHIQQVGR-----FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 499 (674)
T ss_dssp CSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCB
T ss_pred CCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCccc
Confidence 99999999987554 49999999999999999999999999999999999999999999999999986432 3334
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....+++.|+|||++.+.. ++.++|+||||+++|+|++|..||.+. +.......+......+|..+|+++++|
T Consensus 500 ~~~~GT~~Y~APE~l~~~~-----~~~~~DvwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~~~~~~p~~~s~~~~~l 572 (674)
T 3pfq_A 500 KTFCGTPDYIAPEIIAYQP-----YGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSIMEHNVAYPKSMSKEAVAI 572 (674)
T ss_dssp CCCCSCSSSCCHHHHTCCC-----BSTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHSSCCCCCTTSCHHHHHH
T ss_pred ccccCCCcccCHhhhcCCC-----CCccceEechHHHHHHHHcCCCCCCCC--CHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 4567899999999997665 789999999999999999999999753 344566777888889999999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||++
T Consensus 573 i~~lL~~ 579 (674)
T 3pfq_A 573 CKGLMTK 579 (674)
T ss_dssp HHHHSCS
T ss_pred HHHHccC
Confidence 9999974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=304.21 Aligned_cols=232 Identities=32% Similarity=0.586 Sum_probs=190.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+++.||+|++++.........+.+.+|+.+++.++||||+++++++.++...|+||||++
T Consensus 76 ~LG~G~f---G~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 152 (410)
T 3v8s_A 76 VIGRGAF---GEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 152 (410)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEcCCC---EEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 4788888 9999999999999999999977443222233457889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--A 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 159 (246)
|++|.+++... .+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........ .
T Consensus 153 gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 226 (410)
T 3v8s_A 153 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226 (410)
T ss_dssp TEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEEC
T ss_pred CCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccc
Confidence 99999988653 248999999999999999999999999999999999999999999999999987654432 2
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCC--CCCCHh
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYP--TAWSES 235 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~--~~~s~~ 235 (246)
....+++.|+|||.+.+.... ..++.++|+||||+++|+|++|..||.+.+ .......+... ...+| ..+|++
T Consensus 227 ~~~~gt~~Y~APE~l~~~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~ 303 (410)
T 3v8s_A 227 DTAVGTPDYISPEVLKSQGGD-GYYGRECDWWSVGVFLYEMLVGDTPFYADS--LVGTYSKIMNHKNSLTFPDDNDISKE 303 (410)
T ss_dssp CSCCSCGGGCCHHHHHTTTTT-CEEETHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTHHHHCCCCTTCCCCHH
T ss_pred cCCcCCccccCHHHhhccCCC-cCCCCcceEecchHHHHHHHhCCCCCCCCC--hhhHHHHHHhccccccCCCcccccHH
Confidence 356789999999998754311 115679999999999999999999997543 23333344332 23344 479999
Q ss_pred HHHHHHHhhh
Q psy7592 236 TKHLLSQVHR 245 (246)
Q Consensus 236 l~~li~~~l~ 245 (246)
+++||++||+
T Consensus 304 ~~~li~~lL~ 313 (410)
T 3v8s_A 304 AKNLICAFLT 313 (410)
T ss_dssp HHHHHHHHSS
T ss_pred HHHHHHHHcc
Confidence 9999999985
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=297.29 Aligned_cols=229 Identities=24% Similarity=0.348 Sum_probs=191.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|.++.+|+.||+|.+..... +....+.+.+|++++++++||||+++++++.++...++||||+.
T Consensus 18 ~LG~G~f---g~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 93 (444)
T 3soa_A 18 ELGKGAF---SVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVT 93 (444)
T ss_dssp EEEEC-----CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCB
T ss_pred EeccCCC---eEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCC
Confidence 3788888 9999999999999999999987653 33445778999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc---CCCCeEEeecceeeeeccCc-
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD---EEGHAHITDFNIATVLEENQ- 157 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~---~~~~~~l~d~~~~~~~~~~~- 157 (246)
|++|.+.+..... +++..+..++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||++.......
T Consensus 94 gg~L~~~i~~~~~-----~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 94 GGELFEDIVAREY-----YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp CCBHHHHHHHCSC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred CCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 9999999987544 49999999999999999999999999999999999998 45789999999997765432
Q ss_pred cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CCCC
Q psy7592 158 LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAWS 233 (246)
Q Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~s 233 (246)
......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+ .......+......+| ..+|
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~-----~~~~~DIwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s 241 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDP-----YGKPVDLWACGVILYILLVGYPPFWDED--QHRLYQQIKAGAYDFPSPEWDTVT 241 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred eeecccCCcccCCHHHhcCCC-----CCCccccHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHhCCCCCCccccccCC
Confidence 223467899999999987654 7889999999999999999999996543 3344445555544443 3689
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
++++++|.+||+.
T Consensus 242 ~~~~~li~~~L~~ 254 (444)
T 3soa_A 242 PEAKDLINKMLTI 254 (444)
T ss_dssp HHHHHHHHHHSCS
T ss_pred HHHHHHHHHHcCC
Confidence 9999999999964
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=287.54 Aligned_cols=227 Identities=22% Similarity=0.338 Sum_probs=194.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+++++.+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 12 ~lG~G~~---g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 12 DLGRGEF---GIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred EEecCCC---eEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 3788888 999999999999999999997543 334668899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC--CCCeEEeecceeeeeccCccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE--EGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~ 159 (246)
|++|.+++.... ..+++..++.++.|++.|+.|||+.|++|+||+|+||+++. ++.++++|||++.........
T Consensus 85 g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 85 GLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 999999986532 23589999999999999999999999999999999999987 789999999999887665555
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CCCCHh
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAWSES 235 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~ 235 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.. .......+......++ ..+|++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDV-----VSTATDMWSLGTLVYVLLSGINPFLAET--NQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp EEEESCGGGSCHHHHTTCE-----ECHHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred ccccCChhhcCcHHhcCCC-----CCchhhHHHHHHHHHHHHhCCCCCcCCC--HHHHHHHHHcCCCCCChhhhccCCHH
Confidence 5567899999999987664 6889999999999999999999997533 3344455555555554 478999
Q ss_pred HHHHHHHhhhC
Q psy7592 236 TKHLLSQVHRY 246 (246)
Q Consensus 236 l~~li~~~l~~ 246 (246)
++++|++||+.
T Consensus 234 ~~~li~~~L~~ 244 (321)
T 1tki_A 234 AMDFVDRLLVK 244 (321)
T ss_dssp HHHHHHTTSCS
T ss_pred HHHHHHHHcCC
Confidence 99999999963
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=285.52 Aligned_cols=232 Identities=19% Similarity=0.325 Sum_probs=185.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++ +++.||+|.+..... +.+..+.+.+|++++++++||||+++++++.+....++||||+.
T Consensus 44 ~lG~G~~---g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 3p86_A 44 KIGAGSF---GTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS 117 (309)
T ss_dssp EEEECSS---EEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred EeecCCC---eEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCC
Confidence 3788888 99999987 588999999976543 34556788999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH--IIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-L 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~--~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 158 (246)
+++|.+++..... ...+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 118 ~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 195 (309)
T 3p86_A 118 RGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS 195 (309)
T ss_dssp TCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred CCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccc
Confidence 9999999976432 122589999999999999999999999 9999999999999999999999999987644332 2
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKH 238 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ 238 (246)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||....................+|..+++.+.+
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 270 (309)
T 3p86_A 196 SKSAAGTPEWMAPEVLRDEP-----SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270 (309)
T ss_dssp ------CCTTSCHHHHTTCC-----CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred cccCCCCccccChhhhcCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 33456889999999987765 7889999999999999999999997654333322222344467788899999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|++||+.
T Consensus 271 li~~~l~~ 278 (309)
T 3p86_A 271 IIEGCWTN 278 (309)
T ss_dssp HHHHHTCS
T ss_pred HHHHHccC
Confidence 99999963
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=290.56 Aligned_cols=233 Identities=28% Similarity=0.414 Sum_probs=191.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccch--HHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIE--RDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|++ |+||+++++.+++.||+|.+....... ....+.+.+|++++++++||||+++++++.++...++||||
T Consensus 31 ~lG~G~~---g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 107 (351)
T 3c0i_A 31 VIGKGPF---SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEF 107 (351)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEeeCCC---EEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence 4788888 999999999999999999997543211 11246788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC---eEEeecceeeeeccC
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH---AHITDFNIATVLEEN 156 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~---~~l~d~~~~~~~~~~ 156 (246)
++|++|.+.+..... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++++|||++......
T Consensus 108 ~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 186 (351)
T 3c0i_A 108 MDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186 (351)
T ss_dssp CSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCC
Confidence 999999888865432 1334689999999999999999999999999999999999987654 999999999876554
Q ss_pred cc-ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CC
Q psy7592 157 QL-ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TA 231 (246)
Q Consensus 157 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~ 231 (246)
.. .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+. .......+......++ ..
T Consensus 187 ~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 187 GLVAGGRVGTPHFMAPEVVKREP-----YGKPVDVWGCGVILFILLSGCLPFYGT---KERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp SCBCCCCCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSSCSS---HHHHHHHHHHTCCCCCHHHHTT
T ss_pred CeeecCCcCCcCccCHHHHcCCC-----CCchHhhHHHHHHHHHHHHCCCCCCCc---HHHHHHHHHcCCCCCCcccccc
Confidence 32 33456899999999987654 788999999999999999999999652 2334445555544443 46
Q ss_pred CCHhHHHHHHHhhhC
Q psy7592 232 WSESTKHLLSQVHRY 246 (246)
Q Consensus 232 ~s~~l~~li~~~l~~ 246 (246)
+|++++++|.+||++
T Consensus 259 ~s~~~~~li~~~L~~ 273 (351)
T 3c0i_A 259 ISESAKDLVRRMLML 273 (351)
T ss_dssp SCHHHHHHHHHHTCS
T ss_pred CCHHHHHHHHHHCCC
Confidence 899999999999964
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=290.10 Aligned_cols=228 Identities=22% Similarity=0.368 Sum_probs=188.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+|+.||+|+++... ....+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 96 ~lG~G~~---g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 96 ILGGGRF---GQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp ECC--------CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEecCcC---EEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 3788888 999999999999999999998754 2345678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE--cCCCCeEEeecceeeeeccCccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL--DEEGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~--~~~~~~~l~d~~~~~~~~~~~~~ 159 (246)
+++|.+.+.... ..+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++.........
T Consensus 170 ~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 170 GGELFDRIIDES----YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp TCEEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 999998886532 235889999999999999999999999999999999999 56678999999999887665555
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CCCCHh
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAWSES 235 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~ 235 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.. .......+......++ ..++++
T Consensus 246 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~ 318 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDF-----VSFPTDMWSVGVIAYMLLSGLSPFLGDN--DAETLNNILACRWDLEDEEFQDISEE 318 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCB-----CCHHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCCCSCSGGGTTSCHH
T ss_pred ccccCCCcEeChhhccCCC-----CCcHHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccCCCChhhhccCCHH
Confidence 5567899999999987654 7889999999999999999999997543 3334445555444333 468999
Q ss_pred HHHHHHHhhhC
Q psy7592 236 TKHLLSQVHRY 246 (246)
Q Consensus 236 l~~li~~~l~~ 246 (246)
++++|++||++
T Consensus 319 ~~~li~~~L~~ 329 (373)
T 2x4f_A 319 AKEFISKLLIK 329 (373)
T ss_dssp HHHHHHTTSCS
T ss_pred HHHHHHHHcCC
Confidence 99999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=279.75 Aligned_cols=230 Identities=26% Similarity=0.406 Sum_probs=199.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+||+|++ |+||+++++.+++.||+|.+......+....+.+.+|+..+++++||||+++++++.+++..++||||++
T Consensus 22 ~lg~G~~---g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 98 (294)
T 2rku_A 22 FLGKGGF---AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 98 (294)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEeecCC---EEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCC
Confidence 4788888 9999999999999999999987765566667889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-cccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~ 160 (246)
+++|.+++..... +++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+...... ....
T Consensus 99 ~~~L~~~~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (294)
T 2rku_A 99 RRSLLELHKRRKA-----LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 173 (294)
T ss_dssp TCBHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred CCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccc
Confidence 9999998876543 489999999999999999999999999999999999999999999999999876533 2233
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
...++..|+|||.+.+.. ++.++|+||||+++++|++|..||.... .......+......+|..+++.+.++|
T Consensus 174 ~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li 246 (294)
T 2rku_A 174 VLCGTPNYIAPEVLSKKG-----HSFEVDVWSIGCIMYTLLVGKPPFETSC--LKETYLRIKKNEYSIPKHINPVAASLI 246 (294)
T ss_dssp CCCSCCSSCCHHHHTTSC-----BCTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred cccCCCCcCCcchhccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhhccCCCccccCHHHHHHH
Confidence 456788999999987654 6889999999999999999999997533 233445555667778889999999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
++||+.
T Consensus 247 ~~~l~~ 252 (294)
T 2rku_A 247 QKMLQT 252 (294)
T ss_dssp HHHTCS
T ss_pred HHHccc
Confidence 999963
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=285.89 Aligned_cols=228 Identities=21% Similarity=0.352 Sum_probs=188.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+++.||+|.+.... .+..+.+.+|++++++++||||+++++++.++...++||||++
T Consensus 17 ~lG~G~~---g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 17 VLGKGCF---GQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp EEECCSS---EEEEEEEETTTCCEEEEEEESCCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eecCCCC---EEEEEEEECCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 4788888 999999999999999999986543 5566889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-- 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (246)
+++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 91 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 91 GGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999999997632 23589999999999999999999999999999999999999999999999999876433221
Q ss_pred -------------cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH---HHHhhhc
Q psy7592 160 -------------TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK---DVKAIIY 223 (246)
Q Consensus 160 -------------~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~---~~~~~~~ 223 (246)
....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||......... ......
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~- 240 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-----YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL- 240 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH-
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCC-----CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc-
Confidence 1345788999999997654 788999999999999999999998654332211 111111
Q ss_pred CCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 224 SPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 224 ~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
....|..+++.+.++|.+||+.
T Consensus 241 -~~~~~~~~~~~l~~li~~~l~~ 262 (310)
T 3s95_A 241 -DRYCPPNCPPSFFPITVRCCDL 262 (310)
T ss_dssp -HHTCCTTCCTTHHHHHHHHTCS
T ss_pred -cccCCCCCCHHHHHHHHHHccC
Confidence 2234678999999999999963
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=285.28 Aligned_cols=230 Identities=26% Similarity=0.406 Sum_probs=199.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+||+|++ |.||++++..+++.||+|.+...........+.+.+|+.++++++||||+++++++.+++..++||||+.
T Consensus 48 ~lg~G~~---g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 124 (335)
T 2owb_A 48 FLGKGGF---AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124 (335)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEeeCCC---eEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCC
Confidence 4788888 9999999999999999999987766566677889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-cccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~ 160 (246)
+++|.+++..... +++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 125 ~~~L~~~~~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (335)
T 2owb_A 125 RRSLLELHKRRKA-----LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 199 (335)
T ss_dssp TCBHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred CCCHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccccc
Confidence 9999998876543 489999999999999999999999999999999999999999999999999876533 2233
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
...++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.... .......+......+|..+++.+.++|
T Consensus 200 ~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li 272 (335)
T 2owb_A 200 VLCGTPNYIAPEVLSKKG-----HSFEVDVWSIGCIMYTLLVGKPPFETSC--LKETYLRIKKNEYSIPKHINPVAASLI 272 (335)
T ss_dssp CCCSCCSSCCHHHHHTSC-----BCTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred ccCCCccccCHHHhccCC-----CCchhhHHHHHHHHHHHHHCcCCCCCCC--HHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence 456788999999987654 7889999999999999999999997533 233445555667778889999999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
++||+.
T Consensus 273 ~~~l~~ 278 (335)
T 2owb_A 273 QKMLQT 278 (335)
T ss_dssp HHHTCS
T ss_pred HHHccC
Confidence 999963
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=280.34 Aligned_cols=229 Identities=29% Similarity=0.468 Sum_probs=193.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++.++.+++.||+|.+.............+.+|+.++++++||||+++++++.+....++||||++
T Consensus 16 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (279)
T 3fdn_A 16 PLGKGKF---GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 92 (279)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEecCCC---eEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCC
Confidence 3788888 9999999999999999999977654444445778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+.+..... +++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++...... ....
T Consensus 93 ~~~l~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~ 166 (279)
T 3fdn_A 93 LGTVYRELQKLSK-----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTD 166 (279)
T ss_dssp TEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred CCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-cccc
Confidence 9999999876544 489999999999999999999999999999999999999999999999988554332 2334
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.... .......+......+|..+++.++++|.
T Consensus 167 ~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (279)
T 3fdn_A 167 LCGTLDYLPPEMIEGRM-----HDEKVDLWSLGVLCYEFLVGKPPFEANT--YQETYKRISRVEFTFPDFVTEGARDLIS 239 (279)
T ss_dssp -CCCCTTCCHHHHTTCC-----CCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred cCCCCCccCHhHhccCC-----CCccchhHhHHHHHHHHHHCCCCCCCCc--HHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 56789999999987654 7889999999999999999999997433 3344555666677888899999999999
Q ss_pred HhhhC
Q psy7592 242 QVHRY 246 (246)
Q Consensus 242 ~~l~~ 246 (246)
+||+.
T Consensus 240 ~~l~~ 244 (279)
T 3fdn_A 240 RLLKH 244 (279)
T ss_dssp HHCCS
T ss_pred HHhcc
Confidence 99963
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=288.44 Aligned_cols=228 Identities=29% Similarity=0.419 Sum_probs=180.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|++....... +.+.+|+..+++++||||+++++++.+....++||||+.
T Consensus 27 ~lG~G~~---g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 27 DIGSGNF---GVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp EESSSTT---SSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EeccCCC---EEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 4788888 899999999999999999998654322 457789999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC--eEEeecceeeeeccCccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH--AHITDFNIATVLEENQLA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~ 159 (246)
+++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 100 ~~~L~~~l~~~~~-----~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~ 174 (361)
T 3uc3_A 100 GGELYERICNAGR-----FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174 (361)
T ss_dssp SCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence 9999999876544 499999999999999999999999999999999999987765 999999998755444444
Q ss_pred cccccCCCccCCceecccccccCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHhhhcCCCCCCC--CCCH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSY-SVDWWSLGVTLFEILARGRPFDIHSNTS--VKDVKAIIYSPVHYPT--AWSE 234 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~-~~Di~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~--~~s~ 234 (246)
....+++.|+|||.+.+.. +.. ++|+||||+++|+|++|..||.+..... ......+......+|. .+|+
T Consensus 175 ~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQE-----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp ------CTTSCHHHHHCSS-----CCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred CCCcCCCCcCChhhhcCCC-----CCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 5567899999999987654 444 4899999999999999999997644322 2334445555555554 6899
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.+++||++||++
T Consensus 250 ~~~~li~~~L~~ 261 (361)
T 3uc3_A 250 ECCHLISRIFVA 261 (361)
T ss_dssp HHHHHHHHHSCS
T ss_pred HHHHHHHHHccC
Confidence 999999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=287.18 Aligned_cols=230 Identities=21% Similarity=0.269 Sum_probs=185.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC----eEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE----DLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~v~ 77 (246)
.||+|++ |+||++++..+++.||+|+++.....+.+....+.+|++.+++++||||+++++++.... ..++||
T Consensus 19 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~ 95 (311)
T 3ork_A 19 ILGFGGM---SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 95 (311)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEccCCC---EEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEE
Confidence 4788888 999999999999999999998876666677788999999999999999999999987654 349999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||++|++|.+++..... +++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 96 EYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp ECCCEEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred ecCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 99999999999976543 4999999999999999999999999999999999999999999999999987654332
Q ss_pred ----cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCC----C
Q psy7592 158 ----LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY----P 229 (246)
Q Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----~ 229 (246)
......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+... .............. +
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~~l~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQARGDS-----VDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp -----------CCTTCCHHHHHTCC-----CCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHCCCCCHHHHS
T ss_pred cccccccccCcCcccCCHHHhcCCC-----CCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhcCCCCCccccc
Confidence 122345789999999987664 78899999999999999999999975432 22223333332222 2
Q ss_pred CCCCHhHHHHHHHhhhC
Q psy7592 230 TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 ~~~s~~l~~li~~~l~~ 246 (246)
..+|+++.++|.+||+.
T Consensus 244 ~~~~~~l~~li~~~l~~ 260 (311)
T 3ork_A 244 EGLSADLDAVVLKALAK 260 (311)
T ss_dssp TTCCHHHHHHHHHHTCS
T ss_pred CCCCHHHHHHHHHHHhc
Confidence 56999999999999963
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=283.68 Aligned_cols=226 Identities=28% Similarity=0.422 Sum_probs=171.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|+| |+||+++++.+++.||+|.+.... .....+|+..++.++ ||||+++++++.++...++||||+
T Consensus 18 ~lG~G~~---g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 88 (325)
T 3kn6_A 18 PLGEGSF---SICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL 88 (325)
T ss_dssp CSEEETT---EEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccccCCC---eEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence 4788888 999999999999999999997643 356778999999997 999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC---CeEEeecceeeeeccCc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG---HAHITDFNIATVLEENQ 157 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~---~~~l~d~~~~~~~~~~~ 157 (246)
++++|.+++..... +++..++.++.|++.+|.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 89 ~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 89 NGGELFERIKKKKH-----FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp CSCBHHHHHHHCSC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred CCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 99999999987544 49999999999999999999999999999999999998766 79999999998654432
Q ss_pred -cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----cHHHHHhhhcCCCCCC--
Q psy7592 158 -LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT-----SVKDVKAIIYSPVHYP-- 229 (246)
Q Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~-- 229 (246)
......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...... .......+......++
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNG-----YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238 (325)
T ss_dssp --------------------CC-----CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred CcccccCCCcCccCHHHhcCCC-----CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence 223456788999999987664 789999999999999999999999754321 1233444555555554
Q ss_pred --CCCCHhHHHHHHHhhhC
Q psy7592 230 --TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 --~~~s~~l~~li~~~l~~ 246 (246)
..+|+++++||.+||+.
T Consensus 239 ~~~~~s~~~~~li~~~L~~ 257 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTV 257 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCC
T ss_pred cccCCCHHHHHHHHHHCCC
Confidence 35899999999999974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=277.55 Aligned_cols=226 Identities=23% Similarity=0.418 Sum_probs=194.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++.++.++..||+|++....... .+.+.+|++.+++++||||+++++++.++...++||||++
T Consensus 16 ~lg~G~~---g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (277)
T 3f3z_A 16 TIGRGSW---GEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT 89 (277)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEeecCC---EEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence 3788888 999999999999999999998755322 4678889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE---cCCCCeEEeecceeeeeccCcc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL---DEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~---~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
+++|.+.+..... +++..++.++.|++.++.+||+.|++|+||+|+||++ +.++.++++|||.+........
T Consensus 90 ~~~L~~~~~~~~~-----~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 90 GGELFERVVHKRV-----FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp SCBHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 9999998876544 4899999999999999999999999999999999999 7888999999999988776655
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCC----CCCH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPT----AWSE 234 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~s~ 234 (246)
.....+++.|+|||.+.+. ++.++|+||||+++++|++|..||.... .......+......+|. .+|+
T Consensus 165 ~~~~~~t~~y~aPE~~~~~------~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL------YGPECDEWSAGVMMYVLLCGYPPFSAPT--DSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC------BCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred hhccCCCCCccChHHhccc------CCchhhehhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhCCCCCCchhhhcCCH
Confidence 5667789999999987643 6789999999999999999999997533 33444555555666654 7899
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.+.++|.+||+.
T Consensus 237 ~~~~li~~~l~~ 248 (277)
T 3f3z_A 237 QAESLIRRLLTK 248 (277)
T ss_dssp HHHHHHHHHTCS
T ss_pred HHHHHHHHHccC
Confidence 999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=277.81 Aligned_cols=231 Identities=26% Similarity=0.408 Sum_probs=188.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.++.+|+.||+|.+......+.+..+.+.+|++.+++++||||+++++++.+....++||||+.
T Consensus 18 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (276)
T 2h6d_A 18 TLGVGTF---GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94 (276)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred eecCCCC---eEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccC
Confidence 3688888 9999999999999999999987554334445778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++..... +++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+...........
T Consensus 95 ~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 169 (276)
T 2h6d_A 95 GGELFDYICKHGR-----VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 169 (276)
T ss_dssp SCBHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred CCcHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcceec
Confidence 9999999976544 48999999999999999999999999999999999999999999999999877655444445
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..+++.|+|||.+.+.. ..+.++|+||||+++++|++|..||.... .......+......+|..+++.+.++|.
T Consensus 170 ~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~ 243 (276)
T 2h6d_A 170 SCGSPNYAAPEVISGRL----YAGPEVDIWSCGVILYALLCGTLPFDDEH--VPTLFKKIRGGVFYIPEYLNRSVATLLM 243 (276)
T ss_dssp -------CCTGGGTTSC----CCHHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred ccCCccccCHHHHcCCC----CCCccchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHhhcCcccCchhcCHHHHHHHH
Confidence 56788999999987654 13578999999999999999999996533 2334445555667788889999999999
Q ss_pred HhhhC
Q psy7592 242 QVHRY 246 (246)
Q Consensus 242 ~~l~~ 246 (246)
+||+.
T Consensus 244 ~~l~~ 248 (276)
T 2h6d_A 244 HMLQV 248 (276)
T ss_dssp HHTCS
T ss_pred HHccC
Confidence 99963
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=278.72 Aligned_cols=229 Identities=29% Similarity=0.493 Sum_probs=195.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+++.||+|.+...........+.+.+|++.+++++||||+++++++.++...++||||++
T Consensus 21 ~lg~G~~---g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 97 (284)
T 2vgo_A 21 PLGKGKF---GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAP 97 (284)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred eecCCCC---eEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCC
Confidence 3788888 9999999999999999999977543333335678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++..... +++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+...... ....
T Consensus 98 ~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 171 (284)
T 2vgo_A 98 RGELYKELQKHGR-----FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-RRRT 171 (284)
T ss_dssp TEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-CBCC
T ss_pred CCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-cccc
Confidence 9999999976543 489999999999999999999999999999999999999999999999998765432 2234
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.... .......+......+|..+|+.++++|+
T Consensus 172 ~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~ 244 (284)
T 2vgo_A 172 MCGTLDYLPPEMIEGKT-----HDEKVDLWCAGVLCYEFLVGMPPFDSPS--HTETHRRIVNVDLKFPPFLSDGSKDLIS 244 (284)
T ss_dssp CCSCGGGCCHHHHTTCC-----BCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred ccCCCCcCCHHHhccCC-----CCcccchhhHHHHHHHHHHCCCCCCCCC--HhHHHHHHhccccCCCCcCCHHHHHHHH
Confidence 56788999999987654 6889999999999999999999997433 3334455566677788899999999999
Q ss_pred HhhhC
Q psy7592 242 QVHRY 246 (246)
Q Consensus 242 ~~l~~ 246 (246)
+||+.
T Consensus 245 ~~l~~ 249 (284)
T 2vgo_A 245 KLLRY 249 (284)
T ss_dssp HHSCS
T ss_pred HHhhc
Confidence 99963
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=288.76 Aligned_cols=228 Identities=23% Similarity=0.390 Sum_probs=191.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+|+++.+++.||+|.+.... ......+.+|++++++++||||+++++++.++...++||||+.
T Consensus 58 ~LG~G~~---g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 58 ELGSGAF---GVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEecCCC---EEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 3788888 999999999999999999998754 2334578899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC--CCCeEEeecceeeeeccCccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE--EGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~ 159 (246)
+++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||++.........
T Consensus 132 gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 132 GGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp CCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 999999886532 23589999999999999999999999999999999999974 467999999999887655544
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCC----CCCCCHh
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY----PTAWSES 235 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~ 235 (246)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.. .......+......+ +..+|++
T Consensus 208 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlG~il~elltg~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREP-----VGFYTDMWAIGVLGYVLLSGLSPFAGED--DLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp EEECSSGGGCCHHHHTTCC-----BCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred eeeccCCCccCchhccCCC-----CCCcccEeeHhHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCccccccCCHH
Confidence 5567899999999987654 7889999999999999999999997543 233334444433322 3578999
Q ss_pred HHHHHHHhhhC
Q psy7592 236 TKHLLSQVHRY 246 (246)
Q Consensus 236 l~~li~~~l~~ 246 (246)
++++|++||+.
T Consensus 281 ~~~li~~~L~~ 291 (387)
T 1kob_A 281 AKDFIKNLLQK 291 (387)
T ss_dssp HHHHHHTTSCS
T ss_pred HHHHHHHHcCC
Confidence 99999999963
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=286.15 Aligned_cols=230 Identities=27% Similarity=0.378 Sum_probs=187.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+++.||+|++..... .+..+.+.+|+.+++.++||||+++++++.++...++||||++
T Consensus 14 ~lG~G~~---g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 14 TLGEGAY---GEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEecCCC---EEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 3788888 9999999999999999999976542 2234668899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc---c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---L 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~---~ 158 (246)
+++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 89 ~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 89 GGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp TEEGGGGSBTTTB-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCcHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 9999998876544 4999999999999999999999999999999999999999999999999998754322 2
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCC--CCCCCHhH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY--PTAWSEST 236 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l 236 (246)
.....+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||......... ........... ...+++.+
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRRE----FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTYLNPWKKIDSAP 238 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSS----BCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTTCTTSTTGGGSCHHH
T ss_pred cCCCccCcCccCcHHhccCC----CCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhcccccCCccccCCHHH
Confidence 23456889999999987654 1366899999999999999999999765544332 22222222222 25689999
Q ss_pred HHHHHHhhhC
Q psy7592 237 KHLLSQVHRY 246 (246)
Q Consensus 237 ~~li~~~l~~ 246 (246)
.+||.+||+.
T Consensus 239 ~~li~~~L~~ 248 (323)
T 3tki_A 239 LALLHKILVE 248 (323)
T ss_dssp HHHHHHHSCS
T ss_pred HHHHHHHccC
Confidence 9999999964
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=278.39 Aligned_cols=231 Identities=24% Similarity=0.426 Sum_probs=174.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+|+.||+|.+........+..+.+.+|++.+++++||||+++++++.+....++||||++
T Consensus 18 ~lg~G~~---g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (278)
T 3cok_A 18 LLGKGSF---AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCH 94 (278)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eecCCCc---eEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCC
Confidence 3788888 9999999999999999999976543333345778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|.+++.... .++++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 95 ~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 170 (278)
T 3cok_A 95 NGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY 170 (278)
T ss_dssp TEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred CCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcce
Confidence 999999987642 245899999999999999999999999999999999999999999999999988765332 223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
...+++.|+|||.+.+.. ++.++|+||||+++++|++|..||...... .....+.......|..++++++++|
T Consensus 171 ~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li 243 (278)
T 3cok_A 171 TLCGTPNYISPEIATRSA-----HGLESDVWSLGCMFYTLLIGRPPFDTDTVK--NTLNKVVLADYEMPSFLSIEAKDLI 243 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------CCSSCCCCCTTSCHHHHHHH
T ss_pred eccCCCCcCCcchhcCCC-----CCchhhHHHHHHHHHHHHhCCCCCCChhHH--HHHHHHhhcccCCccccCHHHHHHH
Confidence 356788999999987654 688999999999999999999999754432 2233344445667888999999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
.+||+.
T Consensus 244 ~~~l~~ 249 (278)
T 3cok_A 244 HQLLRR 249 (278)
T ss_dssp HHHSCS
T ss_pred HHHccc
Confidence 999963
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=275.68 Aligned_cols=229 Identities=25% Similarity=0.393 Sum_probs=193.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++.++.+++.||+|.+..... +....+.+.+|++++++++||||+++++++.++...+++|||+.
T Consensus 13 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 88 (284)
T 3kk8_A 13 ELGKGAF---SVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 88 (284)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred hhcCcCC---eEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence 3678888 9999999999999999999977553 34445788899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC---eEEeecceeeeeccCcc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH---AHITDFNIATVLEENQL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~---~~l~d~~~~~~~~~~~~ 158 (246)
+++|.+.+..... +++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++++|||.+........
T Consensus 89 ~~~l~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 89 GGELFEDIVAREF-----YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp SCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred CCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 9999988876544 499999999999999999999999999999999999986665 99999999987766555
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CCCCH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAWSE 234 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~s~ 234 (246)
.....+++.|+|||.+.+.. ++.++|+||||+++++|++|..||..... ......+.......| ..+++
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDP-----YSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred ccCCCCCcCCcCchhhcCCC-----CCcccchHHHHHHHHHHHHCCCCCCCCch--hHHHHHHHhccccCCchhhcccCH
Confidence 55567899999999987664 78899999999999999999999965432 333334444433333 47899
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.+.++|.+||+.
T Consensus 237 ~~~~li~~~l~~ 248 (284)
T 3kk8_A 237 EAKSLIDSMLTV 248 (284)
T ss_dssp HHHHHHHHHSCS
T ss_pred HHHHHHHHHccc
Confidence 999999999973
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=281.60 Aligned_cols=230 Identities=25% Similarity=0.411 Sum_probs=194.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchH---HHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIER---DALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |+||+++++.+|+.||+|.+........ ...+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 19 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (321)
T 2a2a_A 19 ELGSGQF---AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE 95 (321)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EeeecCC---EEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEE
Confidence 3788888 9999999999999999999987543221 124678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC----CeEEeecceeeeec
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG----HAHITDFNIATVLE 154 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~----~~~l~d~~~~~~~~ 154 (246)
|+++++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++++|||++....
T Consensus 96 ~~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 96 LVSGGELFDFLAQKES-----LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp CCCSCBHHHHHHTCSC-----EEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 9999999999976543 48999999999999999999999999999999999999888 79999999998876
Q ss_pred cCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----C
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----T 230 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~ 230 (246)
.........+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.. .......+......++ .
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 171 DGVEFKNIFGTPEFVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDT--KQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHTTCCCCCHHHHT
T ss_pred ccccccccCCCCCccCcccccCCC-----CCCccccHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhcccccChhhhc
Confidence 655555567889999999987654 7889999999999999999999996533 2333444444444444 5
Q ss_pred CCCHhHHHHHHHhhhC
Q psy7592 231 AWSESTKHLLSQVHRY 246 (246)
Q Consensus 231 ~~s~~l~~li~~~l~~ 246 (246)
.+|+.++++|++||+.
T Consensus 244 ~~~~~~~~li~~~l~~ 259 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVK 259 (321)
T ss_dssp TCCHHHHHHHHTTSCS
T ss_pred ccCHHHHHHHHHHcCC
Confidence 7899999999999963
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=300.39 Aligned_cols=229 Identities=28% Similarity=0.481 Sum_probs=194.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+|+++.+++.||+|++...........+.+.+|+.++++++||||+++++++.+....++||||+.
T Consensus 33 ~lg~G~~---g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 109 (484)
T 3nyv_A 33 VLGKGSF---GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 109 (484)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEecCCC---EEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 3788888 9999999999999999999977654434445788999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE---cCCCCeEEeecceeeeeccCcc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL---DEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~---~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
+++|.+.+..... +++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++........
T Consensus 110 ~~~L~~~~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 110 GGELFDEIISRKR-----FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp SCBHHHHHHTCSC-----CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred CCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 9999999876544 4899999999999999999999999999999999999 5678899999999987665555
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CCCCH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAWSE 234 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~s~ 234 (246)
.....+++.|+|||.+.+. ++.++||||||+++|+|++|..||.+.. .......+......++ ..+|+
T Consensus 185 ~~~~~gt~~y~aPE~~~~~------~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 185 MKDKIGTAYYIAPEVLHGT------YDEKCDVWSTGVILYILLSGCPPFNGAN--EYDILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp HHHHTTGGGTCCHHHHHTC------CCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred cccCCCCccccCceeecCC------CCCcceeHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCCCCCCcccccCCH
Confidence 5556789999999988652 7889999999999999999999997543 3334445554443332 46899
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.++++|++||++
T Consensus 257 ~~~~li~~~L~~ 268 (484)
T 3nyv_A 257 SAKDLIRKMLTY 268 (484)
T ss_dssp HHHHHHHHHTCS
T ss_pred HHHHHHHHHCCC
Confidence 999999999974
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=285.39 Aligned_cols=226 Identities=27% Similarity=0.388 Sum_probs=174.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.++... ..+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 60 ~lG~G~~---g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 60 ELGRGAT---SIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEeeCCC---EEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 3788888 999999999999999999997643 23567789999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC---CCCeEEeecceeeeeccCcc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE---EGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~---~~~~~l~d~~~~~~~~~~~~ 158 (246)
+++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||++........
T Consensus 132 ~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 132 GGELFDRIVEKGY-----YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp SCBHHHHHTTCSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 9999999876543 489999999999999999999999999999999999975 88999999999987655444
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCC----CCCCCH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY----PTAWSE 234 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~s~ 234 (246)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...... ......+......+ ...+++
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCA-----YGPEVDMWSVGIITYILLCGFEPFYDERGD-QFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------CGGGSCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-HHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred cccccCCCCccCHHHhcCCC-----CCcccchHHHHHHHHHHHhCCCCCCCCccc-HHHHHHHHhCCCccCCchhhhCCH
Confidence 44566889999999987664 788999999999999999999999754433 22334444443322 356899
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
+++++|++||++
T Consensus 281 ~~~~li~~~L~~ 292 (349)
T 2w4o_A 281 NAKDLVRKLIVL 292 (349)
T ss_dssp HHHHHHHTTSCS
T ss_pred HHHHHHHHHccC
Confidence 999999999964
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=296.47 Aligned_cols=229 Identities=26% Similarity=0.451 Sum_probs=191.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchH----------HHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIER----------DALKNVLREMEILTTLEHPFLVNLWFCFQDEE 71 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 71 (246)
.||+|++ |+||+|+++.+++.||+|++........ ...+.+.+|+.++++++||||+++++++.++.
T Consensus 43 ~lG~G~~---g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 119 (504)
T 3q5i_A 43 KLGSGAY---GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK 119 (504)
T ss_dssp EEEC--C---EEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred EecccCC---eEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 4788888 9999999999999999999987543211 23467889999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC---CeEEeecc
Q psy7592 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG---HAHITDFN 148 (246)
Q Consensus 72 ~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~---~~~l~d~~ 148 (246)
..++||||+.|++|.+.+..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||
T Consensus 120 ~~~lv~e~~~gg~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 120 YFYLVTEFYEGGELFEQIINRHK-----FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EEEEEEecCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 99999999999999999876544 49999999999999999999999999999999999998776 69999999
Q ss_pred eeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCC
Q psy7592 149 IATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY 228 (246)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (246)
++.............+++.|+|||.+.+. ++.++|+||||+++|+|++|..||.+.. .......+......+
T Consensus 195 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 195 LSSFFSKDYKLRDRLGTAYYIAPEVLKKK------YNEKCDVWSCGVIMYILLCGYPPFGGQN--DQDIIKKVEKGKYYF 266 (504)
T ss_dssp TCEECCTTSCBCCCCSCTTTCCHHHHTTC------BCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCC
T ss_pred CCEEcCCCCccccccCCcCCCCHHHhccC------CCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCC
Confidence 99887666555667789999999987632 7889999999999999999999997543 334445555555555
Q ss_pred C----CCCCHhHHHHHHHhhhC
Q psy7592 229 P----TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 229 ~----~~~s~~l~~li~~~l~~ 246 (246)
+ ..+|++++++|++||++
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~ 288 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTY 288 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCS
T ss_pred CccccCCCCHHHHHHHHHHcCC
Confidence 4 57899999999999974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=286.44 Aligned_cols=225 Identities=28% Similarity=0.396 Sum_probs=191.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchH-----HHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIER-----DALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |+||+++++.+++.||+|.++....... ...+.+.+|++++++++||||+++++++.+....++|
T Consensus 31 ~lG~G~~---g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 107 (335)
T 3dls_A 31 PLGSGAF---GFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLV 107 (335)
T ss_dssp ECSSSSS---CSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEecCC---EEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEE
Confidence 4788888 8999999999999999999987543221 1234577899999999999999999999999999999
Q ss_pred EeecCCC-ChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 77 SDLLLGG-DLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 77 ~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||++.++ +|.+++..... +++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 108 ~e~~~~g~~l~~~~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRHPR-----LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EECCTTSCBHHHHHHTCCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEeCCCCccHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 9998665 99999877544 49999999999999999999999999999999999999999999999999988766
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHh
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSES 235 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 235 (246)
........+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||... ..........|..+|++
T Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~el~~g~~pf~~~--------~~~~~~~~~~~~~~~~~ 250 (335)
T 3dls_A 183 GKLFYTFCGTIEYCAPEVLMGNP----YRGPELEMWSLGVTLYTLVFEENPFCEL--------EETVEAAIHPPYLVSKE 250 (335)
T ss_dssp TCCBCEECSCGGGCCHHHHTTCC----BCSHHHHHHHHHHHHHHHHHSSCSCSSG--------GGGTTTCCCCSSCCCHH
T ss_pred CCceeccCCCccccChhhhcCCC----CCCCcccchhHHHHHHHHHhCCCchhhH--------HHHHhhccCCCcccCHH
Confidence 55555667899999999987654 1377899999999999999999999641 12344455667789999
Q ss_pred HHHHHHHhhhC
Q psy7592 236 TKHLLSQVHRY 246 (246)
Q Consensus 236 l~~li~~~l~~ 246 (246)
+.++|++||+.
T Consensus 251 l~~li~~~L~~ 261 (335)
T 3dls_A 251 LMSLVSGLLQP 261 (335)
T ss_dssp HHHHHHHHTCS
T ss_pred HHHHHHHHccC
Confidence 99999999973
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=278.84 Aligned_cols=232 Identities=28% Similarity=0.464 Sum_probs=183.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccch-----------------------HHHHHHHHHHHHHHhhCCCC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIE-----------------------RDALKNVLREMEILTTLEHP 58 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~-----------------------~~~~~~~~~e~~~l~~l~h~ 58 (246)
.||+|++ |+||+|++..+++.||+|++....... ....+.+.+|++++++++||
T Consensus 20 ~lG~G~~---g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 96 (298)
T 2zv2_A 20 EIGKGSY---GVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHP 96 (298)
T ss_dssp EEEC--C---CEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCT
T ss_pred EEeecCC---EEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCC
Confidence 3788888 899999999999999999997654221 12246688999999999999
Q ss_pred cceeeeeeeee--CCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE
Q psy7592 59 FLVNLWFCFQD--EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL 136 (246)
Q Consensus 59 ~iv~~~~~~~~--~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~ 136 (246)
||+++++++.+ +...++||||+++++|.+.... .++++..++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 99999999986 5689999999999999775432 246999999999999999999999999999999999999
Q ss_pred cCCCCeEEeecceeeeeccCc-cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH
Q psy7592 137 DEEGHAHITDFNIATVLEENQ-LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV 215 (246)
Q Consensus 137 ~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~ 215 (246)
+.++.++|+|||++....... ......+++.|+|||.+.+.... ..+.++|+||||+++|+|++|..||..... .
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~ 246 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKI--FSGKALDVWAMGVTLYCFVFGQCPFMDERI--M 246 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCC--EESHHHHHHHHHHHHHHHHHSSCSSCCSSH--H
T ss_pred CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCC--CCCchhhhHhHHHHHHHHHHCCCCCCCccH--H
Confidence 999999999999998765432 23345688999999998754310 136789999999999999999999975432 2
Q ss_pred HHHHhhhcCCCCCC--CCCCHhHHHHHHHhhhC
Q psy7592 216 KDVKAIIYSPVHYP--TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 216 ~~~~~~~~~~~~~~--~~~s~~l~~li~~~l~~ 246 (246)
.....+......+| ..+++.++++|.+||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 279 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDK 279 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCS
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhc
Confidence 23333444434443 57999999999999963
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=283.60 Aligned_cols=230 Identities=25% Similarity=0.407 Sum_probs=189.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+++.||+|++......+.+..+.+.+|++++++++||||+++++++.++...++||||+.
T Consensus 61 ~lG~G~~---g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 61 EIGHGSF---GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEccCCC---EEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC
Confidence 3788888 9999999999999999999987655556667889999999999999999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
++|.+.+... ..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 138 -g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~ 209 (348)
T 1u5q_A 138 -GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NS 209 (348)
T ss_dssp -EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CC
T ss_pred -CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---Cc
Confidence 5777777542 234589999999999999999999999999999999999999999999999998765432 34
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~l~~l 239 (246)
..+++.|+|||.+.+.. ...++.++||||||+++++|++|..||..... ......+... +...+..+++.++++
T Consensus 210 ~~gt~~y~aPE~~~~~~--~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp CCSCGGGCCHHHHHTTS--SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred ccCCcceeCHhhhcccc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 56789999999985321 11378899999999999999999999965432 2223333333 233356799999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|.+||+.
T Consensus 286 i~~~l~~ 292 (348)
T 1u5q_A 286 VDSCLQK 292 (348)
T ss_dssp HHHHTCS
T ss_pred HHHHccc
Confidence 9999973
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=283.82 Aligned_cols=233 Identities=20% Similarity=0.358 Sum_probs=191.2
Q ss_pred CcCCCCccCeeeEEEEEec-------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK-------DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 73 (246)
.||+|+| |+||+|++. .++..||+|.++... .....+.+.+|+++++++ +||||+++++++.++...
T Consensus 88 ~LG~G~f---g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 162 (370)
T 2psq_A 88 PLGEGCF---GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162 (370)
T ss_dssp EESCCSS---SEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred EEeeCCC---eeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence 3788998 899999974 356789999997653 345567899999999999 899999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccc-----------cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCe
Q psy7592 74 FMVSDLLLGGDLRYHITQDIK-----------FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHA 142 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~-----------~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~ 142 (246)
++||||+.+++|.+++..... .....++...+..++.|++.||.|||+.|++|+||+|+||+++.++.+
T Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 242 (370)
T 2psq_A 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVM 242 (370)
T ss_dssp EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCE
T ss_pred EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCE
Confidence 999999999999999976432 112346888999999999999999999999999999999999999999
Q ss_pred EEeecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHH
Q psy7592 143 HITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDV 218 (246)
Q Consensus 143 ~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~ 218 (246)
+|+|||++........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+...... .
T Consensus 243 kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~--~ 315 (370)
T 2psq_A 243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-----YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--F 315 (370)
T ss_dssp EECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-----CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--H
T ss_pred EEccccCCcccCcccceecccCCCcccceECHhHhcCCC-----CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--H
Confidence 9999999987654322 12234567899999987654 8899999999999999999 9999976544332 2
Q ss_pred HhhhcC-CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 219 KAIIYS-PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 219 ~~~~~~-~~~~~~~~s~~l~~li~~~l~~ 246 (246)
..+... ....|..+++++.++|.+||+.
T Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 344 (370)
T 2psq_A 316 KLLKEGHRMDKPANCTNELYMMMRDCWHA 344 (370)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 222222 4567788999999999999963
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=281.35 Aligned_cols=226 Identities=26% Similarity=0.427 Sum_probs=188.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+|+.||||++..... ...+.+.+|+..+++++||||+++++++..+...++||||++
T Consensus 52 ~lg~G~~---g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 52 KIGEGST---GIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred EeccCCC---eEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 3788888 9999999999999999999976542 224568889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++....... ...
T Consensus 126 ~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 126 GGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp SCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 99999988642 35899999999999999999999999999999999999999999999999988765432 233
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCC---CCCCCCCCHhHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSP---VHYPTAWSESTK 237 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~l~ 237 (246)
...+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ......+.... ...+..+++.++
T Consensus 200 ~~~gt~~y~aPE~~~~~~-----~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~ 272 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSL-----YATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPPKLKNSHKVSPVLR 272 (321)
T ss_dssp CCCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSCCCCTTGGGSCHHHH
T ss_pred cccCCccccCHhhhcCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcCCCCCcCccccCCHHHH
Confidence 456889999999987654 78899999999999999999999975432 23333333332 222346899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||+.
T Consensus 273 ~li~~~l~~ 281 (321)
T 2c30_A 273 DFLERMLVR 281 (321)
T ss_dssp HHHHHHSCS
T ss_pred HHHHHHccC
Confidence 999999963
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=279.78 Aligned_cols=229 Identities=21% Similarity=0.290 Sum_probs=184.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+++.||+|.+......+....+.+.+|+..+++++||||+++++++.++...+++|||++
T Consensus 41 ~lg~G~~---g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 2h34_A 41 LVGRGGM---GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLIN 117 (309)
T ss_dssp EEEECSS---SEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEcCCCC---eeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecC
Confidence 4688888 8999999999999999999987665556667889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc--cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ--LA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 159 (246)
+++|.+++..... +++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++....... ..
T Consensus 118 ~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (309)
T 2h34_A 118 GVDLAAMLRRQGP-----LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL 192 (309)
T ss_dssp CEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred CCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccc
Confidence 9999999976543 4899999999999999999999999999999999999999999999999987654432 22
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC----CCCCCCCCCHh
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS----PVHYPTAWSES 235 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~ 235 (246)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...... ........ ....+..+|+.
T Consensus 193 ~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 2h34_A 193 GNTVGTLYYMAPERFSESH-----ATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHINQAIPRPSTVRPGIPVA 264 (309)
T ss_dssp ----CCGGGCCGGGTCC---------CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHHSCCCCGGGTSTTCCTH
T ss_pred cccCCCcCccCHHHHcCCC-----CCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhccCCCCccccCCCCCHH
Confidence 2356788999999987654 788999999999999999999999754322 22233332 22345689999
Q ss_pred HHHHHHHhhhC
Q psy7592 236 TKHLLSQVHRY 246 (246)
Q Consensus 236 l~~li~~~l~~ 246 (246)
++++|.+||+.
T Consensus 265 l~~li~~~l~~ 275 (309)
T 2h34_A 265 FDAVIARGMAK 275 (309)
T ss_dssp HHHHHHHHTCS
T ss_pred HHHHHHHhccC
Confidence 99999999963
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=287.45 Aligned_cols=202 Identities=19% Similarity=0.344 Sum_probs=171.2
Q ss_pred CcCCC--CccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSS--KFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g--~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+| ++ |+||+++++.+++.||+|.++.... +.+..+.+.+|++++++++||||+++++++.++...++||||
T Consensus 32 ~lG~G~~~~---g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 107 (389)
T 3gni_B 32 VIGKGFEDL---MTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 107 (389)
T ss_dssp EEEEETTTT---EEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccCCcCCc---eEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEc
Confidence 36777 66 9999999999999999999987653 345567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc--
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-- 157 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (246)
+++++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 108 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~ 184 (389)
T 3gni_B 108 MAYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184 (389)
T ss_dssp CTTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEE
T ss_pred cCCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccc
Confidence 99999999987642 1235899999999999999999999999999999999999999999999999876543221
Q ss_pred ------cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q psy7592 158 ------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT 213 (246)
Q Consensus 158 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~ 213 (246)
......+++.|+|||.+.+.. ..++.++|+||||+++|+|++|..||.+....
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 243 (389)
T 3gni_B 185 QRVVHDFPKYSVKVLPWLSPEVLQQNL---QGYDAKSDIYSVGITACELANGHVPFKDMPAT 243 (389)
T ss_dssp CSCBCCCCTTCTTTGGGSCHHHHSTTS---SCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST
T ss_pred ccccccccccccccccccCHHHHhccC---CCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 112235778899999987631 12788999999999999999999999765433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=294.98 Aligned_cols=228 Identities=28% Similarity=0.479 Sum_probs=187.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+|+++.+++.||+|++....... .....+.+|+.+++.++||||+++++++.+....++||||+.
T Consensus 44 ~lG~G~~---g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 119 (494)
T 3lij_A 44 KLGSGAY---GEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119 (494)
T ss_dssp EEECC------EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEecCCC---EEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 3788888 999999999999999999998754322 224678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC---CCeEEeecceeeeeccCcc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE---GHAHITDFNIATVLEENQL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~---~~~~l~d~~~~~~~~~~~~ 158 (246)
+++|.+.+..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 120 ~g~L~~~~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 120 GGELFDEIIHRMK-----FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp SCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred CCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 9999998876544 4899999999999999999999999999999999999764 4599999999988776655
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CCCCH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAWSE 234 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~s~ 234 (246)
.....+++.|+|||.+.+. ++.++||||||+++|+|++|..||.+.. .......+......++ ..+|+
T Consensus 195 ~~~~~gt~~y~aPE~l~~~------~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~ 266 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLRKK------YDEKCDVWSIGVILFILLAGYPPFGGQT--DQEILRKVEKGKYTFDSPEWKNVSE 266 (494)
T ss_dssp BCCCCSCTTTCCHHHHTTC------BCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred ccccCCCcCeeCHHHHccc------CCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCchhcccCCH
Confidence 5667789999999987532 7889999999999999999999997543 3334444544444443 46899
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.++++|++||++
T Consensus 267 ~~~~li~~~L~~ 278 (494)
T 3lij_A 267 GAKDLIKQMLQF 278 (494)
T ss_dssp HHHHHHHHHTCS
T ss_pred HHHHHHHHHCCC
Confidence 999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=279.95 Aligned_cols=234 Identities=27% Similarity=0.410 Sum_probs=185.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
+||+|++ |+||+++++.+++.||+|.+..... ...+.+.+|++.+.++ +||||+++++++.+++..++||||+
T Consensus 20 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (316)
T 2ac3_A 20 VLGEGAH---ARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM 93 (316)
T ss_dssp CCCCCSS---EEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eecCCce---EEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence 4788888 9999999999999999999976542 2346788899999985 7999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC---eEEeecceeeeeccCc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH---AHITDFNIATVLEENQ 157 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~---~~l~d~~~~~~~~~~~ 157 (246)
++++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++++|||++.......
T Consensus 94 ~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 94 RGGSILSHIHKRRH-----FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp TTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred CCCcHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 99999999976543 489999999999999999999999999999999999988776 9999999987653221
Q ss_pred --------cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-------------HH
Q psy7592 158 --------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS-------------VK 216 (246)
Q Consensus 158 --------~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~-------------~~ 216 (246)
......+++.|+|||.+.........++.++||||||+++|+|++|..||....... ..
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 112244788999999987521111126789999999999999999999997654322 22
Q ss_pred HHHhhhcCCCCCC----CCCCHhHHHHHHHhhhC
Q psy7592 217 DVKAIIYSPVHYP----TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 217 ~~~~~~~~~~~~~----~~~s~~l~~li~~~l~~ 246 (246)
....+......+| ..+|+.++++|++||+.
T Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 282 (316)
T 2ac3_A 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVR 282 (316)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCS
T ss_pred HHHHHhccCcccCchhcccCCHHHHHHHHHHhhC
Confidence 3344455555565 46899999999999963
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=280.29 Aligned_cols=229 Identities=22% Similarity=0.321 Sum_probs=187.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCc---EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ---MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |+||++++..+++ .||+|.++... +....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 56 ~lG~G~~---g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 130 (325)
T 3kul_A 56 IIGSGDS---GEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE 130 (325)
T ss_dssp EEEETTT---EEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEE
T ss_pred EEEeCCC---cEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEee
Confidence 3788888 9999999986555 59999997653 34456789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+++++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 131 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 131 YMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp CCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred CCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 999999999986532 2358999999999999999999999999999999999999999999999999987654321
Q ss_pred c----cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCC
Q psy7592 159 A----TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAW 232 (246)
Q Consensus 159 ~----~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (246)
. ....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||..... ......+... ..+.|..+
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 279 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRT-----FSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDVISSVEEGYRLPAPMGC 279 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCE-----ECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHHHHHTTCCCCCCTTC
T ss_pred ceeeccCCCCcccccCHhHhcCCC-----CCcHHHHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCCCCCCCCc
Confidence 1 1223456799999997665 7889999999999999999 9999965433 2223333333 55667889
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
++.+.++|..||+.
T Consensus 280 ~~~l~~li~~~l~~ 293 (325)
T 3kul_A 280 PHALHQLMLDCWHK 293 (325)
T ss_dssp CHHHHHHHHHHTCS
T ss_pred CHHHHHHHHHHccC
Confidence 99999999999963
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=275.92 Aligned_cols=231 Identities=25% Similarity=0.469 Sum_probs=183.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.+...... ...+.+.+|++.+++++||||+++++++.+....++||||++
T Consensus 29 ~lg~G~~---g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 103 (285)
T 3is5_A 29 KLGSGAF---GDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCE 103 (285)
T ss_dssp EEEECSS---CEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeccCCC---eEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCC
Confidence 4788888 99999999999999999999876422 224678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE---cCCCCeEEeecceeeeeccCcc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL---DEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~---~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
+++|.+.+..... ....+++..++.++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||++........
T Consensus 104 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 182 (285)
T 3is5_A 104 GGELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182 (285)
T ss_dssp CCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------
T ss_pred CCcHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc
Confidence 9999998865422 13446999999999999999999999999999999999999 4567899999999987665554
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC---CCCCHh
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP---TAWSES 235 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~ 235 (246)
.....+++.|+|||.+.+. ++.++|+||||+++++|++|..||.+...... ..........++ ..+++.
T Consensus 183 ~~~~~~t~~y~aPE~~~~~------~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 254 (285)
T 3is5_A 183 STNAAGTALYMAPEVFKRD------VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQKATYKEPNYAVECRPLTPQ 254 (285)
T ss_dssp ----CTTGGGCCHHHHTTC------CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCCCCCC--CCCCHH
T ss_pred CcCcccccCcCChHHhccC------CCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--HhhhccCCcccccccCcCCHH
Confidence 5556788999999987532 78899999999999999999999975443322 222222222222 348999
Q ss_pred HHHHHHHhhhC
Q psy7592 236 TKHLLSQVHRY 246 (246)
Q Consensus 236 l~~li~~~l~~ 246 (246)
+.++|++||+.
T Consensus 255 ~~~li~~~L~~ 265 (285)
T 3is5_A 255 AVDLLKQMLTK 265 (285)
T ss_dssp HHHHHHHHTCS
T ss_pred HHHHHHHHccC
Confidence 99999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=295.01 Aligned_cols=228 Identities=27% Similarity=0.495 Sum_probs=189.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+|+++.+++.||+|++........ ..+.+.+|++++++++||||+++++++.+....++||||+.
T Consensus 29 ~lG~G~~---g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 104 (486)
T 3mwu_A 29 MLGKGSF---GEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104 (486)
T ss_dssp EEECCSS---SEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEeecCC---EEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCC
Confidence 4788888 9999999999999999999976442221 24678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc---CCCCeEEeecceeeeeccCcc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD---EEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~---~~~~~~l~d~~~~~~~~~~~~ 158 (246)
+++|.+.+..... +++..++.++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||++........
T Consensus 105 ~~~L~~~~~~~~~-----~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 105 GGELFDEIIKRKR-----FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp SCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred CCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 9999998876544 49999999999999999999999999999999999995 455799999999977665555
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CCCCH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAWSE 234 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~s~ 234 (246)
.....+++.|+|||.+.+. ++.++||||||+++|+|++|..||.+.. .......+......++ ..+|+
T Consensus 180 ~~~~~gt~~y~aPE~~~~~------~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~ 251 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRGT------YDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKRVETGKYAFDLPQWRTISD 251 (486)
T ss_dssp --CCTTGGGGCCGGGGGSC------CCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCSCSGGGGGSCH
T ss_pred cCCCcCCCCCCCHHHhCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCCcccCCCCH
Confidence 5556789999999998653 7889999999999999999999997543 3334444444433332 46899
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
+++++|++||+.
T Consensus 252 ~~~~li~~~L~~ 263 (486)
T 3mwu_A 252 DAKDLIRKMLTF 263 (486)
T ss_dssp HHHHHHHHHTCS
T ss_pred HHHHHHHHHcCC
Confidence 999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=273.82 Aligned_cols=231 Identities=22% Similarity=0.371 Sum_probs=182.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.+..... +....+.+.+|+.++++++||||+++++++.++...++||||+.
T Consensus 9 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (292)
T 3o0g_A 9 KIGEGTY---GTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEEECSS---SEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EecCCCC---eEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence 4788888 9999999999999999999986553 33345778899999999999999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+ ++.+.+... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 85 ~-~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 85 Q-DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp E-EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred C-CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence 6 455544432 1235999999999999999999999999999999999999999999999999998765332 233
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc---C-------------
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY---S------------- 224 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~------------- 224 (246)
...+++.|+|||.+.+.. .++.++|+||||+++|+|++|..||.... +.......+.. .
T Consensus 160 ~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~~l~~~~~p~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAK----LYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp SCCSCGGGCCHHHHTTCS----CCCTHHHHHHHHHHHHHHTTTSCCSCCCS-SHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CCccccCCcChHHHcCCC----CcCchHHHHHHHHHHHHHHHcCCCCcCCC-CHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 456788999999987643 36889999999999999999888753322 22222222211 0
Q ss_pred -------------CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 225 -------------PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 225 -------------~~~~~~~~s~~l~~li~~~l~~ 246 (246)
....++.+++.+++||++||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 269 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKC 269 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCS
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhcc
Confidence 1112235789999999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=283.04 Aligned_cols=225 Identities=27% Similarity=0.433 Sum_probs=185.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|+| |+||+|+++.+|+.||+|.+..... ...+|++.+.++ +||||+++++++.++...++||||+
T Consensus 29 ~lG~G~~---g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 29 DIGVGSY---SVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEeeCCC---EEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 3788888 9999999999999999999977542 234577777777 7999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC-C---CeEEeecceeeeeccC
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE-G---HAHITDFNIATVLEEN 156 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~-~---~~~l~d~~~~~~~~~~ 156 (246)
.|++|.+.+..... +++..+..++.|++.||.|||+.|++|+||+|+||++..+ + .++++|||++......
T Consensus 99 ~gg~L~~~i~~~~~-----~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 99 KGGELLDKILRQKF-----FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CSCBHHHHHHTCTT-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99999999976544 4999999999999999999999999999999999998543 2 4999999999876543
Q ss_pred c-cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHhhhcCCCCCC----C
Q psy7592 157 Q-LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV-KDVKAIIYSPVHYP----T 230 (246)
Q Consensus 157 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~----~ 230 (246)
. ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||........ .....+......++ .
T Consensus 174 ~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 174 NGLLMTPCYTANFVAPEVLERQG-----YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp TCCBCCSSCCSSCCCHHHHHHHH-----HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred CCceeccCCCccccCHHHhcCCC-----CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 2 233456789999999987664 67899999999999999999999976443333 34444554444443 5
Q ss_pred CCCHhHHHHHHHhhhC
Q psy7592 231 AWSESTKHLLSQVHRY 246 (246)
Q Consensus 231 ~~s~~l~~li~~~l~~ 246 (246)
.+|+++++||++||+.
T Consensus 249 ~~s~~~~~li~~~L~~ 264 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHV 264 (342)
T ss_dssp TSCHHHHHHHHHHTCS
T ss_pred cCCHHHHHHHHHHCCC
Confidence 6899999999999963
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=287.20 Aligned_cols=226 Identities=26% Similarity=0.387 Sum_probs=176.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHh-hCCCCcceeeeeeeee----CCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILT-TLEHPFLVNLWFCFQD----EEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~----~~~~~~v 76 (246)
+||.|++ |+||+++++.+++.||+|+++.. ..+.+|+..+. ..+||||+++++++.. +..+++|
T Consensus 69 ~LG~G~~---g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv 137 (400)
T 1nxk_A 69 VLGLGIN---GKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137 (400)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eeeeccC---eEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence 3688888 99999999999999999999643 24556777764 4489999999999875 5678999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC---CCCeEEeecceeeee
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE---EGHAHITDFNIATVL 153 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~---~~~~~l~d~~~~~~~ 153 (246)
|||+.|++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||++...
T Consensus 138 ~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 99999999999997642 224589999999999999999999999999999999999997 788999999999876
Q ss_pred ccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHhhhcCCCCCC--
Q psy7592 154 EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV--KDVKAIIYSPVHYP-- 229 (246)
Q Consensus 154 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~-- 229 (246)
..........+++.|+|||.+.+.. ++.++||||||+++|+|++|..||........ .....+......+|
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 215 TSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp C-----------CTTCCGGGSCCCC-----SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred CCCCccccCCCCCCccCHhhcCCCC-----CCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 6544445567899999999986654 78899999999999999999999975443221 12233333433333
Q ss_pred --CCCCHhHHHHHHHhhhC
Q psy7592 230 --TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 --~~~s~~l~~li~~~l~~ 246 (246)
..+|+++++||++||+.
T Consensus 290 ~~~~~s~~~~~li~~~L~~ 308 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKT 308 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCS
T ss_pred ccccCCHHHHHHHHHHCCC
Confidence 46899999999999963
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=274.40 Aligned_cols=236 Identities=25% Similarity=0.375 Sum_probs=183.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++.+..+|+.||+|.++.....+....+.+.+|+..+++++||||+++++++.++...++||||+.
T Consensus 39 ~lg~G~~---g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 115 (310)
T 2wqm_A 39 KIGRGQF---SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115 (310)
T ss_dssp EEECC-----CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred eecCCCC---ceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCC
Confidence 3788888 8999999999999999999987555556667889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-AT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 160 (246)
+++|.+++..... ....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||++........ ..
T Consensus 116 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 194 (310)
T 2wqm_A 116 AGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 194 (310)
T ss_dssp SCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------------
T ss_pred CCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcccc
Confidence 9999999865322 133468999999999999999999999999999999999999999999999999876544322 23
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCC-CCC-CCCCCHhHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSP-VHY-PTAWSESTKH 238 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~-~~~~s~~l~~ 238 (246)
...++..|+|||.+.+.. ++.++|+||||+++++|++|..||.+...........+.... .+. +..+++++++
T Consensus 195 ~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 269 (310)
T 2wqm_A 195 SLVGTPYYMSPERIHENG-----YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269 (310)
T ss_dssp ----CCSSCCHHHHTTCC-----CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHH
T ss_pred ccCCCeeEeChHHhCCCC-----CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHH
Confidence 356788999999987654 788999999999999999999999765444333333333332 222 3578999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|++||+.
T Consensus 270 li~~~l~~ 277 (310)
T 2wqm_A 270 LVNMCINP 277 (310)
T ss_dssp HHHHHTCS
T ss_pred HHHHHcCC
Confidence 99999963
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=284.31 Aligned_cols=235 Identities=20% Similarity=0.297 Sum_probs=190.7
Q ss_pred CcCCCCccCeeeEEEEE-----ecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCC-eEE
Q psy7592 2 FCGSSKFCGTSKVCIVQ-----KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEE-DLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~ 74 (246)
.||+|++ |.||+++ +..+++.||+|.++... .....+.+.+|++.++++ +||||+++++++.+.+ ..+
T Consensus 29 ~lG~G~~---g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~ 103 (359)
T 3vhe_A 29 PLGRGAF---GQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 103 (359)
T ss_dssp EEEECSS---EEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred eecCCCC---ceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence 3788888 9999999 66778999999997654 344467899999999999 7999999999988754 489
Q ss_pred EEEeecCCCChHHHHhhcccc-----------------------------------------------------------
Q psy7592 75 MVSDLLLGGDLRYHITQDIKF----------------------------------------------------------- 95 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~----------------------------------------------------------- 95 (246)
+||||+.+++|.+++......
T Consensus 104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3vhe_A 104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183 (359)
T ss_dssp EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence 999999999999999765321
Q ss_pred --ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc---cccccccCCCccC
Q psy7592 96 --YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---LATSMSGTKPYIA 170 (246)
Q Consensus 96 --~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~a 170 (246)
....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ......++..|+|
T Consensus 184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a 263 (359)
T 3vhe_A 184 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263 (359)
T ss_dssp CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCC
T ss_pred chhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEC
Confidence 01226889999999999999999999999999999999999999999999999997653322 1223456778999
Q ss_pred CceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 171 PEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 171 PE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
||.+.+.. ++.++||||||+++|+|++ |..||.+...................|..+++.+.++|.+||+.
T Consensus 264 PE~~~~~~-----~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 335 (359)
T 3vhe_A 264 PETIFDRV-----YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 335 (359)
T ss_dssp HHHHHHCC-----CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred hhhhcCCC-----CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 99987654 7899999999999999998 99999765544332222223336667788999999999999973
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=287.10 Aligned_cols=229 Identities=23% Similarity=0.365 Sum_probs=189.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+++++.+++.||+|.++... ..+..+.+.+|++++++++||||+++++++.++...++||||++
T Consensus 121 ~lG~G~~---g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 195 (377)
T 3cbl_A 121 QIGRGNF---GEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 195 (377)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EeccCCC---CeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCC
Confidence 3688888 999999999999999999997643 34455678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-- 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (246)
+++|.+++..... .+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 196 ~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~ 271 (377)
T 3cbl_A 196 GGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271 (377)
T ss_dssp TCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence 9999999876432 3488999999999999999999999999999999999999999999999998765432211
Q ss_pred -cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhh-cCCCCCCCCCCHhH
Q psy7592 160 -TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAII-YSPVHYPTAWSEST 236 (246)
Q Consensus 160 -~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~l 236 (246)
....++..|+|||.+.... ++.++|+||||+++|+|++ |..||......... ..+. ....+.|..+++.+
T Consensus 272 ~~~~~~~~~y~aPE~~~~~~-----~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l 344 (377)
T 3cbl_A 272 GGLRQVPVKWTAPEALNYGR-----YSSESDVWSFGILLWETFSLGASPYPNLSNQQTR--EFVEKGGRLPCPELCPDAV 344 (377)
T ss_dssp SSCCEEEGGGSCHHHHHHCE-----EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH--HHHHTTCCCCCCTTCCHHH
T ss_pred CCCCCCCcCcCCHhHhccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHHHcCCCCCCCCCCCHHH
Confidence 1122456799999987665 7889999999999999998 99999754432222 2222 22556778899999
Q ss_pred HHHHHHhhhC
Q psy7592 237 KHLLSQVHRY 246 (246)
Q Consensus 237 ~~li~~~l~~ 246 (246)
.++|.+||+.
T Consensus 345 ~~li~~cl~~ 354 (377)
T 3cbl_A 345 FRLMEQCWAY 354 (377)
T ss_dssp HHHHHHHTCS
T ss_pred HHHHHHHcCC
Confidence 9999999963
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=280.19 Aligned_cols=238 Identities=22% Similarity=0.358 Sum_probs=188.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC--eEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE--DLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~~v~e~ 79 (246)
+||+|++ |+||++++..+++.||+|+++...... ..+.+.+|++++++++||||+++++++.... ..++||||
T Consensus 16 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 16 ILGQGAT---ANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EecCCCC---eEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 4788888 999999999999999999998654322 2466788999999999999999999998654 78999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE----cCCCCeEEeecceeeeecc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL----DEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~----~~~~~~~l~d~~~~~~~~~ 155 (246)
+++++|.+++..... ...+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 91 ~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 91 CPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp CTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 999999999976432 2236999999999999999999999999999999999999 7777899999999988766
Q ss_pred CccccccccCCCccCCceeccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHhhhcCCC----
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATD---EVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS--VKDVKAIIYSPV---- 226 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~---~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~---- 226 (246)
........++..|+|||.+..... ....++.++|+||||+++|+|++|..||....... ......+....+
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~ 248 (319)
T 4euu_A 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248 (319)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCC
T ss_pred CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccc
Confidence 655556678999999999863210 01237889999999999999999999996443222 233333332221
Q ss_pred ---------------------CCCCCCCHhHHHHHHHhhhC
Q psy7592 227 ---------------------HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ---------------------~~~~~~s~~l~~li~~~l~~ 246 (246)
.++..+++.+.++|++||++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 289 (319)
T 4euu_A 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289 (319)
T ss_dssp EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred hhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccC
Confidence 11223567888999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=270.31 Aligned_cols=231 Identities=21% Similarity=0.336 Sum_probs=188.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHH----HHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDAL----KNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||+|++ |+||++++..+++.||+|.+........... +.+.+|++++++++||||+++++++.+.. ++||
T Consensus 26 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~ 100 (287)
T 4f0f_A 26 QIGKGGF---GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVM 100 (287)
T ss_dssp ECCCCSS---SCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEE
T ss_pred ccccCCc---eeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEE
Confidence 3788888 8999999999999999999976543322221 67889999999999999999999997665 6899
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCcEEEcCCCC-----eEEeeccee
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH--IIHRDIKPDNILLDEEGH-----AHITDFNIA 150 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~--~~h~~i~~~nil~~~~~~-----~~l~d~~~~ 150 (246)
||+++++|.+.+.... .++++..++.++.|++.++.|||+.| ++|+||+|+||+++.++. ++++|||.+
T Consensus 101 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~ 176 (287)
T 4f0f_A 101 EFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176 (287)
T ss_dssp ECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred EecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence 9999999988886532 24589999999999999999999999 999999999999988776 999999998
Q ss_pred eeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCC
Q psy7592 151 TVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHY 228 (246)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~ 228 (246)
..... ......+++.|+|||.+..... .++.++|+||||+++|+|++|..||.............+... ...+
T Consensus 177 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 4f0f_A 177 QQSVH--SVSGLLGNFQWMAPETIGAEEE---SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251 (287)
T ss_dssp BCCSS--CEECCCCCCTTSCGGGSSCSSC---EECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCC
T ss_pred ccccc--cccccCCCccccCchhhccCCC---CcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCC
Confidence 75333 2334568899999999843221 267899999999999999999999987665554434333333 5567
Q ss_pred CCCCCHhHHHHHHHhhhC
Q psy7592 229 PTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 229 ~~~~s~~l~~li~~~l~~ 246 (246)
|..+++.+.++|++||+.
T Consensus 252 ~~~~~~~l~~li~~~l~~ 269 (287)
T 4f0f_A 252 PEDCPPRLRNVIELCWSG 269 (287)
T ss_dssp CTTSCHHHHHHHHHHTCS
T ss_pred CcccCHHHHHHHHHHhcC
Confidence 788999999999999963
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=271.48 Aligned_cols=230 Identities=25% Similarity=0.426 Sum_probs=187.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchH---HHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIER---DALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |+||+++++.+++.||+|.++....... ...+.+.+|+..+++++||||+++++++.++...++|||
T Consensus 12 ~lg~G~~---g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 88 (283)
T 3bhy_A 12 ELGSGQF---AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILE 88 (283)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhcccCc---eEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEe
Confidence 3788888 9999999999999999999987543221 124678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC----CeEEeecceeeeec
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG----HAHITDFNIATVLE 154 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~----~~~l~d~~~~~~~~ 154 (246)
|+++++|.+++..... +++..++.++.|++.+|.+||+.|++|+||+|+||+++.++ .++++|||.+....
T Consensus 89 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 89 LVSGGELFDFLAEKES-----LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp CCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred ecCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 9999999999976443 48999999999999999999999999999999999998877 79999999998776
Q ss_pred cCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----C
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----T 230 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~ 230 (246)
.........+++.|+|||.+.+.. ++.++|+||||+++++|++|..||..... ......+......++ .
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGETK--QETLTNISAVNYDFDEEYFS 236 (283)
T ss_dssp --------CCCGGGCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHTTCCCCCHHHHT
T ss_pred CCCcccccCCCcCccCcceecCCC-----CCcchhhhhHHHHHHHHHHCCCCCCCcch--HHHHHHhHhcccCCcchhcc
Confidence 554445566888999999987654 78899999999999999999999975432 233333333333333 5
Q ss_pred CCCHhHHHHHHHhhhC
Q psy7592 231 AWSESTKHLLSQVHRY 246 (246)
Q Consensus 231 ~~s~~l~~li~~~l~~ 246 (246)
.+++.++++|++||+.
T Consensus 237 ~~~~~~~~li~~~l~~ 252 (283)
T 3bhy_A 237 NTSELAKDFIRRLLVK 252 (283)
T ss_dssp TCCHHHHHHHHTTSCS
T ss_pred cCCHHHHHHHHHHccC
Confidence 7899999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=280.48 Aligned_cols=235 Identities=28% Similarity=0.447 Sum_probs=193.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeecccc-----chHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC-----IERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 75 (246)
.||+|++ |+||+|+++.+|+.||||+++.... ...+..+.+.+|+.+++++ +||||+++++++......++
T Consensus 101 ~lg~G~~---g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 177 (365)
T 2y7j_A 101 VIGRGVS---SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177 (365)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEE
T ss_pred EEecCCC---EEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEE
Confidence 3788888 9999999999999999999976542 1123356788999999999 79999999999999999999
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||||++|++|.+++..... +++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++++|||++.....
T Consensus 178 v~e~~~g~~L~~~l~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 178 VFDLMRKGELFDYLTEKVA-----LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EECCCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEeCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 9999999999999876443 48999999999999999999999999999999999999999999999999988766
Q ss_pred CccccccccCCCccCCceecccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----C
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDE-VLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----T 230 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~-~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~ 230 (246)
........+++.|+|||.+.+.... ...++.++|+||||+++|+|++|..||.... .......+......++ .
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~ 330 (365)
T 2y7j_A 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--QILMLRMIMEGQYQFSSPEWD 330 (365)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCHHHHS
T ss_pred CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhCCCCCCCcccc
Confidence 5555567789999999998654211 1236789999999999999999999996433 2333344444443333 4
Q ss_pred CCCHhHHHHHHHhhhC
Q psy7592 231 AWSESTKHLLSQVHRY 246 (246)
Q Consensus 231 ~~s~~l~~li~~~l~~ 246 (246)
.+++.+.++|++||+.
T Consensus 331 ~~~~~~~~li~~~L~~ 346 (365)
T 2y7j_A 331 DRSSTVKDLISRLLQV 346 (365)
T ss_dssp SSCHHHHHHHHHHSCS
T ss_pred cCCHHHHHHHHHHcCC
Confidence 6899999999999963
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=276.45 Aligned_cols=200 Identities=24% Similarity=0.374 Sum_probs=163.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+|+.||+|.++.... ....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 12 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (317)
T 2pmi_A 12 KLGNGTY---ATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD 86 (317)
T ss_dssp ----------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC
T ss_pred EECCCCC---EEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC
Confidence 4788888 9999999999999999999976542 2223567889999999999999999999999999999999996
Q ss_pred CCChHHHHhhcccc-ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-ccc
Q psy7592 82 GGDLRYHITQDIKF-YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~ 159 (246)
++|.+++...... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 87 -~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (317)
T 2pmi_A 87 -NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165 (317)
T ss_dssp -CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCC
T ss_pred -CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccC
Confidence 5899888654321 2234689999999999999999999999999999999999999999999999999876433 223
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
....+++.|+|||.+.+.. .++.++|+||||+++|+|++|..||.+..
T Consensus 166 ~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 166 SSEVVTLWYRAPDVLMGSR----TYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp CCCCSCCTTCCHHHHTTCC----CCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCcccccccCchHhhCCC----CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3456789999999986532 37889999999999999999999997544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=276.21 Aligned_cols=226 Identities=21% Similarity=0.302 Sum_probs=178.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+++.||||++...........+.+.++....+..+||||+++++++.++...++|||++
T Consensus 64 ~LG~G~~---g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~- 139 (311)
T 3p1a_A 64 RLGHGSY---GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC- 139 (311)
T ss_dssp EEEEETT---EEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-
T ss_pred eeccCCC---eEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-
Confidence 3788888 999999999999999999987654433443344444444444448999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++.... .++++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 140 ~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 215 (311)
T 3p1a_A 140 GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV 215 (311)
T ss_dssp CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------C
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcc
Confidence 778988886642 3469999999999999999999999999999999999999999999999999887765555555
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~l~~l 239 (246)
..+++.|+|||.+.+. ++.++||||||+++++|++|..|+... . ....+... ...++..+++++.++
T Consensus 216 ~~gt~~y~aPE~~~~~------~~~~~DiwslG~il~el~~g~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~l~~l 284 (311)
T 3p1a_A 216 QEGDPRYMAPELLQGS------YGTAADVFSLGLTILEVACNMELPHGG--E---GWQQLRQGYLPPEFTAGLSSELRSV 284 (311)
T ss_dssp CCCCGGGCCGGGGGTC------CSTHHHHHHHHHHHHHHHHTCCCCSSH--H---HHHHHTTTCCCHHHHTTSCHHHHHH
T ss_pred cCCCccccCHhHhcCC------CCchhhHHHHHHHHHHHHhCCCCCCCc--c---HHHHHhccCCCcccccCCCHHHHHH
Confidence 6689999999988652 788999999999999999997766421 1 12222222 223456899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|.+||+.
T Consensus 285 i~~~L~~ 291 (311)
T 3p1a_A 285 LVMMLEP 291 (311)
T ss_dssp HHHHSCS
T ss_pred HHHHcCC
Confidence 9999963
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=281.35 Aligned_cols=233 Identities=22% Similarity=0.297 Sum_probs=187.0
Q ss_pred CcCCCCccCeeeEEEEE-----ecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQ-----KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|+| |+||+++ +..+++.||+|.++... ......++.+|+.++++++||||+++++++.++...++|
T Consensus 78 ~LG~G~f---g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 152 (367)
T 3l9p_A 78 GLGHGAF---GEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 152 (367)
T ss_dssp ECCCCSS---SCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EeeeCCC---EEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEE
Confidence 3788888 8999999 55678899999997543 234456788899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhcccc--ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC---CeEEeecceee
Q psy7592 77 SDLLLGGDLRYHITQDIKF--YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG---HAHITDFNIAT 151 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~---~~~l~d~~~~~ 151 (246)
|||+.+++|.+++...... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.
T Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~ 232 (367)
T 3l9p_A 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232 (367)
T ss_dssp EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcccc
Confidence 9999999999999765421 123468889999999999999999999999999999999999555 59999999987
Q ss_pred eeccC---ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CC
Q psy7592 152 VLEEN---QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PV 226 (246)
Q Consensus 152 ~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~ 226 (246)
..... .......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||..... ......+... ..
T Consensus 233 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 233 DIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGGRM 305 (367)
T ss_dssp HHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTCCC
T ss_pred ccccccccccCCCcCCcccEECHHHhcCCC-----CCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCC
Confidence 54322 1223345678899999987664 8899999999999999998 9999975432 2223333333 45
Q ss_pred CCCCCCCHhHHHHHHHhhhC
Q psy7592 227 HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ~~~~~~s~~l~~li~~~l~~ 246 (246)
..|..+++.+.++|.+||+.
T Consensus 306 ~~~~~~~~~l~~li~~~l~~ 325 (367)
T 3l9p_A 306 DPPKNCPGPVYRIMTQCWQH 325 (367)
T ss_dssp CCCTTCCHHHHHHHHHHTCS
T ss_pred CCCccCCHHHHHHHHHHcCC
Confidence 56778999999999999973
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=274.74 Aligned_cols=233 Identities=21% Similarity=0.365 Sum_probs=190.9
Q ss_pred CcCCCCccCeeeEEEEEec-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK-----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |.||++++. .+++.||+|.++... +.+..+.+.+|++++++++||||+++++++.++...++|
T Consensus 30 ~lg~G~~---g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 30 TLGEGEF---GKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEECSS---SEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eecccCC---eeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 3788888 899999983 456899999997654 345568899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhcccc-------------------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc
Q psy7592 77 SDLLLGGDLRYHITQDIKF-------------------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD 137 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~-------------------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~ 137 (246)
|||+++++|.+++...... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~ 184 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA 184 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEc
Confidence 9999999999999765321 112358889999999999999999999999999999999999
Q ss_pred CCCCeEEeecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCc
Q psy7592 138 EEGHAHITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNT 213 (246)
Q Consensus 138 ~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~ 213 (246)
.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+....
T Consensus 185 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 185 EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-----YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-----ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-----cCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999987644322 12234567799999987665 7889999999999999999 99999765543
Q ss_pred cHHHHHhhhc-CCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 214 SVKDVKAIIY-SPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 214 ~~~~~~~~~~-~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
... ..+.. .....|..+++.+.++|.+||+.
T Consensus 260 ~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 291 (314)
T 2ivs_A 260 RLF--NLLKTGHRMERPDNCSEEMYRLMLQCWKQ 291 (314)
T ss_dssp GHH--HHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred HHH--HHhhcCCcCCCCccCCHHHHHHHHHHccC
Confidence 322 22222 24566788999999999999963
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=273.91 Aligned_cols=231 Identities=23% Similarity=0.387 Sum_probs=181.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++. +++.||+|.+.... .+....+.+.+|++++++++||||+++++++.++...++||||+.
T Consensus 28 ~lG~G~~---g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 28 KVGEGTY---GVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102 (311)
T ss_dssp EEEECSS---CEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred hccCCCC---eEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence 3788888 999999996 59999999997653 223345678899999999999999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+ +|.+.+.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 103 ~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 177 (311)
T 3niz_A 103 K-DLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT 177 (311)
T ss_dssp E-EHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred C-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccccc
Confidence 5 7777776532 235899999999999999999999999999999999999999999999999998765332 233
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHhhhcCCCC------------
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK-DVKAIIYSPVH------------ 227 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~------------ 227 (246)
...+++.|+|||.+.+.. .++.++|+||||+++|+|++|..||.+....... ........+.+
T Consensus 178 ~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 178 HEVVTLWYRAPDVLMGSK----KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp CCCCCCTTCCHHHHTTCC----SCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred CCcccCCcCCHHHhcCCC----CCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 356789999999986543 3788999999999999999999999765544322 22222211110
Q ss_pred ---------------CCCCCCHhHHHHHHHhhhC
Q psy7592 228 ---------------YPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 228 ---------------~~~~~s~~l~~li~~~l~~ 246 (246)
..+.+++++.+||++||++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 287 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCF 287 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCS
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCC
Confidence 1235788999999999974
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=279.44 Aligned_cols=233 Identities=17% Similarity=0.256 Sum_probs=190.2
Q ss_pred CcCCCCccCeeeEEEEEec-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK-----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |+||++++. .+++.||+|.++... ..+..+.+.+|++++++++||||+++++++.++...++|
T Consensus 54 ~lg~G~~---g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 54 DIGEGAF---GRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp EEEECSS---CEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeecCC---eeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence 3788888 899999997 456899999997654 345567899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhcccc-------------------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc
Q psy7592 77 SDLLLGGDLRYHITQDIKF-------------------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD 137 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~-------------------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~ 137 (246)
|||+++++|.+++...... ...++++..++.++.|++.+|.|||+.|++|+||+|+||+++
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 208 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG 208 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEC
Confidence 9999999999999764211 014568999999999999999999999999999999999999
Q ss_pred CCCCeEEeecceeeeeccCc---cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCc
Q psy7592 138 EEGHAHITDFNIATVLEENQ---LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNT 213 (246)
Q Consensus 138 ~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~ 213 (246)
.++.++|+|||++....... ......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.....
T Consensus 209 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~t~g~~p~~~~~~- 282 (343)
T 1luf_A 209 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-----YTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 282 (343)
T ss_dssp GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-----cCcccccHHHHHHHHHHHhcCCCcCCCCCh-
Confidence 99999999999987654322 122345677899999987664 7899999999999999999 9999975432
Q ss_pred cHHHHHhhhcC-CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 214 SVKDVKAIIYS-PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 214 ~~~~~~~~~~~-~~~~~~~~s~~l~~li~~~l~~ 246 (246)
......+... ....|..+++.+.++|++||+.
T Consensus 283 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 315 (343)
T 1luf_A 283 -EEVIYYVRDGNILACPENCPLELYNLMRLCWSK 315 (343)
T ss_dssp -HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred -HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHccc
Confidence 2223333333 4456788999999999999963
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=272.09 Aligned_cols=226 Identities=27% Similarity=0.441 Sum_probs=186.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+|+.||+|.+..... ...+.+.+|+..+++++||||+++++++.+....++||||++
T Consensus 16 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 16 VLGSGAF---SEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eccCCCC---ceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence 4788888 9999999999999999999986542 223567889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE---cCCCCeEEeecceeeeeccCcc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL---DEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~---~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
+++|.+.+..... +++..++.++.|++.++.+||+.|++|+||+|+||++ +.++.++++|||.+...... .
T Consensus 90 ~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~ 163 (304)
T 2jam_A 90 GGELFDRILERGV-----YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-I 163 (304)
T ss_dssp SCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-T
T ss_pred CccHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-c
Confidence 9999999876543 4899999999999999999999999999999999999 77889999999988654332 2
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCC----CCCCCCCH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPV----HYPTAWSE 234 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~s~ 234 (246)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ......+..... +.+..+|+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKP-----YSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCS-----CCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred cccccCCCCccChHHhccCC-----CCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCCCCCccccccCCH
Confidence 23345789999999987654 78899999999999999999999965432 233334444332 33457899
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.++++|.+||+.
T Consensus 237 ~~~~li~~~l~~ 248 (304)
T 2jam_A 237 SAKDFICHLLEK 248 (304)
T ss_dssp HHHHHHHHHHCS
T ss_pred HHHHHHHHHcCC
Confidence 999999999963
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=281.90 Aligned_cols=234 Identities=33% Similarity=0.590 Sum_probs=191.8
Q ss_pred CcCCCCccCeeeEEEEEec---CCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK---DTKQMYAMKYMHKSQCI-ERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|+| |+||++++. .+++.||+|+++..... .....+.+.+|+++++++ +||||+++++++.++...++|
T Consensus 61 ~lG~G~~---g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 137 (355)
T 1vzo_A 61 VLGTGAY---GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 137 (355)
T ss_dssp EEEETTT---EEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EeccCCC---EEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEE
Confidence 3788888 999999984 58999999999764321 122234566789999999 699999999999999999999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
|||+++++|.+++..... +++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 138 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 138 LDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp ECCCCSCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eecCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 999999999999976544 489999999999999999999999999999999999999999999999999876433
Q ss_pred c--cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHhhhcCCCCCCCCC
Q psy7592 157 Q--LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT--SVKDVKAIIYSPVHYPTAW 232 (246)
Q Consensus 157 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (246)
. ......+++.|+|||.+.+... .++.++|+||||+++|+|++|..||...... .......+.....++|..+
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDS---GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC------CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred CCCcccCcccCcCccChhhhcCCCC---CCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc
Confidence 2 2233568999999999875321 2678999999999999999999999654322 2334445556677888999
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
++.++++|.+||+.
T Consensus 290 ~~~~~~li~~~L~~ 303 (355)
T 1vzo_A 290 SALAKDLIQRLLMK 303 (355)
T ss_dssp CHHHHHHHHHHTCS
T ss_pred CHHHHHHHHHHhhh
Confidence 99999999999963
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=280.22 Aligned_cols=237 Identities=24% Similarity=0.396 Sum_probs=187.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI--ERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|++ |+||+++++.+++.||+|.+...... +.+..+.+.+|++++++++||||+++++++.++...++||||
T Consensus 33 ~lG~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 109 (345)
T 3hko_A 33 AIGQGSY---GVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMEL 109 (345)
T ss_dssp EEEECSS---CEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eeeecCC---eEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeC
Confidence 4788888 89999999999999999999765421 234567899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhcccc-----------------------------------ccCCCChHHHHHHHHHHHHHHHHHHHCCc
Q psy7592 80 LLGGDLRYHITQDIKF-----------------------------------YSVGTRNDTIHLYAFELGLALDYLKTKHI 124 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~ 124 (246)
++|++|.+++...... ....+++..++.++.|++.+|.|||+.|+
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i 189 (345)
T 3hko_A 110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGI 189 (345)
T ss_dssp CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9999999988531110 01123567789999999999999999999
Q ss_pred ccCCCCCCcEEEcCCC--CeEEeecceeeeeccCcc-----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHH
Q psy7592 125 IHRDIKPDNILLDEEG--HAHITDFNIATVLEENQL-----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTL 197 (246)
Q Consensus 125 ~h~~i~~~nil~~~~~--~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l 197 (246)
+|+||+|+||+++.++ .++|+|||.+........ .....+++.|+|||.+.+.. ..++.++||||||+++
T Consensus 190 vH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DiwslG~il 266 (345)
T 3hko_A 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN---ESYGPKCDAWSAGVLL 266 (345)
T ss_dssp ECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS---SCCCTHHHHHHHHHHH
T ss_pred cccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC---CCCCcHHHHHHHHHHH
Confidence 9999999999998777 899999999987643221 23456788999999986532 1378899999999999
Q ss_pred HHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CCCCHhHHHHHHHhhhC
Q psy7592 198 FEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 198 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~l~~li~~~l~~ 246 (246)
|+|++|..||.+.. .......+......++ ..+++.++++|++||+.
T Consensus 267 ~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 267 HLLLMGAVPFPGVN--DADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp HHHHHSSCSSCCSS--HHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCS
T ss_pred HHHHHCCCCCCCCC--hHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCC
Confidence 99999999997543 3334445555544333 24899999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=274.21 Aligned_cols=232 Identities=24% Similarity=0.321 Sum_probs=183.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+|+.||+|++.... .+....+.+.+|++.+++++||||+++++++.++...++||||++
T Consensus 10 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (311)
T 4agu_A 10 KIGEGSY---GVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD 85 (311)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEeecCC---eEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCC
Confidence 3788888 999999999999999999987654 334456778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|.++...... +++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 86 ~~~l~~~~~~~~~-----~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 86 HTVLHELDRYQRG-----VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp EEHHHHHHHTSSC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CchHHHHHhhhcC-----CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence 9999988765443 4899999999999999999999999999999999999999999999999998765332 233
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH-HHhhhcC---------------
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKD-VKAIIYS--------------- 224 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~-~~~~~~~--------------- 224 (246)
...++..|+|||.+.+.. .++.++|+||||+++++|++|..||.+........ .......
T Consensus 161 ~~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDT----QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp -----GGGCCHHHHHTCS----CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred CCcCCccccChHHHhcCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 456788899999987533 37889999999999999999999997654332211 1111110
Q ss_pred ---CCCCC----------CCCCHhHHHHHHHhhhC
Q psy7592 225 ---PVHYP----------TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 225 ---~~~~~----------~~~s~~l~~li~~~l~~ 246 (246)
..+.| +.+|+++.++|++||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 271 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHM 271 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCS
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccC
Confidence 11111 36899999999999974
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=268.79 Aligned_cols=230 Identities=27% Similarity=0.378 Sum_probs=188.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.+..... .+..+.+.+|+..+++++||||+++++++.++...++||||++
T Consensus 14 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (276)
T 2yex_A 14 TLGEGAY---GEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (276)
T ss_dssp EEEECSS---SEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EeecCCC---cEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecC
Confidence 3788888 8999999999999999999976542 2345678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc---c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---L 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~---~ 158 (246)
+++|.+++..... +++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+....... .
T Consensus 89 ~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 89 GGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp TEEGGGGSBTTTB-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCcHHHHHhhccC-----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 9999988865433 4899999999999999999999999999999999999999999999999987654322 1
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCC--CCCCCHhH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY--PTAWSEST 236 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l 236 (246)
.....++..|+|||.+.+.. ..+.++|+||||+++++|++|..||......... ........... +..+++.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRRE----FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTYLNPWKKIDSAP 238 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSS----BCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHTTCTTSTTGGGSCHHH
T ss_pred ccCCccccCccChHHHhcCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhhcccccCchhhcCHHH
Confidence 23456788999999987553 1366899999999999999999999765543322 22223222222 34689999
Q ss_pred HHHHHHhhhC
Q psy7592 237 KHLLSQVHRY 246 (246)
Q Consensus 237 ~~li~~~l~~ 246 (246)
+++|++||+.
T Consensus 239 ~~li~~~l~~ 248 (276)
T 2yex_A 239 LALLHKILVE 248 (276)
T ss_dssp HHHHHHHSCS
T ss_pred HHHHHHHCCC
Confidence 9999999963
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=271.06 Aligned_cols=234 Identities=23% Similarity=0.367 Sum_probs=190.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+||+|++ |+||++++..+++.||+|.+.... ....+.+.+|+..++.++||||+++++++.+....++||||++
T Consensus 29 ~lg~G~~---g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 29 VLGKGTY---GIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp EEEECSS---SEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEeecCc---EEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 5788888 899999999999999999997654 3345678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC-CCCeEEeecceeeeeccCc-cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE-EGHAHITDFNIATVLEENQ-LA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~-~~~~~l~d~~~~~~~~~~~-~~ 159 (246)
+++|.+++..... ....++..+..++.|++.|+.+||+.|++|+||+|+||+++. ++.++++|||.+....... ..
T Consensus 103 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~ 180 (295)
T 2clq_A 103 GGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180 (295)
T ss_dssp EEEHHHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCCHHHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcc
Confidence 9999999876421 233478889999999999999999999999999999999987 8899999999998765432 22
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH-hhhcCCCCCCCCCCHhHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVK-AIIYSPVHYPTAWSESTKH 238 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~l~~ 238 (246)
....++..|+|||.+.+... .++.++|+||||+++|+|++|..||............ ........+|..+++.+.+
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~---~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPR---GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA 257 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGG---GCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred cccCCCccccChhhhcCCCC---CCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence 34567889999999875431 2678999999999999999999999654433322222 2333456678899999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|.+||+.
T Consensus 258 li~~~l~~ 265 (295)
T 2clq_A 258 FILKCFEP 265 (295)
T ss_dssp HHHHTTCS
T ss_pred HHHHHccC
Confidence 99999963
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=270.46 Aligned_cols=228 Identities=25% Similarity=0.374 Sum_probs=175.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccch-HHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIE-RDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||++++. ++.||+|+++...... ....+.+.+|++.+++++||||+++++++.++...++||||+
T Consensus 14 ~lg~G~~---g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (271)
T 3dtc_A 14 IIGIGGF---GKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA 88 (271)
T ss_dssp EEEEETT---EEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECC
T ss_pred eeccCCC---eEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcC
Confidence 4788888 999999984 8999999987654322 233577889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCCCcEEEcC--------CCCeEEeecce
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH---IIHRDIKPDNILLDE--------EGHAHITDFNI 149 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~---~~h~~i~~~nil~~~--------~~~~~l~d~~~ 149 (246)
++++|.+++... ++++..++.++.|++.++.+||+.| ++|+||+|+||+++. ++.++++|||.
T Consensus 89 ~~~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 89 RGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp TTEEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred CCCCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999988532 3589999999999999999999999 889999999999986 67899999999
Q ss_pred eeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC
Q psy7592 150 ATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP 229 (246)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (246)
+........ ....+++.|+|||.+.+.. ++.++|+||||+++++|++|+.||...................+.|
T Consensus 163 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 163 AREWHRTTK-MSAAGAYAWMAPEVIRASM-----FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp --------------CCGGGSCHHHHHHCC-----CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred ccccccccc-cCCCCccceeCHHHhccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence 976544322 2456788999999987664 7889999999999999999999997544333222222233355667
Q ss_pred CCCCHhHHHHHHHhhhC
Q psy7592 230 TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 ~~~s~~l~~li~~~l~~ 246 (246)
..+++.+.++|.+||+.
T Consensus 237 ~~~~~~~~~li~~~l~~ 253 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNP 253 (271)
T ss_dssp TTCCHHHHHHHHHHTCS
T ss_pred cccCHHHHHHHHHHhcC
Confidence 88999999999999963
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=270.46 Aligned_cols=235 Identities=27% Similarity=0.422 Sum_probs=192.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeecccc------chHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC------IERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 74 (246)
.||+|++ |.||+++++.+++.||+|.+..... ......+.+.+|+++++++. ||||+++++++.++...+
T Consensus 24 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 100 (298)
T 1phk_A 24 ILGRGVS---SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 100 (298)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred eecCCCc---eEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEE
Confidence 3788888 9999999999999999999976531 11234567889999999995 999999999999999999
Q ss_pred EEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec
Q psy7592 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~ 154 (246)
+||||+++++|.+++..... +++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+....
T Consensus 101 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 101 LVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp EEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEeccCCCcHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 99999999999999976543 4899999999999999999999999999999999999999999999999998876
Q ss_pred cCccccccccCCCccCCceeccccc-ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATD-EVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP---- 229 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 229 (246)
.........+++.|+|||.+.+... ....++.++|+||||+++++|++|..||..... ......+......++
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 253 (298)
T 1phk_A 176 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMIMSGNYQFGSPEW 253 (298)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCCCTTTG
T ss_pred CCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHHHHHHhcCCcccCcccc
Confidence 5555555678889999999864321 112367899999999999999999999965432 233333443333332
Q ss_pred CCCCHhHHHHHHHhhhC
Q psy7592 230 TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 ~~~s~~l~~li~~~l~~ 246 (246)
..+++.++++|.+||+.
T Consensus 254 ~~~~~~l~~li~~~l~~ 270 (298)
T 1phk_A 254 DDYSDTVKDLVSRFLVV 270 (298)
T ss_dssp GGSCHHHHHHHHHHCCS
T ss_pred cccCHHHHHHHHHHccC
Confidence 36899999999999963
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=268.63 Aligned_cols=228 Identities=22% Similarity=0.388 Sum_probs=186.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee----CCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD----EEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~v~ 77 (246)
.||+|++ |+||++.+..++..||+|.+..... +.+..+.+.+|+.++++++||||+++++++.. +...++||
T Consensus 33 ~lg~G~~---g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 33 EIGRGSF---KTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred eccCCCC---eEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence 3788888 9999999999999999999986543 34456788999999999999999999999875 45689999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCcEEEc-CCCCeEEeecceeeeec
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH--IIHRDIKPDNILLD-EEGHAHITDFNIATVLE 154 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~--~~h~~i~~~nil~~-~~~~~~l~d~~~~~~~~ 154 (246)
||+++++|.+++..... +++..++.++.|++.+|.|||+.| ++|+||+|+||+++ .++.++|+|||++....
T Consensus 109 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 109 ELMTSGTLKTYLKRFKV-----MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EecCCCCHHHHHHHccC-----CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999999976544 489999999999999999999999 99999999999997 78899999999986433
Q ss_pred cCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCCCC
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAW 232 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~ 232 (246)
.. ......+++.|+|||.+.+. ++.++|+||||+++|+|++|..||...... ......+... ...++...
T Consensus 184 ~~-~~~~~~~t~~y~aPE~~~~~------~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 255 (290)
T 1t4h_A 184 AS-FAKAVIGTPEFMAPEMYEEK------YDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIYRRVTSGVKPASFDKVA 255 (290)
T ss_dssp TT-SBEESCSSCCCCCGGGGGTC------CCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHHHHHTTTCCCGGGGGCC
T ss_pred cc-ccccccCCcCcCCHHHHhcc------CCCcchHHHHHHHHHHHHhCCCCCCCcCcH-HHHHHHHhccCCccccCCCC
Confidence 32 23345688999999987532 788999999999999999999999753322 2222233322 33345678
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
++.+.++|.+||+.
T Consensus 256 ~~~l~~li~~~l~~ 269 (290)
T 1t4h_A 256 IPEVKEIIEGCIRQ 269 (290)
T ss_dssp CHHHHHHHHHHSCS
T ss_pred CHHHHHHHHHHccC
Confidence 89999999999963
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=278.26 Aligned_cols=229 Identities=23% Similarity=0.350 Sum_probs=181.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC----------
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE---------- 71 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---------- 71 (246)
.||+|++ |+||+|+++.+|+.||+|+++... .+...+.+.+|++++++++||||+++++++.+..
T Consensus 13 ~lG~G~~---g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 87 (332)
T 3qd2_B 13 CMGRGGF---GVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE 87 (332)
T ss_dssp EEECC-C---SEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred EecCCCC---eEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence 4788888 899999999999999999997654 2334577899999999999999999999986543
Q ss_pred -----------------------------------------------eEEEEEeecCCCChHHHHhhccccccCCCChHH
Q psy7592 72 -----------------------------------------------DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDT 104 (246)
Q Consensus 72 -----------------------------------------------~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~ 104 (246)
..++||||+++++|.+++...... ...+...
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~ 165 (332)
T 3qd2_B 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL--EDREHGV 165 (332)
T ss_dssp --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG--GGSCHHH
T ss_pred hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc--cchhhHH
Confidence 389999999999999999875432 2235667
Q ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-------------cccccccCCCccCC
Q psy7592 105 IHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-------------LATSMSGTKPYIAP 171 (246)
Q Consensus 105 ~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-------------~~~~~~~~~~~~aP 171 (246)
++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ......+++.|+||
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 89999999999999999999999999999999999999999999998765432 12234588899999
Q ss_pred ceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCC-CCCCCCHhHHHHHHHhhhC
Q psy7592 172 EIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVH-YPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 172 E~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~~li~~~l~~ 246 (246)
|.+.+.. ++.++|+||||+++|+|++|..|+. ..............+ .+...++.++++|.+||+.
T Consensus 246 E~~~~~~-----~~~~~Di~slG~il~el~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 312 (332)
T 3qd2_B 246 EQIHGNN-----YSHKVDIFSLGLILFELLYSFSTQM----ERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSP 312 (332)
T ss_dssp HHHHCCC-----CCTHHHHHHHHHHHHHHHSCCCCHH----HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCS
T ss_pred HHhcCCC-----CcchhhHHHHHHHHHHHHHcCCChh----HHHHHHHHhhccCCCcccccCChhHHHHHHHHccC
Confidence 9987654 7899999999999999999877752 111222222222221 1245788999999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=269.65 Aligned_cols=238 Identities=24% Similarity=0.358 Sum_probs=176.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+|+.||+|.++.... .....+.+.++...++.++||||+++++++.++...++||||++
T Consensus 14 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 89 (290)
T 3fme_A 14 ELGRGAY---GVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD 89 (290)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS
T ss_pred hcCCCCC---eEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc
Confidence 4788888 9999999999999999999976542 23334556666667888899999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK-HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~-~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
++|.+++..... ...++++..++.++.|++.++.|||+. |++|+||+|+||+++.++.++++|||.+..........
T Consensus 90 -~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 167 (290)
T 3fme_A 90 -TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD 167 (290)
T ss_dssp -EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred -cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccccccc
Confidence 488777654211 133469999999999999999999998 99999999999999999999999999998766554445
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC-CCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP-TAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~l 239 (246)
...+++.|+|||.+.... ....++.++|+||||+++++|++|..||.....................+ ..+|+.+.++
T Consensus 168 ~~~~t~~y~aPE~~~~~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (290)
T 3fme_A 168 IDAGCKPYMAPERINPEL-NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDF 246 (290)
T ss_dssp --CCCCCCSCHHHHSCCT-TC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHH
T ss_pred ccCCCccccChhhcChhh-cCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHH
Confidence 557889999999973221 11237889999999999999999999997544433333333333333333 4799999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|.+||+.
T Consensus 247 i~~~l~~ 253 (290)
T 3fme_A 247 TSQCLKK 253 (290)
T ss_dssp HHHHTCS
T ss_pred HHHHhhc
Confidence 9999974
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=273.66 Aligned_cols=234 Identities=20% Similarity=0.309 Sum_probs=190.1
Q ss_pred CcCCCCccCeeeEEEEEe-----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQK-----KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 75 (246)
.||+|++ |+||++++ ..+++.||+|.++... .....+.+.+|++.++++ +||||+++++++.+++..++
T Consensus 30 ~lg~G~~---g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 104 (313)
T 1t46_A 30 TLGAGAF---GKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (313)
T ss_dssp EEEECSS---EEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred hhCccCC---cceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEE
Confidence 3788888 99999984 5678999999998654 234457889999999999 89999999999999999999
Q ss_pred EEeecCCCChHHHHhhcccc-------------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCe
Q psy7592 76 VSDLLLGGDLRYHITQDIKF-------------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHA 142 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~-------------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~ 142 (246)
||||+++++|.+++...... ...++++..++.++.|++.||.+||+.|++|+||+|+||+++.++.+
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 184 (313)
T 1t46_A 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184 (313)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEE
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCE
Confidence 99999999999999764321 12246899999999999999999999999999999999999999999
Q ss_pred EEeecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHH
Q psy7592 143 HITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDV 218 (246)
Q Consensus 143 ~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~ 218 (246)
+++|||.+........ .....++..|+|||.+.+.. ++.++|+||||+++++|++ |..||......... .
T Consensus 185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~ 258 (313)
T 1t46_A 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-----YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-Y 258 (313)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-H
T ss_pred EEccccccccccccccceeccCCCCcceeeChHHhcCCC-----CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH-H
Confidence 9999999877644322 12234567899999987654 7899999999999999998 99999765543322 1
Q ss_pred Hhhh-cCCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 219 KAII-YSPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 219 ~~~~-~~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.... ......|..+++.+.++|.+||+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 287 (313)
T 1t46_A 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDA 287 (313)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred HHhccCCCCCCcccCCHHHHHHHHHHcCC
Confidence 2222 224445678999999999999963
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=267.26 Aligned_cols=226 Identities=23% Similarity=0.349 Sum_probs=186.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++. +++.||+|++...... .+++.+|++.+++++||||+++++++.++...++||||++
T Consensus 17 ~lg~G~~---g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 17 EIGSGQF---GLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp EEEECSS---CEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred eecCCCc---cEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 3688888 999999987 5778999999875432 2468889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc--cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ--LA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 159 (246)
+++|.+++.... ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... ..
T Consensus 89 ~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999996532 235899999999999999999999999999999999999999999999999987654322 12
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||.+.+.. ++.++|+||||+++++|++ |..||..... ......+... ....|..+++.+.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSR-----YSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGFRLYKPRLASTHVY 237 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred cCcccccccCCHHHhcCCC-----CCchhhhHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhcCccCCCCCcCCHHHH
Confidence 2334566799999987664 7899999999999999999 9999975433 2333333333 4555678999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||+.
T Consensus 238 ~li~~~l~~ 246 (269)
T 4hcu_A 238 QIMNHCWRE 246 (269)
T ss_dssp HHHHHHTCS
T ss_pred HHHHHHccC
Confidence 999999963
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=286.51 Aligned_cols=232 Identities=15% Similarity=0.179 Sum_probs=176.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHH---HHHhhCCCCcceeee-------eeeeeCC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREM---EILTTLEHPFLVNLW-------FCFQDEE 71 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~~~~~~ 71 (246)
.||+|++ |+||+++++.+|+.||||++......+....+.+.+|+ +.+++++||||++++ +++.+.+
T Consensus 80 ~lG~G~~---g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 156 (377)
T 3byv_A 80 VLGQEDP---YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156 (377)
T ss_dssp EEEEETT---EEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred eeecCCC---EEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence 3788888 99999999999999999999865544455668899999 555566899999998 6665543
Q ss_pred -----------------eEEEEEeecCCCChHHHHhhcccccc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q psy7592 72 -----------------DLFMVSDLLLGGDLRYHITQDIKFYS--VGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132 (246)
Q Consensus 72 -----------------~~~~v~e~~~~~sL~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~ 132 (246)
..+++|||+ +++|.+++........ ..+++..++.++.|++.||+|||+.|++|+||||+
T Consensus 157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~ 235 (377)
T 3byv_A 157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 235 (377)
T ss_dssp SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 278999999 6899999987544310 11234778889999999999999999999999999
Q ss_pred cEEEcCCCCeEEeecceeeeeccCccccccccCCCccCCceeccc------ccccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy7592 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVA------TDEVLGYSYSVDWWSLGVTLFEILARGRP 206 (246)
Q Consensus 133 nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~~~~~~Di~slG~~l~~ll~g~~p 206 (246)
||+++.++.++|+|||++..... ......+ +.|+|||.+.+. ......++.++||||||+++|+|++|..|
T Consensus 236 NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~P 312 (377)
T 3byv_A 236 DIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312 (377)
T ss_dssp GEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCC
T ss_pred HEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCC
Confidence 99999999999999999986332 2334456 899999999876 00001278999999999999999999999
Q ss_pred CCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 207 FDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
|........ .......+..+|++++++|.+||+.
T Consensus 313 f~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~L~~ 346 (377)
T 3byv_A 313 ITKDAALGG------SEWIFRSCKNIPQPVRALLEGFLRY 346 (377)
T ss_dssp C------CC------SGGGGSSCCCCCHHHHHHHHHHTCS
T ss_pred Ccccccccc------hhhhhhhccCCCHHHHHHHHHHcCC
Confidence 965432221 1111223468899999999999974
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=275.06 Aligned_cols=233 Identities=24% Similarity=0.336 Sum_probs=187.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEE--EEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMY--AMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~--avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |.||+++++.++..+ |+|.+.... +.+..+.+.+|++.++++ +||||+++++++.++...++|||
T Consensus 32 ~lg~G~~---g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 106 (327)
T 1fvr_A 32 VIGEGNF---GQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 106 (327)
T ss_dssp EEECGGG---CEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred eeecCCC---ceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence 4788888 899999999888866 999887543 334457788999999999 89999999999999999999999
Q ss_pred ecCCCChHHHHhhccc-----------cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeec
Q psy7592 79 LLLGGDLRYHITQDIK-----------FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDF 147 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~-----------~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~ 147 (246)
|+++++|.+++..... ....++++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Df 186 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 186 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEccc
Confidence 9999999999976531 11235699999999999999999999999999999999999999999999999
Q ss_pred ceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-C
Q psy7592 148 NIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-P 225 (246)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~ 225 (246)
|++.............++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||..... ......+... .
T Consensus 187 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~~~~~~~~~ 259 (327)
T 1fvr_A 187 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-----YTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEKLPQGYR 259 (327)
T ss_dssp TCEESSCEECCC----CCTTTCCHHHHHHCE-----ECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHGGGTCC
T ss_pred CcCccccccccccCCCCCccccChhhhcccc-----CCchhcchHHHHHHHHHHcCCCCCCCCCcH--HHHHHHhhcCCC
Confidence 9987544333333345677899999987654 7889999999999999998 9999975432 2223333333 4
Q ss_pred CCCCCCCCHhHHHHHHHhhhC
Q psy7592 226 VHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 226 ~~~~~~~s~~l~~li~~~l~~ 246 (246)
...|..+++.+.++|.+||+.
T Consensus 260 ~~~~~~~~~~l~~li~~~l~~ 280 (327)
T 1fvr_A 260 LEKPLNCDDEVYDLMRQCWRE 280 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCS
T ss_pred CCCCCCCCHHHHHHHHHHccC
Confidence 556778999999999999963
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=278.16 Aligned_cols=233 Identities=19% Similarity=0.318 Sum_probs=186.9
Q ss_pred CcCCCCccCeeeEEEEEe-----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQK-----KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 75 (246)
.||+|++ |+||++++ ..++..||+|.++... .....+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 52 ~lG~G~~---g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 126 (344)
T 1rjb_A 52 VLGSGAF---GKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 126 (344)
T ss_dssp EEEECSS---EEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eecCCCC---ceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEE
Confidence 4788888 99999997 3467789999997543 233457789999999999 89999999999999999999
Q ss_pred EEeecCCCChHHHHhhccccc------------------cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFY------------------SVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD 137 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~------------------~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~ 137 (246)
||||+++++|.+++....... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++
T Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~ 206 (344)
T 1rjb_A 127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT 206 (344)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEE
T ss_pred EEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEc
Confidence 999999999999997643210 12358889999999999999999999999999999999999
Q ss_pred CCCCeEEeecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCc
Q psy7592 138 EEGHAHITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNT 213 (246)
Q Consensus 138 ~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~ 213 (246)
.++.++|+|||++........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+....
T Consensus 207 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 207 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-----YTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-----CChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 999999999999976643322 12234567899999987654 7899999999999999998 99999765543
Q ss_pred cHHHHHhhhcC--CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 214 SVKDVKAIIYS--PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 214 ~~~~~~~~~~~--~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.. ....... ....|..+++.+.++|.+||+.
T Consensus 282 ~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 314 (344)
T 1rjb_A 282 AN--FYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 314 (344)
T ss_dssp HH--HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred HH--HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 32 2222222 4556778999999999999963
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=286.17 Aligned_cols=233 Identities=32% Similarity=0.525 Sum_probs=177.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc-----hHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI-----ERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|+| |+||+|+++.+++.||+|.+...... .......+.+|++++++++||||+++++++.. ...++|
T Consensus 142 ~LG~G~~---g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv 217 (419)
T 3i6u_A 142 TLGSGAC---GEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIV 217 (419)
T ss_dssp EEEECSS---SEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEE
T ss_pred EEeeCCC---eEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEE
Confidence 3788888 99999999999999999999865422 12223457899999999999999999999864 457899
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC---CeEEeecceeeee
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG---HAHITDFNIATVL 153 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~---~~~l~d~~~~~~~ 153 (246)
|||+.+++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus 218 ~e~~~~g~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 218 LELMEGGELFDKVVGNKR-----LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EECCTTCBGGGGTSSSCC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred EEcCCCCcHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 999999999988866543 49999999999999999999999999999999999997654 4999999999876
Q ss_pred ccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----
Q psy7592 154 EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP---- 229 (246)
Q Consensus 154 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 229 (246)
..........+++.|+|||.+.+.. ...++.++|+||||+++|+|++|..||....... .....+......++
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVG--TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp C-----------CTTCCTTTTC------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHHHTTCCCCCHHHH
T ss_pred CCCccccccCCCCCccCceeeecCC--CCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHHhcCCCCCCchhh
Confidence 6554445567899999999986422 1136789999999999999999999997544322 12223333333332
Q ss_pred CCCCHhHHHHHHHhhhC
Q psy7592 230 TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 ~~~s~~l~~li~~~l~~ 246 (246)
..+++.+.++|++||++
T Consensus 370 ~~~~~~~~~li~~~L~~ 386 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVV 386 (419)
T ss_dssp TTSCHHHHHHHHHHSCS
T ss_pred cccCHHHHHHHHHHccC
Confidence 46899999999999964
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=279.70 Aligned_cols=229 Identities=20% Similarity=0.333 Sum_probs=178.2
Q ss_pred CcCCCCccCeeeEEEEEec---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKK---DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |+||+++++ .++..||+|.++... +....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 52 ~lG~G~f---g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 126 (373)
T 2qol_A 52 VVGAGEF---GEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126 (373)
T ss_dssp EEEECSS---SEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEeeCCC---eEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEe
Confidence 4788888 899999987 568889999997653 34556789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 127 ~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 127 YMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp CCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 999999999997642 2358899999999999999999999999999999999999999999999999987643321
Q ss_pred c----cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCC
Q psy7592 159 A----TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAW 232 (246)
Q Consensus 159 ~----~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (246)
. ....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||..... ......+... ..+.|..+
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--~~~~~~i~~~~~~~~~~~~ 275 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRK-----FTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAVDEGYRLPPPMDC 275 (373)
T ss_dssp -----------CTTSCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--HHHHHHHHTTEECCCCTTC
T ss_pred cceeccCCCcCCCccChhhhccCC-----cCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCccc
Confidence 1 1122456799999987654 8899999999999999998 9999965432 2222333332 44556789
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
++.+.++|.+||+.
T Consensus 276 ~~~l~~li~~cl~~ 289 (373)
T 2qol_A 276 PAALYQLMLDCWQK 289 (373)
T ss_dssp BHHHHHHHHHHTCS
T ss_pred cHHHHHHHHHHhCc
Confidence 99999999999963
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=271.21 Aligned_cols=230 Identities=23% Similarity=0.373 Sum_probs=182.7
Q ss_pred CcCCCCccCeeeEEEEE----ecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee--CCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQ----KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD--EEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~ 75 (246)
.||+|++ |+||+++ +..+++.||+|++.... .+..+.+.+|++++++++||||+++++++.. ....++
T Consensus 17 ~lg~G~~---g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 90 (295)
T 3ugc_A 17 QLGKGNF---GSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 90 (295)
T ss_dssp EEEECSS---EEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred eeeccCC---EEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence 3788888 9999999 66789999999997653 4556789999999999999999999999864 456899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||||+++++|.+++..... .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++++|||++.....
T Consensus 91 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 91 IMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEECCTTCBHHHHHHHCGG----GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEeCCCCCHHHHHHhccc----ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 9999999999999976432 358999999999999999999999999999999999999999999999999987643
Q ss_pred Ccc----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc----------c---HHHH
Q psy7592 156 NQL----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT----------S---VKDV 218 (246)
Q Consensus 156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~----------~---~~~~ 218 (246)
... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...... . ....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESK-----FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCC-----CChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 321 12233556799999987665 789999999999999999999998532110 0 0011
Q ss_pred Hhhh--cCCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 219 KAII--YSPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 219 ~~~~--~~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.... ....+.|..+++++.++|++||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 271 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNN 271 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCS
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCC
Confidence 1111 225566788999999999999963
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=265.63 Aligned_cols=226 Identities=20% Similarity=0.363 Sum_probs=186.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++.++ ++..||+|.++..... .+++.+|++.+++++||||+++++++.++...++||||++
T Consensus 15 ~lg~G~~---g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 15 ELGSGQF---GVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp EEEEETT---EEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred eeccCCC---ceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 3678888 999999876 5778999999875432 2467889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc--
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-- 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (246)
+++|.+++..... ++++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+.........
T Consensus 87 ~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 87 NGCLLNYLRSHGK----GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp TCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred CCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 9999999976432 3589999999999999999999999999999999999999999999999999876543322
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||.+.+.. ++.++|+||||+++++|++ |..||...... .....+... ....|..+|+.+.
T Consensus 163 ~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~ 235 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFK-----YSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--EVVLKVSQGHRLYRPHLASDTIY 235 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSE-----EETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCCCCCCTTSCHHHH
T ss_pred cCCCcCcccCCHHHHhccC-----CchhhhhHHHHHHHHHHHcCCCCCccccChH--HHHHHHHcCCCCCCCCcChHHHH
Confidence 2233456799999987665 6789999999999999999 99999754432 223333333 4555678899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||+.
T Consensus 236 ~li~~~l~~ 244 (268)
T 3sxs_A 236 QIMYSCWHE 244 (268)
T ss_dssp HHHHHTTCS
T ss_pred HHHHHHcCC
Confidence 999999963
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=280.34 Aligned_cols=195 Identities=30% Similarity=0.439 Sum_probs=156.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCC--eEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEE--DLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~~~v~e 78 (246)
.||+|+| |+||+|+++.+|+.||+|++.... ......+.+.+|+..++++. ||||+++++++..++ ..|+|||
T Consensus 16 ~lG~G~~---g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 91 (388)
T 3oz6_A 16 KLGKGAY---GIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFD 91 (388)
T ss_dssp C----------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEE
T ss_pred EeeeCCC---eEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEec
Confidence 4788888 999999999999999999996543 23444577889999999997 999999999997543 6899999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC--
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-- 156 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-- 156 (246)
|+. ++|...+... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 92 ~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 92 YME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp CCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred ccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 996 5888888653 2488899999999999999999999999999999999999999999999999865321
Q ss_pred --------------------ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 157 --------------------QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 157 --------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.......+++.|+|||.+.+.. .++.++||||||+++++|++|++||.+.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST----KYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCC----CCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCC----CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1122346888999999987633 37889999999999999999999997644
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=289.27 Aligned_cols=193 Identities=24% Similarity=0.383 Sum_probs=160.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC------CeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE------EDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~~ 75 (246)
.||+|+| |+||+|++..+++.||+|++.... ......+++.+|+.+++.++||||+++++++... ...|+
T Consensus 69 ~lG~G~~---g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 144 (464)
T 3ttj_A 69 PIGSGAQ---GIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144 (464)
T ss_dssp EEEECSS---CEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EeecCCC---eEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEE
Confidence 3788888 999999999999999999997653 3345567888999999999999999999999654 45799
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||||+.+ +|.+.+.. .+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 145 v~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 145 VMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred EEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 9999965 46555533 248899999999999999999999999999999999999999999999999987765
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
........+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 217 SFMMTPYVVTRYYRAPEVILGMG-----YKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp CCCC----CCCTTCCHHHHTTCC-----CCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcccCCCcccccccCHHHHcCCC-----CCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 55555677899999999998764 8889999999999999999999997644
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=275.45 Aligned_cols=230 Identities=22% Similarity=0.367 Sum_probs=185.3
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
||+|++ |+||+++++.+++.||+|++....... .....+.+|+..+++++ ||||+++++++.+....++||||+.
T Consensus 37 lG~G~~---g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~ 112 (327)
T 3lm5_A 37 LGRGKF---AVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAA 112 (327)
T ss_dssp EEEETT---EEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eCCCCC---eEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecC
Confidence 788888 999999999999999999998654322 23467888999999995 6999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC---CCCeEEeecceeeeeccCcc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE---EGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~---~~~~~l~d~~~~~~~~~~~~ 158 (246)
+++|.+++... ....+++..++.++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||++........
T Consensus 113 ~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 189 (327)
T 3lm5_A 113 GGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189 (327)
T ss_dssp TEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----
T ss_pred CCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc
Confidence 99999887543 1234689999999999999999999999999999999999987 78999999999988765544
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC----CCCCCCCCCH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS----PVHYPTAWSE 234 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~s~ 234 (246)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||....... ....+... ....+..+++
T Consensus 190 ~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~ 262 (327)
T 3lm5_A 190 LREIMGTPEYLAPEILNYDP-----ITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TYLNISQVNVDYSEETFSSVSQ 262 (327)
T ss_dssp ----CCCGGGCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTCCCCCTTTTTTSCH
T ss_pred cccccCCcCccCCeeecCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHHHhcccccCchhhcccCH
Confidence 55567899999999987664 7889999999999999999999997544322 22233222 2333457899
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.++++|.+||+.
T Consensus 263 ~~~~li~~~L~~ 274 (327)
T 3lm5_A 263 LATDFIQSLLVK 274 (327)
T ss_dssp HHHHHHHHHSCS
T ss_pred HHHHHHHHHcCC
Confidence 999999999964
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=272.86 Aligned_cols=231 Identities=26% Similarity=0.353 Sum_probs=181.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccch--HHHHHHHHHHHHHHhhC---CCCcceeeeeeeeeCC-----
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIE--RDALKNVLREMEILTTL---EHPFLVNLWFCFQDEE----- 71 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~----- 71 (246)
.||+|++ |+||++++..+++.||+|.++...... ......+.+|++.++++ +||||+++++++....
T Consensus 16 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~ 92 (308)
T 3g33_A 16 EIGVGAY---GTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI 92 (308)
T ss_dssp EECCSSS---CCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEE
T ss_pred EEecCCC---eEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCce
Confidence 4788888 999999999999999999997543211 11113444566666555 5999999999998755
Q ss_pred eEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 72 ~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
..+++||++. ++|.+++..... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 93 ~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 168 (308)
T 3g33_A 93 KVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR 168 (308)
T ss_dssp EEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTT
T ss_pred eEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcccc
Confidence 5899999995 599999876432 236999999999999999999999999999999999999999999999999998
Q ss_pred eeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc---C--CC
Q psy7592 152 VLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY---S--PV 226 (246)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~--~~ 226 (246)
............+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+..... ....+.. . ..
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 169 IYSYQMALTPVVVTLWYRAPEVLLQST-----YATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPED 241 (308)
T ss_dssp TSTTCCCSGGGGCCCSSCCHHHHHTSC-----CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHHHHHCCCCTT
T ss_pred ccCCCcccCCccccccccCchHHcCCC-----CCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChh
Confidence 766555555667899999999987665 7889999999999999999999997544322 2222221 1 00
Q ss_pred C----------------------CCCCCCHhHHHHHHHhhhC
Q psy7592 227 H----------------------YPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ~----------------------~~~~~s~~l~~li~~~l~~ 246 (246)
. ..+.+++.+.++|.+||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 283 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTF 283 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCS
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcC
Confidence 0 1135789999999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=273.88 Aligned_cols=234 Identities=19% Similarity=0.314 Sum_probs=175.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCc---EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeE-----
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ---MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDL----- 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~----- 73 (246)
.||+|++ |+||+++++.++. .||+|.++..... ....+.+.+|++.+++++||||+++++++......
T Consensus 30 ~lg~G~~---g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (323)
T 3qup_A 30 MLGKGEF---GSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPI 105 (323)
T ss_dssp EEEEETT---EEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------C
T ss_pred eecccCC---eEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCc
Confidence 3688888 9999999987775 8999999765432 33467899999999999999999999999876654
Q ss_pred -EEEEeecCCCChHHHHhhcccc-ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 74 -FMVSDLLLGGDLRYHITQDIKF-YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 74 -~~v~e~~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
+++|||+.+++|.+++...... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++.
T Consensus 106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~ 185 (323)
T 3qup_A 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185 (323)
T ss_dssp EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccc
Confidence 9999999999999998754321 12246899999999999999999999999999999999999999999999999997
Q ss_pred eeccCccc---cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CC
Q psy7592 152 VLEENQLA---TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PV 226 (246)
Q Consensus 152 ~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~ 226 (246)
........ ....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+...... ...+... ..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~~~~~~~~~ 258 (323)
T 3qup_A 186 KIYSGDYYRQGCASKLPVKWLALESLADNL-----YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--YNYLIGGNRL 258 (323)
T ss_dssp ---------------CCGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHHTTCCC
T ss_pred cccccccccccccccCcccccCchhhcCCC-----CCCccchhhHHHHHHHHHhCCCCCccccChHHH--HHHHhcCCCC
Confidence 76443221 2234566899999987764 7899999999999999999 8999976544332 2333332 56
Q ss_pred CCCCCCCHhHHHHHHHhhhC
Q psy7592 227 HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ~~~~~~s~~l~~li~~~l~~ 246 (246)
..|..+++.+.++|.+||+.
T Consensus 259 ~~~~~~~~~l~~li~~~l~~ 278 (323)
T 3qup_A 259 KQPPECMEEVYDLMYQCWSA 278 (323)
T ss_dssp CCCTTCCHHHHHHHHHTTCS
T ss_pred CCCCccCHHHHHHHHHHccC
Confidence 66789999999999999963
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=268.89 Aligned_cols=233 Identities=24% Similarity=0.396 Sum_probs=189.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeee--eCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQ--DEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~~v~e~ 79 (246)
.||+|++ |+||+++++.+++.||+|.+..... +.+..+.+.+|++.+++++||||+++++++. .+...++||||
T Consensus 13 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 88 (279)
T 2w5a_A 13 TIGTGSY---GRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88 (279)
T ss_dssp EEEECSS---SEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred hccCCCC---cEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence 3788888 8999999999999999999986543 3445678999999999999999999999885 36789999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC-----cccCCCCCCcEEEcCCCCeEEeecceeeeec
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH-----IIHRDIKPDNILLDEEGHAHITDFNIATVLE 154 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~-----~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~ 154 (246)
+++++|.+++..... ....+++..++.++.|++.+|++||+.| ++|+||+|+||+++.++.++++|||.+....
T Consensus 89 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~ 167 (279)
T 2w5a_A 89 CEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 167 (279)
T ss_dssp CTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC-
T ss_pred CCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeec
Confidence 999999999976432 1234689999999999999999999999 9999999999999999999999999987654
Q ss_pred cCcc-ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCC
Q psy7592 155 ENQL-ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAW 232 (246)
Q Consensus 155 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (246)
.... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ......+... ...+|..+
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~~~ 240 (279)
T 2w5a_A 168 HDTSFAKTFVGTPYYMSPEQMNRMS-----YNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGKFRRIPYRY 240 (279)
T ss_dssp --CHHHHHHHSCCTTCCHHHHHCC------CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCCCCTTS
T ss_pred cccccccccCCCccccChHHhccCC-----CCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHHhhcccccCCccc
Confidence 3321 22345788999999987654 78899999999999999999999975432 2223333333 44677889
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
++++.++|.+||+.
T Consensus 241 ~~~l~~li~~~l~~ 254 (279)
T 2w5a_A 241 SDELNEIITRMLNL 254 (279)
T ss_dssp CHHHHHHHHHHTCS
T ss_pred CHHHHHHHHHHcCC
Confidence 99999999999963
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=278.19 Aligned_cols=233 Identities=21% Similarity=0.355 Sum_probs=190.7
Q ss_pred CcCCCCccCeeeEEEEEecC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD-------TKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 73 (246)
.||+|+| |+||+|++.. ++..||+|+++... .....+++.+|+++++++ +||||+++++++.++...
T Consensus 76 ~LG~G~~---g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 150 (382)
T 3tt0_A 76 PLGEGAF---GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 150 (382)
T ss_dssp EEEECSS---EEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred EEecCCC---eEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCce
Confidence 3788888 9999999753 34689999997654 345567899999999999 899999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcccc-----------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCe
Q psy7592 74 FMVSDLLLGGDLRYHITQDIKF-----------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHA 142 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~ 142 (246)
++||||+.+++|.+++...... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+
T Consensus 151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 230 (382)
T 3tt0_A 151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 230 (382)
T ss_dssp EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcE
Confidence 9999999999999999765321 12346999999999999999999999999999999999999999999
Q ss_pred EEeecceeeeeccCc---cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHH
Q psy7592 143 HITDFNIATVLEENQ---LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDV 218 (246)
Q Consensus 143 ~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~ 218 (246)
+|+|||++....... ......++..|+|||.+.+.. ++.++||||||+++++|++ |..||.+.... ...
T Consensus 231 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~~~ 303 (382)
T 3tt0_A 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-----YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--ELF 303 (382)
T ss_dssp EECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-----CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH
T ss_pred EEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-----CCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 999999997654332 122334567899999987654 8899999999999999999 99999754432 222
Q ss_pred HhhhcC-CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 219 KAIIYS-PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 219 ~~~~~~-~~~~~~~~s~~l~~li~~~l~~ 246 (246)
..+... ....|..+++++.++|++||+.
T Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 332 (382)
T 3tt0_A 304 KLLKEGHRMDKPSNCTNELYMMMRDCWHA 332 (382)
T ss_dssp HHHHTTCCCCCCSSCCHHHHHHHHHHTCS
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCC
Confidence 333333 5556788999999999999963
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=275.81 Aligned_cols=196 Identities=24% Similarity=0.356 Sum_probs=158.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+++.||+|.++.... .....+.+.+|++++++++||||+++++++.++...++||||+.
T Consensus 41 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 116 (329)
T 3gbz_A 41 KLGEGTY---GEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE 116 (329)
T ss_dssp EEEECSS---SEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCC---eEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC
Confidence 4788888 8999999999999999999976542 33345677889999999999999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc-----CCCCeEEeecceeeeeccC
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD-----EEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~-----~~~~~~l~d~~~~~~~~~~ 156 (246)
++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||++......
T Consensus 117 -~~L~~~~~~~~~-----~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 117 -NDLKKYMDKNPD-----VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp -EEHHHHHHHCTT-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred -CCHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 599999877544 48999999999999999999999999999999999994 4445999999998765432
Q ss_pred -ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 157 -QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 157 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.......++..|+|||.+.+.. .++.++||||||+++|+|++|..||.+..
T Consensus 191 ~~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~ 242 (329)
T 3gbz_A 191 IRQFTHEIITLWYRPPEILLGSR----HYSTSVDIWSIACIWAEMLMKTPLFPGDS 242 (329)
T ss_dssp ---------CCTTCCHHHHTTCC----CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccCCCcCCccccCHHHhcCCC----CCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 2233355788999999987643 37889999999999999999999997543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=270.13 Aligned_cols=228 Identities=20% Similarity=0.333 Sum_probs=190.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.+.... ...+.+.+|++++++++||||+++++++.++...++||||+.
T Consensus 20 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 92 (288)
T 3kfa_A 20 KLGGGQY---GEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 92 (288)
T ss_dssp ESGGGTT---CSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred ecCCCCc---eeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence 3788888 999999999999999999997643 235678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--A 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 159 (246)
+++|.+++.... ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+........ .
T Consensus 93 ~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 169 (288)
T 3kfa_A 93 YGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169 (288)
T ss_dssp TEEHHHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE
T ss_pred CCcHHHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc
Confidence 999999997643 23458999999999999999999999999999999999999999999999999876543322 2
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......... ..+... ....|..+|+.+.
T Consensus 170 ~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~ 242 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNK-----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEKDYRMERPEGCPEKVY 242 (288)
T ss_dssp TTEEECGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--HHHHTTCCCCCCTTCCHHHH
T ss_pred cCCccccCcCChhhhccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHHhccCCCCCCCCCCHHHH
Confidence 2234567899999987664 7899999999999999999 99999765543322 222222 4556788999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||+.
T Consensus 243 ~li~~~l~~ 251 (288)
T 3kfa_A 243 ELMRACWQW 251 (288)
T ss_dssp HHHHHHTCS
T ss_pred HHHHHHhCC
Confidence 999999973
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=273.65 Aligned_cols=197 Identities=26% Similarity=0.402 Sum_probs=165.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+|+.||+|.+.... .+....+.+.+|++.+++++||||+++++++.++...++||||+.
T Consensus 32 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 107 (331)
T 4aaa_A 32 LVGEGSY---GMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD 107 (331)
T ss_dssp EGGGGTT---SSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEeecCC---EEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCC
Confidence 4788888 899999999999999999987654 234445678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-cccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~ 160 (246)
+++|.+....... +++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 108 ~~~l~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (331)
T 4aaa_A 108 HTILDDLELFPNG-----LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182 (331)
T ss_dssp EEHHHHHHHSTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred cchHHHHHhhccC-----CCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccC
Confidence 9999887655433 489999999999999999999999999999999999999999999999999765433 2233
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
...++..|+|||.+.+.. .++.++|+||||+++|+|++|..||....
T Consensus 183 ~~~~t~~y~aPE~~~~~~----~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDV----KYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp -CCCCCTTCCHHHHTTCT----TCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCcCCccccCcccccCCC----CcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 456788999999987642 37889999999999999999999997544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=280.81 Aligned_cols=227 Identities=26% Similarity=0.412 Sum_probs=181.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee------------
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD------------ 69 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------------ 69 (246)
.||+|+| |+||+|++..+|+.||+|++.... ....+|+++++.++||||+++++++..
T Consensus 14 ~lG~G~f---g~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 14 TLGTGSF---GIVCEVFDIESGKRFALKKVLQDP-------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp EEECC-C---EEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred EEEeccC---EEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 4788988 999999999999999999997653 223469999999999999999999843
Q ss_pred --------------------------CCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC
Q psy7592 70 --------------------------EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH 123 (246)
Q Consensus 70 --------------------------~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~ 123 (246)
+...++||||++ ++|.+.+..... ....+++..++.++.|++.||.|||+.|
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 345889999996 577777654211 1334699999999999999999999999
Q ss_pred cccCCCCCCcEEEc-CCCCeEEeecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh
Q psy7592 124 IIHRDIKPDNILLD-EEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA 202 (246)
Q Consensus 124 ~~h~~i~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~ 202 (246)
++|+||+|+||+++ .++.++|+|||++.............+++.|+|||.+.+.. .++.++|+||+|+++|+|++
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGAT----EYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCS----SCCTHHHHHHHHHHHHHHHH
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCC----CCCcchhhhhHHHHHHHHHh
Confidence 99999999999997 68899999999998876665566677899999999987543 37889999999999999999
Q ss_pred CCCCCCCCCCccHHHHHhhhc---C--------------CC------------CCCCCCCHhHHHHHHHhhhC
Q psy7592 203 RGRPFDIHSNTSVKDVKAIIY---S--------------PV------------HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 203 g~~p~~~~~~~~~~~~~~~~~---~--------------~~------------~~~~~~s~~l~~li~~~l~~ 246 (246)
|+.||.+.... .....++. . .. .+|..+|+++.+||++||++
T Consensus 238 g~~pf~~~~~~--~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 238 GKPLFSGETSI--DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp SSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred CCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 99999754422 22222221 0 00 13556899999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=268.90 Aligned_cols=227 Identities=24% Similarity=0.411 Sum_probs=191.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+++.||+|.+...... +..+.+.+|+..+++++||||+++++++.++...++||||++
T Consensus 29 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 29 KIGKGSF---GEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEECSS---SEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhcccCC---eEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 3788888 89999999999999999999765432 335778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|.+++... ++++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 104 ~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 177 (303)
T 3a7i_A 104 GGSALDLLEPG------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 177 (303)
T ss_dssp TEEHHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred CCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence 99999988642 35899999999999999999999999999999999999999999999999998765433 223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh-cCCCCCCCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII-YSPVHYPTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~l~~l 239 (246)
...++..|+|||.+.+.. ++.++|+||||+++++|++|..||...... .....+. .....++..+++.+.++
T Consensus 178 ~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~l 250 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSA-----YDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNPPTLEGNYSKPLKEF 250 (303)
T ss_dssp CCCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCCCCSSCCHHHHHH
T ss_pred ccCCCcCccCHHHHhcCC-----CCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCCCCCccccCHHHHHH
Confidence 456788899999987654 788999999999999999999999754322 2222222 23455677899999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|.+||+.
T Consensus 251 i~~~l~~ 257 (303)
T 3a7i_A 251 VEACLNK 257 (303)
T ss_dssp HHHHCCS
T ss_pred HHHHcCC
Confidence 9999963
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=274.93 Aligned_cols=226 Identities=21% Similarity=0.261 Sum_probs=185.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||++++..+++.||+|.+..... .+.+.+|+++++++ +||||+++++++..+...++||||+
T Consensus 16 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 16 KIGCGNF---GELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp ECCC-CT---TSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred EeeccCC---ceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 4788888 8999999999999999999876432 23577899999999 8999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC-----eEEeecceeeeecc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH-----AHITDFNIATVLEE 155 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~-----~~l~d~~~~~~~~~ 155 (246)
+++|.+++... ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 88 -~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 88 -GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred -CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 99999998763 224599999999999999999999999999999999999998887 99999999987644
Q ss_pred Ccc--------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHhhhcCCC
Q psy7592 156 NQL--------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK-DVKAIIYSPV 226 (246)
Q Consensus 156 ~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~ 226 (246)
... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+....... ....+.....
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKE-----QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-----CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCC-----CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 322 23456889999999988764 789999999999999999999999876544433 2233322222
Q ss_pred CCC-----CCCCHhHHHHHHHhhhC
Q psy7592 227 HYP-----TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ~~~-----~~~s~~l~~li~~~l~~ 246 (246)
+.| ..++ ++.++|..||+.
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~ 261 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRL 261 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHC
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhC
Confidence 222 2345 999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=277.36 Aligned_cols=194 Identities=25% Similarity=0.466 Sum_probs=169.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.+.... .....+.+.+|++++++++||||+++++++.++...++||||++
T Consensus 40 ~lg~G~~---g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 114 (360)
T 3eqc_A 40 ELGAGNG---GVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 114 (360)
T ss_dssp EEEECSS---CEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eecCCCC---eEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCC
Confidence 3788888 999999999999999999998753 34556789999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK-HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~-~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
+++|.+++..... +++..+..++.|++.++.|||+. |++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 115 ~~~L~~~l~~~~~-----~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 188 (360)
T 3eqc_A 115 GGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN 188 (360)
T ss_dssp TCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C--
T ss_pred CCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-ccc
Confidence 9999999977544 48999999999999999999996 9999999999999999999999999988654322 223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
...+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||....
T Consensus 189 ~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTH-----YSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp --CCCCTTCCHHHHTTCC-----CSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred CCCCCCCeECHHHHcCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 456789999999987664 7899999999999999999999997544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=270.90 Aligned_cols=229 Identities=24% Similarity=0.387 Sum_probs=179.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++ .+++.||+|++..... +....+.+.+|++++++++||||+++++++.+++..++|||++.
T Consensus 9 ~lg~G~~---g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 9 KIGEGTY---GVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEETT---EEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred hcccCCC---EEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 3788888 99999999 6799999999976542 22234667889999999999999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-cccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~ 160 (246)
+ +|.+.+.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++...... ....
T Consensus 84 ~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 84 Q-DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp E-EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred C-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 5 8888886532 23588999999999999999999999999999999999999999999999998765432 2223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc---CC------------
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY---SP------------ 225 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~~------------ 225 (246)
...+++.|+|||.+.+.. .++.++|+||||+++|+|++|..||.+..... ....+.. ..
T Consensus 159 ~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSK----KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---CCCTTCCHHHHTTCC----SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccccccCchheeCCC----CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHHCCCChhhchhhhccc
Confidence 346788999999986533 37889999999999999999999997544222 2222211 10
Q ss_pred --------------CCCCCCCCHhHHHHHHHhhhC
Q psy7592 226 --------------VHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 226 --------------~~~~~~~s~~l~~li~~~l~~ 246 (246)
..++..+++++.++|++||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 267 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKL 267 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCS
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCC
Confidence 011245799999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=285.36 Aligned_cols=195 Identities=26% Similarity=0.458 Sum_probs=152.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC-----CeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE-----EDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v 76 (246)
.||+|+| |+||+|+++.+++.||||++.... .+....+++.+|++++++++||||+++++++... ...|+|
T Consensus 60 ~lG~G~~---g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 135 (458)
T 3rp9_A 60 LIGTGSY---GHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV 135 (458)
T ss_dssp C----------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EeeecCC---eEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEE
Confidence 4788888 999999999999999999997643 3444567889999999999999999999999533 568999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
||++ +++|..++..... +++..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 136 ~e~~-~~~L~~~~~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 136 LEIA-DSDFKKLFRTPVY-----LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp ECCC-SEEHHHHHHSSCC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred Eecc-ccchhhhcccCCC-----CCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 9998 6789988876543 499999999999999999999999999999999999999999999999999875422
Q ss_pred c----------------------------cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh------
Q psy7592 157 Q----------------------------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA------ 202 (246)
Q Consensus 157 ~----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~------ 202 (246)
. ......+++.|+|||.+.... .++.++|||||||++|+|++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE----NYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCC----CCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCC----CCCcHhHHHHHHHHHHHHHHhccccc
Confidence 1 122345688999999874332 38899999999999999998
Q ss_pred -----CCCCCCCC
Q psy7592 203 -----RGRPFDIH 210 (246)
Q Consensus 203 -----g~~p~~~~ 210 (246)
|.++|.+.
T Consensus 286 ~~~~~~~p~f~g~ 298 (458)
T 3rp9_A 286 AYHADRGPLFPGS 298 (458)
T ss_dssp SSGGGCCCSCC--
T ss_pred cccccccccCCCC
Confidence 66777553
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=280.41 Aligned_cols=191 Identities=27% Similarity=0.458 Sum_probs=159.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC-----CeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE-----EDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v 76 (246)
.||+|++ |+||+|+++.+++.||||++.... .+....+++.+|++++++++||||+++++++... ...|+|
T Consensus 33 ~lG~G~~---g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 108 (432)
T 3n9x_A 33 LIGRGSY---GYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIV 108 (432)
T ss_dssp EEEEETT---EEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EEeecCC---EEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEE
Confidence 4788888 999999999999999999997643 3344567889999999999999999999999766 569999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
||++. ++|.+.+..... +++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 109 ~e~~~-~~L~~~~~~~~~-----l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 109 LEIAD-SDLKKLFKTPIF-----LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EECCS-EEHHHHHHSSCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EecCC-cCHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 99984 699999876543 499999999999999999999999999999999999999999999999999876433
Q ss_pred cc-----------------------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy7592 157 QL-----------------------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRP 206 (246)
Q Consensus 157 ~~-----------------------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p 206 (246)
.. .....+++.|+|||.+.... .++.++|||||||++|+|++|..|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~----~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE----NYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCS----CCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCC----CCCcccccchHHHHHHHHHhcccc
Confidence 21 23456789999999874433 378999999999999999984333
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=273.23 Aligned_cols=232 Identities=24% Similarity=0.350 Sum_probs=184.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCC--CcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH--PFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|+| |+||++.+. +++.||+|++..... +....+.+.+|++++++++| |||+++++++.++...++|||+
T Consensus 16 ~lG~G~~---g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~ 90 (343)
T 3dbq_A 16 QIGSGGS---SKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 90 (343)
T ss_dssp EESCCSS---EEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEecCCC---eEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC
Confidence 4788888 999999985 699999999976542 34456788999999999986 9999999999999999999995
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL- 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (246)
.+++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++........
T Consensus 91 -~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 91 -GNIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp -CSEEHHHHHHHSCC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred -CCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 58899999987544 48999999999999999999999999999999999996 67899999999977643322
Q ss_pred --ccccccCCCccCCceeccccc------ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCC
Q psy7592 159 --ATSMSGTKPYIAPEIFLVATD------EVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHY 228 (246)
Q Consensus 159 --~~~~~~~~~~~aPE~~~~~~~------~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~ 228 (246)
.....+++.|+|||.+.+... ....++.++||||||+++|+|++|..||..... .......+... ...+
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~ 242 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIIDPNHEIEF 242 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-HHHHHHHHHCTTSCCCC
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-HHHHHHHHhcCCcccCC
Confidence 234568999999999865211 012378899999999999999999999975332 22333444433 5567
Q ss_pred CCCCCHhHHHHHHHhhhC
Q psy7592 229 PTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 229 ~~~~s~~l~~li~~~l~~ 246 (246)
|...++.+.++|.+||+.
T Consensus 243 ~~~~~~~l~~li~~~L~~ 260 (343)
T 3dbq_A 243 PDIPEKDLQDVLKCCLKR 260 (343)
T ss_dssp CCCSCHHHHHHHHHHTCS
T ss_pred cccCCHHHHHHHHHHcCC
Confidence 788899999999999974
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=270.90 Aligned_cols=225 Identities=19% Similarity=0.293 Sum_probs=185.8
Q ss_pred CcCCCCccCeeeEEEEEecCCC-------cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK-------QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 74 (246)
.||+|++ |+||+++++.++ ..||+|.+.... ....+.+.+|++.+++++||||+++++++.+++..+
T Consensus 15 ~lg~G~~---g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (289)
T 4fvq_A 15 SLGQGTF---TKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI 88 (289)
T ss_dssp EEEEETT---EEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred eeccCCC---ceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence 3688888 999999998877 479999997654 333467889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC--------eEEee
Q psy7592 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH--------AHITD 146 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~--------~~l~d 146 (246)
+||||+.+++|.+++..... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++++|
T Consensus 89 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHTGG----GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEECCCCCCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 99999999999999976533 2589999999999999999999999999999999999998887 99999
Q ss_pred cceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCccHHHHHhhhcCC
Q psy7592 147 FNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSVKDVKAIIYSP 225 (246)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~-p~~~~~~~~~~~~~~~~~~~ 225 (246)
||.+...... ....++..|+|||.+.+.. .++.++|+||||+++|+|++|.. ||.. .............
T Consensus 165 fg~~~~~~~~---~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~~~~~~~ 234 (289)
T 4fvq_A 165 PGISITVLPK---DILQERIPWVPPECIENPK----NLNLATDKWSFGTTLWEICSGGDKPLSA---LDSQRKLQFYEDR 234 (289)
T ss_dssp CCSCTTTSCH---HHHHHTTTTSCHHHHHCGG----GCCHHHHHHHHHHHHHHHHTTTCCTTTT---SCHHHHHHHHHTT
T ss_pred CcccccccCc---cccCCcCcccCHHHhCCCC----CCCchhHHHHHHHHHHHHHcCCCCCccc---cchHHHHHHhhcc
Confidence 9988543322 2344678899999987632 27889999999999999999554 5543 2233344555567
Q ss_pred CCCCCCCCHhHHHHHHHhhhC
Q psy7592 226 VHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 226 ~~~~~~~s~~l~~li~~~l~~ 246 (246)
..+|...++++.++|++||+.
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~ 255 (289)
T 4fvq_A 235 HQLPAPKAAELANLINNCMDY 255 (289)
T ss_dssp CCCCCCSSCTTHHHHHHHSCS
T ss_pred CCCCCCCCHHHHHHHHHHcCC
Confidence 777888999999999999974
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=287.52 Aligned_cols=228 Identities=19% Similarity=0.333 Sum_probs=190.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+++++.++..||||.++.... ..+.+.+|++++++++||||+++++++.++...++||||+.
T Consensus 227 ~lG~G~f---g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~ 299 (495)
T 1opk_A 227 KLGGGQY---GEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 299 (495)
T ss_dssp ESGGGTT---SSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EecCCCC---eEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence 4788888 8999999999999999999976532 24678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--A 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 159 (246)
+++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 300 ~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 376 (495)
T 1opk_A 300 YGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376 (495)
T ss_dssp TCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred CCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence 999999997642 22358889999999999999999999999999999999999999999999999987643321 1
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||.+.... ++.++||||||+++|+|++ |..||.+.+..... ..+... ..+.|..+++.+.
T Consensus 377 ~~~~~~~~y~aPE~~~~~~-----~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~ 449 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNK-----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEKDYRMERPEGCPEKVY 449 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCE-----ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--HHHHTTCCCCCCTTCCHHHH
T ss_pred CCCcCCcceeCHhHHhcCC-----CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH--HHHHcCCCCCCCCCCCHHHH
Confidence 2233456899999987665 7889999999999999999 99999765543322 222222 4566788999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
+||.+||+.
T Consensus 450 ~li~~cl~~ 458 (495)
T 1opk_A 450 ELMRACWQW 458 (495)
T ss_dssp HHHHHHTCS
T ss_pred HHHHHHcCc
Confidence 999999973
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=266.97 Aligned_cols=228 Identities=23% Similarity=0.393 Sum_probs=176.6
Q ss_pred CcCCCCccCeeeEEEEEecCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT---KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |+||++++..+ +..||+|.++... +.+..+.+.+|+..+++++||||+++++++. ++..++|||
T Consensus 22 ~lg~G~~---g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 95 (281)
T 1mp8_A 22 CIGEGQF---GDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 95 (281)
T ss_dssp EEEECSS---SEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred EeeecCC---eeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEe
Confidence 3788888 89999998754 5579999987643 3455678999999999999999999999985 456889999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+.+++|.+++.... .++++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||++........
T Consensus 96 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 96 LCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp CCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred cCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 999999999987542 2358999999999999999999999999999999999999999999999999987654322
Q ss_pred c--cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCH
Q psy7592 159 A--TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSE 234 (246)
Q Consensus 159 ~--~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~ 234 (246)
. ....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||........ ...+... ..+.|..+++
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~ 244 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRR-----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRIENGERLPMPPNCPP 244 (281)
T ss_dssp -------CCGGGCCHHHHHHCC-----CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHHTTCCCCCCTTCCH
T ss_pred cccccCCCcccccChhhcccCC-----CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HHHHHcCCCCCCCCCCCH
Confidence 2 2233566899999987654 7889999999999999996 9999976544332 2233332 5567789999
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.+.++|.+||+.
T Consensus 245 ~l~~li~~~l~~ 256 (281)
T 1mp8_A 245 TLYSLMTKCWAY 256 (281)
T ss_dssp HHHHHHHHHTCS
T ss_pred HHHHHHHHHccC
Confidence 999999999963
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=265.58 Aligned_cols=228 Identities=22% Similarity=0.373 Sum_probs=187.1
Q ss_pred CcCCCCccCeeeEEEEEec--CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKK--DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|++ |+||++.+. .++..||+|.++... .....+.+.+|++.+++++||||+++++++ +....++|||+
T Consensus 17 ~lg~G~~---g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~ 90 (287)
T 1u59_A 17 ELGCGNF---GSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEM 90 (287)
T ss_dssp EEECCTT---EEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred cccccCc---eeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEe
Confidence 4788888 999999864 468899999998753 345567899999999999999999999999 45568999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (246)
+.+++|.+++... ..++++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||++.........
T Consensus 91 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 91 AGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp CTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 9999999998643 223589999999999999999999999999999999999999999999999999876533221
Q ss_pred ----cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCC
Q psy7592 160 ----TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWS 233 (246)
Q Consensus 160 ----~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s 233 (246)
....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||....... ....+... ....|..++
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i~~~~~~~~~~~~~ 239 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRK-----FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKRMECPPECP 239 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCE-----ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHTTCCCCCCTTCC
T ss_pred eeccccccccccccCHHHhccCC-----CCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHhcCCcCCCCCCcC
Confidence 2233467899999987654 7889999999999999998 999997544322 22333332 456788999
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
+.+.++|++||+.
T Consensus 240 ~~l~~li~~~l~~ 252 (287)
T 1u59_A 240 PELYALMSDCWIY 252 (287)
T ss_dssp HHHHHHHHHTTCS
T ss_pred HHHHHHHHHHcCC
Confidence 9999999999963
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=265.58 Aligned_cols=226 Identities=18% Similarity=0.344 Sum_probs=184.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++.+. ++..||+|.++..... .+++.+|++.+++++||||+++++++.++...++||||+.
T Consensus 31 ~lg~G~~---g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 31 ELGTGQF---GVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp ECC---C---EEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred hcCCCCC---ceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 3788888 899999886 6888999999865432 2467889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc--cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ--LA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 159 (246)
+++|.+++.... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+....... ..
T Consensus 103 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 103 NGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp TCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 999999997632 235899999999999999999999999999999999999999999999999987654322 12
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||..... ......+... ....|..+++.+.
T Consensus 179 ~~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~ 251 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSK-----FSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAEHIAQGLRLYRPHLASEKVY 251 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCC-----CSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cCCccCcccCCHHHhccCC-----CCchhhHHHHHHHHHHHHhCCCCCccccCh--hHHHHHHhcccCCCCCCcCCHHHH
Confidence 2234566799999987664 7889999999999999998 9999975443 2333334433 4455678899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||+.
T Consensus 252 ~li~~~l~~ 260 (283)
T 3gen_A 252 TIMYSCWHE 260 (283)
T ss_dssp HHHHHTTCS
T ss_pred HHHHHHccC
Confidence 999999963
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=275.15 Aligned_cols=226 Identities=26% Similarity=0.404 Sum_probs=178.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC------eEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE------DLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~~ 75 (246)
.||+|++ |+||+++++.+|+.||+|++.... .+....+++.+|++++++++||||+++++++.... .+++
T Consensus 32 ~lG~G~~---g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 107 (367)
T 1cm8_A 32 PVGSGAY---GAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 107 (367)
T ss_dssp EC---------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EeeecCC---eEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEE
Confidence 3788888 899999999999999999996543 23455678899999999999999999999997653 4699
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||||+ +++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 108 v~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 108 VMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp EEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 99999 88999988652 248999999999999999999999999999999999999999999999999987543
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc---C--------
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY---S-------- 224 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~-------- 224 (246)
. .....+++.|+|||.+.+.. .++.++|+||+|+++++|++|+.||.+.+... ....+.. .
T Consensus 181 ~--~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 181 E--MTGYVVTRWYRAPEVILNWM----RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp S--CCSSCSCGGGCCTHHHHTTT----CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHT
T ss_pred c--cCcCcCCCCcCCHHHHhCCC----CCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHH
Confidence 2 33456788999999987632 37889999999999999999999997544221 1111111 0
Q ss_pred --------------------CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 225 --------------------PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 225 --------------------~~~~~~~~s~~l~~li~~~l~~ 246 (246)
....+...++.+.+||++||++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~ 294 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 294 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCS
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccC
Confidence 0112346799999999999974
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=276.73 Aligned_cols=232 Identities=24% Similarity=0.346 Sum_probs=185.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC--CCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE--HPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|+| |+||++.+.. ++.||||.+..... +....+.+.+|++++++++ ||||+++++++..+...++|||
T Consensus 63 ~LG~G~f---g~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 63 QIGSGGS---SKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEECCSS---EEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred EEccCCC---eEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 4788888 9999999875 99999999976543 3455678999999999996 5999999999999999999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL- 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (246)
+.+++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++........
T Consensus 137 ~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 137 CGNIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp CCSEEHHHHHHHCSS-----CCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred cCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 558899999976543 48889999999999999999999999999999999995 57899999999987643321
Q ss_pred --ccccccCCCccCCceecccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCC
Q psy7592 159 --ATSMSGTKPYIAPEIFLVATDE------VLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHY 228 (246)
Q Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~------~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~ 228 (246)
.....+++.|+|||.+.+.... ...++.++||||||+++|+|++|..||..... .......+... ...+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-~~~~~~~~~~~~~~~~~ 289 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIIDPNHEIEF 289 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHCTTSCCCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-HHHHHHHHhCccccCCC
Confidence 2345689999999998652110 11378899999999999999999999975432 22334444443 4456
Q ss_pred CCCCCHhHHHHHHHhhhC
Q psy7592 229 PTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 229 ~~~~s~~l~~li~~~l~~ 246 (246)
|...+++++++|.+||+.
T Consensus 290 ~~~~~~~~~~li~~~L~~ 307 (390)
T 2zmd_A 290 PDIPEKDLQDVLKCCLKR 307 (390)
T ss_dssp CCCSCHHHHHHHHHHTCS
T ss_pred CccchHHHHHHHHHHccc
Confidence 778899999999999973
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=272.19 Aligned_cols=233 Identities=32% Similarity=0.521 Sum_probs=182.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc-----hHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI-----ERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |+||+++++.+++.||+|.+...... ..+....+.+|++++++++||||+++++++..+. .++|
T Consensus 17 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv 92 (322)
T 2ycf_A 17 TLGSGAC---GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIV 92 (322)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEE
T ss_pred EEecCCC---EEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEE
Confidence 3788888 99999999999999999999764321 2223456889999999999999999999997665 8999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC---eEEeecceeeee
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH---AHITDFNIATVL 153 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~---~~l~d~~~~~~~ 153 (246)
|||+++++|.+.+..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus 93 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 93 LELMEGGELFDKVVGNKR-----LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp EECCTTEETHHHHSTTCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 999999999998876543 489999999999999999999999999999999999987664 999999999876
Q ss_pred ccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCC----C
Q psy7592 154 EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY----P 229 (246)
Q Consensus 154 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----~ 229 (246)
..........+++.|+|||.+.... ...++.++|+||||+++|+|++|..||........ ....+......+ +
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVG--TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQITSGKYNFIPEVW 244 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTT--TTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHHHHTCCCCCHHHH
T ss_pred ccccccccccCCcCccCchhhccCC--CCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHHHhCccccCchhh
Confidence 5544334456889999999875321 11378899999999999999999999975443321 112222232222 2
Q ss_pred CCCCHhHHHHHHHhhhC
Q psy7592 230 TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 ~~~s~~l~~li~~~l~~ 246 (246)
..+++.+.++|++||+.
T Consensus 245 ~~~~~~~~~li~~~l~~ 261 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVV 261 (322)
T ss_dssp TTSCHHHHHHHHHHSCS
T ss_pred hhcCHHHHHHHHHHccc
Confidence 57899999999999963
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=274.14 Aligned_cols=235 Identities=19% Similarity=0.282 Sum_probs=189.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCc-----EEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ-----MYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 75 (246)
.||+|++ |+||++++..+++ .||+|.+.... ..+..+.+.+|+++++++ +||||+++++++.++...++
T Consensus 53 ~lG~G~~---g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 127 (333)
T 2i1m_A 53 TLGAGAF---GKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV 127 (333)
T ss_dssp EEEECSS---EEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred EeccCCC---cceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence 3788888 9999999987665 79999997654 334567889999999999 89999999999999999999
Q ss_pred EEeecCCCChHHHHhhcccc---------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEee
Q psy7592 76 VSDLLLGGDLRYHITQDIKF---------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITD 146 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d 146 (246)
||||+++++|.+++...... ...++++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus 128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 207 (333)
T 2i1m_A 128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 207 (333)
T ss_dssp EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCC
T ss_pred EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECc
Confidence 99999999999999764321 123468899999999999999999999999999999999999999999999
Q ss_pred cceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhh
Q psy7592 147 FNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAII 222 (246)
Q Consensus 147 ~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~ 222 (246)
||++........ .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+.............
T Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 282 (333)
T 2i1m_A 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-----YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282 (333)
T ss_dssp CGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-----CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred cccccccccccceeecCCCCCCccccCHHHhccCC-----CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence 999976543322 12234567899999987654 7899999999999999998 99999765543322111112
Q ss_pred cCCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 223 YSPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 223 ~~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
......|..+++.+.++|.+||+.
T Consensus 283 ~~~~~~~~~~~~~l~~li~~~l~~ 306 (333)
T 2i1m_A 283 GYQMAQPAFAPKNIYSIMQACWAL 306 (333)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcc
Confidence 224455778899999999999963
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=269.97 Aligned_cols=231 Identities=20% Similarity=0.366 Sum_probs=184.3
Q ss_pred CcCCCCccCeeeEEEEE----ecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC--CeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQ----KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE--EDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~ 75 (246)
.||+|++ |+||+++ +..+++.||+|.+.... .....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 28 ~lg~G~~---g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 28 DLGEGHF---GKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEECSS---EEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred ccCCCCc---eEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 3788888 9999999 67789999999997654 223356788999999999999999999999876 66899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||||+++++|.+++.... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+.....
T Consensus 103 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp EEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 999999999999996532 2358999999999999999999999999999999999999999999999999987654
Q ss_pred Ccc----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC------------CCccHHHHH
Q psy7592 156 NQL----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH------------SNTSVKDVK 219 (246)
Q Consensus 156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~------------~~~~~~~~~ 219 (246)
... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..|+... .........
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSK-----FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCE-----EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred CCcceeccCCCCCCccccCCeeecCCC-----CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 432 22345667799999987765 678999999999999999999876321 111112222
Q ss_pred hhhcC--CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 220 AIIYS--PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 220 ~~~~~--~~~~~~~~s~~l~~li~~~l~~ 246 (246)
..... ..+.|..+|+.+.++|++||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 282 (302)
T 4e5w_A 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEF 282 (302)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHcCC
Confidence 22222 5556788999999999999974
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=265.41 Aligned_cols=230 Identities=15% Similarity=0.206 Sum_probs=186.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC--CeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE--EDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~ 79 (246)
.||+|++ |+||+++++ ++.||+|.+..... +....+.+.+|+..+++++||||+++++++.+. ...++||||
T Consensus 17 ~lg~G~~---g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 17 KLNENHS---GELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp EEEEETT---EEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred HhcCCCc---ceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 3688888 999999984 89999999987543 334457799999999999999999999999876 778999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH--IIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~--~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
+++++|.+++..... .++++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.+++.||+++....
T Consensus 91 ~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--- 164 (271)
T 3kmu_A 91 MPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--- 164 (271)
T ss_dssp CTTCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---
T ss_pred cCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec---
Confidence 999999999976432 24689999999999999999999999 9999999999999999999999988764322
Q ss_pred cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHH
Q psy7592 158 LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTK 237 (246)
Q Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 237 (246)
.....+++.|+|||.+.+.... ..+.++|+||||+++|+|++|..||.....................|..+++.+.
T Consensus 165 -~~~~~~t~~y~aPE~~~~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (271)
T 3kmu_A 165 -SPGRMYAPAWVAPEALQKKPED--TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVS 241 (271)
T ss_dssp -CTTCBSCGGGSCHHHHHSCGGG--SCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHH
T ss_pred -ccCccCCccccChhhhccCCCC--CCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 2234568899999998765421 2345799999999999999999999754433322222222335667889999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||+.
T Consensus 242 ~li~~~l~~ 250 (271)
T 3kmu_A 242 KLMKICMNE 250 (271)
T ss_dssp HHHHHHTCS
T ss_pred HHHHHHcCC
Confidence 999999963
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=268.22 Aligned_cols=226 Identities=26% Similarity=0.413 Sum_probs=184.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+|+.||+|.+..... .+.+.+|+..+++++||||+++++++.++...++||||+.
T Consensus 36 ~lg~G~~---g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (314)
T 3com_A 36 KLGEGSY---GSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG 107 (314)
T ss_dssp ECC-------CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eeccCCC---eEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence 4788888 8999999999999999999976531 3567889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
+++|.+++... ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 108 ~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (314)
T 3com_A 108 AGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 183 (314)
T ss_dssp TEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBC
T ss_pred CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccC
Confidence 99999998642 2235899999999999999999999999999999999999999999999999998765432 233
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCCCCCCHhHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPTAWSESTK 237 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~l~ 237 (246)
...++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...... .....+... ....|..+++.+.
T Consensus 184 ~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~ 256 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIG-----YNCVADIWSLGITAIEMAEGKPPYADIHPM--RAIFMIPTNPPPTFRKPELWSDNFT 256 (314)
T ss_dssp CCCSCGGGCCHHHHSSSC-----BCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred ccCCCCCccChhhcCCCC-----CCccccHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhcCCCcccCCcccCCHHHH
Confidence 456788999999987654 788999999999999999999999754322 222222222 2334567899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||+.
T Consensus 257 ~li~~~l~~ 265 (314)
T 3com_A 257 DFVKQCLVK 265 (314)
T ss_dssp HHHHHHTCS
T ss_pred HHHHHHccC
Confidence 999999963
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=263.69 Aligned_cols=228 Identities=20% Similarity=0.262 Sum_probs=185.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||+++++.+++.||+|.++...... ....++.+|+..+.++ +||||+++++++.+++..++||||+
T Consensus 18 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 93 (289)
T 1x8b_A 18 KIGSGEF---GSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYC 93 (289)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhcCCCc---eEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEec
Confidence 3678888 999999999999999999998654323 3346778899999999 8999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC-------------------CC
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE-------------------GH 141 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~-------------------~~ 141 (246)
++++|.+++..... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ ..
T Consensus 94 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (289)
T 1x8b_A 94 NGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172 (289)
T ss_dssp TTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCC
T ss_pred CCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceE
Confidence 99999999976432 12346899999999999999999999999999999999999844 47
Q ss_pred eEEeecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhh
Q psy7592 142 AHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAI 221 (246)
Q Consensus 142 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~ 221 (246)
++++|||.+....... ...+++.|+|||.+.+.. .+++++||||||+++++|++|.+|+... . ....+
T Consensus 173 ~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~----~~~~~~Di~slG~il~~l~~~~~~~~~~--~---~~~~~ 240 (289)
T 1x8b_A 173 FKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENY----THLPKADIFALALTVVCAAGAEPLPRNG--D---QWHEI 240 (289)
T ss_dssp EEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCC----TTHHHHHHHHHHHHHHHHTTCCCCCSSS--H---HHHHH
T ss_pred EEEcccccccccCCcc---ccCCCccccChhHhcCCC----CCCchhhHHHHHHHHHHHhcCCCCCcch--h---HHHHH
Confidence 8999999988765432 235788999999987542 2567999999999999999999876422 1 12223
Q ss_pred hcC-CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 222 IYS-PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 222 ~~~-~~~~~~~~s~~l~~li~~~l~~ 246 (246)
... ...+|..+++.+.++|++||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~li~~~l~~ 266 (289)
T 1x8b_A 241 RQGRLPRIPQVLSQEFTELLKVMIHP 266 (289)
T ss_dssp HTTCCCCCSSCCCHHHHHHHHHHTCS
T ss_pred HcCCCCCCCcccCHHHHHHHHHHhCC
Confidence 333 4566788999999999999963
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=281.76 Aligned_cols=223 Identities=20% Similarity=0.359 Sum_probs=183.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC-eEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE-DLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~v~e~~ 80 (246)
.||+|+| |+||++.++ ++.||||.++... ..+.+.+|++++++++||||+++++++.+.. ..++||||+
T Consensus 200 ~lG~G~f---g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 200 TIGKGEF---GDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp EEEECSS---EEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred eecCcCC---eeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 3788888 999999984 7899999997653 2467889999999999999999999987665 799999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
++++|.+++..... ..++...+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 270 ~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~ 344 (450)
T 1k9a_A 270 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QD 344 (450)
T ss_dssp TTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--cc
Confidence 99999999976432 23488899999999999999999999999999999999999999999999998754332 12
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKH 238 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~ 238 (246)
...++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......... ..+... ..+.|..+++.+.+
T Consensus 345 ~~~~~~~y~aPE~~~~~~-----~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~--~~i~~~~~~~~p~~~~~~l~~ 417 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKK-----FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV--PRVEKGYKMDAPDGCPPAVYD 417 (450)
T ss_dssp --CCCTTTSCHHHHHSSC-----CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH--HHHHTTCCCCCCTTCCHHHHH
T ss_pred CCCCCcceeCHHHhcCCC-----CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHHHcCCCCCCCCcCCHHHHH
Confidence 234577899999987654 8899999999999999998 99999765544332 223222 56678899999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|++||+.
T Consensus 418 li~~cl~~ 425 (450)
T 1k9a_A 418 VMKNCWHL 425 (450)
T ss_dssp HHHHHTCS
T ss_pred HHHHHcCC
Confidence 99999963
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=267.13 Aligned_cols=228 Identities=20% Similarity=0.340 Sum_probs=183.9
Q ss_pred CcCCCCccCeeeEEEEE--ecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQ--KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|++ |+||++. ++.+++.||+|.++... .+....+.+.+|++.+++++||||+++++++ +....++|||+
T Consensus 24 ~lg~G~~---g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~ 98 (291)
T 1xbb_A 24 ELGSGNF---GTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEM 98 (291)
T ss_dssp EEEECSS---EEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred ccccccC---eeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEe
Confidence 4788888 9999994 45678999999997654 2334467899999999999999999999999 55678899999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (246)
+.+++|.+++..... +++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||++.........
T Consensus 99 ~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 99 AELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp CTTEEHHHHHHHCTT-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCCCCHHHHHHhCcC-----CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 999999999976543 489999999999999999999999999999999999999999999999999876543221
Q ss_pred ----cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc-CCCCCCCCCC
Q psy7592 160 ----TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY-SPVHYPTAWS 233 (246)
Q Consensus 160 ----~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~s 233 (246)
....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||....... ....+.. .....|..++
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 246 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYK-----FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGERMGCPAGCP 246 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCE-----EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCCCCCCTTCC
T ss_pred ccccccCCCCceeeChHHhccCC-----CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCCCCCCCCCC
Confidence 1123457799999987654 6789999999999999999 999997544322 2222222 2456678899
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
+.+.++|++||+.
T Consensus 247 ~~l~~li~~~l~~ 259 (291)
T 1xbb_A 247 REMYDLMNLCWTY 259 (291)
T ss_dssp HHHHHHHHHHTCS
T ss_pred HHHHHHHHHHcCC
Confidence 9999999999963
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=273.44 Aligned_cols=229 Identities=19% Similarity=0.316 Sum_probs=178.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEE----EEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMY----AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~----avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||+|++ |+||++++..+++.+ |+|.++... .....+.+.+|+.++++++||||+++++++.++. .++++
T Consensus 22 ~lG~G~~---g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3poz_A 22 VLGSGAF---GTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEETT---EEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred EEeeCCC---eEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence 4788888 999999998887755 777765433 2334577889999999999999999999998765 77899
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
+++.+++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 96 QLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp ECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 9999999999987632 235889999999999999999999999999999999999999999999999997764432
Q ss_pred cc---cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcCCCCCCCCCC
Q psy7592 158 LA---TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYSPVHYPTAWS 233 (246)
Q Consensus 158 ~~---~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s 233 (246)
.. ....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+........... .....+.|..++
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 245 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRI-----YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICT 245 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBC
T ss_pred ccccccCCCccccccChHHhccCC-----CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCCCCCccCC
Confidence 22 2233566899999998765 8899999999999999999 999997655443322111 122455678899
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
..+.++|.+||+.
T Consensus 246 ~~~~~li~~~l~~ 258 (327)
T 3poz_A 246 IDVYMIMVKCWMI 258 (327)
T ss_dssp HHHHHHHHHHTCS
T ss_pred HHHHHHHHHHcCC
Confidence 9999999999974
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=270.40 Aligned_cols=234 Identities=20% Similarity=0.307 Sum_probs=188.6
Q ss_pred CcCCCCccCeeeEEEEEe-----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCC-eEE
Q psy7592 2 FCGSSKFCGTSKVCIVQK-----KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEE-DLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~ 74 (246)
.||+|++ |+||++++ ..+++.||+|.++... ..+..+.+.+|++.++++ +||||+++++++...+ ..+
T Consensus 34 ~lg~G~~---g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~ 108 (316)
T 2xir_A 34 PLGRGAF---GQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 108 (316)
T ss_dssp EEEECSS---EEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred EEcCCCc---eeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceE
Confidence 3788888 99999984 4678999999997654 344557889999999999 6999999999987654 589
Q ss_pred EEEeecCCCChHHHHhhcccc-----------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeE
Q psy7592 75 MVSDLLLGGDLRYHITQDIKF-----------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAH 143 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~ 143 (246)
++|||+++++|.+++...... ....+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~k 188 (316)
T 2xir_A 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 188 (316)
T ss_dssp EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEE
Confidence 999999999999999765321 012258889999999999999999999999999999999999999999
Q ss_pred EeecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHH
Q psy7592 144 ITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVK 219 (246)
Q Consensus 144 l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~ 219 (246)
++|||++........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||......... ..
T Consensus 189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-~~ 262 (316)
T 2xir_A 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-----YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-CR 262 (316)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH-HH
T ss_pred ECCCccccccccCccceeccCCCcceeecCchhhcccc-----ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH-HH
Confidence 999999876543321 22344677899999987654 7899999999999999998 99999765544322 22
Q ss_pred hhh-cCCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 220 AII-YSPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 220 ~~~-~~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.+. ......|..+++.+.++|.+||+.
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~ 290 (316)
T 2xir_A 263 RLKEGTRMRAPDYTTPEMYQTMLDCWHG 290 (316)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred HhccCccCCCCCCCCHHHHHHHHHHcCC
Confidence 222 235566788999999999999963
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=282.58 Aligned_cols=238 Identities=22% Similarity=0.359 Sum_probs=187.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC--eEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE--DLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~~v~e~ 79 (246)
.||+|++ |+||++++..+|+.||+|+++...... ..+.+.+|++++++++||||+++++++.+.. ..++||||
T Consensus 16 ~LG~G~~---g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 16 ILGQGAT---ANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred EEEcCCC---eEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 4788888 999999999999999999998654322 2466778999999999999999999998654 78999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE----cCCCCeEEeecceeeeecc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL----DEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~----~~~~~~~l~d~~~~~~~~~ 155 (246)
+++++|.+++..... ...+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 91 ~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 91 CPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp CTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred CCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 999999999876432 2236999999999999999999999999999999999999 6777899999999988766
Q ss_pred CccccccccCCCccCCceeccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHhhhcCCCC---
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEV---LGYSYSVDWWSLGVTLFEILARGRPFDIHSN--TSVKDVKAIIYSPVH--- 227 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~---~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~--- 227 (246)
........++..|+|||.+.+..... ..++.++|+||||+++|+|++|..||..... ........+....++
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~ 248 (396)
T 4eut_A 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248 (396)
T ss_dssp GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCC
T ss_pred CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccc
Confidence 55555667899999999986521000 1267799999999999999999999964332 223333444333211
Q ss_pred ----------------------CCCCCCHhHHHHHHHhhhC
Q psy7592 228 ----------------------YPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 228 ----------------------~~~~~s~~l~~li~~~l~~ 246 (246)
++..+++.+.++|..||++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~ 289 (396)
T 4eut_A 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289 (396)
T ss_dssp EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred hhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhcc
Confidence 1123466788889999863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=267.20 Aligned_cols=233 Identities=25% Similarity=0.352 Sum_probs=188.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccch-HHHHHHHHHHHHHHhhCCCCcceeeeeeee--eCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIE-RDALKNVLREMEILTTLEHPFLVNLWFCFQ--DEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~~v~e 78 (246)
.||+|++ |.||++.+..+++.||+|.++...... ....+.+.+|++.+++++||||+++++++. +....++|||
T Consensus 12 ~lg~G~~---g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (305)
T 2wtk_C 12 LLGEGSY---GKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME 88 (305)
T ss_dssp EEEECSS---CEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEE
T ss_pred EEecCCC---eEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEeh
Confidence 4678888 899999999999999999997654221 234577899999999999999999999984 4567899999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC--
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-- 156 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-- 156 (246)
|+.++ |.+.+.... ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+......
T Consensus 89 ~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~ 164 (305)
T 2wtk_C 89 YCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164 (305)
T ss_dssp CCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCS
T ss_pred hccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcccc
Confidence 99766 666665432 234689999999999999999999999999999999999999999999999999876432
Q ss_pred -ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHh
Q psy7592 157 -QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSES 235 (246)
Q Consensus 157 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 235 (246)
.......++..|+|||.+.+... ..+.++|+||||+++|+|++|..||.... .......+......+|..+++.
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~i~~~~~~~~~~~~~~ 239 (305)
T 2wtk_C 165 DDTCRTSQGSPAFQPPEIANGLDT---FSGFKVDIWSAGVTLYNITTGLYPFEGDN--IYKLFENIGKGSYAIPGDCGPP 239 (305)
T ss_dssp SCEECCCCSCGGGCCHHHHTCCSC---EESHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHCCCCCCSSSCHH
T ss_pred ccccccCCCCCCCcChhhccCccc---CCcchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHHHhcCCCCCCCccCHH
Confidence 22234557889999998865431 13678999999999999999999997533 3344455566677788899999
Q ss_pred HHHHHHHhhhC
Q psy7592 236 TKHLLSQVHRY 246 (246)
Q Consensus 236 l~~li~~~l~~ 246 (246)
+.++|++||+.
T Consensus 240 l~~li~~~l~~ 250 (305)
T 2wtk_C 240 LSDLLKGMLEY 250 (305)
T ss_dssp HHHHHHHHTCS
T ss_pred HHHHHHHHccC
Confidence 99999999963
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=274.33 Aligned_cols=197 Identities=25% Similarity=0.333 Sum_probs=163.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee--------CCeE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD--------EEDL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~ 73 (246)
.||+|++ |+||+++++.+|+.||+|++...... ......+.+|++++++++||||+++++++.. +...
T Consensus 24 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 99 (351)
T 3mi9_A 24 KIGQGTF---GEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 99 (351)
T ss_dssp ECSSCST---TSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEE
T ss_pred EEecCCC---cEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceE
Confidence 3788888 89999999999999999998665422 2223567789999999999999999999986 3468
Q ss_pred EEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 74 FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
++||||+.+ +|.+.+.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 100 ~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 100 YLVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp EEEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 999999965 6766665432 23599999999999999999999999999999999999999999999999999876
Q ss_pred ccC-----ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 154 EEN-----QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 154 ~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
... .......+++.|+|||.+.+.. .++.++||||||+++|+|++|..||.+..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGER----DYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCC----SCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccCCcccccCccCchhhcCCC----CCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 422 1223355788999999986543 37889999999999999999999997644
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=265.49 Aligned_cols=228 Identities=27% Similarity=0.489 Sum_probs=188.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.+...... ....+.+.+|++.+++++||||+++++++.+....++|||++.
T Consensus 29 ~lg~G~~---g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (287)
T 2wei_A 29 MLGKGSF---GEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104 (287)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEcCCCC---EEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccC
Confidence 3678888 99999999999999999999765432 2234678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC---CeEEeecceeeeeccCcc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG---HAHITDFNIATVLEENQL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~---~~~l~d~~~~~~~~~~~~ 158 (246)
+++|.+.+..... +++..++.++.|++.+|.+||+.|++|+||+|+||+++.++ .++++|||.+........
T Consensus 105 ~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 105 GGELFDEIIKRKR-----FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp SCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred CCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 9999998876543 48999999999999999999999999999999999997644 699999999876655444
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CCCCH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAWSE 234 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~s~ 234 (246)
.....++..|+|||.+.+. ++.++|+||||+++++|++|..||.... .......+......++ ..+|+
T Consensus 180 ~~~~~~~~~y~aPE~~~~~------~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRGT------YDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp CSCHHHHHTTCCHHHHTTC------CCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred cccccCcccccChHHhcCC------CCCchhhHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCCchhhhhcCH
Confidence 4445578889999987643 6789999999999999999999997543 2233334444433332 57899
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
++.++|++||+.
T Consensus 252 ~~~~li~~~l~~ 263 (287)
T 2wei_A 252 DAKDLIRKMLTF 263 (287)
T ss_dssp HHHHHHHHHTCS
T ss_pred HHHHHHHHHccc
Confidence 999999999963
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=275.34 Aligned_cols=193 Identities=24% Similarity=0.392 Sum_probs=156.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC------eEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE------DLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~~ 75 (246)
.||+|++ |+||+|++..+++.||+|++.... .+....+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 32 ~lG~G~~---g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l 107 (371)
T 2xrw_A 32 PIGSGAQ---GIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 107 (371)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred eeEecCC---EEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence 3788888 999999999999999999997643 23455678889999999999999999999997654 7899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||||+. ++|.+.+.. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 108 v~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 108 VMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred EEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 999995 467777743 248899999999999999999999999999999999999999999999999987655
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
........+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.+
T Consensus 180 ~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 180 SFMMTPYVVTRYYRAPEVILGMG-----YKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp ----------CTTCCHHHHTTCC-----CCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccCCceecCCccCHHHhcCCC-----CCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 44444567889999999997754 7889999999999999999999997543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=274.81 Aligned_cols=231 Identities=17% Similarity=0.144 Sum_probs=178.3
Q ss_pred CcCCCCccCeeeEEEEEecC---CCcEEEEEEeeccccchHHH--------HHHHHHHHHHHhhCCCCcceeeeeeeee-
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD---TKQMYAMKYMHKSQCIERDA--------LKNVLREMEILTTLEHPFLVNLWFCFQD- 69 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 69 (246)
.||+|++ |+||+|++.. ++..||+|.+.......... .+.+.+|+..++.++||||+++++++..
T Consensus 44 ~lg~G~~---g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~ 120 (345)
T 2v62_A 44 KIGSGGF---GLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE 120 (345)
T ss_dssp EC---------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEE
T ss_pred eEeecCC---eEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccc
Confidence 4788888 9999999987 88999999998654211111 1235678899999999999999999987
Q ss_pred ---CCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC--CeEE
Q psy7592 70 ---EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG--HAHI 144 (246)
Q Consensus 70 ---~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~--~~~l 144 (246)
+...++||||+ +++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|
T Consensus 121 ~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 121 FKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp SSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred cCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 67899999999 999999987654 349999999999999999999999999999999999999887 9999
Q ss_pred eecceeeeeccCcc--------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH
Q psy7592 145 TDFNIATVLEENQL--------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK 216 (246)
Q Consensus 145 ~d~~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~ 216 (246)
+|||++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||.........
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-----LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-----CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-----CCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 99999987643221 13346889999999988664 789999999999999999999999653333322
Q ss_pred HHHhhhcCCCCCC---------CCCCHhHHHHHHHhhhC
Q psy7592 217 DVKAIIYSPVHYP---------TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 217 ~~~~~~~~~~~~~---------~~~s~~l~~li~~~l~~ 246 (246)
...........+| ..+|++++++|..||+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 308 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSL 308 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhc
Confidence 1111111112222 27899999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=277.55 Aligned_cols=232 Identities=15% Similarity=0.164 Sum_probs=170.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC--CCCcceeee-------eeeeeC--
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL--EHPFLVNLW-------FCFQDE-- 70 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~-------~~~~~~-- 70 (246)
.||+|++ |+||+++++.+|+.||+|++......+....+.+.+|+..++.+ +||||++++ +++...
T Consensus 69 ~lG~G~~---g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 69 PLRVGDR---SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTS
T ss_pred eccCCCC---EEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCC
Confidence 3788888 99999999999999999999987655566677788885544444 699988755 444432
Q ss_pred ---------------CeEEEEEeecCCCChHHHHhhccccccCCCChHHH------HHHHHHHHHHHHHHHHCCcccCCC
Q psy7592 71 ---------------EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTI------HLYAFELGLALDYLKTKHIIHRDI 129 (246)
Q Consensus 71 ---------------~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~------~~~~~qi~~~l~~Lh~~~~~h~~i 129 (246)
...++||||++ ++|.+++...... ++...+ ..++.|++.||.|||+.|++|+||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV----YVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc----cchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 33899999997 8999999865332 245555 677799999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy7592 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDI 209 (246)
Q Consensus 130 ~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~ 209 (246)
||+||+++.++.++|+|||++....... ....+++.|+|||.+.+.. ..++.++||||||+++|+|++|..||..
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~---~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNAST---ATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSE---EECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCC---CCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998654322 1345568999999997521 1278999999999999999999999976
Q ss_pred CCCccHHHHHh-----hhcCCCCC--CCCCCHhHHHHHHHhhhC
Q psy7592 210 HSNTSVKDVKA-----IIYSPVHY--PTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 210 ~~~~~~~~~~~-----~~~~~~~~--~~~~s~~l~~li~~~l~~ 246 (246)
........... .......+ +..+|+.++++|.+||++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 339 (371)
T 3q60_A 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF 339 (371)
T ss_dssp CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCS
T ss_pred cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCC
Confidence 54322111111 11112222 357899999999999974
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=270.46 Aligned_cols=233 Identities=20% Similarity=0.349 Sum_probs=188.1
Q ss_pred CcCCCCccCeeeEEEEEec-------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK-------DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 73 (246)
.||+|++ |+||++++. .+++.||+|.++... .....+.+.+|+++++++ +||||+++++++.+....
T Consensus 42 ~lG~G~~---g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 116 (334)
T 2pvf_A 42 PLGEGAF---GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 116 (334)
T ss_dssp EEEECSS---CEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCC
T ss_pred EEeecCc---eeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCce
Confidence 3788888 999999986 467889999997654 345567899999999999 899999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcccc-----------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCe
Q psy7592 74 FMVSDLLLGGDLRYHITQDIKF-----------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHA 142 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~ 142 (246)
++||||+.+++|.+++...... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+
T Consensus 117 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 196 (334)
T 2pvf_A 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVM 196 (334)
T ss_dssp EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCE
Confidence 9999999999999999764321 12236888999999999999999999999999999999999999999
Q ss_pred EEeecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHH
Q psy7592 143 HITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDV 218 (246)
Q Consensus 143 ~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~ 218 (246)
+|+|||++........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+.... ...
T Consensus 197 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~ 269 (334)
T 2pvf_A 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-----YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--ELF 269 (334)
T ss_dssp EECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-----ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH
T ss_pred EEccccccccccccccccccCCCCcccceeChHHhcCCC-----cChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--HHH
Confidence 9999999987654322 12234567799999987654 7889999999999999999 99999754432 222
Q ss_pred HhhhcC-CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 219 KAIIYS-PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 219 ~~~~~~-~~~~~~~~s~~l~~li~~~l~~ 246 (246)
..+... ....|..+++.+.++|.+||+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 298 (334)
T 2pvf_A 270 KLLKEGHRMDKPANCTNELYMMMRDCWHA 298 (334)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHccC
Confidence 223222 4566788999999999999963
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=265.19 Aligned_cols=229 Identities=21% Similarity=0.322 Sum_probs=183.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCc---EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeE-EEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ---MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDL-FMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~v~ 77 (246)
+||+|++ |+||++++..+++ .||+|.+.... .....+.+.+|+.++++++||||+++++++.+.+.. +++|
T Consensus 28 ~lg~G~~---g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 28 VIGKGHF---GVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEETT---EEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred eeccCCC---ceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 3788888 9999999765444 89999987543 345567889999999999999999999999866554 8999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||+.+++|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 103 e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp CCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred ecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999997632 235888999999999999999999999999999999999999999999999987653322
Q ss_pred -----cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCccHHHHHhhhc-CCCCCCC
Q psy7592 158 -----LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSVKDVKAIIY-SPVHYPT 230 (246)
Q Consensus 158 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~-p~~~~~~~~~~~~~~~~~-~~~~~~~ 230 (246)
......++..|.|||.+.+.. ++.++|+||||+++|+|++|.. ||....... ....+.. ...+.|.
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 251 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYR-----FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LTHFLAQGRRLPQPE 251 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCC-----CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HHHHHHTTCCCCCCT
T ss_pred ccccccCcCCCCCccccChhhhccCC-----CChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HHHHhhcCCCCCCCc
Confidence 122344677899999997664 7889999999999999999555 454333222 2222222 2455677
Q ss_pred CCCHhHHHHHHHhhhC
Q psy7592 231 AWSESTKHLLSQVHRY 246 (246)
Q Consensus 231 ~~s~~l~~li~~~l~~ 246 (246)
.+++.+.++|++||+.
T Consensus 252 ~~~~~l~~li~~~l~~ 267 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEA 267 (298)
T ss_dssp TCCHHHHHHHHHHTCS
T ss_pred cchHHHHHHHHHHccC
Confidence 8999999999999963
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=277.72 Aligned_cols=224 Identities=14% Similarity=0.196 Sum_probs=175.0
Q ss_pred CcCCCCccCeeeEEEE-----EecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC---CCcceeeeeeeeeCCeE
Q psy7592 2 FCGSSKFCGTSKVCIV-----QKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE---HPFLVNLWFCFQDEEDL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~-----~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~ 73 (246)
.||+|+| |+||+| .+..+++.||+|.+.... ...+..|++.++.++ |+||+++++++..++..
T Consensus 72 ~lG~G~~---g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 72 LLGEGAF---AQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp EEEECSS---EEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred EeeccCC---EEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 3788888 999999 467789999999997654 235666777777776 99999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC-----------CCCe
Q psy7592 74 FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE-----------EGHA 142 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~-----------~~~~ 142 (246)
++||||+++++|.+++..........+++..++.++.|++.||+|||+.|++|+||||+||+++. ++.+
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~ 222 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCE
Confidence 99999999999999997644333445799999999999999999999999999999999999998 8999
Q ss_pred EEeecceeeeecc---CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH
Q psy7592 143 HITDFNIATVLEE---NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVK 219 (246)
Q Consensus 143 ~l~d~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 219 (246)
+|+|||++..... ........++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||........
T Consensus 223 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~elltg~~pf~~~~~~~~---- 293 (365)
T 3e7e_A 223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-----WNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---- 293 (365)
T ss_dssp EECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-----BSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----
T ss_pred EEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-----CCccccHHHHHHHHHHHHhCCCccccCCCCce----
Confidence 9999999976542 22334456899999999997765 78999999999999999999999854322110
Q ss_pred hhhcCCCCCCCCCCHhHHHHHHHhhh
Q psy7592 220 AIIYSPVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 220 ~~~~~~~~~~~~~s~~l~~li~~~l~ 245 (246)
....... ....++.+.+++..||+
T Consensus 294 -~~~~~~~-~~~~~~~~~~~~~~~l~ 317 (365)
T 3e7e_A 294 -KPEGLFR-RLPHLDMWNEFFHVMLN 317 (365)
T ss_dssp -EECSCCT-TCSSHHHHHHHHHHHHC
T ss_pred -eechhcc-ccCcHHHHHHHHHHHcC
Confidence 0111110 11246667777777765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=272.15 Aligned_cols=232 Identities=24% Similarity=0.300 Sum_probs=184.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
+||+|++ |+||+++++ +++.||+|.+.... ....+.+.+|++.+++++||||+++++++.++...++||||++
T Consensus 46 ~lg~G~~---g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 118 (321)
T 2qkw_B 46 LIGHGVF---GKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118 (321)
T ss_dssp CSCBCSS---SEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCT
T ss_pred eeecCCC---eeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCC
Confidence 4788888 899999975 69999999987654 2335678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc---c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---L 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~---~ 158 (246)
+++|.+++..... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++....... .
T Consensus 119 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 119 NGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp TCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred CCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999998865422 23346889999999999999999999999999999999999999999999999988654322 1
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH----Hhhh-cC---------
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDV----KAII-YS--------- 224 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~----~~~~-~~--------- 224 (246)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||........... .... ..
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGR-----LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCB-----CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred ccccCCCccccCHHHhcCCC-----CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence 22345788999999987665 78899999999999999999999965443221110 0000 00
Q ss_pred -CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 225 -PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 225 -~~~~~~~~s~~l~~li~~~l~~ 246 (246)
....+...+..+.+++.+||+.
T Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~ 295 (321)
T 2qkw_B 273 LADKIRPESLRKFGDTAVKCLAL 295 (321)
T ss_dssp CTTCSCHHHHHHHHHHHHHHTCS
T ss_pred hccccCHHHHHHHHHHHHHHcCC
Confidence 1112334577899999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=270.18 Aligned_cols=236 Identities=22% Similarity=0.291 Sum_probs=182.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee----CCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD----EEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~v~ 77 (246)
.||+|++ |.||++++..+++.||+|.+.... ....+.+.+|++++++++||||+++++++.. ....++||
T Consensus 36 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 36 KLGEGGF---SYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEC--C---EEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EecCCCC---eEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 4788888 999999999999999999987643 4556788899999999999999999999872 34789999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||+.+++|.+++..... ...++++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 110 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp ECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred EeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 99999999999876321 13346999999999999999999999999999999999999999999999999887643211
Q ss_pred cc----------cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh-cCCC
Q psy7592 158 LA----------TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII-YSPV 226 (246)
Q Consensus 158 ~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~ 226 (246)
.. ....+++.|+|||.+.+.... .++.++|+||||+++|+|++|..||............... ....
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 266 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHC--VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEE--EECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--C
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCc--CCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCC
Confidence 11 123468889999998654211 2577999999999999999999999532111111111111 1233
Q ss_pred CCCCCCCHhHHHHHHHhhhC
Q psy7592 227 HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ~~~~~~s~~l~~li~~~l~~ 246 (246)
+.+..+++.+.++|.+||+.
T Consensus 267 ~~~~~~~~~l~~li~~~l~~ 286 (317)
T 2buj_A 267 PQSPRHSSALWQLLNSMMTV 286 (317)
T ss_dssp CCCTTSCHHHHHHHHHHTCS
T ss_pred CccccCCHHHHHHHHHHhhc
Confidence 44567999999999999963
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=268.47 Aligned_cols=227 Identities=19% Similarity=0.193 Sum_probs=186.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||++++..+++.||+|.+..... .+.+.+|++.++++ +|++++++++++.++...++||||+
T Consensus 17 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 17 RIGEGSF---GVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp EEEECSS---CEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEeecCC---EEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 3788888 8999999999999999999875432 24577899999999 7999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC-----eEEeecceeeeecc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH-----AHITDFNIATVLEE 155 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~-----~~l~d~~~~~~~~~ 155 (246)
+++|.+++.... .++++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++++|||++.....
T Consensus 89 -~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 89 -GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp -CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred -CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 999999997642 23599999999999999999999999999999999999987775 99999999987654
Q ss_pred Ccc--------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHhhhcC--
Q psy7592 156 NQL--------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK-DVKAIIYS-- 224 (246)
Q Consensus 156 ~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~-- 224 (246)
... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......... ....+...
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGRE-----QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-----CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCC-----CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 322 23456889999999987664 789999999999999999999999775543332 22222221
Q ss_pred ---CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 225 ---PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 225 ---~~~~~~~~s~~l~~li~~~l~~ 246 (246)
....+..+|+++.++|..||+.
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~ 263 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNL 263 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHC
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcC
Confidence 1222357899999999999963
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=269.32 Aligned_cols=229 Identities=20% Similarity=0.294 Sum_probs=181.1
Q ss_pred CcCCCCccCeeeEEEEEecCCC----cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK----QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||+|++ |+||+++++.++ ..||+|.++... +......+.+|++++++++||||+++++++.+....++||
T Consensus 51 ~lG~G~~---g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 125 (333)
T 1mqb_A 51 VIGAGEF---GEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 125 (333)
T ss_dssp EEEECSS---SEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EEecCCC---eEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEE
Confidence 4788888 899999987653 469999997654 3444567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||+++++|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 126 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 126 EYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp ECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 9999999999987532 235899999999999999999999999999999999999999999999999998764332
Q ss_pred cc----cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCC
Q psy7592 158 LA----TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTA 231 (246)
Q Consensus 158 ~~----~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (246)
.. ....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||..... ......+... ..+.|..
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~ 274 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRK-----FTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAINDGFRLPTPMD 274 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCC-----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCCCCCCTT
T ss_pred ccccccCCCCccccccCchhcccCC-----CCchhhhHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHCCCcCCCccc
Confidence 11 1223456799999987654 7889999999999999999 9999965432 2223333333 4556778
Q ss_pred CCHhHHHHHHHhhhC
Q psy7592 232 WSESTKHLLSQVHRY 246 (246)
Q Consensus 232 ~s~~l~~li~~~l~~ 246 (246)
+++.+.++|.+||+.
T Consensus 275 ~~~~l~~li~~~l~~ 289 (333)
T 1mqb_A 275 CPSAIYQLMMQCWQQ 289 (333)
T ss_dssp CBHHHHHHHHHHTCS
T ss_pred CCHHHHHHHHHHcCC
Confidence 999999999999963
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=273.33 Aligned_cols=231 Identities=23% Similarity=0.350 Sum_probs=176.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+++.||+|.++.... ......+.+|++++++++||||+++++++.++...++||||+.
T Consensus 9 ~lG~G~~---g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 9 KLGEGTY---ATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred EEcCCCC---EEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 4788888 9999999999999999999976431 1222245579999999999999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-ccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (246)
++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 84 -~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 84 -KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp -EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred -cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence 58888876543 235889999999999999999999999999999999999999999999999997654332 223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHhhhcCCC--C----------
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK-DVKAIIYSPV--H---------- 227 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~--~---------- 227 (246)
...+++.|+|||.+.+.. .++.++|+||||+++|+|++|..||.+....... ...+....+. .
T Consensus 159 ~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGST----DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp ----CGGGCCHHHHTTCC----CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccCcccccChhhhcCCC----CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 356788999999986543 3788999999999999999999999764432221 1112111110 0
Q ss_pred ---------------CCCCCCHhHHHHHHHhhhC
Q psy7592 228 ---------------YPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 228 ---------------~~~~~s~~l~~li~~~l~~ 246 (246)
.++.+++++.+||++||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 268 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQF 268 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCc
Confidence 1135789999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=281.04 Aligned_cols=227 Identities=26% Similarity=0.362 Sum_probs=177.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC------CeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE------EDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~~ 75 (246)
.||+|+| |+||+++++.+|+.||||++.... +...+|++++++++||||+++++++... .+.++
T Consensus 61 ~lG~G~f---g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 61 VIGNGSF---GVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred EEeeCCC---EEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 4788888 999999999999999999997643 2234689999999999999999998532 24778
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC-CCeEEeecceeeeec
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE-GHAHITDFNIATVLE 154 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~-~~~~l~d~~~~~~~~ 154 (246)
||||+.+ ++.+.+..... ....+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||+++...
T Consensus 131 v~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred ehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 9999965 56655543211 23446899999999999999999999999999999999999965 568999999998876
Q ss_pred cCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc-----------
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY----------- 223 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~----------- 223 (246)
.........+++.|+|||.+.+.. .++.++|||||||++|+|++|+.||.+.... .....++.
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTTCS----SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHHH
T ss_pred cCCCceeeeeCCCcCCHHHHcCCC----CCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHH
Confidence 555555567899999999987543 3788999999999999999999999764422 22222211
Q ss_pred ------CCCC------------CCCCCCHhHHHHHHHhhhC
Q psy7592 224 ------SPVH------------YPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 224 ------~~~~------------~~~~~s~~l~~li~~~l~~ 246 (246)
.... ++...++++.+||++||++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~ 323 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 323 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCS
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccC
Confidence 0111 2346789999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=270.08 Aligned_cols=233 Identities=27% Similarity=0.458 Sum_probs=183.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+++.||+|.+.... .+..+.+.+|++.+++++||||+++++++.++...++||||++
T Consensus 26 ~lg~G~~---g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 26 ELGDGAF---GKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp EEECSTT---CCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred eeccCCC---eEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 3788888 899999999999999999987653 2335678889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-cccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~ 160 (246)
+++|.+++... ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||++...... ....
T Consensus 100 ~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (302)
T 2j7t_A 100 GGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175 (302)
T ss_dssp TEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred CCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence 99999988653 223589999999999999999999999999999999999999999999999987543221 1223
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCCCCCCHhHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPTAWSESTK 237 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~l~ 237 (246)
...++..|+|||.+.........++.++|+||||+++|+|++|..||...+.. .....+... ....|..+|+.+.
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKSDPPTLLTPSKWSVEFR 253 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHHhccCCcccCCccccCHHHH
Confidence 35678899999998533222224788999999999999999999999754432 223333333 2233567999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|++||+.
T Consensus 254 ~li~~~l~~ 262 (302)
T 2j7t_A 254 DFLKIALDK 262 (302)
T ss_dssp HHHHHHSCS
T ss_pred HHHHHHccc
Confidence 999999963
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=269.35 Aligned_cols=233 Identities=18% Similarity=0.276 Sum_probs=189.0
Q ss_pred CcCCCCccCeeeEEEEEec-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK-----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |+||+++++ .+++.||+|.+.... .......+.+|++++++++||||+++++++.++...++|
T Consensus 32 ~lg~G~~---g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 106 (322)
T 1p4o_A 32 ELGQGSF---GMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 106 (322)
T ss_dssp EEEECSS---SEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred EeccCCc---eEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEE
Confidence 3788888 899999887 468899999997653 234456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhcccc-----ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceee
Q psy7592 77 SDLLLGGDLRYHITQDIKF-----YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIAT 151 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~ 151 (246)
|||+.+++|.+++...... ...++++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++++|||++.
T Consensus 107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~ 186 (322)
T 1p4o_A 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186 (322)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcccc
Confidence 9999999999998764321 11345888999999999999999999999999999999999999999999999987
Q ss_pred eeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CC
Q psy7592 152 VLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PV 226 (246)
Q Consensus 152 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~ 226 (246)
....... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||...... .....+... ..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~ 259 (322)
T 1p4o_A 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGV-----FTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVLRFVMEGGLL 259 (322)
T ss_dssp GGGGGGCEEGGGSSEECGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHHHHHHTTCCC
T ss_pred ccccccccccccCCCCCCCccChhhhccCC-----CCchhhHHHHHHHHHHHHhcCCCccccCCHH--HHHHHHHcCCcC
Confidence 6543321 12234567899999987654 7889999999999999999 88999754322 222333333 45
Q ss_pred CCCCCCCHhHHHHHHHhhhC
Q psy7592 227 HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ~~~~~~s~~l~~li~~~l~~ 246 (246)
..|..+++.+.++|.+||+.
T Consensus 260 ~~~~~~~~~l~~li~~~l~~ 279 (322)
T 1p4o_A 260 DKPDNCPDMLFELMRMCWQY 279 (322)
T ss_dssp CCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCCCCHHHHHHHHHHcCC
Confidence 56788999999999999963
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=270.47 Aligned_cols=230 Identities=23% Similarity=0.362 Sum_probs=187.2
Q ss_pred CcCCCCccCeeeEEEEE----ecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeee--eCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQ----KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQ--DEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~~ 75 (246)
.||+|++ |+||+++ +..+++.||+|.+.... ....+.+.+|++++++++||||+++++++. +....++
T Consensus 30 ~lg~G~~---g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 30 QLGKGNF---GSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp EEEEETT---EEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hccCCCC---eEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 3678888 9999999 67789999999997654 445677899999999999999999999886 4567899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||||+++++|.+++..... ++++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEeecCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 9999999999999976322 359999999999999999999999999999999999999999999999999987654
Q ss_pred Ccc----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc------------cHHHHH
Q psy7592 156 NQL----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT------------SVKDVK 219 (246)
Q Consensus 156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~------------~~~~~~ 219 (246)
... .....++..|+|||.+.+.. ++.++|+||||+++++|++|..||...... ......
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNI-----FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCE-----EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCC-----CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 322 22234667799999987665 688999999999999999999998532211 111122
Q ss_pred hhhcC--CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 220 AIIYS--PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 220 ~~~~~--~~~~~~~~s~~l~~li~~~l~~ 246 (246)
..... ..+.|..+++.+.++|.+||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 283 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAP 283 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCC
Confidence 22222 4556788999999999999963
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=269.67 Aligned_cols=233 Identities=21% Similarity=0.363 Sum_probs=179.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeee------CCeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQD------EEDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~~~ 74 (246)
.||+|++ |+||++++..+++.||+|.+..... ..+.+.+|+..++++ +||||+++++++.. ....+
T Consensus 31 ~lg~G~~---g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 31 LVGNGTY---GQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred EeccCCC---EEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 3677888 9999999999999999999976532 235678899999999 79999999999986 46799
Q ss_pred EEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec
Q psy7592 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~ 154 (246)
+||||+++++|.+++.... ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 104 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred EEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 9999999999999997642 2345889999999999999999999999999999999999999999999999987654
Q ss_pred cCc-cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCCC
Q psy7592 155 ENQ-LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTA 231 (246)
Q Consensus 155 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 231 (246)
... ......+++.|+|||.+.........++.++|+||||+++|+|++|..||...... .....+... +...+..
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~ 258 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--RALFLIPRNPAPRLKSKK 258 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCCCSCSC
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhcCccccCCccc
Confidence 322 22345678899999998743322234788999999999999999999999654322 222223222 2223467
Q ss_pred CCHhHHHHHHHhhhC
Q psy7592 232 WSESTKHLLSQVHRY 246 (246)
Q Consensus 232 ~s~~l~~li~~~l~~ 246 (246)
+|+.++++|.+||+.
T Consensus 259 ~~~~l~~li~~~l~~ 273 (326)
T 2x7f_A 259 WSKKFQSFIESCLVK 273 (326)
T ss_dssp SCHHHHHHHHHHCCS
T ss_pred cCHHHHHHHHHHhcc
Confidence 999999999999963
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=269.28 Aligned_cols=192 Identities=30% Similarity=0.465 Sum_probs=166.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-----CCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-----HPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |+||++++..+++.||+|+++.. ....+....|+.++++++ ||||+++++++...+..++|
T Consensus 42 ~lG~G~~---g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv 114 (360)
T 3llt_A 42 KMGDGTF---GRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI 114 (360)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred EEcccCC---eEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence 3788888 99999999999999999999753 234466778999999996 99999999999999999999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC------------------
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE------------------ 138 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~------------------ 138 (246)
||++ +++|.+++..... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 115 ~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 115 FEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp ECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred EcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 9999 9999999976432 23588999999999999999999999999999999999975
Q ss_pred -------CCCeEEeecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 139 -------EGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 139 -------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
++.++|+|||++..... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||....
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLG-----WDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCC-----CCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCC-----CCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 78899999999976433 233456788999999998765 8899999999999999999999997543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=261.26 Aligned_cols=226 Identities=23% Similarity=0.355 Sum_probs=186.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++. +++.||+|.+...... .+.+.+|++.+++++||||+++++++.++...+++||+++
T Consensus 15 ~lg~G~~---g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 15 EIGSGQF---GLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp EEEEETT---EEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred EecCCCc---eeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 3678888 999999997 6788999999875432 2568889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc--cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ--LA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 159 (246)
+++|.+++.... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+....... ..
T Consensus 87 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999987642 235899999999999999999999999999999999999999999999999987653321 12
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||..... ......+... ....|..+++.+.
T Consensus 163 ~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~~~l~ 235 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSR-----YSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGFRLYKPRLASTHVY 235 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred ccccccccccChhhhcCCC-----ccchhchhhhHHHHHHHhccCCCCCCCCCH--HHHHHHHhcCCcCCCCccCcHHHH
Confidence 2334566899999987654 7889999999999999999 8999975432 2233333333 4455678999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|++||+.
T Consensus 236 ~li~~~l~~ 244 (267)
T 3t9t_A 236 QIMNHCWRE 244 (267)
T ss_dssp HHHHHHTCS
T ss_pred HHHHHHccC
Confidence 999999963
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=280.29 Aligned_cols=226 Identities=21% Similarity=0.387 Sum_probs=184.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||++.++ ++..||||.++.... ..+.+.+|++++++++||||+++++++. ....++||||+.
T Consensus 195 ~lG~G~f---g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 195 KLGAGQF---GEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp EEECCSS---EEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred EcccCCc---eEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 4788888 999999986 478899999986542 2467899999999999999999999987 557899999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--A 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 159 (246)
+++|.+++..... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 266 ~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 266 KGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp TCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred CCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence 9999999975421 2348889999999999999999999999999999999999999999999999976543211 1
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||.+.... ++.++||||||+++|+|++ |..||.+..... ....+... ..+.|..+++.+.
T Consensus 343 ~~~~~~~~y~aPE~~~~~~-----~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~~~~~~~~~~~l~ 415 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGS-----FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERGYRMPRPENCPEELY 415 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHHTCCCCCCTTSCHHHH
T ss_pred CCCcccccccCHHHhccCC-----CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCCCCCCCCCHHHH
Confidence 2233466799999987654 8899999999999999999 999997544322 22233322 5566788999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||+.
T Consensus 416 ~li~~cl~~ 424 (454)
T 1qcf_A 416 NIMMRCWKN 424 (454)
T ss_dssp HHHHHHTCS
T ss_pred HHHHHHccC
Confidence 999999963
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=272.35 Aligned_cols=228 Identities=19% Similarity=0.296 Sum_probs=182.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcE----EEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQM----YAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||+|++ |+||++++..+++. ||+|.+..... ....+.+.+|+..+++++||||+++++++.+ ...++||
T Consensus 20 ~lG~G~~---g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 93 (325)
T 3kex_A 20 VLGSGVF---GTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVT 93 (325)
T ss_dssp EEECCSS---CEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEEEE
T ss_pred eeeecCC---ceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEEEE
Confidence 4788888 99999999988876 67777654321 1223456789999999999999999999864 5688999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||+.+++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 94 QYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp ECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999999987642 235889999999999999999999999999999999999999999999999998764332
Q ss_pred c---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc-CCCCCCCCC
Q psy7592 158 L---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY-SPVHYPTAW 232 (246)
Q Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (246)
. .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+....... ..+.. .....|..+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 242 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGK-----YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP--DLLEKGERLAQPQIC 242 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH--HHHHTTCBCCCCTTB
T ss_pred ccccccCCCCcccccChHHhccCC-----CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH--HHHHcCCCCCCCCcC
Confidence 2 23345667899999997665 8899999999999999999 99999765443322 22222 255667789
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
++++.++|.+||+.
T Consensus 243 ~~~~~~li~~~l~~ 256 (325)
T 3kex_A 243 TIDVYMVMVKCWMI 256 (325)
T ss_dssp CTTTTHHHHHHTCS
T ss_pred cHHHHHHHHHHcCC
Confidence 99999999999964
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=269.04 Aligned_cols=237 Identities=24% Similarity=0.400 Sum_probs=164.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHH-HHhhCCCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREME-ILTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||++.++.+|+.||+|.++.... .....++..|+. .++.++||||+++++++.+++..++||||+
T Consensus 29 ~lg~G~~---g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~ 103 (327)
T 3aln_A 29 EIGRGAY---GSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM 103 (327)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeccCCC---EEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence 3788888 9999999999999999999976542 233344555555 777789999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK-HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~-~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (246)
.+ +|.+++..........+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||++.........
T Consensus 104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 182 (327)
T 3aln_A 104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182 (327)
T ss_dssp SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccccc
Confidence 65 787777643222234568999999999999999999999 9999999999999999999999999998776554444
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCC----CCCCH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYP----TAWSE 234 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~----~~~s~ 234 (246)
....+++.|+|||.+.... ....++.++|+||||+++|+|++|..||...... ......+... ...++ ..+++
T Consensus 183 ~~~~gt~~y~aPE~~~~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T 3aln_A 183 TRDAGCRPYMAPERIDPSA-SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-FDQLTQVVKGDPPQLSNSEEREFSP 260 (327)
T ss_dssp ------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CCCCCSCCCCCCCCSSCCCCH
T ss_pred ccCCCCccccCceeecccc-CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-HHHHHHHhcCCCCCCCCcccccCCH
Confidence 4456888999999984321 1113788999999999999999999999754322 1222222222 22222 36899
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.+.++|.+||+.
T Consensus 261 ~l~~li~~~l~~ 272 (327)
T 3aln_A 261 SFINFVNLCLTK 272 (327)
T ss_dssp HHHHHHHHHTCS
T ss_pred HHHHHHHHHhhC
Confidence 999999999963
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=265.90 Aligned_cols=234 Identities=18% Similarity=0.292 Sum_probs=179.3
Q ss_pred CcCCCCccCeeeEEEEEecC---CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC-----eE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD---TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE-----DL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 73 (246)
.||+|++ |+||++++.. ++..||+|.++.... +....+.+.+|++.+++++||||+++++++.+.. ..
T Consensus 41 ~lg~G~~---g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 116 (313)
T 3brb_A 41 ILGEGEF---GSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKP 116 (313)
T ss_dssp EEEC-CC---CCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CE
T ss_pred ceeecCC---eEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCccc
Confidence 3788888 8999998775 566899999976542 3445678899999999999999999999998654 35
Q ss_pred EEEEeecCCCChHHHHhhccc-cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 74 FMVSDLLLGGDLRYHITQDIK-FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
++||||+.+++|.+++..... .....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++..
T Consensus 117 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~ 196 (313)
T 3brb_A 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK 196 (313)
T ss_dssp EEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC--
T ss_pred EEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCccee
Confidence 999999999999999854321 1234568999999999999999999999999999999999999999999999999877
Q ss_pred eccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCC
Q psy7592 153 LEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVH 227 (246)
Q Consensus 153 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~ 227 (246)
...... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||........ ...+... ...
T Consensus 197 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~~~~~~~~ 269 (313)
T 3brb_A 197 IYSGDYYRQGRIAKMPVKWIAIESLADRV-----YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--YDYLLHGHRLK 269 (313)
T ss_dssp --------------CCGGGSCHHHHHSSC-----CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHHHTTCCCC
T ss_pred cccccccCcccccCCCccccCchhhcCCC-----ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHHHcCCCCC
Confidence 643321 22234567899999987654 7889999999999999999 8899976544332 2223322 556
Q ss_pred CCCCCCHhHHHHHHHhhhC
Q psy7592 228 YPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 228 ~~~~~s~~l~~li~~~l~~ 246 (246)
.|..+++.+.++|.+||+.
T Consensus 270 ~~~~~~~~l~~li~~~l~~ 288 (313)
T 3brb_A 270 QPEDCLDELYEIMYSCWRT 288 (313)
T ss_dssp CBTTCCHHHHHHHHHTTCS
T ss_pred CCccccHHHHHHHHHHcCC
Confidence 6788999999999999963
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=265.85 Aligned_cols=230 Identities=22% Similarity=0.313 Sum_probs=177.0
Q ss_pred CcCCCCccCeeeEEEEEecC-CC--cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD-TK--QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~-~~--~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |+||++++.. ++ ..||+|.++.....+.+..+.+.+|++.+++++||||+++++++.++. .++|+|
T Consensus 25 ~lg~G~~---g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e 100 (291)
T 1u46_A 25 KLGDGSF---GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTE 100 (291)
T ss_dssp ECC-------CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEE
T ss_pred eecCCCc---eeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEe
Confidence 3788888 8999998653 33 368999998765445566788999999999999999999999998765 789999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
++.+++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 101 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 176 (291)
T 1u46_A 101 LAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176 (291)
T ss_dssp CCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred cccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccccc
Confidence 999999999987642 2358999999999999999999999999999999999999999999999999887654322
Q ss_pred c----cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC--CCCCCCC
Q psy7592 159 A----TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS--PVHYPTA 231 (246)
Q Consensus 159 ~----~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 231 (246)
. ....++..|+|||.+.+.. ++.++|+||||+++++|++ |..||...... .....+... ..+.+..
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~ 249 (291)
T 1u46_A 177 HYVMQEHRKVPFAWCAPESLKTRT-----FSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEGERLPRPED 249 (291)
T ss_dssp EEEC-----CCGGGCCHHHHHHCE-----EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSCCCCCCCTT
T ss_pred chhhhccCCCCceeeCchhhcCCC-----CCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHHHHccCCCCCCCcC
Confidence 1 2234566799999987664 6789999999999999999 99999754432 233333333 4555678
Q ss_pred CCHhHHHHHHHhhhC
Q psy7592 232 WSESTKHLLSQVHRY 246 (246)
Q Consensus 232 ~s~~l~~li~~~l~~ 246 (246)
+++.+.++|.+||+.
T Consensus 250 ~~~~l~~li~~~l~~ 264 (291)
T 1u46_A 250 CPQDIYNVMVQCWAH 264 (291)
T ss_dssp CCHHHHHHHHHHTCS
T ss_pred cCHHHHHHHHHHccC
Confidence 999999999999963
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=272.03 Aligned_cols=231 Identities=28% Similarity=0.442 Sum_probs=180.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccch--HHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIE--RDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|++ |+||+++++.+|+.||+|.+....... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 17 ~lg~G~~---g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 93 (346)
T 1ua2_A 17 FLGEGQF---ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 93 (346)
T ss_dssp EEEEETT---EEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred EEeecCC---EEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEc
Confidence 4788888 999999999999999999997644221 12235678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-c
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-L 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 158 (246)
+.+ +|.+.+.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 94 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (346)
T 1ua2_A 94 MET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 168 (346)
T ss_dssp CSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred CCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCccc
Confidence 965 8888876532 235888999999999999999999999999999999999999999999999987654332 2
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-----CCCC-----
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-----PVHY----- 228 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~----- 228 (246)
.....+++.|+|||.+.+.. .++.++|+||||+++|+|++|.+||.+... ......+... ...+
T Consensus 169 ~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 169 YTHQVVTRWYRAPELLFGAR----MYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp CCCSCCCCTTCCHHHHTTCS----CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred CCcccccccccCchHhhCCC----CCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHcCCCChhhhhhhcc
Confidence 33456788999999986543 368899999999999999999999975432 2222222211 0000
Q ss_pred ------------------CCCCCHhHHHHHHHhhhC
Q psy7592 229 ------------------PTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 229 ------------------~~~~s~~l~~li~~~l~~ 246 (246)
...++++++++|++||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 278 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF 278 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhcc
Confidence 145679999999999963
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=273.42 Aligned_cols=234 Identities=22% Similarity=0.391 Sum_probs=189.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHH--------------HHHHHHHHHHHHhhCCCCcceeeeeee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERD--------------ALKNVLREMEILTTLEHPFLVNLWFCF 67 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~iv~~~~~~ 67 (246)
.||+|++ |+||++++ +++.||+|.+......... ..+.+.+|++.+++++||||+++++++
T Consensus 38 ~lg~G~~---g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 112 (348)
T 2pml_X 38 TLNQGKF---NKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112 (348)
T ss_dssp EEECCSS---CCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEE
T ss_pred EEcCCCC---eEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 3788888 89999999 8999999999765432111 126788999999999999999999999
Q ss_pred eeCCeEEEEEeecCCCChHHHHhhcccc---ccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeE
Q psy7592 68 QDEEDLFMVSDLLLGGDLRYHITQDIKF---YSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGHAH 143 (246)
Q Consensus 68 ~~~~~~~~v~e~~~~~sL~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~~~ 143 (246)
.+.+..++||||+++++|.+++...... ....+++..++.++.|++.|+.+||+ .|++|+||+|+||+++.++.++
T Consensus 113 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~k 192 (348)
T 2pml_X 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVK 192 (348)
T ss_dssp ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEE
T ss_pred eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEE
Confidence 9999999999999999999883211101 13456999999999999999999999 9999999999999999999999
Q ss_pred EeecceeeeeccCccccccccCCCccCCceecccccccCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh
Q psy7592 144 ITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSY-SVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII 222 (246)
Q Consensus 144 l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~-~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 222 (246)
++|||.+...... ......++..|+|||.+.+.. .++. ++|+||||+++++|++|..||..... .......+.
T Consensus 193 l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~i~ 266 (348)
T 2pml_X 193 LSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNES----SYNGAKVDIWSLGICLYVMFYNVVPFSLKIS-LVELFNNIR 266 (348)
T ss_dssp ECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCC----CEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC-SHHHHHHHT
T ss_pred Eeccccccccccc-cccCCCCCcCccCchhhcCCC----CCCcchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHh
Confidence 9999999876443 333456788999999987652 1444 89999999999999999999975443 234444555
Q ss_pred cCCCCCC-------------------CCCCHhHHHHHHHhhhC
Q psy7592 223 YSPVHYP-------------------TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 223 ~~~~~~~-------------------~~~s~~l~~li~~~l~~ 246 (246)
.....+| ..+++.+.++|++||+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 309 (348)
T 2pml_X 267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK 309 (348)
T ss_dssp SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCS
T ss_pred ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccC
Confidence 5555566 67899999999999963
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=275.03 Aligned_cols=232 Identities=15% Similarity=0.137 Sum_probs=178.1
Q ss_pred CcCCCCccCeeeEEEEEecCC-----CcEEEEEEeeccccchHHHH--------HHHHHHHHHHhhCCCCcceeeeeeee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT-----KQMYAMKYMHKSQCIERDAL--------KNVLREMEILTTLEHPFLVNLWFCFQ 68 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~ 68 (246)
.||+|+| |+||++.+..+ ++.||+|.+........... .....|+..+..++||||+++++++.
T Consensus 42 ~lG~G~~---g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 118 (364)
T 3op5_A 42 PIGQGGF---GCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGL 118 (364)
T ss_dssp ECCCC-C---CEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEE
T ss_pred EEecCCC---eEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeee
Confidence 4788888 99999999765 58899999876542111111 22345666778889999999999987
Q ss_pred eC----CeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc--CCCCe
Q psy7592 69 DE----EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD--EEGHA 142 (246)
Q Consensus 69 ~~----~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~--~~~~~ 142 (246)
.. ...++||||+ |++|.+++.... .++++..++.++.|++.||.|||+.|++|+||+|+||+++ .++.+
T Consensus 119 ~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 119 HDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred eccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 64 5589999999 999999997642 2359999999999999999999999999999999999999 88899
Q ss_pred EEeecceeeeeccCccc--------cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc
Q psy7592 143 HITDFNIATVLEENQLA--------TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS 214 (246)
Q Consensus 143 ~l~d~~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~ 214 (246)
+|+|||++......... ....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.....
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-----PSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-----CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-----CCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 99999999876543221 2234889999999987765 7899999999999999999999997543332
Q ss_pred HHHH--Hhhh-cCC-----CC-CCCCCCHhHHHHHHHhhhC
Q psy7592 215 VKDV--KAII-YSP-----VH-YPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 215 ~~~~--~~~~-~~~-----~~-~~~~~s~~l~~li~~~l~~ 246 (246)
.... .... ... .. .+..+++++.++|+.||+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 309 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLL 309 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTC
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcC
Confidence 2111 1000 000 01 1257899999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=262.66 Aligned_cols=221 Identities=24% Similarity=0.340 Sum_probs=184.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee------------
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD------------ 69 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------------ 69 (246)
.||+|++ |.||++++..+++.||+|.++... +.+.+|++.+++++||||+++++++..
T Consensus 18 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 18 LIGSGGF---GQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp EEECSSS---CCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred eeccCCc---eEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 4788888 899999999999999999997653 346679999999999999999998864
Q ss_pred ----CCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEe
Q psy7592 70 ----EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHIT 145 (246)
Q Consensus 70 ----~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~ 145 (246)
....++||||+++++|.+++.... ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 445899999999999999997542 2345889999999999999999999999999999999999999999999
Q ss_pred ecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCC
Q psy7592 146 DFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSP 225 (246)
Q Consensus 146 d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 225 (246)
|||.+.............+++.|+|||.+.+.. ++.++|+||||+++|+|++|..|+.. ......... .
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~~~~~~~~----~~~~~~~~~--~ 233 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD-----YGKEVDLYALGLILAELLHVCDTAFE----TSKFFTDLR--D 233 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSC-----CCTHHHHHHHHHHHHHHHSCCSSHHH----HHHHHHHHH--T
T ss_pred cchhheeccccccccccCCcccccChhhhccCC-----CcchhhhHHHHHHHHHHHhcCCcchh----HHHHHHHhh--c
Confidence 999998776555455567889999999987654 78899999999999999999998742 111222222 2
Q ss_pred CCCCCCCCHhHHHHHHHhhhC
Q psy7592 226 VHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 226 ~~~~~~~s~~l~~li~~~l~~ 246 (246)
..++..+++.++++|++||+.
T Consensus 234 ~~~~~~~~~~~~~li~~~l~~ 254 (284)
T 2a19_B 234 GIISDIFDKKEKTLLQKLLSK 254 (284)
T ss_dssp TCCCTTSCHHHHHHHHHHTCS
T ss_pred ccccccCCHHHHHHHHHHccC
Confidence 345678999999999999963
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=270.09 Aligned_cols=230 Identities=20% Similarity=0.258 Sum_probs=178.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC----eEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE----DLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~v~ 77 (246)
.||+|+| |+||++++. ++.||+|++.... ........|+..+++++||||+++++++.+.. ..++||
T Consensus 31 ~lg~G~~---g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 31 VKARGRF---GCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEECSTT---CEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred eecccCc---eEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 4788888 999999885 8999999997643 22345566999999999999999999998754 479999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC----------CcccCCCCCCcEEEcCCCCeEEeec
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK----------HIIHRDIKPDNILLDEEGHAHITDF 147 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~----------~~~h~~i~~~nil~~~~~~~~l~d~ 147 (246)
||+++++|.+++.... +++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+||
T Consensus 102 e~~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 102 AFHEKGSLSDFLKANV------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp ECCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred ecCCCCCHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999996532 48999999999999999999999 9999999999999999999999999
Q ss_pred ceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----------
Q psy7592 148 NIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT----------- 213 (246)
Q Consensus 148 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~----------- 213 (246)
|++........ .....+++.|+|||.+.+.......++.++||||||+++|+|++|..||.+....
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 99987654332 2235678999999998764321122567899999999999999999999754321
Q ss_pred --cHHHHHhhhcC---CCCCCCC-----CCHhHHHHHHHhhhC
Q psy7592 214 --SVKDVKAIIYS---PVHYPTA-----WSESTKHLLSQVHRY 246 (246)
Q Consensus 214 --~~~~~~~~~~~---~~~~~~~-----~s~~l~~li~~~l~~ 246 (246)
........... .+.++.. .++.+.++|.+||+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCS
T ss_pred CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccC
Confidence 12222222222 2222222 234599999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=270.01 Aligned_cols=229 Identities=26% Similarity=0.424 Sum_probs=183.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC-----CeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE-----EDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v 76 (246)
.||+|++ |+||++++..+++.||+|++.... .....+.+.+|++++++++||||+++++++... ...++|
T Consensus 34 ~lG~G~~---g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 34 YIGEGAY---GMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EeecCCC---eEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 4788888 999999999999999999997543 344557888999999999999999999999754 468999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
||++. ++|.+.+... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 109 ~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 109 QDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 99995 5898888653 2489999999999999999999999999999999999999999999999999876543
Q ss_pred cc----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHhhhcC-------
Q psy7592 157 QL----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK-DVKAIIYS------- 224 (246)
Q Consensus 157 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~------- 224 (246)
.. .....+++.|+|||.+.+.. .++.++|+||||+++|+|++|..||.+....... .+......
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSK----GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBC----SCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred CCccccccccccccCCCCCHHhcCCC----CCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 22 23346888999999875443 3788999999999999999999999765433321 11111110
Q ss_pred ----------------CCC-----CCCCCCHhHHHHHHHhhhC
Q psy7592 225 ----------------PVH-----YPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 225 ----------------~~~-----~~~~~s~~l~~li~~~l~~ 246 (246)
... .++.+++++.+||++||++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 300 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF 300 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCC
Confidence 011 1246799999999999974
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=261.56 Aligned_cols=229 Identities=23% Similarity=0.346 Sum_probs=182.8
Q ss_pred CcCCCCccCeeeEEEEEecC---CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD---TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|++ |+||++++.. ++..||+|.+.... ..+..+.+.+|++.+++++||||+++++++.++ ..++|||
T Consensus 19 ~lg~G~~---g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e 92 (281)
T 3cc6_A 19 ILGEGFF---GEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIME 92 (281)
T ss_dssp EEEECSS---SEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEE
T ss_pred EEEecCC---eeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEe
Confidence 4788888 8999998653 34579999997653 344567899999999999999999999998755 5689999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
++.+++|.+++.... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 93 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 93 LYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp CCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred cCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 999999999997642 2358899999999999999999999999999999999999999999999999876543321
Q ss_pred --ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHh
Q psy7592 159 --ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSES 235 (246)
Q Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 235 (246)
.....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||............ ......+.|..+++.
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRR-----FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-EKGDRLPKPDLCPPV 242 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH-HHTCCCCCCTTCCHH
T ss_pred cccccCCCCcceeCchhhccCC-----CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH-hcCCCCCCCCCCCHH
Confidence 22234567899999987654 7889999999999999998 99999754443332111 122355667789999
Q ss_pred HHHHHHHhhhC
Q psy7592 236 TKHLLSQVHRY 246 (246)
Q Consensus 236 l~~li~~~l~~ 246 (246)
+.++|.+||+.
T Consensus 243 l~~li~~~l~~ 253 (281)
T 3cc6_A 243 LYTLMTRCWDY 253 (281)
T ss_dssp HHHHHHHHTCS
T ss_pred HHHHHHHHccC
Confidence 99999999963
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=268.42 Aligned_cols=229 Identities=19% Similarity=0.314 Sum_probs=179.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEE----EEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMY----AMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~----avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
.||+|++ |+||++++..+++.| |+|.+.... .....+.+.+|+.++++++||||+++++++..+. .++++
T Consensus 22 ~lG~G~~---g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 22 VLGSGAF---GTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEECSS---EEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred EeeeCCC---eEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence 4788888 999999999888765 666664432 2233567889999999999999999999998765 77899
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
+++.+++|.+++.... ..+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 96 QLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp CCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 9999999999987642 235899999999999999999999999999999999999999999999999998764332
Q ss_pred cc---cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcCCCCCCCCCC
Q psy7592 158 LA---TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYSPVHYPTAWS 233 (246)
Q Consensus 158 ~~---~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s 233 (246)
.. ....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+.......... ......+.|..++
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 245 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHRI-----YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICT 245 (327)
T ss_dssp --------CCCGGGSCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCCTTBC
T ss_pred ccccccCCCccccccCHHHHcCCC-----CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCccCC
Confidence 22 2233566799999998665 8899999999999999999 99999765544332211 1222556677899
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
+++.++|.+||+.
T Consensus 246 ~~l~~li~~~l~~ 258 (327)
T 3lzb_A 246 IDVYMIMRKCWMI 258 (327)
T ss_dssp HHHHHHHHHHTCS
T ss_pred HHHHHHHHHHcCC
Confidence 9999999999963
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=262.59 Aligned_cols=229 Identities=20% Similarity=0.321 Sum_probs=181.7
Q ss_pred CcCCCCccCeeeEEEEEecCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeee-eCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT---KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQ-DEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~~v~ 77 (246)
.||+|++ |+||++++..+ +..||+|.++... +....+.+.+|+..+++++||||+++++++. .+...+++|
T Consensus 32 ~lg~G~~---g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 32 VIGRGHF---GCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEETT---EEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred eeeecCC---ceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 3788888 99999997643 3468999987643 3455678999999999999999999999854 566789999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||+.+++|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 107 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 107 PYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp ECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred eCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 9999999999996532 234888999999999999999999999999999999999999999999999997664332
Q ss_pred c-----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCC
Q psy7592 158 L-----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPT 230 (246)
Q Consensus 158 ~-----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 230 (246)
. .....+++.|+|||.+.+.. ++.++|+||||+++++|++ +.+||........ ...+... ....|.
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 255 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLLQGRRLLQPE 255 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--HHHHHTTCCCCCCT
T ss_pred hhccccccCCCCCccccChHHhcCCC-----CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--HHHHhcCCCCCCCc
Confidence 1 12234567899999987664 7889999999999999999 5667765443332 2233333 445577
Q ss_pred CCCHhHHHHHHHhhhC
Q psy7592 231 AWSESTKHLLSQVHRY 246 (246)
Q Consensus 231 ~~s~~l~~li~~~l~~ 246 (246)
.+++.+.++|.+||+.
T Consensus 256 ~~~~~l~~li~~~l~~ 271 (298)
T 3f66_A 256 YCPDPLYEVMLKCWHP 271 (298)
T ss_dssp TCCHHHHHHHHHHTCS
T ss_pred cCCHHHHHHHHHHcCC
Confidence 8999999999999963
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=263.83 Aligned_cols=224 Identities=24% Similarity=0.399 Sum_probs=177.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++. ++.||+|.+... ...+.+.+|++.+++++||||+++++++.+ ..++||||++
T Consensus 15 ~lg~G~~---g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 15 VVGRGAF---GVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp EEECCSS---SEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred EeecCCC---ceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 4788888 899999984 789999998653 234678899999999999999999998874 3789999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCCCcEEEcCCCC-eEEeecceeeeeccCc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT---KHIIHRDIKPDNILLDEEGH-AHITDFNIATVLEENQ 157 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~---~~~~h~~i~~~nil~~~~~~-~~l~d~~~~~~~~~~~ 157 (246)
+++|.+++...... ..++...+..++.|++.++.|||+ .|++|+||+|+||+++.++. ++++|||++......
T Consensus 83 ~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPL--PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TCBHHHHHHCSSSE--ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCHHHHHhccCCC--CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 99999999764321 234788899999999999999999 89999999999999998886 799999998765432
Q ss_pred cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc-CCCCCCCCCCHhH
Q psy7592 158 LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY-SPVHYPTAWSEST 236 (246)
Q Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~l 236 (246)
.....++..|+|||.+.+.. ++.++||||||+++|+|++|..||................ ...+.+..+++.+
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSN-----YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233 (307)
T ss_dssp ------CCTTSSCHHHHTCCC-----CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHH
T ss_pred -cccCCCCCceEChhhhCCCC-----CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHH
Confidence 22345789999999987654 7889999999999999999999997655443333323322 3555677899999
Q ss_pred HHHHHHhhhC
Q psy7592 237 KHLLSQVHRY 246 (246)
Q Consensus 237 ~~li~~~l~~ 246 (246)
.++|.+||+.
T Consensus 234 ~~li~~~l~~ 243 (307)
T 2eva_A 234 ESLMTRCWSK 243 (307)
T ss_dssp HHHHHHHTCS
T ss_pred HHHHHHHhcC
Confidence 9999999963
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=289.87 Aligned_cols=228 Identities=20% Similarity=0.341 Sum_probs=184.0
Q ss_pred CcCCCCccCeeeEEEEEe--cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQK--KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|+| |+||++.+ +.+++.||||+++.... +....+.+.+|++++++++||||+++++++.++ ..++||||
T Consensus 376 ~LG~G~f---G~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~ 450 (635)
T 4fl3_A 376 ELGSGNF---GTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEM 450 (635)
T ss_dssp EEEECSS---EEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEEC
T ss_pred EeccCCC---EEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEc
Confidence 3788888 99999954 56788999999976532 333457899999999999999999999999754 58899999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL- 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (246)
+.+++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 451 ~~~g~L~~~l~~~~~-----l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 451 AELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp CTTEEHHHHHHHCTT-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred cCCCCHHHHHhhCCC-----CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999999976544 48999999999999999999999999999999999999999999999999876543321
Q ss_pred ---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCC
Q psy7592 159 ---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWS 233 (246)
Q Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s 233 (246)
.....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+..... ....+... ....|..++
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~-----~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~~~~p~~~~ 598 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYK-----FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGERMGCPAGCP 598 (635)
T ss_dssp ---------CGGGSCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCCCCCCTTCC
T ss_pred cccccCCCCceeeeChhhhcCCC-----CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCCCCCCCCC
Confidence 11223457799999997664 8899999999999999998 999997544322 22223222 556788999
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
+++.++|+.||+.
T Consensus 599 ~~l~~li~~cl~~ 611 (635)
T 4fl3_A 599 REMYDLMNLCWTY 611 (635)
T ss_dssp HHHHHHHHHHTCS
T ss_pred HHHHHHHHHHcCC
Confidence 9999999999974
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=265.57 Aligned_cols=187 Identities=26% Similarity=0.432 Sum_probs=164.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeee--CCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQD--EEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~~v~e 78 (246)
.||+|++ |+||++++..+++.||+|.++... .+.+.+|++++++++ ||||+++++++.+ ....++|||
T Consensus 43 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 43 KLGRGKY---SEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred EecccCC---eEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 4788888 999999999999999999997543 356888999999997 9999999999987 677899999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-CeEEeecceeeeeccCc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG-HAHITDFNIATVLEENQ 157 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~-~~~l~d~~~~~~~~~~~ 157 (246)
|+.+++|.+.+.. +++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 114 ~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 114 HVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp CCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred ccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 9999999988743 38889999999999999999999999999999999999777 89999999998776655
Q ss_pred cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy7592 158 LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDI 209 (246)
Q Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~ 209 (246)
......++..|+|||.+.+.. .++.++|+||||+++|+|++|..||..
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCC----CCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccChhhhcCCC----cCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 555667888999999986532 378899999999999999999999954
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=266.16 Aligned_cols=233 Identities=21% Similarity=0.285 Sum_probs=182.6
Q ss_pred CcCCCCccCeeeEEEEE-----ecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQ-----KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |+||+++ +..+++.||+|.+.... ......++.+|+..+++++||||+++++++.+....++|
T Consensus 37 ~lg~G~~---g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (327)
T 2yfx_A 37 GLGHGAF---GEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 111 (327)
T ss_dssp ECC--CS---SCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEcCCCC---eeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEE
Confidence 4788888 8999999 56688899999997543 234456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhcccc--ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC---CCeEEeecceee
Q psy7592 77 SDLLLGGDLRYHITQDIKF--YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE---GHAHITDFNIAT 151 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~---~~~~l~d~~~~~ 151 (246)
|||+++++|.+++...... ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ ..++++|||++.
T Consensus 112 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~ 191 (327)
T 2yfx_A 112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191 (327)
T ss_dssp EECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred EecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccccc
Confidence 9999999999999865322 11336888999999999999999999999999999999999844 469999999986
Q ss_pred eeccCc---cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CC
Q psy7592 152 VLEENQ---LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PV 226 (246)
Q Consensus 152 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~ 226 (246)
...... ......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||..... ......+... ..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGI-----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGGRM 264 (327)
T ss_dssp HHHC------CCGGGSCGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTCCC
T ss_pred ccccccccccCCCcCCCcceeCHhHhcCCC-----CCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHHHHHhcCCCC
Confidence 543222 122345677899999987654 7889999999999999998 9999975432 2222333332 45
Q ss_pred CCCCCCCHhHHHHHHHhhhC
Q psy7592 227 HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 227 ~~~~~~s~~l~~li~~~l~~ 246 (246)
..|..+++.+.++|.+||+.
T Consensus 265 ~~~~~~~~~l~~li~~~l~~ 284 (327)
T 2yfx_A 265 DPPKNCPGPVYRIMTQCWQH 284 (327)
T ss_dssp CCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCCCCHHHHHHHHHHhcC
Confidence 56778999999999999963
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=266.19 Aligned_cols=234 Identities=26% Similarity=0.442 Sum_probs=168.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++..+++.||+|.+..... ....+.+.+|+..+++++||||+++++++..++..++||||++
T Consensus 22 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 96 (303)
T 2vwi_A 22 VIGSGAT---AVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96 (303)
T ss_dssp ECC---C---CCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred eeccccc---eEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence 4788888 8999999999999999999876542 2345678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccc---cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-
Q psy7592 82 GGDLRYHITQDIK---FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ- 157 (246)
Q Consensus 82 ~~sL~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (246)
+++|.+++..... .....+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 176 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC----
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCC
Confidence 9999999864211 112346899999999999999999999999999999999999999999999999886543221
Q ss_pred -----cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-C------
Q psy7592 158 -----LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-P------ 225 (246)
Q Consensus 158 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~------ 225 (246)
......+++.|+|||.+.+.. .++.++|+||||+++|+|++|..||......... ...... .
T Consensus 177 ~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~ 250 (303)
T 2vwi_A 177 ITRNKVRKTFVGTPCWMAPEVMEQVR----GYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--MLTLQNDPPSLETG 250 (303)
T ss_dssp -----------CCCTTCCHHHHHHHH----CCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HHHHTSSCCCTTC-
T ss_pred ccchhhhcccCCCccccCHHHhcccc----CCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--HHHhccCCCccccc
Confidence 122345788999999986532 2688999999999999999999999765543322 122211 1
Q ss_pred ---CCCCCCCCHhHHHHHHHhhhC
Q psy7592 226 ---VHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 226 ---~~~~~~~s~~l~~li~~~l~~ 246 (246)
...+..+++.++++|.+||+.
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~l~~ 274 (303)
T 2vwi_A 251 VQDKEMLKKYGKSFRKMISLCLQK 274 (303)
T ss_dssp ----CCCCCCCHHHHHHHHHHCCS
T ss_pred cccchhhhhhhHHHHHHHHHHccC
Confidence 122356899999999999963
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=267.75 Aligned_cols=229 Identities=24% Similarity=0.383 Sum_probs=184.0
Q ss_pred CcCCCCccCeeeEEEEE----ecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee--CCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQ----KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD--EEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~ 75 (246)
.||+|++ |+||++. +..+++.||+|+++... .....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 38 ~lG~G~~---g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 38 DLGEGHF---GKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEECSS---EEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred eecCCCC---eEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 3788888 8997764 45689999999998653 34556789999999999999999999999987 467899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||||+++++|.+++.... +++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 113 v~e~~~~~~L~~~l~~~~------~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGSC------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhCC------CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999986542 48999999999999999999999999999999999999999999999999987654
Q ss_pred Ccc----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc------------cHHHHH
Q psy7592 156 NQL----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT------------SVKDVK 219 (246)
Q Consensus 156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~------------~~~~~~ 219 (246)
... .....++..|+|||.+.+.. ++.++|+||||+++++|++|..||...... ......
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYK-----FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCE-----EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCC-----CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 322 22344667799999997765 678999999999999999999998642211 011122
Q ss_pred hhhcC--CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 220 AIIYS--PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 220 ~~~~~--~~~~~~~~s~~l~~li~~~l~~ 246 (246)
..... ..+.|..+++.+.++|++||+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 290 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWET 290 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCC
Confidence 22222 5556788999999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=261.98 Aligned_cols=235 Identities=24% Similarity=0.383 Sum_probs=169.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++.+|+.||+|.+..... .....+.+.++...++.++||||+++++++.++...++||||+
T Consensus 32 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 106 (318)
T 2dyl_A 32 EMGSGTC---GQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106 (318)
T ss_dssp EC---------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred eeeecCC---eeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence 3678888 9999999999999999999987542 2233345556666788889999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK-HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~-~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
+..+....... ..++++..++.++.|++.+|.|||+. |++|+||+|+||+++.++.++|+|||.+..........
T Consensus 107 ~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 182 (318)
T 2dyl_A 107 GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD 182 (318)
T ss_dssp SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcccc
Confidence 55665555432 22458999999999999999999995 99999999999999999999999999987765544444
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCC--CCCCHhHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYP--TAWSESTK 237 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~--~~~s~~l~ 237 (246)
...+++.|+|||.+.........++.++|+||||+++|+|++|..||...... ......+... ....| ..+++.+.
T Consensus 183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~ 261 (318)
T 2dyl_A 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-FEVLTKVLQEEPPLLPGHMGFSGDFQ 261 (318)
T ss_dssp ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-HHHHHHHHHSCCCCCCSSSCCCHHHH
T ss_pred ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-HHHHHHHhccCCCCCCccCCCCHHHH
Confidence 55688999999998643322334788999999999999999999999754332 2333344433 33333 46899999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||+.
T Consensus 262 ~li~~~l~~ 270 (318)
T 2dyl_A 262 SFVKDCLTK 270 (318)
T ss_dssp HHHHHHTCS
T ss_pred HHHHHHccC
Confidence 999999963
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=275.19 Aligned_cols=226 Identities=26% Similarity=0.371 Sum_probs=175.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC------eEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE------DLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~~ 75 (246)
.||+|+| |+||+|++..+++ ||+|++..... ...+|+++++.++||||+++++++.... ..++
T Consensus 47 ~lG~G~~---g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 47 VIGNGSF---GVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEETT---EEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred EEeeCCC---eEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 4788888 9999999987666 88888765431 2236899999999999999999996433 3889
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc-CCCCeEEeecceeeeec
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD-EEGHAHITDFNIATVLE 154 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~-~~~~~~l~d~~~~~~~~ 154 (246)
||||+.++.+. .+..... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||++....
T Consensus 116 v~e~~~~~l~~-~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 116 VLEYVPETVYR-ASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEECCSEEHHH-HHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeeccCccHHH-HHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 99999665433 3322111 133468999999999999999999999999999999999998 78899999999998876
Q ss_pred cCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc---C-------
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY---S------- 224 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~------- 224 (246)
.........+++.|+|||.+.+.. .++.++||||||+++|+|++|+.||.+.+... ....+.. .
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGAT----NYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCS----SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHH
T ss_pred CCCCCcccccCcCccCHHHHcCCC----CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHH
Confidence 655555677889999999986543 37889999999999999999999997654322 2222211 0
Q ss_pred -------CC------------CCCCCCCHhHHHHHHHhhhC
Q psy7592 225 -------PV------------HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 225 -------~~------------~~~~~~s~~l~~li~~~l~~ 246 (246)
.. .++..+++++.+||.+||++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEY 308 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCC
Confidence 00 12345899999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=271.31 Aligned_cols=193 Identities=27% Similarity=0.468 Sum_probs=149.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC------CeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE------EDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~~ 75 (246)
.||+|++ |+||++.+..+|+.||+|++.... .+....+.+.+|+++++.++||||+++++++... ...++
T Consensus 36 ~lG~G~~---g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l 111 (367)
T 2fst_X 36 PVGSGAY---GSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111 (367)
T ss_dssp ECC-------CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EEeecCC---eEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence 4788888 899999999999999999997643 2344567788999999999999999999998654 56899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
++|++ +++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 112 v~e~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 112 VTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp EEECC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred Eeccc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 99999 78998887642 358999999999999999999999999999999999999999999999999876543
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
. .....+++.|+|||.+.+.. .++.++|+||||+++++|++|+.||.+.+
T Consensus 185 ~--~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 185 E--MTGYVATRWYRAPEIMLNWM----HYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp --------CCCTTCCHHHHTTCC----SCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c--CCCcCcCcCccChHHHcCCc----CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 33456789999999987632 37889999999999999999999997644
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=259.06 Aligned_cols=223 Identities=20% Similarity=0.355 Sum_probs=176.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee-CCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD-EEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~v~e~~ 80 (246)
.||+|++ |+||++.+ +|+.||+|.++... ..+.+.+|++.+++++||||+++++++.+ +...++||||+
T Consensus 28 ~lg~G~~---g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 28 TIGKGEF---GDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp EEEECSS---CEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred EEecCCC---ceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 3788888 89999988 48999999997643 34678899999999999999999998754 45789999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
++++|.+++..... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+...... ..
T Consensus 98 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~ 172 (278)
T 1byg_A 98 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QD 172 (278)
T ss_dssp TTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc--cc
Confidence 99999999976432 12488899999999999999999999999999999999999999999999998765432 22
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKH 238 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~ 238 (246)
...++..|+|||.+.+.. ++.++|+||||+++++|++ |..||........ ...+... ....|..+++.+.+
T Consensus 173 ~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~ 245 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKK-----FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVEKGYKMDAPDGCPPAVYE 245 (278)
T ss_dssp ---CCTTTSCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HHHHTTTCCCCCCTTCCHHHHH
T ss_pred CCCccccccCHHHhCCCC-----CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHhcCCCCCCcccCCHHHHH
Confidence 234577899999987654 7889999999999999998 9999975443322 2223222 45667889999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
+|++||+.
T Consensus 246 li~~~l~~ 253 (278)
T 1byg_A 246 VMKNCWHL 253 (278)
T ss_dssp HHHHHTCS
T ss_pred HHHHHhcC
Confidence 99999963
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=286.89 Aligned_cols=228 Identities=22% Similarity=0.372 Sum_probs=183.6
Q ss_pred CcCCCCccCeeeEEEEEec--CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKK--DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|+| |+||++.++ .++..||||.++... .....+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus 343 ~LG~G~f---G~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~ 416 (613)
T 2ozo_A 343 ELGCGNF---GSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEM 416 (613)
T ss_dssp EEEECSS---SEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred EEecCCC---cEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEe
Confidence 3788888 899999875 456789999997653 22345788999999999999999999999976 468999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (246)
+.+++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 417 ~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 492 (613)
T 2ozo_A 417 AGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492 (613)
T ss_dssp CTTCBHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred CCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence 9999999998653 223589999999999999999999999999999999999999999999999998765432211
Q ss_pred ----cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCC
Q psy7592 160 ----TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWS 233 (246)
Q Consensus 160 ----~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s 233 (246)
....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+..... ....+... ..+.|..++
T Consensus 493 ~~~~~~~~~~~~y~APE~~~~~~-----~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~~~~p~~~~ 565 (613)
T 2ozo_A 493 YTARSAGKWPLKWYAPECINFRK-----FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKRMECPPECP 565 (613)
T ss_dssp ---------CCTTSCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHHTTCCCCCCTTCC
T ss_pred eeeccCCCCccceeCHhhhcCCC-----CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCCCCCCCcCC
Confidence 1123457899999987654 8899999999999999998 999997654432 23333333 556788999
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
+++.++|.+||+.
T Consensus 566 ~~l~~li~~cl~~ 578 (613)
T 2ozo_A 566 PELYALMSDCWIY 578 (613)
T ss_dssp HHHHHHHHHTTCS
T ss_pred HHHHHHHHHHcCC
Confidence 9999999999963
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=270.39 Aligned_cols=229 Identities=19% Similarity=0.320 Sum_probs=176.2
Q ss_pred CcCCCCccCeeeEEEEEecCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeee-eCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT---KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQ-DEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~~v~ 77 (246)
.||+|+| |+||++++..+ +..||+|.++... +....+++.+|+.++++++||||+++++++. .+...++||
T Consensus 96 ~LG~G~f---g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 96 VIGRGHF---GCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEECCSS---SEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred EeeeCCC---eEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 3788998 89999997643 3468999887543 3445678999999999999999999999865 456789999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||+.+++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 171 e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp ECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred ECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999997532 234788899999999999999999999999999999999999999999999997654322
Q ss_pred c-----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCC
Q psy7592 158 L-----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPT 230 (246)
Q Consensus 158 ~-----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 230 (246)
. .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |.+||......... ..+... ....|.
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~--~~~~~~~~~~~p~ 319 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--VYLLQGRRLLQPE 319 (373)
T ss_dssp -----------CCGGGSCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH--HHHHTTCCCCCCT
T ss_pred cccccccCCCCCcccccChHHhcCCC-----CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH--HHHHcCCCCCCCC
Confidence 1 12234566799999987664 7899999999999999999 67788765544332 222222 445577
Q ss_pred CCCHhHHHHHHHhhhC
Q psy7592 231 AWSESTKHLLSQVHRY 246 (246)
Q Consensus 231 ~~s~~l~~li~~~l~~ 246 (246)
.+++.+.++|.+||+.
T Consensus 320 ~~~~~l~~li~~cl~~ 335 (373)
T 3c1x_A 320 YCPDPLYEVMLKCWHP 335 (373)
T ss_dssp TCCHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHcCC
Confidence 8999999999999963
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=259.89 Aligned_cols=229 Identities=22% Similarity=0.325 Sum_probs=172.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++.. .||+|.++... .+....+.+.+|++.+++++||||++++++. .....++||||+.
T Consensus 31 ~lG~G~~---g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~ 102 (289)
T 3og7_A 31 RIGSGSF---GTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCE 102 (289)
T ss_dssp EEEECSS---EEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCC
T ss_pred EecCCCC---eEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecC
Confidence 3788888 9999998743 59999997654 2345567899999999999999999999965 4556889999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC---cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN---QL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~---~~ 158 (246)
+++|.+++.... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 103 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 103 GSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp EEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred CCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 999999986532 23588999999999999999999999999999999999999999999999998765432 22
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh-cC-----CCCCCCCC
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII-YS-----PVHYPTAW 232 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~-----~~~~~~~~ 232 (246)
.....+++.|+|||.+.... ...++.++|+||||+++++|++|..||....... ...... .. ....+..+
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 254 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQD--SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRGSLSPDLSKVRSNC 254 (289)
T ss_dssp -----CCCTTCCHHHHC------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHHHTSCCCCTTSSCTTS
T ss_pred ccccCCCccccCchhhcccC--CCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhcccccCcchhhccccC
Confidence 23356789999999986322 1237889999999999999999999997544322 222222 11 12234578
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
|+.+.++|.+||+.
T Consensus 255 ~~~l~~li~~~l~~ 268 (289)
T 3og7_A 255 PKRMKRLMAECLKK 268 (289)
T ss_dssp CHHHHHHHHHHTCS
T ss_pred CHHHHHHHHHHccC
Confidence 99999999999973
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=258.65 Aligned_cols=226 Identities=20% Similarity=0.360 Sum_probs=183.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++.++ +++.||+|.++.... ..+.+.+|++++++++||||+++++++.++ ..++||||+.
T Consensus 20 ~lg~G~~---g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~ 90 (279)
T 1qpc_A 20 RLGAGQF---GEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYME 90 (279)
T ss_dssp EEEEETT---EEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCT
T ss_pred eecCCCC---eEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcCC-CcEEEEecCC
Confidence 3688888 999999976 577899999976542 135688899999999999999999998754 5889999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--A 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 159 (246)
+++|.+++.... ...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+........ .
T Consensus 91 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 91 NGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp TCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 999999986532 12358999999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||.+.+.. ++.++|+||||+++++|++ |..||...... .....+... ....|..+++.+.
T Consensus 168 ~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~ 240 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGT-----FTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVRPDNCPEELY 240 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCE-----ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cCCCCccCccChhhhccCC-----CCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcccCCCCcccccHHHH
Confidence 2234567899999987654 7889999999999999999 89999754332 223333333 4456778999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||+.
T Consensus 241 ~li~~~l~~ 249 (279)
T 1qpc_A 241 QLMRLCWKE 249 (279)
T ss_dssp HHHHHHTCS
T ss_pred HHHHHHhcc
Confidence 999999963
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=277.15 Aligned_cols=226 Identities=22% Similarity=0.356 Sum_probs=180.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+++++. +..||+|.++.... + .+.+.+|++++++++||||+++++++.+ ...++||||+.
T Consensus 191 ~lG~G~f---g~Vy~~~~~~-~~~vavK~~~~~~~-~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 191 KLGQGCF---GEVWMGTWNG-TTRVAIKTLKPGTM-S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp EEEECSS---CEEEEEEETT-TEEEEEEECCTTSS-C---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred eecCCCC---eEEEEEEECC-CceEEEEEeccCCC-C---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 3788888 8999999975 56799999986542 1 3568899999999999999999999876 56899999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--A 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 159 (246)
+++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 262 ~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 262 KGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp TCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 999999997532 12358899999999999999999999999999999999999999999999999976543221 1
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||.+.... ++.++||||||+++|+|++ |..||.+.... .....+... ..+.|..+|+.+.
T Consensus 339 ~~~~~~~~y~aPE~~~~~~-----~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~~~~~~~~~~l~ 411 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGR-----FTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYRMPCPPECPESLH 411 (452)
T ss_dssp ----CCGGGSCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCCCCCTTSCHHHH
T ss_pred cCCcccccccCHhHHhcCC-----CCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHHHH
Confidence 2234567899999987664 8899999999999999999 99999754432 222233332 5566789999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|.+||+.
T Consensus 412 ~li~~cl~~ 420 (452)
T 1fmk_A 412 DLMCQCWRK 420 (452)
T ss_dssp HHHHHHTCS
T ss_pred HHHHHHccC
Confidence 999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=269.05 Aligned_cols=225 Identities=24% Similarity=0.389 Sum_probs=178.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeE------EE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDL------FM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------~~ 75 (246)
.||+|++ |+||+++++.+|+.||+|++.... .+....+.+.+|+.+++.++||||+++++++...... ++
T Consensus 49 ~lG~G~~---g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 124 (371)
T 4exu_A 49 HVGSGAY---GSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 124 (371)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred EEecCCC---eEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEE
Confidence 3788888 999999999999999999997644 3345567888999999999999999999999876654 99
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||||+. ++|.+.+.. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 125 v~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 125 VMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp EEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred EEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 999995 678777633 258999999999999999999999999999999999999999999999999976543
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc------------
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY------------ 223 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~------------ 223 (246)
. .....+++.|+|||.+.+.. .++.++|+||||+++++|++|..||.+.+... ....+..
T Consensus 197 ~--~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 197 E--MTGYVVTRWYRAPEVILSWM----HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCS----CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCHHHHTT
T ss_pred C--cCCcccCccccCHHHhcCCC----CCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCcHHHHHH
Confidence 2 33456789999999987632 37889999999999999999999997544221 1111111
Q ss_pred -----------C--CC------CCCCCCCHhHHHHHHHhhhC
Q psy7592 224 -----------S--PV------HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 224 -----------~--~~------~~~~~~s~~l~~li~~~l~~ 246 (246)
. .. ..++.+++.+.+||++||++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLEL 310 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCS
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCC
Confidence 0 00 01246799999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=271.02 Aligned_cols=192 Identities=26% Similarity=0.373 Sum_probs=163.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC------CCCcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL------EHPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~~ 75 (246)
.||+|+| |+||+|++..+++.||+|.++... ...+++.+|+++++.+ +|+||+++++++......++
T Consensus 104 ~LG~G~f---g~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 104 VIGKGSF---GQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp EEEESSS---EEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred EcccCcc---EEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 4788888 999999999999999999997642 3345666777777776 57799999999999999999
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC--eEEeecceeeee
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH--AHITDFNIATVL 153 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~--~~l~d~~~~~~~ 153 (246)
|||++ +++|.+++..... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 177 v~e~~-~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 177 TFELL-SMNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEecc-CCCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 99999 4689888876432 23589999999999999999999999999999999999999887 999999998764
Q ss_pred ccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 154 EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 154 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.. ......+++.|+|||.+.+.. ++.++||||||+++|+|++|.+||.+.+
T Consensus 253 ~~--~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 253 HQ--RVYTYIQSRFYRAPEVILGAR-----YGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TC--CCCSSCSCGGGCCHHHHHTBC-----CCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC--cccccCCCCCccChHHHhCCC-----CCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 33 233456788999999998765 7899999999999999999999997654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=265.27 Aligned_cols=194 Identities=25% Similarity=0.480 Sum_probs=162.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC-----CeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE-----EDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v 76 (246)
.||+|++ |+||+++++.+|+.||+|.+.... .......+.+|++++++++||||+++++++... ...+++
T Consensus 18 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 18 LLGEGAY---GVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred EEcCCCC---eEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 4788888 999999999999999999996543 344557788999999999999999999988654 678999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
||++. ++|.+.+... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 93 ~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 93 QELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp ECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 99995 6898888652 3489999999999999999999999999999999999999999999999999876432
Q ss_pred cc-----------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 157 QL-----------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 157 ~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.. .....+++.|+|||.+.... .++.++|+||||+++|+|++|..||.+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSA----KYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCC----CCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCccccccchhhccccccccCCeeeccCC----CccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 11235688899999875432 37889999999999999999999997654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=259.37 Aligned_cols=227 Identities=19% Similarity=0.206 Sum_probs=181.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeee-eeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCF-QDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||++++..+++.||+|.+..... .+++.+|+..+++++|++++..+..+ .++...++||||+
T Consensus 16 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 16 KIGSGSF---GDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp EEEEETT---EEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEccCCC---eEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 3678888 9999999999999999999876542 23578899999999988766655544 6677889999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc---CCCCeEEeecceeeeeccCc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD---EEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~---~~~~~~l~d~~~~~~~~~~~ 157 (246)
+++|.+++.... .++++..++.++.|++.|+.|||+.|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus 88 -~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 88 -GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp -CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred -CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 999999987432 2359999999999999999999999999999999999994 88899999999998765433
Q ss_pred c--------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHhhhcCCCC-
Q psy7592 158 L--------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTS-VKDVKAIIYSPVH- 227 (246)
Q Consensus 158 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~- 227 (246)
. .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||....... ......+......
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIE-----QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCC-----CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cccccccccccccccccccCChhhhcCCC-----CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 2 23456888999999987765 7889999999999999999999997644322 1222222222222
Q ss_pred ----CCCCCCHhHHHHHHHhhhC
Q psy7592 228 ----YPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 228 ----~~~~~s~~l~~li~~~l~~ 246 (246)
.+..+|+.+.++|++||+.
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~ 260 (296)
T 3uzp_A 238 PIEVLCKGYPSEFATYLNFCRSL 260 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTS
T ss_pred chHHHHhhCCHHHHHHHHHHHhc
Confidence 2367999999999999973
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=264.08 Aligned_cols=195 Identities=26% Similarity=0.337 Sum_probs=165.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||++++. +++.||+|.+...... .....+.+|++.+++++||||+++++++.+....++||||+.
T Consensus 37 ~lg~G~~---g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 110 (326)
T 3uim_A 37 ILGRGGF---GKVYKGRLA-DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 110 (326)
T ss_dssp EEECCSS---SEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCT
T ss_pred eEecCCC---cEEEEEEec-CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEecc
Confidence 4788888 899999864 6999999999765421 122368899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK---HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~---~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
+++|.+++..... ...++++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus 111 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 189 (326)
T 3uim_A 111 NGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189 (326)
T ss_dssp TCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS
T ss_pred CCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc
Confidence 9999999976533 234468999999999999999999999 999999999999999999999999999987653322
Q ss_pred --ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy7592 159 --ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFD 208 (246)
Q Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~ 208 (246)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||+
T Consensus 190 ~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 190 HVTTAVRGTIGHIAPEYLSTGK-----SSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CEECCCCSCGGGCCHHHHHHSE-----ECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cccccccCCcCccCHHHhccCC-----CCccccchhHHHHHHHHHhCCCccc
Confidence 23345889999999987665 7889999999999999999999995
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=261.11 Aligned_cols=227 Identities=20% Similarity=0.210 Sum_probs=180.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeee-eeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCF-QDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||++++..+++.||+|.+..... .+++.+|++++++++|++++..+..+ .++...+++||++
T Consensus 16 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 16 KIGSGSF---GDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp EEEECSS---SEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred eecCCCC---eEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 3788888 9999999999999999998765432 24577899999999988776665554 6778899999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE---cCCCCeEEeecceeeeeccCc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL---DEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~---~~~~~~~l~d~~~~~~~~~~~ 157 (246)
+++|.+++... ..++++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 88 -~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 88 -GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp -CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred -CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999998743 2235999999999999999999999999999999999999 788899999999998765432
Q ss_pred c--------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHhhhcCCCCC
Q psy7592 158 L--------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV-KDVKAIIYSPVHY 228 (246)
Q Consensus 158 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~ 228 (246)
. .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||........ .....+.......
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIE-----QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCC-----CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cCccCCCCcccccCCCccccchHHhcCCC-----CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 2 22456788999999988765 78899999999999999999999976543322 2222222222222
Q ss_pred -----CCCCCHhHHHHHHHhhhC
Q psy7592 229 -----PTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 229 -----~~~~s~~l~~li~~~l~~ 246 (246)
+..+|+.+.++|+.||+.
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~ 260 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSL 260 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTS
T ss_pred hhhhhhccCCHHHHHHHHHHHhc
Confidence 367899999999999974
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=264.54 Aligned_cols=230 Identities=23% Similarity=0.366 Sum_probs=184.6
Q ss_pred CcCCCCccCeeeEEEEE----ecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC--eEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQ----KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE--DLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~~ 75 (246)
.||+|++ |.||+++ +..+++.||+|.+.... .+..+.+.+|++.+++++||||+++++++.... ..++
T Consensus 48 ~lg~G~~---g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 121 (326)
T 2w1i_A 48 QLGKGNF---GSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121 (326)
T ss_dssp EEECCSS---EEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred eeccCCC---eEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence 4788888 9999999 56789999999997653 455678999999999999999999999987543 6899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||||+++++|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 122 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 122 IMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999999997642 2358899999999999999999999999999999999999999999999999987654
Q ss_pred Ccc----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----------cc---HHHH
Q psy7592 156 NQL----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN----------TS---VKDV 218 (246)
Q Consensus 156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~----------~~---~~~~ 218 (246)
... .....++..|+|||.+.+.. ++.++|+||||+++++|++|..||..... .. ....
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESK-----FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCE-----EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCC-----CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 322 12234556799999987664 67899999999999999999998853210 00 0111
Q ss_pred Hhhhc--CCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 219 KAIIY--SPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 219 ~~~~~--~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
...+. ...+.|..+++++.++|++||+.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 302 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNN 302 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCS
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCC
Confidence 12222 24556788999999999999963
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=259.40 Aligned_cols=226 Identities=22% Similarity=0.391 Sum_probs=174.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeee-------------
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQ------------- 68 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------------- 68 (246)
.||+|++ |+||+++++.+++.||+|.+.... ....+.+.+|++.+++++||||+++++++.
T Consensus 18 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 18 PLGCGGN---GLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp ECC--------CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred EeccCCC---eEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 3788888 899999999999999999997653 455678899999999999999999998873
Q ss_pred -eCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc-CCCCeEEee
Q psy7592 69 -DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD-EEGHAHITD 146 (246)
Q Consensus 69 -~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~-~~~~~~l~d 146 (246)
+....++||||+. ++|.+++... ++++..++.++.|++.||.+||+.|++|+||+|+||+++ +++.++++|
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccCceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3467899999996 5899888642 348899999999999999999999999999999999997 566899999
Q ss_pred cceeeeeccC----ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh
Q psy7592 147 FNIATVLEEN----QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII 222 (246)
Q Consensus 147 ~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 222 (246)
||.+...... .......++..|+|||.+.... .++.++|+||||+++|+|++|..||.+... ......+.
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~~ 238 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN----NYTKAIDMWAAGCIFAEMLTGKTLFAGAHE--LEQMQLIL 238 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTT----CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcc----cCCchhhhHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHH
Confidence 9998765432 1223345688899999886532 378899999999999999999999975442 22222222
Q ss_pred cCC-------------------------C-----CCCCCCCHhHHHHHHHhhhC
Q psy7592 223 YSP-------------------------V-----HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 223 ~~~-------------------------~-----~~~~~~s~~l~~li~~~l~~ 246 (246)
... . ..++.+|++++++|++||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 292 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTF 292 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCC
Confidence 111 0 11246899999999999963
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=260.57 Aligned_cols=232 Identities=25% Similarity=0.252 Sum_probs=184.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC-IERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|++ |+||++++ +++.||+|.+..... ...+..+.+.+|++++++++||||+++++++.++...+++|||+
T Consensus 38 ~lg~G~~---g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 38 KMGEGGF---GVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp EEEECSS---EEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred ccccCCC---eEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 3788888 99999987 688999999976432 23445678899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-- 158 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 158 (246)
++++|.+++..... ..++++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 113 ~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 113 PNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp TTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred CCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 99999999875322 23468999999999999999999999999999999999999999999999999877543221
Q ss_pred -ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHhh-hc----------C-
Q psy7592 159 -ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV-KDVKAI-IY----------S- 224 (246)
Q Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~~-~~----------~- 224 (246)
.....+++.|+|||.+.+. ++.++|+||||+++|+|++|..||........ ...... .. .
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~------~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE------ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK 264 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE------ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS
T ss_pred cccccCCCcCcCChHHhcCC------CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc
Confidence 2234678899999987653 57899999999999999999999976443321 111111 11 1
Q ss_pred CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 225 PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 225 ~~~~~~~~s~~l~~li~~~l~~ 246 (246)
....+..+++.+.++|.+||+.
T Consensus 265 ~~~~~~~~~~~l~~li~~cl~~ 286 (307)
T 2nru_A 265 MNDADSTSVEAMYSVASQCLHE 286 (307)
T ss_dssp CSCCCHHHHHHHHHHHHHHTCS
T ss_pred ccccchHHHHHHHHHHHHHcCC
Confidence 1122344678899999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=266.92 Aligned_cols=197 Identities=27% Similarity=0.443 Sum_probs=155.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeecccc--------chHHHHHHHHHHHHHHhhCCCCcceeeeeeeee----
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC--------IERDALKNVLREMEILTTLEHPFLVNLWFCFQD---- 69 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 69 (246)
.||+|++ |+||++++.. ++.||+|.+..... .+....+.+.+|++++++++||||+++++++..
T Consensus 29 ~lg~G~~---g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (362)
T 3pg1_A 29 FISSGSY---GAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP 104 (362)
T ss_dssp EEEEETT---EEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTT
T ss_pred EeccCCC---EEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCC
Confidence 4788888 9999999865 99999999865332 234445789999999999999999999999853
Q ss_pred -CCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecc
Q psy7592 70 -EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFN 148 (246)
Q Consensus 70 -~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~ 148 (246)
....++||||+. ++|.+.+.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 105 ~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 105 AMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp TCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred CcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence 346899999996 57777776432 245899999999999999999999999999999999999999999999999
Q ss_pred eeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 149 IATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.+.............+++.|+|||.+.+.. .++.++|+||||+++|+|++|+.||.+..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 180 LAREDTADANKTHYVTHRWYRAPELVMQFK----GFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp C---------------CGGGCCHHHHTTCT----TCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccceecccceecCcHHhcCCC----CCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 997655544445566788899999987632 37889999999999999999999997544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=269.42 Aligned_cols=197 Identities=24% Similarity=0.406 Sum_probs=151.4
Q ss_pred CcCCCCccCeeeEEEEEec--CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee--CCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK--DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD--EEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~ 77 (246)
+||+|+| |+||+|+++ .+++.||+|.+..... ...+.+|+.++++++||||+++++++.. +...++||
T Consensus 28 ~lG~G~~---g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 28 KVGRGTY---GHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp CCC--------EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred EeeecCC---eEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 4788888 999999966 5789999999976532 2357789999999999999999999954 67899999
Q ss_pred eecCCCChHHHHhhcccc----ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE----cCCCCeEEeecce
Q psy7592 78 DLLLGGDLRYHITQDIKF----YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL----DEEGHAHITDFNI 149 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~----~~~~~~~l~d~~~ 149 (246)
||+. ++|.+.+...... ....+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||+
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 9995 5777777543211 12246899999999999999999999999999999999999 6778999999999
Q ss_pred eeeeccC----ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 150 ATVLEEN----QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 150 ~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
+...... .......+++.|+|||.+.+.. .++.++||||||+++|+|++|..||.+..
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR----HYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCC----SCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCC----cccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9876432 1223456789999999987643 37889999999999999999999997544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=262.36 Aligned_cols=228 Identities=20% Similarity=0.321 Sum_probs=165.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeee--------eCCe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQ--------DEED 72 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--------~~~~ 72 (246)
.||+|++ |+||++++..+++.||+|.+.... ....+.+.+|+..++++. ||||+++++++. ....
T Consensus 35 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 35 VLAEGGF---AFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEECCSS---EEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred EEccCCc---eEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 4788888 999999999999999999986653 445577889999999996 999999999984 3445
Q ss_pred EEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCcEEEcCCCCeEEeeccee
Q psy7592 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH--IIHRDIKPDNILLDEEGHAHITDFNIA 150 (246)
Q Consensus 73 ~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~--~~h~~i~~~nil~~~~~~~~l~d~~~~ 150 (246)
.+++|||+ +++|.+++..... ..++++..++.++.|++.+|.|||+.| ++|+||+|+||+++.++.++|+|||++
T Consensus 109 ~~lv~e~~-~g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 109 FLLLTELC-KGQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEECC-SEEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred EEEEEEec-CCCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 89999999 4788888765221 224699999999999999999999999 999999999999999999999999998
Q ss_pred eeeccCccc-------------cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH
Q psy7592 151 TVLEENQLA-------------TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKD 217 (246)
Q Consensus 151 ~~~~~~~~~-------------~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~ 217 (246)
......... ....+++.|+|||.+.... ...++.++||||||+++|+|++|..||......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---- 259 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS--NFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL---- 259 (337)
T ss_dssp BCCSSCC-------------------------------CCT--TSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccc--cCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH----
Confidence 775432211 1344788899999984221 123788999999999999999999999643321
Q ss_pred HHhhhcC--CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 218 VKAIIYS--PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 218 ~~~~~~~--~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.+... ..+.+...++.+.++|.+||+.
T Consensus 260 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 288 (337)
T 3ll6_A 260 --RIVNGKYSIPPHDTQYTVFHSLIRAMLQV 288 (337)
T ss_dssp --------CCCCTTCCSSGGGHHHHHHHSCS
T ss_pred --HhhcCcccCCcccccchHHHHHHHHHccC
Confidence 11222 3334567889999999999973
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=263.31 Aligned_cols=226 Identities=23% Similarity=0.334 Sum_probs=155.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee----CCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD----EEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~v~ 77 (246)
+||+|++ |+||+++++.+++.||+|++.... . ...+....++.++||||+++++++.. +...++||
T Consensus 36 ~lG~G~~---g~V~~~~~~~~~~~vavK~~~~~~----~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 36 VLGLGVN---GKVLECFHRRTGQKCALKLLYDSP----K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEESSH----H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eeeeCCC---eEEEEEEECCCCCEEEEEEecCcH----H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 3688888 999999999999999999997642 1 22233344667799999999999976 45589999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC---CCeEEeecceeeeec
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE---GHAHITDFNIATVLE 154 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~---~~~~l~d~~~~~~~~ 154 (246)
||+++++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 106 e~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 106 ECMEGGELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp ECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred eccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999999997643 2346899999999999999999999999999999999999864 459999999997654
Q ss_pred cCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH--HHHhhhcCCCCC----
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK--DVKAIIYSPVHY---- 228 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~---- 228 (246)
.. ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......... ....+......+
T Consensus 183 ~~-~~~~~~~t~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (336)
T 3fhr_A 183 QN-ALQTPCYTPYYVAPEVLGPEK-----YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256 (336)
T ss_dssp ----------------------CH-----HHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTT
T ss_pred cc-ccccCCCCcCccChhhhCCCC-----CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchh
Confidence 32 223456788999999986654 678999999999999999999999654433211 111222222222
Q ss_pred CCCCCHhHHHHHHHhhhC
Q psy7592 229 PTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 229 ~~~~s~~l~~li~~~l~~ 246 (246)
...+++.++++|.+||+.
T Consensus 257 ~~~~~~~~~~li~~~L~~ 274 (336)
T 3fhr_A 257 WSEVSEDAKQLIRLLLKT 274 (336)
T ss_dssp STTCCHHHHHHHHHHSCS
T ss_pred hccCCHHHHHHHHHHCCC
Confidence 247899999999999963
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=256.01 Aligned_cols=226 Identities=25% Similarity=0.428 Sum_probs=175.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee------------
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD------------ 69 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------------ 69 (246)
.||+|++ |+||++++..+++.||+|.+... ....+.+.+|+.++++++||||+++++++.+
T Consensus 13 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 13 VLGQGAF---GQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred eeccCCc---EEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 4788888 99999999999999999999653 3456788999999999999999999998865
Q ss_pred -CCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecc
Q psy7592 70 -EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFN 148 (246)
Q Consensus 70 -~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~ 148 (246)
....++||||+++++|.+++.... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 356899999999999999997532 234788899999999999999999999999999999999999999999999
Q ss_pred eeeeeccC---------------ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q psy7592 149 IATVLEEN---------------QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT 213 (246)
Q Consensus 149 ~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~ 213 (246)
.+...... .......++..|+|||.+.+.. .++.++|+||||+++|+|++ ||.... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~il~~l~~---p~~~~~-~ 233 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG----HYNEKIDMYSLGIIFFEMIY---PFSTGM-E 233 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCS----CCCTHHHHHHHHHHHHHHHS---CCSSHH-H
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCC----CCcchhhHHHHHHHHHHHHh---ccCCch-h
Confidence 98765321 1122345788999999987542 37889999999999999998 553211 1
Q ss_pred cHHHHHhhhcCCC----CCCCCCCHhHHHHHHHhhhC
Q psy7592 214 SVKDVKAIIYSPV----HYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 214 ~~~~~~~~~~~~~----~~~~~~s~~l~~li~~~l~~ 246 (246)
.......+..... .++...++.++++|.+||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 270 (303)
T 1zy4_A 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDH 270 (303)
T ss_dssp HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccccCccccccchHHHHHHHHHHHhc
Confidence 2222333333333 33456778899999999963
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=268.12 Aligned_cols=225 Identities=17% Similarity=0.188 Sum_probs=178.1
Q ss_pred CcCCCCccCeeeEEEEEecC--------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCccee-----------
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD--------TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVN----------- 62 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~----------- 62 (246)
.||+|++ |+||+++++. +++.||+|.+... +.+.+|++++++++||||++
T Consensus 49 ~lg~G~~---g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 49 FQTRDNQ---GILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEETT---EEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred EecCCCC---eEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 3677888 9999999987 4899999999764 35778999999999999987
Q ss_pred ----eeeeeee-CCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc
Q psy7592 63 ----LWFCFQD-EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD 137 (246)
Q Consensus 63 ----~~~~~~~-~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~ 137 (246)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 5566665 67899999999 999999998641 23459999999999999999999999999999999999999
Q ss_pred CCC--CeEEeecceeeeeccCcc--------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy7592 138 EEG--HAHITDFNIATVLEENQL--------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207 (246)
Q Consensus 138 ~~~--~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~ 207 (246)
.++ .++|+|||++........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-----PSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-----CCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-----CCchhhHHHHHHHHHHHHhCCCCc
Confidence 988 899999999977643321 12346788999999987664 788999999999999999999999
Q ss_pred CCCCCccHHH---HHhhhcCCCCCCC------CCCHhHHHHHHHhhhC
Q psy7592 208 DIHSNTSVKD---VKAIIYSPVHYPT------AWSESTKHLLSQVHRY 246 (246)
Q Consensus 208 ~~~~~~~~~~---~~~~~~~~~~~~~------~~s~~l~~li~~~l~~ 246 (246)
.......... ..........++. .+++.+.++|++||+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 316 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMAL 316 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTC
T ss_pred ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhC
Confidence 7654222221 1112222333332 4699999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=263.82 Aligned_cols=225 Identities=23% Similarity=0.373 Sum_probs=178.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCe------EEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED------LFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~~ 75 (246)
.||+|++ |+||+++++.+|+.||+|.+.... .+....+.+.+|+.++++++||||+++++++..... .++
T Consensus 31 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 106 (353)
T 3coi_A 31 HVGSGAY---GSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 106 (353)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred eEecCCC---eEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEE
Confidence 3788888 999999999999999999997643 334556788899999999999999999999987643 599
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
+|||+. ++|.+.+.. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++.....
T Consensus 107 v~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 107 VMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp EEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred Eecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 999995 578766532 258999999999999999999999999999999999999999999999999876433
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc------------
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY------------ 223 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~------------ 223 (246)
. .....+++.|+|||.+.+.. .++.++|+||||+++++|++|..||.+.+.... ...+..
T Consensus 179 ~--~~~~~~t~~y~aPE~~~~~~----~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 179 E--MTGYVVTRWYRAPEVILSWM----HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp -------CCSBCCSCHHHHSCCS----CCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCCHHHHTT
T ss_pred C--ccccccCcCcCCHHHHhCcC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHH
Confidence 2 23356788999999987532 378899999999999999999999976542221 111110
Q ss_pred -------------------CCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 224 -------------------SPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 224 -------------------~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.....+..+++.++++|++||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 292 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLEL 292 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCS
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCC
Confidence 01122356899999999999963
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=259.64 Aligned_cols=228 Identities=21% Similarity=0.310 Sum_probs=174.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhh--CCCCcceeeeeeeee----CCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTT--LEHPFLVNLWFCFQD----EEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~----~~~~~~ 75 (246)
.||+|++ |+||++++ +++.||+|++.... ...+..|.+++.. ++||||+++++++.+ ....++
T Consensus 15 ~lg~G~~---g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 15 CVGKGRY---GEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp EEEECSS---EEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred eeccCCC---cEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 4788888 99999988 69999999987643 2344556666665 799999999998654 345899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHH--------HCCcccCCCCCCcEEEcCCCCeEEeec
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLK--------TKHIIHRDIKPDNILLDEEGHAHITDF 147 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh--------~~~~~h~~i~~~nil~~~~~~~~l~d~ 147 (246)
||||+++++|.+++... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+||
T Consensus 84 v~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EECCCTTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred ehhhccCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 99999999999999543 3489999999999999999999 999999999999999999999999999
Q ss_pred ceeeeeccCccc-----cccccCCCccCCceecccccccC-CCCcchhHHHHHHHHHHHHhC----------CCCCCCCC
Q psy7592 148 NIATVLEENQLA-----TSMSGTKPYIAPEIFLVATDEVL-GYSYSVDWWSLGVTLFEILAR----------GRPFDIHS 211 (246)
Q Consensus 148 ~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~-~~~~~~Di~slG~~l~~ll~g----------~~p~~~~~ 211 (246)
|++......... ....+++.|+|||.+.+...... .++.++||||||+++|+|++| ..||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 999776543222 22468899999999876531100 144689999999999999999 88885432
Q ss_pred Cc--cHHHHHhhhcC---CCCCCC-----CCCHhHHHHHHHhhhC
Q psy7592 212 NT--SVKDVKAIIYS---PVHYPT-----AWSESTKHLLSQVHRY 246 (246)
Q Consensus 212 ~~--~~~~~~~~~~~---~~~~~~-----~~s~~l~~li~~~l~~ 246 (246)
.. ........... ....|. ..++.+.++|++||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 282 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQ 282 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCS
T ss_pred CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhc
Confidence 22 22223332222 333332 2457899999999964
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=261.82 Aligned_cols=230 Identities=28% Similarity=0.408 Sum_probs=179.6
Q ss_pred CcCCCCccCeeeEEEEEec-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC---CCCcceeeeeeee-----eCCe
Q psy7592 2 FCGSSKFCGTSKVCIVQKK-DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL---EHPFLVNLWFCFQ-----DEED 72 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~~~~ 72 (246)
.||+|++ |+||++++. .+++.||+|.++...... .....+.+|+..++.+ +||||+++++++. ....
T Consensus 18 ~lg~G~~---g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 93 (326)
T 1blx_A 18 EIGEGAY---GKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93 (326)
T ss_dssp EEEEETT---EEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred eeccccc---EEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCce
Confidence 3678888 999999995 678999999997644211 1112344566666555 8999999999987 4567
Q ss_pred EEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 73 ~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
.++||||+. ++|.+++..... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 94 ~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 94 LTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp EEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 899999996 699998876432 2358999999999999999999999999999999999999999999999999987
Q ss_pred eccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc---C-----
Q psy7592 153 LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY---S----- 224 (246)
Q Consensus 153 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~----- 224 (246)
...........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.... .....+.. .
T Consensus 170 ~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 170 YSFQMALTSVVVTLWYRAPEVLLQSS-----YATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCGGG
T ss_pred ccCCCCccccccccceeCHHHHhcCC-----CCcchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCCccc
Confidence 65544444567789999999987664 788999999999999999999999754422 22222211 0
Q ss_pred -------------------CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 225 -------------------PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 225 -------------------~~~~~~~~s~~l~~li~~~l~~ 246 (246)
...++..+++.++++|.+||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 283 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 283 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCS
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCC
Confidence 0112356899999999999963
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=280.17 Aligned_cols=226 Identities=22% Similarity=0.351 Sum_probs=183.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+++++. +..||||.++..... .+.+.+|++++++++||||+++++++.+ ...++||||+.
T Consensus 274 ~lG~G~f---g~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 274 KLGQGCF---GEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp EEEECSS---EEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred ecccCCC---eEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 3788888 9999999975 567999999865421 3568899999999999999999999876 56899999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc--cc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ--LA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 159 (246)
+++|.+++.... ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 345 ~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 345 KGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp TEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred CCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence 999999997532 1235889999999999999999999999999999999999999999999999987654321 11
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||.+.... ++.++||||||+++|+|++ |..||.+.... .....+... ..+.|..+++.+.
T Consensus 422 ~~~~~~~~y~aPE~~~~~~-----~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~~~~~~~~~~l~ 494 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGR-----FTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYRMPCPPECPESLH 494 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCC-----CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cCCcCcccccCHHHhccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHHHH
Confidence 2233566799999987664 8899999999999999999 89999754432 222233322 4556788999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
+||.+||++
T Consensus 495 ~li~~cl~~ 503 (535)
T 2h8h_A 495 DLMCQCWRK 503 (535)
T ss_dssp HHHHHHTCS
T ss_pred HHHHHHcCC
Confidence 999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=264.58 Aligned_cols=224 Identities=22% Similarity=0.326 Sum_probs=185.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchH---HHHHHHHHHHHHHhhCC--CCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIER---DALKNVLREMEILTTLE--HPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|++ |+||++++..+++.||+|.+........ ...+.+.+|+.++++++ |+||+++++++.++...+++
T Consensus 50 ~lg~G~~---g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv 126 (320)
T 3a99_A 50 LLGSGGF---GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126 (320)
T ss_dssp ECSSSSS---CEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred EEeeCCC---eEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEE
Confidence 4788888 9999999999999999999987543221 11244667899999996 59999999999999999999
Q ss_pred EeecCC-CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc-CCCCeEEeecceeeeec
Q psy7592 77 SDLLLG-GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD-EEGHAHITDFNIATVLE 154 (246)
Q Consensus 77 ~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~-~~~~~~l~d~~~~~~~~ 154 (246)
+|++.+ ++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++ +++.++|+|||++....
T Consensus 127 ~e~~~~~~~L~~~l~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~ 201 (320)
T 3a99_A 127 LERPEPVQDLFDFITERGA-----LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 201 (320)
T ss_dssp EECCSSEEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEcCCCCccHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence 999975 899999876544 48999999999999999999999999999999999999 77899999999988765
Q ss_pred cCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCH
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSE 234 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 234 (246)
... .....+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||... ..+......++..+++
T Consensus 202 ~~~-~~~~~gt~~y~aPE~~~~~~----~~~~~~Di~slG~il~el~~g~~pf~~~--------~~~~~~~~~~~~~~~~ 268 (320)
T 3a99_A 202 DTV-YTDFDGTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIPFEHD--------EEIIRGQVFFRQRVSS 268 (320)
T ss_dssp SSC-BCCCCSCGGGSCHHHHHHSC----BCHHHHHHHHHHHHHHHHHHSSCSCCSH--------HHHHHCCCCCSSCCCH
T ss_pred ccc-ccCCCCCccCCChHHhccCC----CCCccchHHhHHHHHHHHHHCCCCCCCh--------hhhhcccccccccCCH
Confidence 432 33456788999999987654 1367899999999999999999999531 1234445667788999
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.+.++|++||+.
T Consensus 269 ~~~~li~~~l~~ 280 (320)
T 3a99_A 269 ECQHLIRWCLAL 280 (320)
T ss_dssp HHHHHHHHHTCS
T ss_pred HHHHHHHHHccC
Confidence 999999999963
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=265.15 Aligned_cols=197 Identities=25% Similarity=0.383 Sum_probs=152.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCe-------EE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED-------LF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-------~~ 74 (246)
.||+|++ |+||+++++.+|+.||+|++...... .....++++.+..++||||+++++++..... .+
T Consensus 30 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 30 MAGQGTF---GTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp ------------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred EEecCCC---eEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence 4788888 99999999999999999998664322 2345567778888899999999999965332 88
Q ss_pred EEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHH--HCCcccCCCCCCcEEEcC-CCCeEEeecceee
Q psy7592 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLK--TKHIIHRDIKPDNILLDE-EGHAHITDFNIAT 151 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh--~~~~~h~~i~~~nil~~~-~~~~~l~d~~~~~ 151 (246)
+||||+.+ +|...+..... ....+++..++.++.|++.++.+|| +.|++|+||+|+||+++. ++.++|+|||++.
T Consensus 103 lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 103 VVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred EEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 99999966 45444432111 1334588899999999999999999 999999999999999996 8899999999998
Q ss_pred eeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 152 VLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
............+++.|+|||.+.+.. .++.++||||||+++|+|++|..||.+..
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFGNQ----HYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTTCS----SCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCCCCcccccCCcceeCHHHHcCCC----CCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 776655555667889999999986543 37889999999999999999999997544
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=256.53 Aligned_cols=232 Identities=24% Similarity=0.348 Sum_probs=182.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC--CCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE--HPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
.||+|++ |+||++.+. +++.||+|.+..... +....+.+.+|++.+++++ ||||+++++++.++...+++||
T Consensus 35 ~lg~G~~---g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 35 QIGSGGS---SKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp EEECCSS---EEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EecCCCC---EEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence 4788888 999999986 599999999976543 3445678899999999997 5999999999999999999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL- 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (246)
+.+++|.+++..... +++..++.++.|++.||.+||+.|++|+||+|+||+++ ++.++|+|||++........
T Consensus 109 ~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 109 CGNIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp CCSEEHHHHHHHCSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-------
T ss_pred cCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcccc
Confidence 558899999976543 48889999999999999999999999999999999995 48999999999876643322
Q ss_pred --ccccccCCCccCCceecccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCC
Q psy7592 159 --ATSMSGTKPYIAPEIFLVATDE------VLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHY 228 (246)
Q Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~------~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~ 228 (246)
.....+++.|+|||.+.+.... ...++.++|+||||+++|+|++|..||..... ........... ...+
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~ 261 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIIDPNHEIEF 261 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-HHHHHHHHHCTTSCCCC
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-HHHHHHHHHhcccccCC
Confidence 2234578899999998652111 12378899999999999999999999975433 22333334433 4456
Q ss_pred CCCCCHhHHHHHHHhhhC
Q psy7592 229 PTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 229 ~~~~s~~l~~li~~~l~~ 246 (246)
|...++.++++|++||+.
T Consensus 262 ~~~~~~~l~~li~~~l~~ 279 (313)
T 3cek_A 262 PDIPEKDLQDVLKCCLKR 279 (313)
T ss_dssp CCCSCHHHHHHHHHHTCS
T ss_pred cccchHHHHHHHHHHccC
Confidence 778899999999999963
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=254.19 Aligned_cols=204 Identities=11% Similarity=0.093 Sum_probs=167.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |.||++++..+++.||+|.++.....+.+..+.+.+|+..+.+++||||+++++++.+++..|+||||++
T Consensus 38 ~lg~G~~---g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 114 (286)
T 3uqc_A 38 FHGGVPP---LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIR 114 (286)
T ss_dssp EEEBSTT---CEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEcccCC---eEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecC
Confidence 3688888 9999999999999999999988766566677889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
|++|.+++... .....+..++.|++.+|.|||+.|++|+||||+||+++.++.+++++.+
T Consensus 115 g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------- 174 (286)
T 3uqc_A 115 GGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------- 174 (286)
T ss_dssp EEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred CCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence 99999998542 1445688899999999999999999999999999999999999987332
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHhhhcCCC----CCCCCCCHhH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK-DVKAIIYSPV----HYPTAWSEST 236 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~----~~~~~~s~~l 236 (246)
|++| ++.++|+||||+++|+|++|+.||.+....... .......... ..+..+++.+
T Consensus 175 ------~~~~------------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 ------TMPD------------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp ------CCTT------------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred ------ccCC------------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 2332 577999999999999999999999765433211 1111112211 1235799999
Q ss_pred HHHHHHhhhC
Q psy7592 237 KHLLSQVHRY 246 (246)
Q Consensus 237 ~~li~~~l~~ 246 (246)
+++|.+||++
T Consensus 237 ~~li~~~l~~ 246 (286)
T 3uqc_A 237 SAVAARSVQG 246 (286)
T ss_dssp HHHHHHHHCT
T ss_pred HHHHHHHccc
Confidence 9999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=268.79 Aligned_cols=193 Identities=28% Similarity=0.391 Sum_probs=161.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC--------CCcceeeeeeee----e
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE--------HPFLVNLWFCFQ----D 69 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~----~ 69 (246)
.||+|++ |+||+|++..+++.||+|+++.. ....+.+.+|++++++++ |+||+++++++. +
T Consensus 44 ~lg~G~~---g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~ 116 (397)
T 1wak_A 44 KLGWGHF---STVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116 (397)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred EeeecCC---eeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence 3688888 99999999999999999999754 344567888999999985 788999999987 5
Q ss_pred CCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEcCCC--------
Q psy7592 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK-HIIHRDIKPDNILLDEEG-------- 140 (246)
Q Consensus 70 ~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~-~~~h~~i~~~nil~~~~~-------- 140 (246)
+...++||||+ ++++.+.+.... ...+++..++.++.|++.||.|||++ |++|+||||+||+++.++
T Consensus 117 ~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 117 GTHICMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EEEEEEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CceEEEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 56799999999 566666655432 12458999999999999999999998 999999999999998775
Q ss_pred -----------------------------------------CeEEeecceeeeeccCccccccccCCCccCCceeccccc
Q psy7592 141 -----------------------------------------HAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATD 179 (246)
Q Consensus 141 -----------------------------------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 179 (246)
.++|+|||.+...... .....+++.|+|||.+.+..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~- 269 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG- 269 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC-
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC-
Confidence 7999999999875432 33456789999999998765
Q ss_pred ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7592 180 EVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN 212 (246)
Q Consensus 180 ~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~ 212 (246)
++.++||||||+++|+|++|..||.....
T Consensus 270 ----~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 270 ----YNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp ----CCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred ----CCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 78899999999999999999999976543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=261.62 Aligned_cols=224 Identities=23% Similarity=0.371 Sum_probs=180.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHH---HHHHHHHHHHHHhhC----CCCcceeeeeeeeeCCeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERD---ALKNVLREMEILTTL----EHPFLVNLWFCFQDEEDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~---~~~~~~~e~~~l~~l----~h~~iv~~~~~~~~~~~~~ 74 (246)
.||+|++ |.||+++++.+++.||+|.+......... ....+.+|+..+.++ +||||+++++++.+.+..+
T Consensus 38 ~lg~G~~---g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~ 114 (312)
T 2iwi_A 38 LLGKGGF---GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114 (312)
T ss_dssp EEEEETT---EEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CE
T ss_pred EEEcCCC---EEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEE
Confidence 3678888 99999999999999999999765432221 223455788888888 8999999999999999999
Q ss_pred EEEee-cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc-CCCCeEEeecceeee
Q psy7592 75 MVSDL-LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD-EEGHAHITDFNIATV 152 (246)
Q Consensus 75 ~v~e~-~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~-~~~~~~l~d~~~~~~ 152 (246)
+++|+ +.+++|.+++..... +++..++.++.|++.+|.+||+.|++|+||+|+||+++ .++.++++|||.+..
T Consensus 115 ~v~e~~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~ 189 (312)
T 2iwi_A 115 LVLERPLPAQDLFDYITEKGP-----LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL 189 (312)
T ss_dssp EEEECCSSEEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred EEEEecCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence 99999 789999999976543 48999999999999999999999999999999999999 788999999999887
Q ss_pred eccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCC
Q psy7592 153 LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAW 232 (246)
Q Consensus 153 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (246)
..... .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||... ..+......+|..+
T Consensus 190 ~~~~~-~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~~~~~~~~~~~ 256 (312)
T 2iwi_A 190 LHDEP-YTDFDGTRVYSPPEWISRHQ----YHALPATVWSLGILLYDMVCGDIPFERD--------QEILEAELHFPAHV 256 (312)
T ss_dssp CCSSC-BCCCCSCTTTSCHHHHHHSC----BCHHHHHHHHHHHHHHHHHHSSCSCCSH--------HHHHHTCCCCCTTS
T ss_pred cccCc-ccccCCcccccCceeeecCC----CCCccchHHHHHHHHHHHHHCCCCCCCh--------HHHhhhccCCcccC
Confidence 65432 33456788999999887554 1345899999999999999999999531 12344566678899
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
++.++++|.+||+.
T Consensus 257 ~~~~~~li~~~l~~ 270 (312)
T 2iwi_A 257 SPDCCALIRRCLAP 270 (312)
T ss_dssp CHHHHHHHHHHTCS
T ss_pred CHHHHHHHHHHccC
Confidence 99999999999963
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=278.52 Aligned_cols=228 Identities=22% Similarity=0.384 Sum_probs=184.0
Q ss_pred CcCCCCccCeeeEEEEEecCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT---KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|+| |+||++++..+ +..||+|.++... ..+..+.+.+|+..+++++||||+++++++.+ +..++|||
T Consensus 397 ~LG~G~f---G~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E 470 (656)
T 2j0j_A 397 CIGEGQF---GDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIME 470 (656)
T ss_dssp EEECCSS---CCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred EEeeCCC---EEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEE
Confidence 3788988 89999998643 5679999887543 34556789999999999999999999999854 56889999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+++++|.+++.... .++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 471 ~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 471 LCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp CCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred cCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence 999999999987532 2358899999999999999999999999999999999999999999999999977644322
Q ss_pred c--cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc-CCCCCCCCCCH
Q psy7592 159 A--TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY-SPVHYPTAWSE 234 (246)
Q Consensus 159 ~--~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~s~ 234 (246)
. ....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+.... .....+.. ...+.|..+++
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~~-----~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~ 619 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFRR-----FTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGERLPMPPNCPP 619 (656)
T ss_dssp -------CCGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHHTCCCCCCTTCCH
T ss_pred eeccCCCCCcceeCHHHhcCCC-----CCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCCCCCCCccccH
Confidence 1 2233567899999987654 7899999999999999997 99999754432 22333333 35667889999
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.+.++|.+||+.
T Consensus 620 ~l~~li~~~l~~ 631 (656)
T 2j0j_A 620 TLYSLMTKCWAY 631 (656)
T ss_dssp HHHHHHHHHTCS
T ss_pred HHHHHHHHHcCC
Confidence 999999999964
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=259.39 Aligned_cols=193 Identities=25% Similarity=0.383 Sum_probs=163.4
Q ss_pred CcCCCCccCeeeEEEEEe-cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCC------cceeeeeeeeeCCeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQK-KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHP------FLVNLWFCFQDEEDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~ 74 (246)
.||+|++ |+||++.+ +.+++.||+|+++.. ....+.+.+|++.++.++|+ +++++++++.+.+..+
T Consensus 21 ~lg~G~~---g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 21 TLGEGAF---GKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp EEEEETT---EEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred EEecCCC---eEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 3678888 99999998 568999999999754 23456778899999888665 4999999999999999
Q ss_pred EEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC----------------
Q psy7592 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE---------------- 138 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~---------------- 138 (246)
+||||+ +++|.+++..... .++++..+..++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 999999 8899999876532 24588999999999999999999999999999999999987
Q ss_pred ---CCCeEEeecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7592 139 ---EGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN 212 (246)
Q Consensus 139 ---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~ 212 (246)
++.++++|||.+..... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALG-----WSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp EESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSC-----CCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCC-----CCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 66899999999876433 233456788999999987654 78899999999999999999999976543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=269.08 Aligned_cols=227 Identities=21% Similarity=0.239 Sum_probs=183.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCC-CcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH-PFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|+| |+||++++..+++.||||++..... ..++.+|+++++.++| +++..+..++.+....++||||+
T Consensus 14 ~LG~G~f---G~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 14 KIGSGSF---GEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp CCEECSS---CEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEeeCCC---EEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 4788888 9999999999999999998876542 1347789999999986 56666667777888999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE---cCCCCeEEeecceeeeeccCc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL---DEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~---~~~~~~~l~d~~~~~~~~~~~ 157 (246)
+++|.+++... ...+++..++.++.||+.+|.|||+.|++|+||+|+|||+ +.++.++|+|||++.......
T Consensus 86 -g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 86 -GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred -CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 99999999753 2235999999999999999999999999999999999999 588899999999998765433
Q ss_pred cc--------cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHhhhcC----
Q psy7592 158 LA--------TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK-DVKAIIYS---- 224 (246)
Q Consensus 158 ~~--------~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~---- 224 (246)
.. ....++..|+|||.+.+.. ++.++||||||+++|+|++|..||.+....... ....+...
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIE-----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCC-----CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCCCccccCHHHhcCCC-----CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 21 2456889999999988765 789999999999999999999999875544322 22222211
Q ss_pred -CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 225 -PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 225 -~~~~~~~~s~~l~~li~~~l~~ 246 (246)
...++..+++++.++|..||++
T Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~ 258 (483)
T 3sv0_A 236 SIEALCRGYPTEFASYFHYCRSL 258 (483)
T ss_dssp CHHHHHTTSCHHHHHHHHHHHTC
T ss_pred cHHHHhcCCcHHHHHHHHHHhcC
Confidence 1223367899999999999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=279.24 Aligned_cols=196 Identities=30% Similarity=0.453 Sum_probs=170.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee------CCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD------EEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~~ 75 (246)
.||+|++ |+||++.+..+|+.||+|.++... +....+.+.+|++++++++||||+++++++.. +...++
T Consensus 21 ~LG~G~f---G~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~L 95 (676)
T 3qa8_A 21 RLGTGGF---GYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL 95 (676)
T ss_dssp CCCBCSS---SBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCC
T ss_pred EEeeCCC---eEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEE
Confidence 4777888 899999999999999999987653 34556789999999999999999999998765 667899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC---eEEeecceeee
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH---AHITDFNIATV 152 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~---~~l~d~~~~~~ 152 (246)
||||++|++|.+++..... ..++++..++.++.|++.|+.|||+.|++|+||+|+||+++.++. ++++|||.+..
T Consensus 96 VmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 96 AMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp EEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 9999999999999976432 224688999999999999999999999999999999999997765 89999999987
Q ss_pred eccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy7592 153 LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDI 209 (246)
Q Consensus 153 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~ 209 (246)
...........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..
T Consensus 174 ~~~~~~~~~~~gt~~Y~APE~l~~~~-----~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 174 LDQGELCTEFVGTLQYLAPELLEQKK-----YTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp TTSCCCCCCCCSCCTTCSSCSSCCSC-----CSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccccccCCcccCChHHhccCC-----CCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 76655555667899999999987654 78899999999999999999999964
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=259.61 Aligned_cols=231 Identities=21% Similarity=0.275 Sum_probs=177.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|++ |+||+++++. .||+|.++.... +.+..+.+.+|+..+++++||||+++++++.+....+++|||++
T Consensus 40 ~lg~G~~---g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 40 LIGKGRF---GQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp BCCCSSS---SEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred EeccCCc---eEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 4788888 8999999853 499999876432 12223557789999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-----
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN----- 156 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~----- 156 (246)
+++|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++ ++.++++|||++......
T Consensus 113 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 113 GRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp SEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 999999987642 2458999999999999999999999999999999999997 679999999987654321
Q ss_pred -ccccccccCCCccCCceecccccc----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCC
Q psy7592 157 -QLATSMSGTKPYIAPEIFLVATDE----VLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYP 229 (246)
Q Consensus 157 -~~~~~~~~~~~~~aPE~~~~~~~~----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~ 229 (246)
.......++..|+|||.+.+.... ...++.++|+||||+++|+|++|..||...... .....+... ....+
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~ 265 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--AIIWQMGTGMKPNLSQ 265 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--HHHHHHHTTCCCCCCC
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhccCCCCCCCc
Confidence 122234578889999998753211 123688999999999999999999999754432 222233332 22223
Q ss_pred CCCCHhHHHHHHHhhhC
Q psy7592 230 TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 ~~~s~~l~~li~~~l~~ 246 (246)
..+++.+.++|.+||+.
T Consensus 266 ~~~~~~l~~li~~~l~~ 282 (319)
T 2y4i_B 266 IGMGKEISDILLFCWAF 282 (319)
T ss_dssp SSCCTTHHHHHHHHHCS
T ss_pred CCCCHHHHHHHHHHhcC
Confidence 46899999999999963
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=253.85 Aligned_cols=228 Identities=21% Similarity=0.329 Sum_probs=170.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC--CCCcceeeeeeeeeC----CeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL--EHPFLVNLWFCFQDE----EDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~----~~~~~ 75 (246)
.||+|++ |+||+++++ ++.||+|++.... ......|.+++..+ +||||+++++++.+. ...++
T Consensus 44 ~lg~G~~---g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 44 QIGKGRY---GEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp EEEEETT---EEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred EeecCCC---eEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 3688888 999999984 9999999986543 12334455555544 899999999999877 78999
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC--------CcccCCCCCCcEEEcCCCCeEEeec
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK--------HIIHRDIKPDNILLDEEGHAHITDF 147 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~--------~~~h~~i~~~nil~~~~~~~~l~d~ 147 (246)
||||+++++|.+++... ++++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+||
T Consensus 113 v~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 99999999999999653 248999999999999999999999 9999999999999999999999999
Q ss_pred ceeeeeccCccc-----cccccCCCccCCceecccccccC-CCCcchhHHHHHHHHHHHHhC----------CCCCCCCC
Q psy7592 148 NIATVLEENQLA-----TSMSGTKPYIAPEIFLVATDEVL-GYSYSVDWWSLGVTLFEILAR----------GRPFDIHS 211 (246)
Q Consensus 148 ~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~-~~~~~~Di~slG~~l~~ll~g----------~~p~~~~~ 211 (246)
|++......... ....+++.|+|||.+.+...... ..+.++||||||+++|+|++| ..||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 999776433221 23468899999999876541110 011249999999999999999 77775432
Q ss_pred Cc--cHHHHHhhhcC---CCCCCC-----CCCHhHHHHHHHhhhC
Q psy7592 212 NT--SVKDVKAIIYS---PVHYPT-----AWSESTKHLLSQVHRY 246 (246)
Q Consensus 212 ~~--~~~~~~~~~~~---~~~~~~-----~~s~~l~~li~~~l~~ 246 (246)
.. ........... ...+|. .+++.+.++|.+||+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 311 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAH 311 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCS
T ss_pred CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhh
Confidence 21 22222222222 333443 4567799999999964
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=256.78 Aligned_cols=228 Identities=21% Similarity=0.326 Sum_probs=167.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHH--HHHHHHhhCCCCcceeeeeeee-----eCCeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVL--REMEILTTLEHPFLVNLWFCFQ-----DEEDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~--~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 74 (246)
.||+|++ |+||++++ +++.||+|++..... ..+. .++..+..++||||+++++.+. ....++
T Consensus 20 ~lg~G~~---g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 20 LIGRGRY---GAVYKGSL--DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp EEEECSS---EEEEEEEE--TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ecccCCC---eEEEEEEE--CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 4788888 99999977 689999999976431 2233 3444455689999999997543 233678
Q ss_pred EEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC---------CcccCCCCCCcEEEcCCCCeEEe
Q psy7592 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK---------HIIHRDIKPDNILLDEEGHAHIT 145 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~---------~~~h~~i~~~nil~~~~~~~~l~ 145 (246)
+||||+++++|.+++.... .++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+
T Consensus 89 lv~e~~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEecCCCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 9999999999999996542 27888999999999999999999 99999999999999999999999
Q ss_pred ecceeeeeccCc---------cccccccCCCccCCceeccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-c
Q psy7592 146 DFNIATVLEENQ---------LATSMSGTKPYIAPEIFLVATDEV--LGYSYSVDWWSLGVTLFEILARGRPFDIHSN-T 213 (246)
Q Consensus 146 d~~~~~~~~~~~---------~~~~~~~~~~~~aPE~~~~~~~~~--~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~-~ 213 (246)
|||++....... ......+++.|+|||.+.+..... ..++.++||||||+++|+|++|..||..... .
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999998764321 112345888999999987632110 1256789999999999999999776532221 1
Q ss_pred c--------------HHHHHhh---hcCCCCCCCCC------CHhHHHHHHHhhhC
Q psy7592 214 S--------------VKDVKAI---IYSPVHYPTAW------SESTKHLLSQVHRY 246 (246)
Q Consensus 214 ~--------------~~~~~~~---~~~~~~~~~~~------s~~l~~li~~~l~~ 246 (246)
. ....... ......+|..+ ++.+.++|.+||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCS
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcC
Confidence 1 1111111 12244445444 34899999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=262.34 Aligned_cols=192 Identities=26% Similarity=0.369 Sum_probs=159.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-----------CCcceeeeeeeeeC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-----------HPFLVNLWFCFQDE 70 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~~ 70 (246)
.||+|++ |+||++++..+++.||+|.+.... ...+.+.+|++.+++++ ||||+++++++...
T Consensus 26 ~lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 26 KLGWGHF---STVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred eeeecCC---eEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 3688888 999999999999999999997543 33466778898888886 78999999999865
Q ss_pred C----eEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEcC------C
Q psy7592 71 E----DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK-HIIHRDIKPDNILLDE------E 139 (246)
Q Consensus 71 ~----~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~-~~~h~~i~~~nil~~~------~ 139 (246)
. ..+++||++ +++|.+++.... ...+++..+..++.|++.||.|||+. |++|+||+|+||+++. .
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 4 789999999 999999987642 22358999999999999999999998 9999999999999953 3
Q ss_pred CCeEEeecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 140 GHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 140 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
+.++|+|||++...... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||....
T Consensus 175 ~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-----WGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-----CCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-----CCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 47999999999775432 23356788999999997764 7889999999999999999999997543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=265.55 Aligned_cols=233 Identities=21% Similarity=0.256 Sum_probs=167.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
+||+|++ |+||.+ ...+|+.||||.+.... .+.+.+|+++++++ +||||+++++++.++...++||||+
T Consensus 22 ~LG~G~~---g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 22 ILGYGSS---GTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp EEEECST---TCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEeeCCC---eEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 4788998 888765 44579999999987643 24567899999876 8999999999999999999999999
Q ss_pred CCCChHHHHhhcccccc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC-------------CCeEEe
Q psy7592 81 LGGDLRYHITQDIKFYS--VGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEE-------------GHAHIT 145 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~-------------~~~~l~ 145 (246)
. ++|.+++........ ...++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 5 699999976543211 011334567899999999999999999999999999999754 379999
Q ss_pred ecceeeeeccCcc-----ccccccCCCccCCceeccccc--ccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHH
Q psy7592 146 DFNIATVLEENQL-----ATSMSGTKPYIAPEIFLVATD--EVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKD 217 (246)
Q Consensus 146 d~~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~--~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~ 217 (246)
|||++........ .....+++.|+|||.+.+... ....++.++||||||+++|+|++ |..||....... ..
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~~ 249 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-SN 249 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-HH
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-HH
Confidence 9999987654321 223468899999999875221 11237889999999999999999 999996543322 11
Q ss_pred HHhhhcCCCCC----CCCCCHhHHHHHHHhhhC
Q psy7592 218 VKAIIYSPVHY----PTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 218 ~~~~~~~~~~~----~~~~s~~l~~li~~~l~~ 246 (246)
........... +..++++++++|.+||+.
T Consensus 250 i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 282 (434)
T 2rio_A 250 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH 282 (434)
T ss_dssp HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCS
T ss_pred HhcCCCCcccccccccccchHHHHHHHHHHhhC
Confidence 11111111111 123568999999999963
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=256.33 Aligned_cols=192 Identities=23% Similarity=0.334 Sum_probs=160.5
Q ss_pred CcCCCCccCeeeEEEEEecCCC-cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCc------ceeeeeeeeeCCeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK-QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPF------LVNLWFCFQDEEDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~~~ 74 (246)
.||+|++ |+||++++..++ +.||+|.++.. ....+.+.+|++.+++++|++ ++.+++++......+
T Consensus 26 ~lg~G~~---g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 26 NLGEGTF---GKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp EEEEETT---EEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred EeeccCC---eEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 3678888 999999998776 79999999754 234567788999999987655 899999999999999
Q ss_pred EEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE------------------
Q psy7592 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL------------------ 136 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~------------------ 136 (246)
+|||++ ++++.+.+.... ..++++..++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 99 lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp EEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred EEEecc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 999999 666666665432 1245899999999999999999999999999999999999
Q ss_pred -cCCCCeEEeecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 137 -DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 137 -~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
+.++.++|+|||++..... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||....
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELG-----WAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp EESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCC-----CCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 5678999999999976433 233456789999999997664 7889999999999999999999997544
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=251.49 Aligned_cols=228 Identities=21% Similarity=0.301 Sum_probs=177.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhh--CCCCcceeeeeeeeeCC----eEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTT--LEHPFLVNLWFCFQDEE----DLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~~~ 75 (246)
.||+|++ |+||++++ +++.||+|.+.... .+.+.+|+++++. ++||||+++++++.... ..++
T Consensus 49 ~lg~G~~---g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l 117 (342)
T 1b6c_B 49 SIGKGRF---GEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 117 (342)
T ss_dssp EEEEETT---EEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred eecCCCC---cEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence 3688888 99999998 59999999996543 2456778888877 68999999999998775 7899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHH--------HCCcccCCCCCCcEEEcCCCCeEEeec
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLK--------TKHIIHRDIKPDNILLDEEGHAHITDF 147 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh--------~~~~~h~~i~~~nil~~~~~~~~l~d~ 147 (246)
||||+++++|.+++.+. ++++..++.++.|++.++.+|| +.|++|+||+|+||+++.++.++|+||
T Consensus 118 v~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 118 VSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp EECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred EEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 99999999999999653 2489999999999999999999 899999999999999999999999999
Q ss_pred ceeeeeccCcc-----ccccccCCCccCCceecccccccC-CCCcchhHHHHHHHHHHHHhC----------CCCCCCCC
Q psy7592 148 NIATVLEENQL-----ATSMSGTKPYIAPEIFLVATDEVL-GYSYSVDWWSLGVTLFEILAR----------GRPFDIHS 211 (246)
Q Consensus 148 ~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~-~~~~~~Di~slG~~l~~ll~g----------~~p~~~~~ 211 (246)
|++........ .....+++.|+|||.+.+...... .++.++|+||||+++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 99987654432 234567889999999876531100 123689999999999999999 78886543
Q ss_pred Cc--cHHHHHhhhcC---CCCCCC-----CCCHhHHHHHHHhhhC
Q psy7592 212 NT--SVKDVKAIIYS---PVHYPT-----AWSESTKHLLSQVHRY 246 (246)
Q Consensus 212 ~~--~~~~~~~~~~~---~~~~~~-----~~s~~l~~li~~~l~~ 246 (246)
.. ........+.. ...+|. ..++.+.++|.+||+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 316 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 316 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCS
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhcc
Confidence 21 22333333322 233333 2346899999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=263.07 Aligned_cols=228 Identities=20% Similarity=0.265 Sum_probs=166.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
+||+|++ |+|+ +....+++.||||++..... ..+.+|+++++++ +||||+++++++.++...++|||++
T Consensus 31 ~LG~G~~---G~V~-~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 31 VLGHGAE---GTIV-YRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEECGG---GCEE-EEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeecCcC---EEEE-EEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 4788888 7765 34456899999999976542 2345789999999 7999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC---CC--CeEEeecceeeeecc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE---EG--HAHITDFNIATVLEE 155 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~---~~--~~~l~d~~~~~~~~~ 155 (246)
. ++|.+++..... ..+...++.++.|++.||.|||+.|++|+||+|+||+++. ++ .++|+|||++.....
T Consensus 101 ~-g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 101 A-ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp S-EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred C-CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 5 699999876432 2355567889999999999999999999999999999953 22 578999999987653
Q ss_pred Cc----cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcCC-CCCC
Q psy7592 156 NQ----LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYSP-VHYP 229 (246)
Q Consensus 156 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~ 229 (246)
.. ......+++.|+|||.+.+.. ...++.++||||||+++|+|++ |..||.................. ...+
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 253 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDC--KENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC-----CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTT
T ss_pred CCcceeeccccCCCcCccChhhhhccc--ccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcc
Confidence 32 223456899999999987432 1136779999999999999999 89999643322221111111111 1112
Q ss_pred CCCCHhHHHHHHHhhhC
Q psy7592 230 TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 ~~~s~~l~~li~~~l~~ 246 (246)
...+..+++||.+||+.
T Consensus 254 ~~~~~~~~~li~~~L~~ 270 (432)
T 3p23_A 254 KHEDVIARELIEKMIAM 270 (432)
T ss_dssp CHHHHHHHHHHHHHSCS
T ss_pred ccccHHHHHHHHHHHhC
Confidence 23567789999999973
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=257.15 Aligned_cols=192 Identities=25% Similarity=0.378 Sum_probs=161.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CC-----cceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HP-----FLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~~~ 75 (246)
.||+|++ |+||++++..+++.||+|+++.. ....+++..|+++++.++ |+ +|+++++++..+...++
T Consensus 61 ~lG~G~~---g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 61 LIGKGSF---GQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp EEEEETT---EEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred EEeecCC---EEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 4788888 99999999999999999999754 334566778888888885 55 48999999999999999
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHH--HCCcccCCCCCCcEEEc--CCCCeEEeecceee
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLK--TKHIIHRDIKPDNILLD--EEGHAHITDFNIAT 151 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh--~~~~~h~~i~~~nil~~--~~~~~~l~d~~~~~ 151 (246)
|||++. ++|.+++..... ..+++..+..++.|++.||.||| +.|++|+||+|+||+++ .++.++|+|||++.
T Consensus 134 v~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEECCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEecCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 999995 599999876421 23589999999999999999999 57999999999999995 46789999999998
Q ss_pred eeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 152 VLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
..... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+
T Consensus 210 ~~~~~--~~~~~~t~~y~aPE~~~~~~-----~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 210 QLGQR--IYQYIQSRFYRSPEVLLGMP-----YDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ETTCC--CCSSCSCGGGCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecccc--cccccCCccccChHHHcCCC-----CCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 75432 33456788999999998764 7899999999999999999999997544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=244.65 Aligned_cols=204 Identities=25% Similarity=0.402 Sum_probs=162.3
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHH-hhCCCCcceeeeeeeee----CCeEEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEIL-TTLEHPFLVNLWFCFQD----EEDLFMVS 77 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~~~v~ 77 (246)
||+|++ |+||++.++.+++.||+|.++.. ....+|+..+ +.++||||+++++++.. +...++||
T Consensus 26 lg~G~~---g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 94 (299)
T 3m2w_A 26 LGLGIN---GKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94 (299)
T ss_dssp EEEETT---EEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cccCCC---eEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence 688888 99999999999999999999653 3455677777 55589999999999986 67799999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC---CCCeEEeecceeeeec
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE---EGHAHITDFNIATVLE 154 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~---~~~~~l~d~~~~~~~~ 154 (246)
||+++++|.+++.... ..++++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++++|||++....
T Consensus 95 e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 95 ECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp CCCCSCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred eecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 9999999999997643 224589999999999999999999999999999999999998 7889999999886532
Q ss_pred cCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH--HHHhhhcCCCCCC---
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK--DVKAIIYSPVHYP--- 229 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~--- 229 (246)
. . .++.++|+||||+++|+|++|..||......... ....+......+|
T Consensus 172 ~---------------------~-----~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 172 G---------------------E-----KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp T---------------------C-----GGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred c---------------------c-----cCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 1 1 1567999999999999999999999654322211 0111222233334
Q ss_pred -CCCCHhHHHHHHHhhhC
Q psy7592 230 -TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 -~~~s~~l~~li~~~l~~ 246 (246)
..+|++++++|.+||+.
T Consensus 226 ~~~~~~~~~~li~~~l~~ 243 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKT 243 (299)
T ss_dssp HTTSCHHHHHHHHHHTCS
T ss_pred cccCCHHHHHHHHHHccc
Confidence 57899999999999964
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=275.82 Aligned_cols=213 Identities=20% Similarity=0.275 Sum_probs=171.8
Q ss_pred cCCCCccCeeeEEEEEecC-CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCe-----EEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKD-TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED-----LFMV 76 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~~~v 76 (246)
||+|++ |+||++.+.. +++.||||.+.... +.+..+.+.+|++++++++||||+++++++..... .|+|
T Consensus 88 lg~G~~---g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv 162 (681)
T 2pzi_A 88 IAHGGL---GWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIV 162 (681)
T ss_dssp EEEETT---EEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred EeeCCC---eEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEE
Confidence 677777 9999999986 79999999987543 34556778899999999999999999999987655 7999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
|||++|++|.+.+.. ++++..++.++.|++.+|.|||+.|++|+||||+||+++.+ .++|+|||++......
T Consensus 163 ~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 163 MEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred EEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 999999999877643 35899999999999999999999999999999999999875 8999999999875543
Q ss_pred ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC-CCCCHh
Q psy7592 157 QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP-TAWSES 235 (246)
Q Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~ 235 (246)
....+++.|+|||.+.+. .+.++||||||+++++|++|..||.+...... ....+ ...++.
T Consensus 235 ---~~~~gt~~y~aPE~~~~~------~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------~~~~~~~~~~~~ 296 (681)
T 2pzi_A 235 ---GYLYGTPGFQAPEIVRTG------PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------PEDDPVLKTYDS 296 (681)
T ss_dssp ---SCCCCCTTTSCTTHHHHC------SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------CTTCHHHHHCHH
T ss_pred ---CccCCCccccCHHHHcCC------CCCceehhhhHHHHHHHHhCCCCCcccccccc---------cccccccccCHH
Confidence 345688999999988654 47899999999999999999998864221110 00011 124688
Q ss_pred HHHHHHHhhhC
Q psy7592 236 TKHLLSQVHRY 246 (246)
Q Consensus 236 l~~li~~~l~~ 246 (246)
+.++|.+||+.
T Consensus 297 l~~li~~~l~~ 307 (681)
T 2pzi_A 297 YGRLLRRAIDP 307 (681)
T ss_dssp HHHHHHHHTCS
T ss_pred HHHHHhhhccC
Confidence 99999999863
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=260.89 Aligned_cols=223 Identities=14% Similarity=0.182 Sum_probs=165.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc-----hHHHHHHHHHHHHHHhhCC---------CCcce------
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI-----ERDALKNVLREMEILTTLE---------HPFLV------ 61 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~---------h~~iv------ 61 (246)
.||+|+| |+||+|++ +|+.||+|++...... .....+.+.+|++++++++ ||||+
T Consensus 27 ~lG~G~~---g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~ 101 (336)
T 2vuw_A 27 KIGEGVF---GEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101 (336)
T ss_dssp EEEEETT---EEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred eecccCc---eEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence 3788888 99999998 6899999999875421 1223466778888888875 55554
Q ss_pred -----------eeeeeeee-------------CCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHH
Q psy7592 62 -----------NLWFCFQD-------------EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALD 117 (246)
Q Consensus 62 -----------~~~~~~~~-------------~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 117 (246)
++++++.+ +...++||||+.++++.+.+.+ ..+++..++.++.|++.||.
T Consensus 102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHHHH
T ss_pred EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHHHH
Confidence 44544443 6789999999998876655533 23489999999999999999
Q ss_pred HHH-HCCcccCCCCCCcEEEcCCC--------------------CeEEeecceeeeeccCccccccccCCCccCCceecc
Q psy7592 118 YLK-TKHIIHRDIKPDNILLDEEG--------------------HAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLV 176 (246)
Q Consensus 118 ~Lh-~~~~~h~~i~~~nil~~~~~--------------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 176 (246)
||| +.|++||||||+|||++.++ .++|+|||+++..... ...+++.|+|||.+.+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence 999 99999999999999999887 8999999999876543 3467899999999875
Q ss_pred cccccCCCCcchhHHHHHHH-HHHHHhCCCCCCCCCCccHHHHHhhh----cCCCCC---CCCCCHhHHHHHHHhhhC
Q psy7592 177 ATDEVLGYSYSVDWWSLGVT-LFEILARGRPFDIHSNTSVKDVKAII----YSPVHY---PTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 177 ~~~~~~~~~~~~Di~slG~~-l~~ll~g~~p~~~~~~~~~~~~~~~~----~~~~~~---~~~~s~~l~~li~~~l~~ 246 (246)
.. +.++||||+++. .++++.|..||...... ......+. ...... +..+|+++++||++||++
T Consensus 252 ~~------~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~ 322 (336)
T 2vuw_A 252 DG------DYQFDIYRLMKKENNNRWGEYHPYSNVLWL-HYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNF 322 (336)
T ss_dssp CS------SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH-HHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGS
T ss_pred CC------ccceehhhhhCCCCcccccccCCCcchhhh-hHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhcc
Confidence 53 679999998766 77788899998421000 00111111 111111 235799999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=256.22 Aligned_cols=232 Identities=16% Similarity=0.162 Sum_probs=167.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCC-Ccceee---------e-------
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH-PFLVNL---------W------- 64 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~---------~------- 64 (246)
+||+|+| |+||++++..+|+.||||+++..........+.+.+|+..++.++| ++.... .
T Consensus 85 ~LG~G~f---G~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 85 VLGQEDP---YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred ccccCCC---EEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 4788888 9999999999999999999985544444456789999999999987 322111 1
Q ss_pred -----eeeee-----CCeEEEEEeecCCCChHHHHhhccc--cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q psy7592 65 -----FCFQD-----EEDLFMVSDLLLGGDLRYHITQDIK--FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132 (246)
Q Consensus 65 -----~~~~~-----~~~~~~v~e~~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~ 132 (246)
.++.. ...++++|+.+ +++|.+++..... ....++++..+..++.|++.||.|||+.|++|+||||+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~ 240 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 240 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccc
Confidence 11111 12367777766 7889988852210 01223477789999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeecceeeeeccCccccccccCCCccCCceecccc-----cccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy7592 133 NILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVAT-----DEVLGYSYSVDWWSLGVTLFEILARGRPF 207 (246)
Q Consensus 133 nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-----~~~~~~~~~~Di~slG~~l~~ll~g~~p~ 207 (246)
||+++.++.++|+|||++...... .....+ +.|+|||.+.+.. .....++.++||||||+++|+|++|+.||
T Consensus 241 NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf 317 (413)
T 3dzo_A 241 DIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317 (413)
T ss_dssp GEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCC
T ss_pred eEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 999999999999999998765433 333456 8999999984221 01123788999999999999999999999
Q ss_pred CCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 208 DIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
....... ....+ ......+|+.++++|.+||+.
T Consensus 318 ~~~~~~~--~~~~~----~~~~~~~~~~~~~li~~~l~~ 350 (413)
T 3dzo_A 318 TDDAALG--GSEWI----FRSCKNIPQPVRALLEGFLRY 350 (413)
T ss_dssp CTTGGGS--CSGGG----GSSCCCCCHHHHHHHHHHTCS
T ss_pred CCcchhh--hHHHH----HhhcccCCHHHHHHHHHHccC
Confidence 6543221 11111 112246889999999999974
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-33 Score=244.19 Aligned_cols=179 Identities=16% Similarity=0.135 Sum_probs=131.6
Q ss_pred eeEEEEEecCCCcEEEEEEeeccccc-------hHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEeecCCC
Q psy7592 12 SKVCIVQKKDTKQMYAMKYMHKSQCI-------ERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSDLLLGG 83 (246)
Q Consensus 12 ~~v~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~ 83 (246)
|.+..+++...|+.|++|++...... .+...+++.+|+++|+++ .|+||++++++++++...|+||||++|+
T Consensus 248 ~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~ 327 (569)
T 4azs_A 248 LAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGR 327 (569)
T ss_dssp ----CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSE
T ss_pred ccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCC
Confidence 56667777778999999999765321 233456799999999999 6999999999999999999999999999
Q ss_pred ChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-cccccc
Q psy7592 84 DLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLATSM 162 (246)
Q Consensus 84 sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~ 162 (246)
+|.+.+...+.. ++. .++.||+.||+|+|++||+||||||+|||++.+|.+||+|||+++..... ......
T Consensus 328 ~L~d~i~~~~~l-----~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~ 399 (569)
T 4azs_A 328 LLSDMLAAGEEI-----DRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNL 399 (569)
T ss_dssp EHHHHHHTTCCC-----CHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHH
T ss_pred cHHHHHHhCCCC-----CHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCc
Confidence 999999876433 443 47899999999999999999999999999999999999999999876443 233446
Q ss_pred ccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCC
Q psy7592 163 SGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG 204 (246)
Q Consensus 163 ~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~ 204 (246)
.+|+.|+|||.+.+. ....+|+||+|++.+.+.++.
T Consensus 400 vGTp~YmAPE~l~g~------~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 400 VQSFFVFVNELFAEN------KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp HHHHHHHHHHHC-----------------------CCCCTTH
T ss_pred eechhhccHHHhCCC------CCCcccccccccchhhhcccc
Confidence 789999999999765 456799999999877765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=208.35 Aligned_cols=183 Identities=15% Similarity=0.165 Sum_probs=143.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccch-----HHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIE-----RDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 76 (246)
+||+|+| |+||++.. .++.+++|......... ....+++.+|++++++++||||+++..++..+...++|
T Consensus 343 ~LG~G~f---g~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 343 LIGKGAE---ADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp -----CC---EEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred EEeeCCC---EEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4788888 99999944 68889999875433221 22346689999999999999999666666677778999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
|||++|++|.+++.. +..++.|++.+|+|||+.|++|+||||+||+++. .++|+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999998864 4578899999999999999999999999999988 9999999999887543
Q ss_pred cc--------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy7592 157 QL--------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPF 207 (246)
Q Consensus 157 ~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~ 207 (246)
.. .....+++.|+|||.+...... ++..+|+|+...-..+-+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~---Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEG---YKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHH---HHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHH---HHHHHhHHHHHHHHHHHHHhcccc
Confidence 22 1245689999999999863322 566789999888888777777666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=171.88 Aligned_cols=141 Identities=16% Similarity=0.114 Sum_probs=111.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchH---------------HHHHHHHHHHHHHhhCCCCcceeeeee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIER---------------DALKNVLREMEILTTLEHPFLVNLWFC 66 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~h~~iv~~~~~ 66 (246)
.||+|++ |.||++++ .+|+.||+|.++....... .....+.+|++++++++ | +++.++
T Consensus 97 ~iG~G~~---g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 97 LMGEGKE---SAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEECSS---EEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred EeccCCC---ceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 3788888 99999999 7899999999975321100 23567889999999999 5 677776
Q ss_pred eeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEee
Q psy7592 67 FQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITD 146 (246)
Q Consensus 67 ~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d 146 (246)
+.. +..++||||++|++|.+ +. ......++.|++.++.+||+.|++|+||+|+||+++ ++.++|+|
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~-----------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VR-----------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CC-----------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred Eec-cceEEEEEecCCCcHHH-cc-----------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 654 44689999999999987 41 123456899999999999999999999999999999 99999999
Q ss_pred cceeeeeccCccccccccCCCccCCceec
Q psy7592 147 FNIATVLEENQLATSMSGTKPYIAPEIFL 175 (246)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 175 (246)
||++... ..+.|||.+.
T Consensus 236 FG~a~~~------------~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVEV------------GEEGWREILE 252 (282)
T ss_dssp CTTCEET------------TSTTHHHHHH
T ss_pred CCCCeEC------------CCCCHHHHHH
Confidence 9998642 3356777663
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-20 Score=147.12 Aligned_cols=136 Identities=11% Similarity=0.016 Sum_probs=102.1
Q ss_pred cCCCCccCeeeEEEEEecCCCcE--EEEEEeeccccc---------------------hHHHHHHHHHHHHHHhhCCCCc
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQM--YAMKYMHKSQCI---------------------ERDALKNVLREMEILTTLEHPF 59 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~--~avK~~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~h~~ 59 (246)
||+|++ |.||++.+..+|+. ||||+++..... .......+.+|++.+++++|++
T Consensus 55 ig~G~~---g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 55 ISTGKE---ANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEECSS---EEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred Eeecce---EEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 688888 99999999778999 999997654211 0112246788999999998886
Q ss_pred ceeeeeeeeeCCeEEEEEeecCC-C----ChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCc
Q psy7592 60 LVNLWFCFQDEEDLFMVSDLLLG-G----DLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLK-TKHIIHRDIKPDN 133 (246)
Q Consensus 60 iv~~~~~~~~~~~~~~v~e~~~~-~----sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh-~~~~~h~~i~~~n 133 (246)
+....-+.. ...++||||+.+ + +|.+.... .++..+..++.|++.++.+|| +.|++|+||+|.|
T Consensus 132 i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 132 VSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp CCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred CCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 532222222 246899999932 3 66665432 135567889999999999999 9999999999999
Q ss_pred EEEcCCCCeEEeecceeeee
Q psy7592 134 ILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 134 il~~~~~~~~l~d~~~~~~~ 153 (246)
|+++. .++++|||++...
T Consensus 202 ILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EEESS--SEEECCCTTCEET
T ss_pred EEEcC--cEEEEECcccccC
Confidence 99988 8999999998753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=2.6e-17 Score=134.45 Aligned_cols=135 Identities=19% Similarity=0.112 Sum_probs=94.9
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc---------------hHHH--H--HHHHHHHHHHhhCCCCcceee
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI---------------ERDA--L--KNVLREMEILTTLEHPFLVNL 63 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~---------------~~~~--~--~~~~~e~~~l~~l~h~~iv~~ 63 (246)
||.|++ |.||.|.+. +|+.||||+++..... .... . -...+|+..+.++.+.++...
T Consensus 103 IG~Gk~---a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp 178 (397)
T 4gyi_A 103 IGVGKE---SDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP 178 (397)
T ss_dssp EEECSS---EEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred eeeCCc---eEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 788888 999999985 6999999997643210 0000 1 112357777777755554322
Q ss_pred eeeeeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC--
Q psy7592 64 WFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGH-- 141 (246)
Q Consensus 64 ~~~~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~-- 141 (246)
.-+.... .++||||++|.+|.... ..+....++.|++.++.+||+.|++||||||.|||+++++.
T Consensus 179 ~p~~~~~--~~LVME~i~G~~L~~l~-----------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 179 EPIAQSR--HTIVMSLVDALPMRQVS-----------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CEEEEET--TEEEEECCSCEEGGGCC-----------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred eeeeccC--ceEEEEecCCccHhhhc-----------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 2222222 36999999988875432 22234567899999999999999999999999999988773
Q ss_pred --------eEEeecceeeeec
Q psy7592 142 --------AHITDFNIATVLE 154 (246)
Q Consensus 142 --------~~l~d~~~~~~~~ 154 (246)
+.++||+-+....
T Consensus 246 d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CTTSEEEEEEECCCTTCEETT
T ss_pred cccccccceEEEEeCCcccCC
Confidence 7899999776543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=1.4e-12 Score=101.91 Aligned_cols=126 Identities=11% Similarity=0.023 Sum_probs=97.0
Q ss_pred eeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeecCCCChHHHHh
Q psy7592 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHIT 90 (246)
Q Consensus 12 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~sL~~~~~ 90 (246)
+.||++... ++.+++|........+ ...+.+|++.++.+. +..+.+++++..+.+..|+|||+++|.+|.+...
T Consensus 28 ~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~ 102 (263)
T 3tm0_A 28 AKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp SEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC
T ss_pred CeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC
Confidence 789999863 7889999987532111 235778999999884 6678889999888889999999999999876531
Q ss_pred hccccccCCCChHHHHHHHHHHHHHHHHHHH-------------------------------------------------
Q psy7592 91 QDIKFYSVGTRNDTIHLYAFELGLALDYLKT------------------------------------------------- 121 (246)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~------------------------------------------------- 121 (246)
+......++.++..++..||+
T Consensus 103 ----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 172 (263)
T 3tm0_A 103 ----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYD 172 (263)
T ss_dssp ----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHH
T ss_pred ----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHH
Confidence 122234667888899999998
Q ss_pred ----------CCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 122 ----------KHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 122 ----------~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
..++|+|++|.||+++.++.+.++||+.+..
T Consensus 173 ~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 173 FLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4489999999999997755567999997643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.31 E-value=8.4e-12 Score=97.20 Aligned_cols=121 Identities=15% Similarity=0.085 Sum_probs=87.1
Q ss_pred eeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCc--ceeeeeeeeeCCeEEEEEeecCCCChHHHH
Q psy7592 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPF--LVNLWFCFQDEEDLFMVSDLLLGGDLRYHI 89 (246)
Q Consensus 12 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~v~e~~~~~sL~~~~ 89 (246)
+.||++.. .+|+.|++|...... ...+.+|++.++.+.+.+ +.+++.+...++..++|||+++|.++. .
T Consensus 34 ~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 34 AAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp CEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred ceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 78999965 467889999876542 235677888888885444 456888888777889999999998884 2
Q ss_pred hhccccccCCCChHHHHHHHHHHHHHHHHHHHCC----------------------------------------------
Q psy7592 90 TQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH---------------------------------------------- 123 (246)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~---------------------------------------------- 123 (246)
... . ...++.++...+..||+..
T Consensus 105 ~~~--------~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 105 SHL--------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp SCC--------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred CcC--------C---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 110 1 1234455556666666532
Q ss_pred ------------cccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 124 ------------IIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 124 ------------~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
++|+|++|.||+++.++.+.++||+.+..
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999997765667999998654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.20 E-value=8.3e-11 Score=96.09 Aligned_cols=137 Identities=17% Similarity=0.227 Sum_probs=97.8
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEee--ccccchHHHHHHHHHHHHHHhhCCC--CcceeeeeeeeeC---CeEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMH--KSQCIERDALKNVLREMEILTTLEH--PFLVNLWFCFQDE---EDLFM 75 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~--~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~---~~~~~ 75 (246)
++.|.. +.+|++... +..+++|+.. .... ......+.+|+++++.+.. ..+++++.++.+. +..++
T Consensus 46 l~~G~s---n~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 46 FKGGQS---NPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CCC-CC---SCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred cCCccc---ceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 445555 799998864 5688999876 3221 1123467789999999974 4567888887766 34789
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH----------------------------------
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT---------------------------------- 121 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~---------------------------------- 121 (246)
|||+++|..+.+... ..++......+..++...|..||+
T Consensus 119 vme~v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 119 IMEFVSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp EEECCCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred EEEecCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 999999887753211 123666777888899999999997
Q ss_pred ------------------------CCcccCCCCCCcEEEcCCCC--eEEeecceeeee
Q psy7592 122 ------------------------KHIIHRDIKPDNILLDEEGH--AHITDFNIATVL 153 (246)
Q Consensus 122 ------------------------~~~~h~~i~~~nil~~~~~~--~~l~d~~~~~~~ 153 (246)
.+++|+|+++.||+++.++. +.++||+.+..-
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999987753 689999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.01 E-value=7.4e-10 Score=88.35 Aligned_cols=179 Identities=18% Similarity=0.196 Sum_probs=106.3
Q ss_pred eeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcc--eeeeeeeeeCC---eEEEEEeecCCCCh
Q psy7592 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFL--VNLWFCFQDEE---DLFMVSDLLLGGDL 85 (246)
Q Consensus 12 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~~---~~~~v~e~~~~~sL 85 (246)
..||++. ..+++|..... .....+.+|++.++.+. +..+ .+++....... ..|+||++++|.++
T Consensus 34 n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l 103 (304)
T 3sg8_A 34 CIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPL 103 (304)
T ss_dssp EEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEEC
T ss_pred ceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeEC
Confidence 6777753 46889986432 33467888999998883 4333 33443333322 34789999999988
Q ss_pred HHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q psy7592 86 RYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-------------------------------------------- 121 (246)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-------------------------------------------- 121 (246)
...... .++......+..|+...+..||+
T Consensus 104 ~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 104 TPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred Cccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 754321 12455555566666666666664
Q ss_pred --------------CCcccCCCCCCcEEEcC--CCCeEEeecceeeeeccCccccccccCCCccCCceecccccccCC--
Q psy7592 122 --------------KHIIHRDIKPDNILLDE--EGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG-- 183 (246)
Q Consensus 122 --------------~~~~h~~i~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~-- 183 (246)
..++|+|++|.||+++. ...+.++||+.+.................-..|+........+..
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 23799999999999988 456789999987654321100000000000112211100000000
Q ss_pred -------CCcchhHHHHHHHHHHHHhCCCCC
Q psy7592 184 -------YSYSVDWWSLGVTLFEILARGRPF 207 (246)
Q Consensus 184 -------~~~~~Di~slG~~l~~ll~g~~p~ 207 (246)
.....+.|+++.+++.+.+|..+|
T Consensus 257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 112368999999999999999887
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.92 E-value=3.9e-08 Score=76.87 Aligned_cols=126 Identities=17% Similarity=0.149 Sum_probs=89.4
Q ss_pred eeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeecCCCChHHHHh
Q psy7592 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYHIT 90 (246)
Q Consensus 12 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~sL~~~~~ 90 (246)
..||++.....+..+++|.-... ....+.+|+..++.+. +--+.+++.++.+.+..++|||+++|.++.+...
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~ 112 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLE 112 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHH
T ss_pred CeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccccc
Confidence 36899998878888999986543 2456778999888884 3346678888888889999999999988776543
Q ss_pred hccccccCCCChHHHHHHHHHHHHHHHHHHHC------------------------------------------------
Q psy7592 91 QDIKFYSVGTRNDTIHLYAFELGLALDYLKTK------------------------------------------------ 122 (246)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~------------------------------------------------ 122 (246)
... .....+..++...+..||+.
T Consensus 113 ~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 113 EYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred CCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 311 11222333344444444421
Q ss_pred ----------CcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 123 ----------HIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 123 ----------~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 268999999999998877778999997754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=3.8e-07 Score=72.68 Aligned_cols=66 Identities=11% Similarity=0.155 Sum_probs=47.1
Q ss_pred eeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCC---cceeeeeeee-eCCeEEEEEeecCCCChHH
Q psy7592 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHP---FLVNLWFCFQ-DEEDLFMVSDLLLGGDLRY 87 (246)
Q Consensus 12 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~~v~e~~~~~sL~~ 87 (246)
..||++ +..+++|+... ......+.+|++.++.+.+. .+.+++.+.. ..+..+++|++++|.++..
T Consensus 33 n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~ 102 (306)
T 3tdw_A 33 NYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGE 102 (306)
T ss_dssp EEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHH
T ss_pred eeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECch
Confidence 678887 56788998532 23456788999999999642 2455555553 3445789999999998876
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=2.5e-06 Score=70.44 Aligned_cols=76 Identities=13% Similarity=0.135 Sum_probs=44.3
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeecccc-chH---HHHHHHHHHHHHHhhCCC--Cc-ceeeeeeeeeCCeEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC-IER---DALKNVLREMEILTTLEH--PF-LVNLWFCFQDEEDLFM 75 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~---~~~~~~~~e~~~l~~l~h--~~-iv~~~~~~~~~~~~~~ 75 (246)
+|+|.. +.||++....+++.|++|....... ..+ ........|++.++.+.. +. +.+++.+ +....++
T Consensus 38 lg~G~~---n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 38 IGDGNL---NYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp CCSSSS---EEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred CCCCce---EEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 466666 8999998766678999998654221 000 012345668888887732 33 3445543 3445679
Q ss_pred EEeecCCC
Q psy7592 76 VSDLLLGG 83 (246)
Q Consensus 76 v~e~~~~~ 83 (246)
|||++.|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.24 E-value=3.5e-05 Score=61.91 Aligned_cols=31 Identities=23% Similarity=0.431 Sum_probs=27.8
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 122 KHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 122 ~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
.+++|+|+++.||+++.++.+.++||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888899999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=2e-05 Score=63.99 Aligned_cols=73 Identities=10% Similarity=0.104 Sum_probs=46.3
Q ss_pred eeeEEEEEec--C----CCcEEEEEEeeccc---cchHHHHHHHHHHHHHHhhCC-C--CcceeeeeeeeeC---CeEEE
Q psy7592 11 TSKVCIVQKK--D----TKQMYAMKYMHKSQ---CIERDALKNVLREMEILTTLE-H--PFLVNLWFCFQDE---EDLFM 75 (246)
Q Consensus 11 ~~~v~~~~~~--~----~~~~~avK~~~~~~---~~~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~---~~~~~ 75 (246)
+..+|++... . +++.+++|...... ..+ ...+.+|+..++.+. + -.+.+++.+..+. ...++
T Consensus 34 ~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~ 110 (357)
T 3ats_A 34 SSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFF 110 (357)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEE
T ss_pred cceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceE
Confidence 3788988753 1 26789999875532 101 134566777777774 3 2456677766554 34678
Q ss_pred EEeecCCCChH
Q psy7592 76 VSDLLLGGDLR 86 (246)
Q Consensus 76 v~e~~~~~sL~ 86 (246)
|||+++|..+.
T Consensus 111 v~e~l~G~~l~ 121 (357)
T 3ats_A 111 LMDYVEGVVPP 121 (357)
T ss_dssp EEECCCCBCCC
T ss_pred EEEecCCCChh
Confidence 99999887654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.89 E-value=0.00018 Score=57.26 Aligned_cols=72 Identities=13% Similarity=0.059 Sum_probs=53.9
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC---CCcceeeeeeeeeCCeEEEEEee
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE---HPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
++.|.. ..+|++.. ++..|++|...... ...+..|++.++.|. ...+++++......+..++|||+
T Consensus 44 l~gG~~---n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 44 LYSGEM---NEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp ECCSSS---SEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eCCccc---eeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 345555 78999986 47788999876532 356778888888884 25677888887777889999999
Q ss_pred cCCCCh
Q psy7592 80 LLGGDL 85 (246)
Q Consensus 80 ~~~~sL 85 (246)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 988764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00037 Score=51.97 Aligned_cols=122 Identities=14% Similarity=0.139 Sum_probs=78.2
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
..||.+.+.. ++.|+.++++|.++.|.+.+|..+-. ..-...=+.|..+++..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~----~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 32 ALSLEEILRL----YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cccHHHHHHH----cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------
Confidence 4578888866 45678999999999999998877622 1222333467889999999888763 1110
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
.....+.|||.... ..+.+.=|||||+++|.-+.-..|-+ -+..+|++|.+||
T Consensus 98 --~~~~~~~~pe~~~~------~~te~~~IysLG~tLY~ALDygL~e~-------------------eE~eLS~~LE~LL 150 (229)
T 2yle_A 98 --AGEPPPVAGKLGYS------QCMETEVIESLGIIIYKALDYGLKEN-------------------EERELSPPLEQLI 150 (229)
T ss_dssp -----------CCSSS------SSCHHHHHHHHHHHHHHHHTTTCCTT-------------------EEECCCHHHHHHH
T ss_pred --ccccCCCChhhccc------cchHHHHHHHHHHHHHHHhhcCCCcc-------------------cchhhCHHHHHHH
Confidence 12335668876531 24678889999999998877555421 2346777888887
Q ss_pred HHhh
Q psy7592 241 SQVH 244 (246)
Q Consensus 241 ~~~l 244 (246)
..|-
T Consensus 151 ~~Mt 154 (229)
T 2yle_A 151 DHMA 154 (229)
T ss_dssp HHHT
T ss_pred HHHH
Confidence 7774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.72 E-value=8.2e-05 Score=58.88 Aligned_cols=30 Identities=23% Similarity=0.254 Sum_probs=25.1
Q ss_pred CcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 123 HIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 123 ~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
.++|+|+.+.|++ ..++.+.++||..+..-
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 3899999999999 56667899999977653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00027 Score=58.69 Aligned_cols=33 Identities=12% Similarity=0.385 Sum_probs=28.2
Q ss_pred HHCCcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 120 KTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 120 h~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
+...++|||++|.||+++.++ +.++||+.+..-
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 356799999999999998776 999999987654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0018 Score=51.54 Aligned_cols=31 Identities=26% Similarity=0.414 Sum_probs=26.2
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 122 KHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 122 ~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
.+++|+|+++.||+++.++.+.++||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3699999999999998776568999987765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0019 Score=52.85 Aligned_cols=133 Identities=16% Similarity=0.189 Sum_probs=78.3
Q ss_pred eeEEEEEecC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeecCCC
Q psy7592 12 SKVCIVQKKD-------TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLLLGG 83 (246)
Q Consensus 12 ~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~ 83 (246)
..+|++.... +++.|++|..-... . ....+.+|.++++.|. +.-..+++..+.+ .+||||++|.
T Consensus 64 N~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~ 135 (379)
T 3feg_A 64 NLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-Q---GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSR 135 (379)
T ss_dssp CCEEEEECCTTSCCCSSCCSEEEEEECC----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEE
T ss_pred ccEEEEEeCCCccccCCCCCeEEEEECCCcc-c---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCc
Confidence 6789988642 35789999863321 1 1344557888888884 3333556665543 2899999886
Q ss_pred ChHHHH-----------hhccccc------cCCC--ChHHHHHHHHHHHH-------------------HHHHH----HH
Q psy7592 84 DLRYHI-----------TQDIKFY------SVGT--RNDTIHLYAFELGL-------------------ALDYL----KT 121 (246)
Q Consensus 84 sL~~~~-----------~~~~~~~------~~~~--~~~~~~~~~~qi~~-------------------~l~~L----h~ 121 (246)
.|...- ....++. ..+. ....+..+..++.. .+..| ..
T Consensus 136 ~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~ 215 (379)
T 3feg_A 136 PLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLES 215 (379)
T ss_dssp ECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHT
T ss_pred cCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhh
Confidence 654210 0000110 1111 12345555544422 12222 22
Q ss_pred C----CcccCCCCCCcEEEcCC----CCeEEeecceeee
Q psy7592 122 K----HIIHRDIKPDNILLDEE----GHAHITDFNIATV 152 (246)
Q Consensus 122 ~----~~~h~~i~~~nil~~~~----~~~~l~d~~~~~~ 152 (246)
. .++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 216 ~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 216 TPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp SCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred cCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 48999999999999876 6899999998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0011 Score=55.14 Aligned_cols=65 Identities=12% Similarity=0.178 Sum_probs=41.4
Q ss_pred eeEEEEEecC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcc-eeeeeeeeeCCeEEEEEeecCCC
Q psy7592 12 SKVCIVQKKD-------TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFL-VNLWFCFQDEEDLFMVSDLLLGG 83 (246)
Q Consensus 12 ~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~v~e~~~~~ 83 (246)
..+|++.... +++.|++|+..... . ...+.+|...++.|...++ .+++..+.+ ..|++|++|.
T Consensus 87 N~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~ 157 (429)
T 1nw1_A 87 NMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSR 157 (429)
T ss_dssp EEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEE
T ss_pred cceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCc
Confidence 7899998642 35789999884421 1 1234468888888753334 556665542 2789999875
Q ss_pred Ch
Q psy7592 84 DL 85 (246)
Q Consensus 84 sL 85 (246)
++
T Consensus 158 ~l 159 (429)
T 1nw1_A 158 PL 159 (429)
T ss_dssp EC
T ss_pred cc
Confidence 54
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0011 Score=51.93 Aligned_cols=70 Identities=11% Similarity=-0.130 Sum_probs=44.7
Q ss_pred CCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCC-Cc--ceeeeeeeeeCCeEEEEEeec
Q psy7592 4 GSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH-PF--LVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 4 g~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~--iv~~~~~~~~~~~~~~v~e~~ 80 (246)
|.|.. +.||+++.. +|+.|++|......... ...+..|++.|+.|.. .. +++++.. +. .+++||++
T Consensus 24 g~G~~---~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~l 92 (288)
T 3f7w_A 24 GHSHR---WHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEWV 92 (288)
T ss_dssp EEETT---EEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEECC
T ss_pred CCCCC---eEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEee
Confidence 44444 899999864 78999999876543222 2346678888888842 22 3334332 23 36789998
Q ss_pred CCCC
Q psy7592 81 LGGD 84 (246)
Q Consensus 81 ~~~s 84 (246)
++..
T Consensus 93 ~~~~ 96 (288)
T 3f7w_A 93 DERP 96 (288)
T ss_dssp CCCC
T ss_pred cccC
Confidence 7654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0017 Score=51.93 Aligned_cols=32 Identities=28% Similarity=0.404 Sum_probs=27.3
Q ss_pred CCcccCCCCCCcEEEcCC----CCeEEeecceeeee
Q psy7592 122 KHIIHRDIKPDNILLDEE----GHAHITDFNIATVL 153 (246)
Q Consensus 122 ~~~~h~~i~~~nil~~~~----~~~~l~d~~~~~~~ 153 (246)
..++|+|+.+.||+++.+ +.+.++||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999874 67899999987654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.00098 Score=54.23 Aligned_cols=29 Identities=21% Similarity=0.417 Sum_probs=24.2
Q ss_pred CcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 123 HIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 123 ~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
+++|+|+.+.||+++.++ +.++||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 589999999999997654 89999987764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.02 Score=45.95 Aligned_cols=32 Identities=25% Similarity=0.396 Sum_probs=27.7
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 122 KHIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 122 ~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
..++|+|+.+.|++++.++.+.++||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 35999999999999998888999999877653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.026 Score=44.82 Aligned_cols=70 Identities=13% Similarity=0.189 Sum_probs=41.9
Q ss_pred eeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCc--ceeeeee-----eeeCCeEEEEEeecCCC
Q psy7592 11 TSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPF--LVNLWFC-----FQDEEDLFMVSDLLLGG 83 (246)
Q Consensus 11 ~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~-----~~~~~~~~~v~e~~~~~ 83 (246)
...||++... +|+.+++|..+.... +. ..+..|+..++.+...+ +++++.. ...++..+.++++++|.
T Consensus 38 ~n~~y~v~~~-~g~~~vlK~~~~~~~-~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~ 112 (328)
T 1zyl_A 38 ENRVYQFQDE-DRRRFVVKFYRPERW-TA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 112 (328)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTS-CH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ccceEEEEcC-CCCEEEEEEcCCCCC-CH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCC
Confidence 3688887653 467899999875422 22 34555777776664222 3334332 12245568899999875
Q ss_pred Ch
Q psy7592 84 DL 85 (246)
Q Consensus 84 sL 85 (246)
.+
T Consensus 113 ~~ 114 (328)
T 1zyl_A 113 QF 114 (328)
T ss_dssp EC
T ss_pred CC
Confidence 53
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0096 Score=49.93 Aligned_cols=66 Identities=15% Similarity=0.207 Sum_probs=42.1
Q ss_pred eeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcc-eeeeeeeeeCCeEEEEEeecCCCCh
Q psy7592 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFL-VNLWFCFQDEEDLFMVSDLLLGGDL 85 (246)
Q Consensus 12 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~v~e~~~~~sL 85 (246)
..+|++....++..|++|+...... . .-+..+|...++.|...++ .+++.++. + ..|+||++|.+|
T Consensus 122 N~~y~v~~~~~~~~~vLRi~g~~~~---~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 122 NILIKVKDMSKQAKYLIRLYGPKTD---E-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEEEEEETTTTEEEEEEEECC-CC---S-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred eEEEEEEECCCCceEEEEECCCChh---h-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 6899998754458899998754320 0 1112468888888864445 45666653 2 249999987654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.81 E-value=0.023 Score=47.11 Aligned_cols=30 Identities=17% Similarity=0.483 Sum_probs=26.2
Q ss_pred CcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 123 HIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 123 ~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
.++|+|+.+.|++ +.++.+.++||..+..-
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~ 292 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAIN 292 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence 4889999999999 77788999999988753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.50 E-value=0.44 Score=35.33 Aligned_cols=115 Identities=10% Similarity=0.118 Sum_probs=75.4
Q ss_pred CCCcceeeeeeeeeCCeEEEEEeecC-CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcE
Q psy7592 56 EHPFLVNLWFCFQDEEDLFMVSDLLL-GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNI 134 (246)
Q Consensus 56 ~h~~iv~~~~~~~~~~~~~~v~e~~~-~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~ni 134 (246)
.||++++. .+-.+++.+.+.++.-+ +-+... +.+ .+....+.++.+|+....++ ..-+|--++|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~--------~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS--------FTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG--------SCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh--------cCHHHHHHHHHHHHHHHHHh--cCceEEEEecceE
Confidence 58888866 56666666666666543 223333 221 27777888888887755333 3347889999999
Q ss_pred EEcCCCCeEEeecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy7592 135 LLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFD 208 (246)
Q Consensus 135 l~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~ 208 (246)
+++.++.+++.-.|+... ++|. ..+...-.-..=+++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~----------------l~P~----------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNV----------------VDPL----------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTT----------------BSCC----------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccC----------------CCCC----------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999886664211 2232 13334455667788888899988884
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.84 E-value=2.1 Score=31.83 Aligned_cols=115 Identities=11% Similarity=0.086 Sum_probs=73.8
Q ss_pred CCCcceeeeeeeeeCCeEEEEEeecCCC-ChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcE
Q psy7592 56 EHPFLVNLWFCFQDEEDLFMVSDLLLGG-DLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNI 134 (246)
Q Consensus 56 ~h~~iv~~~~~~~~~~~~~~v~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~ni 134 (246)
.||++ -..+-.+++.+.+.++.-++. +.. .+.+ .+....+..+.+++.... -|...-+|--++|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~~--------~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIRK--------TTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHHT--------SCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHHh--------cCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceE
Confidence 57888 445556677777777765333 343 3322 177778888877775433 1234567889999999
Q ss_pred EEcCCCCeEEeecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy7592 135 LLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFD 208 (246)
Q Consensus 135 l~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~ 208 (246)
+++.++.+++.-.|+.. -++|.. .+...-.-+.=+++..++.++..|+
T Consensus 116 ~f~~~~~p~i~hRGi~~----------------~lpP~e----------~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKE----------------SLPPDE----------WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETT----------------TBSSCS----------CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCcc----------------cCCCCC----------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999988666432 123321 2333344566677888888888773
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.59 E-value=0.073 Score=44.65 Aligned_cols=57 Identities=5% Similarity=-0.025 Sum_probs=13.4
Q ss_pred eeeEEEEEecCCCcEEEE------EEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeee
Q psy7592 11 TSKVCIVQKKDTKQMYAM------KYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQ 68 (246)
Q Consensus 11 ~~~v~~~~~~~~~~~~av------K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 68 (246)
+|.|+.+..+....+||+ |..+... .+.+....+.+++.+.+.++|||+++.+.+..
T Consensus 152 fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~-~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 152 YTTLNREPAYKKHMPVLKETHDERDSTGQDG-VSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred chhhhcccccccCCchhhhhccCcccccccc-ccccccccccccccccccccccccCCCcceEE
Confidence 589999988766678888 7665432 23344567888999999999999999887654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=80.91 E-value=0.88 Score=37.22 Aligned_cols=30 Identities=30% Similarity=0.464 Sum_probs=25.5
Q ss_pred cccCCCCCCcEEE------cCCCCeEEeecceeeee
Q psy7592 124 IIHRDIKPDNILL------DEEGHAHITDFNIATVL 153 (246)
Q Consensus 124 ~~h~~i~~~nil~------~~~~~~~l~d~~~~~~~ 153 (246)
++|+|+.+.||++ +++..+.++||..+..-
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 6799999999999 45667999999988763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 246 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-50 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-44 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-43 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-40 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-39 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-37 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-37 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-36 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-35 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-34 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-34 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-33 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-33 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-32 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-31 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-31 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-31 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-29 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-08 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 9e-52
Identities = 67/233 (28%), Positives = 110/233 (47%), Gaps = 13/233 (5%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
V + ++K +K + A+K + K+Q + + RE+EI + L HP ++ L+ F D
Sbjct: 18 KFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 77
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
++++ + G + + + KF Y EL AL Y +K +IHRDI
Sbjct: 78 ATRVYLILEYAPLGTVYRELQKLSKF-----DEQRTATYITELANALSYCHSKRVIHRDI 132
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
KP+N+LL G I DF + ++ T + GT Y+ PE+ E + VD
Sbjct: 133 KPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMI-----EGRMHDEKVD 186
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
WSLGV +E L PF+ +NT + K I +P +E + L+S+
Sbjct: 187 LWSLGVLCYEFLVGKPPFE--ANTYQETYKRISRVEFTFPDFVTEGARDLISR 237
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-51
Identities = 62/235 (26%), Positives = 105/235 (44%), Gaps = 9/235 (3%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
KV Q K+T + A K + + L++ + E++IL + +HP +V L F
Sbjct: 24 AFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYY 80
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
E +L+++ + GG + + + + + I + + AL+YL IIHRD+
Sbjct: 81 ENNLWILIEFCAGGAVDAVMLELERPLT----ESQIQVVCKQTLDALNYLHDNKIIHRDL 136
Query: 130 KPDNILLDEEGHAHITDFNIATVLEE-NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
K NIL +G + DF ++ Q S GT ++APE+ + T + Y Y
Sbjct: 137 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 196
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSV-KDVKAIIYSPVHYPTAWSESTKHLLSQ 242
D WSLG+TL E+ P + V + + P+ WS + K L +
Sbjct: 197 DVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 251
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 9e-50
Identities = 59/233 (25%), Positives = 94/233 (40%), Gaps = 10/233 (4%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
V + ++ A+K M S + +++++E+ L L HP + C+
Sbjct: 27 SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 86
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
E ++V + LG + I L YL + ++IHRD+
Sbjct: 87 EHTAWLVMEYCLGSASDLLEVHKKPL-----QEVEIAAVTHGALQGLAYLHSHNMIHRDV 141
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
K NILL E G + DF A+++ A S GT ++APE+ L + Y VD
Sbjct: 142 KAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEG--QYDGKVD 196
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
WSLG+T E+ R P + S A SP WSE ++ +
Sbjct: 197 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 9e-50
Identities = 73/236 (30%), Positives = 117/236 (49%), Gaps = 15/236 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
S V + ++ T + YA+K + K I+ + + V RE ++++ L+HPF V L+F FQD
Sbjct: 20 SFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 79
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+E L+ G+L +I + F Y E+ AL+YL K IIHRD+
Sbjct: 80 DEKLYFGLSYAKNGELLKYIRKIGSF-----DETCTRFYTAEIVSALEYLHGKGIIHRDL 134
Query: 130 KPDNILLDEEGHAHITDFNIATVL---EENQLATSMSGTKPYIAPEIFLVATDEVLGYSY 186
KP+NILL+E+ H ITDF A VL + A S GT Y++PE+
Sbjct: 135 KPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-----SACK 189
Query: 187 SVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
S D W+LG +++++A PF + + + II +P + + L+ +
Sbjct: 190 SSDLWALGCIIYQLVAGLPPFRAGNEYLI--FQKIIKLEYDFPEKFFPKARDLVEK 243
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-48
Identities = 52/228 (22%), Positives = 96/228 (42%), Gaps = 14/228 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
V V K + + A K +H I+ ++RE+++L P++V + F
Sbjct: 18 NGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH-IIHRD 128
+ ++ + + + GG L + + + + + + L YL+ KH I+HRD
Sbjct: 76 DGEISICMEHMDGGSLDQVLKKAGRI-----PEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 129 IKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
+KP NIL++ G + DF ++ L ++ A S GT+ Y++PE YS
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGT-----HYSVQS 184
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSEST 236
D WS+G++L E+ P ++ + T T
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (390), Expect = 2e-46
Identities = 77/233 (33%), Positives = 130/233 (55%), Gaps = 14/233 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
+V +++ + + YAMK + K + +++ E +L+ + HPF++ +W FQD
Sbjct: 16 SFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 75
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+ +FM+ D + GG+L + S N YA E+ LAL+YL +K II+RD+
Sbjct: 76 AQQIFMIMDYIEGGELF-----SLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDL 130
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
KP+NILLD+ GH ITDF A + + ++ GT YIAPE+ Y+ S+D
Sbjct: 131 KPENILLDKNGHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVV-----STKPYNKSID 183
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
WWS G+ ++E+LA PF + + ++K + I+ + + +P ++E K LLS+
Sbjct: 184 WWSFGILIYEMLAGYTPF--YDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 234
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 4e-46
Identities = 60/238 (25%), Positives = 103/238 (43%), Gaps = 17/238 (7%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
+V + + T++ A+K + + D +N+ +E+ I L H +V + ++
Sbjct: 17 AYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRRE 74
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
++ + GG+L I DI + +L + YL I HRDI
Sbjct: 75 GNIQYLFLEYCSGGELFDRIEPDIGM-----PEPDAQRFFHQLMAGVVYLHGIGITHRDI 129
Query: 130 KPDNILLDEEGHAHITDFNIATVLEEN---QLATSMSGTKPYIAPEIFLVATDEVLGYSY 186
KP+N+LLDE + I+DF +ATV N +L M GT PY+APE+ ++
Sbjct: 130 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE----FHAE 185
Query: 187 SVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII--YSPVHYPTAWSESTKHLLSQ 242
VD WS G+ L +LA G + S ++ + ++ + LL +
Sbjct: 186 PVDVWSCGIVLTAMLA-GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-46
Identities = 56/241 (23%), Positives = 104/241 (43%), Gaps = 16/241 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
+ +++K ++ K + E + + ++ E+ +L L+HP +V + D
Sbjct: 16 SYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHPNIVRYYDRIID 74
Query: 70 EED--LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH---- 123
+ L++V + GGDL IT+ K + +L LAL +
Sbjct: 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR-VMTQLTLALKECHRRSDGGH 133
Query: 124 -IIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LATSMSGTKPYIAPEIFLVATDEV 181
++HRD+KP N+ LD + + + DF +A +L + A + GT Y++PE
Sbjct: 134 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM-----NR 188
Query: 182 LGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241
+ Y+ D WSLG L+E+ A PF S + K P +S+ +++
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-KIREGKFRRIPYRYSDELNEIIT 247
Query: 242 Q 242
+
Sbjct: 248 R 248
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 6e-46
Identities = 58/235 (24%), Positives = 104/235 (44%), Gaps = 16/235 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
+ V T Q A++ M+ Q ++ + ++ E+ ++ ++P +VN +
Sbjct: 32 ASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
++L++V + L GG L +T+ I E AL++L + +IHRDI
Sbjct: 89 GDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDI 142
Query: 130 KPDNILLDEEGHAHITDFNIATVLE-ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
K DNILL +G +TDF + E ++M GT ++APE+ Y V
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-----TRKAYGPKV 197
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSP-VHYPTAWSESTKHLLSQ 242
D WSLG+ E++ P+ + + A +P + P S + L++
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 151 bits (382), Expect = 2e-45
Identities = 64/245 (26%), Positives = 114/245 (46%), Gaps = 19/245 (7%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDA------LKNVLREMEILTTL-EHPFLVN 62
+S V K T + YA+K + + A + L+E++IL + HP ++
Sbjct: 15 VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ 74
Query: 63 LWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTK 122
L ++ F+V DL+ G+L ++T+ + L + L
Sbjct: 75 LKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL-----SEKETRKIMRALLEVICALHKL 129
Query: 123 HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVAT-DEV 181
+I+HRD+KP+NILLD++ + +TDF + L+ + + GT Y+APEI + D
Sbjct: 130 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH 189
Query: 182 LGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTA----WSESTK 237
GY VD WS GV ++ +LA PF + ++ I+ + + +S++ K
Sbjct: 190 PGYGKEVDMWSTGVIMYTLLAGSPPFW--HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 247
Query: 238 HLLSQ 242
L+S+
Sbjct: 248 DLVSR 252
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 152 bits (386), Expect = 4e-45
Identities = 73/237 (30%), Positives = 119/237 (50%), Gaps = 14/237 (5%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLRE---MEILTTLEHPFLVNLWFC 66
G +V +K DT +MYAMK + K + + L E + +++T + PF+V + +
Sbjct: 16 GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA 75
Query: 67 FQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
F + L + DL+ GGDL YH++Q F + YA E+ L L+++ + +++
Sbjct: 76 FHTPDKLSFILDLMNGGDLHYHLSQHGVFS-----EADMRFYAAEIILGLEHMHNRFVVY 130
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSY 186
RD+KP NILLDE GH I+D +A + + + GT Y+APE+ Y
Sbjct: 131 RDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGV----AYDS 185
Query: 187 SVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHLLSQ 242
S DW+SLG LF++L PF H ++ + + V P ++S + LL
Sbjct: 186 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 242
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 152 bits (384), Expect = 5e-45
Identities = 53/237 (22%), Positives = 105/237 (44%), Gaps = 16/237 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
V V ++ T +A K++ ++ + V +E++ ++ L HP LVNL F+D
Sbjct: 38 AFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLRHPTLVNLHDAFED 94
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+ ++ M+ + + GG+L + + S D Y ++ L ++ + +H D+
Sbjct: 95 DNEMVMIYEFMSGGELFEKVADEHNKMSE----DEAVEYMRQVCKGLCHMHENNYVHLDL 150
Query: 130 KPDNILL--DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
KP+NI+ + DF + L+ Q +GT + APE+ Y
Sbjct: 151 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK-----PVGYY 205
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSV-KDVKAIIYS-PVHYPTAWSESTKHLLSQ 242
D WS+GV + +L+ PF ++ ++VK+ ++ + SE K + +
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 7e-45
Identities = 84/235 (35%), Positives = 120/235 (51%), Gaps = 14/235 (5%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILT-TLEHPFLVNLWFCFQ 68
KV + + K T Q +A+K + K + D ++ + E +L+ EHPFL +++ FQ
Sbjct: 14 SFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 73
Query: 69 DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRD 128
+E+LF V + L GGDL YHI KF YA E+ L L +L +K I++RD
Sbjct: 74 TKENLFFVMEYLNGGDLMYHIQSCHKF-----DLSRATFYAAEIILGLQFLHSKGIVYRD 128
Query: 129 IKPDNILLDEEGHAHITDFNIATVLE-ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
+K DNILLD++GH I DF + + + GT YIAPEI L Y++S
Sbjct: 129 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-----KYNHS 183
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
VDWWS GV L+E+L PF H + +I YP + K LL +
Sbjct: 184 VDWWSFGVLLYEMLIGQSPF--HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 236
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 151 bits (382), Expect = 1e-44
Identities = 51/237 (21%), Positives = 100/237 (42%), Gaps = 16/237 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
V +K T +++ K+++ +++ V E+ I+ L HP L+NL F+D
Sbjct: 41 AFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHDAFED 97
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+ ++ ++ + L GG+L I + S + Y + L ++ I+H DI
Sbjct: 98 KYEMVLILEFLSGGELFDRIAAEDYKMSE----AEVINYMRQACEGLKHMHEHSIVHLDI 153
Query: 130 KPDNILLD--EEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
KP+NI+ + + I DF +AT L +++ + T + APEI + +
Sbjct: 154 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-----DREPVGFY 208
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSV--KDVKAIIYSPVHYPTAWSESTKHLLSQ 242
D W++GV + +L+ PF + + ++ S K +
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 265
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-43
Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 15/233 (6%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76
V K A+K ++ + + L+ E+ +L H ++ + L +V
Sbjct: 24 VYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLF-MGYSTAPQLAIV 81
Query: 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILL 136
+ G L +H+ + + D A + +DYL K IIHRD+K +NI L
Sbjct: 82 TQWCEGSSLYHHLHIIETKFEMIKLID----IARQTAQGMDYLHAKSIIHRDLKSNNIFL 137
Query: 137 DEEGHAHITDFNIATVLEE---NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSL 193
E+ I DF +ATV + +SG+ ++APE+ + YS+ D ++
Sbjct: 138 HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR--MQDKNPYSFQSDVYAF 195
Query: 194 GVTLFEILARGRPFDIHSNTSV--KDVKAIIYSP--VHYPTAWSESTKHLLSQ 242
G+ L+E++ P+ +N V SP + ++ K L+++
Sbjct: 196 GIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAE 248
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-42
Identities = 47/241 (19%), Positives = 99/241 (41%), Gaps = 21/241 (8%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
V +T A + + + + + E E+L L+HP +V + ++
Sbjct: 21 SFKTVYKGLDTETTVEVAWCELQDRKLTKSE-RQRFKEEAEMLKGLQHPNIVRFYDSWES 79
Query: 70 ----EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH-- 123
++ + +V++L+ G L+ ++ + + + + ++ L +L T+
Sbjct: 80 TVKGKKCIVLVTELMTSGTLKTYLKRFKVM-----KIKVLRSWCRQILKGLQFLHTRTPP 134
Query: 124 IIHRDIKPDNILL-DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVL 182
IIHRD+K DNI + G I D +AT L+ A ++ GT ++APE++
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYE------E 187
Query: 183 GYSYSVDWWSLGVTLFEILARGRPF-DIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241
Y SVD ++ G+ + E+ P+ + + + P + K ++
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 247
Query: 242 Q 242
Sbjct: 248 G 248
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 3e-42
Identities = 59/238 (24%), Positives = 112/238 (47%), Gaps = 17/238 (7%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
S+V + + K T+++ A+K + K ++ E+ +L ++HP +V L ++
Sbjct: 21 AFSEVILAEDKRTQKLVAIKCIAKKA--LEGKEGSMENEIAVLHKIKHPNIVALDDIYES 78
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
L+++ L+ GG+L I + + F++ A+ YL I+HRD+
Sbjct: 79 GGHLYLIMQLVSGGELFDRIVEKGFY-----TERDASRLIFQVLDAVKYLHDLGIVHRDL 133
Query: 130 KPDNILL---DEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSY 186
KP+N+L DE+ I+DF ++ + + + ++ GT Y+APE+ YS
Sbjct: 134 KPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK-----PYSK 188
Query: 187 SVDWWSLGVTLFEILARGRPFDIHSNTSVKD--VKAIIYSPVHYPTAWSESTKHLLSQ 242
+VD WS+GV + +L PF ++ + + +KA Y S+S K +
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-42
Identities = 71/234 (30%), Positives = 121/234 (51%), Gaps = 13/234 (5%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
KV +V++K T + YAMK + K I +D + + + E +L HPFL L + FQ
Sbjct: 17 TFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+ L V + GG+L +H++++ F + Y E+ AL+YL ++ +++RDI
Sbjct: 77 HDRLCFVMEYANGGELFFHLSRERVF-----TEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 130 KPDNILLDEEGHAHITDFNIATVL-EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
K +N++LD++GH ITDF + + + GT Y+APE+ E Y +V
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL-----EDNDYGRAV 186
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
DWW LGV ++E++ PF ++ + + I+ + +P S K LL+
Sbjct: 187 DWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-41
Identities = 49/237 (20%), Positives = 92/237 (38%), Gaps = 17/237 (7%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
V + +K+ Y K++ + V +E+ IL H +++L F+
Sbjct: 17 EFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
E+L M+ + + G D+ I + I Y ++ AL +L + +I H DI
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELN----EREIVSYVHQVCEALQFLHSHNIGHFDI 128
Query: 130 KPDNILLDEEGHAH--ITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
+P+NI+ + I +F A L+ + Y APE+ + S +
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH-----QHDVVSTA 183
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSVKD--VKAIIYSPVHYPTAWSESTKHLLSQ 242
D WSLG ++ +L+ PF +N + + + A S + +
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 137 bits (346), Expect = 3e-40
Identities = 51/243 (20%), Positives = 91/243 (37%), Gaps = 20/243 (8%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
G S+V + + + A+K + + RE + L HP +V ++ +
Sbjct: 19 GMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 78
Query: 70 EED----LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHII 125
E ++V + + G LR + + + AL++ II
Sbjct: 79 ETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-----TPKRAIEVIADACQALNFSHQNGII 133
Query: 126 HRDIKPDNILLDEEGHAHITDFNIATVLEENQ----LATSMSGTKPYIAPEIFLVATDEV 181
HRD+KP NI++ + DF IA + ++ ++ GT Y++PE
Sbjct: 134 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD---- 189
Query: 182 LGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV--KDVKAIIYSPVHYPTAWSESTKHL 239
D +SLG L+E+L PF S SV + V+ P S +
Sbjct: 190 -SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 248
Query: 240 LSQ 242
+ +
Sbjct: 249 VLK 251
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 4e-40
Identities = 72/233 (30%), Positives = 129/233 (55%), Gaps = 14/233 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
+V +V+ K++ YAMK + K + ++ +++ L E IL + PFLV L F F+D
Sbjct: 53 SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+L+MV + + GG++ H+ + +F YA ++ L +YL + +I+RD+
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRF-----SEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
KP+N+L+D++G+ +TDF A ++ ++ GT +APEI L GY+ +VD
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRT--WTLCGTPEALAPEIILSK-----GYNKAVD 220
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
WW+LGV ++E+ A PF ++ ++ + I+ V +P+ +S K LL
Sbjct: 221 WWALGVLIYEMAAGYPPFF--ADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 8e-40
Identities = 50/242 (20%), Positives = 102/242 (42%), Gaps = 19/242 (7%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERD---ALKNVLREMEILTTLEHPFLVNLWFC 66
+ V ++K T YA K++ K + + +++ RE+ IL ++HP ++ L
Sbjct: 22 QFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV 81
Query: 67 FQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
++++ D+ ++ +L+ GG+L + + + + ++ + YL + I H
Sbjct: 82 YENKTDVILILELVAGGELFDFLAEKESLT-----EEEATEFLKQILNGVYYLHSLQIAH 136
Query: 127 RDIKPDNILLDEEG----HAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVL 182
D+KP+NI+L + I DF +A ++ ++ GT ++APEI
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-----NYE 191
Query: 183 GYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV--KDVKAIIYSPVHYPTAWSESTKHLL 240
D WS+GV + +L+ PF + Y + S K +
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 241 SQ 242
+
Sbjct: 252 RR 253
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 4e-39
Identities = 81/242 (33%), Positives = 127/242 (52%), Gaps = 17/242 (7%)
Query: 10 GTSKVCIVQK---KDTKQMYAMKYMHKSQCIER-DALKNVLREMEILTTLEH-PFLVNLW 64
KV +V+K DT ++YAMK + K+ +++ ++ E ++L + PFLV L
Sbjct: 36 AYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 95
Query: 65 FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHI 124
+ FQ E L ++ D + GG+L H++Q +F + +Y E+ LAL++L I
Sbjct: 96 YAFQTETKLHLILDYINGGELFTHLSQRERF-----TEHEVQIYVGEIVLALEHLHKLGI 150
Query: 125 IHRDIKPDNILLDEEGHAHITDFNIATVLE--ENQLATSMSGTKPYIAPEIFLVATDEVL 182
I+RDIK +NILLD GH +TDF ++ E + A GT Y+AP+I
Sbjct: 151 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS--- 207
Query: 183 GYSYSVDWWSLGVTLFEILARGRPF--DIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240
G+ +VDWWSLGV ++E+L PF D N+ + + I+ S YP S K L+
Sbjct: 208 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLI 267
Query: 241 SQ 242
+
Sbjct: 268 QR 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 5e-39
Identities = 45/235 (19%), Positives = 97/235 (41%), Gaps = 16/235 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
V + + + A+K + + E D + E E++ L HP LV L+ +
Sbjct: 17 QFGLVHLGYWLNKDK-VAIKTIREGAMSEED----FIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+ + +V + + G L ++ ++ +T+ ++ + YL+ +IHRD+
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAA----ETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMS--GTKPYIAPEIFLVATDEVLGYSYS 187
N L+ E ++DF + + ++Q +S + +PE+F + YS
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-----RYSSK 182
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
D WS GV ++E+ + G+ + + S ++ P S +++
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-38
Identities = 47/236 (19%), Positives = 95/236 (40%), Gaps = 22/236 (9%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-FCFQ 68
V + + K A+K + + L E ++T L H LV L +
Sbjct: 19 EFGDVMLGDYRGNK--VAVKCIKNDATAQA-----FLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 69 DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRD 128
++ L++V++ + G L ++ + D + ++ ++ A++YL+ + +HRD
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDVCEAMEYLEGNNFVHRD 128
Query: 129 IKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
+ N+L+ E+ A ++DF + Q + + APE +S
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREK-----KFSTKS 181
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSESTKHLLSQ 242
D WS G+ L+EI + GR + +KDV + + P + ++
Sbjct: 182 DVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN 235
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 8e-38
Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 12/209 (5%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERD--ALKNVLREMEILTTLEHPFLVNLWFCF 67
+ V + K+T Q+ A+K + E + LRE+++L L HP ++ L F
Sbjct: 10 QFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF 69
Query: 68 QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
+ ++ +V D + + I Y L+YL I+HR
Sbjct: 70 GHKSNISLVFDFMETDLEVIIKDNSLVLTP-----SHIKAYMLMTLQGLEYLHQHWILHR 124
Query: 128 DIKPDNILLDEEGHAHITDFNIATVL-EENQLATSMSGTKPYIAPEIFLVATDEVLGYSY 186
D+KP+N+LLDE G + DF +A N+ T T+ Y APE+ A Y
Sbjct: 125 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR----MYGV 180
Query: 187 SVDWWSLGVTLFEILARGRPFDIHSNTSV 215
VD W++G L E+L R S+
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQ 209
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 3e-37
Identities = 46/239 (19%), Positives = 90/239 (37%), Gaps = 23/239 (9%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKN---VLREMEILTTL--EHPFLVNLW 64
G V + A+K++ K + + L N V E+ +L + ++ L
Sbjct: 16 GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 75
Query: 65 FCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHI 124
F+ + ++ + + + + + +++ A+ + +
Sbjct: 76 DWFERPDSFVLILERPEPVQDLFDFITERGALQE----ELARSFFWQVLEAVRHCHNCGV 131
Query: 125 IHRDIKPDNILLDEE-GHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG 183
+HRDIK +NIL+D G + DF +L++ T GT+ Y PE
Sbjct: 132 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHR----Y 186
Query: 184 YSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
+ S WSLG+ L++++ PF+ II V + S +HL+
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEHDEE--------IIRGQVFFRQRVSSECQHLIRW 237
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (328), Expect = 3e-37
Identities = 40/238 (16%), Positives = 92/238 (38%), Gaps = 12/238 (5%)
Query: 10 GTSKVCIVQKKDTKQ---MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFC 66
+VC K + A+K + ++ L E I+ +HP +++L
Sbjct: 38 EFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGV 95
Query: 67 FQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
+ ++++ + G L + Q+ ++V + + + YL + +H
Sbjct: 96 VTKSTPVMIITEFMENGSLDSFLRQNDGQFTV----IQLVGMLRGIAAGMKYLADMNYVH 151
Query: 127 RDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG-YS 185
RD+ NIL++ ++DF ++ LE++ + + P + ++
Sbjct: 152 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT 211
Query: 186 YSVDWWSLGVTLFEILARGR-PFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
+ D WS G+ ++E+++ G P+ +N V + Y P + L+
Sbjct: 212 SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL-PPPMDCPSALHQLMLD 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 5e-37
Identities = 42/236 (17%), Positives = 103/236 (43%), Gaps = 18/236 (7%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
V + + A+K + + E + + E +++ L H LV L+
Sbjct: 16 QFGVVKYGKWRGQYD-VAIKMIKEGSMSEDE----FIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+ +F++++ + G L ++ + + + ++ A++YL++K +HRD+
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRHRFQT----QQLLEMCKDVCEAMEYLESKQFLHRDL 126
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMS--GTKPYIAPEIFLVATDEVLGYSYS 187
N L++++G ++DF ++ + +++ +S+ + PE+ +S
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL-----MYSKFSSK 181
Query: 188 VDWWSLGVTLFEILARGR-PFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
D W+ GV ++EI + G+ P++ +N+ + A + P SE ++
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLASEKVYTIMYS 236
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 5e-37
Identities = 47/239 (19%), Positives = 98/239 (41%), Gaps = 20/239 (8%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
GT K Q K + A+K + + + +L E ++ L++P++V + +
Sbjct: 21 GTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVRMIGICEA 79
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
E +V ++ G L ++ Q+ ++ I ++ + + YL+ + +HRD+
Sbjct: 80 E-SWMLVMEMAELGPLNKYLQQNRHV-----KDKNIIELVHQVSMGMKYLEESNFVHRDL 133
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQ----LATSMSGTKPYIAPEIFLVATDEVLGYS 185
N+LL + +A I+DF ++ L ++ T + APE +S
Sbjct: 134 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI-----NYYKFS 188
Query: 186 YSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSESTKHLLSQ 242
D WS GV ++E + G+ + +V A++ + P L++
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 245
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 6e-37
Identities = 51/238 (21%), Positives = 100/238 (42%), Gaps = 18/238 (7%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
G+ + + + + + A+K + + E+ + ++RE +I+ L++P++V L Q
Sbjct: 23 GSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
E L +V ++ GG L + + V + ++ + + YL+ K+ +HRD+
Sbjct: 81 EA-LMLVMEMAGGGPLHKFLVGKREEIPV----SNVAELLHQVSMGMKYLEEKNFVHRDL 135
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQ----LATSMSGTKPYIAPEIFLVATDEVLGYS 185
N+LL +A I+DF ++ L + ++ + APE +S
Sbjct: 136 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-----KFS 190
Query: 186 YSVDWWSLGVTLFEILARGR-PFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
D WS GVT++E L+ G+ P+ V P L+S
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-ECPPECPPELYALMSD 247
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 8e-37
Identities = 40/240 (16%), Positives = 94/240 (39%), Gaps = 19/240 (7%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHK--SQCIERDALKNVLREMEILTTLEHPFLVNLWFCF 67
V + + K + A K +L E ++ ++++P + L
Sbjct: 21 AFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC 80
Query: 68 QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHR 127
+ +++ L+ G L ++ + + + + ++ ++YL+ + ++HR
Sbjct: 81 LTS-TVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRRLVHR 135
Query: 128 DIKPDNILLDEEGHAHITDFNIATVLEENQ---LATSMSGTKPYIAPEIFLVATDEVLGY 184
D+ N+L+ H ITDF +A +L + A ++A E L Y
Sbjct: 136 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-----IY 190
Query: 185 SYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSESTKHLLSQ 242
++ D WS GVT++E++ G + ++ +I+ + P + ++ +
Sbjct: 191 THQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 248
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 6e-36
Identities = 50/237 (21%), Positives = 97/237 (40%), Gaps = 20/237 (8%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
+V + T + A+K + L+E +++ L H LV L +
Sbjct: 29 CFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA----FLQEAQVMKKLRHEKLVQL-YAVVS 82
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
EE +++V++ + G L + + Y R + A ++ + Y++ + +HRD+
Sbjct: 83 EEPIYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVERMNYVHRDL 139
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQL--ATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
+ NIL+ E + DF +A ++E+N+ + APE L ++
Sbjct: 140 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-----RFTIK 194
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSESTKHLLSQ 242
D WS G+ L E+ +GR + ++V + + P ES L+ Q
Sbjct: 195 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (316), Expect = 1e-35
Identities = 44/237 (18%), Positives = 91/237 (38%), Gaps = 18/237 (7%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
+V K A+K + + ++ L+E ++ ++HP LV L
Sbjct: 29 QYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
E +++++ + G+L ++ + + + A ++ A++YL+ K+ IHRD+
Sbjct: 85 EPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEKKNFIHRDL 141
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQL--ATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
N L+ E + DF ++ ++ + + APE +S
Sbjct: 142 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKFSIK 196
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSESTKHLLSQ 242
D W+ GV L+EI G + + V ++ + P E L+
Sbjct: 197 SDVWAFGVLLWEIATYGMSP--YPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-35
Identities = 47/235 (20%), Positives = 95/235 (40%), Gaps = 15/235 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+ A+K + + +A+ + +RE+ + +L+H L+ L+
Sbjct: 26 RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P 84
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
+ MV++L G L + + + + T+ YA ++ + YL++K IHRD+
Sbjct: 85 MKMVTELAPLGSLLDRLRKHQGHFLL----GTLSRYAVQVAEGMGYLESKRFIHRDLAAR 140
Query: 133 NILLDEEGHAHITDFNIATVLEENQ----LATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
N+LL I DF + L +N + + APE +S++
Sbjct: 141 NLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-----TFSHAS 195
Query: 189 DWWSLGVTLFEILARGR-PFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
D W GVTL+E+ G+ P+ + + + + P + +++ Q
Sbjct: 196 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ 250
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-35
Identities = 55/204 (26%), Positives = 85/204 (41%), Gaps = 10/204 (4%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
V + K T ++ A+K + +RE+ +L L HP +V L
Sbjct: 14 TYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
E L++V + L ++ + G I Y F+L L + + ++HRD+
Sbjct: 73 ENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128
Query: 130 KPDNILLDEEGHAHITDFNIATVL-EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSV 188
KP N+L++ EG + DF +A + T T Y APEI L YS +V
Sbjct: 129 KPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK----YYSTAV 184
Query: 189 DWWSLGVTLFEILARGRPFDIHSN 212
D WSLG E++ R F S
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSE 208
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-35
Identities = 49/245 (20%), Positives = 87/245 (35%), Gaps = 17/245 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQ 68
+V + K + +D ++ E+E+L L HP ++NL +
Sbjct: 22 NFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 81
Query: 69 DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRN-----------DTIHLYAFELGLALD 117
L++ + G+L + + + + +A ++ +D
Sbjct: 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 141
Query: 118 YLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVA 177
YL K IHRD+ NIL+ E A I DF ++ E T ++A E
Sbjct: 142 YLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL--- 198
Query: 178 TDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTK 237
Y+ + D WS GV L+EI++ G + K + P +
Sbjct: 199 --NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVY 256
Query: 238 HLLSQ 242
L+ Q
Sbjct: 257 DLMRQ 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-34
Identities = 56/247 (22%), Positives = 95/247 (38%), Gaps = 30/247 (12%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQ 68
KV + K T++ +A+K + RE+E+ + P +V + ++
Sbjct: 24 INGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYE 75
Query: 69 D----EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHI 124
+ + L +V + L GG+L I +G A+ YL + +I
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLHSINI 132
Query: 125 IHRDIKPDNILLD---EEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEV 181
HRD+KP+N+L +TDF A + T+ T Y+APE+
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-----GP 187
Query: 182 LGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV------KDVKAIIYSPVHYPTAWSES 235
Y S D WSLGV ++ +L PF + ++ + P + SE
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247
Query: 236 TKHLLSQ 242
K L+
Sbjct: 248 VKMLIRN 254
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 1e-34
Identities = 43/235 (18%), Positives = 89/235 (37%), Gaps = 16/235 (6%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
+V + + A+K + + L E ++ L+H LV L +
Sbjct: 25 QFGEVWMGYYNGHTK-VAVKSLKQGSMSPDA----FLAEANLMKQLQHQRLVRL-YAVVT 78
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+E ++++++ + G L + + + + A ++ + +++ ++ IHRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQ--LATSMSGTKPYIAPEIFLVATDEVLGYSYS 187
+ NIL+ + I DF +A ++E+N+ + APE T ++
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-----FTIK 190
Query: 188 VDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
D WS G+ L EI+ GR + P E L+
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 3e-34
Identities = 47/236 (19%), Positives = 93/236 (39%), Gaps = 17/236 (7%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW-FCFQDEE 71
++ K A+K +++ + + L E I+ HP +++L C + E
Sbjct: 45 HGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 102
Query: 72 DLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
+V + GDLR I + +V + ++ + +L +K +HRD+
Sbjct: 103 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG----FGLQVAKGMKFLASKKFVHRDLAA 158
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLA-----TSMSGTKPYIAPEIFLVATDEVLGYSY 186
N +LDE+ + DF +A + + + T ++A E + ++
Sbjct: 159 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL-----QTQKFTT 213
Query: 187 SVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
D WS GV L+E++ RG P NT V + + P + ++ +
Sbjct: 214 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 4e-34
Identities = 42/251 (16%), Positives = 96/251 (38%), Gaps = 34/251 (13%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFM 75
+ K A+K + + + + ++ E++++T L H +VNL +++
Sbjct: 61 ISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118
Query: 76 VSDLLLGGDLRYHITQDIKFYSVGTRN------------------DTIHLYAFELGLALD 117
+ + GDL ++ + +S + + +A+++ ++
Sbjct: 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 178
Query: 118 YLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---LATSMSGTKPYIAPEIF 174
+L+ K +HRD+ N+L+ I DF +A + + + + ++APE
Sbjct: 179 FLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238
Query: 175 LVATDEVLGYSYSVDWWSLGVTLFEILARGR-PFDIHSNTSVKDVKAIIYSPVH--YPTA 231
Y+ D WS G+ L+EI + G P+ + +I + P
Sbjct: 239 FEG-----IYTIKSDVWSYGILLWEIFSLGVNPYP--GIPVDANFYKLIQNGFKMDQPFY 291
Query: 232 WSESTKHLLSQ 242
+E ++
Sbjct: 292 ATEEIYIIMQS 302
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-34
Identities = 47/217 (21%), Positives = 79/217 (36%), Gaps = 23/217 (10%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
+V + + T Q A+K + E LRE++IL L+H +VNL +
Sbjct: 22 TFGEVFKARHRKTGQKVALKKVLMENEKEGF-PITALREIKILQLLKHENVVNLIEICRT 80
Query: 70 --------EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT 121
+ +++V D +KF I L L Y+
Sbjct: 81 KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT-----LSEIKRVMQMLLNGLYYIHR 135
Query: 122 KHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-----TSMSGTKPYIAPEIFLV 176
I+HRD+K N+L+ +G + DF +A + + T+ T Y PE+ L
Sbjct: 136 NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL- 194
Query: 177 ATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNT 213
Y +D W G + E+ R ++
Sbjct: 195 ---GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 228
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 1e-33
Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 20/213 (9%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCF-- 67
V + D+ ++ A+K + + + + RE++I+ L+H +V L + F
Sbjct: 32 SFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRYFFYS 84
Query: 68 ----QDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH 123
+DE L +V D + R ++ + LY ++L +L Y+ +
Sbjct: 85 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFRSLAYIHSFG 142
Query: 124 IIHRDIKPDNILLDEEGHAH-ITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVL 182
I HRDIKP N+LLD + + DF A L + S ++ Y APE+
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF----GAT 198
Query: 183 GYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV 215
Y+ S+D WS G L E+L F S
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 4e-33
Identities = 45/232 (19%), Positives = 94/232 (40%), Gaps = 14/232 (6%)
Query: 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEED 72
+ + ++ A+K C + L+E + +HP +V L +
Sbjct: 25 QGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-P 81
Query: 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPD 132
++++ +L G+LR + + ++ LYA++L AL YL++K +HRDI
Sbjct: 82 VWIIMELCTLGELRSFLQVRKYSLDL----ASLILYAYQLSTALAYLESKRFVHRDIAAR 137
Query: 133 NILLDEEGHAHITDFNIATVLEENQL--ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDW 190
N+L+ + DF ++ +E++ A+ ++APE ++ + D
Sbjct: 138 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-----RFTSASDV 192
Query: 191 WSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQ 242
W GV ++EIL G + + + P + L+++
Sbjct: 193 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 244
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 5e-33
Identities = 45/228 (19%), Positives = 89/228 (39%), Gaps = 9/228 (3%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
V + ++T ++ A+K + + + LRE+ +L L+H +V L
Sbjct: 14 TYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
++ L +V + +Y + + + + + F+L L + +++++HRD+
Sbjct: 73 DKKLTLVFEFCDQDLKKYFDSCNGDLD-----PEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
KP N+L++ G + +F +A S + P L YS S+D
Sbjct: 128 KPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL---YSTSID 184
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTK 237
WS G E+ GRP ++ + + W TK
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-32
Identities = 44/244 (18%), Positives = 92/244 (37%), Gaps = 25/244 (10%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFM 75
+ K D A+K + S + ++ E+++L+ L H +VNL +
Sbjct: 47 LIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104
Query: 76 VSDLLLGGDLRYHITQDIKFYSVGTRN-------------DTIHLYAFELGLALDYLKTK 122
+++ GDL + + + + + + +++++ + +L +K
Sbjct: 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164
Query: 123 HIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---LATSMSGTKPYIAPEIFLVATD 179
+ IHRD+ NILL I DF +A ++ + + + ++APE
Sbjct: 165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV- 223
Query: 180 EVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKH 238
Y++ D WS G+ L+E+ + G K K I + P
Sbjct: 224 ----YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD 279
Query: 239 LLSQ 242
++
Sbjct: 280 IMKT 283
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 5e-32
Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 19/212 (8%)
Query: 10 GTSKVCIVQ-KKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL---EHPFLVNLWF 65
KV + K+ + A+K + Q E + +RE+ +L L EHP +V L+
Sbjct: 19 AYGKVFKARDLKNGGRFVALKRVRV-QTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77
Query: 66 CFQDEED-----LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLK 120
L +V + + Y +TI F+L LD+L
Sbjct: 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVP----TETIKDMMFQLLRGLDFLH 133
Query: 121 TKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDE 180
+ ++HRD+KP NIL+ G + DF +A + TS+ T Y APE+ L +
Sbjct: 134 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS--- 190
Query: 181 VLGYSYSVDWWSLGVTLFEILARGRPFDIHSN 212
Y+ VD WS+G E+ R F S+
Sbjct: 191 --SYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (291), Expect = 6e-32
Identities = 37/248 (14%), Positives = 80/248 (32%), Gaps = 29/248 (11%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76
+ + M A+K + + D + RE ++ ++P +V L + + ++
Sbjct: 37 LLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94
Query: 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHL-------------------YAFELGLALD 117
+ + GDL + + + A ++ +
Sbjct: 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 154
Query: 118 YLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN---QLATSMSGTKPYIAPEIF 174
YL + +HRD+ N L+ E I DF ++ + + + + ++ PE
Sbjct: 155 YLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 214
Query: 175 LVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSE 234
Y+ D W+ GV L+EI + G + + P
Sbjct: 215 FYN-----RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPL 269
Query: 235 STKHLLSQ 242
+L+
Sbjct: 270 ELYNLMRL 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-31
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
VC K A+K + + + + LRE++IL H ++ + +
Sbjct: 20 AYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRA 77
Query: 70 E-----EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHI 124
+D+++V+ L+ + TQ + ND I + +++ L Y+ + ++
Sbjct: 78 PTIEQMKDVYLVTHLMGADLYKLLKTQHLS-------NDHICYFLYQILRGLKYIHSANV 130
Query: 125 IHRDIKPDNILLDEEGHAHITDFNIATVLEENQ----LATSMSGTKPYIAPEIFLVATDE 180
+HRD+KP N+LL+ I DF +A V + + T T+ Y APEI
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM----LN 186
Query: 181 VLGYSYSVDWWSLGVTLFEILARGRPFDIHSN 212
GY+ S+D WS+G L E+L+ F
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-31
Identities = 44/207 (21%), Positives = 73/207 (35%), Gaps = 20/207 (9%)
Query: 20 KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTT--LEHPFLVNLWFCFQDEED----L 73
K + A+K + ++ RE EI T L H ++ + L
Sbjct: 23 KWRGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76
Query: 74 FMVSDLLLGGDLRYHITQDIKFYSVGTR--NDTIHLYAFELGLALDYLKTKHIIHRDIKP 131
++VSD G L ++ + + T A + I HRD+K
Sbjct: 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136
Query: 132 DNILLDEEGHAHITDFNIATVLEENQ-----LATSMSGTKPYIAPEIFL-VATDEVLGYS 185
NIL+ + G I D +A + GTK Y+APE+ +
Sbjct: 137 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 196
Query: 186 YSVDWWSLGVTLFEILARGRPFDIHSN 212
D +++G+ +EI R IH +
Sbjct: 197 KRADIYAMGLVFWEIARRCSIGGIHED 223
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-31
Identities = 43/243 (17%), Positives = 90/243 (37%), Gaps = 23/243 (9%)
Query: 10 GTSKVCIVQKKDT----KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWF 65
+V K + + A+K + + L E I+ H ++ L
Sbjct: 19 EFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEG 76
Query: 66 CFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHII 125
+ + ++++ + G L + + +SV + + + YL + +
Sbjct: 77 VISKYKPMMIITEYMENGALDKFLREKDGEFSV----LQLVGMLRGIAAGMKYLANMNYV 132
Query: 126 HRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMS----GTKPYIAPEIFLVATDEV 181
HRD+ NIL++ ++DF ++ VLE++ AT + + APE
Sbjct: 133 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI-----SY 187
Query: 182 LGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVH--YPTAWSESTKHL 239
++ + D WS G+ ++E++ G + S +V I P + L
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGERP--YWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
Query: 240 LSQ 242
+ Q
Sbjct: 246 MMQ 248
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 114 bits (287), Expect = 4e-31
Identities = 51/241 (21%), Positives = 92/241 (38%), Gaps = 24/241 (9%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQ 68
S+V + +K + + K + RE++IL L P ++ L +
Sbjct: 47 KYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVK 100
Query: 69 DEED--LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIH 126
D +V + + D + + I Y +E+ ALDY + I+H
Sbjct: 101 DPVSRTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMGIMH 152
Query: 127 RDIKPDNILLDEEG-HAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYS 185
RD+KP N+++D E + D+ +A Q ++ + PE+ + + Y
Sbjct: 153 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV----DYQMYD 208
Query: 186 YSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLSQVHR 245
YS+D WSLG L ++ R PF D I + + K+ + R
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 246 Y 246
+
Sbjct: 267 F 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 6e-30
Identities = 45/252 (17%), Positives = 96/252 (38%), Gaps = 26/252 (10%)
Query: 8 FCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFC 66
+ K + A+K + L +++ EME++ + +H ++NL
Sbjct: 30 VLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 87
Query: 67 FQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRN-----------DTIHLYAFELGLA 115
+ L+++ + G+LR ++ + N + A+++
Sbjct: 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARG 147
Query: 116 LDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS---MSGTKPYIAPE 172
++YL +K IHRD+ N+L+ E+ I DF +A + ++APE
Sbjct: 148 MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 207
Query: 173 IFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPT 230
Y++ D WS GV L+EI G + V+++ ++ + P+
Sbjct: 208 ALFDR-----IYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEELFKLLKEGHRMDKPS 260
Query: 231 AWSESTKHLLSQ 242
+ ++
Sbjct: 261 NCTNELYMMMRD 272
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 110 bits (275), Expect = 1e-29
Identities = 41/203 (20%), Positives = 79/203 (38%), Gaps = 10/203 (4%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
V Q + +A+K + + + +RE+ IL L+H +V L+
Sbjct: 14 TYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
++ L +V + L + + + T + +L + Y + ++HRD+
Sbjct: 72 KKRLVLVFEHLDQDLKKLLDVCEGGL-----ESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
KP N+L++ EG I DF +A + + L+ + YS ++D
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK---KYSTTID 183
Query: 190 WWSLGVTLFEILARGRPFDIHSN 212
WS+G E++ F S
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSE 206
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 1e-29
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 8/206 (3%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
VC T A+K +++ E A K RE+ +L + H ++ L F
Sbjct: 30 AYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA-KRAYRELRLLKHMRHENVIGLLDVFTP 88
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+E L +D L + + D I +++ L Y+ IIHRD+
Sbjct: 89 DETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE-DRIQFLVYQMLKGLRYIHAAGIIHRDL 147
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
KP N+ ++E+ I DF +A + T T+ Y APE+ L + Y+ +VD
Sbjct: 148 KPGNLAVNEDCELKILDFGLARQADSEM--TGYVVTRWYRAPEVIL----NWMRYTQTVD 201
Query: 190 WWSLGVTLFEILARGRPFDIHSNTSV 215
WS+G + E++ F +
Sbjct: 202 IWSVGCIMAEMITGKTLFKGSDHLDQ 227
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (272), Expect = 4e-29
Identities = 47/249 (18%), Positives = 82/249 (32%), Gaps = 28/249 (11%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLV-NLWFCFQ 68
+ + + A+K + + E +I ++ + + +C
Sbjct: 19 SFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 73
Query: 69 DEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRD 128
+ + MV +LL KF T+ L A ++ ++Y+ +K+ IHRD
Sbjct: 74 EGDYNVMVMELLGPSLEDLFNFCSRKF-----SLKTVLLLADQMISRIEYIHSKNFIHRD 128
Query: 129 IKPDNIL---LDEEGHAHITDFNIATVLEENQL--------ATSMSGTKPYIAPEIFLVA 177
+KPDN L + +I DF +A + + +++GT Y + L
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 178 TDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTK 237
S D SLG L G + K K S T K
Sbjct: 189 -----EQSRRDDLESLGYVLMYFN-LGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 238 HLLSQVHRY 246
S+ Y
Sbjct: 243 GYPSEFATY 251
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 108 bits (271), Expect = 5e-29
Identities = 40/226 (17%), Positives = 77/226 (34%), Gaps = 27/226 (11%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
+ Q A+K+ + + L++ R ++L + N+++ Q+
Sbjct: 17 SFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLA--GCTGIPNVYYFGQE 72
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
+V DLL KF T+ + A ++ + + K +++RDI
Sbjct: 73 GLHNVLVIDLLGPSLEDLLDLCGRKFS-----VKTVAMAAKQMLARVQSIHEKSLVYRDI 127
Query: 130 KPDNILLDE-----EGHAHITDFNIATVLEE--------NQLATSMSGTKPYIAPEIFLV 176
KPDN L+ ++ DF + + + ++SGT Y++ L
Sbjct: 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187
Query: 177 ATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII 222
S D +LG L P+ + K I
Sbjct: 188 R-----EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 2e-28
Identities = 39/236 (16%), Positives = 81/236 (34%), Gaps = 19/236 (8%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMV 76
V K + + A+K ++++ L E ++ +V L + ++
Sbjct: 44 VVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 101
Query: 77 SDLLLGGDLRYHITQDIKFYSVGTRN-----DTIHLYAFELGLALDYLKTKHIIHRDIKP 131
+L+ GDL+ ++ + + A E+ + YL +HRD+
Sbjct: 102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 161
Query: 132 DNILLDEEGHAHITDFNIATVLEENQLATSMS---GTKPYIAPEIFLVATDEVLGYSYSV 188
N ++ E+ I DF + + E +++PE + ++
Sbjct: 162 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-----KDGVFTTYS 216
Query: 189 DWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSP--VHYPTAWSESTKHLLSQ 242
D WS GV L+EI + S + V + + P + L+
Sbjct: 217 DVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRM 270
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 1e-27
Identities = 43/209 (20%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
VC + A+K + + + K RE+ ++ + H +++L F
Sbjct: 29 AQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87
Query: 70 E------EDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH 123
+ +D+++V +L+ + + ++ + +++ + +L +
Sbjct: 88 QKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLYQMLCGIKHLHSAG 139
Query: 124 IIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLG 183
IIHRD+KP NI++ + I DF +A + + T T+ Y APE+ L G
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-----G 194
Query: 184 YSYSVDWWSLGVTLFEILARGRPFDIHSN 212
Y +VD WS+G + E++ F
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDY 223
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 2e-27
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 8/203 (3%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD 69
VC T A+K + + A K RE+ +L ++H ++ L F
Sbjct: 30 AYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLKHMKHENVIGLLDVFTP 88
Query: 70 EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDI 129
L +D+ L L +I +D + +++ L Y+ + IIHRD+
Sbjct: 89 ARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDL 147
Query: 130 KPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVD 189
KP N+ ++E+ I DF +A ++ T T+ Y APEI L + Y+ +VD
Sbjct: 148 KPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIML----NWMHYNQTVD 201
Query: 190 WWSLGVTLFEILARGRPFDIHSN 212
WS+G + E+L F +
Sbjct: 202 IWSVGCIMAELLTGRTLFPGTDH 224
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 4e-25
Identities = 43/244 (17%), Positives = 88/244 (36%), Gaps = 26/244 (10%)
Query: 17 VQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLW--FCFQDEEDLF 74
+ K T + A+K + + + ++ E++IL + H V C + L
Sbjct: 37 IDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 94
Query: 75 MVSDLLLGGDLRYHITQDIKFYSVGTRN-----------DTIHLYAFELGLALDYLKTKH 123
++ + G+L ++ + + + Y+F++ +++L ++
Sbjct: 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 154
Query: 124 IIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---LATSMSGTKPYIAPEIFLVATDE 180
IHRD+ NILL E+ I DF +A + ++ ++APE
Sbjct: 155 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--- 211
Query: 181 VLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY--PTAWSESTKH 238
Y+ D WS GV L+EI + G ++ + P +
Sbjct: 212 --VYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ 268
Query: 239 LLSQ 242
+
Sbjct: 269 TMLD 272
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 89.7 bits (221), Expect = 2e-21
Identities = 42/230 (18%), Positives = 80/230 (34%), Gaps = 25/230 (10%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHP----------- 58
S V + + AMK + + A E+++L +
Sbjct: 25 HFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE----DEIKLLQRVNDADNTKEDSMGAN 80
Query: 59 FLVNLWFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDY 118
++ L F + + ++ + K+ G + + +L L LDY
Sbjct: 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDY 140
Query: 119 LKTKH-IIHRDIKPDNILLDEEGH----AHITDFNIATVLEENQLATSMSGTKPYIAPEI 173
+ + IIH DIKP+N+L++ I ++ ++ T+ T+ Y +PE+
Sbjct: 141 MHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEV 200
Query: 174 FLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY 223
L A + D WS +FE++ F+ S I
Sbjct: 201 LLGA-----PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 50.9 bits (121), Expect = 1e-08
Identities = 25/201 (12%), Positives = 54/201 (26%), Gaps = 32/201 (15%)
Query: 10 GTSKVCIVQKKDTKQMYAMKYMHKS-------QCIERDALKNVLREMEILTTLEHPFLVN 62
S V + + +K+ + + E L
Sbjct: 12 KESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 70
Query: 63 L----WFCFQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDY 118
L E ++ +L+ +L ++ + +
Sbjct: 71 LQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEV------------LDMILEEVAK 118
Query: 119 LKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVAT 178
+ I+H D+ N+L+ EEG I DF + + E + + ++ + T
Sbjct: 119 FYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG-------WREILERDVRNIIT 170
Query: 179 DEVLGYSYSVDWWSLGVTLFE 199
Y D S + +
Sbjct: 171 YFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 246 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.5 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.36 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.44 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.84 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.68 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=339.58 Aligned_cols=229 Identities=30% Similarity=0.484 Sum_probs=201.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+++.||+|++.+....+....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 13 ~iG~G~f---g~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~ 89 (263)
T d2j4za1 13 PLGKGKF---GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 89 (263)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEecCCC---cEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 3788998 9999999999999999999987654444456778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++...... ++..+..++.|++.||.|||+.|++||||||+||+++.++.++++|||++...... ....
T Consensus 90 ~g~L~~~l~~~~~l-----~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~ 163 (263)
T d2j4za1 90 LGTVYRELQKLSKF-----DEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTT 163 (263)
T ss_dssp TCBHHHHHHHHSSC-----CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEE
T ss_pred CCcHHHHHhhcCCC-----CHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cccc
Confidence 99999999875544 99999999999999999999999999999999999999999999999999765433 2344
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+. +.......+......+|..+|+++++||+
T Consensus 164 ~~Gt~~Y~APE~~~~~~-----~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 164 LCGTLDYLPPEMIEGRM-----HDEKVDLWSLGVLCYEFLVGKPPFEAN--TYQETYKRISRVEFTFPDFVTEGARDLIS 236 (263)
T ss_dssp TTEEGGGCCHHHHTTCC-----CCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred cCCCCcccCHHHHcCCC-----CCchhhhhhHhHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 67899999999998765 788999999999999999999999743 33445566677788889999999999999
Q ss_pred HhhhC
Q psy7592 242 QVHRY 246 (246)
Q Consensus 242 ~~l~~ 246 (246)
+||++
T Consensus 237 ~~L~~ 241 (263)
T d2j4za1 237 RLLKH 241 (263)
T ss_dssp HHTCS
T ss_pred HHccC
Confidence 99974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=342.31 Aligned_cols=230 Identities=33% Similarity=0.563 Sum_probs=200.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+|+.||||+++.....+....+.+.+|++++++++||||+++++++.+++.+|+||||++
T Consensus 15 ~lG~G~f---g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 15 ILGEGSF---STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 91 (288)
T ss_dssp EEEECSS---CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEeeCCC---eEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccC
Confidence 4789998 9999999999999999999987654444556789999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc---c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---L 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~---~ 158 (246)
|++|.+++.....+ ++..++.++.|++.||+|||+.|++||||||+||++++++.++++|||+++...... .
T Consensus 92 gg~L~~~~~~~~~l-----~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 92 NGELLKYIRKIGSF-----DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp TEEHHHHHHHHSSC-----CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCHHHhhhccCCC-----CHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence 99999998776544 999999999999999999999999999999999999999999999999998765332 2
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKH 238 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ 238 (246)
.....||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+. +.......+......+|..+|+++++
T Consensus 167 ~~~~~GT~~Y~APE~~~~~~-----~~~~~DiwSlGvilyell~g~~Pf~~~--~~~~~~~~i~~~~~~~p~~~s~~~~~ 239 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLTEKS-----ACKSSDLWALGCIIYQLVAGLPPFRAG--NEYLIFQKIIKLEYDFPEKFFPKARD 239 (288)
T ss_dssp ---CCCCGGGCCHHHHHTCC-----CCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHTTCCCCCTTCCHHHHH
T ss_pred cccccCCccccCceeeccCC-----CCcccceehhhHHHHHHhhCCCCCCCc--CHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 23456899999999997765 889999999999999999999999753 34455566777788899999999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
||++||++
T Consensus 240 li~~~L~~ 247 (288)
T d1uu3a_ 240 LVEKLLVL 247 (288)
T ss_dssp HHHTTSCS
T ss_pred HHHHHccC
Confidence 99999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=345.05 Aligned_cols=230 Identities=31% Similarity=0.614 Sum_probs=204.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+|+.||+|++++....+....+.+.+|+.++++++||||+++++++.+++.+|+||||++
T Consensus 12 ~lG~G~f---g~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~ 88 (337)
T d1o6la_ 12 LLGKGTF---GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEecCcC---eEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccC
Confidence 4799999 9999999999999999999987665445556788999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc-Ccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE-NQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~ 160 (246)
|++|.+++.+.... ++..++.++.|++.||+|||++|++||||||+||+++.+|.++|+|||+++.... .....
T Consensus 89 gg~L~~~~~~~~~~-----~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~ 163 (337)
T d1o6la_ 89 GGELFFHLSRERVF-----TEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp TCBHHHHHHHHSCC-----CHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred CCchhhhhhcccCC-----cHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccc
Confidence 99999999876554 9999999999999999999999999999999999999999999999999987543 33344
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLL 240 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 240 (246)
...||+.|+|||.+.+.. ++.++|+|||||++|+|++|+.||.+.+ .......+......+|..+|+++++||
T Consensus 164 ~~~GT~~Y~aPE~~~~~~-----y~~~~DiwSlGvilyeml~G~~pf~~~~--~~~~~~~i~~~~~~~p~~~s~~~~dli 236 (337)
T d1o6la_ 164 TFCGTPEYLAPEVLEDND-----YGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILMEEIRFPRTLSPEAKSLL 236 (337)
T ss_dssp CCEECGGGCCGGGGSSSC-----BCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred cceeCHHHhhhhhccCCC-----CChhhcccchhhHHHHHHHCCCCCCCcC--HHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence 567899999999998765 8899999999999999999999997544 344566777778899999999999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
++||++
T Consensus 237 ~~~L~~ 242 (337)
T d1o6la_ 237 AGLLKK 242 (337)
T ss_dssp HHHTCS
T ss_pred HhhccC
Confidence 999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-53 Score=334.87 Aligned_cols=225 Identities=26% Similarity=0.402 Sum_probs=192.3
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|+| |+||+|+++.+|+.||+|+++...... .+.+.+|++++++++||||+++++++.+++.+|+||||++|
T Consensus 28 iG~G~f---g~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 28 IGQGAS---GTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp CCCSSS---CEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EecCcC---cEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 788888 999999999999999999998654332 35688999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-cccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-LATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~ 161 (246)
++|.+++.+. ++++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++....... ....
T Consensus 102 g~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 102 GSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp CBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred CcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 9999887543 35999999999999999999999999999999999999999999999999998875433 3445
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc---CCCCCCCCCCHhHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY---SPVHYPTAWSESTKH 238 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~l~~ 238 (246)
..||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+.. .....+.. .....|..+|+++++
T Consensus 176 ~~gt~~Y~aPE~~~~~~-----~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKA-----YGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGTPELQNPEKLSAIFRD 248 (293)
T ss_dssp CCSCGGGCCHHHHSSSC-----BCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHHCSCCCSSGGGSCHHHHH
T ss_pred cccCCCccChhhhcCCC-----CCchhceehHhHHHHHHhhCCCCCCCCCHH--HHHHHHHhCCCCCCCCcccCCHHHHH
Confidence 67899999999998764 788999999999999999999999754432 22222222 244556789999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
||++||+.
T Consensus 249 li~~~L~~ 256 (293)
T d1yhwa1 249 FLNRCLDM 256 (293)
T ss_dssp HHHHHTCS
T ss_pred HHHHHccC
Confidence 99999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=332.65 Aligned_cols=230 Identities=27% Similarity=0.378 Sum_probs=188.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+|+.||+|.++.... .+..+.+.+|++++++++||||+++++++.+++..|+||||++
T Consensus 12 ~lG~G~f---g~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 12 TLGEGAY---GEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEecCcC---eEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 4788888 9999999999999999999976542 2334678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc---c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---L 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~---~ 158 (246)
|++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++...... .
T Consensus 87 gg~L~~~l~~~~~-----l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 87 GGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp TEEGGGGSBTTTB-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCcHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 9999999876544 4999999999999999999999999999999999999999999999999998765332 2
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCC--CCCCCCCHhH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPV--HYPTAWSEST 236 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~l 236 (246)
.....||+.|+|||.+.+.. .++.++||||||+++|+|++|+.||......... ......... ..+..+|+++
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~----~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRRE----FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTYLNPWKKIDSAP 236 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSS----BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHHTTCTTSTTGGGSCHHH
T ss_pred ccceeeCcCccCHhHhcCCC----CCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCCCCCCccccCCHHH
Confidence 33457899999999987654 1356899999999999999999999765443332 222222222 2235789999
Q ss_pred HHHHHHhhhC
Q psy7592 237 KHLLSQVHRY 246 (246)
Q Consensus 237 ~~li~~~l~~ 246 (246)
++||++||++
T Consensus 237 ~~li~~~L~~ 246 (271)
T d1nvra_ 237 LALLHKILVE 246 (271)
T ss_dssp HHHHHHHSCS
T ss_pred HHHHHHHcCC
Confidence 9999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-52 Score=334.72 Aligned_cols=229 Identities=25% Similarity=0.413 Sum_probs=194.9
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|+| |+||+|+++.+|+.||||+++.....+....+.+.+|++++++++||||+++++++.+++..|+||||+.+
T Consensus 23 lG~G~f---g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 99 (309)
T d1u5ra_ 23 IGHGSF---GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99 (309)
T ss_dssp EEECSS---SEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EecCCC---eEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence 789999 89999999999999999999887766677778899999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATSM 162 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 162 (246)
++|........ ++++..++.++.|++.||.|||++|++||||||+|||++.++.++|+|||++..... ....
T Consensus 100 g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~ 171 (309)
T d1u5ra_ 100 SASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSF 171 (309)
T ss_dssp EHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCC
T ss_pred CchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCcc
Confidence 99977665543 359999999999999999999999999999999999999999999999999976543 2345
Q ss_pred ccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCC--CCCCCCCCHhHHHHH
Q psy7592 163 SGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSP--VHYPTAWSESTKHLL 240 (246)
Q Consensus 163 ~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~l~~li 240 (246)
.||+.|+|||.+.+... ..++.++|||||||++|+|++|..||.+.. .......+.... ...+..+|+++++||
T Consensus 172 ~GT~~Y~APE~~~~~~~--~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~s~~~~~li 247 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNESPALQSGHWSEYFRNFV 247 (309)
T ss_dssp CSCGGGCCHHHHTTTTS--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred ccCccccCHHHHhccCC--CCcCchhhhhhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 78999999999865421 237889999999999999999999997543 333344444442 223457999999999
Q ss_pred HHhhhC
Q psy7592 241 SQVHRY 246 (246)
Q Consensus 241 ~~~l~~ 246 (246)
++||++
T Consensus 248 ~~~L~~ 253 (309)
T d1u5ra_ 248 DSCLQK 253 (309)
T ss_dssp HHHTCS
T ss_pred HHHCcC
Confidence 999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-52 Score=335.94 Aligned_cols=228 Identities=35% Similarity=0.675 Sum_probs=201.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+|+.||||+++.....+....+.+.+|+.++++++||||+++++++.+++..|+||||+.
T Consensus 11 ~lG~G~f---g~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 87 (316)
T d1fota_ 11 TLGTGSF---GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 87 (316)
T ss_dssp EEEECSS---CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEecCcC---cEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecC
Confidence 3788888 9999999999999999999987654444456788999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
|++|...+...... ++..++.++.|++.|++|||++|++||||||+||+++.++.++|+|||+++..... ...
T Consensus 88 gg~l~~~~~~~~~~-----~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~ 160 (316)
T d1fota_ 88 GGELFSLLRKSQRF-----PNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYT 160 (316)
T ss_dssp SCBHHHHHHHTSSC-----CHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCC
T ss_pred Cccccccccccccc-----cccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--ccc
Confidence 99999998876554 88899999999999999999999999999999999999999999999999876543 334
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+. +.......+......+|..+|++++++|+
T Consensus 161 ~~Gt~~Y~APE~l~~~~-----y~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTKP-----YNKSIDWWSFGILIYEMLAGYTPFYDS--NTMKTYEKILNAELRFPPFFNEDVKDLLS 233 (316)
T ss_dssp CCSCTTTCCHHHHTTCC-----BCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred ccCcccccCHHHHcCCC-----CCchhhccccchhHHHHHhCCCCCCCc--CHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 67899999999987765 788999999999999999999999753 34455666777788889999999999999
Q ss_pred HhhhC
Q psy7592 242 QVHRY 246 (246)
Q Consensus 242 ~~l~~ 246 (246)
+||++
T Consensus 234 ~~L~~ 238 (316)
T d1fota_ 234 RLITR 238 (316)
T ss_dssp HHTCS
T ss_pred HHhhh
Confidence 99964
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-53 Score=334.75 Aligned_cols=232 Identities=28% Similarity=0.448 Sum_probs=195.6
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|+| |+||+|+++.+|+.||+|+++... .+..+.+.+|++++++++||||+++++++.+++..++||||++|
T Consensus 20 iG~G~f---g~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 20 LGDGAF---GKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEETT---EEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EeeCCC---cEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 788888 999999999999999999997654 23356788999999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-ccccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~ 161 (246)
++|.+++.+.. .++++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .....
T Consensus 94 g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 94 GAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 99999876532 23599999999999999999999999999999999999999999999999999775433 22334
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC---CCCCCCCCCHhHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS---PVHYPTAWSESTKH 238 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~l~~ 238 (246)
..|++.|+|||.+.........++.++|||||||++|+|++|+.||.+.+... ....+... ....|..+|+++++
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HHHHHHcCCCCCCCccccCCHHHHH
Confidence 67899999999987655444558899999999999999999999997654333 33444443 33445689999999
Q ss_pred HHHHhhhC
Q psy7592 239 LLSQVHRY 246 (246)
Q Consensus 239 li~~~l~~ 246 (246)
||++||++
T Consensus 248 li~~~L~~ 255 (288)
T d2jfla1 248 FLKKCLEK 255 (288)
T ss_dssp HHHHHSCS
T ss_pred HHHHHccC
Confidence 99999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-52 Score=332.62 Aligned_cols=228 Identities=26% Similarity=0.444 Sum_probs=176.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+|+.||||.+...... ...+.+.+|++++++++||||+++++++.+++.+|+||||++
T Consensus 16 ~lG~G~f---g~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 16 VLGTGAF---SEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp ESBSGGG---GGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEeeccC---eEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 4789888 99999999999999999999876532 223567889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc---CCCCeEEeecceeeeeccCcc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD---EEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~---~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|++|.+++..... +++..+..++.|++.||+|||+.|++||||||+||++. +++.++++|||++........
T Consensus 91 gg~L~~~l~~~~~-----l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 91 GGELFDRIVEKGF-----YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp SCBHHHHHHTCSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred CCcHHHhhhcccC-----CCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 9999999976544 49999999999999999999999999999999999995 477899999999987766555
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCC----CCCCCCCH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPV----HYPTAWSE 234 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~s~ 234 (246)
.....||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+... ......+..... +.+..+|+
T Consensus 166 ~~~~~GT~~y~APE~~~~~~-----~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~ 238 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKP-----YSKAVDCWSIGVIAYILLCGYPPFYDEND--AKLFEQILKAEYEFDSPYWDDISD 238 (307)
T ss_dssp -------CTTSCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred eeeeeeCccccCcHHHcCCC-----CCcHHHhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHhccCCCCCCccccCCCH
Confidence 55677999999999998764 78999999999999999999999975432 333344444433 33467999
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
++++||++||++
T Consensus 239 ~~~~li~~~L~~ 250 (307)
T d1a06a_ 239 SAKDFIRHLMEK 250 (307)
T ss_dssp HHHHHHHHHSCS
T ss_pred HHHHHHHHHccC
Confidence 999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=328.54 Aligned_cols=233 Identities=24% Similarity=0.407 Sum_probs=185.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee--CCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD--EEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~ 79 (246)
.||+|+| |+||+|+++.+|+.||+|.++.... ++...+.+.+|++++++++||||+++++++.+ +..+|+||||
T Consensus 11 ~iG~G~f---g~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy 86 (269)
T d2java1 11 TIGTGSY---GRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 86 (269)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEEC
T ss_pred EEecCCC---eEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEec
Confidence 3788999 9999999999999999999987653 34456789999999999999999999999865 4568999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC-----cccCCCCCCcEEEcCCCCeEEeecceeeeec
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH-----IIHRDIKPDNILLDEEGHAHITDFNIATVLE 154 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~-----~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~ 154 (246)
+++++|.+++.+... ....+++..++.++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++....
T Consensus 87 ~~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 87 CEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CTTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred CCCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 999999999875432 2345699999999999999999999976 9999999999999999999999999998765
Q ss_pred cCc-cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCC
Q psy7592 155 ENQ-LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAW 232 (246)
Q Consensus 155 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (246)
... ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+ .......+... ...+|..+
T Consensus 166 ~~~~~~~~~~gt~~Y~APE~l~~~~-----~~~~~DIwSlGvilyel~tg~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~ 238 (269)
T d2java1 166 HDTSFAKAFVGTPYYMSPEQMNRMS-----YNEKSDIWSLGCLLYELCALMPPFTAFS--QKELAGKIREGKFRRIPYRY 238 (269)
T ss_dssp ----------CCCSCCCHHHHTTCC-----CCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTCCCCCCTTS
T ss_pred cCCCccccCCCCcccCCHHHHcCCC-----CChHHHHHhhCHHHHHHhhCCCCCCCCC--HHHHHHHHHcCCCCCCCccc
Confidence 433 234467899999999997664 8899999999999999999999997543 23334444444 34567889
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
|+++++||++||+.
T Consensus 239 s~~l~~li~~~L~~ 252 (269)
T d2java1 239 SDELNEIITRMLNL 252 (269)
T ss_dssp CHHHHHHHHHHTCS
T ss_pred CHHHHHHHHHHcCC
Confidence 99999999999973
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-52 Score=336.62 Aligned_cols=228 Identities=32% Similarity=0.630 Sum_probs=202.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+|+.||||++.+....+....+.+.+|++++++++||||+++++++.+....++||||+.
T Consensus 48 ~lG~G~f---g~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~ 124 (350)
T d1rdqe_ 48 TLGTGSF---GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEECSS---CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EeecCcC---cEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccc
Confidence 4788988 9999999999999999999987654444556788999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
|++|...+.....+ ++..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|||+++..... ...
T Consensus 125 ~g~l~~~l~~~~~l-----~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~ 197 (350)
T d1rdqe_ 125 GGEMFSHLRRIGRF-----SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWT 197 (350)
T ss_dssp TCBHHHHHHHHCCC-----CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCC
T ss_pred ccchhhhHhhcCCC-----CHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--ccc
Confidence 99999999776544 99999999999999999999999999999999999999999999999999876543 334
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHLLS 241 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 241 (246)
..|++.|+|||.+.+.. ++.++|||||||++|+|++|..||.+. +.......+......+|..+|++++++|+
T Consensus 198 ~~Gt~~Y~APE~~~~~~-----~~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSKG-----YNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp CEECGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred ccCccccCCHHHHcCCC-----CCccccccchhHHHHHHHhCCCCCCCc--CHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence 67899999999998765 788999999999999999999999743 34556667777788889999999999999
Q ss_pred HhhhC
Q psy7592 242 QVHRY 246 (246)
Q Consensus 242 ~~l~~ 246 (246)
+||++
T Consensus 271 ~~L~~ 275 (350)
T d1rdqe_ 271 NLLQV 275 (350)
T ss_dssp HHSCS
T ss_pred HHhhh
Confidence 99974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=321.35 Aligned_cols=228 Identities=22% Similarity=0.391 Sum_probs=188.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee----CCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD----EEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~v~ 77 (246)
.||+|+| |+||+|+++.+++.||+|.+..... +.+..+.+.+|++++++++||||+++++++.+ +..+++||
T Consensus 16 ~iG~G~f---g~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 16 EIGRGSF---KTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEECSS---EEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEecCcC---cEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 3799999 9999999999999999999977543 34456789999999999999999999999875 34689999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCcEEEc-CCCCeEEeecceeeeec
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKH--IIHRDIKPDNILLD-EEGHAHITDFNIATVLE 154 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~--~~h~~i~~~nil~~-~~~~~~l~d~~~~~~~~ 154 (246)
||+++++|.+++.+.... ++..+..++.|++.||+|||+++ ++||||||+|||++ .++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~~~~-----~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVM-----KIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHSSC-----CHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhccccc-----cHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999775444 99999999999999999999999 99999999999997 57899999999997533
Q ss_pred cCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCCCC
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAW 232 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~ 232 (246)
. .......||+.|+|||.+.+. ++.++||||||+++|+|++|+.||..... .......+... +..++..+
T Consensus 167 ~-~~~~~~~GT~~Y~aPE~~~~~------~~~~~DIwSlGvilyel~~g~~Pf~~~~~-~~~~~~~i~~~~~~~~~~~~~ 238 (270)
T d1t4ha_ 167 A-SFAKAVIGTPEFMAPEMYEEK------YDESVDVYAFGMCMLEMATSEYPYSECQN-AAQIYRRVTSGVKPASFDKVA 238 (270)
T ss_dssp T-TSBEESCSSCCCCCGGGGGTC------CCTHHHHHHHHHHHHHHHHSSCTTTTCSS-HHHHHHHHTTTCCCGGGGGCC
T ss_pred C-CccCCcccCccccCHHHhCCC------CCCcCchhhHHHHHHHHHHCCCCCCCccc-HHHHHHHHHcCCCCcccCccC
Confidence 2 233456789999999987542 78899999999999999999999975332 22223333333 23345678
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
+++++++|++||++
T Consensus 239 ~~~~~~li~~~l~~ 252 (270)
T d1t4ha_ 239 IPEVKEIIEGCIRQ 252 (270)
T ss_dssp CHHHHHHHHHHSCS
T ss_pred CHHHHHHHHHHccC
Confidence 99999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.1e-51 Score=333.39 Aligned_cols=232 Identities=31% Similarity=0.575 Sum_probs=195.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHH---HHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALK---NVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|+| |+||+|+++.+|+.||+|++.+.......... ....++++++.++||||+++++++.+++.+|+|||
T Consensus 11 ~lG~G~f---g~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE 87 (364)
T d1omwa3 11 IIGRGGF---GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 87 (364)
T ss_dssp EEEECSS---CEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEecCCC---eEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEE
Confidence 4799999 89999999999999999999765433222222 23345778888899999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|++|++|.+++.+.... ++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus 88 ~~~gg~L~~~l~~~~~~-----~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~- 161 (364)
T d1omwa3 88 LMNGGDLHYHLSQHGVF-----SEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 161 (364)
T ss_dssp CCCSCBHHHHHHHHCSC-----CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred ecCCCcHHHHHHhcccc-----cHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-
Confidence 99999999999775544 899999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH-HHhhhcCCCCCCCCCCHhHH
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKD-VKAIIYSPVHYPTAWSESTK 237 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~l~ 237 (246)
.....||+.|+|||.+.... .++.++|||||||++|+|++|+.||.+........ ...+......+|..+|++++
T Consensus 162 ~~~~~GT~~y~APE~~~~~~----~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQKGV----AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp CCSCCSCGGGCCHHHHSTTC----CCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred ccccccccccchhHHhhcCC----CCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 33467899999999986433 37889999999999999999999998766555443 33445557778889999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
+||++||++
T Consensus 238 ~li~~~L~~ 246 (364)
T d1omwa3 238 SLLEGLLQR 246 (364)
T ss_dssp HHHHHHTCS
T ss_pred HHHHHHccc
Confidence 999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=328.45 Aligned_cols=230 Identities=37% Similarity=0.621 Sum_probs=197.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHh-hCCCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILT-TLEHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|+| |+||+|+++.+|+.||||++++......+..+.+..|...+. .++||||+++++++.+++..|+||||+
T Consensus 9 ~iG~G~f---g~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~ 85 (320)
T d1xjda_ 9 MLGKGSF---GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 85 (320)
T ss_dssp EEEECSS---SEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEecCCC---cEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeec
Confidence 3788988 899999999999999999998755433344556666766655 689999999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-ccc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLA 159 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~ 159 (246)
++++|.+++...... ++..+..++.|++.||+|||+.|++||||+|+||+++.++.++++|||+++..... ...
T Consensus 86 ~~g~L~~~i~~~~~~-----~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 86 NGGDLMYHIQSCHKF-----DLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp TTCBHHHHHHHHSSC-----CHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred CCCcHHHHhhccCCC-----CHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 999999999876554 99999999999999999999999999999999999999999999999999866533 233
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCHhHHHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSESTKHL 239 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 239 (246)
....|++.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+ .......+....+.+|..+|+++++|
T Consensus 161 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~~~~~~p~~~s~~~~dl 233 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQK-----YNHSVDWWSFGVLLYEMLIGQSPFHGQD--EEELFHSIRMDNPFYPRWLEKEAKDL 233 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cccCCCCCcCCHHHHcCCC-----CCchhhhhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 4467899999999998765 8899999999999999999999997533 34455566677888899999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||++
T Consensus 234 i~~~L~~ 240 (320)
T d1xjda_ 234 LVKLFVR 240 (320)
T ss_dssp HHHHSCS
T ss_pred HHHhccc
Confidence 9999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=324.25 Aligned_cols=229 Identities=23% Similarity=0.403 Sum_probs=196.5
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccch---HHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIE---RDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
||+|+| |+||+|+++.+|+.||||++++..... ....+.+.+|++++++++||||+++++++.++...|+||||
T Consensus 18 lG~G~f---g~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (293)
T d1jksa_ 18 LGSGQF---AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94 (293)
T ss_dssp EEECSS---EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EecCCC---eEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 788888 999999999999999999997654322 12357789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC----CeEEeecceeeeecc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG----HAHITDFNIATVLEE 155 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~----~~~l~d~~~~~~~~~ 155 (246)
++|++|.+++..... +++..++.++.|++.||+|||+.|++||||+|+||+++.++ .++++|||++.....
T Consensus 95 ~~gg~L~~~i~~~~~-----l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 95 VAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp CCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred CCCccccchhccccc-----cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 999999999977544 49999999999999999999999999999999999998776 499999999988776
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TA 231 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~ 231 (246)
........+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+ .......+......++ ..
T Consensus 170 ~~~~~~~~~t~~y~APE~~~~~~-----~~~~~DiwSlGvilyell~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~ 242 (293)
T d1jksa_ 170 GNEFKNIFGTPEFVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDT--KQETLANVSAVNYEFEDEYFSN 242 (293)
T ss_dssp SCBCSCCCCCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHTTCCCCCHHHHTT
T ss_pred CccccccCCCCcccCHHHHcCCC-----CCCcccchhhhHHHHHHHcCCCCCCCCC--HHHHHHHHHhcCCCCCchhcCC
Confidence 66666677899999999997664 7899999999999999999999997533 3334444555444443 57
Q ss_pred CCHhHHHHHHHhhhC
Q psy7592 232 WSESTKHLLSQVHRY 246 (246)
Q Consensus 232 ~s~~l~~li~~~l~~ 246 (246)
+|+++++||++||++
T Consensus 243 ~s~~~~~li~~~L~~ 257 (293)
T d1jksa_ 243 TSALAKDFIRRLLVK 257 (293)
T ss_dssp SCHHHHHHHHTTSCS
T ss_pred CCHHHHHHHHHHccC
Confidence 999999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.3e-51 Score=330.70 Aligned_cols=228 Identities=23% Similarity=0.393 Sum_probs=195.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+|+.||+|+++.... ...+.+.+|++++++++||||++++++|.+++.+|+||||++
T Consensus 36 ~lG~G~f---g~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 36 ELGSGAF---GVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEecCCC---eEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 3788888 9999999999999999999987542 234678889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc--CCCCeEEeecceeeeeccCccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD--EEGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~ 159 (246)
|++|.+.+.... .++++..++.++.|++.||.|||+.|++||||||+|||++ .++.++|+|||++.........
T Consensus 110 gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 110 GGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp CCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 999988775532 2359999999999999999999999999999999999997 5679999999999988776666
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CCCCHh
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAWSES 235 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~ 235 (246)
....+++.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.. .......+......+| ..+|++
T Consensus 186 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~ 258 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREP-----VGFYTDMWAIGVLGYVLLSGLSPFAGED--DLETLQNVKRCDWEFDEDAFSSVSPE 258 (352)
T ss_dssp EEECSSGGGCCHHHHTTCC-----BCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred eeccCcccccCHHHHcCCC-----CCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCcccccCCCHH
Confidence 6678899999999997765 8899999999999999999999997543 3334445555444333 578999
Q ss_pred HHHHHHHhhhC
Q psy7592 236 TKHLLSQVHRY 246 (246)
Q Consensus 236 l~~li~~~l~~ 246 (246)
+++||++||++
T Consensus 259 ~~~li~~~L~~ 269 (352)
T d1koba_ 259 AKDFIKNLLQK 269 (352)
T ss_dssp HHHHHHTTSCS
T ss_pred HHHHHHHHccC
Confidence 99999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.6e-51 Score=329.98 Aligned_cols=228 Identities=23% Similarity=0.403 Sum_probs=195.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++.+|+||||++
T Consensus 33 ~lG~G~f---g~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 33 ELGTGAF---GVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp EEEEETT---EEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred EEecCcC---eEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 3788888 999999999999999999997754 3345678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC--CCCeEEeecceeeeeccCccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE--EGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~ 159 (246)
|++|.+++.... .++++..+..++.||+.||+|||++|++||||||+||+++. ++.++|+|||++.........
T Consensus 107 gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 107 GGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp SCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 999999985432 23599999999999999999999999999999999999964 578999999999987766666
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CCCCHh
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAWSES 235 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~ 235 (246)
....+|+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+ .......+......++ ..+|++
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~-----~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKP-----VGYYTDMWSVGVLSYILLSGLSPFGGEN--DDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp EEECSCTTTCCHHHHHTCC-----BCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred ceecCcccccCHHHHcCCC-----CChhHhhhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCcccccCCCHH
Confidence 6678899999999987765 7889999999999999999999997543 3344455555544443 468999
Q ss_pred HHHHHHHhhhC
Q psy7592 236 TKHLLSQVHRY 246 (246)
Q Consensus 236 l~~li~~~l~~ 246 (246)
+++||++||++
T Consensus 256 ~~~li~~~L~~ 266 (350)
T d1koaa2 256 GKDFIRKLLLA 266 (350)
T ss_dssp HHHHHHHHCCS
T ss_pred HHHHHHHHccC
Confidence 99999999974
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-50 Score=318.87 Aligned_cols=235 Identities=27% Similarity=0.417 Sum_probs=197.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccch------HHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIE------RDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 74 (246)
.||+|+| |+||+|+++.+|+.||||++......+ ....+++.+|+.++++++ ||||+++++++.+++..|
T Consensus 10 ~iG~G~~---g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 86 (277)
T d1phka_ 10 ILGRGVS---SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 86 (277)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred EEecCcC---eEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceE
Confidence 4788988 999999999999999999997654321 233456889999999997 999999999999999999
Q ss_pred EEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeec
Q psy7592 75 MVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLE 154 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~ 154 (246)
+||||++|++|.+++..... ++++.++.++.||+.||+|||+.|++||||+|+||+++.++.++|+|||++....
T Consensus 87 ivmE~~~~g~L~~~l~~~~~-----l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 87 LVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp EEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEcCCCchHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999976554 4999999999999999999999999999999999999999999999999999877
Q ss_pred cCccccccccCCCccCCceeccccc-ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCC----C
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATD-EVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY----P 229 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----~ 229 (246)
.........++..|.|||.+.+... ....++.++||||+|+++|+|++|+.||.+.. .......+......+ +
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~ 239 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRMIMSGNYQFGSPEW 239 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCTTTG
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--HHHHHHHHHhCCCCCCCccc
Confidence 6655666778999999999875432 12236889999999999999999999997543 233334444443322 2
Q ss_pred CCCCHhHHHHHHHhhhC
Q psy7592 230 TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 ~~~s~~l~~li~~~l~~ 246 (246)
.++|+++++||++||+.
T Consensus 240 ~~~s~~~~~li~~~L~~ 256 (277)
T d1phka_ 240 DDYSDTVKDLVSRFLVV 256 (277)
T ss_dssp GGSCHHHHHHHHHHCCS
T ss_pred ccCCHHHHHHHHHHccC
Confidence 47999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=327.98 Aligned_cols=195 Identities=25% Similarity=0.459 Sum_probs=171.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+|+.||+|+++... +....+++.+|+.++++++||||++++++|.++..+++||||++
T Consensus 13 ~iG~G~f---g~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~ 87 (322)
T d1s9ja_ 13 ELGAGNG---GVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 87 (322)
T ss_dssp EEECCSS---CCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEecCCC---eEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4799999 999999999999999999998653 23345788999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (246)
|++|.+++.+... +++..++.++.|++.||.|||+ .|++||||||+|||++.++.+||+|||++...... ...
T Consensus 88 gg~L~~~l~~~~~-----l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~ 161 (322)
T d1s9ja_ 88 GGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN 161 (322)
T ss_dssp TEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC-
T ss_pred CCcHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-ccc
Confidence 9999999987554 4999999999999999999997 49999999999999999999999999999865432 233
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSN 212 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~ 212 (246)
...||+.|+|||.+.+.. ++.++||||+||++|+|++|+.||.+.+.
T Consensus 162 ~~~GT~~Y~APEvl~~~~-----y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTH-----YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp --CCSSCCCCHHHHHCSC-----CCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred cccCCccccCchHHcCCC-----CCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 567899999999998765 89999999999999999999999976543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-50 Score=320.71 Aligned_cols=228 Identities=20% Similarity=0.335 Sum_probs=190.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+++.||||+++.... ..+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 24 ~iG~G~f---g~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 24 KLGGGQY---GEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp ETTTTTT---SSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EEeeCCC---eEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence 3899999 8999999999999999999976542 24578899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--A 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 159 (246)
+++|.+++.... ...+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||+++....... .
T Consensus 97 ~g~l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 97 YGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp TCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred CcchHHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence 999999986542 23468899999999999999999999999999999999999999999999999976544322 2
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC--CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS--PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~l~ 237 (246)
....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.... ......+.+.. ..+.|..+|++++
T Consensus 174 ~~~~g~~~y~aPE~~~~~~-----~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~l~ 246 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNK-----FSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEGCPEKVY 246 (287)
T ss_dssp TTEEECGGGCCHHHHHHCC-----CSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccccccChHHHcCCC-----CCchhhhhhHHHHHHHHHhCCCCCCCcc--hHHHHHHHHhcCCCCCCCccchHHHH
Confidence 2345678899999988765 8899999999999999999776654322 22223333332 5667889999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
+||.+||+.
T Consensus 247 ~li~~cl~~ 255 (287)
T d1opja_ 247 ELMRACWQW 255 (287)
T ss_dssp HHHHHHTCS
T ss_pred HHHHHHcCC
Confidence 999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.9e-50 Score=315.31 Aligned_cols=230 Identities=21% Similarity=0.272 Sum_probs=188.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC----eEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE----DLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~v~ 77 (246)
.||+|+| |+||+|++..+|+.||||+++.....+.+..+.+.+|++++++++||||+++++++.... ..|+||
T Consensus 14 ~lG~G~f---g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvm 90 (277)
T d1o6ya_ 14 ILGFGGM---SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 90 (277)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEeeCCC---eEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEE
Confidence 3788988 999999999999999999998877666777788999999999999999999999997643 489999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||++|++|.+.+...... ++.++..++.|++.||+|||+.|++||||||+||+++.++..+++|||.+.......
T Consensus 91 E~~~g~~L~~~~~~~~~l-----~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 91 EYVDGVTLRDIVHTEGPM-----TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp ECCCEEEHHHHHHHHCSC-----CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred ECCCCCEehhhhcccCCC-----CHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 999999999988776544 999999999999999999999999999999999999999999999999887654322
Q ss_pred ----cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCC----C
Q psy7592 158 ----LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHY----P 229 (246)
Q Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----~ 229 (246)
......|++.|+|||.+.+.. +++++||||||+++|+|++|+.||.+.+ .......+....... +
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDS-----VDARSDVYSLGCVLYEVLTGEPPFTGDS--PVSVAYQHVREDPIPPSARH 238 (277)
T ss_dssp -------------TTCCHHHHTTCC-----CCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHCCCCCGGGTS
T ss_pred ccccccccccCcccccCHHHHcCCC-----CCcceecccchHHHHHHHhCCCCCCCcC--HHHHHHHHHhcCCCCCchhc
Confidence 233456899999999987664 8899999999999999999999997543 333344444443322 3
Q ss_pred CCCCHhHHHHHHHhhhC
Q psy7592 230 TAWSESTKHLLSQVHRY 246 (246)
Q Consensus 230 ~~~s~~l~~li~~~l~~ 246 (246)
..+|++++++|++||++
T Consensus 239 ~~~s~~l~~li~~~L~~ 255 (277)
T d1o6ya_ 239 EGLSADLDAVVLKALAK 255 (277)
T ss_dssp SSCCHHHHHHHHHHTCS
T ss_pred cCCCHHHHHHHHHHccC
Confidence 57899999999999974
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=315.58 Aligned_cols=227 Identities=20% Similarity=0.346 Sum_probs=185.8
Q ss_pred cCCCCccCeeeEEEEEec--CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 3 CGSSKFCGTSKVCIVQKK--DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
||+|+| |+||++++. .+++.||||+++... .+.+..+.+.+|++++++++||||+++++++.++ ..++||||+
T Consensus 15 iG~G~f---G~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~ 89 (277)
T d1xbba_ 15 LGSGNF---GTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMA 89 (277)
T ss_dssp EEECSS---EEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred cccCCC---eEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcC
Confidence 899999 999999854 457899999997643 2344567899999999999999999999999654 578999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-- 158 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 158 (246)
++++|.+++..... +++..+..++.|++.||+|||+.|++||||||+||+++.++.++++|||+++.......
T Consensus 90 ~~g~L~~~l~~~~~-----l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 90 ELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp TTEEHHHHHHHCTT-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCCcHHHHHhhccC-----CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999999876544 49999999999999999999999999999999999999999999999999987654322
Q ss_pred --ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc-CCCCCCCCCCH
Q psy7592 159 --ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY-SPVHYPTAWSE 234 (246)
Q Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~s~ 234 (246)
.....+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.... .....+.. ...+.|..+|+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~-----~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~~~~~~p~~~~~ 237 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYK-----FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERMGCPAGCPR 237 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCE-----EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCCCCCTTCCH
T ss_pred ccccccCCCceecCchhhcCCC-----CCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcCCCCCCCcccCH
Confidence 22345788999999997765 7889999999999999998 89999754432 22233333 35677889999
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
++++||++||+.
T Consensus 238 ~~~~li~~cl~~ 249 (277)
T d1xbba_ 238 EMYDLMNLCWTY 249 (277)
T ss_dssp HHHHHHHHHTCS
T ss_pred HHHHHHHHHcCC
Confidence 999999999974
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.2e-50 Score=317.60 Aligned_cols=229 Identities=19% Similarity=0.333 Sum_probs=179.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCc---EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ---MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
+||+|+| |+||+++++.+++ .||||.+.... +....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 33 ~lG~G~f---g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~E 107 (299)
T d1jpaa_ 33 VIGAGEF---GEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE 107 (299)
T ss_dssp EEEECSS---SEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEeeCCC---eEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 4899999 8999999987665 58899886644 34556789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+++++|.+++.... ..+++.++..++.|++.||.|||+.|++||||||+|||++.++.+||+|||+++.......
T Consensus 108 y~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 108 FMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp CCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 999999999887532 2358999999999999999999999999999999999999999999999999987654322
Q ss_pred c------cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCC
Q psy7592 159 A------TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPT 230 (246)
Q Consensus 159 ~------~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 230 (246)
. ....+++.|+|||.+.... ++.++||||||+++|+|++ |..||.+.... .....+... ..+.|.
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~~~~~~~~ 256 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRK-----FTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQDYRLPPPM 256 (299)
T ss_dssp ------------CGGGSCHHHHHSCC-----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCCCCCT
T ss_pred cceeeecccccCCccccCHHHHhcCC-----CCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCc
Confidence 1 1234677899999987664 8899999999999999998 89999754432 223333333 566778
Q ss_pred CCCHhHHHHHHHhhhC
Q psy7592 231 AWSESTKHLLSQVHRY 246 (246)
Q Consensus 231 ~~s~~l~~li~~~l~~ 246 (246)
.+|+.+.+||.+||+.
T Consensus 257 ~~~~~l~~li~~cl~~ 272 (299)
T d1jpaa_ 257 DCPSALHQLMLDCWQK 272 (299)
T ss_dssp TCCHHHHHHHHHHTCS
T ss_pred cchHHHHHHHHHHcCC
Confidence 8999999999999973
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=313.40 Aligned_cols=227 Identities=23% Similarity=0.378 Sum_probs=188.2
Q ss_pred cCCCCccCeeeEEEEEecC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeec
Q psy7592 3 CGSSKFCGTSKVCIVQKKD--TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
||+|+| |+||++.++. ++..||||.++... +....+.+.+|++++++++||||+++++++.++ ..++||||+
T Consensus 17 iG~G~f---g~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~ 90 (285)
T d1u59a_ 17 LGCGNF---GSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMA 90 (285)
T ss_dssp EECCTT---EEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred EecccC---eEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeC
Confidence 799999 9999998764 45689999997654 344567899999999999999999999998754 578999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-- 158 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 158 (246)
++++|.+++.... .++++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++.......
T Consensus 91 ~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 91 GGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp TTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred CCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999999875432 2459999999999999999999999999999999999999999999999999987754322
Q ss_pred --ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCH
Q psy7592 159 --ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSE 234 (246)
Q Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~ 234 (246)
.....+++.|+|||.+.... ++.++||||||+++|||++ |..||.+.... .....+... ..+.|+.+|+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~-----~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~~~~~~~p~~~~~ 239 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRK-----FSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKRMECPPECPP 239 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCE-----ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTCCCCCCTTCCH
T ss_pred ccccccccCccccChHHHhCCC-----CCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCCcCCH
Confidence 12345678899999987665 7899999999999999998 89999765432 223333333 5677889999
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
++.+||++||++
T Consensus 240 ~l~~li~~cl~~ 251 (285)
T d1u59a_ 240 ELYALMSDCWIY 251 (285)
T ss_dssp HHHHHHHHTTCS
T ss_pred HHHHHHHHHcCC
Confidence 999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=319.34 Aligned_cols=226 Identities=22% Similarity=0.345 Sum_probs=194.5
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|+| |+||+|+++.+|+.||+|.++... .....+.+|++++++++||||+++++++.+++.+|+||||++|
T Consensus 13 lG~G~f---g~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 13 LGRGEF---GIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEECSS---EEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred EecCCC---eEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 788888 999999999999999999998754 2234578899999999999999999999999999999999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC--CeEEeecceeeeeccCcccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG--HAHITDFNIATVLEENQLAT 160 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~--~~~l~d~~~~~~~~~~~~~~ 160 (246)
++|.+++.... .++++.+++.++.||+.|++|||+.|++||||+|+||+++.++ .++++|||++..........
T Consensus 86 g~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 86 LDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 99999987543 2359999999999999999999999999999999999998544 79999999998876655555
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCC----CCCCHhH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYP----TAWSEST 236 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~l 236 (246)
...+++.|+|||...+.. ++.++|||||||++|+|++|..||.+.+ .......+......+| ..+|+++
T Consensus 162 ~~~~t~~y~ape~~~~~~-----~~~~~DiWSlGvily~ll~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDV-----VSTATDMWSLGTLVYVLLSGINPFLAET--NQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp EEESCGGGSCHHHHTTCE-----ECHHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred ccccccccccchhccCCC-----CCchhhcccHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 667889999999987765 7889999999999999999999997543 3344556666666665 3789999
Q ss_pred HHHHHHhhhC
Q psy7592 237 KHLLSQVHRY 246 (246)
Q Consensus 237 ~~li~~~l~~ 246 (246)
++||++||++
T Consensus 235 ~~li~~~L~~ 244 (321)
T d1tkia_ 235 MDFVDRLLVK 244 (321)
T ss_dssp HHHHHTTSCS
T ss_pred HHHHHHHccC
Confidence 9999999974
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=307.21 Aligned_cols=226 Identities=22% Similarity=0.347 Sum_probs=178.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+++++ +++.||||+++..... .+++.+|++.+++++||||+++++++.+++..++||||++
T Consensus 12 ~iG~G~f---g~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 12 EIGSGQF---GLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp EEECCSS---CCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EEeeCCC---eEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 3799999 899999986 5788999999765422 2568899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--A 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 159 (246)
+++|.+++.... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++....... .
T Consensus 84 ~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999886542 2358889999999999999999999999999999999999999999999999987654332 2
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILAR-GRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||.+.+.. ++.++||||||+++|+|+++ .+||.... .......+... ....|..+|+++.
T Consensus 160 ~~~~gt~~y~aPE~l~~~~-----~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~~~~~~~p~~~~~~l~ 232 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSR-----YSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGFRLYKPRLASTHVY 232 (263)
T ss_dssp -----CTTSCCHHHHTTCC-----CCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred cceecCcccCChHHhcCCC-----CCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHHHhcCCCCCccccCHHHH
Confidence 2356788999999987665 89999999999999999995 55665433 22233333333 5566788999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
++|++||+.
T Consensus 233 ~li~~cl~~ 241 (263)
T d1sm2a_ 233 QIMNHCWKE 241 (263)
T ss_dssp HHHHHHTCS
T ss_pred HHHHHHccC
Confidence 999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=318.30 Aligned_cols=226 Identities=26% Similarity=0.387 Sum_probs=186.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeee----CCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQD----EEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~~~v 76 (246)
.||+|+| |+||+|+++.+++.||||+++.. ..+.+|+.++.++ +||||++++++|++ +..+|+|
T Consensus 19 ~lG~G~f---g~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 19 VLGLGIN---GKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp EEEECSS---CEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeccC---eEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 3788888 99999999999999999999753 3466788886654 89999999999975 4678999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC---CCCeEEeecceeeee
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE---EGHAHITDFNIATVL 153 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~---~~~~~l~d~~~~~~~ 153 (246)
|||++|++|.+++.... ..++++..++.++.|++.||+|||+.|++||||||+||+++. ++.++++|||+++..
T Consensus 88 mEy~~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EECCCSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EECCCCCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence 99999999999997542 234599999999999999999999999999999999999985 456999999999987
Q ss_pred ccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH--HHHhhhcCCCCCCC-
Q psy7592 154 EENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK--DVKAIIYSPVHYPT- 230 (246)
Q Consensus 154 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~- 230 (246)
..........+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+....... ....+......+|.
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~-----y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGGG-----GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred cCCCccccccCCcccCCcHHHcCCC-----CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 7766666778999999999998765 889999999999999999999999765443321 12233333444543
Q ss_pred ---CCCHhHHHHHHHhhhC
Q psy7592 231 ---AWSESTKHLLSQVHRY 246 (246)
Q Consensus 231 ---~~s~~l~~li~~~l~~ 246 (246)
.+|+++++||++||++
T Consensus 240 ~~~~~s~~~~~li~~~L~~ 258 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKT 258 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCS
T ss_pred ccccCCHHHHHHHHHHccC
Confidence 5899999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=317.10 Aligned_cols=233 Identities=19% Similarity=0.314 Sum_probs=188.5
Q ss_pred CcCCCCccCeeeEEEEEecCCCc-----EEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ-----MYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 75 (246)
.||+|+| |+||+|++..+++ .||+|.+.... +......+.+|+..+.++ +|||||++++++.+.+..++
T Consensus 44 ~lG~G~f---G~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (325)
T d1rjba_ 44 VLGSGAF---GKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118 (325)
T ss_dssp EEEECSS---EEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred EEeeCCC---eEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence 3788998 9999999876544 69999987643 233456788999999998 89999999999999999999
Q ss_pred EEeecCCCChHHHHhhcccc------------------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc
Q psy7592 76 VSDLLLGGDLRYHITQDIKF------------------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLD 137 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~------------------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~ 137 (246)
||||+++++|.+++...... ....+++..++.++.|++.||+|||+.|++||||||+||+++
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~ 198 (325)
T d1rjba_ 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT 198 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEE
T ss_pred EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccc
Confidence 99999999999999764321 112468889999999999999999999999999999999999
Q ss_pred CCCCeEEeecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCc
Q psy7592 138 EEGHAHITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNT 213 (246)
Q Consensus 138 ~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~ 213 (246)
.++.+||+|||+++....... .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..
T Consensus 199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-----YTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-----CCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999987654332 22345688999999988765 8999999999999999998 89999765543
Q ss_pred cHHHHHhhhcC--CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 214 SVKDVKAIIYS--PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 214 ~~~~~~~~~~~--~~~~~~~~s~~l~~li~~~l~~ 246 (246)
. ....++.. ..+.|..+|+++++||.+||+.
T Consensus 274 ~--~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~ 306 (325)
T d1rjba_ 274 A--NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 306 (325)
T ss_dssp H--HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred H--HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCC
Confidence 3 23333333 5567889999999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-49 Score=308.53 Aligned_cols=230 Identities=22% Similarity=0.291 Sum_probs=180.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+++.+ ..||||+++.... +.+..+.+.+|++++++++||||+++++++.+ ...++||||++
T Consensus 15 ~lG~G~f---g~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~ 86 (276)
T d1uwha_ 15 RIGSGSF---GTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE 86 (276)
T ss_dssp EEEECSS---CEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred EEeeCCC---cEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence 3788888 899999864 3599999976543 33456889999999999999999999998754 46889999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc---c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ---L 158 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~---~ 158 (246)
+++|.+++.... .++++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||++....... .
T Consensus 87 ~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 87 GSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp EEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred CCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 999999986532 235899999999999999999999999999999999999999999999999987654322 2
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-----CCCCCCCCC
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-----PVHYPTAWS 233 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~s 233 (246)
.....+++.|+|||.+.+... ..++.++||||||+++|+|++|+.||.+....... ...+... ....+..+|
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~--~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~~ 239 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDK--NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-IFMVGRGYLSPDLSKVRSNCP 239 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSS--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-HHHHHHTSCCCCGGGSCTTCC
T ss_pred ccccccCcccCCHHHHhcccC--CCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH-HHHHhcCCCCCcchhccccch
Confidence 234568999999999865431 23788999999999999999999999764433221 1112221 123456799
Q ss_pred HhHHHHHHHhhhC
Q psy7592 234 ESTKHLLSQVHRY 246 (246)
Q Consensus 234 ~~l~~li~~~l~~ 246 (246)
+++++||.+||+.
T Consensus 240 ~~l~~li~~cl~~ 252 (276)
T d1uwha_ 240 KAMKRLMAECLKK 252 (276)
T ss_dssp HHHHHHHHHHTCS
T ss_pred HHHHHHHHHHcCC
Confidence 9999999999963
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=306.74 Aligned_cols=226 Identities=20% Similarity=0.348 Sum_probs=184.4
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|+| |+||+++++ +++.||||+++..... .+.+.+|++++++++||||+++++++.++ ..++||||+++
T Consensus 21 iG~G~f---g~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~iv~Ey~~~ 91 (272)
T d1qpca_ 21 LGAGQF---GEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMEN 91 (272)
T ss_dssp EEEETT---EEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTT
T ss_pred EecCCC---cEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeeccC-CeEEEEEeCCC
Confidence 788999 999999986 6789999999765421 35688999999999999999999988654 57899999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--cc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--AT 160 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~ 160 (246)
++|.+++.... ..++++..+..++.|++.|+.|||+.+++||||||+||+++.++.+||+|||+++....... ..
T Consensus 92 g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 92 GSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp CBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence 99999875542 22468999999999999999999999999999999999999999999999999987754332 23
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~l 239 (246)
...+++.|+|||.+.... ++.++||||||+++|+|++|..|+.... ........+... ....|..+|+++++|
T Consensus 169 ~~~gt~~y~APE~~~~~~-----~~~~sDvwS~Gvvl~ellt~~~~~~~~~-~~~~~~~~i~~~~~~~~p~~~~~~l~~l 242 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGT-----FTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRPDNCPEELYQL 242 (272)
T ss_dssp TCCCCTTTSCHHHHHHCE-----ECHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccCCcccccChHHHhCCC-----CCchhhhhhhHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCCCCcccChHHHHHH
Confidence 356788999999998665 7899999999999999999655543222 222333334333 566678999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 243 i~~cl~~ 249 (272)
T d1qpca_ 243 MRLCWKE 249 (272)
T ss_dssp HHHHTCS
T ss_pred HHHHcCC
Confidence 9999973
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=313.60 Aligned_cols=231 Identities=27% Similarity=0.416 Sum_probs=182.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccch--HHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIE--RDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
+||+|+| |+||+|+++.+|+.||||+++...... +...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 5 ~lG~G~f---g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 5 FLGEGQF---ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEETT---EEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred EeccCcC---eEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 5899999 999999999999999999997654221 12245688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc-c
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ-L 158 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 158 (246)
+.++++........ .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.+....... .
T Consensus 82 ~~~~~~~~~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 82 METDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp CSEEHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred hcchHHhhhhhccc-----CCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 98887776655433 34899999999999999999999999999999999999999999999999997654432 2
Q ss_pred ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc---CC----------
Q psy7592 159 ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY---SP---------- 225 (246)
Q Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~~---------- 225 (246)
.....+++.|+|||.+.... .++.++|||||||++|+|++|.+||.+.... .....+.. .+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGAR----MYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCS----CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTSSSTTS
T ss_pred ccceecChhhccHHHHccCC----CCChhhhhhhcchHHHHHHhCcCCCCCCCHH--HHHHHHHHhcCCCChhhccchhc
Confidence 33456899999999986543 3788999999999999999999999754432 22222211 10
Q ss_pred -------CCC--------CCCCCHhHHHHHHHhhhC
Q psy7592 226 -------VHY--------PTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 226 -------~~~--------~~~~s~~l~~li~~~l~~ 246 (246)
... ....|+++++||++||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~ 266 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF 266 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccC
Confidence 000 135689999999999974
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=305.91 Aligned_cols=230 Identities=18% Similarity=0.268 Sum_probs=181.2
Q ss_pred CcCCCCccCeeeEEEEEecCCC----cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK----QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
+||+|+| |+||+|.++.++ ..||||.++... +.+...++.+|++++++++||||+++++++.+....++||
T Consensus 14 ~iG~G~f---G~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 14 VIGAGEF---GEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEECSS---SEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EEeeCCC---eEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 4899999 899999987654 479999997654 3444567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||+.++++.+.+.... ..+++..+..++.|++.|++|||+.+++||||||+|||++.++.+||+|||+++......
T Consensus 89 e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 89 EYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp ECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 9999999998876542 235899999999999999999999999999999999999999999999999998764432
Q ss_pred c----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCC
Q psy7592 158 L----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAW 232 (246)
Q Consensus 158 ~----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (246)
. .....+++.|+|||.+.+.. ++.++||||||+++|+|+++..|+.... ........+... ..+.|..+
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~-----~~~~sDI~S~Gvil~el~t~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~ 238 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYRK-----FTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVMKAINDGFRLPTPMDC 238 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCC-----CCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTTCCCCCCTTC
T ss_pred ccceEeccCCCCccccCHHHHccCC-----CCCcccccccHHHHHHHHhCCCCccccC-CHHHHHHHHhccCCCCCchhh
Confidence 1 22345688899999987664 8899999999999999999766554322 222333333333 56677889
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
++.+.+||++||+.
T Consensus 239 ~~~l~~li~~cl~~ 252 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQ 252 (283)
T ss_dssp BHHHHHHHHHHTCS
T ss_pred HHHHHHHHHHHCcC
Confidence 99999999999963
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=299.24 Aligned_cols=226 Identities=18% Similarity=0.355 Sum_probs=189.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+++++ +++.||||.++..... .+++.+|+.++++++||||+++++++.++..+++||||+.
T Consensus 11 ~iG~G~f---g~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 11 ELGTGQF---GVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCEETT---EEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred EEecCCC---eEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 4788888 999999985 7889999999875532 2568899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc--c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL--A 159 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 159 (246)
+++|.+++..... .+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 83 ~g~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhcccc----CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 9999999765432 348889999999999999999999999999999999999999999999999976544322 2
Q ss_pred cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHH
Q psy7592 160 TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTK 237 (246)
Q Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~ 237 (246)
....++..|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.... .....+... ..+.|...++.++
T Consensus 159 ~~~~~t~~y~aPE~~~~~~-----~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~i~~~~~~~~p~~~~~~l~ 231 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSK-----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRLYRPHLASEKVY 231 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccCCCCCcCCcHHhcCCC-----CCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHHHHhCCCCCCcccccHHHH
Confidence 2355788899999998765 8899999999999999998 89999765433 233333333 5567788999999
Q ss_pred HHHHHhhhC
Q psy7592 238 HLLSQVHRY 246 (246)
Q Consensus 238 ~li~~~l~~ 246 (246)
+||++||+.
T Consensus 232 ~li~~cl~~ 240 (258)
T d1k2pa_ 232 TIMYSCWHE 240 (258)
T ss_dssp HHHHHTTCS
T ss_pred HHHHHHccC
Confidence 999999974
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=300.94 Aligned_cols=229 Identities=22% Similarity=0.318 Sum_probs=178.7
Q ss_pred cCCCCccCeeeEEEEEecCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEee
Q psy7592 3 CGSSKFCGTSKVCIVQKKDT---KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDL 79 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 79 (246)
||+|+| |+||+++.+.+ ...||||++++....+++..+++.+|++++++++||||+++++++.++ ..++||||
T Consensus 16 iG~G~f---g~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e~ 91 (273)
T d1u46a_ 16 LGDGSF---GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTEL 91 (273)
T ss_dssp CC-------CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEEC
T ss_pred EecCCC---eEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chheeeee
Confidence 788888 89999986533 347899999877655666678899999999999999999999999764 67899999
Q ss_pred cCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc
Q psy7592 80 LLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA 159 (246)
Q Consensus 80 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (246)
++++++.+.+.... .++++..+..++.|++.|+.|||+.|++||||+|+||+++.++.++++|||++.........
T Consensus 92 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~ 167 (273)
T d1u46a_ 92 APLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167 (273)
T ss_dssp CTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred ecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCc
Confidence 99999998876543 23599999999999999999999999999999999999999999999999999876443221
Q ss_pred ----cccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC--CCCCCCCC
Q psy7592 160 ----TSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS--PVHYPTAW 232 (246)
Q Consensus 160 ----~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~ 232 (246)
....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+.. .....+... .++.|..+
T Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~-----~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~ 240 (273)
T d1u46a_ 168 YVMQEHRKVPFAWCAPESLKTRT-----FSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEGERLPRPEDC 240 (273)
T ss_dssp EEC-----CCGGGCCHHHHHHCE-----EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSCCCCCCCTTC
T ss_pred ceecCccccCcccCCHHHHhCCC-----CCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHHHhCCCCCCCcccc
Confidence 2234567899999998765 7889999999999999998 89999754433 333444444 45667889
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
|+++++||++||+.
T Consensus 241 ~~~l~~li~~cl~~ 254 (273)
T d1u46a_ 241 PQDIYNVMVQCWAH 254 (273)
T ss_dssp CHHHHHHHHHHTCS
T ss_pred cHHHHHHHHHHcCC
Confidence 99999999999974
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=298.94 Aligned_cols=228 Identities=23% Similarity=0.398 Sum_probs=178.4
Q ss_pred CcCCCCccCeeeEEEEEecCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT---KQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|+| |+||+|++..+ +..||||.++... +....+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 14 ~iG~G~f---g~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E 87 (273)
T d1mp8a_ 14 CIGEGQF---GDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIME 87 (273)
T ss_dssp EEEECSS---SEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred EEeeCCC---cEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEE
Confidence 4799999 99999998754 3568888886543 34556789999999999999999999999964 56899999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL 158 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (246)
|+.+++|.+++.... .++++..++.++.|++.||.|||+.|++||||||+||+++.++.+|++|||+++.......
T Consensus 88 ~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 88 LCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp CCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred eccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 999999998876532 2458999999999999999999999999999999999999999999999999987654322
Q ss_pred --ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCH
Q psy7592 159 --ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSE 234 (246)
Q Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~ 234 (246)
.....+++.|+|||.+.+.. ++.++||||||+++|+|++ |.+||........ ...+... ..++|+.+|+
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~-----~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--~~~i~~~~~~~~~~~~~~ 236 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRR-----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRIENGERLPMPPNCPP 236 (273)
T ss_dssp -------CCGGGCCHHHHHHCC-----CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHHTTCCCCCCTTCCH
T ss_pred eeccceecCcccchhhHhccCC-----CCCccccccchHHHHHHHhcCCCCCCCCCHHHH--HHHHHcCCCCCCCCCCCH
Confidence 22345678899999997665 8899999999999999998 8999976554332 3333333 5678889999
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
.+++||++||+.
T Consensus 237 ~~~~li~~cl~~ 248 (273)
T d1mp8a_ 237 TLYSLMTKCWAY 248 (273)
T ss_dssp HHHHHHHHHTCS
T ss_pred HHHHHHHHHcCC
Confidence 999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=304.10 Aligned_cols=224 Identities=22% Similarity=0.325 Sum_probs=186.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchH---HHHHHHHHHHHHHhhCC--CCcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIER---DALKNVLREMEILTTLE--HPFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~v 76 (246)
+||+|+| |+||+|+++.+|+.||||.++.....+. ....++.+|+.++++++ ||||+++++++.+++..++|
T Consensus 11 ~lG~G~f---g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv 87 (273)
T d1xwsa_ 11 LLGSGGF---GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 87 (273)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred EEeeCCC---eEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEE
Confidence 4788988 9999999999999999999986543211 11234667999999986 89999999999999999999
Q ss_pred EeecCC-CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC-CCCeEEeecceeeeec
Q psy7592 77 SDLLLG-GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE-EGHAHITDFNIATVLE 154 (246)
Q Consensus 77 ~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~-~~~~~l~d~~~~~~~~ 154 (246)
||++.+ +++.+++..... +++..++.++.|++.||.|||+.|++||||||+||+++. ++.++++|||++....
T Consensus 88 ~e~~~~~~~l~~~~~~~~~-----l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 88 LERPEPVQDLFDFITERGA-----LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EECCSSEEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEeccCcchHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 999975 577777766544 499999999999999999999999999999999999985 4789999999997654
Q ss_pred cCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcCCCCCCCCCCH
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYSPVHYPTAWSE 234 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 234 (246)
.. ......||+.|+|||.+.+.. .++.++|||||||++|+|++|+.||... ..+......+|..+|+
T Consensus 163 ~~-~~~~~~GT~~y~aPE~~~~~~----~~~~~~DiwSlGvilyell~g~~Pf~~~--------~~i~~~~~~~~~~~s~ 229 (273)
T d1xwsa_ 163 DT-VYTDFDGTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIPFEHD--------EEIIRGQVFFRQRVSS 229 (273)
T ss_dssp SS-CBCCCCSCGGGSCHHHHHHSC----BCHHHHHHHHHHHHHHHHHHSSCSCCSH--------HHHHHCCCCCSSCCCH
T ss_pred cc-cccccccCCCcCCHHHHcCCC----CCCcccccccceeeehhHhhCCCCCCCc--------hHHhhcccCCCCCCCH
Confidence 32 334567899999999987654 1456799999999999999999999631 2345566778889999
Q ss_pred hHHHHHHHhhhC
Q psy7592 235 STKHLLSQVHRY 246 (246)
Q Consensus 235 ~l~~li~~~l~~ 246 (246)
++++||++||++
T Consensus 230 ~~~~li~~~L~~ 241 (273)
T d1xwsa_ 230 ECQHLIRWCLAL 241 (273)
T ss_dssp HHHHHHHHHTCS
T ss_pred HHHHHHHHHccC
Confidence 999999999974
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=299.03 Aligned_cols=226 Identities=22% Similarity=0.350 Sum_probs=178.3
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|+| |+||+++++.+ +.||||+++.... + .+.+.+|+.++++++||||+++++++.++ ..++||||+++
T Consensus 25 iG~G~f---g~Vy~~~~~~~-~~vAiK~l~~~~~-~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~lv~Ey~~~ 95 (285)
T d1fmka3 25 LGQGCF---GEVWMGTWNGT-TRVAIKTLKPGTM-S---PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSK 95 (285)
T ss_dssp EEECSS---CEEEEEEETTT-EEEEEEECCTTSS-C---HHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEECCCTT
T ss_pred EeeCCC---eEEEEEEECCC-CEEEEEEECcccC-C---HHHHHHHHHHHHhcccCCEeEEEEEEecC-CeEEEEEecCC
Confidence 789999 89999999754 5799999976542 1 25688999999999999999999998654 57899999999
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc--ccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ--LAT 160 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~ 160 (246)
++|..++.... ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++....... ...
T Consensus 96 g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 96 GSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp CBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred Cchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 99998886532 2235899999999999999999999999999999999999999999999999997654332 222
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCCCCHhHHHH
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTAWSESTKHL 239 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~l 239 (246)
...+++.|+|||.+.... ++.++||||||+++|+|++|..|+...... ......+... ..+.|..+|++++++
T Consensus 173 ~~~gt~~y~aPE~~~~~~-----~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~l~~l 246 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGR-----FTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESLHDL 246 (285)
T ss_dssp ---CCGGGSCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred cccccccccChHHHhCCC-----CCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCCCCCCcccCHHHHHH
Confidence 355788999999998765 889999999999999999976655432222 2222233322 566788999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 247 i~~cl~~ 253 (285)
T d1fmka3 247 MCQCWRK 253 (285)
T ss_dssp HHHHTCS
T ss_pred HHHHccc
Confidence 9999974
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-47 Score=301.89 Aligned_cols=233 Identities=24% Similarity=0.334 Sum_probs=187.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcE--EEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQM--YAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e 78 (246)
.||+|+| |+||+|+++.+|.. ||||.++... +.+..+.+.+|+++++++ +||||+++++++.+++..++|||
T Consensus 17 ~iG~G~f---g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 17 VIGEGNF---GQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp EEECGGG---CEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred EEeeCCC---cEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 3799999 99999999988875 6677765433 334457799999999999 79999999999999999999999
Q ss_pred ecCCCChHHHHhhccc-----------cccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeec
Q psy7592 79 LLLGGDLRYHITQDIK-----------FYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDF 147 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~-----------~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~ 147 (246)
|+++++|.+++..... .....+++..+..++.|++.|+.|||+.+++||||+|+|||++.++.+||+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~Df 171 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 171 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccc
Confidence 9999999999975421 12345799999999999999999999999999999999999999999999999
Q ss_pred ceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCccHHHHHhhhcC-C
Q psy7592 148 NIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIHSNTSVKDVKAIIYS-P 225 (246)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~-~ 225 (246)
|++.............++..|+|||.+.... ++.++||||||+++|+|++|. +||.+.+ .......+... .
T Consensus 172 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 172 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-----YTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKLPQGYR 244 (309)
T ss_dssp TCEESSCEECCC----CCTTTCCHHHHHHCE-----ECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHGGGTCC
T ss_pred cccccccccccccceecCCcccchHHhccCC-----CCccceeehhHHHHHHHHhcCCCCCCCCC--HHHHHHHHHhcCC
Confidence 9998765544444566889999999997765 789999999999999999975 5675433 22333334333 6
Q ss_pred CCCCCCCCHhHHHHHHHhhhC
Q psy7592 226 VHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 226 ~~~~~~~s~~l~~li~~~l~~ 246 (246)
++.|..+|+++++||++||+.
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~ 265 (309)
T d1fvra_ 245 LEKPLNCDDEVYDLMRQCWRE 265 (309)
T ss_dssp CCCCTTBCHHHHHHHHHHTCS
T ss_pred CCCCccCCHHHHHHHHHHcCC
Confidence 677889999999999999973
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=302.29 Aligned_cols=228 Identities=19% Similarity=0.326 Sum_probs=181.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCc----EEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQ----MYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
+||+|+| |+||++++..+|+ +||+|.++... +....+++.+|++++++++||||+++++++.++. .++++
T Consensus 16 ~lG~G~f---G~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~v~ 89 (317)
T d1xkka_ 16 VLGSGAF---GTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 89 (317)
T ss_dssp EEEECSS---EEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEE
T ss_pred EEecCCC---eEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeEEE
Confidence 4899999 9999999988876 58888876543 2334577999999999999999999999998764 66788
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
+++.+++|.+.+... ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 90 e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 90 QLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp ECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EeccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 899899998887653 2345899999999999999999999999999999999999999999999999998764332
Q ss_pred c---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc-CCCCCCCCC
Q psy7592 158 L---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY-SPVHYPTAW 232 (246)
Q Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (246)
. .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..... ..+.. ...+.|..+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~-----~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~--~~i~~~~~~~~p~~~ 238 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRI-----YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--SILEKGERLPQPPIC 238 (317)
T ss_dssp C--------CCTTTSCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH--HHHHHTCCCCCCTTB
T ss_pred ccccccccccCccccChHHHhcCC-----CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH--HHHHcCCCCCCCccc
Confidence 2 22245788999999998765 8999999999999999998 78999765544332 22222 356778899
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
|+++.+||++||+.
T Consensus 239 ~~~~~~li~~cl~~ 252 (317)
T d1xkka_ 239 TIDVYMIMVKCWMI 252 (317)
T ss_dssp CHHHHHHHHHHTCS
T ss_pred CHHHHHHHHHhCCC
Confidence 99999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=299.50 Aligned_cols=198 Identities=28% Similarity=0.426 Sum_probs=164.3
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|++..+|+.||+|+++... ..+...+++.+|++++++++||||+++++++.++...|+||||+.
T Consensus 9 ~lG~G~f---g~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~ 84 (298)
T d1gz8a_ 9 KIGEGTY---GVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 84 (298)
T ss_dssp EEEECSS---SEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEecCcC---eEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC
Confidence 4789988 999999999999999999997643 223335778899999999999999999999999999999999996
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC-cccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN-QLAT 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~ 160 (246)
++.+....... ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++++|||.++..... ....
T Consensus 85 ~~~~~~~~~~~----~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~ 160 (298)
T d1gz8a_ 85 QDLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160 (298)
T ss_dssp EEHHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred Cchhhhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence 55444333322 234699999999999999999999999999999999999999999999999999766433 3344
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
...+++.|+|||.+.... ..+.++|+||+|+++|+|++|+.||.+.+
T Consensus 161 ~~~gt~~y~apE~~~~~~----~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCK----YYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp CCBCCCTTCCHHHHTTCS----SCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eecccceeeehhhhcccc----CCCccccccccchhhhHHhhCCCCCCCCC
Confidence 467899999999876554 25789999999999999999999997544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=294.26 Aligned_cols=222 Identities=20% Similarity=0.347 Sum_probs=177.8
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee-CCeEEEEEeecC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD-EEDLFMVSDLLL 81 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~v~e~~~ 81 (246)
||+|+| |.||+++. +|+.||||+++.+. ..+.+.+|++++++++||||+++++++.+ .+.+++||||++
T Consensus 15 lG~G~f---g~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 15 IGKGEF---GDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp EEECSS---CEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred EecCCC---eEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 788999 89999998 47899999997643 23678899999999999999999999865 456899999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccccc
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLATS 161 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (246)
+++|.+++..... .++++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++++|||+++..... ...
T Consensus 85 ~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~~ 159 (262)
T d1byga_ 85 KGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDT 159 (262)
T ss_dssp TEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--Ccc
Confidence 9999999865432 23589999999999999999999999999999999999999999999999999865432 223
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHhhhc-CCCCCCCCCCHhHHHH
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVKAIIY-SPVHYPTAWSESTKHL 239 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~l~~l 239 (246)
..++..|+|||.+.+.. +++++||||||+++|+|++ |++||....... ....+.. ..+++|..+++.+++|
T Consensus 160 ~~~~~~y~aPE~l~~~~-----~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~l 232 (262)
T d1byga_ 160 GKLPVKWTAPEALREKK-----FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYKMDAPDGCPPAVYEV 232 (262)
T ss_dssp --CCTTTSCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTTTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCChHHHhCCC-----CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCCCCCCccCCHHHHHH
Confidence 45678899999987765 8999999999999999998 788887544333 2333333 3677888999999999
Q ss_pred HHHhhhC
Q psy7592 240 LSQVHRY 246 (246)
Q Consensus 240 i~~~l~~ 246 (246)
|++||+.
T Consensus 233 i~~cl~~ 239 (262)
T d1byga_ 233 MKNCWHL 239 (262)
T ss_dssp HHHHTCS
T ss_pred HHHHccc
Confidence 9999974
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=295.85 Aligned_cols=232 Identities=21% Similarity=0.364 Sum_probs=186.5
Q ss_pred cCCCCccCeeeEEEEEecCCC-------cEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTK-------QMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLF 74 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 74 (246)
||+|+| |.||+|++..++ ..||||+++... +......+.+|...+.++ +||||+++++++.++...+
T Consensus 21 iG~G~f---g~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~ 95 (299)
T d1fgka_ 21 LGEGAF---GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 95 (299)
T ss_dssp CC--------CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred EeecCC---cEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEE
Confidence 788888 999999987554 479999997654 344457788899999888 7999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcccc-----------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeE
Q psy7592 75 MVSDLLLGGDLRYHITQDIKF-----------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAH 143 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~ 143 (246)
+||||+++++|.+++...... ....+++.++..++.|++.|++|||+.+++||||||+|||++.++.++
T Consensus 96 ~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~k 175 (299)
T d1fgka_ 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 175 (299)
T ss_dssp EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEE
T ss_pred EEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeE
Confidence 999999999999999765321 123469999999999999999999999999999999999999999999
Q ss_pred EeecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHH
Q psy7592 144 ITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDVK 219 (246)
Q Consensus 144 l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~ 219 (246)
++|||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |.+||.+..... ...
T Consensus 176 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-----y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--~~~ 248 (299)
T d1fgka_ 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-----YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LFK 248 (299)
T ss_dssp ECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHH
T ss_pred eccchhhccccccccccccccCCCChhhhhhhHhcCCC-----CCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--HHH
Confidence 999999987654332 23356788999999997765 8999999999999999998 788887544332 222
Q ss_pred hhhc-CCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 220 AIIY-SPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 220 ~~~~-~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.+.. ..++.|..+|+++++||++||++
T Consensus 249 ~i~~~~~~~~p~~~~~~l~~li~~cl~~ 276 (299)
T d1fgka_ 249 LLKEGHRMDKPSNCTNELYMMMRDCWHA 276 (299)
T ss_dssp HHHTTCCCCCCSSCCHHHHHHHHHHTCS
T ss_pred HHHcCCCCCCCccchHHHHHHHHHHccC
Confidence 2222 36677889999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=300.78 Aligned_cols=234 Identities=34% Similarity=0.603 Sum_probs=194.8
Q ss_pred CcCCCCccCeeeEEEEEec---CCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHhhCCC-CcceeeeeeeeeCCeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKK---DTKQMYAMKYMHKSQCI-ERDALKNVLREMEILTTLEH-PFLVNLWFCFQDEEDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~v 76 (246)
.||+|+| |+||+|++. .+|+.||+|.++..... +....+.+.+|++++++++| |||+++++++.+....+++
T Consensus 31 ~IG~G~f---g~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v 107 (322)
T d1vzoa_ 31 VLGTGAY---GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 107 (322)
T ss_dssp EEEETTT---EEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EEecCCC---eEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeee
Confidence 3789999 999999974 47899999999765432 22234567889999999976 8999999999999999999
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
|||+.+++|.+++...... ++..+..++.|++.|++|+|+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 108 ~e~~~~~~L~~~i~~~~~~-----~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 108 LDYINGGELFTHLSQRERF-----TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp ECCCCSCBHHHHHHHHSCC-----CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eecccccHHHHHHHhcccc-----cHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 9999999999999876655 88999999999999999999999999999999999999999999999999876543
Q ss_pred c--cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHhhhcCCCCCCCCC
Q psy7592 157 Q--LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSV--KDVKAIIYSPVHYPTAW 232 (246)
Q Consensus 157 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 232 (246)
. ......+++.|+|||.+.+... .++.++|||||||++|+|++|+.||.+...... ...........++|..+
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~---~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDS---GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC------CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred ccccccccccccccchhHHhhcCCc---CCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 2 2344678899999999875432 267899999999999999999999976554332 33344556677888899
Q ss_pred CHhHHHHHHHhhhC
Q psy7592 233 SESTKHLLSQVHRY 246 (246)
Q Consensus 233 s~~l~~li~~~l~~ 246 (246)
|+++++||++||++
T Consensus 260 s~~~~~li~~~l~~ 273 (322)
T d1vzoa_ 260 SALAKDLIQRLLMK 273 (322)
T ss_dssp CHHHHHHHHHHTCS
T ss_pred CHHHHHHHHHHccc
Confidence 99999999999974
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=295.26 Aligned_cols=230 Identities=20% Similarity=0.323 Sum_probs=184.6
Q ss_pred CcCCCCccCeeeEEEEEecCCC---cEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee-CCeEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTK---QMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD-EEDLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~v~ 77 (246)
+||+|+| |+||++++..++ ..||||.++... +....+++.+|++++++++||||+++++++.+ +...++||
T Consensus 34 ~iG~G~f---g~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 34 VIGRGHF---GCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEETT---EEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred EEeecCC---eEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 4799999 999999987543 368999987533 45567889999999999999999999999875 56799999
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
||+++++|.+++..... ..+...+..++.|++.|+.|||+.+++||||+|+|||+++++.++|+|||+++......
T Consensus 109 E~~~~g~l~~~~~~~~~----~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp ECCTTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEeecCchhhhhccccc----cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999998875432 34677889999999999999999999999999999999999999999999998764332
Q ss_pred c-----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhcC-CCCCCCC
Q psy7592 158 L-----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIYS-PVHYPTA 231 (246)
Q Consensus 158 ~-----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (246)
. .....++..|+|||.+.... ++.++||||||+++|+|++|..||...... ......+... ....|..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~~g~~~~~p~~ 258 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLLQPEY 258 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCCCCCTT
T ss_pred cccceecccccccccccChHHHhcCC-----CCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCCCCCccc
Confidence 2 12245778899999987765 899999999999999999988877543322 2222333333 5567788
Q ss_pred CCHhHHHHHHHhhhC
Q psy7592 232 WSESTKHLLSQVHRY 246 (246)
Q Consensus 232 ~s~~l~~li~~~l~~ 246 (246)
+++++.+||.+||++
T Consensus 259 ~~~~l~~li~~cl~~ 273 (311)
T d1r0pa_ 259 CPDPLYEVMLKCWHP 273 (311)
T ss_dssp CCHHHHHHHHHHTCS
T ss_pred CcHHHHHHHHHHcCC
Confidence 999999999999974
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-46 Score=296.11 Aligned_cols=232 Identities=18% Similarity=0.277 Sum_probs=189.3
Q ss_pred cCCCCccCeeeEEEEEec-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKK-----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
||+|+| |+||+|+++ .+++.||||+++... +.+..+++.+|++++++++||||+++++++.+....+++|
T Consensus 21 lG~G~f---G~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~ 95 (301)
T d1lufa_ 21 IGEGAF---GRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 95 (301)
T ss_dssp EEECSS---CEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeCCC---eEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEE
Confidence 788888 999999975 467899999997654 3445678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhcccc-------------------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC
Q psy7592 78 DLLLGGDLRYHITQDIKF-------------------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE 138 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~-------------------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~ 138 (246)
||+.+++|.+++...... ....++...+..++.|++.|++|||+.+++||||||+|||++.
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~ 175 (301)
T d1lufa_ 96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE 175 (301)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECC
Confidence 999999999998653211 1233688899999999999999999999999999999999999
Q ss_pred CCCeEEeecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCcc
Q psy7592 139 EGHAHITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIHSNTS 214 (246)
Q Consensus 139 ~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~-~p~~~~~~~~ 214 (246)
++.+||+|||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++|. +||.+.+ .
T Consensus 176 ~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~t~ksDVwS~Gvvl~ell~~~~~p~~~~~--~ 248 (301)
T d1lufa_ 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-----YTTESDVWAYGVVLWEIFSYGLQPYYGMA--H 248 (301)
T ss_dssp GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTTCCTTTTSC--H
T ss_pred CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-----CChhhhhccchhhHHHHHccCCCCCCCCC--H
Confidence 99999999999876543322 22355778899999998765 899999999999999999986 5776433 2
Q ss_pred HHHHHhhhcC-CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 215 VKDVKAIIYS-PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 215 ~~~~~~~~~~-~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.+....+... ..+.|..+|+++.+||..||+.
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~ 281 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSK 281 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCC
Confidence 2333334333 4556889999999999999974
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=294.37 Aligned_cols=234 Identities=20% Similarity=0.301 Sum_probs=178.0
Q ss_pred CcCCCCccCeeeEEEEEecC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeee-CCeEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKD-----TKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQD-EEDLF 74 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~ 74 (246)
.||+|+| |+||+|++.. +++.||||.++... .....+.+.+|...+.++ +|+||+.+++++.+ +..++
T Consensus 20 ~iG~G~f---G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~ 94 (299)
T d1ywna1 20 PLGRGAF---GQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 94 (299)
T ss_dssp EEEECSS---CEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred EEeecCC---eEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence 3789999 8999999753 45789999997644 233456777788888777 68999999998765 45689
Q ss_pred EEEeecCCCChHHHHhhcccc-----------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeE
Q psy7592 75 MVSDLLLGGDLRYHITQDIKF-----------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAH 143 (246)
Q Consensus 75 ~v~e~~~~~sL~~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~ 143 (246)
+||||+++++|.+++...... ....+++..+..++.|++.|+.|||+.|++||||||+|||++.++.+|
T Consensus 95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~K 174 (299)
T d1ywna1 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 174 (299)
T ss_dssp EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEE
T ss_pred EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEE
Confidence 999999999999999764321 123468899999999999999999999999999999999999999999
Q ss_pred EeecceeeeeccCc---cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCccHHHHH
Q psy7592 144 ITDFNIATVLEENQ---LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILAR-GRPFDIHSNTSVKDVK 219 (246)
Q Consensus 144 l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g-~~p~~~~~~~~~~~~~ 219 (246)
|+|||+++...... ......+|+.|+|||.+.+.. ++.++||||||+++|+|++| .+||.+...... ...
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-----~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-~~~ 248 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-----YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCR 248 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-HHH
T ss_pred EccCcchhhccccccccccCceeeCccccchhHhhcCC-----CCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-HHH
Confidence 99999998654332 223356888999999998765 88999999999999999986 567865544332 222
Q ss_pred hhh-cCCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 220 AII-YSPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 220 ~~~-~~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.+. ....+.|..+|++++++|.+||+.
T Consensus 249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~ 276 (299)
T d1ywna1 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHG 276 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHcCC
Confidence 222 236677888999999999999963
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.4e-46 Score=295.14 Aligned_cols=228 Identities=23% Similarity=0.339 Sum_probs=182.0
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecCC
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLLG 82 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 82 (246)
||+|+| |+||+|+++ +|+.||||+++.... ++...+++.+|+.++++++||||+++++++.+++..++++|++.+
T Consensus 10 iG~G~f---g~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~ 84 (286)
T d1ob3a_ 10 IGEGTY---GVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (286)
T ss_dssp EEEETT---EEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred EecCCC---cEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence 788888 999999986 789999999977543 233357888999999999999999999999999999999999977
Q ss_pred CChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCcc-ccc
Q psy7592 83 GDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQL-ATS 161 (246)
Q Consensus 83 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~ 161 (246)
+.+......... +++..++.++.|++.||+|||+.|++||||||+||+++.++.++++|||.+........ ...
T Consensus 85 ~~~~~~~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (286)
T d1ob3a_ 85 DLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (286)
T ss_dssp EHHHHHHTSTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred hhHHHHHhhcCC-----cchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence 777666654443 49999999999999999999999999999999999999999999999999877654322 334
Q ss_pred cccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc---C--------------
Q psy7592 162 MSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY---S-------------- 224 (246)
Q Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~-------------- 224 (246)
..+++.|.|||.+.+.. .++.++|+||||+++|+|++|+.||.+.+.. ....++.. .
T Consensus 160 ~~~~~~y~~pE~~~~~~----~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSK----KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --CCCTTCCHHHHTTCC----SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ecccchhhhHHHHhCCC----CCCcceeehhcCcHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCChhhccchhhhhh
Confidence 56788999999987554 3688999999999999999999999754322 22222111 0
Q ss_pred ------------CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 225 ------------PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 225 ------------~~~~~~~~s~~l~~li~~~l~~ 246 (246)
...++..+|+++++||++||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~ 267 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKL 267 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCS
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccC
Confidence 0112356799999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=295.27 Aligned_cols=230 Identities=27% Similarity=0.391 Sum_probs=179.3
Q ss_pred CcCCCCccCeeeEEEEEecCC-CcEEEEEEeeccccchHHHHHHHHHHHHHHhhC---CCCcceeeeeeeee-----CCe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDT-KQMYAMKYMHKSQCIERDALKNVLREMEILTTL---EHPFLVNLWFCFQD-----EED 72 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~ 72 (246)
.||+|+| |+||+|++..+ ++.||||+++.....+ .....+.+|+..++.+ +||||++++++|.. ...
T Consensus 14 ~LG~G~f---g~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~ 89 (305)
T d1blxa_ 14 EIGEGAY---GKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89 (305)
T ss_dssp EEEEETT---EEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred EEecccC---eEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCce
Confidence 3788888 99999999765 6789999997654221 1123345566666555 89999999999853 346
Q ss_pred EEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 73 LFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 73 ~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
.+++||++.++++....... ...+++..++.++.|++.||+|||+.|++||||||+|||++.++.++++|||++..
T Consensus 90 ~~~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 90 LTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 89999999887766554332 23458999999999999999999999999999999999999999999999999887
Q ss_pred eccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc---C-----
Q psy7592 153 LEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY---S----- 224 (246)
Q Consensus 153 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~----- 224 (246)
...........||+.|+|||.+.+.. ++.++||||+||++|+|++|+.||.+.+.. .....+.. .
T Consensus 166 ~~~~~~~~~~~gT~~Y~APE~~~~~~-----y~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 166 YSFQMALTSVVVTLWYRAPEVLLQSS-----YATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCGGG
T ss_pred hcccccCCCcccChhhcCcchhcCCC-----CChhehhhchHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCchhc
Confidence 66665666778999999999997765 889999999999999999999999754422 22222211 0
Q ss_pred -------------------CCCCCCCCCHhHHHHHHHhhhC
Q psy7592 225 -------------------PVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 225 -------------------~~~~~~~~s~~l~~li~~~l~~ 246 (246)
...++..+|+.+++||++||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~ 279 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 279 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCS
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcC
Confidence 1123456899999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=298.76 Aligned_cols=227 Identities=27% Similarity=0.360 Sum_probs=178.9
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee------CCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD------EEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~~ 75 (246)
+||+|+| |+||+|+++.+|+.||||++.... ....+|++++++++||||++++++|.. ..++++
T Consensus 27 ~LG~G~f---g~Vy~a~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 27 VIGNGSF---GVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEETT---EEEEEEEETTTCCEEEEEEEECCS-------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred EEeeCcC---eEEEEEEECCCCCEEEEEEECccc-------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4899999 999999999999999999997654 123469999999999999999999853 345899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-CeEEeecceeeeec
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG-HAHITDFNIATVLE 154 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~-~~~l~d~~~~~~~~ 154 (246)
||||++++.+....... ....++++..++.++.|++.||+|||++|++||||||+|||++.++ .++|+|||++....
T Consensus 97 v~Ey~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEECCSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEeccCCccHHHHHhhh--hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99999665433332211 1233569999999999999999999999999999999999999775 89999999998876
Q ss_pred cCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhhc-----------
Q psy7592 155 ENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAIIY----------- 223 (246)
Q Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~----------- 223 (246)
.........+++.|+|||.+.+.. .++.++||||+||++|+|++|+.||....... ....+..
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCS----SCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHH
T ss_pred CCcccccccccccccChHHhhccc----CCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhh
Confidence 666666678899999999886543 37899999999999999999999997544222 1222110
Q ss_pred ----C--CCC------------CCCCCCHhHHHHHHHhhhC
Q psy7592 224 ----S--PVH------------YPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 224 ----~--~~~------------~~~~~s~~l~~li~~~l~~ 246 (246)
. ... ....+|+++.+||++||++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~ 289 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 289 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCS
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccC
Confidence 0 111 1235799999999999974
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=291.09 Aligned_cols=233 Identities=20% Similarity=0.316 Sum_probs=189.5
Q ss_pred CcCCCCccCeeeEEEEEe-----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhC-CCCcceeeeeeeeeCCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQK-----KDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTL-EHPFLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 75 (246)
.||+|+| |.||+|++ ..+++.||||.++.... ......+.+|+.+++++ +||||+++++++.++...++
T Consensus 30 ~iG~G~f---g~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~l 104 (311)
T d1t46a_ 30 TLGAGAF---GKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (311)
T ss_dssp EEEECSS---EEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred EEeecCC---eEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEE
Confidence 3789999 99999985 35778999999986542 34456789999999999 69999999999999999999
Q ss_pred EEeecCCCChHHHHhhcccc-------------ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCe
Q psy7592 76 VSDLLLGGDLRYHITQDIKF-------------YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHA 142 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~-------------~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~ 142 (246)
+|||+++++|.+++...... ....+++..+..++.|++.|++|||++|++||||||+||+++.++.+
T Consensus 105 vmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184 (311)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEE
T ss_pred EEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcc
Confidence 99999999999998764321 12346888999999999999999999999999999999999999999
Q ss_pred EEeecceeeeeccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHH
Q psy7592 143 HITDFNIATVLEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILA-RGRPFDIHSNTSVKDV 218 (246)
Q Consensus 143 ~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~ 218 (246)
+++|||.++....... .....+++.|+|||.+.... ++.++||||||+++|+|++ |.+||...+.... .
T Consensus 185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--~ 257 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-----YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--F 257 (311)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--H
T ss_pred cccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-----CCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--H
Confidence 9999999987643322 23356788999999997665 8899999999999999999 5666655443322 2
Q ss_pred Hhhhc--CCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 219 KAIIY--SPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 219 ~~~~~--~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.+++. .....|..+|+.+++||.+||++
T Consensus 258 ~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~ 287 (311)
T d1t46a_ 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDA 287 (311)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred HHHHhcCCCCCCcccccHHHHHHHHHHcCC
Confidence 22222 25556778999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=293.62 Aligned_cols=195 Identities=27% Similarity=0.460 Sum_probs=161.4
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC----eEEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE----DLFMVS 77 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~v~ 77 (246)
.||+|+| |+||+|+++.+|+.||||+++... .....+++.+|++++++++||||+++++++.... ..++++
T Consensus 15 ~LG~G~f---g~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 15 YIGEGAY---GMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp ECC---C---CCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEeeccC---eEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 4788998 899999999999999999997644 2444678899999999999999999999987543 234445
Q ss_pred eecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCc
Q psy7592 78 DLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (246)
+++.+++|.+++... ++++..++.++.|++.||+|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 90 ~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 90 THLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 566699999998653 35999999999999999999999999999999999999999999999999998764432
Q ss_pred c----ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 158 L----ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 158 ~----~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
. .....+++.|+|||.+.... .++.++|+||+|+++|+|++|+.||.+..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSK----GYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBC----SCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccceeeccccccceechHHHhhcCC----CCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 2 23355788999999985543 36889999999999999999999997654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=293.05 Aligned_cols=228 Identities=25% Similarity=0.388 Sum_probs=178.8
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC------eEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE------DLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~~ 75 (246)
.||+|+| |+||+|+++.+|+.||||+++... .++...+++.+|++++++++||||++++++|...+ .+|+
T Consensus 25 ~lG~G~f---g~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 100 (346)
T d1cm8a_ 25 PVGSGAY---GAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 100 (346)
T ss_dssp EC---------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEecCCC---eEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEE
Confidence 3788888 999999999999999999997643 34555688999999999999999999999997654 5799
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||||+ +.+|....... ++++..++.++.|++.||+|||++|++|+||||+||+++.++.++++|||.+.....
T Consensus 101 v~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 101 VMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp EEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 99999 77777766432 349999999999999999999999999999999999999999999999999987544
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHhhh------------
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVK-DVKAII------------ 222 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~------------ 222 (246)
. .....+++.|+|||.+.+.. .++.++||||+||++|+|++|+.||.+.+..... ......
T Consensus 174 ~--~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 174 E--MTGYVVTRWYRAPEVILNWM----RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp S--CCSSCSCGGGCCTHHHHTTT----CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred c--cccccccccccCHHHHcCCC----CCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 2 34567889999999987643 3688999999999999999999999754322211 010000
Q ss_pred -----------cC--C---CCCCCCCCHhHHHHHHHhhhC
Q psy7592 223 -----------YS--P---VHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 223 -----------~~--~---~~~~~~~s~~l~~li~~~l~~ 246 (246)
.. . ...+...|+++.+||++||++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~ 287 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 287 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCS
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcC
Confidence 00 0 112346799999999999974
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=287.92 Aligned_cols=232 Identities=18% Similarity=0.275 Sum_probs=189.9
Q ss_pred cCCCCccCeeeEEEEEec-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKK-----DTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVS 77 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 77 (246)
||+|+| |+||+|+++ .+++.||||+++... .......+.+|++++++++||||+++++++..+...++||
T Consensus 28 lG~G~f---G~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 28 LGQGSF---GMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEECSS---SEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeCCC---eEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence 788888 899999985 346789999997654 3344567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhcccc-----ccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 78 DLLLGGDLRYHITQDIKF-----YSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 78 e~~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
||+.+++|.+++...... ....++...+..++.|++.|+.|||+.+++||||+|+|||++.++.+||+|||+++.
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~ 182 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCG
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeeccccee
Confidence 999999999998654321 113357888999999999999999999999999999999999999999999999976
Q ss_pred eccCcc---ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCccHHHHHhhhcC-CCC
Q psy7592 153 LEENQL---ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARG-RPFDIHSNTSVKDVKAIIYS-PVH 227 (246)
Q Consensus 153 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~-~~~ 227 (246)
...... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|. .||.+.+ .......+... ..+
T Consensus 183 ~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-----~~~~~Dv~S~G~il~El~t~~~~p~~~~~--~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 183 IYETDYYRKGGKGLLPVRWMSPESLKDGV-----FTTYSDVWSFGVVLWEIATLAEQPYQGLS--NEQVLRFVMEGGLLD 255 (308)
T ss_dssp GGGGGCEEGGGSSEECGGGCCHHHHHHCC-----CCHHHHHHHHHHHHHHHHHTSCCTTTTSC--HHHHHHHHHTTCCCC
T ss_pred ccCCcceeeccceecccccCCHHHHccCC-----CCcccccccHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhCCCCC
Confidence 644322 23345788999999988765 888999999999999999984 6776433 22333344433 556
Q ss_pred CCCCCCHhHHHHHHHhhhC
Q psy7592 228 YPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 228 ~~~~~s~~l~~li~~~l~~ 246 (246)
.|..+|+.+.++|..||++
T Consensus 256 ~p~~~~~~l~~li~~cl~~ 274 (308)
T d1p4oa_ 256 KPDNCPDMLFELMRMCWQY 274 (308)
T ss_dssp CCTTCCHHHHHHHHHHTCS
T ss_pred CcccchHHHHHHHHHHcCC
Confidence 6789999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=282.39 Aligned_cols=231 Identities=22% Similarity=0.379 Sum_probs=188.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCCeEEEEEeecC
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEEDLFMVSDLLL 81 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 81 (246)
.||+|+| |+||+|+++.+++.||||+++.... .+...+++.+|+.+++.++||||+++++++.+....+++++++.
T Consensus 9 ~LG~G~f---g~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~ 84 (292)
T d1unla_ 9 KIGEGTY---GTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEEECSS---SEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred EEecCcC---eEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecc
Confidence 3788888 9999999999999999999976553 34456889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccCccc-c
Q psy7592 82 GGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEENQLA-T 160 (246)
Q Consensus 82 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~ 160 (246)
++++.......... ++..+..++.|++.||+|||++|++|+||||+||+++.++.++++|||.+......... .
T Consensus 85 ~~~l~~~~~~~~~~-----~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 85 QDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp EEHHHHHHHTTTCC-----CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred cccccccccccccc-----chhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence 99998887765544 89999999999999999999999999999999999999999999999999887554332 3
Q ss_pred ccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHhhh---c--------------
Q psy7592 161 SMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKDVKAII---Y-------------- 223 (246)
Q Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~-------------- 223 (246)
...++..|.|||.+.... .++.++||||+||++|+|++|+.||....... .....+. .
T Consensus 160 ~~~~~~~~~~pe~~~~~~----~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAK----LYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp SCCSCGGGCCHHHHTTCS----CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred eeccccchhhhhHhccCC----CCCchhhccccchHHHHHhhCCCCCCCCCCHH-HHHHHHHhhcCCCChhhhhhhhhcc
Confidence 345667788999876554 26889999999999999999999874333222 1112111 1
Q ss_pred ------------CCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 224 ------------SPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 224 ------------~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.....+..+|+.+.+||++||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~ 269 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKC 269 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccC
Confidence 11122346789999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=289.10 Aligned_cols=197 Identities=23% Similarity=0.302 Sum_probs=160.7
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee--------CCeE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD--------EEDL 73 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~ 73 (246)
.||+|+| |+||+|+++.+|+.||||++..... .+....++.+|++++++++||||+++++++.. +...
T Consensus 17 ~LG~G~f---g~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~ 92 (318)
T d3blha1 17 KIGQGTF---GEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 92 (318)
T ss_dssp EEEECSS---SEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CE
T ss_pred EEecCcC---eEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceE
Confidence 4788888 8999999999999999999876543 22334678899999999999999999999855 3468
Q ss_pred EEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeee
Q psy7592 74 FMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVL 153 (246)
Q Consensus 74 ~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~ 153 (246)
+++||++.++.+........ .+++..++.++.|++.|+.|||+.|++||||||+||+++.++.++++|||++...
T Consensus 93 ~iv~e~~~~~~~~~~~~~~~-----~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 93 YLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp EEEEECCCEEHHHHHTCTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeccCCCccchhhhccc-----ccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 99999997776665544333 3489999999999999999999999999999999999999999999999999776
Q ss_pred ccCc-----cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 154 EENQ-----LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 154 ~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
.... ......+|+.|+|||.+.+.. .++.++||||+|+++|+|++|+.||.+..
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~----~~~~k~DiwSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGER----DYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCS----SCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccceecCHHHhhHHHHcCCC----CCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence 5322 223346889999999987653 37889999999999999999999997544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-43 Score=286.50 Aligned_cols=189 Identities=26% Similarity=0.423 Sum_probs=164.0
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeee--CCeEEEEEe
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQD--EEDLFMVSD 78 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~~v~e 78 (246)
.||+|+| |+||+|+++.+|+.||+|+++... .+++.+|++++++++ ||||+++++++.. ....++|||
T Consensus 42 ~LG~G~f---g~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 42 KLGRGKY---SEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred EEecCcC---eEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 3788888 999999999999999999997653 356788999999995 9999999999974 456999999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-CeEEeecceeeeeccCc
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEG-HAHITDFNIATVLEENQ 157 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~-~~~l~d~~~~~~~~~~~ 157 (246)
|+.+++|..... .+++..++.++.||+.||.|||++|++|+||||+|||++.++ .++++|||++.......
T Consensus 113 ~~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 113 HVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp CCCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred ecCCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999876532 359999999999999999999999999999999999998665 58999999998876665
Q ss_pred cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 158 LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
......+++.|+|||.+.+.. .++.++|+||+|+++++|++|+.||....
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCC----CCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccCccccCcccccCCC----CCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 566677899999999987654 36889999999999999999999996544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.2e-43 Score=279.22 Aligned_cols=226 Identities=19% Similarity=0.192 Sum_probs=183.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCC-CcceeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEH-PFLVNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|+| |+||+|+++.+|+.||||+++.... .+.+.+|++.++.++| ++++.+++++.++...++|||++
T Consensus 12 ~iG~G~f---G~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 12 RIGEGSF---GVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp EEEECSS---CEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEecCCC---eEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 3788998 8999999999999999999865432 2346778899999975 89999999999999999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC-----CCCeEEeecceeeeecc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE-----EGHAHITDFNIATVLEE 155 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~-----~~~~~l~d~~~~~~~~~ 155 (246)
+++|.+.+.... ..++..++..++.|++.+|++||+.|++||||||+||+++. ++.++++|||+++....
T Consensus 84 -~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 84 -GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp -CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred -CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 789998886543 23589999999999999999999999999999999999974 56799999999988653
Q ss_pred Cc--------cccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH-HHhhhcC--
Q psy7592 156 NQ--------LATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKD-VKAIIYS-- 224 (246)
Q Consensus 156 ~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~-~~~~~~~-- 224 (246)
.. ......||+.|+|||.+.+.. +++++|+||||+++|+|++|..||.+........ ...+...
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-----~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGRE-----QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-----CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCC-----CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 32 122356899999999998764 8899999999999999999999998765544322 2222211
Q ss_pred ---CCCCCCCCCHhHHHHHHHhhh
Q psy7592 225 ---PVHYPTAWSESTKHLLSQVHR 245 (246)
Q Consensus 225 ---~~~~~~~~s~~l~~li~~~l~ 245 (246)
...++..+|+++.++++.|++
T Consensus 234 ~~~~~~l~~~~p~~l~~ii~~~~~ 257 (293)
T d1csna_ 234 STPLRELCAGFPEEFYKYMHYARN 257 (293)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHH
T ss_pred CCChHHhcCCCCHHHHHHHHHHhc
Confidence 122346789999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=286.53 Aligned_cols=193 Identities=23% Similarity=0.362 Sum_probs=155.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeee------CCeEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQD------EEDLFM 75 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~~ 75 (246)
.||+|+| |+||+|+++.+|+.||||+++.... +.....++.+|+.++++++||||++++++|.. ....|+
T Consensus 24 ~LG~G~f---g~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~i 99 (355)
T d2b1pa1 24 PIGSGAQ---GIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99 (355)
T ss_dssp ECSCC-----CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EeecCcC---eEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEE
Confidence 4788888 9999999999999999999987553 44556788999999999999999999999963 367899
Q ss_pred EEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeecc
Q psy7592 76 VSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEE 155 (246)
Q Consensus 76 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (246)
||||+.++.+. .+.. .+++..++.++.|++.|+.|||+.|++|+||||+||+++.++.++++|||.+.....
T Consensus 100 v~Ey~~~~l~~-~~~~-------~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 100 VMELMDANLCQ-VIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp EEECCSEEHHH-HHTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeccchHHHH-hhhc-------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 99999665554 3322 248999999999999999999999999999999999999999999999999887766
Q ss_pred CccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 156 NQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
........+++.|+|||.+.+.. +++++||||+||++++|++|+.||.+.+
T Consensus 172 ~~~~~~~~~t~~y~aPE~l~~~~-----~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 172 SFMMTPYVVTRYYRAPEVILGMG-----YKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp ---------CCTTCCHHHHTTCC-----CCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccccccccChhhhcCCC-----CCCCcccccccchHHHHhhCCCCCCCCC
Confidence 66666677899999999997754 8889999999999999999999997543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-43 Score=285.29 Aligned_cols=194 Identities=26% Similarity=0.417 Sum_probs=160.6
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeC-----CeEEEE
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDE-----EDLFMV 76 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v 76 (246)
.||+|+| |+||+|+++.+|+.||||++.... .+....+++.+|++++++++||||+++++++... ...+++
T Consensus 25 ~LG~G~f---g~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i 100 (348)
T d2gfsa1 25 PVGSGAY---GSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 100 (348)
T ss_dssp ECGGGTT---SSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEecCCC---eEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEE
Confidence 3788888 999999999999999999997654 3344557788999999999999999999998632 334566
Q ss_pred EeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEeecceeeeeccC
Q psy7592 77 SDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITDFNIATVLEEN 156 (246)
Q Consensus 77 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (246)
++++.|++|.+++... ++++..++.++.|++.||+|||+.|++||||||+||+++.++.++++|||.+.....
T Consensus 101 ~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 101 VTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp EEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred EEeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence 7777899999988543 359999999999999999999999999999999999999999999999999875433
Q ss_pred ccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7592 157 QLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHS 211 (246)
Q Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 211 (246)
......+++.|+|||...+.. .++.++|+||||+++|+|++|+.||.+.+
T Consensus 174 -~~~~~~g~~~y~apE~~~~~~----~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 174 -EMTGYVATRWYRAPEIMLNWM----HYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp -GGSSSCHHHHTSCHHHHTTCS----CCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -ccccccccccccCchhhcCCc----cCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 334456788899999876554 36789999999999999999999997544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-42 Score=275.60 Aligned_cols=227 Identities=20% Similarity=0.222 Sum_probs=176.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcc-eeeeeeeeeCCeEEEEEeec
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFL-VNLWFCFQDEEDLFMVSDLL 80 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~v~e~~ 80 (246)
.||+|+| |+||+|+++.+|+.||||.+..... .+++..|++++++++|+++ +.+..++.++...++|||++
T Consensus 14 ~iG~G~f---G~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 14 KIGSGSF---GDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp EEEECSS---SEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEeeCCC---cEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 3788888 9999999999999999999876532 1347789999999987665 55566677888999999999
Q ss_pred CCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC---CCCeEEeecceeeeeccCc
Q psy7592 81 LGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDE---EGHAHITDFNIATVLEENQ 157 (246)
Q Consensus 81 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~---~~~~~l~d~~~~~~~~~~~ 157 (246)
++++.+.+... ...+++..+..++.|++.||+|||++|++||||||+||+++. +..++++|||+++......
T Consensus 86 -~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 86 -GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred -CCchhhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 66666665442 234599999999999999999999999999999999999863 4479999999998875432
Q ss_pred c--------ccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH-HHhhhc-----
Q psy7592 158 L--------ATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIHSNTSVKD-VKAIIY----- 223 (246)
Q Consensus 158 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~-~~~~~~----- 223 (246)
. .....+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||.......... ......
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIE-----QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBC-----CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred cccceeccccCCcCCCccccCHHHHhCCC-----CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 1 23356899999999998765 8899999999999999999999997655433221 111111
Q ss_pred CCCCCCCCCCHhHHHHHHHhhhC
Q psy7592 224 SPVHYPTAWSESTKHLLSQVHRY 246 (246)
Q Consensus 224 ~~~~~~~~~s~~l~~li~~~l~~ 246 (246)
.....+..+|+++.++|+.||++
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~ 258 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSL 258 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHS
T ss_pred ChhHhccCCCHHHHHHHHHHccC
Confidence 12223468999999999999964
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-42 Score=271.81 Aligned_cols=229 Identities=21% Similarity=0.288 Sum_probs=171.1
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcceeeeeeeeeCC----eEEEEEe
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLVNLWFCFQDEE----DLFMVSD 78 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~v~e 78 (246)
||+|+| |+||+++. +|+.||||+++.... .......|+..+.+++||||+++++++.+++ ..++|||
T Consensus 11 iG~G~f---g~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 11 IGKGRF---GEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EECCSS---SEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EeeCCC---eEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 799999 89999987 689999999965431 1122234666667889999999999998653 5899999
Q ss_pred ecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH--------CCcccCCCCCCcEEEcCCCCeEEeeccee
Q psy7592 79 LLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT--------KHIIHRDIKPDNILLDEEGHAHITDFNIA 150 (246)
Q Consensus 79 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~--------~~~~h~~i~~~nil~~~~~~~~l~d~~~~ 150 (246)
|+++++|.+++.+. +++++.+..++.|++.++.|+|+ .|++|+||||+||+++.++.+||+|||++
T Consensus 82 y~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp CCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999764 24889999999999999999997 58999999999999999999999999999
Q ss_pred eeeccCc-----cccccccCCCccCCceeccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------------
Q psy7592 151 TVLEENQ-----LATSMSGTKPYIAPEIFLVATDEV-LGYSYSVDWWSLGVTLFEILARGRPFDIHSN------------ 212 (246)
Q Consensus 151 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~------------ 212 (246)
....... ......+++.|+|||++.+..... ..++.++||||||+++|+|++|..||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 8875432 223456899999999986542110 1146789999999999999999887643221
Q ss_pred ccHHHHHhhhcC---CCCCCCCC-----CHhHHHHHHHhhhC
Q psy7592 213 TSVKDVKAIIYS---PVHYPTAW-----SESTKHLLSQVHRY 246 (246)
Q Consensus 213 ~~~~~~~~~~~~---~~~~~~~~-----s~~l~~li~~~l~~ 246 (246)
............ .+.+|..+ +..+.+|+.+||+.
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~ 277 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCS
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHccc
Confidence 112222222222 22333332 34588999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-36 Score=245.87 Aligned_cols=193 Identities=23% Similarity=0.327 Sum_probs=150.1
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-----------CCcceeeeeeeee-
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-----------HPFLVNLWFCFQD- 69 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~- 69 (246)
.||+|+| |+||+|+++.+|+.||||++++.. ...+.+.+|+++++.++ |+||+++++++..
T Consensus 20 ~LG~G~f---g~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 20 KLGWGHF---STVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp EEEECSS---EEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred EEeeCCC---eEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 3678888 999999999999999999998753 23356677888887775 5789999988864
Q ss_pred -CCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCC------
Q psy7592 70 -EEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKT-KHIIHRDIKPDNILLDEEGH------ 141 (246)
Q Consensus 70 -~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~-~~~~h~~i~~~nil~~~~~~------ 141 (246)
....++++++.............. .....++..++.++.|++.|+.|||+ .|++||||||+||+++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 345666666664443332222211 23345889999999999999999998 89999999999999986654
Q ss_pred eEEeecceeeeeccCccccccccCCCccCCceecccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7592 142 AHITDFNIATVLEENQLATSMSGTKPYIAPEIFLVATDEVLGYSYSVDWWSLGVTLFEILARGRPFDIH 210 (246)
Q Consensus 142 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 210 (246)
++++|||.+..... ......+++.|+|||.+.+.. +++++|+||+|+++++|++|+.||...
T Consensus 171 ~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 171 IKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-----WGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-----CCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eeEeeccccccccc--ccccccccccccChhhccccC-----CCccccccchHHHHHHHHHCCCCCCCC
Confidence 89999999876543 334466888999999988664 788999999999999999999999644
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1.5e-24 Score=160.79 Aligned_cols=132 Identities=17% Similarity=0.152 Sum_probs=102.2
Q ss_pred CcCCCCccCeeeEEEEEecCCCcEEEEEEeecccc---------------chHHHHHHHHHHHHHHhhCCCCcceeeeee
Q psy7592 2 FCGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQC---------------IERDALKNVLREMEILTTLEHPFLVNLWFC 66 (246)
Q Consensus 2 ~lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 66 (246)
.||+|++ |+||+|++. +|+.||||+++.... ...........|+..+.++.|.+++..+++
T Consensus 7 ~IG~G~~---g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 7 LMGEGKE---SAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEECSS---EEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred EeeeCcc---eEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 3788999 999999985 799999998764211 011122345578999999999999888765
Q ss_pred eeeCCeEEEEEeecCCCChHHHHhhccccccCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEee
Q psy7592 67 FQDEEDLFMVSDLLLGGDLRYHITQDIKFYSVGTRNDTIHLYAFELGLALDYLKTKHIIHRDIKPDNILLDEEGHAHITD 146 (246)
Q Consensus 67 ~~~~~~~~~v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~Lh~~~~~h~~i~~~nil~~~~~~~~l~d 146 (246)
. . .+++||++++..+.. ++......++.|++.++.+||+.|++|+||||+||+++++ .++++|
T Consensus 83 ~--~--~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E--G--NAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E--T--TEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECC
T ss_pred c--C--CEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEE
Confidence 3 2 378999997765432 2555577889999999999999999999999999999865 488999
Q ss_pred cceeeeec
Q psy7592 147 FNIATVLE 154 (246)
Q Consensus 147 ~~~~~~~~ 154 (246)
||.+....
T Consensus 146 FG~a~~~~ 153 (191)
T d1zara2 146 FPQSVEVG 153 (191)
T ss_dssp CTTCEETT
T ss_pred CCCcccCC
Confidence 99987654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.50 E-value=6.5e-07 Score=67.63 Aligned_cols=72 Identities=13% Similarity=-0.035 Sum_probs=50.0
Q ss_pred eeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeecCCCChHHH
Q psy7592 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLLLGGDLRYH 88 (246)
Q Consensus 12 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~sL~~~ 88 (246)
+.||++.. +++.+++|......... ...+.+|+..+..+. +--+.+++.+..+++..++||++++|.++...
T Consensus 28 ~~v~rv~~--~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 28 AKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp SEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred CcEEEEEe--CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 57898864 57778889876543222 234556777777663 33356777888888889999999998877544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.36 E-value=1.3e-06 Score=70.10 Aligned_cols=77 Identities=14% Similarity=0.148 Sum_probs=44.1
Q ss_pred cCCCCccCeeeEEEEEecCCCcEEEEEEeeccccc----hHHHHHHHHHHHHHHhhCC-C-C-cceeeeeeeeeCCeEEE
Q psy7592 3 CGSSKFCGTSKVCIVQKKDTKQMYAMKYMHKSQCI----ERDALKNVLREMEILTTLE-H-P-FLVNLWFCFQDEEDLFM 75 (246)
Q Consensus 3 lg~g~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~e~~~l~~l~-h-~-~iv~~~~~~~~~~~~~~ 75 (246)
||.|.. ..||++.+..+++.|++|...+.... .+....+...|++.++.+. + | .+++++.+ ++...++
T Consensus 34 ig~G~~---N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 34 IGDGNL---NYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp CCSSSS---EEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred eCCCce---EeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 466666 89999998878889999975432100 0111234456777777662 2 3 34455543 4445678
Q ss_pred EEeecCCCC
Q psy7592 76 VSDLLLGGD 84 (246)
Q Consensus 76 v~e~~~~~s 84 (246)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.20 E-value=3.9e-06 Score=62.84 Aligned_cols=68 Identities=12% Similarity=0.067 Sum_probs=47.8
Q ss_pred eeEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCC--cceeeeeeeeeCCeEEEEEeecCCCChH
Q psy7592 12 SKVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHP--FLVNLWFCFQDEEDLFMVSDLLLGGDLR 86 (246)
Q Consensus 12 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~~v~e~~~~~sL~ 86 (246)
..||++... ++..+++|....... ..+..|+..++.+... .+.+++.+..+++..+++|++++|.++.
T Consensus 25 ~~v~r~~~~-~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 25 AAVFRLSAQ-GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CEEEEEECT-TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CeEEEEEeC-CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 468998864 577788998765432 2356677777766432 3566777777888889999999877653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.44 E-value=0.00074 Score=52.12 Aligned_cols=67 Identities=13% Similarity=0.169 Sum_probs=43.2
Q ss_pred eEEEEEecCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCCCCcce--eee-----eeeeeCCeEEEEEeecCCCC
Q psy7592 13 KVCIVQKKDTKQMYAMKYMHKSQCIERDALKNVLREMEILTTLEHPFLV--NLW-----FCFQDEEDLFMVSDLLLGGD 84 (246)
Q Consensus 13 ~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv--~~~-----~~~~~~~~~~~v~e~~~~~s 84 (246)
.||+++.. +|+.|++|+.++... + .+++..|++.+..|...++. ... ..+..+...+.++++..|..
T Consensus 37 ~vy~v~~~-dg~~~VlK~~rp~~~-s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 37 RVYQFQDE-DRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp EEEEECCT-TCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred eeEEEEcC-CCCEEEEEEeCCCCC-C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 79999874 789999999987643 2 24566678877777433322 111 22234556788898887644
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.84 E-value=0.0034 Score=49.62 Aligned_cols=66 Identities=11% Similarity=0.143 Sum_probs=41.6
Q ss_pred eeEEEEEecC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhhCC-CCcceeeeeeeeeCCeEEEEEeecCCC
Q psy7592 12 SKVCIVQKKD-------TKQMYAMKYMHKSQCIERDALKNVLREMEILTTLE-HPFLVNLWFCFQDEEDLFMVSDLLLGG 83 (246)
Q Consensus 12 ~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~ 83 (246)
-.+|++.... ..+.|.+++.-... . .-...+|..+++.+. +.-..+++.++.+ ..|+||++|.
T Consensus 56 N~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~ 126 (395)
T d1nw1a_ 56 NMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSR 126 (395)
T ss_dssp EEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEE
T ss_pred cceEEEEeCCCCccccCCCCcEEEEecCCcc----h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccc
Confidence 5899988753 24567777764321 1 124556888888884 4334567777643 5789999876
Q ss_pred ChH
Q psy7592 84 DLR 86 (246)
Q Consensus 84 sL~ 86 (246)
++.
T Consensus 127 ~l~ 129 (395)
T d1nw1a_ 127 PLS 129 (395)
T ss_dssp ECC
T ss_pred cCC
Confidence 543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.68 E-value=0.0045 Score=47.16 Aligned_cols=31 Identities=26% Similarity=0.414 Sum_probs=27.4
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEeecceeee
Q psy7592 122 KHIIHRDIKPDNILLDEEGHAHITDFNIATV 152 (246)
Q Consensus 122 ~~~~h~~i~~~nil~~~~~~~~l~d~~~~~~ 152 (246)
.|++|+|+.++|++++.+....+.||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 3699999999999999887779999998765
|